PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hrdinka, M; Draber, P; Stepanek, O; Ormsby, T; Otahal, P; Angelisova, P; Brdicka, T; Paces, J; Horejsi, V; Drbal, K				Hrdinka, Matous; Draber, Peter; Stepanek, Ondrej; Ormsby, Tereza; Otahal, Pavel; Angelisova, Pavla; Brdicka, Tomas; Paces, Jan; Horejsi, Vaclav; Drbal, Karel			PRR7 Is a Transmembrane Adaptor Protein Expressed in Activated T Cells Involved in Regulation of T Cell Receptor Signaling and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; MEMBRANE MICRODOMAINS; B-CELL; LAT; BINDS; IDENTIFICATION; LYMPHOCYTES; MOLECULE; PROMOTER; FAMILIES	Transmembrane adaptor proteins (TRAPs) are important organizers and regulators of immunoreceptor-mediated signaling. A bioinformatic search revealed several potential novel TRAPs, including a highly conserved protein, proline rich 7 (PRR7), previously described as a component of the PSD-95/N-methyl-D-aspartate receptor protein complex in postsynaptic densities (PSD) of rat neurons. Our data demonstrate that PRR7 is weakly expressed in other tissues but is readily up-regulated in activated human peripheral blood lymphocytes. Transient overexpression of PRR7 in Jurkat T cell line led to gradual apoptotic death dependent on the WW domain binding motif surrounding Tyr-166 in the intracellular part of PRR7. To circumvent the pro-apoptotic effect of PRR7, we generated Jurkat clones with inducible expression of PRR7 (J-iPRR7). In these cells acute induction of PRR7 expression had a dual effect. It resulted in up-regulation of the transcription factor c-Jun and the activation marker CD69 as well as enhanced production of IL-2 after phorbol 12-myristate 13-acetate (PMA) and ionomycin treatment. On the other hand, expression of PRR7 inhibited general tyrosine phosphorylation and calcium influx after T cell receptor cross-linking by antibodies. Moreover, we found PRR7 constitutively tyrosine-phosphorylated and associated with Src. Collectively, these data indicate that PRR7 is a potential regulator of signaling and apoptosis in activated T cells.	[Hrdinka, Matous; Draber, Peter; Stepanek, Ondrej; Ormsby, Tereza; Otahal, Pavel; Angelisova, Pavla; Brdicka, Tomas; Paces, Jan; Horejsi, Vaclav; Drbal, Karel] Acad Sci Czech Republic, Inst Mol Genet, CR-14220 Prague 4, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Drbal, K (corresponding author), Videnska 1083, CZ-14220 Prague 4, Czech Republic.	drbal@img.cas.cz	Draber, Peter/G-3141-2014; Hrdinka, Matous/B-9187-2011; Stepanek, Ondrej/F-8882-2013; Pačes, Jan/C-8851-2009; Horejsi, Vaclav/G-3113-2014; Brdicka, Tomas/G-6205-2014; Otahal, Pavel/G-3153-2014; Angelisova, Pavla/G-3131-2014; Ormsby, Tereza/O-3854-2018; Stepanek, Ondrej/AAG-3180-2020; Drbal, Karel/G-9329-2011	Draber, Peter/0000-0001-8658-4614; Hrdinka, Matous/0000-0002-2981-2825; Stepanek, Ondrej/0000-0002-2735-3311; Pačes, Jan/0000-0003-3059-6127; Horejsi, Vaclav/0000-0003-4925-0142; Brdicka, Tomas/0000-0002-1560-4398; Ormsby, Tereza/0000-0002-2953-9208; Stepanek, Ondrej/0000-0002-2735-3311; Drbal, Karel/0000-0003-4450-4625; Otahal, Pavel/0000-0002-5513-4159	Academy of Sciences of the Czech Republic [AV0Z50520514]; GACR [MEM/09/E011]; Center of Molecular and Cellular Immunology (Ministry of Education, Youth, and Sports of the Czech Republic) [1M0506]; Faculty of Science, Charles University in Prague	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); GACR(Grant Agency of the Czech Republic); Center of Molecular and Cellular Immunology (Ministry of Education, Youth, and Sports of the Czech Republic)(Ministry of Education, Youth & Sports - Czech Republic); Faculty of Science, Charles University in Prague	This work was supported in part by Academy of Sciences of the Czech Republic Project AV0Z50520514, GACR (Project MEM/09/E011), and by the Center of Molecular and Cellular Immunology (Project 1M0506, Ministry of Education, Youth, and Sports of the Czech Republic).; Supported in part by the Faculty of Science, Charles University in Prague.	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brannetti B, 2003, NUCLEIC ACIDS RES, V31, P3709, DOI 10.1093/nar/gkg592; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brdicka T, 1998, BIOCHEM BIOPH RES CO, V248, P356, DOI 10.1006/bbrc.1998.8857; Brdickova N, 2003, J EXP MED, V198, P1453, DOI 10.1084/jem.20031484; Bruyns E, 1998, J EXP MED, V188, P561, DOI 10.1084/jem.188.3.561; Castellanos MD, 1997, J IMMUNOL, V159, P5463; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FRASER JD, 1989, P NATL ACAD SCI USA, V86, P7133, DOI 10.1073/pnas.86.18.7133; Fuller DM, 2009, IMMUNOL REV, V232, P72, DOI 10.1111/j.1600-065X.2009.00828.x; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Horejsi V, 2004, IMMUNOL LETT, V92, P43, DOI 10.1016/j.imlet.2003.10.013; Horejsi V, 2010, FEBS J, V277, P4383, DOI 10.1111/j.1742-4658.2010.07831.x; Hur EM, 2003, J EXP MED, V198, P1463, DOI 10.1084/jem.20030232; JADOT M, 1992, J BIOL CHEM, V267, P11069; JAIN J, 1992, J IMMUNOL, V148, P1240; Janssen E, 2003, NAT IMMUNOL, V4, P117, DOI 10.1038/ni882; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Koelsch U, 2008, J IMMUNOL, V181, P5930, DOI 10.4049/jimmunol.181.9.5930; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lessard J, 2007, PROSTATE, V67, P808, DOI 10.1002/pros.20559; Liu Y, 2008, J LEUKOCYTE BIOL, V84, P842, DOI 10.1189/jlb.0208087; Marie-Cardine A, 1999, J EXP MED, V189, P1181, DOI 10.1084/jem.189.8.1181; Murata Y, 2005, BIOCHEM BIOPH RES CO, V327, P183, DOI 10.1016/j.bbrc.2004.11.154; Otahal P, 2010, J IMMUNOL, V184, P3689, DOI 10.4049/jimmunol.0902075; QIAO L, 1991, GASTROENTEROLOGY, V101, P1529, DOI 10.1016/0016-5085(91)90388-2; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Round JL, 2005, J EXP MED, V201, P419, DOI 10.1084/jem.20041428; Saras J, 1996, TRENDS BIOCHEM SCI, V21, P455, DOI 10.1016/S0968-0004(96)30044-3; Simeoni L, 2004, CURR OPIN IMMUNOL, V16, P304, DOI 10.1016/j.coi.2004.03.001; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhu MH, 2002, J BIOL CHEM, V277, P46151, DOI 10.1074/jbc.M208946200	37	11	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19617	19629		10.1074/jbc.M110.175117	http://dx.doi.org/10.1074/jbc.M110.175117			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21460222	hybrid, Green Published			2022-12-27	WOS:000291027700045
J	Sasaki, J; Tsai, AI; Spudich, JL				Sasaki, Jun; Tsai, Ah-Iim; Spudich, John L.			Opposite Displacement of Helix F in Attractant and Repellent Signaling by Sensory Rhodopsin-Htr Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON TRANSLOCATION; MOLECULAR-MECHANISM; TRANSDUCER PROTEIN; STRUCTURAL-CHANGES; N INTERMEDIATE; TRANSPORT; PHARAONIS; BACTERIORHODOPSIN; INSIGHTS; RECEPTOR	Two forms of the phototaxis receptor sensory rhodopsin I distinguished by differences in its photoactive site have been shown to be directly correlated with attractant and repellent signaling by the dual-signaling protein. In prior studies, differences in the photoactive site defined the two forms, namely the direction of light-induced proton transfer from the chromophore and the pK(a) of an Asp counterion to the protonated chromophore. Here, we show by both in vivo and in vitro measurements that the two forms are distinct protein conformers with structural similarities to two conformers seen in the light-driven proton transport cycle of the related protein bacteriorhodopsin. Measurements of spontaneous cell motility reversal frequencies, an in vivo measure of histidine kinase activity in the phototaxis system, indicate that the two forms are a photointerconvertible pair, with one conformer activating and the other inhibiting the kinase. Protein conformational changes in these photoconversions monitored by site-directed spin labeling show that opposite structural changes in helix F, distant from the photoactive site, correspond to the opposite phototaxis signals. The results provide the first direct evidence that displacements of helix F are directly correlated with signaling and impact our understanding of the sensory rhodopsin I signaling mechanism and the evolution of diverse functionality in this protein family.	[Sasaki, Jun; Spudich, John L.] Univ Texas Houston, Sch Med, Ctr Membrane Biol, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Tsai, Ah-Iim] Univ Texas Houston, Sch Med, Div Hematol, Dept Internal Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Spudich, JL (corresponding author), 6431 Fannin St, Houston, TX 77030 USA.	John.L.Spudich@uth.tmc.edu			National Institutes of Health [R37GM27750, RO1HL095820]; Department of Energy [DE-FG02-07ER15867]; Robert A. Welch Foundation [AU-0009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37GM27750 (to J. L. S.) and Grant RO1HL095820 (to A.-L. T.). This work was also supported by Department of Energy Grant DE-FG02-07ER15867 and Endowed Chair AU-0009 from the Robert A. Welch Foundation (to J. L. S.).	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Bergo V, 2000, BIOCHEMISTRY-US, V39, P2823, DOI 10.1021/bi991676d; BOGOMOLNI RA, 1994, P NATL ACAD SCI USA, V91, P10188, DOI 10.1073/pnas.91.21.10188; Chen XP, 2002, BIOCHEMISTRY-US, V41, P3891, DOI 10.1021/bi015966h; Chizhov I, 1998, BIOPHYS J, V75, P999, DOI 10.1016/S0006-3495(98)77588-5; Dioumaev AK, 1998, BIOCHEMISTRY-US, V37, P9889, DOI 10.1021/bi980934o; Furutani Y, 2008, BIOCHEMISTRY-US, V47, P2875, DOI 10.1021/bi702050c; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; Inoue K, 2007, BIOPHYS J, V92, P2028, DOI 10.1529/biophysj.106.097493; Jung KH, 1998, J BACTERIOL, V180, P2033, DOI 10.1128/JB.180.8.2033-2042.1998; Jung KH, 2007, PHOTOCHEM PHOTOBIOL, V83, P63, DOI 10.1562/2006-03-20-IR-853; Kamikubo H, 1996, P NATL ACAD SCI USA, V93, P1386, DOI 10.1073/pnas.93.4.1386; Kamo N, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1277, DOI 10.1023/A:1013187403599; Klare Johann P., 2008, V45, P73, DOI 10.1007/400_2007_041; Klare JP, 2004, FEBS LETT, V564, P219, DOI 10.1016/S0014-5793(04)00193-0; LANYI JK, 1990, PHYSIOL REV, V70, P319, DOI 10.1152/physrev.1990.70.2.319; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; OESTERHELT D, 1992, J BIOENERG BIOMEMBR, V24, P181, DOI 10.1007/BF00762676; Rath P, 1996, BIOCHEMISTRY-US, V35, P6690, DOI 10.1021/bi9600355; RUDOLPH J, 1995, EMBO J, V14, P667, DOI 10.1002/j.1460-2075.1995.tb07045.x; Sasaki J, 2000, BBA-BIOENERGETICS, V1460, P230, DOI 10.1016/S0005-2728(00)00142-0; Sasaki J, 1998, BIOPHYS J, V75, P2435, DOI 10.1016/S0006-3495(98)77687-8; Sasaki J, 2008, PHOTOCHEM PHOTOBIOL, V84, P863, DOI 10.1111/j.1751-1097.2008.00314.x; Sasaki J, 2007, MOL MICROBIOL, V66, P1321, DOI 10.1111/j.1365-2958.2007.05983.x; Sasaki J, 2007, BIOPHYS J, V92, P4045, DOI 10.1529/biophysj.106.101121; Sasaki J, 2011, BIOPHYS J, V100, P2178, DOI 10.1016/j.bpj.2011.03.026; Schmies G, 2001, P NATL ACAD SCI USA, V98, P1555, DOI 10.1073/pnas.031562298; Shibata M, 2010, NAT NANOTECHNOL, V5, P208, DOI [10.1038/NNANO.2010.7, 10.1038/nnano.2010.7]; Sineshchekov OA, 2004, PHOTOCH PHOTOBIO SCI, V3, P548, DOI 10.1039/b316207a; Sineshchekov OA, 2008, P NATL ACAD SCI USA, V105, P16159, DOI 10.1073/pnas.0807486105; Sineshchekov OA, 2010, BIOCHEMISTRY-US, V49, P6696, DOI 10.1021/bi100798w; Spudich EN, 1997, P NATL ACAD SCI USA, V94, P4960, DOI 10.1073/pnas.94.10.4960; SPUDICH JL, 1988, ANNU REV BIOPHYS BIO, V17, P193; SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; Sudo Y, 2001, BIOPHYS J, V80, P916, DOI 10.1016/S0006-3495(01)76070-5; Sudo Y, 2006, P NATL ACAD SCI USA, V103, P16129, DOI 10.1073/pnas.0607467103; Sudo Y, 2006, J BIOL CHEM, V281, P34239, DOI 10.1074/jbc.M605907200; Trivedi VD, 2003, BIOCHEMISTRY-US, V42, P13887, DOI 10.1021/bi034399q; Vonck J, 1996, BIOCHEMISTRY-US, V35, P5870, DOI 10.1021/bi952663c; Wegener AA, 2000, J MOL BIOL, V301, P881, DOI 10.1006/jmbi.2000.4008; Wegener AA, 2001, EMBO J, V20, P5312, DOI 10.1093/emboj/20.19.5312; Xiao WZ, 2000, J MOL BIOL, V304, P715, DOI 10.1006/jmbi.2000.4255; YAN B, 1991, P NATL ACAD SCI USA, V88, P9412, DOI 10.1073/pnas.88.21.9412	50	6	6	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18868	18877		10.1074/jbc.M110.200345	http://dx.doi.org/10.1074/jbc.M110.200345			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454480	Green Published, hybrid			2022-12-27	WOS:000290785700059
J	Wang, LX; Nomura, M; Goto, Y; Tanaka, K; Sakamoto, R; Abe, I; Sakamoto, S; Shibata, A; Enciso, PLM; Adachi, M; Ohnaka, K; Kawate, H; Takayanagi, R				Wang, Lixiang; Nomura, Masatoshi; Goto, Yutaka; Tanaka, Kimitaka; Sakamoto, Ryuichi; Abe, Ichiro; Sakamoto, Shohei; Shibata, Atsushi; Enciso, Patricio L. M.; Adachi, Masahiro; Ohnaka, Keizo; Kawate, Hisaya; Takayanagi, Ryoichi			Smad2 Protein Disruption in the Central Nervous System Leads to Aberrant Cerebellar Development and Early Postnatal Ataxia in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BETA-S; GROWTH-FACTOR; TRANSFORMING GROWTH-FACTOR-BETA-1; PROGRESSIVE CEREBELLAR; ALZHEIMERS-DISEASE; GRANULE NEURONS; IN-VITRO; EXPRESSION; RAT; PROLIFERATION	Smad2 is a critical mediator of TGF-beta signals that are known to play an important role in a wide range of biological processes in various cell types. Its role in the development of the CNS, however, is largely unknown. Mice lacking Smad2 in the CNS (Smad2-CNS-KO) were generated by a Cre-loxP approach. These mice exhibited behavioral abnormalities in motor coordination from an early postnatal stage and mortality at approximately 3 weeks of age, suggestive of severe cerebellar dysfunction. Gross observation of Smad2-CNS-KO cerebella demonstrated aberrant foliations in lobule IX and X. Further analyses revealed increased apoptotic cell death, delayed migration and maturation of granule cells, and retardation of dendritic arborization of Purkinje cells. These findings indicate that Smad2 plays a key role in cerebellar development and motor function control.	[Wang, Lixiang; Nomura, Masatoshi; Goto, Yutaka; Tanaka, Kimitaka; Sakamoto, Ryuichi; Abe, Ichiro; Sakamoto, Shohei; Shibata, Atsushi; Enciso, Patricio L. M.; Adachi, Masahiro; Ohnaka, Keizo; Kawate, Hisaya; Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Nomura, M (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	nomura@med.kyushu-u.ac.jp	Tanaka, Kimitaka/AAN-1479-2021	Tanaka, Kimitaka/0000-0001-9899-4581; Shibata, Atsushi/0000-0003-4521-8962	Ministry of Education, Science, Sports, and Culture (Japan)	Ministry of Education, Science, Sports, and Culture (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture (Japan).	Abe K, 1996, BRAIN RES, V723, P206, DOI 10.1016/0006-8993(96)00253-3; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; Bottner M, 2000, J NEUROCHEM, V75, P2227, DOI 10.1046/j.1471-4159.2000.0752227.x; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.3.CO;2-E; Chalmers KA, 2007, J NEUROPATH EXP NEUR, V66, P1019, DOI 10.1097/nen.0b013e31815885ad; Chalmers KA, 2007, J NEUROPATH EXP NEUR, V66, P158, DOI 10.1097/nen.0b013e3180303b93; Clark HB, 1997, J NEUROSCI, V17, P7385; CONSTAM DB, 1994, EUR J NEUROSCI, V6, P766, DOI 10.1111/j.1460-9568.1994.tb00988.x; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Dunn NR, 2005, GENE DEV, V19, P152, DOI 10.1101/gad.1243205; Elvers M, 2005, MECH DEVELOP, V122, P587, DOI 10.1016/j.mod.2004.10.012; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Heyer J, 1999, P NATL ACAD SCI USA, V96, P12595, DOI 10.1073/pnas.96.22.12595; LABOURDETTE G, 1990, J CELL PHYSIOL, V144, P473, DOI 10.1002/jcp.1041440315; Lee HG, 2006, J NEUROSCI RES, V84, P1856, DOI 10.1002/jnr.21072; Lu J, 2005, DEVELOPMENT, V132, P3231, DOI 10.1242/dev.01893; Luo J, 2006, P NATL ACAD SCI USA, V103, P18326, DOI 10.1073/pnas.0605077103; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Oliver PL, 2007, BEHAV BRAIN RES, V181, P239, DOI 10.1016/j.bbr.2007.04.012; Rubino FA, 2002, NEUROLOGIST, V8, P254, DOI 10.1097/00127893-200207000-00005; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHOLL DA, 1953, J ANAT, V87, P387; Simon D, 2004, J NEUROSCI, V24, P1987, DOI 10.1523/JNEUROSCI.4549-03.2004; Stegmuller J, 2008, J NEUROSCI, V28, P1961, DOI 10.1523/JNEUROSCI.3061-07.2008; Takayama C, 2004, DEV BRAIN RES, V148, P169, DOI 10.1016/j.devbrainres.2003.11.007; Tanaka M, 2005, NEUROSCI LETT, V390, P182, DOI 10.1016/j.neulet.2005.08.017; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; TORUDELBAUFFE D, 1990, J NEUROCHEM, V54, P1056, DOI 10.1111/j.1471-4159.1990.tb02357.x; Ueberham U, 2006, EUR J NEUROSCI, V24, P2327, DOI 10.1111/j.1460-9568.2006.05109.x; Ueberham U, 2009, INT J DEV NEUROSCI, V27, P501, DOI 10.1016/j.ijdevneu.2009.04.001; Unsicker K, 2000, EUR J BIOCHEM, V267, P6972, DOI 10.1046/j.1432-1327.2000.01824.x; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Weinstein M, 2000, CYTOKINE GROWTH F R, V11, P49, DOI 10.1016/S1359-6101(99)00028-3; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Xing Y, 2010, J NEUROCHEM, V115, P1486, DOI 10.1111/j.1471-4159.2010.07053.x; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Zhou YX, 2003, J BIOL CHEM, V278, P42313, DOI 10.1074/jbc.M308287200	47	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18766	18774		10.1074/jbc.M111.223271	http://dx.doi.org/10.1074/jbc.M111.223271			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21464123	Green Published, hybrid			2022-12-27	WOS:000290785700049
J	LeNoue-Newton, M; Watkins, GR; Zou, P; Germane, KL; McCorvey, LR; Wadzinski, BE; Spiller, BW				LeNoue-Newton, Michele; Watkins, Guy R.; Zou, Ping; Germane, Katherine L.; McCorvey, Lisa R.; Wadzinski, Brian E.; Spiller, Benjamin W.			The E3 Ubiquitin Ligase- and Protein Phosphatase 2A (PP2A)-binding Domains of the Alpha4 Protein Are Both Required for Alpha4 to Inhibit PP2A Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; TPR DOMAIN; OPITZ-SYNDROME; BINDING; REGULATOR; COMPLEX; PHOSPHORYLATION; ASSOCIATION; MUTATIONS; SYSTEM	Protein phosphatase 2A (PP2A) is regulated through a variety of mechanisms, including post-translational modifications and association with regulatory proteins. Alpha4 is one such regulatory protein that binds the PP2A catalytic subunit (PP2Ac) and protects it from polyubiquitination and degradation. Alpha4 is a multidomain protein with a C-terminal domain that binds Mid1, a putative E3 ubiquitin ligase, and an N-terminal domain containing the PP2Ac-binding site. In this work, we present the structure of the N-terminal domain of mammalian Alpha4 determined by x-ray crystallography and use double electron-electron resonance spectroscopy to show that it is a flexible tetratricopeptide repeat-like protein. Structurally, Alpha4 differs from its yeast homolog, Tap42, in two important ways: 1) the position of the helix containing the PP2Ac-binding residues is in a more open conformation, showing flexibility in this region; and 2) Alpha4 contains a ubiquitin-interacting motif. The effects of wild-type and mutant Alpha4 on PP2Ac ubiquitination and stability were examined in mammalian cells by performing tandem ubiquitin-binding entity precipitations and cycloheximide chase experiments. Our results reveal that both the C-terminal Mid1-binding domain and the PP2Ac-binding determinants are required for Alpha4-mediated protection of PP2Ac from polyubiquitination and degradation.	[LeNoue-Newton, Michele; Watkins, Guy R.; McCorvey, Lisa R.; Wadzinski, Brian E.; Spiller, Benjamin W.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Germane, Katherine L.; Spiller, Benjamin W.] Vanderbilt Univ, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Zou, Ping] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Spiller, BW (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	benjamin.spiller@vanderbilt.edu		germane, katherine/0000-0002-5191-2670	National Institutes of Health [GM051366, DK070787, T32 GM07628]; American Cancer Society [IRG-58-009-49]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320, R56GM051366, R01GM051366, T32GM007628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG039947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM051366 and DK070787 (to B. E. W.) and T32 GM07628 (to M.L.-N. and G. R. W.). This work was also supported by American Cancer Society Grant IRG-58-009-49 (to B. W. S.).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Cliff MJ, 2005, J MOL BIOL, V346, P717, DOI 10.1016/j.jmb.2004.12.017; Smetana JHC, 2006, BBA-PROTEINS PROTEOM, V1764, P724, DOI 10.1016/j.bbapap.2006.01.018; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Fontanella B, 2008, HUM MUTAT, V29, P584, DOI 10.1002/humu.20706; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; GUO H, 1993, P NATL ACAD SCI USA, V90, P2500, DOI 10.1073/pnas.90.6.2500; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Kong M, 2007, J BIOL CHEM, V282, P29712, DOI 10.1074/jbc.M703159200; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Kowluru A, 2005, BIOCHEM PHARMACOL, V69, P1681, DOI 10.1016/j.bcp.2005.03.018; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Liu J, 2001, P NATL ACAD SCI USA, V98, P6650, DOI 10.1073/pnas.111154698; Liu Rong, 2009, Pathophysiology, V16, P273, DOI 10.1016/j.pathophys.2009.02.008; McConnell JL, 2007, ONCOGENE, V26, P6021, DOI 10.1038/sj.onc.1210406; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nanahoshi M, 1999, FEBS LETT, V446, P108, DOI 10.1016/S0014-5793(99)00189-1; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; Prickett TD, 2006, J BIOL CHEM, V281, P30503, DOI 10.1074/jbc.M601054200; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schweiger S, 2003, BIOESSAYS, V25, P356, DOI 10.1002/bies.10256; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Yang J, 2007, BIOCHEMISTRY-US, V46, P8807, DOI 10.1021/bi7007118; Zolnierowicz S, 2000, BIOCHEM PHARMACOL, V60, P1225, DOI 10.1016/S0006-2952(00)00424-X; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	49	40	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17665	17671		10.1074/jbc.M111.222414	http://dx.doi.org/10.1074/jbc.M111.222414			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454489	hybrid, Green Published			2022-12-27	WOS:000290585200030
J	Rock, K; Grandoch, M; Majora, M; Krutmann, J; Fischer, JW				Roeck, Katharina; Grandoch, Maria; Majora, Marc; Krutmann, Jean; Fischer, Jens W.			Collagen Fragments Inhibit Hyaluronan Synthesis in Skin Fibroblasts in Response to Ultraviolet B (UVB) NEW INSIGHTS INTO MECHANISMS OF MATRIX REMODELING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE-CELLS; BREAST-CANCER CELLS; NUCLEAR TRANSLOCATION; PROCOLLAGEN SYNTHESIS; DISACCHARIDE ANALYSIS; EXTRACELLULAR-MATRIX; ACTIN CYTOSKELETON; FOCAL ADHESIONS; RETINOIC ACID	UVB irradiation causes characteristic features of skin aging including remodeling of the dermal extracellular matrix. A key feature during this process is the up-regulation of matrix metalloproteinases and cleavage of collagen. Hyaluronic acid (HA), a major component of the dermal matrix, decreases after chronic UVB exposure. However, the factors that govern the decline of HA synthesis during the course of actinic aging are largely unknown. The aim of the present study was to explore whether collagen degradation causes inhibition of HA synthesis in human skin fibroblasts. After treatment of fibroblasts with collagen fragments (CF) in vitro, resolution of the actin cytoskeleton and inhibition of HA secretion occurred because of specific down-regulation of hyaluronan synthase 2 (HAS2) expression. The alpha(v)beta(3)-agonist, RGDS, latrunculin A, and an inhibitor of Rho-activated kinase inhibited HAS2 expression. Conversely, blocking antibodies to alpha(v)beta(3) abolished the down-regulation of HAS2 and the cytoskeletal effects. Furthermore, inhibition of cofilin phosphorylation in response to CF was prevented by alpha(v)beta(3)-blocking antibodies. The key role of ERK signaling was shown by reduced nuclear accumulation of phosphoERK and of ELK-1 phosphorylation in response to CF. In addition, the ERK inhibitor PD98059 reduced HAS2 expression. Also, UVB irradiation of fibroblasts caused down-regulation of HAS2, which was sensitive to matrix metalloproteinase inhibitors and to alpha(v)beta(3)-blocking antibodies. In conclusion, these data suggest that CF activate alpha(v)beta(3)-integrins and in turn inhibit Rho kinase (ROCK) signaling and nuclear translocation of phosphoERK, resulting in reduced HAS2 expression. Therefore, a novel mechanism is presented how proteolytic collagen cleavage may inhibit HA synthesis in dermal fibroblasts during extrinsic skin aging.	[Fischer, Jens W.] Univ Dusseldorf, Univ Klinikum Dusseldorf, Inst Pharmakol & Klin Pharmakol, D-40225 Dusseldorf, Germany; [Majora, Marc; Krutmann, Jean] Univ Dusseldorf, IUF Leibniz Inst Environm Med, D-40221 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF)	Fischer, JW (corresponding author), Univ Dusseldorf, Univ Klinikum Dusseldorf, Inst Pharmakol & Klin Pharmakol, Moorenstr 5, D-40225 Dusseldorf, Germany.	jens.fischer@uni-duesseldorf.de			Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Center (SFB) [TP C6, TP C1]	Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Center (SFB)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Center (SFB) 728 (Grants TP C6 and TP C1).	Ahmed M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-101; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Averbeck M, 2007, J INVEST DERMATOL, V127, P687, DOI 10.1038/sj.jid.5700614; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; BRULS WAG, 1984, PHOTOCHEM PHOTOBIOL, V39, P63, DOI 10.1111/j.1751-1097.1984.tb03405.x; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Carragher NO, 1999, J CELL BIOL, V147, P619, DOI 10.1083/jcb.147.3.619; Chen J, 2001, J BIOL CHEM, V276, P47901, DOI 10.1074/jbc.M107574200; Dai G, 2007, AM J PATHOL, V171, P1451, DOI 10.2353/ajpath.2007.070136; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; DAVIS GE, 1992, BIOCHEM BIOPH RES CO, V182, P1025, DOI 10.1016/0006-291X(92)91834-D; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; DEOLIVEIRA CA, 1988, LIFE SCI, V43, P1825, DOI 10.1016/0024-3205(88)90282-2; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Fligiel SEG, 2003, J INVEST DERMATOL, V120, P842, DOI 10.1046/j.1523-1747.2003.12148.x; GRIFFITHS CEM, 1993, NEW ENGL J MED, V329, P530, DOI 10.1056/NEJM199308193290803; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 1996, BIOCHEM BIOPH RES CO, V222, P816, DOI 10.1006/bbrc.1996.0827; Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200; Lee DY, 2008, J BONE MINER RES, V23, P1140, DOI 10.1359/JBMR.080302; Lipinski KV, 2006, CARDIOVASC RES, V69, P697, DOI 10.1016/j.cardiores.2005.08.005; Liu YL, 2004, CIRC RES, V95, P579, DOI 10.1161/01.RES.0000141428.53262.a4; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Majora M, 2009, AM J PATHOL, V175, P1019, DOI 10.2353/ajpath.2009.080832; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; Manuskiatti W, 1996, INT J DERMATOL, V35, P539, DOI 10.1111/j.1365-4362.1996.tb03650.x; Marchand-Brynaert J, 1999, BIOMATERIALS, V20, P1773, DOI 10.1016/S0142-9612(99)00072-1; Margelin D, 1996, J INVEST DERMATOL, V106, P505, DOI 10.1111/1523-1747.ep12343819; Masiero L, 1999, J CELL SCI, V112, P3205; MONTGOMERY AMP, 1994, P NATL ACAD SCI USA, V91, P8856, DOI 10.1073/pnas.91.19.8856; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Ortega-Velazquez R, 2003, FASEB J, V17, P1529, DOI 10.1096/fj.02-0785fje; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Putnam AJ, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-10; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Stuhlmeier KM, 2004, J BIOL CHEM, V279, P8753, DOI 10.1074/jbc.M303945200; Takahashi Y, 1996, J DERMATOL SCI, V11, P129, DOI 10.1016/0923-1811(95)00430-0; TAKAHASHI Y, 1995, J DERMATOL SCI, V10, P139, DOI 10.1016/0923-1811(95)00396-A; Tammi RH, 2009, J INVEST DERMATOL, V129, P1858, DOI 10.1038/jid.2009.91; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Twarock S, 2010, J BIOL CHEM, V285, P23274, DOI 10.1074/jbc.M109.093146; van Leeuwen FN, 2003, BIOCHEM SOC T, V31, P1209; Varani J, 2004, J INVEST DERMATOL, V122, P1471, DOI 10.1111/j.0022-202X.2004.22614.x; Varani J, 2002, J INVEST DERMATOL, V119, P122, DOI 10.1046/j.1523-1747.2002.01810.x; Varani J, 2001, AM J PATHOL, V158, P931, DOI 10.1016/S0002-9440(10)64040-0; Varani J, 2000, J INVEST DERMATOL, V114, P480, DOI 10.1046/j.1523-1747.2000.00902.x; Lipinski KV, 2006, CIRC RES, V98, P1490, DOI 10.1161/01.RES.0000229267.77982.0d; Weber AA, 2002, BRIT J HAEMATOL, V117, P424, DOI 10.1046/j.1365-2141.2002.03423.x; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wilkinson TS, 2004, AM J RESP CELL MOL, V31, P92, DOI 10.1165/rcmb.2003-0380OC; YONEDA M, 1988, J CELL SCI, V90, P265	57	64	67	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18268	18276		10.1074/jbc.M110.201665	http://dx.doi.org/10.1074/jbc.M110.201665			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454612	hybrid, Green Published			2022-12-27	WOS:000290585200087
J	Ding, SY; Nkobena, A; Kraft, CA; Markwardt, ML; Rizzo, MA				Ding, Shi-Ying; Nkobena, Andongfac; Kraft, Catherine A.; Markwardt, Michele L.; Rizzo, Mark A.			Glucagon-like Peptide 1 Stimulates Post-translational Activation of Glucokinase in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; INSULIN-SECRETION; S-NITROSYLATION; GLUCOSE; RECEPTOR; INTERNALIZATION; HYPOGLYCEMIA; MUTATIONS; DYNAMICS; CA2+	Glucagon-like peptide 1 (GLP-1) potentiates glucose-stimulated insulin secretion from pancreatic beta cells, yet does not directly stimulate secretion. The mechanisms underlying this phenomenon are incompletely understood. Here, we report that GLP-1 augments glucose-dependent rises in NAD(P)H autofluorescence in both beta TC3 insulinoma cells and islets in a manner consistent with post-translational activation of glucokinase (GCK). GLP-1 treatment increased GCK activity and enhanced GCK S-nitrosylation in beta TC3 cells. A 2-fold increase in S-nitrosylated GCK was also observed in mouse islets. Furthermore, GLP-1 activated a FRET-based GCK reporter in living cells. Activation of this reporter was sensitive to inhibition of nitricoxide synthase (NOS), and incorporating the S-nitrosylation-blocking V367M mutation into this sensor prevented activation by GLP-1. GLP-1 potentiation of the glucose-dependent increase in islet NAD(P)H autofluorescence was also sensitive to a NOS inhibitor, whereas NOS inhibition did not affect the response to glucose alone. Expression of the GCK(V367M) mutant also blocked GLP-1 potentiation of the NAD(P) H response to glucose in beta TC3 cells, but did not significantly affect metabolism of glucose in the absence of GLP-1. Co-expression of WT or mutant GCK proteins with a sensor for insulin secretory granule fusion also revealed that blockade of post-translational GCK S-nitrosylation diminished the effects of GLP-1 on granule exocytosis by similar to 40% in beta TC3 cells. These results suggest that post-translational activation of GCK is an important mechanism for mediating the insulinotropic effects of GLP-1.	[Ding, Shi-Ying; Nkobena, Andongfac; Kraft, Catherine A.; Markwardt, Michele L.; Rizzo, Mark A.] Univ Maryland, Dept Physiol, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Rizzo, MA (corresponding author), 660 W Redwood St,HH 525B, Baltimore, MD 21201 USA.	mrizz001@umaryland.edu			National Institutes of Health [R21-DK067415, R01-DK077140, DK077140-02S1, P60-DK079637, P30-DK072488]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079637, R21DK067415, P30DK072488, R01DK077140, P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R21-DK067415, R01-DK077140, and DK077140-02S1 (to M. A. R.) and P60-DK079637 and P30-DK072488.	Arden C, 2007, DIABETES, V56, P1773, DOI 10.2337/db06-1151; AXELROD D, 1981, J CELL BIOL, V89, P141, DOI 10.1083/jcb.89.1.141; Bennett BD, 1996, J BIOL CHEM, V271, P3647; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; DALESSIO DA, 1989, DIABETES, V38, P1534, DOI 10.2337/diabetes.38.12.1534; Davis EA, 1999, DIABETOLOGIA, V42, P1175, DOI 10.1007/s001250051289; Ding SY, 2010, MOL ENDOCRINOL, V24, P171, DOI 10.1210/me.2009-0138; GERMAN MS, 1993, P NATL ACAD SCI USA, V90, P1781, DOI 10.1073/pnas.90.5.1781; Gloyn AL, 2004, FRONT DIABETES, V16, P92; Gloyn AL, 2003, DIABETES, V52, P2433, DOI 10.2337/diabetes.52.9.2433; GOKE R, 1993, RES EXP MED, V193, P97, DOI 10.1007/BF02576216; Hao M, 2007, DIABETES, V56, P2328, DOI 10.2337/db07-0056; Henningsson R, 2002, AM J PHYSIOL-CELL PH, V283, pC296, DOI 10.1152/ajpcell.00537.2001; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kaneko Y, 2003, AM J PHYSIOL-CELL PH, V284, pC1215, DOI 10.1152/ajpcell.00223.2002; Kang GX, 2008, J PHYSIOL-LONDON, V586, P1307, DOI 10.1113/jphysiol.2007.143818; Kwan EP, 2005, DIABETES, V54, P2734, DOI 10.2337/diabetes.54.9.2734; Lajoix AD, 2001, DIABETES, V50, P1311, DOI 10.2337/diabetes.50.6.1311; Light PE, 2002, MOL ENDOCRINOL, V16, P2135, DOI 10.1210/me.2002-0084; Matschinsky FM, 1998, DIABETES, V47, P307, DOI 10.2337/diabetes.47.3.307; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; MEGLASSON MD, 1983, P NATL ACAD SCI-BIOL, V80, P85, DOI 10.1073/pnas.80.1.85; Mica OI, 2004, BIOCHEM J, V381, P13, DOI 10.1042/BJ20040434; Michael DJ, 2007, DIABETES, V56, P1277, DOI 10.2337/db06-0367; Michael DJ, 2004, BIOPHYS J, V87, pL3, DOI 10.1529/biophysj.104.052175; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; Peyot ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006221; Rizzo MA, 2003, J CELL BIOL, V161, P243, DOI 10.1083/jcb.200301063; Rizzo MA, 2002, J BIOL CHEM, V277, P34168, DOI 10.1074/jbc.M112478200; Rocheleau JV, 2006, PLOS BIOL, V4, P221, DOI 10.1371/journal.pbio.0040026; Salehi A, 1996, AM J PHYSIOL-CELL PH, V270, pC1634, DOI 10.1152/ajpcell.1996.270.6.C1634; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Smukler SR, 2002, DIABETES, V51, P3450, DOI 10.2337/diabetes.51.12.3450; Stubbs M, 2000, DIABETES, V49, P2048, DOI 10.2337/diabetes.49.12.2048; Tiedge M, 2000, ARCH BIOCHEM BIOPHYS, V375, P251, DOI 10.1006/abbi.1999.1666; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Vazquez P, 2005, J ENDOCRINOL, V186, P221, DOI 10.1677/joe.1.06179; Velho G, 1997, DIABETOLOGIA, V40, P217, DOI 10.1007/s001250050666; Wang HY, 1997, P NATL ACAD SCI USA, V94, P4372, DOI 10.1073/pnas.94.9.4372; WEIR GC, 1989, DIABETES, V38, P338, DOI 10.2337/diabetes.38.3.338; WIDMANN C, 1995, BIOCHEM J, V310, P203, DOI 10.1042/bj3100203; Widmann C, 1997, MOL ENDOCRINOL, V11, P1094, DOI 10.1210/me.11.8.1094	44	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16768	16774		10.1074/jbc.M110.192799	http://dx.doi.org/10.1074/jbc.M110.192799			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454584	Green Published, hybrid			2022-12-27	WOS:000290301900025
J	Koumanov, F; Richardson, JD; Murrow, BA; Holman, GD				Koumanov, Francoise; Richardson, Judith D.; Murrow, Beverley A.; Holman, Geoffrey D.			AS160 Phosphotyrosine-binding Domain Constructs Inhibit Insulin-stimulated GLUT4 Vesicle Fusion with the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT ADIPOSE-CELLS; AKT SUBSTRATE; SKELETAL-MUSCLE; TRANSLOCATION; PROTEIN; PHOSPHORYLATION; TBC1D1; MUTATION; AS160/TBC1D4; TRAFFICKING	AS160 (TBC1D4) is a known Akt substrate that is phosphorylated downstream of insulin action and that leads to regulated traffic of GLUT4. As GLUT4 vesicle fusion with the plasma membrane is a highly regulated step in GLUT4 traffic, we investigated whether AS160 and 14-3-3 interactions are involved in this process. Fusion was inhibited by a human truncated AS160 variant that encompasses the first N-terminal phosphotyrosine-binding (PTB) domain, by either of the two N-terminal PTB domains, and by a tandem construct of both PTB domains of rat AS160. We also found that in vitro GLUT4 vesicle fusion was strongly inhibited by the 14-3-3-quenching inhibitors R18 and fusicoccin. To investigate the mode of interaction of AS160 and 14-3-3, we examined insulin-dependent increases in the levels of these proteins on GLUT4 vesicles. 14-3-3 gamma was enriched on insulin-stimulated vesicles, and its binding to AS160 on GLUT4 vesicles was inhibited by the AS160 tandem PTB domain construct. These data suggest a model for PTB domain action on GLUT4 vesicle fusion in which these constructs inhibit insulin-stimulated 14-3-3 gamma interaction with AS160 rather than AS160 phosphorylation.	[Koumanov, Francoise; Richardson, Judith D.; Murrow, Beverley A.; Holman, Geoffrey D.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Holman, GD (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	g.d.holman@bath.ac.uk	Koumanov, Francoise/AAV-7654-2020	Koumanov, Francoise/0000-0002-9029-3390; Holman, Geoffrey/0000-0001-7045-1358	Wellcome Trust; Diabetes UK; British Heart Foundation [PG/11/52/28989] Funding Source: researchfish; Medical Research Council [G9225018] Funding Source: researchfish; MRC [G9225018] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust and Diabetes UK.	Al-Hasani H, 1998, J BIOL CHEM, V273, P17504, DOI 10.1074/jbc.273.28.17504; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Dash S, 2010, DIABETOLOGIA, V53, P1239, DOI 10.1007/s00125-010-1724-x; Dash S, 2009, P NATL ACAD SCI USA, V106, P9350, DOI 10.1073/pnas.0900909106; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Jiang L, 2008, J BIOL CHEM, V283, P8508, DOI 10.1074/jbc.M708688200; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Liang SF, 2009, ELECTROPHORESIS, V30, P4152, DOI 10.1002/elps.200900249; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Meyre D, 2008, HUM MOL GENET, V17, P1798, DOI 10.1093/hmg/ddn070; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Moorhead G, 1996, CURR BIOL, V6, P1104, DOI 10.1016/S0960-9822(02)70677-5; Peck GR, 2006, MOL ENDOCRINOL, V20, P2576, DOI 10.1210/me.2005-0476; QUON MJ, 1994, P NATL ACAD SCI USA, V91, P5587, DOI 10.1073/pnas.91.12.5587; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; SATOH S, 1993, J BIOL CHEM, V268, P17820; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; Somwar R, 2001, J BIOL CHEM, V276, P46079, DOI 10.1074/jbc.M109093200; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; Yip MF, 2008, CELL METAB, V8, P384, DOI 10.1016/j.cmet.2008.09.011; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	42	26	26	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16574	16582		10.1074/jbc.M111.226092	http://dx.doi.org/10.1074/jbc.M111.226092			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454690	Green Published, hybrid			2022-12-27	WOS:000290301900006
J	Liu, JL; Vitorin, JFE; Weintraub, ST; Gu, SM; Shi, Q; Burt, JM; Jiang, JX				Liu, Jialu; Vitorin, Jose F. Ek; Weintraub, Susan T.; Gu, Sumin; Shi, Qian; Burt, Janis M.; Jiang, Jean X.			Phosphorylation of Connexin 50 by Protein Kinase A Enhances Gap Junction and Hemichannel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LENS-FIBER CONNEXINS; CARBOXYL-TERMINAL DOMAIN; CYCLIC-AMP; INTERCELLULAR COMMUNICATION; VOLTAGE-DEPENDENCE; MEDIATED PHOSPHORYLATION; CELLULAR-DISTRIBUTION; CHANNELS; CELLS; SELECTIVITY	Phosphorylation of connexins is an important mechanism regulating gap junction channels. However, the role(s) of connexin (Cx) phosphorylation in vivo are largely unknown. Here, we showed by mass spectrometry that Ser-395 in the C terminus of chicken Cx50 was phosphorylated in the lens. Ser-395 is located within a PKA consensus site. Analyses of Cx50 phosphorylation by two-dimensional thin layer chromatography tryptic phosphopeptide profiles suggested that Ser-395 was targeted by PKA in vivo. PKA activation increased both gap junction dye coupling and hemichannel dye uptake in a manner not involving increases in total Cx50 expression or relocation to the cell surface or gap junctional plaques. Single channel recordings indicated PKA enhanced transitions between the closed and similar to 200-pS open state while simultaneously reducing transitions between this open state and a similar to 65-pS subconductance state. The mutation of Ser-395 to alanine significantly attenuated PKA-induced increases in dye coupling and uptake by Cx50. However, channel records indicated that phosphorylation at this site was unnecessary for enhanced transitions between the closed and similar to 200-pS conductance state. Together, these results suggest that Cx50 is phosphorylated in vivo by PKA at Ser-395 and that this event, although unnecessary for PKA-induced alterations in channel conductance, promotes increased dye permeability of Cx50 channels, which plays an important role in metabolic coupling and transport in lens fibers.	[Liu, Jialu; Weintraub, Susan T.; Gu, Sumin; Shi, Qian; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Vitorin, Jose F. Ek; Burt, Janis M.] Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA	University of Texas System; University of Texas Health San Antonio; University of Arizona	Jiang, JX (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu	Shi, Qian/C-5962-2013; Ek-Vitorin, Jose F./AAF-8533-2020	Jiang, Jean/0000-0002-2185-5716	National Institutes of Health [EY012085]; Welch Foundation [AQ-1507]; NATIONAL EYE INSTITUTE [R29EY012085, R01EY012085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY012085 (to J. X. J.). This work was also supported by Welch Foundation Grant AQ-1507 (to J. X. J.).	Anumonwo JMB, 2001, CIRC RES, V88, P666, DOI 10.1161/hh0701.088833; ATKINSON MM, 1995, J CELL SCI, V108, P3079; Banks EA, 2009, J CELL SCI, V122, P378, DOI 10.1242/jcs.034124; Bao L, 2004, AM J PHYSIOL-CELL PH, V287, pC1389, DOI 10.1152/ajpcell.00220.2004; Berthoud VM, 1997, EUR J BIOCHEM, V244, P89, DOI 10.1111/j.1432-1033.1997.00089.x; Burghardt RC, 1995, J MEMBRANE BIOL, V148, P243; Cheng HL, 2001, J MEMBRANE BIOL, V181, P21, DOI 10.1007/s0023200100055; Cheng HL, 1999, EUR J BIOCHEM, V263, P276, DOI 10.1046/j.1432-1327.1999.00502.x; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Cruciani V, 2002, BIOL CELL, V94, P433, DOI 10.1016/S0248-4900(02)00014-X; Daniels GM, 1998, METHOD ENZYMOL, V296, P307; DeRosa AM, 2009, EXP CELL RES, V315, P1063, DOI 10.1016/j.yexcr.2009.01.017; DONALDSON PJ, 1995, AM J PHYSIOL-CELL PH, V269, pC590, DOI 10.1152/ajpcell.1995.269.3.C590; Ebihara L, 1999, BIOPHYS J, V76, P198, DOI 10.1016/S0006-3495(99)77189-4; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Gong X, 2007, J MEMBRANE BIOL, V218, P9, DOI 10.1007/s00232-007-9033-0; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Heyman NS, 2008, BIOPHYS J, V94, P840, DOI 10.1529/biophysj.107.115634; Heyman NS, 2009, AM J PHYSIOL-HEART C, V297, pH450, DOI 10.1152/ajpheart.00287.2009; HUR KC, 1989, BIOCHIM BIOPHYS ACTA, V1010, P56; Jiang JX, 1998, EUR J BIOCHEM, V255, P37, DOI 10.1046/j.1432-1327.1998.2550037.x; JIANG JX, 1994, MOL BIOL CELL, V5, P363, DOI 10.1091/mbc.5.3.363; Jiang JX, 2001, METH MOL B, V154, P159; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; Mitropoulou G, 2003, J NEUROSCI RES, V72, P147, DOI 10.1002/jnr.10572; Moreno AP, 2002, CIRC RES, V90, P450, DOI 10.1161/hh0402.105667; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Ouyang XS, 2005, MOL BRAIN RES, V135, P1, DOI 10.1016/j.molbrainres.2004.10.045; Paulson AF, 2000, J CELL SCI, V113, P3037; Shah MM, 2002, MOL CELL BIOCHEM, V238, P57, DOI 10.1023/A:1019902920693; Shearer D, 2008, INVEST OPHTH VIS SCI, V49, P1553, DOI 10.1167/iovs.07-1193; Shibayama J, 2006, BIOPHYS J, V91, P4054, DOI 10.1529/biophysj.106.085787; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Srinivas M, 1999, J PHYSIOL-LONDON, V517, P673, DOI 10.1111/j.1469-7793.1999.0673s.x; Stergiopoulos K, 1999, CIRC RES, V84, P1144, DOI 10.1161/01.RES.84.10.1144; TenBroek EM, 2001, J CELL BIOL, V155, P1307, DOI 10.1083/jcb.200102017; Tong JJ, 2006, BIOPHYS J, V91, P2142, DOI 10.1529/biophysj.106.082859; Urschel S, 2006, J BIOL CHEM, V281, P33163, DOI 10.1074/jbc.M606396200; Wang Z, 2009, EXP EYE RES, V89, P898, DOI 10.1016/j.exer.2009.07.015; White TW, 2007, INVEST OPHTH VIS SCI, V48, P5630, DOI 10.1167/iovs.06-1540; Xu X, 2002, J MEMBRANE BIOL, V186, P101, DOI 10.1007/s00232-001-0139-5; Yin XY, 2000, J BIOL CHEM, V275, P6850, DOI 10.1074/jbc.275.10.6850; Yin XY, 2001, J BIOL CHEM, V276, P34567, DOI 10.1074/jbc.M106073200	47	34	34	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16914	16928		10.1074/jbc.M111.218735	http://dx.doi.org/10.1074/jbc.M111.218735			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454606	hybrid, Green Published			2022-12-27	WOS:000290301900041
J	Mosialou, I; Krasagakis, K; Kardassis, D				Mosialou, Ioanna; Krasagakis, Konstantin; Kardassis, Dimitris			Opposite Regulation of the Human Apolipoprotein M Gene by Hepatocyte Nuclear Factor 1 and Jun Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; PROTEIN-KINASE-C; CORONARY-HEART-DISEASE; ACUTE-PHASE RESPONSE; CHOLESTEROL EFFLUX; HDL METABOLISM; THERAPEUTIC TARGETS; LIPID OXIDATION; SIGNAL PEPTIDE; II GENE	HDL is a negative risk factor for atherosclerosis because of its multiple atheroprotective functions. Inflammation converts HDL particles from anti-atherogenic to pro-atherogenic, and this transformation is associated with changes in HDL structure and composition. Apolipoprotein M (apoM) has been recently shown to play a role in the maturation of HDL in plasma and to protect from atherosclerosis. ApoM gene is expressed primarily in the liver and kidney and is down-regulated by pro-inflammatory signals. We now show that the human apoM promoter harbors a dual specificity regulatory element in the proximal region that binds hepatocyte nuclear factor 1 (HNF-1) and members of the AP-1 family of pro-inflammatory transcription factors (c-Jun and JunB). Overexpression of c-Jun or JunB repressed both the basal and the HNF-1-mediated transactivation of the human apoM promoter. Treatment of HepG2 cells with potent inflammation-inducing phorbol esters or overexpression of PKC alpha was associated with a marked inhibition of apoM gene expression in a c-Jun/JunB-dependent manner. We provide evidence for a novel mechanism of inflammation-induced transcriptional repression that is based on the competition between HNF-1 and Jun proteins for binding to the same regulatory region. A similar mechanism accounts for the down-regulation of the liver-specific apolipoprotein A-II gene by Jun factors. Our studies provide novel insights on the mechanisms that control the expression of liver-specific apolipoprotein genes during inflammation and could affect the maturation and the functionality of HDL particles.	[Mosialou, Ioanna; Kardassis, Dimitris] Univ Crete, Sch Med, Dept Basic Sci, Iraklion 71003, Greece; [Krasagakis, Konstantin] Univ Crete, Sch Med, Dept Internal Med, Iraklion 71003, Greece; [Kardassis, Dimitris] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71003, Greece	University of Crete; University of Crete; Foundation for Research & Technology - Hellas (FORTH)	Kardassis, D (corresponding author), Univ Crete, Sch Med, Dept Basic Sci, Iraklion 71003, Greece.	kardasis@imbb.forth.gr			Greek Ministry of Development; General Secretariat for Research and Technology [PENED03-780]; COST [BM0904]	Greek Ministry of Development; General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); COST(European Cooperation in Science and Technology (COST))	This work was supported by Greek Ministry of Development, General Secretariat for Research and Technology Grant PENED03-780 and COST Action Grant BM0904 (to D. K.).	ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Axler O, 2008, FEBS LETT, V582, P826, DOI 10.1016/j.febslet.2008.02.007; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Barter PJ, 1996, ATHEROSCLEROSIS, V121, P1, DOI 10.1016/0021-9150(95)05675-0; BENGAL E, 1992, CELL, V68, P507, DOI 10.1016/0092-8674(92)90187-H; CABANA VG, 1989, J LIPID RES, V30, P39; CARDOT P, 1993, BIOCHEMISTRY-US, V32, P9080, DOI 10.1021/bi00086a013; CARDOT P, 1991, J BIOL CHEM, V266, P24460; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Christoffersen C, 2008, J BIOL CHEM, V283, P18765, DOI 10.1074/jbc.M800695200; Christoffersen C, 2008, J BIOL CHEM, V283, P1839, DOI 10.1074/jbc.M704576200; Christoffersen C, 2006, J LIPID RES, V47, P1833, DOI 10.1194/jlr.M600055-JLR200; Churchill E, 2008, ANNU REV PHARMACOL, V48, P569, DOI 10.1146/annurev.pharmtox.48.121806.154902; Dahlback B, 2009, CELL MOL LIFE SCI, V66, P559, DOI 10.1007/s00018-009-8764-8; Davidson MH, 2007, AM J CARDIOL, V100, p32N, DOI 10.1016/j.amjcard.2007.08.011; Deakin JE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-281; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; Feingold KR, 2008, ATHEROSCLEROSIS, V199, P19, DOI 10.1016/j.atherosclerosis.2007.10.007; Hadzopoulou-Cladaras M, 1998, BIOCHEMISTRY-US, V37, P14078, DOI 10.1021/bi9804176; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; HOWCROFT TK, 1993, EMBO J, V12, P3163, DOI 10.1002/j.1460-2075.1993.tb05985.x; Hu YW, 2010, BBA-MOL CELL BIOL L, V1801, P100, DOI 10.1016/j.bbalip.2009.10.013; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Koutsodontis G, 2004, ONCOGENE, V23, P9190, DOI 10.1038/sj.onc.1208141; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; LI L, 1992, GENE DEV, V6, P676, DOI 10.1101/gad.6.4.676; Li Q, 1999, J BIOL CHEM, V274, P3764, DOI 10.1074/jbc.274.6.3764; LI Q, 1994, J BIOL CHEM, V269, P17508; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; LUCIBELLO FC, 1989, CELL, V59, P999, DOI 10.1016/0092-8674(89)90756-3; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Memon RA, 2001, J BIOL CHEM, V276, P30118, DOI 10.1074/jbc.M102516200; MILLER GJ, 1975, LANCET, V1, P16; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Mosialou I, 2010, J BIOL CHEM, V285, P30719, DOI 10.1074/jbc.M110.131771; Nielsen LB, 2009, TRENDS ENDOCRIN MET, V20, P66, DOI 10.1016/j.tem.2008.11.003; Nikolaidou-Neokosmidou V, 2006, BIOCHEM J, V398, P439, DOI 10.1042/BJ20060169; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; PESTELL RG, 1994, J BIOL CHEM, V269, P31090; Richter S, 2003, DIABETES, V52, P2989, DOI 10.2337/diabetes.52.12.2989; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SCHULE R, 1990, CELL, V61, P497, DOI 10.1016/0092-8674(90)90531-I; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P786, DOI 10.1001/jama.298.7.786; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Vasilaki E, 2010, FASEB J, V24, P891, DOI 10.1096/fj.09-134742; Venteclef N, 2008, J BIOL CHEM, V283, P3694, DOI 10.1074/jbc.M706382200; von Eckardstein A, 2005, CURR OPIN CLIN NUTR, V8, P147, DOI 10.1097/00075197-200503000-00007; Watts GF, 2008, CURR OPIN LIPIDOL, V19, P395, DOI 10.1097/MOL.0b013e328306596d; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Wolfrum C, 2008, J BIOL CHEM, V283, P16940, DOI 10.1074/jbc.M801930200; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4; ZANNIS VI, 1993, ADV HUM GENET, V21, P145; Zannis VI., 2004, MOL MECH ATHEROSCLER, V8, P111; Zhang XY, 2003, ACTA HISTOCHEM, V105, P67, DOI 10.1078/0065-1281-00687	61	14	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17259	17269		10.1074/jbc.M110.200659	http://dx.doi.org/10.1074/jbc.M110.200659			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454713	Green Published, hybrid			2022-12-27	WOS:000290301900074
J	Veitinger, T; Riffell, JR; Veitinger, S; Nascimento, JM; Triller, A; Chandsawangbhuwana, C; Schwane, K; Geerts, A; Wunder, F; Berns, MW; Neuhaus, EM; Zimmer, RK; Spehr, M; Hatt, H				Veitinger, Thomas; Riffell, Jeffrey R.; Veitinger, Sophie; Nascimento, Jaclyn M.; Triller, Annika; Chandsawangbhuwana, Charlie; Schwane, Katlen; Geerts, Andreas; Wunder, Frank; Berns, Michael W.; Neuhaus, Eva M.; Zimmer, Richard K.; Spehr, Marc; Hatt, Hanns			Chemosensory Ca2+ Dynamics Correlate with Diverse Behavioral Phenotypes in Human Sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLFACTORY RECEPTOR GENES; SEA-URCHIN SPERM; ODORANT RECEPTORS; MAMMALIAN SPERM; GERM-CELLS; INTRACELLULAR CALCIUM; HUMAN SPERMATOZOA; CUMULUS CELLS; EXPRESSION; MOTILITY	In the female reproductive tract, mammalian sperm undergo a regulated sequence of prefusion changes that "prime" sperm for fertilization. Among the least understood of these complex processes are the molecular mechanisms that underlie sperm guidance by environmental chemical cues. A "hard-wired" Ca2+ signaling strategy that orchestrates specific motility patterns according to given functional requirements is an emerging concept for regulation of sperm swimming behavior. The molecular players involved, the spatiotemporal characteristics of such motility-associated Ca2+ dynamics, and the relation between a distinct Ca2+ signaling pattern and a behavioral sperm phenotype, however, remain largely unclear. Here, we report the functional characterization of two human sperm chemoreceptors. Using complementary molecular, physiological, and behavioral approaches, we comparatively describe sperm Ca2+ responses to specific agonists of these novel receptors and bourgeonal, a known sperm chemoattractant. We further show that individual receptor activation induces specific Ca2+ signaling patterns with unique spatiotemporal dynamics. These distinct Ca2+ dynamics are correlated to a set of stimulus-specific stereotyped behavioral responses that could play vital roles during various stages of prefusion sperm-egg chemical communication.	[Spehr, Marc] Rhein Westfal TH Aachen, LuF Chemosensor, Inst Biol 2, Dept Chemosensat, D-52074 Aachen, Germany; [Veitinger, Thomas; Veitinger, Sophie; Triller, Annika; Schwane, Katlen; Hatt, Hanns] Ruhr Univ Bochum, Dept Cellular Physiol, D-44780 Bochum, Germany; [Riffell, Jeffrey R.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA; [Nascimento, Jaclyn M.] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Chandsawangbhuwana, Charlie; Berns, Michael W.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Geerts, Andreas; Wunder, Frank] Bayer Schering Pharma AG, Pharma Res Ctr, D-42096 Wuppertal, Germany; [Berns, Michael W.] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA USA; [Neuhaus, Eva M.] Charite NeuroSci Res Ctr, D-10117 Berlin, Germany; [Zimmer, Richard K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Neurosci Program, Los Angeles, CA 90095 USA; [Zimmer, Richard K.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	RWTH Aachen University; Ruhr University Bochum; University of Arizona; University of California System; University of California San Diego; University of California System; University of California San Diego; Bayer AG; Bayer Healthcare Pharmaceuticals; University of California System; University of California Irvine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Spehr, M (corresponding author), Rhein Westfal TH Aachen, LuF Chemosensor, Inst Biol 2, Dept Chemosensat, D-52074 Aachen, Germany.	m.spehr@sensorik.rwth-aachen.de	Spehr, Marc/AAK-3162-2021; Neuhaus, Eva M./L-1428-2015; Spehr, Marc/B-3140-2011	Spehr, Marc/0000-0001-6616-4196; Neuhaus, Eva M./0000-0003-3363-1231; Spehr, Marc/0000-0001-6616-4196; Wunder, Frank/0000-0002-1311-2357; Berns, Michael/0000-0002-9640-2885	National Institutes of Health [2 K12 GM000708-06]; Volkswagen Foundation; Deutsche Forschungsgemeinschaft; National Science Foundation [IOS 08-20645]; Graduate Research Fellowship; Heinrich und Alma Vogelsang-Foundation; United States Department of Defense; Beckman Laser Institute Inc. Foundation; UCLA Council on Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); Graduate Research Fellowship; Heinrich und Alma Vogelsang-Foundation; United States Department of Defense(United States Department of Defense); Beckman Laser Institute Inc. Foundation; UCLA Council on Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2 K12 GM000708-06 (to J. R. R.). This work was also supported by grants from the Volkswagen Foundation (to M. S.), the Deutsche Forschungsgemeinschaft (to H. H. and M. S.), National Science Foundation Grant IOS 08-20645 (to R. K. Z.), a Graduate Research Fellowship (to C. C.), the Heinrich und Alma Vogelsang-Foundation (to K. S.), the United States Department of Defense (to C. C.) (National Defense Science and Engineering Graduate Fellowship), the Beckman Laser Institute Inc. Foundation (to M. W. B. and J. M. N.), and the UCLA Council on Research (to R. K. Z.).	Asai H, 1996, BIOCHEM BIOPH RES CO, V221, P240, DOI 10.1006/bbrc.1996.0580; Bahat A, 2003, NAT MED, V9, P149, DOI 10.1038/nm0203-149; Baker MA, 2008, PROTEOMICS, V8, P1720, DOI 10.1002/pmic.200701020; BEDFORD JM, 1993, J EXP ZOOL, V265, P321, DOI 10.1002/jez.1402650314; Bedu-Addo K, 2008, INT J DEV BIOL, V52, P615, DOI 10.1387/ijdb.072535kb; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; Berridge MJ, 2000, SCIENCE, V287, P1604, DOI 10.1126/science.287.5458.1604; Branscomb A, 2000, GENETICS, V156, P785; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; Breitbart H, 1999, REV REPROD, V4, P151; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Castillo K, 2010, EUR J NEUROSCI, V32, P932, DOI 10.1111/j.1460-9568.2010.07393.x; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; Costello S, 2009, REPRODUCTION, V138, P425, DOI 10.1530/REP-09-0134; Darszon A, 2007, Soc Reprod Fertil Suppl, V65, P229; De la Cruz O, 2009, MOL BIOL EVOL, V26, P491, DOI 10.1093/molbev/msn294; Doszczak L, 2007, ANGEW CHEM INT EDIT, V46, P3367, DOI 10.1002/anie.200605002; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Eisenbach M, 1999, BIOESSAYS, V21, P203, DOI 10.1002/(SICI)1521-1878(199903)21:3<203::AID-BIES4>3.0.CO;2-T; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Fukuda N, 2006, GENES CELLS, V11, P71, DOI 10.1111/j.1365-2443.2005.00915.x; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Gakamsky A, 2009, HUM REPROD, V24, P1152, DOI 10.1093/humrep/den409; Gee CC, 1997, J EXP BIOL, V200, P3185; Goto T, 2001, MOL HUM REPROD, V7, P553, DOI 10.1093/molehr/7.6.553; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Ho HC, 2003, BIOL REPROD, V68, P1590, DOI 10.1095/biolreprod.102.011320; Jacquier V, 2006, J NEUROCHEM, V97, P537, DOI 10.1111/j.1471-4159.2006.03771.x; Jimenez-Gonzalez C, 2006, HUM REPROD UPDATE, V12, P253, DOI 10.1093/humupd/dmi050; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kaiser L, 2008, P NATL ACAD SCI USA, V105, P15726, DOI 10.1073/pnas.0804766105; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kaupp UB, 2003, NAT CELL BIOL, V5, P109, DOI 10.1038/ncb915; Kwitny S, 2010, BIOL REPROD, V82, P669, DOI 10.1095/biolreprod.109.079566; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Marrakchi M, 2007, EUR BIOPHYS J BIOPHY, V36, P1015, DOI 10.1007/s00249-007-0187-6; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Nascimento JL, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2337559; Nascimento JM, 2008, J R SOC INTERFACE, V5, P297, DOI 10.1098/rsif.2007.1118; Navarro B, 2008, INT J DEV BIOL, V52, P607, DOI 10.1387/ijdb.072554bn; Neuhaus EM, 2006, CHEM SENSES, V31, P445, DOI 10.1093/chemse/bjj049; Neuhaus EM, 2006, J CELL SCI, V119, P3047, DOI 10.1242/jcs.03046; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; Oren-Benaroya R, 2008, HUM REPROD, V23, P2339, DOI 10.1093/humrep/den265; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Platts AE, 2007, HUM MOL GENET, V16, P763, DOI 10.1093/hmg/ddm012; Publicover S, 2007, NAT CELL BIOL, V9, P235, DOI 10.1038/ncb0307-235; Publicover SJ, 2008, FRONT BIOSCI, V13, P5623; Riffell JA, 2002, J EXP BIOL, V205, P1439; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Shi LZ, 2008, BIOMED MICRODEVICES, V10, P573, DOI 10.1007/s10544-008-9169-4; Spehr M, 2004, J BIOL CHEM, V279, P40194, DOI 10.1074/jbc.M403913200; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Spehr M, 2006, MOL CELL ENDOCRINOL, V250, P128, DOI 10.1016/j.mce.2005.12.035; Spehr M, 2009, J NEUROCHEM, V109, P1570, DOI 10.1111/j.1471-4159.2009.06085.x; Strunker T, 2006, NAT CELL BIOL, V8, P1149, DOI 10.1038/ncb1473; Sun F, 2005, HUM REPROD, V20, P761, DOI 10.1093/humrep/deh657; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; TOFFLE RC, 1985, FERTIL STERIL, V43, P743; Triller A, 2008, CHEM BIODIVERS, V5, P862, DOI 10.1002/cbdv.200890101; VANDERHAEGHEN P, 1993, J CELL BIOL, V123, P1441, DOI 10.1083/jcb.123.6.1441; Vanderhaeghen P, 1997, BIOCHEM BIOPH RES CO, V237, P283, DOI 10.1006/bbrc.1997.7043; Vanderhaeghen P, 1997, GENOMICS, V39, P239, DOI 10.1006/geno.1996.4490; WALENSKY LD, 1995, MOL MED, V1, P130, DOI 10.1007/BF03401561; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Wood CD, 2005, J CELL BIOL, V169, P725, DOI 10.1083/jcb.200411001; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101	79	55	58	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17311	17325		10.1074/jbc.M110.211524	http://dx.doi.org/10.1074/jbc.M110.211524			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454470	Green Published, hybrid			2022-12-27	WOS:000290301900079
J	Benanti, EL; Chivers, PT				Benanti, Erin L.; Chivers, Peter T.			Helicobacter pylori NikR Protein Exhibits Distinct Conformations When Bound to Different Promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICKEL-RESPONSIVE REGULATOR; N-TERMINAL ARM; DNA-BINDING; GNOTOBIOTIC PIGLETS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; OPERATOR COMPLEX; STRUCTURAL BASIS; BETA-SHEETS; REPRESSOR	Helicobacter pylori NikR (HpNikR) is a ribbon-helix-helix (RHH) DNA-binding protein that binds to several different promoter regions. The binding site sequences are not absolutely conserved. The ability of HpNikR to discriminate specific DNA sites resides partly in its nine-amino acid N-terminal arm. Previously, indirect evidence indicated that the arm exists in different conformations when HpNikR is bound to the nixA and ureA promoters. Here, we directly examined HpNikR conformation when it was bound to nixA and ureA DNA fragments by tethering (S)-1{[bis(carboxymethyl) amino] methyl}-2-{4-[(2-bromoacetyl) amino] phenylethyl}(carboxymethyl)amino]acetic acid, iron(III) to different positions in the N-terminal arm and RHH DNA binding domain. Different cleavage patterns at each promoter directly demonstrated that both the RHH domain and the arm adopt different conformations on the nixA and ureA promoters. Additionally, the two RHH domain dimers of the HpNikR tetramer are in distinct conformations at ureA. Site-directed mutagenesis identified an interchain salt bridge (Lys(48)-Glu(47')) in the RHH domain remote from the DNA binding interface that is required for high affinity binding to ureA but not nixA. Finally, DNA affinity measurements of wild-type HpNikR and a salt bridge mutant (K48A) to hybrid nixA-ureA promoters demonstrated that inverted repeat half-sites, spacers, and flanking DNA are all required for sequence-specific DNA binding by HpNikR. Notably, the spacer region made the largest contribution to DNA affinity. HpNikR exhibits a substantially expanded regulon compared with other NikR proteins. The results presented here provide a molecular basis for understanding regulatory network expansion by NikR as well as other prokaryotic regulatory proteins.	[Benanti, Erin L.; Chivers, Peter T.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Chivers, PT (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, Box 8231,660 S Euclid Ave, St Louis, MO 63108 USA.	chivers@wustl.edu		Chivers, Peter/0000-0002-8779-1452	National Science Foundation [MCB 0520877]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB 0520877.	Abraham LO, 2006, J INORG BIOCHEM, V100, P1005, DOI 10.1016/j.jinorgbio.2005.10.014; Akada JK, 2000, MOL MICROBIOL, V36, P1071, DOI 10.1046/j.1365-2958.2000.01918.x; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Bahlawane C, 2010, NUCLEIC ACIDS RES, V38, P3106, DOI 10.1093/nar/gkp1216; Benanti EL, 2007, J BIOL CHEM, V282, P20365, DOI 10.1074/jbc.M702982200; Benanti EL, 2010, J BACTERIOL, V192, P4327, DOI 10.1128/JB.00152-10; Benanti EL, 2009, J BACTERIOL, V191, P2405, DOI 10.1128/JB.01657-08; Berggrun A, 2000, J MOL BIOL, V301, P959, DOI 10.1006/jmbi.2000.4007; Berggrun A, 2001, P NATL ACAD SCI USA, V98, P2301, DOI 10.1073/pnas.041612198; Bradley MJ, 2008, J MOL BIOL, V378, P1155, DOI 10.1016/j.jmb.2008.03.010; Chivers PT, 1999, PROTEIN SCI, V8, P2494, DOI 10.1110/ps.8.11.2494; Chivers PT, 1996, EMBO J, V15, P2659, DOI 10.1002/j.1460-2075.1996.tb00626.x; Chivers PT, 2000, J BIOL CHEM, V275, P19735, DOI 10.1074/jbc.M002232200; Chivers PT, 2002, CHEM BIOL, V9, P1141, DOI 10.1016/S1074-5521(02)00241-7; Contreras M, 2003, MOL MICROBIOL, V49, P947, DOI 10.1046/j.1365-2958.2003.03621.x; Davis GS, 2006, INFECT IMMUN, V74, P6811, DOI 10.1128/IAI.01188-06; De Pina K, 1999, J BACTERIOL, V181, P670, DOI 10.1128/JB.181.2.670-674.1999; Delany I, 2005, J BACTERIOL, V187, P7703, DOI 10.1128/JB.187.22.7703-7715.2005; DELSOLAR G, 1992, MOL MICROBIOL, V6, P83; Dian C, 2006, J MOL BIOL, V361, P715, DOI 10.1016/j.jmb.2006.06.058; Dosanjh NS, 2006, CURR OPIN CHEM BIOL, V10, P123, DOI 10.1016/j.cbpa.2006.02.011; Dosanjh NS, 2007, BIOCHEMISTRY-US, V46, P2520, DOI 10.1021/bi062092w; Dosanjh NS, 2009, BIOCHEMISTRY-US, V48, P527, DOI 10.1021/bi801481j; EATON KA, 1994, INFECT IMMUN, V62, P3604, DOI 10.1128/IAI.62.9.3604-3607.1994; EATON KA, 1991, INFECT IMMUN, V59, P2470, DOI 10.1128/IAI.59.7.2470-2475.1991; Ernst FD, 2005, INFECT IMMUN, V73, P7252, DOI 10.1128/IAI.73.11.7252-7258.2005; Ernst FD, 2006, INFECT IMMUN, V74, P6821, DOI 10.1128/IAI.01196-06; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gomis-Ruth FX, 1998, EMBO J, V17, P7404, DOI 10.1093/emboj/17.24.7404; Hall KB, 1999, METHODS, V18, P78, DOI 10.1006/meth.1999.0759; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hopper S, 2000, INFECT IMMUN, V68, P896, DOI 10.1128/IAI.68.2.896-905.2000; KNIGHT KL, 1989, P NATL ACAD SCI USA, V86, P797, DOI 10.1073/pnas.86.3.797; KOUDELKA GB, 1987, NATURE, V326, P886, DOI 10.1038/326886a0; Li YJ, 2009, BIOCHEMISTRY-US, V48, P2486, DOI 10.1021/bi801742r; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; MARQUSEE S, 1990, PROTEIN FOLDING : DECIPHERING THE SECOND HALF OF THE GENETIC CODE, P85; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Mukherjee S, 2002, CELL, V110, P81, DOI 10.1016/S0092-8674(02)00815-2; Ni L, 2009, NUCLEIC ACIDS RES, V37, P6970, DOI 10.1093/nar/gkp756; OLD IG, 1991, PROG BIOPHYS MOL BIO, V56, P145, DOI 10.1016/0079-6107(91)90012-H; Olson JW, 2002, SCIENCE, V298, P1788, DOI 10.1126/science.1077123; PABO CO, 1982, NATURE, V298, P441, DOI 10.1038/298441a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAUMANN BE, 1994, NATURE, V367, P754, DOI 10.1038/367754a0; RAUMANN BE, 1994, CURR OPIN STRUC BIOL, V4, P36, DOI 10.1016/S0959-440X(94)90057-4; Schreiter ER, 2007, NAT REV MICROBIOL, V5, P710, DOI 10.1038/nrmicro1717; Schreiter ER, 2006, P NATL ACAD SCI USA, V103, P13676, DOI 10.1073/pnas.0606247103; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B; Sindhikara DJ, 2009, BIOCHEMISTRY-US, V48, P12024, DOI 10.1021/bi9013352; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; SUSSKIND MM, 1978, MICROBIOL REV, V42, P385, DOI 10.1128/MMBR.42.2.385-413.1978; Weihofen WA, 2006, NUCLEIC ACIDS RES, V34, P1450, DOI 10.1093/nar/gkl015; Zambelli B, 2008, J MOL BIOL, V383, P1129, DOI 10.1016/j.jmb.2008.08.066	56	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.196055	http://dx.doi.org/10.1074/jbc.M110.196055			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21393642	Green Published, hybrid			2022-12-27	WOS:000290022800012
J	Nishikori, S; Esaki, M; Yamanaka, K; Sugimoto, S; Ogura, T				Nishikori, Shingo; Esaki, Masatoshi; Yamanaka, Kunitoshi; Sugimoto, Shinya; Ogura, Teru			Positive Cooperativity of the p97 AAA ATPase Is Critical for Essential Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; CAENORHABDITIS-ELEGANS; MEMBRANE-FUSION; PROTEIN VCP; ER; HYDROLYSIS; P97/VCP; BINDING; CYCLE	p97 is composed of two conserved AAA (ATPases associated with diverse cellular activities) domains, which form a tandem hexameric ring. We characterized the ATP hydrolysis mechanism of CDC-48.1, a p97 homolog of Caenorhabditis elegans. The ATPase activity of the N-terminal AAA domain was very low at physiological temperature, whereas the C-terminal AAA domain showed high ATPase activity in a coordinated fashion with positive cooperativity. The cooperativity and coordination are generated by different mechanisms because a noncooperative mutant still showed the coordination. Interestingly, the growth speed of yeast cells strongly related to the positive cooperativity rather than the ATPase activity itself, suggesting that the positive cooperativity is critical for the essential functions of p97.	[Nishikori, Shingo; Esaki, Masatoshi; Yamanaka, Kunitoshi; Sugimoto, Shinya; Ogura, Teru] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Mol Cell Biol, Kumamoto 8600811, Japan	Kumamoto University	Ogura, T (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Mol Cell Biol, 2-2-1 Honjo, Kumamoto 8600811, Japan.	ogura@gpo.kumamoto-u.ac.jp	Esaki, Masatoshi/ABS-6645-2022; Esaki, Masatoshi/L-6591-2017	Sugimoto, Shinya/0000-0002-3114-8513; Ogura, Teru/0000-0003-3784-0970	Japan Society for the Promotion of Science; Ministry of Education, Culture, Science, Sports and Technology of Japan; Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [23590521] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Japan Society for the Promotion of Science, the Ministry of Education, Culture, Science, Sports and Technology of Japan, and the Core Research for Evolutional Science and Technology program by the Japan Science and Technology Agency.	Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Briggs LC, 2008, J BIOL CHEM, V283, P13745, DOI 10.1074/jbc.M709632200; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; Davies JM, 2005, STRUCTURE, V13, P183, DOI 10.1016/j.str.2004.11.014; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Esaki M, 2010, BIOCHEM CELL BIOL, V88, P109, DOI [10.1139/o09-116, 10.1139/O09-116]; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; HUANG TG, 1994, J BIOL CHEM, V269, P16502; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Nishikori S, 2008, GENES CELLS, V13, P827, DOI 10.1111/j.1365-2443.2008.01214.x; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Patel SK, 1998, CELL, V92, P611, DOI 10.1016/S0092-8674(00)81129-0; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Roy L, 2000, MOL BIOL CELL, V11, P2529, DOI 10.1091/mbc.11.8.2529; Sasagawa Y, 2007, BIOCHEM BIOPH RES CO, V358, P920, DOI 10.1016/j.bbrc.2007.05.022; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; Sugimoto S, 2010, J BIOL CHEM, V285, P6648, DOI 10.1074/jbc.M109.080739; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zalk R, 2003, BIOCHEM J, V374, P473, DOI 10.1042/BJ20030219	30	38	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.201400	http://dx.doi.org/10.1074/jbc.M110.201400			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454554	hybrid, Green Published			2022-12-27	WOS:000290022800022
J	Sharma, P; Dube, D; Singh, A; Mishra, B; Singh, N; Sinha, M; Dey, S; Kaur, P; Mitra, DK; Sharma, S; Singh, TP				Sharma, Pradeep; Dube, Divya; Singh, Amar; Mishra, Biswajit; Singh, Nagendra; Sinha, Mau; Dey, Sharmistha; Kaur, Punit; Mitra, Dipendra K.; Sharma, Sujata; Singh, Tej P.			Structural Basis of Recognition of Pathogen-associated Molecular Patterns and Inhibition of Proinflammatory Cytokines by Camel Peptidoglycan Recognition Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; LIPOTEICHOIC ACID; INFECTION; IMMUNITY; SEPSIS; LPS	Peptidoglycan recognition proteins (PGRPs) are involved in the recognition of pathogen-associated molecular patterns. The well known pathogen-associated molecular patterns include LPS from Gram-negative bacteria and lipoteichoic acid (LTA) from Gram-positive bacteria. In this work, the crystal structures of two complexes of the short form of camel PGRP (CPGRP-S) with LPS and LTA determined at 1.7- and 2.1-angstrom resolutions, respectively, are reported. Both compounds were held firmly inside the complex formed with four CPGRP-S molecules designated A, B, C, and D. The binding cleft is located at the interface of molecules C and D, which is extendable to the interface of molecules A and C. The interface of molecules A and B is tightly packed, whereas that of molecules B and D forms a wide channel. The hydrophilic moieties of these compounds occupy a common region, whereas hydrophobic chains interact with distinct regions in the binding site. The binding studies showed that CPGRP-S binds to LPS and LTA with affinities of 1.6 x 10(-9) and 2.4 x 10(-8) M, respectively. The flow cytometric studies showed that both LPS- and LTA-induced expression of the pro-inflammatory cytokines TNF-alpha and IL-6 was inhibited by CPGRP-S. The results of animal studies using mouse models indicated that both LPS- and LTA-induced mortality rates decreased drastically when CPGRP-S was administered. The recognition of both LPS and LTA, their high binding affinities for CPGRP-S, the significant decrease in the production of LPS- and LTA-induced TNF-alpha and IL-6, and the drastic reduction in the mortality rates in mice by CPGRP-S indicate its useful properties as an antibiotic agent.	[Sharma, Pradeep; Dube, Divya; Mishra, Biswajit; Singh, Nagendra; Sinha, Mau; Dey, Sharmistha; Kaur, Punit; Sharma, Sujata; Singh, Tej P.] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Singh, Amar; Mitra, Dipendra K.] All India Inst Med Sci, Dept Transplantat Immunol & Immunogenet, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Singh, TP (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	tpsingh.aiims@gmail.com		SINHA, MAU/0000-0003-3011-9160; Singh, Nagendra/0000-0003-0419-0684	Department of Science and Technology, Ministry of Science and Technology, Government of India (New Delhi); Council of Scientific and Industrial Research (CSIR; New Delhi); International Center for Diffraction Data (ICDD); Department of Biotechnology; Department of Biotechnology, Ministry of Science and Technology, Government of India (New Delhi)	Department of Science and Technology, Ministry of Science and Technology, Government of India (New Delhi)(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR; New Delhi)(Council of Scientific & Industrial Research (CSIR) - India); International Center for Diffraction Data (ICDD); Department of Biotechnology; Department of Biotechnology, Ministry of Science and Technology, Government of India (New Delhi)(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by the Departments of Science and Technology and Biotechnology, Ministry of Science and Technology, Government of India (New Delhi).; Recipient of fellowships from the Council of Scientific and Industrial Research (CSIR; New Delhi) and the International Center for Diffraction Data (ICDD).; Supported by a Distinguished Biotechnology Research Professorship grant from the Department of Biotechnology.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Charland M. B., 1995, SIGMAPLOT SCI VERS 8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Ginsburg I, 2002, LANCET INFECT DIS, V2, P171, DOI 10.1016/S1473-3099(02)00226-8; Guan RJ, 2006, PROTEIN SCI, V15, P1199, DOI 10.1110/ps.062077606; Guan RJ, 2005, J MOL BIOL, V347, P683, DOI 10.1016/j.jmb.2005.01.070; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hu YJ, 2010, PROTEIN J, V29, P234, DOI 10.1007/s10930-010-9244-6; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kappeler SR, 2004, J DAIRY SCI, V87, P2660, DOI 10.3168/jds.S0022-0302(04)73392-5; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; KINI RM, 1995, BIOCHEM BIOPH RES CO, V212, P1115, DOI 10.1006/bbrc.1995.2084; Kitaigorodskii A. I., 1955, ORGANIC CHEM CRYSTAL; Komai-Koma M, 2009, EUR J IMMUNOL, V39, P1564, DOI 10.1002/eji.200838866; Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; Medzhitov R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI 10.1016/S0952-7915(98)80024-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pauling L., 1960, NATURE CHEM BOND; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reiser JB, 2004, J MOL BIOL, V340, P909, DOI 10.1016/j.jmb.2004.04.077; Sarrias MR, 2007, P NATL ACAD SCI USA, V104, P11724, DOI 10.1073/pnas.0702815104; Sharma P, 2008, J MOL BIOL, V378, P923, DOI 10.1016/j.jmb.2008.03.018; Wang JE, 2003, SHOCK, V20, P402, DOI 10.1097/01.shk.0000092268.01859.0d; Zhang YO, 2005, BBA-PROTEINS PROTEOM, V1752, P34, DOI 10.1016/j.bbapap.2005.07.001	31	31	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.228163	http://dx.doi.org/10.1074/jbc.M111.228163			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454594	hybrid, Green Published			2022-12-27	WOS:000290022800060
J	Zhu, YX; Gumlaw, N; Karman, J; Zhao, HM; Zhang, JH; Jiang, JL; Maniatis, P; Edling, A; Chuang, WL; Siegel, C; Shayman, JA; Kaplan, J; Jiang, CW; Cheng, SH				Zhu, Yunxiang; Gumlaw, Nathan; Karman, Jozsef; Zhao, Hongmei; Zhang, Jinhua; Jiang, Ji-Lei; Maniatis, Pete; Edling, Andrea; Chuang, Wei-Lien; Siegel, Craig; Shayman, James A.; Kaplan, Johanne; Jiang, Canwen; Cheng, Seng H.			Lowering Glycosphingolipid Levels in CD4(+) T Cells Attenuates T Cell Receptor Signaling, Cytokine Production, and Differentiation to the Th-17 Lineage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; LCK TYROSINE KINASE; LIPID-RAFTS; MEMBRANE MICRODOMAINS; IMMUNOLOGICAL SYNAPSE; INSULIN SENSITIVITY; HUMAN-LYMPHOCYTES; ANTIGEN RECEPTOR; GLCNAC TERMINI; ACTIVATION	Lipid rafts reportedly have a role in coalescing key signaling molecules into the immunological synapse during T cell activation, thereby modulating T cell receptor (TCR) signaling activity. Recent findings suggest that a correlation may exist between increased levels of glycosphingolipids (GSLs) in the lipid rafts of T cells and a heightened response of those T cells toward activation. Here, we show that lowering the levels of GSLs in CD4(+) T cells using a potent inhibitor of glucosylceramide synthase (Genz-122346) led to a moderation of the T cell response toward activation. TCR proximal signaling events, such as phosphorylation of Lck, Zap70 and LAT, as well as early Ca2+ mobilization, were attenuated by treatment with Genz-122346. Concomitant with these events were significant reductions in IL-2 production and T cell proliferation. Similar findings were obtained with CD4(+) T cells isolated from transgenic mice genetically deficient in GM3 synthase activity. Interestingly, lowering the GSL levels in CD4(+) T cells by either pharmacological inhibition or disruption of the gene for GM3 synthase also specifically inhibited the differentiation of T cells to the Th-17 lineage but not to other Th subsets in vitro. Taken together with the recently reported effects of Raftlin deficiency on Th-17 differentiation, these results strongly suggest that altering the GSL composition of lipid rafts modulates TCR signaling activity and affects Th-17 differentiation.	[Zhu, Yunxiang; Gumlaw, Nathan; Karman, Jozsef; Zhao, Hongmei; Zhang, Jinhua; Jiang, Ji-Lei; Maniatis, Pete; Edling, Andrea; Chuang, Wei-Lien; Siegel, Craig; Kaplan, Johanne; Jiang, Canwen; Cheng, Seng H.] Genzyme Corp, Framingham, MA 01701 USA; [Shayman, James A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Sanofi-Aventis; Genzyme Corporation; University of Michigan System; University of Michigan	Zhu, YX (corresponding author), Genzyme Corp, 49 New York Ave, Framingham, MA 01701 USA.	yunxiang.zhu@genzyme.com	Cheng, Seng H/AAC-6564-2022		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS079633] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK055823] Funding Source: Medline; NINDS NIH HHS [R21 NS079633] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Blank N, 2005, BIOCHEM PHARMACOL, V71, P126, DOI 10.1016/j.bcp.2005.10.004; Deng GM, 2008, J IMMUNOL, V181, P4019, DOI 10.4049/jimmunol.181.6.4019; Dykstra M, 2001, J LEUKOCYTE BIOL, V70, P699; Garofalo T, 2002, J BIOL CHEM, V277, P11233, DOI 10.1074/jbc.M109601200; Harder T, 2004, TRAFFIC, V5, P265, DOI 10.1111/j.1600-0854.2003.00163.x; He X, 2002, EUR J IMMUNOL, V32, P2578, DOI 10.1002/1521-4141(200209)32:9<2578::AID-IMMU2578>3.0.CO;2-3; Horejsi V, 2004, IMMUNOL LETT, V92, P43, DOI 10.1016/j.imlet.2003.10.013; Horejsi V, 2003, IMMUNOL REV, V191, P148, DOI 10.1034/j.1600-065X.2003.00001.x; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jury EC, 2004, J CLIN INVEST, V113, P1176, DOI 10.1172/JCI200420345; Jury EC, 2006, J IMMUNOL, V177, P7416, DOI 10.4049/jimmunol.177.10.7416; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Kasahara K, 2000, GLYCOCONJUGATE J, V17, P153, DOI 10.1023/A:1026576804247; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; Kosugi A, 2001, IMMUNOL LETT, V76, P133, DOI 10.1016/S0165-2478(01)00174-2; Krishnan S, 2004, J IMMUNOL, V172, P7821, DOI 10.4049/jimmunol.172.12.7821; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Ma XY, 2007, BIOCHEM BIOPH RES CO, V356, P67, DOI 10.1016/j.bbrc.2007.02.080; Miceli MC, 2001, SEMIN IMMUNOL, V13, P115, DOI 10.1006/smim.2000.0303; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Nakamura I, 1996, TOHOKU J EXP MED, V179, P291, DOI 10.1620/tjem.179.291; Pizzo P, 2002, EUR J IMMUNOL, V32, P3082, DOI 10.1002/1521-4141(200211)32:11<3082::AID-IMMU3082>3.0.CO;2-2; Rouquette-Jazdanian AK, 2006, CELL SIGNAL, V18, P105, DOI 10.1016/j.cellsig.2005.03.024; Rouquette-Jazdanian AK, 2007, CELL SIGNAL, V19, P1404, DOI 10.1016/j.cellsig.2007.01.015; Saeki K, 2009, J IMMUNOL, V182, P5929, DOI 10.4049/jimmunol.0802672; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sorice M, 2003, GLYCOCONJUGATE J, V20, P63, DOI 10.1023/B:GLYC.0000018018.29488.c6; Tavano R, 2004, J IMMUNOL, V173, P5392, DOI 10.4049/jimmunol.173.9.5392; Tuosto L, 2001, EUR J IMMUNOL, V31, P345, DOI 10.1002/1521-4141(200102)31:2<345::AID-IMMU345>3.3.CO;2-C; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yasuda K, 2000, J IMMUNOL, V165, P3226, DOI 10.4049/jimmunol.165.6.3226; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Yoon SJ, 2006, GLYCOCONJUGATE J, V23, P639, DOI 10.1007/s10719-006-9001-4; Zeyda M, 2006, PROG LIPID RES, V45, P187, DOI 10.1016/j.plipres.2006.01.002; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	39	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14787	14794		10.1074/jbc.M111.218610	http://dx.doi.org/10.1074/jbc.M111.218610			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21402703	Green Published, hybrid			2022-12-27	WOS:000289788300008
J	Zou, WQ; Xiao, XZ; Yuan, J; Puoti, G; Fujioka, HS; Wang, XL; Richardson, S; Zhou, XC; Zou, R; Li, SH; Zhu, XW; McGeer, PL; McGeehan, J; Kneale, G; Rincon-Limas, DE; Fernandez-Funez, P; Lee, HG; Smith, MA; Petersen, RB; Guo, JP				Zou, Wen-Quan; Xiao, Xiangzhu; Yuan, Jue; Puoti, Gianfranco; Fujioka, Hisashi; Wang, Xinglong; Richardson, Sandy; Zhou, Xiaochen; Zou, Roger; Li, Shihao; Zhu, Xiongwei; McGeer, Patrick L.; McGeehan, John; Kneale, Geoff; Rincon-Limas, Diego E.; Fernandez-Funez, Pedro; Lee, Hyoung-gon; Smith, Mark A.; Petersen, Robert B.; Guo, Jian-Ping			Amyloid-beta 42 Interacts Mainly with Insoluble Prion Protein in the Alzheimer Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; MONOCLONAL-ANTIBODY; COGNITIVE DEFICITS; NEURONAL ISOFORM; APLYSIA CPEB; MEMORY; DISEASE; GENE; FORM; PRPC	The prion protein (PrP) is best known for its association with prion diseases. However, a controversial new role for PrP in Alzheimer disease (AD) has recently emerged. In vitro studies and mouse models of AD suggest that PrP may be involved in AD pathogenesis through a highly specific interaction with amyloid-beta (A beta 42) oligomers. Immobilized recombinant human PrP (huPrP) also exhibited high affinity and specificity for A beta 42 oligomers. Here we report the novel finding that aggregated forms of huPrP and A beta 42 are co-purified from AD brain extracts. Moreover, an anti-PrP antibody and an agent that specifically binds to insoluble PrP (iPrP) co-precipitate insoluble A beta from human AD brain. Finally, using peptide membrane arrays of 99 13-mer peptides that span the entire sequence of mature huPrP, two distinct types of A beta binding sites on huPrP are identified in vitro. One specifically binds to A beta 42 and the other binds to both A beta 42 and A beta 40. Notably, A beta 42-specific binding sites are localized predominantly in the octapeptide repeat region, whereas sites that bind both A beta 40 and A beta 42 are mainly in the extreme N-terminal or C-terminal domains of PrP. Our study suggests that iPrP is the major PrP species that interacts with insoluble A beta 42 in vivo. Although this work indicated the interaction of A beta 42 with huPrP in the AD brain, the pathophysiological relevance of the iPrP/A beta 42 interaction remains to be established.	[Zou, Wen-Quan] Case Western Reserve Univ, Inst Pathol, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Zou, Wen-Quan; Xiao, Xiangzhu; Yuan, Jue] Case Western Reserve Univ, Sch Med, Natl Prion Dis Pathol Surveillance Ctr, Cleveland, OH 44106 USA; [Fujioka, Hisashi] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Elect Microscopy Facil,Ctr Mitochondrial Dis, Cleveland, OH 44106 USA; [Petersen, Robert B.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [McGeer, Patrick L.; Guo, Jian-Ping] Univ British Columbia, Fac Med, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1Z3, Canada; [McGeehan, John; Kneale, Geoff] Univ Portsmouth, Inst Biomed & Biomol Sci, Biophys Labs, Portsmouth PO1 2DT, Hants, England; [Rincon-Limas, Diego E.; Fernandez-Funez, Pedro; Smith, Mark A.] Univ Florida, McKnight Brain Inst, Dept Neurol, Gainesville, FL 32610 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of British Columbia; University of Portsmouth; State University System of Florida; University of Florida	Zou, WQ (corresponding author), Case Western Reserve Univ, Inst Pathol, Sch Med, Dept Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.	wenquan.zou@case.edu	xiao, xiangzhu/B-9300-2014; Zhu, Xiongwei/A-9629-2009; Lee, Hyoung-gon/A-9637-2009; Petersen, Robert/B-5075-2011; Puoti, Gianfranco/AAB-8288-2019; Zou, Wenquan/GWQ-3489-2022; /C-1310-2010; Zou, Wenquan/ABF-2875-2020	xiao, xiangzhu/0000-0002-8013-9074; Zhu, Xiongwei/0000-0003-2092-6508; Petersen, Robert/0000-0002-3154-0072; puoti, gianfranco/0000-0002-6452-2321; McGeehan, John/0000-0002-6750-1462; Rincon-Limas, Diego/0000-0003-3099-0642; Wang, Xinglong/0000-0001-8657-0159	National Institutes of Health [R01NS062787]; Creutzfeldt-Jakob Disease Foundation; Alliance BioSecure; University Center on Aging and Health; McGregor Foundation; Case Western Reserve University; Pacific Alzheimer Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062787] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/E500595/1] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Creutzfeldt-Jakob Disease Foundation; Alliance BioSecure; University Center on Aging and Health; McGregor Foundation; Case Western Reserve University; Pacific Alzheimer Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS062787 (to W.-Q.Z.), grants from the Creutzfeldt-Jakob Disease Foundation (to W.-Q.Z.), Alliance BioSecure (to W.-Q.Z.), the University Center on Aging and Health with the support of the McGregor Foundation and the President's Discretionary Fund (Case Western Reserve University) (to W.-Q.Z.), and the Pacific Alzheimer Research Foundation (to J.-P.G. and P.L.M.).	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Benilova I, 2010, EMBO MOL MED, V2, P289, DOI 10.1002/emmm.201000088; Berr C, 2003, ACTA NEUROPATHOL, V106, P71, DOI 10.1007/s00401-003-0700-7; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1997, EXP NEUROL, V146, P104, DOI 10.1006/exnr.1997.6505; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Del Bo R, 2006, NEUROBIOL AGING, V27, DOI 10.1016/j.neurobiolaging.2005.05.025; Dudal S, 2004, NEUROBIOL AGING, V25, P861, DOI 10.1016/j.neurobiolaging.2003.08.008; Esiri MM, 2000, NEUROPATH APPL NEURO, V26, P273, DOI 10.1046/j.1365-2990.2000.00239.x; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P49; Giasson BI, 2003, NEUROMOL MED, V4, P49, DOI 10.1385/NMM:4:1-2:49; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Gunther EC, 2010, J MOL MED, V88, P331, DOI 10.1007/s00109-009-0568-7; Guo JP, 2006, P NATL ACAD SCI USA, V103, P1953, DOI 10.1073/pnas.0509386103; Guo JP, 2004, VIROLOGY, V324, P251, DOI 10.1016/j.virol.2004.04.017; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; Kandel ER, 2009, J NEUROSCI, V29, P12748, DOI 10.1523/JNEUROSCI.3958-09.2009; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kovacs GG, 2002, NEUROSCI LETT, V329, P269, DOI 10.1016/S0304-3940(02)00668-7; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Ledford H, 2010, NATURE, V466, P1031, DOI 10.1038/4661031a; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Oliver AW, 2000, J MOL BIOL, V301, P575, DOI 10.1006/jmbi.2000.3991; Papassotiropoulos A, 2005, HUM MOL GENET, V14, P2241, DOI 10.1093/hmg/ddi228; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Schwarze-Eicker KA, 2005, NEUROBIOL AGING, V26, P1177, DOI 10.1016/j.neurobiolaging.2004.10.004; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Tompa P, 1998, NEUROSCIENCE, V86, P1037; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Yuan J, 2008, CELL MOL LIFE SCI, V65, P631, DOI 10.1007/s00018-007-7478-z; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang H, 1997, BIOCHEMISTRY-US, V36, P3543, DOI 10.1021/bi961965r; Zou WQ, 2007, CELL MOL LIFE SCI, V64, P3266, DOI 10.1007/s00018-007-7380-8; Zou WQ, 2010, J BIOL CHEM, V285, P13874, DOI 10.1074/jbc.M109.088831; Zou WQ, 2004, P NATL ACAD SCI USA, V101, P1380, DOI 10.1073/pnas.0307825100	49	67	67	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15095	15105		10.1074/jbc.M110.199356	http://dx.doi.org/10.1074/jbc.M110.199356			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21393248	Green Published, hybrid			2022-12-27	WOS:000289788300040
J	Orabi, AI; Shah, AU; Muili, K; Luo, YH; Mahmood, SM; Ahmad, A; Reed, A; Husain, SZ				Orabi, Abrahim I.; Shah, Ahsan U.; Muili, Kamaldeen; Luo, Yuhuan; Mahmood, Syeda Maham; Ahmad, Asim; Reed, Anamika; Husain, Sohail Z.			Ethanol Enhances Carbachol-induced Protease Activation and Accelerates Ca2+ Waves in Isolated Rat Pancreatic Acini	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL TRISPHOSPHATE RECEPTORS; CALCIUM-RELEASE CHANNELS; C-ALPHA PHOSPHORYLATION; RYANODINE RECEPTOR; KINASE-C; BASOLATERAL EXOCYTOSIS; ALCOHOLIC PANCREATITIS; ZYMOGEN ACTIVATION; ETHYL-ESTERS; ENZYME ACTIVATION	Alcohol abuse is a leading cause of pancreatitis, accounting for 30% of acute cases and 70-90% of chronic cases, yet the mechanisms leading to alcohol-associated pancreatic injury are unclear. An early and critical feature of pancreatitis is the aberrant signaling of Ca2+ within the pancreatic acinar cell. An important conductor of this Ca2+ is the basolaterally localized, intracellular Ca2+ channel ryanodine receptor (RYR). In this study, we examined the effect of ethanol on mediating both pathologic intra-acinar protease activation, a precursor to pancreatitis, as well as RYR Ca2+ signals. We hypothesized that ethanol sensitizes the acinar cell to protease activation by modulating RYR Ca2+. Acinar cells were freshly isolated from rat, pretreated with ethanol, and stimulated with the muscarinic agonist carbachol (1 mu M). Ethanol caused a doubling in the carbachol-induced activation of the proteases trypsin and chymotrypsin (p < 0.02). The RYR inhibitor dantrolene abrogated the enhancement of trypsin and chymotrypsin activity by ethanol (p < 0.005 for both proteases). Further, ethanol accelerated the speed of the apical to basolateral Ca2+ wave from 9 to 18 mu m/s (p < 0.0005; n = 18-22 cells/group); an increase in Ca2+ wave speed was also observed with a change from physiologic concentrations of carbachol (1 mu M) to a supraphysiologic concentration (1 mM) that leads to protease activation. Dantrolene abrogated the ethanol-induced acceleration of wave speed (p < 0.05; n = 10-16 cells/group). Our results suggest that the enhancement of pathologic protease activation by ethanol is dependent on the RYR and that a novel mechanism for this enhancement may involve RYR-mediated acceleration of Ca2+ waves.	[Orabi, Abrahim I.; Shah, Ahsan U.; Muili, Kamaldeen; Luo, Yuhuan; Mahmood, Syeda Maham; Ahmad, Asim; Reed, Anamika; Husain, Sohail Z.] Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Husain, SZ (corresponding author), Yale Child Hlth Res Ctr, 464 Congress Ave,Rm 222, New Haven, CT 06520 USA.	sohail.husain@yale.edu			National Institutes of Health [RO1 DK083327, R03 DK078707, K12 HD001401, DK34989]; American Gastroenterological Association; Children's Digestive Health and Nutrition Young Investigator Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090104, R01DK083327, P30DK034989, R03DK078707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association; Children's Digestive Health and Nutrition Young Investigator Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK083327, R03 DK078707, K12 HD001401, and DK34989 (to S. Z. H.), an American Gastroenterological Association Fellowship to Faculty Transition Award (to A. R.), and a Children's Digestive Health and Nutrition Young Investigator Award (to S. Z. H.).	Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Best CA, 2003, FRONT BIOSCI-LANDMRK, V8, pE202, DOI 10.2741/931; Cosen-Binker LI, 2008, J CLIN INVEST, V118, P2535, DOI 10.1172/JCI34672; Cosen-Binker LI, 2007, GASTROENTEROLOGY, V132, P1527, DOI 10.1053/j.gastro.2007.01.042; Cosen-Binker LI, 2007, J BIOL CHEM, V282, P13047, DOI 10.1074/jbc.M611132200; Cosen-Binker LI, 2007, CAN J GASTROENTEROL, V21, P19, DOI 10.1155/2007/930424; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Fernandez-Sanchez M, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-77; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Fitzsimmons TJ, 2000, BIOCHEM J, V351, P265, DOI 10.1042/0264-6021:3510265; Gerasimenko JV, 2009, P NATL ACAD SCI USA, V106, P10758, DOI 10.1073/pnas.0904818106; Gonzalez A, 1999, BIOCHEM BIOPH RES CO, V261, P726, DOI 10.1006/bbrc.1999.1106; Gonzalez A, 1998, AM J PHYSIOL-CELL PH, V275, pC810, DOI 10.1152/ajpcell.1998.275.3.C810; Gonzalez A, 2008, ALCOHOL, V42, P565, DOI 10.1016/j.alcohol.2008.06.005; Grady T, 1998, AM J PHYSIOL-GASTR L, V275, pG1010, DOI 10.1152/ajpgi.1998.275.5.G1010; Gukovskaya AS, 2002, GASTROENTEROLOGY, V122, P106, DOI 10.1053/gast.2002.30302; HABER PS, 1993, J LAB CLIN MED, V121, P759; Haber PS, 1998, J LAB CLIN MED, V132, P294, DOI 10.1016/S0022-2143(98)90042-7; Husain SZ, 2007, AM J PHYSIOL-GASTR L, V292, pG1594, DOI 10.1152/ajpgi.00500.2006; Husain SZ, 2005, P NATL ACAD SCI USA, V102, P14386, DOI 10.1073/pnas.0503215102; Ito K, 1999, J CELL BIOL, V146, P405, DOI 10.1083/jcb.146.2.405; KASAI H, 1993, CELL, V74, P669, DOI 10.1016/0092-8674(93)90514-Q; Katz M, 1996, AM J PHYSIOL-GASTR L, V270, pG171, DOI 10.1152/ajpgi.1996.270.1.G171; Lam PPL, 2007, TRAFFIC, V8, P605, DOI 10.1111/j.1600-0854.2007.00557.x; LAPOSATA EA, 1986, SCIENCE, V231, P497, DOI 10.1126/science.3941913; Leite MF, 2002, GASTROENTEROLOGY, V122, P415, DOI 10.1053/gast.2002.30982; Lerch MM, 2000, MED CLIN N AM, V84, P549, DOI 10.1016/S0025-7125(05)70239-X; Lowenfels Albert B, 2005, Curr Gastroenterol Rep, V7, P90, DOI 10.1007/s11894-005-0045-6; Lu Z, 2002, AM J PHYSIOL-GASTR L, V282, pG501, DOI 10.1152/ajpgi.00388.2001; Lugea A, 2010, ALCOHOL CLIN EXP RES, V34, P1768, DOI 10.1111/j.1530-0277.2010.01264.x; NATHANSON MH, 1992, J BIOL CHEM, V267, P18118; NORDBACK IH, 1991, ANN SURG, V214, P671, DOI 10.1097/00000658-199112000-00006; Orabi AI, 2010, AM J PHYSIOL-GASTR L, V299, pG196, DOI 10.1152/ajpgi.00498.2009; OWYANG C, 1996, AM J PHYSIOL, V271, P1; Pandol SJ, 1999, GASTROENTEROLOGY, V117, P706, DOI 10.1016/S0016-5085(99)70465-8; Pfeiffer F, 1998, AM J PHYSIOL-CELL PH, V274, pC663; PONNAPPA BC, 1987, BIOCHEM PHARMACOL, V36, P69, DOI 10.1016/0006-2952(87)90383-2; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; Satoh A, 2006, AM J PHYSIOL-GASTR L, V291, pG432, DOI 10.1152/ajpgi.00579.2005; Shah AU, 2008, AM J PHYSIOL-GASTR L, V294, pG1328, DOI 10.1152/ajpgi.00440.2007; Shah AU, 2009, AM J PHYSIOL-GASTR L, V297, pG967, DOI 10.1152/ajpgi.00181.2009; STEINBERG W, 1994, NEW ENGL J MED, V330, P1198, DOI 10.1056/NEJM199404283301706; Straub SV, 2000, J GEN PHYSIOL, V116, P547, DOI 10.1085/jgp.116.4.547; Virlos I, 2004, INTENS CARE MED, V30, P1645, DOI 10.1007/s00134-004-2328-z; WAKUI M, 1989, NATURE, V339, P317, DOI 10.1038/339317a0; Weber H, 2004, AM J PHYSIOL-GASTR L, V286, pG932, DOI 10.1152/ajpgi.00406.2003; Weber H, 2009, INT J EXP PATHOL, V90, P387, DOI 10.1111/j.1365-2613.2009.00638.x; Werner J, 1997, GASTROENTEROLOGY, V113, P286, DOI 10.1016/S0016-5085(97)70106-9; WILSON JS, 1990, J LAB CLIN MED, V115, P749; Zhou H, 2007, BIOCHEM BIOPH RES CO, V352, P277, DOI 10.1016/j.bbrc.2006.10.174	55	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14090	14097		10.1074/jbc.M110.196832	http://dx.doi.org/10.1074/jbc.M110.196832			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21372126	Green Published, hybrid			2022-12-27	WOS:000289556200032
J	Diaz, A; Martinez-Pons, C; Fita, I; Ferrer, JC; Guinovart, JJ				Diaz, Adelaida; Martinez-Pons, Carlos; Fita, Ignacio; Ferrer, Juan C.; Guinovart, Joan J.			Processivity and Subcellular Localization of Glycogen Synthase Depend on a Non-catalytic High Affinity Glycogen-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PROTEIN; DEGRADATION; MECHANISM; DISEASE; GLUCOSE; LAFORA; DOMAIN	Glycogen synthase, a central enzyme in glucose metabolism, catalyzes the successive addition of alpha-1,4-linked glucose residues to the non-reducing end of a growing glycogen molecule. A non-catalytic glycogen-binding site, identified by x-ray crystallography on the surface of the glycogen synthase from the archaeon Pyrococcus abyssi, has been found to be functionally conserved in the eukaryotic enzymes. The disruption of this binding site in both the archaeal and the human muscle glycogen synthases has a large impact when glycogen is the acceptor substrate. Instead, the catalytic efficiency remains essentially unchanged when small oligosaccharides are used as substrates. Mutants of the human muscle enzyme with reduced affinity for glycogen also show an altered intracellular distribution and a marked decrease in their capacity to drive glycogen accumulation in vivo. The presence of a high affinity glycogen-binding site away from the active center explains not only the long-recognized strong binding of glycogen synthase to glycogen but also the processivity and the intracellular localization of the enzyme. These observations demonstrate that the glycogen-binding site is a critical regulatory element responsible for the in vivo catalytic efficiency of GS.	[Diaz, Adelaida; Martinez-Pons, Carlos; Fita, Ignacio; Guinovart, Joan J.] CSIC, Inst Res Biomed, E-08028 Barcelona, Spain; [Fita, Ignacio] CSIC, Inst Biol Mol Barcelona, E-08028 Barcelona, Spain; [Ferrer, Juan C.; Guinovart, Joan J.] Univ Barcelona, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain; [Diaz, Adelaida; Martinez-Pons, Carlos; Guinovart, Joan J.] CIBER Diabet & Enfermedades Metab, Barcelona 08017, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Guinovart, JJ (corresponding author), Baldiri & Reixac 10, Barcelona 08028, Spain.	guinovart@irbbarcelona.org	Fita, Ignasi/R-4515-2019; Ferrer, Joan C./AAP-2145-2021	Fita, Ignasi/0000-0002-7521-2679; Diaz-Vilchis, Adelaida/0000-0001-5891-1470; Ferrer, Joan C./0000-0003-1212-5161	Direccion General de Investigacion, Ministerio de Ciencia y Tecnologia, Spain [BFU2009-09268, CTQ2006-00743, BFU2008-00769]; Generalitat de Catalunya [2009SGR-1176]; Fundacion Marcelino Botin; CIBER de Diabetes y Enfermedades Metabolicas Asociadas; Ministerio de Ciencia e Innovacion; Juan de la Cierva [JCI-2006-4024-4021]; Ministerio de Educacion [AP2005-3078]	Direccion General de Investigacion, Ministerio de Ciencia y Tecnologia, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Fundacion Marcelino Botin; CIBER de Diabetes y Enfermedades Metabolicas Asociadas; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Juan de la Cierva(Instituto de Salud Carlos III); Ministerio de Educacion	This work was supported by the Direccion General de Investigacion, Ministerio de Ciencia y Tecnologia, Spain Grants BFU2009-09268 (to I. F.), CTQ2006-00743 (to J. C. F.), and BFU2008-00769 (to J. J. G.), a grant from the Generalitat de Catalunya AGAUR 2009SGR-1176 (to J. J. G.), a grant from the Fundacion Marcelino Botin, and the CIBER de Diabetes y Enfermedades Metabolicas Asociadas.; Recipient of a postdoctoral fellowship from the Ministerio de Ciencia e Innovacion and currently JCI-2006-4024-4021 Juan de la Cierva.; Recipient of Predoctoral Fellowship AP2005-3078 from the Ministerio de Educacion.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Baba O, 1993, Kokubyo Gakkai Zasshi, V60, P264; Baskaran S, 2010, P NATL ACAD SCI USA, V107, P17563, DOI 10.1073/pnas.1006340107; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Cid E, 2005, FEBS J, V272, P3197, DOI 10.1111/j.1742-4658.2005.04738.x; Cid E, 2002, FEBS LETT, V528, P5, DOI 10.1016/S0014-5793(02)03313-6; Cohen PTW, 2002, J CELL SCI, V115, P241; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer JC, 1997, FEBS LETT, V415, P249, DOI 10.1016/S0014-5793(97)01136-8; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Horcajada C, 2006, J BIOL CHEM, V281, P2923, DOI 10.1074/jbc.M507394200; Horcajada C, 2003, ACTA CRYSTALLOGR D, V59, P2322, DOI 10.1107/S0907444903021279; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; MELENDEZHEVIA E, 1993, BIOCHEM J, V295, P477, DOI 10.1042/bj2950477; NEWGARD CB, 1983, J BIOL CHEM, V258, P8046; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Pinotsis N, 2003, PROTEIN SCI, V12, P1914, DOI 10.1110/ps.03149503; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Sheng F, 2009, BIOCHEMISTRY-US, V48, P10089, DOI 10.1021/bi900916t; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; SKURAT AV, 1994, J BIOL CHEM, V269, P25534; Stapleton D, 2010, PROTEOMICS, V10, P2320, DOI 10.1002/pmic.200900628; TAKEDA Y, 1975, J BIOL CHEM, V250, P8943; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wilson WA, 2010, CAN J MICROBIOL, V56, P408, DOI [10.1139/W10-027, 10.1139/w10-027]; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200	35	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18505	18514		10.1074/jbc.M111.236109	http://dx.doi.org/10.1074/jbc.M111.236109			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21464127	hybrid, Green Published			2022-12-27	WOS:000290785700023
J	de Oliveira, AL; Gallo, M; Pazzagli, L; Benedetti, CE; Cappugi, G; Scala, A; Pantera, B; Spisni, A; Pertinhez, TA; Cicero, DO				de Oliveira, Aline L.; Gallo, Mariana; Pazzagli, Luigia; Benedetti, Celso E.; Cappugi, Gianni; Scala, Aniello; Pantera, Barbara; Spisni, Alberto; Pertinhez, Thelma A.; Cicero, Daniel O.			The Structure of the Elicitor Cerato-platanin (CP), the First Member of the CP Fungal Protein Family, Reveals a Double psi beta-Barrel Fold and Carbohydrate Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUAL DIPOLAR COUPLINGS; RESONANCE ASSIGNMENTS; PHYTOTOXIC PROTEIN; BIOCHEMICAL-CHARACTERIZATION; SYSTEMIC RESISTANCE; MAGNAPORTHE-GRISEA; CRYSTAL-STRUCTURE; SECRETED PROTEIN; SH3 DOMAIN; SEQUENCE	Cerato-platanin (CP) is a secretion protein produced by the fungal pathogen Ceratocystis platani, the causal agent of the plane canker disease and the first member of the CP family. CP is considered a pathogen-associated molecular pattern because it induces various defense responses in the host, including production of phytoalexins and cell death. Although much is known about the properties of CP and related proteins as elicitors of plant defense mechanisms, its biochemical activity and host target(s) remain elusive. Here, we present the three-dimensional structure of CP. The protein, which exhibits a remarkable pH and thermal stability, has a double psi beta-barrel fold quite similar to those found in expansins, endoglucanases, and the plant defense protein barwin. Interestingly, although CP lacks lytic activity against a variety of carbohydrates, it binds oligosaccharides. We identified the CP region responsible for binding as a shallow surface located at one side of the beta-barrel. Chemical shift perturbation of the protein amide protons, induced by oligo-N-acetylglucosamines of various size, showed that all the residues involved in oligosaccharide binding are conserved among the members of the CP family. Overall, the results suggest that CP might be involved in polysaccharide recognition and that the double psi beta-barrel fold is widespread in distantly related organisms, where it is often involved in host-microbe interactions.	[Spisni, Alberto; Pertinhez, Thelma A.] Univ Parma, Dept Expt Med, I-43125 Parma, Italy; [de Oliveira, Aline L.; Benedetti, Celso E.] Natl Lab Biosci, BR-13083100 Campinas, SP, Brazil; [Gallo, Mariana; Cicero, Daniel O.] Univ Roma Tor Vergata, Dept Chem Sci & Technol, I-00133 Rome, Italy; [Pazzagli, Luigia; Cappugi, Gianni; Pantera, Barbara] Univ Florence, Dept Biochem Sci, I-50134 Florence, Italy; [Scala, Aniello] Univ Florence, Dept Agr Biotechnol, I-50134 Florence, Italy	University of Parma; University of Rome Tor Vergata; University of Florence; University of Florence	Spisni, A (corresponding author), Univ Parma, Dept Expt Med, Via Volturno 39, I-43125 Parma, Italy.	alberto.spisni@unipr.it; cicero@scienze.uniroma2.it	Oliveira, Aline L/D-2953-2012; Cicero, Daniel/AAV-5203-2021; Spisni, Alberto/AAY-7778-2020; Citros, Inct/I-2442-2013	Oliveira, Aline L/0000-0002-6928-078X; Benedetti, Celso/0000-0002-4602-0256; Gallo, Mariana/0000-0002-0022-4499	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [99/11030-9, TAP 00/02026-7, Smolbnet 00/10266-8]; Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR) [20050717.5-002]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [BEX3666/05-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported in part by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (NMR Project 99/11030-9, TAP 00/02026-7, Smolbnet 00/10266-8) and from the Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR) (PRIN 2005 20050717.5-002). Some of the CD and NMR experiments were carried out using equipment at the Centro Interfacolta Misure, University of Parma.; Supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Fellowship 03/12418-8 and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Fellowship BEX3666/05-0. Present address: Inst. de Quimica, Universidade Federal de Goias, 74001-970 Goiania, Brazil.	Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bernardi R., 2011, FOREST PATH IN PRESS, V41; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Boddi S, 2004, FEMS MICROBIOL LETT, V233, P341, DOI [10.1016/j.femsle.2004.03.001, 10.1111/j.1574-6968.2004.tb09501.x]; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Carresi L, 2006, PROTEIN EXPRES PURIF, V49, P159, DOI 10.1016/j.pep.2006.07.006; Castillo RM, 1999, STRUCTURE, V7, P227, DOI 10.1016/S0969-2126(99)80028-8; CERVONE F, 1989, PLANT PHYSIOL, V90, P542, DOI 10.1104/pp.90.2.542; Cicero DO, 2006, J MAGN RESON, V180, P222, DOI 10.1016/j.jmr.2006.02.016; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Comparini C, 2009, APPL MICROBIOL BIOT, V84, P309, DOI 10.1007/s00253-009-1998-4; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davies GJ, 1995, BIOCHEMISTRY-US, V34, P16210, DOI 10.1021/bi00049a037; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; de Wit PJGM, 2007, CELL MOL LIFE SCI, V64, P2726, DOI 10.1007/s00018-007-7284-7; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Djonovic S, 2007, PLANT PHYSIOL, V145, P875, DOI 10.1104/pp.107.103689; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Eliseo T, 2007, BIOCHEMISTRY-US, V46, P12557, DOI 10.1021/bi7013085; Eriksson J, 2005, J COLLOID INTERF SCI, V285, P94, DOI 10.1016/j.jcis.2004.10.042; Fontana F, 2008, J PLANT PATHOL, V90, P295; GILKES NR, 1991, MICROBIOL REV, V55, P303, DOI 10.1128/MMBR.55.2.303-315.1991; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Gueguen Y, 1997, J BIOL CHEM, V272, P31258, DOI 10.1074/jbc.272.50.31258; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Hirvonen M, 2003, J MOL BIOL, V329, P403, DOI 10.1016/S0022-2836(03)00467-4; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hseu YC, 2005, INT IMMUNOPHARMACOL, V5, P1914, DOI 10.1016/j.intimp.2005.06.013; Jeong JS, 2007, FEMS MICROBIOL LETT, V273, P157, DOI 10.1111/j.1574-6968.2007.00796.x; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jones JA, 1997, J BIOMOL NMR, V10, P199, DOI 10.1023/A:1018304117895; Juge N, 2006, TRENDS PLANT SCI, V11, P359, DOI 10.1016/j.tplants.2006.05.006; Kerff F, 2008, P NATL ACAD SCI USA, V105, P16876, DOI 10.1073/pnas.0809382105; Kim YT, 2010, MOL BIOL REP, V37, P717, DOI 10.1007/s11033-009-9570-y; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; LUDVIGSEN S, 1992, BIOCHEMISTRY-US, V31, P8783, DOI 10.1021/bi00152a014; McFeeters R, 2005, J BIOMOL NMR, V31, P35, DOI 10.1007/s10858-004-6057-y; MUHANDIRAM DR, 1993, J MAGN RESON SER B, V102, P317, DOI 10.1006/jmrb.1993.1102; Oliveira AL, 2006, J BIOMOL NMR, V36, P50, DOI 10.1007/s10858-006-9023-z; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; PAN SC, 1995, INFECT IMMUN, V63, P3994, DOI 10.1128/IAI.63.10.3994-4002.1995; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; Pazzagli L, 2006, CELL BIOCHEM BIOPHYS, V44, P512, DOI 10.1385/CBB:44:3:512; Pazzagli L, 2009, BBA-GEN SUBJECTS, V1790, P1334, DOI 10.1016/j.bbagen.2009.07.014; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Powell AJ, 2006, J MOL BIOL, V359, P122, DOI 10.1016/j.jmb.2006.03.023; Rementeria Aitor, 2005, Revista Iberoamericana de Micologia, V22, P1, DOI 10.1016/S1130-1406(05)70001-2; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Scala A, 2004, J PLANT PATHOL, V86, P27; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Seidl V, 2006, FEBS J, V273, P4346, DOI 10.1111/j.1742-4658.2006.05435.x; Svozilova Z, 2009, ANAL BIOCHEM, V390, P115, DOI 10.1016/j.ab.2009.04.012; Vargas WA, 2008, J BIOL CHEM, V283, P19804, DOI 10.1074/jbc.M802724200; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Waldeck AR, 1997, PROG NUCL MAG RES SP, V30, P39, DOI 10.1016/S0079-6565(96)01034-5; Wang YX, 1998, J AM CHEM SOC, V120, P7385, DOI 10.1021/ja980862o; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Wilson LM, 2002, MOL PLANT PATHOL, V3, P487, DOI 10.1046/j.1364-3703.2002.00144.x; Wood T.M., 1988, METHOD ENZYMOL, P87, DOI DOI 10.1016/0076-6879(88)60109-1; Yang YY, 2009, PLANT BIOTECHNOL J, V7, P763, DOI 10.1111/j.1467-7652.2009.00442.x; YORK WS, 1986, METHOD ENZYMOL, V118, P3; Zaparoli G, 2009, MYCOL RES, V113, P61, DOI 10.1016/j.mycres.2008.08.004; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	69	78	78	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17560	17568		10.1074/jbc.M111.223644	http://dx.doi.org/10.1074/jbc.M111.223644			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454637	Green Published, hybrid			2022-12-27	WOS:000290585200018
J	Nour, AM; Reichelt, M; Ku, CC; Ho, MY; Heineman, TC; Arvin, AM				Nour, Adel M.; Reichelt, Mike; Ku, Chia-Chi; Ho, Min-Yin; Heineman, Thomas C.; Arvin, Ann M.			Varicella-Zoster Virus Infection Triggers Formation of an Interleukin-1 beta (IL-1 beta)-processing Inflammasome Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR MESANGIAL CELLS; INNATE IMMUNE-RESPONSE; NALP3 INFLAMMASOME; AIM2 INFLAMMASOME; MONONUCLEAR-CELLS; CASPASE-1 ACTIVATION; MURINE MACROPHAGES; NLRP3 INFLAMMASOME; VIRAL REPLICATION; DENDRITIC CELLS	Innate cellular immunity is the immediate host response against pathogens, and activation of innate immunity also modulates the induction of adaptive immunity. The nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) are a family of intracellular receptors that recognize conserved patterns associated with intracellular pathogens, but information about their role in the host defense against DNA viruses is limited. Here we report that varicella-zoster virus (VZV), an alphaherpesvirus that is the causative agent of varicella and herpes zoster, induces formation of the NLRP3 inflammasome and the associated processing of the proinflammatory cytokine IL-1 beta by activated caspase-1 in infected cells. NLRP3 inflammasome formation was induced in VZV-infected human THP-1 cells, which are a transformed monocyte cell line, primary lung fibroblasts, and melanoma cells. Absent in melanoma gene-2 (AIM2) is an interferon-inducible protein that can form an alternative inflammasome complex with caspase-1 in virus-infected cells. Experiments in VZV-infected melanoma cells showed that NLRP3 protein recruits the adaptor protein ASC and caspase-1 to form an NLRP3 inflammasome complex independent of AIM2 protein and in the absence of free radical reactive oxygen species release. NLRP3 was also expressed extensively in infected skin xenografts in the severe combined immunodeficiency mouse model of VZV pathogenesis in vivo. We conclude that NLRP3 inflammasome formation is an innate cellular response to infection with this common pathogenic human herpesvirus.	[Nour, Adel M.; Reichelt, Mike; Arvin, Ann M.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Nour, Adel M.; Reichelt, Mike; Arvin, Ann M.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Heineman, Thomas C.] GlaxoSmithKline Biol, King Of Prussia, PA 19101 USA; [Ku, Chia-Chi; Ho, Min-Yin] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan	Stanford University; Stanford University; GlaxoSmithKline; National Taiwan University	Nour, AM (corresponding author), Stanford Univ, Dept Pediat, Sch Med, 300 Pasteur Dr, Stanford, CA 94305 USA.	adelmn@stanford.edu		KU, CHIA-CHI/0000-0002-5740-1505	NCI, National Institutes of Health [AI20459, AI053846, CA49605]; NATIONAL CANCER INSTITUTE [P01CA049605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020459, R01AI053846, R01AI020459] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI20459 and AI053846 and Grant CA49605 from the NCI.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; ARBEIT RD, 1982, INTERVIROLOGY, V18, P56, DOI 10.1159/000149304; Arlehamn CSL, 2010, J BIOL CHEM, V285, P10508, DOI 10.1074/jbc.M109.067298; ARVIN AM, 1986, J INFECT DIS, V154, P422, DOI 10.1093/infdis/154.3.422; Bannister B., 2006, INFECTION MICROBIOLO; BEUSCHER HU, 1990, J IMMUNOL, V144, P2179; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Bruder E, 2000, VIRCHOWS ARCH, V437, P440, DOI 10.1007/s004280000236; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Choubey D, 2000, FEBS LETT, V474, P38, DOI 10.1016/S0014-5793(00)01571-4; Cohen J. I., 2007, VIROLOGY, P2773; COHEN JI, 1993, P NATL ACAD SCI USA, V90, P7376, DOI 10.1073/pnas.90.15.7376; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; DeYoung KL, 1997, ONCOGENE, V15, P453, DOI 10.1038/sj.onc.1201206; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Fujioka N, 1999, J VIROL, V73, P2401, DOI 10.1128/JVI.73.3.2401-2409.1999; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hwang SM, 2009, CELL HOST MICROBE, V5, P166, DOI 10.1016/j.chom.2008.12.013; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Jaworska J, 2007, J VIROL, V81, P5737, DOI 10.1128/JVI.02443-06; Joly S, 2009, J IMMUNOL, V183, P3578, DOI 10.4049/jimmunol.0901323; Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07; KAKIZAKI Y, 1993, CLIN EXP IMMUNOL, V91, P521; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Ku CC, 2004, J EXP MED, V200, P917, DOI 10.1084/jem.20040634; Ku CC, 2011, IMMUNOL CELL BIOL, V89, P173, DOI 10.1038/icb.2010.83; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Lagos D, 2008, CELL HOST MICROBE, V4, P470, DOI 10.1016/j.chom.2008.09.012; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; LOVETT DH, 1988, AM J PATHOL, V133, P472; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2007, EUR J IMMUNOL, V37, P3003, DOI 10.1002/eji.200737871; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; Monack DM, 2000, J EXP MED, V192, P249, DOI 10.1084/jem.192.2.249; Mueller NH, 2008, NEUROL CLIN, V26, P675, DOI 10.1016/j.ncl.2008.03.011; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nour AM, 2009, INFECT IMMUN, V77, P1262, DOI 10.1128/IAI.01032-08; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Reichelt M, 2009, J VIROL, V83, P3904, DOI 10.1128/JVI.02137-08; ROY S, 1995, FEBS LETT, V376, P164, DOI 10.1016/0014-5793(95)01266-X; Sen N, 2010, J VIROL, V84, P9240, DOI 10.1128/JVI.01147-10; Shaikh S, 2002, AM FAM PHYSICIAN, V66, P1723; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Silveira TN, 2010, INFECT IMMUN, V78, P1403, DOI 10.1128/IAI.00905-09; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Squires RC, 2007, J BIOL CHEM, V282, P34260, DOI 10.1074/jbc.M705687200; TAKAHASH.M, 1974, LANCET, V2, P1288, DOI 10.1016/S0140-6736(74)90144-5; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Torigoe S, 2000, MICROBIOL IMMUNOL, V44, P1027, DOI 10.1111/j.1348-0421.2000.tb02599.x; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; WHITACRE CM, 1992, CELL IMMUNOL, V144, P287, DOI 10.1016/0008-8749(92)90245-K; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zhu SM, 2009, J ZHEJIANG UNIV-SC B, V10, P625, DOI 10.1631/jzus.B0920049	77	69	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17921	17933		10.1074/jbc.M110.210575	http://dx.doi.org/10.1074/jbc.M110.210575			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21385879	hybrid, Green Published			2022-12-27	WOS:000290585200055
J	Yan, WS; Zhang, YH; Zhang, J; Liu, S; Cho, SJ; Chen, XB				Yan, Wensheng; Zhang, Yanhong; Zhang, Jin; Liu, Shou; Cho, Seong Jun; Chen, Xinbin			Mutant p53 Protein Is Targeted by Arsenic for Degradation and Plays a Role in Arsenic-mediated Growth Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; LI-FRAUMENI-SYNDROME; GENE-EXPRESSION; INDUCED APOPTOSIS; OXIDATIVE STRESS; TP53 MUTATIONS; NUCLEAR EXPORT; HUMAN CANCERS; CORE DOMAIN; CELL LINES	p53 is frequently mutated in tumor cells, and mutant p53 is often highly expressed due to its increased half-life. Thus, targeting mutant p53 for degradation might be explored as a therapeutic strategy to manage tumors that are addicted to mutant p53 for survival. Arsenic trioxide, a drug for patients with acute promyelocytic leukemia, is found to target and degrade a class of proteins with high levels of cysteine residues and vicinal thiol groups, such as promyelocytic leukemia protein (PML) and PML-retinoic acid receptor alpha fusion protein. Interestingly, wild type p53 is accumulated in cells treated with arsenic compounds, presumably due to arsenic-induced oxidative stresses. In this study, we found that wild type p53 is induced by arsenic trioxide in tumor cells, consistent with published studies. In contrast, we found that arsenic compounds degrade both endogenous and ectopically expressed mutant p53 in time-and dose-dependent manners. We also found that arsenic trioxide decreases the stability of mutant p53 protein through a proteasomal pathway, and blockage of mutant p53 nuclear export can alleviate the arsenic-induced mutant p53 degradation. Furthermore, we found that knockdown of endogenous mutant p53 sensitizes, whereas ectopic expression of mutant p53 desensitizes, tumor cells to arsenic treatment. Taken together, we found that mutant p53 is a target of arsenic compounds, which provides an insight into exploring arsenic compound-based therapy for tumors harboring a mutant p53.	[Yan, Wensheng; Zhang, Yanhong; Zhang, Jin; Liu, Shou; Cho, Seong Jun; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu	liu, shou/C-5406-2015; qiao, zhixin/I-3408-2012; Cho, Seong-Jun/P-2491-2019		National Institutes of Health [R01CA121137]; NATIONAL CANCER INSTITUTE [P30CA093373, R01CA121137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA121137.	Bergamaschi D, 2003, CANCER CELL, V3, P387, DOI 10.1016/S1535-6108(03)00079-5; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Carney DA, 2008, LEUKEMIA LYMPHOMA, V49, P1846, DOI 10.1080/10428190802464745; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Cheng YH, 2006, ARCH TOXICOL, V80, P310, DOI 10.1007/s00204-005-0045-1; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Haupt S, 2009, CANCER RES, V69, P4818, DOI 10.1158/0008-5472.CAN-08-4010; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ichimiya S, 1999, ONCOGENE, V18, P1061, DOI 10.1038/sj.onc.1202390; Ishitsuka K, 2000, LEUKEMIA LYMPHOMA, V37, P649, DOI 10.3109/10428190009058521; Jeanne M, 2010, CANCER CELL, V18, P88, DOI 10.1016/j.ccr.2010.06.003; Jiang XH, 2001, INT J CANCER, V91, P173, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1039>3.0.CO;2-D; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; Kim J, 2010, P NATL ACAD SCI USA, V107, P13432, DOI 10.1073/pnas.1006822107; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee JH, 2008, J BIOL CHEM, V283, P19826, DOI 10.1074/jbc.M706201200; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; Lundgren K, 1997, GENE DEV, V11, P714, DOI 10.1101/gad.11.6.714; Mann KK, 2008, MOL CANCER THER, V7, P1680, DOI 10.1158/1535-7163.MCT-07-2164; Miller WH, 2002, CANCER RES, V62, P3893; Moll UM, 2004, MOL CANCER RES, V2, P371; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Pelicano H, 2003, J BIOL CHEM, V278, P37832, DOI 10.1074/jbc.M301546200; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Platanias LC, 2009, J BIOL CHEM, V284, P18583, DOI 10.1074/jbc.R900003200; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Rollig C, 2009, CANCER TREAT REV, V35, P425, DOI 10.1016/j.ctrv.2009.04.007; Sakurai Teruaki, 2006, Environmental Sciences, V13, P101; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Shackelford D, 2006, CANCER RES, V66, P11360, DOI 10.1158/0008-5472.CAN-06-1774; Shen L, 2000, J BIOL REG HOMEOS AG, V14, P116; Shen Y, 2001, LEUKEMIA, V15, P735, DOI 10.1038/sj.leu.2402106; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Wu XS, 2010, CANCER BIOL THER, V10, P1202, DOI 10.4161/cbt.10.11.13669; Yan WS, 2008, CANCER RES, V68, P6789, DOI 10.1158/0008-5472.CAN-08-0810; Yan WS, 2010, J BIOL CHEM, V285, P14229, DOI 10.1074/jbc.M109.097253; Yan WS, 2009, J BIOL CHEM, V284, P12178, DOI 10.1074/jbc.M900994200; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Zalcenstein A, 2003, ONCOGENE, V22, P5667, DOI 10.1038/sj.onc.1206724; Zhang QY, 2009, P NATL ACAD SCI USA, V106, P3378, DOI 10.1073/pnas.0813142106; Zhang TD, 2001, ONCOGENE, V20, P7146, DOI 10.1038/sj.onc.1204762; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	62	45	49	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17478	17486		10.1074/jbc.M111.231639	http://dx.doi.org/10.1074/jbc.M111.231639			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454520	Green Published, hybrid			2022-12-27	WOS:000290585200009
J	Giddings, LA; Liscombe, DK; Hamilton, JP; Childs, KL; DellaPenna, D; Buell, CR; O'Connor, SE				Giddings, Lesley-Ann; Liscombe, David K.; Hamilton, John P.; Childs, Kevin L.; DellaPenna, Dean; Buell, C. Robin; O'Connor, Sarah E.			A Stereoselective Hydroxylation Step of Alkaloid Biosynthesis by a Unique Cytochrome P450 in Catharanthus roseus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MADAGASCAR PERIWINKLE; TABERSONINE; ENZYME; EXPRESSION; CULTURES; CHEMISTRY; GENES; YEAST	Plant cytochrome P450s are involved in the production of over a hundred thousand metabolites such as alkaloids, terpenoids, and phenylpropanoids. Although cytochrome P450 genes constitute one of the largest superfamilies in plants, many of the catalytic functions of the enzymes they encode remain unknown. Here, we report the identification and functional characterization of a cytochrome P450 gene in a new subfamily of CYP71, CYP71BJ1, involved in alkaloid biosynthesis. Co-expression analysis of putative cytochrome P450 genes in the Catharanthus roseus transcriptome identified candidate genes with expression profiles similar to known terpene indole alkaloid biosynthetic genes. Screening of these candidate genes by functional expression in Saccharomyces cerevisiae yielded a unique P450-dependent enzyme that stereoselectively hydroxylates the alkaloids tabersonine and lochnericine at the 19-position of the aspidosperma-type alkaloid scaffold. Tabersonine, which can be converted to either vindoline or 19-O-acetylhorhammericine, represents a branch point in alkaloid biosynthesis. The discovery of CYP71BJ1, which forms part of the pathway leading to 19-O-acetylhorhammericine, will help illuminate how this branch point is controlled in C. roseus.	[Giddings, Lesley-Ann; Liscombe, David K.; O'Connor, Sarah E.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Hamilton, John P.; Childs, Kevin L.; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [DellaPenna, Dean] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Massachusetts Institute of Technology (MIT); Michigan State University; Michigan State University	O'Connor, SE (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	soc@mit.edu	O'Connor, Sarah Ellen/X-2893-2019; Hamilton, John P/G-1379-2016; O'Connor, Sarah/O-5850-2016; Childs, Kevin/C-9513-2014	Hamilton, John P/0000-0002-8682-5526; Giddings, Lesley-Ann/0000-0003-1089-1276; Buell, C Robin/0000-0002-6727-4677; O'Connor, Sarah/0000-0003-0356-6213; Childs, Kevin/0000-0002-3680-062X	National Institutes of Health [GM074820, RC2GM092521, 1S10RR13886-01]; National Science Foundation; Ford Foundation; Natural Sciences and Engineering Research Council of Canada; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092521, R01GM074820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Ford Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the National Institutes of Health (GM074820 and RC2GM092521). Funding for the MIT-DCIF Avance (DPX) 400 MHz NMR spectrometer was provided by the National Institutes of Health (Award 1S10RR13886-01).; Supported by fellowships from National Science Foundation and the Ford Foundation.; Recipient of a Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship.	ABRAHAM DJ, 1969, J ORG CHEM, V34, P1575, DOI 10.1021/jo01258a009; Collu G, 2001, FEBS LETT, V508, P215, DOI 10.1016/S0014-5793(01)03045-9; Ehlting J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-47; Facchini PJ, 2008, PLANT J, V54, P763, DOI 10.1111/j.1365-313X.2008.03438.x; FURUYA T, 1992, PHYTOCHEMISTRY, V31, P3065, DOI 10.1016/0031-9422(92)83447-7; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hisiger Steve, 2007, Phytochemistry Reviews, V6, P207, DOI 10.1007/s11101-006-9036-y; HOTZE M, 1995, FEBS LETT, V374, P345, DOI 10.1016/0014-5793(95)01141-Z; Irmler S, 2000, PLANT J, V24, P797, DOI 10.1046/j.1365-313x.2000.00922.x; Jensen K, 2010, PHYTOCHEMISTRY, V71, P132, DOI 10.1016/j.phytochem.2009.10.017; Kaltenbach M, 1999, PLANT J, V19, P183, DOI 10.1046/j.1365-313X.1999.00524.x; KOHL W, 1981, Z NATURFORSCH B, V36, P1153; KUTNEY JP, 1980, PHYTOCHEMISTRY, V19, P2589, DOI 10.1016/S0031-9422(00)83924-2; Laflamme P, 2001, PLANT PHYSIOL, V125, P189, DOI 10.1104/pp.125.1.189; LANGLOIS N, 1979, J ORG CHEM, V44, P2468, DOI 10.1021/jo01328a028; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liscombe DK, 2010, P NATL ACAD SCI USA, V107, P18793, DOI 10.1073/pnas.1009003107; Matsuno M, 2009, SCIENCE, V325, P1688, DOI 10.1126/science.1174095; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Morgan JA, 1999, PHYTOCHEMISTRY, V51, P61, DOI 10.1016/S0031-9422(98)00585-8; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; NIELSEN KA, 2005, CYTOCHROME P450 STRU, P553; O'Connor SE, 2006, NAT PROD REP, V23, P532, DOI 10.1039/b512615k; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Rodriguez S, 2003, PHYTOCHEMISTRY, V64, P401, DOI 10.1016/S0031-9422(03)00269-3; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schroder G, 1999, FEBS LETT, V458, P97, DOI 10.1016/S0014-5793(99)01138-2; Shanks JV, 1998, BIOTECHNOL BIOENG, V58, P333, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3&lt;333::AID-BIT35&gt;3.0.CO;2-A; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	29	91	94	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16751	16757		10.1074/jbc.M111.225383	http://dx.doi.org/10.1074/jbc.M111.225383			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454651	Green Published, hybrid			2022-12-27	WOS:000290301900023
J	Giralt, A; Hondares, E; Villena, JA; Ribas, F; Diaz-Delfin, J; Giralt, M; Iglesias, R; Villarroya, F				Giralt, Albert; Hondares, Elayne; Villena, Josep A.; Ribas, Francesc; Diaz-Delfin, Julieta; Giralt, Marta; Iglesias, Roser; Villarroya, Francesc			Peroxisome Proliferator-activated Receptor-gamma Coactivator-1 alpha Controls Transcription of the Sirt3 Gene, an Essential Component of the Thermogenic Brown Adipocyte Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE ACETYLATION; EXPRESSION; HOMOLOG; ALPHA; FAT; DIFFERENTIATION; MITOCHONDRIA; METABOLISM; SIRTUINS; DEACETYLASE	Sirt3 (silent mating type information regulation 2, homolog 3), a member of the sirtuin family of protein deacetylases with multiple actions on metabolism and gene expression is expressed in association with brown adipocyte differentiation. Using Sirt3-null brown adipocytes, we determined that Sirt3 is required for an appropriate responsiveness of cells to noradrenergic, cAMP-mediated activation of the expression of brown adipose tissue thermogenic genes. The transcriptional coactivator Pgc-1 alpha (peroxisome proliferator-activated receptor-gamma coactivator-1 alpha) induced Sirt3 gene expression in white adipocytes and embryonic fibroblasts as part of its overall induction of a brown adipose tissue-specific pattern of gene expression. In cells lacking Sirt3, Pgc-1 alpha failed to fully induce the expression of brown fat-specific thermogenic genes. Pgc-1 alpha activates Sirt3 gene transcription through coactivation of the orphan nuclear receptor Err (estrogen-related receptor)-alpha, which bound the proximal Sirt3 gene promoter region. Err alpha knockdown assays indicated that Err alpha is required for full induction of Sirt3 gene expression in response to Pgc-1 alpha. The present results indicate that Pgc-1 alpha controls Sirt3 gene expression and this action is an essential component of the overall mechanisms by which Pgc-1 alpha induces the full acquisition of a brown adipocyte differentiated phenotype.	[Giralt, Albert; Hondares, Elayne; Ribas, Francesc; Diaz-Delfin, Julieta; Giralt, Marta; Iglesias, Roser; Villarroya, Francesc] Univ Barcelona, IBUB, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain; [Giralt, Albert; Hondares, Elayne; Ribas, Francesc; Diaz-Delfin, Julieta; Giralt, Marta; Iglesias, Roser; Villarroya, Francesc] CIBER Fisiopatol Obesidad & Nutr, Barcelona 08028, Spain; [Villena, Josep A.] Inst Recerca Vall Hebron, Barcelona 08035, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Villarroya, F (corresponding author), Univ Barcelona, IBUB, Dept Bioquim & Biol Mol, Avda Diagonal 645, E-08028 Barcelona, Spain.	fvillarroya@ub.edu	Villarroya, Francesc/K-4357-2014; Aulinas, Francesc Ribas/B-7677-2018; Villena, Josep A/H-1597-2015; Giralt, Albert/M-7672-2015; Iglesias, Roser/C-5561-2017; Giralt, Marta/A-4756-2013	Aulinas, Francesc Ribas/0000-0001-7672-4775; Giralt, Albert/0000-0001-5334-0963; Iglesias, Roser/0000-0002-7107-8097; Giralt, Marta/0000-0001-7968-4190; Villarroya, Francesc/0000-0003-1266-9142; Giralt, Albert/0000-0003-4498-063X; Villena, Josep A/0000-0002-2200-2985	Ministerio de Ciencia e Innovacion, Spain [SAF2008-01896]; Generalitat de Catalunya [2009SGR-284]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	The work was supported by Grant SAF2008-01896 from the Ministerio de Ciencia e Innovacion, Spain, and Grant 2009SGR-284 from the Generalitat de Catalunya.	Bao JJ, 2010, CELL MOL LIFE SCI, V67, P3073, DOI 10.1007/s00018-010-0402-y; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Bellizzi D, 2007, GENOMICS, V89, P143, DOI 10.1016/j.ygeno.2006.09.004; Busch BB, 2004, J MED CHEM, V47, P5593, DOI 10.1021/jm049334f; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carmona MC, 2005, BIOCHEM J, V389, P47, DOI 10.1042/BJ20050009; Debevec D, 2007, MOL ENDOCRINOL, V21, P1581, DOI 10.1210/me.2007-0103; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Herzog B, 2006, J BIOL CHEM, V281, P99, DOI 10.1074/jbc.M509276200; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Jacobs KM, 2008, INT J BIOL SCI, V4, P291; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; KLAUS S, 1994, J CELL SCI, V107, P313; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Mercader J, 2010, OBESITY, V18, P655, DOI 10.1038/oby.2009.330; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Villarroya F, 2009, J PHYSIOL SCI, V59, P279; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520	32	153	165	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16958	16966		10.1074/jbc.M110.202390	http://dx.doi.org/10.1074/jbc.M110.202390			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454513	hybrid, Green Published			2022-12-27	WOS:000290301900045
J	Komori, T; Nakamura, T; Matsunaga, I; Morita, D; Hattori, Y; Kuwata, H; Fujiwara, N; Hiromatsu, K; Harashima, H; Sugita, M				Komori, Takaya; Nakamura, Takashi; Matsunaga, Isamu; Morita, Daisuke; Hattori, Yuki; Kuwata, Hirotaka; Fujiwara, Nagatoshi; Hiromatsu, Kenji; Harashima, Hideyoshi; Sugita, Masahiko			A Microbial Glycolipid Functions as a New Class of Target Antigen for Delayed-type Hypersensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; OCTAARGININE-MODIFIED LIPOSOMES; T-CELL RECOGNITION; LIPID ANTIGENS; INTRACELLULAR TRAFFICKING; ENDOPLASMIC-RETICULUM; PRESENTING MOLECULES; IMMUNE-RESPONSES; CD1 MOLECULES; GUINEA-PIGS	Delayed-type hypersensitivity (DTH) is marked by high levels of protein antigen-specific T cell responses in sensitized individuals. Recent evidence has revealed a distinct pathway for T cell immunity directed against glycolipid antigens, but DTH to this class of antigen has been undetermined and difficult to prove due to their insolubility in aqueous solutions. Here, glucose monomycolate (GMM), a highly hydrophobic glycolipid of the cell wall of mycobacteria, was dispersed in aqueous solutions in the form of octaarginine-modified liposomes and tested for its ability to elicit cutaneous DTH responses in bacillus Calmette-Guerin (BCG)-immunized guinea pigs. After an intradermal challenge with the GMM liposome, a significant skin induration was observed in BCG-immunized, but not mock-treated, animals. The skin reaction peaked at around 2 days with local infiltration by mononuclear cells, and therefore, the response shared basic features with the classical DTH to protein antigens. Lymph node T cells from BCG-immunized guinea pigs specifically increased IFN-gamma transcription in response to the GMM liposome, and this response was completely blocked by antibodies to CD1 lipid antigen-presenting molecules. Finally, whereas the T cells increased transcription of both T helper (Th) 1-type (IFN-gamma and TNF-alpha) and Th2-type (IL-5 and IL-10) cytokines in response to the purified protein derivative or tuberculin, their GMM-specific response was skewed to Th1-type cytokine production known to be critical for protection against tuberculosis. Thus, our study reveals a novel form of DTH with medical implications.	[Komori, Takaya; Matsunaga, Isamu; Morita, Daisuke; Hattori, Yuki; Kuwata, Hirotaka; Sugita, Masahiko] Kyoto Univ, Inst Virus Res, Lab Cell Regulat, Kyoto 6068507, Japan; [Komori, Takaya; Matsunaga, Isamu; Morita, Daisuke; Hattori, Yuki; Sugita, Masahiko] Grad Sch Biostudies, Lab Cell Regulat & Mol Network, Kyoto 6068507, Japan; [Nakamura, Takashi; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; [Fujiwara, Nagatoshi] Osaka City Univ, Grad Sch Med, Dept Bacteriol, Osaka 5458585, Japan; [Hiromatsu, Kenji] Fukuoka Univ, Fac Med, Dept Microbiol & Immunol, Fukuoka 8140180, Japan	Kyoto University; Hokkaido University; Osaka Metropolitan University; Fukuoka University	Sugita, M (corresponding author), 53 Kawahara Cho,Sakyo Ku, Kyoto 6068507, Japan.	msugita@virus.kyoto-u.ac.jp	Komori, Takaya/AAW-7731-2021; Harashima, Hideyoshi/D-8390-2012; Kuwata, Hiro/N-2023-2019; Hattori, Yuki/AAW-2061-2021; Nakamura, Takashi/F-4419-2016	Kuwata, Hiro/0000-0002-5023-1777; Nakamura, Takashi/0000-0001-9019-1426; Hattori, Yuki/0000-0001-6576-0121; Sugita, Masahiko/0000-0001-5511-1304	Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology (grant-in-aid for Scientific Research on Priority Areas) and from the Japan Society for the Promotion of Science (grant-in-aid for Scientific Research (B) (to M. S.)).	Batuwangala T, 2004, J IMMUNOL, V172, P2382, DOI 10.4049/jimmunol.172.4.2382; Behar SM, 2007, CURR TOP MICROBIOL, V314, P215; Dascher CC, 2003, INT IMMUNOL, V15, P915, DOI 10.1093/intimm/dxg091; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; Hiromatsu K, 2002, J IMMUNOL, V169, P330, DOI 10.4049/jimmunol.169.1.330; Hiromatsu K, 2002, IMMUNOLOGY, V106, P159, DOI 10.1046/j.1365-2567.2002.01422.x; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; Homhuan A, 2009, J CONTROL RELEASE, V136, P79, DOI 10.1016/j.jconrel.2009.01.004; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Kawashima T, 2003, J IMMUNOL, V170, P5345, DOI 10.4049/jimmunol.170.11.5345; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Kobayashi K, 2001, MICROSC RES TECHNIQ, V53, P241, DOI 10.1002/jemt.1090; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; Matsunaga I, 2008, J BIOL CHEM, V283, P28835, DOI 10.1074/jbc.M805776200; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Morita D, 2008, BIOCHEM BIOPH RES CO, V377, P889, DOI 10.1016/j.bbrc.2008.10.075; Nakamura T, 2008, MOL THER, V16, P1507, DOI 10.1038/mt.2008.122; Nakao H, 2009, J BIOCHEM, V146, P659, DOI 10.1093/jb/mvp113; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Orme IM, 1999, IMMUNOL TODAY, V20, P307, DOI 10.1016/S0167-5699(98)01438-8; Otsuka A, 2008, J IMMUNOL, V181, P8528, DOI 10.4049/jimmunol.181.12.8528; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Rosat JP, 1999, J IMMUNOL, V162, P366; Ryll R, 2001, MICROBIOL IMMUNOL, V45, P801, DOI 10.1111/j.1348-0421.2001.tb01319.x; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Sugita M, 2000, P NATL ACAD SCI USA, V97, P8445, DOI 10.1073/pnas.150236797; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; Sugita M, 1997, J IMMUNOL, V159, P2358; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; Ulrichs T, 2003, INFECT IMMUN, V71, P3076, DOI 10.1128/IAI.71.6.3076-3087.2003; Van Rhijn I, 2009, EUR J IMMUNOL, V39, P3031, DOI 10.1002/eji.200939619; Watanabe Y, 2006, VACCINE, V24, P5700, DOI 10.1016/j.vaccine.2006.04.049	36	28	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16800	16806		10.1074/jbc.M110.217224	http://dx.doi.org/10.1074/jbc.M110.217224			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454504	Green Published, hybrid			2022-12-27	WOS:000290301900029
J	Rambhadran, A; Gonzalez, J; Jayaraman, V				Rambhadran, Anu; Gonzalez, Jennifer; Jayaraman, Vasanthi			Conformational Changes at the Agonist Binding Domain of the N-Methyl-D-Aspartic Acid Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONOTROPIC GLUTAMATE-RECEPTOR; LIGAND-PROTEIN INTERACTIONS; CRYSTAL-STRUCTURES; NMR-SPECTROSCOPY; NMDA RECEPTORS; AMPA RECEPTORS; CORE; ACTIVATION; MECHANISM; SUBUNIT	The conformational changes in the agonist binding domain of the glycine-binding GluN1 and glutamate-binding GluN2A subunits of the N-methyl D-aspartic acid receptor upon binding agonists of varying efficacy have been investigated by luminescence resonance energy transfer (LRET) measurements. The LRET-based distances indicate a cleft closure conformational change at the GluN1 subunit upon binding agonists; however, no significant changes in the cleft closure are observed between partial and full agonists. This is consistent with the previously reported crystal structures for the isolated agonist binding domain of this receptor. Additionally, the LRET-based distances show that the agonist binding domain of the glutamate-binding GluN2A subunit exhibits a graded cleft closure with the extent of cleft closure being proportional to the extent of activation, indicating that the mechanism of activation in this subunit is similar to that of the glutamate binding alpha-amino-5-methyl-3-hydroxy-4-isoxazole propionate and kainate subtypes of the ionotropic glutamate receptors.	[Rambhadran, Anu; Gonzalez, Jennifer; Jayaraman, Vasanthi] Univ Texas Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Jayaraman, V (corresponding author), Univ Texas Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, Grad Sch Biomed Sci, MSB 6-174,6431 Fannin St, Houston, TX 77030 USA.	vasanthi.jayaraman@uth.tmc.edu			National Institutes of Health [R01GM073102, GM082023-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073102, F31GM082023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM073102.; Supported by National Institutes of Health Grant GM082023-01 through the NRSA. Present address: Baylor College of Medicine, Houston, TX 77030.	Ahmed AH, 2007, J BIOL CHEM, V282, P12773, DOI 10.1074/jbc.M610077200; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; BENVENISTE M, 1991, BIOPHYS J, V59, P560, DOI 10.1016/S0006-3495(91)82272-X; Cheng Q, 2005, NAT CHEM BIOL, V1, P329, DOI 10.1038/nchembio738; Cheng Q, 2004, J BIOL CHEM, V279, P26346, DOI 10.1074/jbc.M403111200; Cheng Q, 2002, BIOCHEMISTRY-US, V41, P1602, DOI 10.1021/bi015729e; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Deming D, 2003, J BIOL CHEM, V278, P17589, DOI 10.1074/jbc.C300105200; Du M, 2005, J BIOL CHEM, V280, P8633, DOI 10.1074/jbc.C400590200; Erreger K, 2007, MOL PHARMACOL, V72, P907, DOI 10.1124/mol.107.037333; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gonzalez J, 2008, BIOCHEMISTRY-US, V47, P10027, DOI 10.1021/bi800690b; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jayaraman V, 2000, BIOCHEMISTRY-US, V39, P8693, DOI 10.1021/bi000892f; Jayaraman V, 2004, METHOD ENZYMOL, V380, P170; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Landes CF, 2011, NAT CHEM BIOL, V7, P168, DOI 10.1038/NCHEMBIO.523; Madden DR, 2004, BIOCHEMISTRY-US, V43, P15838, DOI 10.1021/bi048447y; Madden DR, 2001, J BIOL CHEM, V276, P37821; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Maltsev AS, 2010, J BIOL CHEM, V285, P10154, DOI 10.1074/jbc.M109.088641; Mankiewicz KA, 2007, BRAZ J MED BIOL RES, V40, P1419, DOI 10.1590/S0100-879X2007001100001; Mankiewicz KA, 2008, BIOCHEMISTRY-US, V47, P398, DOI 10.1021/bi702004b; Mankiewicz KA, 2007, BIOCHEMISTRY-US, V46, P1343, DOI 10.1021/bi062270l; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; McFeeters RL, 2004, FASEB J, V18, P428, DOI 10.1096/fj.03-0873rev; McFeeters RL, 2002, BIOCHEMISTRY-US, V41, P10472, DOI 10.1021/bi026010p; Nanao MH, 2005, P NATL ACAD SCI USA, V102, P1708, DOI 10.1073/pnas.0409573102; Naur P, 2005, FEBS LETT, V579, P1154, DOI 10.1016/j.febslet.2005.01.012; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Rambhadran A, 2010, J BIOL CHEM, V285, P15296, DOI 10.1074/jbc.M109.085035; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a	38	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16953	16957		10.1074/jbc.M111.224576	http://dx.doi.org/10.1074/jbc.M111.224576			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454656	hybrid, Green Published			2022-12-27	WOS:000290301900044
J	Sano, H; Peck, GR; Kettenbach, AN; Gerber, SA; Lienhard, GE				Sano, Hiroyuki; Peck, Grantley R.; Kettenbach, Arminja N.; Gerber, Scott A.; Lienhard, Gustav E.			Insulin-stimulated GLUT4 Protein Translocation in Adipocytes Requires the Rab10 Guanine Nucleotide Exchange Factor Dennd4C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED MEMBRANE AMINOPEPTIDASE; GTPASE-ACTIVATING-PROTEIN; EXOCYST COMPLEX; MUSCLE; DOMAIN; CELLS; AS160	Insulin-stimulated translocation of the glucose transporter GLUT4 to the cell surface in fat and muscle cells is the basis for insulin-stimulated glucose transport. Studies in adipocytes strongly support the following molecular mechanism for this process. Insulin-elicited phosphorylation of the GTPase-activating protein TBC1D4 (AS160) suppresses its activity toward Rab10 and thereby leads to an increase in the GTP-bound form of Rab10, which in turn triggers movement of vesicles containing GLUT4 to the plasma membrane and their fusion with the membrane. This process is expected to require the participation of a guanine nucleotide exchange factor (GEF) to generate the GTP-bound form of Rab10, but this GEF has not hitherto been identified. The present study identifies Dennd4C, a recently described GEF for Rab10, as the primary GEF required for GLUT4 translocation. Knockdown of Dennd4C markedly inhibited GLUT4 translocation, and ectopic expression of Dennd4C slightly stimulated it. Dennd4C was found in isolated GLUT4 vesicles. This study thus identifies another key component in the machinery of GLUT4 translocation. Moreover, it provides a potential explanation for the moderate association of a variant in the Dennd4C gene with type 2 diabetes.	[Sano, Hiroyuki; Peck, Grantley R.; Lienhard, Gustav E.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Kettenbach, Arminja N.; Gerber, Scott A.] Dartmouth Med Sch, Dept Genet, Lebanon, NH 03756 USA; [Kettenbach, Arminja N.; Gerber, Scott A.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Lienhard, GE (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA.	gustav.e.lienhard@dartmouth.edu	Peck, Grantley/H-2318-2013	Gerber, Scott/0000-0002-2964-5051; Kettenbach, Arminja/0000-0003-3979-4576	National Institutes of Health [DK25336]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK025336, R01DK025336, R55DK025336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK25336 (to G. E. L.).	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Babbey CM, 2010, AM J PHYSIOL-RENAL, V299, pF495, DOI 10.1152/ajprenal.00198.2010; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Ishikura S, 2008, AM J PHYSIOL-CELL PH, V295, pC1016, DOI 10.1152/ajpcell.00277.2008; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Lyons PD, 2009, BIOSCIENCE REP, V29, P229, DOI 10.1042/BSR20080162; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Pimienta Genaro, 2009, V527, P107, DOI 10.1007/978-1-60327-834-8_9; Ross SA, 1996, J BIOL CHEM, V271, P3328, DOI 10.1074/jbc.271.6.3328; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Yoshizaki T, 2007, MOL CELL BIOL, V27, P5172, DOI 10.1128/MCB.02298-06; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723	24	51	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16541	16545		10.1074/jbc.C111.228908	http://dx.doi.org/10.1074/jbc.C111.228908			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454697	Green Published, hybrid			2022-12-27	WOS:000290301900002
J	Shewmaker, F; McGlinchey, RP; Wickner, RB				Shewmaker, Frank; McGlinchey, Ryan P.; Wickner, Reed B.			Structural Insights into Functional and Pathological Amyloid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SOLID-STATE NMR; PARALLEL BETA-SHEET; NUCLEAR-MAGNETIC-RESONANCE; TRANSMISSION ELECTRON-MICROSCOPY; S PRION PROTEIN; EXPERIMENTAL CONSTRAINTS; FORMING SEQUENCES; FIBRIL FORMATION; MOLECULAR-BASIS; REPEAT DOMAIN	Amyloid is traditionally viewed as a consequence of protein misfolding and aggregation and is most notorious for its association with debilitating and chronic human diseases. However, a growing list of examples of "functional amyloid" challenges this bad reputation and indicates that many organisms can employ the biophysical properties of amyloid for their benefit. Because of developments in the structural studies of amyloid, a clearer picture is emerging about what defines amyloid structure and the properties that unite functional and pathological amyloids. Here, we review various amyloids and place them within the framework of the latest structural models.	[Shewmaker, Frank] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA; [McGlinchey, Ryan P.; Wickner, Reed B.] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Shewmaker, F (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	fshewmaker@usuhs.mil			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075018, ZIADK024950] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adda CG, 2009, MOL BIOCHEM PARASIT, V166, P159, DOI 10.1016/j.molbiopara.2009.03.012; Ader C, 2010, P NATL ACAD SCI USA, V107, P6281, DOI 10.1073/pnas.0910163107; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Apostol MI, 2010, J BIOL CHEM, V285, P29671, DOI 10.1074/jbc.C110.158303; Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330; Balbach JJ, 2002, BIOPHYS J, V83, P1205, DOI 10.1016/S0006-3495(02)75244-2; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Bieler S, 2005, J BIOL CHEM, V280, P26880, DOI 10.1074/jbc.M502031200; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Chen B, 2009, P NATL ACAD SCI USA, V106, P14339, DOI 10.1073/pnas.0907821106; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; COHEN AS, 1959, NATURE, V183, P1202, DOI 10.1038/1831202a0; Debelouchina GT, 2010, J AM CHEM SOC, V132, P10414, DOI 10.1021/ja102775u; Diaz-Avalos R, 2005, P NATL ACAD SCI USA, V102, P10165, DOI 10.1073/pnas.0504599102; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Du ZQ, 2010, MOL CELL BIOL, V30, P4644, DOI 10.1128/MCB.00225-10; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goldsbury C, 2011, J STRUCT BIOL, V173, P1, DOI 10.1016/j.jsb.2010.09.018; Graether SP, 2003, BIOPHYS J, V84, P552, DOI 10.1016/S0006-3495(03)74874-7; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Hoashi T, 2006, J BIOL CHEM, V281, P21198, DOI 10.1074/jbc.M601643200; Iconomidou VA, 2000, FEBS LETT, V479, P141, DOI 10.1016/S0014-5793(00)01888-3; Iwata K, 2006, P NATL ACAD SCI USA, V103, P18119, DOI 10.1073/pnas.0607180103; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jaskolski M, 2001, ACTA BIOCHIM POL, V48, P807; Jordal PB, 2009, APPL ENVIRON MICROB, V75, P4101, DOI 10.1128/AEM.02107-08; Kwan AHY, 2006, P NATL ACAD SCI USA, V103, P3621, DOI 10.1073/pnas.0505704103; Ladner CL, 2010, J BIOL CHEM, V285, P17137, DOI 10.1074/jbc.M110.117234; LANSBURY PT, 1995, NAT STRUCT BIOL, V2, P990, DOI 10.1038/nsb1195-990; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; Louis JM, 2005, J MOL BIOL, V348, P687, DOI 10.1016/j.jmb.2005.02.071; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Mackay JP, 2001, STRUCTURE, V9, P83, DOI 10.1016/S0969-2126(00)00559-1; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2006, J BIOL CHEM, V281, P37820, DOI 10.1074/jbc.M605336200; Margittai M, 2006, METHOD ENZYMOL, V413, P122, DOI 10.1016/S0076-6879(06)13007-4; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; McGlinchey RP, 2011, J BIOL CHEM, V286, P8385, DOI 10.1074/jbc.M110.197152; McGlinchey RP, 2009, P NATL ACAD SCI USA, V106, P13731, DOI 10.1073/pnas.0906509106; Neet KE, 2008, J BIOL CHEM, V283, P29613, DOI 10.1074/jbc.R800051200; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nielsen JT, 2009, ANGEW CHEM INT EDIT, V48, P2118, DOI 10.1002/anie.200804198; Oh J, 2007, J BIOL CHEM, V282, P13601, DOI 10.1074/jbc.M602576200; Olofsson A, 2004, J BIOL CHEM, V279, P5699, DOI 10.1074/jbc.M310605200; Otoo HN, 2008, EUKARYOT CELL, V7, P776, DOI 10.1128/EC.00309-07; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Petkova AT, 2004, J MOL BIOL, V335, P247, DOI 10.1016/j.jmb.2003.10.044; Ramsook CB, 2010, EUKARYOT CELL, V9, P393, DOI 10.1128/EC.00068-09; Roberts BT, 2003, GENE DEV, V17, P2083, DOI 10.1101/gad.1115803; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Ross CA, 2003, P NATL ACAD SCI USA, V100, P1, DOI 10.1073/pnas.0237018100; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Serag AA, 2002, NAT STRUCT BIOL, V9, P734, DOI 10.1038/nsb838; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Shewmaker F, 2009, J BIOL CHEM, V284, P25065, DOI 10.1074/jbc.M109.007054; Shewmaker F, 2009, BIOCHEMISTRY-US, V48, P5074, DOI 10.1021/bi900345q; Siemer AB, 2006, J BIOMOL NMR, V34, P75, DOI 10.1007/s10858-005-5582-7; Sikorski P, 2005, BIOMACROMOLECULES, V6, P425, DOI 10.1021/bm0494388; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Sipe JD, 2010, AMYLOID, V17, P101, DOI 10.3109/13506129.2010.526812; Staniforth RA, 2001, EMBO J, V20, P4774, DOI 10.1093/emboj/20.17.4774; Sunde M, 2008, MICRON, V39, P773, DOI 10.1016/j.micron.2007.08.003; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; Toombs JA, 2010, MOL CELL BIOL, V30, P319, DOI 10.1128/MCB.01140-09; Tycko R, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2437194; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Villar-Pique A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013625; Wang L, 2008, PLOS BIOL, V6, P1791, DOI 10.1371/journal.pbio.0060195; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wasmer C, 2010, J MOL BIOL, V402, P311, DOI 10.1016/j.jmb.2010.06.053; Wasmer C, 2009, J MOL BIOL, V394, P119, DOI 10.1016/j.jmb.2009.09.015; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394	100	127	133	0	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16533	16540		10.1074/jbc.R111.227108	http://dx.doi.org/10.1074/jbc.R111.227108			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454545	Green Published, hybrid			2022-12-27	WOS:000290301900001
J	Shin, MK; Jang, YH; Yoo, HJ; Kang, DW; Park, MH; Kim, MK; Song, JH; Kim, SD; Min, G; You, HK; Choi, KY; Bae, YS; Min, DS				Shin, Min Kyoung; Jang, Young Hoon; Yoo, Hyun Jung; Kang, Dong Woo; Park, Mi Hee; Kim, Mi Kyoung; Song, Ju Hyun; Kim, Sang Doo; Min, Gyesik; You, Hyung Keun; Choi, Kang-Yell; Bae, Yoe-Sik; Min, Do Sik			N-Formyl-Methionyl-Leucyl-Phenylalanine (fMLP) Promotes Osteoblast Differentiation via the N-Formyl Peptide Receptor 1-mediated Signaling Pathway in Human Mesenchymal Stem Cells from Bone Marrow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-D; CYCLOSPORINE-H; PROTEIN-KINASE; STROMAL CELLS; EXPRESSION; OSTEOPOROSIS; NEUTROPHILS; FRACTURES; ZEBRAFISH; ANNEXIN-1	Binding of N-formyl-methionyl-leucyl-phenylalanine (fMLP) to its specific cell surface receptor, N-formyl peptide receptor (FPR), triggers different cascades of biochemical events, eventually leading to cellular activation. However, the physiological role of fMLP and FPR during differentiation of mesenchymal stem cells is unknown. In this study, we attempted to determine whether fMLP regulates differentiation of mesenchymal stem cells derived from bone marrow. Analysis by quantitative-PCR and flow cytometry showed significantly increased expression of FPR1, but not FPR2 and FPR3, during osteoblastic differentiation. fMLP, a specific ligand of FPR1, promotes osteoblastic commitment and suppresses adipogenic commitment under differentiation conditions. Remarkably, fMLP-stimulated osteogenesis is associated with increased expression of osteogenic markers and mineralization, which were blocked by cyclosporine H, a selective FPR1 antagonist. In addition, fMLP inhibited expression of peroxisome proliferator-activated receptor-gamma 1, a major regulator of adipocytic differentiation. fMLP-stimulated osteogenic differentiation was mediated via FPR1-phospholipase C/phospholipase D-Ca2+-calmodulin-dependent kinase II-ERK-CREB signaling pathways. Finally, fMLP promoted bone formation in zebrafish and rabbits, suggesting its physiological relevance in vivo. Collectively, our findings provide novel insight into the functional role of fMLP in bone biology, with important implications for its potential use as a therapeutic agent for treatment of bone-related disorders.	[Shin, Min Kyoung; Jang, Young Hoon; Yoo, Hyun Jung; Kang, Dong Woo; Park, Mi Hee; Kim, Mi Kyoung; Song, Ju Hyun; Min, Do Sik] Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Pusan 609735, South Korea; [Kim, Sang Doo; Bae, Yoe-Sik] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Min, Gyesik] Gyeongnam Natl Univ Sci & Technol, Dept Pharmaceut Engn, Jinju 660758, South Korea; [You, Hyung Keun] Wonkwang Univ, Coll Dent, Dept Periodontol, Iksan 570740, South Korea; [Choi, Kang-Yell; Min, Do Sik] Yonsei Univ, Translat Res Ctr Prot Funct Control, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Choi, Kang-Yell; Min, Do Sik] Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Pusan National University; Sungkyunkwan University (SKKU); Gyeongnam National University of Science and Technology; Wonkwang University; Yonsei University; Yonsei University	Min, DS (corresponding author), Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, 30 Jangjeon Dong, Pusan 609735, South Korea.	minds@pusan.ac.kr		Jang, Younghoon/0000-0002-5705-4945	Korean Government; Translational Research Center for Protein Function Control, South Korea [NSF 2009-0092960]; PNU Tenure-track Faculty	Korean Government(Korean Government); Translational Research Center for Protein Function Control, South Korea; PNU Tenure-track Faculty	This work was supported by National Research Foundation Grant KRF-2008-313-C00698 funded by the Korean Government, Translational Research Center for Protein Function Control Grant NSF 2009-0092960, South Korea, and by Financial Supporting Project of Long Term Overseas Dispatch of the PNU Tenure-track Faculty, 2009.	CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429; CARP H, 1982, J EXP MED, V155, P264, DOI 10.1084/jem.155.1.264; Chan GK, 2002, GERONTOLOGY, V48, P62, DOI 10.1159/000048929; CHRISTMAS P, 1991, J BIOL CHEM, V266, P2499; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Du SJ, 2001, DEV BIOL, V238, P239, DOI 10.1006/dbio.2001.0390; Fleet JC, 1996, ENDOCRINOLOGY, V137, P4605, DOI 10.1210/en.137.11.4605; Flores MV, 2006, DEV DYNAM, V235, P3166, DOI 10.1002/dvdy.20957; Fulfaro F, 1998, PAIN, V78, P157, DOI 10.1016/S0304-3959(98)00135-3; Gangji V, 1999, CLIN RHEUMATOL, V18, P266, DOI 10.1007/s100670050099; Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Johnson EE, 2000, CLIN ORTHOP RELAT R, P61, DOI 10.1097/00003086-200002000-00008; Kim MK, 2007, FEBS LETT, V581, P1917, DOI 10.1016/j.febslet.2007.03.078; La M, 2001, FASEB J, V15, P2247, DOI 10.1096/fj.01-0196com; Le YY, 2001, CYTOKINE GROWTH F R, V12, P91, DOI 10.1016/S1359-6101(01)00003-X; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; MARASCO WA, 1984, J BIOL CHEM, V259, P5430; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MEUNIER P, 1971, CLIN ORTHOP RELAT R, V80, P147, DOI DOI 10.1097/00003086-197110000-00021; Min DS, 2001, NEUROPHARMACOLOGY, V41, P384, DOI 10.1016/S0028-3908(01)00070-3; Min DS, 2001, CARCINOGENESIS, V22, P1641, DOI 10.1093/carcin/22.10.1641; NOVIKOFF AB, 1980, J CELL BIOL, V87, P180, DOI 10.1083/jcb.87.1.180; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; PEREZALBUERNE ED, 1993, P NATL ACAD SCI USA, V90, P11960, DOI 10.1073/pnas.90.24.11960; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; RIGGS BL, 1992, NEW ENGL J MED, V327, P620; Selvatici R, 2006, EUR J PHARMACOL, V534, P1, DOI 10.1016/j.ejphar.2006.01.034; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; VanCompernolle SE, 2003, J IMMUNOL, V171, P2050, DOI 10.4049/jimmunol.171.4.2050; Viswanathan A, 2007, STEM CELLS, V25, P1263, DOI 10.1634/stemcells.2006-0522; WENZELSEIFERT K, 1993, J IMMUNOL, V150, P4591; WENZELSEIFERT K, 1991, J IMMUNOL, V147, P1940; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681	42	28	30	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17133	17143		10.1074/jbc.M110.197772	http://dx.doi.org/10.1074/jbc.M110.197772			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21372136	hybrid, Green Published			2022-12-27	WOS:000290301900063
J	Moghekar, A; Rao, S; Li, M; Ruben, D; Mammen, A; Tang, XP; O'Brien, RJ				Moghekar, Abhay; Rao, Sneha; Li, Ming; Ruben, Dawn; Mammen, Andrew; Tang, Xiaopei; O'Brien, Richard J.			Large Quantities of A beta Peptide Are Constitutively Released during Amyloid Precursor Protein Metabolism in Vivo and in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-BLOOD-FLOW; INTERNAL CAROTID-ARTERY; SYNAPTIC NMDA RECEPTORS; ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; SPINAL NEURONS; HEALTHY-ADULTS; BRAIN; ACCUMULATION; PATHOGENESIS	The metabolism of the amyloid precursor protein (APP) has been extensively investigated because its processing generates the amyloid-beta-peptide (A beta), which is a likely cause of Alzheimer disease. Much prior research has focused on APP processing using transgenic constructs and heterologous cell lines. Work to date in native neuronal cultures suggests that A beta is produced in very large amounts. We sought to investigate APP metabolism and A beta production simultaneously under more physiological conditions in vivo and in vitro using cultured rat cortical neurons and live pigs. We found in cultured neurons that both APP and A beta are secreted rapidly and at extremely high rates into the extracellular space (2-4 molecules/neuron/s for A beta). Little APP is degraded outside of the pathway that leads to extracellular release. Two metabolic pools of APP are identified, one that is metabolized extremely rapidly (t(1/2) = 2.2 h), and another, surface pool, composed of both synaptic and extrasynaptic elements, that turns over very slowly. A beta release and accumulation in the extracellular medium can be accounted for stoichiometrically by the extracellular release of beta-cleaved forms of the APP ecto-domain. Two beta-cleavages of APP occur for every beta-cleavage. Consistent with the results seen in cultured neurons, an extremely high rate of A beta production and secretion from the brain was seen in juvenile pigs. In summary, our experiments show an enormous and rapid production and extracellular release of A beta and the soluble APP ectodomain. A small, slowly metabolized, surface pool of full-length APP is also identified.	[Moghekar, Abhay; Rao, Sneha; Li, Ming; Mammen, Andrew; Tang, Xiaopei; O'Brien, Richard J.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Ruben, Dawn] Johns Hopkins Univ, Sch Med, Dept Comparat Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	O'Brien, RJ (corresponding author), Johns Hopkins Bayview Med Ctr, Mason Lord Ctr Tower,Rm 5100,5200 Eastern Ave, Baltimore, MD 21224 USA.	robrien@jhmi.edu	Mammen, Andrew/AAF-2885-2021; Rao, Sneha/AAE-1503-2020	Rao, Sneha/0000-0003-2147-3248	National Institutes of Health [P50 AG05146]; NIA; Burroughs Wellcome Fund for Translational Research; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Burroughs Wellcome Fund for Translational Research(Burroughs Wellcome Fund); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant P50 AG05146 from the NIA and the Burroughs Wellcome Fund for Translational Research.	Beck M, 2000, NEUROSCIENCE, V95, P243; Braitenberg V, 2001, J COMPUT NEUROSCI, V10, P71, DOI 10.1023/A:1008920127052; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Hoe HS, 2009, J BIOL CHEM, V284, P8495, DOI 10.1074/jbc.M900141200; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kienlen-Campard P, 2002, J BIOL CHEM, V277, P15666, DOI 10.1074/jbc.M200887200; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Mammen AL, 1997, J NEUROSCI, V17, P7351; MarquezSterling NR, 1997, J NEUROSCI, V17, P140, DOI 10.1523/JNEUROSCI.17-01-00140.1997; Meadow W, 1999, PEDIATR RES, V45, P324, DOI 10.1203/00006450-199903000-00006; Mi RF, 2004, NEURON, V44, P335, DOI 10.1016/j.neuron.2004.09.029; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Oh ES, 2009, NEUROBIOL AGING, V30, P1238, DOI 10.1016/j.neurobiolaging.2007.12.024; Rosen KM, 2007, MOL CELL NEUROSCI, V34, P578, DOI 10.1016/j.mcn.2006.12.008; Scheel P, 2000, STROKE, V31, P147, DOI 10.1161/01.STR.31.1.147; SCHONING M, 1994, STROKE, V25, P17, DOI 10.1161/01.STR.25.1.17; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shepherd C, 2009, ACTA NEUROPATHOL, V118, P37, DOI 10.1007/s00401-009-0521-4; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Soustiel JF, 2003, STROKE, V34, P1876, DOI 10.1161/01.STR.0000080942.32331.39; Storey E, 1999, EUR J NEUROSCI, V11, P1779, DOI 10.1046/j.1460-9568.1999.00599.x; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; VANGOOL WA, 1994, NEUROSCI LETT, V172, P122, DOI 10.1016/0304-3940(94)90677-7; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085	34	22	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.191262	http://dx.doi.org/10.1074/jbc.M110.191262			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454701	Green Published, hybrid			2022-12-27	WOS:000290022800039
J	Song, DS; Lee, FS				Song, Daisheng; Lee, Frank S.			Mouse Knock-out of IOP1 Protein Reveals Its Essential Role in Mammalian Cytosolic Iron-Sulfur Protein Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-S CLUSTER; SIGNALING PATHWAYS; HOMEOSTASIS; MECHANISMS; CELLS; DEGRADATION; MATURATION; APOPTOSIS; AUTOPHAGY; COMPONENT	Iron-sulfur proteins play an essential role in a variety of biologic processes and exist in multiple cellular compartments. The biogenesis of these proteins has been the subject of extensive investigation, and particular focus has been placed on the pathways that assemble iron-sulfur clusters in the different cellular compartments. Iron-only hydrogenase-like protein 1 (IOP1; also known as nuclear prelamin A recognition factor like protein, or NARFL) is a human protein that is homologous to Nar1, a protein in Saccharomyces cerevisiae that, in turn, is an essential component of the cytosolic iron-sulfur protein assembly pathway in yeast. Previous siRNA-induced knockdown studies using mammalian cells point to a similar role for IOP1 in mammals. In the present studies, we pursued this further by knocking out Iop1 in Mus musculus. We find that Iop1 knock-out results in embryonic lethality before embryonic day 10.5. Acute, inducible global knock-out of Iop1 in adult mice results in lethality and significantly diminished activity of cytosolic aconitase, an iron-sulfur protein, in liver extracts. Inducible knock-out of Iop1 in mouse embryonic fibroblasts results in diminished activity of cytosolic but not mitochondrial aconitase and loss of cell viability. Therefore, just as with knock-out of Nar1 in yeast, we find that knock-out of Iop1/Narfl in mice results in lethality and defective cytosolic iron-sulfur cluster assembly. The findings demonstrate an essential role for IOP1 in this pathway.	[Lee, Frank S.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Stellar Chance Labs 605, Philadelphia, PA 19104 USA	University of Pennsylvania	Lee, FS (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Stellar Chance Labs 605, 422 Curie Blvd, Philadelphia, PA 19104 USA.	franklee@mail.med.upenn.edu		Lee, Frank/0000-0003-2511-1834	National Institutes of Health [R01-GM71459]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM71459 (to F. S. L.).	Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Barton RM, 1999, J BIOL CHEM, V274, P30008, DOI 10.1074/jbc.274.42.30008; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; HENDERSON BR, 1995, J BIOL CHEM, V270, P20509, DOI 10.1074/jbc.270.35.20509; Huang JH, 2007, BIOCHEM J, V401, P341, DOI 10.1042/BJ20060635; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; Li XP, 2010, BLOOD CELL MOL DIS, V45, P9, DOI 10.1016/j.bcmd.2010.03.003; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; McClung JM, 2010, AM J PHYSIOL-CELL PH, V298, pC542, DOI 10.1152/ajpcell.00192.2009; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ravikumar B, 2009, J CELL SCI, V122, P1707, DOI 10.1242/jcs.031773; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Song DS, 2008, J BIOL CHEM, V283, P9231, DOI 10.1074/jbc.M708077200; Song DS, 2009, J BIOL CHEM, V284, P35297, DOI 10.1074/jbc.M109.040014; Srinivasan V, 2007, STRUCTURE, V15, P1246, DOI 10.1016/j.str.2007.08.009; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Thomson AM, 2000, J BIOL CHEM, V275, P31609, DOI 10.1074/jbc.M002354200; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Wang J, 2007, MOL CELL BIOL, V27, P2423, DOI 10.1128/MCB.01111-06; XU J, 2005, CURRENT PROTOCOLS MO; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Yu YJ, 2002, J VIROL, V76, P3731, DOI 10.1128/JVI.76.8.3731-3738.2002; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	43	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.201731	http://dx.doi.org/10.1074/jbc.M110.201731			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21367862	Green Published, hybrid			2022-12-27	WOS:000290022800020
J	Tsuchiya, Y; Yamashita, S				Tsuchiya, Yuichi; Yamashita, Shigeru			Anti-apoptotic Activity and Proteasome-mediated Degradation of Xenopus Mcl-1 Protein in Egg Extracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; BCL-2 FAMILY-MEMBERS; CELL-FREE APOPTOSIS; CYTOCHROME-C; BID CLEAVAGE; BH3 DOMAINS; BAX; LAEVIS; DEATH; PERMEABILIZATION	Xenopus egg extracts execute spontaneous apoptosis without the requirement of transcription and translation, and this intrinsic mechanism is supposed to be involved in the physiological elimination of aged eggs. Although apoptosis in this system is carried out by maternally stockpiled materials, the endogenous apoptosis regulators present in egg extracts are still poorly characterized. Here we examined the mRNA expression profiles and apoptosis-regulating functions of 13 Xenopus Bcl-2 family proteins in egg extracts. Among these, we found that endogenous Xenopus Mcl-1 (xMcl-1) physiologically inhibited apoptosis by counteracting the pro-apoptotic activity of endogenous Xenopus Bid in egg extracts. Exogenously added recombinant xMcl-1 was rapidly degraded by proteasome in egg extracts, and we identified the destabilizing region in the N terminus of xMcl-1. Our results suggest that the proteolytic decay of xMcl-1 may change the functional balance between pro-and anti-apoptotic activities of Bcl-2 family proteins, thereby regulating the timing of cytochrome c release in egg extracts.	[Tsuchiya, Yuichi; Yamashita, Shigeru] Toho Univ, Sch Med, Dept Biochem, Ota Ku, Tokyo 1438540, Japan		Yamashita, S (corresponding author), Toho Univ, Sch Med, Dept Biochem, Ota Ku, 5-21-16 Omori Nishi, Tokyo 1438540, Japan.	yamasita@med.toho-u.ac.jp	Yamashita, Shigeru/AAM-1563-2020		Toho University School of Medicine [20-19]; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Toho University School of Medicine(Toho University); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Toho University School of Medicine Project Research Grant 20-19 and in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Aouacheria A, 2005, MOL BIOL EVOL, V22, P2395, DOI 10.1093/molbev/msi234; Blaineau SV, 2009, APOPTOSIS, V14, P923, DOI 10.1007/s10495-009-0376-0; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Coen L, 2001, P NATL ACAD SCI USA, V98, P7869, DOI 10.1073/pnas.141226798; Coen L, 2007, P NATL ACAD SCI USA, V104, P8502, DOI 10.1073/pnas.0608877104; Cosulich SC, 1999, CURR BIOL, V9, P147, DOI 10.1016/S0960-9822(99)80068-2; Cosulich SC, 1997, CURR BIOL, V7, P913, DOI 10.1016/S0960-9822(06)00410-6; Cosulich SC, 1996, CURR BIOL, V6, P997, DOI 10.1016/S0960-9822(02)00644-9; Coultas L, 2002, CELL DEATH DIFFER, V9, P1163, DOI 10.1038/sj.cdd.4401096; CRUZREYES J, 1995, GENE, V158, P171, DOI 10.1016/0378-1119(95)00159-4; De Marco N, 2010, CELL DEATH DIFFER, V17, P360, DOI 10.1038/cdd.2009.128; Deming Paula, 2006, V322, P379; Du Pasquier D, 2007, GENESIS, V45, P1, DOI 10.1002/dvg.20252; Du Pasquier D, 2006, DEV DYNAM, V235, P2083, DOI 10.1002/dvdy.20874; Finkielstein CV, 2001, P NATL ACAD SCI USA, V98, P1006, DOI 10.1073/pnas.98.3.1006; Freel CD, 2008, J BIOL CHEM, V283, P367, DOI 10.1074/jbc.M708931200; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; Guillemin Y, 2009, J MOL MED, V87, P923, DOI 10.1007/s00109-009-0495-7; Johnson CE, 2010, CELL DEATH DIFFER, V17, P170, DOI 10.1038/cdd.2009.120; Johnston J, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-20; Kloc M, 2007, GENESIS, V45, P523, DOI 10.1002/dvg.20322; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kluck RM, 1999, J CELL BIOL, V147, P809, DOI 10.1083/jcb.147.4.809; Kominami K, 2006, GENES CELLS, V11, P701, DOI 10.1111/j.1365-2443.2006.00983.x; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Miyashita MUT, 2001, FEBS LETT, V509, P135, DOI 10.1016/S0014-5793(01)03145-3; Moradi-Ameli M, 2002, BIOCHEMISTRY-US, V41, P8540, DOI 10.1021/bi0110286; Nakajima K, 2003, DEV DYNAM, V227, P246, DOI 10.1002/dvdy.10300; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; Newmeyer DD, 2000, CELL DEATH DIFFER, V7, P402, DOI 10.1038/sj.cdd.4400665; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Rowe I, 2005, DEV DYNAM, V233, P76, DOI 10.1002/dvdy.20312; Sachs LM, 2004, DEV DYNAM, V231, P671, DOI 10.1002/dvdy.20166; Saitoh T, 2009, BIOCHEM BIOPH RES CO, V384, P491, DOI 10.1016/j.bbrc.2009.05.004; Saitoh Tomohiro, 2009, Reproductive Medicine and Biology, V8, P3, DOI 10.1007/s12522-008-0001-x; Schafer B, 2009, MOL BIOL CELL, V20, P2276, DOI 10.1091/mbc.E08-10-1056; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Tribulo C, 2004, DEV BIOL, V275, P325, DOI 10.1016/j.ydbio.2004.07.041; Tsuchiya Y, 2005, FEBS J, V272, P2237, DOI 10.1111/j.1742-4658.2005.04648.x; Tsuchiya Yuichi, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-5; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; von Ahsen O, 2000, METHOD ENZYMOL, V322, P183; Yoon SJ, 2009, BIOL REPROD, V81, P497, DOI 10.1095/biolreprod.108.073759; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000106	50	7	7	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.175927	http://dx.doi.org/10.1074/jbc.M110.175927			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454490	Green Published, hybrid			2022-12-27	WOS:000290022800021
J	Jaffe, EK; Shanmugam, D; Gardberg, A; Dieterich, S; Sankaran, B; Stewart, LJ; Myler, PJ; Roos, DS				Jaffe, Eileen K.; Shanmugam, Dhanasekaran; Gardberg, Anna; Dieterich, Shellie; Sankaran, Banumathi; Stewart, Lance J.; Myler, Peter J.; Roos, David S.			Crystal Structure of Toxoplasma gondii Porphobilinogen Synthase INSIGHTS ON OCTAMERIC STRUCTURE AND PORPHOBILINOGEN FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUATERNARY STRUCTURE ISOFORMS; X-RAY-STRUCTURE; CATALYZED REACTION; ESCHERICHIA-COLI; ACID; DEHYDRATASE; MORPHEEINS; CRYSTALLOGRAPHY; BIOSYNTHESIS; INHIBITOR	Porphobilinogen synthase (PBGS) is essential for heme biosynthesis, but the enzyme of the protozoan parasite Toxoplasma gondii (TgPBGS) differs from that of its human host in several important respects, including subcellular localization, metal ion dependence, and quaternary structural dynamics. We have solved the crystal structure of TgPBGS, which contains an octamer in the crystallographic asymmetric unit. Crystallized in the presence of substrate, each active site contains one molecule of the product porphobilinogen. Unlike prior structures containing a substrate-derived heterocycle directly bound to an active site zinc ion, the product-bound TgPBGS active site contains neither zinc nor magnesium, placing in question the common notion that all PBGS enzymes require an active site metal ion. Unlike human PBGS, the TgPBGS octamer contains magnesium ions at the intersections between pro-octamer dimers, which are presumed to function in allosteric regulation. TgPBGS includes N- and C-terminal regions that differ considerably from previously solved crystal structures. In particular, the C-terminal extension found in all apicomplexan PBGS enzymes forms an intersubunit beta-sheet, stabilizing a pro-octamer dimer and preventing formation of hexamers that can form in human PBGS. The TgPBGS structure suggests strategies for the development of parasite-selective PBGS inhibitors.	[Jaffe, Eileen K.] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA; [Shanmugam, Dhanasekaran; Roos, David S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Gardberg, Anna; Dieterich, Shellie; Stewart, Lance J.] Emerald BioStruct Inc, Bainbridge Isl, WA 98110 USA; [Sankaran, Banumathi] Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA; [Myler, Peter J.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Myler, Peter J.] Univ Washington, Dept Global Hlth & Med Educ, Seattle, WA 98195 USA; [Stewart, Lance J.] Univ Washington, Dept Biomed Informat, Seattle, WA 98195 USA; [Gardberg, Anna; Dieterich, Shellie; Stewart, Lance J.; Myler, Peter J.] Seattle Struct Genom Ctr Infect Dis, Seattle, WA 98109 USA	Fox Chase Cancer Center; University of Pennsylvania; Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Jaffe, EK (corresponding author), Fox Chase Canc Ctr, Inst Canc Res, 333 Cottman Ave, Philadelphia, PA 19111 USA.	eileen.jaffe@fccc.edu	Myler, Peter John/AAR-9535-2021	Myler, Peter/0000-0002-0056-0513; Roos, David Siker/0000-0001-6725-4089	National Institutes of Health NIAID [HHSN272200700057C]; NIAID [R56AI077577]; NIEHS [R01ES003654]; National Institutes of Health; NIGMS; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI077577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003654] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health NIAID under Federal Contract HHSN272200700057C, NIAID Grant R56AI077577 (to E. K. J.), and NIEHS Grant R01ES003654 (to E. K. J.). The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, NIGMS, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract DE-AC02-05CH11231.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; BRANDEN C, 1999, INTRO PROTEIN STRUCT, P53; Breinig S, 2003, NAT STRUCT BIOL, V10, P757, DOI 10.1038/nsb963; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coates L, 2005, ACTA CRYSTALLOGR D, V61, P1594, DOI 10.1107/S0907444905030350; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erskine PT, 1997, NAT STRUCT BIOL, V4, P1025, DOI 10.1038/nsb1297-1025; Erskine PT, 2001, FEBS LETT, V503, P196, DOI 10.1016/S0014-5793(01)02721-1; Frankenberg N, 1999, J MOL BIOL, V289, P591, DOI 10.1006/jmbi.1999.2808; Frankenberg N, 1999, BIOCHEMISTRY-US, V38, P13976, DOI 10.1021/bi9906470; Heinemann IU, 2010, ANTIMICROB AGENTS CH, V54, P267, DOI 10.1128/AAC.00553-09; Holliday GL, 2007, NAT PROD REP, V24, P972, DOI 10.1039/b703107f; Jaffe EK, 2004, BIOORG CHEM, V32, P316, DOI 10.1016/j.bioorg.2004.05.010; Jaffe EK, 2003, CHEM BIOL, V10, P25, DOI 10.1016/S1074-5521(02)00296-X; JAFFE EK, 1995, BIOCHEMISTRY-US, V34, P244, DOI 10.1021/bi00001a029; JAFFE EK, 1986, J BIOL CHEM, V261, P9348; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kervinen J, 2001, BIOCHEMISTRY-US, V40, P8227, DOI 10.1021/bi010656k; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Kokona B, 2008, BIOCHEMISTRY-US, V47, P10649, DOI 10.1021/bi801128d; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawrence SH, 2008, CHEM BIOL, V15, P586, DOI 10.1016/j.chembiol.2008.04.012; Lawrence SH, 2008, BIOCHEM MOL BIOL EDU, V36, P274, DOI 10.1002/bmb.20211; Lawrence SH, 2009, J BIOL CHEM, V284, P35807, DOI 10.1074/jbc.M109.026294; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLSDAVIES NL, 2000, THESIS U SOUTHAMPTON; MITCHELL LW, 1993, ARCH BIOCHEM BIOPHYS, V300, P169, DOI 10.1006/abbi.1993.1024; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Sawada N, 2005, J BIOL INORG CHEM, V10, P199, DOI 10.1007/s00775-005-0629-5; Selwood T, 2008, BIOCHEMISTRY-US, V47, P3245, DOI 10.1021/bi702113z; Shanmugam D, 2010, J BIOL CHEM, V285, P22122, DOI 10.1074/jbc.M110.107243; SPANO AJ, 1991, BIOCHIM BIOPHYS ACTA, V1076, P29, DOI 10.1016/0167-4838(91)90216-M; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tang L, 2006, J BIOL CHEM, V281, P6682, DOI 10.1074/jbc.M511134200; Tang L, 2005, J BIOL CHEM, V280, P15786, DOI 10.1074/jbc.M500218200; Van Voorhis WC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000530	43	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15298	15307		10.1074/jbc.M111.226225	http://dx.doi.org/10.1074/jbc.M111.226225			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21383008	Green Published, hybrid			2022-12-27	WOS:000289788300061
J	Ling, SY; Lin, WC				Ling, Shiyun; Lin, Weei-Chin			EDD Inhibits ATM-mediated Phosphorylation of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; E3 UBIQUITIN LIGASE; TUMOR-SUPPRESSOR GENE; HYPERPLASTIC-DISCS; BINDING-PROTEIN; HISTONE H2AX; ACTIVATION; CANCER; CHECKPOINTS; TOPBP1	The EDD (E3 identified by differential display) gene, first identified as a progestin-induced gene in T-47D breast cancer cells, encodes an E3 ubiquitin ligase with a HECT domain. It was reported that EDD is involved in the G(2)/M progression through ubiquitination of phospho-katanin p60. Previous study has also shown that EDD can act as a transcription cofactor independently of its E3 ligase activity. In this study, we uncover a new role for EDD during cell cycle progression in an E3 ligase-independent manner. We demonstrate that EDD can physically interact with p53 and that this interaction blocks the phosphorylation of p53 by ataxia telangiectasia mutated (ATM). Silencing of EDD induces phosphorylation of p53 at Ser(15) and activates p53 target genes in fibroblasts and some transformed cells without activation of DNA damage response. The G(1)/S arrest induced by EDD depletion depends on p53. On the other hand, overexpression of EDD inhibits p53-Ser(15) phosphorylation and suppresses the induction of p53 target genes during DNA damage, and this effect does not require its E3 ligase activity. Thus, through binding to p53, EDD actively inhibits p53 phosphorylation by ATM and plays a role in ensuring smooth G(1)/S progression.	Baylor Coll Med, Dept Med, Hematol Oncol Sect, Houston, TX 77030 USA; [Lin, Weei-Chin] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Ling, Shiyun] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	Baylor College of Medicine; Baylor College of Medicine; University of Alabama System; University of Alabama Birmingham	Lin, WC (corresponding author), 1 Baylor Plaza,MS BCM187, Houston, TX 77030 USA.	weeichil@bcm.edu	Ling, Shiyun/P-2242-2014		National Institutes of Health [RO1CA100857, RO1CA138641, ARRA 3 P30CA125123-03S5]; Department of Defense [W81XWH-09-1-0338]; NATIONAL CANCER INSTITUTE [R01CA138641, P30CA125123, R01CA100857] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1CA100857, RO1CA138641 (to W.C.L.), and ARRA 3 P30CA125123-03S5 and the Department of Defense Breast Cancer Research Program (Grant W81XWH-09-1-0338) (to W.C.L.).	Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bartkova J, 2005, CELL CYCLE, V4, P838, DOI 10.4161/cc.4.6.1742; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cheng WH, 2003, BIOCHEM J, V370, P927, DOI 10.1042/BJ20021870; Clancy JL, 2003, ONCOGENE, V22, P5070, DOI 10.1038/sj.onc.1206775; Dohoney KM, 2004, ONCOGENE, V23, P49, DOI 10.1038/sj.onc.1207005; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Honda Y, 2002, J BIOL CHEM, V277, P3599, DOI 10.1074/jbc.M104347200; Hu GQ, 2010, J BIOL CHEM, V285, P11800, DOI 10.1074/jbc.M109.079384; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; Kruse JP, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.020; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lee JD, 2002, DEVELOPMENT, V129, P5697, DOI 10.1242/dev.00159; Li DWC, 2006, ONCOGENE, V25, P3006, DOI 10.1038/sj.onc.1209334; Lin WC, 2001, GENE DEV, V15, P1833; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Liu K, 2006, EMBO J, V25, P4795, DOI 10.1038/sj.emboj.7601355; Liu K, 2009, MOL CELL BIOL, V29, P2673, DOI 10.1128/MCB.01140-08; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; MacPhail SH, 2003, RADIAT RES, V159, P759, DOI 10.1667/RR3003; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; MANSFIELD E, 1994, DEV BIOL, V165, P507, DOI 10.1006/dbio.1994.1271; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McDonald WJ, 2010, J CELL BIOCHEM, V110, P1123, DOI 10.1002/jcb.22624; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Munoz MA, 2007, CELL CYCLE, V6, P3070, DOI 10.4161/cc.6.24.5021; O'Brien PM, 2008, BRIT J CANCER, V98, P1085, DOI 10.1038/sj.bjc.6604281; Ohshima R, 2007, GENES CELLS, V12, P1339, DOI 10.1111/j.1365-2443.2007.01138.x; Okorokov AL, 2003, CELL CYCLE, V2, P233, DOI 10.4161/cc.2.3.394; Perfettini JL, 2005, J EXP MED, V201, P279, DOI 10.1084/jem.20041502; RENZING J, 1995, ONCOGENE, V10, P1865; Sarkaria JN, 1998, CANCER RES, V58, P4375; Saunders DN, 2004, MOL CELL BIOL, V24, P7225, DOI 10.1128/MCB.24.16.7225-7234.2004; Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079	44	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14972	14982		10.1074/jbc.M110.182527	http://dx.doi.org/10.1074/jbc.M110.182527			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21383020	Green Published, hybrid			2022-12-27	WOS:000289788300027
J	Ogwang, S; Nguyen, HT; Sherman, M; Bajaksouzian, S; Jacobs, MR; Boom, WH; Zhang, GF; Nguyen, L				Ogwang, Sam; Nguyen, Hoa T.; Sherman, Marissa; Bajaksouzian, Saralee; Jacobs, Michael R.; Boom, W. Henry; Zhang, Guo-Fang; Nguyen, Liem			Bacterial Conversion of Folinic Acid Is Required for Antifolate Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOPPORTUNISTIC INFECTION AGENTS; ESCHERICHIA-COLI; METHENYLTETRAHYDROFOLATE SYNTHETASE; MYCOBACTERIUM-TUBERCULOSIS; 5,10-METHENYLTETRAHYDROFOLATE SYNTHETASE; 5-FORMYLTETRAHYDROFOLATE CYCLOLIGASE; SERINE HYDROXYMETHYLTRANSFERASE; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; FOLATE HOMEOSTASIS	Antifolates, which are among the first antimicrobial agents invented, inhibit cell growth by creating an intracellular state of folate deficiency. Clinical resistance to antifolates has been mainly attributed to mutations that alter structure or expression of enzymes involved in de novo folate synthesis. We identified a Mycobacterium smegmatis mutant, named FUEL (which stands for folate utilization enzyme for leucovorin), that is hypersusceptible to antifolates. Chemical complementation indicated that FUEL is unable to metabolize folinic acid (also known as leucovorin or 5-formyltetrahydrofolate), whose metabolic function remains unknown. Targeted mutagenesis, genetic complementation, and biochemical studies showed that FUEL lacks 5,10-methenyltetrahydrofolate synthase (MTHFS; also called 5-formyltetrahydrofolate cyclo-ligase; EC 6.3.3.2) activity responsible for the only ATP-dependent, irreversible conversion of folinic acid to 5,10-methenyltetrahydrofolate. In trans expression of active MTHFS proteins from bacteria or human restored both antifolate resistance and folinic acid utilization to FUEL. Absence of MTHFS resulted in marked cellular accumulation of polyglutamylated species of folinic acid. Importantly, MTHFS also affected M. smegmatis utilization of monoglutamylated 5-methyltetrahydrofolate exogenously added to the medium. Likewise, Escherichia coli mutants lacking MTHFS became susceptible to antifolates. These results indicate that folinic acid conversion by MTHFS is required for bacterial intrinsic antifolate resistance and folate homeostatic control. This novel mechanism of antimicrobial antifolate resistance might be targeted to sensitize bacterial pathogens to classical antifolates.	[Ogwang, Sam; Nguyen, Hoa T.; Sherman, Marissa; Nguyen, Liem] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Bajaksouzian, Saralee; Jacobs, Michael R.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Boom, W. Henry] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Zhang, Guo-Fang] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Nguyen, L (corresponding author), Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, W222,10900 Euclid Ave, Cleveland, OH 44106 USA.	liem.nguyen@case.edu		Nguyen, Liem/0000-0002-1523-1472	National Institutes of Health [R01AI087903]; Case/University Hospital Center for AIDS Research; AIDS International Training Hospital; Fogarty Center [TW000011]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087903] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case/University Hospital Center for AIDS Research; AIDS International Training Hospital; Fogarty Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI087903 (to L. N.). This work was also supported by a Center for AIDS Research developmental award from the Case/University Hospital Center for AIDS Research (to L. N.).; Supported by the AIDS International Training Hospital Research Program, Fogarty Center Grant TW000011 at Case Western Reserve University. Present address: Joint Clinical Research Centre, Makerere University, Kampala, Uganda.	Akhtar TA, 2010, PLANT J, V64, P256, DOI 10.1111/j.1365-313X.2010.04330.x; Anguera MC, 2004, PROTEIN EXPRES PURIF, V35, P276, DOI 10.1016/j.pep.2004.02.010; Anguera MC, 2003, J BIOL CHEM, V278, P29856, DOI 10.1074/jbc.M302883200; Argyrou A, 2006, NAT STRUCT MOL BIOL, V13, P408, DOI 10.1038/nsmb1089; Bermingham A, 2002, BIOESSAYS, V24, P637, DOI 10.1002/bies.10114; Bertino JR, 1971, FOLATE ANTAGONISTS C; Blakley R.L., 1969, N HOLLAND RES MONOGR, P1; Braunstein M, 2002, METHOD ENZYMOL, V358, P67; Date AA, 2010, B WORLD HEALTH ORGAN, V88, P253, DOI 10.2471/BLT.09.066522; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAYAN A, 1995, GENE, V165, P307, DOI 10.1016/0378-1119(95)00321-V; De Brouwer V, 2007, PHYTOCHEM ANALYSIS, V18, P496, DOI 10.1002/pca.1006; DOULL J A, 1963, Int J Lepr, V31, P143; FASS RJ, 1979, ANTIMICROB AGENTS CH, V16, P622, DOI 10.1128/AAC.16.5.622; Field MS, 2006, J BIOL CHEM, V281, P4215, DOI 10.1074/jbc.M510624200; Forgacs P, 2009, ANTIMICROB AGENTS CH, V53, P4789, DOI 10.1128/AAC.01658-08; Gangjee A, 2008, ANTI-CANCER AGENT ME, V8, P205, DOI 10.2174/187152008783497064; Gangjee A, 2007, ANTI-CANCER AGENT ME, V7, P524, DOI 10.2174/187152007781668724; Gao LY, 2003, INFECT IMMUN, V71, P922, DOI 10.1128/IAI.71.2.922-929.2003; Girgis S, 1997, J BIOL CHEM, V272, P4729, DOI 10.1074/jbc.272.8.4729; Gorlick R, 1996, NEW ENGL J MED, V335, P1041, DOI 10.1056/NEJM199610033351408; Goyer A, 2005, J BIOL CHEM, V280, P26137, DOI 10.1074/jbc.M503106200; Green J. C., 1996, ESCHERICHIA COLI SAL, P665; Grim SA, 2005, PHARMACOTHERAPY, V25, P253, DOI 10.1592/phco.25.2.253.56956; HAMMES W, 1973, J BACTERIOL, V116, P1029, DOI 10.1128/JB.116.2.1029-1053.1973; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; Holmes WB, 2002, J BIOL CHEM, V277, P20205, DOI 10.1074/jbc.M201242200; Jeanguenin L, 2010, J BIOL CHEM, V285, P41557, DOI 10.1074/jbc.M110.190504; Johnson JE, 2004, J BACTERIOL, V186, P2418, DOI 10.1128/JB.186.8.2418-2429.2004; Jolivet, 1996, Oncologist, V1, P248; Kamen B, 1997, SEMIN ONCOL, V24, P30; KLOPMAN G, 1993, ANTIMICROB AGENTS CH, V37, P1799, DOI 10.1128/AAC.37.9.1799; KRUSCHWITZ HL, 1994, J BIOL CHEM, V269, P28757; Lampe DJ, 1999, P NATL ACAD SCI USA, V96, P11428, DOI 10.1073/pnas.96.20.11428; Libecco JA, 2004, PEDIATR REV, V25, P375; Mwenya DM, 2010, ANTIMICROB AGENTS CH, V54, P3756, DOI 10.1128/AAC.01409-09; *NAT COMM CLIN LAB, 2003, M24A NAT COMM CLIN L, V23; Nguyen HT, 2010, J UROLOGY, V184, P305, DOI 10.1016/j.juro.2010.03.084; Nguyen L, 2005, J BACTERIOL, V187, P6603, DOI 10.1128/JB.187.19.6603-6611.2005; Nguyen L, 2007, J BACTERIOL, V189, P7896, DOI 10.1128/JB.00726-07; Nijhout HF, 2004, J BIOL CHEM, V279, P55008, DOI 10.1074/jbc.M410818200; Ong W, 2010, ANTIMICROB AGENTS CH, V54, P2748, DOI 10.1128/AAC.00029-10; Proctor RA, 2008, CLIN INFECT DIS, V46, P584, DOI 10.1086/525536; Recht J, 2001, J BACTERIOL, V183, P5718, DOI 10.1128/JB.183.19.5718-5724.2001; Rengarajan J, 2004, MOL MICROBIOL, V53, P275, DOI 10.1111/j.1365-2958.2004.04120.x; Roje S, 2002, J BIOL CHEM, V277, P42748, DOI 10.1074/jbc.M205632200; Rubin EJ, 1999, P NATL ACAD SCI USA, V96, P1645, DOI 10.1073/pnas.96.4.1645; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; SAUER H, 1977, BRIT J HAEMATOL, V36, P189, DOI 10.1111/j.1365-2141.1977.tb00639.x; Sedlaczek L, 1999, APPL MICROBIOL BIOT, V52, P563, DOI 10.1007/s002530051561; SHIN YS, 1975, CAN J BIOCHEM CELL B, V53, P338, DOI 10.1139/o75-047; STOVER P, 1993, TRENDS BIOCHEM SCI, V18, P102, DOI 10.1016/0968-0004(93)90162-G; STOVER P, 1990, J BIOL CHEM, V265, P14227; STOVER P, 1991, J BIOL CHEM, V266, P1543; Suh JR, 2001, ANNU REV NUTR, V21, P255, DOI 10.1146/annurev.nutr.21.1.255; Waites KB, 1998, J CLIN MICROBIOL, V36, P2052, DOI 10.1128/JCM.36.7.2052-2056.1998; WASHINGTON JA, 1972, APPL MICROBIOL, V24, P1013, DOI 10.1128/AEM.24.6.1013-1013.1972; Wolff KA, 2009, ANTIMICROB AGENTS CH, V53, P3515, DOI 10.1128/AAC.00012-09; Wright GD, 2000, CHEM BIOL, V7, pR127, DOI 10.1016/S1074-5521(00)00126-5; Wright GD, 2007, TRENDS MOL MED, V13, P260, DOI 10.1016/j.molmed.2007.04.004; Wu D, 2009, CANCER RES, V69, P7294, DOI 10.1158/0008-5472.CAN-09-1927; Young LS, 2009, ANTIMICROB AGENTS CH, V53, P4577, DOI 10.1128/AAC.00887-09; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang GF, 2005, J CHROMATOGR A, V1078, P59, DOI 10.1016/j.chroma.2005.04.085	64	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15377	15390		10.1074/jbc.M111.231076	http://dx.doi.org/10.1074/jbc.M111.231076			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21372133	Green Published, hybrid			2022-12-27	WOS:000289788300068
J	Suissa, Y; Ziv, O; Dinur, T; Arama, E; Gerlitz, O				Suissa, Yaron; Ziv, Oren; Dinur, Tama; Arama, Eli; Gerlitz, Offer			The NAB-Brk Signal Bifurcates at JNK to Independently Induce Apoptosis and Compensatory Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA IMAGINAL DISCS; DEVELOPMENTAL CELL-DEATH; CASPASE DRONC; DEPENDENT APOPTOSIS; REAPER; HID; INHIBITION; REQUIRES; DIAP1; REGENERATION	Apoptosis operates to eliminate damaged or potentially dangerous cells. This loss is often compensated by extra proliferation of neighboring cells. Studies in Drosophila imaginal discs suggest that the signal for the additional growth emanates from the dying cells. In particular, it was suggested that the initiator caspase Dronc mediates compensatory proliferation (CP) through Dp53 in wing discs. However, the exact mechanism that governs this CP remained poorly understood. We have previously shown that elimination of misspecified cells due to reduced Dpp signaling is achieved by the interaction of the corepressor NAB with the transcriptional repressor Brk, which in turn induces Jun N-terminal kinase-dependent apoptosis. Here, we performed a systematic in vivo loss-and gain-of-function analysis to study NAB-induced death and CP. Our findings indicate that the NAB primary signal activates JNK, which in turn transmits two independent signals. One triggers apoptosis through the pro-apoptotic proteins Reaper and Hid, which in turn promote activation of caspases by the apoptosome components Ark and Dronc. The other signal induces CP in a manner that is independent of the death signal, Dronc, or Dp53. Once induced, the apoptotic pathway further activates a CP response. Our data suggest that JNK is the candidate factor that differentiates between apoptosis that involves CP and apoptosis that does not.	[Suissa, Yaron; Ziv, Oren; Dinur, Tama; Gerlitz, Offer] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel; [Arama, Eli] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Weizmann Institute of Science	Gerlitz, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel.	offerg@ekmd.huji.ac.il	Arama, Eli/GYJ-0491-2022	Gerlitz, Offer/0000-0002-1574-2088	Israel Science Foundation [869/04]; Israel Cancer Research Foundation; Abisch-Frenkel Foundation [0304624]	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Foundation; Abisch-Frenkel Foundation	This work was supported by Israel Science Foundation Grant 869/04, the Israel Cancer Research Foundation, and Abisch-Frenkel Foundation Grant 0304624.	Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Adrain C, 2006, TRENDS BIOCHEM SCI, V31, P243, DOI 10.1016/j.tibs.2006.03.004; Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Bergantinos C, 2010, DEVELOPMENT, V137, P1169, DOI 10.1242/dev.045559; Bosch M, 2005, DEV BIOL, V280, P73, DOI 10.1016/j.ydbio.2005.01.002; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Burke R, 1996, DEVELOPMENT, V122, P2261; Chew SK, 2004, DEV CELL, V7, P897, DOI 10.1016/j.devcel.2004.09.016; Daish TJ, 2004, DEV CELL, V7, P909, DOI 10.1016/j.devcel.2004.09.018; Ditzel M, 2008, MOL CELL, V32, P540, DOI 10.1016/j.molcel.2008.09.025; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Felix JT, 2007, DEVELOPMENT, V134, P1845, DOI 10.1242/dev.003830; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Igaki T, 2009, APOPTOSIS, V14, P1021, DOI 10.1007/s10495-009-0361-7; Kondo S, 2006, MOL CELL BIOL, V26, P7258, DOI 10.1128/MCB.00183-06; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Lisi S, 2000, GENETICS, V154, P669; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Mattila J, 2005, INT J DEV BIOL, V49, P391, DOI 10.1387/ijdb.052006jm; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Perez-Garijo A, 2009, DEVELOPMENT, V136, P1169, DOI 10.1242/dev.034017; Peters M, 2002, P NATL ACAD SCI USA, V99, P11305, DOI 10.1073/pnas.172382899; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Shapiro PJ, 2008, NAT CELL BIOL, V10, P1440, DOI 10.1038/ncb1803; Smith-Bolton RK, 2009, DEV CELL, V16, P797, DOI 10.1016/j.devcel.2009.04.015; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wells BS, 2006, CURR BIOL, V16, P1606, DOI 10.1016/j.cub.2006.07.046; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Xu DB, 2005, DEVELOPMENT, V132, P2125, DOI 10.1242/dev.01790; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Ziv O, 2009, DEVELOPMENT, V136, P1137, DOI 10.1242/dev.032383	40	15	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15556	15564		10.1074/jbc.M110.193235	http://dx.doi.org/10.1074/jbc.M110.193235			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21385866	hybrid, Green Published			2022-12-27	WOS:000289788300083
J	Parikh, RB; Bali, M; Akabas, MH				Parikh, Rishi B.; Bali, Moez; Akabas, Myles H.			Structure of the M2 Transmembrane Segment of GLIC, a Prokaryotic Cys Loop Receptor Homologue from Gloeobacter violaceus, Probed by Substituted Cysteine Accessibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; ANESTHETIC BINDING-SITE; MEMBRANE-SPANNING SEGMENT; GABA(A) RECEPTOR; SULFHYDRYL GROUPS; 5-HT3 RECEPTORS; LINING RESIDUES; PROTEIN PACKING; HIGH-RESOLUTION	GLIC is a homopentameric proton-gated, prokaryotic homologue of the Cys loop receptor family of neurotransmitter-gated ion channels. Recently, crystal structures of GLIC hypothesized to represent an open channel state were published. To explore the channel structure in functional GLIC channels, we tested the ability of p-chloromercuribenzenesulfonate to react with 30 individual cysteine substitution mutants in and flanking the M2 channel-lining segment in the closed state (pH 7.5) and in a submaximally activated state (pH 5.0). Nine mutants did not tolerate cysteine substitution and were not functional. From positions 10' to 27', p-chloromercuribenzenesulfonate significantly modified the currents at pH 7.5 and 5.0 in all mutants except H234C (11'), I235C (12'), V241C (18'), T243C (20'), L245C (22'), and Y250C (27'), which were not functional, except for 12'. Currents for P246C (23') and K247C (24') were only significantly altered at pH5.0. The reaction rates were all > 1000 M-1 s(-1). The reactive residues were more accessible in the activated than in the resting state. We infer that M2 is tightly associated with the adjacent transmembrane helices at the intracellular end but is more loosely packed from 10' to the extracellular end than the x-ray structures suggest. We infer that the charge selectivity filter is in the cytoplasmic half of the channel. We also show that below pH 5.0, GLIC desensitizes on a time scale of minutes and infer that the crystal structures may represent a desensitized state.	[Parikh, Rishi B.; Bali, Moez; Akabas, Myles H.] Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Akabas, Myles H.] Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Akabas, Myles H.] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Akabas, MH (corresponding author), Dept Physiol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	myles.akabas@einstein.yu.edu		Akabas, Myles/0000-0001-8781-7846	National Institutes of Health [NS030808, GM077660]; NIGMS MSTP [GM007288]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288, R01GM077660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS030808 and GM077660 (to M. H. A.). R. B. P. was supported in part by NIGMS MSTP training grant GM007288.	Akabas MH, 2004, INT REV NEUROBIOL, V62, P1, DOI 10.1016/S0074-7742(04)62001-0; AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Bali M, 2007, J GEN PHYSIOL, V129, P145, DOI 10.1085/jgp.200609639; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bondarenko V, 2010, BBA-BIOMEMBRANES, V1798, P1608, DOI 10.1016/j.bbamem.2010.04.014; Braun T, 2003, MOL CANCER RES, V1, P186; Changeux JP, 2010, ANNU REV PHARMACOL, V50, P1, DOI 10.1146/annurev.pharmtox.010909.105741; Corringer P J, 1999, Novartis Found Symp, V225, P215; Cross TA, 2011, TRENDS BIOCHEM SCI, V36, P117, DOI 10.1016/j.tibs.2010.07.005; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Gonzalez-Gutierrez G, 2010, J MOL BIOL, V403, P693, DOI 10.1016/j.jmb.2010.09.026; Goren EN, 2004, J BIOL CHEM, V279, P11198, DOI 10.1074/jbc.M314050200; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; HALBACH S, 1985, ARCH TOXICOL, V57, P139, DOI 10.1007/BF00343125; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; HASINOFF BB, 1971, CAN J BIOCHEM CELL B, V49, P742, DOI 10.1139/o71-105; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Horenstein J, 1998, MOL PHARMACOL, V53, P870; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2000, BIOPHYS J, V79, P247, DOI 10.1016/S0006-3495(00)76287-4; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Lide D. R., 2000, HDB CHEM PHYS; Menard C, 2005, J BIOL CHEM, V280, P27502, DOI 10.1074/jbc.M501624200; MILLER C, 1989, NEURON, V2, P1195, DOI 10.1016/0896-6273(89)90304-8; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Pless SA, 2008, CLIN EXP PHARMACOL P, V35, P1137, DOI 10.1111/j.1440-1681.2008.04954.x; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Tasneem A, 2005, GENOME BIOL, V6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VANSTEVENINCK J, 1965, J GEN PHYSIOL, V48, P617, DOI 10.1085/jgp.48.4.617; Vedula LS, 2009, J BIOL CHEM, V284, P24176, DOI 10.1074/jbc.M109.017814; VILLARROEL A, 1991, P ROY SOC B-BIOL SCI, V243, P69, DOI 10.1098/rspb.1991.0012; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Williams DB, 1999, BIOPHYS J, V77, P2563, DOI 10.1016/S0006-3495(99)77091-8; Wiltfong RE, 2009, J NEUROSCI, V29, P1626, DOI 10.1523/JNEUROSCI.4121-08.2009; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195	55	48	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14098	14109		10.1074/jbc.M111.221895	http://dx.doi.org/10.1074/jbc.M111.221895			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21362624	hybrid, Green Published			2022-12-27	WOS:000289556200033
J	Stalnaker, SH; Aoki, K; Lim, JM; Porterfield, M; Liu, MA; Satz, JS; Buskirk, S; Xiong, YF; Zhang, P; Campbell, KP; Hu, HY; Live, D; Tiemeyer, M; Wells, L				Stalnaker, Stephanie H.; Aoki, Kazuhiro; Lim, Jae-Min; Porterfield, Mindy; Liu, Mian; Satz, Jakob S.; Buskirk, Sean; Xiong, Yufang; Zhang, Peng; Campbell, Kevin P.; Hu, Huaiyu; Live, David; Tiemeyer, Michael; Wells, Lance			Glycomic Analyses of Mouse Models of Congenital Muscular Dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-DYSTROGLYCAN; ABNORMAL GLYCOSYLATION; GLYCOPROTEIN COMPLEX; MUTATIONS; LAMININ; GLYCANS; BINDING; POMT1; FORM; H-1	Dystroglycanopathies are a subset of congenital muscular dystrophies wherein alpha-dystroglycan (alpha-DG) is hypoglycosylated. alpha-DG is an extensively O-glycosylated extracellular matrix-binding protein and a key component of the dystrophinglycoprotein complex. Previous studies have shown alpha-DG to be post-translationally modified by both O-GalNAc-and O-mannose-initiated glycan structures. Mutations in defined or putative glycosyltransferase genes involved in O-mannosylation are associated with a loss of ligand-binding activity of alpha-DG and are causal for various forms of congenital muscular dystrophy. In this study, we sought to perform glycomic analysis on brain O-linked glycan structures released from proteins of three different knock-out mouse models associated with O-mannosylation (POMGnT1, LARGE (Myd), and DAG1(-/-)). Using mass spectrometry approaches, we were able to identify nine O-mannose-initiated and 25 O-GalNAc-initiated glycan structures in wild-type littermate control mouse brains. Through our analysis, we were able to confirm that POMGnT1 is essential for the extension of all observed O-mannose glycan structures with beta 1,2-linked GlcNAc. Loss of LARGE expression in the Myd mouse had no observable effect on the O-mannose-initiated glycan structures characterized here. Interestingly, we also determined that similar amounts of O-mannose-initiated glycan structures are present on brain proteins from alpha-DG-lacking mice (DAG1) compared with wild-type mice, indicating that there must be additional proteins that are O-mannosylated in the mammalian brain. Our findings illustrate that classical beta 1,2-elongation and beta 1,6-GlcNAc branching of O-mannose glycan structures are dependent upon the POMGnT1 enzyme and that O-mannosylation is not limited solely to alpha-DG in the brain.	[Stalnaker, Stephanie H.; Aoki, Kazuhiro; Lim, Jae-Min; Porterfield, Mindy; Liu, Mian; Buskirk, Sean; Live, David; Tiemeyer, Michael; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Satz, Jakob S.; Campbell, Kevin P.] Howard Hughes Med Inst, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Xiong, Yufang; Zhang, Peng; Hu, Huaiyu] SUNY Upstate Med Univ, Syracuse, NY 13210 USA	University System of Georgia; University of Georgia; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wells, L (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	lwells@ccrc.uga.edu	Buskirk, Sean/AAM-1228-2021; Wells, Lance/H-3118-2013; Aoki, Kazuhiro/H-8283-2014	Buskirk, Sean/0000-0003-1213-8130; Aoki, Kazuhiro/0000-0003-0029-4291; Campbell, Kevin/0000-0003-2066-5889; Wells, Lance/0000-0003-4956-5363	National Institutes of Health [HD060458, NS066582]; Muscular Dystrophy Association; National Center for Research Resources Center [P41RR018502]; Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [1U54NS053672]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060458] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066582, U54NS053672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); National Center for Research Resources Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center(Ohio State University); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD060458 and NS066582 (to H. H.). This work was also supported by the Muscular Dystrophy Association (to L. W.), National Center for Research Resources Center Grant P41RR018502 (to L. W. and M. T.), and Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant 1U54NS053672 (to K. P. C.).	Alvarez-Manilla G, 2010, GLYCOBIOLOGY, V20, P166, DOI 10.1093/glycob/cwp158; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Bubb WA, 2003, CONCEPT MAGN RESON A, V19A, P1, DOI 10.1002/cmr.a.10080; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; Chiba A, 1997, J BIOL CHEM, V272, P2156; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Combs AC, 2005, BIOCHEM J, V390, P303, DOI 10.1042/BJ20050375; Endo T, 1999, BBA-GEN SUBJECTS, V1473, P237, DOI 10.1016/S0304-4165(99)00182-8; Endo Tamao, 2006, V347, P43; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Jimenez-Mallebrera C, 2005, CELL MOL LIFE SCI, V62, P809, DOI 10.1007/s00018-004-4510-4; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Lisi MT, 2007, BBA-MOL BASIS DIS, V1772, P159, DOI 10.1016/j.bbadis.2006.09.006; Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Martin PT, 2007, CURR MOL MED, V7, P417, DOI 10.2174/156652407780831601; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Nakamura N, 2010, GLYCOBIOLOGY, V20, P381, DOI 10.1093/glycob/cwp189; PODLASEK CA, 1995, J AM CHEM SOC, V117, P8635, DOI 10.1021/ja00138a020; Spiropoulou CF, 2002, J VIROL, V76, P5140, DOI 10.1128/JVI.76.10.5140-5146.2002; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Sutton-Smith M, 2002, BIOCHEM SOC SYMP, V69, P105; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	37	59	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21180	21190		10.1074/jbc.M110.203281	http://dx.doi.org/10.1074/jbc.M110.203281			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21460210	hybrid, Green Published			2022-12-27	WOS:000291464700018
J	Zamborlini, A; Coiffic, A; Beauclair, G; Delelis, O; Paris, J; Koh, Y; Magne, F; Giron, ML; Tobaly-Tapiero, J; Deprez, E; Emiliani, S; Engelman, A; de The, H; Saib, A				Zamborlini, Alessia; Coiffic, Audrey; Beauclair, Guillaume; Delelis, Olivier; Paris, Joris; Koh, Yashuiro; Magne, Fabian; Giron, Marie-Lou; Tobaly-Tapiero, Joelle; Deprez, Eric; Emiliani, Stephane; Engelman, Alan; de The, Hugues; Saib, Ali			Impairment of Human Immunodeficiency Virus Type-1 Integrase SUMOylation Correlates with an Early Replication Defect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 INTEGRASE; REVERSE-TRANSCRIPTASE; DNA-BINDING; IN-VITRO; NONDIVIDING CELLS; VIRAL INTEGRATION; SUMO MODIFICATION; GENE-EXPRESSION; TERMINAL DOMAIN; RETROVIRAL DNA	HIV-1 integrase (IN) orchestrates the integration of the reverse transcribed viral cDNA into the host cell genome and participates also in other steps of HIV-1 replication. Cellular and viral factors assist IN in performing its multiple functions, and post-translational modifications contribute to modulate its activities. Here, we show that HIV-1 IN is modified by SUMO proteins and that phylogenetically conserved SUMOylation consensus motifs represent major SUMO acceptor sites. Viruses harboring SUMOylation site IN mutants displayed a replication defect that was mapped during the early stages of infection, before integration but after reverse transcription. Because SUMOylation-defective IN mutants retained WT catalytic activity, we hypothesize that SUMOylation might regulate the affinity of IN for co-factors, contributing to efficient HIV-1 replication.	[Zamborlini, Alessia; Coiffic, Audrey; Beauclair, Guillaume; Paris, Joris; Magne, Fabian; Giron, Marie-Lou; Tobaly-Tapiero, Joelle; de The, Hugues; Saib, Ali] Univ Paris 07, CNRS, INSERM, Inst Univ Hematol,UMR7212,U944, F-75475 Paris, France; [Zamborlini, Alessia; Magne, Fabian; Saib, Ali] Conservatoire Arts & Metiers, Paris, France; [Delelis, Olivier; Deprez, Eric] Ecole Normale Super, Lab Biotechnol & Pharmacol Genet Appl, CNRS, UMR8113, F-94235 Cachan, France; [Emiliani, Stephane] Univ Paris 05, INSERM, CNRS, Inst Cochin,U1016,UMR8104, F-75014 Paris, France; [Koh, Yashuiro; Engelman, Alan] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Dana-Farber Cancer Institute	Saib, A (corresponding author), Univ Paris 07, CNRS, INSERM, Inst Univ Hematol,UMR7212,U944, F-75475 Paris, France.	ali.saib@cnam.fr	Guillaume, Beauclair/ABF-6429-2020; Zamborlini, Alessia/ABE-2256-2021; Magne, Fabien/F-1393-2014	Guillaume, Beauclair/0000-0001-5323-5987; Zamborlini, Alessia/0000-0002-8902-1996; Magne, Fabien/0000-0002-8210-4561; Tobaly-Tapiero, Joelle/0000-0001-6318-8627	National Institutes of Health [AI052014]; Agence Nationale pour la Recherche sur le SIDA et les Hepatites Virales (ANRS); Sidaction; French Research Ministry; Mitsubishi Pharma Foundation; Conseil Regional d'Ile de France; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052014, P30AI060354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale pour la Recherche sur le SIDA et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); Sidaction; French Research Ministry(Ministry of Research, France); Mitsubishi Pharma Foundation; Conseil Regional d'Ile de France(Region Ile-de-France); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI052014 (to A. E.). This work was also supported by Sidaction and by Agence Nationale pour la Recherche sur le SIDA et les Hepatites Virales (ANRS).; Supported by the French Research Ministry.; Supported by the Mitsubishi Pharma Foundation.; We thank D. Gabuzda, R. Niedenthal, F. Mammano, R. Hay, and D. Trono for reagents; P. Lesage, S. Basmaciogullari, V. Lallemand-Breitenbach, and M. Benkirane for discussion and critical reading of the manuscript; and F. Lacoste for informatics supplies. We thank N. Setterblad and C. Doliger at the Imagery and Cell Sorting Department of the Institut Universitaire d'Hematologie-Hopital St-Louis IFR105 (supported by grants from the Conseil Regional d'Ile de France and the French Research Ministry) for technical assistance.	Al-Mawsawi LQ, 2007, TRENDS PHARMACOL SCI, V28, P526, DOI 10.1016/j.tips.2007.09.005; ALLOUCH A, 2009, AMINO ACIDS IN PRESS; Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008; BOWERMAN B, 1989, GENE DEV, V3, P469, DOI 10.1101/gad.3.4.469; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Briones MS, 2010, J VIROL, V84, P5181, DOI 10.1128/JVI.02382-09; Brussel A, 2004, J VIROL, V78, P11263, DOI 10.1128/JVI.78.20.11263-11271.2004; Bukovsky A, 1996, J VIROL, V70, P6820, DOI 10.1128/JVI.70.10.6820-6825.1996; Cannon PM, 1996, J VIROL, V70, P651, DOI 10.1128/JVI.70.1.651-657.1996; Carayon K, 2010, NUCLEIC ACIDS RES, V38, P3692, DOI 10.1093/nar/gkq087; Carteau S, 1999, J VIROL, V73, P6670, DOI 10.1128/JVI.73.8.6670-6679.1999; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Cereseto A, 2005, EMBO J, V24, P3070, DOI 10.1038/sj.emboj.7600770; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2000, FASEB J, V14, P1389, DOI 10.1096/fj.14.10.1389; Craigie R, 2001, J BIOL CHEM, V276, P23213, DOI 10.1074/jbc.R100027200; CRAIGIE R, 1990, CELL, V62, P829, DOI 10.1016/0092-8674(90)90126-Y; Devroe E, 2003, J CELL SCI, V116, P4401, DOI 10.1242/jcs.00747; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Engelman A, 1999, ADV VIRUS RES, V52, P411, DOI 10.1016/S0065-3527(08)60309-7; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; Esposito D, 1999, ADV VIRUS RES, V52, P319, DOI 10.1016/S0065-3527(08)60304-8; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; GOFF SP, 2001, FIELDS VIROLOGY, P1871; Gurer C, 2005, J VIROL, V79, P910, DOI 10.1128/JVI.79.2.910-917.2005; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Hehl EA, 2004, J VIROL, V78, P5056, DOI 10.1128/JVI.78.10.5056-5067.2004; Hindmarsh P, 1999, ADV VIRUS RES, V52, P397, DOI 10.1016/S0065-3527(08)60308-5; Ikeda T, 2004, J VIROL, V78, P11563, DOI 10.1128/JVI.78.21.11563-11573.2004; Jaber T, 2009, J VIROL, V83, P10448, DOI 10.1128/JVI.00237-09; KATZ RA, 1990, CELL, V63, P87, DOI 10.1016/0092-8674(90)90290-U; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; KUIKEN CL, 2002, HIV SEQUENCE COMPEND; Leavitt AD, 1996, J VIROL, V70, P721, DOI 10.1128/JVI.70.2.721-728.1996; Leh H, 2000, BIOCHEMISTRY-US, V39, P9285, DOI 10.1021/bi000398b; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Liu HM, 1997, J VIROL, V71, P7704, DOI 10.1128/JVI.71.10.7704-7710.1997; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Lu R, 2005, J VIROL, V79, P2493, DOI 10.1128/JVI.79.4.2493-2505.2005; Manganaro L, 2010, NAT MED, V16, P329, DOI 10.1038/nm.2102; Martinez NW, 2008, J VIROL, V82, P9937, DOI 10.1128/JVI.00819-08; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Mousnier A, 2007, P NATL ACAD SCI USA, V104, P13615, DOI 10.1073/pnas.0705162104; Mulder LCF, 2000, J BIOL CHEM, V275, P29749, DOI 10.1074/jbc.M004670200; Petit C, 1999, J VIROL, V73, P5079, DOI 10.1128/JVI.73.6.5079-5088.1999; Quillent C, 1996, VIROLOGY, V219, P29, DOI 10.1006/viro.1996.0219; Rhee SY, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-74; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; SHIN CG, 1994, J VIROL, V68, P1633, DOI 10.1128/JVI.68.3.1633-1642.1994; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Swanson CM, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.005; Tasara T, 2001, FEBS LETT, V507, P39, DOI 10.1016/S0014-5793(01)02945-3; Terreni M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-18; Topper M, 2007, J VIROL, V81, P3012, DOI 10.1128/JVI.02257-06; Tsurutani N, 2000, J VIROL, V74, P4795, DOI 10.1128/JVI.74.10.4795-4806.2000; Vandegraaff Nick, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000257; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Weldon RA, 2003, VIROLOGY, V314, P62, DOI 10.1016/S0042-6822(03)00348-9; Wilson VG, 2001, VIRUS RES, V81, P17, DOI 10.1016/S0168-1702(01)00365-3; Wu XY, 1999, J VIROL, V73, P2126, DOI 10.1128/JVI.73.3.2126-2135.1999; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Yoder KE, 2000, J VIROL, V74, P11191, DOI 10.1128/JVI.74.23.11191-11200.2000; Yueh A, 2006, J VIROL, V80, P342, DOI 10.1128/JVI.80.1.342-352.2006; Zhu K, 2004, J VIROL, V78, P5045, DOI 10.1128/JVI.78.10.5045-5055.2004	70	48	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					21013	21022		10.1074/jbc.M110.189274	http://dx.doi.org/10.1074/jbc.M110.189274			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21454548	Green Published, hybrid			2022-12-27	WOS:000291267600085
J	Dai, YF; Walker, SA; de Vet, E; Cook, S; Welch, HCE; Lockyer, PJ				Dai, Yanfeng; Walker, Simon A.; de Vet, Edwin; Cook, Simon; Welch, Heidi C. E.; Lockyer, Peter J.			Ca2+-dependent Monomer and Dimer Formation Switches CAPRI Protein between Ras GTPase-activating Protein (GAP) and RapGAP Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE-FINGER; FLUORESCENCE COMPLEMENTATION; CELL-PROLIFERATION; CA2+ OSCILLATIONS; C2 DOMAIN; KINASE-II; FAMILY; RAP1; COMPLEX; IDENTIFICATION	CAPRI is a member of the GAP1 family of GTPase-activating proteins (GAPs) for small G proteins. It is known to function as an amplitude sensor for intracellular Ca2+ levels stimulated by extracellular signals and has a catalytic domain with dual RasGAP and RapGAP activities. Here, we have investigated the mechanism that switches CAPRI between its two GAP activities. We demonstrate that CAPRI forms homodimers in vitro and in vivo in a Ca2+-dependent manner. The site required for dimerization was pinpointed by deletion and point mutations to a helix motif that forms a hydrophobic face in the extreme C-terminal tail of the CAPRI protein. Deletion of this helix motif abolished dimer formation but did not affect translocation of CAPRI to the plasma membrane upon cell stimulation with histamine. We found that dimeric and monomeric CAPRI coexist in cells and that the ratio of dimeric to monomeric CAPRI increases upon cell stimulation with histamine. Free Ca2+ at physiologically relevant concentrations was both necessary and sufficient for dimer formation. Importantly, the monomeric and dimeric forms of CAPRI exhibited differential GAP activities in vivo; the wild-type form of CAPRI had stronger RapGAP activity than RasGAP activity, whereas a monomeric CAPRI mutant showed stronger RasGAP than RapGAP activity. These results demonstrate that CAPRI switches between its dual GAP roles by forming monomers or homodimers through a process regulated by Ca2+. We propose that Ca2+-dependent dimerization of CAPRI may serve to coordinate Ras and Rap1 signaling pathways.	[Dai, Yanfeng; Walker, Simon A.; de Vet, Edwin; Cook, Simon; Lockyer, Peter J.] Babraham Inst, Mol Signalling Lab, Cambridge CB22 3AT, England; [Dai, Yanfeng; Welch, Heidi C. E.] Babraham Inst, Inositide Lab, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Dai, YF (corresponding author), Inner Mongolia Univ, Coll Life Sci, Hohhot 010021, Peoples R China.	yfdai9698@gmail.com		Welch, Heidi/0000-0001-7865-7000; Dai, Yanfeng/0000-0002-6151-2654; dai, dai yan feng/0000-0001-7147-1748; Walker, Simon/0000-0001-9185-4922	Biotechnology and Biological Sciences Research Council [C20001, BBS/E/B/0000C231, BBS/E/B/0000C199, BBS/E/B/0000M090, BBS/E/B/0000C197] Funding Source: Medline; BBSRC [BBS/E/B/0000C231] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; Brinkmann T, 2002, J BIOL CHEM, V277, P12525, DOI 10.1074/jbc.M109176200; Chakrabarti PP, 2004, J BIOL CHEM, V279, P46226, DOI 10.1074/jbc.M405603200; Cook SJ, 2006, CELL CALCIUM, V39, P101, DOI 10.1016/j.ceca.2005.10.014; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; Cullen PJ, 2006, CURR OPIN CELL BIOL, V18, P157, DOI 10.1016/j.ceb.2006.02.012; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dote H, 2004, CLIN CANCER RES, V10, P2082, DOI 10.1158/1078-0432.CCR-03-0236; Hames BD., 1990, GEL ELECTROPHORESIS, P1; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kim JH, 2003, J NEUROSCI, V23, P1119; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kupzig S, 2006, J BIOL CHEM, V281, P9891, DOI 10.1074/jbc.M512802200; Kupzig S, 2009, MOL CELL BIOL, V29, P3929, DOI 10.1128/MCB.00427-09; Liu Q, 2005, J CELL BIOL, V170, P183, DOI 10.1083/jcb.200504167; Lockyer PJ, 2001, CURR BIOL, V11, P981, DOI 10.1016/S0960-9822(01)00261-5; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Oh JS, 2004, J BIOL CHEM, V279, P17980, DOI 10.1074/jbc.M314109200; Ohba Y, 2001, EMBO J, V20, P3333, DOI 10.1093/emboj/20.13.3333; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Sot B, 2010, EMBO J, V29, P1205, DOI 10.1038/emboj.2010.20; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Walker SA, 2004, EMBO J, V23, P1749, DOI 10.1038/sj.emboj.7600197; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Yarwood S, 2006, BIOCHEM SOC T, V34, P846, DOI 10.1042/BST0340846; Zhang J, 2005, NAT IMMUNOL, V6, P911, DOI 10.1038/ni1232	41	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19905	19916		10.1074/jbc.M110.201301	http://dx.doi.org/10.1074/jbc.M110.201301			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21460216	Green Published, hybrid			2022-12-27	WOS:000291027700070
J	Campbell, GR; Spector, SA				Campbell, Grant R.; Spector, Stephen A.			Hormonally Active Vitamin D3 (1 alpha,25-Dihydroxycholecalciferol) Triggers Autophagy in Human Macrophages That Inhibits HIV-1 Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; ANTIRETROVIRAL THERAPY; HIGHER EUKARYOTES; DOWN-REGULATION; LEUKEMIA CELLS; D DEFICIENCY; ASSOCIATION; REPLICATION	Autophagy is a self-digestion pathway essential for maintaining cellular homeostasis and cell survival and for degrading intracellular pathogens. Human immunodeficiency virus-1 (HIV-1) may utilize autophagy for replication as the autophagy-related protein-7 (ATG-7), microtubule-associated protein 1 light chain 3, ATG-12, and ATG-16L2 are required for productive HIV-1 infection; however, the effects of autophagy induction on HIV-1 infection are unknown. HIV-1-infected individuals have lower levels of 1 alpha,25-dihydroxycholecalciferol, the hormonally active form of vitamin D, than uninfected individuals. with the lowest concentrations found in persons with AIDS. Using human macrophages and RNA interference for ATG-5 and Beclin-1 and chemical inhibition of phosphatidylinositol 3-kinase, we have found that physiologically relevant concentrations of 1 alpha,25-dihydroxycholecalciferol induce autophagy in human macrophages through a phosphatidylinositol 3-kinase-, ATG-5-, and Beclin-1-dependent mechanism that significantly inhibits HIV-1 replication in a dose-dependent manner. We also show that the inhibition of basal autophagy inhibits HIV-1 replication. Furthermore, although 1 alpha,25-dihydroxycholecalciferol induces the secretion of human cathelicidin, at the concentrations produced in vitro, cathelicidin does not trigger autophagy. Our findings support an important role for autophagy during HIV-1 infection and provide new insights into novel approaches to prevent and treat HIV-1 infection and related opportunistic infections.	[Campbell, Grant R.; Spector, Stephen A.] Univ Calif San Diego, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA; [Spector, Stephen A.] Rady Childrens Hosp, San Diego, CA 92123 USA	University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Spector, SA (corresponding author), Univ Calif San Diego, Dept Pediat, Div Infect Dis, 9500 Gilman Dr, La Jolla, CA 92093 USA.	saspector@ucsd.edu	Campbell, Grant/C-9018-2011	Campbell, Grant/0000-0003-3927-1994	National Institutes of Health (NIAID) [AI084573, AI068632]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI084573, U01AI068632, UM1AI068632] Funding Source: NIH RePORTER	National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI084573 and AI068632 (NIAID; to the International Maternal Pediatric Adolescent AIDS Clinical Trials Group).	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bergman P, 2007, CURR HIV RES, V5, P410; Blanchet FP, 2010, IMMUNITY, V32, P654, DOI 10.1016/j.immuni.2010.04.011; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brady NR, 2007, FEBS J, V274, P3184, DOI 10.1111/j.1742-4658.2007.05849.x; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; CAMPBELL GR, 2011, AIDS RES HU IN PRESS; Campbell GR, 2008, J BIOL CHEM, V283, P30745, DOI 10.1074/jbc.M804112200; Campbell GR, 2010, J BIOL CHEM, V285, P1681, DOI 10.1074/jbc.M109.049957; de Luis D A, 2002, Nutr Hosp, V17, P285; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; DeMasters G, 2006, MOL CANCER THER, V5, P2786, DOI 10.1158/1535-7163.MCT-06-0316; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Denizot M, 2008, AUTOPHAGY, V4, P998, DOI 10.4161/auto.6880; Di Benedetto F, 2010, TRANSPLANTATION, V89, P733, DOI 10.1097/TP.0b013e3181c7dcc0; Dixon WJ, 1983, INTRO STAT ANAL, P92; Eng KE, 2010, AUTOPHAGY, V6, P634, DOI 10.4161/auto.6.5.12112; Espert L, 2006, M S-MED SCI, V22, P677, DOI 10.1051/medsci/20062289677; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Espert L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005787; FEDERIGHI ET, 1959, J AM STAT ASSOC, V54, P683, DOI 10.2307/2282546; Francois F, 2003, J VIROL, V77, P2539, DOI 10.1128/JVI.77.4.2539-2549.2003; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; HARRIS J, 2009, CURR PROTOC IMMUNOL, pCH14; HAUG C, 1994, J INFECT DIS, V169, P889, DOI 10.1093/infdis/169.4.889; Haug CJ, 1998, J CLIN ENDOCR METAB, V83, P3832, DOI 10.1210/jc.83.11.3832; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Heredia A, 2003, P NATL ACAD SCI USA, V100, P10411, DOI 10.1073/pnas.1834278100; Hoyer-Hansen M, 2005, CELL DEATH DIFFER, V12, P1297, DOI 10.1038/sj.cdd.4401651; JAPOUR AJ, 1993, ANTIMICROB AGENTS CH, V37, P1095, DOI 10.1128/AAC.37.5.1095; Joint United Nations Programme on HIV/AIDS, 2008, REP GLOB HIV AIDS EP; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; Martineau AR, 2007, J STEROID BIOCHEM, V103, P793, DOI 10.1016/j.jsbmb.2006.12.052; Mehta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008770; Mehta S, 2009, J INFECT DIS, V200, P1022, DOI 10.1086/605699; Mercalli A, 2006, AM J TRANSPLANT, V6, P1331, DOI 10.1111/j.1600-6143.2006.01332.x; Misse D, 2005, AIDS, V19, P897, DOI 10.1097/01.aids.0000171403.07995.92; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mueller NJ, 2010, AIDS, V24, P1127, DOI 10.1097/QAD.0b013e328337b161; Pathak S, 2009, SCAND J IMMUNOL, V70, P264, DOI 10.1111/j.1365-3083.2009.02299.x; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Pepper C, 2003, BLOOD, V101, P2454, DOI 10.1182/blood-2002-07-1984; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Popovic M., 1988, RETROVIRUSES HUMAN A, P21; Roy J, 2002, ANTIMICROB AGENTS CH, V46, P3447, DOI 10.1128/AAC.46.11.3447-3455.2002; Sly LM, 2001, J BIOL CHEM, V276, P35482, DOI 10.1074/jbc.M102876200; Teichmann J, 2003, J INFECTION, V46, P221, DOI 10.1053/jinf.2002.1109; Teichmann J, 2000, METABOLISM, V49, P1134, DOI 10.1053/meta.2000.8609; Trump DL, 2006, CANCER-AM CANCER SOC, V106, P2136, DOI 10.1002/cncr.21890; Wang JR, 2008, J BIOL CHEM, V283, P25596, DOI 10.1074/jbc.M801716200; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Welz T, 2010, AIDS, V24, P1923, DOI 10.1097/QAD.0b013e32833c3281; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Zhou DJ, 2008, AIDS, V22, P695, DOI 10.1097/QAD.0b013e3282f4a836	60	122	124	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18890	18902		10.1074/jbc.M110.206110	http://dx.doi.org/10.1074/jbc.M110.206110			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454634	Green Published, hybrid			2022-12-27	WOS:000290785700061
J	Droescher, M; Begitt, A; Marg, A; Zacharias, M; Vinkemeier, U				Droescher, Mathias; Begitt, Andreas; Marg, Andreas; Zacharias, Martin; Vinkemeier, Uwe			Cytokine-induced Paracrystals Prolong the Activity of Signal Transducers and Activators of Transcription (STAT) and Provide a Model for the Regulation of Protein Solubility by Small Ubiquitin-like Modifier (SUMO)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; TYROSINE-PHOSPHATASE; NUCLEAR ACCUMULATION; GENE ACTIVATION; SUMOYLATION; DOMAIN; DIMERIZATION; DIMERS; PHOSPHOTYROSINE; INACTIVATION	The biological effects of cytokines are mediated by STAT proteins, a family of dimeric transcription factors. In order to elicit transcriptional activity, the STATs require activation by phosphorylation of a single tyrosine residue. Our experiments revealed that fully tyrosine-phosphorylated STAT dimers polymerize via Tyr(P)-Src homology 2 domain interactions and assemble into paracrystalline arrays in the nucleus of cytokine-stimulated cells. Paracrystals are demonstrated to be dynamic reservoirs that protect STATs from dephosphorylation. Activated STAT3 forms such paracrystals in acute phase liver cells. Activated STAT1, in contrast, does not normally form paracrystals. By reversing the abilities of STAT1 and STAT3 to be sumoylated, we show that this is due to the unique ability of STAT1 among the STATs to conjugate to small ubiquitin-like modifier (SUMO). Sumoylation had one direct effect; it obstructed proximal tyrosine phosphorylation, which led to semiphosphorylated STAT dimers. These competed with their fully phosphorylated counterparts and interfered with their polymerization into paracrystals. Consequently, sumoylation, by preventing paracrystal formation, profoundly curtailed signal duration and reporter gene activation in response to cytokine stimulation of cells. The study thus identifies polymerization of activated STAT transcription factors as a positive regulatory mechanism in cytokine signaling. It provides a unifying explanation for the different subnuclear distributions of STAT transcription factors and reconciles the conflicting results as to the role of SUMO modification in STAT1 functioning. We present a generally applicable system in which protein solubility is maintained by a disproportionately small SUMO-modified fraction, whereby modification by SUMO partially prevents formation of polymerization interfaces, thus generating competitive polymerization inhibitors.	[Droescher, Mathias; Begitt, Andreas; Vinkemeier, Uwe] Univ Nottingham, Sch Med, Sch Biomed Sci, Nottingham NG7 2UH, England; [Marg, Andreas] Charite Univ Med Berlin, Expt & Clin Res Ctr, D-10117 Berlin, Germany; [Zacharias, Martin] Tech Univ Munich, Lehrstuhl Mol Dynam, D-80333 Munich, Germany	University of Nottingham; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich	Vinkemeier, U (corresponding author), Queens Med Ctr, Clifton Blvd, Nottingham NG7 2UH, England.	uwe.vinkemeier@nottingham.ac.uk		Vinkemeier, Uwe/0000-0001-6924-1783	Deutsche Forschungsgemeinschaft (DFG) [KFO 192, VI 218/4, 218/5]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG; KFO 192) Grants VI 218/4 and 218/5 (to U. V.).	Bartlett NW, 2004, J GEN VIROL, V85, P1401, DOI 10.1099/vir.0.79980-0; Begitt A, 2000, P NATL ACAD SCI USA, V97, P10418, DOI 10.1073/pnas.190318397; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta S, 1996, EMBO J, V15, P1075, DOI 10.1002/j.1460-2075.1996.tb00445.x; Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Herrington J, 1999, J BIOL CHEM, V274, P5138, DOI 10.1074/jbc.274.8.5138; Herrmann A, 2004, J CELL SCI, V117, P339, DOI 10.1242/jcs.00833; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Kaminsky R, 2009, DEV CELL, V17, P724, DOI 10.1016/j.devcel.2009.10.005; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lillemeier BF, 2001, EMBO J, V20, P2508, DOI 10.1093/emboj/20.10.2508; Lodige I, 2005, J BIOL CHEM, V280, P43087, DOI 10.1074/jbc.M509180200; Lorenz D, 2003, EMBO REP, V4, P88, DOI 10.1038/sj.embor.embor711; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Marg A, 2008, CYTOM PART A, V73A, P1128, DOI 10.1002/cyto.a.20635; Matsui T, 2002, J BIOL CHEM, V277, P36167, DOI 10.1074/jbc.M203184200; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Meyer T, 2002, EMBO J, V21, P344, DOI 10.1093/emboj/21.3.344; Meyer T, 2003, GENE DEV, V17, P1992, DOI 10.1101/gad.268003; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Ota N, 2004, NAT IMMUNOL, V5, P208, DOI 10.1038/ni1032; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ray S, 2005, GASTROENTEROLOGY, V129, P1616, DOI 10.1053/j.gastro.2005.07.055; Rogers RS, 2003, J BIOL CHEM, V278, P30091, DOI 10.1074/jbc.M301344200; Roingeard P, 2008, BIOL CELL, V100, P491, DOI 10.1042/BC20070173; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; Soler-Lopez M, 2004, MOL CELL, V13, P791, DOI 10.1016/S1097-2765(04)00130-3; Song L, 2006, BLOOD, V108, P3237, DOI 10.1182/blood-2006-04-020271; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Tonozuka Y, 2004, BLOOD, V104, P3550, DOI 10.1182/blood-2004-03-1066; Truchet S, 2004, BIOL REPROD, V71, P1330, DOI 10.1095/biolreprod.104.029405; Ungureanu D, 2005, BLOOD, V106, P224, DOI 10.1182/blood-2004-11-4514; Ungureanu D, 2003, BLOOD, V102, P3311, DOI 10.1182/blood-2002-12-3816; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; Wang Y, 2006, FASEB J, V20, P1641, DOI 10.1096/fj.06-6051com; Wenta N, 2008, P NATL ACAD SCI USA, V105, P9238, DOI 10.1073/pnas.0802130105; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zimnik S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp020	46	39	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18731	18746		10.1074/jbc.M111.235978	http://dx.doi.org/10.1074/jbc.M111.235978			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21460228	Green Published, hybrid			2022-12-27	WOS:000290785700046
J	Lee, HY; Johnson, KD; Boyer, ME; Bresnick, EH				Lee, Hsiang-Ying; Johnson, Kirby D.; Boyer, Meghan E.; Bresnick, Emery H.			Relocalizing Genetic Loci into Specific Subnuclear Neighborhoods	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; CHROMATIN DOMAIN ACTIVATION; EMBRYONIC STEM-CELLS; BETA-GLOBIN LOCUS; ERYTHROID DEVELOPMENT; DEPENDENT REGULATION; FINGER PROTEIN; KRUPPEL FAMILY; CONTROL REGION; EXPRESSION	A poorly understood problem in genetics is how the three-dimensional organization of the nucleus contributes to establishment and maintenance of transcriptional networks. Genetic loci can reside in chromosome "territories" and undergo dynamic changes in subnuclear positioning. Such changes appear to be important for regulating transcription, although many questions remain regarding how loci reversibly transit in and out of their territories and the functional significance of subnuclear transitions. We addressed this issue using GATA-1, a master regulator of hematopoiesis implicated in human leukemogenesis, which often functions with the coregulator Friend of GATA-1 (FOG-1). In a genetic complementation assay in GATA-1-null cells, GATA-1 expels FOG-1-dependent target genes from the nuclear periphery during erythroid maturation, but the underlying mechanisms are unknown. We demonstrate that GATA-1 induces extrusion of the beta-globin locus away from its chromosome territory at the nuclear periphery, and extrusion precedes the maturation-associated transcriptional surge and morphological transition. FOG-1 and its interactor Mi-2 beta, a chromatin remodeling factor commonly linked to repression, were required for locus extrusion. Erythroid Kruppel-like factor, a pivotal regulator of erythropoiesis that often co-occupies chromatin with GATA-1, also promoted locus extrusion. Disruption of transcriptional maintenance did not restore the locus subnuclear position that preceded activation. These results lead to a model for how a master developmental regulator relocalizes a locus into a new subnuclear neighborhood that is permissive for high level transcription as an early step in establishing a cell type-specific genetic network. Alterations in the regulatory milieu can abrogate maintenance without reversion of locus residency back to its original neighborhood.	[Lee, Hsiang-Ying; Johnson, Kirby D.; Boyer, Meghan E.; Bresnick, Emery H.] Univ Wisconsin, Wisconsin Inst Med Res, Paul Carbone Canc Ctr, Dept Cell & Regenerat Biol,Sch Med & Publ Hlth, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Bresnick, EH (corresponding author), Univ Wisconsin, Wisconsin Inst Med Res, Paul Carbone Canc Ctr, Dept Cell & Regenerat Biol,Sch Med & Publ Hlth, Madison, WI 53705 USA.	ehbresni@wisc.edu		Lee, Hsiang-Ying/0000-0002-1503-5818	National Institutes of Health [DK50190, DK68634]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK050190, R01DK050190, R56DK068634, R37DK050107, R01DK068634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK50190 and DK68634 (to E. H. B.).; Recipient of a predoctoral fellowship from the American Heart Association.	Bresnick EH, 2006, PROG NUCLEIC ACID RE, V81, P435, DOI 10.1016/S0079-6603(06)81011-1; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; Dean A, 2006, TRENDS GENET, V22, P38, DOI 10.1016/j.tig.2005.11.001; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deniaud E, 2009, CURR OPIN GENET DEV, V19, P187, DOI 10.1016/j.gde.2009.01.005; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Gao ZG, 2010, EMBO J, V29, P457, DOI 10.1038/emboj.2009.368; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Im H, 2005, P NATL ACAD SCI USA, V102, P17065, DOI 10.1073/pnas.0506164102; Johnson KD, 2007, BLOOD, V109, P5230, DOI 10.1182/blood-2007-02-072983; Johnson KD, 2006, P NATL ACAD SCI USA, V103, P15939, DOI 10.1073/pnas.0604041103; Kim SI, 2007, ONCOGENE, V26, P6777, DOI 10.1038/sj.onc.1210761; Kim SI, 2007, MOL CELL BIOL, V27, P4551, DOI 10.1128/MCB.00235-07; Kim SI, 2009, P NATL ACAD SCI USA, V106, P2259, DOI 10.1073/pnas.0806420106; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; Lee HY, 2009, MOL CELL, V36, P984, DOI 10.1016/j.molcel.2009.11.005; Letting DL, 2004, P NATL ACAD SCI USA, V101, P476, DOI 10.1073/pnas.0306315101; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; Miccio A, 2010, MOL CELL BIOL, V30, P3460, DOI 10.1128/MCB.00001-10; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; PERKINS AC, 1995, NATURE, V375, P318; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Pope NJ, 2010, NUCLEIC ACIDS RES, V38, P2190, DOI 10.1093/nar/gkp1159; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Shimizu R, 2008, NAT REV CANCER, V8, P279, DOI 10.1038/nrc2348; SIMON MC, 1992, NAT GENET, V1, P92, DOI 10.1038/ng0592-92; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Volpi EV, 2000, J CELL SCI, V113, P1565; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Zhao R, 2009, CURR OPIN GENET DEV, V19, P172, DOI 10.1016/j.gde.2009.02.007	50	31	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18834	18844		10.1074/jbc.M111.221481	http://dx.doi.org/10.1074/jbc.M111.221481			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21398517	hybrid, Green Published			2022-12-27	WOS:000290785700056
J	Yu, XF; Yi, HF; Guo, CQ; Zuo, DM; Wang, YP; Kim, HL; Subjeck, JR; Wang, XY				Yu, Xiaofei; Yi, Huanfa; Guo, Chunqing; Zuo, Daming; Wang, Yanping; Kim, Hyung L.; Subjeck, John R.; Wang, Xiang-Yang			Pattern Recognition Scavenger Receptor CD204 Attenuates Toll-like Receptor 4-induced NF-kappa B Activation by Directly Inhibiting Ubiquitination of Tumor Necrosis Factor (TNF) Receptor-associated Factor 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; MACROPHAGES; RESPONSES; PROTEINS; KINASE; CELLS; EXPRESSION; INDUCTION; INFECTION; PATHWAY	The collaboration and cross-talk between different classes of innate pattern recognition receptors are crucial for a well coordinated inflammatory response and host defense. Here we report a previously unrecognized role of scavenger receptor A (SRA; also known as CD204) as a signaling regulator in the context of Toll-like receptor 4 (TLR4) activation. We show that SRA/CD204 deficiency leads to greater sensitivity to LPS-induced endotoxic shock. SRA/CD204 down-regulates inflammatory gene expression in dendritic cells by suppressing TLR4-induced activation of the transcription factor NF-kappa B. For the first time, we demonstrate that SRA/CD204 executes its regulatory functions by directly interacting with the TRAF-C domain of TNF receptor-associated factor 6 (TRAF6), resulting in inhibition of TRAF6 dimerization and ubiquitination. The attenuation of NF-kappa B activity by SRA/CD204 is independent of its ligand-binding domain, indicating that the signaling-regulatory feature of SRA/CD204 can be uncoupled from its conventional endocytic functions. Collectively, we have identified the molecular linkage between SRA/CD204 and the TLR4 signaling pathways, and our results reveal a novel mechanism by which a non-TLR pattern recognition receptor restricts TLR4 activation and consequent inflammatory response.	[Yu, Xiaofei; Yi, Huanfa; Guo, Chunqing; Zuo, Daming; Wang, Xiang-Yang] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Yu, Xiaofei; Yi, Huanfa; Guo, Chunqing; Zuo, Daming; Wang, Xiang-Yang] Virginia Commonwealth Univ, Inst Mol Med, Richmond, VA 23298 USA; [Yu, Xiaofei; Yi, Huanfa; Guo, Chunqing; Zuo, Daming; Wang, Xiang-Yang] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Wang, Yanping; Kim, Hyung L.] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Subjeck, John R.] Roswell Pk Canc Inst, Dept Cellar Stress Biol, Buffalo, NY 14263 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Cedars Sinai Medical Center; Roswell Park Cancer Institute	Wang, XY (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Med Coll Virginia Campus, Richmond, VA 23298 USA.	xywang@vcu.edu	GUO, CHUNQING/F-4524-2014; Yu, Xiaofei/N-7860-2013; Zuo, Daming/AAO-8461-2021; Yu, Xiaofei/C-2893-2014; Kim, Hyung/F-5129-2017	Yu, Xiaofei/0000-0003-3119-4920; Yu, Xiaofei/0000-0002-4944-1865; Kim, Hyung/0000-0003-2085-6140	National Institutes of Health (NIH) [CA129111, CA154708, CA099362]; NIH Cancer Center; American Cancer Society [RSG-08-187-01-LIB]; Harrison Endowed Scholarship; NATIONAL CANCER INSTITUTE [R01CA154708, R01CA129111] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Harrison Endowed Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants CA129111, CA154708 (to X.-Y. W.) and CA099362 (to J. S.) and an NIH Cancer Center Support Grant to the Massey Cancer Center, Virginia Commonwealth University. This work was also supported by American Cancer Society Grant RSG-08-187-01-LIB (to X.-Y. W.) and a Harrison Endowed Scholarship (to X.-Y. W.).	Amiel E, 2009, INFECT IMMUN, V77, P4567, DOI 10.1128/IAI.00727-09; Andreakos E, 2006, P NATL ACAD SCI USA, V103, P14459, DOI 10.1073/pnas.0603493103; Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Cotena A, 2004, J IMMUNOL, V173, P6427, DOI 10.4049/jimmunol.173.10.6427; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DeWitte-Orr SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000829; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hollifield M, 2007, INFECT IMMUN, V75, P3999, DOI 10.1128/IAI.00393-07; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Jozefowski S, 2005, J IMMUNOL, V175, P8032, DOI 10.4049/jimmunol.175.12.8032; Jozefowski S, 2004, J LEUKOCYTE BIOL, V76, P1066, DOI 10.1189/jlb.0504270; Jozefowski S, 2006, J LEUKOCYTE BIOL, V80, P870, DOI 10.1189/jlb.0705357; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lind EF, 2008, J IMMUNOL, V181, P354, DOI 10.4049/jimmunol.181.1.354; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moore F, 2007, J IMMUNOL, V178, P1301, DOI 10.4049/jimmunol.178.3.1301; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; Park J, 2003, BIOCHEMISTRY-US, V42, P14893, DOI 10.1021/bi030122e; Platt N, 2001, J CLIN INVEST, V108, P649, DOI 10.1172/JCI200113903; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Thomas CA, 2000, J EXP MED, V191, P147, DOI 10.1084/jem.191.1.147; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Yi HF, 2009, BLOOD, V113, P5819, DOI 10.1182/blood-2008-11-190033	36	66	68	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18795	18806		10.1074/jbc.M111.224345	http://dx.doi.org/10.1074/jbc.M111.224345			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21460221	Green Published, hybrid			2022-12-27	WOS:000290785700052
J	Jagannathan, I; Pepenella, S; Hayes, JJ				Jagannathan, Indu; Pepenella, Sharon; Hayes, Jeffrey J.			Activity of FEN1 Endonuclease on Nucleosome Substrates Is Dependent upon DNA Sequence but Not Flap Orientation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; HISTONE OCTAMER; CORE PARTICLES; CHROMATIN; COMPLEX; REPLICATION; MECHANISM; BINDING; URACIL; RNA	We demonstrated previously that human FEN1 endonuclease, an enzyme involved in excising single-stranded DNA flaps that arise during Okazaki fragment processing and base excision repair, cleaves model flap substrates assembled into nucleosomes. Here we explore the effect of flap orientation with respect to the surface of the histone octamer on nucleosome structure and FEN1 activity in vitro. We find that orienting the flap substrate toward the histone octamer does not significantly alter the rotational orientation of two different nucleosome positioning sequences on the surface of the histone octamer but does cause minor perturbation of nucleosome structure. Surprisingly, flaps oriented toward the nucleosome surface are accessible to FEN1 cleavage in nucleosomes containing the Xenopus 5S positioning sequence. In contrast, neither flaps oriented toward nor away from the nucleosome surface are cleaved by the enzyme in nucleosomes containing the high-affinity 601 nucleosome positioning sequence. The data are consistent with a model in which sequence-dependent motility of DNA on the nucleosome is a major determinant of FEN1 activity. The implications of these findings for the activity of FEN1 in vivo are discussed.	[Hayes, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Hayes, JJ (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.	Jeffrey_Hayes@urmc.rochester.edu			National Institutes of Health [RO1GM52426]; American Cancer Society [RPG GMC-99742]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411, R01GM052426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM52426. This work was also supported by American Cancer Society Grant RPG GMC-99742.	Aoyagi S, 2003, J BIOL CHEM, V278, P30562, DOI 10.1074/jbc.M304148200; Aoyagi S, 2002, MOL CELL BIOL, V22, P3653, DOI 10.1128/MCB.22.11.3653-3662.2002; Beard BC, 2005, DNA REPAIR, V4, P203, DOI 10.1016/j.dnarep.2004.09.011; Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; Chafin DR, 2000, EMBO J, V19, P5492, DOI 10.1093/emboj/19.20.5492; Cole HA, 2010, J BIOL CHEM, V285, P2876, DOI 10.1074/jbc.M109.073544; CUSICK ME, 1983, BIOCHEMISTRY-US, V22, P3873, DOI 10.1021/bi00285a024; Edayathumangalam RS, 2005, J MOL BIOL, V345, P103, DOI 10.1016/j.jmb.2004.10.012; Gong F, 2008, CELL CYCLE, V7, P1067, DOI 10.4161/cc.7.8.5647; Gong F, 2006, NAT STRUCT MOL BIOL, V13, P902, DOI 10.1038/nsmb1152; HAYES JJ, 1990, P NATL ACAD SCI USA, V87, P7405, DOI 10.1073/pnas.87.19.7405; Henricksen LA, 1998, LEUKEMIA RES, V22, P1, DOI 10.1016/S0145-2126(97)00113-6; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Huggins CF, 2002, MOL CELL, V10, P1201, DOI 10.1016/S1097-2765(02)00736-0; Ishlbashi T, 2008, MOL CELL BIOL, V28, P4734, DOI 10.1128/MCB.00588-08; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kassabov SR, 2002, MOL CELL BIOL, V22, P7524, DOI 10.1128/MCB.22.21.7524-7534.2002; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; Kulaeva OI, 2009, NAT STRUCT MOL BIOL, V16, P1272, DOI 10.1038/nsmb.1689; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lowary PT, 1997, P NATL ACAD SCI USA, V94, P1183, DOI 10.1073/pnas.94.4.1183; Matsuzaki Y, 2002, NUCLEIC ACIDS RES, V30, P3273, DOI 10.1093/nar/gkf440; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Nilsen H, 2002, EMBO J, V21, P5943, DOI 10.1093/emboj/cdf581; Ong MS, 2007, J MOL BIOL, V368, P1067, DOI 10.1016/j.jmb.2007.02.062; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Prasad A, 2007, MOL CELL BIOL, V27, P8442, DOI 10.1128/MCB.00791-07; Qiu JZ, 1999, J BIOL CHEM, V274, P17893, DOI 10.1074/jbc.274.25.17893; RHODES D, 1985, EMBO J, V4, P3473, DOI 10.1002/j.1460-2075.1985.tb04106.x; ROBINS P, 1994, J BIOL CHEM, V269, P28535; Suto RK, 2003, J MOL BIOL, V326, P371, DOI 10.1016/S0022-2836(02)01407-9; Thiriet C, 1998, J BIOL CHEM, V273, P21352, DOI 10.1074/jbc.273.33.21352; Yang ZY, 2007, J BIOL CHEM, V282, P7930, DOI 10.1074/jbc.M610584200	37	4	5	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17521	17529		10.1074/jbc.M111.229658	http://dx.doi.org/10.1074/jbc.M111.229658			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454907	Green Published, hybrid			2022-12-27	WOS:000290585200014
J	Lee, YC; Jogie-Brahim, S; Lee, DY; Han, JF; Harada, A; Murphy, LJ; Oh, Y				Lee, Yong-Chul; Jogie-Brahim, Sherryline; Lee, Dae-Yeol; Han, Jinfeng; Harada, Aki; Murphy, Liam J.; Oh, Youngman			Insulin-like Growth Factor-binding Protein-3 (IGFBP-3) Blocks the Effects of Asthma by Negatively Regulating NF-kappa B Signaling through IGFBP-3R-mediated Activation of Caspases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA; FACTOR-I; EPITHELIAL-CELLS; CLEAVAGE; BREAST; EXPRESSION; HYPERRESPONSIVENESS; DIFFERENTIATION; INFLAMMATION; INVOLVEMENT	Insulin-like growth factor-binding protein-3 (IGFBP-3) is a multifunctional protein known for modulating mitogenic and metabolic actions of IGFs as well as exerting a variety of biological actions not involving IGFs. Here, we show that IGFBP-3 blocks specific physiological consequences of asthma in an IGF-independent manner in vitro and in vivo. IGFBP-3 treatment effectively reduced all physiological manifestations of asthma examined in vivo (airway hyper-responsiveness, cellular and pathological changes in bronchoalveolar lavage fluid and lung tissue, and expression of numerous proinflammatory molecules). These unique IGFBP-3 effects were further confirmed in IGFBP-3-transgenic mice, thus strengthening the notion of IGFBP-3 actions within the respiratory system. Using human epithelial cells, we demonstrated the following: 1) IGFBP-3 blocks TNF-alpha-induced expression of proinflammatory molecules; 2) IGFBP-3 attenuates the TNF-alpha-induced migratory response of eosinophils; and 3) IGFBP-3 negatively regulates TNF-alpha-induced expression of the key NF-kappa B regulatory molecules I kappa B alpha and p65-NF-kappa B at the post-translational level. We identified that IGFBP-3 degrades I kappa Ba and p65-NF-kappa B proteins through IGFBP-3 receptor (IGFBP-3R)-mediated activation of caspases thereby inhibiting TNF-alpha-induced activation of NF-kappa B signaling cascades. This unique IGFBP-3/IGFBP-3R action was further confirmed by demonstrating complete inhibition of IGFBP-3 action in the presence of caspase inhibitors as well as IGFBP-3R siRNAs. Non-IGF-binding IGFBP-3 mutants further proved the IGF-independent action of IGFBP-3. Our findings indicate that IGFBP-3 inhibits airway inflammation and hyper-responsiveness via an IGF-independent mechanism that involves activation of IGFBP-3R signaling and cross-talk with NF-kappa B signaling. The IGFBP-3/IGFBP-3R system therefore plays a pivotal role in the pathogenesis of asthma and can serve as a newly identified potential therapeutic target for this debilitating disease.	[Lee, Yong-Chul] Chonbuk Natl Univ, Dept Internal Med, Sch Med, Jeonju 56182, South Korea; [Lee, Dae-Yeol] Chonbuk Natl Univ, Dept Pediat, Sch Med, Jeonju 56182, South Korea; [Murphy, Liam J.] Univ Manitoba, Dept Internal Med, Winnipeg, MB R2E 0W3, Canada; [Murphy, Liam J.] Univ Manitoba, Dept Physiol, Winnipeg, MB R2E 0W3, Canada; [Jogie-Brahim, Sherryline; Han, Jinfeng; Harada, Aki; Oh, Youngman] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pathol, Richmond, VA 23298 USA	Jeonbuk National University; Jeonbuk National University; University of Manitoba; University of Manitoba; Virginia Commonwealth University	Oh, Y (corresponding author), 1101 E Marshall St,POB 980662, Richmond, VA 23298 USA.	yoh@mcvh-vcu.edu			Korea Healthcare Technology RD Project [A084144]; United States Department of Defense [PC04097, PC061151]	Korea Healthcare Technology RD Project; United States Department of Defense(United States Department of Defense)	This work was supported by Korea Healthcare Technology R&D Project Grant A084144 (to Y.-C.L.) and United States Department of Defense Grants PC04097 and PC061151 (to Y.O.). Y.O. is a founder of BioCure Pharma LLC.	Allen JT, 1998, AM J RESP CELL MOL, V19, P250, DOI 10.1165/ajrcmb.19.2.3080; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Barkett M, 1997, J BIOL CHEM, V272, P29419, DOI 10.1074/jbc.272.47.29419; Barnes PJ, 2006, EUR RESPIR J, V27, P413, DOI 10.1183/09031936.06.00125404; BAXTER RC, 1991, ACTA PAEDIATR SCAND, P107; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Blackman MR, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2271; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Buckway CK, 2001, J CLIN ENDOCR METAB, V86, P4943, DOI 10.1210/jc.86.10.4943; CAMBREY AD, 1995, CLIN SCI, V89, P611, DOI 10.1042/cs0890611; Chan SSY, 2009, AM J PHYSIOL-ENDOC M, V296, pE654, DOI 10.1152/ajpendo.90846.2008; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Chen XY, 2006, GROWTH HORM IGF RES, V16, P41, DOI 10.1016/j.ghir.2005.09.003; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; De Benedetti F, 2001, ENDOCRINOLOGY, V142, P4818, DOI 10.1210/en.142.11.4818; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Deveci F, 2008, RESPIROLOGY, V13, P488, DOI 10.1111/j.1440-1843.2008.01278.x; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Eivindson M, 2007, GROWTH HORM IGF RES, V17, P33, DOI 10.1016/j.ghir.2006.10.003; Eum SY, 2003, AM J RESP CELL MOL, V28, P25, DOI 10.1165/rcmb.4532; Forgues M, 2001, J BIOL CHEM, V276, P22797, DOI 10.1074/jbc.M101259200; FRIGAS E, 1986, J ALLERGY CLIN IMMUN, V77, P527, DOI 10.1016/0091-6749(86)90341-6; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grimberg A, 2005, J CLIN ENDOCR METAB, V90, P3568, DOI 10.1210/jc.2004-1213; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Holgate ST, 2000, J ALLERGY CLIN IMMUN, V105, P193, DOI 10.1016/S0091-6749(00)90066-6; Hoshino M, 1998, CLIN EXP ALLERGY, V28, P568; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Ingermann AR, 2010, J BIOL CHEM, V285, P30233, DOI 10.1074/jbc.M110.122226; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KAY AB, 1991, J ALLERGY CLIN IMMUN, V87, P893, DOI 10.1016/0091-6749(91)90408-G; Kielczewski JL, 2009, CIRC RES, V105, P897, DOI 10.1161/CIRCRESAHA.109.199059; Kim HS, 2004, CANCER RES, V64, P2229, DOI 10.1158/0008-5472.CAN-03-1675; Kim KW, 2002, J CELL BIOCHEM, V85, P334, DOI 10.1002/jcb.10139; Kim KS, 2007, AGING CELL, V6, P535, DOI 10.1111/j.1474-9726.2007.00315.x; Koyama S, 1999, EUR RESPIR J, V14, P767, DOI 10.1034/j.1399-3003.1999.14d07.x; Krunkosky TM, 2000, AM J RESP CELL MOL, V22, P685, DOI 10.1165/ajrcmb.22.6.3925; Kwak YG, 2003, J CLIN INVEST, V111, P1083, DOI 10.1172/JCI200316440; Launay S, 2005, ONCOGENE, V24, P5137, DOI 10.1038/sj.onc.1208524; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Lofqvist C, 2007, P NATL ACAD SCI USA, V104, P10589, DOI 10.1073/pnas.0702031104; Martin JL, 2006, ENDOCRINOLOGY, V147, P4400, DOI 10.1210/en.2006-0094; Netea MG, 2008, P NATL ACAD SCI USA, V105, P3515, DOI 10.1073/pnas.0712381105; OH YM, 1993, J BIOL CHEM, V268, P14964; Ozen M, 2004, PEDIATR INT, V46, P429, DOI 10.1111/j.1442-200x.2004.01925.x; Park GY, 2006, CURR DRUG TARGETS, V7, P661, DOI 10.2174/138945006777435317; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; ROSENFELD RG, 1986, J PEDIATR-US, V109, P428, DOI 10.1016/S0022-3476(86)80112-3; Rotwein P, 1991, Growth Factors, V5, P3, DOI 10.3109/08977199109000267; SHIMASAKI S, 1991, Progress in Growth Factor Research, V3, P243, DOI 10.1016/0955-2235(91)90003-M; Veraldi KL, 2009, AM J RESP CRIT CARE, V180, P611, DOI 10.1164/rccm.200810-1555OC; WERNER H, 2001, ADV CELL AGING GERON, V6, P1; Wong SC, 2008, GROWTH HORM IGF RES, V18, P369, DOI 10.1016/j.ghir.2008.01.006; Yamashita N, 2005, CELL IMMUNOL, V235, P85, DOI 10.1016/j.cellimm.2005.07.006	59	62	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17898	17909		10.1074/jbc.M111.231035	http://dx.doi.org/10.1074/jbc.M111.231035			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21383009	Green Published, hybrid			2022-12-27	WOS:000290585200053
J	Zi, M; Kimura, TE; Liu, W; Jin, JW; Higham, J; Kharche, S; Hao, GL; Shi, Y; Shen, WJ; Prehar, S; Mironov, A; Neyses, L; Bierhuizen, MFA; Boyett, MR; Zhang, HG; Lei, M; Cartwright, EJ; Wang, X				Zi, Min; Kimura, Tomomi E.; Liu, Wei; Jin, Jiawei; Higham, Jonathan; Kharche, Sanjay; Hao, Guoliang; Shi, Ying; Shen, Weijian; Prehar, Sukhpal; Mironov, Aleksandr; Neyses, Ludwig; Bierhuizen, Marti F. A.; Boyett, Mark R.; Zhang, Henggui; Lei, Ming; Cartwright, Elizabeth J.; Wang, Xin			Mitogen-activated Protein Kinase Kinase 4 Deficiency in Cardiomyocytes Causes Connexin 43 Reduction and Couples Hypertrophic Signals to Ventricular Arrhythmogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL-RAT CARDIOMYOCYTES; CARDIAC MYOCYTES; HEART-FAILURE; GAP-JUNCTIONS; TRANSMURAL DISPERSION; CONDUCTION-VELOCITY; INDUCED DELETION; CELL-CELL; IN-VIVO; EXPRESSION		[Kimura, Tomomi E.; Liu, Wei; Jin, Jiawei; Mironov, Aleksandr; Wang, Xin] Univ Manchester, Fac Life Sci, Manchester M13 9NT, Lancs, England; [Zi, Min; Hao, Guoliang; Shi, Ying; Prehar, Sukhpal; Neyses, Ludwig; Boyett, Mark R.; Lei, Ming; Cartwright, Elizabeth J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester M13 9NT, Lancs, England; [Higham, Jonathan; Kharche, Sanjay; Shen, Weijian; Zhang, Henggui] Univ Manchester, Sch Phys & Astron, Manchester M13 9NT, Lancs, England; [Bierhuizen, Marti F. A.] Univ Med Ctr Utrecht, Dept Med Physiol, Div Heart & Lungs, NL-3584 CM Utrecht, Netherlands	University of Manchester; University of Manchester; University of Manchester; Utrecht University; Utrecht University Medical Center	Wang, X (corresponding author), Univ Manchester, Fac Life Sci, CTF Bldg,46 Grafton St, Manchester M13 9NT, Lancs, England.	xin.wang@manchester.ac.uk	Neyses, Ludwig/AGY-7446-2022; Kharche, Sanjay Ram/I-2130-2014; jin, jiawei/AAJ-7378-2021; Zhang, Henggui/AAM-1043-2020; Zhang, Henggui/D-6712-2011	Kharche, Sanjay Ram/0000-0002-2634-4894; Liu, Wei/0000-0003-1592-6693; Higham, Jonathan/0000-0002-9779-9968; Mironov, Aleksandr/0000-0002-1497-328X; Cartwright, Elizabeth/0000-0002-6836-7795; , Jiawei Jin/0000-0001-5598-6039; Boyett, Mark/0000-0003-3931-2020; Prehar, Sukhpal/0000-0002-4334-7931	British Heart Foundation [PG/07/055/23144, PG/09/052/27833]; MRC [G0802004] Funding Source: UKRI; Medical Research Council [G0802004] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by British Heart Foundation Grants PG/07/055/23144 (to X. W. and E.J.C.) and PG/09/052/27833 (to X. W., E.J.C. and M. L.).	Ai ZW, 2000, J CLIN INVEST, V105, P161, DOI 10.1172/JCI7798; Antzelevitch C, 2001, CARDIOVASC RES, V50, P426, DOI 10.1016/S0008-6363(01)00285-1; Boogerd KJ, 2008, CARDIOVASC RES, V78, P485, DOI 10.1093/cvr/cvn049; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Cameron SJ, 2003, J BIOL CHEM, V278, P18682, DOI 10.1074/jbc.M213283200; Danik SB, 2004, CIRC RES, V95, P1035, DOI 10.1161/01.RES.0000148664.33695.2a; Dupont E, 2001, J MOL CELL CARDIOL, V33, P359, DOI 10.1006/jmcc.2000.1308; Gutstein DE, 2003, AM J PHYSIOL-HEART C, V285, pH1091, DOI 10.1152/ajpheart.00100.2003; Gutstein DE, 2001, CIRCULATION, V104, P1194, DOI 10.1161/hc3601.093990; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; Lampe PD, 2006, J CELL SCI, V119, P3435, DOI 10.1242/jcs.03089; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Liu W, 2009, CIRC RES, V104, P905, DOI 10.1161/CIRCRESAHA.108.188292; Maass K, 2007, CIRC RES, V101, P1283, DOI 10.1161/CIRCRESAHA.107.162818; Matsushita T, 1999, CIRC RES, V85, P1046; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Mitchell JA, 2005, ENDOCRINOLOGY, V146, P2048, DOI 10.1210/en.2004-1066; Ogawa T, 2004, J CELL SCI, V117, P2087, DOI 10.1242/jcs.01056; PETERS NS, 1993, CIRCULATION, V88, P864, DOI 10.1161/01.CIR.88.3.864; Petrich BG, 2004, J BIOL CHEM, V279, P15330, DOI 10.1074/jbc.M314142200; Petrich BG, 2002, CIRC RES, V91, P640, DOI 10.1161/01.RES.0000035854.11082.01; Saffitz JE, 2005, ANN NY ACAD SCI, V1047, P336, DOI 10.1196/annals.1341.030; Saffitz JE, 2004, CIRC RES, V94, P585, DOI 10.1161/01.RES.0000121575.34653.50; Salameh A, 2004, EUR J PHARMACOL, V503, P9, DOI 10.1016/j.ejphar.2004.09.024; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Shyu KG, 2004, CARDIOVASC RES, V63, P98, DOI 10.1016/j.cardiores.2004.02.018; Teunissen BEJ, 2003, GENE, V322, P123, DOI 10.1016/j.gene.2003.08.011; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; van Rijen HVM, 2004, CIRCULATION, V109, P1048, DOI 10.1161/01.CIR.0000117402.70689.75; Wang X, 2007, MOL CELL BIOL, V27, P7935, DOI 10.1128/MCB.00226-07; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Wiegerinck RF, 2006, CIRCULATION, V113, P806, DOI 10.1161/CIRCULATIONAHA.105.565804; Wiegerinck RF, 2008, HEART RHYTHM, V5, P1178, DOI 10.1016/j.hrthm.2008.04.026	37	11	11	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17821	17830		10.1074/jbc.M111.228791	http://dx.doi.org/10.1074/jbc.M111.228791			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454599	hybrid, Green Published			2022-12-27	WOS:000290585200045
J	Barr, I; Smith, AT; Senturia, R; Chen, YQ; Scheidemantle, BD; Burstyn, JN; Guo, F				Barr, Ian; Smith, Aaron T.; Senturia, Rachel; Chen, Yanqiu; Scheidemantle, Brooke D.; Burstyn, Judith N.; Guo, Feng			DiGeorge Critical Region 8 (DGCR8) Is a Double-cysteine-ligated Heme Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOGENOUS THIOLATE LIGATION; FERRIC CHLOROPEROXIDASE; MICROPROCESSOR COMPLEX; REGULATORY MOTIFS; ACTIVE-SITE; BINDING; BIOGENESIS; MICRORNAS; OXYGENASE-2; MECHANISM	All known heme-thiolate proteins ligate the heme iron using one cysteine side chain. We previously found that DiGeorge Critical Region 8 (DGCR8), an essential microRNA processing factor, associates with heme of unknown redox state when over-expressed in Escherichia coli. On the basis of the similarity of the 450-nm Soret absorption peak of the DGCR8-heme complex to that of cytochrome P450 containing ferrous heme with CO bound, we identified cysteine 352 as a probable axial ligand in DGCR8. Here we further characterize the DGCR8-heme interaction using biochemical and spectroscopic methods. The DGCR8-heme complex is highly stable, with a half-life exceeding 4 days. Mutation of the conserved proline 351 to an alanine increases the rate of heme dissociation and allows the DGCR8-heme complex to be reconstituted biochemically. Surprisingly, DGCR8 binds ferric heme without CO to generate a hyperporphyrin spectrum. The electronic absorption, magnetic circular dichroism, and electron paramagnetic resonance spectra of the DGCR8-heme complex suggest a ferric heme bearing two cysteine ligands. This model was further confirmed using selenomethionine-substituted DGCR8 and mercury titration. DGCR8 is the first example of a heme-binding protein with two endogenous cysteine side chains serving as axial ligands. We further show that native DGCR8 binds heme when expressed in eukaryotic cells. This study provides a chemical basis for understanding the function of the DGCR8-heme interaction in microRNA maturation.	[Smith, Aaron T.; Burstyn, Judith N.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Barr, Ian; Senturia, Rachel; Chen, Yanqiu; Scheidemantle, Brooke D.; Guo, Feng] Univ Calif Los Angeles, Inst Mol Biol, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Burstyn, JN (corresponding author), 1101 Univ Ave, Madison, WI 53706 USA.	burstyn@chem.wisc.edu; fguo@mbi.ucla.edu	Guo, Feng/HIK-3259-2022	Barr, Ian/0000-0002-7351-418X; Smith, Aaron/0000-0002-9332-8683; Burstyn, Judith/0000-0003-3245-5563; Barr, Ian/0000-0003-1805-1415	National Institutes of Health [GM080563, HL065217]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project is supported, in whole or in part, by National Institutes of Health Grants GM080563 (to F. G.) and HL065217 (to J. N. B.).	BLUMBERG WE, 1971, ADV CHEM, V100, P271; DAWSON JH, 1988, SCIENCE, V240, P433, DOI 10.1126/science.3358128; DAWSON JH, 1987, CHEM REV, V87, P1255, DOI 10.1021/cr00081a015; de Montellano PRO, 2000, CURR OPIN CHEM BIOL, V4, P221; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Derbyshire Emily R., 2009, V191, P17, DOI 10.1007/978-3-540-68964-5_2; Faller M, 2010, RNA, V16, P1570, DOI 10.1261/rna.2111310; Faller M, 2008, BBA-GENE REGUL MECH, V1779, P663, DOI 10.1016/j.bbagrm.2008.08.005; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Gupta N, 2011, J BIOL CHEM, V286, P4392, DOI 10.1074/jbc.M110.193466; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; HARGROVE MS, 1994, BIOCHEMISTRY-US, V33, P11767, DOI 10.1021/bi00205a012; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Igarashi J, 2008, ACTA CHIM SLOV, V55, P67; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Low DW, 2001, P NATL ACAD SCI USA, V98, P6554, DOI 10.1073/pnas.121178598; McCoubrey WK, 1997, J BIOL CHEM, V272, P12568, DOI 10.1074/jbc.272.19.12568; Omura T, 2005, BIOCHEM BIOPH RES CO, V338, P404, DOI 10.1016/j.bbrc.2005.08.267; Ortiz de Montellano P.R., 2004, CYTOCHROME P450 STRU, V3rd; Paoli M, 2002, DNA CELL BIOL, V21, P271, DOI 10.1089/104454902753759690; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Rousseau DL, 2005, J INORG BIOCHEM, V99, P306, DOI 10.1016/j.jinorgbio.2004.11.007; RUF HH, 1977, J AM CHEM SOC, V99, P5499, DOI 10.1021/ja00458a054; Senturia R, 2010, PROTEIN SCI, V19, P1354, DOI 10.1002/pro.414; SONO M, 1982, J BIOL CHEM, V257, P8308; SONO M, 1985, INORG CHEM, V24, P4339, DOI 10.1021/ic00219a028; SONO M, 1984, J BIOL CHEM, V259, P13209; SONO M, 1991, BIOCHIM BIOPHYS ACTA, V1078, P351, DOI 10.1016/0167-4838(91)90156-T; STERN JO, 1974, J BIOL CHEM, V249, P7495; Udit AK, 2005, BIOCHEM BIOPH RES CO, V338, P470, DOI 10.1016/j.bbrc.2005.08.087; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; WALLACE CJA, 1992, J BIOL CHEM, V267, P3852; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; YU CA, 1974, J BIOL CHEM, V249, P94; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	43	49	50	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16716	16725		10.1074/jbc.M110.180844	http://dx.doi.org/10.1074/jbc.M110.180844			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454614	Green Published, hybrid			2022-12-27	WOS:000290301900019
J	Gruszczyk, J; Fleurie, A; Olivares-Illana, V; Bechet, E; Zanella-Cleon, I; Morera, S; Meyer, P; Pompidor, G; Kahn, R; Grangeasse, C; Nessler, S				Gruszczyk, Jakub; Fleurie, Aurore; Olivares-Illana, Vanesa; Bechet, Emmanuelle; Zanella-Cleon, Isabelle; Morera, Solange; Meyer, Philippe; Pompidor, Guillaume; Kahn, Richard; Grangeasse, Christophe; Nessler, Sylvie			Structure Analysis of the Staphylococcus aureus UDP-N-acetyl-mannosamine Dehydrogenase Cap5O Involved in Capsular Polysaccharide Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; CRYSTAL-STRUCTURE; SEROTYPE 5; INSIGHTS; PHOSPHATASE; RESIDUES; GENES; UGD	Bacterial UDP-sugar dehydrogenases are part of the biosynthesis pathway of extracellular polysaccharides. These compounds act as important virulence factors by protecting the cell from opsonophagocytosis and complement-mediated killing. In Staphylococcus aureus, the protein Cap5O catalyzes the oxidation of UDP-N-acetyl-mannosamine to UDP-N-acetyl-mannosaminuronic acid. Cap5O is crucial for the production of serotype 5 capsular polysaccharide that prevents the interaction of bacteria with both phagocytic and nonphagocytic eukaryotic cells. However, details of its catalytic mechanism remain unknown. We thus crystallized Cap5O and solved the first structure of an UDP-N-acetyl-mannosamine dehydrogenase. This study revealed that the catalytic cysteine makes a disulfide bond that has never been observed in other structurally characterized members of the NDP-sugar dehydrogenase family. Biochemical and mutagenesis experiments demonstrated that the formation of this disulfide bridge regulates the activity of Cap5O. We also identified two arginine residues essential for Cap5O activity. Previous data suggested that Cap5O is activated by tyrosine phosphorylation, so we characterized the phosphorylation site and examined the underlying regulatory mechanism.	[Fleurie, Aurore; Bechet, Emmanuelle; Zanella-Cleon, Isabelle; Grangeasse, Christophe] Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot, F-69367 Lyon, France; [Gruszczyk, Jakub; Olivares-Illana, Vanesa; Morera, Solange; Meyer, Philippe; Nessler, Sylvie] CNRS, Ctr Rech Gif, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Pompidor, Guillaume; Kahn, Richard] UJF, CEA, CNRS, Inst Biol Struct JP Ebel,UMR 5075, F-38027 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Grangeasse, C (corresponding author), Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot, 7 Passage Vercors, F-69367 Lyon, France.	c.grangeasse@ibcp.fr; nessler@lebs.cnrs-gif.fr	Meyer, Philippe/AAC-6038-2019; Olivares-Illana, Vanesa/AAF-9710-2021; Nessler, Sylvie/R-4296-2016	Meyer, Philippe/0000-0002-6220-0679; Nessler, Sylvie/0000-0003-4973-9941; Olivares-Illana, Vanesa/0000-0001-6949-5986; BECHET, Emmanuelle/0000-0001-5528-0263; Gruszczyk, Jakub/0000-0003-4536-2964; Grangeasse, Christophe/0000-0002-5484-4589	CNRS; University of Lyon; Agence National de la Recherche [ANR-05-MIIM-031, ANR-07-JCJC0125, ANR-08-BLAN-0143]; Association pour la Recherche sur le Cancer; Direction Generale des Armees; Region Rhone-Alpes cluster; Region Ile de France	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lyon; Agence National de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Direction Generale des Armees; Region Rhone-Alpes cluster(Region Auvergne-Rhone-Alpes); Region Ile de France(Region Ile-de-France)	This work was supported in part by grants from the CNRS, the University of Lyon, and the Agence National de la Recherche (ANR-05-MIIM-031, ANR-07-JCJC0125, and ANR-08-BLAN-0143), the Association pour la Recherche sur le Cancer, and the "Direction Generale des Armees" (to E. B.), "Region Rhone-Alpes cluster 10" (to A. F.), and "Region Ile de France" (to J. G.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Campbell RE, 1999, J ORG CHEM, V64, P9487, DOI 10.1021/jo991092h; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; Chen CY, 2009, BIOCHEMISTRY-US, V48, P1399, DOI 10.1021/bi801973z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ge X, 2004, EUR J BIOCHEM, V271, P14, DOI 10.1046/j.1432-1033.2003.03876.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Jones C, 2005, CARBOHYD RES, V340, P1097, DOI 10.1016/j.carres.2005.02.001; KAWAMURA T, 1979, J BIOL CHEM, V254, P8457; Kettenhofen NJ, 2010, CHEM RES TOXICOL, V23, P1633, DOI 10.1021/tx100237w; Lacour S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003053; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mijakovic I, 2003, EMBO J, V22, P4709, DOI 10.1093/emboj/cdg458; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Olivares-Illana V, 2008, PLOS BIOL, V6, P1321, DOI 10.1371/journal.pbio.0060143; Petranovic D, 2009, J MOL MICROB BIOTECH, V17, P83, DOI 10.1159/000206635; Pohlmann-Dietze P, 2000, INFECT IMMUN, V68, P4865, DOI 10.1128/IAI.68.9.4865-4871.2000; Pompidor G, 2008, ANGEW CHEM INT EDIT, V47, P3388, DOI 10.1002/anie.200704683; Portoles M, 2001, INFECT IMMUN, V69, P917, DOI 10.1128/IAI.69.2.917-923.2001; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Rehder DS, 2010, BIOCHEMISTRY-US, V49, P7748, DOI 10.1021/bi1008694; Sau S, 1997, MICROBIOL-UK, V143, P2395, DOI 10.1099/00221287-143-7-2395; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Snook CF, 2003, BIOCHEMISTRY-US, V42, P4658, DOI 10.1021/bi027328k; Sohn J, 2003, BIOCHEMISTRY-US, V42, P10060, DOI 10.1021/bi0345081; Soufi B, 2008, BBA-PROTEINS PROTEOM, V1784, P186, DOI 10.1016/j.bbapap.2007.07.018; Soulat D, 2007, J MOL MICROB BIOTECH, V13, P45, DOI 10.1159/000103596; Soulat D, 2006, J BIOL CHEM, V281, P14048, DOI 10.1074/jbc.M513600200; Thakker M, 1998, INFECT IMMUN, V66, P5183, DOI 10.1128/IAI.66.11.5183-5189.1998; Tsai SJ, 2009, BIOCHEMISTRY-US, V48, P4838, DOI 10.1021/bi900166y; Uziel O, 2004, J BACTERIOL, V186, P326, DOI 10.1128/JB.186.2.326-334.2004; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Watts A, 2005, INFECT IMMUN, V73, P3502, DOI 10.1128/IAI.73.6.3502-3511.2005	36	17	17	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17112	17121		10.1074/jbc.M110.216002	http://dx.doi.org/10.1074/jbc.M110.216002			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454499	Green Published, hybrid			2022-12-27	WOS:000290301900061
J	Dou, XW; Menkari, CE; Shanmugasundararaj, S; Miller, KW; Charness, ME				Dou, Xiaowei; Menkari, Carrie E.; Shanmugasundararaj, Sivananthaperumal; Miller, Keith W.; Charness, Michael E.			Two Alcohol Binding Residues Interact across a Domain Interface of the L1 Neural Cell Adhesion Molecule and Regulate Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOPHILIC ADHESION; NEURITE OUTGROWTH; CRYSTAL-STRUCTURE; ETHANOL; MUTATIONS; INHIBITION; MECHANISM; RECEPTOR; PROTEIN; CUTOFF	Ethanol may cause fetal alcohol spectrum disorders (FASD) in part by inhibiting cell adhesion mediated by the L1 neural cell adhesion molecule. Azialcohols photolabel Glu-33 and Tyr-418, two residues that are predicted by homology modeling to lie within 2.8 angstrom of each other at the interface between the Ig1 and Ig4 domains of L1 (Arevalo, E., Shanmugasundararaj, S., Wilkemeyer, M. F., Dou, X., Chen, S., Charness, M. E., and Miller, K. W. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 371-375). Using transient transfection of NIH/3T3 cells with wild type (WT-L1) and mutated L1, we found that cysteine substitution of both residues (E33C/Y418C-L1) significantly increased L1 adhesion above levels observed for WT-L1 or the single cysteine substitutions E33C-L1 or Y418C-L1. The reducing agent beta-mercaptoethanol (beta ME) reversibly decreased the adhesion of E33C/Y418C-L1, but had no effect on WT-L1, E33C-L1, or Y418C-L1. Thus, disulfide bond formation occurs between Cys-33 and Cys-418, confirming both the close proximity of these residues and the importance of Ig1-Ig4 interactions in L1 adhesion. Maximal ethanol inhibition of cell adhesion was significantly lower in cells expressing E33C/Y418C-L1 than in those expressing WT-L1, E33C-L1, or Y418C-L1. Moreover, the effects of beta ME and ethanol on E33C/Y418C-L1 adhesion were non-additive. The cutoff for alcohol inhibition of WT-L1 adhesion was between 1-butanol and 1-pentanol. Increasing the size of the alcohol binding pocket by mutating Glu-33 to Ala-33, increased the alcohol cutoff from 1-butanol to 1-decanol. These findings support the hypothesis that alcohol binding within a pocket bordered by Glu-33 and Tyr-418 inhibits L1 adhesion by disrupting the Ig1-Ig4 interaction.	[Dou, Xiaowei; Menkari, Carrie E.; Charness, Michael E.] Harvard Univ, Sch Med, Dept Neurol, Vet Affairs Boston Healthcare Syst, W Roxbury, MA 02132 USA; [Shanmugasundararaj, Sivananthaperumal; Miller, Keith W.] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA; [Miller, Keith W.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Charness, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Vet Affairs Boston Healthcare Syst, W Roxbury, MA 02132 USA.	mcharness@hms.harvard.edu	Dou, Xiaowei/ABC-8814-2021	Charness, Michael/0000-0002-3301-8966	NIAAA, National Institutes of Health [R37-AA12974]; NIAAA, as a component of the Collaborative Initiative on Fetal Alcohol Spectrum Disorders [U24-AA014811]; Medical Research Service, Dept. of Veterans Affairs; Dept. of Anesthesia and Critical Care, MA General Hospital; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA014811, R37AA012974] Funding Source: NIH RePORTER	NIAAA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA, as a component of the Collaborative Initiative on Fetal Alcohol Spectrum Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Medical Research Service, Dept. of Veterans Affairs(US Department of Veterans Affairs); Dept. of Anesthesia and Critical Care, MA General Hospital; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by NIAAA, National Institutes of Health Grant R37-AA12974 (to M. E. C.); NIAAA U24-AA014811, as a component of the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (to M. E. C.); the Medical Research Service, Dept. of Veterans Affairs (to M. E. C.); and the Dept. of Anesthesia and Critical Care, MA General Hospital (to K. W. M.).	ABEL EL, 1986, LANCET, V2, P1222; Arevalo E, 2008, P NATL ACAD SCI USA, V105, P371, DOI 10.1073/pnas.0707815105; Bateman A, 1996, EMBO J, V15, P6050, DOI 10.1002/j.1460-2075.1996.tb00993.x; Bearer CF, 1999, J BIOL CHEM, V274, P13264, DOI 10.1074/jbc.274.19.13264; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; CHARNESS ME, 1994, J BIOL CHEM, V269, P9304; Chen MM, 2010, MOL BIOL CELL, V21, P1671, DOI 10.1091/mbc.E09-10-0900; Chen SY, 2005, DEV NEUROSCI-BASEL, V27, P13, DOI 10.1159/000084528; Chen SY, 2001, FASEB J, V15, P1649, DOI 10.1096/fj.00-0862fje; De Angelis E, 2002, HUM MOL GENET, V11, P1, DOI 10.1093/hmg/11.1.1; De Angelis E, 1999, EMBO J, V18, P4744, DOI 10.1093/emboj/18.17.4744; FRANKS NP, 1985, NATURE, V316, P349, DOI 10.1038/316349a0; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Goodlett CR, 2001, ALCOHOL RES HEALTH, V25, P175; Gouveia RM, 2008, J BIOL CHEM, V283, P28038, DOI 10.1074/jbc.M804991200; Harris RA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.128re7; Haspel J, 2003, FRONT BIOSCI-LANDMRK, V8, pS1210, DOI 10.2741/1108; Haspel J, 2000, J NEUROBIOL, V42, P287, DOI 10.1002/(SICI)1097-4695(20000215)42:3<287::AID-NEU1>3.3.CO;2-O; He YN, 2009, STRUCTURE, V17, P460, DOI 10.1016/j.str.2009.01.009; Hoyme HE, 2005, PEDIATRICS, V115, P39, DOI 10.1542/peds.2004-0259; Jacob J, 2002, J NEUROBIOL, V51, P177, DOI 10.1002/neu.10052; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu HL, 2011, J BIOL CHEM, V286, P797, DOI 10.1074/jbc.M110.180281; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; Parnell SE, 2007, ALCOHOL CLIN EXP RES, V31, P2059, DOI 10.1111/j.1530-0277.2007.00524.x; PRINGLE MJ, 1981, MOL PHARMACOL, V19, P49; Ramanathan R, 1996, J CELL BIOL, V133, P381, DOI 10.1083/jcb.133.2.381; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Spong CY, 2001, J PHARMACOL EXP THER, V297, P774; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; Wick MJ, 1998, P NATL ACAD SCI USA, V95, P6504, DOI 10.1073/pnas.95.11.6504; Wilkemeyer MF, 2004, J PHARMACOL EXP THER, V309, P1183, DOI 10.1124/jpet.103.063818; Wilkemeyer MF, 1999, ALCOHOL CLIN EXP RES, V23, P1711, DOI 10.1097/00000374-199911000-00002; Wilkemeyer MF, 2003, P NATL ACAD SCI USA, V100, P8543, DOI 10.1073/pnas.1331636100; Wilkemeyer MF, 2002, MOL PHARMACOL, V62, P1053, DOI 10.1124/mol.62.5.1053; Wilkemeyer MF, 2002, J PHARMACOL EXP THER, V303, P110, DOI 10.1124/jpet.102.036277; Wilkemeyer WF, 2000, P NATL ACAD SCI USA, V97, P3690, DOI 10.1073/pnas.97.7.3690; Ye Q, 1998, J BIOL CHEM, V273, P3314, DOI 10.1074/jbc.273.6.3314; Yeaney NK, 2009, J NEUROCHEM, V110, P779, DOI 10.1111/j.1471-4159.2009.06143.x; Zhou FC, 2004, J MOL NEUROSCI, V24, P189, DOI 10.1385/JMN:24:2:189	44	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.209254	http://dx.doi.org/10.1074/jbc.M110.209254			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21367865	Green Published, hybrid			2022-12-27	WOS:000290022800053
J	Lee, S; Kang, C				Lee, Sooncheol; Kang, Changwon			Opposite Consequences of Two Transcription Pauses Caused by an Intrinsic Terminator Oligo(U) ANTITERMINATION VERSUS TERMINATION BY BACTERIOPHAGE T7 RNA POLYMERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 RNA-POLYMERASE; SEQUENCE-SPECIFIC TERMINATION; ESCHERICHIA-COLI; ELONGATION COMPLEX; DNA HYBRID; ANTITERMINATION; MECHANISM; T7-RNA-POLYMERASE; PREDICTION; HAIRPIN	The RNA oligo(U) sequence, along with an immediately preceding RNA hairpin structure, is an essential cis-acting element for bacterial class I intrinsic termination. This sequence not only causes a pause in transcription during the beginning of the termination process but also facilitates transcript release at the end of the process. In this study, the oligo(U) sequence of the bacteriophage T7 intrinsic terminator T phi, rather than the hairpin structure, induced pauses of phage T7 RNA polymerase not only at the termination site, triggering a termination process, but also 3 bp upstream, exerting an antitermination effect. The upstream pause presumably allowed RNA to form a thermodynamically more stable secondary structure rather than a terminator hairpin and to persist because the 5'-half of the terminator hairpin-forming sequence could be sequestered by a farther upstream sequence via sequence-specific hybridization, prohibiting formation of the terminator hairpin and termination. The putative antiterminator RNA structure lacked several base pairs essential for termination when probed using RNases A, T1, and V1. When the antiterminator was destabilized by incorporation of IMP into nascent RNA at G residue positions, antitermination was abolished. Furthermore, antitermination strength increased with more stable antiterminator secondary structures and longer pauses. Thus, the oligo(U)-mediated pause prior to the termination site can exert a cis-acting antitermination activity on intrinsic terminator T phi, and the termination efficiency depends primarily on the termination-interfering pause that precedes the termination-facilitating pause at the termination site.	[Lee, Sooncheol; Kang, Changwon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Kang, C (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Taejon 305701, South Korea.	ckang@kaist.ac.kr	Kang, Changwon/C-1938-2011	Kang, Changwon/0000-0002-0867-6385	National Research Foundation of Korea [2010-0014162]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Grant 2010-0014162 from the National Research Foundation of Korea.	Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; CARAFA YD, 1990, J MOL BIOL, V216, P835, DOI 10.1016/S0022-2836(99)80005-9; Ciampi MS, 2006, MICROBIOL-SGM, V152, P2515, DOI 10.1099/mic.0.28982-0; DUNN JJ, 1980, NUCLEIC ACIDS RES, V8, P2119, DOI 10.1093/nar/8.10.2119; Epshtein V, 2007, MOL CELL, V28, P991, DOI 10.1016/j.molcel.2007.10.011; FARNHAM PJ, 1982, CELL, V29, P945, DOI 10.1016/0092-8674(82)90457-3; Grundy FJ, 2002, P NATL ACAD SCI USA, V99, P11121, DOI 10.1073/pnas.162366799; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; HENKIN TM, 1994, MOL MICROBIOL, V13, P381, DOI 10.1111/j.1365-2958.1994.tb00432.x; Huang JB, 2000, J MOL BIOL, V303, P347, DOI 10.1006/jmbi.2000.4150; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Larson MH, 2008, CELL, V132, P971, DOI 10.1016/j.cell.2008.01.027; LEE JT, 1991, MOL CELLS, V1, P203; Lee S, 2010, NUCLEIC ACIDS RES, V38, P6045, DOI 10.1093/nar/gkq450; LOWMAN HB, 1986, J BIOL CHEM, V261, P5396; Lyakhov DL, 1998, J MOL BIOL, V280, P201, DOI 10.1006/jmbi.1998.1854; MARTIN FH, 1980, NUCLEIC ACIDS RES, V8, P2295, DOI 10.1093/nar/8.10.2295; MCALLISTER WT, 1981, J MOL BIOL, V153, P527, DOI 10.1016/0022-2836(81)90406-X; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; REYNOLDS R, 1992, J MOL BIOL, V224, P31, DOI 10.1016/0022-2836(92)90574-4; SANTALUCIA J, 1992, SCIENCE, V256, P217, DOI 10.1126/science.1373521; Shen HH, 2001, J BIOL CHEM, V276, P4080, DOI 10.1074/jbc.M008616200; Sohn YH, 2005, P NATL ACAD SCI USA, V102, P75, DOI 10.1073/pnas.0406581101; Sohn YH, 2003, METHOD ENZYMOL, V371, P170; Song HS, 2001, GENES CELLS, V6, P291, DOI 10.1046/j.1365-2443.2001.00420.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; WILSON KS, 1994, J MOL BIOL, V244, P36, DOI 10.1006/jmbi.1994.1702; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	32	2	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.203521	http://dx.doi.org/10.1074/jbc.M110.203521			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21398520	hybrid, Green Published			2022-12-27	WOS:000290022800013
J	Li, Y; Tu, CK; Wang, H; Silverman, DN; Frost, SC				Li, Ying; Tu, Chingkuang; Wang, Hai; Silverman, David N.; Frost, Susan C.			Catalysis and pH Control by Membrane-associated Carbonic Anhydrase IX in MDA-MB-231 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; INTRACELLULAR PH; O-18 EXCHANGE; ISOZYME-IX; PROTON-TRANSFER; MN/CA IX; CA-IX; EXPRESSION; HYPOXIA; INHIBITORS	Carbonic anhydrase IX (CAIX) is a membrane-bound, tumor-related enzyme whose expression is often considered a marker for hypoxia, an indicator of poor prognosis in the majority of cancer patients, and is associated with acidification of the tumor microenvironment. Here, we describe for the first time the catalytic properties of native CAIX in MDA-MB-231 breast cancer cells that exhibit hypoxia-inducible CAIX expression. Using O-18 exchange measured by membrane inlet mass spectrometry, we determined catalytic activity in membrane ghosts and intact cells. Exofacial carbonic anhydrase activity increases with exposure to hypoxia, an activity which is suppressed by impermeant sulfonamide CA inhibitors. Inhibition by sulfonamide inhibitors is not sensitive to reoxygenation. CAIX activity in intact cells increases in response to reduced pH. Data from membrane ghosts show that the increase in activity at reduced pH is largely due to an increase in the dehydration reaction. In addition, the kinetic constants of CAIX in membrane ghosts are very similar to our previous measurements for purified, recombinant, truncated forms. Hence, the activity of CAIX is not affected by the proteoglycan extension or membrane environment. These activities were measured at a total concentration for all CO2 species at 25 mM and close to chemical equilibrium, conditions which approximate the physiological extracellular environment. Our data suggest that CAIX is particularly well suited to maintain the extracellular pH at a value that favors the survival fitness of tumor cells.	[Li, Ying; Wang, Hai; Frost, Susan C.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Tu, Chingkuang; Silverman, David N.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Frost, SC (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Box 100245,1600 SW Archer Rd, Gainesville, FL 32610 USA.	sfrost@ufl.edu			National Institutes of Health [DK45035, GM25254]; Department of Defense [BC073020]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK45035 (to S. C. F.) and GM25254 (to D. N. S.). This work was also supported by Department of Defense Grant BC073020 (to S. C. F.).	Alterio V, 2009, P NATL ACAD SCI USA, V106, P16233, DOI 10.1073/pnas.0908301106; Alterio V, 2006, J AM CHEM SOC, V128, P8329, DOI 10.1021/ja061574s; Cairns R, 2006, MOL CANCER RES, V4, P61, DOI 10.1158/1541-7786.MCR-06-0002; Cecchi A, 2005, J MED CHEM, V48, P4834, DOI 10.1021/jm0501073; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; Delacruz J, 2010, ANAL BIOCHEM, V403, P74, DOI 10.1016/j.ab.2010.04.019; Dubois L, 2007, RADIOTHER ONCOL, V83, P367, DOI 10.1016/j.radonc.2007.04.018; Dubois L, 2009, RADIOTHER ONCOL, V92, P423, DOI 10.1016/j.radonc.2009.06.019; Endeward V, 2009, J PHYSIOL-LONDON, V587, P1153, DOI 10.1113/jphysiol.2008.165027; Fisher SZ, 2007, BIOCHEMISTRY-US, V46, P3803, DOI 10.1021/bi602620k; Generali D, 2006, ENDOCR-RELAT CANCER, V13, P921, DOI 10.1677/erc.1.01216; Gillies RJ, 2007, J BIOENERG BIOMEMBR, V39, P251, DOI 10.1007/s10863-007-9085-y; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hilvo M, 2008, J BIOL CHEM, V283, P27799, DOI 10.1074/jbc.M800938200; ITADA N, 1977, J BIOL CHEM, V252, P3881; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI Y, 2010, BIOCHIM BIOPHYS ACTA, V1813, P159; Li Y, 2009, CANCER INVEST, V27, P613, DOI 10.1080/07357900802653464; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; McMurtrie HL, 2004, J ENZYM INHIB MED CH, V19, P231, DOI 10.1080/14756360410001704443; Opavsky R, 1996, GENOMICS, V33, P480, DOI 10.1006/geno.1996.0223; PASTOREK J, 1994, ONCOGENE, V9, P2877; Pastorekova S, 2004, CRC ENZYM INHIB SER, P255; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Pastorekova S, 1997, GASTROENTEROLOGY, V112, P398, DOI 10.1053/gast.1997.v112.pm9024293; Potter C, 2004, CELL CYCLE, V3, P164; Potter CPS, 2003, BRIT J CANCER, V89, P2, DOI 10.1038/sj.bjc.6600936; Rafajova M, 2004, INT J ONCOL, V24, P995; Robertson N, 2004, CANCER RES, V64, P6160, DOI 10.1158/0008-5472.CAN-03-2224; Saarnio J, 1998, J HISTOCHEM CYTOCHEM, V46, P497, DOI 10.1177/002215549804600409; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; SIMONSSON I, 1979, EUR J BIOCHEM, V93, P409, DOI 10.1111/j.1432-1033.1979.tb12837.x; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Smallbone K, 2007, J THEOR BIOL, V244, P703, DOI 10.1016/j.jtbi.2006.09.010; Span PN, 2003, BRIT J CANCER, V89, P271, DOI 10.1038/sj.bjc.6601122; Stockwin LH, 2006, J PROTEOME RES, V5, P2996, DOI 10.1021/pr0601739; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Svastova E, 2003, EXP CELL RES, V290, P332, DOI 10.1016/S0014-4827(03)00351-3; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Swietach P, 2008, J BIOL CHEM, V283, P20473, DOI 10.1074/jbc.M801330200; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; Tan EY, 2009, BRIT J CANCER, V100, P405, DOI 10.1038/sj.bjc.6604844; TU C, 1978, J BIOL CHEM, V253, P8178; Tu C, 2007, FREE RADICAL BIO MED, V43, P1453, DOI 10.1016/j.freeradbiomed.2007.07.026; Wingo T, 2001, BIOCHEM BIOPH RES CO, V288, P666, DOI 10.1006/bbrc.2001.5824; Wykoff CC, 2001, AM J PATHOL, V158, P1011, DOI 10.1016/S0002-9440(10)64048-5; [No title captured]	50	39	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.188524	http://dx.doi.org/10.1074/jbc.M110.188524			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454639	Green Published, hybrid			2022-12-27	WOS:000290022800019
J	Muylaert, I; Tang, KW; Elias, P				Muylaert, Isabella; Tang, Ka-Wei; Elias, Per			Replication and Recombination of Herpes Simplex Virus DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ORIGIN-BINDING PROTEIN; HELICASE-PRIMASE INHIBITORS; TYPE-1 ALKALINE NUCLEASE; IN-VITRO; CRYSTAL-STRUCTURE; PROCESSIVITY FACTOR; STRUCTURAL BASIS; REPAIR FACTORS; FINGER MOTIF; UL8 PROTEIN	Replication of herpes simplex virus takes place in the cell nucleus and is carried out by a replisome composed of six viral proteins: the UL30-UL42 DNA polymerase, the UL5-UL8-UL52 helicase-primase, and the UL29 single-stranded DNA-binding protein ICP8. The replisome is loaded on origins of replication by the UL9 initiator origin-binding protein. Virus replication is intimately coupled to recombination and repair, often performed by cellular proteins. Here, we review new significant developments: the three-dimensional structures for the DNA polymerase, the polymerase accessory factor, and the single-stranded DNA-binding protein; the reconstitution of a functional replisome in vitro; the elucidation of the mechanism for activation of origins of DNA replication; the identification of cellular proteins actively involved in or responding to viral DNA replication; and the elucidation of requirements for formation of replication foci in the nucleus and effects on protein localization.	[Muylaert, Isabella; Tang, Ka-Wei; Elias, Per] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, S-40530 Gothenburg, Sweden	University of Gothenburg	Elias, P (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, S-40530 Gothenburg, Sweden.	per.elias@medkem.gu.se		Tang, Ka-Wei/0000-0003-1189-5092	Swedish Cancer Foundation; Swedish Research Council; Sahlgrenska University Hospital Lakarutbildningsavtal	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Sahlgrenska University Hospital Lakarutbildningsavtal	This work was supported by grants from the Swedish Cancer Foundation, the Swedish Research Council, and the Sahlgrenska University Hospital Lakarutbildningsavtal. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Aslani A, 2002, J BIOL CHEM, V277, P41204, DOI 10.1074/jbc.M208270200; AVERETT DR, 1983, J BIOL CHEM, V258, P9831; Balasubramanian N, 2010, J VIROL, V84, P12504, DOI 10.1128/JVI.01506-10; Barnard EC, 1997, VIROLOGY, V237, P97, DOI 10.1006/viro.1997.8763; Biswas N, 1999, J BIOL CHEM, V274, P8068, DOI 10.1074/jbc.274.12.8068; Biswas S, 2008, J ANTIMICROB CHEMOTH, V61, P1044, DOI 10.1093/jac/dkn057; Bogani F, 2008, P NATL ACAD SCI USA, V105, P11709, DOI 10.1073/pnas.0806375105; Bogani F, 2010, J BIOL CHEM, V285, P27664, DOI 10.1074/jbc.M110.131235; Bridges KG, 2000, J BIOL CHEM, V275, P472, DOI 10.1074/jbc.275.1.472; Cavanaugh NA, 2009, J BIOL CHEM, V284, P1523, DOI 10.1074/jbc.M805476200; Chaudhuri M, 2003, J BIOL CHEM, V278, P8996, DOI 10.1074/jbc.M210023200; Chen Y, 2005, J VIROL, V79, P9088, DOI 10.1128/JVI.79.14.9088-9096.2005; Chen Y, 2007, J VIROL, V81, P8742, DOI 10.1128/JVI.00174-07; Chen Y, 2011, J VIROL, V85, P968, DOI 10.1128/JVI.01690-10; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Chono K, 2010, J ANTIMICROB CHEMOTH, V65, P1733, DOI 10.1093/jac/dkq198; Crute JJ, 2002, NAT MED, V8, P386, DOI 10.1038/nm0402-386; CRUTE JJ, 1988, NUCLEIC ACIDS RES, V16, P6585, DOI 10.1093/nar/16.14.6585; CRUTE JJ, 1989, P NATL ACAD SCI USA, V86, P2186, DOI 10.1073/pnas.86.7.2186; Daikoku T, 2006, J BIOL CHEM, V281, P11422, DOI 10.1074/jbc.M510314200; DRACHEVA S, 1995, J BIOL CHEM, V270, P14148, DOI 10.1074/jbc.270.23.14148; ELIAS P, 1986, P NATL ACAD SCI USA, V83, P6322, DOI 10.1073/pnas.83.17.6322; Eom CY, 2004, P NATL ACAD SCI USA, V101, P4036, DOI 10.1073/pnas.0400738101; Eom CY, 2003, P NATL ACAD SCI USA, V100, P9803, DOI 10.1073/pnas.1733876100; Falkenberg M, 1998, J BIOL CHEM, V273, P32154, DOI 10.1074/jbc.273.48.32154; Falkenberg M, 1997, J BIOL CHEM, V272, P22766, DOI 10.1074/jbc.272.36.22766; Falkenberg M, 2000, P NATL ACAD SCI USA, V97, P3896, DOI 10.1073/pnas.97.8.3896; GOTTLIEB J, 1990, J VIROL, V64, P5976, DOI 10.1128/JVI.64.12.5976-5987.1990; GravesWoodward KL, 1997, J BIOL CHEM, V272, P4623, DOI 10.1074/jbc.272.7.4623; GUSTAFSSON CM, 1994, P NATL ACAD SCI USA, V91, P4629, DOI 10.1073/pnas.91.11.4629; GUSTAFSSON CM, 1995, J BIOL CHEM, V270, P19028, DOI 10.1074/jbc.270.32.19028; Hanes JW, 2007, J BIOL CHEM, V282, P25159, DOI 10.1074/jbc.M703972200; He XD, 2001, P NATL ACAD SCI USA, V98, P3024, DOI 10.1073/pnas.061028298; HERNANDEZ TR, 1990, J BIOL CHEM, V265, P11227; Huang KJ, 2006, P NATL ACAD SCI USA, V103, P8995, DOI 10.1073/pnas.0603445103; Kleymann G, 2002, NAT MED, V8, P392, DOI 10.1038/nm0402-392; Komazin-Meredith G, 2008, J BIOL CHEM, V283, P6154, DOI 10.1074/jbc.M708691200; Kudoh A, 2009, J VIROL, V83, P6641, DOI 10.1128/JVI.00049-09; Lehman IR, 1999, J BIOL CHEM, V274, P28059, DOI 10.1074/jbc.274.40.28059; Lilley CE, 2005, P NATL ACAD SCI USA, V102, P5844, DOI 10.1073/pnas.0501916102; Link MA, 2007, J VIROL, V81, P10699, DOI 10.1128/JVI.01213-07; Liu SP, 2006, J BIOL CHEM, V281, P18193, DOI 10.1074/jbc.M602414200; Livingston CM, 2008, J VIROL, V82, P6324, DOI 10.1128/JVI.00455-08; LOCKSHON D, 1988, MOL CELL BIOL, V8, P4018, DOI 10.1128/MCB.8.10.4018; Macao B, 2004, J BIOL CHEM, V279, P29211, DOI 10.1074/jbc.M400371200; Makhov AM, 2006, J MOL BIOL, V355, P911, DOI 10.1016/j.jmb.2005.11.022; Makhov AM, 2003, P NATL ACAD SCI USA, V100, P898, DOI 10.1073/pnas.0237171100; Manolaridis I, 2009, J BIOL CHEM, V284, P16343, DOI 10.1074/jbc.M806134200; Mapelli M, 2005, J BIOL CHEM, V280, P2990, DOI 10.1074/jbc.M406780200; Mapelli M, 2000, J VIROL, V74, P8812, DOI 10.1128/JVI.74.19.8812-8822.2000; Marsden HS, 1997, J VIROL, V71, P6390, DOI 10.1128/JVI.71.9.6390-6397.1997; MARSDEN HS, 1987, J VIROL, V61, P2428, DOI 10.1128/JVI.61.8.2428-2437.1987; Martinez R, 1996, J VIROL, V70, P2075, DOI 10.1128/JVI.70.4.2075-2085.1996; MCLEAN GW, 1994, J GEN VIROL, V75, P2699, DOI 10.1099/0022-1317-75-10-2699; Mohni KN, 2010, J VIROL, V84, P12152, DOI 10.1128/JVI.01643-10; Muylaert I, 2007, J BIOL CHEM, V282, P10865, DOI 10.1074/jbc.M611834200; Muylaert I, 2010, J BIOL CHEM, V285, P13761, DOI 10.1074/jbc.M110.107920; Nimonkar AV, 2003, P NATL ACAD SCI USA, V100, P10201, DOI 10.1073/pnas.1534569100; Nimonkar AV, 2003, J BIOL CHEM, V278, P9678, DOI 10.1074/jbc.M212555200; Nimonkar AV, 2002, J BIOL CHEM, V277, P15182, DOI 10.1074/jbc.M109988200; OLIVO PD, 1988, P NATL ACAD SCI USA, V85, P5414, DOI 10.1073/pnas.85.15.5414; Olsson M, 2009, J BIOL CHEM, V284, P16246, DOI 10.1074/jbc.M807551200; Porter IM, 2004, J GEN VIROL, V85, P583, DOI 10.1099/vir.0.19657-0; Ramirez-Aguilar KA, 2004, BIOCHEMISTRY-US, V43, P9084, DOI 10.1021/bi049335+; Ramirez-Aguilar KA, 2002, BIOCHEMISTRY-US, V41, P14569, DOI 10.1021/bi026680v; Randell JC, 2001, MOL CELL, V8, P911, DOI 10.1016/S1097-2765(01)00355-0; Reuven NB, 2003, J VIROL, V77, P7425, DOI 10.1128/JVI.77.13.7425-7433.2003; Schildgen O, 2005, J VIROL, V79, P7273, DOI 10.1128/JVI.79.11.7273-7278.2005; Severini A, 2003, VIROLOGY, V314, P443, DOI 10.1016/S0042-6822(03)00451-3; Shirata N, 2005, J BIOL CHEM, V280, P30336, DOI 10.1074/jbc.M500976200; Simonsson S, 1998, J BIOL CHEM, V273, P24633, DOI 10.1074/jbc.273.38.24633; Skaliter R, 1996, J VIROL, V70, P1132, DOI 10.1128/JVI.70.2.1132-1136.1996; Song LP, 2004, J BIOL CHEM, V279, P18535, DOI 10.1074/jbc.M309848200; Stengel G, 2011, J VIROL, V85, P957, DOI 10.1128/JVI.01688-10; Strang BL, 2005, J VIROL, V79, P12487, DOI 10.1128/JVI.79.19.12487-12494.2005; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Taylor TJ, 2004, J VIROL, V78, P5856, DOI 10.1128/JVI.78.11.5856-5866.2004; Urban M, 2009, BIOCHEMISTRY-US, V48, P10866, DOI 10.1021/bi901476k; WEBER PC, 1988, CELL, V54, P369, DOI 10.1016/0092-8674(88)90200-0; Yao XD, 2001, J BIOL CHEM, V276, P2905, DOI 10.1074/jbc.M005627200; Zhu YL, 2010, J VIROL, V84, P7459, DOI 10.1128/JVI.01875-09; Zuccola HJ, 2000, MOL CELL, V5, P267, DOI 10.1016/S1097-2765(00)80422-0	82	40	42	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.R111.233981	http://dx.doi.org/10.1074/jbc.R111.233981			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21362621	Green Published, hybrid			2022-12-27	WOS:000290022800001
J	Nevzorov, IA; Nikolaeva, OP; Kainov, YA; Redwood, CS; Levitsky, DI				Nevzorov, Ilya A.; Nikolaeva, Olga P.; Kainov, Yaroslav A.; Redwood, Charles S.; Levitsky, Dmitrii I.			Conserved Noncanonical Residue Gly-126 Confers Instability to the Middle Part of the Tropomyosin Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE THIN-FILAMENTS; HELICAL COILED-COILS; ALPHA-TROPOMYOSIN; MYOSIN SUBFRAGMENT-1; LABELED TROPOMYOSIN; ACTIN; PROTEIN; BINDING; REGION; FLEXIBILITY	Tropomyosin (Tm) is a two-stranded alpha-helical coiled-coil protein with a well established role in regulation of actin cytoskeleton and muscle contraction. It is believed that many Tm functions are enabled by its flexibility whose nature has not been completely understood. We hypothesized that the well conserved non-canonical residue Gly-126 causes local destabilization of Tm. To test this, we substituted Gly-126 in skeletal muscle alpha-Tm either with an Ala residue, which should stabilize the Tm alpha-helix, or with an Arg residue, which is expected to stabilize both alpha-helix and coiled-coil structure of Tm. We have shown that both mutations dramatically reduce the rate of Tm proteolysis by trypsin at Asp-133. Differential scanning calorimetry was used for detailed investigation of thermal unfolding of the Tm mutants, both free in solution and bound to F-actin. It was shown that a significant part of wild type Tm unfolds in a non-cooperative manner at low temperature, and both mutations confer cooperativity to this part of the Tm molecule. The size of the flexible middle part of Tm is estimated to be 60-70 amino acid residues, about a quarter of the Tm molecule. Thus, our results show that flexibility is unevenly distributed in the Tm molecule and achieves the highest extent in its middle part. We conclude that the highly conserved Gly-126, acting in concert with the previously identified non-canonical Asp-137, destabilizes the middle part of Tm, resulting in a more flexible region that is important for Tm function.	[Nevzorov, Ilya A.; Levitsky, Dmitrii I.] Russian Acad Sci, AN Bach Inst Biochem, Moscow 119071, Russia; [Nevzorov, Ilya A.] Moscow MV Lomonosov State Univ, Sch Biol, Dept Biochem, Moscow 119992, Russia; [Nikolaeva, Olga P.; Levitsky, Dmitrii I.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119992, Russia; [Kainov, Yaroslav A.] NN Blokhin Canc Res Ctr, Inst Carcinogenesis, Oncogene Regulat Dept, Moscow 115478, Russia; [Redwood, Charles S.] Univ Oxford, Dept Cardiovasc Med, Oxford OX3 7BN, England	Research Center of Biotechnology RAS; Russian Academy of Sciences; Lomonosov Moscow State University; Lomonosov Moscow State University; N.N. Blokhin Russian Cancer Research Center; University of Oxford	Levitsky, DI (corresponding author), Russian Acad Sci, AN Bach Inst Biochem, Leninsky Prospect 33, Moscow 119071, Russia.	Levitsky@inbi.ras.ru		Kainov, Yaroslav/0000-0003-0664-9102	Russian Foundation for Basic Research [09-04-00339, 09-04-00266]; Russian Academy of Sciences; Russian Federation [MK 2965.2009.4]; Muscular Dystrophy Campaign	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Russian Federation(Russian Federation); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission)	This work was supported by Russian Foundation for Basic Research Grants 09-04-00339 (to I. A. N. and O. P. N.) and 09-04-00266 (to D. I. L.), the Program "Molecular and Cell Biology" of the Russian Academy of Sciences (to D. I. L.), Grant MK 2965.2009.4 of the President of the Russian Federation (to I. A. N.), and the Muscular Dystrophy Campaign (to C. S. R.).	Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Brown JH, 1996, PROTEINS, V26, P134; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Dragan AI, 2002, J MOL BIOL, V321, P891, DOI 10.1016/S0022-2836(02)00699-X; GORDON ANI, 2000, Regnir M Physioi Ics, V80, P924; GREASER ML, 1971, J BIOL CHEM, V246, P4226; Greenfield NJ, 1995, BIOCHEMISTRY-US, V34, P16797, DOI 10.1021/bi00051a030; Hitchcock-DeGregori SE, 2010, J STRUCT BIOL, V170, P319, DOI 10.1016/j.jsb.2009.12.013; Hitchcock-DeGregori SE, 2002, BIOCHEMISTRY-US, V41, P15036, DOI 10.1021/bi026519k; Hodges RS, 2009, J MOL BIOL, V392, P747, DOI 10.1016/j.jmb.2009.07.039; HODGES RS, 1981, J BIOL CHEM, V256, P1214; Holmes KC, 2008, J MUSCLE RES CELL M, V29, P213, DOI 10.1007/s10974-008-9157-6; ISHII Y, 1985, BIOCHEMISTRY-US, V24, P6631, DOI 10.1021/bi00344a050; ISHII Y, 1990, BIOCHEMISTRY-US, V29, P1160, DOI 10.1021/bi00457a010; Kazakov AS, 2009, BIOPHYS CHEM, V145, P79, DOI 10.1016/j.bpc.2009.09.003; Kremneva E, 2006, FEBS J, V273, P588, DOI 10.1111/j.1742-4658.2005.05092.x; Kremneva E, 2004, BIOPHYS J, V87, P3922, DOI 10.1529/biophysj.104.048793; Levitsky D. I., 2004, The nature of biological systems as revealed by thermal methods, P127; Li XC, 2010, J MOL BIOL, V395, P327, DOI 10.1016/j.jmb.2009.10.060; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Mirza M, 2007, J BIOL CHEM, V282, P13487, DOI 10.1074/jbc.M701071200; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Nevzorov I, 2008, J MUSCLE RES CELL M, V29, P173, DOI 10.1007/s10974-009-9171-3; PANUSZ HT, 1970, ANAL BIOCHEM, V35, P494, DOI 10.1016/0003-2697(70)90212-5; PATO MD, 1981, J BIOL CHEM, V256, P593; Permyakoy SE, 2008, PROTEINS, V72, P822, DOI 10.1002/prot.21974; Privalov P L, 1986, Methods Enzymol, V131, P4; Sakuma A, 2006, BIOCHEMISTRY-US, V45, P9550, DOI 10.1021/bi060963w; Singh A, 2006, STRUCTURE, V14, P43, DOI 10.1016/j.str.2005.09.016; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STURTEVANT JM, 1991, BIOPOLYMERS, V31, P489, DOI 10.1002/bip.360310504; Sumida JP, 2008, J BIOL CHEM, V283, P6728, DOI 10.1074/jbc.M707485200; UENO H, 1984, BIOCHEMISTRY-US, V23, P4791, DOI 10.1021/bi00315a040; WAY M, 1990, EMBO J, V9, P4103, DOI 10.1002/j.1460-2075.1990.tb07632.x; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; WILLIAMS DL, 1981, BIOCHEMISTRY-US, V20, P3856, DOI 10.1021/bi00516a029	40	30	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.209353	http://dx.doi.org/10.1074/jbc.M110.209353			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454502	Green Published, hybrid			2022-12-27	WOS:000290022800016
J	Song, WZ; Du, YZ; Liu, ZQ; Luo, NG; Turkov, M; Gordon, D; Gurevitz, M; Goldin, AL; Dong, K				Song, Weizhong; Du, Yuzhe; Liu, Zhiqi; Luo, Ningguang; Turkov, Michael; Gordon, Dalia; Gurevitz, Michael; Goldin, Alan L.; Dong, Ke			Substitutions in the Domain III Voltage-sensing Module Enhance the Sensitivity of an Insect Sodium Channel to a Scorpion beta-Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-MECHANISMS; MEMBRANE-PROTEIN; SENSOR; SPECIFICITY; MODULATION; EXPRESSION; TIPE; LOOP	Scorpion beta-toxins bind to the extracellular regions of the voltage-sensing module of domain II and to the pore module of domain III in voltage-gated sodium channels and enhance channel activation by trapping and stabilizing the voltage sensor of domain II in its activated state. We investigated the interaction of a highly potent insect-selective scorpion depressant beta-toxin, Lqh-dprIT(3), from Leiurus quinquestriatus hebraeus with insect sodium channels from Blattella germanica (BgNa(v)). Like other scorpion beta-toxins, Lqh-dprIT(3) shifts the voltage dependence of activation of BgNa(v) channels expressed in Xenopus oocytes to more negative membrane potentials but only after strong depolarizing prepulses. Notably, among 10 BgNa(v) splice variants tested for their sensitivity to the toxin, only BgNa(v)1-1 was hypersensitive due to an L1285P substitution in IIIS1 resulting from a U-to-C RNA-editing event. Furthermore, charge reversal of a negatively charged residue (E1290K) at the extracellular end of IIIS1 and the two innermost positively charged residues (R4E and R5E) in IIIS4 also increased the channel sensitivity to Lqh-dprIT(3). Besides enhancement of toxin sensitivity, the R4E substitution caused an additional 20-mV negative shift in the voltage dependence of activation of toxin-modified channels, inducing a unique toxin-modified state. Our findings provide the first direct evidence for the involvement of the domain III voltage-sensing module in the action of scorpion beta-toxins. This hypersensitivity most likely reflects an increase in IIS4 trapping via allosteric mechanisms, suggesting coupling between the voltage sensors in neighboring domains during channel activation.	[Song, Weizhong; Du, Yuzhe; Liu, Zhiqi; Luo, Ningguang; Dong, Ke] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Song, Weizhong; Du, Yuzhe; Liu, Zhiqi; Luo, Ningguang; Dong, Ke] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Song, Weizhong; Du, Yuzhe; Liu, Zhiqi; Luo, Ningguang; Dong, Ke] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Turkov, Michael; Gordon, Dalia; Gurevitz, Michael] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Plant Mol Biol & Ecol, IL-69978 Tel Aviv, Israel; [Goldin, Alan L.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	Michigan State University; Michigan State University; Michigan State University; Tel Aviv University; University of California System; University of California Irvine	Dong, K (corresponding author), Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA.	dongk@msu.edu	Goldin, Alan/A-8385-2015	Goldin, Alan/0000-0001-7159-0288	National Institutes of Health [GM057440]; United States-Israel Binational Agricultural Research and Development Grant [IS-4066-07]; National Science Foundation [IBN 9808156]; Israeli Science Foundation [107/08]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Agricultural Research and Development Grant; National Science Foundation(National Science Foundation (NSF)); Israeli Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM057440 (to K. D.). This work was also supported by United States-Israel Binational Agricultural Research and Development Grant IS-4066-07 (to D. G., M. G., and K. D.), National Science Foundation Grant IBN 9808156 (to K. D.), and Israeli Science Foundation Grant 107/08 (to M. G. and D. G.).	ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Campos FV, 2007, J GEN PHYSIOL, V130, P257, DOI 10.1085/jgp.200609719; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2001, J GEN PHYSIOL, V118, P291, DOI 10.1085/jgp.118.3.291; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Chanda B, 2004, J GEN PHYSIOL, V123, P217, DOI 10.1085/jgp.200308971; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Cohen L, 2007, J BIOL CHEM, V282, P29424, DOI 10.1074/jbc.M704651200; Dong K., 2010, INSECT PHARM CHANNEL, P25; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; FENG GP, 1995, CELL, V82, P1001, DOI 10.1016/0092-8674(95)90279-1; Goldin AL, 1999, ANN NY ACAD SCI, V868, P38, DOI 10.1111/j.1749-6632.1999.tb11272.x; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Gordon D, 1997, TOXINS SIGNAL TRANSD, P119; Gordon Dalia, 1997, Invertebrate Neuroscience, V3, P103, DOI 10.1007/BF02480365; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; HODGKIN AL, 1952, COLD SPRING HARB SYM, V17, P43, DOI 10.1101/SQB.1952.017.01.007; Leipold E, 2006, MOL PHARMACOL, V70, P340, DOI 10.1124/mol.106.024034; Marcotte P, 1997, CIRC RES, V80, P363, DOI 10.1161/01.RES.80.3.363; MARTINEAUCLAIRE MF, 1995, HDN NEUROTOXICOLOGY; Nicholson GM, 2007, TOXICON, V49, P490, DOI 10.1016/j.toxicon.2006.11.027; SODERLUND DM, 2010, SODIUM CHANNELS; Song WZ, 2004, J BIOL CHEM, V279, P32554, DOI 10.1074/jbc.M402392200; Strugatsky D, 2005, BIOCHEMISTRY-US, V44, P9179, DOI 10.1021/bi050235t; Tan JG, 2005, MOL PHARMACOL, V67, P513, DOI 10.1124/mol.104.006205; Tan JG, 2002, J NEUROSCI, V22, P5300; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Tsushima RG, 1999, PFLUG ARCH EUR J PHY, V437, P661, DOI 10.1007/s004240050830; Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119	33	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.217000	http://dx.doi.org/10.1074/jbc.M110.217000			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454658	hybrid, Green Published			2022-12-27	WOS:000290022800018
J	Tran, H; Gourrier, N; Lemercier-Neuillet, C; Dhaenens, CM; Vautrin, A; Fernandez-Gomez, FJ; Arandel, L; Carpentier, C; Obriot, H; Eddarkaoui, S; Delattre, L; Van Brussels, E; Holt, I; Morris, GE; Sablonniere, B; Buee, L; Charlet-Berguerand, N; Schraen-Maschke, S; Furling, D; Behm-Ansmant, I; Branlant, C; Caillet-Boudin, ML; Sergeant, N				Tran, Helene; Gourrier, Nathalie; Lemercier-Neuillet, Camille; Dhaenens, Claire-Marie; Vautrin, Audrey; Fernandez-Gomez, Francisco Jose; Arandel, Ludovic; Carpentier, Celine; Obriot, Helene; Eddarkaoui, Sabiha; Delattre, Lucie; Van Brussels, Edwige; Holt, Ian; Morris, Glenn E.; Sablonniere, Bernard; Buee, Luc; Charlet-Berguerand, Nicolas; Schraen-Maschke, Susanna; Furling, Denis; Behm-Ansmant, Isabelle; Branlant, Christiane; Caillet-Boudin, Marie-Laure; Sergeant, Nicolas			Analysis of Exonic Regions Involved in Nuclear Localization, Splicing Activity, and Dimerization of Muscleblind-like-1 Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPANDED-REPEAT TRANSCRIPTS; CARDIAC TROPONIN-T; PRE-MESSENGER-RNA; MYOTONIC-DYSTROPHY; CUG REPEATS; IN-VIVO; PROTEINS; MBNL1; GENE; DROSOPHILA	Muscleblind-like-1 (MBNL1) is a splicing regulatory factor controlling the fetal-to-adult alternative splicing transitions during vertebrate muscle development. Its capture by nuclear CUG expansions is one major cause for type 1 myotonic dystrophy (DM1). Alternative splicing produces MBNL1 isoforms that differ by the presence or absence of the exonic regions 3, 5, and 7. To understand better their respective roles and the consequences of the deregulation of their expression in DM1, here we studied the respective roles of MBNL1 alternative and constitutive exons. By combining genetics, molecular and cellular approaches, we found that (i) the exon 5 and 6 regions are both needed to control the nuclear localization of MBNL1; (ii) the exon 3 region strongly enhances the affinity of MBNL1 for its pre-mRNA target sites; (iii) the exon 3 and 6 regions are both required for the splicing regulatory activity, and this function is not enhanced by an exclusive nuclear localization of MBNL1; and finally (iv) the exon 7 region enhances MBNL1-MBNL1 dimerization properties. Consequently, the abnormally high inclusion of the exon 5 and 7 regions in DM1 is expected to enhance the potential of MBNL1 of being sequestered with nuclear CUG expansions, which provides new insight into DM1 pathophysiology.	[Gourrier, Nathalie; Vautrin, Audrey; Behm-Ansmant, Isabelle; Branlant, Christiane] Nancy Univ, Lab Lab ARN Ribonucl Particles Maturat Struct Fun, Unite Mixte Rech 7214, CNRS,Fac Sci, F-54506 Vandoeuvre Les Nancy, France; [Sergeant, Nicolas] Univ Lille Nord France, INSERM, U837, USDL,IMPRT, F-59045 Lille, France; [Tran, Helene; Dhaenens, Claire-Marie; Fernandez-Gomez, Francisco Jose; Carpentier, Celine; Obriot, Helene; Eddarkaoui, Sabiha; Delattre, Lucie; Van Brussels, Edwige; Sablonniere, Bernard; Buee, Luc; Schraen-Maschke, Susanna; Caillet-Boudin, Marie-Laure; Sergeant, Nicolas] Univ Lille 2, Univ Lille Nord France, Inst Predict Med & Therapeut Res, Fac Med,Jean Pierre Aubert Res Ctr, F-59045 Lille, France; [Lemercier-Neuillet, Camille; Furling, Denis] Univ Paris 06, Unite Mixte 76, Inst Myol, F-75013 Paris, France; [Lemercier-Neuillet, Camille; Arandel, Ludovic; Furling, Denis] CNRS, Unite Mixte Rech 7215, F-75013 Paris, France; [Lemercier-Neuillet, Camille; Arandel, Ludovic; Furling, Denis] INSERM, U974, F-75013 Paris, France; [Charlet-Berguerand, Nicolas] IGBMC, F-67404 Illkirch Graffenstaden, France; [Holt, Ian; Morris, Glenn E.] Robert Jones & Agnes Hunt Orthopaed Hosp, Wolfson Ctr Inherited Neuromuscular Dis, Owestry, England; [Holt, Ian; Morris, Glenn E.] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Keele University	Branlant, C (corresponding author), Nancy Univ, Lab Lab ARN Ribonucl Particles Maturat Struct Fun, Unite Mixte Rech 7214, CNRS,Fac Sci, BP 70239, F-54506 Vandoeuvre Les Nancy, France.	christiane.branlant@maem.uhp-nancy.fr; nicolas.sergeant@inserm.fr	Sergeant, Nicolas/O-5467-2017; BEHM-ANSMANT, Isabelle/B-1406-2012; Charlet-Berguerand, Nicolas/GZM-6636-2022; Charlet-Berguerand, Nicolas/I-6727-2016; BUEE, Luc/B-3126-2010; Furling, Denis/M-2346-2017; Fernández-Gómez, Francisco José/GOP-0463-2022	Sergeant, Nicolas/0000-0003-1448-124X; Charlet-Berguerand, Nicolas/0000-0002-4423-4920; Charlet-Berguerand, Nicolas/0000-0002-4423-4920; BUEE, Luc/0000-0002-6261-4230; Furling, Denis/0000-0001-7912-4409; SCHRAEN, Susanna/0000-0002-7247-4809; Branlant, Christiane/0000-0003-4728-5499; Fernandez-Gomez, Francisco Jose/0000-0002-7891-8634; Behm-Ansmant, Isabelle/0000-0001-8909-0660	Association Francaise contre les Myopathies [14269, 15047]; Agence Nationale de Recherche Neuro-SplicedeTau BLAN [1114 01]; EU [FP6]; Centre National de la Recherche Scientifique; Institut National pour la Sante et la Recherche Medicale; French Ministry for Youth, National Education and Research; Lorraine Region	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de Recherche Neuro-SplicedeTau BLAN(French National Research Agency (ANR)); EU(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National pour la Sante et la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministry for Youth, National Education and Research; Lorraine Region(Region Grand-Est)	This work was supported by the Association Francaise contre les Myopathies Grants 14269 and 15047, the Agence Nationale de Recherche Neuro-SplicedeTau BLAN 1114 01, the EURASNET EU Contract FP6, life sciences, genomics and biotechnology for health, the Centre National de la Recherche Scientifique, the Institut National pour la Sante et la Recherche Medicale, the French Ministry for Youth, National Education and Research, and the Lorraine Region.	Adereth Y, 2005, NAT CELL BIOL, V7, P1240, DOI 10.1038/ncb1335; Artero R, 1998, DEV BIOL, V195, P131, DOI 10.1006/dbio.1997.8833; Begemann G, 1997, DEVELOPMENT, V124, P4321; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BROOK, 1992, CELL, V69, P385; Cooper TA, 1998, MOL CELL BIOL, V18, P4519, DOI 10.1128/MCB.18.8.4519; Dhaenens CM, 2008, EXP NEUROL, V210, P467, DOI 10.1016/j.expneurol.2007.11.020; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; EDOM F, 1994, DEV BIOL, V164, P219, DOI 10.1006/dbio.1994.1193; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; Fernandez-Costa JM, 2010, MOL CELLS, V30, P65, DOI 10.1007/s10059-010-0089-9; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Goers ES, 2010, NUCLEIC ACIDS RES, V38, P2467, DOI 10.1093/nar/gkp1209; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Holt I, 2007, GENES CELLS, V12, P1035, DOI 10.1111/j.1365-2443.2007.01112.x; Holt I, 2009, AM J PATHOL, V174, P216, DOI 10.2353/ajpath.2009.080520; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Kosaki A, 1998, J BIOL CHEM, V273, P10331, DOI 10.1074/jbc.273.17.10331; Lee JE, 2009, BIOCHEM SOC T, V37, P1281, DOI 10.1042/BST0371281; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mooers BHM, 2005, P NATL ACAD SCI USA, V102, P16626, DOI 10.1073/pnas.0505873102; Onishi H, 2008, J NEUROSCI RES, V86, P1994, DOI 10.1002/jnr.21655; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Sen S, 2010, J BIOL CHEM, V285, P25426, DOI 10.1074/jbc.M109.095224; Taneja KL, 1998, BIOTECHNIQUES, V24, P472, DOI 10.2144/98243rr02; Teplova M, 2008, NAT STRUCT MOL BIOL, V15, P1343, DOI 10.1038/nsmb.1519; Terenzi F, 2010, RNA BIOL, V7, P43, DOI 10.4161/rna.7.1.10401; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Warf MB, 2009, P NATL ACAD SCI USA, V106, P9203, DOI 10.1073/pnas.0900342106; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601	37	42	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.194928	http://dx.doi.org/10.1074/jbc.M110.194928			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454535	Green Published, hybrid			2022-12-27	WOS:000290022800081
J	Amano, Y; Yamashita, Y; Kojima, K; Yoshino, K; Tanaka, N; Sugamura, K; Takeshita, T				Amano, Yuji; Yamashita, Yuki; Kojima, Katsuhiko; Yoshino, Kazuhisa; Tanaka, Nobuyuki; Sugamura, Kazuo; Takeshita, Toshikazu			Hrs Recognizes a Hydrophobic Amino Acid Cluster in Cytokine Receptors during Ubiquitin-independent Endosomal Sorting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSDUCING ADAPTER MOLECULE; HUMAN IL-2 RECEPTOR; FACTOR-II RECEPTOR; ESCRT-III; PLASMA-MEMBRANE; GAMMA-CHAIN; TYROSINE PHOSPHORYLATION; RAPID INTERNALIZATION; MONOCLONAL-ANTIBODIES; CYTOPLASMIC TAIL	Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) is a component of the ESCRT-0 protein complex that captures ubiquitylated cargo proteins and sorts them to the lysosomal pathway. Although Hrs acts as a key transporter for ubiquitin-dependent endosomal sorting, we previously reported that Hrs is also involved in ubiquitin-independent endosomal sorting of interleukin-2 receptor beta (IL-2R beta). Here, we show direct interactions between bacterially expressed Hrs and interleukin-4 receptor alpha (IL-4R alpha), indicating that their binding is not required for ubiquitylation of the receptors, similar to the case for IL-2R beta. Examinations of the Hrs binding regions of the receptors reveal that a hydrophobic amino acid cluster in both IL-2R beta and IL-4R alpha is essential for the binding. Whereas the wild-type receptors are delivered to LAMP1-positive late endosomes, mutant receptors lacking the hydrophobic amino acid cluster are sorted to lysobisphosphatidic acid-positive late endosomes rather than LAMP1-positive late endosomes. We also show that the degradation of these mutant receptors is attenuated. Accordingly, Hrs functions during ubiquitin-independent endosomal sorting of the receptors by recognizing the hydrophobic amino acid cluster. These findings suggest the existence of a group of cargo proteins that have this hydrophobic amino acid cluster as a ubiquitin-independent sorting signal.	[Amano, Yuji; Yamashita, Yuki; Kojima, Katsuhiko; Yoshino, Kazuhisa; Takeshita, Toshikazu] Shinshu Univ, Sch Med, Dept Microbiol & Immunol, Nagano 3908621, Japan; [Sugamura, Kazuo] Miyagi Canc Ctr, Res Inst, Natori, Miyagi 9811293, Japan; [Tanaka, Nobuyuki] Div Immunol, Natori, Miyagi 9811293, Japan	Shinshu University; Miyagi Cancer Center	Takeshita, T (corresponding author), Shinshu Univ, Sch Med, Dept Microbiol & Immunol, 3-1-1 Asahi, Nagano 3908621, Japan.	takesit@shinshu-u.ac.jp	Takeshita, Toshikazu/AAL-1382-2021		 [C21590530]		This work was supported in part by a Grant-in-aid for Scientific Research C21590530 (to T. T.).	Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Bishop N, 2002, J CELL BIOL, V157, P91, DOI 10.1083/jcb.200112080; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Gillooly DJ, 2003, HISTOCHEM CELL BIOL, V120, P445, DOI 10.1007/s00418-003-0591-7; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; HARADA N, 1992, J BIOL CHEM, V267, P22752; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; HUMPHREY JS, 1993, J CELL BIOL, V120, P1123, DOI 10.1083/jcb.120.5.1123; ISHII N, 1994, INT IMMUNOL, V6, P1273, DOI 10.1093/intimm/6.8.1273; JADOT M, 1992, J BIOL CHEM, V267, P11069; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; KOMADA M, 1995, MOL CELL BIOL, V15, P6213; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; OHBO K, 1991, J IMMUNOL METHODS, V142, P61, DOI 10.1016/0022-1759(91)90293-O; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Schmidt U, 2006, J CELL SCI, V119, P2321, DOI 10.1242/jcs.02943; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Slagsvold T, 2005, J BIOL CHEM, V280, P19600, DOI 10.1074/jbc.M501510200; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Suzuki J, 1989, Int Immunol, V1, P373, DOI 10.1093/intimm/1.4.373; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; Takeshita T, 1996, BIOCHEM BIOPH RES CO, V225, P1035, DOI 10.1006/bbrc.1996.1290; TANAKA Y, 1985, MICROBIOL IMMUNOL, V29, P959, DOI 10.1111/j.1348-0421.1985.tb02960.x; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yamashita Y, 2008, J CELL SCI, V121, P1727, DOI 10.1242/jcs.024455; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	52	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15458	15472		10.1074/jbc.M110.191924	http://dx.doi.org/10.1074/jbc.M110.191924			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21362618	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000289788300074
J	Francescone, RA; Scully, S; Faibish, M; Taylor, SL; Oh, D; Moral, L; Yan, W; Bentley, B; Shao, R				Francescone, Ralph A.; Scully, Steve; Faibish, Michael; Taylor, Sherry L.; Oh, Dennis; Moral, Luis; Yan, Wei; Bentley, Brooke; Shao, Rong			Role of YKL-40 in the Angiogenesis, Radioresistance, and Progression of Glioblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-GROWTH-FACTOR; HUMAN CARTILAGE GLYCOPROTEIN-39; ACTIVATED PROTEIN-KINASE; TUMOR ANGIOGENESIS; BREAST-CANCER; SERUM YKL-40; TYROSINE PHOSPHORYLATION; MALIGNANT GLIOMAS; GENE-EXPRESSION; SHORT SURVIVAL	Glioblastoma is one of the most fatal cancers, characterized by a strong vascularized phenotype. YKL-40, a secreted glycoprotein, is overexpressed in patients with glioblastomas and has potential as a novel tumor biomarker. The molecular mechanisms of YKL-40 in glioblastoma development, however, are poorly understood. Here, we aimed to elucidate the role YKL-40 plays in the regulation of VEGF expression, tumor angiogenesis, and radioresistance. YKL-40 up-regulated VEGF expression in glioblastoma cell line U87, and both YKL-40 and VEGF synergistically promote endothelial cell angiogenesis. Interestingly, long term inhibition of VEGF up-regulated YKL-40. YKL-40 induced coordination of membrane receptor syndecan-1 and integrin alpha v beta 5, and triggered a signaling cascade through FAK(397) to ERK-1 and ERK-2, leading to elevated VEGF and enhanced angiogenesis. In addition, gamma-irradiation of U87 cells increased YKL-40 expression that protects cell death through AKT activation and also enhances endothelial cell angiogenesis. Blockade of YKL-40 activity or expression decreased tumor growth, angiogenesis, and metastasis in xenografted animals. Immunohistochemical analysis of human glioblastomas revealed a correlation between YKL-40, VEGF, and patient survival. These findings have shed light on the mechanisms by which YKL-40 promotes tumor angiogenesis and malignancy, and thus provide a therapeutic target for tumor treatment.	[Scully, Steve; Bentley, Brooke; Shao, Rong] Univ Massachusetts Amherst, Pioneer Valley Life Sci Inst, Springfield, MA 01107 USA; [Francescone, Ralph A.; Scully, Steve; Faibish, Michael; Yan, Wei; Shao, Rong] Univ Massachusetts, Morrill Sci Ctr, Mol & Cellular Biol Program, Amherst, MA 01003 USA; [Shao, Rong] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Taylor, Sherry L.; Oh, Dennis] Tufts Univ, Baystate Med Ctr, Dept Neurosurg, Springfield, MA 01199 USA; [Moral, Luis] Tufts Univ, Baystate Med Ctr, Dept Pathol, Springfield, MA 01199 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Baystate Medical Center; Tufts University; Baystate Medical Center; Tufts University	Shao, R (corresponding author), Univ Massachusetts Amherst, Pioneer Valley Life Sci Inst, Springfield, MA 01107 USA.	rong.shao@bhs.org		Francescone, Ralph/0000-0002-3149-6825	National Institutes of Health from the NCI [R01 CA120659]; NATIONAL CANCER INSTITUTE [R01CA120659] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA120659 from the NCI (to R. S.).	Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bergmann OJ, 2005, CLIN CANCER RES, V11, P8644, DOI 10.1158/1078-0432.CCR-05-1317; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Cintin C, 1999, BRIT J CANCER, V79, P1494, DOI 10.1038/sj.bjc.6690238; Cintin C, 2002, CANCER-AM CANCER SOC, V95, P267, DOI 10.1002/cncr.10644; De Ceuninck F, 2001, BIOCHEM BIOPH RES CO, V285, P926, DOI 10.1006/bbrc.2001.5253; Dreyfuss JM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-71; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; FABISH M, 2011, MOL CANC TH IN PRESS; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; Hogdall EVS, 2003, ONCOL REP, V10, P1535; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Hormigo A, 2006, CLIN CANCER RES, V12, P5698, DOI 10.1158/1078-0432.CCR-06-0181; Ido K, 2008, NEUROPATHOLOGY, V28, P604, DOI 10.1111/j.1440-1789.2008.00926.x; Ilhan A, 2009, ANTICANCER RES, V29, P731; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Jensen BV, 2003, CLIN CANCER RES, V9, P4423; Johansen JS, 2000, J HEPATOL, V32, P911, DOI 10.1016/S0168-8278(00)80095-1; Johansen JS, 2003, BREAST CANCER RES TR, V80, P15, DOI 10.1023/A:1024431000710; JOHANSEN JS, 1992, J BONE MINER RES, V7, P501; Kirkpatrick RB, 1997, EXP CELL RES, V237, P46, DOI 10.1006/excr.1997.3764; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Lal A, 1999, CANCER RES, V59, P5403; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Li HF, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-43; Lorger M, 2009, P NATL ACAD SCI USA, V106, P10666, DOI 10.1073/pnas.0903035106; Malinda KM, 1999, EXP CELL RES, V250, P168, DOI 10.1006/excr.1999.4511; Millauer B, 1996, CANCER RES, V56, P1615; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pelloski CE, 2005, CLIN CANCER RES, V11, P3326, DOI 10.1158/1078-0432.CCR-04-1765; Pelloski CE, 2006, CLIN CANCER RES, V12, P3935, DOI 10.1158/1078-0432.CCR-05-2202; Prewett M, 1999, CANCER RES, V59, P5209; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Renkema GH, 1998, EUR J BIOCHEM, V251, P504, DOI 10.1046/j.1432-1327.1998.2510504.x; Richert MM, 2005, BREAST CANCER RES, V7, pR819, DOI 10.1186/bcr1292; Saidi A, 2008, INT J CANCER, V122, P2187, DOI 10.1002/ijc.23313; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Sharif M, 2006, RHEUMATOLOGY, V45, P522, DOI 10.1093/rheumatology/kei216; Tanwar MK, 2002, CANCER RES, V62, P4364; Verhoeff JJC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-444; Volck B, 2001, OSTEOARTHR CARTILAGE, V9, P203, DOI 10.1053/joca.2000.0377; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wheeler-Jones C, 1997, FEBS LETT, V420, P28, DOI 10.1016/S0014-5793(97)01481-6; Wick W, 2010, J CLIN ONCOL, V28, pE188, DOI 10.1200/JCO.2009.26.9027; Yan W, 2008, MOL BIOL CELL, V19, P2278, DOI 10.1091/mbc.E07-10-1068; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zhang Z, 2010, CELL DEATH DIFFER, V17, P499, DOI 10.1038/cdd.2009.152; Zhao JH, 2004, CANCER LETT, V204, P87, DOI 10.1016/j.canlet.2003.09.018	56	172	184	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15332	15343		10.1074/jbc.M110.212514	http://dx.doi.org/10.1074/jbc.M110.212514			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21385870	Green Published, hybrid			2022-12-27	WOS:000289788300064
J	Guttenberg, G; Papatheodorou, P; Genisyuerek, S; Lu, W; Jank, T; Einsle, O; Aktories, K				Guttenberg, Gregor; Papatheodorou, Panagiotis; Genisyuerek, Selda; Lue, Wei; Jank, Thomas; Einsle, Oliver; Aktories, Klaus			Inositol Hexakisphosphate-dependent Processing of Clostridium sordellii Lethal Toxin and Clostridium novyi alpha-Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFICILE TOXIN; CONFORMATIONAL-CHANGES; CLEAVAGE; GLUCOSYLATION; PROTEINS; CELLS; RHO; TRANSLOCATION; RAS	Clostridium sordellii lethal toxin and Clostridium novyi alpha-toxin, which are virulence factors involved in the toxic shock and gas gangrene syndromes, are members of the family of clostridial glucosylating toxins. The toxins inactivate Rho/Ras proteins by glucosylation or attachment of GlcNAc (alpha-toxin). Here, we studied the activation of the autoproteolytic processing of the toxins by inositol hexakisphosphate (InsP(6)) and compared it with the processing of Clostridium difficile toxin B. In the presence of low concentrations of InsP(6) (< 1 mu M), toxin fragments consisting of the N-terminal glucosyltransferase (or GlcNActransferase) domains and the cysteine protease domains (CPDs) of C. sordellii lethal toxin, C. novyi alpha-toxin, and C. difficile toxin B were autocatalytically processed. The cleavage sites of lethal toxin (Leu-543) and alpha-toxin (Leu-548) and the catalytic cysteine residues (Cys-698 of lethal toxin and Cys-707 of alpha-toxin) were identified. Affinity of the CPDs for binding InsP(6) was determined by isothermal titration calorimetry. In contrast to full-length toxin B and alpha-toxin, autocatalytic cleavage and InsP(6) binding of full-length lethal toxin depended on low pH (pH 5) conditions. The data indicate that C. sordellii lethal toxin and C. novyi alpha-toxin are InsP(6)-dependently processed. However, full-length lethal toxin, but not its short toxin fragments consisting of the glucosyltransferase domain and the CPD, requires a pH-sensitive conformational change to allow binding of InsP(6) and subsequent processing of the toxin.	[Guttenberg, Gregor; Papatheodorou, Panagiotis; Genisyuerek, Selda; Jank, Thomas; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; [Lue, Wei; Einsle, Oliver] Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Aktories, K (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Albertstr 25,Otto Krayer Haus, D-79104 Freiburg, Germany.	klaus.aktories@pharmakol.uni-freiburg.de	Jank, Thomas/R-9627-2017; Aktories, Klaus/CAJ-5682-2022; Papatheodorou, Panagiotis/N-7509-2015	Aktories, Klaus/0000-0002-5397-0436; Einsle, Oliver/0000-0001-8722-2893; Papatheodorou, Panagiotis/0000-0003-3571-695X	Deutsche Forschungsgemeinschaft [AK6/16-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant AK6/16-3.	Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; BORIELLO SP, 2005, TOPLEY WILSONS MICRO, P1089; Cohen AL, 2007, OBSTET GYNECOL, V110, P1027, DOI 10.1097/01.AOG.0000287291.19230.ba; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Egerer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000942; Egerer M, 2009, J BIOL CHEM, V284, P3389, DOI 10.1074/jbc.M806002200; Genisyuerek S, 2011, MOL MICROBIOL, V79, P1643, DOI 10.1111/j.1365-2958.2011.07549.x; Greco A, 2006, NAT STRUCT MOL BIOL, V13, P460, DOI 10.1038/nsmb1084; Ho CS, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.023; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Hofmann F, 1997, J BIOL CHEM, V272, P11074; IQBAL TH, 1994, GUT, V35, P1233, DOI 10.1136/gut.35.9.1233; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; JUST I, 1995, J CLIN INVEST, V95, P1026, DOI 10.1172/JCI117747; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; Just I, 1996, J BIOL CHEM, V271, P10149, DOI 10.1074/jbc.271.17.10149; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kelly CP, 2008, NEW ENGL J MED, V359; Kreimeyer I, 2011, N-S ARCH PHARMACOL, V383, P253, DOI 10.1007/s00210-010-0574-x; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Popoff MR, 1996, J BIOL CHEM, V271, P10217, DOI 10.1074/jbc.271.17.10217; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Prochazkova K, 2009, J BIOL CHEM, V284, P26557, DOI 10.1074/jbc.M109.025510; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Pruitt RN, 2009, J BIOL CHEM, V284, P21934, DOI 10.1074/jbc.M109.018929; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Qa'Dan M, 2001, INFECT IMMUN, V69, P5487, DOI 10.1128/IAI.69.9.5487-5493.2001; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Selzer J, 1996, J BIOL CHEM, V271, P25173, DOI 10.1074/jbc.271.41.25173; Tsokos M, 2008, INT J LEGAL MED, V122, P35, DOI 10.1007/s00414-007-0163-9; VONEICHELSTREIBER C, 1992, J BACTERIOL, V174, P6707, DOI 10.1128/JB.174.20.6707-6710.1992; Voth DE, 2004, INFECT IMMUN, V72, P3366, DOI 10.1128/IAI.72.6.3366-3372.2004; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Ziegler MOP, 2008, J MOL BIOL, V377, P1346, DOI 10.1016/j.jmb.2007.12.065	38	21	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14779	14786		10.1074/jbc.M110.200691	http://dx.doi.org/10.1074/jbc.M110.200691			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21385871	hybrid, Green Published			2022-12-27	WOS:000289788300007
J	Pedemonte, N; Tomati, V; Sondo, E; Caci, E; Millo, E; Armirotti, A; Damonte, G; Zegarra-Moran, O; Galietta, LJV				Pedemonte, Nicoletta; Tomati, Valeria; Sondo, Elvira; Caci, Emanuela; Millo, Enrico; Armirotti, Andrea; Damonte, Gianluca; Zegarra-Moran, Olga; Galietta, Luis J. V.			Dual Activity of Aminoarylthiazoles on the Trafficking and Gating Defects of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Caused by Cystic Fibrosis Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL MONOLAYERS; ION-CHANNEL; WILD-TYPE; CFTR; RESCUE; DELTA-F508; G551D; CORRECTORS; GENISTEIN; AFFINITY	A large fraction of mutations causing cystic fibrosis impair the function of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel by causing reduced channel activity (gating defect) and/or impaired exit from the endoplasmic reticulum (trafficking defect). Such defects need to be treated with separate pharmacological compounds termed potentiators and correctors, respectively. Here, we report the characterization of aminoarylthiazoles (AATs) as compounds having dual activity. Cells expressing mutant CFTR were studied with functional assays (fluorescence-based halide transport and short circuit current measurements) to assess the effect of acute and chronic treatment with compounds. We found that AATs are effective on F508del, the most frequent cystic fibrosis mutation, which is associated with both a gating and a trafficking defect. AATs are also effective on mutations like G1349D and G551D, which cause only a gating defect. Evaluation of a panel of AAT analogs identified EN277I as the most effective compound. Incubation of cells expressing mutant CFTR with EN277I caused a strong stimulation of channel activity as demonstrated by single channel recordings. Compounds with dual activity such as AATs may be useful for the development of effective drugs for the treatment of cystic fibrosis.	[Pedemonte, Nicoletta; Tomati, Valeria; Sondo, Elvira; Caci, Emanuela; Zegarra-Moran, Olga; Galietta, Luis J. V.] Ist Giannina Gaslini, Genet Mol Lab, I-16100 Genoa, Italy; [Tomati, Valeria; Sondo, Elvira; Armirotti, Andrea] Ctr Biotecnol Avanzate, I-16100 Genoa, Italy; [Millo, Enrico; Damonte, Gianluca] Dipartimento Med Sperimentale, Sez Biochim, I-16100 Genoa, Italy; [Millo, Enrico; Damonte, Gianluca] Ctr Eccellenza Ric Biomed, I-16100 Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini	Galietta, LJV (corresponding author), Ist Giannina Gaslini, Genet Mol Lab, Largo Gerolamo Gaslini 5, I-16147 Genoa, Italy.	galietta@unige.it	Millo, Enrico/K-3218-2018; Sondo, Elvira/K-3789-2018; Armirotti, Andrea/AAB-3284-2019; Tomati, Valeria/AAB-4543-2021; Pedemonte, Nicoletta/B-3607-2010; Galietta, Luis JV/HCG-8692-2022	Millo, Enrico/0000-0002-4019-0051; Sondo, Elvira/0000-0003-0971-2082; Tomati, Valeria/0000-0003-3761-1916; Pedemonte, Nicoletta/0000-0002-5161-1720; Galietta, Luis/0000-0001-8686-3461; Armirotti, Andrea/0000-0002-3766-8755	Cystic Fibrosis Foundation Therapeutics; Telethon Foundation [GGP10026]; Fondazione Italiana Fibrosi Cistica [2/2009, 3/2009]; Delegazione FFC di Vicenza, Anna Iacomini, Gruppo di Sostegno FFC "Rita" Verona, Delegazione FFC di Como	Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Telethon Foundation(Fondazione Telethon); Fondazione Italiana Fibrosi Cistica(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Delegazione FFC di Vicenza, Anna Iacomini, Gruppo di Sostegno FFC "Rita" Verona, Delegazione FFC di Como	This work was supported by funds from Cystic Fibrosis Foundation Therapeutics, Telethon Foundation Grant GGP10026, and Fondazione Italiana Fibrosi Cistica Grants FFC#2/2009 and FFC#3/2009 with the contribution of Delegazione FFC di Vicenza, Anna Iacomini, Gruppo di Sostegno FFC "Rita" Verona, Delegazione FFC di Como.	Ai T, 2004, MOL PHARMACOL, V65, P1415, DOI 10.1124/mol.65.6.1415; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bilodeau MT, 2004, J MED CHEM, V47, P6363, DOI 10.1021/jm049697f; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; Cai ZW, 2002, J BIOL CHEM, V277, P19546, DOI 10.1074/jbc.M108023200; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Haws CM, 1996, AM J PHYSIOL-CELL PH, V270, pC1544, DOI 10.1152/ajpcell.1996.270.5.C1544; HORN R, 1991, BIOPHYS J, V60, P433, DOI 10.1016/S0006-3495(91)82069-0; Hosoya Y, 1996, J GEN PHYSIOL, V108, P485, DOI 10.1085/jgp.108.6.485; Lansdell KA, 2000, J PHYSIOL-LONDON, V524, P317, DOI 10.1111/j.1469-7793.2000.t01-1-00317.x; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; McAuley D F, 2000, Paediatr Respir Rev, V1, P93, DOI 10.1053/prrv.2000.0029; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Noel S, 2006, J PHARMACOL EXP THER, V319, P349, DOI 10.1124/jpet.106.104521; Pedemonte N, 2005, MOL PHARMACOL, V68, P1736, DOI 10.1124/mol.105.015149; Pedemonte N, 2005, MOL PHARMACOL, V67, P1797, DOI 10.1124/mol.105.010959; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pedemonte N, 2007, MOL PHARMACOL, V72, P197, DOI 10.1124/mol.107.034702; Pedemonte N, 2010, AM J PHYSIOL-CELL PH, V298, pC866, DOI 10.1152/ajpcell.00404.2009; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Taddei A, 2004, FEBS LETT, V558, P52, DOI 10.1016/S0014-5793(04)00011-0; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Wang F, 1998, J GEN PHYSIOL, V111, P477, DOI 10.1085/jgp.111.3.477; Wang Y, 2006, MOL PHARMACOL, V70, P297, DOI 10.1124/mol.106.023994; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608; Zegarra-Moran O, 2002, BRIT J PHARMACOL, V137, P504, DOI 10.1038/sj.bjp.0704882	36	50	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15215	15226		10.1074/jbc.M110.184267	http://dx.doi.org/10.1074/jbc.M110.184267			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21383017	Green Published, hybrid			2022-12-27	WOS:000289788300053
J	Oz, S; Tsemakhovich, V; Christel, CJ; Lee, A; Dascal, N				Oz, Shimrit; Tsemakhovich, Vladimir; Christel, Carl J.; Lee, Amy; Dascal, Nathan			CaBP1 Regulates Voltage-dependent Inactivation and Activation of Ca(V)1.2 (L-type) Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CA2+ CHANNELS; PROTEIN-KINASE-C; VISININ-LIKE PROTEIN-2; AUDITORY HAIR-CELLS; N-TERMINUS; CA2+-DEPENDENT INACTIVATION; CA(V)2.1 CHANNELS; ALPHA(1C) SUBUNIT; MOLECULAR DETERMINANTS; CA2+-BINDING PROTEIN-1	CaBP1 is a Ca2+-binding protein that regulates the gating of voltage-gated (Ca-V) Ca2+ channels. In the Ca(V)1.2 channel alpha(1)-subunit (alpha(1C)), CaBP1 interacts with cytosolic N- and C-terminal domains and blunts Ca2+-dependent inactivation. To clarify the role of the alpha(1C) N-terminal domain in CaBP1 regulation, we compared the effects of CaBP1 on two alternatively spliced variants of alpha(1C) containing a long or short N-terminal domain. In both isoforms, CaBP1 inhibited Ca2+-dependent inactivation but also caused a depolarizing shift in voltage-dependent activation and enhanced voltage-dependent inactivation (VDI). In binding assays, CaBP1 interacted with the distal third of the N-terminal domain in a Ca2+-independent manner. This segment is distinct from the previously identified calmodulin-binding site in the N terminus. However, deletion of a segment in the proximal N-terminal domain of both alpha(1C) isoforms, which spared the CaBP1-binding site, inhibited the effect of CaBP1 on VDI. This result suggests a modular organization of the alpha(1C) N-terminal domain, with separate determinants for CaBP1 binding and transduction of the effect on VDI. Our findings expand the diversity and mechanisms of Ca-V channel regulation by CaBP1 and define a novel modulatory function for the initial segment of the N terminus of alpha(1C).	[Oz, Shimrit; Tsemakhovich, Vladimir; Dascal, Nathan] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Christel, Carl J.; Lee, Amy] Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA	Tel Aviv University; Sackler Faculty of Medicine; University of Iowa	Dascal, N (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	dascaln@post.tau.ac.il	Dascal, Nathan/O-3915-2015	Dascal, Nathan/0000-0002-5397-4146; Oz, Shimrit/0000-0001-5110-3833; Lee, Amy/0000-0001-8021-0443	National Institutes of Health [HL087120, DC009433, T32 HL07121]; United States-Israel Binational Science Foundation [2005340]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121, R01HL087120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC009433, R01DC009433] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants HL087120 and DC009433 (to A.L.) and T32 HL07121 (to C.J.C.). This work was also supported by United States-Israel Binational Science Foundation Grant 2005340 (to N.D. and A.L.).	Abernethy DR, 2002, J PHARMACOL EXP THER, V300, P724, DOI 10.1124/jpet.300.3.724; Babich O, 2007, J GEN PHYSIOL, V129, P477, DOI 10.1085/jgp.200709734; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Benmocha A, 2009, CHANNELS, V3, P337, DOI 10.4161/chan.3.5.9686; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; Blumenstein Y, 2002, J BIOL CHEM, V277, P3419, DOI 10.1074/jbc.C100642200; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Calin-Jageman I, 2008, J NEUROCHEM, V105, P573, DOI 10.1111/j.1471-4159.2008.05286.x; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cens T, 2006, PROG BIOPHYS MOL BIO, V90, P104, DOI 10.1016/j.pbiomolbio.2005.05.013; Cens T, 1999, J BIOL CHEM, V274, P5483, DOI 10.1074/jbc.274.9.5483; Cheng XY, 2007, J BIOL CHEM, V282, P29211, DOI 10.1074/jbc.M610623200; Cui GY, 2007, J PHYSIOL-LONDON, V585, P791, DOI 10.1113/jphysiol.2007.142307; Dai BS, 2002, BIOCHEM BIOPH RES CO, V296, P429, DOI 10.1016/S0006-291X(02)00894-X; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Few AP, 2005, J NEUROSCI, V25, P7071, DOI 10.1523/JNEUROSCI.0452-05.2005; Findeisen F, 2010, STRUCTURE, V18, P1617, DOI 10.1016/j.str.2010.09.012; Findlay I, 2004, J PHYSIOL-LONDON, V554, P275, DOI 10.1113/jphysiol.2003.047902; Findlay I, 2002, J PHYSIOL-LONDON, V541, P741, DOI 10.1113/jphysiol.2002.019737; Fowler MR, 2009, PFLUG ARCH EUR J PHY, V457, P1049, DOI 10.1007/s00424-008-0575-5; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; HALLING DB, 2006, SCI STKE, pER1, DOI DOI 10.1126/STKE.3152005RE15; Hering S, 2000, J PHYSIOL-LONDON, V528, P237, DOI 10.1111/j.1469-7793.2000.t01-1-00237.x; Herzig S, 2007, FASEB J, V21, P1527, DOI 10.1096/fj.06-7377com; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Jangsangthong W, 2010, PFLUG ARCH EUR J PHY, V459, P399, DOI 10.1007/s00424-009-0738-z; Kanevsky N, 2006, J GEN PHYSIOL, V128, P15, DOI 10.1085/jgp.200609485; Kobrinsky E, 2005, J BIOL CHEM, V280, P12474, DOI 10.1074/jbc.M412140200; Kobrinsky E, 2003, J BIOL CHEM, V278, P5021, DOI 10.1074/jbc.M211254200; Lautermilch NJ, 2005, J NEUROSCI, V25, P7062, DOI 10.1523/JNEUROSCI.0447-05.2005; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Lee D, 2006, CELL CALCIUM, V39, P475, DOI 10.1016/j.ceca.2006.01.010; Meyers MB, 1998, J BIOL CHEM, V273, P18930, DOI 10.1074/jbc.273.30.18930; Morad M, 2005, CELL CALCIUM, V38, P223, DOI 10.1016/j.ceca.2005.06.027; Pang L, 2003, FEBS LETT, V546, P349, DOI 10.1016/S0014-5793(03)00629-X; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Shistik E, 1999, J BIOL CHEM, V274, P31145, DOI 10.1074/jbc.274.44.31145; Shistik E, 1998, J BIOL CHEM, V273, P17901, DOI 10.1074/jbc.273.28.17901; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; Soldatov MM, 2003, TRENDS PHARMACOL SCI, V24, P167, DOI 10.1016/S0165-6147(03)00065-8; SOLDATOV NM, 1994, GENOMICS, V22, P77, DOI 10.1006/geno.1994.1347; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Stotz SC, 2004, J PHYSIOL-LONDON, V554, P263, DOI 10.1113/jphysiol.2003.047068; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200; Zhou H, 2004, J NEUROSCI, V24, P4698, DOI 10.1523/JNEUROSCI.5523-03.2004; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	54	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13945	13953		10.1074/jbc.M110.198424	http://dx.doi.org/10.1074/jbc.M110.198424			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21383011	Green Published, hybrid			2022-12-27	WOS:000289556200017
J	Elsawa, SF; Almada, LL; Ziesmer, SC; Novak, AJ; Witzig, TE; Ansell, SM; Fernandez-Zapico, ME				Elsawa, Sherine F.; Almada, Luciana L.; Ziesmer, Steven C.; Novak, Anne J.; Witzig, Thomas E.; Ansell, Stephen M.; Fernandez-Zapico, Martin E.			GLI2 Transcription Factor Mediates Cytokine Cross-talk in the Tumor Microenvironment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG SIGNALING PATHWAY; MESENCHYMAL STROMAL CELLS; SCID-HU MICE; MYELOMA CELLS; MULTIPLE-MYELOMA; IN-VIVO; WALDENSTROMS MACROGLOBULINEMIA; CANCER CELLS; IMMUNOGLOBULIN SECRETION; THERAPEUTIC TARGET	Tumor cells interact with their surrounding microenvironment to survive and persist within the host. Cytokines play a key role in regulating this crosstalk between malignant cells and surrounding cells in the microenvironment. Although this phenomenon is clearly established, the molecular mechanisms mediating this cellular event remain elusive. Here, using as a model bone marrow stromal cells, we describe a novel signaling mechanism initiated by CCL5 in these cells leading to up-regulation of immunoglobulin secretion by malignant B cells. CCL5 increases IL-6 expression and secretion in bone marrow stromal cells. IL-6 in turn induces Ig secretion by malignant B cells. Analysis of the mechanism reveals that CCL5 signaling induces GLI2 through a PI3K-AKT-I kappa B alpha-p65 pathway and requires GLI2 transcriptional activity to modulate IL-6 expression and Ig secretion in vitro and in vivo. Together, these results identify a novel signaling pathway mediating the stromal-cancer cell interactions, leading to increased Ig production by malignant cells.	[Elsawa, Sherine F.; Almada, Luciana L.; Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA; [Ziesmer, Steven C.; Novak, Anne J.; Witzig, Thomas E.; Ansell, Stephen M.] Mayo Clin, Div Hematol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Fernandez-Zapico, ME (corresponding author), Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA.	fernandezzapico.martin@mayo.edu		Elsawa, Sherine/0000-0002-3917-3078	National Institutes of Health [T32 HL67742, CA92104, CA97274]; International Waldenstrom's Macroglobulinemia Foundation; Predolin Foundation; Schulze Center for Novel Therapeutics; Mayo Clinic Cancer Center; Mayo Clinic Pancreatic [P50 CA102701]; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30 DK084567]; Mayo/Iowa Lymphoma [P50 CA097274]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P50CA102701, P50CA097274, R01CA092104] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL067742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Waldenstrom's Macroglobulinemia Foundation; Predolin Foundation; Schulze Center for Novel Therapeutics; Mayo Clinic Cancer Center; Mayo Clinic Pancreatic; Mayo Clinic Center for Cell Signaling in Gastroenterology; Mayo/Iowa Lymphoma; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 HL67742 (to S. F. E.), CA92104, and CA97274. This work was also supported by a grant from the International Waldenstrom's Macroglobulinemia Foundation (to S. M. A.) and the Predolin Foundation (to T. E. W.) M. E. F.-Z. was supported by the Schulze Center for Novel Therapeutics, the Mayo Clinic Cancer Center, Mayo Clinic Pancreatic SPORE Grant P50 CA102701, Mayo Clinic Center for Cell Signaling in Gastroenterology Grant P30 DK084567, Mayo/Iowa Lymphoma SPORE Grant P50 CA097274, and the Leukemia and Lymphoma Society Translational Research Program.	Akira S, 1992, Semin Cancer Biol, V3, P17; Altaba AR, 2003, CURR OPIN GENET DEV, V13, P513, DOI 10.1016/j.gde.2003.08.005; Arendt BK, 2002, LEUKEMIA, V16, P2142, DOI 10.1038/sj.leu.2402714; Badache A, 2001, CANCER RES, V61, P383; Berghuis D, 2011, J PATHOL, V223, P347, DOI 10.1002/path.2819; Bergsagel FL, 2008, BLOOD, V112, P917, DOI 10.1182/blood-2008-05-154831; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Burger JA, 2000, BLOOD, V96, P2655; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Chauhan D, 2009, CANCER CELL, V16, P309, DOI 10.1016/j.ccr.2009.08.019; Chen M, 2009, CELL CYCLE, V8, P149, DOI 10.4161/cc.8.1.7532; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Drexler HG, 2008, LEUKEMIA RES, V32, P1669, DOI 10.1016/j.leukres.2008.04.016; Eliopoulos N, 2010, AM J PHYSIOL-RENAL, V299, pF1288, DOI 10.1152/ajprenal.00671.2009; Elsawa SF, 2009, CLIN LYMPHOMA MYELOM, V9, P43, DOI 10.3816/CLM.2009.n.010; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Forst B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010374; French JD, 2003, J IMMUNOL, V170, P3717, DOI 10.4049/jimmunol.170.7.3717; French JD, 2002, LEUKEMIA, V16, P1189, DOI 10.1038/sj.leu.2402516; GARTNER S, 1980, P NATL ACAD SCI-BIOL, V77, P4756, DOI 10.1073/pnas.77.8.4756; GOLDSTEIN H, 1993, J IMMUNOL, V151, P6701; Gunn WG, 2006, STEM CELLS, V24, P986, DOI 10.1634/stemcells.2005-0220; Hegde GV, 2008, MOL CANCER RES, V6, P1928, DOI 10.1158/1541-7786.MCR-08-0142; Hideshima T, 2009, BLOOD, V113, P5228, DOI 10.1182/blood-2008-06-161505; HIRANO T, 1991, INT J CELL CLONING, V9, P166, DOI 10.1002/stem.5530090303; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Jiang J, 2006, CELL CYCLE, V5, P2457, DOI 10.4161/cc.5.21.3406; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; Lagneaux L, 1998, BLOOD, V91, P2387, DOI 10.1182/blood.V91.7.2387.2387_2387_2396; Laner-Plamberger S, 2009, ONCOGENE, V28, P1639, DOI 10.1038/onc.2009.10; Lau J, 2006, CELL MOL LIFE SCI, V63, P642, DOI 10.1007/s00018-005-5357-z; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Leleu X, 2007, BLOOD, V110, P4417, DOI 10.1182/blood-2007-05-092098; Li J, 2011, MOL THER, V19, P650, DOI 10.1038/mt.2010.312; Lis R, 2011, INT J CANCER, V128, P715, DOI 10.1002/ijc.25619; Lu C, 1996, CLIN CANCER RES, V2, P1417; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Mishra P, 2011, J LEUKOCYTE BIOL, V89, P31, DOI 10.1189/jlb.0310182; Mitsiades CS, 2004, CANCER CELL, V6, P439, DOI 10.1016/j.ccr.2004.10.020; Moreau AS, 2007, BLOOD, V109, P4964, DOI 10.1182/blood-2006-10-054577; Mullor JL, 2002, TRENDS CELL BIOL, V12, P562, DOI 10.1016/S0962-8924(02)02405-4; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Santos DD, 2007, EXP HEMATOL, V35, P1366, DOI 10.1016/j.exphem.2007.05.022; Schnidar H, 2009, CANCER RES, V69, P1284, DOI 10.1158/0008-5472.CAN-08-2331; Secchiero P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011140; Seshi B, 2000, BLOOD CELL MOL DIS, V26, P234, DOI 10.1006/bcmd.2000.0301; Sheng H, 2002, CANCER RES, V62, P5308; Shiao RT, 1996, LEUKEMIA LYMPHOMA, V21, P293, DOI 10.3109/10428199209067610; TAKAHASHI S, 1995, ENDOCRINOLOGY, V136, P1441, DOI 10.1210/en.136.4.1441; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Villanueva J, 2008, CURR ONCOL REP, V10, P439, DOI 10.1007/s11912-008-0067-y; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Xie KP, 2003, CANCER CELL, V4, P245, DOI 10.1016/S1535-6108(03)00246-0; Yaccoby S, 1998, BLOOD, V92, P2908, DOI 10.1182/blood.V92.8.2908.420a32_2908_2913; Yanez R, 2010, EXP CELL RES, V316, P3109, DOI 10.1016/j.yexcr.2010.08.008; Zardawi SJ, 2009, HISTOL HISTOPATHOL, V24, P385, DOI 10.14670/HH-24.385	61	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21524	21534		10.1074/jbc.M111.234146	http://dx.doi.org/10.1074/jbc.M111.234146			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21454528	Green Published, hybrid			2022-12-27	WOS:000291464700050
J	Cottrell, JW; Scott, LG; Fedor, MJ				Cottrell, Joseph W.; Scott, Lincoln G.; Fedor, Martha J.			The pH Dependence of Hairpin Ribozyme Catalysis Reflects Ionization of an Active Site Adenine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BASE CATALYSIS; TERTIARY STRUCTURE; PROTON BINDING; IMINO GROUP; RNA; PK(A); FLUORESCENCE; MECHANISM; CLEAVAGE; LINKAGE	Understanding how self-cleaving ribozymes mediate catalysis is crucial in light of compelling evidence that human and bacterial gene expression can be regulated through RNA self-cleavage. The hairpin ribozyme catalyzes reversible phosphodiester bond cleavage through a mechanism that does not require divalent metal cations. Previous structural and biochemical evidence implicated the amidine group of an active site adenosine, A38, in a pH-dependent step in catalysis. We developed a way to determine microscopic pK(a) values in active ribozymes based on the pH-dependent fluorescence of 8-azaadenosine (8azaA). We compared the microscopic pKa for ionization of 8azaA at position 38 with the apparent pK(a) for the self-cleavage reaction in a fully functional hairpin ribozyme with a unique 8azaA at position 38. Microscopic and apparent pK(a) values were virtually the same, evidence that A38 protonation accounts for the decrease in catalytic activity with decreasing pH. These results implicate the neutral unprotonated form of A38 in a transition state that involves formation of the 5'-oxygen-phosphorus bond.	[Cottrell, Joseph W.; Fedor, Martha J.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Cottrell, Joseph W.; Fedor, Martha J.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Cottrell, Joseph W.; Fedor, Martha J.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Scott, Lincoln G.] Cassia LLC, San Diego, CA 92109 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Fedor, MJ (corresponding author), Scripps Res Inst, Dept Physiol Chem, MB35,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mfedor@scripps.edu			National Institutes of Health [R01 GM046422]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM046422 (to M.J.F.).	Bevilacqua PC, 2005, BIOCHEM SOC T, V33, P466, DOI 10.1042/BST0330466; Bevilacqua PC, 2004, BIOPOLYMERS, V73, P90, DOI 10.1002/bip.10519; Bevilacqua PC, 2003, BIOCHEMISTRY-US, V42, P2259, DOI 10.1021/bi027273m; Bevilacqua PC, 2006, CURR OPIN CHEM BIOL, V10, P455, DOI 10.1016/j.cbpa.2006.08.014; Cai ZP, 1996, BIOCHEMISTRY-US, V35, P6026, DOI 10.1021/bi952985g; Chen JH, 2009, BIOCHEMISTRY-US, V48, P1498, DOI 10.1021/bi8020108; CLAUWAERT J, 1968, Z NATURFORSCH PT B, VB 23, P25, DOI 10.1515/znb-1968-0105; Da Costa CP, 2007, J AM CHEM SOC, V129, P3426, DOI 10.1021/ja067699e; Ditzler MA, 2009, RNA, V15, P560, DOI 10.1261/rna.1416709; Fedor MJ, 2009, ANNU REV BIOPHYS, V38, P271, DOI 10.1146/annurev.biophys.050708.133710; Fedor MJ, 1999, BIOCHEMISTRY-US, V38, P11040, DOI 10.1021/bi991069q; Gong B, 2007, J AM CHEM SOC, V129, P13335, DOI 10.1021/Ja0743893; Gong B, 2009, BIOCHEMISTRY-US, V48, P11961, DOI 10.1021/bi901091v; Gong B, 2009, METHODS, V49, P101, DOI 10.1016/j.ymeth.2009.04.016; Guo M, 2009, J AM CHEM SOC, V131, P12908, DOI 10.1021/ja9060883; Hampel A, 1997, CHEM BIOL, V4, P513, DOI 10.1016/S1074-5521(97)90323-9; Jean JM, 2001, P NATL ACAD SCI USA, V98, P37, DOI 10.1073/pnas.011442198; Jencks W. P., 1969, CATALYSIS CHEM ENZYM, P163; Kochetkov N. K., 1971, ORGANIC CHEM NUCL AC, P148; Kuzmin YI, 2005, J MOL BIOL, V349, P989, DOI 10.1016/j.jmb.2005.04.005; Kuzmin YI, 2004, J MOL BIOL, V340, P233, DOI 10.1016/j.jmb.2004.04.067; Lebruska LL, 2002, CHEM BIOL, V9, P465, DOI 10.1016/S1074-5521(02)00130-8; Liu L, 2009, NAT CHEM BIOL, V5, P351, DOI 10.1038/nchembio.156; Luptak A, 2001, J AM CHEM SOC, V123, P8447, DOI 10.1021/ja016091x; Millar DP, 1996, CURR OPIN STRUC BIOL, V6, P322, DOI 10.1016/S0959-440X(96)80050-9; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; Mlynsky V, 2010, J PHYS CHEM B, V114, P6642, DOI 10.1021/jp1001258; Moody EM, 2005, RNA, V11, P157, DOI 10.1261/rna.7177505; Murray JB, 1998, CHEM BIOL, V5, P587, DOI 10.1016/S1074-5521(98)90116-8; Nam K, 2008, RNA, V14, P1501, DOI 10.1261/rna.863108; Nesbitt S, 1997, CHEM BIOL, V4, P619, DOI 10.1016/S1074-5521(97)90247-7; Nesbitt SM, 1999, J MOL BIOL, V286, P1009, DOI 10.1006/jmbi.1999.2543; Pinard R, 1999, BIOCHEMISTRY-US, V38, P16035, DOI 10.1021/bi992024s; PUGLISI JD, 1990, BIOCHEMISTRY-US, V29, P4215, DOI 10.1021/bi00469a026; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Ravindranathan S, 2000, BIOCHEMISTRY-US, V39, P16026, DOI 10.1021/bi001976r; Rogstad KN, 2003, CHEM RES TOXICOL, V16, P1455, DOI 10.1021/tx034068e; Rupert PB, 2002, SCIENCE, V298, P1421, DOI 10.1126/science.1076093; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; Ryder SP, 1999, J MOL BIOL, V291, P295, DOI 10.1006/jmbi.1999.2959; Ryder SP, 2001, RNA, V7, P1454; Saenger W., 1984, PRINCIPLES NUCL ACID, P107; Shih IH, 2002, ANNU REV BIOCHEM, V71, P887, DOI 10.1146/annurev.biochem.71.110601.135349; Siwkowski A, 1997, BIOCHEMISTRY-US, V36, P3930, DOI 10.1021/bi9628735; Spitale RC, 2009, J AM CHEM SOC, V131, P6093, DOI 10.1021/ja900450h; Suydam IT, 2010, BIOCHEMISTRY-US, V49, P3723, DOI 10.1021/bi100234v; Tang CL, 2007, J MOL BIOL, V366, P1475, DOI 10.1016/j.jmb.2006.12.001; Tolman RC, 1938, PRINCIPLES STAT MECH; Torelli AT, 2007, RNA, V13, P1052, DOI 10.1261/rna.510807; UHLENBECK OC, 1977, NUCLEIC ACIDS RES, V4, P85, DOI 10.1093/nar/4.1.85; Wadkins TS, 2001, J MOL BIOL, V305, P1045, DOI 10.1006/jmbi.2000.4368; Walter NG, 1999, NAT STRUCT BIOL, V6, P544; WARD DC, 1969, J BIOL CHEM, V244, P1228; Wierzchowski J, 1996, BBA-GEN SUBJECTS, V1290, P9, DOI 10.1016/0304-4165(95)00181-6; Yadava RS, 2001, J MOL BIOL, V309, P893, DOI 10.1006/jmbi.2001.4713; Young KJ, 1997, NUCLEIC ACIDS RES, V25, P3760, DOI 10.1093/nar/25.19.3760	56	31	31	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17658	17664		10.1074/jbc.M111.234906	http://dx.doi.org/10.1074/jbc.M111.234906			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454684	Green Published, hybrid			2022-12-27	WOS:000290585200029
J	Huebner, EA; Kim, BG; Duffy, PJ; Brown, RH; Strittmatter, SM				Huebner, Eric A.; Kim, Byung G.; Duffy, Philip J.; Brown, Rebecca H.; Strittmatter, Stephen M.			A Multi-domain Fragment of Nogo-A Protein Is a Potent Inhibitor of Cortical Axon Regeneration via Nogo Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; SPINAL-CORD-INJURY; FUNCTIONAL RECOVERY; DEFICIENT MICE; GROWTH; LIMITS; ACTIVATION; PLASTICITY; COMPLEXES; TRAUMA	Nogo-A limits axon regeneration and functional recovery after central nervous system injury in adult mammals. Three regions of Nogo-A (Nogo-A-24, Nogo-66, and Nogo-C39) interact with the neuronal Nogo-66 receptor 1 (NgR1). Nogo-66 also interacts with a structurally unrelated cell surface receptor, paired immunoglobulin-like receptor (PirB). We show here that the other two NgR1-interacting domains, Nogo-A-24 and Nogo-C39, also bind to PirB with high affinity. A purified 22-kDa protein containing all three NgR1- and PirB-interacting domains (Nogo-22) is a substantially more potent growth cone-collapsing molecule than Nogo-66 for chick dorsal root ganglion neurons and mature cortical neurons. Moreover, Nogo-22 inhibits axon regeneration of mature cortical neurons in vitro more potently than does Nogo-66. Although all three NgR1-interacting domains of Nogo-A also interact with PirB, expression of PirB in mature cortical cultures is nearly undetectable. Consistent with a relatively minor role for PirB in mature cortical neurons, Nogo-22 inhibition of axon regeneration is abolished by genetic deletion of NgR1. Thus, NgR1 is the predominant receptor for Nogo-22 in regenerating cortical neurons.	[Huebner, Eric A.; Kim, Byung G.; Duffy, Philip J.; Brown, Rebecca H.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06536 USA; [Huebner, Eric A.; Kim, Byung G.; Duffy, Philip J.; Brown, Rebecca H.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06536 USA; [Kim, Byung G.] Ajou Univ, Sch Med, Dept Neurol, Suwon 443749, South Korea; [Kim, Byung G.] Ajou Univ, Sch Med, Brain Dis Res Ctr, Inst Med Sci, Suwon 443749, South Korea	Yale University; Yale University; Ajou University; Ajou University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	Kim, Byung Gon/L-6884-2019; Strittmatter, Stephen/F-5739-2011	Kim, Byung Gon/0000-0003-2233-9569; Strittmatter, Stephen/0000-0001-8188-3092	National Institutes of Health [MSTP TG T32GM07205, R01NS42304, R01NS39962, R01NS33020]; Falk Medical Research Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033020, R01NS039962, R01NS042304, R37NS033020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Falk Medical Research Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MSTP TG T32GM07205 (to E. A. H.) and R01NS42304, R01NS39962, and R01NS33020 (to S. M. S.). This work was also supported by the Falk Medical Research Trust (to S. M. S.). S. M. S. is a cofounder of Axerion Therapeutics, which seeks to develop PrP- and NgR-based therapeutics.	Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Cafferty WBJ, 2007, NEURON, V54, P195, DOI 10.1016/j.neuron.2007.04.005; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; Cafferty WBJ, 2010, J NEUROSCI, V30, P6825, DOI 10.1523/JNEUROSCI.6239-09.2010; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Duffy P, 2009, J NEUROSCI, V29, P15266, DOI 10.1523/JNEUROSCI.4650-09.2009; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Hu FH, 2005, J NEUROSCI, V25, P5298, DOI 10.1523/JNEUROSCI.5235-04.2005; Huebner EA, 2009, RESULTS PROBL CELL D, V48, P339, DOI 10.1007/400_2009_19; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Lauren J, 2007, J BIOL CHEM, V282, P5715, DOI 10.1074/jbc.M609797200; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; Li SX, 2003, J NEUROSCI, V23, P4219; Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Munitz A, 2008, BLOOD, V111, P5694, DOI 10.1182/blood-2007-12-126748; Nakamura Y, 2011, J BIOL CHEM, V286, P1876, DOI 10.1074/jbc.M110.163493; Niederost B, 2002, J NEUROSCI, V22, P10368; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Seymour AB, 2005, J CEREBR BLOOD F MET, V25, P1366, DOI 10.1038/sj.jcbfm.9600134; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Uehara T, 2001, J CLIN INVEST, V108, P1041, DOI 10.1172/JCI200112195; Wang XX, 2002, J NEUROSCI, V22, P5505; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3	28	49	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18026	18036		10.1074/jbc.M110.208108	http://dx.doi.org/10.1074/jbc.M110.208108			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454605	Green Published, hybrid			2022-12-27	WOS:000290585200064
J	Coleman, JA; Molday, RS				Coleman, Jonathan A.; Molday, Robert S.			Critical Role of the beta-Subunit CDC50A in the Stable Expression, Assembly, Subcellular Localization, and Lipid Transport Activity of the P-4-ATPase ATP8A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; PLASMA-MEMBRANE; PHOSPHATIDYLSERINE ASYMMETRY; TRANSLOCASE ACTIVITY; GLYCOSYLATION SITES; PROTEIN-TRANSPORT; FLIPPASE ACTIVITY; DRS2P; YEAST; IDENTIFICATION	P-4-ATPases have been implicated in the transport of lipids across cellular membranes. Some P-4-ATPases are known to associate with members of the CDC50 protein family. Previously, we have shown that the P-4-ATPase ATP8A2 purified from photoreceptor membranes and reconstituted into liposomes catalyzes the active transport of phosphatidylserine across membranes. However, it was unclear whether ATP8A2 functioned alone or as a complex with a CDC50 protein. Here, we show by mass spectrometry and Western blotting using newly generated anti-CDC50A antibodies that CDC50A is associated with ATP8A2 purified from photoreceptor membranes. ATP8A2 expressed in HEK293T cells assembles with endogenous or expressed CDC50A, but not CDC50B, to generate a heteromeric complex that actively transports phosphatidylserine and to a lesser extent phosphatidylethanolamine across membranes. Chimera CDC50 proteins in which various domains of CDC50B were replaced with the corresponding domains of CDC50A were used to identify domains important in the formation of a functional ATP8A2-CDC50 complex. These studies indicate that both the transmembrane and exocytoplasmic domains of CDC50A are required to generate a functionally active complex. The N-terminal cytoplasmic domain of CDC50A appears to play a direct role in the reaction cycle. Mutagenesis studies further indicate that the N-linked oligosaccharide chains of CDC50A are required for stable expression of an active ATP8A2-CDC50A lipid transport complex. Together, our studies indicate that CDC50A is the beta-subunit of ATP8A2 and is crucial for the correct folding, stable expression, export from endoplasmic reticulum, and phosphatidylserine flippase activity of ATP8A2.	[Coleman, Jonathan A.; Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, Ctr Macular Res, Vancouver, BC V6T 1Z3, Canada; [Molday, Robert S.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Ctr Macular Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Molday, RS (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Ctr Macular Res, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	molday@interchange.ubc.ca		Coleman, Jonathan/0000-0003-0001-6195	Canadian Institutes of Health [MOP-106667]; University of British Columbia; National Sciences and Engineering Council	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); University of British Columbia; National Sciences and Engineering Council	This work was supported by Canadian Institutes of Health Research Grant MOP-106667.; Supported by a University of British Columbia and National Sciences and Engineering Council predoctoral studentship.	Abe K, 2009, EMBO J, V28, P1637, DOI 10.1038/emboj.2009.102; Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; Cacciagli P, 2010, EUR J HUM GENET, V18, P1360, DOI 10.1038/ejhg.2010.126; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; DOI T, 1990, P NATL ACAD SCI USA, V87, P4991, DOI 10.1073/pnas.87.13.4991; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; GONZALEZROMO P, 1992, ANAL BIOCHEM, V200, P235, DOI 10.1016/0003-2697(92)90458-J; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hasler U, 2001, J BIOL CHEM, V276, P16356, DOI 10.1074/jbc.M008778200; Hasler U, 1998, J BIOL CHEM, V273, P30826, DOI 10.1074/jbc.273.46.30826; JAUNIN P, 1993, J CELL BIOL, V123, P1751, DOI 10.1083/jcb.123.6.1751; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Katoh Y, 2004, ONCOL REP, V12, P939; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Lopez-Marques RL, 2010, MOL BIOL CELL, V21, P791, DOI 10.1091/mbc.E09-08-0656; MACKENZIE D, 1982, J BIOL CHEM, V257, P7100; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Meguro M, 2001, NAT GENET, V28, P19, DOI 10.1038/ng0501-19; MOLDAY LL, 1990, J BIOL CHEM, V265, P18690; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Osada N, 2007, GENE, V392, P151, DOI 10.1016/j.gene.2006.11.021; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Puts CF, 2009, BBA-MOL CELL BIOL L, V1791, P603, DOI 10.1016/j.bbalip.2009.02.005; Romsicki Y, 2001, BIOCHEMISTRY-US, V40, P6937, DOI 10.1021/bi0024456; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; Wang L, 2004, DEV BIOL, V267, P203, DOI 10.1016/j.ydbio.2003.11.004; Xu P, 2007, ACTA BIOCH BIOPH SIN, V39, P739, DOI 10.1111/j.1745-7270.2007.00342.x; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	44	89	94	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17205	17216		10.1074/jbc.M111.229419	http://dx.doi.org/10.1074/jbc.M111.229419			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454556	Green Published, hybrid			2022-12-27	WOS:000290301900069
J	Kong, SY; Kim, SJ; Sandal, B; Lee, SM; Gao, BX; Zhang, DD; Fang, DY				Kong, Sinyi; Kim, Seung-Jae; Sandal, Barry; Lee, Sang-Myeong; Gao, Beixue; Zhang, Donna D.; Fang, Deyu			The Type III Histone Deacetylase Sirt1 Protein Suppresses p300-mediated Histone H3 Lysine 56 Acetylation at Bclaf1 Promoter to Inhibit T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DNA-DAMAGE; TRANSCRIPTIONAL REPRESSOR; APOPTOTIC RESPONSE; H3K56 ACETYLATION; GENE-EXPRESSION; STABILITY; BINDING; BTF; DEGRADATION	The NAD-dependent histone deacetylase Sirt1 is a negative regulator of T cell activation. Here we report that Sirt1 inhibits T cell activation by suppressing the transcription of Bcl2-associated factor 1 (Bclaf1), a protein required for T cell activation. Sirt1-null T cells have increased acetylation of the histone 3 lysine 56 residue (H3K56) at the bclaf1 promoter, as well as increasing Bclaf1 transcription. Sirt1 binds to bclaf1 promoter upon T cell receptor (TCR)/CD28 stimulation by forming a complex with histone acetyltransferase p300 and NF-kappa B transcription factor Rel-A. The recruitment of Sirt1, but not p300, requires Rel-A because blocking Rel-A nuclear translocation in T cells and siRNA-mediated knockdown of Rel-A can inhibit Sirt1 binding to bclaf1 promoter. Although knockdown of either p300 or GCN5 partially suppressed global H3K56 acetylation, only p300 knockdown specifically attenuated H3K56 acetylation at the bclaf1 promoter. Lastly, knockdown of Bclaf1 suppresses the hyperactivation observed in Sirt1(-/-) T cells, indicated by less IL-2 production in CD4(+) T cells and reduced proliferation. Therefore, Sirt1 negatively regulates T cell activation via H3K56 deacetylation at the promoter region to inhibit transcription of Bclaf1.	[Kong, Sinyi; Kim, Seung-Jae; Sandal, Barry; Lee, Sang-Myeong; Gao, Beixue; Fang, Deyu] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Zhang, Donna D.] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	Northwestern University; Feinberg School of Medicine; University of Arizona	Fang, DY (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	FangD@Northwestern.edu	Zhang, Donna/B-1015-2012; Fang, Deyu/I-7245-2013	Fang, Deyu/0000-0002-4211-2751	NIAID NIH HHS [R01 AI079056, R01AI079056] Funding Source: Medline; NIA NIH HHS [R21 AG028493, R21AG028493] Funding Source: Medline; NIDDK NIH HHS [DP2 DK083050, DK083050] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK083050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG028493] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Atanassov BS, 2009, MOL CELL, V35, P352, DOI 10.1016/j.molcel.2009.06.015; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Bracken CP, 2008, CANCER RES, V68, P7621, DOI 10.1158/0008-5472.CAN-08-1217; Chen A, 2009, MOL CELL BIOL, V29, P5348, DOI 10.1128/MCB.00407-09; COHN RH, 1979, CELL, V18, P855, DOI 10.1016/0092-8674(79)90137-5; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Gao BX, 2006, J BIOL CHEM, V281, P29711, DOI 10.1074/jbc.M604596200; Gillum M. P., 2010, TRENDS MOL IN PRESS; Gratchev A, 2008, J IMMUNOL, V180, P6553, DOI 10.4049/jimmunol.180.10.6553; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Haraguchi T, 2004, EUR J BIOCHEM, V271, P1035, DOI 10.1111/j.1432-1033.2004.04007.x; Hebert C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r51; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Johnson CA, 1998, NUCLEIC ACIDS RES, V26, P994, DOI 10.1093/nar/26.4.994; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kasof GM, 1999, MOL CELL BIOL, V19, P4390; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Lee KM, 2010, NUCLEIC ACIDS RES, V38, P3340, DOI 10.1093/nar/gkq017; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Liu H, 2007, MOL CELL BIOL, V27, P8480, DOI 10.1128/MCB.01126-07; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; McPherson JP, 2009, CELL DEATH DIFFER, V16, P331, DOI 10.1038/cdd.2008.167; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; SHORE D, 1984, EMBO J, V3, P2817, DOI 10.1002/j.1460-2075.1984.tb02214.x; Silvestre R, 2009, IMMUNOLOGY, V128, P484, DOI 10.1111/j.1365-2567.2009.03132.x; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Thaminy S, 2007, J BIOL CHEM, V282, P37805, DOI 10.1074/jbc.M706384200; Vempati RK, 2010, J BIOL CHEM, V285, P28553, DOI 10.1074/jbc.M110.149393; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Ziegelbauer JM, 2009, NAT GENET, V41, P130, DOI 10.1038/ng.266	39	71	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16967	16975		10.1074/jbc.M111.218206	http://dx.doi.org/10.1074/jbc.M111.218206			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454709	hybrid, Green Published			2022-12-27	WOS:000290301900046
J	Wheeler, LJ; Mathews, CK				Wheeler, Linda J.; Mathews, Christopher K.			Nucleoside Triphosphate Pool Asymmetry in Mammalian Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA PRECURSOR ASYMMETRIES; REPLICATION FIDELITY; SYNTHETIC OLIGONUCLEOTIDES; RAT-LIVER; NUCLEOTIDES; ATP	Our laboratory has reported that deoxyribonucleoside triphosphate (dNTP) pools in rat tissue mitochondria are highly asymmetric, with dGTP predominating, and that the imbalance probably contributes toward the high spontaneous mutation rate of the mitochondrial genome. Ferraro et al. (Ferraro, P., Nicolosi, L., Bernardi, P., Reichard, P., and Bianchi, V. (2006) Proc. Natl. Acad. Sci. U.S.A. 103, 18586-18591) have challenged these findings, based upon their studies of mouse liver mitochondria. Moreover, they have identified a potential artifact in the DNA polymerase-based assay for dNTPs, based upon overestimation of dGTP when GTP levels in extracts are much higher than dGTP levels. We measured ribonucleoside triphosphate (rNTP) pools in rat mitochondrial extracts and found that GTP pools exceed dGTP pools by 50-fold or less, not enough to interfere with the dGTP assay. Analysis of dNTP pools in state 3 mitochondria, after incubation with ADP and oxidizable substrates, gave similar results. We confirmed our earlier finding that rat mitochondrial dNTP pools are highly asymmetric. dNTP pools in cytosolic extracts are uniformly low, suggesting that the dNTP pool asymmetry arises within the mitochondrion. Moreover, we found rat tissue rNTP pools to be even more highly asymmetric, with ATP, for example, at least 2 orders of magnitude more abundant than CTP in liver extracts. This finding raises the possibility that transcription of the mitochondrial genome is more error-prone than transcription in the nucleus.	[Wheeler, Linda J.; Mathews, Christopher K.] Oregon State Univ, Dept Biochem, Corvallis, OR 97331 USA	Oregon State University	Mathews, CK (corresponding author), Oregon State Univ, Dept Biochem, 2011 Agr & Life Sci Bldg, Corvallis, OR 97331 USA.	mathewsc@onid.orst.edu			National Institutes of Health [R01 GM073744]; Army Research Office [55953-LS]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM073744. This work was also supported by Army Research Office Grant 55953-LS.	Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Enriquez JA, 1996, EUR J BIOCHEM, V237, P601, DOI 10.1111/j.1432-1033.1996.0601p.x; ENRIQUEZ JA, 1994, NUCLEIC ACIDS RES, V22, P1861, DOI 10.1093/nar/22.10.1861; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; HAMMAN HC, 1983, ARCH BIOCHEM BIOPHYS, V223, P85, DOI 10.1016/0003-9861(83)90574-X; Kamiya H, 2003, NUCLEIC ACIDS RES, V31, P517, DOI 10.1093/nar/gkg137; Martomo SA, 2002, MUTAT RES-FUND MOL M, V499, P197, DOI 10.1016/S0027-5107(01)00283-4; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mathews CK, 2009, METHODS MOL BIOL, V554, P371, DOI 10.1007/978-1-59745-521-3_22; MATHEWS CK, 1992, BIOESSAYS, V14, P295, DOI 10.1002/bies.950140502; Pursell ZF, 2008, NUCLEIC ACIDS RES, V36, P2174, DOI 10.1093/nar/gkn062; SCHWENKE WD, 1981, BIOCHEM J, V200, P405, DOI 10.1042/bj2000405; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361	16	28	29	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16992	16996		10.1074/jbc.M111.236968	http://dx.doi.org/10.1074/jbc.M111.236968			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454602	Green Published, hybrid			2022-12-27	WOS:000290301900049
J	Miller, EH; Harrison, JS; Radoshitzky, SR; Higgins, CD; Chi, XL; Dong, L; Kuhn, JH; Bavari, S; Lai, JR; Chandran, K				Miller, Emily Happy; Harrison, Joseph S.; Radoshitzky, Sheli R.; Higgins, Chelsea D.; Chi, Xiaoli; Dong, Lian; Kuhn, Jens H.; Bavari, Sina; Lai, Jonathan R.; Chandran, Kartik			Inhibition of Ebola Virus Entry by a C-peptide Targeted to Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL MEMBRANE-FUSION; HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN; RECEPTOR-BINDING; AVIAN-SARCOMA; COILED-COIL; TYPE-1 GP41; INFECTION; MECHANISMS; PROTEINS	Ebola virus (EboV) and Marburg virus (MarV) (filoviruses) are the causative agents of severe hemorrhagic fever. Infection begins with uptake of particles into cellular endosomes, where the viral envelope glycoprotein (GP) catalyzes fusion between the viral and host cell membranes. This fusion event is thought to involve conformational rearrangements of the transmembrane subunit (GP2) of the envelope spike that ultimately result in formation of a six-helix bundle by the N- and C-terminal heptad repeat (NHR and CHR, respectively) regions of GP2. Infection by other viruses employing similar viral entry mechanisms (such as HIV-1 and severe acute respiratory syndrome coronavirus) can be inhibited with synthetic peptides corresponding to the native CHR sequence ("C-peptides"). However, previously reported EboV C-peptides have shown weak or insignificant antiviral activity. To determine whether the activity of a C-peptide could be improved by increasing its intracellular concentration, we prepared an EboV C-peptide conjugated to the arginine-rich sequence from HIV-1 Tat, which is known to accumulate in endosomes. We found that this peptide specifically inhibited viral entry mediated by filovirus GP proteins and infection by authentic filoviruses. We determined that antiviral activity was dependent on both the Tat sequence and the native EboV CHR sequence. Mechanistic studies suggested that the peptide acts by blocking a membrane fusion intermediate.	[Harrison, Joseph S.; Higgins, Chelsea D.; Lai, Jonathan R.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Miller, Emily Happy; Chandran, Kartik] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Radoshitzky, Sheli R.; Chi, Xiaoli; Dong, Lian; Bavari, Sina] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Kuhn, Jens H.] NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD 21702 USA; [Kuhn, Jens H.] Tunnell Consulting Inc, King Of Prussia, PA 19406 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lai, JR (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	jon.lai@einstein.yu.edu; kartik.chandran@einstein.yu.edu	Radoshitzky, Sheli/L-8410-2019; Kuhn, Jens H./B-7615-2011; Bavari, Sina/L-3642-2019; Radoshitzky, Sheli S/F-2766-2019	Radoshitzky, Sheli/0000-0001-8976-8056; Kuhn, Jens H./0000-0002-7800-6045; Bavari, Sina/0000-0001-8424-5635; Miller, Emily/0000-0002-0640-5653; Harrison, Joseph/0000-0002-2118-6524	National Institutes of Health [R01 AI088027, R01 AI090249]; Albert Einstein College of Medicine; Arnold and Mabel Beckman Foundation; Joint Science and Technology Office Transformational Medical Technologies [TMTI0048_09_RD_T]; Defense Threat Reduction Agency [4.10022_08_RD_B]; NIAID [HHSN272200200016I]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090249, R01AI088027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine; Arnold and Mabel Beckman Foundation; Joint Science and Technology Office Transformational Medical Technologies; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI088027 (to K. C.) and R01 AI090249 (to J. R. L.). This work was also supported by the Albert Einstein College of Medicine, the Arnold and Mabel Beckman Foundation Young Investigators Program (to J. R. L.), and Joint Science and Technology Office Transformational Medical Technologies Proposal TMTI0048_09_RD_T and Defense Threat Reduction Agency Proposal 4.10022_08_RD_B (to S. B.). J. H. K. performed this work as an employee of Tunnell Consulting, Inc., a subcontractor to Battelle Memorial Institute under its prime contract with NIAID, under Contract No. HHSN272200200016I.	Akkarawongsa R, 2008, ANTIMICROB AGENTS CH, V52, P2120, DOI 10.1128/AAC.01424-07; Brindley MA, 2007, J VIROL, V81, P7702, DOI 10.1128/JVI.02433-06; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Dube D, 2009, J VIROL, V83, P2883, DOI 10.1128/JVI.01956-08; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Earp LJ, 2003, J VIROL, V77, P3058, DOI 10.1128/JVI.77.5.3058-3066.2003; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gallaher WR, 1996, CELL, V85, P477, DOI 10.1016/S0092-8674(00)81248-9; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Heinrich BS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000958; HOOD CL, J VIROL, V84, P2972; Ingallinella P, 2009, P NATL ACAD SCI USA, V106, P5801, DOI 10.1073/pnas.0901007106; Ito H, 1999, J VIROL, V73, P8907, DOI 10.1128/JVI.73.10.8907-8912.1999; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Kaletsky RL, 2007, J VIROL, V81, P13378, DOI 10.1128/JVI.01170-07; Kuhn JH, 2006, J BIOL CHEM, V281, P15951, DOI 10.1074/jbc.M601796200; Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x; Kuhn Jens H, 2008, Arch Virol Suppl, V20, P13; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lee JE, 2009, FUTURE VIROL, V4, P621, DOI 10.2217/FVL.09.56; Lin G, 2003, J VIROL, V77, P1337, DOI 10.1128/JVI.77.2.1337-1346.2003; Malashkevich VN, 1999, P NATL ACAD SCI USA, V96, P2662, DOI 10.1073/pnas.96.6.2662; Manicassamy B, 2005, J VIROL, V79, P4793, DOI 10.1128/JVI.79.8.4793-4805.2005; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Netter RC, 2004, J VIROL, V78, P13430, DOI 10.1128/JVI.78.24.13430-13439.2004; Porotto M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001168; Porotto M, 2010, J VIROL, V84, P6760, DOI 10.1128/JVI.00135-10; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Russell CJ, 2001, EMBO J, V20, P4024, DOI 10.1093/emboj/20.15.4024; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Smith JG, 2004, J VIROL, V78, P1403, DOI 10.1128/JVI.78.3.1403-1410.2004; Takada A, 2004, J VIROL, V78, P2943, DOI 10.1128/JVI.78.6.2943-2947.2004; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Ujike M, 2008, J VIROL, V82, P588, DOI 10.1128/JVI.01697-07; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Watanabe S, 2000, J VIROL, V74, P10194, DOI 10.1128/JVI.74.21.10194-10201.2000; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; Wexler-Cohen Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000509; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Wong AC, 2010, J VIROL, V84, P163, DOI 10.1128/JVI.01832-09; Wool-Lewis RJ, 1999, J VIROL, V73, P1419, DOI 10.1128/JVI.73.2.1419-1426.1999; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998	48	54	58	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.207084	http://dx.doi.org/10.1074/jbc.M110.207084			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454542	Green Published, hybrid			2022-12-27	WOS:000290022800026
J	Reichau, S; Jiao, WT; Walker, SR; Hutton, RD; Baker, EN; Parker, EJ				Reichau, Sebastian; Jiao, Wanting; Walker, Scott R.; Hutton, Richard D.; Baker, Edward N.; Parker, Emily J.			Potent Inhibitors of a Shikimate Pathway Enzyme from Mycobacterium tuberculosis COMBINING MECHANISM- AND MODELING-BASED DESIGN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHATE SYNTHASE; AMINO-ACID BIOSYNTHESIS; KDO8P SYNTHASE; CRYSTAL-STRUCTURE; PURIFICATION; PRODRUGS; COMPLEX; CRYSTALLOGRAPHY; SYNTHETASE; PHOSPHATES	Tuberculosis remains a serious global health threat, with the emergence of multidrug-resistant strains highlighting the urgent need for novel antituberculosis drugs. The enzyme 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase (DAH7PS) catalyzes the first step of the shikimate pathway for the biosynthesis of aromatic compounds. This pathway has been shown to be essential in Mycobacterium tuberculosis, the pathogen responsible for tuberculosis. DAH7PS catalyzes a condensation reaction between P-enolpyruvate and erythrose 4-phosphate to give 3-deoxy-D-arabino-heptulosonate 7-phosphate. The enzyme reaction mechanism is proposed to include a tetrahedral intermediate, which is formed by attack of an active site water on the central carbon of P-enolpyruvate during the course of the reaction. Molecular modeling of this intermediate into the active site reported in this study shows a configurational preference consistent with water attack from the re face of P-enolpyruvate. Based on this model, we designed and synthesized an inhibitor of DAH7PS that mimics this reaction intermediate. Both enantiomers of this intermediate mimic were potent inhibitors of M. tuberculosis DAH7PS, with inhibitory constants in the nanomolar range. The crystal structure of the DAH7PS-inhibitor complex was solved to 2.35 angstrom. Both the position of the inhibitor and the conformational changes of active site residues observed in this structure correspond closely to the predictions from the intermediate modeling. This structure also identifies a water molecule that is located in the appropriate position to attack the re face of P-enolpyruvate during the course of the reaction, allowing the catalytic mechanism for this enzyme to be clearly defined.	[Parker, Emily J.] Univ Canterbury, Dept Chem, Christchurch 8140, New Zealand; Univ Canterbury, Biomol Interact Ctr, Christchurch 8140, New Zealand; [Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand; [Baker, Edward N.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand	University of Canterbury; University of Canterbury; University of Auckland; University of Auckland	Parker, EJ (corresponding author), Univ Canterbury, Dept Chem, Private Bag 4800, Christchurch 8140, New Zealand.	emily.parker@canterbury.ac.nz	Reichau, Sebastian/C-2525-2016; Jiao, Wanting/I-3159-2019	Jiao, Wanting/0000-0002-0234-7206; Parker, Emily/0000-0002-9571-9987; Baker, Edward/0000-0003-2456-7661; Reichau, Sebastian/0000-0003-1370-8991	Maurice Wilkins Centre for Molecular Biodiscovery; University of Canterbury; New Zealand International Doctoral Research Scholarship (NZIDRS); New Zealand Tertiary Education Commission; International Synchrotron Access Program (ISAP)	Maurice Wilkins Centre for Molecular Biodiscovery; University of Canterbury; New Zealand International Doctoral Research Scholarship (NZIDRS); New Zealand Tertiary Education Commission; International Synchrotron Access Program (ISAP)	This research was funded in part by the Maurice Wilkins Centre for Molecular Biodiscovery.; Supported by a University of Canterbury Doctoral Scholarship and a New Zealand International Doctoral Research Scholarship (NZIDRS).; Supported by a New Zealand Tertiary Education Commission Top Achiever Doctoral Scholarship.; This research was undertaken on the MX2 beamline at the Australian Synchrotron, Victoria, Australia (48). We acknowledge travel funding provided by the International Synchrotron Access Program (ISAP) managed by the Australian Synchrotron and the New Zealand Synchrotron Group.	Ahn M, 2005, ORG BIOMOL CHEM, V3, P4046, DOI 10.1039/b511661a; [Anonymous], 2005, MAESTR VERS 7 5; [Anonymous], 2005, MACROMODEL VERS 9 1; [Anonymous], 2005, SCHROD SUIT 2006 IND; [Anonymous], 2005, GLID VERS 4 0; Armarego W.L.F., 2003, PURIFICATION LAB CHE; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barry CE, 2010, CURR OPIN CHEM BIOL, V14, P456, DOI 10.1016/j.cbpa.2010.04.008; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Campbell SA, 2004, INT J PARASITOL, V34, P5, DOI 10.1016/j.ijpara.2003.10.006; DELEO AB, 1973, J BIOL CHEM, V248, P2344; DESS DB, 1991, J AM CHEM SOC, V113, P7277, DOI 10.1021/ja00019a027; Friis GJ, 1996, EUR J PHARM SCI, V4, P49, DOI 10.1016/0928-0987(95)00031-3; Grison C, 2005, CARBOHYD RES, V340, P529, DOI 10.1016/j.carres.2004.11.019; Grison C, 2000, TETRAHEDRON LETT, V41, P6571, DOI 10.1016/S0040-4039(00)01053-4; Hartmann M, 2003, P NATL ACAD SCI USA, V100, P862, DOI 10.1073/pnas.0337566100; Hecker SJ, 2008, J MED CHEM, V51, P2328, DOI 10.1021/jm701260b; IRELAND RE, 1993, J ORG CHEM, V58, P2899, DOI 10.1021/jo00062a040; Kona F, 2007, BIOCHEMISTRY-US, V46, P4532, DOI 10.1021/bi6024879; Kona F, 2009, BIOCHEMISTRY-US, V48, P3610, DOI 10.1021/bi801955h; Konig V, 2004, J MOL BIOL, V337, P675, DOI 10.1016/j.jmb.2004.01.055; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Meya DB, 2007, J INTERN MED, V261, P309, DOI 10.1111/j.1365-2796.2007.01795.x; Parish T, 2002, MICROBIOL-SGM, V148, P3069, DOI 10.1099/00221287-148-10-3069; Petit Y, 1998, ORG SYNTH, V75, P37; RAY PH, 1980, J BACTERIOL, V141, P635, DOI 10.1128/JB.141.2.635-644.1980; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Schofield LR, 2005, BIOCHEMISTRY-US, V44, P11950, DOI 10.1021/bi050577z; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; SCHONER R, 1976, J BIOL CHEM, V251, P5440; Schultz C, 2003, BIOORGAN MED CHEM, V11, P885, DOI 10.1016/S0968-0896(02)00552-7; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Shumilin IA, 2004, J MOL BIOL, V341, P455, DOI 10.1016/j.jmb.2004.05.077; Shumilin IA, 2003, BIOCHEMISTRY-US, V42, P3766, DOI 10.1021/bi027257p; Sikorski JA, 1997, ACCOUNTS CHEM RES, V30, P2, DOI 10.1021/ar950122+; Wagner T, 2000, J MOL BIOL, V301, P389, DOI 10.1006/jmbi.2000.3957; Walker SR, 2011, BIOORG MED CHEM LETT, V21, P5092, DOI 10.1016/j.bmcl.2011.03.071; Walker SR, 2009, ORG BIOMOL CHEM, V7, P3031, DOI 10.1039/b909241b; Walker SR, 2006, BIOORG MED CHEM LETT, V16, P2951, DOI 10.1016/j.bmcl.2006.02.073; Wang J, 2001, BIOCHEMISTRY-US, V40, P15676, DOI 10.1021/bi015568e; Webby CJ, 2010, J BIOL CHEM, V285, P30567, DOI 10.1074/jbc.M110.111856; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Webby CJ, 2005, ACTA CRYSTALLOGR F, V61, P403, DOI 10.1107/S1744309105007931; Webby CJ, 2005, BIOCHEM J, V390, P223, DOI 10.1042/BJ20050259; WHO, 2009, GLOB TUB CONTR EP ST, P6; Williamson RM, 2005, BIOORG MED CHEM LETT, V15, P2339, DOI 10.1016/j.bmcl.2005.02.080	49	36	37	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.211649	http://dx.doi.org/10.1074/jbc.M110.211649			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454647	hybrid, Green Published			2022-12-27	WOS:000290022800059
J	Marois, L; Vaillancourt, M; Pare, G; Gagne, V; Fernandes, MJG; Rollet-Labelle, E; Naccache, PH				Marois, Louis; Vaillancourt, Myriam; Pare, Guillaume; Gagne, Valerie; Fernandes, Maria J. G.; Rollet-Labelle, Emmanuelle; Naccache, Paul H.			CIN85 Modulates the Down-regulation of Fc gamma RIIa Expression and Function by c-Cbl in a PKC-dependent Manner in Human Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RECEPTOR-MEDIATED PHAGOCYTOSIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TYROSINE PHOSPHORYLATION; LIPID RAFTS; RHEUMATOID-ARTHRITIS; IMMUNOGLOBULIN-G; ADAPTER PROTEIN; CROSS-LINKING; HIGH-DENSITY	We previously described a non-classical mechanism that arrests Fc gamma RIIa signaling in human neutrophils once engaged by immune complexes or opsonized pathogens. The engagement of Fc gamma RIIa leads to its ubiquitination by the ubiquitin ligase c-Cbl and degradation by the proteasome. Herein, we further examined some of the events regulating this novel pathway. The adaptor protein CIN85 was described in other systems to be involved in the regulation of the c-Cbl-dependent pathway. We found that CIN85 is expressed in human neutrophils and that it translocates like c-Cbl from the cytosol to the plasma membrane following receptor cross-linking. CIN85 was also recruited to the same subset of high density detergent-resistant membrane fractions in which stimulated Fc gamma RIIa partitioned with c-Cbl. The integrity of these microdomains is essential to the Fc gamma RIIa degradation process because the cholesterol-depleting agent methyl-beta-cyclodextrin inhibits this event. Silencing the expression of CIN85 by siRNA in dibutyryl cyclic AMP-differentiated PLB 985 cells prevented Fc gamma RIIa degradation and increased IgG-mediated phagocytosis. Confocal microscopy revealed that the presence of CIN85 is essential to the proper sorting of Fc gamma RIIa during endocytosis. We also provide direct evidence that CIN85 is a substrate of serine/threonine kinase PKCs. Classical PKCs positively regulate Fc gamma RIIa ubiquitination and degradation because these events were inhibited by Go6976, a classical PKC inhibitor. We conclude that the ubiquitination and degradation of stimulated Fc gamma RIIa mediated by c-Cbl are positively regulated by the adaptor protein CIN85 in a PKC-dependent manner and that these events contribute to the termination of Fc gamma RIIa signaling.	[Marois, Louis; Vaillancourt, Myriam; Pare, Guillaume; Gagne, Valerie; Fernandes, Maria J. G.; Rollet-Labelle, Emmanuelle; Naccache, Paul H.] Univ Laval, Ctr Rech Rhumatol & Immunol, Ctr Rech CHUQ, Dept Microbiol Infectiol & Immunol,Fac Med, Quebec City, PQ G1V 4G2, Canada	Laval University	Rollet-Labelle, E (corresponding author), Univ Laval, Ctr Rech Rhumatol & Immunol, Ctr Rech CHUQ, Dept Microbiol Infectiol & Immunol,Fac Med, 2705 Blvd Laurier,Room T1-49, Quebec City, PQ G1V 4G2, Canada.	emmanuelle.rollet@crchul.ulaval.ca		Marois, Louis/0000-0002-1567-5583	Canadian Institutes of Health Research (CIHR); Canadian Arthritis Network	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Arthritis Network	This work was supported in part by grants from the Canadian Institutes of Health Research (CIHR).; Recipient of a Canadian Arthritis Network Graduate Award and a CIHR Doctoral Research Award.	Artcanuthurry Valerie, 1996, Seminars in Thrombosis and Hemostasis, V22, P317, DOI 10.1055/s-2007-999026; Barabe F, 2002, J IMMUNOL, V168, P4042, DOI 10.4049/jimmunol.168.8.4042; Barabe F, 2002, J BIOL CHEM, V277, P13473, DOI 10.1074/jbc.M112149200; Belostocki K, 2005, CLIN IMMUNOL, V117, P78, DOI 10.1016/j.clim.2005.07.001; BRUMELL JH, 1994, AM J PHYSIOL-CELL PH, V267, pC1574, DOI 10.1152/ajpcell.1994.267.6.C1574; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; Danielsen EM, 2006, MOL MEMBR BIOL, V23, P71, DOI 10.1080/09687860500445604; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; DUSI S, 1994, BIOCHEM BIOPH RES CO, V201, P30, DOI 10.1006/bbrc.1994.1665; Fernandes MJG, 2006, BIOCHEM J, V393, P351, DOI 10.1042/BJ20050129; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gout I, 2000, EMBO J, V19, P4015, DOI 10.1093/emboj/19.15.4015; Havrylov S, 2010, TRAFFIC, V11, P721, DOI 10.1111/j.1600-0854.2010.01061.x; Hogarth PM, 2002, CURR OPIN IMMUNOL, V14, P798, DOI 10.1016/S0952-7915(02)00409-0; HUIZINGA TWJ, 1989, J IMMUNOL, V142, P2365; HUNDT M, 1992, EUR J IMMUNOL, V22, P811, DOI 10.1002/eji.1830220327; HUNTER S, 1994, P NATL ACAD SCI USA, V91, P10232, DOI 10.1073/pnas.91.21.10232; Ibarrola I, 1997, BBA-MOL CELL RES, V1357, P348, DOI 10.1016/S0167-4889(97)00034-7; INDIK Z, 1991, J CLIN INVEST, V88, P1766, DOI 10.1172/JCI115496; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kabouridis PS, 2006, MOL MEMBR BIOL, V23, P49, DOI 10.1080/09687860500453673; KIMBERLY RP, 1995, ARTHRITIS RHEUM, V38, P306, DOI 10.1002/art.1780380303; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; Kjeldsen L, 1999, J IMMUNOL METHODS, V232, P131, DOI 10.1016/S0022-1759(99)00171-4; Kowanetz K, 2003, J BIOL CHEM, V278, P39735, DOI 10.1074/jbc.M304541200; Kurakin AV, 2003, J BIOL CHEM, V278, P34102, DOI 10.1074/jbc.M305264200; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LIANG L, 1995, BIOCHEM J, V306, P489, DOI 10.1042/bj3060489; Lowry MB, 1998, J EXP MED, V187, P161, DOI 10.1084/jem.187.2.161; Manes S, 2006, MOL MEMBR BIOL, V23, P59, DOI 10.1080/09687860500430069; MAROIS L, 2011, ADV MED BIOL, V15, P123; Marois L, 2011, J BIOL CHEM, V286, P3509, DOI 10.1074/jbc.M110.169516; Marois L, 2009, J IMMUNOL, V182, P2374, DOI 10.4049/jimmunol.0801420; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mayer AMS, 1997, LIFE SCI, V61, pPL199, DOI 10.1016/S0024-3205(97)00713-3; Melander F, 2004, BIOCHEM BIOPH RES CO, V317, P1000, DOI 10.1016/j.bbrc.2004.03.147; Molfetta R, 2005, J IMMUNOL, V175, P4208, DOI 10.4049/jimmunol.175.7.4208; Naccache PH, 1997, J LEUKOCYTE BIOL, V62, P901, DOI 10.1002/jlb.62.6.901; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Peruzzi G, 2007, J IMMUNOL, V179, P2089, DOI 10.4049/jimmunol.179.4.2089; Popa-Nita O, 2009, J IMMUNOL, V183, P2104, DOI 10.4049/jimmunol.0900906; Qiu WS, 1998, J LEUKOCYTE BIOL, V63, P631, DOI 10.1002/jlb.63.5.631; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; RICHARD S, 1994, BIOCHEM BIOPH RES CO, V199, P653, DOI 10.1006/bbrc.1994.1278; ROLLET E, 1994, J IMMUNOL, V153, P353; Rollet-Labelle E, 2004, BIOCHEM J, V381, P919, DOI 10.1042/BJ20031808; Rollet-Labelle E, 2000, J IMMUNOL, V164, P1020, DOI 10.4049/jimmunol.164.2.1020; Salmon JE, 2001, ARTHRITIS RHEUM, V44, P739; Sardjono CT, 2003, IMMUNOL CELL BIOL, V81, P374, DOI 10.1046/j.1440-1711.2003.01182.x; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Shao DM, 2003, FEBS LETT, V550, P101, DOI 10.1016/S0014-5793(03)00845-7; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Slaughter N, 2003, CLIN IMMUNOL, V108, P138, DOI 10.1016/S1521-6616(03)00097-4; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Su KH, 2007, J IMMUNOL, V178, P3272, DOI 10.4049/jimmunol.178.5.3272; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; SWERDLOW PS, 1986, ANAL BIOCHEM, V156, P147, DOI 10.1016/0003-2697(86)90166-1; Szymkiewicz I, 2002, J BIOL CHEM, V277, P39666, DOI 10.1074/jbc.M205535200; Take H, 2000, BIOCHEM BIOPH RES CO, V268, P321, DOI 10.1006/bbrc.2000.2147; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wijngaarden S, 2005, RHEUMATOLOGY, V44, P729, DOI 10.1093/rheumatology/keh583	63	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15073	15084		10.1074/jbc.M110.213660	http://dx.doi.org/10.1074/jbc.M110.213660			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21372129	Green Published, hybrid			2022-12-27	WOS:000289788300038
J	Melendez, J; Stengel, K; Zhou, X; Chauhan, BK; Debidda, M; Andreassen, P; Lang, RA; Zheng, Y				Melendez, Jaime; Stengel, Kristy; Zhou, Xuan; Chauhan, Bharesh K.; Debidda, Marcella; Andreassen, Paul; Lang, Richard A.; Zheng, Yi			RhoA GTPase Is Dispensable for Actomyosin Regulation but Is Essential for Mitosis in Primary Mouse Embryonic Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN STRESS FIBERS; CITRON-KINASE; FAMILY GTPASES; TRANSFORMED-CELLS; CONTRACTILE RING; MAMMALIAN-CELLS; BINDING PROTEIN; CLEAVAGE FURROW; CDC42 GTPASES; DNA-DAMAGE	RhoA, the founding member of mammalian Rho GTPase family, is thought to be essential for actomyosin regulation. To date, the physiologic function of RhoA in mammalian cell regulation has yet to be determined genetically. Here we have created RhoA conditional knock-out mice. Mouse embryonic fibroblasts deleted of RhoA showed no significant change in actin stress fiber or focal adhesion complex formation in response to serum or LPA, nor any detectable change in Rho-kinase signaling activity. Concomitant knock-out or knockdown of RhoB and RhoC in the RhoA(-/-) cells resulted in a loss of actin stress fiber and focal adhesion similar to that of C3 toxin treatment. Proliferation of RhoA(-/-) cells was impaired due to a complete cell cycle block during mitosis, an effect that is associated with defective cytokinesis and chromosome segregation and can be readily rescued by exogenous expression of RhoA. Furthermore, RhoA deletion did not affect the transcriptional activity of Stat3, NF kappa B, or serum response factor, nor the expression of the cell division kinase inhibitor p21(Cip)1 or p27(Kip1). These genetic results demonstrate that in primary mouse embryonic fibroblasts, RhoA is uniquely required for cell mitosis but is redundant with related RhoB and RhoC GTPases in actomyosin regulation.	[Melendez, Jaime; Stengel, Kristy; Zhou, Xuan; Debidda, Marcella; Andreassen, Paul; Zheng, Yi] Univ Cincinnati, Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Chauhan, Bharesh K.; Lang, Richard A.] Univ Cincinnati, Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Zheng, Y (corresponding author), Childrens Hosp, Med Ctr, Div Expt Hematol & Canc Biol, 3333 Brunet Ave, Cincinnati, OH 45229 USA.	yi.zheng@cchmc.org	Lang, Richard/E-5578-2011; Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074; Lang, Richard/0000-0002-5212-254X; Chauhan, Bharesh/0000-0002-6429-9190; Stengel, Kristy/0000-0002-8330-5744; Melendez Rojel, Jaime/0000-0003-4711-864X	National Institutes of Health [R01 CA150547, R01 HL085362, P30 DK090971]; NATIONAL CANCER INSTITUTE [R01CA150547] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA150547, R01 HL085362, and P30 DK090971 (to Y.Z.).	Andreassen PR, 2001, CANCER RES, V61, P7660; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Aznar S, 2001, MOL BIOL CELL, V12, P3282, DOI 10.1091/mbc.12.10.3282; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8; Eda M, 2001, J CELL SCI, V114, P3273; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fritz G, 1997, J BIOL CHEM, V272, P30637, DOI 10.1074/jbc.272.49.30637; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Jackson B, 2011, MOL BIOL CELL, V22, P593, DOI 10.1091/mbc.E09-10-0859; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Just I, 2001, INT J MED MICROBIOL, V291, P243, DOI 10.1078/1438-4221-00127; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Liu AX, 2001, P NATL ACAD SCI USA, V98, P6192, DOI 10.1073/pnas.111137198; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Lohez OD, 2003, J CELL BIOL, V161, P67, DOI 10.1083/jcb.200208140; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Mammoto A, 2004, J BIOL CHEM, V279, P26323, DOI 10.1074/jbc.M402725200; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Ridley AJ, 2001, J CELL SCI, V114, P2713; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rosario CO, 2010, P NATL ACAD SCI USA, V107, P6888, DOI 10.1073/pnas.0910941107; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang L, 2003, J BIOL CHEM, V278, P44617, DOI 10.1074/jbc.M308929200; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Werner M, 2008, BIOCHEM SOC T, V36, P371, DOI 10.1042/BST0360371; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466	51	51	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15132	15137		10.1074/jbc.C111.229336	http://dx.doi.org/10.1074/jbc.C111.229336			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21454503	hybrid, Green Published			2022-12-27	WOS:000289788300044
J	Koksal, AC; Cingolani, G				Koksal, Adem C.; Cingolani, Gino			Dimerization of Vaccinia Virus VH1 Is Essential for Dephosphorylation of STAT1 at Tyrosine 701	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; PROTEIN PHOSPHATASES; CRYSTAL-STRUCTURE; H1 PHOSPHATASE; IN-VIVO; SPECIFICITY; PHOSPHORYLATION; ULTRACENTRIFUGATION; MACROMOLECULES	The gene product of Vaccinia virus gene H1, VH1, is the first identified dual specificity phosphatase (DSP). The human genome encodes 38 different VH1-like DSPs, which include major regulators of signaling pathways, highly dysregulated in disease states. VH1 down-regulates cellular antiviral response by dephosphorylating activated STAT1 in the IFN-gamma/STAT1 signaling pathway. In this report, we have investigated the molecular basis for VH1 catalytic activity. Using small-angle x-ray scattering (SAXS), we determined that VH1 exists in solution as a boomerang-shaped dimer. Targeted alanine mutations in the dimerization domain (aa 1-27) decrease phosphatase activity while leaving the dimer intact. Deletion of the N-terminal dimer swapped helix (aa 1-20) completely abolishes dimerization and severely reduces phosphatase activity. An engineered chimera of VH1 that contains only one active site retains wild-type levels of catalytic activity. Thus, a dimeric quaternary structure, as opposed to two cooperative active sites within the same dimer is essential for VH1 catalytic activity. Together with laforin, VH1 is the second DSP reported in literature for which dimerization via an N-terminal dimerization domain is necessary for optimal catalytic activity. We propose that dimerization may represent a common mechanism to regulate the activity and substrate recognition of DSPs, often assumed to function as monomers.	[Koksal, Adem C.; Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Koksal, Adem C.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	Jefferson University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Cingolani, G (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	gino.cingolani@jefferson.edu		Koksal, Adem/0000-0002-3163-7421	National Institutes of Health [GM074846-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074846-01A1.	Agarwal R, 2008, J BIOL CHEM, V283, P8946, DOI 10.1074/jbc.M708945200; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alonso A, 2004, J BIOL CHEM, V279, P35768, DOI 10.1074/jbc.M403412200; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; DeLano W.L, PYMOL MOL GRAPHICS S; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; Derrien M, 1999, J VIROL, V73, P7287, DOI 10.1128/JVI.73.9.7287-7296.1999; Deshpande T, 1999, J BIOL CHEM, V274, P16590, DOI 10.1074/jbc.274.23.16590; Ducruet AP, 2005, ANNU REV PHARMACOL, V45, P725, DOI 10.1146/annurev.pharmtox.45.120403.100040; Gentry MS, 2009, TRENDS BIOCHEM SCI, V34, P628, DOI 10.1016/j.tibs.2009.08.002; Gronenborn AM, 2009, CURR OPIN STRUC BIOL, V19, P39, DOI 10.1016/j.sbi.2008.12.002; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; Jackson MD, 2001, CHEM REV, V101, P2313, DOI 10.1021/cr000247e; Koksal AC, 2009, J BIOL CHEM, V284, P10129, DOI 10.1074/jbc.M808362200; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LIU K, 1995, J VIROL, V69, P7823, DOI 10.1128/JVI.69.12.7823-7834.1995; Liu Y, 2006, J BIOL CHEM, V281, P34768, DOI 10.1074/jbc.M607778200; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Mann BA, 2008, J INTERF CYTOK RES, V28, P367, DOI 10.1089/jir.2007.0113; Mercer J, 2003, J VIROL, V77, P8857, DOI 10.1128/JVI.77.16.8857-8871.2003; Najarro P, 2001, J VIROL, V75, P3185, DOI 10.1128/JVI.75.7.3185-3196.2001; Nardozzi J, 2010, J MOL BIOL, V402, P83, DOI 10.1016/j.jmb.2010.07.013; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Phan J, 2007, ACTA CRYSTALLOGR D, V63, P698, DOI 10.1107/S0907444907014904; Portman JJ, 2010, CURR OPIN STRUC BIOL, V20, P11, DOI 10.1016/j.sbi.2009.12.013; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wenta N, 2008, P NATL ACAD SCI USA, V105, P9238, DOI 10.1073/pnas.0802130105; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616	37	24	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14373	14382		10.1074/jbc.M111.226357	http://dx.doi.org/10.1074/jbc.M111.226357			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21362620	Green Published, hybrid			2022-12-27	WOS:000289556200059
J	Hasegawa, H; Wendling, J; He, F; Trilisky, E; Stevenson, R; Franey, H; Kinderman, F; Li, G; Piedmonte, DM; Osslund, T; Shen, M; Ketchem, RR				Hasegawa, Haruki; Wendling, John; He, Feng; Trilisky, Egor; Stevenson, Riki; Franey, Heather; Kinderman, Francis; Li, Gary; Piedmonte, Deirdre Murphy; Osslund, Timothy; Shen, Min; Ketchem, Randal R.			In Vivo Crystallization of Human IgG in the Endoplasmic Reticulum of Engineered Chinese Hamster Ovary (CHO) Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; RECOMBINANT PROTEINS; SECRETORY PATHWAY; INCLUSION-BODIES; MESSENGER-RNA; HIGH-LEVEL; ER STRESS; EXPRESSION; TRANSGENE; FACTORIES	Protein synthesis and secretion are essential to cellular life. Although secretory activities may vary in different cell types, what determines the maximum secretory capacity is inherently difficult to study. Increasing protein synthesis until reaching the limit of secretory capacity is one strategy to address this key issue. Under highly optimized growth conditions, recombinant CHO cells engineered to produce a model human IgG clone started housing rod-shaped crystals in the endoplasmic reticulum (ER) lumen. The intra-ER crystal growth was accompanied by cell enlargement and multinucleation and continued until crystals outgrew cell size to breach membrane integrity. The intra-ER crystals were composed of correctly folded, endoglycosidase H-sensitive IgG. Crystallizing propensity was due to the intrinsic physicochemical properties of the model IgG, and the crystallization was reproduced in vitro by exposing a high concentration of IgG to a near neutral pH. The striking cellular phenotype implicated the efficiency of IgG protein synthesis and oxidative folding exceeded the capacity of ER export machinery. As a result, export-ready IgG accumulated progressively in the ER lumen until a threshold concentration was reached to nucleate crystals. Using an in vivo system that reports accumulation of correctly folded IgG, we showed that the ER-toGolgi transport steps became rate-limiting in cells with high secretory activity.	[Hasegawa, Haruki; Shen, Min; Ketchem, Randal R.] Amgen Inc, Dept Prot Sci, Seattle, WA 98119 USA; [Wendling, John] Amgen Inc, Dept Cell Sci & Technol, Seattle, WA 98119 USA; [He, Feng] Amgen Inc, Dept Formulat & Analyt Resources, Seattle, WA 98119 USA; [Trilisky, Egor] Amgen Inc, Dept Purificat Proc Dev, Seattle, WA 98119 USA; [Stevenson, Riki; Franey, Heather; Kinderman, Francis; Li, Gary; Piedmonte, Deirdre Murphy] Amgen Inc, Dept Formulat & Analyt Resources, Thousand Oaks, CA 91320 USA; [Osslund, Timothy] Amgen Inc, Dept Analyt & Formulat Sci, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen; Amgen; Amgen; Amgen	Hasegawa, H (corresponding author), Amgen Inc, Dept Prot Sci, 1201 Amgen Court W, Seattle, WA 98119 USA.	harukih@amgen.com	Ketchem, Randal R/K-2258-2017; Ketchem, Randal/AAB-4372-2020	Ketchem, Randal R/0000-0002-7821-2682; Ketchem, Randal/0000-0002-7821-2682; Hasegawa, Haruki/0000-0002-3464-4715				Aldrich TL, 1998, CYTOTECHNOLOGY, V28, P9, DOI 10.1023/A:1008048807588; Alete DE, 2005, PROTEOMICS, V5, P4689, DOI 10.1002/pmic.200500019; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Barnes LM, 2006, CURR OPIN BIOTECH, V17, P381, DOI 10.1016/j.copbio.2006.06.005; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brewer JW, 2005, NAT IMMUNOL, V6, P23, DOI 10.1038/ni1149; Carrio MM, 2002, J BIOTECHNOL, V96, P3, DOI 10.1016/S0168-1656(02)00032-9; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Dinnis DM, 2005, BIOTECHNOL BIOENG, V91, P180, DOI 10.1002/bit.20499; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; GIPSON IK, 1975, INVEST OPHTH VISUAL, V14, P937; Hand DB, 1935, J GEN PHYSIOL, V18, P847, DOI 10.1085/jgp.18.6.847; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hawi SR, 1997, J LIPID RES, V38, P1591; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; He F, 2010, J PHARM SCI-US, V99, P1707, DOI 10.1002/jps.21955; Jenkins N, 2008, MOL BIOTECHNOL, V39, P113, DOI 10.1007/s12033-008-9049-4; Jenkins N, 2009, BIOTECHNOL APPL BIOC, V53, P73, DOI 10.1042/BA20080258; KABAT EA, 1977, J BIOL CHEM, V252, P6609; Kantardjieff KA, 2004, BIOINFORMATICS, V20, P2162, DOI 10.1093/bioinformatics/bth066; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lee J, 2007, BIOTECHNOL LETT, V29, P1797, DOI 10.1007/s10529-007-9490-7; Lucas BK, 1996, NUCLEIC ACIDS RES, V24, P1774, DOI 10.1093/nar/24.9.1774; Mariati, 2010, PROTEIN EXPRES PURIF, V69, P9, DOI 10.1016/j.pep.2009.08.010; Markossian KA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P971, DOI 10.1023/B:BIRY.0000043539.07961.4c; Muller D, 2008, TRENDS BIOTECHNOL, V26, P359, DOI 10.1016/j.tibtech.2008.03.010; O'Callaghan Peter M., 2008, Briefings in Functional Genomics & Proteomics, V7, P95, DOI 10.1093/bfgp/eln012; Ortsater H, 2007, MOL CELL ENDOCRINOL, V277, P1, DOI 10.1016/j.mce.2007.06.006; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Peng RW, 2010, METAB ENG, V12, P18, DOI 10.1016/j.ymben.2009.08.007; Pilbrough W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008432; Rasmussen B, 1998, CYTOTECHNOLOGY, V28, P31, DOI 10.1023/A:1008052908496; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Shukla AA, 2010, TRENDS BIOTECHNOL, V28, P253, DOI 10.1016/j.tibtech.2010.02.001; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Tagliavacca L, 2003, BIOL CHEM, V384, P1273, DOI 10.1515/BC.2003.141; Tigges M, 2006, METAB ENG, V8, P264, DOI 10.1016/j.ymben.2006.01.006; Vitale A, 2004, PLANT PHYSIOL, V136, P3420, DOI 10.1104/pp.104.050351; Wang TY, 2008, CELL BIOL INT, V32, P1279, DOI 10.1016/j.cellbi.2008.07.014; Williams S, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-17; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145	48	51	52	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19917	19931		10.1074/jbc.M110.204362	http://dx.doi.org/10.1074/jbc.M110.204362			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21464137	Green Published, hybrid			2022-12-27	WOS:000291027700071
J	Ruiz-Garcia, A; Monsalve, E; Novellasdemunt, L; Navarro-Sabate, A; Manzano, A; Rivero, S; Castrillo, A; Casado, M; Laborda, J; Bartrons, R; Diaz-Guerra, MJM				Ruiz-Garcia, Almudena; Monsalve, Eva; Novellasdemunt, Laura; Navarro-Sabate, Aurea; Manzano, Anna; Rivero, Samuel; Castrillo, Antonio; Casado, Marta; Laborda, Jorge; Bartrons, Ramon; Diaz-Guerra, Maria Jose M.			Cooperation of Adenosine with Macrophage Toll-4 Receptor Agonists Leads to Increased Glycolytic Flux through the Enhanced Expression of PFKFB3 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; UP-REGULATION; TRANSCRIPTION FACTOR; FACTOR INDUCTION; IMMUNE-RESPONSE; NITRIC-OXIDE; C/EBP-DELTA	Macrophages activated through Toll receptor triggering increase the expression of the A(2A) and A(2B) adenosine receptors. In this study, we show that adenosine receptor activation enhances LPS-induced pfkfb3 expression, resulting in an increase of the key glycolytic allosteric regulator fructose 2,6-bisphosphate and the glycolytic flux. Using shRNA and differential expression of A(2A) and A(2B) receptors, we demonstrate that the A(2A) receptor mediates, in part, the induction of pfkfb3 by LPS, whereas the A(2B) receptor, with lower adenosine affinity, cooperates when high adenosine levels are present. pfkfb3 promoter sequence deletion analysis, site-directed mutagenesis, and inhibition by shRNAs demonstrated that HIF1 alpha is a key transcription factor driving pfkfb3 expression following macrophage activation by LPS, whereas synergic induction of pfkfb3 expression observed with the A(2) receptor agonists seems to depend on Sp1 activity. Furthermore, levels of phospho-AMP kinase also increase, arguing for increased PFKFB3 activity by phosphorylation in long term LPS-activated macrophages. Taken together, our results show that, in macrophages, endogenously generated adenosine cooperates with bacterial components to increase PFKFB3 isozyme activity, resulting in greater fructose 2,6-bisphosphate accumulation. This process enhances the glycolytic flux and favors ATP generation helping to develop and maintain the long term defensive and reparative functions of the macrophages.	[Ruiz-Garcia, Almudena; Monsalve, Eva; Rivero, Samuel; Laborda, Jorge; Diaz-Guerra, Maria Jose M.] Ctr Reg Invest Biomed, Fac Med, E-02006 Albacete, Spain; [Novellasdemunt, Laura; Navarro-Sabate, Aurea; Manzano, Anna; Bartrons, Ramon] Univ Barcelona, Unitat Bioquim & Biol Mol, Dept Ciences Fisiol 2, Inst Invest Biomed Bellvitge, E-08907 Lhospitalet De Llobregat, Spain; [Castrillo, Antonio] Univ Las Palmas, Fac Med, ULPGC, Las Palmas Gran Canaria 35016, Spain; [Casado, Marta] Inst Biomed Valencia, Valencia 46010, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Universidad de Las Palmas de Gran Canaria; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Diaz-Guerra, MJM (corresponding author), Ctr Reg Invest Biomed, Fac Med, Av Almansa 14, E-02006 Albacete, Spain.	MariaJose.Martinez@uclm.es	Laborda, Jorge/L-5726-2014; Ruiz-García, Almudena/ABA-1492-2021; Manzano, Anna/ABG-3422-2020; Monsalve Argandona, Eva Maria/F-7156-2015; Navarro-Sabate, Aurea/K-6329-2018; Casado Pinna, Marta/L-2078-2014	Laborda, Jorge/0000-0002-9210-838X; Manzano, Anna/0000-0002-9106-3132; Monsalve Argandona, Eva Maria/0000-0003-4933-4602; Novellasdemunt Vilaseca, Laura/0000-0003-1590-9842; Navarro-Sabate, Aurea/0000-0002-8286-9732; Rivero Hinojosa, Samuel/0000-0002-3595-8273; Casado Pinna, Marta/0000-0001-6457-4650; Martinez Diaz-Guerra, Maria Jose/0000-0003-3843-3912; Bartrons, Ramon/0000-0001-9349-5847	Ministerio de Sanidad y Consumo [PI060449]; Ministerio de Ciencia e Innovacion [BFU 2009-07380]; Consejeria de Sanidad [SAN06-015]; Consejeria de Educacion y Ciencia, Junta de Comunidades de Castilla-La Mancha, Spain [PII1/09-0211-7101]	Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejeria de Sanidad; Consejeria de Educacion y Ciencia, Junta de Comunidades de Castilla-La Mancha, Spain(Junta de Comunidades de Castilla-La Mancha)	This work was supported by Grant PI060449 from the Ministerio de Sanidad y Consumo, Grant BFU 2009-07380 from Ministerio de Ciencia e Innovacion, Grant SAN06-015 from Consejeria de Sanidad, and Grant PII1/09-0211-7101 from the Consejeria de Educacion y Ciencia, Junta de Comunidades de Castilla-La Mancha, Spain.	Akira S, 1997, ADV IMMUNOL, V65, P1, DOI 10.1016/S0065-2776(08)60740-3; Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; Atsumi T, 2002, CANCER RES, V62, P5881; Bando H, 2005, CLIN CANCER RES, V11, P5784, DOI 10.1158/1078-0432.CCR-05-0149; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; CRONSTEIN BN, 1994, J APPL PHYSIOL, V76, P5, DOI 10.1152/jappl.1994.76.1.5; Csoka B, 2007, BLOOD, V110, P2685, DOI 10.1182/blood-2007-01-065870; De Ponti C, 2007, J LEUKOCYTE BIOL, V82, P392, DOI 10.1189/jlb.0107060; Duran J, 2009, FEBS J, V276, P4555, DOI 10.1111/j.1742-4658.2009.07161.x; Escoll P, 2003, BIOCHEM BIOPH RES CO, V311, P465, DOI 10.1016/j.bbrc.2003.10.019; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HOHORST HJ, 1965, ANN NY ACAD SCI, V119, P974, DOI 10.1111/j.1749-6632.1965.tb47456.x; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Jung YJ, 2003, BIOCHEM J, V370, P1011, DOI 10.1042/BJ20021279; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kawaguchi T, 2001, J BIOL CHEM, V276, P28554, DOI 10.1074/jbc.M101396200; KAY NE, 1980, J RETICULOENDOTH SOC, V28, P367; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; Kempner W, 1939, J CLIN INVEST, V18, P291, DOI 10.1172/JCI101045; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; Krebs H A, 1972, Essays Biochem, V8, P1; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu YW, 2007, CELL MOL LIFE SCI, V64, P3282, DOI 10.1007/s00018-007-7375-5; Liu YW, 2006, CELL SIGNAL, V18, P1492, DOI 10.1016/j.cellsig.2005.12.001; Lukashev D, 2004, J IMMUNOL, V173, P21, DOI 10.4049/jimmunol.173.1.21; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; Minchenko A, 2002, J BIOL CHEM, V277, P6183, DOI 10.1074/jbc.M110978200; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; Murphree LJ, 2005, BIOCHEM J, V391, P575, DOI 10.1042/BJ20050888; NATSUKA S, 1992, BLOOD, V79, P460; Navarro-Sabate A, 2001, GENE, V264, P131, DOI 10.1016/S0378-1119(00)00591-6; Nemeth ZH, 2003, BIOCHEM BIOPH RES CO, V312, P883, DOI 10.1016/j.bbrc.2003.11.006; Obach M, 2004, J BIOL CHEM, V279, P53562, DOI 10.1074/jbc.M406096200; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; PILKIS SJ, 1995, ANNU REV BIOCHEM, V64, P799, DOI 10.1146/annurev.bi.64.070195.004055; Pinhal-Enfield G, 2003, AM J PATHOL, V163, P711, DOI 10.1016/S0002-9440(10)63698-X; Ramanathan M, 2007, MOL BIOL CELL, V18, P14, DOI 10.1091/mbc.E06-07-0596; Riera L, 2003, FEBS LETT, V550, P23, DOI 10.1016/S0014-5793(03)00808-1; Riera L, 2002, BBA-MOL CELL RES, V1589, P89, DOI 10.1016/S0167-4889(02)00169-6; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Sandau KB, 2001, J BIOL CHEM, V276, P39805, DOI 10.1074/jbc.M107689200; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2005, TRENDS IMMUNOL, V26, P299, DOI 10.1016/j.it.2005.04.004; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Turner L, 1999, EUR J IMMUNOL, V29, P2280, DOI 10.1002/(SICI)1521-4141(199907)29:07<2280::AID-IMMU2280>3.0.CO;2-C; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wu Z, 2005, MOL CELL BIOL, V25, P9741, DOI 10.1128/MCB.25.22.9741-9752.2005; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Zheng XL, 2001, J BIOL CHEM, V276, P13822, DOI 10.1074/jbc.M011031200; Zheng XL, 2000, J BIOL CHEM, V275, P31747, DOI 10.1074/jbc.M000621200	64	54	55	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19247	19258		10.1074/jbc.M110.190298	http://dx.doi.org/10.1074/jbc.M110.190298			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21464136	Green Published, hybrid			2022-12-27	WOS:000291027700007
J	Heise, RL; Stober, V; Cheluvaraju, C; Hollingsworth, JW; Garantziotis, S				Heise, Rebecca L.; Stober, Vandy; Cheluvaraju, Chaitra; Hollingsworth, John W.; Garantziotis, Stavros			Mechanical Stretch Induces Epithelial-Mesenchymal Transition in Alveolar Epithelia via Hyaluronan Activation of Innate Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; PULMONARY-FIBROSIS; TARGETED DISRUPTION; IN-VIVO; CELLS; MATRIX; CD44; DIFFERENTIATION; VENTILATION	Epithelial injury is a central event in the pathogenesis of many inflammatory and fibrotic lung diseases like acute respiratory distress syndrome, pulmonary fibrosis, and iatrogenic lung injury. Mechanical stress is an often underappreciated contributor to lung epithelial injury. Following injury, differentiated epithelia can assume a myofibroblast phenotype in a process termed epithelial to mesenchymal transition (EMT), which contributes to aberrant wound healing and fibrosis. We demonstrate that cyclic mechanical stretch induces EMT in alveolar type II epithelial cells, associated with increased expression of low molecular mass hyaluronan (sHA). We show that sHA is sufficient for induction of EMT in statically cultured alveolar type II epithelial cells and necessary for EMT during cell stretch. Furthermore, stretch-induced EMT requires the innate immune adaptor molecule MyD88. We examined the Wnt/beta-catenin pathway, which is known to mediate EMT. The Wnt target gene Wnt-inducible signaling protein 1 (wisp-1) is significantly up-regulated in stretched cells in hyaluronan- and MyD88-dependent fashion, and blockade of WISP-1 prevents EMT in stretched cells. In conclusion, we show for the first time that innate immunity transduces mechanical stress responses through the matrix component hyaluronan, and activation of the Wnt/beta-catenin pathway.	[Heise, Rebecca L.; Stober, Vandy; Cheluvaraju, Chaitra; Garantziotis, Stavros] NIEHS, Lab Resp Biol, NIH, Res Triangle Pk, NC 27709 USA; [Hollingsworth, John W.] Duke Univ, Dept Med, Med Ctr, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University	Garantziotis, S (corresponding author), NIEHS, Lab Resp Biol, NIH, POB 12233,MD CU01, Res Triangle Pk, NC 27709 USA.	garantziotis@niehs.nih.gov	Garantziotis, Stavros/A-6903-2009; Heise, Rebecca/N-7797-2016	Garantziotis, Stavros/0000-0003-4007-375X; Heise, Rebecca/0000-0002-6602-6700	National Institutes of Health [ES016126]; Division of Intramural Research, NIEHS/National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZIAES102605, R01ES016126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, NIEHS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES016126 (to J. W. H.). This work was also supported by intramural funds from the Division of Intramural Research, NIEHS/National Institutes of Health (to S. G.).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akimoto T, 2005, BIOCHEM BIOPH RES CO, V329, P381, DOI 10.1016/j.bbrc.2005.01.136; Arnsdorf EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005388; Aytekin M, 2008, AM J PHYSIOL-LUNG C, V295, pL789, DOI 10.1152/ajplung.90306.2008; Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; Bannerman DD, 2003, AM J PHYSIOL-LUNG C, V284, pL899, DOI 10.1152/ajplung.00338.2002; Berthiaume Y, 1999, THORAX, V54, P150, DOI 10.1136/thx.54.2.150; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; BRENNAN NJ, 1983, THORAX, V38, P62, DOI 10.1136/thx.38.1.62; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Camara J, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-2; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Corvol H, 2009, INT J BIOCHEM CELL B, V41, P1643, DOI 10.1016/j.biocel.2009.02.009; Crapo J D, 1982, Am Rev Respir Dis, V125, P740; Dell'Accio F, 2003, EXP CELL RES, V287, P16, DOI 10.1016/S0014-4827(03)00036-3; Garantziotis S, 2008, AM J RESP CRIT CARE, V178, P939, DOI 10.1164/rccm.200803-386OC; Garantziotis S, 2010, AM J RESP CRIT CARE, V181, P666, DOI 10.1164/rccm.200903-0381OC; Garantziotis S, 2009, J BIOL CHEM, V284, P11309, DOI 10.1074/jbc.M802400200; Jansen JHW, 2010, J ORTHOP RES, V28, P390, DOI 10.1002/jor.20991; Janssens S, 2003, FEBS LETT, V548, P103, DOI 10.1016/S0014-5793(03)00747-6; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Lauer ME, 2008, J BIOL CHEM, V283, P26283, DOI 10.1074/jbc.M803350200; Lionetti V, 2005, CURR OPIN CRIT CARE, V11, P82, DOI 10.1097/00075198-200502000-00013; LWEBUGAMUKASA JS, 1991, AM REV RESPIR DIS, V144, P452, DOI 10.1164/ajrccm/144.2.452; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P403, DOI 10.1513/pats.200508-090JS; Mascarenhas MM, 2004, AM J RESP CELL MOL, V30, P51, DOI 10.1165/rcmb.2002-0167OC; Mummert ME, 2000, J EXP MED, V192, P769, DOI 10.1084/jem.192.6.769; Muto J, 2009, MOL IMMUNOL, V47, P449, DOI 10.1016/j.molimm.2009.08.026; Pedreira PR, 2008, AM J PHYSIOL-LUNG C, V295, pL820, DOI 10.1152/ajplung.90211.2008; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Savani RC, 2000, AM J RESP CELL MOL, V23, P475, DOI 10.1165/ajrcmb.23.4.3944; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Taliana L, 2006, MOL VIS, V12, P1233; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Toole BP, 2005, CELLS TISSUES ORGANS, V179, P66, DOI 10.1159/000084510; Treggiari MM, 2007, AM J RESP CRIT CARE, V176, P685, DOI 10.1164/rccm.200701-165OC; Tremblay LN, 2002, CRIT CARE MED, V30, P1693, DOI 10.1097/00003246-200208000-00003; Tschumperlin DJ, 1999, J APPL PHYSIOL, V86, P2026, DOI 10.1152/jappl.1999.86.6.2026; Vaneker M, 2008, ANESTHESIOLOGY, V109, P465, DOI 10.1097/ALN.0b013e318182aef1; Wang HX, 2008, MOL BIOL CELL, V19, P1519, DOI 10.1091/mbc.E07-08-0817; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wurfel Mark M, 2007, Proc Am Thorac Soc, V4, P77, DOI 10.1513/pats.200608-149JG; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	54	103	113	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17435	17444		10.1074/jbc.M110.137273	http://dx.doi.org/10.1074/jbc.M110.137273			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21398522	Green Published, hybrid			2022-12-27	WOS:000290585200005
J	Pryde, KR; Hirst, J				Pryde, Kenneth R.; Hirst, Judy			Superoxide Is Produced by the Reduced Flavin in Mitochondrial Complex I A SINGLE, UNIFIED MECHANISM THAT APPLIES DURING BOTH FORWARD AND REVERSE ELECTRON TRANSFER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN SPECIES GENERATION; IRON-SULFUR CLUSTERS; UBIQUINONE-OXIDOREDUCTASE; OXIDATIVE PHOSPHORYLATION; HEART-MITOCHONDRIA; HYDROGEN-PEROXIDE; SUBMITOCHONDRIAL PARTICLES; NADH; REDUCTION; DEHYDROGENASE	NADH:ubiquinone oxidoreductase (complex I) is a major source of reactive oxygen species in mitochondria and a contributor to cellular oxidative stress. In isolated complex I the reduced flavin is known to react with molecular oxygen to form predominantly superoxide, but studies using intact mitochondria contend that superoxide may result from a semiquinone species that responds to the proton-motive force (Delta p) also. Here, we use bovine heart submitochondrial particles to show that a single mechanism describes superoxide production by complex I under all conditions (during both NADH oxidation and reverse electron transfer). NADH-induced superoxide production is inhibited by complex I flavin-site inhibitors but not by inhibitors of ubiquinone reduction, and it is independent of Delta p. Reverse electron transfer (RET) through complex I in submitochondrial particles, driven by succinate oxidation and the Delta p created by ATP hydrolysis, reduces the flavin, leading to NAD(+) and O-2 reduction. RET-induced superoxide production is inhibited by both flavin-site and ubiquinone-reduction inhibitors. The potential dependence of NADH-induced superoxide production (set by the NAD(+) potential) matches that of RET-induced superoxide production (set by the succinate potential and Delta p), and they both match the potential dependence of the flavin. Therefore, both NADH- and RET-induced superoxide are produced by the flavin, according to the same molecular mechanism. The unified mechanism describes how reactive oxygen species production by complex I responds to changes in cellular conditions. It establishes a route to understanding causative connections between the enzyme and its pathological effects and to developing rational strategies for addressing them.	[Pryde, Kenneth R.; Hirst, Judy] Med Res Council Mitochondrial Biol Unit, Cambridge CB2 0XY, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Hirst, J (corresponding author), Med Res Council Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	jh@mrc-mbu.cam.ac.uk	Hirst, Judy/F-4803-2011	Hirst, Judy/0000-0001-8667-6797	Medical Research Council; Medical Research Council [MC_U105663141] Funding Source: researchfish; MRC [MC_U105663141] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council.	Aon MA, 2010, BBA-BIOENERGETICS, V1797, P865, DOI 10.1016/j.bbabio.2010.02.016; AZZI A, 1975, BIOCHEM BIOPH RES CO, V65, P597, DOI 10.1016/S0006-291X(75)80188-4; BASHFORD CL, 1977, J BIOL CHEM, V252, P8459; BELTRAN C, 1984, EUR J BIOCHEM, V144, P151, DOI 10.1111/j.1432-1033.1984.tb08443.x; Biason JV, 2011, J MOL BIOL, V406, P443, DOI 10.1016/j.jmb.2010.12.025; Birrell JA, 2009, BIOCHEMISTRY-US, V48, P12005, DOI 10.1021/bi901706w; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; CHANCE B, 1960, NATURE, V185, P666, DOI 10.1038/185666a0; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Grivennikova VG, 2010, BBA-BIOENERGETICS, V1797, P939, DOI 10.1016/j.bbabio.2010.02.013; HANSEN M, 1964, BIOCHIM BIOPHYS ACTA, V81, P214, DOI 10.1016/0926-6569(64)90036-7; HILLE R, 1981, J BIOL CHEM, V256, P9090; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Hirst J, 2010, BIOCHEM J, V425, P327, DOI 10.1042/BJ20091382; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; JAULT JM, 1993, J BIOL CHEM, V268, P1558; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; Kotlyar AB, 2005, FEBS LETT, V579, P4861, DOI 10.1016/j.febslet.2005.07.076; KOTLYAR AB, 1984, BIOCHIM BIOPHYS ACTA, V784, P24, DOI 10.1016/0167-4838(84)90168-7; KSENZENKO M, 1983, FEBS LETT, V155, P19, DOI 10.1016/0014-5793(83)80200-2; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lambert AJ, 2008, BBA-BIOENERGETICS, V1777, P397, DOI 10.1016/j.bbabio.2008.03.005; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; LINNANE AW, 1958, BIOCHIM BIOPHYS ACTA, V29, P630, DOI 10.1016/0006-3002(58)90021-0; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; MAJANDER A, 1994, J BIOL CHEM, V269, P21037; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; ORR GA, 1984, ANAL BIOCHEM, V142, P232, DOI 10.1016/0003-2697(84)90544-X; PULLMAN ME, 1960, J BIOL CHEM, V235, P3322; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Reda T, 2008, BIOCHEMISTRY-US, V47, P8885, DOI 10.1021/bi800437g; ROTTENBERG H, 1975, BIOCHEMISTRY-US, V14, P2675, DOI 10.1021/bi00683a017; Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107; Selivanov VA, 2008, J BIOL CHEM, V283, P29292, DOI 10.1074/jbc.M801019200; SLED VD, 1994, BIOCHEMISTRY-US, V33, P10069, DOI 10.1021/bi00199a034; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; SORGATO MC, 1978, BIOCHEM J, V174, P237, DOI 10.1042/bj1740237; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Treberg JR, 2010, FEBS J, V277, P2766, DOI 10.1111/j.1742-4658.2010.07693.x; Vinogradov AD, 2005, BIOCHEMISTRY-MOSCOW+, V70, P120, DOI 10.1007/s10541-005-0090-7; Votyakova TV, 2004, ARCH BIOCHEM BIOPHYS, V431, P138, DOI 10.1016/j.abb.2004.07.025; Yakovlev G, 2007, BIOCHEMISTRY-US, V46, P14250, DOI 10.1021/bi7017915; Zharova TV, 1997, BBA-BIOENERGETICS, V1320, P256, DOI 10.1016/S0005-2728(97)00029-7; Zoccarato F, 2007, BIOCHEM J, V406, P125, DOI 10.1042/BJ20070215	48	198	207	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18056	18065		10.1074/jbc.M110.186841	http://dx.doi.org/10.1074/jbc.M110.186841			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21393237	Green Published, hybrid			2022-12-27	WOS:000290585200067
J	Yoshizumi, A; Fletcher, JM; Yu, ZX; Persikov, AV; Bartlett, GJ; Boyle, AL; Vincent, TL; Woolfson, DN; Brodsky, B				Yoshizumi, Ayumi; Fletcher, Jordan M.; Yu, Zhuoxin; Persikov, Anton V.; Bartlett, Gail J.; Boyle, Aimee L.; Vincent, Thomas L.; Woolfson, Derek N.; Brodsky, Barbara			Designed Coiled Coils Promote Folding of a Recombinant Bacterial Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX; CIRCULAR-DICHROISM; PROTEIN; NUCLEATION; MECHANISM; PEPTIDE; DOMAINS; MOTIFS; SITE	Collagen triple helices fold slowly and inefficiently, often requiring adjacent globular domains to assist this process. In the Streptococcus pyogenes collagen-like protein Scl2, a V domain predicted to be largely alpha-helical, occurs N-terminal to the collagen triple helix (CL). Here, we replace this natural trimerization domain with a de novo designed, hyperstable, parallel, three-stranded, alpha-helical coiled coil (CC), either at the N terminus (CC-CL) or the C terminus (CL-CC) of the collagen domain. CD spectra of the constructs are consistent with additivity of independently and fully folded CC and CL domains, and the proteins retain their distinctive thermal stabilities, CL at similar to 37 degrees C and CC at >90 degrees C. Heating the hybrid proteins to 50 degrees C unfolds CL, leavingCCintact, and upon cooling, the rate of CL refolding is somewhat faster for CL-CC than for CC-CL. A construct with coiled coils on both ends, CC-CL-CC, retains the similar to 37 degrees C thermal stability for CL but shows less triple helix at low temperature and less denaturation at 50 degrees C. Most strikingly however, in CC-CL-CC, the CL refolds slower than in either CC-CL or CL-CC by almost two orders of magnitude. We propose that a single CC promotes folding of the CL domain via nucleation and in-register growth from one end, whereas initiation and growth from both ends in CC-CL-CC results in mismatched registers that frustrate folding. Bioinformatics analysis of natural collagens lends support to this because, where present, there is generally only one coiled-coil domain close to the triple helix, and it is nearly always N-terminal to the collagen repeat.	[Fletcher, Jordan M.; Bartlett, Gail J.; Boyle, Aimee L.; Vincent, Thomas L.; Woolfson, Derek N.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Yoshizumi, Ayumi; Yu, Zhuoxin; Brodsky, Barbara] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Persikov, Anton V.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Vincent, Thomas L.] Univ Bristol, Bristol Ctr Complex Sci, Bristol BS8 1TR, Avon, England; [Woolfson, Derek N.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	University of Bristol; Rutgers State University New Brunswick; Rutgers State University Medical Center; Princeton University; University of Bristol; University of Bristol; Tufts University	Woolfson, DN (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	D.N.Woolfson@bristol.ac.uk; Barbara.Brodsky@tufts.edu	Woolfson, Dek Neil/ABC-4338-2021; Bartlett, Gail/F-3064-2015; Yu, Zhuoxin/L-1512-2013	Boyle, Aimee/0000-0003-4176-6080; Fletcher, Jordan/0000-0003-3203-4355; Woolfson, Derek/0000-0002-0394-3202	National Institutes of Health [GM60048]; Biotechnology and Biological Sciences Research Council [BB/G008833/1]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060048] Funding Source: NIH RePORTER; BBSRC [BB/G008833/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60048 (to. B. B.). This work was also supported by Biotechnology and Biological Sciences Research Council Grant BB/G008833/1 (to D. N. W.).	Armstrong CT, 2009, FARADAY DISCUSS, V143, P305, DOI 10.1039/b901610d; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Baum Jean, 1999, Current Opinion in Structural Biology, V9, P122, DOI 10.1016/S0959-440X(99)80016-5; Beck K, 1998, J STRUCT BIOL, V122, P17, DOI 10.1006/jsbi.1998.3965; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; Feng YB, 1997, BIOCHEMISTRY-US, V36, P8716, DOI 10.1021/bi962980z; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HARRINGT.WF, 1970, BIOCHEMISTRY-US, V9, P3725, DOI 10.1021/bi00821a011; Hayes D. B., 1995, SEDNTERP VERSION 1 0; HOPPE HJ, 1994, FEBS LETT, V344, P191, DOI 10.1016/0014-5793(94)00383-1; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; WOOLFSON DN, 1995, PROTEIN SCI, V4, P1596, DOI 10.1002/pro.5560040818; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Xu CY, 2010, BIOMACROMOLECULES, V11, P348, DOI 10.1021/bm900894b; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134; Yu ZX, 2010, PROTEIN SCI, V19, P775, DOI 10.1002/pro.356; ZITZEWITZ JA, 1995, BIOCHEMISTRY-US, V34, P12812, DOI 10.1021/bi00039a042	29	24	25	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17512	17520		10.1074/jbc.M110.217364	http://dx.doi.org/10.1074/jbc.M110.217364			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454493	Green Published, hybrid			2022-12-27	WOS:000290585200013
J	Alvarez, Y; Municio, C; Hugo, E; Zhu, J; Alonso, S; Hu, XY; Fernandez, N; Crespo, MS				Alvarez, Yolanda; Municio, Cristina; Hugo, Etzel; Zhu, Jimmy; Alonso, Sara; Hu, Xiaoyu; Fernandez, Nieves; Sanchez Crespo, Mariano			Notch- and Transducin-like Enhancer of Split (TLE)-dependent Histone Deacetylation Explain Interleukin 12 (IL-12) p70 Inhibition by Zymosan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROTEIN KINASE-1 MSK1; HUMAN DENDRITIC CELLS; TOLL-LIKE RECEPTOR-2; C-REL; GENE-EXPRESSION; BETA-GLUCANS; IL-23 P19; TRANSCRIPTIONAL ACTIVITY; DEPENDENT TRANSCRIPTION	The fungal analog zymosan induces IL-23 and low amounts of IL-12 p70. This study addresses the molecular mechanisms underlying this cytokine pattern in human monocyte-derived dendritic cells. The transcriptional regulation of il23a, one of the chains of IL-23, depended on the activation of c-Rel and histone H3 phosphorylation, as judged from the association of c-Rel with the il23a promoter and the correlation between IL-23 production and Ser-10-histone H3 phosphorylation. Consistent with its reduced ability to produce IL-12 p70, zymosan induced a transient occupancy of the il12a promoter by c-Rel, blocked the production of IL-12 p70 and the transcription of il12a induced by other stimuli, and triggered the expression and nuclear translocation of the transcriptional repressors of the Notch family hairy and enhancer of split (Hes)-1, Hes5, hairy/enhancer-of-split related with YRPW motif protein (Hey)-1, and transducin-like enhancer of split (TLE). Zymosan also induced the interaction of Hes1 and TLE with histone H3 phosphorylated on Ser-10 and deacetylated on Lys-14. Inhibition of class III histone deacetylases increased the production of IL-12 p70 and partially blunted the inhibitory effect of zymosan on the production of IL-12 p70 elicited by LPS and IFN-gamma. These results indicate that the selective induction of IL-23 by beta-glucans is explained by the activation of c-Rel associated with Ser-10-histone H3 phosphorylation in the il23a promoter mediated by mitogen-and stress-activated kinase and/or protein kinase A and inhibition of il12a transcription by a mechanism involving activation of several corepressors with the ability to bind TLE and to promote histone deacetylation.	[Alvarez, Yolanda; Municio, Cristina; Hugo, Etzel; Alonso, Sara; Sanchez Crespo, Mariano] Inst Biol & Genet Mol, Consejo Super Invest Cientif, Valladolid 47003, Spain; [Zhu, Jimmy; Hu, Xiaoyu] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Fernandez, Nieves] Univ Valladolid, Dept Bioquim & Biol Mol, Fac Med, E-47005 Valladolid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid	Crespo, MS (corresponding author), Inst Biol & Genet Mol, Consejo Super Invest Cientif, C Sanz & Fores 3, Valladolid 47003, Spain.	mscres@ibgm.uva.es	Hu, Xiaoyu/D-5403-2017; Fernández, Nieves/N-5426-2018; Alvarez, Yolanda/AAD-4964-2021; Municio, Cristina/D-2916-2019	Hu, Xiaoyu/0000-0002-4289-6998; Fernández, Nieves/0000-0002-9141-3956; Municio, Cristina/0000-0002-8552-8183; Alvarez, Yolanda/0000-0002-4851-8277; Sanchez Crespo, Mariano/0000-0002-6149-154X; zhu, jimmy/0000-0003-4957-8885	Plan Nacional de Salud y Farmacia [SAF2007-60446, SAF2010-15070]; Fundacion Ramon Areces, Red Tematica de Investigacion Cardiovascular; Junta de Castilla y Leon [GR230]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056729] Funding Source: NIH RePORTER	Plan Nacional de Salud y Farmacia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces, Red Tematica de Investigacion Cardiovascular; Junta de Castilla y Leon(Junta de Castilla y Leon); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Plan Nacional de Salud y Farmacia Grants SAF2007-60446 and SAF2010-15070, Fundacion Ramon Areces, Red Tematica de Investigacion Cardiovascular, and Junta de Castilla y Leon Grant GR230.	Al-Salleeh F, 2008, J IMMUNOL, V181, P4523, DOI 10.4049/jimmunol.181.7.4523; Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Bode KA, 2007, IMMUNOLOGY, V122, P596, DOI 10.1111/j.1365-2567.2007.02678.x; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Cinnamon E, 2008, CURR OPIN GENET DEV, V18, P435, DOI 10.1016/j.gde.2008.07.010; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; DeManno DA, 1999, MOL ENDOCRINOL, V13, P91, DOI 10.1210/me.13.1.91; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Du ZM, 2006, J IMMUNOL, V176, P4785, DOI 10.4049/jimmunol.176.8.4785; Du ZM, 2005, P NATL ACAD SCI USA, V102, P10267, DOI 10.1073/pnas.0408854102; Feng D, 2010, J IMMUNOL, V185, P6003, DOI 10.4049/jimmunol.1000482; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Ghosh HS, 2007, BIOCHEM J, V408, P105, DOI 10.1042/BJ20070817; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Goriely S, 2006, BLOOD, V107, P1078, DOI 10.1182/blood-2005-06-2416; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Harokopakis E, 2005, EUR J IMMUNOL, V35, P1201, DOI 10.1002/eji.200425883; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Huang HB, 2009, INFECT IMMUN, V77, P1774, DOI 10.1128/IAI.00086-09; Huang ZY, 2011, J BIOL CHEM, V286, P160, DOI 10.1074/jbc.M110.163030; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Ivashkiv LB, 2010, CELL HOST MICROBE, V8, P132, DOI 10.1016/j.chom.2010.07.011; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kollet JI, 2006, MOL IMMUNOL, V43, P623, DOI 10.1016/j.molimm.2005.04.004; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lemos HP, 2009, P NATL ACAD SCI USA, V106, P5954, DOI 10.1073/pnas.0812782106; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Liu JG, 2003, J EXP MED, V198, P1265, DOI 10.1084/jem.20030026; Liu WC, 2009, J BIOL CHEM, V284, P24006, DOI 10.1074/jbc.M109.025528; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Palaparti A, 1997, J BIOL CHEM, V272, P26604, DOI 10.1074/jbc.272.42.26604; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Smeekens SP, 2010, INT IMMUNOL, V22, P889, DOI 10.1093/intimm/dxq442; Snijders A, 1998, INT IMMUNOL, V10, P1593, DOI 10.1093/intimm/10.11.1593; Spooren A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/275892; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Valera I, 2008, J IMMUNOL, V180, P5727, DOI 10.4049/jimmunol.180.8.5727; van Bruggen R, 2009, MOL IMMUNOL, V47, P575, DOI 10.1016/j.molimm.2009.09.018; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang JM, 2007, J IMMUNOL, V178, P6777, DOI 10.4049/jimmunol.178.11.6777; Wenink MH, 2009, J IMMUNOL, V183, P6960, DOI 10.4049/jimmunol.0900713; Yarmus M, 2006, P NATL ACAD SCI USA, V103, P7384, DOI 10.1073/pnas.0602470103; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoon C, 2008, J NEUROSCI, V28, P3738, DOI 10.1523/JNEUROSCI.4439-07.2008; Yu SH, 2004, J MOL MED, V82, P621, DOI 10.1007/s00109-004-0559-7; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	70	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16583	16595		10.1074/jbc.M111.222158	http://dx.doi.org/10.1074/jbc.M111.222158			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21402701	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000290301900007
J	Coffin, SR; Hollis, T; Perrino, FW				Coffin, Stephanie R.; Hollis, Thomas; Perrino, Fred W.			Functional Consequences of the RNase H2A Subunit Mutations That Cause Aicardi-Goutieres Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURES; DNA; TREX1; COMPLEX; YEAST; HII; SPECIFICITY; EXPRESSION; PROTEINS	Mutations in the three genes encoding the heterotrimeric RNase H2 complex cause Aicardi-Goutieres Syndrome (AGS). Our mouse RNase H2 structure revealed that the catalytic RNase H2A subunit interfaces mostly with the RNase H2C subunit that is intricately interwoven with the RNase H2B subunit. We mapped the positions of AGS-causing RNase H2A mutations using the mouse RNase H2 structure and proposed that these mutations cause varied effects on catalytic potential. To determine the functional consequences of these mutations, heterotrimeric human RNase H2 complexes containing the RNase H2A subunit mutations were prepared, and catalytic efficiencies and nucleic acid binding properties were compared with the wild-type (WT) complex. These analyses reveal a dramatic range of effects with mutations at conserved positions G37S, R186W, and R235Q, reducing enzymatic activities and substrate binding affinities by as much as a 1000-fold, whereas mutations at non-conserved positions R108W, N212I, F230L, T240M, and R291H reduced activities and binding modestly or not at all. All mutants purify as three-subunit complexes, further supporting the required heterotrimeric structure in eukaryotic RNase H2. These kinetic properties reveal varied functional consequences of AGS-causing mutations in the catalytic RNase H2A subunit and reflect the complex mechanisms of nuclease dysfunction that include catalytic deficiencies and altered protein-nucleic acid interactions relevant in AGS.	[Coffin, Stephanie R.; Hollis, Thomas; Perrino, Fred W.] Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University School of Medicine	Perrino, FW (corresponding author), Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA.	fperrino@wfubmc.edu	Pinheiro, Maísa/E-7424-2012		National Institutes of Health [GM069962, F32GM095290]; Alliance for Lupus Research [179222]; American Heart Association [10GRNT3650033]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962, F32GM095290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069962 (to F. W. P.). This work was also supported by the Alliance for Lupus Research 179222 (to F. W. P.), American Heart Association Grant 10GRNT3650033 (to T.H.), and National Institutes of Health Postdoctoral Fellowship Award F32GM095290 (to S. R. C.).	AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Figiel M, 2011, J BIOL CHEM, V286, P10540, DOI 10.1074/jbc.M110.181974; Frank P, 1998, P NATL ACAD SCI USA, V95, P12872, DOI 10.1073/pnas.95.22.12872; Goutieres F, 1998, ANN NEUROL, V44, P900, DOI 10.1002/ana.410440608; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; ITAYA M, 1990, P NATL ACAD SCI USA, V87, P8587, DOI 10.1073/pnas.87.21.8587; Jeong HS, 2004, NUCLEIC ACIDS RES, V32, P407, DOI 10.1093/nar/gkh209; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Perrino FW, 2009, J MOL MED-JMM, V87, P25, DOI 10.1007/s00109-008-0422-3; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Reijns MAM, 2011, J BIOL CHEM, V286, P10530, DOI 10.1074/jbc.M110.177394; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Rohman MS, 2008, FEBS J, V275, P4836, DOI 10.1111/j.1742-4658.2008.06622.x; Rychlik MP, 2010, MOL CELL, V40, P658, DOI 10.1016/j.molcel.2010.11.001; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Shaban NM, 2010, J BIOL CHEM, V285, P3617, DOI 10.1074/jbc.M109.059048	32	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16984	16991		10.1074/jbc.M111.228833	http://dx.doi.org/10.1074/jbc.M111.228833			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454563	Green Published, hybrid			2022-12-27	WOS:000290301900048
J	Dalrymple, MB; Jaeger, WC; Eidne, KA; Pfleger, KDG				Dalrymple, Matthew B.; Jaeger, Werner C.; Eidne, Karin A.; Pfleger, Kevin D. G.			Temporal Profiling of Orexin Receptor-Arrestin-Ubiquitin Complexes Reveals Differences between Receptor Subtypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; RESONANCE ENERGY-TRANSFER; BETA-ARRESTIN; HORMONE RECEPTOR; INDEPENDENT INTERNALIZATION; 7-TRANSMEMBRANE RECEPTORS; DEPENDENT INTERNALIZATION; ENDOCYTIC TRAFFICKING; MEDIATED ENDOCYTOSIS; ERK1/2 ACTIVATION	Orexin G protein-coupled receptors (OxRs) and their cognate agonists have been implicated in a number of disorders since their recent discovery, ranging from narcolepsy to formation of addictive behavior. Bioluminescence resonance energy transfer assays of agonist-occupied OxRs provided evidence for a strong dose-dependent interaction with both trafficking proteins beta-arrestin 1 and 2 that required unusually high agonist concentrations compared with inositol phosphate signaling. This appears to be reflected in functional differences in potency with respect to orexin A (OxA) and OxR2-dependent ERK1/2 phosphorylation after 90 min compared with 2 min, potentially consistent with beta-arrestin-mediated versus G protein-mediated signaling, respectively. Furthermore, extended bioluminescence resonance energy transfer kinetic data monitoring OxA-dependent receptor-beta-arrestin and beta-arrestin-ubiquitin proximity suggested subtype-specific differences in receptor trafficking, with OxR2 activation resulting in more sustained receptor-beta-arrestin-ubiquitin complex formation than elicited by OxR1 activation. Enzyme-linked immunosorbent assay (ELISA) data also revealed that OxR1 underwent significantly more rapid recycling compared with OxR2. Finally, we have observed sustained OxA-dependent ERK1/2 phosphorylation in the presence of OxR2 compared with OxR1. Although both OxR subtypes could be classified as class B receptors for beta-arrestin usage based on the initial strength of interaction with both beta-arrestins, our temporal profiling revealed tangible differences between OxR subtypes. Consequently, OxR1 appears to fit uneasily into the commonly used beta-arrestin classification scheme. More importantly, it is hoped that this improved profiling capability, enabling the subtleties of protein complex formation, stability, and duration to be assessed in live cells, will help unlock the therapeutic potential of targeting these receptors.	[Pfleger, Kevin D. G.] Western Australian Inst Med Res, Lab Mol Endocrinol G Protein Coupled Receptors, QEII Med Ctr, Perth, WA 6009, Australia; Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia	Pfleger, KDG (corresponding author), Western Australian Inst Med Res, Lab Mol Endocrinol G Protein Coupled Receptors, QEII Med Ctr, B Block, Perth, WA 6009, Australia.	kpfleger@waimr.uwa.edu.au	Pfleger, Kevin/H-5629-2014	Pfleger, Kevin/0000-0001-8261-9189	National Health and Medical Research Council of Australia [404087, 212064, 353709]; Australian postgraduate award; Australian Research Council [FT100100271]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian postgraduate award(Australian Government); Australian Research Council(Australian Research Council)	This work was supported in part by the National Health and Medical Research Council of Australia via Project Grant 404087 (to K. A. E. and K. D. G. P.) and Fellowships 212064 and 353709 (to K. A. E. and K. D. G. P., respectively).; Recipient of an Australian postgraduate award.; Australian Research Council Future Fellow supported by Grant FT100100271.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Berglund MM, 2003, J PHARMACOL EXP THER, V306, P147, DOI 10.1124/jpet.103.051227; Bhatnagar A, 2001, J BIOL CHEM, V276, P8269, DOI 10.1074/jbc.M006968200; Celver JP, 2001, J BIOL CHEM, V276, P4894, DOI 10.1074/jbc.M007437200; Cervantes D, 2010, CIRC RES, V106, P79, DOI 10.1161/CIRCRESAHA.109.198580; Charest PG, 2003, J BIOL CHEM, V278, P41541, DOI 10.1074/jbc.M306589200; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dikic I, 2009, NAT STRUCT MOL BIOL, V16, P1208, DOI 10.1038/nsmb1209-1209; Dromey Jasmin R., 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P51, DOI 10.2174/187153008783928352; Gehret AU, 2010, BIOCHEM J, V428, P235, DOI 10.1042/BJ20100139; Gray JA, 2003, MOL PHARMACOL, V63, P961, DOI 10.1124/mol.63.5.961; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hanyaloglu AC, 2001, J BIOL CHEM, V276, P18066, DOI 10.1074/jbc.M009275200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Heding A, 2000, ENDOCRINOLOGY, V141, P299, DOI 10.1210/en.141.1.299; Heinonen MV, 2008, ACTA PHYSIOL, V192, P471, DOI 10.1111/j.1748-1716.2008.01836.x; Hislop JN, 2011, TRAFFIC, V12, P137, DOI 10.1111/j.1600-0854.2010.01121.x; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Hislop JN, 2005, J MOL ENDOCRINOL, V35, P177, DOI 10.1677/jme.1.01809; Kocan M, 2008, J BIOMOL SCREEN, V13, P888, DOI 10.1177/1087057108324032; Kroeger KM, 2001, J BIOL CHEM, V276, P12736, DOI 10.1074/jbc.M011311200; Lee HJ, 2007, BIOCHEM J, V404, P141, DOI 10.1042/BJ20061826; Luttrell LM, 2002, J CELL SCI, V115, P455; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Milasta S, 2005, BIOCHEM J, V387, P573, DOI 10.1042/BJ20041745; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Pfleger KDG, 2007, BIOCHEM SOC T, V35, P764, DOI 10.1042/BST0350764; Pfleger KDG, 2006, CELL SIGNAL, V18, P1664, DOI 10.1016/j.cellsig.2006.01.004; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Ponimaskin E, 2005, MOL PHARMACOL, V67, P1434, DOI 10.1124/mol.104.008748; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Prossnitz ER, 2004, LIFE SCI, V75, P893, DOI 10.1016/j.lfs.2004.04.003; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rasmussen TN, 2004, EUR J BIOCHEM, V271, P4366, DOI 10.1111/j.1432-1033.2004.04371.x; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; See HB, 2011, ASSAY DRUG DEV TECHN, V9, P21, DOI 10.1089/adt.2010.0336; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Simaan M, 2005, CELL SIGNAL, V17, P1074, DOI 10.1016/j.cellsig.2004.12.001; Tang JY, 2008, CELL SIGNAL, V20, P1651, DOI 10.1016/j.cellsig.2008.05.010; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Torrecilla I, 2006, CURR PHARM DESIGN, V12, P1797, DOI 10.2174/138161206776873716; Tsujino N, 2009, PHARMACOL REV, V61, P162, DOI 10.1124/pr.109.001321; Tulipano G, 2004, J BIOL CHEM, V279, P21374, DOI 10.1074/jbc.M313522200; van Koppen CJ, 2004, MOL PHARMACOL, V66, P365, DOI 10.1124/mol.104.003822; Vrecl M, 1998, MOL ENDOCRINOL, V12, P1818, DOI 10.1210/me.12.12.1818; Werry TD, 2006, CURR PHARM DESIGN, V12, P1683, DOI 10.2174/138161206776873725	68	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16726	16733		10.1074/jbc.M111.223537	http://dx.doi.org/10.1074/jbc.M111.223537			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21378163	Green Published, hybrid			2022-12-27	WOS:000290301900020
J	Liao, BJ; Bao, XC; Liu, LQ; Feng, SP; Zovoilis, A; Liu, WB; Xue, YT; Cai, J; Guo, XP; Qin, BM; Zhang, RS; Wu, JY; Lai, LX; Teng, MK; Niu, LW; Zhang, BL; Esteban, MA; Pei, DQ				Liao, Baojian; Bao, Xichen; Liu, Longqi; Feng, Shipeng; Zovoilis, Athanasios; Liu, Wenbo; Xue, Yanting; Cai, Jie; Guo, Xiangpeng; Qin, Baoming; Zhang, Ruosi; Wu, Jiayan; Lai, Liangxue; Teng, Maikun; Niu, Liwen; Zhang, Biliang; Esteban, Miguel A.; Pei, Duanqing			MicroRNA Cluster 302-367 Enhances Somatic Cell Reprogramming by Accelerating a Mesenchymal-to-Epithelial Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; PLURIPOTENCY; DIFFERENTIATION; OCT4; ZEB1; SOX2; RNA	MicroRNAs (miRNAs) are emerging critical regulators of cell function that frequently reside in clusters throughout the genome. They influence a myriad of cell functions, including the generation of induced pluripotent stem cells, also termed reprogramming. Here, we have successfully delivered entire miRNA clusters into reprogramming fibroblasts using retroviral vectors. This strategy avoids caveats associated with transient transfection of chemically synthesized miRNA mimics. Overexpression of 2 miRNA clusters, 106a-363 and in particular 302-367, allowed potent increases in induced pluripotent stem cell generation efficiency in mouse fibroblasts using 3 exogenous factors (Sox2, Klf4, and Oct4). Pathway analysis highlighted potential relevant effectors, including mesenchymal-to-epithelial transition, cell cycle, and epigenetic regulators. Further study showed that miRNA cluster 302-367 targeted TGF beta receptor 2, promoted increased E-cadherin expression, and accelerated mesenchymal-to-epithelial changes necessary for colony formation. Our work thus provides an interesting alternative for improving reprogramming using miRNAs and adds new evidence for the emerging relationship between pluripotency and the epithelial phenotype.	[Liao, Baojian; Bao, Xichen; Liu, Longqi; Liu, Wenbo; Xue, Yanting; Cai, Jie; Guo, Xiangpeng; Qin, Baoming; Lai, Liangxue; Esteban, Miguel A.; Pei, Duanqing] Chinese Acad Sci, Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Bao, Xichen; Feng, Shipeng; Zhang, Biliang] Chinese Acad Sci, Lab RNA Chem Biol, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China; [Liao, Baojian; Bao, Xichen; Xue, Yanting; Teng, Maikun; Niu, Liwen] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Liao, Baojian; Bao, Xichen; Xue, Yanting; Teng, Maikun; Niu, Liwen] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Zovoilis, Athanasios] European Neurosci Inst Gottingen, D-37077 Gottingen, Germany; [Zhang, Ruosi; Wu, Jiayan] Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing 10029, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Esteban, MA (corresponding author), Chinese Acad Sci, Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China.	zhang_biliang@gibh.ac.cn; esteban@gibh.org	Lai, Liangxue/H-4545-2011; Liao, Baojian/AAI-6286-2021; Qin, Baoming/G-1553-2015	Qin, Baoming/0000-0001-7652-161X; Feng, Shipeng/0000-0002-3365-9990; Zovoilis, Athanasios/0000-0001-6425-0402; wu, jia yan/0000-0001-6048-405X	Ministry of Science and Technology 973 Program [2007CB948002, 2007CB947804, 2009CB941102, 2009CB940902, 2010CB944800, 2011CBA01106]; International Technology Cooperation Program [2010DFB30430]; Chinese Academy of Sciences [KSCX2-YW-R-221, KSCX2-YW-R-244, KSCX2-YW-R-086, KSCX2-YW-R-237]; Bureau of Science and Technology of Guangzhou Municipality [2007Z1-E4041'2008A1-E4011]	Ministry of Science and Technology 973 Program(National Basic Research Program of China); International Technology Cooperation Program; Chinese Academy of Sciences(Chinese Academy of Sciences); Bureau of Science and Technology of Guangzhou Municipality	This work was supported by Ministry of Science and Technology 973 Program Grants 2007CB948002, 2007CB947804, 2009CB941102, 2009CB940902, 2010CB944800, and 2011CBA01106 and International Technology Cooperation Program Grant 2010DFB30430; Chinese Academy of Sciences Grants KSCX2-YW-R-221, KSCX2-YW-R-244, KSCX2-YW-R-086, and KSCX2-YW-R-237; and Bureau of Science and Technology of Guangzhou Municipality Grant 2007Z1-E4041 ' 2008A1-E4011.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gunaratne PH, 2009, CURR STEM CELL RES T, V4, P168, DOI 10.2174/157488809789057400; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; van Wolfswinkel JC, 2010, J CELL SCI, V123, P1825, DOI 10.1242/jcs.061713; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038	20	198	222	1	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17359	17364		10.1074/jbc.C111.235960	http://dx.doi.org/10.1074/jbc.C111.235960			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454525	hybrid, Green Published			2022-12-27	WOS:000290301900083
J	Waters, LC; Strong, SL; Ferlemann, E; Oka, O; Muskett, FW; Veverka, V; Banerjee, S; Schmedt, T; Henry, AJ; Klempnauer, KH; Carr, MD				Waters, Lorna C.; Strong, Sarah L.; Ferlemann, Eva; Oka, Ojore; Muskett, Frederick W.; Veverka, Vaclav; Banerjee, Sreemoti; Schmedt, Thore; Henry, Alistair J.; Klempnauer, Karl-Heinz; Carr, Mark D.			Structure of the Tandem MA-3 Region of Pdcd4 Protein and Characterization of Its Interactions with eIF4A and eIF4G MOLECULAR MECHANISMS OF A TUMOR SUPPRESSOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC INITIATION-FACTORS; PROGRAMMED CELL-DEATH; FACTOR 4G EIF4G; TRANSLATION INITIATION; HELICASE ACTIVITY; INHIBITS TRANSLATION; CRYSTAL-STRUCTURE; MESSENGER-RNA; UP-REGULATION; CORE DOMAIN	One of the key regulatory points of translation initiation is recruitment of the 43S preinitation complex to the 5' mRNA cap by the eIF4F complex (eIF4A, eIF4E, and eIF4G). The tumor suppressor protein Pdcd4 has been shown to inhibit cap-dependent translation by interacting tightly with the RNA helicase eIF4A via its tandem MA-3 domains. The NMR studies reported here reveal a fairly extensive and well defined interface between the two MA-3 domains in solution, which appears to be stabilized by a network of interdomain salt bridges and hydrogen bonds, and reveals a unique orientation of the two domains. Characterization of the stoichiometry of the Pdcd4-eIF4A complex suggests that under physiological conditions Pdcd4 binds to a single molecule of eIF4A, which involves contacts with both Pdcd4 MA-3 domains. We also show that contacts mediated by a conserved acidic patch on the middle MA-3 domain of Pdcd4 are essential for forming a tight complex with eIF4A in vivo, whereas the equivalent region of the C-terminal MA-3 domain appears to have no role in complex formation in vivo. The formation of a 1: 1 eIF4A-Pdcd4 complex in solution is consistent with the reported presence in vivo of only one molecule of eIF4A in the eIF4F complex. Pdcd4 has also been reported to interact directly with the middle region of eIF4G, however, we were unable to obtain any evidence for even a weak, transient direct interaction.	[Waters, Lorna C.; Strong, Sarah L.; Oka, Ojore; Muskett, Frederick W.; Veverka, Vaclav] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Ferlemann, Eva; Schmedt, Thore; Klempnauer, Karl-Heinz] Univ Munster, Inst Biochem, D-48149 Munster, Germany; [Henry, Alistair J.] UCB Celltech, Res & Dev, Slough SL1 3WE, Berks, England	University of Leicester; University of Munster; Celltech Group Ltd	Waters, LC (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	lw83@le.ac.uk; mdc12@le.ac.uk	Veverka, Vaclav/G-9174-2014; Oka, Ojore/H-4456-2013; Veverka, Vaclav/P-5251-2019	Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Carr, Mark/0000-0002-3939-0996	Wellcome Trust [083629, 080085, 063632]; Wilhelm-Sander-Stiftung; Deutsche Krebshilfe	Wellcome Trust(Wellcome TrustEuropean Commission); Wilhelm-Sander-Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported Wellcome Trust Grants 083629, 080085, and 063632, the Wilhelm-Sander-Stiftung, and the Deutsche Krebshilfe.	ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826; Afonja O, 2004, ONCOGENE, V23, P8135, DOI 10.1038/sj.onc.1207983; Bitomsky N, 2008, ONCOGENE, V27, P4820, DOI 10.1038/onc.2008.115; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Bohm M, 2003, ONCOGENE, V22, P4905, DOI 10.1038/sj.onc.1206710; Boozer C, 2006, CURR OPIN BIOTECH, V17, P400, DOI 10.1016/j.copbio.2006.06.012; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Hilliard A, 2006, J IMMUNOL, V177, P8095, DOI 10.4049/jimmunol.177.11.8095; Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jansen AP, 2004, MOL CANCER THER, V3, P103; Kang MJ, 2002, BIOCHEM BIOPH RES CO, V293, P617, DOI 10.1016/S0006-291X(02)00264-4; Korneeva NL, 2001, J BIOL CHEM, V276, P2872, DOI 10.1074/jbc.M006345200; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; LaRonde-LeBlanc N, 2007, MOL CELL BIOL, V27, P147, DOI 10.1128/MCB.00867-06; Li W, 2001, J BIOL CHEM, V276, P29111, DOI 10.1074/jbc.C100284200; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Morino S, 2000, MOL CELL BIOL, V20, P468, DOI 10.1128/MCB.20.2.468-477.2000; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Nielsen K. H., 2011, NUCL ACIDS IN PRESS; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Ponting CP, 2000, TRENDS BIOCHEM SCI, V25, P423, DOI 10.1016/S0968-0004(00)01628-5; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Richter-Cook NJ, 1998, J BIOL CHEM, V273, P7579, DOI 10.1074/jbc.273.13.7579; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; Singh P, 2009, ONCOGENE, V28, P3758, DOI 10.1038/onc.2009.239; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Wang XY, 2008, ANTICANCER RES, V28, P2991; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; Waters L, 2006, J BIOL CHEM, V281, P14787, DOI 10.1074/jbc.M600237200; Waters LC, 2006, J BIOMOL NMR, V36, P18, DOI 10.1007/s10858-005-5887-6; Waters LC, 2010, BIOMOL NMR ASSIGN, V4, P49, DOI 10.1007/s12104-009-9205-1; Wedeken Lena, 2010, Genes Cancer, V1, P293, DOI 10.1177/1947601910364227; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634	53	24	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17270	17280		10.1074/jbc.M110.166157	http://dx.doi.org/10.1074/jbc.M110.166157			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454508	hybrid, Green Published			2022-12-27	WOS:000290301900075
J	Franklin, NE; Taylor, GS; Vacratsis, PO				Franklin, Norah E.; Taylor, Gregory S.; Vacratsis, Panayiotis O.			Endosomal Targeting of the Phosphoinositide 3-Phosphatase MTMR2 Is Regulated by an N-terminal Phosphorylation Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARIE-TOOTH-DISEASE; MYOTUBULARIN-RELATED PROTEIN-2; TUMOR-SUPPRESSOR; MASS-SPECTROMETRY; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; MEMBRANE TRAFFICKING; LIPID 2ND-MESSENGER; PDZ DOMAIN; PHOSPHATASE; PTEN	MTMR2 is a member of the myotubularin family of inositol lipid phosphatases, a large protein-tyrosine phosphatase subgroup that is conserved from yeast to humans. Furthermore, the peripheral neuromuscular disease Charcot-Marie Tooth disease type 4B has been attributed to mutations in the mtmr2 gene. Because the molecular mechanisms regulating MTMR2 have been poorly defined, we investigated whether reversible phosphorylation might regulate MTMR2 function. We used mass spectrometry-based methods to identify a high stoichiometry phosphorylation site on serine 58 of MTMR2. Phosphorylation at Ser(58), or a phosphomimetic S58E mutation, markedly decreased MTMR2 localization to endocytic vesicular structures. In contrast, a phosphorylation-deficient MTMR2 mutant (S58A) displayed constitutive localization to early endocytic structures. This localization pattern was accompanied by displacement of a PI(3) P-specific sensor protein and an increase in signal transduction pathways. Thus, MTMR2 phosphorylation is likely to be a critical mechanism by which MTMR2 access to its lipid substrate(s) is temporally and spatially regulated, thereby contributing to the control of downstream endosome maturation events.	[Franklin, Norah E.; Vacratsis, Panayiotis O.] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada; [Taylor, Gregory S.] Univ Nebraska, Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA	University of Windsor; University of Nebraska System; University of Nebraska Medical Center	Taylor, GS (corresponding author), Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada.	gstaylor@unmc.edu; vacratsi@uwindsor.ca			National Institutes of Health National Center for Research Resources; Canadian Institutes of Health Research (CIHR) [89870]	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported, in whole or in part, by a National Institutes of Health National Center for Research Resources grant to the Nebraska Center for Cellular Signaling (to G. S. T.) and Operating Grant 89870 from Canadian Institutes of Health Research (CIHR) (to P. O. V.).	Alexiou GA, 2010, NEUROL NEUROCHIR POL, V44, P80; Azzedine H, 2003, AM J HUM GENET, V72, P1141, DOI 10.1086/375034; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Begley MJ, 2003, MOL CELL, V12, P1391, DOI 10.1016/S1097-2765(03)00486-6; Berger P, 2003, P NATL ACAD SCI USA, V100, P12177, DOI 10.1073/pnas.2132732100; Birle D, 2002, J IMMUNOL, V169, P286, DOI 10.4049/jimmunol.169.1.286; Boersema PJ, 2009, J MASS SPECTROM, V44, P861, DOI 10.1002/jms.1599; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Cullen PJ, 2001, CURR BIOL, V11, pR882, DOI 10.1016/S0960-9822(01)00523-1; DAVENPORT KR, 1995, J BIOL CHEM, V270, P30157; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Downes CP, 2005, TRENDS CELL BIOL, V15, P259, DOI 10.1016/j.tcb.2005.03.008; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; GUAN KL, 1991, J BIOL CHEM, V266, P17026; Keough T, 2000, RAPID COMMUN MASS SP, V14, P2348, DOI 10.1002/1097-0231(20001230)14:24<2348::AID-RCM175>3.0.CO;2-8; Kim SA, 2003, P NATL ACAD SCI USA, V100, P4492, DOI 10.1073/pnas.0431052100; Kim SA, 2002, J BIOL CHEM, V277, P4526, DOI 10.1074/jbc.M111087200; Klemm C, 2006, J MASS SPECTROM, V41, P1623, DOI 10.1002/jms.1129; Laporte J, 2002, J CELL SCI, V115, P3105; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; LIN A, 1990, P NATL ACAD SCI USA, V87, P8565, DOI 10.1073/pnas.87.21.8565; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Merithew E, 2003, J BIOL CHEM, V278, P8494, DOI 10.1074/jbc.M211514200; Mochizuki Y, 2003, P NATL ACAD SCI USA, V100, P9768, DOI 10.1073/pnas.1333958100; Nandurkar HH, 2003, P NATL ACAD SCI USA, V100, P8660, DOI 10.1073/pnas.1033097100; Nicot AS, 2008, TRAFFIC, V9, P1240, DOI 10.1111/j.1600-0854.2008.00754.x; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Robinson FL, 2005, J BIOL CHEM, V280, P31699, DOI 10.1074/jbc.M505159200; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; Suter U, 2007, CELL MOL LIFE SCI, V64, P3261, DOI 10.1007/s00018-007-7381-7; Taylor Gregory S, 2004, Methods Mol Biol, V284, P217; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; TILLY BC, 1993, J BIOL CHEM, V268, P19919; Vacratsis PO, 2002, BIOCHEMISTRY-US, V41, P5613, DOI 10.1021/bi016075c; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vartak N, 2010, EMBO J, V29, P2689, DOI 10.1038/emboj.2010.184; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Xu DZ, 2010, J BIOL CHEM, V285, P39935, DOI 10.1074/jbc.M110.166462; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	49	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.209122	http://dx.doi.org/10.1074/jbc.M110.209122			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21372139	Green Published, hybrid			2022-12-27	WOS:000290022800025
J	Meissner, M; Weissgerber, P; Londono, JEC; Prenen, J; Link, S; Ruppenthal, S; Molkentin, JD; Lipp, P; Nilius, B; Freichel, M; Flockerzi, V				Meissner, Marcel; Weissgerber, Petra; Londono, Juan E. Camacho; Prenen, Jean; Link, Sabine; Ruppenthal, Sandra; Molkentin, Jeffery D.; Lipp, Peter; Nilius, Bernd; Freichel, Marc; Flockerzi, Veit			Moderate Calcium Channel Dysfunction in Adult Mice with Inducible Cardiomyocyte-specific Excision of the cacnb2 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT; CARDIAC DEVELOPMENT; CA2+ CHANNELS; HEART; HETEROGENEITY; EXPRESSION; PROTEIN; MODELS; BRAIN	The major L-type voltage-gated calcium channels in heart consist of an alpha 1C (Ca(V)1.2) subunit usually associated with an auxiliary beta subunit (Ca-V beta 2). In embryonic cardiomyocytes, both the complete and the cardiac myocyte-specific null mutant of Ca-V beta 2 resulted in reduction of L-type calcium currents by up to 75%, compromising heart function and causing defective remodeling of intra-and extra-embryonic blood vessels followed by embryonic death. Here we conditionally excised the Ca-V beta 2 gene (cacnb2) specifically in cardiac myocytes of adult mice (KO). Upon gene deletion, Ca-V beta 2 protein expression declined by > 96% in isolated cardiac myocytes and by > 74% in protein fractions from heart. These latter protein fractions include Ca-V beta 2 proteins expressed in cardiac fibroblasts. Surprisingly, mice did not show any obvious impairment, although cacnb2 excision was not compensated by expression of other Ca-V beta proteins or changes of Ca(V)1.2 protein levels. Calcium currents were still dihydropyridine-sensitive, but current density at 0 mV was reduced by < 29%. The voltage for half-maximal activation was slightly shifted to more depolarized potentials in KO cardiomyocytes when compared with control cells, but the difference was not significant. In summary, Ca-V beta 2 appears to be a much stronger modulator of L-type calcium currents in embryonic than in adult cardiomyocytes. Although essential for embryonic survival, Ca-V beta 2 down-regulation in cardiomyocytes is well tolerated by the adult mice.	[Meissner, Marcel; Weissgerber, Petra; Londono, Juan E. Camacho; Link, Sabine; Ruppenthal, Sandra; Lipp, Peter; Freichel, Marc; Flockerzi, Veit] Univ Saarland, D-66421 Homburg, Germany; [Prenen, Jean; Nilius, Bernd] Katholieke Univ Leuven, Dept Mol Celbiol, Lab Ionenkanaalonderzoek, B-3000 Louvain, Belgium; [Molkentin, Jeffery D.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA	Saarland University; KU Leuven; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Flockerzi, V (corresponding author), Univ Saarland, Gebaude 46, D-66421 Homburg, Germany.	veit.flockerzi@uks.eu		Camacho Londono, Juan E./0000-0003-0673-7583; Molkentin, Jeffery/0000-0002-3558-6529	Interuniversity Attraction Poles Programme Belgian State - Belgian Science Policy [P6/28]; Research Council of the KU Leuven [GOA 2004/07]; Flemish Government [EF/95/010]; Deutsche Forschungsgemeinschaft [SFB530, KFO196, GK 1326, SFB894]; Homburger Forschungsforderungsprogramm HOMFOR; Forschungskommission der Universitaet des Saarlandes	Interuniversity Attraction Poles Programme Belgian State - Belgian Science Policy(Belgian Federal Science Policy Office); Research Council of the KU Leuven(KU Leuven); Flemish Government(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Homburger Forschungsforderungsprogramm HOMFOR; Forschungskommission der Universitaet des Saarlandes	This work was supported by Interuniversity Attraction Poles Programme Belgian State - Belgian Science Policy, P6/28, the Research Council of the KU Leuven (Grant GOA 2004/07), the Flemish Government (Excellentiefinanciering, Grant EF/95/010) (to B. N. and J. P.), the Deutsche Forschungsgemeinschaft (Grants SFB530, KFO196, and GK 1326 (to P. L., M. F., and V. F.), Grant SFB894 (to P. W., M. F., and V. F.), the Homburger Forschungsforderungsprogramm HOMFOR (P. L., M. M., P. W., M. F., and V. F.), and the Forschungskommission der Universitaet des Saarlandes (P. L., M. F., and V. F.).	Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Berggren PO, 2004, CELL, V119, P273, DOI 10.1016/j.cell.2004.09.033; BERROW NS, 1995, J PHYSIOL-LONDON, V482, P481, DOI 10.1113/jphysiol.1995.sp020534; Canti C, 2001, BIOPHYS J, V81, P1439, DOI 10.1016/S0006-3495(01)75799-2; Catalucci D, 2009, J CELL BIOL, V184, P923, DOI 10.1083/jcb.200805063; Cingolani E, 2007, CIRC RES, V101, P166, DOI 10.1161/CIRCRESAHA.107.155721; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; DROOGMANS G, 1989, J PHYSIOL-LONDON, V419, P627, DOI 10.1113/jphysiol.1989.sp017890; Droogmans G., 1997, WINASCD; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; Jaleel N, 2008, CIRC RES, V103, P1109, DOI 10.1161/CIRCRESAHA.108.185611; Link S, 2009, J BIOL CHEM, V284, P30129, DOI 10.1074/jbc.M109.045583; Murakami M, 2002, J BIOL CHEM, V277, P40342, DOI 10.1074/jbc.M203425200; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Obermair GJ, 2008, CURR OPIN PHARMACOL, V8, P311, DOI 10.1016/j.coph.2008.01.008; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Striessnig J, 2008, CHANNELS, V2, P233, DOI 10.4161/chan.2.4.5847; Takahashi SX, 2003, BIOPHYS J, V84, P3007, DOI 10.1016/S0006-3495(03)70027-7; Verrou C, 1999, BIOL CHEM, V380, P1435, DOI 10.1515/BC.1999.184; Wei S, 2000, CIRC RES, V86, P175, DOI 10.1161/01.RES.86.2.175; Weissgerber P, 2006, CIRC RES, V99, P749, DOI 10.1161/01.RES.0000243978.15182.c1	24	36	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.227819	http://dx.doi.org/10.1074/jbc.M111.227819			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21357697	Green Published, hybrid			2022-12-27	WOS:000290022800028
J	Sun, RL; Zhang, Y; Lv, QS; Liu, B; Jin, M; Zhang, WJ; He, Q; Deng, MJ; Liu, XT; Li, GC; Li, YH; Zhou, GH; Xie, PL; Xie, XM; Hu, JY; Duan, ZJ				Sun, Ruili; Zhang, Yu; Lv, Qingshan; Liu, Bei; Jin, Miao; Zhang, Weijia; He, Qing; Deng, Minjie; Liu, Xueting; Li, Guancheng; Li, Yuehui; Zhou, Guohua; Xie, Pingli; Xie, Xiumei; Hu, Jinyue; Duan, Zhaojun			Toll-like Receptor 3 (TLR3) Induces Apoptosis via Death Receptors and Mitochondria by Up-regulating the Transactivating p63 Isoform alpha (TAP63 alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; NEGATIVE REGULATION; CANCER-CELLS; P53 HOMOLOG; RECOGNITION; VIRUS; ACTIVATION; INTERFERON; INFECTION	Toll-like receptor 3 (TLR3), a member of the pathogen recognition receptors, is widely expressed in various cells and has been shown to activate immune signaling pathways by recognizing viral double-stranded RNA. Recently, it was reported that the activation of TLR3 induced apoptosis in some cells, but the detailed molecular mechanism is not fully understood. In this study, we found that in endothelial cells polyinosinic-polycytidylic acid (poly(I-C)) induced dose-and time-dependent cell apoptosis, which was elicited by TLR3 activation, as TLR3 neutralization and down-regulation repressed the apoptosis. Poly(I-C) induced the activation of both caspases 8 and 9, indicating that TLR3 triggered the signaling of both the extrinsic and intrinsic apoptotic pathways. Poly(I-C) up-regulated tumor necrosis factor-related apoptosis-inducing ligand and its receptors, death receptors 4/5, resulting in initiating the extrinsic pathway. Furthermore, poly(I-C) down-regulated anti-apoptotic protein, B cell lymphoma 2 (Bcl-2), and up-regulated Noxa, a key Bcl-2 homology 3-only antagonist of Bcl-2, leading to the priming of the intrinsic pathway. A p53-related protein, the transactivating p63 isoform alpha (TAp63 alpha), was induced by TLR3 activation and contributed to the activation of both the intrinsic and extrinsic apoptotic pathways. Both the cells deficient in p63 gene expression by RNA interference and cells that overexpressed the N-terminally truncated p63 isoform alpha (Delta Np63 alpha), a dominant-negative variant of TAp63 alpha, by gene transfection, survived TLR3 activation. Taken together, TAp63 alpha is a crucial regulator downstream of TLR3 to induce cell death via death receptors and mitochondria.	[Sun, Ruili; He, Qing; Deng, Minjie; Liu, Xueting; Hu, Jinyue] Wuhan Univ, Cent Lab, Renmin Hosp, Wuhan 430060, Peoples R China; [Zhang, Yu; Zhang, Weijia; Li, Guancheng; Li, Yuehui; Zhou, Guohua; Xie, Pingli; Hu, Jinyue] Cent S Univ, Canc Res Inst, Changsha 410078, Hunan, Peoples R China; [Sun, Ruili] XinXiang Med Univ, Dept Lab Med, Xinxiang 453003, Peoples R China; [Lv, Qingshan; Xie, Xiumei] Cent S Univ, Dept Geriatr Cardiol, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Liu, Bei] Wuhan Univ Sci & Technol, Dept Pathol, Affiliated Tianyou Hosp, Wuhan 430064, Peoples R China; [Jin, Miao; Duan, Zhaojun] China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing 100052, Peoples R China	Wuhan University; Central South University; Xinxiang Medical University; Central South University; Wuhan University of Science & Technology; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Hu, JY (corresponding author), Wuhan Univ, Cent Lab, Renmin Hosp, 99 Ziyang Rd, Wuhan 430060, Peoples R China.	jinyuehu@whu.edu.cn; zhaojund@126.com	Lyu, Qingshan/AAE-1924-2019		State Key Laboratory for Molecular Virology and Genetic Engineering, China [2008-K-0002]	State Key Laboratory for Molecular Virology and Genetic Engineering, China	The work was supported in part by the Opening Project of State Key Laboratory for Molecular Virology and Genetic Engineering Grant 2008-K-0002, China.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dogusan Z, 2008, DIABETES, V57, P1236, DOI 10.2337/db07-0844; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gifford SM, 2004, J ENDOCRINOL, V182, P485, DOI 10.1677/joe.0.1820485; Gowen BB, 2006, J IMMUNOL, V177, P6301, DOI 10.4049/jimmunol.177.9.6301; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hutchens M, 2008, J IMMUNOL, V180, P483, DOI 10.4049/jimmunol.180.1.483; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kaiser WJ, 2004, J IMMUNOL, V172, P1699, DOI 10.4049/jimmunol.172.3.1699; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kemp TJ, 2005, BLOOD, V106, P3474, DOI 10.1182/blood-2005-03-1327; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; Paone A, 2008, CARCINOGENESIS, V29, P1334, DOI 10.1093/carcin/bgn149; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Ruckdeschel K, 2004, J IMMUNOL, V173, P3320, DOI 10.4049/jimmunol.173.5.3320; Salaun B, 2007, CLIN CANCER RES, V13, P4565, DOI 10.1158/1078-0432.CCR-07-0274; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sun YP, 2005, J BIOL CHEM, V280, P15561, DOI 10.1074/jbc.m412630200; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Weber A, 2010, CELL DEATH DIFFER, V17, P942, DOI 10.1038/cdd.2009.190; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhao BX, 2006, EMBO J, V25, P5703, DOI 10.1038/sj.emboj.7601435	42	89	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.178798	http://dx.doi.org/10.1074/jbc.M110.178798			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21367858	hybrid, Green Published			2022-12-27	WOS:000290022800032
J	Cappell, SD; Dohlman, HG				Cappell, Steven D.; Dohlman, Henrik G.			Selective Regulation of MAP Kinase Signaling by an Endomembrane Phosphatidylinositol 4-Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PHEROMONE RESPONSE PATHWAY; G-BETA-GAMMA; G-PROTEIN SUBUNITS; FILAMENTOUS GROWTH; PLASMA-MEMBRANE; ADAPTER PROTEIN; TRANSDUCTION PATHWAY; SCAFFOLD PROTEIN; BINDING DOMAINS	Multiple MAP kinase pathways share components yet initiate distinct biological processes. Signaling fidelity can be maintained by scaffold proteins and restriction of signaling complexes to discreet subcellular locations. For example, the yeast MAP kinase scaffold Ste5 binds to phospholipids produced at the plasma membrane and promotes selective MAP kinase activation. Here we show that Pik1, a phosphatidylinositol 4-kinase that localizes primarily to the Golgi, also regulates MAP kinase specificity but does so independently of Ste5. Pik1 is required for full activation of the MAP kinases Fus3 and Hog1 and represses activation of Kss1. Further, we show by genetic epistasis analysis that Pik1 likely regulates Ste11 and Ste50, components shared by all three MAP kinase pathways, through their interaction with the scaffold protein Opy2. These findings reveal a new regulator of signaling specificity functioning at endomembranes rather than at the plasma membrane.	[Dohlman, Henrik G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Cappell, Steven D.; Dohlman, Henrik G.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu	Cappell, Steven/O-4072-2018	Cappell, Steven/0000-0002-2885-7327; Dohlman, Henrik/0000-0003-2443-0729	National Institutes of Health [R01 GM059167, GM080739]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059167, R01GM080739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM059167 and GM080739.	Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cappell SD, 2010, MOL CELL, V38, P746, DOI 10.1016/j.molcel.2010.05.026; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; CHOI KY, 1994, CELL, V78, P499; COLE GM, 1990, MOL CELL BIOL, V10, P510, DOI 10.1128/MCB.10.2.510; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DORER R, 1995, J CELL BIOL, V131, P845, DOI 10.1083/jcb.131.4.845; Edwards MC, 1997, GENETICS, V147, P1063; Elion EA, 2001, J CELL SCI, V114, P3967; Erdman S, 2001, GENETICS, V159, P919; Galperin E, 2008, TRAFFIC, V9, P1776, DOI 10.1111/j.1600-0854.2008.00788.x; Garrenton LS, 2006, GENE DEV, V20, P1946, DOI 10.1101/gad.1413706; Garrenton LS, 2010, P NATL ACAD SCI USA, V107, P11805, DOI 10.1073/pnas.1005817107; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Hao N, 2008, J BIOL CHEM, V283, P33798, DOI 10.1074/jbc.C800179200; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Hirschman JE, 1999, MOL CELL BIOL, V19, P7705; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Homma K, 1998, J BIOL CHEM, V273, P15779, DOI 10.1074/jbc.273.25.15779; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; MARCUS S, 1994, P NATL ACAD SCI USA, V91, P7762, DOI 10.1073/pnas.91.16.7762; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; NOMOTO S, 1990, EMBO J, V9, P691, DOI 10.1002/j.1460-2075.1990.tb08161.x; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Posas F, 1998, MOL CELL BIOL, V18, P5788, DOI 10.1128/MCB.18.10.5788; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; RAD MR, 1992, MOL GEN GENET, V236, P145; Rad MR, 1998, MOL GEN GENET, V259, P29, DOI 10.1007/s004380050785; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; STEVENSON BJ, 1992, GENE DEV, V6, P1293, DOI 10.1101/gad.6.7.1293; STONE DE, 1991, GENE DEV, V5, P1969, DOI 10.1101/gad.5.11.1969; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Takahashi S, 2007, MOL BIOL CELL, V18, P4945, DOI 10.1091/mbc.E07-07-0676; Tatebayashi K, 2006, EMBO J, V25, P3033, DOI 10.1038/sj.emboj.7601192; Truckses DM, 2006, MOL CELL BIOL, V26, P912, DOI 10.1128/MCB.26.3.912-928.2006; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; van Drogen F, 2001, NAT CELL BIOL, V3, P1051, DOI 10.1038/ncb1201-1051; WHITEWAY M, 1990, MOL CELL BIOL, V10, P217, DOI 10.1128/MCB.10.1.217; Wild AC, 2004, J BIOL CHEM, V279, P17101, DOI 10.1074/jbc.M314035200; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Wu CL, 1999, MOL BIOL CELL, V10, P2425, DOI 10.1091/mbc.10.7.2425; Wu CL, 2006, GENE DEV, V20, P734, DOI 10.1101/gad.1375706; Xu G, 1996, MOL MICROBIOL, V20, P773, DOI 10.1111/j.1365-2958.1996.tb02516.x; Yamamoto K, 2010, MOL CELL, V40, P87, DOI 10.1016/j.molcel.2010.09.011; Yang HY, 2009, EMBO J, V28, P1380, DOI 10.1038/emboj.2009.104; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	65	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14852	14860		10.1074/jbc.M110.195073	http://dx.doi.org/10.1074/jbc.M110.195073			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21388955	Green Published, hybrid			2022-12-27	WOS:000289788300015
J	Chen, S; Barbieri, JT				Chen, Sheng; Barbieri, Joseph T.			Association of Botulinum Neurotoxin Serotype A Light Chain with Plasma Membrane-bound SNAP-25	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE RECOGNITION; ENDOPLASMIC-RETICULUM; PSEUDOMONAS EXOTOXIN; TOXIN; LOCALIZATION; TRANSLOCATION; RESIDUES; COMPLEX; SYSTEM; TRAFFICKING	The Clostridium botulinum neurotoxins (BoNTs) cleave SNARE proteins, which inhibit binding and thus fusion of neurotransmitter vesicles to the plasma membrane of peripheral neurons. BoNTs comprise an N-terminal light chain (LC) and C-terminal heavy chain, which are linked by a disulfide bond. There are seven serotypes (A-G) of BoNTs based upon immunological neutralization. Although the binding and entry of BoNT/A into neurons has been subjected to considerable investigation, the intracellular events that allow BoNT/A to efficiently cleave SNAP-25 within neurons is less well understood. Earlier studies showed that intracellular LC/A bound to the plasma membrane of neurons. In this study, intracellular LC/A is shown to directly bind SNAP-25 on the plasma membrane. Solid phase binding showed that the N-terminal residues of LC/A bound residues 80-110 of SNAP-25, which was also observed in cultured neurons. Association of the N-terminal 8 amino acids of LC/A and residues 80-110 of SNAP-25 also enhanced substrate cleavage. These findings explain how LC/A associates with SNAP-25 on the plasma membrane and provide a basis for LC/A cleavage of SNAP-25 within the SNARE complex.	[Chen, Sheng] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hung Hom Kowloon, Hong Kong, Peoples R China; [Barbieri, Joseph T.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Hong Kong Polytechnic University; Medical College of Wisconsin	Barbieri, JT (corresponding author), 8701 Watertown Plank Rd,Microbiol & Mol Genet BSB, Milwaukee, WI 53226 USA.	jtb01@mcw.edu		Chen, Sheng/0000-0003-3526-7808	National Institutes of Health through the Great Lakes Regional Center of Excellence [U54 AI057153]; Hong Kong PolyU Competitive Research Grant for Newly Recruited Junior Academic Staff [G-YH87]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	National Institutes of Health through the Great Lakes Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong PolyU Competitive Research Grant for Newly Recruited Junior Academic Staff; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant U54 AI057153 through the Great Lakes Regional Center of Excellence (to J.T.B.).; Supported by Hong Kong PolyU Competitive Research Grant for Newly Recruited Junior Academic Staff (Grant G-YH87).	Agarwal R, 2005, BIOCHEMISTRY-US, V44, P8291, DOI 10.1021/bi050253a; Bajohrs M, 2004, EMBO REP, V5, P1090, DOI 10.1038/sj.embor.7400278; Baldwin MR, 2007, BIOCHEMISTRY-US, V46, P3200, DOI 10.1021/bi602396x; Bhidayasiri Roongroj, 2006, Expert Rev Neurother, V6, P863, DOI 10.1586/14737175.6.6.863; Binz T, 2002, BIOCHEMISTRY-US, V41, P1717, DOI 10.1021/bi0157969; Bossi P, 2003, PRESSE MED, V32, P463; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Carruthers A, 2008, Skin Therapy Lett, V13, P1; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; Chen S, 2007, J BIOL CHEM, V282, P9621, DOI 10.1074/jbc.M611211200; Dolly JO, 2006, EUR J NEUROL, V13, P1, DOI 10.1111/j.1468-1331.2006.01648.x; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Fernandez-Salas E, 2004, MOVEMENT DISORD, V19, pS23, DOI 10.1002/mds.20006; Fernandez-Salas E, 2004, P NATL ACAD SCI USA, V101, P3208, DOI 10.1073/pnas.0400229101; Fischer A, 2007, J BIOL CHEM, V282, P29604, DOI 10.1074/jbc.M703619200; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Iglesias-Bartolome R, 2009, BBA-BIOMEMBRANES, V1788, P2526, DOI 10.1016/j.bbamem.2009.09.018; Jackson ME, 1999, J CELL SCI, V112, P467; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Josko Deborah, 2004, Clin Lab Sci, V17, P30; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Mahajan ST, 2007, AM J OBSTET GYNECOL, V196, P7, DOI 10.1016/j.ajog.2006.03.108; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; Perez-Branguli F, 1999, FEBS LETT, V458, P60, DOI 10.1016/S0014-5793(99)01120-5; Rossetto O, 2002, CURR PROBL DERMATOL, V30, P117; Salinas S, 2010, NAT REV MICROBIOL, V8, P645, DOI 10.1038/nrmicro2395; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Smith DC, 2006, TRAFFIC, V7, P379, DOI 10.1111/j.1600-0854.2006.00391.x; Spooner RA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-26; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tsai YC, 2010, P NATL ACAD SCI USA, V107, P16554, DOI 10.1073/pnas.1008302107; Turton K, 2002, TRENDS BIOCHEM SCI, V27, P552, DOI 10.1016/S0968-0004(02)02177-1; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; Walchli S, 2008, MOL BIOL CELL, V19, P95, DOI 10.1091/mbc.E07-06-0565; Wang JF, 2011, J BIOL CHEM, V286, P6375, DOI 10.1074/jbc.M110.181784; Washbourne P, 2001, BIOCHEM J, V357, P625, DOI 10.1042/0264-6021:3570625; Watson P, 2006, ADV DRUG DELIVER REV, V58, P1581, DOI 10.1016/j.addr.2006.09.016; Zhang Y, 2007, CELL MICROBIOL, V9, P2192, DOI 10.1111/j.1462-5822.2007.00949.x; Zhang Y, 2007, J BIOL CHEM, V282, P13022, DOI 10.1074/jbc.M606305200	42	35	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15067	15072		10.1074/jbc.M111.224493	http://dx.doi.org/10.1074/jbc.M111.224493			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21378164	Green Published, hybrid			2022-12-27	WOS:000289788300037
J	Kilaru, A; Herrfurth, C; Keereetaweep, J; Hornung, E; Venables, BJ; Feussner, I; Chapman, KD				Kilaru, Aruna; Herrfurth, Cornelia; Keereetaweep, Jantana; Hornung, Ellen; Venables, Barney J.; Feussner, Ivo; Chapman, Kent D.			Lipoxygenase-mediated Oxidation of Polyunsaturated N-Acylethanolamines in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID AMIDE HYDROLASE; 9-LIPOXYGENASE PATHWAY; CANNABINOID RECEPTOR; THALIANA SEEDLINGS; ROOT DEVELOPMENT; ANANDAMIDE; METABOLISM; ENDOCANNABINOIDS; OXYLIPINS; SUBSTRATE	N-Acylethanolamines (NAEs) are bioactive fatty acid derivatives that occur in all eukaryotes. In plants, NAEs have potent negative growth-regulating properties, and fatty acid amide hydrolase (FAAH)-mediated hydrolysis is a primary catabolic pathway that operates during seedling establishment to deplete these compounds. Alternatively, polyunsaturated (PU)-NAEs may serve as substrates for lipid oxidation. In Arabidopsis, PU-NAEs (NAE 18: 2 and NAE 18: 3) were the most abundant NAE species in seeds, and their levels were depleted during seedling growth even in FAAH tDNA knock-out plants. Therefore, we hypothesized that lipoxygenase (LOX) participated in the metabolism of PU-NAEs through the formation of NAE-oxylipins. Comprehensive chromatographic and mass spectrometric methods were developed to identify NAE hydroperoxides and -hydroxides. Recombinant Arabidopsis LOX enzymes expressed in Escherichia coli utilized NAE 18: 2 and NAE 18: 3 as substrates with AtLOX1 and AtLOX5 exhibiting 9-LOX activity and AtLOX2, AtLOX3, AtLOX4, and AtLOX6 showing predominantly 13-LOX activity. Feeding experiments with exogenous PU-NAEs showed they were converted to hydroxide metabolites indicating that indeed Arabidopsis seedlings had the capacity for LOX-mediated metabolism of PU-NAEs in planta. Detectable levels of endogenous NAE-oxylipin metabolites were identified in FAAH fatty acid amide hydrolase seedlings but not in wild-type or FAAH overexpressors, suggesting that NAE hydroxide pools normally do not accumulate unless flux through hydrolysis is substantially reduced. These data suggest that Arabidopsis LOXs indeed compete with FAAH to metabolize PU-NAEs during seedling establishment. Identification of endogenous amide-conjugated oxylipins suggests potential significance of these metabolites in vivo, and FAAH mutants may offer opportunities to address this in the future.	[Kilaru, Aruna; Keereetaweep, Jantana; Venables, Barney J.; Chapman, Kent D.] Univ N Texas, Dept Biol Sci, Ctr Plant Lipid Res, Denton, TX 76203 USA; [Herrfurth, Cornelia; Hornung, Ellen; Feussner, Ivo] Univ Gottingen, Dept Plant Biochem, Albrecht von Haller Inst Plant Sci, D-37077 Gottingen, Germany	University of North Texas System; University of North Texas Denton; University of Gottingen	Kilaru, A (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	akilaru@msu.edu	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003; Keereetaweep, Jantana/0000-0001-8314-9289; Chapman, Kent/0000-0003-0489-3072	United States Department of Energy, Office of Energy Biosciences [DE-FG02-05ER15647]	United States Department of Energy, Office of Energy Biosciences(United States Department of Energy (DOE))	This work was supported by United States Department of Energy, Office of Energy Biosciences, Grant DE-FG02-05ER15647.	Bannenberg G, 2009, LIPIDS, V44, P85, DOI 10.1007/s11745-008-3245-7; Berger S, 2001, BBA-MOL CELL BIOL L, V1533, P266, DOI 10.1016/S1388-1981(01)00161-5; Blancaflor EB, 2003, PLANTA, V217, P206, DOI 10.1007/s00425-003-0985-8; Blee E, 1998, PROG LIPID RES, V37, P33, DOI 10.1016/S0163-7827(98)00004-6; Bradshaw HB, 2009, VITAM HORM, V81, P191, DOI 10.1016/S0083-6729(09)81008-X; Buseman CM, 2006, PLANT PHYSIOL, V142, P28, DOI 10.1104/pp.106.082115; Chapman KD, 1999, PLANT PHYSIOL, V120, P1157, DOI 10.1104/pp.120.4.1157; Chapman KD, 2004, PROG LIPID RES, V43, P302, DOI 10.1016/j.plipres.2004.03.002; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; De Petrocellis L, 2010, J NEUROIMMUNE PHARM, V5, P103, DOI 10.1007/s11481-009-9177-z; De Petrocellis L, 2009, BEST PRACT RES CL EN, V23, P1, DOI 10.1016/j.beem.2008.10.013; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2009, PHARMACOL RES, V60, P77, DOI 10.1016/j.phrs.2009.02.010; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Fonseca S, 2009, CURR OPIN PLANT BIOL, V12, P539, DOI 10.1016/j.pbi.2009.07.013; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Gfeller A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3109cm3; Glaser ST, 2010, J PHARMACOL EXP THER, V335, P380, DOI 10.1124/jpet.110.168831; Gobel C, 2001, J BIOL CHEM, V276, P6267, DOI 10.1074/jbc.M008606200; Hanus LO, 2007, CHEM BIODIVERS, V4, P1828, DOI 10.1002/cbdv.200790154; Kang L, 2008, PLANT J, V56, P336, DOI 10.1111/j.1365-313X.2008.03603.x; Keereetaweep J, 2010, FEBS LETT, V584, P3215, DOI 10.1016/j.febslet.2010.06.008; Kilaru A, 2007, CHEM BIODIVERS, V4, P1933, DOI 10.1002/cbdv.200790161; Kim SC, 2010, PLANT SCI, V178, P411, DOI 10.1016/j.plantsci.2010.02.017; Kim SC, 2009, J BIOL CHEM, V284, P34065, DOI 10.1074/jbc.M109.059022; Kozak KR, 2002, PROSTAG LEUKOTR ESS, V66, P211, DOI 10.1054/plef.2001.0359; Kozak KR, 2004, CURR PHARM DESIGN, V10, P659, DOI 10.2174/1381612043453081; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Motes CM, 2005, PROTOPLASMA, V226, P109, DOI 10.1007/s00709-005-0124-4; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Pappan K, 1998, ARCH BIOCHEM BIOPHYS, V353, P131, DOI 10.1006/abbi.1998.0640; Petrosino S, 2009, CURR OPIN CHEM BIOL, V13, P309, DOI 10.1016/j.cbpa.2009.04.616; Schmid HHO, 2000, CHEM PHYS LIPIDS, V108, P71, DOI 10.1016/S0009-3084(00)00188-2; Shrestha R, 2003, J BIOL CHEM, V278, P34990, DOI 10.1074/jbc.M305613200; Shrestha R, 2002, PLANT PHYSIOL, V130, P391, DOI 10.1104/pp.004689; Shrestha R, 2006, BBA-MOL CELL BIOL L, V1761, P324, DOI 10.1016/j.bbalip.2006.03.004; Snider NT, 2008, J PHARMACOL EXP THER, V327, P538, DOI 10.1124/jpet.108.141796; Snider NT, 2010, PHARMACOL REV, V62, P136, DOI 10.1124/pr.109.001081; Snider NT, 2009, MOL PHARMACOL, V75, P965, DOI 10.1124/mol.108.053439; Teaster ND, 2007, PLANT CELL, V19, P2454, DOI 10.1105/tpc.106.048702; van der Stelt M, 2000, EUR J BIOCHEM, V267, P2000, DOI 10.1046/j.1432-1327.2000.01203.x; van Zadelhoff G, 1998, BIOCHEM BIOPH RES CO, V248, P33, DOI 10.1006/bbrc.1998.8910; vanderStelt M, 1997, FEBS LETT, V411, P287, DOI 10.1016/S0014-5793(97)00718-7; Vellosillo T, 2007, PLANT CELL, V19, P831, DOI 10.1105/tpc.106.046052; Venables BJ, 2005, PHYTOCHEMISTRY, V66, P1913, DOI 10.1016/j.phytochem.2005.06.014; Wang YS, 2006, P NATL ACAD SCI USA, V103, P12197, DOI 10.1073/pnas.0603571103; Weichert H, 1999, FEBS LETT, V464, P133, DOI 10.1016/S0014-5793(99)01697-X; Woodward DF, 2008, PHARMACOL THERAPEUT, V120, P71, DOI 10.1016/j.pharmthera.2008.08.001; Woodward DF, 2008, BRIT J PHARMACOL, V153, P410, DOI 10.1038/sj.bjp.0707434	50	24	24	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15205	15214		10.1074/jbc.M110.217588	http://dx.doi.org/10.1074/jbc.M110.217588			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21372125	Green Published, hybrid			2022-12-27	WOS:000289788300052
J	Zhou, WB; Bercury, K; Cummiskey, J; Luong, N; Lebin, J; Freed, CR				Zhou, Wenbo; Bercury, Kathryn; Cummiskey, Jessica; Luong, Nancy; Lebin, Jacob; Freed, Curt R.			Phenylbutyrate Up-regulates the DJ-1 Protein and Protects Neurons in Cell Culture and in Animal Models of Parkinson Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-SYNUCLEIN; TRANSGENIC MOUSE MODEL; SODIUM PHENYLBUTYRATE; CHEMICAL CHAPERONES; LEWY BODIES; IN-VITRO; GENE; EXPRESSION; AGGREGATION; MUTATIONS	Parkinson disease is caused by the death of midbrain dopamine neurons from oxidative stress, abnormal protein aggregation, and genetic predisposition. In 2003, Bonifati et al. (23) found that a single amino acid mutation in the DJ-1 protein was associated with early-onset, autosomal recessive Parkinson disease (PARK7). The mutation L166P prevents dimerization that is essential for the antioxidant and gene regulatory activity of the DJ-1 protein. Because low levels of DJ-1 cause Parkinson, we reasoned that overexpression might stop the disease. We found that overexpression of DJ-1 improved tolerance to oxidative stress by selectively up-regulating the rate-limiting step in glutathione synthesis. When we imposed a different metabolic insult, A53T mutant alpha-synuclein, we found that DJ-1 turned on production of the chaperone protein Hsp-70 without affecting glutathione synthesis. After screening a number of small molecules, we have found that the histone deacetylase inhibitor phenylbutyrate increases DJ-1 expression by 300% in the N27 dopamine cell line and rescues cells from oxidative stress and mutant alpha-synuclein toxicity. In mice, phenylbutyrate treatment leads to a 260% increase in brain DJ-1 levels and protects dopamine neurons against 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine (MPTP) toxicity. In a transgenic mouse model of diffuse Lewy body disease, long-term administration of phenylbutyrate reduces alpha-synuclein aggregation in brain and prevents age-related deterioration in motor and cognitive function. We conclude that drugs that up-regulate DJ-1 gene expression may slow the progression of Parkinson disease by moderating oxidative stress and protein aggregation.	[Zhou, Wenbo; Freed, Curt R.] Univ Colorado Denver, Sch Med, Div Clin Pharmacol & Toxicol, Dept Med, Aurora, CO 80045 USA; [Zhou, Wenbo; Freed, Curt R.] Univ Colorado Denver, Sch Med, Div Clin Pharmacol & Toxicol, Dept Pharmacol, Aurora, CO 80045 USA; [Zhou, Wenbo; Freed, Curt R.] Univ Colorado Denver, Sch Med, Div Clin Pharmacol & Toxicol, Dept Neurol, Aurora, CO 80045 USA; [Zhou, Wenbo; Freed, Curt R.] Univ Colorado Denver, Sch Med, Div Clin Pharmacol & Toxicol, Dept Neurosurg, Aurora, CO 80045 USA; [Zhou, Wenbo; Bercury, Kathryn; Freed, Curt R.] Univ Colorado Denver, Sch Med, Neurosci Program, Aurora, CO 80045 USA; [Cummiskey, Jessica; Freed, Curt R.] Univ Colorado Denver, Sch Med, Human Med Genet Program, Aurora, CO 80045 USA; [Luong, Nancy; Freed, Curt R.] Univ Colorado Denver, Sch Med, Program Biomed Sci, Aurora, CO 80045 USA; [Lebin, Jacob] Univ Colorado, Biochem Program, Boulder, CO 80309 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder	Freed, CR (corresponding author), Univ Colorado Denver, Sch Med, Div Clin Pharmacol & Toxicol, Dept Med, Mailstop C-237,12700 E 19th Ave, Aurora, CO 80045 USA.	curt.freed@ucdenver.edu			Parkinson Disease Foundation	Parkinson Disease Foundation	This work was supported by Charles and Joanne Ackerman, the Leopold Korn and Michael Korn Professorship in Parkinson Disease at the University of Colorado School of Medicine, and the Parkinson Disease Foundation.	Adams FS, 1996, NEUROCHEM RES, V21, P619, DOI 10.1007/BF02527762; Allam MF, 2005, NEUROL RES, V27, P206, DOI 10.1179/016164105X22057; Andreassi C, 2004, EUR J HUM GENET, V12, P59, DOI 10.1038/sj.ejhg.5201102; Baba M, 1998, AM J PATHOL, V152, P879; Bonifati V, 2005, Minerva Med, V96, P175; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brahe C, 2005, EUR J HUM GENET, V13, P256, DOI 10.1038/sj.ejhg.5201320; Brown RC, 2005, ENVIRON HEALTH PERSP, V113, P1250, DOI 10.1289/ehp.7567; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Clark LN, 2004, MOVEMENT DISORD, V19, P796, DOI 10.1002/mds.20131; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Cudkowicz ME, 2009, AMYOTROPH LATERAL SC, V10, P99, DOI 10.1080/17482960802320487; da Costa CA, 2002, J BIOL CHEM, V277, P50980, DOI 10.1074/jbc.M207825200; Gardian G, 2004, NEUROMOL MED, V5, P235, DOI 10.1385/NMM:5:3:235; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Gondcaille C, 2005, J CELL BIOL, V169, P93, DOI 10.1083/jcb.200501036; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Hashimoto M, 2003, ANN NY ACAD SCI, V991, P171; Hogarth P, 2007, MOVEMENT DISORD, V22, P1962, DOI 10.1002/mds.21632; Huang Y, 2004, BRAIN RES REV, V46, P44, DOI 10.1016/j.brainresrev.2004.04.007; Ibanez P, 2003, NEUROLOGY, V61, P1429, DOI 10.1212/01.WNL.0000094121.48373.FD; Inden M, 2007, J NEUROCHEM, V101, P1491, DOI 10.1111/j.1471-4159.2006.04440.x; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Kaul S, 2005, MOL BRAIN RES, V139, P137, DOI 10.1016/j.molbrainres.2005.05.022; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kim S, 2006, BIOCHEM BIOPH RES CO, V342, P1168, DOI 10.1016/j.bbrc.2006.02.081; Kim YH, 2004, CARCINOGENESIS, V25, P1813, DOI 10.1093/carcin/bgh188; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; Morris HR, 2005, ANN MED, V37, P86, DOI 10.1080/07853890510007269; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Ono K, 2009, PARKINSONISM RELAT D, V15, P649, DOI 10.1016/j.parkreldis.2009.03.002; Papp E, 2006, HANDB EXP PHARM, V172, P405; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Taira T, 2001, GENE, V263, P285, DOI 10.1016/S0378-1119(00)00590-4; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Tremolizzo L, 2005, AMYOTROPH LATERAL SC, V6, P185, DOI 10.1080/14660820510033614; Trojanowski JQ, 1998, ARCH NEUROL-CHICAGO, V55, P151, DOI 10.1001/archneur.55.2.151; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Yam GHT, 2007, INVEST OPHTH VIS SCI, V48, P1683, DOI 10.1167/iovs.06-0943; Ying MY, 2006, J BIOL CHEM, V281, P12580, DOI 10.1074/jbc.M511677200; Yokota T, 2004, ONCOGENE, V23, P5340, DOI 10.1038/sj.onc.1207689; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200; Zhou WB, 2004, J BIOL CHEM, V279, P10128, DOI 10.1074/jbc.M307563200; Zhou WB, 2002, BRAIN RES, V926, P42, DOI 10.1016/S0006-8993(01)03292-9; Zhou W, 2008, J BIOL CHEM, V283, P9863, DOI 10.1074/jbc.M710232200	58	114	119	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14941	14951		10.1074/jbc.M110.211029	http://dx.doi.org/10.1074/jbc.M110.211029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21372141	Green Published, hybrid			2022-12-27	WOS:000289788300024
J	Kodama, T; Takehara, T; Hikita, H; Shimizu, S; Shigekawa, M; Li, W; Miyagi, T; Hosui, A; Tatsumi, T; Ishida, H; Kanto, T; Hiramatsu, N; Yin, XM; Hayashi, N				Kodama, Takahiro; Takehara, Tetsuo; Hikita, Hayato; Shimizu, Satoshi; Shigekawa, Minoru; Li, Wei; Miyagi, Takuya; Hosui, Atsushi; Tatsumi, Tomohide; Ishida, Hisashi; Kanto, Tatsuya; Hiramatsu, Naoki; Yin, Xiao-Ming; Hayashi, Norio			BH3-only Activator Proteins Bid and Bim Are Dispensable for Bak/Bax-dependent Thrombocyte Apoptosis Induced by Bcl-xL Deficiency MOLECULAR REQUISITES FOR THE MITOCHONDRIAL PATHWAY TO APOPTOSIS IN PLATELETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PERMEABILIZATION; BH3 DOMAINS; CELL-DEATH; BAX; FAMILY; MICE; MCL-1; LIVER; LIFE; DISRUPTION	A pivotal step in the mitochondrial pathway of apoptosis is activation of Bak and Bax, although the molecular mechanism remains controversial. To examine whether mitochondrial apoptosis can be induced by just a lack of antiapoptotic Bcl-2-like proteins or requires direct activators of the BH3-only proteins including Bid and Bim, we studied the molecular requisites for platelet apoptosis induced by Bcl-xL deficiency. Severe thrombocytopenia induced by thrombocyte-specific Bcl-xL knock-out was fully rescued in a Bak and Bax double knock-out background but not with single knock-out of either one. In sharp contrast, deficiency of either Bid, Bim, or both did not alleviate thrombocytopenia in Bcl-xL knock-out mice. An in vitro study revealed that ABT-737, a Bad mimetic, induced platelet apoptosis in association with a conformational change of the amino terminus, translocation from the cytosol to mitochondria, and homo-oligomerization of Bax. ABT-737-induced Bax activation and apoptosis were also observed in Bid/Bim-deficient platelets. Human platelets, upon storage, underwent spontaneous apoptosis with a gradual decline of Bcl-xL expression despite a decrease in Bid and Bim expression. Apoptosis was attenuated in Bak/Bax-deficient or Bcl-xL-overexpressing platelets but not in Bid/Bim-deficient platelets upon storage. In conclusion, platelet lifespan is regulated by a fine balance between anti-and proapoptotic multidomain Bcl-2 family proteins. Despite residing in platelets, BH3-only activator proteins Bid and Bim are dispensable for Bax activation and mitochondrial apoptosis.	[Kodama, Takahiro; Takehara, Tetsuo; Hikita, Hayato; Shimizu, Satoshi; Shigekawa, Minoru; Li, Wei; Miyagi, Takuya; Hosui, Atsushi; Tatsumi, Tomohide; Ishida, Hisashi; Kanto, Tatsuya; Hiramatsu, Naoki] Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Yin, Xiao-Ming] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Hayashi, Norio] Kansai Rosai Hosp, Amagasaki, Hyogo 6608511, Japan	Osaka University; Indiana University System; Indiana University-Purdue University Indianapolis; Kansai Rosai Hospital	Takehara, T (corresponding author), Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takehara@gh.med.osaka-u.ac.jp	Kodama, Takahiro/AAW-9605-2021; Hosui, Atsushi/AAC-1771-2020	Kodama, Takahiro/0000-0002-6250-1324; Hosui, Atsushi/0000-0003-0777-8045				Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; AULT KA, 1995, EXP HEMATOL, V23, P996; Bertino AM, 2003, TRANSFUSION, V43, P857, DOI 10.1046/j.1537-2995.2003.t01-4-00431.x; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Chaiyarit S, 2009, ANAL BIOCHEM, V394, P249, DOI 10.1016/j.ab.2009.07.026; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Dzhagalov I, 2008, J IMMUNOL, V181, P521, DOI 10.4049/jimmunol.181.1.521; FEINSTEIN MB, 1975, J GEN PHYSIOL, V66, P561, DOI 10.1085/jgp.66.5.561; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; Hamasaki A, 1998, J EXP MED, V188, P1985, DOI 10.1084/jem.188.11.1985; Hikita H, 2009, HEPATOLOGY, V50, P1972, DOI 10.1002/hep.23207; Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126; HOLMSEN H, 1989, ANN MED, V21, P23, DOI 10.3109/07853898909149178; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Jabbour AM, 2009, CELL DEATH DIFFER, V16, P555, DOI 10.1038/cdd.2008.179; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kodama T, 2010, GASTROENTEROLOGY, V138, P2487, DOI 10.1053/j.gastro.2010.02.054; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li JZ, 2000, TRANSFUSION, V40, P1320, DOI 10.1046/j.1537-2995.2000.40111320.x; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Perrotta PL, 2003, TRANSFUSION, V43, P526, DOI 10.1046/j.1537-2995.2003.00349.x; Print CG, 1998, P NATL ACAD SCI USA, V95, P12424, DOI 10.1073/pnas.95.21.12424; Ross AJ, 1998, NAT GENET, V18, P251, DOI 10.1038/ng0398-251; Takehara T, 2003, CANCER RES, V63, P3054; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Vanags DM, 1997, BRIT J HAEMATOL, V99, P824, DOI 10.1046/j.1365-2141.1997.4813284.x; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Yamagata H, 2009, ONCOGENE, V28, P3563, DOI 10.1038/onc.2009.213; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zhang H, 2007, CELL DEATH DIFFER, V14, P943, DOI 10.1038/sj.cdd.4402081	44	68	71	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13905	13913		10.1074/jbc.M110.195370	http://dx.doi.org/10.1074/jbc.M110.195370			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21367852	hybrid, Green Published			2022-12-27	WOS:000289556200013
J	Lee, DE; Lee, KW; Byun, S; Jung, SK; Song, N; Lim, SH; Heo, YS; Kim, JE; Kang, NJ; Kim, BY; Bowden, GT; Bode, AM; Lee, HJ; Dong, Z				Lee, Dong Eun; Lee, Ki Won; Byun, Sanguine; Jung, Sung Keun; Song, Nury; Lim, Sung Hwan; Heo, Yong-Seok; Kim, Jong Eun; Kang, Nam Joo; Kim, Bo Yeon; Bowden, G. Tim; Bode, Ann M.; Lee, Hyong Joo; Dong, Zigang			7,3 ',4 '-Trihydroxyisoflavone, a Metabolite of the Soy Isoflavone Daidzein, Suppresses Ultraviolet B-induced Skin Cancer by Targeting Cot and MKK4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE KINASE; MOUSE SKIN; OXIDATIVE-METABOLISM; COX-2 EXPRESSION; IN-VITRO; ACTIVATION; CARCINOGENESIS; GENISTEIN; PHOSPHORYLATION; PHYTOESTROGENS	Nonmelanoma skin cancer is one of the most frequently occurring cancers in the United States. Chronic exposure to UVB irradiation is a major cause of this cancer. Daidzein, along with genistein, is a major isoflavone found in soybeans; however, little is known about the chemopreventive effects of daidzein and its metabolites in UVB-induced skin cancer. Here, we found that 7,3',4'-trihydroxyisoflavone (THIF), a major metabolite of daidzein, effectively inhibits UVB-induced cyclooxygenase 2 (COX-2) expression through the inhibition of NF-kappa B transcription activity in mouse skin epidermal JB6 P+ cells. In contrast, daidzein had no effect on COX-2 expression levels. Data from Western blot and kinase assays showed that 7,3',4'-THIF inhibited Cot and MKK4 activity, thereby suppressing UVB-induced phosphorylation of mitogen-activated protein kinases. Pull-down assays indicated that 7,3',4' -THIF competed with ATP to inhibit Cot or MKK4 activity. Topical application of 7,3',4'-THIF clearly suppressed the incidence and multiplicity of UVB-induced tumors in hairless mouse skin. Hairless mouse skin results also showed that 7,3',4'-THIF inhibits Cot or MKK4 kinase activity directly, resulting in suppressed UVB-induced COX-2 expression. A docking study revealed that 7,3',4'-THIF, but not daidzein, easily docked to the ATP binding site of Cot and MKK4, which is located between the N-and C-lobes of the kinase domain. Collectively, these results provide insight into the biological actions of 7,3',4'-THIF, a potential skin cancer chemopreventive agent.	[Lee, Dong Eun; Lee, Ki Won; Byun, Sanguine; Jung, Sung Keun; Song, Nury; Kim, Jong Eun; Bode, Ann M.; Dong, Zigang] Seoul Natl Univ, Food Sci & Biotechnol Program, Seoul 151921, South Korea; [Lee, Dong Eun; Byun, Sanguine; Jung, Sung Keun; Song, Nury; Kim, Jong Eun] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Heo, Yong-Seok] Konkuk Univ, Dept Chem, Seoul 143701, South Korea; [Kang, Nam Joo] Kyungpook Natl Univ, Sch Food Sci & Biotechnol, Coll Agr & Life Sci, Taegu 702701, South Korea; [Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol, Choongbuk 363883, South Korea; [Bowden, G. Tim] Univ Arizona, Ctr Canc, Tucson, AZ 85724 USA	Seoul National University (SNU); University of Minnesota System; Konkuk University; Kyungpook National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Arizona	Lee, HJ (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151742, South Korea.	leehyjo@snu.ac.kr; zgdong@hi.umn.edu	Byun, Sanguine/AAR-5451-2021; kim, jong-eun/B-3550-2017; Heo, Yong-Seok/D-8244-2011; Lee, Ki Won/M-4114-2018	kim, jong-eun/0000-0002-5030-6126; Byun, Sanguine/0000-0003-3903-5887	Hormel Foundation; National Institutes of Health [CA077646, CA027502, CA111536, CA120388, R37CA081064, ES016548]; World Class University [R31-2008-00-10056-0]; World Class Institute [2009-0093824]; Leap Research Program [2010-0029233]; National Research Foundation of Korea [2009-0090797]; NATIONAL CANCER INSTITUTE [P01CA027502, R01CA120388, R37CA081064, R01CA111536, R01CA077646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Class University; World Class Institute; Leap Research Program; National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported, in whole or in part, by The Hormel Foundation and National Institutes of Health Grants CA077646, CA027502, CA111536, CA120388, R37CA081064, and ES016548. This work was also supported by World Class University Program Grant R31-2008-00-10056-0, World Class Institute Program Grant 2009-0093824, Leap Research Program Grant 2010-0029233, and Basic Science Research Program Grant 2009-0090797 through the National Research Foundation of Korea.	Athar M, 2001, BIOCHEM BIOPH RES CO, V280, P1042, DOI 10.1006/bbrc.2000.4201; Babu G, 2006, J BIOL CHEM, V281, P14041, DOI 10.1074/jbc.M512375200; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Buckman SY, 1998, CARCINOGENESIS, V19, P723, DOI 10.1093/carcin/19.5.723; Chen N, 2008, PHOTOCHEM PHOTOBIOL, V84, P1551, DOI 10.1111/j.1751-1097.2008.00383.x; Choi HS, 2008, FASEB J, V22, P113, DOI 10.1096/fj.07-9078com; Cuenda A, 2000, INT J BIOCHEM CELL B, V32, P581, DOI 10.1016/S1357-2725(00)00003-0; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Jung SK, 2008, CANCER RES, V68, P6021, DOI 10.1158/0008-5472.CAN-08-0899; Kang NJ, 2008, J BIOL CHEM, V283, P20664, DOI 10.1074/jbc.M800263200; Katiyar SK, 1997, JNCI-J NATL CANCER I, V89, P556, DOI 10.1093/jnci/89.8.556; Krcova Z, 2008, BIOMED PAP, V152, P21, DOI 10.5507/bp.2008.003; Kulling SE, 2000, J AGR FOOD CHEM, V48, P4963, DOI 10.1021/jf000524i; Kulling SE, 2002, J CHROMATOGR B, V777, P211, DOI 10.1016/S1570-0232(02)00215-5; Kulling SE, 2001, J AGR FOOD CHEM, V49, P3024, DOI 10.1021/jf0012695; Lee HJ, 2009, PHYTOTHER RES, V23, P399, DOI 10.1002/ptr.2640; Mantena SK, 2006, FREE RADICAL BIO MED, V40, P1603, DOI 10.1016/j.freeradbiomed.2005.12.032; Marwaha V, 2005, J BIOL CHEM, V280, P32379, DOI 10.1074/jbc.M503245200; Moore JO, 2006, CARCINOGENESIS, V27, P1627, DOI 10.1093/carcin/bgi367; Muller-Decker K, 2007, MOL CARCINOGEN, V46, P705, DOI 10.1002/mc.20326; Muller-Decker K, 2002, P NATL ACAD SCI USA, V99, P12483, DOI 10.1073/pnas.192323799; Ouyang WM, 2007, ENVIRON HEALTH PERSP, V115, P513, DOI 10.1289/ehp.9588; Rundhaug JE, 2008, PHOTOCHEM PHOTOBIOL, V84, P322, DOI 10.1111/j.1751-1097.2007.00261.x; Stafford MJ, 2006, FEBS LETT, V580, P4010, DOI 10.1016/j.febslet.2006.06.004; Tiano HF, 2002, CANCER RES, V62, P3395; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Wittwer T, 2008, BIOCHEM BIOPH RES CO, V371, P294, DOI 10.1016/j.bbrc.2008.04.069; Yaomura T, 2008, NEPHROLOGY, V13, P397, DOI 10.1111/j.1440-1797.2008.00959.x	31	54	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14246	14256		10.1074/jbc.M110.147348	http://dx.doi.org/10.1074/jbc.M110.147348			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21378167	Green Published, hybrid			2022-12-27	WOS:000289556200048
J	de la Pena, FA; Kanasaki, K; Kanasaki, M; Tangirala, N; Maeda, G; Kalluri, R				de la Pena, Francisco Ayala; Kanasaki, Keizo; Kanasaki, Megumi; Tangirala, Neelima; Maeda, Genta; Kalluri, Raghu			Loss of p53 and Acquisition of Angiogenic MicroRNA Profile Are Insufficient to Facilitate Progression of Bladder Urothelial Carcinoma in Situ to Invasive Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITIONAL-CELL CARCINOMA; ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; MESENCHYMAL TRANSITION; CANCER; EXPRESSION; METASTASIS; VEGF; IDENTIFICATION; TUMORIGENESIS	Activation of oncogenes or inactivation of tumor suppressors in urothelium is considered critical for development of urothelial cancer. Here we report cloning of the urothelium-specific promoter uroplakin-II (UPK II) and generation of transgenic mice in which expression of SV40 large T antigen is driven by UPKII promoter. Inactivation of tumor suppressor p53 and pRb in urothelium by SV40 T antigen resulted in urothelial carcinoma, resembling human high-grade carcinoma in situ. Specific deletion of p53 in urothelial cells using the newly generated UPK II-Cre mice results in normal bladders without any evidence of cancer. The high-grade carcinoma in situ in the UPK II-SV40 mice is associated with significant activation of angiogenic signals consisting of hypoxia-inducible factor-1 alpha (HIF-1 alpha) and VEGF and a down-regulation of thrombospondin-1. Interestingly, such pro-angiogenic activity was not associated with progression to invasive cancer. Analysis of bladder-associated microRNAs in carcinoma in situ lesions reveals a pro-angiogenic profile, with specific overexpression of miR-18a and miR-19a and down-regulation of miR-107. A group of microRNAs (miRs) identified as associated with invasive human urothelial cancer remained unchanged in this mouse model. Collectively, our results support the notion that activation of angiogenesis and loss of p53 are not sufficient for progression to invasive cancer. Our studies identify a new mouse model for bladder cancer that can be used to study factors that determine progression to an invasive phenotype of bladder cancer.	[de la Pena, Francisco Ayala; Kanasaki, Keizo; Kanasaki, Megumi; Tangirala, Neelima; Maeda, Genta; Kalluri, Raghu] Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA; [Kalluri, Raghu] Harvard Univ, Sch Med, Harvard Mit Div Hlth Sci & Technol, Boston, MA 02215 USA; [Kalluri, Raghu] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kalluri, R (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA.	rkalluri@bidmc.harvard.edu	Ayala, Francisco/C-5280-2011; Kalluri, Raghu/E-2677-2015	Ayala, Francisco/0000-0001-6311-920X; Kalluri, Raghu/0000-0002-2190-547X	National Institutes of Health [DK62987, DK55001, AA13913, DK61688, CA125550]; Champalimaud Metastasis Program; Department of Medicine for the Division of Matrix Biology at Beth Israel Deaconess Medical Center; Ministry of Health, Spain; Health Service (SMS) from the Comunidad Autonoma of Murcia, Spain; NATIONAL CANCER INSTITUTE [R01CA125550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061688, R01DK055001, R01DK062987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Champalimaud Metastasis Program; Department of Medicine for the Division of Matrix Biology at Beth Israel Deaconess Medical Center; Ministry of Health, Spain(Spanish Government); Health Service (SMS) from the Comunidad Autonoma of Murcia, Spain; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK62987, DK55001, AA13913, DK61688, and CA125550 (to R. K.), the Champalimaud Metastasis Program, and funds from the Department of Medicine for the Division of Matrix Biology at Beth Israel Deaconess Medical Center.; Supported by Grant BAE-90057 from the Health Research Fund (FIS), Ministry of Health, Spain, and by the Health Service (SMS) from the Comunidad Autonoma of Murcia, Spain.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bochner BH, 1997, CLIN CANCER RES, V3, P1615; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Catalano A, 2002, ONCOGENE, V21, P2896, DOI 10.1038/sj.onc.1205382; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng J, 2003, CANCER RES, V63, P179; Cordon-Cardo C, 2008, SCAND J UROL NEPHROL, V42, P154, DOI 10.1080/03008880802291915; Crew JP, 1999, J UROLOGY, V161, P799, DOI 10.1016/S0022-5347(01)61772-5; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; Fauconnet S, 2009, ONCOL REP, V21, P1495, DOI 10.3892/or_00000380; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; Gao J, 2004, ONCOGENE, V23, P687, DOI 10.1038/sj.onc.1207169; Grossfeld GD, 1997, J NATL CANCER I, V89, P219, DOI 10.1093/jnci/89.3.219; He F, 2009, CANCER RES, V69, P9413, DOI 10.1158/0008-5472.CAN-09-2158; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Ioachim E, 2006, UROL INT, V77, P255, DOI 10.1159/000094819; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Izawa JI, 2001, ONCOL REP, V8, P9; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson Aimee M, 2008, BMC Urol, V8, P7, DOI 10.1186/1471-2490-8-7; Jones A, 2001, CLIN CANCER RES, V7, P1263; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Mitra AP, 2006, J CLIN ONCOL, V24, P5552, DOI 10.1200/JCO.2006.08.2073; Mo L, 2005, AM J PHYSIOL-RENAL, V289, pF562, DOI 10.1152/ajprenal.00368.2004; Neely LA, 2010, UROL ONCOL-SEMIN ORI, V28, P39, DOI 10.1016/j.urolonc.2008.06.006; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Ostenfeld MS, 2010, ONCOGENE, V29, P1073, DOI 10.1038/onc.2009.395; Palit V, 2005, ONCOL REP, V14, P909; Pasin Erik, 2008, Rev Urol, V10, P31; Puzio-Kuter AM, 2009, GENE DEV, V23, P675, DOI 10.1101/gad.1772909; Sagol O, 2001, UROLOGY, V57, P895, DOI 10.1016/S0090-4295(01)00905-0; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stavropoulos NE, 2004, INT UROL NEPHROL, V36, P163, DOI 10.1023/B:UROL.0000034676.50636.e0; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Turner KJ, 2002, BRIT J CANCER, V86, P1276, DOI 10.1038/sj.bjc.6600215; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Zhang ZT, 1999, CANCER RES, V59, P3512	52	52	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20778	20787		10.1074/jbc.M110.198069	http://dx.doi.org/10.1074/jbc.M110.198069			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21388952	hybrid, Green Published			2022-12-27	WOS:000291267600063
J	Wu, EY; Beese, LS				Wu, Eugene Y.; Beese, Lorena S.			The Structure of a High Fidelity DNA Polymerase Bound to a Mismatched Nucleotide Reveals an "Ajar" Intermediate Conformation in the Nucleotide Selection Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I KLENOW FRAGMENT; CRYSTAL-STRUCTURE; TERNARY COMPLEXES; ACTIVE-SITE; REPLICATION; FAMILY; BYPASS; BETA	To achieve accurate DNA synthesis, DNA polymerases must rapidly sample and discriminate against incorrect nucleotides. Here we report the crystal structure of a high fidelity DNA polymerase I bound to DNA primer-template caught in the act of binding a mismatched (dG: dTTP) nucleoside triphosphate. The polymerase adopts a conformation in between the previously established "open" and "closed" states. In this "ajar" conformation, the template base has moved into the insertion site but misaligns an incorrect nucleotide relative to the primer terminus. The displacement of a conserved active site tyrosine in the insertion site by the template base is accommodated by a distinctive kink in the polymerase O helix, resulting in a partially open ternary complex. We suggest that the ajar conformation allows the template to probe incoming nucleotides for complementarity before closure of the enzyme around the substrate. Based on solution fluorescence, kinetics, and crystallographic analyses of wild-type and mutant polymerases reported here, we present a three-state reaction pathway in which nucleotides either pass through this intermediate conformation to the closed conformation and catalysis or are misaligned within the intermediate, leading to destabilization of the closed conformation.	[Wu, Eugene Y.; Beese, Lorena S.] DUMC, Dept Biochem, Durham, NC 27710 USA	Duke University	Beese, LS (corresponding author), DUMC, Dept Biochem, Box 3711, Durham, NC 27710 USA.	lb12@duke.edu	Classen, Scott/AAY-8176-2020; Wu, Eugene Y/K-5677-2015	Wu, Eugene Y/0000-0002-5189-7036	National Institutes of Health [5 P01 CA92584, R01 GM91487]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM091487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 P01 CA92584 and R01 GM91487 (to L. S. B.).	Arana ME, 2008, NUCLEIC ACIDS RES, V36, P3847, DOI 10.1093/nar/gkn310; Astatke M, 1998, J MOL BIOL, V278, P147, DOI 10.1006/jmbi.1998.1672; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Bell JB, 1997, J BIOL CHEM, V272, P7345, DOI 10.1074/jbc.272.11.7345; Bermek O, 2011, J BIOL CHEM, V286, P3755, DOI 10.1074/jbc.M110.167593; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Florian J, 2005, P NATL ACAD SCI USA, V102, P6819, DOI 10.1073/pnas.0408173102; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Gerstein M, 2001, INT TABLES CRYSTALLO, V22, P531; Golosov AA, 2010, STRUCTURE, V18, P83, DOI 10.1016/j.str.2009.10.014; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kiefer JR, 1997, STRUCTURE, V5, P95, DOI 10.1016/S0969-2126(97)00169-X; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Li Y, 1998, PROTEIN SCI, V7, P1116, DOI 10.1002/pro.5560070505; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200; Maga G, 2002, J MOL BIOL, V319, P359, DOI 10.1016/S0022-2836(02)00325-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206; Rothwell PJ, 2007, J BIOL CHEM, V282, P28884, DOI 10.1074/jbc.M704824200; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; TABOR S, 1995, P NATL ACAD SCI USA, V92, P6339, DOI 10.1073/pnas.92.14.6339; Takata K, 2006, J BIOL CHEM, V281, P23445, DOI 10.1074/jbc.M604317200; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103	40	78	79	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19758	19767		10.1074/jbc.M110.191130	http://dx.doi.org/10.1074/jbc.M110.191130			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21454515	hybrid, Green Published			2022-12-27	WOS:000291027700058
J	Dixit, A; Ray, K; Lakowicz, JR; Black, LW				Dixit, Aparna; Ray, Krishanu; Lakowicz, Joseph R.; Black, Lindsay W.			Dynamics of the T4 Bacteriophage DNA Packasome Motor ENDONUCLEASE VII RESOLVASE RELEASE OF ARRESTED Y-DNA SUBSTRATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PACKAGING MOTOR; PORTAL PROTEIN; GENE-20 PRODUCT; BACTERIOPHAGE-T4; FLUORESCENCE; TERMINASE; PHAGE-T4; TRANSLOCATION; SPECTROSCOPY; MECHANISM	Conserved bacteriophage ATP-based DNA translocation motors consist of a multimeric packaging terminase docked onto a unique procapsid vertex containing a portal ring. DNA is translocated into the empty procapsid through the portal ring channel to high density. In vivo the T4 phage packaging motor deals with Y- or X-structures in the replicative concatemer substrate by employing a portal-bound Holliday junction resolvase that trims and releases these DNA roadblocks to packaging. Here using dye-labeled packaging anchored 3.7-kb Y-DNAs or linear DNAs, we demonstrate FRET between the dye-labeled substrates and GFP portal-containing procapsids and between GFP portal and single dye-labeled terminases. We show using FRET-fluorescence correlation spectroscopy that purified T4 gp49 endonuclease VII resolvase can release DNA compression in vitro in prohead portal packaging motor anchored and arrested Y-DNA substrates. In addition, using active terminases labeled at the N- and C-terminal ends with a single dye molecule, we show by FRET distance of the N-terminal GFP-labeled portal protein containing prohead at 6.9 nm from the N terminus and at 5.7 nm from the C terminus of the terminase. Packaging with a C-terminal fluorescent terminase on a GFP portal prohead, FRET shows a reduction in distance to the GFP portal of 0.6 nm in the arrested Y-DNA as compared with linear DNA; the reduction is reversed by resolvase treatment. Conformational changes in both the motor proteins and the DNA substrate itself that are associated with the power stroke of the motor are consistent with a proposed linear motor employing a terminal-to-portal DNA grip-and-release mechanism.	[Dixit, Aparna; Ray, Krishanu; Lakowicz, Joseph R.; Black, Lindsay W.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Ray, Krishanu; Lakowicz, Joseph R.] Univ Maryland, Sch Med, Ctr Fluorescence Spect, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Black, LW (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	lblack@umaryland.edu			National Institutes of Health [AI11676, HG002655, K25AI087968]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI011676, R37AI011676, K25AI087968, R21AI011676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI11676 (to L. W. B.), HG002655 (to J. R. L.), and K25AI087968 (to K. R.).	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Baumann RG, 2003, J BIOL CHEM, V278, P4618, DOI 10.1074/jbc.M208574200; Baumann RG, 2006, MOL MICROBIOL, V61, P16, DOI 10.1111/j.1365-2958.2006.05203.x; Black LW, 2006, J BIOL CHEM, V281, P25635, DOI 10.1074/jbc.M602093200; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Black LW, 1993, MOL BIOL BACTERIOPHA; Cuervo A, 2007, J BIOL CHEM, V282, P18907, DOI 10.1074/jbc.M701808200; DRIEDONKS RA, 1983, J MOL BIOL, V166, P341, DOI 10.1016/S0022-2836(83)80089-8; DRIEDONKS RA, 1981, J MOL BIOL, V152, P641, DOI 10.1016/0022-2836(81)90121-2; Duckworth BP, 2007, CHEMBIOCHEM, V8, P98, DOI 10.1002/cbic.200600340; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; Golz S, 1999, J MOL BIOL, V285, P1131, DOI 10.1006/jmbi.1998.2399; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P4779, DOI 10.1073/pnas.75.10.4779; Hugel T, 2007, PLOS BIOL, V5, P558, DOI 10.1371/journal.pbio.0050059; JENSCH F, 1986, EMBO J, V5, P181, DOI 10.1002/j.1460-2075.1986.tb04194.x; Johnson JE, 2007, CURR OPIN STRUC BIOL, V17, P237, DOI 10.1016/j.sbi.2007.03.011; Kainov DE, 2006, CELL MOL LIFE SCI, V63, P1095, DOI 10.1007/s00018-005-5450-3; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE; Lebedev AA, 2007, EMBO J, V26, P1984, DOI 10.1038/sj.emboj.7601643; Lin HC, 1999, J MOL BIOL, V289, P249, DOI 10.1006/jmbi.1999.2781; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Oram M, 2008, J MOL BIOL, V381, P61, DOI 10.1016/j.jmb.2008.05.074; POTTMEYER S, 1992, J MOL BIOL, V223, P607, DOI 10.1016/0022-2836(92)90977-R; RAO VB, 1985, J MOL BIOL, V185, P565, DOI 10.1016/0022-2836(85)90072-5; Rao VB, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-356; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Ray K, 2010, VIROLOGY, V398, P224, DOI 10.1016/j.virol.2009.11.047; Ray K, 2009, VIROLOGY, V391, P44, DOI 10.1016/j.virol.2009.05.029; Rickgauer JP, 2008, BIOPHYS J, V94, P159, DOI 10.1529/biophysj.107.104612; Sabanayagam CR, 2007, BIOPHYS J, V93, pL17, DOI 10.1529/biophysj.107.111526; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Sheaffer AK, 2001, J VIROL, V75, P687, DOI 10.1128/JVI.75.2.687-698.2001; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015	35	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18878	18889		10.1074/jbc.M111.222828	http://dx.doi.org/10.1074/jbc.M111.222828			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454482	Green Published, hybrid			2022-12-27	WOS:000290785700060
J	Hernandez-Varas, P; Colo, GP; Bartolome, RA; Paterson, A; Medrano-Fernandez, I; Arellano-Sanchez, N; Cabanas, C; Sanchez-Mateos, P; Lafuente, EM; Boussiotis, VA; Stromblad, S; Teixido, J				Hernandez-Varas, Pablo; Colo, Georgina P.; Bartolome, Ruben A.; Paterson, Andrew; Medrano-Fernandez, Iria; Arellano-Sanchez, Nohem; Cabanas, Carlos; Sanchez-Mateos, Paloma; Lafuente, Esther M.; Boussiotis, Vassiliki A.; Stromblad, Staffan; Teixido, Joaquin			Rap1-GTP-interacting Adaptor Molecule (RIAM) Protein Controls Invasion and Growth of Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE; INTEGRIN ACTIVATION; MIGRATION; ADHESION; RAP1; METASTASIS; MYOSIN; PROLIFERATION; INACTIVATION; RECEPTORS	The Mig-10/RIAM/lamellipodin (MRL) family member Rap1-GTP-interacting adaptor molecule (RIAM) interacts with active Rap1, a small GTPase that is frequently activated in tumors such as melanoma and prostate cancer. We show here that RIAM is expressed in metastatic human melanoma cells and that both RIAM and Rap1 are required for BLM melanoma cell invasion. RIAM silencing in melanoma cells led to inhibition of tumor growth and to delayed metastasis in a severe combined immunodeficiency xenograft model. Defective invasion of RIAM-silenced melanoma cells arose from impairment in persistent cell migration directionality, which was associated with deficient activation of a Vav2-RhoA-ROCK-myosin light chain pathway. Expression of constitutively active Vav2 and RhoA in cells depleted for RIAM partially rescued their invasion, indicating that Vav2 and RhoA mediate RIAM function. These results suggest that inhibition of cell invasion in RIAM-silenced melanoma cells is likely based on altered cell contractility and cell polarization. Furthermore, we show that RIAM depletion reduces beta 1 integrin-dependent melanoma cell adhesion, which correlates with decreased activation of both Erk1/2 MAPK and phosphatidylinositol 3-kinase, two central molecules controlling cell growth and cell survival. In addition to causing inhibition of cell proliferation, RIAM silencing led to higher susceptibility to cell apoptosis. Together, these data suggest that defective activation of these kinases in RIAM-silenced cells could account for inhibition of melanoma cell growth and that RIAM might contribute to the dissemination of melanoma cells.	[Hernandez-Varas, Pablo; Colo, Georgina P.; Bartolome, Ruben A.; Arellano-Sanchez, Nohem; Teixido, Joaquin] Ctr Invest Biol, Dept Cellular & Mol Med, Madrid 28040, Spain; [Paterson, Andrew; Stromblad, Staffan] Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, SE-14183 Huddinge, Sweden; [Medrano-Fernandez, Iria; Lafuente, Esther M.] Univ Complutense Madrid, Fac Med, Dept Microbiol, Madrid 28041, Spain; [Medrano-Fernandez, Iria; Lafuente, Esther M.] Univ Complutense Madrid, Inst Invest Hosp 12 Octubre, Madrid 28041, Spain; [Cabanas, Carlos] Univ Autonoma Madrid, Ctr Biol Mol, E-28049 Madrid, Spain; [Sanchez-Mateos, Paloma] Hosp Univ Gregorio Maranon, Serv Inmunooncol, Madrid 28007, Spain; [Boussiotis, Vassiliki A.] Harvard Univ, Sch Med, Div Hematol & Oncol, Dept Med, Boston, MA 02115 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Karolinska Institutet; Complutense University of Madrid; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Autonomous University of Madrid; General University Gregorio Maranon Hospital; Harvard University; Harvard Medical School	Teixido, J (corresponding author), Ctr Invest Biol, Dept Cellular & Mol Med, Madrid 28040, Spain.	joaquint@cib.csic.es	CABAÑAS, CARLOS/J-4595-2012; Lafuente, Esther M/K-5684-2014; Sánchez, Nohemí Arellano/K-1210-2014; Teixidó, Joaquin/J-8543-2014; Medraño-Fernandez, Iria/AAN-4357-2020; Sanchez-Mateos, Paloma/E-8931-2013; LAFUENTE, ESTHER M/AAA-3149-2019; Bartolome, Ruben A/M-1873-2014	CABAÑAS, CARLOS/0000-0002-8767-060X; Lafuente, Esther M/0000-0001-8466-1022; Medraño-Fernandez, Iria/0000-0002-7956-9915; Bartolome, Ruben A/0000-0002-3292-1491; Stromblad, Staffan/0000-0002-1236-6339; Hernandez-Varas, Pablo/0000-0001-8664-9203; Sanchez-Mateos, Paloma/0000-0001-6589-4445	Ministerio de Ciencia e Innovacion [SAF2008-00479, SAF2007-60578, CCG08-UCM/SAL-4259, RETICS RD06/0020/0011, BFU2007-66443]; Fundacion Ramon Areces; EU; European Union [HEALTH-2007-201862]; Swedish Cancer Society; Swedish Research Council [2RO1 AI43552]; Fundacion de Investigacion Cientifica de la Asociacion Espanola Contra el Cancer; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043552] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Ramon Areces; EU(European Commission); European Union(European Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Fundacion de Investigacion Cientifica de la Asociacion Espanola Contra el Cancer; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grants SAF2008-00479 from the Ministerio de Ciencia e Innovacion (to J. T.), Grants SAF2007-60578 and CCG08-UCM/SAL-4259 from the Ministerio de Ciencia e Innovacion (to E. M. L.), Grant RETICS RD06/0020/0011 from the Ministerio de Ciencia e Innovacion (to J. T.), Grant BFU2007-66443 from the Ministerio de Ciencia e Innovacion (to C. C.), a 2006 Grant from the Fundacion Ramon Areces (to P. S.-M.), Grant EU-FP7-MetaFight, European Union HEALTH-2007-201862 (to J. T. and S. S.), a grant from the Swedish Cancer Society and the Swedish Research Council (to S. S.), Grant 2RO1 AI43552 (to V. A. B.), and by a grant from the Fundacion de Investigacion Cientifica de la Asociacion Espanola Contra el Cancer (to R. A. B.).	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Assoian RK, 2008, TRENDS CELL BIOL, V18, P347, DOI 10.1016/j.tcb.2008.05.002; Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; Bao WJ, 2004, J CELL BIOL, V167, P745, DOI 10.1083/jcb.200404018; Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Bartolome RA, 2004, CANCER RES, V64, P2534, DOI 10.1158/0008-5472.CAN-03-3398; Bartolome RA, 2008, CANCER RES, V68, P8221, DOI 10.1158/0008-5472.CAN-08-0561; Bartolome RA, 2009, AM J PATHOL, V174, P602, DOI 10.2353/ajpath.2009.080636; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; Gao L, 2006, CANCER RES, V66, P7880, DOI 10.1158/0008-5472.CAN-06-0254; Garcia-Bernal D, 2009, IMMUNITY, V31, P953, DOI 10.1016/j.immuni.2009.09.021; Go RS, 1999, J CLIN ONCOL, V17, P409, DOI 10.1200/JCO.1999.17.1.409; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Lim J, 2010, J CELL BIOCHEM, V111, P999, DOI 10.1002/jcb.22788; Lyulcheva E, 2008, DEV CELL, V15, P680, DOI 10.1016/j.devcel.2008.09.020; Menasche G, 2007, MOL CELL BIOL, V27, P4070, DOI 10.1128/MCB.02011-06; Molina-Ortiz I, 2009, J BIOL CHEM, V284, P15147, DOI 10.1074/jbc.M807834200; MONTGOMERY AMP, 1994, P NATL ACAD SCI USA, V91, P8856, DOI 10.1073/pnas.91.19.8856; Patsoukis N, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000409; Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robledo MM, 2001, J BIOL CHEM, V276, P45098, DOI 10.1074/jbc.M106912200; Schwartz MA, 2001, J CELL SCI, V114, P2553; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Ticchioni M, 2002, BLOOD, V99, P3111, DOI 10.1182/blood.V99.9.3111; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; YEDNOCK TA, 1995, J BIOL CHEM, V270, P28740, DOI 10.1074/jbc.270.48.28740	38	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18492	18504		10.1074/jbc.M110.189811	http://dx.doi.org/10.1074/jbc.M110.189811			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454517	Green Published, hybrid			2022-12-27	WOS:000290785700022
J	Mahawar, M; Tran, V; Sharp, JS; Maier, RJ				Mahawar, Manish; ViLinh Tran; Sharp, Joshua S.; Maier, Robert J.			Synergistic Roles of Helicobacter pylori Methionine Sulfoxide Reductase and GroEL in Repairing Oxidant-damaged Catalase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOCHLOROUS ACID; OXIDATIVE STRESS; BIOLOGICAL FUNCTION; ESCHERICHIA-COLI; AMINO-ACIDS; PROTEINS; INACTIVATION; EXPRESSION; NITRATION; CHAPERONE	Hypochlorous acid (HOCl) produced via the enzyme myeloperoxidase is a major antibacterial oxidant produced by neutrophils, and Met residues are considered primary amino acid targets of HOCl damage via conversion to Met sulfoxide. Met sulfoxide can be repaired back to Met by methionine sulfoxide reductase (Msr). Catalase is an important antioxidant enzyme; we show it constitutes 4-5% of the total Helicobacter pylori protein levels. msr and katA strains were about 14- and 4-fold, respectively, more susceptible than the parent to killing by the neutrophil cell line HL-60 cells. Catalase activity of an msr strain was much more reduced by HOCl exposure than for the parental strain. Treatment of pure catalase with HOCl caused oxidation of specific MS-identified Met residues, as well as structural changes and activity loss depending on the oxidant dose. Treatment of catalase with HOCl at a level to limit structural perturbation (at a catalase/HOCl molar ratio of 1:60) resulted in oxidation of six identified Met residues. Msr repaired these residues in an in vitro reconstituted system, but no enzyme activity could be recovered. However, addition of GroEL to the Msr repair mixture significantly enhanced catalase activity recovery. Neutrophils produce large amounts of HOCl at inflammation sites, and bacterial catalase may be a prime target of the host inflammatory response; at high concentrations of HOCl (1:100), we observed loss of catalase secondary structure, oligomerization, and carbonylation. The same HOCl-sensitive Met residue oxidation targets in catalase were detected using chloramine-T as a milder oxidant.	[Mahawar, Manish; Maier, Robert J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [ViLinh Tran; Sharp, Joshua S.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Maier, RJ (corresponding author), Univ Georgia, Dept Microbiol, 805 Biol Sci Bldg, Athens, GA 30602 USA.	rmaier@uga.edu			National Institutes of Health [RO1 AI077569]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI077569.	Abulimiti A, 2003, BIOCHEM BIOPH RES CO, V305, P87, DOI 10.1016/S0006-291X(03)00685-5; Alamuri P, 2004, MOL MICROBIOL, V53, P1397, DOI 10.1111/j.1365-2958.2004.04190.x; Alamuri P, 2006, J BACTERIOL, V188, P5839, DOI 10.1128/JB.00430-06; Algood HMS, 2006, CLIN MICROBIOL REV, V19, P597, DOI 10.1128/CMR.00006-06; Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Basu M, 2004, HELICOBACTER, V9, P211, DOI 10.1111/j.1083-4389.2004.00226.x; Berlett BS, 1998, P NATL ACAD SCI USA, V95, P2784, DOI 10.1073/pnas.95.6.2784; Bonini MG, 2007, FREE RADICAL BIO MED, V42, P530, DOI 10.1016/j.freeradbiomed.2006.11.019; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Brennan LA, 2009, BBA-GEN SUBJECTS, V1790, P1665, DOI 10.1016/j.bbagen.2009.08.011; Cao G, 2010, J BIOL CHEM, V285, P26081, DOI 10.1074/jbc.M110.103655; Chao CC, 1997, P NATL ACAD SCI USA, V94, P2969, DOI 10.1073/pnas.94.7.2969; Chapman ALP, 2003, BIOCHEM J, V375, P33, DOI 10.1042/BJ20030685; Ezraty B, 2005, BBA-PROTEINS PROTEOM, V1703, P221, DOI 10.1016/j.bbapap.2004.08.017; Ezraty B, 2004, EMBO J, V23, P1868, DOI 10.1038/sj.emboj.7600172; Georgopoulos C, 2006, GENETICS, V174, P1699, DOI 10.1534/genetics.104.68262; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Handa O, 2010, INFLAMM RES, V59, P997, DOI 10.1007/s00011-010-0245-x; HARLOW E, 1988, ANTIBODIES LAB MANUA, P598; Harris AG, 2003, MICROBIOL-SGM, V149, P665, DOI 10.1099/mic.0.26012-0; Hawkins CL, 2005, CHEM RES TOXICOL, V18, P1600, DOI 10.1021/tx050207b; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; HAZELL SL, 1991, J GEN MICROBIOL, V137, P57, DOI 10.1099/00221287-137-1-57; Hook DWA, 1997, EUR J BIOCHEM, V247, P380, DOI 10.1111/j.1432-1033.1997.00380.x; Hope HR, 2000, PROTEIN EXPRES PURIF, V18, P269, DOI 10.1006/prep.1999.1197; HUGHES MN, 1968, J CHEM SOC A, P450, DOI 10.1039/j19680000450; Khor HK, 2004, J BIOL CHEM, V279, P19486, DOI 10.1074/jbc.M310045200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lancellotti S, 2010, FREE RADICAL BIO MED, V48, P446, DOI 10.1016/j.freeradbiomed.2009.11.020; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Loewen PC, 2004, BIOCHEMISTRY-US, V43, P3089, DOI 10.1021/bi035663i; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Lund PA, 2009, FEMS MICROBIOL REV, V33, P785, DOI 10.1111/j.1574-6976.2009.00178.x; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; McLean S, 2010, J BIOL CHEM, V285, P20724, DOI 10.1074/jbc.M109.085506; Melkani GC, 2002, BIOCHEM BIOPH RES CO, V294, P893, DOI 10.1016/S0006-291X(02)00575-2; Mondal P, 2008, PROTEIN PEPTIDE LETT, V15, P1075, DOI 10.2174/092986608786071058; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Ramarao N, 2000, MOL MICROBIOL, V38, P103, DOI 10.1046/j.1365-2958.2000.02114.x; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; Sharp JS, 2006, BIOCHEMISTRY-US, V45, P6260, DOI 10.1021/bi060470r; Su Z, 2007, BIOCHEM PHARMACOL, V74, P702, DOI 10.1016/j.bcp.2007.06.002; Tanaka M, 2007, P NATL ACAD SCI USA, V104, P66, DOI 10.1073/pnas.0609737104; Tien M, 1999, P NATL ACAD SCI USA, V96, P7809, DOI 10.1073/pnas.96.14.7809; Tsvetkov PO, 2005, BIOCHIMIE, V87, P473, DOI 10.1016/j.biochi.2004.11.020; Venkatesh S, 2007, RAPID COMMUN MASS SP, V21, P3927, DOI 10.1002/rcm.3291; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Wang G, 2005, FREE RADICAL RES, V39, P1183, DOI 10.1080/10715760500194018; Wang G, 2004, J BIOL CHEM, V279, P51908, DOI 10.1074/jbc.M408450200; Wang G, 2006, MOL MICROBIOL, V61, P847, DOI 10.1111/j.1365-2958.2006.05302.x; Wang G, 2010, INFECT IMMUN, V78, P4660, DOI 10.1128/IAI.00307-10; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107	56	49	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19159	19169		10.1074/jbc.M111.223677	http://dx.doi.org/10.1074/jbc.M111.223677			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21460217	Green Published, hybrid			2022-12-27	WOS:000290785700085
J	Alvarez, F; Munoz, F; Schilcher, P; Imhof, A; Almouzni, G; Loyola, A				Alvarez, Francisca; Munoz, Francisca; Schilcher, Pierre; Imhof, Axel; Almouzni, Genevieve; Loyola, Alejandra			Sequential Establishment of Marks on Soluble Histones H3 and H4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE; ACETYLATION; DEPOSITION; COMPLEX; IMPORT; DAXX	Much progress has been made concerning histone function in the nucleus; however, following their synthesis, how their marking and subcellular traffic king are regulated remains to be explored. To gain an insight into these issues, we focused on soluble histones and analyzed endogenous and tagged H3 histones in parallel. We distinguished six complexes that we could place to account for maturation events occurring on histones H3 and H4 from their synthesis onward. In each complex, a different set of chaperones is involved, and we found specific post-translational modifications. Interestingly, we revealed that histones H3 and H4 are transiently poly-(ADP-ribosylated). The impact of these marks in histone metabolism proved to be important as we found that acetylation of lysines 5 and 12 on histone H4 stimulated its nuclear translocation. Furthermore, we showed that, depending on particular histone H3 modifications, the balance in the presence of the different translocation complexes changes. Therefore, our results enabled us to propose a regulatory means of these marks for controlling cytoplasmic/nuclear shuttling and the establishment of early modification patterns.	[Alvarez, Francisca; Munoz, Francisca; Loyola, Alejandra] Fdn Ciencia Vida, Santiago 7780272, Chile; [Schilcher, Pierre; Imhof, Axel] Munich Ctr Integrated Prot Sci, D-80336 Munich, Germany; [Schilcher, Pierre; Imhof, Axel] Adolf Butenandt Inst, D-80336 Munich, Germany; [Almouzni, Genevieve] Inst Curie, CNRS, UMR 218, F-75248 Paris, France; [Loyola, Alejandra] Univ San Sebastian, Santiago, Chile	University of Munich; University of Munich; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Universidad San Sebastian	Loyola, A (corresponding author), Avda Zanartu 1482, Santiago, Chile.	alejandra.loyola@bionova.cl	Imhof, Axel/AAU-5313-2021; Almouzni, Genevieve/ABG-1029-2021; Loyola, Maria Alejandra/A-2613-2013; Loyola, Alejandra/ABE-8337-2020	Imhof, Axel/0000-0003-2993-8249; Almouzni, Genevieve/0000-0001-5570-0723; 	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1090270]; Basal Project [PFB16]; Iniciativa Cientifica Milenio-Millenium Institute of Fundamental Applied Biology; Institut Curie/CNRS	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Basal Project(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Iniciativa Cientifica Milenio-Millenium Institute of Fundamental Applied Biology; Institut Curie/CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant 1090270, Basal Project PFB16, and the Iniciativa Cientifica Milenio-Millenium Institute of Fundamental Applied Biology (to A. L.) and by grants from the Institut Curie/CNRS (to G. A.).	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; Campos EI, 2010, GENE DEV, V24, P1334, DOI 10.1101/gad.1946810; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Corpet A, 2011, EMBO J, V30, P480, DOI 10.1038/emboj.2010.335; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Loyola A, 2007, TRENDS BIOCHEM SCI, V32, P425, DOI 10.1016/j.tibs.2007.08.004; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Loyola A, 2009, EMBO REP, V10, P769, DOI 10.1038/embor.2009.90; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001	25	80	80	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17714	17721		10.1074/jbc.M111.223453	http://dx.doi.org/10.1074/jbc.M111.223453			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454524	Green Published, hybrid			2022-12-27	WOS:000290585200035
J	Ingraham, CA; Park, GC; Makarenkova, HP; Crossin, KL				Ingraham, Christopher A.; Park, Gabriel C.; Makarenkova, Helen P.; Crossin, Kathryn L.			Matrix Metalloproteinase (MMP)-9 Induced by Wnt Signaling Increases the Proliferation and Migration of Embryonic Neural Stem Cells at Low O-2 Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; HIGH-ALTITUDE ADAPTATION; CENTRAL-NERVOUS-SYSTEM; MTT ASSAY; COLORIMETRIC ASSAY; PROGENITOR CELLS; OXYGEN-TENSION; ENHANCES PROLIFERATION; STEM/PROGENITOR CELLS	Recent studies have shown that various neural and embryonic stem cells cultured in 1-8% oxygen (O-2), levels lower than those typically used in cell culture (20.9%), displayed increased rates of proliferation; however, the molecular mechanisms underlying these changes are largely undefined. In this study, using rigorously controlled O-2 levels, we found that neural stem cells (NSCs) from embryonic day 15 rat cortex increased their rate of proliferation and migration in 1% O-2 relative to 20% O-2 without changes in viability. We sought to identify molecular changes in NSCs grown in 1% O-2 that might account for these increases. In 1% O-2, levels of the hypoxia-inducible transcription factor HIF-1 alpha were transiently increased. Reduced adherence of NSCs in 1% O-2 to basement membrane-coated plates was observed, and quantitative RT-PCR analysis confirmed that the levels of mRNA for an assortment of cell adhesion and extracellular matrix molecules were altered. Most notable was a 5-fold increase in matrix metalloproteinase (MMP)-9 mRNA. Specific inhibition of MMP-9 activity, verified using a fluorescent substrate assay, prevented the increase in proliferation and migration in 1% O-2. The canonical Wnt pathway was recently shown to be activated in stem cells in low O-2 via HIF-1 alpha. Inhibition of Wnt signaling by DKK-1 also prevented the increase in proliferation, migration, and MMP-9 expression. Thus, MMP-9 is a key molecular effector, downstream of HIF-1 alpha and Wnt activation, responsible for increased rates of NSC proliferation and migration in 1% O-2.	[Ingraham, Christopher A.; Park, Gabriel C.; Makarenkova, Helen P.; Crossin, Kathryn L.] Scripps Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA	Scripps Research Institute	Crossin, KL (corresponding author), Scripps Res Inst, Dept Neurobiol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	kcrossin@scripps.edu			National Institutes of Health [AR053163]; Department of Neurobiology, The Scripps Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Neurobiology, The Scripps Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by National Institutes of Health Grant AR053163 (to H. P. M.). This work was also supported by the Department of Neurobiology, The Scripps Research Institute.	Agrawal SM, 2008, SEMIN CELL DEV BIOL, V19, P42, DOI 10.1016/j.semcdb.2007.06.003; Ardi VC, 2009, J BIOL CHEM, V284, P25854, DOI 10.1074/jbc.M109.033472; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Brahimi-Horn MC, 2011, CURR OPIN GENET DEV, V21, P67, DOI 10.1016/j.gde.2010.10.006; Candela ME, 2010, J CELL PHYSIOL, V224, P144, DOI 10.1002/jcp.22111; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chen HL, 2007, STEM CELLS, V25, P2291, DOI 10.1634/stemcells.2006-0609; Chen X, 2010, NEUROSCIENCE, V165, P705, DOI 10.1016/j.neuroscience.2009.11.007; Cho A, 2002, CIRC RES, V91, P845, DOI 10.1161/01.RES.0000040420.17366.2E; Clarke L, 2009, STEM CELLS, V27, P1879, DOI 10.1002/stem.96; DIRKEN MNJ, 1948, Q J EXP PHYSIOL CMS, V34, P193, DOI 10.1113/expphysiol.1948.sp000929; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fedi P, 1999, J BIOL CHEM, V274, P19465, DOI 10.1074/jbc.274.27.19465; GERLIER D, 1986, J IMMUNOL METHODS, V94, P57, DOI 10.1016/0022-1759(86)90215-2; Giese AK, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-94; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Harms KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009767; Harrison JF, 2011, ANNU REV PHYSIOL, V73, P95, DOI 10.1146/annurev-physiol-012110-142155; HAYNES LW, 1988, MOL NEUROBIOL, V2, P263, DOI 10.1007/BF02935635; Hernandez-Guillamon M, 2009, J NEUROSCI RES, V87, P2115, DOI 10.1002/jnr.22034; Higgins S, 2009, ENDOCRINOLOGY, V150, P4044, DOI 10.1210/en.2008-1797; HOFFMAN CE, 1946, AM J PHYSIOL, V145, P685, DOI 10.1152/ajplegacy.1946.145.5.685; Horie N, 2008, CELL MOL NEUROBIOL, V28, P833, DOI 10.1007/s10571-007-9237-y; Horng CT, 2008, AVIAT SPACE ENVIR MD, V79, P666, DOI 10.3357/ASEM.2160.2008; JABBAR SAB, 1989, BRIT J CANCER, V60, P523, DOI 10.1038/bjc.1989.306; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kang SS, 2008, BRAIN RES, V1228, P20, DOI 10.1016/j.brainres.2008.06.056; Kenagy RD, 1997, CIRCULATION, V96, P3555; Kim DH, 2008, J NEUROSCI, V28, P208, DOI 10.1523/JNEUROSCI.3674-07.2008; Kim TS, 2008, J NEUROSCI RES, V86, P2353, DOI 10.1002/jnr.21687; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Levin JI, 2001, BIOORG MED CHEM LETT, V11, P2189, DOI 10.1016/S0960-894X(01)00419-X; Li HG, 2009, J EXP ZOOL PART A, V311A, P134, DOI 10.1002/jez.510; Lin Q, 2008, GENE REGUL SYST BIO, V2, P43; Liu HQ, 2010, J NEUROPATH EXP NEUR, V69, P386, DOI 10.1097/NEN.0b013e3181d68d12; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Lu ZJ, 2010, FASEB J, V24, P1925, DOI 10.1096/fj.09-150573; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Meng H, 2009, J BIOL CHEM, V284, P7866, DOI 10.1074/jbc.M803650200; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Millman JR, 2009, CURR OPIN ORGAN TRAN, V14, P694, DOI 10.1097/MOT.0b013e3283329d53; Milosevic J, 2009, NEUROTOX RES, V15, P367, DOI 10.1007/s12640-009-9043-z; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Newby D, 2005, PLACENTA, V26, P353, DOI 10.1016/j.placenta.2004.07.002; Noles SR, 2007, MOL CELL NEUROSCI, V35, P549, DOI 10.1016/j.mcn.2007.04.012; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; PAGLIACCI MC, 1993, EUR J CANCER, V29A, P1573, DOI 10.1016/0959-8049(93)90297-S; Panchision DM, 2009, J CELL PHYSIOL, V220, P562, DOI 10.1002/jcp.21812; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Pistollato F, 2007, MOL CELL NEUROSCI, V35, P424, DOI 10.1016/j.mcn.2007.04.003; Rodrigues CAV, 2010, BIOTECHNOL BIOENG, V106, P260, DOI 10.1002/bit.22648; Rytkonen KT, 2011, EMBO REP, V12, P3, DOI 10.1038/embor.2010.192; Santilli G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008575; Shams I, 2004, P NATL ACAD SCI USA, V101, P9698, DOI 10.1073/pnas.0403540101; Shams Imad, 2005, FASEB J, V19, P307; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; SOLER RC, 1995, DEV BRAIN RES, V88, P37; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Storz JF, 2010, J EXP BIOL, V213, P4125, DOI 10.1242/jeb.048181; Studer L, 2000, J NEUROSCI, V20, P7377; Toledo EM, 2008, PROG NEUROBIOL, V86, P281, DOI 10.1016/j.pneurobio.2008.08.001; Tonti GA, 2009, INT J DEV BIOL, V53, P1, DOI 10.1387/ijdb.082573gt; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; Tsatmali M, 2006, MOL CELL NEUROSCI, V33, P345, DOI 10.1016/j.mcn.2006.08.005; Tuuli MG, 2011, PLACENTA, V32, pS109, DOI 10.1016/j.placenta.2010.12.013; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Vieira HLA, 2011, PROG NEUROBIOL, V93, P444, DOI 10.1016/j.pneurobio.2011.01.007; Vlodavsky I, 1996, CANCER METAST REV, V15, P177, DOI 10.1007/BF00437470; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Webster KA, 2003, J EXP BIOL, V206, P2911, DOI 10.1242/jeb.00516; Wenger RH, 1997, BIOL CHEM, V378, P609; Wexler EM, 2008, MOL PSYCHIATR, V13, P285, DOI 10.1038/sj.mp.4002093; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; York JL, 1998, BIOTECHNIQUES, V25, P622, DOI 10.2144/98254st03; Zadori A, 2011, EXP NEUROL, V227, P136, DOI 10.1016/j.expneurol.2010.10.004; Zhang XB, 2001, CANCER RES, V61, P6050; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhang Y, 2007, J NEUROSCI, V27, P4499, DOI 10.1523/JNEUROSCI.0200-07.2007; Zhang ZD, 1996, BIOCHEM MOL BIOL INT, V38, P431; Zhao T, 2008, FEBS J, V275, P1824, DOI 10.1111/j.1742-4658.2008.06340.x; Zhou D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000490; Zhou D, 2009, PEDIATR RES, V66, P239, DOI 10.1203/PDR.0b013e3181b27275; Zhou L, 2006, NEURODEGENER DIS, V3, P50, DOI 10.1159/000092093	97	63	66	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17649	17657		10.1074/jbc.M111.229427	http://dx.doi.org/10.1074/jbc.M111.229427			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21460212	Green Published, hybrid			2022-12-27	WOS:000290585200028
J	Mirza, AM; Aguilar, HC; Zhu, QY; Mahon, PJ; Rota, PA; Lee, B; Iorio, RM				Mirza, Anne M.; Aguilar, Hector C.; Zhu, Qiyun; Mahon, Paul J.; Rota, Paul A.; Lee, Benhur; Iorio, Ronald M.			Triggering of the Newcastle Disease Virus Fusion Protein by a Chimeric Attachment Protein That Binds to Nipah Virus Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN; REPORTER GENE ACTIVATION; HENDRA-VIRUS; CELL-FUSION; MONOCLONAL-ANTIBODIES; HN PROTEIN; FUNCTIONAL INTERACTION; PARAMYXOVIRUS FUSION; MEMBRANE-FUSION; VIRAL ENTRY	The fusion (F) proteins of Newcastle disease virus (NDV) and Nipah virus (NiV) are both triggered by binding to receptors, mediated in both viruses by a second protein, the attachment protein. However, the hemagglutinin-neuraminidase (HN) attachment protein of NDV recognizes sialic acid receptors, whereas the NiV G attachment protein recognizes ephrinB2/B3 as receptors. Chimeric proteins composed of domains from the two attachment proteins have been evaluated for fusion-promoting activity with each F protein. Chimeras having NiV G-derived globular domains and NDV HN-derived stalks, transmembranes, and cytoplasmic tails are efficiently expressed, bind ephrinB2, and trigger NDV F to promote fusion in Vero cells. Thus, the NDV F protein can be triggered by binding to the NiV receptor, indicating that an aspect of the triggering cascade induced by the binding of HN to sialic acid is conserved in the binding of NiV G to ephrinB2. However, the fusion cascade for triggering NiV F by the G protein and that of triggering NDV F by the chimeras can be distinguished by differential exposure of a receptor-induced conformational epitope. The enhanced exposure of this epitope marks the triggering of NiV F by NiV G but not the triggering of NDV F by the chimeras. Thus, the triggering cascade for NiV G-F fusion may be more complex than that of NDV HN and F. This is consistent with the finding that reciprocal chimeras having NDV HN-derived heads and NiV G-derived stalks, transmembranes, and tails do not trigger either F protein for fusion, despite efficient cell surface expression and receptor binding.	[Mirza, Anne M.; Zhu, Qiyun; Mahon, Paul J.; Iorio, Ronald M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Iorio, Ronald M.] Univ Massachusetts, Sch Med, Program Immunol & Virol, Worcester, MA 01655 USA; [Aguilar, Hector C.; Lee, Benhur] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Rota, Paul A.] Ctr Dis Control & Prevent, Measles Mumps Rubella & Herpesvirus Lab Branch, Atlanta, GA 30333 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Centers for Disease Control & Prevention - USA	Iorio, RM (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, 55 Lake Ave N, Worcester, MA 01655 USA.	ronald.iorio@umassmed.edu	Pacific-Southwest, RCE/B-6155-2009; Aguilar, Hector/AAD-6663-2022; Lee, Benhur/A-8554-2016	Lee, Benhur/0000-0003-0760-1709	National Institutes of Health [AI49268]; Pacific Southwest Regional Center for Excellence in Biodefense and Emerging Infectious Diseases [U54 AI065359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069317, U19AI057319, R01AI049268, U54AI065359, R56AI049268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pacific Southwest Regional Center for Excellence in Biodefense and Emerging Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI49268 (to R. M. I.), a subproject of U19 Grant AI057319 (to the University of Massachusetts Center for Translational Research on Human Immunology and Biodefense), and AI069317 (to B. L.). This work was also supported by Subproject Award U54 AI065359 from the Pacific Southwest Regional Center for Excellence in Biodefense and Emerging Infectious Diseases.	Aguilar HC, 2007, J VIROL, V81, P4520, DOI 10.1128/JVI.02205-06; Aguilar HC, 2006, J VIROL, V80, P4878, DOI 10.1128/JVI.80.10.4878-4889.2006; Aguilar HC, 2009, J BIOL CHEM, V284, P1628, DOI 10.1074/jbc.M807469200; Bishop KA, 2007, J VIROL, V81, P5893, DOI 10.1128/JVI.02022-06; Bonaparte MI, 2005, P NATL ACAD SCI USA, V102, P10652, DOI 10.1073/pnas.0504887102; Bowden TA, 2008, NAT STRUCT MOL BIOL, V15, P567, DOI 10.1038/nsmb.1435; Bowden TA, 2010, BIOCHEM SOC T, V38, P1349, DOI 10.1042/BST0381349; Bukreyev A, 2008, CURR OPIN MOL THER, V10, P46; Connolly SA, 2009, J VIROL, V83, P10857, DOI 10.1128/JVI.01191-09; Corey EA, 2003, J VIROL, V77, P6913, DOI 10.1128/JVI.77.12.6913-6922.2003; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; DENG RT, 1995, VIROLOGY, V209, P457, DOI 10.1006/viro.1995.1278; Harcourt BH, 2000, VIROLOGY, V271, P334, DOI 10.1006/viro.2000.0340; IORIO RM, 1989, VIRUS RES, V13, P245, DOI 10.1016/0168-1702(89)90019-1; IORIO RM, 1991, J VIROL, V65, P4999, DOI 10.1128/JVI.65.9.4999-5006.1991; IORIO RM, 1986, J GEN VIROL, V67, P1393, DOI 10.1099/0022-1317-67-7-1393; IORIO RM, 1983, J VIROL, V48, P440, DOI 10.1128/JVI.48.2.440-450.1983; Iorio RM, 2009, FUTURE VIROL, V4, P335, DOI 10.2217/FVL.09.17; Lee JK, 2008, J BIOL CHEM, V283, P16561, DOI 10.1074/jbc.M801018200; Li JR, 2004, J VIROL, V78, P5299, DOI 10.1128/JVI.78.10.5299-5310.2004; Lorio RM, 2008, TRENDS MICROBIOL, V16, P135, DOI 10.1016/j.tim.2008.01.006; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Mahon PJ, 2008, J VIROL, V82, P10386, DOI 10.1128/JVI.00581-08; MCGINNES LW, 1994, VIROLOGY, V200, P470, DOI 10.1006/viro.1994.1210; Melanson VR, 2006, J VIROL, V80, P623, DOI 10.1128/JVI.80.2.623-633.2006; Melanson VR, 2004, J VIROL, V78, P13053, DOI 10.1128/JVI.78.23.13053-13061.2004; MIRZA AM, 1994, J VIROL, V68, P5093, DOI 10.1128/JVI.68.8.5093-5099.1994; MIRZA AM, 1993, J BIOL CHEM, V268, P21425; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Negrete Oscar A, 2006, PLoS Pathog, V2, pe7; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; Okuma K, 1999, VIROLOGY, V254, P235, DOI 10.1006/viro.1998.9530; Paal T, 2009, J VIROL, V83, P10480, DOI 10.1128/JVI.01195-09; Schirrmacher Volker, 2009, V542, P565, DOI 10.1007/978-1-59745-561-9_30; SHEEHAN JP, 1987, VIROLOGY, V161, P603, DOI 10.1016/0042-6822(87)90158-9; Smith EC, 2009, FEBS J, V276, P7217, DOI 10.1111/j.1742-4658.2009.07401.x; Tanabayashi K, 1996, J VIROL, V70, P6112, DOI 10.1128/JVI.70.9.6112-6118.1996; TSURUDOME M, 1995, VIROLOGY, V213, P190, DOI 10.1006/viro.1995.1559; Xu K, 2008, P NATL ACAD SCI USA, V105, P9953, DOI 10.1073/pnas.0804797105; Yu M, 1998, VIROLOGY, V251, P227, DOI 10.1006/viro.1998.9302; Zaitsev V, 2004, J VIROL, V78, P3733, DOI 10.1128/JVI.78.7.3733-3741.2004	42	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17851	17860		10.1074/jbc.M111.233965	http://dx.doi.org/10.1074/jbc.M111.233965			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21460213	hybrid, Green Published			2022-12-27	WOS:000290585200048
J	Mitra, R; Guo, ZJ; Milani, M; Mesaros, C; Rodriguez, M; Nguyen, J; Luo, XH; Clarke, D; Lamba, J; Schuetz, E; Donner, DB; Puli, N; Falck, JR; Capdevila, J; Gupta, K; Blair, IA; Potter, DA				Mitra, Ranjana; Guo, Zhijun; Milani, Monica; Mesaros, Clementina; Rodriguez, Mariangellys; Nguyen, Julia; Luo, Xianghua; Clarke, Duncan; Lamba, Jatinder; Schuetz, Erin; Donner, David B.; Puli, Narender; Falck, John R.; Capdevila, Jorge; Gupta, Kalpna; Blair, Ian A.; Potter, David A.			CYP3A4 Mediates Growth of Estrogen Receptor-positive Breast Cancer Cells in Part by Inducing Nuclear Translocation of Phospho-Stat3 through Biosynthesis of (+/-)-14, 15-Epoxyeicosatrienoic Acid (EET)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; EPOXYEICOSATRIENOIC ACIDS; RECOMBINANT ENZYMES; EPOXIDE HYDROLASE; MOLECULAR-CLONING; CELLULAR FUNCTION; LIVER-MICROSOMES; CARCINOMA LINES; C-SRC; CYTOCHROME-P450	CYP3A4 expression in breast cancer correlates with decreased overall survival, but the mechanisms are unknown. Cytochrome P450 gene profiling by RNAi silencing demonstrates that CYP3A or 2C8 gene expression is specifically required for growth of the breast cancer lines MCF7, T47D, and MDA-MB-231. CYP3A4 silencing blocks the cell cycle at the G(2)/M checkpoint and induces apoptosis in the MCF7 line, thereby inhibiting anchorage-dependent growth and survival. CYP3A4 was profiled for NADPH-dependent arachidonic acid (AA) metabolism and synthesized AA epoxygenase products (+/-)-8,9-, (+/-)-11,12-, and (+/-)-14,15-epoxyeicosatrienoic acid (EET) (total turnover of similar to 2 pmol/pmol CYP3A4/min) but not hydroxylase products (+/-)-15-, (+/-)-19-, or 20-hydroxyeicosatetraenoic acid. Furthermore, eicosanoid profiling revealed that MCF7 cells synthesize EETs in a CYP3A4-dependent manner. The (+/-)-14,15-EET regioisomer selectively rescues breast cancer cells from CYP3A4 silencing in a concentration-dependent fashion and promotes mitogenesis and anchorage-dependent cloning. Stat3 (Tyr-705) phosphorylation was inhibited by CYP3A4 silencing, providing a potential mechanism for CYP3A4 involvement in breast cancer cell growth. Silencing Stat3 blocks breast cancer cell growth and abrogates (+/-)-14,15-EET-induced proliferation, indicating a Stat3 requirement for (+/-)-14,15-EET-mediated cell growth. Although silencing of CYP3A4 reduces nuclear Tyr(P)-705-Stat3, (+/-)-14,15-EET restores this signaling process and promotes Tyr(P)-705-Stat3 translocation to the nucleus, suggesting that (+/-)-14,15-EET may be involved in an autocrine/paracrine pathway driving cell growth. These studies indicate that CYP3A4 is a highly active AA epoxygenase that promotes Stat3-mediated breast cancer cell growth in part through (+/-)-14,15-EET biosynthesis. Furthermore, these studies indicate an essential role for Stat3 as a mediator of epoxygenase activity in breast cancer.	[Potter, David A.] Univ Minnesota, Div Hematol Oncol & Transplantat, Dept Med, Minneapolis, MN 55455 USA; [Mitra, Ranjana; Guo, Zhijun; Milani, Monica; Rodriguez, Mariangellys; Nguyen, Julia; Luo, Xianghua; Gupta, Kalpna; Potter, David A.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Mesaros, Clementina; Blair, Ian A.] Univ Penn, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Mesaros, Clementina; Blair, Ian A.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Luo, Xianghua] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Clarke, Duncan] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Lamba, Jatinder] Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Schuetz, Erin] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Donner, David B.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Puli, Narender; Falck, John R.] Univ Texas SW Med Ctr Dallas, Dept Biochem & Pharmacol, Dallas, TX 75390 USA; [Capdevila, Jorge] Vanderbilt Univ, Dept Med, Nashville, TN 37240 USA; [Capdevila, Jorge] Vanderbilt Ingram Canc Ctr, Nashville, TN 37240 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania; University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; Vanderbilt University	Potter, DA (corresponding author), Univ Minnesota, Div Hematol Oncol & Transplantat, Dept Med, 420 Delaware St SE,MMC 480, Minneapolis, MN 55455 USA.	dapotter@umn.edu	Falck, John R/B-3030-2011	Falck, John R/0000-0002-9219-7845; Mitra, Ranjana/0000-0001-9421-3610; Clarke, Duncan/0000-0002-7795-3294	National Institutes of Health [R01CA113570, R01CA091016, P30ES013508, P01DK038226, R01-GM31278, 1S10RR024618-01A1, R01 CA109582, P30CA077598]; Masonic Cancer Center, Flight Attendant Medical Research Institute [042257]; Susan G. Komen for the Cure Grants [BCTR0504012, KG090861]; Robert A. Welch Foundation; Fairview Foundation; NATIONAL CANCER INSTITUTE [R01CA091016, P30CA077598, R01CA113570, R01CA109582] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Masonic Cancer Center, Flight Attendant Medical Research Institute; Susan G. Komen for the Cure Grants(Susan G. Komen Breast Cancer Foundation); Robert A. Welch Foundation(The Welch Foundation); Fairview Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA113570, R01CA091016, P30ES013508, P01DK038226, R01-GM31278, and 1S10RR024618-01A1. This work was also supported by the Cancer Experimental Therapeutics Program of the Masonic Cancer Center, Flight Attendant Medical Research Institute Grant 042257, Susan G. Komen for the Cure Grants BCTR0504012 and KG090861, the Robert A. Welch Foundation, and a grant from the Dr. Barbara Bowers Oncology Fund of the Fairview Foundation.; Supported by National Institutes of Health Grant R01 CA109582.; Dr. Philip McGlave and the Division of Hematology/Oncology and Transplantation are gratefully acknowledged. We acknowledge the expert help of Drs. Stephen Hecht and Peter Villalta and the Analytical Biochemistry Core of the Masonic Cancer Center, University of Minnesota. We thank Drs. Bruce Hammock and Sung Hee Hwang for the epoxide hydrolase inhibitor 1471. We thank Drs. Carol Lange, Douglas Yee, Rory Remmel, David Flockhart, George Sledge, Harikrishna Nakshatri, Christy Orschell, Jacqueline Bromberg, and Faris Farassati for helpful advice on the studies. We are grateful to Michael Franklin for outstanding help with editing. The Masonic Cancer Center, University of Minnesota, was recipient of National Institutes of Health Grant P30CA077598.	Ayajiki K, 2003, HYPERTENS RES, V26, P237, DOI 10.1291/hypres.26.237; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bylund J, 1998, J PHARMACOL EXP THER, V284, P51; CAPDEVILA JH, 1991, METHOD ENZYMOL, V206, P441; Chen C, 2006, CURR NEUROVASC RES, V3, P171, DOI 10.2174/156720206778018767; Chen JK, 1999, J BIOL CHEM, V274, P4764, DOI 10.1074/jbc.274.8.4764; Chen JK, 1998, J BIOL CHEM, V273, P29254, DOI 10.1074/jbc.273.44.29254; Cheranov SY, 2008, BLOOD, V111, P5581, DOI 10.1182/blood-2007-11-126680; Dieudonne MN, 2002, BIOCHEM BIOPH RES CO, V293, P622, DOI 10.1016/S0006-291X(02)00205-X; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Enayetallah AE, 2006, J MOL HISTOL, V37, P133, DOI 10.1007/s10735-006-9050-9; Ernest CS, 2005, J PHARMACOL EXP THER, V312, P583, DOI 10.1124/jpet.104.075416; Gauthier KM, 2004, PHARMACOL RES, V49, P515, DOI 10.1016/j.phrs.2003.09.014; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Guo M, 2005, J PHARMACOL EXP THER, V315, P526, DOI 10.1124/jpet.105.088567; Haas S, 2006, INT J CANCER, V119, P1785, DOI 10.1002/ijc.21915; Jiang JG, 2005, CANCER RES, V65, P4707, DOI 10.1158/0008-5472.CAN-04-4173; Klaassen I, 2001, CLIN CANCER RES, V7, P1017; Lee SH, 2003, RAPID COMMUN MASS SP, V17, P2168, DOI 10.1002/rcm.1170; Li L, 2002, J BIOL CHEM, V277, P17397, DOI 10.1074/jbc.M109962200; Lin L, 2010, NEOPLASIA, V12, P39, DOI 10.1593/neo.91196; Ma J, 2003, J BIOL CHEM, V278, P29252, DOI 10.1074/jbc.M304196200; Mesaros C, 2009, J CHROMATOGR B, V877, P2736, DOI 10.1016/j.jchromb.2009.03.011; Murray GI, 2010, HISTOPATHOLOGY, V57, P202, DOI 10.1111/j.1365-2559.2010.03606.x; Nakano M, 2009, DRUG METAB DISPOS, V37, P2119, DOI 10.1124/dmd.109.028530; Nilsson UK, 2003, LIPIDS, V38, P1057, DOI 10.1007/s11745-006-1161-2; Pincheira R, 2008, J IMMUNOL, V181, P1288, DOI 10.4049/jimmunol.181.2.1288; RIFKIND AB, 1995, ARCH BIOCHEM BIOPHYS, V320, P380, DOI 10.1016/0003-9861(95)90023-3; Sevrioukova IF, 2010, P NATL ACAD SCI USA, V107, P18422, DOI 10.1073/pnas.1010693107; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Sirvent A, 2007, ONCOGENE, V26, P7313, DOI 10.1038/sj.onc.1210543; Smirnova IV, 2000, J BIOL CHEM, V275, P9377, DOI 10.1074/jbc.275.13.9377; Smith G, 2003, LANCET, V361, P1336, DOI 10.1016/S0140-6736(03)13081-4; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Srirangam A, 2006, CLIN CANCER RES, V12, P1883, DOI 10.1158/1078-0432.CCR-05-1167; Stark K, 2008, FEBS J, V275, P3706, DOI 10.1111/j.1742-4658.2008.06518.x; Walsky RL, 2005, J CLIN PHARMACOL, V45, P68, DOI 10.1177/0091270004270642; Wu S, 1996, J BIOL CHEM, V271, P3460; Wu ZL, 2006, MOL PHARMACOL, V69, P2007, DOI 10.1124/mol.106.023648; ZELDIN DC, 1993, J BIOL CHEM, V268, P6402; ZELDIN DC, 1995, ARCH BIOCHEM BIOPHYS, V322, P76, DOI 10.1006/abbi.1995.1438; Zhang JH, 2007, ANAL BIOCHEM, V365, P40, DOI 10.1016/j.ab.2007.03.001; Zhao W, 2010, J BIOL CHEM, V285, P35855, DOI 10.1074/jbc.M110.154088	44	77	78	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17543	17559		10.1074/jbc.M110.198515	http://dx.doi.org/10.1074/jbc.M110.198515			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21402692	hybrid, Green Published			2022-12-27	WOS:000290585200017
J	Yuan, BF; You, CJ; Andersen, N; Jiang, Y; Moriya, M; O'Connor, TR; Wang, YS				Yuan, Bifeng; You, Changjun; Andersen, Nisana; Jiang, Yong; Moriya, Masaaki; O'Connor, Timothy R.; Wang, Yinsheng			The Roles of DNA Polymerases kappa and iota in the Error-free Bypass of N-2-Carboxyalkyl-2 '-deoxyguanosine Lesions in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XERODERMA-PIGMENTOSUM VARIANT; CALF THYMUS DNA; TRANSLESION SYNTHESIS; IN-VIVO; POL-KAPPA; ADDUCT; REPAIR; ETA; MUTAGENESIS; N-2-(1-CARBOXYETHYL)-2'-DEOXYGUANOSINE	To counteract the deleterious effects of DNA damage, cells are equipped with specialized polymerases to bypass DNA lesions. Previous biochemical studies revealed that DinB family DNA polymerases, including Escherichia coli DNA polymerase IV and human DNA polymerase kappa, efficiently incorporate the correct nucleotide opposite some N-2-modified 2'-deoxyguanosine derivatives. Herein, we used shuttle vector technology and demonstrated that deficiency in Polk or Poli in mouse embryonic fibroblast (MEF) cells resulted in elevated frequencies of G-->T and G-->A mutations at N-2-(1-carboxyethyl)-2'-deoxyguanosine (N-2-CEdG) and N-2-carboxymethyl-2'-deoxyguanosine (N-2-CMdG) sites. Steady-state kinetic measurements revealed that human DNA polymerase iota preferentially inserts the correct nucleotide, dCMP, opposite N-2-CEdG lesions. In contrast, no mutation was found after the N-2-CEdG-and N-2-CMdG-bearing plasmids were replicated in POLH-deficient human cells or Rev3-deficient MEF cells. Together, our results revealed that, in mammalian cells, both polymerases kappa and iota are necessary for the error-free bypass of N-2-CEdG and N-2-CMdG. However, in the absence of polymerase kappa or iota, other translesion synthesis polymerase(s) could incorporate nucleotide(s) opposite these lesions but would do so inaccurately.	[Yuan, Bifeng; You, Changjun; Andersen, Nisana; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Jiang, Yong; Wang, Yinsheng] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA; [Yuan, Bifeng] Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Peoples R China; [Moriya, Masaaki] SUNY Stony Brook, Dept Pharmacol Sci, Biol Chem Lab, Stony Brook, NY 11794 USA; [O'Connor, Timothy R.] City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA 91010 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; Wuhan University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; City of Hope; Beckman Research Institute of City of Hope	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	yinsheng.wang@ucr.edu	Yuan, Bi-Feng/K-5803-2013	Yuan, Bi-Feng/0000-0001-5223-4659; Jiang, Yong/0000-0002-1198-1807; O'Connor, Timothy/0000-0001-5848-3592; You, Changjun/0000-0003-4301-2098	National Institutes of Health [R01 DK082779]; California Tobacco-related Disease Research Program [17RT-0109, 18DT-0009, 18XT-0073]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Tobacco-related Disease Research Program(University of California System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant R01 DK082779 (to Y. W.). This work was also supported by the California Tobacco-related Disease Research Program Grants 17RT-0109 (to T. R. O.), 18DT-0009 (to N. A.), and 18XT-0073 (to Y. W.).	Avkin S, 2004, J BIOL CHEM, V279, P53298, DOI 10.1074/jbc.M409155200; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; Bullock SK, 2001, CARCINOGENESIS, V22, P233, DOI 10.1093/carcin/22.2.233; Cao HC, 2007, J AM CHEM SOC, V129, P12123, DOI 10.1021/ja072130e; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Delaney JC, 2006, METHOD ENZYMOL, V408, P1, DOI 10.1016/S0076-6879(06)08001-3; Delaney JC, 1999, CHEM BIOL, V6, P743, DOI 10.1016/S1074-5521(00)80021-6; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Frischmann M, 2005, CHEM RES TOXICOL, V18, P1586, DOI 10.1021/tx0501278; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hong HZ, 2007, NUCLEIC ACIDS RES, V35, P7118, DOI 10.1093/nar/gkm851; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Levine RL, 2000, CANCER RES, V60, P4098; Li H, 2006, KIDNEY INT, V69, P388, DOI 10.1038/sj.ki.5000064; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; McDonald JP, 2003, J EXP MED, V198, P635, DOI 10.1084/jem.20030767; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Ohmori H, 2004, ADV PROTEIN CHEM, V69, P265; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; Pluskota-Karwatka D, 2008, BIOORG CHEM, V36, P57, DOI 10.1016/j.bioorg.2007.10.004; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Schneider M, 2004, CHEM RES TOXICOL, V17, P1385, DOI 10.1021/tx049929d; Wang HX, 2010, CHEM RES TOXICOL, V23, P74, DOI 10.1021/tx900286c; Wittschieben JP, 2006, CANCER RES, V66, P134, DOI 10.1158/0008-5472.CAN-05-2982; Wolfle WT, 2006, MOL CELL BIOL, V26, P381, DOI 10.1128/MCB.26.1.381-386.2006; Yang IY, 2002, CHEM RES TOXICOL, V15, P160, DOI 10.1021/tx010123c; Yasui M, 2004, BIOCHEMISTRY-US, V43, P15005, DOI 10.1021/bi048279+; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Yuan BF, 2008, J BIOL CHEM, V283, P23665, DOI 10.1074/jbc.M804047200; Yuan BF, 2008, P NATL ACAD SCI USA, V105, P8679, DOI 10.1073/pnas.0711546105; Yuan BF, 2010, ACS CHEM BIOL, V5, P1021, DOI 10.1021/cb100214b; Zewail-Foote M, 2001, CHEM BIOL, V8, P1033, DOI 10.1016/S1074-5521(01)00071-0; Ziv O, 2009, P NATL ACAD SCI USA, V106, P11552, DOI 10.1073/pnas.0812548106	47	49	48	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17503	17511		10.1074/jbc.M111.232835	http://dx.doi.org/10.1074/jbc.M111.232835			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454642	Green Published, hybrid			2022-12-27	WOS:000290585200012
J	Fasquelle, L; Scott, HS; Lenoir, M; Wang, J; Rebillard, G; Gaboyard, S; Venteo, S; Francois, F; Mausset-Bonnefont, AL; Antonarakis, SE; Neidhart, E; Chabbert, C; Puel, JL; Guipponi, M; Delprat, B				Fasquelle, Lydie; Scott, Hamish S.; Lenoir, Marc; Wang, Jing; Rebillard, Guy; Gaboyard, Sophie; Venteo, Stephanie; Francois, Florence; Mausset-Bonnefont, Anne-Laure; Antonarakis, Stylianos E.; Neidhart, Elizabeth; Chabbert, Christian; Puel, Jean-Luc; Guipponi, Michel; Delprat, Benjamin			Tmprss3, a Transmembrane Serine Protease Deficient in Human DFNB8/10 Deafness, Is Critical for Cochlear Hair Cell Survival at the Onset of Hearing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL RECESSIVE DEAFNESS; EPITHELIAL SODIUM-CHANNEL; INNER-EAR; RAT; MOUSE; ACTIVATION; MUTATIONS; PROTEINS; DOMAIN	Mutations in the type II transmembrane serine protease 3 (TMPRSS3) gene cause non-syndromic autosomal recessive deafness (DFNB8/10), characterized by congenital or childhood onset bilateral profound hearing loss. In order to explore the physiopathology of TMPRSS3 related deafness, we have generated an ethyl-nitrosourea-induced mutant mouse carrying a protein-truncating nonsense mutation in Tmprss3 (Y260X) and characterized the functional and histological consequences of Tmprss3 deficiency. Auditory brainstem response revealed that wild type and heterozygous mice have normal hearing thresholds up to 5 months of age, whereas Tmprss3(Y260X) homozygous mutant mice exhibit severe deafness. Histological examination showed degeneration of the organ of Corti in adult mutant mice. Cochlear hair cell degeneration starts at the onset of hearing, postnatal day 12, in the basal turn and progresses very rapidly toward the apex, reaching completion within 2 days. Given that auditory and vestibular deficits often co-exist, we evaluated the balancing abilities of Tmprss3(Y260X) mice by using rotating rod and vestibular behavioral tests. Tmprss3(Y260X) mice effectively displayed mild vestibular syndrome that correlated histologically with a slow degeneration of saccular hair cells. In situ hybridization in the developing inner ear showed that Tmprss3 mRNA is localized in sensory hair cells in the cochlea and the vestibule. Our results show that Tmprss3 acts as a permissive factor for cochlear hair cells survival and activation at the onset of hearing and is required for saccular hair cell survival. This mouse model will certainly help to decipher the molecular mechanisms underlying DFNB8/10 deafness and cochlear function.	[Scott, Hamish S.] SA Pathol, Dept Mol Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Fasquelle, Lydie; Lenoir, Marc; Wang, Jing; Rebillard, Guy; Gaboyard, Sophie; Venteo, Stephanie; Francois, Florence; Mausset-Bonnefont, Anne-Laure; Chabbert, Christian; Puel, Jean-Luc; Delprat, Benjamin] Hop St Eloi, INSERM, U 583, Inst Neurosci, F-34091 Montpellier, France; [Fasquelle, Lydie; Lenoir, Marc; Wang, Jing; Rebillard, Guy; Gaboyard, Sophie; Venteo, Stephanie; Francois, Florence; Mausset-Bonnefont, Anne-Laure; Chabbert, Christian; Puel, Jean-Luc; Delprat, Benjamin] Univ Montpellier, F-34091 Montpellier, France; [Fasquelle, Lydie; Antonarakis, Stylianos E.; Neidhart, Elizabeth; Guipponi, Michel] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland; [Fasquelle, Lydie; Antonarakis, Stylianos E.; Neidhart, Elizabeth; Guipponi, Michel] Univ Hosp Geneva, CH-1211 Geneva 4, Switzerland; [Scott, Hamish S.] Univ Adelaide, Sch Med, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Centre for Cancer Biology; SA Pathology; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; University of Geneva; University of Geneva; University of Adelaide	Scott, HS (corresponding author), SA Pathol, Dept Mol Pathol, Ctr Canc Biol, Box 14 Rundle Mall PO, Adelaide, SA 5000, Australia.	hamish.scott@health.sa.gov.au; jean-luc.puel@inserm.fr	Scott, Hamish/B-2122-2009; Bonnefont, Anne-Laure/AAB-5022-2020; Delprat, Benjamin/O-3791-2018; Antonarakis, Stylianos E/N-8866-2014	Scott, Hamish/0000-0002-5813-631X; Bonnefont, Anne-Laure/0000-0003-4119-1475; Antonarakis, Stylianos E/0000-0001-8907-5823; Delprat, Benjamin/0000-0002-2457-6923; Gaboyard-Niay, Sophie/0000-0001-8256-8692; CHABBERT, CHRISTIAN/0000-0003-3932-0223; Puel, jean-luc/0000-0002-3772-5190	Swiss National Science Foundation [3100A0-114077-1]; National Health and Medical Research Council of Australia [257501, 215305, 71601, 461204]; Region Languedoc-Roussillon (Chercheur d'Avenir)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Region Languedoc-Roussillon (Chercheur d'Avenir)(Region Occitanie)	This work was supported Swiss National Science Foundation Grant 3100A0-114077-1 (to M. G.); National Health and Medical Research Council of Australia Grants 257501, 215305, 71601, and 461204 (to H. S. S.); and a grant from the Region Languedoc-Roussillon (Chercheur d'Avenir) (to B. D.).	Ahmed Zubair M, 2004, BMC Med Genet, V5, P24, DOI 10.1186/1471-2350-5-24; Altamura S, 2010, BIOCHEM J, V431, P363, DOI 10.1042/BJ20100668; ARAN JM, 1982, ACTA OTO-LARYNGOL, P1, DOI 10.3109/00016488209108895; Behrens M, 2004, CELL MOL LIFE SCI, V61, P2866, DOI 10.1007/s00018-004-4263-0; Beraneck M, 2008, J NEUROPHYSIOL, V100, P945, DOI 10.1152/jn.90319.2008; Boadas-Vaello P, 2005, TOXICOL SCI, V88, P456, DOI 10.1093/toxsci/kfi314; Bourane S, 2009, NEURON, V64, P857, DOI 10.1016/j.neuron.2009.12.004; Brugeaud A, 2007, J NEUROSCI, V27, P3503, DOI 10.1523/JNEUROSCI.5185-06.2007; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Couloigner V, 2001, AM J PHYSIOL-RENAL, V280, pF214, DOI 10.1152/ajprenal.2001.280.2.F214; Desai SS, 2005, J NEUROPHYSIOL, V93, P251, DOI 10.1152/jn.00746.2003; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; Grunder S, 2001, EUR J NEUROSCI, V13, P641, DOI 10.1046/j.1460-9568.2001.01426.x; Guipponi M, 2002, HUM MOL GENET, V11, P2829, DOI 10.1093/hmg/11.23.2829; Guipponi M, 2008, HUM MUTAT, V29, P130, DOI 10.1002/humu.20617; Guipponi M, 2007, AM J PATHOL, V171, P608, DOI 10.2353/ajpath.2007.070068; KRAUS HJ, 1981, HEARING RES, V4, P89, DOI 10.1016/0378-5955(81)90038-1; Ladrech S, 2004, J COMP NEUROL, V477, P149, DOI 10.1002/cne.20252; Lee YJ, 2003, J MED GENET, V40, P629, DOI 10.1136/jmg.40.8.629; Masmoudi S, 2001, HUM MUTAT, V18, P101, DOI 10.1002/humu.1159; Ou HC, 2000, HEARING RES, V145, P123, DOI 10.1016/S0378-5955(00)00082-4; Peters TA, 2006, ACTA OTO-LARYNGOL, V126, P237, DOI 10.1080/00016480500388893; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; SHNERSON A, 1983, DEV BRAIN RES, V9, P305, DOI 10.1016/0165-3806(83)90028-7; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Wang J, 2003, J NEUROSCI, V23, P8596; Wattenhofer M, 2005, HUM GENET, V117, P528, DOI 10.1007/s00439-005-1332-x; Zhong SX, 2004, HEARING RES, V193, P1, DOI 10.1016/j.heares.2004.03.001	32	51	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17383	17397		10.1074/jbc.M110.190652	http://dx.doi.org/10.1074/jbc.M110.190652			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454591	Green Published, hybrid			2022-12-27	WOS:000290301900086
J	Plaza-Menacho, I; Morandi, A; Mologni, L; Boender, P; Gambacorti-Passerini, C; Magee, AI; Hofstra, RMW; Knowles, P; McDonald, NQ; Isacke, CM				Plaza-Menacho, Ivan; Morandi, Andrea; Mologni, Luca; Boender, Piet; Gambacorti-Passerini, Carlo; Magee, Anthony I.; Hofstra, Robert M. W.; Knowles, Phillip; McDonald, Neil Q.; Isacke, Clare M.			Focal Adhesion Kinase (FAK) Binds RET Kinase via Its FERM Domain, Priming a Direct and Reciprocal RET-FAK Transactivation Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; TYROSINE KINASE; THYROID-CANCER; PEPTIDE ARRAYS; IN-VITRO; RECEPTOR; INHIBITION; EXPRESSION; TUMORS; PHOSPHORYLATION	Whether RET is able to directly phosphorylate and activate downstream targets independently of the binding of proteins that contain Src homology 2 or phosphotyrosine binding domains and whether mechanisms in trans by cytoplasmic kinases can modulate RET function and signaling remain largely unexplored. In this study, oligopeptide arrays were used to screen substrates directly phosphorylated by purified recombinant wild-type and oncogenic RET kinase domain in the presence or absence of small molecule inhibitors. The results of the peptide array were validated by enzyme kinetics, in vitro kinase, and cell-based experiments. The identification of focal adhesion kinase (FAK) as a direct substrate for RET kinase revealed (i) a RET-FAK transactivation mechanism consisting of direct phosphorylation of FAK Tyr-576/577 by RET and a reciprocal phosphorylation of RET by FAK, which crucially is able to rescue the kinase-impaired RET K758M mutant and (ii) that FAK binds RET via its FERM domain. Interestingly, this interaction is abolished upon RET phosphorylation, indicating that RET binding to the FERM domain of FAK is a priming step for RET-FAK transactivation. Finally, our data indicate that FAK inhibitors could be used as potential therapeutic agents for patients with multiple endocrine neoplasia type 2 tumors because both, treatment with the FAK kinase inhibitor NVP-TAE226 and FAK down-regulation by siRNA reduced RET phosphorylation and signaling as well as the proliferation and survival of tumor and transfected cell lines expressing oncogenic RET.	[Plaza-Menacho, Ivan; Knowles, Phillip; McDonald, Neil Q.] Canc Res UK, Struct Biol Lab, London Res Inst, London WC2A 3LY, England; [Plaza-Menacho, Ivan; Morandi, Andrea; Isacke, Clare M.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Mologni, Luca; Gambacorti-Passerini, Carlo] Univ Milano Bicocca, Dept Clin & Prevent Med, I-20052 Monza, Italy; [Boender, Piet] PamGene Int BV, NL-5200 BJ S Hertogenbosh, Netherlands; [Magee, Anthony I.] Univ London Imperial Coll Sci Technol & Med, Sect Mol Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Hofstra, Robert M. W.] Univ Groningen, Dept Genet, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Milano-Bicocca; PamGene International BV; Imperial College London; University of Groningen	Plaza-Menacho, I (corresponding author), Canc Res UK, Struct Biol Lab, London Res Inst, London WC2A 3LY, England.	Ivan.Plaza-Menacho@cancer.org.uk	Magee, Anthony/V-8345-2019; Mologni, Luca/AAC-1065-2022; Piris, Alejandro/D-3830-2014; Plaza-Menacho, Ivan/K-8517-2017	Mologni, Luca/0000-0002-6365-5149; Hofstra, Robert/0000-0001-7498-3829; Morandi, Andrea/0000-0002-9222-5332; Isacke, Clare/0000-0002-9222-3345; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; Plaza-Menacho, Ivan/0000-0003-4666-9431	Breakthrough Breast Cancer; Ministerio de Educacion y Ciencia of Spain [EX2006_1341]; Cancer Research UK; National Health Service; Cancer Research UK [10747] Funding Source: researchfish	Breakthrough Breast Cancer; Ministerio de Educacion y Ciencia of Spain(Spanish Government); Cancer Research UK(Cancer Research UK); National Health Service; Cancer Research UK(Cancer Research UK)	This work was supported by grants from Breakthrough Breast Cancer (to C. M. I.), Ministerio de Educacion y Ciencia of Spain Grant EX2006_1341 (to I.P.-M.), and Cancer Research UK (to I.P.-M. and N.Q.M.).; We thank Novartis for the NVP-TAE226 inhibitor, Rob Ruijtenbeek (PamGene) for helpful comments on the manuscript, Prof. M. Schaller for providing the GST-FERM-FAK plasmids, and Roger Georges and the Protein Production Facility (London Research Institute, Cancer Research UK) for helping with baculovirus expression of recombinant protein. The National Institute for Health Research Biomedical Research Centre is supported by the National Health Service.	Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Carlomagno F, 2004, ONCOGENE, V23, P6056, DOI 10.1038/sj.onc.1207810; Carlomagno F, 2006, JNCI-J NATL CANCER I, V98, P326, DOI 10.1093/jnci/djj069; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; de Groot JWB, 2006, ENDOCR REV, V27, P535, DOI 10.1210/er.2006-0017; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P222, DOI 10.1002/mc.20380; Halder J, 2007, CANCER RES, V67, P10976, DOI 10.1158/0008-5472.CAN-07-2667; Han NM, 1997, ANN SURG ONCOL, V4, P264, DOI 10.1007/BF02306620; Hilhorst R, 2009, ANAL BIOCHEM, V387, P150, DOI 10.1016/j.ab.2009.01.022; ILIC D, 1995, BIOCHEM BIOPH RES CO, V209, P300, DOI 10.1006/bbrc.1995.1503; ILLC D, 1995, NATURE, V377, P539; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Lim ST, 2008, CELL CYCLE, V7, P2306, DOI 10.4161/cc.6367; Liu TJ, 2007, MOL CANCER THER, V6, P1357, DOI 10.1158/1535-7163.MCT-06-0476; Maat W, 2009, BRIT J CANCER, V101, P312, DOI 10.1038/sj.bjc.6605172; Manie S, 2001, TRENDS GENET, V17, P580, DOI 10.1016/S0168-9525(01)02420-9; Mologni L, 2005, PROTEIN EXPRES PURIF, V41, P177, DOI 10.1016/j.pep.2005.01.002; Murakami H, 1999, ONCOGENE, V18, P1975, DOI 10.1038/sj.onc.1202514; Natarajan M, 2003, CANCER J, V9, P126, DOI 10.1097/00130404-200303000-00008; Owens LV, 1996, ANN SURG ONCOL, V3, P100, DOI 10.1007/BF02409059; Panta GR, 2005, SURGERY, V138, P269, DOI 10.1016/j.surg.2005.04.007; Panta GR, 2004, SURGERY, V136, P1212, DOI 10.1016/j.surg.2004.06.048; PARSONS JT, 1994, J CELL SCI, P109; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Plaza-Menacho I, 2010, ONCOGENE, V29, P4648, DOI 10.1038/onc.2010.209; Plaza-Menacho I, 2007, J BIOL CHEM, V282, P29230, DOI 10.1074/jbc.M703461200; Plaza-Menacho I, 2006, TRENDS GENET, V22, P627, DOI 10.1016/j.tig.2006.09.005; Reineke U, 2001, CURR OPIN BIOTECH, V12, P59, DOI 10.1016/S0958-1669(00)00178-6; Sala E, 2006, INT J BIOL MACROMOL, V39, P60, DOI 10.1016/j.ijbiomac.2006.01.006; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHLESSINGER J, 2000, MOL CELL BIOL, V103, P8461; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Schutkowski M, 2005, CHEMBIOCHEM, V6, P513, DOI 10.1002/cbic.200400314; Shi Q, 2007, MOL CARCINOGEN, V46, P488, DOI 10.1002/mc.20297; Sikkema AH, 2009, CANCER RES, V69, P5987, DOI 10.1158/0008-5472.CAN-08-3660; Thomas JW, 1999, J BIOL CHEM, V274, P36684, DOI 10.1074/jbc.274.51.36684; Tremblay L, 1996, INT J CANCER, V68, P164, DOI 10.1002/(SICI)1097-0215(19961009)68:2<169::AID-IJC4>3.0.CO;2-W; Zwick E, 2001, ENDOCR-RELAT CANCER, V8, P161, DOI 10.1677/erc.0.0080161	42	42	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17292	17302		10.1074/jbc.M110.168500	http://dx.doi.org/10.1074/jbc.M110.168500			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454698	Green Published, hybrid			2022-12-27	WOS:000290301900077
J	Bimboese, P; Gibson, CJ; Schmidt, S; Xiang, WQ; Ehrlich, BE				Bimboese, Patricia; Gibson, Craig J.; Schmidt, Stefan; Xiang, Wanqing; Ehrlich, Barbara E.			Isoform-specific Regulation of the Inositol 1,4,5-Trisphosphate Receptor by O-Linked Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ACINAR-CELLS; III INSP(3) RECEPTOR; PROTEIN-KINASE-A; N-ACETYLGLUCOSAMINE; INSULIN-RESISTANCE; GLCNAC TRANSFERASE; HEXOSAMINE BIOSYNTHESIS; DIABETIC-RATS; BETA-CELLS; CALCIUM	The inositol 1,4,5-trisphosphate receptor (InsP(3)R), an intracellular calcium channel, has three isoforms with >65% sequence homology, yet the isoforms differ in their function and regulation by post-translational modifications. We showed previously that InsP(3)R-1 is functionally modified by O-linked beta-N-acetylglucosamine glycosylation (O-GlcNAcylation) (Rengifo, J., Gibson, C. J., Winkler, E., Collin, T., and Ehrlich, B. E. (2007) J. Neurosci. 27, 13813-13821). We now report the effect of O-GlcNAcylation on InsP(3)R-2 and InsP(3)R-3. Analysis of AR4-2J cells, a rat pancreatoma cell line expressing predominantly InsP(3)R-2, showed no detectable O-GlcNAcylation of InsP(3)R-2 and no significant functional changes despite the presence of the enzymes for addition (O-beta-N-acetylglucosaminyltransferase) and removal (O-beta-N-acetylglucosaminidase) of the monosaccharide. In contrast, InsP(3)R-3 in Mz-ChA-1 cells, a human cholangiocarcinoma cell line expressing predominantly InsP(3)R-3, was functionally modified by O-GlcNAcylation. Interestingly, the functional impact of O-GlcNAcylation on the InsP(3)R-3 channel was opposite the effect measured with InsP(3)R-1. Addition of O-GlcNAc by O-beta-N-acetylglucosaminyltransferase increased InsP(3)R-3 single channel open probability. Incubation of Mz-ChA-1 cells in hyperglycemic medium caused an increase in the InsP(3)-dependent calcium release from the endoplasmic reticulum. The dynamic and inducible nature of O-GlcNAcylation and the InsP(3)R isoform specificity suggest that this form of modification of InsP(3)R and subsequent changes in intracellular calcium transients are important in physiological and pathophysiological processes.	[Ehrlich, Barbara E.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University; Yale University	Ehrlich, BE (corresponding author), Yale Univ, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	barbara.ehrlich@yale.edu	/AAX-8408-2021; Bimboese, Patricia/ABA-1227-2021	/0000-0001-9657-9704; Bimboese, Patricia/0000-0003-3282-1762; Schmidt, Stefan/0000-0001-8590-6319	National Institutes of Health [DK57751, DK61747]; German National Merit Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057751, R01DK061747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German National Merit Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57751 and DK61747. This work was also supported by scholarships from the German National Merit Foundation (to P. B., S. S., and W. X.).	Akimoto Yoshihiro, 2005, Medical Molecular Morphology, V38, P84, DOI 10.1007/s00795-004-0264-1; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; DANIELS MC, 1993, MOL ENDOCRINOL, V7, P1041, DOI 10.1210/me.7.8.1041; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Forrest ARR, 2003, GENOME RES, V13, P1443, DOI 10.1101/gr.954803; FURUICHI T, 1995, J NEUROCHEM, V64, P953, DOI 10.1046/j.1471-4159.1995.64030953.x; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Futatsugi A, 1998, BIOCHEM J, V334, P559, DOI 10.1042/bj3340559; Gibson CJ, 2008, CELL CALCIUM, V43, P228, DOI 10.1016/j.ceca.2007.05.008; Hagar RE, 1998, NATURE, V396, P81, DOI 10.1038/23954; Hagar RE, 2000, BIOPHYS J, V79, P271, DOI 10.1016/S0006-3495(00)76289-8; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Kaznacheyeva E, 1998, J GEN PHYSIOL, V111, P847, DOI 10.1085/jgp.111.6.847; KORNFELD R, 1967, J BIOL CHEM, V242, P3135; Lee B, 1999, ENDOCRINOLOGY, V140, P2173, DOI 10.1210/en.140.5.2173; Lee B, 1998, J MOL ENDOCRINOL, V21, P31, DOI 10.1677/jme.0.0210031; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Marshall S, 2003, ANAL BIOCHEM, V314, P169, DOI 10.1016/S0003-2697(02)00686-3; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; MICHIKAWA T, 1994, J BIOL CHEM, V269, P9184; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Minagawa N, 2005, J BIOL CHEM, V280, P33637, DOI 10.1074/jbc.M503210200; NATHANSON MH, 1994, J BIOL CHEM, V269, P4693; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Perez PJ, 1997, J BIOL CHEM, V272, P23961, DOI 10.1074/jbc.272.38.23961; Rengifo J, 2007, J NEUROSCI, V27, P13813, DOI 10.1523/JNEUROSCI.2069-07.2007; ROBINSON KA, 1995, DIABETES, V44, P1438, DOI 10.2337/diabetes.44.12.1438; Ryu Gyeong Ryul, 2004, Pancreas, V29, pe106, DOI 10.1097/00006676-200411000-00164; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sharma K, 1999, AM J PHYSIOL-RENAL, V276, pF54, DOI 10.1152/ajprenal.1999.276.1.F54; Slawson C, 2003, CURR OPIN STRUC BIOL, V13, P631, DOI 10.1016/j.sbi.2003.08.003; Sliter DA, 2011, J BIOL CHEM, V286, P1074, DOI 10.1074/jbc.M110.188383; Sliter DA, 2008, J BIOL CHEM, V283, P35319, DOI 10.1074/jbc.M807288200; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; Straub SV, 2002, J BIOL CHEM, V277, P31949, DOI 10.1074/jbc.M204318200; Tang TS, 2003, J NEUROSCI, V23, P403, DOI 10.1523/JNEUROSCI.23-02-00403.2003; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Vermassen E, 2004, BIOL CELL, V96, P3, DOI 10.1016/j.biolcel.2003.11.004; Wagner LE, 2008, J PHYSIOL-LONDON, V586, P3577, DOI 10.1113/jphysiol.2008.152314; Wagner LE, 2004, J BIOL CHEM, V279, P46242, DOI 10.1074/jbc.M405849200; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200; WATRAS J, 1991, J NEUROSCI, V11, P3239; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; WOJCIKIEWICZ RJH, 1994, J BIOL CHEM, V269, P7963; Yamazaki H, 2010, J NUTR SCI VITAMINOL, V56, P1, DOI 10.3177/jnsv.56.1; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; YU Z, 1994, AM J PHYSIOL, V266, pH2334, DOI 10.1152/ajpheart.1994.266.6.H2334; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	67	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.206482	http://dx.doi.org/10.1074/jbc.M110.206482			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21383013	Green Published, hybrid			2022-12-27	WOS:000290022800008
J	VanderWielen, BD; Yuan, ZY; Friedmann, DR; Kovall, RA				VanderWielen, Bradley D.; Yuan, Zhenyu; Friedmann, David R.; Kovall, Rhett A.			Transcriptional Repression in the Notch Pathway THERMODYNAMIC CHARACTERIZATION OF CSL-MINT (Msx2-INTERACTING NUCLEAR TARGET PROTEIN) COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; ACCESSIBLE SURFACE-AREAS; RBP-J; SIGNALING PATHWAY; CRYSTAL-STRUCTURE; ANKYRIN REPEATS; HEAT-CAPACITY; CO-REPRESSOR; TARGET GENES; BINDING	The Notch pathway is a conserved cell-to-cell signaling mechanism that mediates cell fate decisions in metazoans. Canonical signaling results in changes in gene expression, which is regulated by the nuclear effector of the pathway CSL (CBF1/RBP-J, Su(H), Lag-1). CSL is a DNA binding protein that functions as either a repressor or an activator of transcription, depending upon whether it is complexed by transcriptional corepressor or coactivator proteins, respectively. In stark contrast to CSL-coactivator complexes, e. g. the transcriptionally active CSL-Notch-Mastermind ternary complex, the structure and function of CSL-corepressor complexes are poorly understood. The corepressor MINT (Msx2-interacting nuclear target protein) has been shown in vivo to antagonize Notch signaling and shown in vitro to biochemically interact with CSL; however, the molecular details of this interaction are only partially defined. Here, we provide a quantitative thermodynamic binding analysis of CSL-MINT complexes. Using isothermal titration calorimetry, we demonstrate that MINT forms a high affinity complex with CSL, and we also delineate the domains of MINT and CSL that are necessary and sufficient for complex formation. Moreover, we show in cultured cells that this region of MINT can inhibit Notch signaling in transcriptional reporter assays. Taken together, our results provide functional insights into how CSL is converted from a repressor to an activator of transcription.	[VanderWielen, Bradley D.; Yuan, Zhenyu; Kovall, Rhett A.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Friedmann, David R.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University System of Ohio; University of Cincinnati; The Wistar Institute	Kovall, RA (corresponding author), 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	kovallra@ucmail.uc.edu			National Institutes of Health [CA120199]; Leukemia and Lymphoma Society; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA120199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA120199. This work was also supported by a Leukemia and Lymphoma Society award (to R. A. K.) and a predoctoral fellowship from the American Heart Association (to D. R. F.).	Ariyoshi M, 2003, GENE DEV, V17, P1909, DOI 10.1101/gad.266203; Arnett KL, 2010, NAT STRUCT MOL BIOL, V17, P1312, DOI 10.1038/nsmb.1938; Bertagna A, 2008, BIOCHEM SOC T, V36, P157, DOI 10.1042/BST0360157; Bigas A, 2010, INT J DEV BIOL, V54, P1175, DOI 10.1387/ijdb.093049ab; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Del Bianco C, 2008, J MOL BIOL, V376, P131, DOI 10.1016/j.jmb.2007.11.061; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Friedmann DR, 2008, J BIOL CHEM, V283, P14781, DOI 10.1074/jbc.M709501200; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Johnson SE, 2010, J BIOL CHEM, V285, P6681, DOI 10.1074/jbc.M109.019968; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kato H, 1997, DEVELOPMENT, V124, P4133; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; LIVINGSTONE JR, 1991, BIOCHEMISTRY-US, V30, P4237, DOI 10.1021/bi00231a019; Lubman OY, 2007, J MOL BIOL, V365, P577, DOI 10.1016/j.jmb.2006.09.071; MacGrogan D, 2010, CURR TOP DEV BIOL, V92, P333, DOI 10.1016/S0070-2153(10)92011-5; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Nam YS, 2007, P NATL ACAD SCI USA, V104, P2103, DOI 10.1073/pnas.0611092104; Newberry EP, 1999, BIOCHEMISTRY-US, V38, P10678, DOI 10.1021/bi990967j; OKA C, 1995, DEVELOPMENT, V121, P3291; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Oswald F, 2005, MOL CELL BIOL, V25, P10379, DOI 10.1128/MCB.25.23.10379-10390.2005; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Salat D, 2008, MOL CELL BIOL, V28, P3502, DOI 10.1128/MCB.01966-07; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; Surendran K, 2010, DEV BIOL, V337, P386, DOI 10.1016/j.ydbio.2009.11.017; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Tsuji M, 2007, P NATL ACAD SCI USA, V104, P1610, DOI 10.1073/pnas.0610520104; Waltzer L, 1995, NUCLEIC ACIDS RES, V23, P4939, DOI 10.1093/nar/23.24.4939; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wyman J, 1990, BINDING LINKAGE FUNC; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Zweifel ME, 2001, BIOCHEMISTRY-US, V40, P14344, DOI 10.1021/bi011435h; Zweifel ME, 2001, BIOCHEMISTRY-US, V40, P14357, DOI 10.1021/bi011436+	56	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14892	14902		10.1074/jbc.M110.181156	http://dx.doi.org/10.1074/jbc.M110.181156			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21372128	Green Published, hybrid			2022-12-27	WOS:000289788300019
J	Kothandapani, A; Dangeti, VSMN; Brown, AR; Banze, LA; Wang, XH; Sobol, RW; Patrick, SM				Kothandapani, Anbarasi; Dangeti, Venkata Srinivas Mohan Nimai; Brown, Ashley R.; Banze, Lauren A.; Wang, Xiao-Hong; Sobol, Robert W.; Patrick, Steve M.			Novel Role of Base Excision Repair in Mediating Cisplatin Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTRAND CROSS-LINK; DNA-POLYMERASE-BETA; REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; HOMOLOGOUS RECOMBINATION; CYTOSINE DEAMINATION; CARRIER LIGAND; ABASIC SITES; GPG ADDUCTS; DAMAGED DNA	Using isogenic mouse embryonic fibroblasts and human cancer cell lines, we show that cells defective in base excision repair (BER) display a cisplatin-specific resistant phenotype. This was accompanied by enhanced repair of cisplatin interstrand cross-links (ICLs) and ICL-induced DNA double strand breaks, but not intrastrand adducts. Cisplatin induces abasic sites with a reduced accumulation in uracil DNA glycosylase (UNG) null cells. We show that cytosines that flank the cisplatin ICLs undergo preferential oxidative deamination in vitro, and AP endonuclease 1 (APE1) can cleave the resulting ICL DNA substrate following removal of the flanking uracil. We also show that DNA polymerase beta has low fidelity at the cisplatin ICL site after APE1 incision. Down-regulating ERCC1-XPF in BER-deficient cells restored cisplatin sensitivity. Based on our results, we propose a novel model in which BER plays a positive role in maintaining cisplatin cytotoxicity by competing with the productive cisplatin ICL DNA repair pathways.	[Kothandapani, Anbarasi; Dangeti, Venkata Srinivas Mohan Nimai; Patrick, Steve M.] Univ Toledo, Dept Biochem & Canc Biol, Toledo, OH 43614 USA; [Sobol, Robert W.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Brown, Ashley R.; Banze, Lauren A.; Wang, Xiao-Hong; Sobol, Robert W.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Sobol, Robert W.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15213 USA	University System of Ohio; University of Toledo; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Patrick, SM (corresponding author), 3035 Arlington Ave, Toledo, OH 43614 USA.	Stephan.Patrick@utoledo.edu	Sobol, Robert W./E-4125-2013	Sobol, Robert W./0000-0001-7385-3563	National Institutes of Health [1R01-GM088249, CA132385, GM087798, CA148629]; American Cancer Society (ACS) [RSG-06-163-01-GMC]; NATIONAL CANCER INSTITUTE [R01CA148629, P20CA132385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088249, R43GM087798, R44GM087798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society (ACS)(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01-GM088249 (to S. M. P.) and CA132385, GM087798, and CA148629 (to R. W. S.). This study was also supported by grants from the American Cancer Society (ACS, RSG-06-163-01-GMC) (to S. M. P.).	Al-Minawi AZ, 2009, NUCLEIC ACIDS RES, V37, P6400, DOI 10.1093/nar/gkp705; Albertella MR, 2005, DNA REPAIR, V4, P583, DOI 10.1016/j.dnarep.2005.01.005; Allan JM, 1998, CANCER RES, V58, P3965; Arora S, 2010, DNA REPAIR, V9, P745, DOI 10.1016/j.dnarep.2010.03.010; Bergoglio V, 2001, ONCOGENE, V20, P6181, DOI 10.1038/sj.onc.1204743; Boudsocq F, 2005, MOL PHARMACOL, V67, P1485, DOI 10.1124/mol.104.001776; BRABEC V, 1990, BIOPHYS CHEM, V35, P129, DOI 10.1016/0301-4622(90)80003-P; BRABEC V, 1993, BIOCHEMISTRY-US, V32, P11676, DOI 10.1021/bi00094a025; Carpenter M, 2006, NUCLEIC ACIDS RES, V34, P3762, DOI 10.1093/nar/gkl545; CHEN H, 1993, BIOCHEMISTRY-US, V32, P3535, DOI 10.1021/bi00065a003; Clingen PH, 2008, BIOCHEM PHARMACOL, V76, P19, DOI 10.1016/j.bcp.2008.03.025; Clingen PH, 2007, EXP CELL RES, V313, P753, DOI 10.1016/j.yexcr.2006.11.007; Coste F, 1999, NUCLEIC ACIDS RES, V27, P1837, DOI 10.1093/nar/27.8.1837; Couve-Privat S, 2007, NUCLEIC ACIDS RES, V35, P5672, DOI 10.1093/nar/gkm592; De Silva IU, 2002, NUCLEIC ACIDS RES, V30, P3848, DOI 10.1093/nar/gkf479; EASTMAN A, 1988, BIOCHEMISTRY-US, V27, P4730, DOI 10.1021/bi00413a022; Fagan PA, 1996, NUCLEIC ACIDS RES, V24, P1566, DOI 10.1093/nar/24.8.1566; FORTINI P, 1992, CARCINOGENESIS, V13, P87, DOI 10.1093/carcin/13.1.87; FREDERICO LA, 1993, BIOCHEMISTRY-US, V32, P6523, DOI 10.1021/bi00077a005; FROSINA G, 1994, BIOCHEM J, V304, P699, DOI 10.1042/bj3040699; Hlavin EM, 2010, BIOCHEMISTRY-US, V49, P3977, DOI 10.1021/bi902169q; KASPARKOVA J, 1995, BIOCHEMISTRY-US, V34, P12379, DOI 10.1021/bi00038a035; Kasparkova J, 2008, CHEM-EUR J, V14, P1330, DOI 10.1002/chem.200701352; KUMARESAN KR, 1992, BIOCHEMISTRY-US, V31, P6774, DOI 10.1021/bi00144a018; LIUZZI M, 1985, J BIOL CHEM, V260, P5252; Lukin M, 2006, CHEM REV, V106, P607, DOI 10.1021/cr0404646; Miyagawa K, 2008, CANCER SCI, V99, P187, DOI 10.1111/j.1349-7006.2007.00644.x; Mogi S, 2006, DNA REPAIR, V5, P731, DOI 10.1016/j.dnarep.2006.03.009; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Nakamura J, 2003, NUCLEIC ACIDS RES, V31, P1790, DOI 10.1093/nar/gkg263; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Patrick SM, 1999, J BIOL CHEM, V274, P14972, DOI 10.1074/jbc.274.21.14972; Patrick SM, 2008, BIOCHEMISTRY-US, V47, P10188, DOI 10.1021/bi800460d; Prewett M, 2007, CLIN CANCER RES, V13, P7432, DOI 10.1158/1078-0432.CCR-07-1768; Raaphorst GP, 2002, INT J HYPERTHER, V18, P33, DOI 10.1080/02656730110072352; Raaphorst GP, 2001, ANTICANCER RES, V21, P2079; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Reardon JT, 1999, CANCER RES, V59, P3968; Satoh M, 2003, J PHARMACOL EXP THER, V305, P1183, DOI 10.1124/jpet.102.047522; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; TILBY MJ, 1991, CANCER RES, V51, P123; Trivedi RN, 2008, MOL PHARMACOL, V74, P505, DOI 10.1124/mol.108.045112; Turchi JJ, 1997, BIOCHEMISTRY-US, V36, P7586, DOI 10.1021/bi963124q; Vaisman A, 2000, J BIOL CHEM, V275, P13017, DOI 10.1074/jbc.275.17.13017; Vaisman A, 1999, BIOCHEMISTRY-US, V38, P11026, DOI 10.1021/bi9909187; Vaisman A, 2000, BIOCHEMISTRY-US, V39, P4575, DOI 10.1021/bi000130k; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang D, 2009, LUNG CANCER, V66, P298, DOI 10.1016/j.lungcan.2009.02.019; Wang X, 2001, MOL CELL BIOL, V21, P713, DOI 10.1128/MCB.21.3.713-720.2001; Wilson DM, 2010, TRENDS BIOCHEM SCI, V35, P247, DOI 10.1016/j.tibs.2010.01.003; Yan L, 2007, CLIN CANCER RES, V13, P1532, DOI 10.1158/1078-0432.CCR-06-1595	51	61	63	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14564	14574		10.1074/jbc.M111.225375	http://dx.doi.org/10.1074/jbc.M111.225375			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357694	Green Published, hybrid			2022-12-27	WOS:000289556200076
J	Liu, H; Aldrich, RW				Liu, He; Aldrich, Richard W.			Tissue-specific N Terminus of the HCN4 Channel Affects Channel Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-GATED CHANNELS; RABBIT SINOATRIAL NODE; PACEMAKER CHANNELS; CATION CHANNELS; INTERSUBUNIT INTERACTION; SOCIAL SIGNAL; HUMAN HEART; CURRENT IF; MODULATION; CAMP	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are expressed in the brain and heart and are essential for physiological functions in cardiac and nervous systems. We identified two Hcn4 mRNA variants with different transcription start sites and differential expression patterns in mouse brain and heart. Only one mRNA variant was detected in the brain, whereas both variants were found in the heart. Patch clamp recordings of these two variants in HEK293H cells revealed different electrophysiological properties in channel activation. Mutagenesis studies showed that three positively charged amino acids (Arg-9, Lys-10, and Lys-22) contribute to the functional difference. Our results demonstrate that HCN4 channels are expressed in different patterns in mouse brain and heart and that the N terminus is important for HCN4 channel activation.	[Liu, He; Aldrich, Richard W.] Univ Texas Austin, Neurobiol Sect, Ctr Learning & Memory, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Aldrich, RW (corresponding author), Univ Texas Austin, Neurobiol Sect, Ctr Learning & Memory, 1 Univ Stn,C0920, Austin, TX 78712 USA.	raldrich@mail.utexas.edu						Accili EA, 1997, J PHYSIOL-LONDON, V500, P643, DOI 10.1113/jphysiol.1997.sp022049; Allen D, 2007, J NEUROSCI, V27, P2369, DOI 10.1523/JNEUROSCI.3565-06.2007; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; DIFRANCESCO D, 1986, J PHYSIOL-LONDON, V377, P61, DOI 10.1113/jphysiol.1986.sp016177; DIFRANCESCO D, 1991, J PHYSIOL-LONDON, V434, P23, DOI 10.1113/jphysiol.1991.sp018457; Gordon SE, 1997, NEURON, V19, P431, DOI 10.1016/S0896-6273(00)80951-4; Ishii TM, 2007, BIOCHEM BIOPH RES CO, V359, P592, DOI 10.1016/j.bbrc.2007.05.127; Ishii TM, 2001, J PHYSIOL-LONDON, V537, P93, DOI 10.1111/j.1469-7793.2001.0093k.x; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Lin HX, 2009, CELL PHYSIOL BIOCHEM, V23, P317, DOI 10.1159/000218178; Liu H, 2008, J NEUROSCI, V28, P9173, DOI 10.1523/JNEUROSCI.2783-08.2008; Liu H, 2007, DEV NEUROBIOL, V67, P1289, DOI 10.1002/dneu.20404; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Mohapatra DP, 2009, CHANNELS, V3, P46, DOI 10.4161/chan.3.1.7655; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Sala F, 2005, J BIOL CHEM, V280, P6642, DOI 10.1074/jbc.M411048200; Schulteis CT, 1996, BIOCHEMISTRY-US, V35, P12133, DOI 10.1021/bi961083s; Shi WM, 1999, CIRC RES, V85, pE1; Stillitano F, 2008, J MOL CELL CARDIOL, V45, P289, DOI 10.1016/j.yjmcc.2008.04.013; Todorovic J, 2010, P NATL ACAD SCI USA, V107, P7987, DOI 10.1073/pnas.1001845107; Tran N, 2002, J BIOL CHEM, V277, P43588, DOI 10.1074/jbc.M208477200; Viscomi C, 2001, J BIOL CHEM, V276, P29930, DOI 10.1074/jbc.M103971200; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Wicks NL, 2009, PFLUG ARCH EUR J PHY, V458, P877, DOI 10.1007/s00424-009-0687-6; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zakon HH, 2008, J EXP BIOL, V211, P1814, DOI 10.1242/jeb.015982; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zheng J, 2003, J NEUROSCI, V23, P8167	33	5	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14209	14214		10.1074/jbc.M110.215640	http://dx.doi.org/10.1074/jbc.M110.215640			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21372143	hybrid, Green Published			2022-12-27	WOS:000289556200044
J	Shi, JH; Qian, W; Yin, XM; Iqbal, K; Grundke-Iqbal, I; Gu, XS; Ding, F; Gong, CX; Liu, F				Shi, Jianhua; Qian, Wei; Yin, Xiaomin; Iqbal, Khalid; Grundke-Iqbal, Inge; Gu, Xiaosong; Ding, Fei; Gong, Cheng-Xin; Liu, Fei			Cyclic AMP-dependent Protein Kinase Regulates the Alternative Splicing of Tau Exon 10 A MECHANISM INVOLVED IN TAU PATHOLOGY OF ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; SR PROTEINS; NUCLEAR IMPORT; PICKS-DISEASE; FRONTOTEMPORAL DEMENTIA; SPORADIC TAUOPATHIES; CATALYTIC SUBUNIT; FACTOR ASF/SF2; MOUSE-BRAIN; PHOSPHORYLATION	Hyperphosphorylation and deposition of tau into neurofibrillary tangles is a hallmark of Alzheimer disease (AD). Alternative splicing of tau exon 10 generates tau isoforms containing three or four microtubule binding repeats (3R-tau and 4R-tau), which are equally expressed in adult human brain. Dysregulation of exon 10 causes neurofibrillary degeneration. Here, we report that cyclic AMP-dependent protein kinase, PKA, phosphorylates splicing factor SRSF1, modulates its binding to tau pre-mRNA, and promotes tau exon 10 inclusion in cultured cells and in vivo in rat brain. PKA-C alpha, but not PKA-C alpha, interacts with SRSF1 and elevates SRSF1-mediated tau exon 10 inclusion. In AD brain, the decreased level of PKA-C alpha correlates with the increased level of 3R-tau. These findings suggest that a down-regulation of PKA dysregulates the alternative splicing of tau exon 10 and contributes to neurofibrillary degeneration in AD by causing an imbalance in 3R-tau and 4R-tau expression.	[Liu, Fei] Nantong Univ, Sch Med, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China; [Shi, Jianhua; Qian, Wei; Yin, Xiaomin] Nantong Univ, Sch Med, Dept Biochem, Nantong 226001, Jiangsu, Peoples R China; [Iqbal, Khalid; Grundke-Iqbal, Inge; Gong, Cheng-Xin; Liu, Fei] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA	Nantong University; Nantong University; Institute for Basic Research in Developmental Disabilities	Liu, F (corresponding author), Nantong Univ, Sch Med, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China.	feiliu63@hotmail.com	Shi, Jianhua/L-8463-2016	Shi, Jianhua/0000-0002-5351-406X	National Institutes of Health [AG027429, AG019158]; National Natural Science Foundation of China [30973143, 81030059, 30801202]; Natural Science Foundation of Jiangsu Province, China [BK2009159]; U.S. Alzheimer's Association [NIRG-08-91126]; NIA, National Institutes of Health [P30 AG19610]; NATIONAL INSTITUTE ON AGING [R01AG027429, R01AG019158, P30AG019610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); U.S. Alzheimer's Association(Alzheimer's Association); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG027429 (to C.-X. G.) and AG019158 (to K. I.). This work was supported by National Natural Science Foundation of China Grants 30973143 and 81030059 (to F. L.) and 30801202 (to J. S.), Natural Science Foundation of Jiangsu Province, China, Grant BK2009159 (to F. L.), and U.S. Alzheimer's Association Grant NIRG-08-91126 (to F. L.).; We thank M. Marlow for editorial suggestions and J. Murphy for secretarial assistance. The Brain Donation Program is supported in part by NIA, National Institutes of Health Grant P30 AG19610 (to the Arizona Alzheimer's Disease Core Center).	Allemand E, 2002, MOL BIOL CELL, V13, P2436, DOI 10.1091/mbc.E02-02-0102; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Boutajangout A, 2004, FEBS LETT, V576, P183, DOI 10.1016/j.febslet.2004.09.011; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Bronner IF, 2005, BRAIN, V128, P2645, DOI 10.1093/brain/awh591; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; CADD G, 1989, NEURON, V3, P71, DOI 10.1016/0896-6273(89)90116-5; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chambers CB, 1999, ANN NEUROL, V46, P325, DOI 10.1002/1531-8249(199909)46:3<325::AID-ANA8>3.0.CO;2-V; Chevyreva I, 2008, EXP MOL PATHOL, V84, P71, DOI 10.1016/j.yexmp.2007.08.019; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Connell JW, 2005, MOL BRAIN RES, V137, P104, DOI 10.1016/j.molbrainres.2005.02.014; D'Souza I, 2006, J BIOL CHEM, V281, P2460, DOI 10.1074/jbc.M505809200; D'Souza I, 2005, BBA-MOL BASIS DIS, V1739, P104, DOI 10.1016/j.bbadis.2004.08.009; DEGARCINI EM, 1986, BIOCHEM BIOPH RES CO, V141, P790, DOI 10.1016/S0006-291X(86)80242-X; Espinoza M, 2008, J ALZHEIMERS DIS, V14, P1; FOSS KB, 1992, CYTOGENET CELL GENET, V60, P22, DOI 10.1159/000133286; Gao L, 2007, MOL CELL NEUROSCI, V34, P48, DOI 10.1016/j.mcn.2006.10.004; Glatz DC, 2006, J NEUROCHEM, V96, P635, DOI 10.1111/j.1471-4159.2005.03552.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; Graveley BR, 2004, MOL CELL, V13, P302, DOI 10.1016/S1097-2765(04)00055-3; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Hartmann AM, 2001, MOL CELL NEUROSCI, V18, P80, DOI 10.1006/mcne.2001.1000; Kanopka A, 1998, NATURE, V393, P185, DOI 10.1038/30277; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Kondo S, 2004, GENES CELLS, V9, P121, DOI 10.1111/j.1356-9597.2004.00709.x; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Kvissel AK, 2007, EXP CELL RES, V313, P2795, DOI 10.1016/j.yexcr.2007.05.014; Lace G, 2009, BRAIN, V132, P1324, DOI 10.1093/brain/awp059; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; LI H, 1991, CELL, V67, P335, DOI 10.1016/0092-8674(91)90185-2; Li HZ, 2009, J BIOL CHEM, V284, P16191, DOI 10.1074/jbc.M900393200; Liang ZH, 2007, J NEUROCHEM, V103, P2462, DOI 10.1111/j.1471-4159.2007.04942.x; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu F, 2006, FEBS LETT, V580, P6269, DOI 10.1016/j.febslet.2006.10.033; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Neumann M, 2001, ANN NEUROL, V50, P503, DOI 10.1002/ana.1223; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Pickering-Brown S, 2000, ANN NEUROL, V48, P859, DOI 10.1002/1531-8249(200012)48:6<859::AID-ANA6>3.0.CO;2-1; Prasad J, 1999, MOL CELL BIOL, V19, P6991; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Shi JH, 2008, J BIOL CHEM, V283, P28660, DOI 10.1074/jbc.M802645200; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Wang JN, 2004, J NEUROCHEM, V88, P1078, DOI 10.1046/j.1471-4159.2003.02232.x; Wang YZ, 2005, J BIOL CHEM, V280, P14230, DOI 10.1074/jbc.M413846200; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359; Yasojima K, 1999, BRAIN RES, V831, P301, DOI 10.1016/S0006-8993(99)01486-9; Yoshida M, 2006, NEUROPATHOLOGY, V26, P457, DOI 10.1111/j.1440-1789.2006.00743.x	61	67	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14639	14648		10.1074/jbc.M110.204453	http://dx.doi.org/10.1074/jbc.M110.204453			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21367856	hybrid, Green Published			2022-12-27	WOS:000289556200083
J	Baldys, A; Raymond, JR				Baldys, Aleksander; Raymond, John R.			Role of c-Cbl Carboxyl Terminus in Serotonin 5-HT2A Receptor Recycling and Resensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; INDEPENDENT INTERNALIZATION; DOWN-REGULATION; TRAFFICKING; ENDOCYTOSIS; UBIQUITINATION; HRS; DEGRADATION; ENDOSOMES; MECHANISM	The 5-hydroxytryptamine 2A receptor (5-HT2AR) undergoes constitutive and agonist-dependent internalization. Despite many advances in our understanding of G protein-coupled receptor trafficking, the exact mechanism of endocytic sorting of G protein-coupled receptors remains obscure. Recently, we have reported a novel finding documenting a global role for the ubiquitin ligase c-Cbl in regulating vesicular sorting of epidermal growth factor receptor (Baldys, A., Gooz, M., Morinelli, T. A., Lee, M. H., Raymond, J. R., Jr., Luttrell, L. M., and Raymond, J. R., Sr. (2009) Biochemistry 48, 1462-1473). Thus, we tested the hypothesis that c-Cbl might play a role in 5-HT2AR recycling. In this study, we demonstrated an association of 5-HT2AR with c-Cbl. Furthermore, down-regulation of c-Cbl by RNA interference blocked efficient recycling of 5-HT2AR to the plasma membrane. Immunofluorescence microscopy revealed that 5-HT2A receptors were trapped in early endosome antigen 1- and Rab11-positive sorting endosomes in cells overexpressing c-Cbl mutants lacking carboxyl termini. This inhibitory effect was associated with a relative decrease in association of c-Cbl truncation proteins with the 5-HT2AR, compared with that observed for the full-length c-Cbl fusion protein. Consistent with the delayed recycling, 5-HT2AR resensitization was greatly attenuated in the presence of c-Cbl mutants lacking carboxyl termini, as detected by changes in the cytosolic calcium. Taken together, these studies have led to the discovery that the C-terminal region of c-Cbl plays a crucial role in the temporal and spatial control of 5-HT2AR recycling.	Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA; Ralph H Johnson Vet Affairs Med Ctr, Med Serv, Charleston, SC 29425 USA; Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29425 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Raymond, JR (corresponding author), Med Coll Wisconsin, Off President, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jraymondj@mcw.edu			National Institutes of Health [DK052448, GM063909]; Department of Veterans Affairs; American Heart Association; Medical University of South Carolina Division of Nephrology and Dialysis Clinics, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052448, R56DK052448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association); Medical University of South Carolina Division of Nephrology and Dialysis Clinics, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK052448 and GM063909 (to J. R. R.), Department of Veterans Affairs Merit and Research Enhancement Award Program grants (to J. R. R.), a American Heart Association (Mid-Atlantic) fellowship (to A. B.), and laboratory endowments jointly supported by the Medical University of South Carolina Division of Nephrology and Dialysis Clinics, Inc. (to J. R. R.).	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Baldys A, 2009, BIOCHEMISTRY-US, V48, P9321, DOI 10.1021/bi900865u; Baldys A, 2009, BIOCHEMISTRY-US, V48, P1462, DOI 10.1021/bi801771g; Berg KA, 2005, TRENDS PHARMACOL SCI, V26, P625, DOI 10.1016/j.tips.2005.10.008; Berry SA, 1996, MOL PHARMACOL, V50, P306; Bhatnagar A, 2001, J BIOL CHEM, V276, P8269, DOI 10.1074/jbc.M006968200; Bhattacharyya S, 2002, P NATL ACAD SCI USA, V99, P14470, DOI 10.1073/pnas.212517999; Bonita DP, 1997, MOL CELL BIOL, V17, P4597, DOI 10.1128/MCB.17.8.4597; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Gray JA, 2003, MOL PHARMACOL, V63, P961, DOI 10.1124/mol.63.5.961; Gray JA, 2001, BRAIN RES BULL, V56, P441, DOI 10.1016/S0361-9230(01)00623-2; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hanyaloglu AC, 2007, J BIOL CHEM, V282, P3095, DOI 10.1074/jbc.M605398200; Idkowiak-Baldys J, 2009, J BIOL CHEM, V284, P22322, DOI 10.1074/jbc.M109.026765; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Lill NL, 2000, J BIOL CHEM, V275, P367, DOI 10.1074/jbc.275.1.367; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Singh AJ, 2007, P NATL ACAD SCI USA, V104, P5413, DOI 10.1073/pnas.0700809104; Stern KA, 2007, MOL CELL BIOL, V27, P888, DOI 10.1128/MCB.02356-05; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694	28	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24656	24665		10.1074/jbc.M110.119891	http://dx.doi.org/10.1074/jbc.M110.119891			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21464131	Green Published, hybrid			2022-12-27	WOS:000292547900016
J	Eathiraj, S; Palma, R; Volckova, E; Hirschi, M; France, DS; Ashwell, MA; Chan, TCK				Eathiraj, Sudharshan; Palma, Rocio; Volckova, Erika; Hirschi, Marscha; France, Dennis S.; Ashwell, Mark A.; Chan, Thomas C. K.			Discovery of a Novel Mode of Protein Kinase Inhibition Characterized by the Mechanism of Inhibition of Human Mesenchymal-epithelial Transition Factor (c-Met) Protein Autophosphorylation by ARQ 197	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; HEPATOCYTE GROWTH-FACTOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MASS SPECTROMETRY; BINDING MODES; CANCER; AUTOINHIBITION; ACTIVATION; INSULIN	A number of human malignancies exhibit sustained stimulation, mutation, or gene amplification of the receptor tyrosine kinase human mesenchymal-epithelial transition factor (c-Met). ARQ 197 is a clinically advanced, selective, orally bioavailable, and well tolerated c-Met inhibitor, currently in Phase 3 clinical testing in non-small cell lung cancer patients. Herein, we describe the molecular and structural basis by which ARQ 197 selectively targets c-Met. Through our analysis we reveal a previously undisclosed, novel inhibitory mechanism that utilizes distinct regulatory elements of the c-Met kinase. The structure of ARQ 197 in complex with the c-Met kinase domain shows that the inhibitor binds a conformation that is distinct from published kinase structures. ARQ197 inhibits c-Met autophosphorylation and is highly selective for the inactive or unphosphorylated form of c-Met. Through our analysis of the interplay between the regulatory and catalytic residues of c-Met, and by comparison between the autoinhibited canonical conformation of c-Met bound by ARQ 197 to previously described kinase domains of type III receptor tyrosine kinases, we believe this to be the basis of a powerful new in silico approach for the design of similar inhibitors for other protein kinases of therapeutic interest.	[Eathiraj, Sudharshan; Palma, Rocio; Volckova, Erika; Hirschi, Marscha; France, Dennis S.; Ashwell, Mark A.; Chan, Thomas C. K.] ArQule Inc, Woburn, MA 01801 USA		Chan, TCK (corresponding author), 19 Presidential Way, Woburn, MA 01801 USA.	tchan@arqule.com			NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NIBIB NIH HHS [P30 EB009998] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Albrecht BK, 2008, J MED CHEM, V51, P2879, DOI 10.1021/jm800043g; Asses Y, 2009, CHEM BIOL DRUG DES, V74, P560, DOI 10.1111/j.1747-0285.2009.00895.x; Backes AC, 2008, EXPERT OPIN DRUG DIS, V3, P1427, DOI 10.1517/17460440802580106; Bagai R, 2010, IDRUGS, V13, P404; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Bellon SF, 2008, J BIOL CHEM, V283, P2675, DOI 10.1074/jbc.M705774200; Canadas I, 2010, CLIN TRANSL ONCOL, V12, P253, DOI 10.1007/s12094-010-0501-0; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Danilkovitch-Miagkova A, 2002, J CLIN INVEST, V109, P863; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DeLano W.L, PYMOL MOL GRAPHICS S; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Dussault I, 2008, CELL CYCLE, V7, P1157, DOI 10.4161/cc.7.9.5827; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Garuti L, 2010, CURR MED CHEM, V17, P2804, DOI 10.2174/092986710791859333; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Hashigasako A, 2004, J BIOL CHEM, V279, P26445, DOI 10.1074/jbc.M314254200; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kufareva I, 2008, J MED CHEM, V51, P7921, DOI 10.1021/jm8010299; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LEE DJ, 2010, CLIN LUNG CANCER, V11, P303; Liu XD, 2010, TRENDS MOL MED, V16, P37, DOI 10.1016/j.molmed.2009.11.005; Martin TA, 2010, ANTI-CANCER AGENT ME, V10, P2, DOI 10.2174/1871520611009010002; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Muckenschnabel I, 2004, ANAL BIOCHEM, V324, P241, DOI 10.1016/j.ab.2003.09.040; Munshi N, 2010, MOL CANCER THER, V9, P1544, DOI 10.1158/1535-7163.MCT-09-1173; Porter J, 2009, BIOORG MED CHEM LETT, V19, P2780, DOI 10.1016/j.bmcl.2009.03.110; Reilly JT, 2002, BRIT J HAEMATOL, V116, P744, DOI 10.1046/j.0007-1048.2001.03294.x; Schiering N, 2003, P NATL ACAD SCI USA, V100, P12654, DOI 10.1073/pnas.1734128100; Schiller JH, 2010, J CLIN ONCOL S, V28, p18s; Sheth PR, 2008, BIOCHEMISTRY-US, V47, P4028, DOI 10.1021/bi701892f; Timofeevski SL, 2009, BIOCHEMISTRY-US, V48, P5339, DOI 10.1021/bi900438w; Walter M, 2007, J MOL BIOL, V367, P839, DOI 10.1016/j.jmb.2007.01.036; Wang WR, 2006, P NATL ACAD SCI USA, V103, P3563, DOI 10.1073/pnas.0600048103; Whitehurst CE, 2008, COMB CHEM HIGH T SCR, V11, P427, DOI 10.2174/138620708784911447	40	113	117	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20666	20676		10.1074/jbc.M110.213801	http://dx.doi.org/10.1074/jbc.M110.213801			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21454604	Green Published, hybrid			2022-12-27	WOS:000291267600053
J	Escobar-Cabrera, E; Okon, M; Lau, DKW; Dart, CF; Bonvin, AMJJ; McIntosh, LP				Escobar-Cabrera, Eric; Okon, Mark; Lau, Desmond K. W.; Dart, Christopher F.; Bonvin, Alexandre M. J. J.; McIntosh, Lawrence P.			Characterizing the N- and C-terminal Small Ubiquitin-like Modifier (SUMO)-interacting Motifs of the Scaffold Protein DAXX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO-BINDING-MOTIF; THYMINE-DNA GLYCOSYLASE; TRANSCRIPTIONAL ACTIVITY; STRUCTURAL-CHARACTERIZATION; INTERACTING MOTIFS; CRYSTAL-STRUCTURE; NMR; SUMOYLATION; COMPLEX; PML	DAXX is a scaffold protein with diverse roles that often depend upon binding SUMO via its N- and/or C-terminal SUMO-interacting motifs (SIM-N and SIM-C). Using NMR spectroscopy, we characterized the in vitro binding properties of peptide models of SIM-N and SIM-C to SUMO-1 and SUMO-2. In each case, binding was mediated by hydrophobic and electrostatic interactions and weakened with increasing ionic strength. Neither isolated SIM showed any significant paralog specificity, and the measured mu M range K-D values of SIM-N toward both SUMO-1 and SUMO-2 were similar to 4-fold lower than those of SIM-C. Furthermore, SIM-N bound SUMO-1 predominantly in a parallel orientation, whereas SIM-C interconverted between parallel and antiparallel binding modes on an ms to mu s time scale. The differences in affinities and binding modes are attributed to the differences in charged residues that flank the otherwise identical hydrophobic core sequences of the two SIMs. In addition, within its native context, SIM-N bound intramolecularly to the adjacent N-terminal helical bundle domain of DAXX, thus reducing its apparent affinity for SUMO. This behavior suggests a possible autoregulatory mechanism for DAXX. The interaction of a C-terminal fragment of DAXX with an N-terminal fragment of the sumoylated Ets1 transcription factor was mediated by SIM-C. Importantly, this interaction did not involve any direct contacts between DAXX and Ets1, but rather was derived from the non-covalent binding of SIM-C to SUMO-1, which in turn was covalently linked to the unstructured N-terminal segment of Ets1. These results provide insights into the binding mechanisms and hence biological roles of the DAXX SUMO-interacting motifs.	[McIntosh, Lawrence P.] Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada; [Escobar-Cabrera, Eric; Okon, Mark; Lau, Desmond K. W.; McIntosh, Lawrence P.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z3, Canada; [Escobar-Cabrera, Eric; Okon, Mark; Lau, Desmond K. W.; McIntosh, Lawrence P.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z3, Canada; [Bonvin, Alexandre M. J. J.] Univ Utrecht, Bijvoet Ctr Biomol Res, Fac Sci, NL-3584 CH Utrecht, Netherlands	University of British Columbia; University of British Columbia; University of British Columbia; Utrecht University	McIntosh, LP (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	mcintosh@chem.ubc.ca	Bonvin, Alexandre M.J.J./A-5420-2009	Bonvin, Alexandre M.J.J./0000-0001-7369-1322	Canadian Cancer Society [017308]; Netherlands Organization for Scientific Research [700.56.442]; British Columbia Knowledge Development Fund; University of British Columbia Blusson Fund	Canadian Cancer Society(Canadian Cancer Society (CCS)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); British Columbia Knowledge Development Fund; University of British Columbia Blusson Fund	This work was supported in part by the Canadian Cancer Society (Grant 017308 to L. P. M.).; Supported by Netherlands Organization for Scientific Research VICI Grant 700.56.442.; We thank Pitter Huesgen, Alexander Ishov, Lewis Kay, and Cameron Mackereth for advice and helpful ideas. Instrument support was provided by the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, the British Columbia Knowledge Development Fund, the University of British Columbia Blusson Fund, and the Michael Smith Foundation for Health Research.	Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Baba D, 2006, J MOL BIOL, V359, P137, DOI 10.1016/j.jmb.2006.03.036; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chupreta S, 2005, MOL CELL BIOL, V25, P4272, DOI 10.1128/MCB.25.10.4272-4282.2005; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donaldson LW, 2001, J AM CHEM SOC, V123, P9843, DOI 10.1021/ja011241p; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; Escobar-Cabrera E, 2010, STRUCTURE, V18, P1642, DOI 10.1016/j.str.2010.09.016; Fukuyo Y, 2009, CANCER RES, V69, P7512, DOI 10.1158/0008-5472.CAN-09-2148; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; GODDARD TD, 2004, SPARKY 3 VERSION 3; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hollenbach AD, 2002, J CELL SCI, V115, P3319; HOLLENHORST P, 2011, ANNU REV BI IN PRESS; Huang YS, 2009, BIOCHEM BIOPH RES CO, V386, P762, DOI 10.1016/j.bbrc.2009.06.126; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Ishov AM, 2004, J CELL SCI, V117, P3807, DOI 10.1242/jcs.01230; Ji Z, 2007, ONCOGENE, V26, P395, DOI 10.1038/sj.onc.1209789; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson PE, 1996, BIOCHEMISTRY-US, V35, P13895, DOI 10.1021/bi961186a; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; KOSEN PA, 1989, METHOD ENZYMOL, V177, P86; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Lehembre F, 2001, ONCOGENE, V20, P1, DOI 10.1038/sj.onc.1204063; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Lindsay CR, 2008, FRONT BIOSCI-LANDMRK, V13, P7132, DOI 10.2741/3216; Macauley MS, 2006, J BIOL CHEM, V281, P4164, DOI 10.1074/jbc.M510488200; Macauley MS, 2004, J BIOL CHEM, V279, P49131, DOI 10.1074/jbc.M408705200; Matunis MJ, 2006, DEV CELL, V11, P596, DOI 10.1016/j.devcel.2006.10.011; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Muromoto R, 2004, J IMMUNOL, V172, P2985, DOI 10.4049/jimmunol.172.5.2985; Naik MT, 2011, BIOMOL NMR ASSIGN, V5, P75, DOI 10.1007/s12104-010-9271-4; Nelson ML, 2010, P NATL ACAD SCI USA, V107, P10026, DOI 10.1073/pnas.0915137107; Nishida T, 2006, BIOCHEM BIOPH RES CO, V345, P1536, DOI 10.1016/j.bbrc.2006.05.065; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; Puto LA, 2008, GENE DEV, V22, P998, DOI 10.1101/gad.1632208; Reibarkh M, 2006, J AM CHEM SOC, V128, P2160, DOI 10.1021/ja055971z; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Ryu SW, 2000, BIOCHEM BIOPH RES CO, V279, P6, DOI 10.1006/bbrc.2000.3882; Santiago A, 2009, CELL CYCLE, V8, P76, DOI 10.4161/cc.8.1.7493; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Shih HM, 2007, BIOCHEM SOC T, V35, P1397, DOI 10.1042/BST0351397; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Su XC, 2010, J BIOMOL NMR, V46, P101, DOI 10.1007/s10858-009-9331-1; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	69	24	26	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19816	19829		10.1074/jbc.M111.231647	http://dx.doi.org/10.1074/jbc.M111.231647			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21383010	hybrid, Green Published			2022-12-27	WOS:000291027700063
J	Aertgeerts, K; Skene, R; Yano, J; Sang, BC; Zou, H; Snell, G; Jennings, A; Iwamoto, K; Habuka, N; Hirokawa, A; Ishikawa, T; Tanaka, T; Miki, H; Ohta, Y; Sogabe, S				Aertgeerts, Kathleen; Skene, Robert; Yano, Jason; Sang, Bi-Ching; Zou, Hua; Snell, Gyorgy; Jennings, Andy; Iwamoto, Keiji; Habuka, Noriyuki; Hirokawa, Aki; Ishikawa, Tomoyasu; Tanaka, Toshimasa; Miki, Hiroshi; Ohta, Yoshikazu; Sogabe, Satoshi			Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; SOMATIC MUTATIONS; EGF RECEPTOR; BREAST; EXPRESSION; RESISTANCE; LAPATINIB; THERAPY; PROGRAM; ERBB-2	Aberrant signaling of ErbB family members human epidermal growth factor 2 (HER2) and epidermal growth factor receptor (EGFR) is implicated in many human cancers, and HER2 expression is predictive of human disease recurrence and prognosis. Small molecule kinase inhibitors of EGFR and of both HER2 and EGFR have received approval for the treatment of cancer. We present the first high resolution crystal structure of the kinase domain of HER2 in complex with a selective inhibitor to understand protein activation, inhibition, and function at the molecular level. HER2 kinase domain crystallizes as a dimer and suggests evidence for an allosteric mechanism of activation comparable with previously reported activation mechanisms for EGFR and HER4. A unique Gly-rich region in HER2 following the alpha-helix C is responsible for increased conformational flexibility within the active site and could explain the low intrinsic catalytic activity previously reported for HER2. In addition, we solved the crystal structure of the kinase domain of EGFR in complex with a HER2/EGFR dual inhibitor (TAK-285). Comparison with previously reported inactive and active EGFR kinase domain structures gave insight into the mechanism of HER2 and EGFR inhibition and may help guide the design and development of new cancer drugs with improved potency and selectivity.	[Aertgeerts, Kathleen; Skene, Robert; Yano, Jason; Sang, Bi-Ching; Zou, Hua; Snell, Gyorgy; Jennings, Andy] Takeda San Diego Inc, San Diego, CA 92121 USA; [Ishikawa, Tomoyasu; Ohta, Yoshikazu] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Tsukuba, Ibaraki 3004293, Japan; [Iwamoto, Keiji; Habuka, Noriyuki; Hirokawa, Aki; Tanaka, Toshimasa; Miki, Hiroshi; Sogabe, Satoshi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Yodogawa Ku, Osaka 5328686, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Aertgeerts, K (corresponding author), Takeda San Diego Inc, 10410 Sci Ctr Dr, San Diego, CA 92130 USA.	kaertgeerts@takedasd.com		Skene, Robert/0000-0002-1482-6546; Yano, Jason/0000-0002-9774-2611	Office of Science, Office of Basic Energy Sciences, Materials Sciences Division of the United States Department of Energy at Lawrence Berkeley National Laboratory [AC03-76SF00098]; TAK-285 project team of Millennium Pharmaceuticals	Office of Science, Office of Basic Energy Sciences, Materials Sciences Division of the United States Department of Energy at Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); TAK-285 project team of Millennium Pharmaceuticals	The authors thank Keith Wilson, Paul Steed, and David Weitz for critical review of this manuscript. We also thank Advanced Light Source, which is supported by the Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences Division of the United States Department of Energy under Contract DE-AC03-76SF00098 at Lawrence Berkeley National Laboratory. The authors thank the office staff of Pharmaceutical Consortium for Protein Structure Analysis and the technical staff of the BL41XU at SPring-8 for facilitating synchrotron data collection. The authors also thank the TAK-285 project team of Millennium Pharmaceuticals and the senior management member of Pharmaceutical Research Division for consultation and research support.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Brignola PS, 2002, J BIOL CHEM, V277, P1576, DOI 10.1074/jbc.M105907200; Cappuzzo F, 2005, J CLIN ONCOL, V23, P5007, DOI 10.1200/JCO.2005.09.111; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Case D. A., 2021, AMBER 2022; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Cohen BD, 1996, J BIOL CHEM, V271, P30897, DOI 10.1074/jbc.271.48.30897; Emlet DR, 2006, BRIT J CANCER, V94, P1144, DOI 10.1038/sj.bjc.6603078; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan YX, 2008, J BIOL CHEM, V283, P1588, DOI 10.1074/jbc.M708116200; Higa GM, 2007, EXPERT REV ANTICANC, V7, P1183, DOI 10.1586/14737140.7.9.1183; ISHIKAWA T, 2007, Patent No. 2007064045; ISHIKAWA T, 2005, Patent No. 2005118588; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; Lenferink AEG, 1998, EMBO J, V17, P3385, DOI 10.1093/emboj/17.12.3385; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; QIAN XL, 1994, P NATL ACAD SCI USA, V91, P1500, DOI 10.1073/pnas.91.4.1500; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; SCHULTZ RM, 2005, ADV TARGETED CANC TH; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Trowe T, 2008, CLIN CANCER RES, V14, P2465, DOI 10.1158/1078-0432.CCR-07-4367; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WADA T, 1990, ONCOGENE, V5, P489; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Worthylake R, 1999, J BIOL CHEM, V274, P8865, DOI 10.1074/jbc.274.13.8865; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Ye DW, 1999, ONCOGENE, V18, P731, DOI 10.1038/sj.onc.1202319; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	43	218	230	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18756	18765		10.1074/jbc.M110.206193	http://dx.doi.org/10.1074/jbc.M110.206193			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454582	Green Published, hybrid			2022-12-27	WOS:000290785700048
J	Brodrick, B; Vidrich, A; Porter, E; Bradley, L; Buzan, JM; Cohn, SM				Brodrick, Brooks; Vidrich, Alda; Porter, Edith; Bradley, Leigh; Buzan, Jenny M.; Cohn, Steven M.			Fibroblast Growth Factor Receptor-3 (FGFR-3) Regulates Expression of Paneth Cell Lineage-specific Genes in Intestinal Epithelial Cells through both TCF4/beta-Catenin-dependent and -independent Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; STEM-CELLS; WNT/BETA-CATENIN; HUMAN DEFENSIN-5; ALPHA-DEFENSINS; INNATE IMMUNITY; COLON-CANCER; IN-VITRO; SPONTANEOUS DIFFERENTIATION; GASTROINTESTINAL-TRACT	Fibroblast growth factor receptor-3 (FGFR-3) expression in the developing intestine is restricted to the undifferentiated epithelial cells within the lower portion of the crypt. We previously showed that mice lacking functional FGFR-3 have a significant decrease in the number of Paneth cells in the small intestine. Here, we used Caco2 cells to investigate whether FGFR-3 signaling can directly modulate expression of Paneth cell differentiation markers through its effects on TCF4/beta-catenin or through other signaling pathways downstream of this receptor. Caco2 cells treated with FGFR-3 ligands or expressing FGFR-3(K650E), a constitutively active mutant, resulted in a significantly increased expression of genes characteristic of mature Paneth cells, including human alpha-defensins 5 and 6 (HD5 and HD6) and Paneth cell lysozyme, whereas enterocytic differentiation markers were reduced. Activation of FGFR-3 signaling sustained high levels of beta-catenin mRNA expression, leading to increased TCF4/beta-catenin-regulated transcriptional activity in Caco2 cells. Sustained activity of the TCF4/beta-catenin pathway was required for the induction of Paneth cell markers. Activation of the MAPK pathway by FGFR-3 is also required for the induction of Paneth cell markers in addition to and independent of the effect of FGFR-3 on TCF4/beta-catenin activity. These studies suggest that coordinate activation of multiple independent signaling pathways downstream of FGFR-3 is involved in regulation of Paneth cell differentiation.	[Brodrick, Brooks; Vidrich, Alda; Bradley, Leigh; Buzan, Jenny M.; Cohn, Steven M.] Univ Virginia, Div Gastroenterol & Hepatol, Charlottesville, VA 22908 USA; [Porter, Edith] Univ Calif Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA	University of Virginia; University of California System; University of California Los Angeles	Cohn, SM (corresponding author), Univ Virginia Hlth Syst, Digest Hlth Ctr, Box 800708, Charlottesville, VA 22908 USA.	SC6W@virginia.edu			National Institutes of Health [R01 DK064751, P20 MD001824]; Molecular Biology and Morphology Cores of the University of Virginia National Institutes of Health/NIDDK Digestive Diseases Research Core Center [DK50306]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, P30DK067629, R01DK064751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Biology and Morphology Cores of the University of Virginia National Institutes of Health/NIDDK Digestive Diseases Research Core Center; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK064751 (to S. M. C.) and through the Molecular Biology and Morphology Cores of the University of Virginia National Institutes of Health/NIDDK Digestive Diseases Research Core Center Grant (Grant DK50306).; Supported by National Institutes of Health Grant P20 MD001824.	Aliaga JC, 1999, AM J PHYSIOL-GASTR L, V277, pG631, DOI 10.1152/ajpgi.1999.277.3.G631; Andreu P, 2008, DEV BIOL, V324, P288, DOI 10.1016/j.ydbio.2008.09.027; *APPL BIOS, 1997, US B APPL BIOS, V2; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Bevins CL, 2005, AM J PHYSIOL-GASTR L, V289, pG173, DOI 10.1152/ajpgi.00079.2005; Brock P, 1999, CYTOMETRY, V35, P353, DOI 10.1002/(SICI)1097-0320(19990401)35:4<353::AID-CYTO8>3.0.CO;2-M; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cunliffe RN, 2004, J LEUKOCYTE BIOL, V75, P49, DOI 10.1189/jlb.0503249; Cunliffe RN, 2001, GUT, V48, P176, DOI 10.1136/gut.48.2.176; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Ducroc R, 2002, LIFE SCI, V70, P1359, DOI 10.1016/S0024-3205(01)01519-3; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; HARA A, 1993, JPN J CANCER RES, V84, P625, DOI 10.1111/j.1349-7006.1993.tb02022.x; Hart KC, 2001, MOL BIOL CELL, V12, P931, DOI 10.1091/mbc.12.4.931; HOLLINGSWORTH MA, 1994, INT J CANCER, V57, P198, DOI 10.1002/ijc.2910570212; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Houchen CW, 1999, AM J PHYSIOL-GASTR L, V276, pG249, DOI 10.1152/ajpgi.1999.276.1.G249; Kanai M, 1997, AM J PHYSIOL-GASTR L, V272, pG885, DOI 10.1152/ajpgi.1997.272.4.G885; Kannan K, 2000, IUBMB LIFE, V49, P197; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; L'Hote CGM, 2005, EXP CELL RES, V304, P417, DOI 10.1016/j.yexcr.2004.11.012; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mariadason JM, 2002, CANCER RES, V62, P4791; Mariadason JM, 2001, CANCER RES, V61, P3465; Mariadason JM, 2000, J CELL PHYSIOL, V183, P347, DOI 10.1002/(SICI)1097-4652(200006)183:3<347::AID-JCP7>3.0.CO;2-W; MOLMENTI EP, 1993, J CLIN INVEST, V92, P2022, DOI 10.1172/JCI116797; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; NIV Y, 1992, INT J CANCER, V50, P147, DOI 10.1002/ijc.2910500129; Ogle CK, 2002, CRIT CARE MED, V30, P428, DOI 10.1097/00003246-200202000-00027; Ouellette AJ, 2001, INFLAMM BOWEL DIS, V7, P43, DOI 10.1097/00054725-200102000-00007; PODOLSKY DK, 1993, AM J PHYSIOL, V264, pG179, DOI 10.1152/ajpgi.1993.264.2.G179; Porter E, 2005, INFECT IMMUN, V73, P4823, DOI 10.1128/IAI.73.8.4823-4833.2005; Porter EM, 1997, INFECT IMMUN, V65, P2396, DOI 10.1128/IAI.65.6.2396-2401.1997; Porter EM, 1998, FEBS LETT, V434, P272, DOI 10.1016/S0014-5793(98)00994-6; Quayle AJ, 1998, AM J PATHOL, V152, P1247; Saaf AM, 2007, MOL BIOL CELL, V18, P4245, DOI 10.1091/mbc.E07-04-0309; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sturgill TW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-104; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; VANBEERS EH, 1995, BIOCHEM J, V308, P769, DOI 10.1042/bj3080769; Varnat F, 2006, GASTROENTEROLOGY, V131, P538, DOI 10.1053/j.gastro.2006.05.004; Vidrich A, 2005, AM J PATHOL, V166, P1055, DOI 10.1016/S0002-9440(10)62326-7; Vidrich A, 2004, DEV DYNAM, V230, P114, DOI 10.1002/dvdy.20018; Vidrich A, 2009, AM J PHYSIOL-GASTR L, V297, pG168, DOI 10.1152/ajpgi.90589.2008; Vreugdenhil ACE, 2000, J IMMUNOL, V165, P4561, DOI 10.4049/jimmunol.165.8.4561; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wehkamp J, 2005, J LEUKOCYTE BIOL, V77, P460, DOI 10.1189/jlb.0904543; Wehkamp J, 2002, DIGEST DIS SCI, V47, P1349, DOI 10.1023/A:1015334917273; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	60	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18515	18525		10.1074/jbc.M111.229252	http://dx.doi.org/10.1074/jbc.M111.229252			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21388956	Green Published, hybrid			2022-12-27	WOS:000290785700024
J	Cardano, M; Diaferia, GR; Cattaneo, M; Dessl, SS; Long, QM; Conti, L; DeBlasio, P; Cattaneo, E; Biunno, I				Cardano, Marina; Diaferia, Giuseppe R.; Cattaneo, Monica; Dessl, Sara S.; Long, Qiaoming; Conti, Luciano; DeBlasio, Pasquale; Cattaneo, Elena; Biunno, Ida			mSEL-1L (Suppressor/Enhancer Lin12-like) Protein Levels Influence Murine Neural Stem Cell Self-renewal and Lineage Commitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; CENTRAL-NERVOUS-SYSTEM; IN-VITRO; CAENORHABDITIS-ELEGANS; NS CELLS; DIFFERENTIATION; GENE; DEGRADATION; PROTEASOME; PATHWAY	Murine SEL-1L (mSEL-1L) is a key component of the endoplasmic reticulum-associated degradation pathway. It is essential during development as revealed by the multi-organ dysfunction and in uterus lethality occurring in homozygous mSEL-1L-deficient mice. Here we show that mSEL-1L is highly expressed in pluripotent embryonic stem cells and multipotent neural stem cells (NSCs) but silenced in all mature neural derivatives (i.e. astrocytes, oligodendrocytes, and neurons) by mmu-miR-183. NSCs derived from homozygous mSEL-1L-deficient embryos (mSEL-1L(-/-) NSCs) fail to proliferate in vitro, show a drastic reduction of the Notch effector HES-5, and reveal a significant down-modulation of the early neural progenitor markers PAX-6 and OLIG-2, when compared with the wild type (mSEL-1L(+/+) NSCs) counterpart. Furthermore, these cells are almost completely deprived of the neural marker Nestin, display a significant decrease of SOX-2 expression, and rapidly undergo premature astrocytic commitment and apoptosis. The data suggest severe self-renewal defects occurring in these cells probably mediated by misregulation of the Notch signaling. The results reported here denote mSEL-1L as a primitive marker with a possible involvement in the regulation of neural progenitor stemness maintenance and lineage determination.	[Cattaneo, Monica; Biunno, Ida] Inst Genet & Biomed Res, I-20138 Milan, Italy; [Cardano, Marina] Univ Milan, Doctorate Sch Mol Med, I-20100 Milan, Italy; [Cardano, Marina; Diaferia, Giuseppe R.; Dessl, Sara S.; DeBlasio, Pasquale; Biunno, Ida] Integrated Syst Engn, I-20138 Milan, Italy; [Long, Qiaoming] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Conti, Luciano; Cattaneo, Elena] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; [DeBlasio, Pasquale] Biorep Srl, I-20138 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Milan; Cornell University; University of Milan	Biunno, I (corresponding author), Inst Genet & Biomed Res, I-20138 Milan, Italy.	ida.biunno@itb.cnr.it	Diaferia, Giuseppe/AAN-5910-2020; Long, Qiaoming/L-5074-2017; Conti, Luciano/H-4184-2012	Diaferia, Giuseppe/0000-0003-4022-8483; Long, Qiaoming/0000-0001-8243-589X; Conti, Luciano/0000-0002-2050-9846; , IDA_2/0000-0002-1068-4763; CATTANEO, ELENA/0000-0002-0755-4917; /0000-0002-1866-5866	Italian Government [MIUR-FIRB nRBIP064CRT]; Regione Lombardia "Metadistretto"; EU	Italian Government; Regione Lombardia "Metadistretto"; EU(European Commission)	This work was supported by Grant MIUR-FIRB nRBIP064CRT from the Italian Government (to I. B. and P. D. B.), funds from Regione Lombardia "Metadistretto" (to I. B. and P. D. B.), and in part by the EU-FP6 Neuroscreen Project.	Alvarez-Manilla G, 2010, J PROTEOME RES, V9, P2062, DOI 10.1021/pr8007489; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Bianchi L, 2005, PROTEOMICS, V5, P2433, DOI 10.1002/pmic.200401283; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; Bonvini P, 1998, ONCOGENE, V16, P1131, DOI 10.1038/sj.onc.1201625; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bruggeman SWM, 2009, BBA-GEN SUBJECTS, V1790, P351, DOI 10.1016/j.bbagen.2009.03.009; Buszczak M, 2009, SCIENCE, V323, P248, DOI 10.1126/science.1165678; Campos LS, 2005, BIOESSAYS, V27, P698, DOI 10.1002/bies.20256; Cattaneo M, 2005, NEOPLASIA, V7, P1030, DOI 10.1593/neo.05451; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; Cattaneo M, 2009, J BIOL CHEM, V284, P11405, DOI 10.1074/jbc.M805408200; Chen DH, 2005, CURR BIOL, V15, P179, DOI 10.1016/j.cub.2005.01.004; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Choi MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011885; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Dieguez-Acuna F, 2010, INT J BIOCHEM CELL B, V42, P1651, DOI 10.1016/j.biocel.2009.12.001; Donoviel DB, 1998, MECH DEVELOP, V78, P203, DOI 10.1016/S0925-4773(98)00146-4; Francisco AB, 2010, J BIOL CHEM, V285, P13694, DOI 10.1074/jbc.M109.085340; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Grant B, 1996, GENETICS, V143, P237; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kim CG, 2006, MOL CELLS, V21, P343; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Li GR, 2010, J BIOL CHEM, V285, P5461, DOI 10.1074/jbc.M109.037127; Li SA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-19; LIU Q, 2010, CANC PREV RES, V3, pB52; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Mellodew K, 2004, DEV BRAIN RES, V151, P13, DOI 10.1016/j.devbrainres.2004.03.018; Nagao M, 2008, J CELL BIOL, V183, P1243, DOI 10.1083/jcb.200807130; Namihira M, 2008, PHILOS T R SOC B, V363, P2099, DOI 10.1098/rstb.2008.2262; Naujokat C, 2009, ARCH IMMUNOL THER EX, V57, P177, DOI 10.1007/s00005-009-0019-8; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Orlandi R, 2002, CANCER RES, V62, P567; Orlandi R, 2002, INT J BIOL MARKER, V17, P104, DOI 10.1177/172460080201700205; Satoh M, 2000, NEUROSCI LETT, V284, P143, DOI 10.1016/S0304-3940(00)00981-2; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010; Spiliotopoulos D, 2009, NEUROBIOL DIS, V34, P320, DOI 10.1016/j.nbd.2009.02.007; Stipursky J, 2007, GLIA, V55, P1023, DOI 10.1002/glia.20522; SUNDARAM M, 1993, GENETICS, V135, P765; Suzuki S, 2010, J HISTOCHEM CYTOCHEM, V58, P721, DOI 10.1369/jhc.2010.955609; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Verret L, 2007, PSYCHONEUROENDOCRINO, V32, pS26, DOI 10.1016/j.psyneuen.2007.04.014; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wen S, 2009, PROG NEUROBIOL, V87, P98, DOI 10.1016/j.pneurobio.2008.10.002; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Whetton AD, 2008, CELL STEM CELL, V2, P215, DOI 10.1016/j.stem.2008.02.003; Yamasaki L, 2004, CURR OPIN CELL BIOL, V16, P623, DOI 10.1016/j.ceb.2004.08.005; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Zhang XC, 2007, INT J DEV NEUROSCI, V25, P455, DOI 10.1016/j.ijdevneu.2007.08.007; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727	65	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18708	18719		10.1074/jbc.M110.210740	http://dx.doi.org/10.1074/jbc.M110.210740			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454627	hybrid, Green Published			2022-12-27	WOS:000290785700044
J	Pesiridis, GS; Tripathy, K; Tanik, S; Trojanowski, JQ; Lee, VMY				Pesiridis, G. Scott; Tripathy, Kalyan; Tanik, Selcuk; Trojanowski, John Q.; Lee, Virginia M. -Y.			A "Two-hit" Hypothesis for Inclusion Formation by Carboxyl-terminal Fragments of TDP-43 Protein Linked to RNA Depletion and Impaired Microtubule-dependent Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN-43; PRE-MESSENGER-RNA; GENE-EXPRESSION; HNRNP PROTEINS; NUCLEAR; MUTATIONS; COMPLEX; DISEASE	Carboxyl-terminal fragments (CTFs) of TDP-43 aggregate to form the diagnostic signature inclusions of frontotemporal lobar degeneration and amyotrophic lateral sclerosis, but the biological significance of these CTFs and how they are generated remain enigmatic. To address these issues, we engineered mammalian cells with an inducible tobacco etch virus (TEV) protease that cleaves TDP-43 containing a TEV cleavage site. Regions of TDP-43 flanking the second RNA recognition motif (RRM2) are efficiently cleaved by TEV, whereas sites within this domain are more resistant to cleavage. CTFs containing RRM2 generated from de novo cleavage of nuclear TDP-43 are transported to the cytoplasm and efficiently cleared, indicating that cleavage alone is not sufficient to initiate CTF aggregation. However, CTFs rapidly aggregated into stable cytoplasmic inclusions following de novo cleavage when dynein-mediated microtubule transport was disrupted, RNA was depleted, or natively misfolded CTFs were introduced into these cells. Our data support a "two-hit" mechanism of CTF aggregation dependent on TDP-43 cleavage.	[Pesiridis, G. Scott; Tripathy, Kalyan; Tanik, Selcuk; Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Lee, VMY (corresponding author), Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, 3600 Spruce St,3rd Floor,Maloney Bldg, Philadelphia, PA 19104 USA.	vmylee@upenn.edu			National Institutes of Health [AG17586]; Koller Foundation for ALS Research; NATIONAL INSTITUTE ON AGING [P01AG017586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Koller Foundation for ALS Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG17586. This work was also supported by the Koller Foundation for ALS Research as well as a gift from the Podolin family.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; BONNER WM, 1975, J CELL BIOL, V64, P421, DOI 10.1083/jcb.64.2.421; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; BURD CG, 1991, MOL CELL BIOL, V11, P3419, DOI 10.1128/MCB.11.7.3419; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; CORTHESYTHEULAZ I, 1992, J CELL BIOL, V118, P1333, DOI 10.1083/jcb.118.6.1333; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Jansens Annemieke, 2003, Methods Mol Biol, V232, P133; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kredel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004391; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Mili S, 2001, MOL CELL BIOL, V21, P7307, DOI 10.1128/MCB.21.21.7307-7319.2001; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nishimura AL, 2010, BRAIN, V133, P1763, DOI 10.1093/brain/awq111; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; PinolRoma S, 1997, SEMIN CELL DEV BIOL, V8, P57, DOI 10.1006/scdb.1996.0122; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Prasanth KV, 2003, MOL BIOL CELL, V14, P1043, DOI 10.1091/mbc.E02-10-0669; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; WILLIAMS KR, 1985, P NATL ACAD SCI USA, V82, P5666, DOI 10.1073/pnas.82.17.5666; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zhapparova ON, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1233, DOI 10.1134/S0006297907110090	43	86	87	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18845	18855		10.1074/jbc.M111.231118	http://dx.doi.org/10.1074/jbc.M111.231118			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454607	Green Published, hybrid			2022-12-27	WOS:000290785700057
J	Lamp, J; Keyser, B; Koeller, DM; Ullrich, K; Braulke, T; Muhlhausen, C				Lamp, Jessica; Keyser, Britta; Koeller, David M.; Ullrich, Kurt; Braulke, Thomas; Muehlhausen, Chris			Glutaric Aciduria Type 1 Metabolites Impair the Succinate Transport from Astrocytic to Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORTERS; COA DEHYDROGENASE-DEFICIENCY; ACIDEMIA TYPE-I; 3-HYDROXYGLUTARIC ACID; MOUSE MODEL; FUNCTIONAL-CHARACTERIZATION; EXPRESSION; FAMILY; BRAIN; NEURODEGENERATION	The inherited neurodegenerative disorder glutaric aciduria type 1 (GA1) results from mutations in the gene for the mitochondrial matrix enzyme glutaryl-CoA dehydrogenase (GCDH), which leads to elevations of the dicarboxylates glutaric acid (GA) and 3-hydroxyglutaric acid (3OHGA) in brain and blood. The characteristic clinical presentation of GA1 is a sudden onset of dystonia during catabolic situations, resulting from acute striatal injury. The underlying mechanisms are poorly understood, but the high levels of GA and 3OHGA that accumulate during catabolic illnesses are believed to play a primary role. Both GA and 3OHGA are known to be substrates for Na+-coupled dicarboxylate transporters, which are required for the anaplerotic transfer of the tricarboxylic acid cycle (TCA) intermediate succinate between astrocytes and neurons. We hypothesized that GA and 3OHGA inhibit the transfer of succinate from astrocytes to neurons, leading to reduced TCA cycle activity and cellular injury. Here, we show that both GA and 3OHGA inhibit the uptake of [C-14] succinate by Na+-coupled dicarboxylate transporters in cultured astrocytic and neuronal cells of wild-type and Gcdh(-/-) mice. In addition, we demonstrate that the efflux of [C-14] succinate from Gcdh(-/-) astrocytic cells mediated by a not yet identified transporter is strongly reduced. This is the first experimental evidence that GA and 3OHGA interfere with two essential anaplerotic transport processes: astrocytic efflux and neuronal uptake of TCA cycle intermediates, which occur between neurons and astrocytes. These results suggest that elevated levels of GA and 3OHGA may lead to neuronal injury and cell death via disruption of TCA cycle activity.	[Lamp, Jessica; Keyser, Britta; Ullrich, Kurt; Braulke, Thomas; Muehlhausen, Chris] Univ Med Ctr Hamburg Eppendorf, Childrens Hosp, Dept Biochem, D-20246 Hamburg, Germany; [Koeller, David M.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Oregon Health & Science University	Muhlhausen, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Childrens Hosp, Dept Biochem, Martinistr 52, D-20246 Hamburg, Germany.	muehlhau@uke.uni-hamburg.de	Braulke, Thomas/AAV-9121-2020	Braulke, Thomas/0000-0002-2336-8532; Muhlhausen, Chris/0000-0003-0516-1826	Deutsche Forschungsgemeinschaft [MU1778/2-1, 2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants MU1778/2-1 and 2-2(to C.M.,B.K., and J.L.).	Alebouyeh M, 2003, J PHARMACOL SCI, V93, P430, DOI 10.1254/jphs.93.430; Anzai N, 2006, J PHARMACOL SCI, V100, P411, DOI 10.1254/jphs.CRJ06006X; Bahn A, 2005, AM J PHYSIOL-CELL PH, V289, pC1075, DOI 10.1152/ajpcell.00619.2004; Das AM, 2003, MOL GENET METAB, V78, P108, DOI 10.1016/S1096-7192(02)00227-5; Freudenberg F, 2004, NEUROBIOL DIS, V16, P581, DOI 10.1016/j.nbd.2004.05.001; Goodman S, 2001, METABOLIC MOL BASES, P2195; Hagos Y, 2008, PFLUG ARCH EUR J PHY, V457, P223, DOI 10.1007/s00424-008-0489-2; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; Inoue K, 2004, BIOCHEM J, V378, P949, DOI 10.1042/BJ20031261; Inoue K, 2002, J BIOL CHEM, V277, P39469, DOI 10.1074/jbc.M207072200; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Keyser B, 2008, BBA-MOL BASIS DIS, V1782, P385, DOI 10.1016/j.bbadis.2008.02.008; Keyser B, 2008, HUM MOL GENET, V17, P3854, DOI 10.1093/hmg/ddn284; Koeller DM, 2002, HUM MOL GENET, V11, P347, DOI 10.1093/hmg/11.4.347; Kolker S, 2004, ANN NEUROL, V55, P7, DOI 10.1002/ana.10784; Kulkens S, 2005, NEUROLOGY, V64, P2142, DOI 10.1212/01.WNL.0000167428.12417.B2; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Lund TM, 2004, J NEUROSCI RES, V77, P143, DOI 10.1002/jnr.20136; Matzner U, 2000, GENE THER, V7, P805, DOI 10.1038/sj.gt.3301150; Muhlhausen C, 2008, J INHERIT METAB DIS, V31, P188, DOI 10.1007/s10545-008-0825-x; Muhlhausen C, 2006, PEDIATR RES, V59, P196, DOI 10.1203/01.pdr.0000197313.44265.cb; Pajor AM, 2001, AM J PHYSIOL-CELL PH, V280, pC1215, DOI 10.1152/ajpcell.2001.280.5.C1215; Pavlova A, 2000, AM J PHYSIOL-RENAL, V278, pF635, DOI 10.1152/ajprenal.2000.278.4.F635; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Quitsch A, 2005, J NEUROSCI, V25, P479, DOI 10.1523/JNEUROSCI.2699-04.2005; Rizwan AN, 2007, PHARM RES-DORDR, V24, P450, DOI 10.1007/s11095-006-9181-4; Sauer SW, 2005, J BIOL CHEM, V280, P21830, DOI 10.1074/jbc.M502845200; Schousboe A, 1997, GLIA, V21, P99; Stellmer F, 2007, J MOL MED-JMM, V85, P763, DOI 10.1007/s00109-007-0174-5; STOKKE O, 1976, CLIN CHIM ACTA, V66, P411, DOI 10.1016/0009-8981(76)90241-2; Strauss KA, 2003, AM J MED GENET C, V121C, P38, DOI 10.1002/ajmg.c.20007; Ullrich K, 1999, J INHERIT METAB DIS, V22, P392, DOI 10.1023/A:1005595921323; Uwai Y, 1998, FEBS LETT, V438, P321, DOI 10.1016/S0014-5793(98)01328-3; Yodoya E, 2006, J NEUROCHEM, V97, P162, DOI 10.1111/j.1471-4159.2006.03720.x; Zhou FF, 2007, PHARM RES-DORDR, V24, P28, DOI 10.1007/s11095-006-9144-9; Zinnanti WJ, 2007, J CLIN INVEST, V117, P3258, DOI 10.1172/JCI31617; Zinnanti WJ, 2006, BRAIN, V129, P899, DOI 10.1093/brain/awl009	37	63	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17777	17784		10.1074/jbc.M111.232744	http://dx.doi.org/10.1074/jbc.M111.232744			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454630	Green Published, hybrid			2022-12-27	WOS:000290585200041
J	Brodbeck, J; McGuire, J; Liu, ZP; Meyer-Franke, A; Balestra, ME; Jeong, DE; Pleiss, M; McComas, C; Hess, F; Witter, D; Peterson, S; Childers, M; Goulet, M; Liverton, N; Hargreaves, R; Freedman, S; Weisgraber, KH; Mahley, RW; Huang, YD				Brodbeck, Jens; McGuire, Jim; Liu, Zhaoping; Meyer-Franke, Anke; Balestra, Maureen E.; Jeong, Dah-eun; Pleiss, Mike; McComas, Casey; Hess, Fred; Witter, David; Peterson, Scott; Childers, Matthew; Goulet, Mark; Liverton, Nigel; Hargreaves, Richard; Freedman, Stephen; Weisgraber, Karl H.; Mahley, Robert W.; Huang, Yadong			Structure-dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-molecule Structure Correctors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; CENTRAL NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; ENDOPLASMIC-RETICULUM; TRANSGENIC MICE; QUALITY-CONTROL; DOMAIN INTERACTION; NEURITE OUTGROWTH; NEURONAL CELLS; CONTAINING LIPOPROTEINS	Apolipoprotein (apo) E4 is the major genetic risk factor for Alzheimer disease (AD) and likely contributes to neuropathology through various pathways. Here we report that the intracellular trafficking of apoE4 is impaired in Neuro-2a cells and primary neurons, as shown by measuring fluorescence recovery after photobleaching. In Neuro-2a cells, more apoE4 than apoE3 molecules remained immobilized in the endoplasmic reticulum (ER) and the Golgi apparatus, and the lateral motility of apoE4 was significantly lower in the Golgi apparatus (but not in the ER) than that of apoE3. Likewise, the immobile fraction was larger, and the lateral motility was lower for apoE4 than apoE3 in mouse primary hippocampal neurons. ApoE4 with the R61T mutation, which abolishes apoE4 domain interaction, was less immobilized, and its lateral motility was comparable with that of apoE3. The trafficking impairment of apoE4 was also rescued by disrupting domain interaction with the small-molecule structure correctors GIND25 and PH002. PH002 also rescued apoE4-induced impairments of neurite outgrowth in Neuro-2a cells and dendritic spine development in primary neurons. ApoE4 did not affect trafficking of amyloid precursor protein, another AD-related protein, through the secretory pathway. Thus, domain interaction renders more newly synthesized apoE4 molecules immobile and slows their trafficking along the secretory pathway. Correcting the pathological structure of apoE4 by disrupting domain interaction is a potential therapeutic approach to treat or prevent AD related to apoE4.	[Brodbeck, Jens; McGuire, Jim; Liu, Zhaoping; Balestra, Maureen E.; Jeong, Dah-eun; Weisgraber, Karl H.; Mahley, Robert W.; Huang, Yadong] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Brodbeck, Jens; McGuire, Jim; Liu, Zhaoping; Meyer-Franke, Anke; Balestra, Maureen E.; Jeong, Dah-eun; Pleiss, Mike; Freedman, Stephen; Weisgraber, Karl H.; Mahley, Robert W.; Huang, Yadong] Univ Calif San Francisco, Gladstone Ctr Translat Res, San Francisco, CA 94158 USA; [Weisgraber, Karl H.; Mahley, Robert W.; Huang, Yadong] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Mahley, Robert W.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Weisgraber, Karl H.; Mahley, Robert W.; Huang, Yadong] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA; [Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Weisgraber, Karl H.; Mahley, Robert W.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [McComas, Casey; Hess, Fred; Liverton, Nigel; Hargreaves, Richard] Merck Res Labs, West Point, PA 19486 USA; [Witter, David; Peterson, Scott; Childers, Matthew; Goulet, Mark] Merck Res Labs, Boston, MA 02115 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Merck & Company; Merck & Company	Huang, YD (corresponding author), 1650 Owens St, San Francisco, CA 94158 USA.	yhuang@gladstone.ucsf.edu	Brodbeck, Jens/AAB-9275-2020; liu, zhao/GXV-6141-2022		Merck Research Laboratories; National Institutes of Health [P01 AG022074]; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	Merck Research Laboratories(Merck & Company); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Merck Research Laboratories. This work was also supported, in part, by National Institutes of Health Grant P01 AG022074.	Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; Boschert U, 1999, NEUROBIOL DIS, V6, P508, DOI 10.1006/nbdi.1999.0251; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Brodbeck J, 2008, P NATL ACAD SCI USA, V105, P1343, DOI 10.1073/pnas.0709906104; Buttini M, 2010, AM J PATHOL, V177, P563, DOI 10.2353/ajpath.2010.090973; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; DeMattos RB, 2001, NEUROCHEM INT, V39, P415, DOI 10.1016/S0197-0186(01)00049-3; DILIBERTO EJ, 1976, J NEUROCHEM, V26, P1159, DOI 10.1111/j.1471-4159.1976.tb07001.x; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P203, DOI 10.1073/pnas.82.1.203; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Harris FM, 2004, J BIOL CHEM, V279, P3862, DOI 10.1074/jbc.M309475200; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hatters DM, 2005, J BIOL CHEM, V280, P26477, DOI 10.1074/jbc.M503910200; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; Huang Y, 2006, CURR OPIN DRUG DISC, V9, P627; Huang YD, 2010, TRENDS MOL MED, V16, P287, DOI 10.1016/j.molmed.2010.04.004; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Ji Y, 2003, NEUROSCIENCE, V122, P305, DOI 10.1016/j.neuroscience.2003.08.007; Kalid O, 2010, J COMPUT AID MOL DES, V24, P971, DOI 10.1007/s10822-010-9390-0; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; LINTON MF, 1991, J CLIN INVEST, V88, P270, DOI 10.1172/JCI115288; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MessmerJoudrier S, 1996, EUR J NEUROSCI, V8, P2652, DOI 10.1111/j.1460-9568.1996.tb01560.x; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; NATHAN BP, 1995, J BIOL CHEM, V270, P19791, DOI 10.1074/jbc.270.34.19791; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Romisch K, 2004, TRAFFIC, V5, P815, DOI 10.1111/j.1600-0854.2004.00231.x; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Xu PT, 1999, AM J PATHOL, V154, P601, DOI 10.1016/S0002-9440(10)65305-9; Xu Q, 2004, J BIOL CHEM, V279, P25511, DOI 10.1074/jbc.M311256200; Xu Q, 2008, J NEUROSCI, V28, P1452, DOI 10.1523/JNEUROSCI.3253-07.2008; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Ye SM, 2005, P NATL ACAD SCI USA, V102, P18700, DOI 10.1073/pnas.0508693102; Zhong N, 2009, J BIOL CHEM, V284, P27273, DOI 10.1074/jbc.M109.014464; Zhong N, 2009, J BIOL CHEM, V284, P6027, DOI 10.1074/jbc.R800009200	55	71	73	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17217	17226		10.1074/jbc.M110.217380	http://dx.doi.org/10.1074/jbc.M110.217380			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454574	hybrid, Green Published			2022-12-27	WOS:000290301900070
J	Pulimeno, P; Paschoud, S; Citi, S				Pulimeno, Pamela; Paschoud, Serge; Citi, Sandra			A Role for ZO-1 and PLEKHA7 in Recruiting Paracingulin to Tight and Adherens Junctions of Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CINGULIN; PROTEIN; EXPRESSION; ADHESION; COMPLEX; BINDING; GTPASE; PLAQUE; INHIBITION; ACTIVATION	Paracingulin is a 160-kDa protein localized in the cytoplasmic region of epithelial tight and adherens junctions, where it regulates RhoA and Rac1 activities by interacting with guanine nucleotide exchange factors. Here, we investigate the molecular mechanisms that control the recruitment of paracingulin to cell-cell junctions. We show that paracingulin forms a complex with the tight junction protein ZO-1, and the globular head domain of paracingulin interacts directly with ZO-1 through an N-terminal region containing a conserved ZIM (ZO-1-Interaction-Motif) sequence. Recruitment of paracingulin to cadherin-based cell-cell junctions in Rat1 fibroblasts requires the ZIM-containing region, whereas in epithelial cells removal of this region decreases the junctional localization of paracingulin at tight junctions but not at adherens junctions. Depletion of ZO-1, but not ZO-2, reduces paracingulin accumulation at tight junctions. A yeast two-hybrid screen identifies both ZO-1 and the adherens junction protein PLEKHA7 as paracingulin-binding proteins. Paracingulin forms a complex with PLEKHA7 and its interacting partner p120ctn, and the globular head domain of paracingulin interacts directly with a central region of PLEKHA7. Depletion of PLEKHA7 from Madin-Darby canine kidney cells results in the loss of junctional localization of paracingulin and a decrease in its expression. In summary, we characterize ZO-1 and PLEKHA7 as paracingulin-interacting proteins that are involved in its recruitment to epithelial tight and adherens junctions, respectively.	[Pulimeno, Pamela; Paschoud, Serge; Citi, Sandra] Univ Geneva, Dept Mol Biol, CH-1205 Geneva, Switzerland	University of Geneva	Citi, S (corresponding author), Univ Geneva, Dept Mol Biol, 4 Blvd Yvoy, CH-1205 Geneva, Switzerland.	sandra.citi@unige.ch	Citi, Sandra/E-4514-2014	Citi, Sandra/0000-0002-6537-4818	Swiss National Fonds [31003A103637, 31003A116763]; State of Geneva	Swiss National Fonds(Swiss National Science Foundation (SNSF)); State of Geneva	This work was supported by Swiss National Fonds Grants 31003A103637 and 31003A116763 and the State of Geneva.	Aijaz S, 2005, DEV CELL, V8, P777, DOI 10.1016/j.devcel.2005.03.003; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Bordin M, 2004, MOL CANCER RES, V2, P692; Braga VMM, 2005, CURR OPIN CELL BIOL, V17, P466, DOI 10.1016/j.ceb.2005.08.012; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; CITI S, 1988, NATURE, V333, P272, DOI 10.1038/333272a0; Citi S, 2001, CELL CELL INTERACTIO, P153; CITI S, 2001, TIGHT JUNCTIONS, P231; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; D'Atri F, 2002, J BIOL CHEM, V277, P27757, DOI 10.1074/jbc.M203717200; Dohn MR, 2009, J CELL BIOL, V184, P437, DOI 10.1083/jcb.200807096; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Fanning AS, 2002, FASEB J, V16, P1835, DOI 10.1096/fj.02-0121fje; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Godsel LM, 2010, MOL BIOL CELL, V21, P2844, DOI 10.1091/mbc.E10-02-0131; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Guillemot L, 2004, J CELL SCI, V117, P5245, DOI 10.1242/jcs.01399; Guillemot L, 2008, MOL BIOL CELL, V19, P4442, DOI 10.1091/mbc.E08-06-0558; Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032; Guillemot L, 2006, MOL BIOL CELL, V17, P3569, DOI 10.1091/mbc.E06-02-0122; Guillemot Laurent, 2006, P54; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; McCrea PD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002923; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Ohnishi H, 2004, J BIOL CHEM, V279, P46014, DOI 10.1074/jbc.M402616200; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Paschoud S, 2011, MOL MEMBR BIOL, V28, P123, DOI 10.3109/09687688.2010.538937; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Pulimeno P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012207; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Samarin S, 2009, FRONT BIOSCI-LANDMRK, V14, P1129, DOI 10.2741/3298; Severson EA, 2009, MOL BIOL CELL, V20, P1916, DOI 10.1091/mbc.E08-10-1014; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Terry SJ, 2011, NAT CELL BIOL, V13, P159, DOI 10.1038/ncb2156; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; VanItallie CM, 1997, J CELL SCI, V110, P1113; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Wittchen ES, 2003, MOL BIOL CELL, V14, P1757, DOI 10.1091/mbc.E02-08-0486	45	46	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16743	16750		10.1074/jbc.M111.230862	http://dx.doi.org/10.1074/jbc.M111.230862			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454477	Green Published, hybrid			2022-12-27	WOS:000290301900022
J	Suzuki, K; Oneyama, C; Kimura, H; Tajima, S; Okada, M				Suzuki, Kei; Oneyama, Chitose; Kimura, Hironobu; Tajima, Shoji; Okada, Masato			Down-regulation of the Tumor Suppressor C-terminal Src Kinase (Csk)-binding Protein (Cbp)/PAG1 Is Mediated by Epigenetic Histone Modifications via the Mitogen-activated Protein Kinase (MAPK)/Phosphatidylinositol 3-Kinase (PI3K) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY TYROSINE KINASES; T-CELL-ACTIVATION; V-SRC; TRANSMEMBRANE ADAPTER; CANCER; CSK; TRANSFORMATION; COMPLEX; GENE; METHYLATION	The transmembrane adaptor protein Cbp (or PAG1) functions as a suppressor of Src-mediated tumor progression by promoting the inactivation of Src. The expression of Cbp is down-regulated in Src-transformed cells and in various human cancer cells, suggesting a potential role for Cbp as a tumor suppressor. However, the mechanisms underlying the down-regulation of Cbp remain unknown. The present study shows that Cbp expression is down-regulated by epigenetic histone modifications via the MAPK/PI3K pathway. In mouse embryonic fibroblasts, transformation by oncogenic Src and Ras induced a marked down-regulation of Cbp expression. The levels of Cbp expression were inversely correlated with the activity of MEK and Akt, and Cbp down-regulation was suppressed by inhibiting MEK and PI3K. Src transformation did not affect the stability of Cbp mRNA, the transcriptional activity of the cbp promoter, or the DNA methylation status of the cbp promoter CpG islands. However, Cbp expression was restored by treatment with histone deacetylase (HDAC) inhibitors and by siRNA-mediated knockdown of HDAC1/2. Src transformation significantly decreased the acetylation levels of histone H4 and increased the trimethylation levels of histone H3 lysine 27 in the cbp promoter. EGF-induced Cbp down-regulation was also suppressed by inhibiting MEK and HDAC. Furthermore, the inhibition of MEK or HDAC restored Cbp expression in human cancer cells harboring Cbp down-regulation through promoter hypomethylation. These findings suggest that Cbp down-regulation is primarily mediated by epigenetic histone modifications via oncogenic MAPK/PI3K pathways in a subset of cancer cells.	[Suzuki, Kei; Oneyama, Chitose; Okada, Masato] Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 5650871, Japan; [Kimura, Hironobu; Tajima, Shoji] Osaka Univ, Inst Prot Res, Lab Epigenet, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Okada, M (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	okadam@biken.osaka-u.ac.jp	Kimura, Hironobu/B-3731-2010		Uehara Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22689009] Funding Source: KAKEN	Uehara Foundation(Uehara Memorial Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Uehara Foundation and a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Baylin S, 2001, Dev Biol (Basel), V106, P85; Baylin S, 2001, DEV BIOL BASEL, V106, P143; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Bu Y, 2007, J BIOL CHEM, V282, P26725, DOI 10.1074/jbc.M702885200; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Jiang LQ, 2006, ONCOGENE, V25, P5495, DOI 10.1038/sj.onc.1209554; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Oneyama C, 2008, GENES CELLS, V13, P1, DOI 10.1111/j.1365-2443.2007.01145.x; Oneyama C, 2009, MOL CELL BIOL, V29, P6462, DOI 10.1128/MCB.00941-09; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; PIERANI A, 1993, MOL CELL BIOL, V13, P3401, DOI 10.1128/MCB.13.6.3401; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shima T, 2003, P NATL ACAD SCI USA, V100, P14897, DOI 10.1073/pnas.2432139100; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Sung J, 2005, CARCINOGENESIS, V26, P487, DOI 10.1093/carcin/bgh318; Yagi R, 2007, EMBO J, V26, P1234, DOI 10.1038/sj.emboj.7601595; Yan PS, 2001, CANCER RES, V61, P8375	28	26	27	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.195362	http://dx.doi.org/10.1074/jbc.M110.195362			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21388951	hybrid, Green Published			2022-12-27	WOS:000290022800009
J	Zhang, YY; Wu, JW; Wang, ZX				Zhang, Yuan-Yuan; Wu, Jia-Wei; Wang, Zhi-Xin			Mitogen-activated Protein Kinase (MAPK) Phosphatase 3-mediated Cross-talk between MAPKs ERK2 and p38 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTINUOUS SPECTROPHOTOMETRIC ASSAY; DUAL-SPECIFICITY PHOSPHATASES; EXCHANGE MASS-SPECTROMETRY; SIGNAL-REGULATED KINASE-2; CRYSTAL-STRUCTURE; TYROSINE-PHOSPHATASE; PHYSIOLOGICAL FUNCTIONS; CATALYTIC ACTIVATION; P38; SUBSTRATE	MAPK phosphatase 3 (MKP3) is highly specific for ERK1/2 inactivation via dephosphorylation of both phosphotyrosine and phosphothreonine critical for enzymatic activation. Here, we show that MKP3 is able to effectively dephosphorylate the phosphotyrosine, but not phosphothreonine, in the activation loop of p38 alpha in vitro and in intact cells. The catalytic constant of the MKP3 reaction for p38 alpha is comparable with that for ERK2. Remarkably, MKP3, ERK2, and phosphorylated p38 alpha can form a stable ternary complex in solution, and the phosphatase activity of MKP3 toward p38 alpha substrate is allosterically regulated by ERK2-MKP3 interaction. This suggests that MKP3 not only controls the activities of ERK2 and p38 alpha but also mediates cross-talk between these two MAPK pathways. The crystal structure of bisphosphorylated p38 alpha has been determined at 2.1 angstrom resolution. Comparisons between the phosphorylated MAPK structures reveal the molecular basis of MKP3 substrate specificity.	[Zhang, Yuan-Yuan; Wu, Jia-Wei; Wang, Zhi-Xin] Tsinghua Univ, Sch Life Sci, Minist Educ Key Lab Bioinformat, Beijing 100084, Peoples R China; [Wang, Zhi-Xin] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Wang, ZX (corresponding author), Tsinghua Univ, Sch Life Sci, Minist Educ Key Lab Bioinformat, Beijing 100084, Peoples R China.	zhixinwang@mail.tsinghua.edu.cn	wang, zhixin/GZH-2500-2022		Ministry of Science and Technology of China [2007CB914400, 2011CB910803]; National Natural Science Foundation of China [30770476]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Ministry of Science and Technology of China Grants 2007CB914400 and 2011CB910803 and by National Natural Science Foundation of China Grant 30770476.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; CHENG Q, 1995, ANAL BIOCHEM, V226, P68, DOI 10.1006/abio.1995.1192; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estrada Y, 2009, PIGM CELL MELANOMA R, V22, P66, DOI 10.1111/j.1755-148X.2008.00520.x; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Farooq A, 2001, MOL CELL, V7, P387, DOI 10.1016/S1097-2765(01)00186-1; Fjeld CC, 2000, J BIOL CHEM, V275, P6749, DOI 10.1074/jbc.275.10.6749; Galanis A, 2001, J BIOL CHEM, V276, P965, DOI 10.1074/jbc.M007697200; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Jeong DG, 2006, J MOL BIOL, V360, P946, DOI 10.1016/j.jmb.2006.05.059; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Larsen TA, 1998, STRUCT FOLD DES, V6, P421, DOI 10.1016/S0969-2126(98)00044-6; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mourey RJ, 1996, J BIOL CHEM, V271, P3795; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1996, J BIOL CHEM, V271, P4319; Muda M, 1998, J BIOL CHEM, V273, P9323, DOI 10.1074/jbc.273.15.9323; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saxena M, 1999, J BIOL CHEM, V274, P11693, DOI 10.1074/jbc.274.17.11693; SERGIENKO EA, 1994, ANAL BIOCHEM, V221, P348, DOI 10.1006/abio.1994.1424; Stewart AE, 1999, NAT STRUCT BIOL, V6, P174; Szafranska AE, 2005, FEBS J, V272, P4631, DOI 10.1111/j.1742-4658.2005.04827.x; Szafranska AE, 2005, ANAL BIOCHEM, V336, P1, DOI 10.1016/j.ab.2004.09.039; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wiland AM, 1996, J BIOL CHEM, V271, P33486, DOI 10.1074/jbc.271.52.33486; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200; Zhao Y, 2001, J BIOL CHEM, V276, P32382, DOI 10.1074/jbc.M103369200; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; Zhou B, 2001, J BIOL CHEM, V276, P6506, DOI 10.1074/jbc.M009753200; Zhou B, 1999, J BIOL CHEM, V274, P35526, DOI 10.1074/jbc.274.50.35526; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200; Zhou B, 2006, J BIOL CHEM, V281, P38834, DOI 10.1074/jbc.M608916200	49	48	49	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.203786	http://dx.doi.org/10.1074/jbc.M110.203786			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454500	Green Published, hybrid			2022-12-27	WOS:000290022800055
J	Park, H; Cox, D				Park, Haein; Cox, Dianne			Syk Regulates Multiple Signaling Pathways Leading to CX3CL1 Chemotaxis in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WISKOTT-ALDRICH-SYNDROME; TYROSINE KINASE SYK; ATHEROSCLEROTIC LESION FORMATION; RECEPTOR-MEDIATED PHAGOCYTOSIS; SYNDROME PROTEIN; RHEUMATOID-ARTHRITIS; ACTIN POLYMERIZATION; LEUKOCYTE MIGRATION; CELL-MIGRATION; MAST-CELLS	Several studies have clearly established the importance of the interaction between macrophages and CX3CL1 in the progression of disease. A previous study demonstrated that Syk was required for CX3CL1-mediated actin polymerization and chemotaxis. Here, we delineated the signaling cascade of Syk-mediated cell migration in response to CX3CL1. Inhibition of Syk in bone marrow-derived macrophages or reduction of Syk expression using siRNA in RAW/LR5 cells indicated that Syk was required for the activation of PI3K, Cdc42, and Rac1. Also, reduction in WASP or WAVE2 levels, common downstream effectors of Cdc42 or Rac1, resulted in impaired cell migration to CX3CL1. Syk indirectly regulated WASP tyrosine phosphorylation through Cdc42 activation. Altogether, our data identify that Syk mediated chemotaxis toward CX3CL1 by regulating both Rac1/WAVE2 and Cdc42/WASP pathways, whereas Src family kinases were required for proper WASP tyrosine phosphorylation.	[Park, Haein; Cox, Dianne] Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Cox, Dianne] Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Park, H (corresponding author), 1300 Morris Pk Ave,MRRC306, Bronx, NY 10461 USA.	hapark@aecom.yu.edu; dianne.cox@einstein.yu.edu		Cox, Dianne/0000-0002-0591-9767	National Institutes of Health [GM071828]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071828 (to D.C.).	Abou Kheir W, 2005, J CELL SCI, V118, P5369, DOI 10.1242/jcs.02638; Abou-Kheir W, 2008, J CELL SCI, V121, P379, DOI 10.1242/jcs.010272; Allen LAH, 1996, CURR OPIN IMMUNOL, V8, P36, DOI 10.1016/S0952-7915(96)80102-6; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Allen WE, 1997, J CELL SCI, V110, P707; Badolato R, 1998, J IMMUNOL, V161, P1026; Cambien B, 2001, BLOOD, V97, P2031, DOI 10.1182/blood.V97.7.2031; Cammer M, 2009, J BIOL CHEM, V284, P23302, DOI 10.1074/jbc.M109.036384; CLARK EA, 1994, J BIOL CHEM, V269, P28859; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Cory GOC, 2002, J BIOL CHEM, V277, P45115, DOI 10.1074/jbc.M203346200; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Cox D, 2001, SEMIN IMMUNOL, V13, P339, DOI 10.1006/smim.2001.0330; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Dovas A, 2009, J CELL SCI, V122, P3873, DOI 10.1242/jcs.051755; Fraticelli P, 2001, J CLIN INVEST, V107, P1173, DOI 10.1172/JCI11517; Ganju RK, 2000, J BIOL CHEM, V275, P17263, DOI 10.1074/jbc.M000689200; Gevrey JC, 2005, J IMMUNOL, V175, P3737, DOI 10.4049/jimmunol.175.6.3737; Goda S, 2000, J IMMUNOL, V164, P4313, DOI 10.4049/jimmunol.164.8.4313; Greenberg S, 1999, J LEUKOCYTE BIOL, V66, P712, DOI 10.1002/jlb.66.5.712; Greenberg S, 1996, P NATL ACAD SCI USA, V93, P1103, DOI 10.1073/pnas.93.3.1103; Haddad E, 2001, BLOOD, V97, P33, DOI 10.1182/blood.V97.1.33; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Jones GE, 2002, INT J BIOCHEM CELL B, V34, P806, DOI 10.1016/S1357-2725(01)00162-5; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; McDermott DH, 2001, CIRC RES, V89, P401, DOI 10.1161/hh1701.095642; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miki H, 2002, BIOCHEM BIOPH RES CO, V293, P93, DOI 10.1016/S0006-291X(02)00218-8; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Moatti D, 2001, BLOOD, V97, P1925, DOI 10.1182/blood.V97.7.1925; Mocsai A, 2003, BLOOD, V101, P4155, DOI 10.1182/blood-2002-07-2346; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Nanki T, 2002, ARTHRITIS RHEUM, V46, P2878, DOI 10.1002/art.10622; Navara CS, 2004, CURR PHARM DESIGN, V10, P1739, DOI 10.2174/1381612043384493; Oda A, 2005, BLOOD, V105, P3141, DOI 10.1182/blood-2003-04-1319; Oda A, 2001, BLOOD, V97, P2633, DOI 10.1182/blood.V97.9.2633; Park H, 2009, MOL BIOL CELL, V20, P4500, DOI 10.1091/mbc.E09-03-0230; Raffaghello L, 2009, SEMIN CANCER BIOL, V19, P97, DOI 10.1016/j.semcancer.2008.10.003; Ruth JH, 2001, ARTHRITIS RHEUM, V44, P1568, DOI 10.1002/1529-0131(200107)44:7<1568::AID-ART280>3.0.CO;2-1; Saederup N, 2008, CIRCULATION, V117, P1642, DOI 10.1161/CIRCULATIONAHA.107.743872; Sawai H, 2005, ARTHRITIS RHEUM-US, V52, P1392, DOI 10.1002/art.21140; Schmitz U, 2001, J BIOL CHEM, V276, P22003, DOI 10.1074/jbc.M102450200; Schymeinsky J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001132; Schymeinsky J, 2006, BLOOD, V108, P3919, DOI 10.1182/blood-2005-12-030387; Sheffer I, 2001, J IMMUNOL, V167, P475, DOI 10.4049/jimmunol.167.1.475; Shi J, 2005, J BIOL CHEM, V280, P29849, DOI 10.1074/jbc.M500617200; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Stabile H, 2010, BLOOD, V115, P2818, DOI 10.1182/blood-2009-07-235804; Stanley E R, 1997, Methods Mol Biol, V75, P301; Strzelecka A, 1997, CELL MOTIL CYTOSKEL, V38, P287, DOI 10.1002/(SICI)1097-0169(1997)38:3<287::AID-CM7>3.0.CO;2-2; Suen PW, 1999, J CELL SCI, V112, P4067; Takenawa T, 2001, J CELL SCI, V114, P1801; Torres E, 2006, J BIOL CHEM, V281, P3513, DOI 10.1074/jbc.M509416200; Torres E, 2003, MOL CELL, V11, P1215, DOI 10.1016/S1097-2765(03)00139-4; Truman LA, 2008, BLOOD, V112, P5026, DOI 10.1182/blood-2008-06-162404; Tsuboi S, 2007, J BIOL CHEM, V282, P34194, DOI 10.1074/jbc.M705999200; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Umehara H, 2004, ARTERIOSCL THROM VAS, V24, P34, DOI 10.1161/01.ATV.0000095360.62479.1F; Wan Y, 1996, NATURE, V380, P541, DOI 10.1038/380541a0; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Zicha D, 1998, BRIT J HAEMATOL, V101, P659, DOI 10.1046/j.1365-2141.1998.00767.x	66	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14762	14769		10.1074/jbc.M110.185181	http://dx.doi.org/10.1074/jbc.M110.185181			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21388954	hybrid, Green Published			2022-12-27	WOS:000289788300005
J	Syeda, F; Fagan, RL; Wean, M; Avvakumov, GV; Walker, JR; Xue, S; Dhe-Paganon, S; Brenner, C				Syeda, Farisa; Fagan, Rebecca L.; Wean, Matthew; Avvakumov, George V.; Walker, John R.; Xue, Sheng; Dhe-Paganon, Sirano; Brenner, Charles			The Replication Focus Targeting Sequence (RFTS) Domain Is a DNA-competitive Inhibitor of Dnmt1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMI-METHYLATED DNA; SRA DOMAIN; METHYLTRANSFERASE; UHRF1; COMPLEX; ENZYME; RECOGNITION; ACTIVATION; MECHANISM; INSIGHTS	Dnmt1 (DNA methyltransferase 1) is the principal enzyme responsible for maintenance of cytosine methylation at CpG dinucleotides in the mammalian genome. The N-terminal replication focus targeting sequence (RFTS) domain of Dnmt1 has been implicated in subcellular localization, protein association, and catalytic function. However, progress in understanding its function has been limited by the lack of assays for and a structure of this domain. Here, we show that the naked DNA-and polynucleosome- binding activities of Dnmt1 are inhibited by the RFTS domain, which functions by virtue of binding the catalytic domain to the exclusion of DNA. Kinetic analysis with a fluorogenic DNA substrate established the RFTS domain as a 600-fold inhibitor of Dnmt1 enzymatic activity. The crystal structure of the RFTS domain reveals a novel fold and supports a mechanism in which an RFTS-targeted Dnmt1-binding protein, such as Uhrf1, may activate Dnmt1 for DNA binding.	[Syeda, Farisa; Avvakumov, George V.; Walker, John R.; Xue, Sheng; Dhe-Paganon, Sirano] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Syeda, Farisa; Avvakumov, George V.; Walker, John R.; Xue, Sheng; Dhe-Paganon, Sirano] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada; [Fagan, Rebecca L.; Wean, Matthew; Brenner, Charles] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA	University of Toronto; Structural Genomics Consortium; University of Toronto; University of Iowa	Dhe-Paganon, S (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.	sirano.dhepaganon@utoronto.ca	Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226; /0000-0002-5255-895X; Switzer, Rebecca/0000-0003-0591-2538	National Institutes of Health [CA075954]; NCI [HHSN261200433000C]; United States Department of Energy Office of Basic Energy Sciences [DE-AC02-06CH11357]; Canadian Institutes of Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA075954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work performed at the University of Iowa was supported by National Institutes of Health Grant CA075954 and Contract HHSN261200433000C from NCI and a generous gift from the Roy J. Carver Foundation. Use of the Advanced Photon Source was supported by United States Department of Energy Office of Basic Energy Sciences Contract DE-AC02-06CH11357. The Structural Genomics Consortium is a registered charity (1097737) supported by the Canadian Institutes of Health Research, the Canadian Foundation for Innovation, and Genome Canada through the Ontario Genomics Institute.; Supported by an American Cancer Society postdoctoral fellowship.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Bacik JP, 2010, J BIOL CHEM, V285, P20273, DOI 10.1074/jbc.M110.102921; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Callebaut I, 1999, FEBS LETT, V446, P189, DOI 10.1016/S0014-5793(99)00132-5; CHA S, 1970, J BIOL CHEM, V245, P4814; CHAN S, 1988, J BIOL CHEM, V263, P15643; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Goldstein A, 1944, J GEN PHYSIOL, V27, P529, DOI 10.1085/jgp.27.6.529; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jeltsch A, 2006, EPIGENETICS-US, V1, P63, DOI 10.4161/epi.1.2.2767; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pradhan M, 2008, BIOCHEMISTRY-US, V47, P10000, DOI 10.1021/bi8011725; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Svedruzic ZM, 2005, BIOCHEMISTRY-US, V44, P9472, DOI 10.1021/bi050295z; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wood RJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq047; Yokochi T, 2002, J BIOL CHEM, V277, P11735, DOI 10.1074/jbc.M106590200	29	83	86	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15344	15351		10.1074/jbc.M110.209882	http://dx.doi.org/10.1074/jbc.M110.209882			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21389349	Green Published, hybrid			2022-12-27	WOS:000289788300065
J	Wade, F; Espagne, A; Persuy, MA; Vidic, J; Monnerie, R; Merola, F; Pajot-Augy, E; Sanz, G				Wade, Fallou; Espagne, Agathe; Persuy, Marie-Annick; Vidic, Jasmina; Monnerie, Regine; Merola, Fabienne; Pajot-Augy, Edith; Sanz, Guenhael			Relationship between Homo-oligomerization of a Mammalian Olfactory Receptor and Its Activation State Demonstrated by Bioluminescence Resonance Energy Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTORS; LIVING CELLS; BETA(2)-ADRENERGIC RECEPTOR; SACCHAROMYCES-CEREVISIAE; CONFORMATIONAL-CHANGES; IN-VIVO; DIMERIZATION; COMPLEXES; YEAST; HETERODIMERIZATION	G-protein-coupled receptor homo-oligomerization has been increasingly reported. However, little is known regarding the relationship between activation of the receptor and its association/conformational states. The mammalian olfactory receptors (ORs) belong to the G protein-coupled receptor superfamily. In this study, the homo-oligomerization status of the human OR1740 receptor and its involvement in receptor activation upon odorant ligand binding were addressed by co-immuno-precipitation and bioluminescence resonance energy transfer approaches using crude membranes or membranes from different cellular compartments. For the first time, our data clearly show that mammalian ORs constitutively self-associate into homodimers at the plasma membrane level. This study also demonstrates that ligand binding mediates a conformational change and promotes an inactive state of the OR dimers at high ligand concentrations. These findings support and validate our previously proposed model of OR activation/inactivation based on the tripartite odorant-binding protein-odorant-OR partnership.	[Wade, Fallou; Persuy, Marie-Annick; Monnerie, Regine; Pajot-Augy, Edith; Sanz, Guenhael] INRA, Neurobiol Olfact & Modelisat Imagerie UR1197, F-78350 Jouy En Josas, France; [Vidic, Jasmina] INRA, Virol & Immunol Mol UR892, F-78350 Jouy En Josas, France; [Espagne, Agathe; Merola, Fabienne] Univ Paris 11, Lab Chim Phys, UMR 8000, IFR Neuro Sud Paris France 144, F-91405 Orsay, France; [Espagne, Agathe; Merola, Fabienne] CNRS, F-91405 Orsay, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Sanz, G (corresponding author), INRA, Neurobiol Olfact & Modelisat Imagerie UR1197, F-78350 Jouy En Josas, France.	guenhael.sanz@jouy.inra.fr	Vidic, Jasmina/AFP-6747-2022; Merola, Fabienne/A-1172-2012	Vidic, Jasmina/0000-0002-8549-8199; Espagne, Agathe/0000-0002-2333-0227	Institut National de la Recherche Agronomique (INRA); Agence Nationale de la Recherche (New Olfactory SEnsors) [ANR-07-PCVI-0027-01]	Institut National de la Recherche Agronomique (INRA); Agence Nationale de la Recherche (New Olfactory SEnsors)(French National Research Agency (ANR))	This work was supported by the Institut National de la Recherche Agronomique (INRA) and Agence Nationale de la Recherche (New Olfactory SEnsors) Grant ANR-07-PCVI-0027-01.	Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Araneda RC, 2004, J PHYSIOL-LONDON, V555, P743, DOI 10.1113/jphysiol.2003.058040; Armstrong D, 2001, J BIOL CHEM, V276, P22621, DOI 10.1074/jbc.M006936200; Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Bacart Johan, 2008, Biotechnol J, V3, P311, DOI 10.1002/biot.200700222; Baker JG, 2007, TRENDS PHARMACOL SCI, V28, P374, DOI 10.1016/j.tips.2007.06.011; Bush CF, 2007, J BIOL CHEM, V282, P19042, DOI 10.1074/jbc.M610781200; Chabre M, 2009, TRENDS PHARMACOL SCI, V30, P182, DOI 10.1016/j.tips.2009.01.003; Cheng ZJ, 2001, J BIOL CHEM, V276, P48040, DOI 10.1074/jbc.M105668200; Cook BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002920; Crowe ML, 2000, J RECEPT SIGNAL TR R, V20, P61, DOI 10.3109/10799890009150037; Duncan RR, 2004, J MICROSC-OXFORD, V215, P1, DOI 10.1111/j.0022-2720.2004.01343.x; Eraso P, 2006, BBA-BIOMEMBRANES, V1758, P164, DOI 10.1016/j.bbamem.2006.01.010; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Guan RB, 2009, J BIOL CHEM, V284, P7483, DOI 10.1074/jbc.M809150200; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Hague C, 2004, MOL INTERV, V4, P321, DOI 10.1124/mi.4.6.4; Hague C, 2004, P NATL ACAD SCI USA, V101, P13672, DOI 10.1073/pnas.0403854101; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hebert TE, 2006, CELL BIOCHEM BIOPHYS, V45, P85, DOI 10.1385/CBB:45:1:85; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Jacquier V, 2006, J NEUROCHEM, V97, P537, DOI 10.1111/j.1471-4159.2006.03771.x; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kenworthy A, 2002, TRENDS BIOCHEM SCI, V27, P435, DOI 10.1016/S0968-0004(02)02178-3; Ko HJ, 2006, BIOL CHEM, V387, P59, DOI 10.1515/BC.2006.009; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Milligan G, 2005, FEBS J, V272, P2914, DOI 10.1111/j.1742-4658.2005.04731.x; Milligan G, 2005, J MOL NEUROSCI, V26, P161, DOI 10.1385/JMN:26:2-3:161; Minic J, 2005, FEBS J, V272, P524, DOI 10.1111/j.1742-4658.2004.04494.x; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Pajot-Augy E, 2003, J RECEPT SIG TRANSD, V23, P155, DOI 10.1081/RRS-120025196; Park PSH, 2004, BIOCHEMISTRY-US, V43, P15643, DOI 10.1021/bi047907k; Pfleger KDG, 2005, BIOCHEM J, V385, P625, DOI 10.1042/BJ20041361; PRICE LA, 1995, MOL CELL BIOL, V15, P6188; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Sanz G, 2005, CHEM SENSES, V30, P69, DOI 10.1093/chemse/bji002; SCHIESTL RH, 1993, MOL CELL BIOL, V13, P2697, DOI 10.1128/MCB.13.5.2697; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Steinbrecht RA, 1998, ANN NY ACAD SCI, V855, P323, DOI 10.1111/j.1749-6632.1998.tb10591.x; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Vidic J, 2008, LAB CHIP, V8, P678, DOI 10.1039/b717724k; Vidic J, 2007, ANAL CHEM, V79, P3280, DOI 10.1021/ac061774m; Vidic JM, 2006, LAB CHIP, V6, P1026, DOI 10.1039/b603189g; Xu PX, 2005, SCIENCE, V310, P798, DOI 10.1126/science.1121249; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	51	29	29	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15252	15259		10.1074/jbc.M110.184580	http://dx.doi.org/10.1074/jbc.M110.184580			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21454689	Green Published, hybrid			2022-12-27	WOS:000289788300056
J	Xie, WB; Li, ZG; Miano, JM; Long, XC; Chen, SY				Xie, Wei-Bing; Li, Zuguo; Miano, Joseph M.; Long, Xiaochun; Chen, Shi-You			Smad3-mediated Myocardin Silencing A NOVEL MECHANISM GOVERNING THE INITIATION OF SMOOTH MUSCLE DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; TGF-BETA; CELL-DIFFERENTIATION; EXPRESSION; TRANSCRIPTION; SIGNALS; MARKER; SMAD3; GENE; SUFFICIENT	Both TGF-beta and myocardin (MYOCD) are important for smooth muscle cell (SMC) differentiation, but their precise role in regulating the initiation of SMC development is less clear. In TGF-beta-induced SMC differentiation of pluripotent C3H10T1/2 progenitors, we found that TGF-beta did not significantly induce Myocd mRNA expression until 18 h of stimulation. On the other hand, early SMC markers such as SM alpha-actin, SM22 alpha, and SM calponin were detectable beginning 2 or 4 h after TGF-beta treatment. These results suggest that Myocd expression is blocked during the initiation of TGF-beta-induced SMC differentiation. Consistent with its endogenous expression, Myocd promoter activity was not elevated until 18 h following TGF-beta stimulation. Surprisingly, Smad signaling was inhibitory to Myocd expression because blockade of Smad signaling enhanced Myocd promoter activity. Overexpression of Smad3, but not Smad2, inhibited Myocd promoter activity. Conversely, shRNA knockdown of Smad3 allowed TGF-beta to activate the Myocd promoter in the initial phase of induction. Myocd was activated by PI3 kinase signaling and its downstream target Nkx2.5. Interestingly, Smad3 did not affect PI3 kinase activity. However, Smad3 physically interacted with Nkx2.5. This interaction blocked Nkx2.5 binding to the Myocd promoter in the early stage of TGF-beta induction, leading to inhibition of Myocd mRNA expression. Moreover, Smad3 inhibited Nkx2.5-activated Myocd promoter activity in a dose-dependent manner. Taken together, our results reveal a novel mechanism for Smad3-mediated inhibition of Myocd in the initiation phase of SMC differentiation.	[Xie, Wei-Bing; Li, Zuguo; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA; [Miano, Joseph M.; Long, Xiaochun] Univ Rochester, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA	University System of Georgia; University of Georgia; University of Rochester	Chen, SY (corresponding author), 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu	; Miano, Joseph/L-5634-2018	Long, Xiaochun/0000-0001-9714-0023; Miano, Joseph/0000-0001-7522-3207	National Institutes of Health [HL093429, HL091168]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091168, R01HL093429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL093429 (to S.-Y.C.) and HL091168 (to J.M.M.).	ARCINIEGAS E, 1992, J CELL SCI, V103, P521; Briones VR, 2006, BIOCHEM BIOPH RES CO, V345, P595, DOI 10.1016/j.bbrc.2006.04.052; Chang H, 1999, DEVELOPMENT, V126, P1631; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chen SY, 2006, J BIOL CHEM, V281, P1765, DOI 10.1074/jbc.M507771200; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; De Caestecker M, 2001, RESPIR RES, V2, P193; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; de Caestecker MP, 2000, J BIOL CHEM, V275, P2115, DOI 10.1074/jbc.275.3.2115; deCaestecker MP, 1997, J BIOL CHEM, V272, P13690, DOI 10.1074/jbc.272.21.13690; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; HOOFNAGLE MH, 2011, AM J PHYSL IN PRESS; Kawai-Kowase K, 2005, MOL CELL BIOL, V25, P8009, DOI 10.1128/MCB.25.18.8009-8023.2005; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Li FM, 2007, J BIOL CHEM, V282, P10133, DOI 10.1074/jbc.C600225200; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Masszi A, 2010, J CELL BIOL, V188, P383, DOI 10.1083/jcb.200906155; Naito AT, 2003, EXP CELL RES, V291, P56, DOI 10.1016/S0014-4827(03)00378-1; Nicolas FJ, 2004, J CELL SCI, V117, P4113, DOI 10.1242/jcs.01289; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Owens Gary K, 2007, Novartis Found Symp, V283, P174; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Qiu P, 2003, J MOL CELL CARDIOL, V35, P1407, DOI 10.1016/j.yjmcc.2003.09.002; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Sun Q, 2009, J BIOL CHEM, V284, P32582, DOI 10.1074/jbc.M109.033910; Ueyama T, 2003, MOL CELL BIOL, V23, P9222, DOI 10.1128/MCB.23.24.9222-9232.2003; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yang X, 1999, DEVELOPMENT, V126, P1571; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhang JCL, 2001, MOL CELL BIOL, V21, P1336, DOI 10.1128/MCB.2001.21.4.1336-1344.2001; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	44	41	41	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15050	15057		10.1074/jbc.M110.202747	http://dx.doi.org/10.1074/jbc.M110.202747			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21402709	Green Published, hybrid			2022-12-27	WOS:000289788300035
J	Isomura, R; Kitajima, K; Sato, C				Isomura, Ryo; Kitajima, Ken; Sato, Chihiro			Structural and Functional Impairments of Polysialic Acid by a Mutated Polysialyltransferase Found in Schizophrenia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; FRONTAL AFFINITY-CHROMATOGRAPHY; CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; DENTATE GYRUS; ADULT-RAT; NCAM-H; N-CAM; EXPRESSION; BRAIN	Polysialic acid (polySia), a unique acidic glycan modifying neural cell adhesion molecule (NCAM), is known to regulate embryonic neural development and adult brain functions. Polysialyltransferase STX is responsible for the synthesis of polySia, and two single nucleotide polymorphisms (SNPs) of the coding region of STX are reported from schizophrenic patients: SNP7 and SNP9, respectively, giving STX(G421A) with E141K and STX(C621G) with silent mutations. In this study, we focused on these mutations and a binding activity of polySia to neural materials, such as brain-derived neurotrophic factor (BDNF). Here we describe three new findings. First, STX(G421A) shows a dramatic decrease in polySia synthetic activity on NCAM, whereas STX(C621G) does not. The STX(G421A)-derived polySia-NCAM contains a lower amount of polySia with a shorter chain length. Second, polySia shows a dopamine (DA) binding activity, which is a new function of polySia as revealed by frontal affinity chromatography for measuring the polySia-neurotransmitter interactions. Interestingly, the STX(G421A)-derived polySia-NCAM completely loses the DA binding activity, whereas it greatly diminishes but does not lose the BDNF binding activity. Third, an impairment of the polySia structure with an endosialidase modulates the DA-mediated Akt signaling. Taken together, impairment of the amount and quality of polySia may be involved in psychiatric disorders through impaired binding to BDNF and DA, which are deeply involved in schizophrenia and other psychiatric disorders, such as depression and bipolar disorder.	[Isomura, Ryo; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Isomura, Ryo; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Sato, C (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	chi@agr.nagoya-u.ac.jp	SATO, Chihiro/B-7396-2014		Ministry of Education, Science, Sports, and Culture [20570107, 23570133]; Hayashi Foundation; CREST of Japan Science and Technology Agency	Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hayashi Foundation; CREST of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This research was supported in part by Grants-in-Aid for Scientific Research (C) 20570107 and 23570133 from the Ministry of Education, Science, Sports, and Culture and by the Hayashi Foundation (to C. S.) and by the CREST of Japan Science and Technology Agency (to K. K.).	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata K, 2007, MOL CELL BIOL, V27, P6659, DOI 10.1128/MCB.00205-07; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; Asahina S, 2006, J BIOCHEM, V140, P687, DOI 10.1093/jb/mvj200; Ashe PC, 2001, PROG NEURO-PSYCHOPH, V25, P691, DOI 10.1016/S0278-5846(01)00159-2; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; BAUMANN H, 1993, BIOCHEMISTRY-US, V32, P4007, DOI 10.1021/bi00066a022; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Brocco M, 2003, J NEUROSCI RES, V74, P744, DOI 10.1002/jnr.10781; Calandreau L, 2010, GENES BRAIN BEHAV, V9, P958, DOI 10.1111/j.1601-183X.2010.00635.x; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Drake PM, 2008, J IMMUNOL, V181, P6850, DOI 10.4049/jimmunol.181.10.6850; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Enomoto A, 2009, NEURON, V63, P774, DOI 10.1016/j.neuron.2009.08.015; Freyberg Z, 2010, AM J PSYCHIAT, V167, P388, DOI 10.1176/appi.ajp.2009.08121873; Guillin O, 2007, INT REV NEUROBIOL, V78, P377, DOI 10.1016/S0074-7742(06)78012-6; HALBERSTADT JB, 1993, ANAL BIOCHEM, V209, P136, DOI 10.1006/abio.1993.1093; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Kanato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P2735, DOI 10.1271/bbb.90637; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; KASAI KI, 1978, J BIOCHEM-TOKYO, V84, P1051, DOI 10.1093/oxfordjournals.jbchem.a132219; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; LACKIE PM, 1991, DIFFERENTIATION, V47, P85, DOI 10.1111/j.1432-0436.1991.tb00226.x; Lang UE, 2007, CELL PHYSIOL BIOCHEM, V20, P687, DOI 10.1159/000110430; MACKAY AVP, 1982, ARCH GEN PSYCHIAT, V39, P991; Maziade M, 2005, MOL PSYCHIATR, V10, P486, DOI 10.1038/sj.mp.4001594; Mikkonen M, 1999, EUR J NEUROSCI, V11, P1754, DOI 10.1046/j.1460-9568.1999.00593.x; Millar JK, 2001, MOL PSYCHIATR, V6, P173, DOI 10.1038/sj.mp.4000784; Murphy KJ, 2006, NEUROPSYCHOPHARMACOL, V31, P90, DOI 10.1038/sj.npp.1300810; Nakata D, 2005, J BIOL CHEM, V280, P38305, DOI 10.1074/jbc.M508762200; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Oizumi H, 2008, NEUROSCI RES, V60, P15, DOI 10.1016/j.neures.2007.09.004; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sato C, 1999, TRENDS GLYCOSCI GLYC, V11, P371, DOI 10.4052/tigg.11.371; SATO C, 1995, J BIOL CHEM, V270, P18923, DOI 10.1074/jbc.270.32.18923; Sato C, 1998, ANAL BIOCHEM, V261, P191, DOI 10.1006/abio.1998.2718; Sato C, 2010, METHOD ENZYMOL, V478, P219, DOI 10.1016/S0076-6879(10)78010-1; Schiff M, 2009, J NEUROCHEM, V110, P1661, DOI 10.1111/j.1471-4159.2009.06267.x; Schuster T, 2001, J NEUROBIOL, V49, P142, DOI 10.1002/neu.1071; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; SEKI T, 1991, NEUROSCI RES, V12, P503, DOI 10.1016/S0168-0102(09)80003-5; Seki T, 2004, TRENDS GLYCOSCI GLYC, V16, P319, DOI 10.4052/tigg.16.319; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; Strous RD, 1997, PSYCHIAT RES, V69, P71, DOI 10.1016/S0165-1781(96)03111-3; Tan HY, 2008, J CLIN INVEST, V118, P2200, DOI [10.1172/JCI3472S, 10.1172/JCI34725]; Tateno H, 2007, NAT PROTOC, V2, P2529, DOI 10.1038/nprot.2007.357; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; TROY FA, 1996, BIOL SIALIC ACIDS, P95; Turetsky BI, 2003, ARCH GEN PSYCHIAT, V60, P1193, DOI 10.1001/archpsyc.60.12.1193; Uryu K, 1999, J COMP NEUROL, V405, P216, DOI 10.1002/(SICI)1096-9861(19990308)405:2<216::AID-CNE6>3.0.CO;2-6; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Woods BT, 1998, AM J PSYCHIAT, V155, P1661, DOI 10.1176/ajp.155.12.1661; Xiao MF, 2009, J NEUROSCI, V29, P14752, DOI 10.1523/JNEUROSCI.4860-09.2009; Yoshimi K, 2005, ANN NEUROL, V58, P31, DOI 10.1002/ana.20506	62	89	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21535	21545		10.1074/jbc.M111.221143	http://dx.doi.org/10.1074/jbc.M111.221143			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21464126	Green Published, hybrid			2022-12-27	WOS:000291464700051
J	Sato, Y; Hirayama, M; Morimoto, K; Yamamoto, N; Okuyama, S; Hori, K				Sato, Yuichiro; Hirayama, Makoto; Morimoto, Kinjiro; Yamamoto, Naoki; Okuyama, Satomi; Hori, Kanji			High Mannose-binding Lectin with Preference for the Cluster of alpha 1-2-Mannose from the Green Alga Boodlea coacta Is a Potent Entry Inhibitor of HIV-1 and Influenza Viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONCANONICAL GENETIC-CODE; FRESH-WATER CYANOBACTERIUM; CYANOVIRIN-N; INACTIVATING PROTEIN; OSCILLATORIA-AGARDHII; ANTIVIRAL ACTIVITIES; VIRAL HEMAGGLUTININ; ENVELOPED VIRUSES; PLANT-LECTINS; SPECIFICITY	The complete amino acid sequence of a lectin from the green alga Boodlea coacta (BCA), which was determined by a combination of Edman degradation of its peptide fragments and cDNA cloning, revealed the following: 1) B. coacta used a non-canonical genetic code (where TAA and TAG codons encode glutamine rather than a translation termination), and 2) BCA consisted of three internal tandem-repeated domains, each of which contains the sequence motif similar to the carbohydrate-binding site of Galanthus nivalis agglutinin-related lectins. Carbohydrate binding specificity of BCA was examined by a centrifugal ultrafiltration-HPLC assay using 42 pyridylaminated oligosaccharides. BCA bound to high mannose-type N-glycans but not to the complex-type, hybrid-type core structure of N-glycans or oligosaccharides from glycolipids. This lectin had exclusive specificity for alpha 1-2-linked mannose at the nonreducing terminus. The binding activity was enhanced as the number of terminal alpha 1-2-linked mannose substitutions increased. Mannobiose, mannotriose, and mannopentaose were incapable of binding to BCA. Thus, BCA preferentially recognized the nonreducing terminal alpha 1-2-mannose cluster as a primary target. As predicted from carbohydrate-binding propensity, this lectin inhibited the HIV-1 entry into the host cells at a half-maximal effective concentration of 8.2 nM. A high association constant (3.71 x 10(8) M-1) of BCA with the HIV envelope glycoprotein gp120 was demonstrated by surface plasmon resonance analysis. Moreover, BCA showed the potent anti-influenza activity by directly binding to viral envelope hemagglutinin against various strains, including a clinical isolate of pandemic H1N1-2009 virus, revealing its potential as an antiviral reagent.	[Sato, Yuichiro; Hirayama, Makoto; Okuyama, Satomi; Hori, Kanji] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; [Sato, Yuichiro; Morimoto, Kinjiro] Yasuda Womens Univ, Fac Pharm, Asaminami Ku, Hiroshima 7310153, Japan; [Yamamoto, Naoki] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore	Hiroshima University; National University of Singapore	Hori, K (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Kagamiyama 1-4-4, Higashihiroshima 7398528, Japan.	kanhori@hiroshima-u.ac.jp			Japan Society of the Promotion of Science	Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant-in-aid for scientific research (B) from Japan Society of the Promotion of Science.	Abe Y, 2004, J VIROL, V78, P9605, DOI 10.1128/JVI.78.18.9605-9611.2004; Balzarini Jan, 2007, Antiviral Chemistry & Chemotherapy, V18, P1; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Barre A, 1996, PLANT PHYSIOL, V112, P1531, DOI 10.1104/pp.112.4.1531; Barre A, 2001, BIOCHIMIE, V83, P645, DOI 10.1016/S0300-9084(01)01315-3; Barrientos LG, 2003, ANTIVIR RES, V58, P47, DOI 10.1016/S0166-3542(02)00183-3; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; Bokesch HR, 2003, BIOCHEMISTRY-US, V42, P2578, DOI 10.1021/bi0205698; Botos I, 2005, PROG BIOPHYS MOL BIO, V88, P233, DOI 10.1016/j.pbiomolbio.2004.05.001; Botos I, 2002, J BIOL CHEM, V277, P34336, DOI 10.1074/jbc.M205909200; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; de Koning AP, 2008, ENVIRON MICROBIOL, V10, P65, DOI 10.1111/j.1462-2920.2007.01430.x; Dey B, 2000, J VIROL, V74, P4562, DOI 10.1128/JVI.74.10.4562-4569.2000; Fouquaert E, 2009, BIOCHEM BIOPH RES CO, V380, P260, DOI 10.1016/j.bbrc.2009.01.048; Fouquaert E, 2007, PLANT CELL PHYSIOL, V48, P1010, DOI 10.1093/pcp/pcm071; Gile GH, 2009, J EUKARYOT MICROBIOL, V56, P367, DOI 10.1111/j.1550-7408.2009.00411.x; Hartshorn KL, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-65; Helle F, 2006, J BIOL CHEM, V281, P25177, DOI 10.1074/jbc.M602431200; Hester G, 1996, J MOL BIOL, V262, P516, DOI 10.1006/jmbi.1996.0532; HORI K, 1986, BOT MAR, V29, P323, DOI 10.1515/botm.1986.29.4.323; Hori K, 2007, GLYCOBIOLOGY, V17, P479, DOI 10.1093/glycob/cwm007; Huskens D, 2008, INT J BIOCHEM CELL B, V40, P2802, DOI 10.1016/j.biocel.2008.05.023; Job ER, 2010, J IMMUNOL, V185, P4284, DOI 10.4049/jimmunol.1001613; Keeling PJ, 2003, J MOL BIOL, V326, P1337, DOI 10.1016/S0022-2836(03)00057-3; Keeling PJ, 1997, MOL BIOL EVOL, V14, P895, DOI 10.1093/oxfordjournals.molbev.a025832; Keeling PJ, 1996, EMBO J, V15, P2285, DOI 10.1002/j.1460-2075.1996.tb00581.x; Krishnamoorthy L, 2009, NAT CHEM BIOL, V5, P244, DOI 10.1038/nchembio.151; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE YC, 1983, J BIOL CHEM, V258, P199; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lozupone CA, 2001, CURR BIOL, V11, P65, DOI 10.1016/S0960-9822(01)00028-8; MANDAL DK, 1994, EUR J BIOCHEM, V221, P547, DOI 10.1111/j.1432-1033.1994.tb18767.x; McFeeters RL, 2007, J MOL BIOL, V369, P451, DOI 10.1016/j.jmb.2007.03.030; MirShekari SY, 1997, J BIOL CHEM, V272, P4027, DOI 10.1074/jbc.272.7.4027; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Mortell KH, 1996, J AM CHEM SOC, V118, P2297, DOI 10.1021/ja953574q; O'Keefe BR, 2010, J VIROL, V84, P2511, DOI 10.1128/JVI.02322-09; O'Keefe BR, 2003, ANTIMICROB AGENTS CH, V47, P2518, DOI 10.1128/AAC.47.8.2518-2525.2003; OKAMOTO R, 1990, EXPERIENTIA, V46, P975, DOI 10.1007/BF01939393; Parret AHA, 2005, APPL ENVIRON MICROB, V71, P5197, DOI 10.1128/AEM.71.9.5197-5207.2005; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; Peumans WJ, 2002, PLANT PHYSIOL, V129, P1054, DOI 10.1104/pp.010959; Rudiger H, 1998, ACTA ANAT, V161, P130; Sato Y, 2000, COMP BIOCHEM PHYS B, V125, P169, DOI 10.1016/S0305-0491(99)00164-9; Sato Y, 2007, J BIOL CHEM, V282, P11021, DOI 10.1074/jbc.M701252200; Sato Y, 2011, BIOCHEM BIOPH RES CO, V405, P291, DOI 10.1016/j.bbrc.2011.01.031; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHNEIDER SU, 1991, CURR GENET, V20, P173, DOI 10.1007/BF00312782; SCHNEIDER SU, 1989, MOL GEN GENET, V218, P445, DOI 10.1007/BF00332408; Shahzad-Ul-Hussan S, 2009, J AM CHEM SOC, V131, P16500, DOI 10.1021/ja905929c; Tanaka H, 2009, P NATL ACAD SCI USA, V106, P15633, DOI 10.1073/pnas.0907572106; TOURANCHEAU AB, 1995, EMBO J, V14, P3262, DOI 10.1002/j.1460-2075.1995.tb07329.x; Van Damme EJM, 2007, BIOCHEM J, V404, P51, DOI 10.1042/BJ20061819; VANDAMME EJM, 1992, EUR J BIOCHEM, V206, P413, DOI 10.1111/j.1432-1033.1992.tb16941.x; Williams DC, 2005, J BIOL CHEM, V280, P29269, DOI 10.1074/jbc.M504642200; Yamaguchi M, 1999, BIOCHEM BIOPH RES CO, V265, P703, DOI 10.1006/bbrc.1999.1749; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Ziolkowska NE, 2006, ACTA BIOCHIM POL, V53, P617	60	52	57	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19446	19458		10.1074/jbc.M110.216655	http://dx.doi.org/10.1074/jbc.M110.216655			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21460211	Green Published, hybrid			2022-12-27	WOS:000291027700028
J	Lobito, AA; Ramani, SR; Tom, I; Bazan, JF; Luis, E; Fairbrother, WJ; Ouyang, WJ; Gonzalez, LC				Lobito, Adrian A.; Ramani, Sree R.; Tom, Irene; Bazan, J. Fernando; Luis, Elizabeth; Fairbrother, Wayne J.; Ouyang, Wenjun; Gonzalez, Lino C.			Murine Insulin Growth Factor-like (IGFL) and Human IGFL1 Proteins Are Induced in Inflammatory Skin Conditions and Bind to a Novel Tumor Necrosis Factor Receptor Family Member, IGFLR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA TNF-ALPHA; INTERFERON-GAMMA; PSORIASIS; KERATINOCYTES; CELLS; LIGAND; IL-22; SUPERFAMILY; MONOTHERAPY; ENHANCEMENT	Psoriasis is a human skin condition characterized by epidermal hyperproliferation and infiltration of multiple leukocyte populations. In characterizing a novel insulin growth factor (IGF)-like (IGFL) gene in mice (mIGFL), we found transcripts of this gene to be most highly expressed in skin with enhanced expression in models of skin wounding and psoriatic-like inflammation. A possible functional ortholog in humans, IGFL1, was uniquely and significantly induced in psoriatic skin samples. In vitro IGFL1 expression was up-regulated in cultured primary keratinocytes stimulated with tumor necrosis factor alpha but not by other psoriasis-associated cytokines. Finally, using a secreted and transmembrane protein library, we discovered high affinity interactions between human IGFL1 and mIGFL and the TMEM149 ectodomain. TMEM149 (renamed here as IGFLR1) is an uncharacterized gene with structural similarity to the tumor necrosis factor receptor family. Our studies demonstrate that IGFLR1 is expressed primarily on the surface of mouse T cells. The connection between mIGFL and IGFLR1 receptor suggests mIGFL may influence T cell biology within inflammatory skin conditions.	[Lobito, Adrian A.; Ramani, Sree R.; Tom, Irene; Luis, Elizabeth; Gonzalez, Lino C.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Bazan, J. Fernando; Fairbrother, Wayne J.] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Gonzalez, LC (corresponding author), Genentech Inc, Dept Prot Chem, 1 DNA Way MS63, San Francisco, CA 94080 USA.	gonzalez.lino@gene.com	Gonzalez, Lino/E-4102-2012; Ouyang, Wenjun/ABA-8763-2020	Gonzalez, Lino/0000-0003-3817-6450; Ouyang, Wenjun/0000-0002-1811-5864				Albanesi C, 2007, CLIN DERMATOL, V25, P581, DOI 10.1016/j.clindermatol.2007.08.013; Banno T, 2003, ANTIVIR THER, V8, P541; Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; BETTINGER DA, 1994, J TRAUMA, V36, P810, DOI 10.1097/00005373-199406000-00010; Buck M, 1996, AM J PATHOL, V149, P195; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; Cheung TC, 2009, P NATL ACAD SCI USA, V106, P6244, DOI 10.1073/pnas.0902115106; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Emtage P, 2006, GENOMICS, V88, P513, DOI 10.1016/j.ygeno.2006.05.012; ETTEHADI P, 1994, CLIN EXP IMMUNOL, V96, P146, DOI 10.1111/j.1365-2249.1994.tb06244.x; FLOCKNER H, 1995, PROTEINS, V23, P376, DOI 10.1002/prot.340230311; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Gonzalez LC, 2005, P NATL ACAD SCI USA, V102, P1116, DOI 10.1073/pnas.0409071102; Jubb Adrian M, 2006, Methods Mol Biol, V326, P255; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; Lai JJ, 2009, J CLIN INVEST, V119, P3739, DOI 10.1172/JCI39335; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mori R, 2002, FASEB J, V16, P963, DOI 10.1096/fj.01-0776com; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Tonel G, 2009, INT J BIOCHEM CELL B, V41, P963, DOI 10.1016/j.biocel.2008.10.022; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Vashisth H, 2010, J MOL BIOL, V400, P645, DOI 10.1016/j.jmb.2010.05.025; WARD CW, 1995, PROTEINS, V22, P141, DOI 10.1002/prot.340220207; Whitbeck JC, 1997, J VIROL, V71, P6083, DOI 10.1128/JVI.71.8.6083-6093.1997; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2009, EUR J IMMUNOL, V39, P3570, DOI 10.1002/eji.200939687; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; Wong AW, 2007, J BIOL CHEM, V282, P22953, DOI 10.1074/jbc.M611015200; Wong AW, 2010, BIOTECHNOL BIOENG, V106, P751, DOI 10.1002/bit.22749; Zhang GY, 2004, CURR OPIN STRUC BIOL, V14, P154, DOI 10.1016/j.sbi.2004.03.003	47	27	34	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18969	18981		10.1074/jbc.M111.224626	http://dx.doi.org/10.1074/jbc.M111.224626			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454693	hybrid, Green Published			2022-12-27	WOS:000290785700068
J	Asmat, TM; Agarwal, V; Rath, S; Hildebrandt, JP; Hammerschmidt, S				Asmat, Tauseef M.; Agarwal, Vaibhav; Raeth, Susann; Hildebrandt, Jan-Peter; Hammerschmidt, Sven			Streptococcus pneumoniae Infection of Host Epithelial Cells via Polymeric Immunoglobulin Receptor Transiently Induces Calcium Release from Intracellular Stores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LISTERIA-MONOCYTOGENES; SIGNAL-TRANSDUCTION; PHOSPHOLIPASE-C; MEDIATED INTERNALIZATION; SALMONELLA-TYPHIMURIUM; SECRETORY COMPONENT; VIRULENCE FACTORS; CA2+ ENTRY; PROTEIN; INVASION	The pneumococcal surface protein C (PspC) is a major adhesin of Streptococcus pneumoniae (pneumococci) that interacts in a human-specific manner with the ectodomain of the human polymeric immunoglobulin receptor (pIgR) produced by respiratory epithelial cells. This interaction promotes bacterial colonization and bacterial internalization by initiating host signal transduction cascades. Here, we examined alterations of intracellular calcium ([Ca2+](i)) levels in epithelial cells during host cell infections with pneumococci via the PspC-hpIgR mechanism. The release of [Ca2+](i) from intracellular stores in host cells was significantly increased by wild-type pneumococci but not by PspC-deficient pneumococci. The increase in [Ca2+](i) was dependent on phospholipase C as pretreatment of cells with a phospholipase C-specific inhibitor U73122 abolished the increase in [Ca2+](i). In addition, we demonstrated the effect of [Ca2+](i) on pneumococcal internalization by epithelial cells. Uptake of pneumococci was significantly increased after pretreatment of epithelial cells with the cell-permeable calcium chelator 1,2-bis-(o-aminophenoxy)-ethane-N,N,N' ,N' -tetraacetic acid-tetraacetoxymethyl ester or use of EGTA as an extracellular Ca2+ -chelating agent. In contrast, thapsigargin, an inhibitor of endoplasmic reticulum Ca2+ ATPase, which increases [Ca2+](i) in a sustained fashion, significantly reduced pIgR-mediated pneumococcal invasion. Importantly, pneumococcal adherence to pIgR-expressing cells was not altered in the presence of inhibitors as demonstrated by immunofluorescence microscopy. In conclusion, these results demonstrate that pneumococcal infections induce mobilization of [Ca2+](i) from intracellular stores. This may constitute a defense response of host cells as the experimental reduction of intracellular calcium levels facilitates pneumococcal internalization by pIgR-expressing cells, whereas elevated calcium levels diminished bacterial internalization by host epithelial cells.	[Asmat, Tauseef M.; Agarwal, Vaibhav; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Dept Genet Microorganisms, D-17487 Greifswald, Germany; [Raeth, Susann; Hildebrandt, Jan-Peter] Ernst Moritz Arndt Univ Greifswald, Inst Zool, D-17487 Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Hammerschmidt, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Dept Genet Microorganisms, Friedrich Ludwig Jahn Str 15A, D-17487 Greifswald, Germany.	sven.hammerschmidt@uni-greifswald.de	Asmat, Tauseef M/Q-3801-2019; Hammerschmidt, Sven/G-2598-2010	Hammerschmidt, Sven/0000-0002-6382-6681; Hildebrandt, Jan-Peter/0000-0001-7827-8481	Deutsche Forschungsgemeinschaft [HA 3125/2-1, HA 3125/4-1]; European Union [EU-CP223111]; Higher Education Commission of Pakistan; German Academic Exchange Service	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported in part by Deutsche Forschungsgemeinschaft Grants HA 3125/2-1 and HA 3125/4-1 and European Union Grant EU FP7 CAREPNEUMO (EU-CP223111).; Recipient of a fellowship from the Higher Education Commission of Pakistan and German Academic Exchange Service.	Agarwal V, 2010, J BIOL CHEM, V285, P35615, DOI 10.1074/jbc.M110.172999; Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bierne H, 2000, CELL MICROBIOL, V2, P465, DOI 10.1046/j.1462-5822.2000.00069.x; Birnbaumer L, 2000, RECENT PROG HORM RES, V55, P127; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; BOOTMAN MD, 1995, CELL, V83, P675, DOI 10.1016/0092-8674(95)90179-5; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Cardone MH, 1996, J CELL BIOL, V133, P997, DOI 10.1083/jcb.133.5.997; Cartwright K, 2002, EUR J PEDIATR, V161, P188, DOI 10.1007/s00431-001-0907-3; Chang LC, 2000, EUR J PHARMACOL, V390, P61, DOI 10.1016/S0014-2999(00)00033-9; Denlinger LC, 1996, J BIOL CHEM, V271, P337, DOI 10.1074/jbc.271.1.337; Eichstaedt S, 2009, CELL CALCIUM, V45, P165, DOI 10.1016/j.ceca.2008.09.001; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; Eto DS, 2008, CELL MICROBIOL, V10, P2553, DOI 10.1111/j.1462-5822.2008.01229.x; Gekara NO, 2007, CELL MICROBIOL, V9, P2008, DOI 10.1111/j.1462-5822.2007.00932.x; Gewirtz AT, 2000, J CLIN INVEST, V105, P79, DOI 10.1172/JCI8066; Giffroy D, 2001, SCAND J IMMUNOL, V53, P56, DOI 10.1046/j.1365-3083.2001.00843.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hammerschmidt S, 1997, MOL MICROBIOL, V25, P1113, DOI 10.1046/j.1365-2958.1997.5391899.x; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; HORIKOSHI Y, 1994, BIOCHEM J, V304, P57, DOI 10.1042/bj3040057; Hu L, 2005, MICROBIOL-SGM, V151, P3097, DOI 10.1099/mic.0.27866-0; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Lu L, 2003, J BIOL CHEM, V278, P48178, DOI 10.1074/jbc.M306906200; MAJEED M, 1994, INFECT IMMUN, V62, P126, DOI 10.1128/IAI.62.1.126-134.1994; PACE J, 1993, CELL, V72, P505, DOI 10.1016/0092-8674(93)90070-7; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Repp H, 2002, CELL MICROBIOL, V4, P483, DOI 10.1046/j.1462-5822.2002.00207.x; Rose F, 2001, INFECT IMMUN, V69, P897, DOI 10.1128/IAI.69.2.897-905.2001; RUSCHKOWSKI S, 1992, FEMS MICROBIOL LETT, V95, P121; Saha S, 2005, TOXICON, V45, P361, DOI 10.1016/j.toxicon.2004.11.007; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856; TSIEN RY, 1989, METHOD CELL BIOL, V30, P127; van Haasteren G, 1999, J RECEPT SIGNAL TR R, V19, P481, DOI 10.3109/10799899909036666; Wadsworth SJ, 1999, INFECT IMMUN, V67, P1770; Wu J, 2000, MOL PHARMACOL, V58, P1368, DOI 10.1124/mol.58.6.1368; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Yoshihara M, 2004, NEUROSCIENTIST, V10, P566, DOI 10.1177/1073858404268770; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	46	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17861	17869		10.1074/jbc.M110.212225	http://dx.doi.org/10.1074/jbc.M110.212225			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454571	Green Published, hybrid			2022-12-27	WOS:000290585200049
J	Chien, R; Zeng, WH; Kawauchi, S; Bender, MA; Santos, R; Gregson, HC; Schmiesing, JA; Newkirk, DA; Kong, XD; Ball, AR; Calof, AL; Lander, AD; Groudine, MT; Yokomori, K				Chien, Richard; Zeng, Weihua; Kawauchi, Shimako; Bender, M. A.; Santos, Rosaysela; Gregson, Heather C.; Schmiesing, John A.; Newkirk, Daniel A.; Kong, Xiangduo; Ball, Alexander R., Jr.; Calof, Anne L.; Lander, Arthur D.; Groudine, Mark T.; Yokomori, Kyoko			Cohesin Mediates Chromatin Interactions That Regulate Mammalian beta-globin Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; GENE-EXPRESSION; ERYTHROID-DIFFERENTIATION; SACCHAROMYCES-CEREVISIAE; HEMOGLOBIN SYNTHESIS; ACTIVE CHROMATIN; NIPPED-B; CTCF; TRANSCRIPTION; PROTEIN	The beta-globin locus undergoes dynamic chromatin interaction changes in differentiating erythroid cells that are thought to be important for proper globin gene expression. However, the underlying mechanisms are unclear. The CCCTC-binding factor, CTCF, binds to the insulator elements at the 5' and 3' boundaries of the locus, but these sites were shown to be dispensable for globin gene activation. We found that, upon induction of differentiation, cohesin and the cohesin loading factor Nipped-B-like (Nipbl) bind to the locus control region (LCR) at the CTCF insulator and distal enhancer regions as well as at the specific target globin gene that undergoes activation upon differentiation. Nipbl-dependent cohesin binding is critical for long-range chromatin interactions, both between the CTCF insulator elements and between the LCR distal enhancer and the target gene. We show that the latter interaction is important for globin gene expression in vivo and in vitro. Furthermore, the results indicate that such cohesin-mediated chromatin interactions associated with gene regulation are sensitive to the partial reduction of Nipbl caused by heterozygous mutation. This provides the first direct evidence that Nipbl haploinsufficiency affects cohesin-mediated chromatin interactions and gene expression. Our results reveal that dynamic Nipbl/cohesin binding is critical for developmental chromatin organization and the gene activation function of the LCR in mammalian cells.	[Yokomori, Kyoko] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA; [Kawauchi, Shimako; Santos, Rosaysela; Calof, Anne L.] Univ Calif Irvine, Sch Med, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Lander, Arthur D.] Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Bender, M. A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Groudine, Mark T.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Yokomori, K (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA.	kyokomor@uci.edu	Lander, Arthur/L-2827-2019; Calof, Anne/A-8644-2013; Lander, Arthur D/C-9008-2011; Zeng, Weihua/E-9146-2012	Lander, Arthur/0000-0002-4380-5525; Calof, Anne/0000-0003-3676-2499; Lander, Arthur D/0000-0002-4380-5525; 	National Institutes of Health [HD052860, DK044746, HL065440, AR058548, HD062951, T32 CA113265]; FSH Society [FSHS-DHY-001, FSHS-DHY-002]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD052860, T32HD060555] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD062951] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203, T32CA113265] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR058548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044746, R37DK044746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FSH Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HD052860 (to A. D. L. and A. L. C.), DK044746 (to M. T. G.), HL065440 (to M. T. G.), AR058548 (to K. Y.), HD062951 (to K. Y.), and T32 CA113265 (to R. C.). This work was also supported by FSH Society Helen Younger and David Younger Fellowship Grant FSHS-DHY-001 (to K. Y.) and FSHS-DHY-002 (to W. Z.).	Alami R, 2000, GENOMICS, V63, P417, DOI 10.1006/geno.1999.6104; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Bausch C, 2007, MOL CELL BIOL, V27, P8522, DOI 10.1128/MCB.01007-07; Bender MA, 2006, BLOOD, V108, P1395, DOI 10.1182/blood-2006-04-014431; Bender MA, 1998, BLOOD, V92, P4394, DOI 10.1182/blood.V92.11.4394.423k48_4394_4403; BENZ EJ, 1980, P NATL ACAD SCI-BIOL, V77, P3509, DOI 10.1073/pnas.77.6.3509; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Douay Luc, 2009, V482, P127, DOI 10.1007/978-1-59745-060-7_8; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Farrell CM, 2002, MOL CELL BIOL, V22, P3820, DOI 10.1128/MCB.22.11.3820-3831.2002; Farrell CM, 2000, P NATL ACAD SCI USA, V97, P14554, DOI 10.1073/pnas.97.26.14554; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hallson G, 2008, P NATL ACAD SCI USA, V105, P12405, DOI 10.1073/pnas.0801698105; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Jahnke P, 2008, NUCLEIC ACIDS RES, V36, P6450, DOI 10.1093/nar/gkn688; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kawauchi S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000650; Kogut I, 2009, GENE DEV, V23, P2345, DOI 10.1101/gad.1819409; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Kooren J, 2007, J BIOL CHEM, V282, P16544, DOI 10.1074/jbc.M701159200; KOVACH JS, 1967, J MOL BIOL, V25, P131, DOI 10.1016/0022-2836(67)90284-7; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Liu J, 2009, CLIN GENET, V76, P303, DOI 10.1111/j.1399-0004.2009.01271.x; Mishiro T, 2009, EMBO J, V28, P1234, DOI 10.1038/emboj.2009.81; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wada Y, 2009, P NATL ACAD SCI USA, V106, P18357, DOI 10.1073/pnas.0902573106; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wendt KS, 2009, CHROMOSOME RES, V17, P201, DOI 10.1007/s10577-008-9017-7; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	51	71	77	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17870	17878		10.1074/jbc.M110.207365	http://dx.doi.org/10.1074/jbc.M110.207365			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454523	Green Published, hybrid			2022-12-27	WOS:000290585200050
J	Fox, JH; Connor, T; Stiles, M; Kama, J; Lu, Z; Dorsey, K; Liebermann, G; Sapp, E; Cherny, RA; Banks, M; Volitakis, I; DiFiglia, M; Berezovska, O; Bush, AI; Hersch, SM				Fox, Jonathan H.; Connor, Teal; Stiles, Megan; Kama, Jibrin; Lu, Zhen; Dorsey, Kathryn; Liebermann, Gregory; Sapp, Ellen; Cherny, Robert A.; Banks, Mary; Volitakis, Irene; DiFiglia, Marian; Berezovska, Oksana; Bush, Ashley I.; Hersch, Steven M.			Cysteine Oxidation within N-terminal Mutant Huntingtin Promotes Oligomerization and Delays Clearance of Soluble Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE MODEL; BASAL GANGLIA; IN-VIVO; DISEASE; METABOLISM; STRESS; ACID; NEURODEGENERATION; CONFORMATION; DEGRADATION	Huntington disease (HD) is a progressive neurodegenerative disorder caused by expression of polyglutamine-expanded mutant huntingtin protein (mhtt). Most evidence indicates that soluble mhtt species, rather than insoluble aggregates, are the important mediators of HD pathogenesis. However, the differential roles of soluble monomeric and oligomeric mhtt species in HD and the mechanisms of oligomer formation are not yet understood. We have shown previously that copper interacts with and oxidizes the polyglutamine-containing N171 fragment of huntingtin. In this study we report that oxidation-dependent oligomers of huntingtin form spontaneously in cell and mouse HD models. Levels of these species are modulated by copper, hydrogen peroxide, and glutathione. Mutagenesis of all cysteine residues within N171 blocks the formation of these oligomers. In cells, levels of oligomerization-blocked mutant N171 were decreased compared with native N171. We further show that a subset of the oligomerization-blocked form of glutamine-expanded N171 huntingtin is rapidly depleted from the soluble pool compared with "native" mutant N171. Taken together, our data indicate that huntingtin is subject to specific oxidations that are involved in the formation of stable oligomers and that also delay removal from the soluble pool. These findings show that inhibiting formation of oxidation-dependent huntingtin oligomers, or promoting their dissolution, may have protective effects in HD by decreasing the burden of soluble mutant huntingtin.	[Fox, Jonathan H.; Stiles, Megan; Lu, Zhen] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Fox, Jonathan H.; Stiles, Megan; Lu, Zhen] Univ Wyoming, Grad Program Neurosci, Laramie, WY 82071 USA; [Fox, Jonathan H.; Connor, Teal; Kama, Jibrin; Dorsey, Kathryn; Liebermann, Gregory; Sapp, Ellen; Banks, Mary; DiFiglia, Marian; Berezovska, Oksana; Hersch, Steven M.] MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; [Cherny, Robert A.; Volitakis, Irene; Bush, Ashley I.] Mental Hlth Res Inst Victoria, Parkville, Vic 3052, Australia	University of Wyoming; University of Wyoming	Fox, JH (corresponding author), 1174 Snowy Range Rd, Laramie, WY 82070 USA.	jfox7@uwyo.edu	Bush, Ashley/Y-2457-2019; Bush, Ashley I/A-1186-2007	Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; Volitakis, Irene/0000-0003-0766-817X	National Institutes of Health [NS045806, 5P20RR015640-10, 1R21NS072372]; Huntington's Disease Society of America; Cure Huntington's Disease initiative; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS045806, R21NS072372] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huntington's Disease Society of America; Cure Huntington's Disease initiative; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS045806 (to S. H.), 5P20RR015640-10 (to University of Wyoming Neuroscience COBRE), and 1R21NS072372 (to J. F.). This work was also supported by Huntington's Disease Society of America awards (to S. H. (Coalition for the Cure) and J. F.) and also by the Cure Huntington's Disease initiative (to S. H.).	Sorolla MA, 2010, FREE RADICAL BIO MED, V49, P612, DOI 10.1016/j.freeradbiomed.2010.05.016; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Azzu V, 2010, BIOCHEM J, V426, P13, DOI 10.1042/BJ20091321; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Browne SE, 1999, BRAIN PATHOL, V9, P147; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; DeRooij KE, 1996, HUM MOL GENET, V5, P1093, DOI 10.1093/hmg/5.8.1093; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; Fox JH, 2004, J NEUROCHEM, V91, P413, DOI 10.1111/j.1471-4159.2004.02726.x; Fox JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000334; FREEDMAN JH, 1989, J BIOL CHEM, V264, P5598; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Gerber R, 2007, J BIOL CHEM, V282, P6300, DOI 10.1074/jbc.M608926200; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Hashemy SI, 2007, J BIOL CHEM, V282, P14428, DOI 10.1074/jbc.M700927200; Hillmer AS, 2010, BIOCHEM BIOPH RES CO, V391, P461, DOI 10.1016/j.bbrc.2009.11.080; Horng YC, 2005, J BIOL CHEM, V280, P34113, DOI 10.1074/jbc.M506801200; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Nadanaka S, 2007, MOL CELL BIOL, V27, P1027, DOI 10.1128/MCB.00408-06; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Sathyasaikumar KV, 2010, J NEUROCHEM, V113, P1416, DOI 10.1111/j.1471-4159.2010.06675.x; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Stadtman E. R., 2006, REDOX PROTEOMICS PRO, P10; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zainelli GM, 2003, J NEUROPATH EXP NEUR, V62, P14, DOI 10.1093/jnen/62.1.14	42	46	46	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18320	18330		10.1074/jbc.M110.199448	http://dx.doi.org/10.1074/jbc.M110.199448			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454633	Green Published, hybrid			2022-12-27	WOS:000290585200092
J	Godard, F; Tetaud, E; Duvezin-Caubet, S; di Rago, JP				Godard, Francois; Tetaud, Emmanuel; Duvezin-Caubet, Stephane; di Rago, Jean-Paul			A Genetic Screen Targeted on the F-O Component of Mitochondrial ATP Synthase in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-RING ROTATION; NUCLEAR GENE; F1F0-ATP SYNTHASE; BUDDING YEAST; DELTA-SUBUNIT; OLI1 GENE; EXPRESSION; F-1-ATPASE; IDENTIFICATION; MECHANISM	In yeast, the two main F-O proton-translocating subunits of the ATP synthase (subunits 6/a and 9/c) are encoded by mitochondrial DNA (mtDNA). Unfortunately, mutations that inactivate the F-O typically result in loss of mtDNA under the form of rho(-)/rho(0) cells. Thus, we have designed a novel genetic strategy to circumvent this problem. It exploits previous findings that a null mutation in the nuclear ATP16 gene encoding ATP synthase subunit delta results in massive and lethal F-O-mediated protons leaks across the inner mitochondrial membrane. Mutations that inactivate the F-O can thus, in these conditions, be selected positively as cell viability rescuing events. A first set of seven mutants was analyzed and all showed, as expected, very severe F-O deficiencies. Two mutants carried nuclear mutations in known genes (AEP1, AEP2) required for subunit c expression. The five other mutations were located in mtDNA. Of these, three affect synthesis or stability of subunit a transcripts and the two last consisted in a single amino acid replacement in subunit c. One of the subunit c mutations is particularly interesting. It consists in an alanine to valine change at position 60 of subunit c adjacent to the essential glutamate of subunit c (at position 59) that interacts with the essential arginine 186 of subunit a. The properties of this mutant suggest that the contact zone between subunit a and the ten subunits c-ring structure only involves critical transient interactions confined to the region where protons are exchanged between the subunit a and the c-ring.	[Godard, Francois; Tetaud, Emmanuel; Duvezin-Caubet, Stephane; di Rago, Jean-Paul] Univ Bordeaux 2, CNRS, UMR 5095, Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Tetaud, E (corresponding author), Univ Bordeaux 2, CNRS, UMR 5095, Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France.	tetaud@ibgc.cnrs.fr; jp.dirago@ibgc.cnrs.fr		Duvezin-Caubet, Stephane/0000-0002-0243-2697	Conseil Regional d'Aquitaine; Agence Nationale de la Recherche (ANR)	Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by grants from the Conseil Regional d'Aquitaine and the Agence Nationale de la Recherche (ANR).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; ACKERMAN SH, 1991, FEBS LETT, V278, P234, DOI 10.1016/0014-5793(91)80124-L; ALLEN RD, 1995, PROTOPLASMA, V189, P1, DOI 10.1007/BF01280286; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arselin G, 1996, J BIOL CHEM, V271, P20284, DOI 10.1074/jbc.271.34.20284; Bianchet MA, 1998, P NATL ACAD SCI USA, V95, P11065, DOI 10.1073/pnas.95.19.11065; Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; CLAISSE ML, 1974, EUR J BIOCHEM, V49, P49, DOI 10.1111/j.1432-1033.1974.tb03810.x; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; Dautant A, 2010, J BIOL CHEM, V285, P29502, DOI 10.1074/jbc.M110.124529; Devenish RJ, 2008, INT REV CEL MOL BIO, V267, P1, DOI 10.1016/S1937-6448(08)00601-1; Duvezin-Caubet S, 2003, P NATL ACAD SCI USA, V100, P13235, DOI 10.1073/pnas.2135169100; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P16305, DOI 10.1074/jbc.M513805200; Ellis TP, 2004, J BIOL CHEM, V279, P15728, DOI 10.1074/jbc.M314162200; Fillingame RH, 2002, BBA-BIOMEMBRANES, V1565, P232, DOI 10.1016/S0005-2736(02)00572-2; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; FINNEGAN PM, 1995, FEBS LETT, V368, P505, DOI 10.1016/0014-5793(95)00727-Q; FINNEGAN PM, 1991, CURR GENET, V20, P53, DOI 10.1007/BF00312765; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Giraud MF, 1997, EUR J BIOCHEM, V245, P813, DOI 10.1111/j.1432-1033.1997.00813.x; Guerin B, 1979, Methods Enzymol, V55, P149; Hong S, 2002, ARCH BIOCHEM BIOPHYS, V405, P38, DOI 10.1016/S0003-9861(02)00303-X; Jie LZ, 1999, EMBO J, V18, P58, DOI 10.1093/emboj/18.1.58; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lefebvre-Legendre L, 2003, MOL MICROBIOL, V47, P1329, DOI 10.1046/j.1365-2958.2003.03371.x; Lefebvre-Legendre L, 2001, J BIOL CHEM, V276, P6789, DOI 10.1074/jbc.M009557200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meier T, 2009, J MOL BIOL, V391, P498, DOI 10.1016/j.jmb.2009.05.082; Mitome N, 2010, BIOCHEM J, V430, P171, DOI 10.1042/BJ20100621; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; PAUL MF, 1989, EUR J BIOCHEM, V185, P163, DOI 10.1111/j.1432-1033.1989.tb15098.x; PAUL MF, 1992, THESIS U BORDEAUX 2; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; PAYNE MJ, 1993, CURR GENET, V24, P126, DOI 10.1007/BF00324676; PAYNE MJ, 1991, CURR GENET, V19, P343, DOI 10.1007/BF00309594; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; Rak M, 2009, P NATL ACAD SCI USA, V106, P18509, DOI 10.1073/pnas.0910351106; Rak M, 2009, BBA-MOL CELL RES, V1793, P108, DOI 10.1016/j.bbamcr.2008.07.001; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P898, DOI 10.1073/pnas.031564198; Velours J, 2000, J BIOENERG BIOMEMBR, V32, P383, DOI 10.1023/A:1005580020547; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Zeng XM, 2007, MOL BIOL CELL, V18, P617, DOI 10.1091/mbc.E06-09-0801; ZIAJA K, 1993, J MOL BIOL, V229, P909, DOI 10.1006/jmbi.1993.1095	54	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18181	18189		10.1074/jbc.M110.214825	http://dx.doi.org/10.1074/jbc.M110.214825			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454598	Green Published, hybrid			2022-12-27	WOS:000290585200078
J	Klenchin, VA; Frye, JJ; Jones, MH; Winey, M; Rayment, I				Klenchin, Vadim A.; Frye, Jeremiah J.; Jones, Michele H.; Winey, Mark; Rayment, Ivan			Structure-Function Analysis of the C-terminal Domain of CNM67, a Core Component of the Saccharomyces cerevisiae Spindle Pole Body	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIKELIHOOD DENSITY MODIFICATION; PREDICTING COILED COILS; CRYSTAL-STRUCTURE; ATOMIC STRUCTURES; SPACER PROTEIN; DUPLICATION; VECTORS; MICROTUBULES; TROPOMYOSIN; RECOGNITION	The spindle pole body of the budding yeast Saccharomyces cerevisiae has served as a model system for understanding microtubule organizing centers, yet very little is known about the molecular structure of its components. We report here the structure of the C-terminal domain of the core component Cnm67 at 2.3 angstrom resolution. The structure determination was aided by a novel approach to crystallization of proteins containing coiled-coils that utilizes globular domains to stabilize the coiled-coils. This enhances their solubility in Escherichia coli and improves their crystallization. The Cnm67 C-terminal domain (residues Asn-429-Lys-581) exhibits a previously unseen dimeric, interdigitated, all alpha-helical fold. In vivo studies demonstrate that this domain alone is able to localize to the spindle pole body. In addition, the structure reveals a large functionally indispensable positively charged surface patch that is implicated in spindle pole body localization. Finally, the C-terminal eight residues are disordered but are critical for protein folding and structural stability.	[Klenchin, Vadim A.; Frye, Jeremiah J.; Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Jones, Michele H.; Winey, Mark] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado Boulder	Rayment, I (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	ivan_rayment@biochem.wisc.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835	National Institutes of Health [GM083987, GM051312]; United States Department of Energy, Office of Energy Research [W-31-109-ENG-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083987, R01GM051312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Energy Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM083987 (to I. R.) and GM051312 (to M. W.).; We thank Dr. Dwight Anderson (University of Minnesota) for the expression vector encoding the scaffolding protein Gp7 from bacteriophage phi 29. We also thank Kirsten Dennison for help in constructing the Gp7 expression vector and construction of pKLD115 and Sean Newmister for recording the CD spectra. We thank Dr. Hazel Holden for help in the initial model building of Gp-Cnm67. Use of the Structural Biology BM19 beamline Argonne National Laboratory Advanced Photon Source was supported by the United States Department of Energy, Office of Energy Research, under Contract W-31-109-ENG-38.	Adams IR, 1999, J CELL BIOL, V145, P809, DOI 10.1083/jcb.145.4.809; Al-Bassam J, 2007, STRUCTURE, V15, P355, DOI 10.1016/j.str.2007.01.012; Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; [Anonymous], 1991, Methods Enzymol, V194, P1; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Brachat A, 1998, MOL BIOL CELL, V9, P977, DOI 10.1091/mbc.9.5.977; Bullitt E, 1997, CELL, V89, P1077, DOI 10.1016/S0092-8674(00)80295-0; Chen GJ, 2000, BIOTECHNIQUES, V28, P498, DOI 10.2144/00283st08; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Elliott S, 1999, P NATL ACAD SCI USA, V96, P6205, DOI 10.1073/pnas.96.11.6205; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; KILMARTIN JV, 1993, J CELL BIOL, V123, P1175, DOI 10.1083/jcb.123.5.1175; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lau CK, 2004, EUKARYOT CELL, V3, P447, DOI 10.1128/EC.3.2.447-458.2004; Li S, 2006, J CELL BIOL, V173, P867, DOI 10.1083/jcb.200603153; Li Y, 2003, NATURE, V424, P341, DOI 10.1038/nature01801; Li Y, 2002, P NATL ACAD SCI USA, V99, P7378, DOI 10.1073/pnas.102179999; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Morais MC, 2003, NAT STRUCT BIOL, V10, P572, DOI 10.1038/nsb939; Morrow JA, 2000, BIOCHEMISTRY-US, V39, P11657, DOI 10.1021/bi000099m; Muller EGD, 2005, MOL BIOL CELL, V16, P3341, DOI 10.1091/mbc.E05-03-0214; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Nitanai Y, 2007, ADV EXP MED BIOL, V592, P137; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Rose A, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-66; Schaerer F, 2001, MOL BIOL CELL, V12, P2519, DOI 10.1091/mbc.12.8.2519; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; SIKORSKI RS, 1989, GENETICS, V122, P19; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 1997, ACTA CRYSTALLOGR D, V53, P571, DOI 10.1107/S0907444997005398; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Zizlsperger N, 2008, BIOCHEMISTRY-US, V47, P11858, DOI 10.1021/bi801378z	50	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18240	18250		10.1074/jbc.M111.227371	http://dx.doi.org/10.1074/jbc.M111.227371			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454609	Green Published, hybrid			2022-12-27	WOS:000290585200084
J	Ganesh, K; Adam, S; Taylor, B; Simpson, P; Rada, C; Neuberger, M				Ganesh, Karuna; Adam, Salome; Taylor, Benjamin; Simpson, Paul; Rada, Cristina; Neuberger, Michael			CTNNBL1 Is a Novel Nuclear Localization Sequence-binding Protein That Recognizes RNA-splicing Factors CDC5L and Prp31	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-SWITCH RECOMBINATION; IMPORTIN-ALPHA; RETINITIS-PIGMENTOSA; STRUCTURAL BASIS; GENE PRPF31; AID; SPLICEOSOME; IDENTIFICATION; KARYOPHERINS; RECEPTOR	Nuclear proteins typically contain short stretches of basic amino acids (nuclear localization sequences; NLSs) that bind karyopherin alpha family members, directing nuclear import. Here, we identify CTNNBL1 (catenin-beta-like 1), an armadillo motifcontaining nuclear protein that exhibits no detectable primary sequence homology to karyopherin alpha, as a novel, selective NLS-binding protein. CTNNBL1 (a single-copy gene conserved from fission yeast to man) was previously found associated with Prp19-containing RNA-splicing complexes as well as with the antibody-diversifying enzyme AID. We find that CTNNBL1 association with the Prp19 complex is mediated by recognition of the NLS of the CDC5L component of the complex and show that CTNNBL1 also interacts with Prp31 (another U4/U6. U5 tri-snRNP-associated splicing factor) through its NLS. As with karyopherin alpha s, CTNNBL1 binds NLSs via its armadillo (ARM) domain, but displays a separate, more selective NLS binding specificity. Furthermore, the CTNNBL1/AID interaction depends on amino acids forming the AID conformational NLS with CTNNBL1-deficient cells showing a partial defect in AID nuclear accumulation. However, in further contrast to karyopherin alpha s, the CTNNBL1 N-terminal region itself binds karyopherin alpha s (rather than karyopherin beta), suggesting a function divergent from canonical nuclear transport. Thus, CTNNBL1 is a novel NLS-binding protein, distinct from karyopherin alpha s, with the results suggesting a possible role in the selective intranuclear targeting or interactions of some splicing-associated complexes.	[Ganesh, Karuna; Adam, Salome; Taylor, Benjamin; Simpson, Paul; Rada, Cristina; Neuberger, Michael] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Neuberger, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	msn@mrc-lmb.cam.ac.uk		Taylor, Benjamin/0000-0001-6101-3786; Simpson, Paul/0000-0002-5069-8588	Laboratory of Molecular Biology; James Baird Fund; Ecole Normale Superieure de Cachan; Medical Research Council [MC_U105178806] Funding Source: researchfish; MRC [MC_U105178806] Funding Source: UKRI	Laboratory of Molecular Biology; James Baird Fund; Ecole Normale Superieure de Cachan; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a Laboratory of Molecular Biology International Scholarship and the James Baird Fund.; Supported by the Ecole Normale Superieure de Cachan.	Aoufouchi S, 2008, J EXP MED, V205, P1357, DOI 10.1084/jem.20070950; Bernstein HS, 1997, J BIOL CHEM, V272, P5833, DOI 10.1074/jbc.272.9.5833; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; Deery EC, 2002, HUM MOL GENET, V11, P3209, DOI 10.1093/hmg/11.25.3209; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Geisberger R, 2009, P NATL ACAD SCI USA, V106, P6736, DOI 10.1073/pnas.0810808106; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Grote M, 2010, MOL CELL BIOL, V30, P2105, DOI 10.1128/MCB.01505-09; Han L, 2010, J IMMUNOL, V185, P1379, DOI 10.4049/jimmunol.1001643; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Jabbour L, 2003, GENOMICS, V81, P292, DOI 10.1016/S0888-7543(02)00038-1; Jensen ON, 1997, ANAL CHEM, V69, P4741, DOI 10.1021/ac970896z; Liu LS, 2003, CELL BIOCHEM BIOPHYS, V39, P119, DOI 10.1385/CBB:39:2:119; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Makarova OV, 2002, EMBO J, V21, P1148, DOI 10.1093/emboj/21.5.1148; Mason DA, 2002, GENETICS, V161, P157; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Ordinario EC, 2009, J IMMUNOL, V183, P4545, DOI 10.4049/jimmunol.0900673; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Randow Felix, 2006, Subcell Biochem, V40, P383; Schaffert N, 2004, EMBO J, V23, P3000, DOI 10.1038/sj.emboj.7600296; Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Stanek D, 2006, CHROMOSOMA, V115, P343, DOI 10.1007/s00412-006-0056-6; Tsai WY, 1999, J BIOL CHEM, V274, P9455, DOI 10.1074/jbc.274.14.9455; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521	30	35	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17091	17102		10.1074/jbc.M110.208769	http://dx.doi.org/10.1074/jbc.M110.208769			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21385873	Green Published, hybrid			2022-12-27	WOS:000290301900059
J	Guo, Q; Fast, W				Guo, Qin; Fast, Walter			Citrullination of Inhibitor of Growth 4 (ING4) by Peptidylarginine Deminase 4 (PAD4) Disrupts the Interaction between ING4 and p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR ING4; MYELIN BASIC-PROTEIN; ARGININE DEIMINASE 4; STRUCTURAL BASIS; GENE-EXPRESSION; METHYLATION; BINDING; DEMETHYLIMINATION; ACTIVATION; DEACETYLATION	Gene expression is regulated by a number of interrelated posttranslational modifications of histones, including citrullination. For example, peptidylarginine deminase 4 (PAD4) converts peptidyl arginine to citrulline in histone H3 and can repress gene expression. However, regulation of gene expression through citrullination of non-histone proteins is less well defined. Herein, we identify a tumor suppressor protein, inhibitor of growth 4 (ING4), as a novel non-histone substrate of PAD4. ING4 is known to bind p53 via its nuclear localization signal (NLS) region and to enhance transcriptional activity of p53. We show that PAD4 preferentially citrullinates ING4 in the same NLS region and thereby disrupts the interaction between ING4 and p53. A citrulline-mimicking Arg-NLS-Gln ING4 mutant, which has all Arg residues in the NLS mutated to Gln, loses its affinity for p53, can no longer promote p53 acetylation, and results in repression of downstream p21 expression. In addition, we found that citrullination leads to increased susceptibility of ING4 to degradation, likely impacting p53-independent pathways as well. These findings elucidate an interaction between posttranslational citrullination, acetylation, and methylation and highlight an unusual mechanism whereby citrullination of a non-histone protein impacts gene regulation.	[Guo, Qin; Fast, Walter] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Fast, W (corresponding author), Univ Texas Austin, Coll Pharm, Div Med Chem, BME 6-202D,1 Univ Stn,C0850, Austin, TX 78712 USA.	waltfast@mail.utexas.edu			National Institutes of Health [GM69754]; Robert A. Welch Foundation [F-1572]; Texas Institute for Drug and Diagnostic Development [H-F-0032]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069754] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Texas Institute for Drug and Diagnostic Development; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM69754. This work was also supported by grants from the Robert A. Welch Foundation (F-1572) and a seed grant from the Texas Institute for Drug and Diagnostic Development (Welch Foundation Grant H-F-0032).	Andrade F, 2010, ARTHRITIS RHEUM-US, V62, P1630, DOI 10.1002/art.27439; Arita K, 2006, P NATL ACAD SCI USA, V103, P5291, DOI 10.1073/pnas.0509639103; Arita K, 2004, NAT STRUCT MOL BIOL, V11, P777, DOI 10.1038/nsmb799; Bates IR, 2002, PROTEIN EXPRES PURIF, V25, P330, DOI 10.1016/S1046-5928(02)00017-7; Culurgioni S, 2010, ACTA CRYSTALLOGR F, V66, P567, DOI 10.1107/S1744309110010080; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Denis H, 2009, MOL CELL BIOL, V29, P4982, DOI 10.1128/MCB.00285-09; Fang F, 2009, CANCER EPIDEM BIOMAR, V18, P409, DOI 10.1158/1055-9965.EPI-08-0575; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Jones JE, 2009, CURR OPIN DRUG DISC, V12, P616; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Lee YH, 2005, P NATL ACAD SCI USA, V102, P3611, DOI 10.1073/pnas.0407159102; Li M, 2009, J PATHOL, V219, P87, DOI 10.1002/path.2571; Li P, 2010, ONCOGENE, V29, P3153, DOI 10.1038/onc.2010.51; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Li XH, 2011, ORAL ONCOL, V47, P217, DOI 10.1016/j.oraloncology.2011.01.004; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; ORRENIUS S, 1994, J NEURAL TRANSM-SUPP, P1; Palacios A, 2008, J BIOL CHEM, V283, P15956, DOI 10.1074/jbc.M710020200; Palacios A, 2006, FEBS LETT, V580, P6903, DOI 10.1016/j.febslet.2006.11.055; Palacios A, 2010, J MOL BIOL, V396, P1117, DOI 10.1016/j.jmb.2009.12.049; Pritzker LB, 2000, BIOCHEMISTRY-US, V39, P5374, DOI 10.1021/bi9925569; Saha A, 2011, J VIROL, V85, P2079, DOI 10.1128/JVI.02279-10; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Shiseki M, 2003, CANCER RES, V63, P2373; Slack JL, 2011, CELL MOL LIFE SCI, V68, P709, DOI 10.1007/s00018-010-0480-x; Stensland ME, 2009, BIOL CHEM, V390, P99, DOI 10.1515/BC.2009.019; Stone EM, 2005, BIOCHEMISTRY-US, V44, P13744, DOI 10.1021/bi051341y; Struyf S, 2009, J IMMUNOL, V182, P666, DOI 10.4049/jimmunol.182.1.666; Tanikawa C, 2009, CANCER RES, V69, P8761, DOI 10.1158/0008-5472.CAN-09-2280; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Tsai KW, 2008, EXP CELL RES, V314, P3130, DOI 10.1016/j.yexcr.2008.08.002; Unoki M, 2009, CANCER SCI, V100, P1173, DOI 10.1111/j.1349-7006.2009.01183.x; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang QS, 2010, HISTOPATHOLOGY, V57, P271, DOI 10.1111/j.1365-2559.2010.03623.x; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Zhang X, 2005, BIOCHEM BIOPH RES CO, V331, P1032, DOI 10.1016/j.bbrc.2005.04.023	38	83	88	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17069	17078		10.1074/jbc.M111.230961	http://dx.doi.org/10.1074/jbc.M111.230961			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454715	Green Published, hybrid			2022-12-27	WOS:000290301900057
J	MacPherson, M; Lek, HS; Prescott, A; Fagerholm, SC				MacPherson, Matthew; Lek, Hwee San; Prescott, Alan; Fagerholm, Susanna C.			A Systemic Lupus Erythematosus-associated R77H Substitution in the CD11b Chain of the Mac-1 Integrin Compromises Leukocyte Adhesion and Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELLS; ALPHA-CHAIN; I DOMAIN; ACTIVATION; COMPLEMENT; ITGAM; PATHWAYS; LFA-1	The Mac-1 integrin is expressed mainly on myeloid cells and binds several ligands, including members of the ICAM family and the complement factor iC3b. It is involved in essential immunological processes, such as leukocyte extravasation and phagocytosis. In addition, Mac-1 has been described to negatively regulate immune cell signaling. Recently, a single nucleotide polymorphism conferring an amino acid change in the Mac-1 integrin extracellular domain, R77H, was shown to be associated with systemic lupus erythematosus. Here, we demonstrate that the R77H-substituted Mac-1 can be expressed on the cell surface in transfected cells and can undergo conformational changes in response to integrin activation. The affinity of the integrin for ICAMs is only partially reduced, but cell adhesion to ICAM-1 and ICAM-2 is severely compromised, and J beta 2.7 cells expressing R77H substituted integrins are deficient in adhesion to ICAM-1 under shear flow conditions. Importantly, cell adhesion to the complement factor iC3b is also diminished, and COS cells expressing R77H-substituted integrins display reduced iC3b-dependent phagocytosis. In addition, U937 cells expressing R77H-CD11b display increased IL-6 production as compared with WT-CD11b-expressing cells. These results suggest that the R77H substitution results in the deficiency of the mutated integrin to mediate cell adhesion to ligands such as ICAMs and iC3b. These deficiencies may ultimately lead to detrimental effects on the immune system and contribute to the development of systemic lupus erythematosus.	[MacPherson, Matthew] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Oncol & Mol Med, Div Med Sci, Dundee DD1 9SY, Scotland; [Prescott, Alan] Univ Dundee, Coll Life Sci, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee	MacPherson, M (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Ctr Oncol & Mol Med, Div Med Sci, Mail Box 3, Dundee DD1 9SY, Scotland.	s.c.fagerholm@dundee.ac.uk; m.r.macpherson@dundee.ac.uk	Prescott, Alan/Y-5956-2018	Prescott, Alan/0000-0002-0747-7317; Fagerholm, Susanna Carola/0000-0002-0354-8763	Cancer Research UK; Biotechnology and Biological Sciences Research Council; Tenovus Scotland; Biotechnology and Biological Sciences Research Council [BB/G017123/1] Funding Source: researchfish; BBSRC [BB/G017123/1] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tenovus Scotland; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by Cancer Research UK, Biotechnology and Biological Sciences Research Council, and Tenovus Scotland.	Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Chow C. W., 2004, CURR PROTOC CELL BIO, V15, P15; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Ehirchiou D, 2007, J EXP MED, V204, P1519, DOI 10.1084/jem.20062292; Fagerholm S, 2002, EUR J IMMUNOL, V32, P1670, DOI 10.1002/1521-4141(200206)32:6<1670::AID-IMMU1670>3.0.CO;2-M; Fagerholm SC, 2005, J CELL BIOL, V171, P705, DOI 10.1083/jcb.200504016; Fagerholm SC, 2006, BLOOD, V108, P3379, DOI 10.1182/blood-2006-03-013557; Gaipl US, 2005, AUTOIMMUN REV, V4, P189, DOI 10.1016/j.autrev.2004.10.007; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Kelley JM, 2010, AUTOIMMUN REV, V9, P473, DOI 10.1016/j.autrev.2010.02.003; Kevil CG, 2004, AM J PATHOL, V165, P609, DOI 10.1016/S0002-9440(10)63325-1; Kim-Howard X, 2010, ANN RHEUM DIS, V69, P1329, DOI 10.1136/ard.2009.120543; Li Y, 2003, J BIOL CHEM, V278, P34395, DOI 10.1074/jbc.M304190200; Lim J, 2007, MOL BIOL CELL, V18, P976, DOI 10.1091/mbc.E06-09-0813; Lim J, 2010, J CELL BIOCHEM, V111, P999, DOI 10.1002/jcb.22788; Lomakina E, 2009, BLOOD CELL MOL DIS, V42, P177, DOI 10.1016/j.bcmd.2009.01.006; Manderson AP, 2004, ANNU REV IMMUNOL, V22, P431, DOI 10.1146/annurev.immunol.22.012703.104549; Morelli AE, 2003, BLOOD, V101, P611, DOI 10.1182/blood-2002-06-1769; Nalbandian A, 2009, CLIN EXP IMMUNOL, V157, P209, DOI 10.1111/j.1365-2249.2009.03944.x; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Palucka AK, 2002, IMMUNOL CELL BIOL, V80, P484, DOI 10.1046/j.1440-1711.2002.01112.x; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Podgrabinska S, 2009, J IMMUNOL, V183, P1767, DOI 10.4049/jimmunol.0802167; Sachs UJH, 2004, BLOOD, V104, P727, DOI 10.1182/blood-2003-11-3809; Tackey E, 2004, LUPUS, V13, P339, DOI 10.1191/0961203304lu1023oa; Varga G, 2007, BLOOD, V109, P661, DOI 10.1182/blood-2005-12-023044; Weber KSC, 1999, MOL BIOL CELL, V10, P861, DOI 10.1091/mbc.10.4.861; Weber KSC, 1997, J IMMUNOL, V158, P273; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Yalamanchili P, 2000, J BIOL CHEM, V275, P21877, DOI 10.1074/jbc.M908868199	33	54	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17303	17310		10.1074/jbc.M110.182998	http://dx.doi.org/10.1074/jbc.M110.182998			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454473	hybrid, Green Published			2022-12-27	WOS:000290301900078
J	Siddals, KW; Allen, J; Sinha, S; Canfield, AE; Kalra, PA; Gibson, JM				Siddals, Kirk W.; Allen, Justine; Sinha, Smeeta; Canfield, Ann E.; Kalra, Philip A.; Gibson, J. Martin			Apposite Insulin-like Growth Factor (IGF) Receptor Glycosylation Is Critical to the Maintenance of Vascular Smooth Muscle Phenotype in the Presence of Factors Promoting Osteogenic Differentiation and Mineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCOSYLATION; BONE MORPHOGENETIC PROTEIN-2; COA REDUCTASE INHIBITORS; LIPID-LOWERING TREATMENT; HUMAN CAROTID ARTERIES; FACTOR-I; ATHEROSCLEROTIC LESIONS; AORTIC-STENOSIS; REGULATORY ROLE; MEVALONIC ACID	Vascular calcification is strongly linked with increased morbidity and mortality from cardiovascular disease. Vascular calcification is an active cell-mediated process that involves the differentiation of vascular smooth muscle cells (VSMCs) to an osteoblast-like phenotype. Several inhibitors of this process have been identified, including insulin-like growth factor-I (IGF-I). In this study, we examined the role of the IGF receptor (IGFR) and the importance of IGFR glycosylation in the maintenance of the VSMC phenotype in the face of factors known to promote osteogenic conversion. IGF-I (25 ng/ml) significantly protected VSMCs from beta-glycerophosphate-induced osteogenic differentiation (p < 0.005) and mineral deposition (p < 0.01). Mevalonic acid depletion (induced by 100 nM cerivastatin) significantly inhibited these IGF protective effects (p < 0.01). Mevalonic acid depletion impaired IGFR processing, decreased the expression of mature IGFRs at the cell surface, and inhibited the downstream activation of Akt and MAPK. Inhibitors of N-linked glycosylation (tunicamycin, deoxymannojirimycin, and deoxynojirimycin) also markedly attenuated the inhibitory effect of IGF-I on beta-glycerophosphate-induced mineralization (p < 0.05) and activation of Akt and MAPK. These results demonstrate that alterations in the glycosylation of the IGFR disrupt the ability of IGF-I to protect against the osteogenic differentiation and mineralization of VSMCs by several interrelated mechanisms: decreased IGFR processing, reduced IGFR cell-surface expression, and reduced downstream signaling via the Akt and MAPK pathways. IGF-I thus occupies a critical position in the maintenance of normal VSMC phenotype and protection from factors known to stimulate vascular calcification.	[Siddals, Kirk W.; Allen, Justine; Sinha, Smeeta; Kalra, Philip A.; Gibson, J. Martin] Salford Royal Fdn Trust, Vasc Res Grp, Salford M6 8HD, Lancs, England; [Siddals, Kirk W.; Allen, Justine; Sinha, Smeeta; Kalra, Philip A.; Gibson, J. Martin] Univ Manchester, Sch Canc & Enabling Sci, Imaging Genom & Prote Grp, Manchester M13 9PY, Lancs, England; [Canfield, Ann E.] Univ Manchester, Fac Med & Human Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Canfield, Ann E.] Univ Manchester, Fac Med & Human Sci, Cardiovasc Res Grp, Manchester M13 9PT, Lancs, England	Salford Royal NHS Foundation Trust; University of Manchester; University of Manchester; University of Manchester	Siddals, KW (corresponding author), Salford Royal Fdn Trust, Vasc Res Grp, Clin Sci Bldg,Stott Lane, Salford M6 8HD, Lancs, England.	kirk.siddals@manchester.ac.uk		Canfield, Ann/0000-0002-8983-5674; gibson, martin/0000-0002-1331-1524				Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Arad Y, 2005, J AM COLL CARDIOL, V46, P166, DOI 10.1016/j.jacc.2005.02.089; Bellosta S, 2000, ANN MED, V32, P164, DOI 10.3109/07853890008998823; Bellosta S, 2000, DIABETES CARE, V23, pB72; Bellosta S, 1998, ATHEROSCLEROSIS, V137, pS101, DOI 10.1016/S0021-9150(97)00319-5; Benton JA, 2009, ARTERIOSCL THROM VAS, V29, P1950, DOI 10.1161/ATVBAHA.109.195271; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Boucher K, 2006, MICROVASC RES, V71, P91, DOI 10.1016/j.mvr.2005.11.007; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Carlberg M, 1996, J BIOL CHEM, V271, P17453, DOI 10.1074/jbc.271.29.17453; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; Collett GDM, 2005, CIRC RES, V96, P930, DOI 10.1161/01.RES.0000163634.51301.0d; COLLIER E, 1993, BIOCHEMISTRY-US, V32, P7818, DOI 10.1021/bi00081a029; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Cuthbert JA, 1997, CANCER RES, V57, P3498; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Dricu A, 1999, GLYCOBIOLOGY, V9, P571, DOI 10.1093/glycob/9.6.571; Emmanuele L, 2003, BIOCHEM BIOPH RES CO, V302, P67, DOI 10.1016/S0006-291X(03)00109-8; FRINK RJ, 1970, AM J CARDIOL, V26, P241, DOI 10.1016/0002-9149(70)90790-3; FUHRMANN U, 1984, NATURE, V307, P755, DOI 10.1038/307755a0; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; Houslay ES, 2006, HEART, V92, P1207, DOI 10.1136/hrt.2005.080929; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Hwang JB, 1999, J BIOL CHEM, V274, P22813, DOI 10.1074/jbc.274.32.22813; Jaffe IZ, 2007, ARTERIOSCL THROM VAS, V27, P799, DOI 10.1161/01.ATV.0000258414.59393.89; Jeziorska M, 1998, J PATHOL, V185, P10; Jeziorska M, 1998, VIRCHOWS ARCH, V433, P559, DOI 10.1007/s004280050289; Kanazawa I, 2009, HORM METAB RES, V41, P612, DOI 10.1055/s-0029-1220684; Kizu A, 2004, J CELL BIOCHEM, V93, P1011, DOI 10.1002/jcb.20207; Konig J, 2006, N-S ARCH PHARMACOL, V372, P432, DOI 10.1007/s00210-006-0040-y; LANGAN TJ, 1991, J CELL PHYSIOL, V149, P284, DOI 10.1002/jcp.1041490215; LARSSON O, 1992, J CELL SCI, V103, P1065; Li XW, 2008, ATHEROSCLEROSIS, V199, P271, DOI 10.1016/j.atherosclerosis.2007.11.031; LODISH HF, 1984, J CELL BIOL, V98, P1720, DOI 10.1083/jcb.98.5.1720; Maeda T, 2003, ENDOCRINOLOGY, V144, P681, DOI 10.1210/en.2002-220682; Maeda T, 2004, J CELL BIOCHEM, V92, P458, DOI 10.1002/jcb.20074; MartinezGonzalez J, 1996, EUR J CLIN INVEST, V26, P1023, DOI 10.1046/j.1365-2362.1996.2550586.x; MCDOWELL W, 1988, BIOCHIMIE, V70, P1535, DOI 10.1016/0300-9084(88)90290-8; Monzack EL, 2009, ARTERIOSCL THROM VAS, V29, P246, DOI 10.1161/ATVBAHA.108.179218; Porter KE, 2002, J VASC SURG, V36, P150, DOI 10.1067/mva.2002.122029; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Proudfoot D, 1998, ARTERIOSCL THROM VAS, V18, P379, DOI 10.1161/01.ATV.18.3.379; Qiao JH, 2003, HUM PATHOL, V34, P402, DOI 10.1053/hupa.2003.72; Radcliff K, 2005, CIRC RES, V96, P398, DOI 10.1161/01.RES.0000157671.47477.71; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Schenk B, 2001, GLYCOBIOLOGY, V11, p61R, DOI 10.1093/glycob/11.5.61R; Schmermund A, 2006, CIRCULATION, V113, P427, DOI 10.1161/CIRCULATIONAHA.105.568147; Shroff RC, 2008, CIRCULATION, V118, P1748, DOI 10.1161/CIRCULATIONAHA.108.783738; Siddals KW, 2004, J BIOL CHEM, V279, P38353, DOI 10.1074/jbc.M404838200; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; Son BK, 2006, CIRC RES, V98, P1024, DOI 10.1161/01.RES.0000218859.90970.8d; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Trion A, 2008, MOL CELL BIOCHEM, V308, P25, DOI 10.1007/s11010-007-9608-1; Valentinis B, 2001, J CLIN PATHOL-MOL PA, V54, P133, DOI 10.1136/mp.54.3.133; Wang M, 1999, EXP CELL RES, V246, P38, DOI 10.1006/excr.1998.4280; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; Xi G, 2004, J CELL PHYSIOL, V200, P387, DOI 10.1002/jcp.20068	58	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16623	16630		10.1074/jbc.M110.202929	http://dx.doi.org/10.1074/jbc.M110.202929			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454560	hybrid, Green Published			2022-12-27	WOS:000290301900011
J	Zhang, L; Jouret, F; Rinehart, J; Sfakianos, J; Mellman, I; Lifton, RP; Young, LH; Caplan, MJ				Zhang, Li; Jouret, Francois; Rinehart, Jesse; Sfakianos, Jeff; Mellman, Ira; Lifton, Richard P.; Young, Lawrence H.; Caplan, Michael J.			AMP-activated Protein Kinase (AMPK) Activation and Glycogen Synthase Kinase-3 beta (GSK-3 beta) Inhibition Induce Ca2+-independent Deposition of Tight Junction Components at the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE UVOMORULIN; INTESTINAL EPITHELIAL-CELLS; PANCREATIC ACINAR-CELLS; OCCLUDING JUNCTIONS; BETA-CATENIN; NEURONAL POLARITY; ADHERENS JUNCTION; ALPHA-CATENIN; ACTIN-BINDING; CADHERIN	Extracellular Ca2+ is essential for the development of stable epithelial tight junctions. We find that in the absence of extracellular Ca2+, AMP-activated protein kinase (AMPK) activation and glycogen synthase kinase (GSK)-3 beta inhibition independently induce the localization of epithelial tight junction components to the plasma membrane. The Ca2+-independent deposition of junctional proteins induced by AMPK activation and GSK-3 beta inhibition is independent of E-cadherin. Furthermore, the nectin-afadin system is required for the deposition of tight junction components induced by AMPK activation, but it is not required for that induced by GSK-3 beta inhibition. Phosphorylation studies demonstrate that afadin is a substrate for AMPK. These data demonstrate that two kinases involved in regulating cell growth and metabolism act through distinct pathways to influence the deposition of the components of epithelial tight junctions.	[Jouret, Francois; Young, Lawrence H.; Caplan, Michael J.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Zhang, Li; Sfakianos, Jeff; Mellman, Ira; Caplan, Michael J.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Rinehart, Jesse; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Young, Lawrence H.] Yale Univ, Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT 06520 USA; [Sfakianos, Jeff; Mellman, Ira] Genentech Inc, San Francisco, CA 94080 USA	Yale University; Yale University; Yale University; Yale University; Roche Holding; Genentech	Caplan, MJ (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, POB 208026, New Haven, CT 06520 USA.	michael.caplan@yale.edu	Zhang, Li/N-3674-2013; Mellman, Ira/ABG-5896-2020	Caplan, Michael/0000-0001-5768-4405	National Institutes of Health [DK17433, 072614]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017433, R01DK072614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK17433 and 072614.	ABERLE H, 1994, J CELL SCI, V107, P3655; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; BIRCHMEIER C, 1993, ANNU REV CELL BIOL, V9, P511, DOI 10.1146/annurev.cb.09.110193.002455; BOLLER K, 1985, J CELL BIOL, V100, P327, DOI 10.1083/jcb.100.1.327; Brakeman PR, 2009, AM J PHYSIOL-RENAL, V296, pF564, DOI 10.1152/ajprenal.90328.2008; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; CEREIJIDO M, 1981, AM J PHYSIOL, V240, pC96, DOI 10.1152/ajpcell.1981.240.3.C96; CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853; Chen XY, 2006, METHOD ENZYMOL, V406, P362, DOI 10.1016/S0076-6879(06)06026-5; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; GALLI P, 1976, EXP CELL RES, V99, P178, DOI 10.1016/0014-4827(76)90694-7; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; GUMBINER B, 1988, TRENDS BIOCHEM SCI, V13, P75, DOI 10.1016/0968-0004(88)90040-0; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; HAYS RM, 1965, J CELL BIOL, V25, P195, DOI 10.1083/jcb.25.3.195; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; MARRS JA, 1995, J CELL BIOL, V129, P507, DOI 10.1083/jcb.129.2.507; MARTINEZPALOMO A, 1980, J CELL BIOL, V87, P736, DOI 10.1083/jcb.87.3.736; MCNEILL H, 1990, CELL, V62, P309, DOI 10.1016/0092-8674(90)90368-O; MELDOLESI J, 1978, J CELL BIOL, V79, P156, DOI 10.1083/jcb.79.1.156; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; PALANT CE, 1983, AM J PHYSIOL, V245, pC203, DOI 10.1152/ajpcell.1983.245.3.C203; PITELKA DR, 1983, J CELL BIOL, V96, P606, DOI 10.1083/jcb.96.3.606; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Rajasekaran AK, 1996, J CELL BIOL, V132, P451, DOI 10.1083/jcb.132.3.451; Reymond N, 2000, GENE, V255, P347, DOI 10.1016/S0378-1119(00)00316-4; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; RINGWALD M, 1987, EMBO J, V6, P3647, DOI 10.1002/j.1460-2075.1987.tb02697.x; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; SEDAR AW, 1964, J CELL BIOL, V22, P173, DOI 10.1083/jcb.22.1.173; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Tsukamoto T, 1999, AM J PHYSIOL-RENAL, V276, pF737, DOI 10.1152/ajprenal.1999.276.5.F737; Van Itallie CM, 2004, PHYSIOLOGY, V19, P331, DOI 10.1152/physiol.00027.2004; Vleminckx K, 1999, BIOESSAYS, V21, P211, DOI 10.1002/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.3.CO;2-G; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Yamada A, 2006, ONCOGENE, V25, P5085, DOI 10.1038/sj.onc.1209525; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785; YONEMURA S, 1995, J CELL SCI, V108, P127; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103	59	44	45	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16879	16890		10.1074/jbc.M110.186932	http://dx.doi.org/10.1074/jbc.M110.186932			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21383016	hybrid, Green Published			2022-12-27	WOS:000290301900037
J	Su, D; Hu, Q; Zhou, H; Thompson, JR; Xu, RM; Zhang, ZG; Mer, G				Su, Dan; Hu, Qi; Zhou, Hui; Thompson, James R.; Xu, Rui-Ming; Zhang, Zhiguo; Mer, Georges			Structure and Histone Binding Properties of the Vps75-Rtt109 Chaperone-Lysine Acetyltransferase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTALLOGRAPHIC STRUCTURE DETERMINATION; DNA-REPLICATION; RTT109; ACETYLATION; H3; SOFTWARE; SPECIFICITY; ACTIVATION; PHENIX; MODEL	The histone chaperone Vps75 presents the remarkable property of stimulating the Rtt109-dependent acetylation of several histone H3 lysine residues within (H3-H4)(2) tetramers. To investigate this activation mechanism, we determined x-ray structures of full-length Vps75 in complex with full-length Rtt109 in two crystal forms. Both structures show similar asymmetric assemblies of a Vps75 dimer bound to an Rtt109 monomer. In the Vps75-Rtt109 complexes, the catalytic site of Rtt109 is confined to an enclosed space that can accommodate the N-terminal tail of histone H3 in (H3-H4)(2). Investigation of Vps75-Rtt109-(H3-H4)(2) and Vps75-(H3-H4)(2) complexes by NMR spectroscopy-probed hydrogen/deuterium exchange suggests that Vps75 guides histone H3 in the catalytic enclosure. These findings clarify the basis for the enhanced acetylation of histone H3 tail residues by Vps75-Rtt109.	[Su, Dan; Hu, Qi; Zhou, Hui; Zhang, Zhiguo; Mer, Georges] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Thompson, James R.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Xu, Rui-Ming] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Mayo Clinic; Mayo Clinic; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, ZG (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	zhang.zhiguo@mayo.edu; mer.georges@mayo.edu	xu, rui/GRX-5734-2022; Mer, Georges/AAT-4946-2021; hu, qi/K-1462-2014; su, dan/GYJ-1940-2022	Mer, Georges/0000-0002-1900-1578; 	National Institutes of Health [CA132878, GM81838]; United States Department of Energy [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA132878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132878 (to G. M.) and GM81838 (to Z. Z.).; We acknowledge the use of beamline 19-ID at the APS, Argonne National Laboratory. The APS is operated by UChicago Argonne, LLC, for the United States Department of Energy under Contract DE-AC02-06CH11357. We are grateful to Younchang Kim and Rongguang Zhang at the APS for expert assistance with x-ray data collection. We thank Karolin Luger and Aaron Hieb for the advice on histone purification. We thank Maria Victoria Botuyan for careful reading of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Albaugh BN, 2010, BIOCHEMISTRY-US, V49, P6375, DOI 10.1021/bi100381y; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Dyson HJ, 2008, FEBS LETT, V582, P1495, DOI 10.1016/j.febslet.2008.03.043; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Kato H, 2009, J AM CHEM SOC, V131, P15104, DOI 10.1021/ja9070078; Kolonko EM, 2010, P NATL ACAD SCI USA, V107, P20275, DOI 10.1073/pnas.1009860107; Lin CQ, 2008, STRUCTURE, V16, P1503, DOI 10.1016/j.str.2008.07.006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Park YJ, 2008, NAT STRUCT MOL BIOL, V15, P957, DOI 10.1038/nsmb.1480; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Stavropoulos P, 2008, P NATL ACAD SCI USA, V105, P12236, DOI 10.1073/pnas.0805813105; Tang Y, 2008, P NATL ACAD SCI USA, V105, P12206, DOI 10.1073/pnas.0802393105; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006	29	32	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.C111.220715	http://dx.doi.org/10.1074/jbc.C111.220715			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454705	Green Published, hybrid			2022-12-27	WOS:000290022800002
J	Bannister, JP; Thomas-Gatewood, CM; Neeb, ZP; Adebiyi, A; Cheng, XY; Jaggar, JH				Bannister, John P.; Thomas-Gatewood, Candice M.; Neeb, Zachary P.; Adebiyi, Adebowale; Cheng, Xiaoyang; Jaggar, Jonathan H.			Ca(V)1.2 Channel N-terminal Splice Variants Modulate Functional Surface Expression in Resistance Size Artery Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNEL; HIGH BLOOD-PRESSURE; CA2+ CHANNEL; AUXILIARY SUBUNITS; ALPHA(1) SUBUNIT; BETA-SUBUNIT; GENE; CALMODULIN; MECHANISM; CURRENTS	Voltage-dependent Ca2+ (Ca(V)1.2) channels are the primary Ca2+ influx pathway in arterial smooth muscle cells and are essential for contractility regulation by a variety of stimuli, including intravascular pressure. Arterial smooth muscle cell Ca(V)1.2 mRNA is alternatively spliced at exon 1 (e1), generating e1b or e1c variants, with e1c exhibiting relatively smooth muscle-specific expression in the cardiovascular system. Here, we examined physiological functions of Ca(V)1.2e1 variants and tested the hypothesis that targeting Ca(V)1.2e1 modulates resistance size cerebral artery contractility. Custom antibodies that selectively recognize Ca(V)1.2 channel proteins containing sequences encoded by either e1b (Ca(V)1.2e1b) or e1c (Ca(V)1.2e1c) both detected Ca(V)1.2 in rat and human cerebral arteries. shRNA targeting e1b or e1c reduced expression of that Ca(V)1.2 variant, induced compensatory up-regulation of the other variant, decreased total Ca(V)1.2, and reduced intravascular pressure- and depolarization-induced vasoconstriction. Ca(V)1.2e1b and Ca(V)1.2e1c knockdown reduced whole cell Ca(V)1.2 currents, with Ca(V)1.2e1c knockdown most effectively reducing total Ca(V)1.2 and inducing the largest vasodilation. Knockdown of alpha(2)delta-1, a Ca(V)1.2 auxiliary subunit, reduced surface expression of both Ca(V)1.2e1 variants, inhibiting Ca(V)1.2e1c more than Ca(V)1.2e1b. e1b or e1c overexpression reduced Ca(V)1.2 surface expression and whole cell currents, leading to vasodilation, with e1c overexpression inducing the largest effect. In summary, data indicate that arterial smooth muscle cells express Ca(V)1.2 channels containing e1b or e1c-encoded N termini that contribute to Ca(V)1.2 surface expression, alpha(2)delta-1 preferentially traffics the Ca(V)1.2e1c variant to the plasma membrane, and targeting of Ca(V)1.2e1 message or the Ca(V)1.2 channel proximal N terminus induces vasodilation.	[Bannister, John P.; Thomas-Gatewood, Candice M.; Neeb, Zachary P.; Adebiyi, Adebowale; Cheng, Xiaoyang; Jaggar, Jonathan H.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Jaggar, JH (corresponding author), UT Memphis Hlth Sci Ctr, Dept Physiol, 894 Union Ave,Ste 426, Memphis, TN 38163 USA.	jjaggar@uthsc.edu	Cheng, Xiaoyang/N-9970-2019; Tuluc, Petronel/C-2527-2011; Cheng, Xiaoyang/M-1257-2017; Cheng, Xiaoyang/A-1729-2012	Cheng, Xiaoyang/0000-0003-1446-2815; Cheng, Xiaoyang/0000-0003-1446-2815; Cheng, Xiaoyang/0000-0003-1446-2815; Adebiyi, Adebowale/0000-0002-7033-1871	National Institutes of Health [HL67061, HL094378, KO1 HL096411]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094378, K01HL096411, R01HL067061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL67061 and HL094378 (to J.H.J.) and KO1 HL096411 (to A.A.).	Abernethy DR, 2002, J PHARMACOL EXP THER, V300, P724, DOI 10.1124/jpet.300.3.724; Adebiyi A, 2008, MOL PHARMACOL, V74, P736, DOI 10.1124/mol.108.048165; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Babai N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008602; Bannister JP, 2009, CIRC RES, V105, P948, DOI 10.1161/CIRCRESAHA.109.203620; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Cheng XY, 2007, J BIOL CHEM, V282, P29211, DOI 10.1074/jbc.M610623200; Cheng XY, 2009, AM J PHYSIOL-HEART C, V297, pH680, DOI 10.1152/ajpheart.00109.2009; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Gollasch M, 1997, KIDNEY BLOOD PRESS R, V20, P355, DOI 10.1159/000174250; HENKEL AW, 1994, ANAL BIOCHEM, V223, P329, DOI 10.1006/abio.1994.1595; Jaggar JH, 2001, AM J PHYSIOL-CELL PH, V281, pC439, DOI 10.1152/ajpcell.2001.281.2.C439; Jurkat-Rott K, 2004, J PHYSIOL-LONDON, V554, P609, DOI 10.1113/jphysiol.2003.052712; LESH RE, 1995, CIRC RES, V77, P220, DOI 10.1161/01.RES.77.2.220; Liao P, 2004, J BIOL CHEM, V279, P50329, DOI 10.1074/jbc.M409436200; Marsh James D, 2008, Trans Am Clin Climatol Assoc, V119, P171; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; Navedo MF, 2007, AM J PHYSIOL-HEART C, V293, pH1359, DOI 10.1152/ajpheart.00450.2007; NELSON MT, 1990, AM J PHYSIOL, V259, pC3; Obermair GJ, 2008, CURR OPIN PHARMACOL, V8, P311, DOI 10.1016/j.coph.2008.01.008; Pesic A, 2004, CIRC RES, V94, pE97, DOI 10.1161/01.RES.0000131495.93500.3c; POWERS PA, 1991, GENOMICS, V10, P835, DOI 10.1016/0888-7543(91)90471-P; Pratt PF, 2002, HYPERTENSION, V40, P214, DOI 10.1161/01.HYP.0000025877.23309.36; Reimer D, 2000, FEBS LETT, V467, P65, DOI 10.1016/S0014-5793(00)01124-8; Selli C, 2009, VASC PHARMACOL, V51, P96, DOI 10.1016/j.vph.2009.04.001; Seth M, 2004, P NATL ACAD SCI USA, V101, P16683, DOI 10.1073/pnas.0407537101; Sonkusare S, 2006, VASC PHARMACOL, V44, P131, DOI 10.1016/j.vph.2005.10.005; Takahashi E, 2006, COMPARATIVE MED, V56, P168; Tang ZZ, 2007, CELL CALCIUM, V41, P417, DOI 10.1016/j.ceca.2006.08.002; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; Triggle DJ, 2007, BIOCHEM PHARMACOL, V74, P1, DOI 10.1016/j.bcp.2007.01.016; Wamhoff BR, 2006, CIRC RES, V98, P868, DOI 10.1161/01.RES.0000216596.73005.3c; Zhao GL, 2008, AM J PHYSIOL-CELL PH, V295, pC1376, DOI 10.1152/ajpcell.00362.2008; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200	39	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15058	15066		10.1074/jbc.M110.182816	http://dx.doi.org/10.1074/jbc.M110.182816			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21357696	Green Published, hybrid			2022-12-27	WOS:000289788300036
J	Bouillot, S; Tillet, E; Carmona, G; Prandini, MH; Gauchez, AS; Hoffmann, P; Alfaidy, N; Cand, F; Huber, P				Bouillot, Stephanie; Tillet, Emmanuelle; Carmona, Guillaume; Prandini, Marie-Helene; Gauchez, Anne-Sophie; Hoffmann, Pascale; Alfaidy, Nadia; Cand, Francine; Huber, Philippe			Protocadherin-12 Cleavage Is a Regulated Process Mediated by ADAM10 Protein EVIDENCE OF SHEDDING UP-REGULATION IN PRE-ECLAMPSIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; VASCULAR ENDOTHELIAL-CADHERIN; GAMMA-PROTOCADHERINS; TUMOR-SUPPRESSOR; HUMAN PLACENTA; LARGE FAMILY; MIGRATION; PREECLAMPSIA; EXPRESSION; ADAM-10	Protocadherins are a group of transmembrane proteins with homophilic binding activity, members of the cadherin superfamily. Apart from their role in adhesion, the cellular functions of protocadherins are essentially unknown. Protocadherin (PCDH) 12 was previously identified in invasive trophoblasts and endothelial and mesangial cells in the mouse. Invalidation studies revealed that the protein was required for optimal placental development. In this article, we show that its human homolog is abundantly expressed in various trophoblast subtypes of the human placenta and at lower levels in endothelial cells. We demonstrate that PCDH12 is shed at high rates in vitro. The shedding mechanism depends on ADAM10 and results in reduced cellular adhesion in a cell migration assay. PCDH12 is subsequently cleaved by the gamma-secretase complex, and its cytoplasmic domain is rapidly degraded by the proteasome. PCDH12 shedding is regulated by interlinked intracellular pathways, including those involving protein kinase C, PI3K, and cAMP, that either increase or inhibit cleavage. In endothelial cells, VEGF, prostaglandin E-2, or histamine regulates PCDH12 shedding. The extracellular domain of PCDH12 was also detected in human serum and urine, thus providing evidence of PCDH12 shedding in vivo. Importantly, we observed an increase in circulating PCDH12 in pregnant women who later developed a pre-eclampsia, a frequent pregnancy syndrome and a major cause of maternal and fetal morbidity and mortality. In conclusion, we speculate that, like in mice, PCDH12 may play an important role in human placental development and that proteolytic cleavage in response to external factors, such as cytokines and pathological settings, regulates its activity.	[Huber, Philippe] CEA, iRTSV LAPV U882, Lab Angiogenese & Physiopathol Vasc, F-38054 Grenoble, France; [Bouillot, Stephanie; Tillet, Emmanuelle; Carmona, Guillaume; Prandini, Marie-Helene; Cand, Francine; Huber, Philippe] INSERM, U882, F-38054 Grenoble, France; [Alfaidy, Nadia] INSERM, U878, F-38054 Grenoble, France; [Bouillot, Stephanie; Tillet, Emmanuelle; Carmona, Guillaume; Prandini, Marie-Helene; Alfaidy, Nadia; Cand, Francine; Huber, Philippe] Univ Grenoble 1, F-38041 Grenoble, France; [Gauchez, Anne-Sophie] CHR Univ Grenoble, Dept Biol Integrat, F-38043 Grenoble, France; [Hoffmann, Pascale] CHR Univ Grenoble, Dept Gynecol Obstet & Med Reprod, F-38043 Grenoble, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Huber, P (corresponding author), CEA, iRTSV LAPV U882, Lab Angiogenese & Physiopathol Vasc, 17 Rue Martyrs, F-38054 Grenoble, France.	phuber@cea.fr	Alfaidy, N./I-2972-2016; GAUCHEZ, Anne-Sophie/M-5534-2014; Huber, Philippe/C-7971-2019	Alfaidy, N./0000-0002-0718-2447; GAUCHEZ, Anne-Sophie/0000-0003-2332-0966; Huber, Philippe/0000-0002-4153-7694; Tillet, Emmanuelle/0000-0002-0076-8007; Hoffmann, Pascale/0000-0003-3305-5414; BOUILLOT, Stephanie/0000-0001-7567-557X	CEA; INSERM; Universite Grenoble 1	CEA(French Atomic Energy Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Grenoble 1	This work was supported by the CEA, INSERM, and Universite Grenoble 1.	Aamar E, 2008, DEV BIOL, V318, P335, DOI 10.1016/j.ydbio.2008.03.040; Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Bass KE, 1997, DEV GENET, V21, P61, DOI 10.1002/(SICI)1520-6408(1997)21:1<61::AID-DVG7>3.0.CO;2-6; Bononi J, 2008, MECH DEVELOP, V125, P1033, DOI 10.1016/j.mod.2008.07.007; Bouillot S, 2006, PLACENTA, V27, P882, DOI 10.1016/j.placenta.2005.09.009; Cetin I, 2011, PLACENTA, V32, pS4, DOI 10.1016/j.placenta.2010.11.022; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dibbens LM, 2008, NAT GENET, V40, P776, DOI 10.1038/ng.149; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Emond MR, 2008, DEV BIOL, V321, P175, DOI 10.1016/j.ydbio.2008.06.011; Haas IG, 2005, J BIOL CHEM, V280, P9313, DOI 10.1074/jbc.M412909200; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Junghans D, 2005, CURR OPIN CELL BIOL, V17, P446, DOI 10.1016/j.ceb.2005.08.008; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kuroda H, 2002, DEV BIOL, V244, P267, DOI 10.1006/dbio.2002.0589; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Medina A, 2004, EMBO J, V23, P3249, DOI 10.1038/sj.emboj.7600329; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Morishita H, 2007, CURR OPIN CELL BIOL, V19, P584, DOI 10.1016/j.ceb.2007.09.006; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nakao S, 2008, J CELL BIOL, V182, P395, DOI 10.1083/jcb.200802069; Okazaki N, 2002, CARCINOGENESIS, V23, P1139, DOI 10.1093/carcin/23.7.1139; POLETTE M, 1994, LAB INVEST, V71, P838; Rampon C, 2005, EXP CELL RES, V302, P48, DOI 10.1016/j.yexcr.2004.08.024; Rampon C, 2008, PHYSIOL GENOMICS, V34, P193, DOI 10.1152/physiolgenomics.00220.2007; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Reiners J, 2005, MOL VIS, V11, P347; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Reiss K, 2006, J BIOL CHEM, V281, P21735, DOI 10.1074/jbc.M602663200; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Telo P, 1998, J BIOL CHEM, V273, P17565, DOI 10.1074/jbc.273.28.17565; Tillet E, 1997, J BIOL CHEM, V272, P10769; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yu JS, 2008, ONCOGENE, V27, P4657, DOI 10.1038/onc.2008.101; Zhao S, 2010, PLACENTA, V31, P512, DOI 10.1016/j.placenta.2010.03.014	45	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15195	15204		10.1074/jbc.M111.230045	http://dx.doi.org/10.1074/jbc.M111.230045			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21402705	hybrid, Green Published			2022-12-27	WOS:000289788300051
J	Guo, JL; Lee, VMY				Guo, Jing L.; Lee, Virginia M. -Y.			Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; PAIRED HELICAL FILAMENTS; BLOOD-BRAIN-BARRIER; FTDP-17 MISSENSE MUTATIONS; FIBRILLIZATION IN-VITRO; FRONTOTEMPORAL DEMENTIA; NEUROFIBRILLARY TANGLES; P301L TAU; ADSORPTIVE ENDOCYTOSIS; ALPHA-SYNUCLEIN	Neurofibrillary tangles (NFTs) in Alzheimer disease and related tauopathies are composed of insoluble hyperphosphorylated Tau protein, but the mechanisms underlying the conversion of highly soluble Tau into insoluble NFTs remain elusive. Here, we demonstrate that introduction of minute quantities of misfolded preformed Tau fibrils (Tau pffs) into Tau-expressing cells rapidly recruit large amounts of soluble Tau into filamentous inclusions resembling NFTs with unprecedented efficiency, suggesting a "seeding"-recruitment process as a highly plausible mechanism underlying NFT formation in vivo. Consistent with the emerging concept of prion-like transmissibility of disease-causing amyloidogenic proteins, we found that spontaneous uptake of Tau pffs into cells is likely mediated by endocytosis, suggesting a potential mechanism for the propagation of Tau lesions in tauopathy brains. Furthermore, sequestration of soluble Tau by pff-induced Tau aggregates attenuates microtubule overstabilization in Tau-expressing cells, supporting the hypothesis of a Tau loss-of-function toxicity in cells harboring NFTs. In summary, our study establishes a cellular system that robustly develops authentic NFT-like Tau aggregates, which provides mechanistic insights into NFT pathogenesis and a potential tool for identifying Tau-based therapeutics.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Inst Aging, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), 3rd Floor,Maloney Bldg,3600 Spruce St, Philadelphia, PA 19104 USA.	vmylee@upenn.edu			National Institutes of Health [AG17586]; Cure Alzheimer Fund; NATIONAL INSTITUTE ON AGING [P01AG017586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG17586. This work was also supported by Cure Alzheimer Fund.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bandyopadhyay B, 2007, J BIOL CHEM, V282, P16454, DOI 10.1074/jbc.M700192200; Banks WA, 1998, J CELL SCI, V111, P533; Banks WA, 1997, LIFE SCI, V61, pPL119, DOI 10.1016/S0024-3205(97)00597-3; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Boutte AM, 2005, J ALZHEIMERS DIS, V8, P1; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BROADWELL RD, 1988, P NATL ACAD SCI USA, V85, P632, DOI 10.1073/pnas.85.2.632; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Ferrari A, 2003, J BIOL CHEM, V278, P40162, DOI 10.1074/jbc.M308243200; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; GONATAS NK, 1973, J CELL BIOL, V59, P436, DOI 10.1083/jcb.59.2.436; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hempen B, 1996, J NEUROPATH EXP NEUR, V55, P964, DOI 10.1097/00005072-199609000-00003; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2005, BBA-MOL BASIS DIS, V1739, P251, DOI 10.1016/j.bbadis.2004.06.014; LEE VMY, 1994, NEUROBIOL AGING, V15, pS87; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Matsumura N, 1999, AM J PATHOL, V154, P1649, DOI 10.1016/S0002-9440(10)65420-X; Merrick SE, 1997, J NEUROSCI, V17, P5726; Mirra SS, 1999, J NEUROPATH EXP NEUR, V58, P335, DOI 10.1097/00005072-199904000-00004; Miyasaka T, 2001, J NEUROPATH EXP NEUR, V60, P872, DOI 10.1093/jnen/60.9.872; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; PAULABARBOSA M, 1987, BRAIN RES, V417, P139, DOI 10.1016/0006-8993(87)90188-0; POLLOCK NJ, 1986, LANCET, V2, P1211; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; Sato S, 2002, J BIOL CHEM, V277, P42060, DOI 10.1074/jbc.M202241200; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; van Swieten JC, 1999, ANN NEUROL, V46, P617, DOI 10.1002/1531-8249(199910)46:4<617::AID-ANA10>3.0.CO;2-I; Vogelsberg-Ragaglia V, 2000, MOL BIOL CELL, V11, P4093, DOI 10.1091/mbc.11.12.4093; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; WITMAN GB, 1976, P NATL ACAD SCI USA, V73, P4070, DOI 10.1073/pnas.73.11.4070; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102	67	408	418	1	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15317	15331		10.1074/jbc.M110.209296	http://dx.doi.org/10.1074/jbc.M110.209296			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21372138	Green Published, hybrid			2022-12-27	WOS:000289788300063
J	Kato, A; Okamoto, O; Ishikawa, K; Sumiyoshi, H; Matsuo, N; Yoshioka, H; Nomizu, M; Shimada, T; Fujiwara, S				Kato, Aiko; Okamoto, Osamu; Ishikawa, Kazushi; Sumiyoshi, Hideaki; Matsuo, Noritaka; Yoshioka, Hidekatsu; Nomizu, Motoyoshi; Shimada, Tatsuo; Fujiwara, Sakuhei			Dermatopontin Interacts with Fibronectin, Promotes Fibronectin Fibril Formation, and Enhances Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX PROTEIN; SELF-ASSOCIATION; BINDING-SITE; IN-VITRO; FIBRILLOGENESIS; COLLAGEN; SKIN; IDENTIFICATION; SUPERFIBRONECTIN; LOCALIZATION	We report that dermatopontin (DP), an abundant dermal extracellular matrix protein, is found in the fibrin clot and in the wound fluid, which comprise the provisional matrix at the initial stage of wound healing. DP was also found in the serum but at a lower concentration than that in wound fluid. DP co-localized with both fibrin and fibronectin on fibrin fibers and interacted with both proteins. Both normal fibroblast and HT1080 cell adhesion to the fibrin-fibronectin matrix were dose-dependently enhanced by DP, and the adhesion was mediated by alpha 5 beta 1 integrin. The cytoskeleton was more organized in the cells that adhered to the fibrin-fibronectin-DP complex. When incubated with DP, fibronectin formed an insoluble complex of fibronectin fibrils as visualized by electron microscopy. The interacting sites of fibronectin with DP were the first, thirteenth, and fourteenth type III repeats (III1, III13, and III14), with III13 and III14 assumed to be the major sites. The interaction between III2-3 and III12-14 was inhibited by DP, whereas the interaction between I1-5 and III12-14 was specifically and strongly enhanced by DP. Because the interaction between III2-3 and III12-14 is involved in forming a globular conformation of fibronectin, and that between I1-5 and III12-14 is required for forming fibronectin fibrils, DP promotes fibronectin fibril formation probably by changing the fibronectin conformation. These results suggest that DP has an accelerating role in fibroblast cell adhesion to the provisional matrix in the initial stage of wound healing.	[Okamoto, Osamu; Ishikawa, Kazushi; Fujiwara, Sakuhei] Oita Univ, Dept Dermatol, Yufu, Oita 8795593, Japan; [Kato, Aiko] Oita Univ, Dept Plast Surg, Yufu, Oita 8795593, Japan; [Sumiyoshi, Hideaki; Matsuo, Noritaka; Yoshioka, Hidekatsu] Oita Univ, Dept Biochem, Yufu, Oita 8795593, Japan; [Shimada, Tatsuo] Oita Univ, Fac Med, Yufu, Oita 8795593, Japan; [Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Clin Biochem, Tokyo 1920392, Japan	Oita University; Oita University; Oita University; Oita University; Tokyo University of Pharmacy & Life Sciences	Okamoto, O (corresponding author), Oita Univ, Dept Dermatol, 1-1 Idaigaoka,Hasama Machi, Yufu, Oita 8795593, Japan.	ookamoto@oita-u.ac.jp			Ministry of Education, Culture, Science, Sports, and Technology of Japan	Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the Ministry of Education, Culture, Science, Sports, and Technology of Japan (to A.K.).	AGUIRRE KM, 1994, J BIOL CHEM, V269, P27863; Bultmann H, 1998, J BIOL CHEM, V273, P2601, DOI 10.1074/jbc.273.5.2601; CRONSHAW AD, 1993, MATRIX, V13, P255, DOI 10.1016/S0934-8832(11)80009-0; DICKINSON CD, 1994, J MOL BIOL, V236, P1079, DOI 10.1016/0022-2836(94)90013-2; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; FOGERTY FJ, 1990, J CELL BIOL, V111, P699, DOI 10.1083/jcb.111.2.699; FUJII N, 1992, J BIOL CHEM, V267, P22452; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Hynes RO, 1990, FIBRONECTINS; Ingham KC, 1997, J BIOL CHEM, V272, P1718, DOI 10.1074/jbc.272.3.1718; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Koblinski JE, 2005, J CELL SCI, V118, P2965, DOI 10.1242/jcs.02411; LEWANDOWSKA K, 1991, J CELL SCI, V99, P657; MACBEATH JRE, 1993, J BIOL CHEM, V268, P19826; Makogonenko E, 2002, BIOCHEMISTRY-US, V41, P7907, DOI 10.1021/bi025770x; Makogonenko E, 2007, BIOCHEMISTRY-US, V46, P5418, DOI 10.1021/bi7001373; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Midwood KS, 2006, J INVEST DERM SYMP P, V11, P73, DOI 10.1038/sj.jidsymp.5650005; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079; NEAME PJ, 1989, J BIOL CHEM, V264, P5474; Ohashi T, 2005, J BIOL CHEM, V280, P39143, DOI 10.1074/jbc.M509082200; Okamoto O, 1996, J BIOCHEM-TOKYO, V119, P106; Okamoto O, 1999, BIOCHEM J, V337, P537, DOI 10.1042/0264-6021:3370537; Okamoto O, 2006, CONNECT TISSUE RES, V47, P177, DOI 10.1080/03008200600846564; Okamoto O, 2010, BIOCHEMISTRY-US, V49, P147, DOI 10.1021/bi901066f; PETERS DMP, 1990, J CELL BIOL, V111, P249, DOI 10.1083/jcb.111.1.249; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Sechler JL, 2000, J CELL SCI, V113, P1491; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9; SUPERTIFURGA A, 1993, GENOMICS, V17, P463, DOI 10.1006/geno.1993.1348; Takeda U, 2002, J INVEST DERMATOL, V119, P678, DOI 10.1046/j.1523-1747.2002.01863.x; Takemoto S, 2002, BASIC RES CARDIOL, V97, P461, DOI 10.1007/s00395-002-0371-x; Tzen CY, 2004, EXP CELL RES, V294, P30, DOI 10.1016/j.yexcr.2003.10.026; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Viglio S, 2008, J INVEST DERMATOL, V128, P1915, DOI 10.1038/jid.2008.33; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Wu CY, 1996, CELL ADHES COMMUN, V4, P149, DOI 10.3109/15419069609014219	39	47	50	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14861	14869		10.1074/jbc.M110.179762	http://dx.doi.org/10.1074/jbc.M110.179762			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21398523	Green Published, hybrid			2022-12-27	WOS:000289788300016
J	Yoshimura, K; Miyamoto, Y; Yasuhara, R; Maruyama, T; Akiyama, T; Yamada, A; Takami, M; Suzawa, T; Tsunawaki, S; Tachikawa, T; Baba, K; Kamijo, R				Yoshimura, Kentaro; Miyamoto, Yoichi; Yasuhara, Rika; Maruyama, Toshifumi; Akiyama, Tomohito; Yamada, Atsushi; Takami, Masamichi; Suzawa, Tetsuo; Tsunawaki, Shoko; Tachikawa, Tetsuhiko; Baba, Kazuyoshi; Kamijo, Ryutaro			Monocarboxylate Transporter-1 Is Required for Cell Death in Mouse Chondrocytic ATDC5 Cells Exposed to Interleukin-1 beta via Late Phase Activation of Nuclear Factor kappa B and Expression of Phagocyte-type NADPH Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ARTICULAR CHONDROCYTES; MITOCHONDRIAL DYSFUNCTION; PATHWAY; FAMILY; TRANSCRIPTION; LOCALIZATION; DEGRADATION; COMPLEX; ALPHA; DRUG	Interleukin-1 beta(IL-1 beta) induces cell death in chondrocytes in a nitric oxide (NO)- and reactive oxygen species (ROS)-dependent manner. In this study, increased production of lactate was observed in IL-1 beta-treated mouse chondrocytic ATDC5 cells prior to the onset of their death. IL-1 beta-induced cell death in ATDC5 cells was suppressed by introducing an siRNA for monocarboxylate transporter-1 (MCT-1), a lactate transporter distributed in plasma and mitochondrial inner membranes. Mct-1 knockdown also prevented IL-1 beta-induced expression of phagocyte-type NADPH oxidase (NOX-2), an enzyme specialized for production of ROS, whereas it did not have an effect on inducible NO synthase. Suppression of IL-1 beta-induced cell death by Nox-2 siRNA indicated that NOX-2 is involved in cell death. Phosphorylation and degradation of inhibitor of kappa B alpha (I kappa B alpha) from 5 to 20 min after the addition of IL-1 beta was not affected by Mct-1 siRNA. In addition, I kappa B alpha was slightly decreased after 12 h of incubation with IL-1 beta, and the decrease was prominent after 36 h, whereas activation of p65/RelA was observed from 12 to 48 h after exposure to IL-1 beta. These changes were not seen in Mct-1-silenced cells. Forced expression of I kappa B alpha super repressor as well as treatment with the I kappa B kinase inhibitor BAY 11-7082 suppressed NOX-2 expression. Furthermore, Mct-1 siRNA lowered the level of ROS generated after 15-h exposure to IL-1 beta, whereas a ROS scavenger, N-acetylcysteine, suppressed both late phase degradation of I kappa B alpha and Nox-2 expression. These results suggest that MCT-1 contributes to NOX-2 expression via late phase activation of NF-kappa B in a ROS-dependent manner in ATDC5 cells exposed to IL-1 beta.	[Yoshimura, Kentaro; Miyamoto, Yoichi; Maruyama, Toshifumi; Akiyama, Tomohito; Yamada, Atsushi; Takami, Masamichi; Suzawa, Tetsuo; Kamijo, Ryutaro] Showa Univ, Sch Dent, Dept Biochem, Tokyo 1428555, Japan; [Yasuhara, Rika; Tachikawa, Tetsuhiko] Showa Univ, Sch Dent, Dept Oral Pathol & Diag, Tokyo 1428555, Japan; [Maruyama, Toshifumi; Akiyama, Tomohito; Baba, Kazuyoshi] Showa Univ, Sch Dent, Dept Prosthodont, Tokyo 1428555, Japan; [Tsunawaki, Shoko] Natl Res Inst Child Hlth & Dev, Dept Infect Dis, Tokyo 1578535, Japan	Showa University; Showa University; Showa University; National Center for Child Health & Development - Japan	Miyamoto, Y (corresponding author), 1-5-8 Hatanodai,Shinagawa Ku, Tokyo 1428555, Japan.	yoichim@dent.showa-u.ac.jp	Baba, Kazuyoshi/AAY-2304-2021	Takami, Masamichi/0000-0002-4506-3975; Yasuhara, Rika/0000-0003-2282-6295; Baba, Kazuyoshi/0000-0001-8025-2168	Japan Society for the Promotion of Science [21592372]; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [22890181] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research 21592372 from the Japan Society for the Promotion of Science and by the High-Tech Research Center Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, 2005-2009.	Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Clark RA, 2004, MECH AGEING DEV, V125, P799, DOI 10.1016/j.mad.2004.08.009; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Cristofanon S, 2009, FASEB J, V23, P45, DOI 10.1096/fj.07-104109; Daheshia M, 2008, J RHEUMATOL, V35, P2306, DOI 10.3899/jrheum.080346; DECLERCK LS, 1994, J IMMUNOL METHODS, V172, P115, DOI 10.1016/0022-1759(94)90384-0; Del Carlo M, 2002, ARTHRITIS RHEUM, V46, P394, DOI 10.1002/art.10056; Del Carlo Marcello Jr, 2008, Curr Rheumatol Rep, V10, P37; Enesa K, 2008, J BIOL CHEM, V283, P18582, DOI 10.1074/jbc.M801312200; Frein D, 2005, BIOCHEM PHARMACOL, V70, P811, DOI 10.1016/j.bcp.2005.04.012; Ganster RW, 2000, NITRIC OXIDE BIOL PA, P129; Gauss KA, 2007, J LEUKOCYTE BIOL, V82, P729, DOI 10.1189/jlb.1206735; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com; Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1237, DOI 10.1152/ajpendo.00594.2005; HELESTRAP AP, 2004, PFLUGERS ARCH, V447, P619; Henrotin YE, 2003, OSTEOARTHR CARTILAGE, V11, P747, DOI 10.1016/S1063-4584(03)00150-X; Kamata H, 2002, FEBS LETT, V519, P231, DOI 10.1016/S0014-5793(02)02712-6; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Krebs Danielle L., 1999, Methods in Cell Science, V21, P57, DOI 10.1023/A:1009843325770; MAIER R, 1994, BBA-PROTEIN STRUCT M, V1208, P145, DOI 10.1016/0167-4838(94)90171-6; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Morris ME, 2008, AAPS J, V10, P311, DOI 10.1208/s12248-008-9035-6; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Rozen S, 2000, Methods Mol Biol, V132, P365; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Samuvel DJ, 2009, J IMMUNOL, V182, P2476, DOI 10.4049/jimmunol.0802059; Shikhman AR, 2004, AM J PHYSIOL-ENDOC M, V286, pE980, DOI 10.1152/ajpendo.00243.2003; Shukunami C, 1997, J BONE MINER RES, V12, P1174, DOI 10.1359/jbmr.1997.12.8.1174; Tsuchiya Y, 2010, MOL CELL, V39, P570, DOI 10.1016/j.molcel.2010.07.030; Whiteman M, 2004, FASEB J, V18, P1395, DOI 10.1096/fj.03-1096fje; Yasuhara R, 2005, BIOCHEM J, V389, P315, DOI 10.1042/BJ20041996	37	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14744	14752		10.1074/jbc.M111.221259	http://dx.doi.org/10.1074/jbc.M111.221259			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21372137	Green Published, hybrid			2022-12-27	WOS:000289788300003
J	Liebau, MC; Hopker, K; Muller, RU; Schmedding, I; Zank, S; Schairer, B; Fabretti, F; Hohne, M; Bartram, MP; Dafinger, C; Hackl, M; Burst, V; Habbig, S; Zentgraf, H; Blaukat, A; Walz, G; Benzing, T; Schermer, B				Liebau, Max C.; Hoepker, Katja; Mueller, Roman U.; Schmedding, Ingolf; Zank, Sibylle; Schairer, Benjamin; Fabretti, Francesca; Hoehne, Martin; Bartram, Malte P.; Dafinger, Claudia; Hackl, Matthias; Burst, Volker; Habbig, Sandra; Zentgraf, Hanswalter; Blaukat, Andree; Walz, Gerd; Benzing, Thomas; Schermer, Bernhard			Nephrocystin-4 Regulates Pyk2-induced Tyrosine Phosphorylation of Nephrocystin-1 to Control Targeting to Monocilia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE NEPHRONOPHTHISIS; CAENORHABDITIS-ELEGANS; PACS-1 BINDING; PRIMARY CILIUM; PROTEIN; GENE; PYK2; KINASE; ACTIVATION; MUTATIONS	Nephronophthisis is the most common genetic cause of end-stage renal failure during childhood and adolescence. Genetic studies have identified disease-causing mutations in at least 11 different genes (NPHP1-11), but the function of the corresponding nephrocystin proteins remains poorly understood. The two evolutionarily conserved proteins nephrocystin-1 (NPHP1) and nephrocystin-4 (NPHP4) interact and localize to cilia in kidney, retina, and brain characterizing nephronophthisis and associated pathologies as result of a ciliopathy. Here we show that NPHP4, but not truncating patient mutations, negatively regulates tyrosine phosphorylation of NPHP1. NPHP4 counteracts Pyk2-mediated phosphorylation of three defined tyrosine residues of NPHP1 thereby controlling binding of NPHP1 to the trans-Golgi sorting protein PACS-1. Knockdown of NPHP4 resulted in an accumulation of NPHP1 in trans-Golgi vesicles of ciliated retinal epithelial cells. These data strongly suggest that NPHP4 acts upstream of NPHP1 in a common pathway and support the concept of a role for nephrocystin proteins in intracellular vesicular transport.	[Liebau, Max C.; Hoepker, Katja; Mueller, Roman U.; Schmedding, Ingolf; Zank, Sibylle; Schairer, Benjamin; Fabretti, Francesca; Hoehne, Martin; Bartram, Malte P.; Dafinger, Claudia; Hackl, Matthias; Burst, Volker; Habbig, Sandra; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Div Renal, Dept Med, D-50937 Cologne, Germany; [Liebau, Max C.; Hoepker, Katja; Mueller, Roman U.; Schmedding, Ingolf; Zank, Sibylle; Schairer, Benjamin; Fabretti, Francesca; Hoehne, Martin; Bartram, Malte P.; Dafinger, Claudia; Hackl, Matthias; Burst, Volker; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Ctr Mol Med, D-50937 Cologne, Germany; [Liebau, Max C.; Habbig, Sandra] Univ Cologne, Dept Pediat, D-50937 Cologne, Germany; [Zentgraf, Hanswalter] German Canc Res Ctr, Dept Tumor Virol, D-69120 Heidelberg, Germany; [Blaukat, Andree] Merck KGaA, TA Oncol, Merck Serono Res, D-64293 Darmstadt, Germany; [Walz, Gerd] Univ Hosp Freiburg, Div Renal, D-79104 Freiburg, Germany	University of Cologne; University of Cologne; University of Cologne; Helmholtz Association; German Cancer Research Center (DKFZ); Merck KGaA; EMD Serono Inc.; University of Freiburg	Schermer, B (corresponding author), Univ Hosp Cologne, Div Renal, Dept Med, Kerpener Str 62, D-50937 Cologne, Germany.	bernhard.schermer@uk-koeln.de	Liebau, Max Christoph/K-3470-2019; Benzing, Thomas/X-5476-2019; Müller, Roman-Ulrich/AAK-3493-2021; Schermer, Bernhard/E-9972-2014; Habbig, Sandra/AHC-1168-2022	Liebau, Max Christoph/0000-0003-0494-9080; Müller, Roman-Ulrich/0000-0001-6910-0745; Schermer, Bernhard/0000-0002-5194-9000; Hohne, Martin/0000-0001-8698-5389; Hackl, Matthias/0000-0002-4199-3374	German Research Foundation [BE 2212, SCHE 1562, SFB 635, SFB 832]	German Research Foundation(German Research Foundation (DFG))	This work was supported by German Research Foundation Grants BE 2212, SCHE 1562, SFB 635, and SFB 832.	Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Astier A, 1997, J BIOL CHEM, V272, P228; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Blaukat A, 2001, J BIOL CHEM, V276, P40431, DOI 10.1074/jbc.M107024200; Blaukat A, 1999, J BIOL CHEM, V274, P14893, DOI 10.1074/jbc.274.21.14893; Crump CM, 2001, EMBO J, V20, P2191, DOI 10.1093/emboj/20.9.2191; Delous M, 2009, HUM MOL GENET, V18, P4711, DOI 10.1093/hmg/ddp434; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hildebrandt F, 2009, J AM SOC NEPHROL, V20, P23, DOI 10.1681/ASN.2008050456; Hinners I, 2003, EMBO REP, V4, P1182, DOI 10.1038/sj.embor.7400018; Hoefele Julia, 2005, Hum Mutat, V25, P411, DOI 10.1002/humu.9326; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Jauregui AR, 2008, J CELL BIOL, V180, P973, DOI 10.1083/jcb.200707090; Jauregui AR, 2005, EXP CELL RES, V305, P333, DOI 10.1016/j.yexcr.2005.01.008; Jenkins PM, 2009, J NEUROSCI, V29, P10541, DOI 10.1523/JNEUROSCI.1590-09.2009; Kruljac-Letunic A, 2003, J BIOL CHEM, V278, P29560, DOI 10.1074/jbc.M302278200; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Otto E, 2002, AM J HUM GENET, V71, P1161, DOI 10.1086/344395; Otto EA, 2009, J MED GENET, V46, P663, DOI 10.1136/jmg.2009.066613; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Roepman R, 2005, P NATL ACAD SCI USA, V102, P18520, DOI 10.1073/pnas.0505774102; Ruff SJ, 1997, J BIOL CHEM, V272, P1263, DOI 10.1074/jbc.272.2.1263; Salomon R, 2009, PEDIATR NEPHROL, V24, P2333, DOI 10.1007/s00467-008-0840-z; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Scott GK, 2003, EMBO J, V22, P6234, DOI 10.1093/emboj/cdg596; Scott GK, 2006, EMBO J, V25, P4423, DOI 10.1038/sj.emboj.7601336; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Snell WJ, 2004, CELL, V117, P693, DOI 10.1016/j.cell.2004.05.019; Tokiwa G, 1996, SCIENCE, V273, P792, DOI 10.1126/science.273.5276.792; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Wang Q, 2003, J BIOL CHEM, V278, P32936, DOI 10.1074/jbc.M303261200; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; Winkelbauer ME, 2005, J CELL SCI, V118, P5575, DOI 10.1242/jcs.02665; Wolf MTF, 2005, J AM SOC NEPHROL, V16, P676, DOI 10.1681/ASN.2003121025	43	17	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14237	14245		10.1074/jbc.M110.165464	http://dx.doi.org/10.1074/jbc.M110.165464			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357692	Green Published, hybrid			2022-12-27	WOS:000289556200047
J	Pena, J; Harris, E				Pena, Jose; Harris, Eva			Dengue Virus Modulates the Unfolded Protein Response in a Time-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH PROGRAM; ER STRESS; TRANSLATIONAL CONTROL; KINASE; INITIATION; INFECTION; REPLICATION; RNA; PATHWAY	Flaviviruses, such as dengue virus (DENV), depend on the host endoplasmic reticulum for translation, replication, and packaging of their genomes. Here we report that DENV-2 infection modulates the unfolded protein response in a time-dependent manner. We show that early DENV-2 infection triggers and then suppresses PERK-mediated eIF2 alpha phosphorylation and that in mid and late DENV-2 infection, the IRE1-XBP1 and ATF6 pathways are activated, respectively. Activation of IRE1-XBP1 correlated with induction of downstream targets GRP78, CHOP, and GADD34. Furthermore, induction of CHOP did not induce apoptoticmarkers, such as suppression of anti-apoptotic protein Bcl-2, activation of caspase-9 or caspase-3, and cleavage of poly(ADPribose) polymerase. Finally, we show that DENV-2 replication is affected inPERK(-/-) and IRE1(-/-) mouse embryo fibroblasts when compared with wild-type mouse embryo fibroblasts. These results demonstrate that time-dependent activation of the unfolded protein response by DENV-2 can override inhibition of translation, prevent apoptosis, and prolong the viral life cycle.	[Pena, Jose; Harris, Eva] Univ Calif Berkeley, Div Infect Dis & Vaccinol, Sch Publ Hlth, Berkeley, CA 94720 USA; Univ Calif Berkeley, Grad Grp Microbiol, Dept Plant & Microbial Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Pena, J (corresponding author), Univ Calif Berkeley, Div Infect Dis & Vaccinol, Sch Publ Hlth, 1 Barker Hall, Berkeley, CA 94720 USA.	jpena360@yahoo.com; eharris@berkeley.edu			National Institutes of Health [AI052324]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI052324 (to E. H.) and a supplemental National Institutes of Health grant (to J. P.).	Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bommiasamy H, 2009, J CELL SCI, V122, P1626, DOI 10.1242/jcs.045625; Ceballos-Olvera I, 2010, VIROLOGY, V396, P30, DOI 10.1016/j.virol.2009.10.019; Dever T.E., 2007, TRANSLATIONAL CONTRO, P319; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hetz CA, 2007, ANTIOXID REDOX SIGN, V9, P2345, DOI 10.1089/ars.2007.1793; Huerta-Zepeda A, 2008, THROMB HAEMOSTASIS, V99, P936, DOI [10.1160/TH07-08-0483, 10.1160/TH07-08-0438]; Jordan R, 2002, J VIROL, V76, P9588, DOI 10.1128/JVI.76.19.9588-9599.2002; Krishnamoorthy J, 2008, CELL CYCLE, V7, P2346, DOI 10.4161/cc.6323; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lindenbach B., 2011, FIELDS VIROLOGY, V5th ed., P1101; Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pavio N, 2003, J VIROL, V77, P3578, DOI 10.1128/JVI.77.6.3578-3585.2003; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Ron D, 2007, TRANSLATIONAL CONTRO, P345; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shen JS, 2005, METHODS, V35, P382, DOI 10.1016/j.ymeth.2004.10.011; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200; Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06	46	134	138	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14226	14236		10.1074/jbc.M111.222703	http://dx.doi.org/10.1074/jbc.M111.222703			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21385877	Green Published, hybrid			2022-12-27	WOS:000289556200046
J	Beer, NL; van de Bunt, M; Colclough, K; Lukacs, C; Arundel, P; Chik, CL; Grimsby, J; Ellard, S; Gloyn, AL				Beer, Nicola L.; van de Bunt, Martijn; Colclough, Kevin; Lukacs, Christine; Arundel, Paul; Chik, Constance L.; Grimsby, Joseph; Ellard, Sian; Gloyn, Anna L.			Discovery of a Novel Site Regulating Glucokinase Activity following Characterization of a New Mutation Causing Hyperinsulinemic Hypoglycemia in Humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL DIABETES-MELLITUS; PANCREATIC BETA-CELLS; YOUNG TYPE-2 MODY-2; PLASMA-GLUCOSE; ACTIVATOR RO4389620; FASTING GLUCOSE; PROTEIN; PREVALENCE; CHILDREN; OVEREXPRESSION	Type 2 diabetes is a global problem, and current ineffective therapeutic strategies pave the way for novel treatments like small molecular activators targeting glucokinase (GCK). GCK activity is fundamental to beta cell and hepatocyte glucose metabolism, and heterozygous activating and inactivating GCK mutations cause hyperinsulinemic hypoglycemia (HH) and maturity onset diabetes of the young (MODY) respectively. Over 600 naturally occurring inactivating mutations have been reported, whereas only 13 activating mutations are documented to date. We report two novel GCK HH mutations (V389L and T103S) at residues where MODY mutations also occur (V389D and T103I). Using recombinant proteins with in vitro assays, we demonstrated that both HH mutants had a greater relative activity index than wild type (6.0 for V389L, 8.4 for T103S, and 1.0 for wild type). This was driven by an increased affinity for glucose (S-0.5, 3.3 +/- 0.1 and 3.5 +/- 0.1 mM, respectively) versus wild type (7.5 +/- 0.1 mM). Correspondingly, the V389D and T103I MODY mutants had markedly reduced relative activity indexes (<0.1). T103I had an altered affinity for glucose (S-0.5, 24.9 +/- 0.6 mM), whereas V389D also exhibited a reduced affinity for ATP and decreased catalysis rate (S-0.5, 78.6 +/- 4.5 mM; ATP(Km), 1.5 +/- 0.1 mM; K-cat, 10.3 +/- 1.1s(-1)) compared with wild type (ATP(Km), 0.4 +/- <0.1; K-cat, 62.9 +/- 1.2). Both Thr-103 mutants showed reduced inhibition by the endogenous hepatic inhibitor glucokinase regulatory protein. Molecular modeling demonstrated that Thr-103 maps to the allosteric activator site, whereas Val-389 is located remotely to this position and all other previously reported activating mutations, highlighting alpha -helix 11 as a novel region regulating GCK activity. Our data suggest that pharmacological manipulation of GCK activity at locations distal from the allosteric activator site is possible.	[Beer, Nicola L.; van de Bunt, Martijn; Gloyn, Anna L.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Colclough, Kevin] Royal Devon & Exeter Natl Hlth Serv NHS Fdn, Dept Mol Genet, Exeter EX2 5AD, Devon, England; [Lukacs, Christine] Hoffmann La Roche Inc, Dept Discovery Technol, Nutley, NJ 07110 USA; [Grimsby, Joseph] Hoffmann La Roche Inc, Dept Metab Dis, Nutley, NJ 07110 USA; [Arundel, Paul] Sheffield Childrens Natl Hlth Serv NHS Fdn Trust, Sheffield S10 2TH, S Yorkshire, England; [Chik, Constance L.] Univ Alberta, Div Endocrinol & Metab, Edmonton, AB T6G 2S2, Canada; [Ellard, Sian] Univ Exeter, Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England	University of Oxford; Roche Holding; Roche Holding; University of Alberta; University of Exeter	Gloyn, AL (corresponding author), Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Old Rd, Oxford OX3 7LJ, England.	anna.gloyn@drl.ox.ac.uk		Gloyn, Anna/0000-0003-1205-1844; van de Bunt, Martijn/0000-0002-6744-6125; Ellard, Sian/0000-0002-7620-5526	Oxford by the Medical Research Council (MRC); MRC [81696]; MRC [G0700222] Funding Source: UKRI; Medical Research Council [G0700222] Funding Source: researchfish	Oxford by the Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part in Oxford by the Medical Research Council (MRC).; Supported by MRC New Investigator Grant 81696. To whom correspondence should be addressed: Oxford Centre for Diabetes Endocrinology and Metabolism, Churchill Hospital, Old Rd., Headington, Oxford OX3 7LJ, UK. Fax: 44-1865-857299; E-mail: anna.gloyn@drl.ox.ac.uk.	Alvarez E, 2002, J NEUROCHEM, V80, P45, DOI 10.1046/j.0022-3042.2001.00677.x; Arden C, 2007, DIABETES, V56, P1773, DOI 10.2337/db06-1151; *ARR BIOPHARMA INC, 2009, GLUC ACT ARRY 403 PH; Baltrusch S, 2005, DIABETES, V54, P2829, DOI 10.2337/diabetes.54.10.2829; Baltrusch S, 2001, J BIOL CHEM, V276, P43915, DOI 10.1074/jbc.M105470200; Barbetti F, 2009, MOL ENDOCRINOL, V23, P1983, DOI 10.1210/me.2009-0094; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Bjorkhaug L, 2007, J BIOL CHEM, V282, P22757, DOI 10.1074/jbc.M700517200; Bonadonna RC, 2008, DIABETOLOGIA, V51, pS371; Bonadonna RC, 2010, J CLIN ENDOCR METAB, V95, P5028, DOI 10.1210/jc.2010-1041; Brocklehurst KJ, 2004, BIOCHEM J, V378, P693, DOI 10.1042/BJ20031414; Brocklehurst KJ, 2004, DIABETES, V53, P535, DOI 10.2337/diabetes.53.3.535; Bruce S, 2000, AM J HUM BIOL, V12, P542, DOI 10.1002/1520-6300(200007/08)12:4&lt;542::AID-AJHB13&gt;3.0.CO;2-7; Burke CV, 1999, BIOCHEM J, V342, P345, DOI 10.1042/0264-6021:3420345; Castelhano AL, 2005, BIOORG MED CHEM LETT, V15, P1501, DOI 10.1016/j.bmcl.2004.12.083; Christesen HBT, 2002, DIABETES, V51, P1240, DOI 10.2337/diabetes.51.4.1240; Christesen HBT, 2008, EUR J ENDOCRINOL, V159, P27, DOI 10.1530/EJE-08-0203; Coghlan M, 2008, EXPERT OPIN INV DRUG, V17, P145, DOI 10.1517/13543784.17.2.145; Cuesta-Munoz AL, 2004, DIABETES, V53, P2164, DOI 10.2337/diabetes.53.8.2164; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Davis EA, 1999, DIABETOLOGIA, V42, P1175, DOI 10.1007/s001250051289; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Gloyn AL, 2004, FRONT DIABETES, V16, P92; Gloyn AL, 2005, J BIOL CHEM, V280, P14105, DOI 10.1074/jbc.M413146200; Gloyn AL, 2003, DIABETES, V52, P2433, DOI 10.2337/diabetes.52.9.2433; Grimsby J, 2004, FRONT DIABETES, V16, P360; Grimsby J, 2000, J BIOL CHEM, V275, P7826, DOI 10.1074/jbc.275.11.7826; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; Heredia VV, 2006, J BIOL CHEM, V281, P40201, DOI 10.1074/jbc.M607987200; HOLLAND GW, 2004, Patent No. 1169312; HOLLAND GW, 2004, Patent No. 0058293; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kassem S, 2010, NEW ENGL J MED, V362, P1348, DOI 10.1056/NEJMc0909845; LIANG Y, 1995, BIOCHEM J, V309, P167, DOI 10.1042/bj3090167; LYNEDJIAN P, 2004, GLUCOKINASE GLYCAEMI, P156; Massa L, 2004, DIABETES, V53, P1020, DOI 10.2337/diabetes.53.4.1020; Massa O, 2001, DIABETOLOGIA, V44, P898; Matschinsky F. M., 2010, F1000 MED REP, V2, P43, DOI DOI 10.3410/M2-43; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; McKerrecher D, 2006, BIOORG MED CHEM LETT, V16, P2705, DOI 10.1016/j.bmcl.2006.02.022; McKerrecher D, 2005, BIOORG MED CHEM LETT, V15, P2103, DOI 10.1016/j.bmcl.2005.01.087; MCKERRECHER D, 2004, Patent No. 1404335; MCKERRECHER D, 2004, Patent No. 03000267; Meissner T, 2009, HORM METAB RES, V41, P320, DOI 10.1055/s-0028-1102922; Miller SP, 1999, DIABETES, V48, P1645, DOI 10.2337/diabetes.48.8.1645; Njolstad PR, 2001, NEW ENGL J MED, V344, P1588, DOI 10.1056/NEJM200105243442104; Njolstad PR, 2003, DIABETES, V52, P2854, DOI 10.2337/diabetes.52.11.2854; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Pal P, 2009, BIOCHEMISTRY-US, V48, P814, DOI 10.1021/bi802142q; Porter JR, 2005, J PEDIATR-US, V146, P131, DOI 10.1016/j.jpeds.2004.09.008; Rubio-Cabezas O, 2008, PEDIATR DIABETES, V9, P245, DOI 10.1111/j.1399-5448.2007.00361.x; Sagen JV, 2006, DIABETES, V55, P1713, DOI 10.2337/db05-1513; Sayed S, 2009, DIABETES, V58, P1419, DOI 10.2337/db08-1792; Shiota C, 1999, J BIOL CHEM, V274, P37125, DOI 10.1074/jbc.274.52.37125; Slosberg ED, 2001, DIABETES, V50, P1813, DOI 10.2337/diabetes.50.8.1813; Turkkahraman D, 2008, J PEDIATR-US, V153, P122, DOI 10.1016/j.jpeds.2007.12.037; van Schaftingen E, 2004, FRONT DIABETES, V16, P193; Wabitsch M, 2007, DIABETIC MED, V24, P1393, DOI 10.1111/j.1464-5491.2007.02285.x; Weedon MN, 2006, AM J HUM GENET, V79, P991, DOI 10.1086/509517; YIN L, 1992, DIABETES, V41, P792; ZAWALICH WS, 1977, J BIOL CHEM, V252, P8519; Zhai S, 2008, DIABETOLOGIA, V51, pS372; Zhi J, 2008, DIABETOLOGIA, V51, pS23; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	71	19	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19118	19126		10.1074/jbc.M111.223362	http://dx.doi.org/10.1074/jbc.M111.223362			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454522	Green Published, hybrid			2022-12-27	WOS:000290785700081
J	Lee, BC; Lobanov, AV; Marino, SM; Kaya, A; Seravalli, J; Hatfield, DL; Gladyshev, VN				Lee, Byung Cheon; Lobanov, Alexey V.; Marino, Stefano M.; Kaya, Alaattin; Seravalli, Javier; Hatfield, Dolph L.; Gladyshev, Vadim N.			A 4-Selenocysteine, 2-Selenocysteine Insertion Sequence (SECIS) Element Methionine Sulfoxide Reductase from Metridium senile Reveals a Non-catalytic Function of Selenocysteines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMATE DEHYDROGENASE; ESCHERICHIA-COLI; SELENOPROTEIN SYNTHESIS; GLYCINE REDUCTASE; IDENTIFICATION; SELENIUM; GENE; EXPRESSION; PROTEINS; FAMILY	Selenocysteine (Sec) residues occur in thiol oxidoreductase families, and functionally characterized selenoenzymes typically have a single Sec residue used directly for redox catalysis. However, how new Sec residues evolve and whether non-catalytic Sec residues exist in proteins is not known. Here, we computationally identified several genes with multiple Sec insertion sequence (SECIS) elements, one of which was a methionine-R-sulfoxide reductase (MsrB) homolog from Metridium senile that has four in-frame UGA codons and two nearly identical SECIS elements. One of the UGA codons corresponded to the conserved catalytic Sec or Cys in MsrBs, whereas the three other UGA codons evolved recently and had no homologs with Sec or Cys in these positions. Metabolic Se-75 labeling showed that all four in-frame UGA codons supported Sec insertion and that both SECIS elements were functional and collaborated in Sec insertion at each UGA codon. Interestingly, recombinant M. senile MsrB bound iron, and further analyses suggested the possibility of binding an iron-sulfur cluster by the protein. These data show that Sec residues may appear transiently in genes containing SECIS elements and be adapted for non-catalytic functions.	[Lee, Byung Cheon; Lobanov, Alexey V.; Marino, Stefano M.; Kaya, Alaattin; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, Boston, MA 02115 USA; [Kaya, Alaattin; Seravalli, Javier] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Kaya, Alaattin; Seravalli, Javier] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gladyshev, VN (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, New Res Bldg,Rm 435,77 Ave Louis Pasteur, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Gladyshev, Vadim N/J-6187-2013; Kaya, Alaattin/T-6427-2017; Gladyshev, Vadim N/A-9894-2013	Kaya, Alaattin/0000-0002-6132-5197; Gladyshev, Vadim/0000-0002-0372-7016; Lee, Byung Cheon/0000-0003-1467-1940	National Institutes of Health [AG021518, GM061603]; Center for Cancer Research, NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010767, ZIABC010889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants AG021518 and GM061603 (to V. N. G.) and by the Intramural Research Program at the Center for Cancer Research, NCI, National Institutes of Health (to D. L. H.).	Almendra MJ, 1999, BIOCHEMISTRY-US, V38, P16366, DOI 10.1021/bi990069n; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Berry SM, 2002, J AM CHEM SOC, V124, P2084, DOI 10.1021/ja0169163; CONE JE, 1976, P NATL ACAD SCI USA, V73, P2659, DOI 10.1073/pnas.73.8.2659; Conrad M, 2010, ANTIOXID REDOX SIGN, V12, P851, DOI 10.1089/ars.2009.2912; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Fletcher JE, 2001, RNA, V7, P1442; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Fomenko DE, 2009, J BIOL CHEM, V284, P5986, DOI 10.1074/jbc.M805770200; GARCIA GE, 1992, J BACTERIOL, V174, P7080, DOI 10.1128/jb.174.22.7080-7089.1992; GLADYSHEV VN, 1994, P NATL ACAD SCI USA, V91, P7708, DOI 10.1073/pnas.91.16.7708; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hoffmann PR, 2005, THYROID, V15, P769, DOI 10.1089/thy.2005.15.769; Hubert N, 1996, NUCLEIC ACIDS RES, V24, P464, DOI 10.1093/nar/24.3.464; Hubert N, 1996, BIOCHIMIE, V78, P590, DOI 10.1016/S0300-9084(96)80005-8; Jiang L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-289; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Kryukov GV, 1999, J BIOL CHEM, V274, P33888, DOI 10.1074/jbc.274.48.33888; Kryukov GV, 2002, METHOD ENZYMOL, V347, P84; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kumaraswamy E, 2000, J BIOL CHEM, V275, P35540, DOI 10.1074/jbc.M004014200; LEE BJ, 1989, J BIOL CHEM, V264, P9724; Lee BC, 2009, BBA-GEN SUBJECTS, V1790, P1471, DOI 10.1016/j.bbagen.2009.04.014; Lobanov AV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r198; Lobanov AV, 2006, NUCLEIC ACIDS RES, V34, P4012, DOI 10.1093/nar/gkl541; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Lobanov AV, 2006, NUCLEIC ACIDS RES, V34, P496, DOI 10.1093/nar/gkj450; ROCHER C, 1992, EUR J BIOCHEM, V205, P955, DOI 10.1111/j.1432-1033.1992.tb16862.x; Shchedrina VA, 2007, P NATL ACAD SCI USA, V104, P13919, DOI 10.1073/pnas.0703448104; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; STADTMAN TC, 1991, BIOFACTORS, V3, P21; Taskov K, 2005, NUCLEIC ACIDS RES, V33, P2227, DOI 10.1093/nar/gki507; URSINI F, 1995, METHOD ENZYMOL, V252, P38; Wessjohann LA, 2007, BIOL CHEM, V388, P997, DOI 10.1515/BC.2007.138; Zhang Y, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r37; ZINONI F, 1986, P NATL ACAD SCI USA, V83, P4650, DOI 10.1073/pnas.83.13.4650	40	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18747	18755		10.1074/jbc.M111.229807	http://dx.doi.org/10.1074/jbc.M111.229807			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21393246	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000290785700047
J	Zuckerman, DM; Hicks, SW; Charron, G; Hang, HC; Machamer, CE				Zuckerman, David M.; Hicks, Stuart W.; Charron, Guillaume; Hang, Howard C.; Machamer, Carolyn E.			Differential Regulation of Two Palmitoylation Sites in the Cytoplasmic Tail of the beta(1)-Adrenergic Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA-ADRENERGIC-RECEPTORS; 5-HYDROXYTRYPTAMINE(4A) RECEPTOR; BETA(2)-ADRENERGIC RECEPTORS; SIGNALING PATHWAYS; CRYSTAL-STRUCTURE; CARDIAC MYOCYTES; HEART-FAILURE; ENDOCYTOSIS; RHODOPSIN	S-Palmitoylation of G protein-coupled receptors (GPCRs) is a prevalent modification, contributing to the regulation of receptor function. Despite its importance, the palmitoylation status of the beta(1)-adrenergic receptor, a GPCR critical for heart function, has never been determined. We report here that the beta(1)-adrenergic receptor is palmitoylated on three cysteine residues at two sites in the C-terminal tail. One site (proximal) is adjacent to the seventh transmembrane domain and is a consensus site for GPCRs, and the other (distal) is downstream. These sites are modified in different cellular compartments, and the distal palmitoylation site contributes to efficient internalization of the receptor following agonist stimulation. Using a bioorthogonal palmitate reporter to quantify palmitoylation accurately, we found that the rates of palmitate turnover at each site are dramatically different. Although palmitoylation at the proximal site is remarkably stable, palmitoylation at the distal site is rapidly turned over. This is the first report documenting differential dynamics of palmitoylation sites in a GPCR. Our results have important implications for function and regulation of the clinically important beta(1)-adrenergic receptor.	[Zuckerman, David M.; Machamer, Carolyn E.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Hicks, Stuart W.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06519 USA; [Charron, Guillaume; Hang, Howard C.] Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, New York, NY 10065 USA	Johns Hopkins University; Yale University; Rockefeller University	Machamer, CE (corresponding author), 725 N Wolfe St,WBSB 104, Baltimore, MD 21205 USA.	machamer@jhmi.edu	Hicks, Stuart/R-9815-2019		National Institutes of Health [GM42522, 1R01GM087544, AI069704]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI069704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445, R01GM042522, R01GM087544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM42522 (to C. E. M.) and 1R01GM087544 (to H. C. H.).; Supported by National Research Service Award Postdoctoral Fellowship AI069704 from the National Institutes of Health.	Blanpain C, 2001, J BIOL CHEM, V276, P23795, DOI 10.1074/jbc.M100583200; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Charron G, 2009, CURR OPIN CHEM BIOL, V13, P382, DOI 10.1016/j.cbpa.2009.07.010; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Chini B, 2009, J MOL ENDOCRINOL, V42, P371, DOI 10.1677/JME-08-0114; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Fukushima Y, 2001, BBA-MOL CELL RES, V1539, P181, DOI 10.1016/S0167-4889(01)00104-5; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Hakalahti AE, 2010, J BIOL CHEM, V285, P28850, DOI 10.1074/jbc.M110.149989; Hall RA, 2004, SEMIN CELL DEV BIOL, V15, P281, DOI 10.1016/j.semcdb.2003.12.017; Hicks SW, 2006, TRAFFIC, V7, P1666, DOI 10.1111/j.1600-0854.2006.00504.x; Hicks SW, 2002, J BIOL CHEM, V277, P35833, DOI 10.1074/jbc.M206280200; Kaumann AJ, 2008, PHARMACOL THERAPEUT, V118, P303, DOI 10.1016/j.pharmthera.2008.03.009; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; Kvachnina E, 2009, BBA-MOL CELL RES, V1793, P1646, DOI 10.1016/j.bbamcr.2009.08.008; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lundstrom K, 2009, METHODS MOL BIOL, V552, P51, DOI 10.1007/978-1-60327-317-6_4; Maeda A, 2010, P NATL ACAD SCI USA, V107, P8428, DOI 10.1073/pnas.1000640107; Mason DA, 1999, J BIOL CHEM, V274, P12670, DOI 10.1074/jbc.274.18.12670; Morisco C, 2008, CARDIOVASC RES, V78, P36, DOI 10.1093/cvr/cvn008; Muthumala A, 2008, EUR J HEART FAIL, V10, P3, DOI 10.1016/j.ejheart.2007.11.008; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; Ohta E, 2003, J BIOL CHEM, V278, P51957, DOI 10.1074/jbc.M310014200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Patel PA, 2009, J MOL CELL CARDIOL, V46, P300, DOI 10.1016/j.yjmcc.2008.11.015; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Petaja-Repo UE, 2006, J BIOL CHEM, V281, P15780, DOI 10.1074/jbc.M602267200; Ponimaskin E, 2005, MOL PHARMACOL, V67, P1434, DOI 10.1124/mol.104.008748; Ponimaskin EG, 2002, J BIOL CHEM, V277, P2534, DOI 10.1074/jbc.M106529200; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Reid HM, 2007, CELL SIGNAL, V19, P1056, DOI 10.1016/j.cellsig.2006.12.001; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; RESH MD, 2006, SCI STKE, pRE114; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Shcherbakova OG, 2007, J CELL BIOL, V176, P521, DOI 10.1083/jcb.200604167; Shiina T, 2000, J BIOL CHEM, V275, P29082, DOI 10.1074/jbc.M909757199; Shimamura T, 2008, J BIOL CHEM, V283, P17753, DOI 10.1074/jbc.C800040200; Small KM, 2003, ANNU REV PHARMACOL, V43, P381, DOI 10.1146/annurev.pharmtox.43.100901.135823; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Uribe A, 2008, BIOL REPROD, V78, P869, DOI 10.1095/biolreprod.107.063925; Van Tassell BW, 2008, PHARMACOTHERAPY, V28, P1523, DOI 10.1592/phco.28.12.1523; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Xiao RP, 2004, TRENDS PHARMACOL SCI, V25, P358, DOI 10.1016/j.tips.2004.05.007; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-458	53	32	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19014	19023		10.1074/jbc.M110.189977	http://dx.doi.org/10.1074/jbc.M110.189977			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21464135	Green Published, hybrid			2022-12-27	WOS:000290785700072
J	Bu, LT; Beckham, GT; Shirts, MR; Nimlos, MR; Adney, WS; Himmel, ME; Crowley, MF				Bu, Lintao; Beckham, Gregg T.; Shirts, Michael R.; Nimlos, Mark R.; Adney, William S.; Himmel, Michael E.; Crowley, Michael F.			Probing Carbohydrate Product Expulsion from a Processive Cellulase with Multiple Absolute Binding Free Energy Methods	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI CELLOBIOHYDROLASE; MOLECULAR-DYNAMICS SIMULATIONS; FACTORS INFLUENCING GLYCOSYLATION; ENZYMATIC-HYDROLYSIS; PERTURBATION CALCULATIONS; FORCE-FIELDS; SIMULTANEOUS SACCHARIFICATION; THERMODYNAMIC INTEGRATION; WATER-MOLECULES; N-GLYCOSYLATION	Understanding the enzymatic mechanism that cellulases employ to degrade cellulose is critical to efforts to efficiently utilize plant biomass as a sustainable energy resource. A key component of cellulase action on cellulose is product inhibition from monosaccharide and disaccharides in the product site of cellulase tunnel. The absolute binding free energy of cellobiose and glucose to the product site of the catalytic tunnel of the Family 7 cellobiohydrolase (Cel7A) of Trichoderma reesei (Hypocrea jecorina) was calculated using two different approaches: steered molecular dynamics (SMD) simulations and alchemical free energy perturbation molecular dynamics (FEP/MD) simulations. For the SMD approach, three methods based on Jarzynski's equality were used to construct the potential of mean force from multiple pulling trajectories. The calculated binding free energies, -14.4 kcal/mol using SMD and -11.2 kcal/mol using FEP/MD, are in good qualitative agreement. Analysis of the SMD pulling trajectories suggests that several protein residues (Arg-251, Asp-259, Asp-262, Trp-376, and Tyr-381) play key roles in cellobiose and glucose binding to the catalytic tunnel. Five mutations (R251A, D259A, D262A, W376A, and Y381A) were made computationally to measure the changes in free energy during the product expulsion process. The absolute binding free energies of cellobiose to the catalytic tunnel of these five mutants are -13.1, -6.0, -11.5, -7.5, and -8.8 kcal/mol, respectively. The results demonstrated that all of the mutants tested can lower the binding free energy of cellobiose, which provides potential applications in engineering the enzyme to accelerate the product expulsion process and improve the efficiency of biomass conversion.	[Bu, Lintao; Beckham, Gregg T.; Nimlos, Mark R.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Adney, William S.; Himmel, Michael E.; Crowley, Michael F.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA; [Shirts, Michael R.] Univ Virginia, Dept Chem Engn, Charlottesville, VA 22904 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Colorado School of Mines; University of Virginia	Bu, LT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA.	Lintao.Bu@nrel.gov; Michael.Crowley@nrel.gov	crowley, michael F/A-4852-2013	crowley, michael F/0000-0001-5163-9398	Department of Energy Office of the Biomass Program; National Science Foundation through Ranger at Texas Advanced Computing Center and Athena at the National Institute for Computational Sciences [TG-MCB090159]; Office of Energy Efficiency and Renewable Energy of the United States Department of Energy [DE-AC36-08GO28308]	Department of Energy Office of the Biomass Program(United States Department of Energy (DOE)); National Science Foundation through Ranger at Texas Advanced Computing Center and Athena at the National Institute for Computational Sciences; Office of Energy Efficiency and Renewable Energy of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Department of Energy Office of the Biomass Program and in part by the National Science Foundation through TeraGrid resources provided by Ranger at Texas Advanced Computing Center and Athena at the National Institute for Computational Sciences under Grant TG-MCB090159, as well as by the National Renewable Energy Laboratory Computational Science Center, which is supported by the Office of Energy Efficiency and Renewable Energy of the United States Department of Energy under Contract DE-AC36-08GO28308.	Adney WS, 2009, CELLULOSE, V16, P699, DOI 10.1007/s10570-009-9305-1; Andric P, 2010, BIOTECHNOL ADV, V28, P308, DOI 10.1016/j.biotechadv.2010.01.003; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Barr BK, 1996, BIOCHEMISTRY-US, V35, P586, DOI 10.1021/bi9520388; Beckham G. T., 2011, CURR OPIN BIOTECH, DOI [10.1016/j.10pbio.2010.11.005, DOI 10.1016/J.10PBIO.2010.11.005]; Beckham GT, 2010, BIOPHYS J, V99, P3773, DOI 10.1016/j.bpj.2010.10.032; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.bb.18.060189.002243; Bezerra RMF, 2005, APPL BIOCHEM BIOTECH, V126, P49, DOI 10.1007/s12010-005-0005-5; Bezerra RMF, 2004, APPL BIOCHEM BIOTECH, V112, P173, DOI 10.1385/ABAB:112:3:173; Boresch S, 2003, J PHYS CHEM B, V107, P9535, DOI 10.1021/jp0217839; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bu LT, 2009, J PHYS CHEM B, V113, P10994, DOI 10.1021/jp904003z; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chundawat S., 2011, ANN REV CHE IN PRESS, DOI [10.1146/annurev-chem-bioeng-061010-114205, DOI 10.1146/ANNUREV-CHEM-BIOENG-061010-114205]; Crespo A, 2005, J AM CHEM SOC, V127, P6940, DOI 10.1021/ja0452830; Crowley MF, 2009, INT J QUANTUM CHEM, V109, P3767, DOI 10.1002/qua.22372; Cuendet MA, 2008, BIOPHYS J, V95, P3575, DOI 10.1529/biophysj.108.131383; Deng YQ, 2004, J PHYS CHEM B, V108, P16567, DOI 10.1021/jp048502c; Deng YQ, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2842080; Deng YQ, 2006, J CHEM THEORY COMPUT, V2, P1255, DOI 10.1021/ct060037v; Deng YQ, 2009, J PHYS CHEM B, V113, P2234, DOI 10.1021/jp807701h; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Efron B., 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feig M, 2003, J PHYS CHEM B, V107, P2831, DOI 10.1021/jp027293y; Florian J, 2000, J PHYS CHEM B, V104, P10092, DOI 10.1021/jp001760z; Gan Q, 2003, PROCESS BIOCHEM, V38, P1003, DOI 10.1016/S0032-9592(02)00220-0; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Godbole S, 1999, BIOTECHNOL PROGR, V15, P828, DOI 10.1021/bp9901116; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; GUSAKOV AV, 1987, BIOTECHNOL BIOENG, V29, P906, DOI 10.1002/bit.260290715; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Harrison MJ, 1998, EUR J BIOCHEM, V256, P119, DOI 10.1046/j.1432-1327.1998.2560119.x; Hermans J, 1997, J AM CHEM SOC, V119, P2707, DOI 10.1021/ja963568+; Himmel ME, 1999, CURR OPIN BIOTECH, V10, P358, DOI 10.1016/S0958-1669(99)80065-2; Himmel ME, 2008, BIOMASS RECALCITRANC; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HSU TA, 1980, BIOTECHNOL BIOENG, V22, P2305, DOI 10.1002/bit.260221108; Hui JPM, 2001, J CHROMATOGR B, V752, P349, DOI 10.1016/S0378-4347(00)00373-X; Hummer G, 2001, P NATL ACAD SCI USA, V98, P3658, DOI 10.1073/pnas.071034098; Hummer G, 2001, J CHEM PHYS, V114, P7330, DOI 10.1063/1.1363668; Isralewitz B, 2001, J MOL GRAPH MODEL, V19, P13, DOI 10.1016/S1093-3263(00)00133-9; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jayachandran G, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2221680; Jensen MO, 2002, P NATL ACAD SCI USA, V99, P6731, DOI 10.1073/pnas.102649299; Jeoh T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-10; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Klarskov K, 1997, CARBOHYD RES, V304, P143, DOI 10.1016/S0008-6215(97)00215-2; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; Levine SE, 2010, BIOTECHNOL BIOENG, V107, P37, DOI 10.1002/bit.22789; Lu ND, 2001, J CHEM PHYS, V114, P7303, DOI 10.1063/1.1359181; Lu ND, 2001, J CHEM PHYS, V115, P6866, DOI 10.1063/1.1405449; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martin HSC, 2009, J CHEM THEORY COMPUT, V5, P2135, DOI 10.1021/ct9000894; Mobley DL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2221683; NIDETZKY B, 1994, ENZYME MICROB TECH, V16, P43, DOI 10.1016/0141-0229(94)90108-2; Nimlos MR, 2007, PROTEIN ENG DES SEL, V20, P179, DOI 10.1093/protein/gzm010; Oh KK, 2000, APPL BIOCHEM BIOTECH, V89, P15, DOI 10.1385/ABAB:89:1:15; Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311; PHILIPPIDIS GP, 1993, BIOTECHNOL BIOENG, V41, P846, DOI 10.1002/bit.260410903; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Roux B, 1996, BIOPHYS J, V71, P670, DOI 10.1016/S0006-3495(96)79267-6; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shirts MR, 2007, ANN REP COMP CHEM, V3, P41, DOI 10.1016/S1574-1400(07)03004-6; Shirts MR, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1873592; Simonson T, 2002, ACCOUNTS CHEM RES, V35, P430, DOI 10.1021/ar010030m; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; Stals I, 2004, GLYCOBIOLOGY, V14, P713, DOI 10.1093/glycob/cwh080; Stals I, 2004, GLYCOBIOLOGY, V14, P725, DOI 10.1093/glycob/cwh081; STRAATSMA TP, 1992, ANNU REV PHYS CHEM, V43, P407; TEERI TT, 1987, GENE, V51, P43, DOI 10.1016/0378-1119(87)90472-0; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; VRSANSKA M, 1992, CARBOHYD RES, V227, P19, DOI 10.1016/0008-6215(92)85058-8; WALD S, 1984, BIOTECHNOL BIOENG, V26, P221, DOI 10.1002/bit.260260305; Wang JY, 2006, BIOPHYS J, V91, P2798, DOI 10.1529/biophysj.106.084301; WEEKS JD, 1971, J CHEM PHYS, V54, P5237, DOI 10.1063/1.1674820; Woo HJ, 2005, P NATL ACAD SCI USA, V102, P6825, DOI 10.1073/pnas.0409005102; Ytreberg FM, 2004, J COMPUT CHEM, V25, P1749, DOI 10.1002/jcc.20103; Zhang DQ, 2006, J AM CHEM SOC, V128, P3019, DOI 10.1021/ja057292u; Zhong L, 2008, CELLULOSE, V15, P261, DOI 10.1007/s10570-007-9186-0; Zhong LH, 2009, CARBOHYD RES, V344, P1984, DOI 10.1016/j.carres.2009.07.005	89	61	62	0	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18161	18169		10.1074/jbc.M110.212076	http://dx.doi.org/10.1074/jbc.M110.212076			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454590	hybrid, Green Published			2022-12-27	WOS:000290585200076
J	Mathias, A; Corthesy, B				Mathias, Amandine; Corthesy, Blaise			Recognition of Gram-positive Intestinal Bacteria by Hybridoma- and Colostrum-derived Secretory Immunoglobulin A Is Mediated by Carbohydrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BIOFILM FORMATION; DENDRITIC CELLS; IGA; MUCOSAL; COMPONENT; GUT; ANTIGEN; PROTECTION; INNATE	Humans live in symbiosis with 10(14) commensal bacteria among which > 99% resides in their gastrointestinal tract. The molecular bases pertaining to the interaction between mucosal secretory IgA (SIgA) and bacteria residing in the intestine are not known. Previous studies have demonstrated that commensals are naturally coated by SIgA in the gut lumen. Thus, understanding how natural SIgA interacts with commensal bacteria can provide new clues on its multiple functions at mucosal surfaces. Using fluorescently labeled, nonspecific SIgA or secretory component (SC), we visualized by confocal microscopy the interaction with various commensal bacteria, including Lactobacillus, Bifidobacteria, Escherichia coli, and Bacteroides strains. These experiments revealed that the interaction between SIgA and commensal bacteria involves Fab- and Fc-independent structural motifs, featuring SC as a crucial partner. Removal of glycans present on free SC or bound in SIgA resulted in a drastic drop in the interaction with Gram-positive bacteria, indicating the essential role of carbohydrates in the process. In contrast, poor binding of Gram-positive bacteria by control IgG was observed. The interaction with Gram-negative bacteria was preserved whatever the molecular form of protein partner used, suggesting the involvement of different binding motifs. Purified SIgA and SC from either mouse hybridoma cells or human colostrum exhibited identical patterns of recognition for Gram-positive bacteria, emphasizing conserved plasticity between species. Thus, sugar-mediated binding of commensals by SIgA highlights the currently underappreciated role of glycans in mediating the interaction between a highly diverse microbiota and the mucosal immune system.	[Corthesy, Blaise] CHU Vaudois, Univ State Hosp, Dept Immunol & Allergy, R&D Lab,Div Immunol & Allergy, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Corthesy, B (corresponding author), CHU Vaudois, Univ State Hosp, Dept Immunol & Allergy, R&D Lab,Div Immunol & Allergy, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	blaise.corthesy@chuv.ch			Swiss Science Research Foundation [3200-122039]	Swiss Science Research Foundation(Swiss National Science Foundation (SNSF))	This work was supported by Swiss Science Research Foundation Grant 3200-122039.	Bollinger RR, 2003, IMMUNOLOGY, V109, P580; Bonner A, 2009, MUCOSAL IMMUNOL, V2, P74, DOI 10.1038/mi.2008.68; Bos NA, 2001, GUT, V48, P762, DOI 10.1136/gut.48.6.762; Busch N, 1998, GASTROENTEROLOGY, V115, P129, DOI 10.1016/S0016-5085(98)70374-9; Carbonare CB, 2005, PEDIAT ALLERG IMM-UK, V16, P574, DOI 10.1111/j.1399-3038.2005.00332.x; Chapot-Chartier MP, 2010, J BIOL CHEM, V285, P10464, DOI 10.1074/jbc.M109.082958; Corthesy B, 2010, FUTURE MICROBIOL, V5, P817, DOI 10.2217/FMB.10.39; Crottet P, 1998, J IMMUNOL, V161, P5445; Crottet P, 1999, J BIOL CHEM, V274, P31445, DOI 10.1074/jbc.274.44.31445; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Favre LI, 2003, J CHROMATOGR B, V786, P143, DOI 10.1016/S1570-0232(02)00723-7; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frankel G, 2001, TRENDS MICROBIOL, V9, P214, DOI 10.1016/S0966-842X(01)02016-9; Gonzalez-Chavez SA, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.07.020; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; Hendrickson BA, 1996, J IMMUNOL, V157, P750; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hughes GJ, 1999, BBA-PROTEIN STRUCT M, V1434, P86, DOI 10.1016/S0167-4838(99)00168-5; Kadaoui KA, 2007, J IMMUNOL, V179, P7751, DOI 10.4049/jimmunol.179.11.7751; Le Blay G, 2007, LETT APPL MICROBIOL, V45, P252, DOI 10.1111/j.1472-765X.2007.02178.x; Lullau E, 1996, J BIOL CHEM, V271, P16300, DOI 10.1074/jbc.271.27.16300; MacKenzie DA, 2009, J BIOL CHEM, V284, P32444, DOI 10.1074/jbc.M109.040907; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mathias A, 2010, J BIOL CHEM, V285, P33906, DOI 10.1074/jbc.M110.135111; Mestecky J, 1999, GUT, V44, P2, DOI 10.1136/gut.44.1.2; Mestecky J, 2009, IMMUNOL LETT, V124, P57, DOI 10.1016/j.imlet.2009.03.013; MICHETTI P, 1992, INFECT IMMUN, V60, P1786, DOI 10.1128/IAI.60.5.1786-1792.1992; MOREAU MC, 1978, INFECT IMMUN, V21, P532, DOI 10.1128/IAI.21.2.532-539.1978; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; Orndorff PE, 2004, INFECT IMMUN, V72, P1929, DOI 10.1128/IAI.72.4.1929-1938.2004; PARR EL, 1995, J IMMUNOL METHODS, V180, P147, DOI 10.1016/0022-1759(94)00310-S; Perrier C, 2006, J BIOL CHEM, V281, P14280, DOI 10.1074/jbc.M512958200; Phalipon A, 2006, J IMMUNOL, V176, P1686, DOI 10.4049/jimmunol.176.3.1686; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; PHALIPON A, 1995, J EXP MED, V182, P769, DOI 10.1084/jem.182.3.769; POGER ME, 1974, J EXP MED, V139, P629, DOI 10.1084/jem.139.3.629; Quan CP, 1997, INFECT IMMUN, V65, P3997, DOI 10.1128/IAI.65.10.3997-4004.1997; Riedel CU, 2006, INT J FOOD MICROBIOL, V110, P62, DOI 10.1016/j.ijfoodmicro.2006.01.040; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; Royle L, 2003, J BIOL CHEM, V278, P20140, DOI 10.1074/jbc.M301436200; Schenk M, 2007, SEMIN IMMUNOL, V19, P84, DOI 10.1016/j.smim.2006.09.002; Schroten H, 1998, INFECT IMMUN, V66, P3971, DOI 10.1128/IAI.66.8.3971-3973.1998; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P1842, DOI 10.1111/j.1365-2222.2009.03326.x; Stoel M, 2005, J IMMUNOL, V174, P1046, DOI 10.4049/jimmunol.174.2.1046; Talham GL, 1999, INFECT IMMUN, V67, P1992; Thierry AC, 2009, CLIN EXP ALLERGY, V39, P527, DOI 10.1111/j.1365-2222.2008.03185.x; Tsuruta T, 2009, FEMS IMMUNOL MED MIC, V56, P185, DOI 10.1111/j.1574-695X.2009.00568.x; van der Waaij LA, 2004, EUR J GASTROEN HEPAT, V16, P669, DOI 10.1097/01.meg.0000108346.41221.19; VANDERMEER JWM, 1984, SEMIN HEMATOL, V21, P123; vanderWaaij LA, 1996, GUT, V38, P348, DOI 10.1136/gut.38.3.348; WELTZIN R, 1994, ANTIMICROB AGENTS CH, V38, P2785, DOI 10.1128/AAC.38.12.2785; WOLD AE, 1990, INFECT IMMUN, V58, P3073, DOI 10.1128/IAI.58.9.3073-3077.1990	54	79	80	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17239	17247		10.1074/jbc.M110.209015	http://dx.doi.org/10.1074/jbc.M110.209015			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454510	hybrid, Green Published			2022-12-27	WOS:000290301900072
J	Baljuls, A; Mahr, R; Schwarzenau, I; Muller, T; Polzien, L; Hekman, M; Rapp, UR				Baljuls, Angela; Mahr, Regina; Schwarzenau, Inge; Mueller, Thomas; Polzien, Lisa; Hekman, Mirko; Rapp, Ulf R.			Single Substitution within the RKTR Motif Impairs Kinase Activity but Promotes Dimerization of RAF Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-RAF; PROTEIN-KINASE; A-RAF; C-RAF; BIOLOGICAL-ACTIVITY; PHOSPHATIDIC-ACID; WILD-TYPE; FEEDBACK PHOSPHORYLATION; ONCOGENIC RAS; LIPID RAFTS	The serine/threonine kinase RAF is a central component of the MAPK cascade. Regulation of RAF activity is highly complex and involves recruitment to membranes and association with Ras and scaffold proteins as well as multiple phosphorylation and dephosphorylation events. Previously, we identified by molecular modeling an interaction between the N-region and the RKTR motif of the kinase domain in RAF and assigned a new function to this tetrapeptide segment. Here we found that a single substitution of each basic residue within the RKTR motif inhibited catalytic activity of all three RAF isoforms. However, the inhibition and phosphorylation pattern of C-RAF and A-RAF differed from B-RAF. Furthermore, substitution of the first arginine led to hyperphosphorylation and accumulation of A-RAF and C-RAF in plasma membrane fraction, indicating that this residue interferes with the recycling process of A-RAF and C-RAF but not B-RAF. In contrast, all RAF isoforms behave similarly with respect to the RKTR motif-dependent dimerization. The exchange of the second arginine led to exceedingly increased dimerization as long as one of the protomers was not mutated, suggesting that substitution of this residue with alanine may result in similar a structural rearrangement of the RAF kinase domain, as has been found for the C-RAF kinase domain co-crystallized with a dimerization-stabilizing RAF inhibitor. In summary, we provide evidence that each of the basic residues within the RKTR motif is indispensable for correct RAF function.	[Baljuls, Angela; Mahr, Regina; Schwarzenau, Inge; Polzien, Lisa; Hekman, Mirko; Rapp, Ulf R.] Univ Wurzburg, Dept Microbiol, Theodor Boveri Inst Biosci, D-97074 Wurzburg, Germany; [Mueller, Thomas] Univ Wurzburg, Dept Mol Plant Physiol & Biophys, Julius von Sachs Inst Biosci, D-97082 Wurzburg, Germany; [Rapp, Ulf R.] Max Planck Inst Biochem, Dept Mol Biol, D-82159 Martinsried, Germany	University of Wurzburg; University of Wurzburg; Max Planck Society	Rapp, UR (corresponding author), Univ Wurzburg, Dept Microbiol, Theodor Boveri Inst Biosci, D-97074 Wurzburg, Germany.	angela.baljuls@mail.uni-wuerzburg.de		Mueller, Thomas/0000-0003-1862-7357	Deutsche Forschungsgemeinschaft [SFB 487, C3, B2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 487, Projects C3 and B2.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Andresen BT, 2002, FEBS LETT, V531, P65, DOI 10.1016/S0014-5793(02)03483-X; Baljuls A, 2008, J BIOL CHEM, V283, P27239, DOI 10.1074/jbc.M801782200; Baljuls A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702429200; BONNER TI, 1985, MOL CELL BIOL, V5, P1400, DOI 10.1128/MCB.5.6.1400; Chen CM, 2004, BLOOD, V104, P73, DOI 10.1182/blood-2003-04-1340; Cox AD, 2010, CANCER CELL, V17, P221, DOI 10.1016/j.ccr.2010.02.029; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2002, ARCH BIOCHEM BIOPHYS, V404, P3, DOI 10.1016/S0003-9861(02)00244-8; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Fischer A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M607458200; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Ghosh S, 2003, J BIOL CHEM, V278, P45690, DOI 10.1074/jbc.M302933200; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Hagemann C, 1999, EXP CELL RES, V253, P34, DOI 10.1006/excr.1999.4689; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Hekman M, 2005, FEBS LETT, V579, P464, DOI 10.1016/j.febslet.2004.11.105; Hekman M, 2004, J BIOL CHEM, V279, P14074, DOI 10.1074/jbc.M309620200; HULEIHEL M, 1986, MOL CELL BIOL, V6, P2655, DOI 10.1128/MCB.6.7.2655; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; IKAWA S, 1988, MOL CELL BIOL, V8, P2651, DOI 10.1128/MCB.8.6.2651; Johnson LM, 2005, BIOCHEMISTRY-US, V44, P3432, DOI 10.1021/bi0487692; Lu KK, 1998, CELL GROWTH DIFFER, V9, P367; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Nekhoroshkova E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004647; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Rapp UR, 2006, CANCER CELL, V9, P9, DOI 10.1016/j.ccr.2005.12.022; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Ritt DA, 2007, CURR BIOL, V17, P179, DOI 10.1016/j.cub.2006.11.061; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Roskoski R, 2010, BIOCHEM BIOPH RES CO, V399, P313, DOI 10.1016/j.bbrc.2010.07.092; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Schreck R, 2006, INT J CANCER, V119, P2261, DOI 10.1002/ijc.22144; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wartmann M, 1997, J BIOL CHEM, V272, P3915, DOI 10.1074/jbc.272.7.3915; WARTMANN M, 1994, J BIOL CHEM, V269, P6695; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	57	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.194167	http://dx.doi.org/10.1074/jbc.M110.194167			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454547	hybrid, Green Published			2022-12-27	WOS:000290022800086
J	Bozna, BL; Polzella, P; Rankl, C; Zhu, R; Salio, M; Shepherd, D; Duman, M; Cerundolo, V; Hinterdorfer, P				Bozna, Bianca L.; Polzella, Paolo; Rankl, Christian; Zhu, Rong; Salio, Mariolina; Shepherd, Dawn; Duman, Memed; Cerundolo, Vincenzo; Hinterdorfer, Peter			Binding Strength and Dynamics of Invariant Natural Killer Cell T Cell Receptor/CD1d-Glycosphingolipid Interaction on Living Cells by Single Molecule Force Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE; NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; RECOGNITION EVENTS; DENDRITIC CELLS; ADHESION FORCES; CROSS-LINKING; HUMAN CD1D; IN-VIVO; MICROSCOPY	Invariant natural killer T (iNKT) cells are a population of T lymphocytes that play an important role in regulating immunity to infection and tumors by recognizing endogenous and exogenous CD1d-bound lipid molecules. Using soluble iNKT T cell receptor (TCR) molecules, we applied single molecule force spectroscopy for the investigation of the iNKT TCR affinity for human CD1d molecules loaded with glycolipids differing in the length of the phytosphingosine chain using either recombinant CD1d molecules or lipid-pulsed THP1 cells. In both settings, the dissociation of the iNKT TCR from human CD1d molecules loaded with the lipid containing the longer phytosphingosine chain required higher unbinding forces compared with the shorter phytosphingosine lipid. Our findings are discussed in the context of previous results obtained by surface plasmon resonance measurements. We present new insights into the energy landscape and the kinetic rate constants of the iNKT TCR/human CD1d-glycosphingolipid interaction and emphasize the unique potential of single molecule force spectroscopy on living cells.	[Bozna, Bianca L.; Zhu, Rong; Duman, Memed; Hinterdorfer, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Rankl, Christian] Agilent Technol Austria GmbH, A-4040 Linz, Austria; [Hinterdorfer, Peter] Univ Linz, Christian Doppler Lab Nanoscop Methods Biophys, A-4040 Linz, Austria; [Polzella, Paolo; Salio, Mariolina; Shepherd, Dawn; Cerundolo, Vincenzo] Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med,Nuffield Dept Med, Oxford OX3 7BN, England	Johannes Kepler University Linz; Agilent Technologies; Johannes Kepler University Linz; University of Oxford	Hinterdorfer, P (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Altenberger Str 69, A-4040 Linz, Austria.	peter.hinterdorfer@jku.at	Duman, Memed/B-9957-2014; Hinterdorfer, Peter/C-4235-2013	Shepherd, Dawn/0000-0003-1304-6051; Rankl, Christian/0000-0002-7354-7651; Cerundolo, Vincenzo/0000-0003-0040-3793; Salio, Mariolina/0000-0002-4821-3801; Hinterdorfer, Peter/0000-0003-2583-1305	European Commission [RTN-CT-2006-035946 IMMUNANOMAP]; Cancer Research UK [C399/A2291]; Cancer Research UK [11331] Funding Source: researchfish; Medical Research Council [G1000800] Funding Source: researchfish; MRC [G1000800] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by European Commission Grant Marie Curie RTN-CT-2006-035946 IMMUNANOMAP and Cancer Research UK Grant C399/A2291.	Baumgartner W, 2000, ULTRAMICROSCOPY, V82, P85, DOI 10.1016/S0304-3991(99)00154-0; Baumgartner W., 2000, Single Molecules, V1, P119, DOI 10.1002/1438-5171(200006)1:2<119::AID-SIMO119>3.0.CO;2-K; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chen A, 2000, BIOPHYS J, V78, P2814, DOI 10.1016/S0006-3495(00)76824-X; Dupres V, 2005, NAT METHODS, V2, P515, DOI 10.1038/NMETH769; Ebner A, 2007, BIOCONJUGATE CHEM, V18, P1176, DOI 10.1021/bc070030s; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 1999, BIOPHYS J, V76, P2439, DOI 10.1016/S0006-3495(99)77399-6; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; HASELGRUBLER T, 1995, BIOCONJUGATE CHEM, V6, P242, DOI 10.1021/bc00033a002; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Hosseini BH, 2009, P NATL ACAD SCI USA, V106, P17852, DOI 10.1073/pnas.0905384106; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003; Lehenkari PP, 1999, BIOCHEM BIOPH RES CO, V259, P645, DOI 10.1006/bbrc.1999.0827; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309; Peter Atkins P., 2014, ATKINSPHYSICAL CHEM; Pfister G, 2005, J CELL SCI, V118, P1587, DOI 10.1242/jcs.02292; Rankl C, 2008, P NATL ACAD SCI USA, V105, P17778, DOI 10.1073/pnas.0806451105; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; te Riet J, 2007, J CELL SCI, V120, P3965, DOI 10.1242/jcs.004010; Wojcikiewicz EP, 2006, BIOMACROMOLECULES, V7, P3188, DOI 10.1021/bm060559c; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8	34	19	19	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.192674	http://dx.doi.org/10.1074/jbc.M110.192674			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454514	Green Published, hybrid			2022-12-27	WOS:000290022800037
J	Fukunaka, A; Kurokawa, Y; Teranishi, F; Sekler, I; Oda, K; Ackland, ML; Faundez, V; Hiromura, M; Masuda, S; Nagao, M; Enomoto, S; Kambe, T				Fukunaka, Ayako; Kurokawa, Yayoi; Teranishi, Fumie; Sekler, Israel; Oda, Kimimitsu; Ackland, M. Leigh; Faundez, Victor; Hiromura, Makoto; Masuda, Seiji; Nagao, Masaya; Enomoto, Shuichi; Kambe, Taiho			Tissue Nonspecific Alkaline Phosphatase Is Activated via a Two-step Mechanism by Zinc Transport Complexes in the Early Secretory Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE CELLS; ENDOPLASMIC-RETICULUM; FUNCTIONAL-CHARACTERIZATION; QUALITY-CONTROL; PROTEIN; HYPOPHOSPHATASIA; DEGRADATION; HOMEOSTASIS; EXPRESSION; MEMBRANE	A number of enzymes become functional by binding to zinc during their journey through the early secretory pathway. The zinc transporters (ZnTs) located there play important roles in this step. We have previously shown that two zinc transport complexes, ZnT5/ZnT6 heterodimers and ZnT7 homo-oligomers, are required for the activation of alkaline phosphatases, by converting them from the apo- to the holo-form. Here, we investigated the molecular mechanisms of this activation. ZnT1 and ZnT4 expressed in chicken DT40 cells did not contribute to the activation of tissue nonspecific alkaline phosphatase ( TNAP). The reduced activity of TNAP in DT40 cells deficient in both ZnT complexes was not restored by zinc supplementation nor by exogenous expression of other ZnTs that increase the zinc content in the secretory pathway. Moreover, we showed that expression of ZnT5/ZnT6 heterodimers reconstituted with zinc transport-incompetent ZnT5 mutant failed to restore TNAP activity but could stabilize the TNAP protein as the apo- form, regardless of zinc status. These findings demonstrate that TNAP is activated not simply by passive zinc binding but by an elaborate two-step mechanism via protein stabilization followed by enzyme conversion from the apo- to the holo-form with zinc loaded by ZnT complexes in the early secretory pathway.	[Fukunaka, Ayako; Hiromura, Makoto; Enomoto, Shuichi] RIKEN Kobe Inst, Ctr Mol Imaging Sci, Kobe, Hyogo 6500047, Japan; [Sekler, Israel] Ben Gurion Univ Negev, Dept Physiol, IL-84105 Beer Sheva, Israel; [Oda, Kimimitsu] Niigata Univ, Grad Sch Med & Dent Sci, Div Biochem, Niigata 9518514, Japan; [Ackland, M. Leigh] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic 3125, Australia; [Faundez, Victor] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; [Fukunaka, Ayako; Kurokawa, Yayoi; Teranishi, Fumie; Masuda, Seiji; Nagao, Masaya; Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan; [Enomoto, Shuichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	RIKEN; Ben Gurion University; Niigata University; Deakin University; Emory University; Kyoto University; Okayama University	Kambe, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan.	kambe1@kais.kyoto-u.ac.jp	Ackland, M Leigh/L-5086-2018; Enomoto, Shuichi/G-8524-2012; ENOMOTO, Shuichi/B-2333-2011	Ackland, M Leigh/0000-0002-7474-6556; Kambe, Taiho/0000-0001-9757-063X; Faundez, Victor/0000-0002-2114-5271	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Nestle Nutrition Council, Japan; Danone Institute of Japan; Central Miso Research Institute; Kieikai Research Foundation; Yamada Bee Farm grant for Honeybee Research; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Fuji Foundation for Protein Research; Grants-in-Aid for Scientific Research [23380059] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Nestle Nutrition Council, Japan; Danone Institute of Japan(Danone Nutricia); Central Miso Research Institute; Kieikai Research Foundation(Kieikai Research Foundation); Yamada Bee Farm grant for Honeybee Research; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Fuji Foundation for Protein Research(Fuji Foundation for Protein Research); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to A. F. and T. K.), grants-in-aid for scientific research from the Ministry of Health, Labor, and Welfare of Japan (to S. E.), Nestle Nutrition Council, Japan, 2010 research grant from Danone Institute of Japan, Central Miso Research Institute, Kieikai Research Foundation, Yamada Bee Farm grant for Honeybee Research, Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the Fuji Foundation for Protein Research (to T. K.).	Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ellis CD, 2005, J BIOL CHEM, V280, P28811, DOI 10.1074/jbc.M505500200; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; Fang Y, 2008, MOL BIOL CELL, V19, P1295, DOI 10.1091/mbc.E07-08-0805; Fujimori A, 2001, EMBO J, V20, P5513, DOI 10.1093/emboj/20.19.5513; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Fukushi M, 1998, BIOCHEM BIOPH RES CO, V246, P613, DOI 10.1006/bbrc.1998.8674; Fukushi-Irie M, 2000, BIOCHEM J, V348, P633, DOI 10.1042/0264-6021:3480633; Haremaki T, 2007, P NATL ACAD SCI USA, V104, P12029, DOI 10.1073/pnas.0701413104; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Inoue K, 2002, HUM MOL GENET, V11, P1775, DOI 10.1093/hmg/11.15.1775; Ishida Y, 2003, J BIOCHEM, V134, P63, DOI 10.1093/jb/mvg114; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Jirakulaporn T, 2004, J BIOL CHEM, V279, P27807, DOI 10.1074/jbc.M401210200; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Lazarczyk M, 2008, J EXP MED, V205, P35, DOI 10.1084/jem.20071311; Levy S, 2009, J BIOL CHEM, V284, P32434, DOI 10.1074/jbc.M109.058842; Matsuura W, 2009, BIOSCI BIOTECH BIOCH, V73, P1142, DOI 10.1271/bbb.80910; Michalczyk AA, 2002, BIOCHEM J, V364, P105, DOI 10.1042/bj3640105; MILLAN JL, 1995, CRIT REV CL LAB SCI, V32, P1, DOI 10.3109/10408369509084680; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; Purkerson JM, 2007, KIDNEY INT, V71, P103, DOI 10.1038/sj.ki.5002020; Qiao W, 2009, MOL MICROBIOL, V72, P320, DOI 10.1111/j.1365-2958.2009.06644.x; Qin ZY, 2006, FASEB J, V20, P334, DOI 10.1096/fj.05-4564fje; Ranaldi G, 2002, AM J PHYSIOL-RENAL, V283, pF1365, DOI 10.1152/ajprenal.00094.2002; Salazar G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005896; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Szigeti R, 2006, J INVEST DERMATOL, V126, P2370, DOI 10.1038/sj.jid.5700447; Taylor KM, 2008, ENDOCRINOLOGY, V149, P4912, DOI 10.1210/en.2008-0351; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Turner AJ, 1997, FASEB J, V11, P355, DOI 10.1096/fasebj.11.5.9141502; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Whyte MP, 2010, ANN NY ACAD SCI, V1192, P190, DOI 10.1111/j.1749-6632.2010.05387.x	46	51	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.227173	http://dx.doi.org/10.1074/jbc.M111.227173			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21402707	hybrid, Green Published			2022-12-27	WOS:000290022800074
J	Hakvoort, TBM; Moerland, PD; Frijters, R; Sokolovic, A; Labruyere, WT; Vermeulen, JLM; van Themaat, EVL; Breit, TM; Wittink, FRA; van Kampen, AHC; Verhoeven, AJ; Lamers, WH; Sokolovic, M				Hakvoort, Theodorus B. M.; Moerland, Perry D.; Frijters, Raoul; Sokolovic, Aleksandar; Labruyere, Wilhelmina T.; Vermeulen, Jacqueline L. M.; van Themaat, Emiel Ver Loren; Breit, Timo M.; Wittink, Floyd R. A.; van Kampen, Antoine H. C.; Verhoeven, Arthur J.; Lamers, Wouter H.; Sokolovic, Milka			Interorgan Coordination of the Murine Adaptive Response to Fasting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; SKELETAL-MUSCLE ATROPHY; AMINO ACID METABOLISM; GENE-EXPRESSION; ADIPONECTIN RECEPTORS; PROLONGED STARVATION; KETONE-BODIES; PROTEIN; CHOLESTEROL; HOMEOSTASIS	Starvation elicits a complex adaptive response in an organism. No information on transcriptional regulation of metabolic adaptations is available. We, therefore, studied the gene expression profiles of brain, small intestine, kidney, liver, and skeletal muscle in mice that were subjected to 0-72 h of fasting. Functional-category enrichment, text mining, and network analyses were employed to scrutinize the overall adaptation, aiming to identify responsive pathways, processes, and networks, and their regulation. The observed transcriptomics response did not follow the accepted "carbohydrate-lipid-protein" succession of expenditure of energy substrates. Instead, these processes were activated simultaneously in different organs during the entire period. The most prominent changes occurred in lipid and steroid metabolism, especially in the liver and kidney. They were accompanied by suppression of the immune response and cell turnover, particularly in the small intestine, and by increased proteolysis in the muscle. The brain was extremely well protected from the sequels of starvation. 60% of the identified overconnected transcription factors were organ-specific, 6% were common for 4 organs, with nuclear receptors as protagonists, accounting for almost 40% of all transcriptional regulators during fasting. The common transcription factors were PPAR alpha, HNF4 alpha, GCR alpha, AR (androgen receptor), SREBP1 and -2, FOXOs, EGR1, c-JUN, c-MYC, SP1, YY1, and ETS1. Our data strongly suggest that the control of metabolism in four metabolically active organs is exerted by transcription factors that are activated by nutrient signals and serves, at least partly, to prevent irreversible brain damage.	[Hakvoort, Theodorus B. M.; Sokolovic, Aleksandar; Labruyere, Wilhelmina T.; Vermeulen, Jacqueline L. M.; Lamers, Wouter H.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 BK Amsterdam, Netherlands; [Moerland, Perry D.; van Themaat, Emiel Ver Loren; van Kampen, Antoine H. C.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, NL-1105 AZ Amsterdam, Netherlands; [Moerland, Perry D.; Breit, Timo M.; van Kampen, Antoine H. C.] Netherlands Bioinformat Ctr, NL-1105 AZ Amsterdam, Netherlands; [Frijters, Raoul] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, Computat Drug Discovery Grp, NL-6525 GA Nijmegen, Netherlands; [Breit, Timo M.; Wittink, Floyd R. A.] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, MicroArray Dept, NL-1090 GE Amsterdam, Netherlands; [Breit, Timo M.; Wittink, Floyd R. A.] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, Integrat Bioinformat Unit, NL-1090 GE Amsterdam, Netherlands; [van Kampen, Antoine H. C.] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1105 AZ Amsterdam, Netherlands; [Verhoeven, Arthur J.; Sokolovic, Milka] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; University of Amsterdam; University of Amsterdam; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Sokolovic, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, POB 22700, NL-1100 DE Amsterdam, Netherlands.	m.sokolovic@amc.uva.nl	Lamers, Wouter H./D-2965-2012; Moerland, Perry/AAG-1425-2020; Sokolovic, Milka/C-2115-2009; Ver Loren van Themaat, Emiel/F-2564-2012; Sokolovic, Milka/AAY-1618-2020	Moerland, Perry/0000-0002-2357-3659; Sokolovic, Milka/0000-0002-3957-4656	Dutch Ministry of Economic Affairs [IGE01016]; Top Institute Pharma [T2-110]; Netherlands Genomics Initiative; John Emmett Foundation for Urology	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Top Institute Pharma; Netherlands Genomics Initiative; John Emmett Foundation for Urology	This study was supported by Dutch Ministry of Economic Affairs through the Innovative Oriented Research Program on Genomics (IOP Genomics IGE01016) and by a grant T2-110 from Top Institute Pharma.; Bioinformatics was part of the BioRange program of the Netherlands Bioinformatics Center, supported by an Investment Grants for Knowledge Infrastructure grant through the Netherlands Genomics Initiative. The microarrays were provided and hybridizations were performed by MicroArray Department, Swammerdam Institute for Life Sciences, Faculty of Science, University of Amsterdam. We are indebted to Dr. N. Dabhoiwala (Department of Urology, Academic Medical Center, University of Amsterdam) and the John Emmett Foundation for Urology for financing a part of the microarray analysis. We thank D. Wehkamp and Dr. L. Gilhuijs-Pederson for input into the initial design of the experiment, Dr. M. Swat for useful suggestions for data visualization, Dr. Y. Nikolsky for support with MetaCore analyses, Dr. S. M. Houten for beta-hydroxybutyrate measurement, and Prof. Dr. A. K. Groen and Dr. C. A. Argmann for constructive discussions.	Alako BTF, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-51; Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auer RN, 2004, METAB BRAIN DIS, V19, P169, DOI 10.1023/B:MEBR.0000043967.78763.5b; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Caloin M, 2004, AM J PHYSIOL-ENDOC M, V287, pE790, DOI 10.1152/ajpendo.00414.2003; Cao PR, 2005, INT J BIOCHEM CELL B, V37, P2088, DOI 10.1016/j.biocel.2004.11.010; Carter ME, 2007, CURR BIOL, V17, pR113, DOI 10.1016/j.cub.2007.01.008; CHEREL Y, 1991, CLIN SCI, V81, P611, DOI 10.1042/cs0810611; D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Dobbin K, 2002, BIOINFORMATICS, V18, P1438, DOI 10.1093/bioinformatics/18.11.1438; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ekins S, 2005, DRUG METAB DISPOS, V33, P474, DOI 10.1124/dmd.104.002717; FELIG P, 1969, J CLIN INVEST, V48, P584, DOI 10.1172/JCI106017; FELIG P, 1970, AM J CLIN NUTR, V23, P986; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Freeman MR, 2007, STEROIDS, V72, P210, DOI 10.1016/j.steroids.2006.11.012; Frijters R, 2008, NUCLEIC ACIDS RES, V36, pW406, DOI 10.1093/nar/gkn215; Frijters R, 2007, PHARMACOGENOMICS, V8, P1521, DOI 10.2217/14622416.8.11.1521; GARBER AJ, 1974, J CLIN INVEST, V54, P981, DOI 10.1172/JCI107839; Gatti D, 2007, HEPATOLOGY, V46, P548, DOI 10.1002/hep.21682; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guillod-Maximin E, 2009, J ENDOCRINOL, V200, P93, DOI 10.1677/JOE-08-0348; Habold C, 2006, PFLUG ARCH EUR J PHY, V451, P749, DOI 10.1007/s00424-005-1506-3; Habold C, 2005, J PHYSIOL-LONDON, V566, P575, DOI 10.1113/jphysiol.2005.085217; Hagen RM, 2010, FEBS LETT, V584, P2689, DOI 10.1016/j.febslet.2010.04.004; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; HANNAFORD MC, 1982, AM J PHYSIOL, V243, pE251, DOI 10.1152/ajpendo.1982.243.3.E251; He YJ, 2010, J BIOL CHEM, V285, P9516, DOI 10.1074/jbc.M109.092429; Hegardt FG, 1998, BIOCHIMIE, V80, P803, DOI 10.1016/S0300-9084(00)88874-4; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; HENRIKSSON J, 1990, EUR J CLIN NUTR, V44, P55; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Jonker MJ, 2009, CARCINOGENESIS, V30, P1805, DOI 10.1093/carcin/bgp190; JUREVICS H, 1995, J NEUROCHEM, V64, P895; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Korade Z, 2009, J NEUROSCI RES, V87, P866, DOI 10.1002/jnr.21917; Koutnikova H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000591; Lamont KR, 2010, ADV CANCER RES, V107, P137, DOI 10.1016/S0065-230X(10)07005-3; Langeveld M, 2009, PROG LIPID RES, V48, P196, DOI 10.1016/j.plipres.2009.03.002; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; LEMAHO Y, 1981, AM J PHYSIOL, V241, pE342, DOI 10.1152/ajpendo.1981.241.5.E342; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mithieux G, 2005, CURR OPIN CLIN NUTR, V8, P445, DOI 10.1097/01.mco.0000172587.17385.aa; Mounier C, 2006, CAN J PHYSIOL PHARM, V84, P713, DOI 10.1139/Y05-152; Nikolsky Y, 2005, DRUG DISCOV TODAY, V10, P653, DOI 10.1016/S1359-6446(05)03420-3; Nikolsky Y, 2009, METHODS MOL BIOL, V563, P177, DOI 10.1007/978-1-60761-175-2_10; Ning YX, 2009, ATHEROSCLEROSIS, V204, P114, DOI 10.1016/j.atherosclerosis.2008.09.006; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; OWEN OE, 1969, J CLIN INVEST, V48, P574, DOI 10.1172/JCI106016; Owen OE, 1998, AM J CLIN NUTR, V68, P12, DOI 10.1093/ajcn/68.1.12; Piruzian E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-41; RANDLE PJ, 1994, J CELL BIOCHEM, V55, P1, DOI 10.1002/jcb.240550002; REICHARD GA, 1974, J CLIN INVEST, V53, P508, DOI 10.1172/JCI107584; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rogatsky I, 2006, TISSUE ANTIGENS, V68, P1, DOI 10.1111/j.1399-0039.2006.00599.x; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; SCHREIBER RA, 1984, DRUG ALCOHOL DEPEN, V13, P151, DOI 10.1016/0376-8716(84)90055-3; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SIGLER MH, 1975, J CLIN INVEST, V55, P377, DOI 10.1172/JCI107941; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sodersten P, 2006, HORM BEHAV, V50, P572, DOI 10.1016/j.yhbeh.2006.06.030; Sokolovic M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-361; Sokolovic M, 2010, J HEPATOL, V52, P737, DOI 10.1016/j.jhep.2009.11.028; Sokolovic M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-528; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; VanItallie TB, 2003, NUTR REV, V61, P327, DOI 10.1301/nr.2003.oct.327-341; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Vesely PW, 2009, MUTAT RES-REV MUTAT, V682, P7, DOI 10.1016/j.mrrev.2009.01.001; Wallner B, 2009, PROG NEURO-PSYCHOPH, V33, P391, DOI 10.1016/j.pnpbp.2009.02.006; Xiao XQ, 2004, ENDOCRINOLOGY, V145, P5344, DOI 10.1210/en.2004-0721; Yang G, 2009, J BIOL CHEM, V284, P3719, DOI 10.1074/jbc.M804965200; Zajac-Kaye M, 2001, LUNG CANCER-J IASLC, V34, pS43, DOI 10.1016/S0169-5002(01)00343-9	84	38	38	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.216986	http://dx.doi.org/10.1074/jbc.M110.216986			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21393243	Green Published, hybrid			2022-12-27	WOS:000290022800071
J	Wilson, LS; Baillie, GS; Pritchard, LM; Umana, B; Terrin, A; Zaccolo, M; Houslay, MD; Maurice, DH				Wilson, Lindsay S.; Baillie, George S.; Pritchard, Lisa M.; Umana, Bibiana; Terrin, Anna; Zaccolo, Manuela; Houslay, Miles D.; Maurice, Donald H.			A Phosphodiesterase 3B-based Signaling Complex Integrates Exchange Protein Activated by cAMP 1 and Phosphatidylinositol 3-Kinase Signals in Human Arterial Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; PHOSPHOINOSITIDE 3-KINASE; REGULATORY SUBUNIT; PROGENITOR CELLS; KINASE-A; PATHWAYS; PI3K; RAS; ANGIOGENESIS; STIMULATION	Enzymes of the phosphodiesterase 3 (PDE3) and PDE4 families each regulate the activities of both protein kinases A (PKAs) and exchange proteins activated by cAMP (EPACs) in cells of the cardiovascular system. At present, the mechanisms that allow selected PDEs to individually regulate the activities of these two effectors are ill understood. The objective of this study was to determine how a specific PDE3 variant, namely PDE3B, interacts with and regulates EPAC1-based signaling in human arterial endothelial cells (HAECs). Using several biochemical approaches, we show that PDE3B and EPAC1 bind directly through protein-protein interactions. By knocking down PDE3B expression or by antagonizing EPAC1 binding with PDE3B, we show that PDE3B regulates cAMP binding by its tethered EPAC1. Interestingly, we also show that PDE3B binds directly to p84, a PI3K gamma regulatory subunit, and that this interaction allows PI3K gamma recruitment to the PDE3B-EPAC1 complex. Of potential cardiovascular importance, we demonstrate that PDE3B-tethered EPAC1 regulates HAEC PI3K gamma activity and that this allows dynamic cAMP-dependent regulation of HAEC adhesion, spreading, and tubule formation. We identify and molecularly characterize a PDE3B-based "signalosome" that integrates cAMP-and PI3K gamma-encoded signals and show how this signal integration regulates HAEC functions of importance in angiogenesis.	[Umana, Bibiana; Maurice, Donald H.] Queens Univ, Dept Pharmacol & Toxicol, Kingston, ON K7L 3N6, Canada; [Wilson, Lindsay S.; Pritchard, Lisa M.; Maurice, Donald H.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada; [Baillie, George S.; Terrin, Anna; Zaccolo, Manuela; Houslay, Miles D.] Univ Glasgow, Inst Biomed & Life Sci, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland	Queens University - Canada; McMaster University; Queens University - Canada; University of Glasgow	Maurice, DH (corresponding author), Queens Univ, Dept Pharmacol & Toxicol, Botterell Hall,A208, Kingston, ON K7L 3N6, Canada.	mauriced@queensu.ca	Zaccolo, Manuela/B-3802-2011; Zaccolo, Manuela/AAP-6706-2020; Houslay, Miles/AAM-5281-2020; Maurice, Donald/AAE-9332-2019; Houslay, Miles D/A-6825-2011	Zaccolo, Manuela/0000-0002-0934-3662; Houslay, Miles/0000-0002-3826-8091	Canadian Institutes of Health Research [MOP57699]; Medical Research Council [G0600765]; Fondation Leducq [06CVD02]; MRC [G0600765] Funding Source: UKRI	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fondation Leducq(Leducq Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Canadian Institutes of Health Research Grant MOP57699 (to D. H. M.), Medical Research Council Grant G0600765 (to M. D. H. and G. S. B.), and Fondation Leducq Grant 06CVD02.	Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Bjorgo E, 2010, MOL CELL BIOL, V30, P1660, DOI 10.1128/MCB.00696-09; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Carmona G, 2008, BLOOD, V111, P2640, DOI 10.1182/blood-2007-04-086231; Chavakis E, 2008, CIRC RES, V102, P942, DOI 10.1161/CIRCRESAHA.107.164376; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Damilano F, 2010, ANN NY ACAD SCI, V1188, P39, DOI 10.1111/j.1749-6632.2009.05081.x; De Jesus ML, 2006, J BIOL CHEM, V281, P21837, DOI 10.1074/jbc.M604156200; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Johnson C, 2007, ONCOGENE, V26, P7049, DOI 10.1038/sj.onc.1210504; Kurig B, 2009, P NATL ACAD SCI USA, V106, P20312, DOI 10.1073/pnas.0905506106; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; McCahill A, 2005, CELL SIGNAL, V17, P1158, DOI 10.1016/j.cellsig.2005.04.003; Netherton SJ, 2005, MOL PHARMACOL, V67, P263, DOI 10.1124/mol.104.004853; Netherton SJ, 2007, CIRC RES, V101, P768, DOI 10.1161/CIRCRESAHA.106.146159; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Pawson CT, 2010, NAT STRUCT MOL BIOL, V17, P653, DOI 10.1038/nsmb.1843; Rampersad SN, 2010, J BIOL CHEM, V285, P33614, DOI 10.1074/jbc.M110.140004; Raymond DR, 2007, CELL SIGNAL, V19, P2507, DOI 10.1016/j.cellsig.2007.08.005; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Suire S, 2005, CURR BIOL, V15, P566, DOI 10.1016/j.cub.2005.02.020; Suire S, 2002, CURR BIOL, V12, P1068, DOI 10.1016/S0960-9822(02)00933-8; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Voigt P, 2006, J BIOL CHEM, V281, P9977, DOI 10.1074/jbc.M512502200; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	32	42	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.217026	http://dx.doi.org/10.1074/jbc.M110.217026			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21393242	hybrid, Green Published			2022-12-27	WOS:000290022800067
J	Zhao, JX; Yue, WF; Zhu, MJ; Du, M				Zhao, Jun-Xing; Yue, Wan-Fu; Zhu, Mei-Jun; Du, Min			AMP-activated Protein Kinase Regulates beta-Catenin Transcription via Histone Deacetylase 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE REGENERATION; PLURIPOTENT STEM-CELLS; GENE-EXPRESSION; NUCLEAR EXPORT; ADIPOCYTE DIFFERENTIATION; MYOGENIC DIFFERENTIATION; DIRECT PHOSPHORYLATION; CHROMATIN-STRUCTURE; 3T3-L1 CELLS; P19 CELLS	AMP-activated protein kinase (AMPK) is a key regulator of energy metabolism; it is inhibited under obese conditions and is activated by exercise and by many anti-diabetic drugs. Emerging evidence also suggests that AMPK regulates cell differentiation, but the underlying mechanisms are unclear. We hypothesized that AMPK regulates cell differentiation via altering beta-catenin expression, which involves phosphorylation of class IIa histone deacetylase 5 (HDAC5). In both C3H10T1/2 cells and mouse embryonic fibroblasts (MEFs), AMPK activity was positively correlated with beta-catenin content. Chemical inhibition of HDAC5 increased beta-catenin mRNA expression. HDAC5 overexpression reduced and HDAC5 knockdown increased H3K9 acetylation and cellular beta-catenin content. HDAC5 formed a complex with myocyte enhancer factor-2 to down-regulate beta-catenin mRNA expression. AMPK phosphorylated HDAC5, which promoted HDAC5 exportation from the nucleus; mutation of two phosphorylation sites in HDAC5, Ser-259 and -498, abolished the regulatory role of AMPK on beta-catenin expression. In conclusion, AMPK promotes beta-catenin expression through phosphorylation of HDAC5, which reduces HDAC5 interaction with the beta-catenin promoter via myocyte enhancer factor-2. Thus, the data indicate that AMPK regulates cell differentiation and development via cross-talk with the wingless and Int (Wnt)/beta-catenin signaling pathway.	[Zhao, Jun-Xing; Yue, Wan-Fu; Zhu, Mei-Jun; Du, Min] Univ Wyoming, Dept Anim Sci, Dev Biol Grp, Laramie, WY 82071 USA	University of Wyoming	Du, M (corresponding author), Dept 3684,1000 E Univ Ave, Laramie, WY 82071 USA.	mindu@uwyo.edu	Zhu, Mei-Jun/A-4248-2013; Du, Min/H-4311-2011	Du, Min/0000-0002-7232-072X	National Institutes of Health [1R01HD067449, INBRE P20RR016474, 1R03HD057506]; USDA-NRI [2008-35206-18826]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067449] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD057506] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA-NRI(United States Department of Agriculture (USDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01HD067449, INBRE P20RR016474, and 1R03HD057506, and by USDA-NRI 2008-35206-18826.	Al-Khalili L, 2004, AM J PHYSIOL-CELL PH, V286, pC1410, DOI 10.1152/ajpcell.00444.2003; Armstrong DD, 2005, AM J PHYSIOL-CELL PH, V289, pC853, DOI 10.1152/ajpcell.00093.2005; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Dagon Y, 2006, BIOCHEM BIOPH RES CO, V340, P43, DOI 10.1016/j.bbrc.2005.11.159; De Santa F, 2007, MOL CELL BIOL, V27, P7248, DOI 10.1128/MCB.02199-06; Felsenfeld G, 1996, P NATL ACAD SCI USA, V93, P9384, DOI 10.1073/pnas.93.18.9384; Giri S, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-31; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Ha CH, 2010, P NATL ACAD SCI USA, V107, P15467, DOI 10.1073/pnas.1000462107; Habinowski SA, 2001, BIOCHEM BIOPH RES CO, V286, P852, DOI 10.1006/bbrc.2001.5484; Hardie DG, 2004, MED SCI SPORT EXER, V36, P28, DOI 10.1249/01.MSS.0000106171.38299.64; Inoue E, 2006, BIOCHEM BIOPH RES CO, V351, P793, DOI 10.1016/j.bbrc.2006.10.124; Kasai T, 2009, J CELL PHYSIOL, V221, P740, DOI 10.1002/jcp.21917; Kim J, 2004, J APPL PHYSIOL, V96, P575, DOI 10.1152/japplphysiol.00909.2003; Kim KI, 2006, ARTERIOSCL THROM VAS, V26, P91, DOI 10.1161/01.ATV.0000193569.12490.4b; Kuribayashi T, 2010, INT J MOL MED, V25, P25, DOI 10.3892/ijmm_00000309; Leff T, 2003, BIOCHEM SOC T, V31, P224; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Li QJ, 2004, GENOMICS, V83, P231, DOI 10.1016/j.ygeno.2003.08.004; LIU ML, 1994, J BIOL CHEM, V269, P28514; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mcgee SL, 2008, FRONT BIOSCI-LANDMRK, V13, P3022, DOI 10.2741/2907; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; McGee SL, 2007, APPL PHYSIOL NUTR ME, V32, P852, DOI 10.1139/H07-082; McGee SL, 2010, CLIN SCI, V118, P507, DOI 10.1042/CS20090533; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Mermelstein CS, 2007, DIFFERENTIATION, V75, P184, DOI 10.1111/j.1432-0436.2006.00129.x; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Osler ME, 2008, ENDOCRINOLOGY, V149, P935, DOI 10.1210/en.2007-1441; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; Pan WJ, 2005, P NATL ACAD SCI USA, V102, P17378, DOI 10.1073/pnas.0505922102; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Petropoulos H, 2002, J BIOL CHEM, V277, P15393, DOI 10.1074/jbc.M112141200; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Selvi B. Ruthrotha, 2009, Biotechnology Journal, V4, P375, DOI 10.1002/biot.200900032; Shah M, 2010, BONE, V47, P309, DOI 10.1016/j.bone.2010.04.596; Shang YC, 2007, CYTOTHERAPY, V9, P667, DOI 10.1080/14653240701508437; Singh R, 2006, ENDOCRINOLOGY, V147, P141, DOI 10.1210/en.2004-1649; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Steinberg GR, 2009, FRONT BIOSCI-LANDMRK, V14, P1902, DOI 10.2741/3350; Takemori H, 2009, ENDOCR J, V56, P121, DOI 10.1507/endocrj.K08E-173; Tamura Masato, 2010, Front Biosci (Elite Ed), V2, P1405; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; Tong JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE917, DOI 10.1152/ajpendo.90924.2008; Vaughan OA, 2001, J CELL SCI, V114, P2577; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Yamanouchi K, 2007, J REPROD DEVELOP, V53, P51, DOI 10.1262/jrd.18094; Yan X, 2010, ENDOCRINOLOGY, V151, P380, DOI 10.1210/en.2009-0849; Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200; Zhao JX, 2010, BIOCHEM BIOPH RES CO, V395, P146, DOI 10.1016/j.bbrc.2010.03.161; Zhu MJ, 2008, J PHYSIOL-LONDON, V586, P2651, DOI 10.1113/jphysiol.2007.149633	66	44	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.199372	http://dx.doi.org/10.1074/jbc.M110.199372			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454484	Green Published, hybrid			2022-12-27	WOS:000290022800080
J	Guo, LW; Ruoho, AE				Guo, Lian-Wang; Ruoho, Arnold E.			N-terminal Half of the cGMP Phosphodiesterase gamma-Subunit Contributes to Stabilization of the GTPase-accelerating Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSDUCIN ALPHA-SUBUNIT; CYCLIC-GMP PHOSPHODIESTERASE; ROD OUTER SEGMENTS; PHOTORECEPTOR G-PROTEIN; CATALYTIC SUBUNITS; CRYSTAL-STRUCTURE; STRUCTURAL DETERMINANTS; EFFECTOR-BINDING; HIGH-AFFINITY; SITES	In the visual signal terminating transition state, the cyclic GMP phosphodiesterase (PDE6) inhibitory gamma-subunit (PDE gamma) stimulates GTPase activity of the alpha-subunit of transducin (alpha t) by enhancing the interaction between alpha t and its regulator of G protein signaling (RGS9), which is constitutively bound to the type 5 G protein beta-subunit (beta 5). Although it is known from a crystal structure of partial molecules that the PDE gamma C terminus contacts with both alpha t and RGS9, contributions from the intrinsically disordered PDE gamma N-terminal half remain unclear. In this study, we were able to investigate this issue using a photolabel transfer strategy that allows for mapping the interface of full-length proteins. We observed label transfer from PDE gamma N-terminal positions 50, 30, and 16 to RGS9 center dot beta 5 in the GTPase-accelerating protein (GAP) complex composed of PDE gamma center dot alpha t center dot RGS9 center dot beta 5. In support of a direct PDE gamma N-terminal interaction with RGS9 center dot beta 5, the PDE gamma N-terminal peptide PDE gamma(1-61) abolished label transfer to RGS9 center dot beta 5, and another N-terminal peptide, PDE gamma (10-30), disassembled the GAP complex in label transfer and pulldown experiments. Furthermore, we determined that the PDE gamma C-terminal interaction with alpha t was enhanced whereas the N-terminal interaction was weakened upon changing the alpha t conformation from the signaling state to the transition state. This "rearrangement" of PDE gamma domain interactions with alpha t appears to facilitate the interaction of the PDE gamma N-terminal half with RGS9 center dot beta 5 and hence its contribution to optimal stabilization of the GAP complex.	[Guo, Lian-Wang; Ruoho, Arnold E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Guo, LW (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, 1300 Univ Ave, Madison, WI 53706 USA.	lianwangguo@wisc.edu			National Institutes of Health [GM-33138]; Retina Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Retina Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-33138 (to A. E. R. and L.-W. G. and a Retina Research Foundation Edwin and Dorothy Gamewell Professorship (to A. E. R.).	Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; ARTEMYEV NO, 1992, BIOCHEM J, V283, P273, DOI 10.1042/bj2830273; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; Artemyev NO, 1997, BIOCHEMISTRY-US, V36, P4188, DOI 10.1021/bi963002y; BAEHR W, 1979, J BIOL CHEM, V254, P1669; Baker SA, 2006, BIOCHEMISTRY-US, V45, P10690, DOI 10.1021/bi060376a; Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284; BROWN RL, 1992, BIOCHEMISTRY-US, V31, P5918, DOI 10.1021/bi00140a031; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Cote R. H., 2008, VISUAL TRANSDUCTION, P141; FAUROBERT E, 1993, EMBO J, V12, P4191, DOI 10.1002/j.1460-2075.1993.tb06103.x; FUNG BKK, 1983, J BIOL CHEM, V258, P503; Grant JE, 2006, J BIOL CHEM, V281, P6194, DOI 10.1074/jbc.M509511200; Guo LW, 2007, PROTEIN EXPRES PURIF, V51, P187, DOI 10.1016/j.pep.2006.07.012; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; Guo LW, 2010, J BIOL CHEM, V285, P15209, DOI 10.1074/jbc.M109.086116; Guo LW, 2008, CURR PROTEIN PEPT SC, V9, P611, DOI 10.2174/138920308786733930; Guo LW, 2005, BIOCONJUGATE CHEM, V16, P685, DOI 10.1021/bc050016k; Guo LW, 2005, J BIOL CHEM, V280, P12585, DOI 10.1074/jbc.M410380200; He W, 2000, J BIOL CHEM, V275, P37093, DOI 10.1074/jbc.M006982200; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; Martemyanov KA, 2004, METHOD ENZYMOL, V390, P196; Martemyanov KA, 2002, J BIOL CHEM, V277, P32843, DOI 10.1074/jbc.M205170200; MAZZONI MR, 1991, J BIOL CHEM, V266, P14072; McEntaffer RL, 1999, BIOCHEMISTRY-US, V38, P4931, DOI 10.1021/bi982636x; Mittal R, 1996, SCIENCE, V271, P1413, DOI 10.1126/science.271.5254.1413; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov H, 2004, VISION RES, V44, P2437, DOI 10.1016/j.visres.2004.05.013; Natochin M, 1998, J BIOL CHEM, V273, P21808, DOI 10.1074/jbc.273.34.21808; Natochin M, 1997, J BIOL CHEM, V272, P17444, DOI 10.1074/jbc.272.28.17444; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Shankaranarayanan A, 2008, J BIOL CHEM, V283, P34923, DOI 10.1074/jbc.M805860200; Skiba NP, 2000, J BIOL CHEM, V275, P32716, DOI 10.1074/jbc.C000413200; SKIBA NP, 1995, J BIOL CHEM, V270, P13210, DOI 10.1074/jbc.270.22.13210; Skiba NP, 1999, J BIOL CHEM, V274, P8770, DOI 10.1074/jbc.274.13.8770; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Skiba NP, 2001, J BIOL CHEM, V276, P37365, DOI 10.1074/jbc.M106431200; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SLEPAK VZ, 1995, J BIOL CHEM, V270, P14319, DOI 10.1074/jbc.270.24.14319; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Song J, 2008, P NATL ACAD SCI USA, V105, P1505, DOI 10.1073/pnas.0709558105; Sowa ME, 2000, P NATL ACAD SCI USA, V97, P1483, DOI 10.1073/pnas.030409597; Sowa ME, 2001, NAT STRUCT BIOL, V8, P234, DOI 10.1038/84974; Tsang SH, 2007, J PHYSIOL-LONDON, V579, P303, DOI 10.1113/jphysiol.2006.121772; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010; Zhang XJ, 2010, J BIOL CHEM, V285, P4455, DOI 10.1074/jbc.M109.057406	49	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15260	15267		10.1074/jbc.M110.210567	http://dx.doi.org/10.1074/jbc.M110.210567			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21393250	Green Published, hybrid			2022-12-27	WOS:000289788300057
J	Miki, Y; Calvino, FR; Pogni, R; Giansanti, S; Ruiz-Duenas, FJ; Martinez, MJ; Basosi, R; Romero, A; Martinez, AT				Miki, Yuta; Calvino, Fabiola R.; Pogni, Rebecca; Giansanti, Stefania; Ruiz-Duenas, Francisco J.; Jesus Martinez, Mara; Basosi, Riccardo; Romero, Antonio; Martinez, Angel T.			Crystallographic, Kinetic, and Spectroscopic Study of the First Ligninolytic Peroxidase Presenting a Catalytic Tyrosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; VERSATILE PEROXIDASE; HORSERADISH-PEROXIDASE; MICROBIAL-DEGRADATION; PLEUROTUS-ERYNGII; SUBSTRATE-BINDING; ELECTRON-TRANSFER; PROTEIN RADICALS; VERATRYL ALCOHOL; OXIDATION SITES	Trametes cervina lignin peroxidase (LiP) is a unique enzyme lacking the catalytic tryptophan strictly conserved in all other LiPs and versatile peroxidases (more than 30 sequences available). Recombinant T. cervina LiP and site-directed variants were investigated by crystallographic, kinetic, and spectroscopic techniques. The crystal structure shows three substrate oxidation site candidates involving His-170, Asp-146, and Tyr-181. Steady-state kinetics for oxidation of veratryl alcohol (the typical LiP substrate) by variants at the above three residues reveals a crucial role of Tyr-181 in LiP activity. Moreover, assays with ferrocytochrome c show that its ability to oxidize large molecules (a requisite property for oxidation of the lignin polymer) originates in Tyr-181. This residue is also involved in the oxidation of 1,4-dimethoxybenzene, a reaction initiated by the one-electron abstraction with formation of substrate cation radical, as described for the well known Phanerochaete chrysosporium LiP. Detailed spectroscopic and kinetic investigations, including low temperature EPR, show that the porphyrin radical in the two-electron activated T. cervina LiP is unstable and rapidly receives one electron from Tyr-181, forming a catalytic protein radical, which is identified as an H-bonded neutral tyrosyl radical. The crystal structure reveals a partially exposed location of Tyr-181, compatible with its catalytic role, and several neighbor residues probably contributing to catalysis: (i) by enabling substrate recognition by aromatic interactions; (ii) by acting as proton acceptor/donor from Tyr-181 or H-bonding the radical form; and (iii) by providing the acidic environment that would facilitate oxidation. This is the first structure-function study of the only ligninolytic peroxidase described to date that has a catalytic tyrosine.	[Miki, Yuta; Calvino, Fabiola R.; Ruiz-Duenas, Francisco J.; Jesus Martinez, Mara; Romero, Antonio; Martinez, Angel T.] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; [Pogni, Rebecca; Giansanti, Stefania; Basosi, Riccardo] Univ Siena, Dept Chem, I-53100 Siena, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Siena	Martinez, AT (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, E-28040 Madrid, Spain.	ATMartinez@cib.csic.es	Romero, Antonio/K-5754-2014; Ruiz-Dueñas, Francisco J/L-9837-2015; Martínez, Angel T/G-7284-2017; Martinez, Maria Jesus/F-9147-2015; Basosi, Riccardo/E-7497-2011	Romero, Antonio/0000-0002-6990-6973; Ruiz-Dueñas, Francisco J/0000-0002-9837-5665; Martínez, Angel T/0000-0002-1584-2863; Martinez, Maria Jesus/0000-0003-2166-1097; Basosi, Riccardo/0000-0003-1026-7668	Spanish projects (RAPERO) [BIO2008-01533, BFU2008-02595]; European project BIORENEW [NMP2-CT-2006-026456]; European project PEROXICATS [KBBE-2010-4-265397]; Italian Ministry of University and Research (MIUR) [20072R7WWA]	Spanish projects (RAPERO); European project BIORENEW; European project PEROXICATS; Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Spanish projects BIO2008-01533 (RAPERO) and BFU2008-02595, the European projects BIORENEW (NMP2-CT-2006-026456) and PEROXICATS (KBBE-2010-4-265397), and the Italian Ministry of University and Research (MIUR) project 20072R7WWA.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARRY BA, 1988, CHEM SCRIPTA, V28A, P117; BENECKY MJ, 1993, BIOCHEMISTRY-US, V32, P11929, DOI 10.1021/bi00095a024; Bernini C, 2010, APPL MAGN RESON, V37, P279, DOI 10.1007/s00723-009-0068-5; Blodig W, 1999, ARCH BIOCHEM BIOPHYS, V370, P86, DOI 10.1006/abbi.1999.1365; Brunow G., 2010, LIGNIN LIGNANS ADV C, V1st, P267; Choinowski T, 1999, J MOL BIOL, V286, P809, DOI 10.1006/jmbi.1998.2507; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Davydov R, 2010, J AM CHEM SOC, V132, P14995, DOI 10.1021/ja1059747; DeLano W.L, PYMOL MOL GRAPHICS S; Doyle WA, 1998, BIOCHEMISTRY-US, V37, P15097, DOI 10.1021/bi981633h; Dunford H. B., 1999, HEME PEROXIDASES, P281; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gelpke MDS, 2002, BIOCHEMISTRY-US, V41, P3498, DOI 10.1021/bi011930d; Gold MH, 2000, MET IONS BIOL SYST, V37, P559; Guallar V, 2008, J PHYS CHEM B, V112, P13460, DOI 10.1021/jp806435d; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kapich AN, 2010, ENZYME MICROB TECH, V46, P136, DOI 10.1016/j.enzmictec.2009.09.014; KERSTEN PJ, 1990, BIOCHEM J, V268, P475, DOI 10.1042/bj2680475; KERSTEN PJ, 1985, J BIOL CHEM, V260, P2609; Khindaria A, 1996, BIOCHEMISTRY-US, V35, P13107, DOI 10.1021/bi961297+; Khindaria A, 1996, BIOCHEMISTRY-US, V35, P6418, DOI 10.1021/bi9601666; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Martinez AT, 2009, CURR OPIN BIOTECH, V20, P348, DOI 10.1016/j.copbio.2009.05.002; Martinez AT, 2002, ENZYME MICROB TECH, V30, P425, DOI 10.1016/S0141-0229(01)00521-X; MCCONNELL HM, 1957, J PHYS CHEM-US, V61, P1018, DOI 10.1021/j150553a048; Mester T, 2001, J BIOL CHEM, V276, P22985, DOI 10.1074/jbc.M010739200; Miki Y, 2006, J FAC AGR KYUSHU U, V51, P99; Miki Y, 2011, BIOTECHNOL LETT, V33, P1423, DOI 10.1007/s10529-011-0571-2; Miki Y, 2010, FEMS MICROBIOL LETT, V304, P39, DOI 10.1111/j.1574-6968.2009.01880.x; Miki Y, 2009, PROTEIN EXPRES PURIF, V68, P208, DOI 10.1016/j.pep.2009.06.003; Mino H, 2008, PHOTOSYNTH RES, V98, P151, DOI 10.1007/s11120-008-9380-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PALMER G, 1983, IRON PORPHYRINS 2, P43; PATTERSON WR, 1995, BIOCHEMISTRY-US, V34, P4342, DOI 10.1021/bi00013a024; Perez-Boada M, 2005, J MOL BIOL, V354, P385, DOI 10.1016/j.jmb.2005.09.047; Piontek K, 2001, BIOCHEM SOC T, V29, P111, DOI 10.1042/BST0290111; Pogni R, 2006, J BIOL CHEM, V281, P9517, DOI 10.1074/jbc.M510424200; Ruiz-Duenas FJ, 2007, BIOCHEMISTRY-US, V46, P66, DOI 10.1021/bi061542h; Ruiz-Duenas FJ, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P37, DOI 10.1007/978-3-642-12627-7_3; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Ruiz-Duenas FJ, 2009, J EXP BOT, V60, P441, DOI 10.1093/jxb/ern261; Ruiz-Duenas FJ, 2009, J BIOL CHEM, V284, P7986, DOI 10.1074/jbc.M808069200; Sasaki S, 2008, PHYTOCHEMISTRY, V69, P348, DOI 10.1016/j.phytochem.2007.08.020; SCHULZ CE, 1979, FEBS LETT, V103, P102, DOI 10.1016/0014-5793(79)81259-4; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Smith AT, 2009, P NATL ACAD SCI USA, V106, P16084, DOI 10.1073/pnas.0904535106; Smith AT, 1998, CURR OPIN CHEM BIOL, V2, P269, DOI 10.1016/S1367-5931(98)80069-0; SMITH WL, 1992, BIOCHEMISTRY-US, V31, P3, DOI 10.1021/bi00116a001; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Sundaramoorthy M, 1997, J BIOL CHEM, V272, P17574, DOI 10.1074/jbc.272.28.17574; Svistunenko DA, 2002, BIOPHYS J, V83, P2845, DOI 10.1016/S0006-3495(02)75293-4; Tommos C, 1999, BIOCHEMISTRY-US, V38, P9495, DOI 10.1021/bi990609g; Un S, 2001, J AM CHEM SOC, V123, P3048, DOI 10.1021/ja003650b; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WARIISHI H, 1994, BIOCHEMISTRY-US, V33, P5545, DOI 10.1021/bi00184a025	58	42	42	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15525	15534		10.1074/jbc.M111.220996	http://dx.doi.org/10.1074/jbc.M111.220996			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21367853	Green Published, hybrid			2022-12-27	WOS:000289788300080
J	Pan, PW; Feldman, JL; Devries, MK; Dong, AP; Edwards, AM; Denu, JM				Pan, Patricia W.; Feldman, Jessica L.; Devries, Mark K.; Dong, Aiping; Edwards, Aled M.; Denu, John M.			Structure and Biochemical Functions of SIRT6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE/PROTEIN DEACETYLASES; ADP-RIBOSE; DEPENDENT DEACETYLATION; PROTEIN DEACETYLASE; CALORIE RESTRICTION; GLUCOSE-HOMEOSTASIS; MAXIMUM-LIKELIHOOD; SIR2-LIKE PROTEINS; LIFE-SPAN; MECHANISM	SIRT6 is a member of the evolutionarily conserved sirtuin family of NAD(+)-dependent protein deacetylases and functions in genomic stability and transcriptional control of glucose metabolism. Early reports suggested that SIRT6 performs ADP-ribosylation, whereas more recent studies have suggested that SIRT6 functions mainly as a histone deacetylase. Thus, the molecular functions of SIRT6 remain uncertain. Here, we perform biochemical, kinetic, and structural studies to provide new mechanistic insight into the functions of SIRT6. Utilizing three different assays, we provide biochemical and kinetic evidence that SIRT6-dependent histone deacetylation produces O-acetyl-ADP-ribose but at a rate similar to 1,000 times slower than other highly active sirtuins. To understand the molecular basis for such low deacetylase activity, we solved the first crystal structures of this class IV sirtuin in complex with ADP-ribose and the non-hydrolyzable analog of O-acetyl-ADP-ribose, 2'-N-acetyl-ADP-ribose. The structures revealed unique features of human SIRT6, including a splayed zinc-binding domain and the absence of a helix bundle that in other sirtuin structures connects the zinc-binding motif and Rossmann fold domain. SIRT6 also lacks the conserved, highly flexible, NAD(+)-binding loop and instead contains a stable single helix. These differences led us to hypothesize that SIRT6, unlike all other studied sirtuins, would be able to bind NAD(+) in the absence of an acetylated substrate. Indeed, we found that SIRT6 binds NAD(+) with relatively high affinity (K-d = 27 +/- 1 mu M) in the absence of an acetylated substrate. Isothermal titration calorimetry and tryptophan fluorescence binding assays suggested that ADP-ribose and NAD(+) induce different structural perturbations and that NADH does not bind to SIRT6. Collectively, these new insights imply a unique activating mechanism and/or the possibility that SIRT6 could act as an NAD(+) metabolite sensor.	[Feldman, Jessica L.; Devries, Mark K.; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Pan, Patricia W.; Edwards, Aled M.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Edwards, Aled M.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L7, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Toronto; Structural Genomics Consortium; University of Toronto; University of Toronto	Denu, JM (corresponding author), Univ Wisconsin, Dept Biomol Chem, 1300 Univ Ave,MSC 551, Madison, WI 53706 USA.	jmdenu@wisc.edu		Edwards, Aled/0000-0002-4782-6016	National Institutes of Health [GM065386]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059785, R01GM065386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065386 (to J. M. D.). This research was also supported by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.	Anamika K, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/365637; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Avalos JL, 2004, MOL CELL, V13, P639, DOI 10.1016/S1097-2765(04)00082-6; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Borra MT, 2004, METHOD ENZYMOL, V376, P171; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Chang JH, 2002, J BIOL CHEM, V277, P34489, DOI 10.1074/jbc.M205460200; Comstock LR, 2007, ORG BIOMOL CHEM, V5, P3087, DOI 10.1039/b710231c; Cosgrove MS, 2006, BIOCHEMISTRY-US, V45, P7511, DOI 10.1021/bi0526332; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hawse WF, 2008, STRUCTURE, V16, P1368, DOI 10.1016/j.str.2008.05.015; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jin L, 2009, J BIOL CHEM, V284, P24394, DOI 10.1074/jbc.M109.014928; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kanfi Y, 2008, FEBS LETT, V582, P543, DOI [10.1016/j.febslet.2008.01.019, 10.1016/j.febslet.2008.06.005]; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pils B, 2004, MOL BIOL EVOL, V21, P625, DOI 10.1093/molbev/msh055; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sanders BD, 2007, MOL CELL, V25, P463, DOI 10.1016/j.molcel.2006.12.022; Sanders BD, 2010, BBA-PROTEINS PROTEOM, V1804, P1604, DOI 10.1016/j.bbapap.2009.09.009; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Schuetz A, 2007, STRUCTURE, V15, P377, DOI 10.1016/j.str.2007.02.002; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tennen RI, 2010, MECH AGEING DEV, V131, P185, DOI 10.1016/j.mad.2010.01.006; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Zhao KH, 2003, NAT STRUCT BIOL, V10, P864, DOI 10.1038/nsb978; Zhao KH, 2004, J MOL BIOL, V337, P731, DOI 10.1016/j.jmb.2004.01.060; Zhao KH, 2003, STRUCTURE, V11, P1403, DOI 10.1016/j.str.2003.09.016; Zhao KH, 2004, P NATL ACAD SCI USA, V101, P8563, DOI 10.1073/pnas.0401057101; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	61	194	203	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14575	14587		10.1074/jbc.M111.218990	http://dx.doi.org/10.1074/jbc.M111.218990			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21362626	Green Published, hybrid			2022-12-27	WOS:000289556200077
J	Zucchelli, S; Marcuzzi, F; Codrich, M; Agostoni, E; Vilotti, S; Biagioli, M; Pinto, M; Carnemolla, A; Santoro, C; Gustincich, S; Persichetti, F				Zucchelli, Silvia; Marcuzzi, Federica; Codrich, Marta; Agostoni, Elena; Vilotti, Sandra; Biagioli, Marta; Pinto, Milena; Carnemolla, Alisia; Santoro, Claudio; Gustincich, Stefano; Persichetti, Francesca			Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Associates with Huntingtin Protein and Promotes Its Atypical Ubiquitination to Enhance Aggregate Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRANUCLEAR INCLUSIONS; POLYUBIQUITIN CHAINS; CELL-DEATH; DISEASE; DEGRADATION; CAG; P62/SQSTM1; AUTOPHAGY; DJ-1; GENE	Huntington disease (HD) is a neurodegenerative disorder caused by an expansion of polyglutamines in the first exon of huntingtin (HTT), which confers aggregation-promoting properties to amino-terminal fragments of the protein (N-HTT). Mutant N-HTT aggregates are enriched for ubiquitin and contain ubiquitin E3 ligases, thus suggesting a role for ubiquitination in aggregate formation. Here, we report that tumor necrosis factor receptor-associated factor 6 (TRAF6) binds to WT and polyQ-expanded N-HTT in vitro as well as to endogenous full-length proteins in mouse and human brain in vivo. Endogenous TRAF6 is recruited to cellular inclusions formed by mutant N-HTT. Transient overexpression of TRAF6 promotes WT and mutant N-HTT atypical ubiquitination with Lys(6), Lys(27), and Lys(29) linkage formation. Both interaction and ubiquitination seem to be independent from polyQ length. In cultured cells, TRAF6 enhances mutant N-HTT aggregate formation, whereas it has no effect on WT N-HTT protein localization. Mutant N-HTT inclusions are enriched for ubiquitin staining only when TRAF6 and Lys(6), Lys(27), and Lys(29) ubiquitin mutants are expressed. Finally, we show that TRAF6 is up-regulated in postmortem brains from HD patients where it is found in the insoluble fraction. These results suggest that TRAF6 atypical ubiquitination warrants investigation in HD pathogenesis.	[Zucchelli, Silvia; Marcuzzi, Federica; Codrich, Marta; Agostoni, Elena; Vilotti, Sandra; Biagioli, Marta; Pinto, Milena; Carnemolla, Alisia; Gustincich, Stefano; Persichetti, Francesca] Int Sch Adv Studies SISSA, Sector Neurobiol, I-34136 Trieste, Italy; [Zucchelli, Silvia; Gustincich, Stefano] Italian Inst Technol, SISSA Unit, I-34136 Trieste, Italy; [Zucchelli, Silvia; Biagioli, Marta; Gustincich, Stefano] SISSA, Giovanni Armenise Harvard Fdn Lab, I-34136 Trieste, Italy; [Santoro, Claudio] Univ Piemonte Orientale, Dept Med Sci, I-28100 Novara, Italy; [Persichetti, Francesca] Univ Piemonte Orientale, Dept Environm & Life Sci, I-15121 Alessandria, Italy	International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT; International School for Advanced Studies (SISSA); University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Persichetti, F (corresponding author), Univ Piemonte Orientale, Dipartimento Sci Ambiente & Vita, Viale T Michel 11, I-15121 Alessandria, Italy.	francesca.persichetti@mfn.unipmn.it	Carnemolla, Alisia/AAV-2154-2021; santoro, claudio/G-6819-2012; Pinto, Milena/K-6095-2017; Codrich, Marta/AAC-7724-2022	Pinto, Milena/0000-0001-9202-1527; Zucchelli, Silvia/0000-0003-4556-2990; Biagioli, Marta/0000-0001-8295-8025; Persichetti, Francesca/0000-0002-9804-644X; Gustincich, Stefano/0000-0002-2749-2514	Telethon Foundation of Italy [GGP07185]; Italian Institute of Technology	Telethon Foundation of Italy(Fondazione Telethon); Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT)	This work was supported by the Telethon Foundation of Italy (Grant GGP07185) and the Italian Institute of Technology.	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; de Pril R, 2007, MOL CELL NEUROSCI, V34, P10, DOI 10.1016/j.mcn.2006.09.006; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Fossale E, 2002, HUM MOL GENET, V11, P2233, DOI 10.1093/hmg/11.19.2233; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hendricks AE, 2009, AM J MED GENET A, V149A, P1375, DOI 10.1002/ajmg.a.32901; Hilditch-Maguire P, 2000, HUM MOL GENET, V9, P2789, DOI 10.1093/hmg/9.19.2789; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ikeda H, 2008, MOL BIOL CELL, V19, P4588, DOI 10.1091/mbc.E08-05-0496; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Persichetti F, 1999, NEUROBIOL DIS, V6, P364, DOI 10.1006/nbdi.1999.0260; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Sieradzan KA, 1999, EXP NEUROL, V156, P92, DOI 10.1006/exnr.1998.7005; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009; Zucchelli S, 2009, CELL DEATH DIFFER, V16, P428, DOI 10.1038/cdd.2008.169; Zucchelli S, 2010, HUM MOL GENET, V19, P3759, DOI 10.1093/hmg/ddq290	37	46	50	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25108	25117		10.1074/jbc.M110.187591	http://dx.doi.org/10.1074/jbc.M110.187591			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21454471	Green Published, hybrid			2022-12-27	WOS:000292547900059
J	Logue, JS; Whiting, JL; Tunquist, B; Langeberg, LK; Scott, JD				Logue, Jeremy S.; Whiting, Jennifer L.; Tunquist, Brian; Langeberg, Lorene K.; Scott, John D.			Anchored Protein Kinase A Recruitment of Active Rac GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IQGAP1 INTEGRATES CA2+/CALMODULIN; REGULATORY SUBUNIT RII; CELL-MIGRATION; AKAP-LBC; SIGNALING COMPLEX; CDC42; BINDING; SCAFFOLD; IDENTIFICATION; LOCALIZATION	Protein kinase A-anchoring proteins (AKAPs) influence fundamental cellular processes by directing the cAMP-dependent protein kinase (PKA) toward its intended substrates. In this report we describe the identification and characterization of a ternary complex of AKAP220, the PKA holoenzyme, and the IQ domain GTPase-activating protein 2 isoform (IQGAP2) that is enriched at cortical regions of the cell. Formation of an IQGAP2-AKAP220 core complex initiates a subsequent phase of protein recruitment that includes the small GTPase Rac. Biochemical and molecular biology approaches reveal that PKA phosphorylation of Thr-716 on IQGAP2 enhances association with the active form of the Rac GTPase. Cell-based experiments indicate that overexpression of an IQGAP2 phosphomimetic mutant (IQGAP2 T716D) enhances the formation of actin-rich membrane ruffles at the periphery of HEK 293 cells. In contrast, expression of a nonphosphorylatable IQGAP2 T716A mutant or gene silencing of AKAP220 suppresses formation of membrane ruffles. These findings imply that IQGAP2 and AKAP220 act synergistically to sustain PKA-mediated recruitment of effectors such as Rac GTPases that impact the actin cytoskeleton.	[Logue, Jeremy S.; Whiting, Jennifer L.; Tunquist, Brian; Langeberg, Lorene K.; Scott, John D.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Whiting, Jennifer L.; Langeberg, Lorene K.; Scott, John D.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Logue, Jeremy S.] Univ Washington, Sch Med, Mol & Cellular Biol Program, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Scott, JD (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, 1959 Pacific Ave NE,Box 357750, Seattle, WA 98195 USA.	scottjdw@u.washington.edu			National Institutes of Health [DK54441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported, in whole or in part, by National Institutes of Health Grant DK54441.	Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Bauman AL, 2002, NAT CELL BIOL, V4, pE203, DOI 10.1038/ncb0802-e203; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; CARR DW, 1992, TRENDS BIOCHEM SCI, V17, P246, DOI 10.1016/0968-0004(92)90402-U; CARR DW, 1992, J BIOL CHEM, V267, P13376; CARR DW, 1991, J BIOL CHEM, V266, P14188; Corbin J D, 1974, Methods Enzymol, V38, P287; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2004, EMBO J, V23, P2811, DOI 10.1038/sj.emboj.7600287; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; FIRST EA, 1988, J BIOL CHEM, V263, P5176; FLOCKHART DA, 1980, J BIOL CHEM, V255, P4435; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Grohmanova K, 2004, J BIOL CHEM, V279, P48495, DOI 10.1074/jbc.M408113200; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2000, NAT CELL BIOL, V2, P593, DOI 10.1038/35023536; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lester LB, 1996, J BIOL CHEM, V271, P9460, DOI 10.1074/jbc.271.16.9460; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Logue JS, 2010, FEBS J, V277, P4370, DOI 10.1111/j.1742-4658.2010.07866.x; LOHMANN SM, 1984, P NATL ACAD SCI-BIOL, V81, P6723, DOI 10.1073/pnas.81.21.6723; Mataraza JM, 2007, CELL SIGNAL, V19, P1857, DOI 10.1016/j.cellsig.2007.04.011; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Meiri D, 2009, MOL CELL BIOL, V29, P5963, DOI 10.1128/MCB.01268-08; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Paulucci-Holthauzen AA, 2009, J BIOL CHEM, V284, P5956, DOI 10.1074/jbc.M805606200; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Reinton N, 2000, DEV BIOL, V223, P194, DOI 10.1006/dbio.2000.9725; Ren JG, 2008, J BIOL CHEM, V283, P22972, DOI 10.1074/jbc.M804626200; Schillace RV, 1999, CURR BIOL, V9, P321, DOI 10.1016/S0960-9822(99)80141-9; SCOTT JD, 1994, MOL ENDOCRINOL, V8, P5, DOI 10.1210/me.8.1.5; SCOTT JD, 1990, J BIOL CHEM, V265, P21561; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Tanji C, 2002, J BIOL CHEM, V277, P36955, DOI 10.1074/jbc.M206210200; Tao JC, 2003, EMBO J, V22, P6419, DOI 10.1093/emboj/cdg628; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; THEURKAUF WE, 1982, J BIOL CHEM, V257, P3284; Wang SJ, 2007, J CELL SCI, V120, P567, DOI 10.1242/jcs.03356; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	60	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22113	22121		10.1074/jbc.M111.232660	http://dx.doi.org/10.1074/jbc.M111.232660			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21460214	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000291719900017
J	Gonzalez-Cabo, P; Bolinches-Amoros, A; Cabello, J; Ros, S; Moreno, S; Baylis, HA; Palau, F; Vazquez-Manrique, RP				Gonzalez-Cabo, Pilar; Bolinches-Amoros, Arantxa; Cabello, Juan; Ros, Sheila; Moreno, Sergio; Baylis, Howard A.; Palau, Francesc; Vazquez-Manrique, Rafael P.			Disruption of the ATP-binding Cassette B7 (ABTM-1/ABCB7) Induces Oxidative Stress and Premature Cell Death in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED SIDEROBLASTIC ANEMIA; SULFUR CLUSTER BIOGENESIS; LIFE-SPAN; FRIEDREICHS-ATAXIA; SENSITIVE MUTANT; TRANSPORTER; NEMATODE; FRATAXIN; MUTATION; PROTEINS	X-linked sideroblastic anemia with ataxia (XLSA/A) is a rare inherited disorder characterized by mild anemia and ataxia. XLSA/A is caused by mutations in the ABCB7 gene, which encodes a member of the ATP-binding cassette transporter family. Studies in yeast, mammalian cells, and mice have shown that ABCB7 functions in the transport of iron-sulfur (Fe-S) clusters into the cytoplasm. To further investigate the mechanism of this disease, we have identified and characterized the Caenorhabditis elegans homologue of the ABCB7 gene, abtm-1. We have studied the function of abtm-1 using mutants and RNAi. abtm-1-depleted animals produce arrested embryos that have morphogenetic defects and unusual premature, putative apoptotic events. abtm-1(RNAi) animals also show accumulation of ferric iron and increased oxidative stress. Despite the increased level of oxidative stress in abtm-1(RNAi) animals, they have an increased life span. We observed accumulation of DAF-16/FOXO in the nuclei of affected animals and elevation of the expression of SOD-3, a well established target of DAF-16, which may explain the increased life span extension of these animals. abtm-1 is strongly expressed in tissues with a high energy demand, and abtm-1(RNAi) animals have phenotypes that reflect the need for abtm-1 in these tissues. Finally, we show that reducing the function of other genes involved in Fe-S cluster production produces similar phenotypic consequences to abtm-1 loss of function. Therefore, ablation of abtm-1 in C. elegans provides a model in which to investigate the mechanism underlying XLSA/A.	[Gonzalez-Cabo, Pilar; Bolinches-Amoros, Arantxa; Ros, Sheila; Palau, Francesc] CSIC, Inst Biomed Valencia, Lab Genet & Mol Med, Valencia 46010, Spain; [Gonzalez-Cabo, Pilar; Bolinches-Amoros, Arantxa; Palau, Francesc] CIBER Enfermedades Raras, Valencia 46010, Spain; [Cabello, Juan; Moreno, Sergio] Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc, Salamanca 37007, Spain; [Cabello, Juan] Ctr Biomed Res La Rioja, Oncol Area, Logrono 26006, Spain; [Baylis, Howard A.; Vazquez-Manrique, Rafael P.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Cambridge	Vazquez-Manrique, RP (corresponding author), INSERM, Lab Neuronal Cell Biol & Pathol, Psychiat & Neurosci Ctr U894, 2Ter Rue Alesia, F-75014 Paris, France.	rafael.vazquez@inserm.fr	Palau, Francesc/A-9391-2014; Cabello, Juan/AAM-1683-2020; González-Cabo, Pilar/ABG-5080-2020; Moreno, Sergio/K-3671-2014; Gonzalez-Cabo, Pilar/H-1862-2015; Vázquez-Manrique, Rafael/K-7882-2014	Palau, Francesc/0000-0002-8635-5421; Cabello, Juan/0000-0002-3835-0116; González-Cabo, Pilar/0000-0003-3131-6334; Moreno, Sergio/0000-0002-8039-1413; Gonzalez-Cabo, Pilar/0000-0003-3131-6334; Vázquez-Manrique, Rafael/0000-0002-1594-0033; Baylis, Howard/0000-0002-5959-3256	Spanish Ministry of Education and Science [SAF2006-01147, BFU2008-01808, BFU2010-21794]; Consolider [CSD2007-00015]; Generalitat Valenciana; Junta de Castilla y Leon [CSI03A08]; Grupo de Excelencia [GR 265]; Welcome Trust; Medical Research Council; Medical Research Council [G117/466] Funding Source: researchfish; MRC [G117/466] Funding Source: UKRI	Spanish Ministry of Education and Science(Spanish Government); Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Junta de Castilla y Leon(Junta de Castilla y Leon); Grupo de Excelencia; Welcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Spanish Ministry of Education and Science Grants SAF2006-01147, BFU2008-01808, BFU2010-21794, and Consolider CSD2007-00015, Generalitat Valenciana, Junta de Castilla y Leon Grants CSI03A08 and Grupo de Excelencia GR 265, The Welcome Trust, and Medical Research Council. The CIBERER is an initiative of the Instituto de Salud Carlos III.	Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Baumeister R, 2006, J ENDOCRINOL, V190, P191, DOI 10.1677/joe.1.06856; Baylis HA, 2005, CELL, V123, P5, DOI 10.1016/j.cell.2005.09.018; Bekri S, 2000, BLOOD, V96, P3256; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2007, BLOOD, V109, P3552, DOI 10.1182/blood-2006-08-041632; Chisholm A. D., 2005, WORMBOOK, P1, DOI DOI 10.1895/WORMBOOK.1.35.1; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109, DOI 10.1093/gerona/57.3.B109; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Gonzalez-Cabo P, 2009, ADV EXP MED BIOL, V652, P247, DOI 10.1007/978-90-481-2813-6_17; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; ISHII N, 1990, MUTAT RES, V237, P165, DOI 10.1016/0921-8734(90)90022-J; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kharade SV, 2005, FEBS LETT, V579, P6809, DOI 10.1016/j.febslet.2005.11.017; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Maguire A, 2001, BRIT J HAEMATOL, V115, P910, DOI 10.1046/j.1365-2141.2001.03015.x; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miao R, 2008, BIOCHEMISTRY-US, V47, P9888, DOI 10.1021/bi801047q; Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n; Miguel-Aliaga I, 1999, HUM MOL GENET, V8, P2133, DOI 10.1093/hmg/8.12.2133; MURRAY AW, 1993, CELL CYCLE INTRO, P42; PAGON RA, 1985, J MED GENET, V22, P267, DOI 10.1136/jmg.22.4.267; Palau F, 2001, INT J MOL MED, V7, P581; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Pondarre C, 2007, BLOOD, V109, P3567, DOI 10.1182/blood-2006-04-015768; ROSE AM, 1984, MOL GEN GENET, V195, P52, DOI 10.1007/BF00332723; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Savary S, 1997, GENOMICS, V41, P275, DOI 10.1006/geno.1997.4658; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Segalat L, 2006, ACS CHEM BIOL, V1, P277, DOI 10.1021/cb600221m; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tsang WY, 2003, BBA-MOL BASIS DIS, V1638, P91, DOI 10.1016/S0925-4439(03)00079-6; Vazquez-Manrique RP, 2005, FASEB J, V19, P172, DOI 10.1096/fj.05-4212fje; Ventura N, 2005, AGING CELL, V4, P109, DOI 10.1111/j.1474-9726.2005.00149.x; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wilson Robert B, 2006, Semin Pediatr Neurol, V13, P166, DOI 10.1016/j.spen.2006.08.005; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Yamamoto K, 1996, MUTAT RES-FUND MOL M, V358, P1, DOI 10.1016/0027-5107(96)00070-X; Zeviani M, 2003, CURR OPIN NEUROL, V16, P585, DOI 10.1097/00019052-200310000-00004; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	57	22	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21304	21314		10.1074/jbc.M110.211201	http://dx.doi.org/10.1074/jbc.M110.211201			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21464130	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000291464700029
J	Sivertsen, B; Lang, MJ; Frimurer, TM; Holliday, ND; Bach, A; Els, S; Engelstoft, MS; Petersen, PS; Madsen, AN; Schwartz, TW; Beck-Sickinger, AG; Holst, B				Sivertsen, Bjorn; Lang, Manja; Frimurer, Thomas M.; Holliday, Nicholas D.; Bach, Anders; Els, Sylvia; Engelstoft, Maja S.; Petersen, Pia S.; Madsen, Andreas N.; Schwartz, Thue W.; Beck-Sickinger, Annette G.; Holst, Birgitte			Unique Interaction Pattern for a Functionally Biased Ghrelin Receptor Agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE SECRETAGOGUE; HETEROTRIMERIC G-PROTEINS; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; INVERSE AGONISTS; STRUCTURAL BASIS; LIGAND; IDENTIFICATION; ACTIVATION; PEPTIDE	Based on the conformationally constrained D-Trp-Phe-D-Trp (wFw) core of the prototype inverse agonist [D-Arg(1), D-Phe(5), D-Trp(7,9), Leu(11)] substance P, a series of novel, small, peptide-mimetic agonists for the ghrelin receptor were generated. By using various simple, ring-constrained spacers connecting the D-Trp-Phe-D-Trp motif with the important C-terminal carboxyamide group, 40 nM agonism potency was obtained and also in one case (wFw-Isn-NH2, where Isn is isonipecotic acid) similar to 80% efficacy. However, in contrast to all previously reported ghrelin receptor agonists, the piperidine-constrained wFw-Isn-NH2 was found to be a functionally biased agonist. Thus, wFw-Isn-NH2 mediated potent and efficacious signaling through the G alpha(q) and ERK1/2 signaling pathways, but in contrast to all previous ghrelin receptor agonists it did not signal through the serum response element, conceivably the G alpha(12/13) pathway. The recognition pattern of wFw-Isn-NH2 with the ghrelin receptor also differed significantly from that of all previously characterized unbiased agonists. Most importantly, wFw-Isn-NH2 was not dependent on GluIII:09 (Glu3.33), which otherwise is an obligatory TM III anchor point residue for ghrelin agonists. Molecular modeling and docking experiments indicated that wFw-Isn-NH2 binds in the classical agonist binding site between the extracellular segments of TMs III, VI, and VII, interacting closely with the aromatic cluster between TMs VI and VII, but that it does so in an opposite orientation as compared with, for example, the wFw peptide agonists. It is concluded that the novel peptide-mimetic ligand wFw-Isn-NH2 is a biased ghrelin receptor agonist and that the selective signaling pattern presumably is due to its unique receptor recognition pattern lacking interaction with key residues especially in TM III.	[Sivertsen, Bjorn; Bach, Anders; Engelstoft, Maja S.; Petersen, Pia S.; Madsen, Andreas N.; Schwartz, Thue W.; Holst, Birgitte] Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Lang, Manja; Els, Sylvia; Beck-Sickinger, Annette G.] Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, D-04103 Leipzig, Germany; [Frimurer, Thomas M.] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Holliday, Nicholas D.] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2UH, England	University of Copenhagen; Leipzig University; University of Copenhagen; University of Nottingham	Holst, B (corresponding author), Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	holst@sund.ku.dk		Schwartz, Thue W./0000-0002-0261-6904; Holliday, Nicholas/0000-0002-2900-828X; Holst, Birgitte/0000-0001-7432-097X; Bach, Anders/0000-0003-4305-9910; Frimruer, Thomas/0000-0002-9682-8245	Danish Medical Research Council; NovoNordisk Foundation; Lundbeck Foundation; Alfred Benzon Foundation; German Science Foundation [KFO 152]; Danish Ministry of Science, Technology, and Innovation; Medical Research Council [G0700049]; MRC [G0700049] Funding Source: UKRI	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NovoNordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Alfred Benzon Foundation; German Science Foundation(German Research Foundation (DFG)); Danish Ministry of Science, Technology, and Innovation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from the Danish Medical Research Council, the NovoNordisk Foundation, the Lundbeck Foundation, the Alfred Benzon Foundation, and the German Science Foundation for Financial Support (KFO 152). This work was carried out as part of the "Food, Fitness & Pharma for Health and Disease" research program of the UNIK project, supported by the Danish Ministry of Science, Technology, and Innovation.; Supported by Medical Research Council Grant G0700049.	Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Bach MA, 2004, J AM GERIATR SOC, V52, P516, DOI 10.1111/j.1532-5415.2004.52156.x; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Chu KM, 2007, INT J BIOCHEM CELL B, V39, P752, DOI 10.1016/j.biocel.2006.11.007; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; Falls HD, 2006, J MOL ENDOCRINOL, V37, P51, DOI 10.1677/jme.1.01943; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Galandrin S, 2008, MOL PHARMACOL, V74, P162, DOI 10.1124/mol.107.043893; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Gbahou F, 2003, P NATL ACAD SCI USA, V100, P11086, DOI 10.1073/pnas.1932276100; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2005, MOL ENDOCRINOL, V19, P2400, DOI 10.1210/me.2005-0059; Holst B, 2004, TRENDS PHARMACOL SCI, V25, P113, DOI 10.1016/j.tips.2004.01.010; Holst B, 2001, J BIOL CHEM, V276, P19793, DOI 10.1074/jbc.M100621200; Holst B, 2007, J BIOL CHEM, V282, P15799, DOI 10.1074/jbc.M609796200; Holst B, 2006, MOL PHARMACOL, V70, P936, DOI 10.1124/mol.106.024422; Holst B, 2009, MOL PHARMACOL, V75, P44, DOI 10.1124/mol.108.049189; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2001, TRENDS ENDOCRIN MET, V12, P118, DOI 10.1016/S1043-2760(00)00362-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang MJ, 2004, J MED CHEM, V47, P1153, DOI 10.1021/jm030982t; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Lundholm K, 2010, CANCER-AM CANCER SOC, V116, P2044, DOI 10.1002/cncr.24917; MATTOS C, 1995, STRUCT BIOL, V1, P55; Michel MC, 2007, MOL PHARMACOL, V72, P1097, DOI 10.1124/mol.107.040923; Mousseaux D, 2006, BRIT J PHARMACOL, V148, P350, DOI 10.1038/sj.bjp.0706727; Murphy MG, 2001, J CLIN ENDOCR METAB, V86, P1116, DOI 10.1210/jc.86.3.1116; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Petersen PS, 2009, ENDOCRINOLOGY, V150, P4920, DOI 10.1210/en.2008-1638; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Reis RI, 2007, REGUL PEPTIDES, V140, P32, DOI 10.1016/j.regpep.2006.11.028; Richman JG, 2007, J BIOL CHEM, V282, P18028, DOI 10.1074/jbc.M701866200; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenkilde MM, 2006, J BIOL CHEM, V281, P13199, DOI 10.1074/jbc.M602245200; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Yang J, 2008, P NATL ACAD SCI USA, V105, P10750, DOI 10.1073/pnas.0805353105; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Zhang L, 2009, MOL PHARMACOL, V75, P235, DOI 10.1124/mol.108.050906	55	38	38	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20845	20860		10.1074/jbc.M110.173237	http://dx.doi.org/10.1074/jbc.M110.173237			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21402696	Green Published, hybrid			2022-12-27	WOS:000291267600069
J	Bernier, M; Paul, RK; Martin-Montalvo, A; Scheibye-Knudsen, M; Song, SM; He, HJ; Armour, SM; Hubbard, BP; Bohr, VA; Wang, LL; Zong, YP; Sinclair, DA; de Cabo, R				Bernier, Michel; Paul, Rajib K.; Martin-Montalvo, Alejandro; Scheibye-Knudsen, Morten; Song, Shaoming; He, Hua-Jun; Armour, Sean M.; Hubbard, Basil P.; Bohr, Vilhelm A.; Wang, Lili; Zong, Yaping; Sinclair, David A.; de Cabo, Rafael			Negative Regulation of STAT3 Protein-mediated Cellular Respiration by SIRT1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; SERINE PHOSPHORYLATION; SIGNAL TRANSDUCER; CALORIE RESTRICTION; MITOCHONDRIAL STAT3; DIRECT ACTIVATOR; RESVERATROL; INSULIN; TRANSCRIPTION; ACETYLATION	In mammals, the transcriptional activity of signal transducer and activator of transcription 3 (STAT3) is regulated by the deacetylase SIRT1. However, whether the newly described non-genomic actions of STAT3 toward mitochondrial oxidative phosphorylation are dependent on SIRT1 is unclear. In this study, Sirt1 gene knock-out murine embryonic fibroblast (MEF) cells were used to delineate the role of SIRT1 in the regulation of STAT3 mitochondrial function. Here, we show that STAT3 mRNA and protein levels and the accumulation of serine-phosphorylated STAT3 in mitochondria were increased significantly in Sirt1-KO cells as compared with wild-type MEFs. Various mitochondrial bioenergetic parameters, such as the oxygen consumption rate in cell cultures, enzyme activities of the electron transport chain complexes in isolated mitochondria, and production of ATP and lactate, indicated that Sirt1-KO cells exhibited higher mitochondrial respiration as compared with wildtype MEFs. Two independent approaches, including ectopic expression of SIRT1 and siRNA-mediated knockdown of STAT3, led to reduction in intracellular ATP levels and increased lactate production in Sirt1-KO cells that were approaching those of wild-type controls. Comparison of profiles of phospho-antibody array data indicated that the deletion of SirT1 was accompanied by constitutive activation of the proinflammatory NF-kappa B pathway, which is key for STAT3 induction and increased cellular respiration in Sirt1-KO cells. Thus, SIRT1 appears to be a functional regulator of NF-kappa B-dependent STAT3 expression that induces mitochondrial biogenesis. These results have implications for understanding the interplay between STAT3 and SIRT1 in pro-inflammatory conditions.	[Bernier, Michel] NIA, Clin Invest Lab, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [He, Hua-Jun; Wang, Lili] Natl Inst Stand & Technol, Gaithersburg, MD 20899 USA; [Paul, Rajib K.; Martin-Montalvo, Alejandro; de Cabo, Rafael] NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA; [Scheibye-Knudsen, Morten; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Armour, Sean M.; Hubbard, Basil P.; Sinclair, David A.] Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs, Boston, MA 02115 USA; [Zong, Yaping] Full Moon Biosyst Inc, Sunnyvale, CA 94085 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institute of Standards & Technology (NIST) - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Harvard Medical School	Bernier, M (corresponding author), NIA, Clin Invest Lab, NIH, Biomed Res Ctr, 251 Bayview Blvd,Ste 100, Baltimore, MD 21224 USA.	Bernierm@mail.nih.gov; deCaboRa@grc.nia.nih.gov	de Cabo, Rafael Carlos/J-5230-2016; wang, lili/HDL-7210-2022; de Cabo, Rafael/E-7996-2010; Martin-Montalvo, Alejandro/C-2031-2017; Bohr, Vilhelm/AAP-5931-2020; Bernier, Michel/Y-7139-2019; Bernier, Michel/AAO-3983-2021; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0003-2830-5693; Martin-Montalvo, Alejandro/0000-0002-3886-5355; Bernier, Michel/0000-0002-5948-368X; de Cabo, Rafael/0000-0002-3354-2442; Sinclair, David/0000-0002-9936-436X; Scheibye-Knudsen, Morten/0000-0002-6637-1280; Hubbard, Basil/0000-0003-4353-9674	National Institutes of Health NIA; NATIONAL INSTITUTE ON AGING [ZIAAG000900, R37AG028730, ZIAAG000733, ZIAAG000361, R01AG019719, ZIAAG000362, ZIAAG000363, R01AG028730] Funding Source: NIH RePORTER	National Institutes of Health NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health NIA Intramural Research Program.	Affourtit C, 2009, METHOD ENZYMOL, V457, P405, DOI 10.1016/S0076-6879(09)05023-X; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Ceresa BP, 1996, J BIOL CHEM, V271, P12121, DOI 10.1074/jbc.271.21.12121; Ceresa BP, 1997, ENDOCRINOLOGY, V138, P4131, DOI 10.1210/en.138.10.4131; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Csiszar A, 2009, MECH AGEING DEV, V130, P518, DOI 10.1016/j.mad.2009.06.004; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Fern R, 2003, J NEUROSCI RES, V71, P759, DOI 10.1002/jnr.10553; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Gnaiger E, 2003, ADV EXP MED BIOL, V543, P39; Gorospe M, 2008, TRENDS CELL BIOL, V18, P77, DOI 10.1016/j.tcb.2007.11.007; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; He HJ, 2009, PROTEOM CLIN APPL, V3, P1440, DOI 10.1002/prca.200900020; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Jeong K, 2009, EXP MOL MED, V41, P226, DOI 10.3858/emm.2009.41.4.025; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kojima H, 2005, P NATL ACAD SCI USA, V102, P4524, DOI 10.1073/pnas.0500679102; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Leslie K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2725; Liu HT, 2003, BLOOD, V102, P344, DOI 10.1182/blood-2002-11-3396; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Meyer T, 2002, EXP CELL RES, V272, P45, DOI 10.1006/excr.2001.5405; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Myers MG, 2009, SCIENCE, V323, P723, DOI 10.1126/science.1169660; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pauli JR, 2010, MECH AGEING DEV, V131, P323, DOI 10.1016/j.mad.2010.03.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Phillips D, 2010, J BIOL CHEM, V285, P23532, DOI 10.1074/jbc.C110.152652; Potla R, 2006, MOL CELL BIOL, V26, P8562, DOI 10.1128/MCB.00497-06; Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092; Ray S, 2005, GASTROENTEROLOGY, V129, P1616, DOI 10.1053/j.gastro.2005.07.055; Ray S, 2008, NUCLEIC ACIDS RES, V36, P4510, DOI 10.1093/nar/gkn419; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Salminen A, 2008, BIOESSAYS, V30, P939, DOI 10.1002/bies.20799; Sato N, 2005, INT IMMUNOL, V17, P1543, DOI 10.1093/intimm/dxh331; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Schuringa JJ, 2001, J BIOL CHEM, V276, P27709, DOI 10.1074/jbc.M009821200; Shulga N, 2010, J CELL SCI, V123, P894, DOI 10.1242/jcs.061846; Tang BL, 2010, BRAIN RES BULL, V81, P359, DOI 10.1016/j.brainresbull.2009.12.007; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Togi S, 2009, BIOCHEM BIOPH RES CO, V379, P616, DOI 10.1016/j.bbrc.2008.12.132; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valenza F, 2005, CRIT CARE, V9, P588, DOI 10.1186/cc3818; Vaquero A, 2009, GENE DEV, V23, P1849, DOI 10.1101/gad.1807009; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wierenga ATJ, 2003, EXP HEMATOL, V31, P398, DOI 10.1016/S0301-472X(03)00045-6; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Yeh YT, 2006, INT J CANCER, V118, P2943, DOI 10.1002/ijc.21771; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yu LJ, 2008, NEOPLASIA, V10, P736, DOI 10.1593/neo.08304; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhang YG, 2003, J BIOL CHEM, V278, P12650, DOI 10.1074/jbc.M210368200; Zhang YG, 2001, J BIOL CHEM, V276, P42534, DOI 10.1074/jbc.M106044200; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	72	95	101	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19270	19279		10.1074/jbc.M110.200311	http://dx.doi.org/10.1074/jbc.M110.200311			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21467030	Green Published, hybrid			2022-12-27	WOS:000291027700009
J	Gaidukov, L; Nager, AR; Xu, SZ; Penman, M; Krieger, M				Gaidukov, Leonid; Nager, Andrew R.; Xu, Shangzhe; Penman, Marsha; Krieger, Monty			Glycine Dimerization Motif in the N-terminal Transmembrane Domain of the High Density Lipoprotein Receptor SR-BI Required for Normal Receptor Oligomerization and Lipid Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-LIGAND ADSORPTION; CORONARY-HEART-DISEASE; NITRIC-OXIDE SYNTHASE; SCAVENGER RECEPTOR; NEGATIVE COOPERATIVITY; STRUCTURAL BASIS; LDL RECEPTOR; CHOLESTERYL ESTER; DEFICIENT MICE; ERYTHROPOIETIN RECEPTOR	Scavenger receptor class B, type I (SR-BI), a CD36 superfamily member, is an oligomeric high density lipoprotein (HDL) receptor that mediates negatively cooperative HDL binding and selective lipid uptake. We identified in the N-terminal transmembrane (N-TM) domain of SR-BI a conserved glycine dimerization motif, G(15)X(2)G(18)X(3)AX(2)G(25), of which the submotif G(18)X(3)AX(2)G(25) significantly contributes to homodimerization and lipid uptake activity. SR-BI variants were generated by mutations (single or multiple Gly -> Leu substitutions) or by replacing the N-TM domain with those from other CD36 super-family members containing (croquemort) or lacking (lysosomal integral membrane protein (LIMP) II) this glycine motif (chimeras). None of the SR-BI variants exhibited altered surface expression (based on antibody binding) or HDL binding. However, the G15L/G18L/G25L triple mutant exhibited reductions in cell surface homo-oligomerization (> 10-fold) and the rate of selective lipid uptake (similar to 2-fold). Gly(18) and Gly(25) were necessary for normal lipid uptake activity of SR-BI and the SR-BI/croquemort chimera. The lipid uptake activity of the glycine motif-deficient SR-BI/LIMP II chimera was low but could be increased by introducing glycines at positions 18 and 25. The rate of lipid uptake mediated by SR-BI/LIMP II chimeras was proportional to the extent of receptor oligomerization. Thus, the glycine dimerization motif G(18)X(3)AX(2)G(25) in the N-TM domain of SR-BI contributes substantially to the homo-oligomerization and lipid transport activity of SR-BI but does not influence the negative cooperativity of HDL binding. Oligomerization-independent binding cooperativity suggests that classic allostery is not involved and that the negative cooperativity is probably the consequence of a "lattice effect" (interligand steric interference accompanying binding to adjacent receptors).	[Gaidukov, Leonid; Nager, Andrew R.; Xu, Shangzhe; Penman, Marsha; Krieger, Monty] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Krieger, M (corresponding author), MIT, Dept Biol, Rm 68-483,77 Massachusetts Ave, Cambridge, MA 02139 USA.	krieger@mit.edu			National Institutes of Health [HL52212, HL066105]; Merck/Massachusetts Institute of Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052212, P01HL066105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck/Massachusetts Institute of Technology(Merck & Company); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL52212 and HL066105 (to M. K.). This work was also supported by a Merck/Massachusetts Institute of Technology fellowship (to L. G.).	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; Archibald K, 1998, NEUROPHARMACOLOGY, V37, P1345, DOI 10.1016/S0028-3908(98)00135-X; ASHKENAS J, 1993, J LIPID RES, V34, P983; Azhar S, 2002, J LIPID RES, V43, P861; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; Braun A, 2003, P NATL ACAD SCI USA, V100, P7283, DOI 10.1073/pnas.1237725100; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; CHAPPELL DA, 1991, J BIOL CHEM, V266, P19296; CHUNG BH, 1980, J LIPID RES, V21, P284; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; De Meyts P, 2009, ANN NY ACAD SCI, V1160, P45, DOI 10.1111/j.1749-6632.2009.03837.x; DEMEYTS P, 1976, J BIOL CHEM, V251, P1877; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; Ebie AZ, 2007, J MOL BIOL, V366, P517, DOI 10.1016/j.jmb.2006.11.035; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; GLOMSET JA, 1968, J LIPID RES, V9, P155; Goetz H, 2004, J BIOCHEM BIOPH METH, V60, P281, DOI 10.1016/j.jbbm.2004.01.007; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; GREENWALT DE, 1992, BLOOD, V80, P1105; Gu XJ, 2000, J BIOL CHEM, V275, P9120, DOI 10.1074/jbc.275.13.9120; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; GWYNNE JT, 1989, J BIOL CHEM, V264, P8141; HARDY MR, 1985, BIOCHEMISTRY-US, V24, P22, DOI 10.1021/bi00322a004; Hatzopoulos AK, 1998, J LIPID RES, V39, P495; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; Koshland DE, 1996, CURR OPIN STRUC BIOL, V6, P757, DOI 10.1016/S0959-440X(96)80004-2; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Lear JD, 2004, BIOPHYS J, V87, P3421, DOI 10.1529/biophysj.103.032839; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; LEVITZKI A, 1969, P NATL ACAD SCI USA, V62, P1121, DOI 10.1073/pnas.62.4.1121; Li E, 2006, BIOCHEMISTRY-US, V45, P6241, DOI 10.1021/bi060609y; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; LIMBIRD LE, 2005, CELL SURFACE RECEPTO, P113; Liu T, 2002, J BIOL CHEM, V277, P21576, DOI 10.1074/jbc.M112103200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; MILLER GJ, 1975, LANCET, V1, P16; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Nieland TJF, 2011, BIOCHEMISTRY-US, V50, P1818, DOI 10.1021/bi101657j; Patsch J R, 1986, Methods Enzymol, V129, P3; Peng Y, 2004, MOL BIOL CELL, V15, P384, DOI 10.1091/mbc.e03-06-0445; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; Reaven E, 2004, J LIPID RES, V45, P513, DOI 10.1194/jlr.M300370-JLR200; Riek RP, 2008, MOL PHARMACOL, V73, P1092, DOI 10.1124/mol.107.043042; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; Sackett DL, 1996, FEBS LETT, V397, P1, DOI 10.1016/S0014-5793(96)01020-4; Sahoo D, 2007, BBA-MOL CELL BIOL L, V1771, P818, DOI 10.1016/j.bbalip.2007.04.019; Sahoo D, 2007, BBA-MOL CELL BIOL L, V1771, P807, DOI 10.1016/j.bbalip.2006.03.003; SALHANY JM, 1989, BIOCHEM BIOPH RES CO, V159, P1337, DOI 10.1016/0006-291X(89)92257-2; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; SCHOUTEN D, 1990, ARTERIOSCLEROSIS, V10, P1127, DOI 10.1161/01.ATV.10.6.1127; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; STANKOWSKI S, 1983, BIOCHIM BIOPHYS ACTA, V735, P352, DOI 10.1016/0005-2736(83)90149-9; STANKOWSKI S, 1983, BIOCHIM BIOPHYS ACTA, V735, P341, DOI 10.1016/0005-2736(83)90148-7; STEIN Y, 1983, BIOCHIM BIOPHYS ACTA, V752, P98, DOI 10.1016/0005-2760(83)90237-0; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Uittenbogaard A, 2000, J BIOL CHEM, V275, P11278, DOI 10.1074/jbc.275.15.11278; VEGA MA, 1991, J BIOL CHEM, V266, P16818; Vergeer M, 2011, NEW ENGL J MED, V364, P136, DOI 10.1056/NEJMoa0907687; Vinals M, 2003, J BIOL CHEM, V278, P5325, DOI 10.1074/jbc.M211073200; Williams DL, 2000, J BIOL CHEM, V275, P18897, DOI 10.1074/jbc.M002411200; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986	88	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18452	18464		10.1074/jbc.M111.229872	http://dx.doi.org/10.1074/jbc.M111.229872			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454587	hybrid, Green Published			2022-12-27	WOS:000290785700018
J	Liu, W; Iiizumi-Gairani, M; Okuda, H; Kobayashi, A; Watabe, M; Pai, SK; Pandey, PR; Xing, F; Fukuda, K; Modur, V; Hirota, S; Suzuki, K; Chiba, T; Endo, M; Sugai, T; Watabe, K				Liu, Wen; Iiizumi-Gairani, Megumi; Okuda, Hiroshi; Kobayashi, Aya; Watabe, Misako; Pai, Sudha K.; Pandey, Puspa R.; Xing, Fei; Fukuda, Koji; Modur, Vishnu; Hirota, Shigeru; Suzuki, Kazuyuki; Chiba, Toshimi; Endo, Masaki; Sugai, Tamotsu; Watabe, Kounosuke			KAI1 Gene Is Engaged in NDRG1 Gene-mediated Metastasis Suppression through the ATF3-NF kappa B Complex in Human Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLON-CANCER; FACTOR-KAPPA-B; TUMOR-METASTASIS; DOWN-REGULATION; MECHANISTIC INSIGHTS; PANCREATIC-CANCER; ALLELIC LOSS; CELL-LINES; SHORT ARM; EXPRESSION	NDRG1 and KAI1 belong to metastasis suppressor genes, which impede the dissemination of tumor cells from primary tumors to distant organs. Previously, we identified the metastasis promoting transcription factor, ATF3, as a downstream target of NDRG1. Further analysis revealed that the KAI1 promoter contained a consensus binding motif of ATF3, suggesting a possibility that NDRG1 suppresses metastasis through inhibition of ATF3 expression followed by activation of the KAI1 gene. In this report, we found that ectopic expression of NDRG1 was able to augment endogenous KAI1 gene expression in prostate cancer cell lines, whereas silencing NDRG1 was accompanied with significant decrease in KAI1 expression in vitro and in vivo. In addition, our results of ChIP analysis indicate that ATF3 indeed bound to the promoter of the KAI1 gene. Importantly, our promoter-based analysis revealed that ATF3 modulated KAI1 transcription through cooperation with other endogenous transcription factor as co-activator (ATF3-JunB) or co-repressor (ATF3-NF kappa B). Moreover, loss of KAI1 expression significantly abrogated NDRG1-mediated metastatic suppression in vitro as well as in a spontaneous metastasis animal model, indicating that KAI1 is a functional downstream target of the NDRG1 pathway. Our result of immunohistochemical analysis showed that loss of NDRG1 and KAI1 occurs in parallel as prostate cancer progresses. We also found that a combined expression status of these two genes serves as a strong independent prognostic marker to predict metastasis-free survival of prostate cancer patients. Taken together, our result revealed a novel regulatory network of two metastasis suppressor genes, NDRG1 and KAI1, which together concerted metastasis-suppressive activities through an intrinsic transcriptional cascade.	[Liu, Wen; Iiizumi-Gairani, Megumi; Okuda, Hiroshi; Kobayashi, Aya; Watabe, Misako; Pai, Sudha K.; Pandey, Puspa R.; Xing, Fei; Fukuda, Koji; Modur, Vishnu; Watabe, Kounosuke] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA; [Hirota, Shigeru] Iwate Med Sch, Dept Internal Med, Morioka, Iwate 0208505, Japan; [Suzuki, Kazuyuki; Chiba, Toshimi; Endo, Masaki] Iwate Med Sch, Dept Gastroenterol & Hepatol, Morioka, Iwate 0208505, Japan; [Sugai, Tamotsu] Iwate Med Sch, Dept Diagnost Pathol, Morioka, Iwate 0208505, Japan	Southern Illinois University System; Southern Illinois University; Iwate Medical University; Iwate Medical University; Iwate Medical University	Watabe, K (corresponding author), So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA.	kwatabe@siumed.edu	Kobayashi, Aya/AAA-2530-2020	Okuda, Hiroshi/0000-0002-5747-8086; Chiba, Toshimi/0000-0001-7072-3157	National Institutes of Health [R01CA124650, R01CA129000]; U. S. Department of Defense [BC044370, PC061256]; NATIONAL CANCER INSTITUTE [R01CA129000, R01CA124650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA124650 and R01CA129000 (to K. W.). This work was also supported by U. S. Department of Defense Grants BC044370 and PC061256 (to K. W.).	Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Bandyopadhyay S, 2006, CANCER RES, V66, P11983, DOI 10.1158/0008-5472.CAN-06-0943; Berger JC, 2005, CANCER BIOL THER, V4, P805, DOI 10.4161/cbt.4.8.1865; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Dong JT, 1997, GENOMICS, V41, P25, DOI 10.1006/geno.1997.4618; Dong JT, 1996, CANCER RES, V56, P4387; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; El Touny LH, 2007, BIOCHEM BIOPH RES CO, V361, P169, DOI 10.1016/j.bbrc.2007.07.010; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; GAUGITSCH HW, 1991, EUR J IMMUNOL, V21, P377, DOI 10.1002/eji.1830210219; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Guang RJ, 2000, CANCER RES, V60, P749; Hai T, 1999, GENE EXPRESSION, V7, P321; Hosoi F, 2009, CANCER RES, V69, P4983, DOI 10.1158/0008-5472.CAN-08-4882; ICHIKAWA T, 1991, CANCER RES, V51, P3788; ICHIKAWA T, 1992, CANCER RES, V52, P3486; Iiizumi M, 2008, BBA-REV CANCER, V1786, P87, DOI 10.1016/j.bbcan.2008.07.002; Ishiguro T, 1996, CANCER RES, V56, P875; Ishiguro T, 2000, JPN J CANCER RES, V91, P833, DOI 10.1111/j.1349-7006.2000.tb01021.x; Jackson P, 2000, CANCER LETT, V157, P169, DOI 10.1016/S0304-3835(00)00483-3; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Kawana Y, 1997, PROSTATE, V32, P205; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Konishi N, 2008, CLIN CANCER RES, V14, P4408, DOI 10.1158/1078-0432.CCR-07-4120; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Kurdistani SK, 1998, CANCER RES, V58, P4439; Lakshman M, 2011, CLIN EXP METASTAS, V28, P39, DOI 10.1007/s10585-010-9356-6; Lee JH, 2003, CANCER RES, V63, P7247; Liu WM, 2006, CANCER LETT, V240, P183, DOI 10.1016/j.canlet.2005.08.018; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Marreiros A, 2005, ONCOGENE, V24, P637, DOI 10.1038/sj.onc.1208216; Marreiros A, 2003, GENE, V302, P155, DOI 10.1016/S0378-1119(02)01101-0; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Mashimo T, 1998, P NATL ACAD SCI USA, V95, P11307, DOI 10.1073/pnas.95.19.11307; Mashimo T, 2000, BIOCHEM BIOPH RES CO, V274, P370, DOI 10.1006/bbrc.2000.3139; Miyazaki K, 2009, NUCLEIC ACIDS RES, V37, P1438, DOI 10.1093/nar/gkn1082; Miyazaki T, 2000, CANCER-AM CANCER SOC, V89, P955, DOI 10.1002/1097-0142(20000901)89:5<955::AID-CNCR3>3.0.CO;2-Z; Nash KT, 2006, FRONT BIOSCI-LANDMRK, V11, P647, DOI 10.2741/1824; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nishio S, 2008, CANCER LETT, V264, P36, DOI 10.1016/j.canlet.2008.01.020; Ono M, 1999, CANCER RES, V59, P2335; Ross JS, 2004, CLIN CANCER RES, V10, P2466, DOI 10.1158/1078-0432.CCR-0543-3; Schoenfeld N, 2004, FASEB J, V18, P158, DOI 10.1096/fj.03-0420fje; Shevde LA, 2003, CANCER LETT, V198, P1, DOI 10.1016/S0304-3835(03)00304-5; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Steeg Patricia S, 2003, Clin Breast Cancer, V4, P51, DOI 10.3816/CBC.2003.n.012; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Suh J, 2004, J CELL BIOCHEM, V91, P100, DOI 10.1002/jcb.10729; Tagawa K, 1999, JPN J CANCER RES, V90, P970, DOI 10.1111/j.1349-7006.1999.tb00843.x; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; vanBelzen N, 1997, LAB INVEST, V77, P85; Xu X, 2008, MOL PHARMACOL, V73, P833, DOI 10.1124/mol.107.041335; Zhang Q, 2009, CLIN CANCER RES, V15, P3557, DOI 10.1158/1078-0432.CCR-08-1656	54	77	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18949	18959		10.1074/jbc.M111.232637	http://dx.doi.org/10.1074/jbc.M111.232637			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454613	Green Published, hybrid			2022-12-27	WOS:000290785700066
J	Kasaikina, MV; Lobanov, AV; Malinouski, MY; Lee, BC; Seravalli, J; Fomenko, DE; Turanov, AA; Finney, L; Vogt, S; Park, TJ; Miller, RA; Hatfield, DL; Gladyshev, VN				Kasaikina, Marina V.; Lobanov, Alexei V.; Malinouski, Mikalai Y.; Lee, Byung Cheon; Seravalli, Javier; Fomenko, Dmitri E.; Turanov, Anton A.; Finney, Lydia; Vogt, Stefan; Park, Thomas J.; Miller, Richard A.; Hatfield, Dolph L.; Gladyshev, Vadim N.			Reduced Utilization of Selenium by Naked Mole Rats Due to a Specific Defect in GPx1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONGEST-LIVING RODENT; GLUTATHIONE-PEROXIDASE; OXIDATIVE STRESS; MICE; RESISTANCE; SELENOCYSTEINE; CELLS; SELENOPROTEINS; DETERMINANTS; REQUIREMENT	Naked mole rat (MR) Heterocephalus glaber is a rodent model of delayed aging because of its unusually long life span (> 28 years). It is also not known to develop cancer. In the current work, tissue imaging by x-ray fluorescence microscopy and direct analyses of trace elements revealed low levels of selenium in the MR liver and kidney, whereas MR and mouse brains had similar selenium levels. This effect was not explained by uniform selenium deficiency because methionine sulfoxide reductase activities were similar in mice and MR. However, glutathione peroxidase activity was an order of magnitude lower in MR liver and kidney than in mouse tissues. In addition, metabolic labeling of MR cells with Se-75 revealed a loss of the abundant glutathione peroxidase 1 (GPx1) band, whereas other selenoproteins were preserved. To characterize the MR selenoproteome, we sequenced its liver transcriptome. Gene reconstruction revealed standard selenoprotein sequences except for GPx1, which had an early stop codon, and SelP, which had low selenocysteine content. When expressed in HEK 293 cells, MR GPx1 was present in low levels, and its expression could be rescued neither by removing the early stop codon nor by replacing its SECIS element. In addition, GPx1 mRNA was present in lower levels in MR liver than in mouse liver. To determine if GPx1 deficiency could account for the reduced selenium content, we analyzed GPx1 knock-out mice and found reduced selenium levels in their livers and kidneys. Thus, MR is characterized by the reduced utilization of selenium due to a specific defect in GPx1 expression.	[Kasaikina, Marina V.; Lobanov, Alexei V.; Malinouski, Mikalai Y.; Lee, Byung Cheon; Turanov, Anton A.; Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Kasaikina, Marina V.; Lobanov, Alexei V.; Malinouski, Mikalai Y.; Lee, Byung Cheon; Turanov, Anton A.; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kasaikina, Marina V.; Malinouski, Mikalai Y.; Lee, Byung Cheon; Seravalli, Javier; Fomenko, Dmitri E.; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Kasaikina, Marina V.; Malinouski, Mikalai Y.; Lee, Byung Cheon; Seravalli, Javier; Fomenko, Dmitri E.; Gladyshev, Vadim N.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Finney, Lydia] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA; [Vogt, Stefan] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [Park, Thomas J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; [Miller, Richard A.] Univ Michigan, Ann Arbor, MI 48109 USA; [Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gladyshev, VN (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, New Res Bldg,Rm 435,77 Ave Louis Pasteur, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Vogt, Stefan/B-9547-2009; Gladyshev, Vadim N/A-9894-2013; Vogt, Stefan/J-7937-2013; Gladyshev, Vadim N/J-6187-2013	Vogt, Stefan/0000-0002-8034-5513; Vogt, Stefan/0000-0002-8034-5513; Lee, Byung Cheon/0000-0003-1467-1940; Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health [GM061603, CA080946, AG021518]; Center for Cancer Research, NCI, National Institutes of Health; Department of Energy Office of Science [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA080946, ZIABC005317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021518, U19AG023122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Energy Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM061603, CA080946, and AG021518 (to V. N. G.) and the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health (to D. L. H.). This work was also supported by the Department of Energy Office of Science under Contract DE-AC02-06CH11357.	Andziak B, 2005, MECH AGEING DEV, V126, P1206, DOI 10.1016/j.mad.2005.06.009; Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; Beck MA, 1998, FASEB J, V12, P1143, DOI 10.1096/fasebj.12.12.1143; BEHNE D, 1983, J NUTR, V113, P456, DOI 10.1093/jn/113.2.456; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; de Haan JB, 1998, J BIOL CHEM, V273, P22528, DOI 10.1074/jbc.273.35.22528; Donovan J, 2010, ANTIOXID REDOX SIGN, V12, P881, DOI 10.1089/ars.2009.2878; Edrey YH, 2011, EXP GERONTOL, V46, P116, DOI 10.1016/j.exger.2010.09.005; ESWORTHY RS, 1995, CANCER RES, V55, P957; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; Fu YX, 1999, FREE RADICAL BIO MED, V27, P605, DOI 10.1016/S0891-5849(99)00104-5; Gladyshev VN, 1998, BIOCHEM BIOPH RES CO, V251, P488, DOI 10.1006/bbrc.1998.9495; Gorbunova V, 2008, AGE, V30, P111, DOI 10.1007/s11357-008-9053-4; Ichimura Y, 2004, J UROLOGY, V172, P728, DOI 10.1097/01.ju.0000130942.40597.9d; Jensen C, 2008, J ANIM PHYSIOL AN N, V92, P481, DOI 10.1111/j.1439-0396.2007.00738.x; Kehr S, 2009, J MOL BIOL, V389, P808, DOI 10.1016/j.jmb.2009.04.024; Kramer B, 2004, GEN COMP ENDOCR, V139, P206, DOI 10.1016/j.ygcen.2004.09.006; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Larson J, 2009, NEUROREPORT, V20, P1634, DOI 10.1097/WNR.0b013e32833370cf; Latreche L, 2009, NUCLEIC ACIDS RES, V37, P5868, DOI 10.1093/nar/gkp635; Lee BC, 2008, J BIOL CHEM, V283, P28361, DOI 10.1074/jbc.M805059200; Lee BC, 2009, BBA-GEN SUBJECTS, V1790, P1471, DOI 10.1016/j.bbagen.2009.04.014; Lei XG, 2002, METHOD ENZYMOL, V347, P213; Lei XG, 2007, ANNU REV NUTR, V27, P41, DOI 10.1146/annurev.nutr.27.061406.093716; Lei XG, 2005, J NUTR, V135, P2295, DOI 10.1093/jn/135.10.2295; Lei XG, 2011, ANTIOXID REDOX SIGN, V14, P489, DOI 10.1089/ars.2010.3416; Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09; Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x; Lobanov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r62; Lubos E., 2010, ANTIOXID RE IN PRESS; McMullen CA, 2010, ANAT REC, V293, P918, DOI 10.1002/ar.21107; MILLS GC, 1957, J BIOL CHEM, V229, P189; MOSCOW JA, 1994, CARCINOGENESIS, V15, P2769, DOI 10.1093/carcin/15.12.2769; Mueller AS, 2009, J ANIM PHYSIOL AN N, V93, P313, DOI 10.1111/j.1439-0396.2008.00849.x; Novoselov SV, 2007, P NATL ACAD SCI USA, V104, P7857, DOI 10.1073/pnas.0610683104; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106; Schomburg L, 2009, BBA-GEN SUBJECTS, V1790, P1453, DOI 10.1016/j.bbagen.2009.03.015; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Sunde RA, 1997, BIOMED ENVIRON SCI, V10, P346; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Twining BS, 2003, ANAL CHEM, V75, P3806, DOI 10.1021/ac034227z; Wang XD, 2011, ANTIOXID REDOX SIGN, V14, P391, DOI 10.1089/ars.2010.3302; Wen W, 1998, J BIOL CHEM, V273, P28533, DOI 10.1074/jbc.273.43.28533; Woodley R, 2002, COMP BIOCHEM PHYS A, V133, P827, DOI 10.1016/S1095-6433(02)00199-X	47	24	24	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17005	17014		10.1074/jbc.M110.216267	http://dx.doi.org/10.1074/jbc.M110.216267			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21372135	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000290301900051
J	Lu, KF; Li, P; Zhang, MH; Xing, GC; Li, X; Zhou, WH; Bartlam, M; Zhang, LQ; Rao, ZH; He, FC				Lu, Kefeng; Li, Ping; Zhang, Minghua; Xing, Guichun; Li, Xin; Zhou, Weihong; Bartlam, Mark; Zhang, Lingqiang; Rao, Zihe; He, Fuchu			Pivotal Role of the C2 Domain of the Smurf1 Ubiquitin Ligase in Substrate Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL DIVERSITY; CELL POLARITY; NEDD4 FAMILY; DEGRADATION; RECEPTOR; TARGETS; SMAD7	The C2-WW-HECT-type ubiquitin ligases Smurf1 and Smurf2 play a critical role in embryogenesis and adult bone homeostasis via regulation of bone morphogenetic protein, Wnt, and RhoA signaling pathways. The intramolecular interaction between C2 and HECT domains autoinhibits the ligase activity of Smurf2. However, the role of the Smurf1 C2 domain remains elusive. Here, we show that the C2-HECT autoinhibition mechanism is not observed in Smurf1, and instead its C2 domain functions in substrate selection. The Smurf1 C2 domain exerts a key role in localization to the plasma membrane and endows Smurf1 with differential activity toward RhoA versus Smad5 and Runx2. Crystal structure analysis reveals that the Smurf1 C2 domain possesses a typical anti-parallel beta-sandwich fold. Examination of the sulfate-binding site analysis reveals two key lysine residues, Lys-28 and Lys-85, within the C2 domain that are important for Smurf1 localization at the plasma membrane, regulation on cell migration, and robust ligase activity toward RhoA, which further supports a Ca2+-independent localization mechanism for Smurf1. These findings demonstrate a previously unidentified role of the Smurf1 C2 domain in substrate selection and cellular localization.	[Lu, Kefeng; Zhang, Minghua; Xing, Guichun; Zhang, Lingqiang; He, Fuchu] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China; [Li, Ping; Li, Xin; Zhou, Weihong; Bartlam, Mark; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China	Academy of Military Medical Sciences - China; Nankai University	Zhang, LQ (corresponding author), Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China.	zhanglq@nic.bmi.ac.cn; raozh@nankai.edu.cn	Zhang, Minghua/AAC-4782-2020; Rao, Zihe/HCH-6944-2022	Bartlam, Mark/0000-0001-5173-5080; Lu, Kefeng/0000-0001-8200-9380	National Basic Research Program [2011CB910602, 2007CB914601, 2007CB914301]; National Natural Science Foundation [30830029, 30970601]; National Key Technologies R&D Program for New Drugs [2009ZX09503-002, 2009ZX09301-002]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program for New Drugs(National Key Technology R&D Program)	This work was supported by National Basic Research Program Grants 2011CB910602, 2007CB914601, and 2007CB914301, National Natural Science Foundation Project Grants 30830029 and 30970601, and National Key Technologies R&D Program for New Drugs Grants 2009ZX09503-002 and 2009ZX09301-002.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Chong PA, 2010, P NATL ACAD SCI USA, V107, P18404, DOI 10.1073/pnas.1003023107; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Kalkan T, 2009, MOL BIOL CELL, V20, P3436, DOI 10.1091/mbc.E08-03-0325; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li S, 2010, MOL CELL BIOCHEM, V338, P11, DOI 10.1007/s11010-009-0315-y; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ogunjimi AA, 2010, J BIOL CHEM, V285, P6308, DOI 10.1074/jbc.M109.044537; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang Q, 2007, J BIOL CHEM, V282, P10742, DOI 10.1074/jbc.M610997200; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yamaguchi K, 2008, BIOL CHEM, V389, P405, DOI 10.1515/BC.2008.036; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Ying SX, 2003, J BIOL CHEM, V278, P39029, DOI 10.1074/jbc.M301193200; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	40	35	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16861	16870		10.1074/jbc.M110.211979	http://dx.doi.org/10.1074/jbc.M110.211979			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21402695	Green Published, hybrid			2022-12-27	WOS:000290301900035
J	Sotomayor-Perez, AC; Ladant, D; Chenal, A				Sotomayor-Perez, Ana Cristina; Ladant, Daniel; Chenal, Alexandre			Calcium-induced Folding of Intrinsically Disordered Repeat-in-Toxin (RTX) Motifs via Changes of Protein Charges and Oligomerization States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-CYCLASE TOXIN; NATIVELY UNFOLDED PROTEINS; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; BETA-HELIX; SECRETION; DOMAIN; BACTERIA	Ligand-induced disorder-to-order transition plays a key role in the biological functions of many proteins that contain intrinsically disordered regions. This trait is exhibited by so-called RTX (repeat-in-toxin) motifs found in many virulence factors secreted by numerous Gram-negative pathogenic bacteria: RTX proteins are natively disordered in the absence of calcium but fold upon calcium binding. The adenylate cyclase toxin (CyaA) produced by Bordetella pertussis, the causative agent of whooping cough, contains similar to 40 RTX motifs organized in five successive blocks separated by non-RTX flanking regions. This RTX domain mediates toxin binding to its eukaryotic cell receptor. We previously showed that the last block of the RTX domain, block V, which is critical for CyaA toxicity, exhibits the hall-marks of intrinsically disordered proteins in the absence of calcium. Moreover, the C-terminal flanking region of CyaA block V is required for its calcium-induced folding. Here, we describe a comprehensive analysis of the hydrodynamic and electrophoretic properties of several block V RTX polypeptides that differ in the presence and/or length of the flanking regions. Our results indicate that the length of the C-terminal flanking region not only controls the calcium-induced folding but also the calcium-induced multimerization of the RTX polypeptides. Moreover, we showed that calcium binding is accompanied by a strong reduction of the net charge of the RTX polypeptides. These data indicate that the disorder-to-order transition in RTX proteins is controlled by a calcium-induced change of the polypeptide charges and stabilized by multimerization.	[Sotomayor-Perez, Ana Cristina; Ladant, Daniel; Chenal, Alexandre] Inst Pasteur, CNRS, URA 2185, Unite Biochim Interact Macromol,Dept Biol Struct, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ladant, D (corresponding author), Inst Pasteur, CNRS, URA 2185, Unite Biochim Interact Macromol,Dept Biol Struct, 28 Rue Dr Roux, F-75724 Paris 15, France.	daniel.ladant@pasteur.fr; alexandre.chenal@pasteur.fr	Chenal, Alexandre/C-2240-2009	Chenal, Alexandre/0000-0002-4959-1003; LADANT, Daniel/0000-0003-1955-548X	CNRS Institut Pasteur Projet Transversal de Recherche [374]; Agence Nationale de la Recherche Programme Jeunes Chercheurs [ANR-09-JCJC-0012]; Allocation de These de la Region Ile-de-France	CNRS Institut Pasteur Projet Transversal de Recherche; Agence Nationale de la Recherche Programme Jeunes Chercheurs(French National Research Agency (ANR)); Allocation de These de la Region Ile-de-France(Region Ile-de-France)	This work was supported by CNRS Institut Pasteur Projet Transversal de Recherche Grant PTR#374 and the Agence Nationale de la Recherche Programme Jeunes Chercheurs Grant ANR-09-JCJC-0012.; Supported by the Allocation de These de la Region Ile-de-France Ph.D. program.	BASAK SK, 1995, ANAL BIOCHEM, V226, P51, DOI 10.1006/abio.1995.1190; Bauche C, 2006, J BIOL CHEM, V281, P16914, DOI 10.1074/jbc.M601594200; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; Beaman TW, 1997, BIOCHEMISTRY-US, V36, P489, DOI 10.1021/bi962522q; Bejerano M, 1999, MOL MICROBIOL, V31, P381, DOI 10.1046/j.1365-2958.1999.01183.x; Blenner MA, 2010, J MOL BIOL, V400, P244, DOI 10.1016/j.jmb.2010.04.056; Bourdeau RW, 2009, J BIOL CHEM, V284, P14645, DOI 10.1074/jbc.M807631200; Chenal A, 2010, BIOPHYS J, V99, P3744, DOI 10.1016/j.bpj.2010.10.016; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; COOTE JG, 1992, FEMS MICROBIOL LETT, V88, P137, DOI 10.1016/0378-1097(92)90688-K; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eliezer D, 2009, CURR OPIN STRUC BIOL, V19, P23, DOI 10.1016/j.sbi.2008.12.004; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; HARDING SE, 1995, ANAL BIOCHEM, V228, P131, DOI 10.1006/abio.1995.1324; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; IWAKI M, 1995, MOL MICROBIOL, V17, P1015, DOI 10.1111/j.1365-2958.1995.mmi_17061015.x; Karst JC, 2010, BIOCHEMISTRY-US, V49, P318, DOI 10.1021/bi9016389; Kisker C, 1996, EMBO J, V15, P2323, DOI 10.1002/j.1460-2075.1996.tb00588.x; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; Lilie H, 2000, FEBS LETT, V470, P173, DOI 10.1016/S0014-5793(00)01308-9; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Meier R, 2007, J BIOL CHEM, V282, P31477, DOI 10.1074/jbc.M704942200; Midic U, 2009, PROTEIN PEPTIDE LETT, V16, P1533, DOI 10.2174/092986609789839377; Pimenta AL, 2005, J BACTERIOL, V187, P7471, DOI 10.1128/JB.187.21.7471-7480.2005; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Sotomayor Perez AC, 2010, J MOL BIOL, V397, P534, DOI 10.1016/j.jmb.2010.01.031; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Szilvay GR, 2009, BIOCHEMISTRY-US, V48, P11273, DOI 10.1021/bi901447j; Tompa P, 2010, BIOCHEM CELL BIOL, V88, P167, DOI [10.1139/O09-163, 10.1139/o09-163]; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003	38	38	39	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16997	17004		10.1074/jbc.M110.210393	http://dx.doi.org/10.1074/jbc.M110.210393			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454565	Green Published, hybrid			2022-12-27	WOS:000290301900050
J	Afanasieva, EG; Kushnirov, VV; Tuite, MF; Ter-Avanesyan, MD				Afanasieva, Evgenia G.; Kushnirov, Vitaly V.; Tuite, Mick F.; Ter-Avanesyan, Michael D.			Molecular Basis for Transmission Barrier and Interference between Closely Related Prion Proteins in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SPECIES BARRIER; SUP35 PROTEIN; PROPAGATION; AMYLOIDS; GENE; ELECTROPHORESIS; DETERMINANT; DIVERSITY; DISEASE	Replicating amyloids, called prions, are responsible for transmissible neurodegenerative diseases in mammals and some heritable phenotypes in fungi. The transmission of prions between species is usually inhibited, being highly sensitive to small differences in amino acid sequence of the prion-forming proteins. To understand the molecular basis of this prion interspecies barrier, we studied the transmission of the [PSI+] prion state from Sup35 of Saccharomyces cerevisiae to hybrid Sup35 proteins with prion-forming domains from four other closely related Saccharomyces species. Whereas all the hybrid Sup35 proteins could adopt a prion form in S. cerevisiae, they could not readily acquire the prion form from the [PSI+] prion of S. cerevisiae. Expression of the hybrid Sup35 proteins in S. cerevisiae [PSI+] cells often resulted in frequent loss of the native [PSI+] prion. Furthermore, all hybrid Sup35 proteins showed different patterns of interaction with the native [PSI+] prion in terms of co-polymerization, acquisition of the prion state, and induced prion loss, all of which were also dependent on the [PSI+] variant. The observed loss of S. cerevisiae [PSI+] can be related to inhibition of prion polymerization of S. cerevisiae Sup35 and formation of a non-heritable form of amyloid. We have therefore identified two distinct molecular origins of prion transmission barriers between closely sequence-related prion proteins: first, the inability of heterologous proteins to co-aggregate with host prion polymers, and second, acquisition by these proteins of a non-heritable amyloid fold.	[Afanasieva, Evgenia G.; Kushnirov, Vitaly V.; Ter-Avanesyan, Michael D.] Cardiol Res Ctr, Moscow 121552, Russia; [Tuite, Mick F.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England	National Medical Research Center of Cardiology; University of Kent	Kushnirov, VV (corresponding author), Cardiol Res Ctr, 3rd Cherepkovskaya Str 15A, Moscow 121552, Russia.	vvkushnirov@gmail.com; mdter@cardio.ru	Tuite, Mick/ABC-7909-2020; Vitaly, Kushnirov/AAU-6003-2021	Tuite, Mick/0000-0002-5214-540X; Kushnirov, Vitaly/0000-0003-0316-0766	Wellcome Trust; Russian Foundation for Fundamental Research	Wellcome Trust(Wellcome TrustEuropean Commission); Russian Foundation for Fundamental Research(Russian Foundation for Basic Research (RFBR))	The work was supported by the Wellcome Trust (to V. V. K. and M. F. T.) and the Russian Foundation for Fundamental Research (to M. D. T.-A.).	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Alexandrov IM, 2008, J BIOL CHEM, V283, P15185, DOI 10.1074/jbc.M802071200; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Caughey B, 2001, ADV VIRUS RES, V56, P277, DOI 10.1016/S0065-3527(01)56031-5; Chen BX, 2007, P NATL ACAD SCI USA, V104, P2791, DOI 10.1073/pnas.0611158104; Chen BX, 2010, MOL MICROBIOL, V76, P1483, DOI 10.1111/j.1365-2958.2010.07177.x; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Derkatch IL, 1996, GENETICS, V144, P1375; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Horwich AL, 1997, CELL, V89, P499, DOI 10.1016/S0092-8674(00)80232-9; Kochneva-Pervukhova NV, 2001, YEAST, V18, P489, DOI 10.1002/yea.700; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kushnirov VV, 2006, METHODS, V39, P50, DOI 10.1016/j.ymeth.2006.04.007; Kushnirov VV, 2007, PRION, V1, P179, DOI 10.4161/pri.1.3.4840; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Naumova ES, 2003, FEMS YEAST RES, V3, P177, DOI 10.1016/S1567-1356(02)00191-5; Naumova ES, 2003, ANTON LEEUW INT J G, V83, P155, DOI 10.1023/A:1023328320228; Nemecek J, 2009, P NATL ACAD SCI USA, V106, P1892, DOI 10.1073/pnas.0812470106; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1997, MOL CELL BIOL, V17, P2798, DOI 10.1128/MCB.17.5.2798; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; Shkundina IS, 2006, GENETICS, V172, P827, DOI 10.1534/genetics.105.048660; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Urakov VN, 2010, PRION, V4, P45, DOI 10.4161/pri.4.1.11074; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170	42	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.183889	http://dx.doi.org/10.1074/jbc.M110.183889			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454674	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000290022800017
J	Chen, XF; Overcash, R; Green, T; Hoffman, D; Asch, AS; Ruiz-Echevarra, MJ				Chen, Xiaofei; Overcash, Ryan; Green, Thomas; Hoffman, Donald; Asch, Adam S.; Ruiz-Echevarra, Maria J.			The Tumor Suppressor Activity of the Transmembrane Protein with Epidermal Growth Factor and Two Follistatin Motifs 2 (TMEFF2) Correlates with Its Ability to Modulate Sarcosine Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAUROSPORINE INDUCES APOPTOSIS; PROSTATE-CANCER; NERVOUS-SYSTEM; METHYLATION; IDENTIFICATION; PROMOTER; EXPRESSION; RECEPTOR; ISOFORM; GLYCINE	The type I transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2) is expressed in brain and prostate and overexpressed in prostate cancer, but its role in this disease is unclear. Several studies have suggested that TMEFF2 plays a role in suppressing the growth and invasive potential of human cancer cells, whereas others suggest that the shed portion of TMEFF2, which lacks the cytoplasmic region, has a growth-promoting activity. Here we show that TMEFF2 has a dual mode of action. Ectopic expression of wild-type full-length TMEFF2 inhibits soft agar colony formation, cellular invasion, and migration and increases cellular sensitivity to apoptosis. However, expression of the ectodomain portion of TMEFF2 increases cell proliferation. Using affinity chromatography and mass spectrometry, we identify sarcosine dehydrogenase (SARDH), the enzyme that converts sarcosine to glycine, as a TMEFF2-interacting protein. Co-immunoprecipitation and immunofluorescence analysis confirms the interaction of SARDH with full-length TMEFF2. The ectodomain does not bind to SARDH. Moreover, expression of the full-length TMEFF2 but not the ectodomain results in a decreased level of sarcosine in the cells. These results suggest that the tumor suppressor activity of TMEFF2 requires the cytoplasmic/transmembrane portion of the protein and correlates with its ability to bind to SARDH and to modulate the level of sarcosine.	[Green, Thomas; Asch, Adam S.; Ruiz-Echevarra, Maria J.] Brody Sch Med, Dept Med Hematol Oncol, Greenville, NC 27834 USA; [Chen, Xiaofei; Overcash, Ryan] Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27834 USA; [Hoffman, Donald] Brody Sch Med, Dept Pathol, Greenville, NC 27834 USA; [Asch, Adam S.; Ruiz-Echevarra, Maria J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Ruiz-Echevarra, MJ (corresponding author), Brody Sch Med, Dept Med Hematol Oncol, Greenville, NC 27834 USA.	ruizechevarriam@ecu.edu		Ruiz Echevarria, Maria Jesus/0000-0001-7133-9982	Division of Research and Graduate Studies at East Carolina University; Brody Brothers Foundation	Division of Research and Graduate Studies at East Carolina University; Brody Brothers Foundation	This work was supported in part by contributions from the Division of Research and Graduate Studies at East Carolina University and the Brody Brothers Foundation fund (to M. J. R.- E.).	Afar DEH, 2004, MOL CANCER THER, V3, P921; Ali N, 2007, J BIOL CHEM, V282, P37378, DOI 10.1074/jbc.M702170200; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Belouchi A., 2008, [No title captured], Patent No. [PCT/US2008/003125, 2008003125]; Belouchi A., 2008, World Intellectual Property Organization Patent, Patent No. [WO/2008/112177, 2008112177]; Bergeron F, 1998, EUR J BIOCHEM, V257, P556, DOI 10.1046/j.1432-1327.1998.2570556.x; Brucher BLDM, 2006, INT J CANCER, V119, P1298, DOI 10.1002/ijc.21990; Chang CB, 2003, DEV BIOL, V255, P1, DOI 10.1016/S0012-1606(02)00075-1; Elahi A, 2008, INT J CANCER, V122, P1567, DOI 10.1002/ijc.23202; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; Gery S, 2003, J MOL BIOL, V328, P977, DOI 10.1016/S0022-2836(03)00404-2; Gery S, 2002, ONCOGENE, V21, P4739, DOI 10.1038/sj.onc.1205142; Glynne-Jones E, 2001, INT J CANCER, V94, P178, DOI 10.1002/ijc.1450; Gonzalo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008777; Harms PW, 2003, GENE DEV, V17, P2624, DOI 10.1101/gad.1127703; Heanue TA, 2006, P NATL ACAD SCI USA, V103, P6919, DOI 10.1073/pnas.0602152103; Hellwinkel OJC, 2008, BJU INT, V101, P753, DOI 10.1111/j.1464-410X.2007.07322.x; Horie M, 2000, GENOMICS, V67, P146, DOI 10.1006/geno.2000.6228; Ivanauskas A, 2008, DIGEST LIVER DIS, V40, P920, DOI 10.1016/j.dld.2008.05.004; Javitt DC, 2009, CURR OPIN DRUG DISC, V12, P468; Kanemoto N, 2001, MOL BRAIN RES, V86, P48, DOI 10.1016/S0169-328X(00)00257-6; Kang YK, 2008, CANCER RES, V68, P7887, DOI 10.1158/0008-5472.CAN-08-1734; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Lim SO, 2002, BIOCHEM BIOPH RES CO, V291, P1031, DOI 10.1006/bbrc.2002.6547; Lin H, 2003, LIFE SCI, V73, P1617, DOI 10.1016/S0024-3205(03)00514-9; Mohler JL, 2002, PROSTATE, V51, P247, DOI 10.1002/pros.10086; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Pan D, 2009, EMBO J, V28, P3500, DOI 10.1038/emboj.2009.250; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Quayle SN, 2006, GENOMICS, V87, P633, DOI 10.1016/j.ygeno.2005.12.004; Rodriguez Luis G., 2004, V294, P23; Siegel DA, 2002, INT J DEV NEUROSCI, V20, P373, DOI 10.1016/S0736-5748(02)00055-2; Siegel DA, 2006, J NEUROCHEM, V98, P34, DOI 10.1111/j.1471-4159.2006.03801.x; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stover PJ, 2009, J NUTR, V139, P2402, DOI 10.3945/jn.109.113670; Suzuki M, 2005, BRIT J CANCER, V93, P1029, DOI 10.1038/sj.bjc.6602837; Tsunoda S, 2009, ONCOL REP, V21, P1067, DOI 10.3892/or_00000325; Uchida T, 1999, BIOCHEM BIOPH RES CO, V266, P593, DOI 10.1006/bbrc.1999.1873; Zhang HX, 2009, J PHYSIOL-LONDON, V587, P3207, DOI 10.1113/jphysiol.2009.168757; Zhang XD, 2004, MOL CANCER THER, V3, P187	43	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.193805	http://dx.doi.org/10.1074/jbc.M110.193805			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21393249	Green Published, hybrid			2022-12-27	WOS:000290022800049
J	Hemsworth, GR; Moroz, OV; Fogg, MJ; Scott, B; Bosch-Navarrete, C; Gonzalez-Pacanowska, D; Wilson, KS				Hemsworth, Glyn R.; Moroz, Olga V.; Fogg, Mark J.; Scott, Benjamin; Bosch-Navarrete, Cristina; Gonzalez-Pacanowska, Dolores; Wilson, Keith S.			The Crystal Structure of the Leishmania major Deoxyuridine Triphosphate Nucleotidohydrolase in Complex with Nucleotide Analogues, dUMP, and Deoxyuridine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC CHARACTERIZATION; METAL-BINDING; DUTPASE; HYDROLYSIS; REFINEMENT; MECHANISM; ENZYME; SITE; ION	Members of the Leishmania genus are the causative agents of the life-threatening disease leishmaniasis. New drugs are being sought due to increasing resistance and adverse side effects with current treatments. The knowledge that dUTPase is an essential enzyme and that the all alpha-helical dimeric kinetoplastid dUT-Pases have completely different structures compared with the trimeric beta-sheet type dUTPase possessed by most organisms, including humans, make the dimeric enzymes attractive drug targets. Here, we present crystal structures of the Leishmania major dUTPase in complex with substrate analogues, the product dUMP and a substrate fragment, and of the homologous Campylobacter jejuni dUTPase in complex with a triphosphate substrate analogue. The metal-binding properties of both enzymes are shown to be dependent upon the ligand identity, a previously unseen characteristic of this family. Furthermore, structures of the Leishmania enzyme in the presence of dUMP and deoxyuridine coupled with tryptophan fluorescence quenching indicate that occupation of the phosphate binding region is essential for induction of the closed conformation and hence for substrate binding. These findings will aid in the development of dUTPase inhibitors as potential new lead anti-trypanosomal compounds.	[Hemsworth, Glyn R.; Moroz, Olga V.; Fogg, Mark J.; Scott, Benjamin; Wilson, Keith S.] Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Bosch-Navarrete, Cristina; Gonzalez-Pacanowska, Dolores] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Armilla, Spain	University of York - UK; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Wilson, KS (corresponding author), Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England.	keith@ysbl.york.ac.uk	Hemsworth, Glyn/AAS-5473-2021	Hemsworth, Glyn/0000-0002-8226-1380; Wilson, Keith/0000-0002-3581-2194; bosch-navarrete, cristina/0000-0002-6064-0064; Gonzalez-Pacanowska, Dolores/0000-0002-4303-5209; Fogg, Mark/0000-0002-6692-122X; Moroz, Olga/0000-0002-0354-6119	European Union [223238]; Spanish Plan Nacional [SAF2007-62596]; FIS Network [RD06/0021]; Junta de Andalucia [CVI-199]	European Union(European Commission); Spanish Plan Nacional(Spanish Government); FIS Network; Junta de Andalucia(Junta de Andalucia)	This work was funded by European Union Grant agreement 223238, Spanish Plan Nacional Grant SAF2007-62596, FIS Network Grant RD06/0021, and the Junta de Andalucia Grant CVI-199.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barabas O, 2004, J BIOL CHEM, V279, P42907, DOI 10.1074/jbc.M406135200; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Camacho A, 2000, BIOCHEM J, V346, P163, DOI 10.1042/0264-6021:3460163; Castillo-Acosta VM, 2008, INT J BIOCHEM CELL B, V40, P2901, DOI 10.1016/j.biocel.2008.06.009; Dauter Z, 1999, J MOL BIOL, V285, P655, DOI 10.1006/jmbi.1998.2332; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DESJEUX P, 1996, Nat Struct Biol, V14, P485; ELHAJJ HH, 1988, J BACTERIOL, V170, P1069, DOI 10.1128/jb.170.3.1069-1075.1988; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fogg MJ, 2008, BIOCHEM SOC T, V36, P771, DOI 10.1042/BST0360771; GADSDEN MH, 1993, EMBO J, V12, P4425, DOI 10.1002/j.1460-2075.1993.tb06127.x; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Harkiolaki M, 2004, STRUCTURE, V12, P41, DOI 10.1016/j.str.2003.11.016; Hidalgo-Zarco F, 2001, CURR PROTEIN PEPT SC, V2, P389, DOI 10.2174/1389203013381026; Hidalgo-Zarco F, 2001, PROTEIN SCI, V10, P1426, DOI 10.1110/ps.48801; Kovari J, 2004, J BIOL CHEM, V279, P17932, DOI 10.1074/jbc.M313643200; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Larsson G, 1996, J BIOL CHEM, V271, P24010, DOI 10.1074/jbc.271.39.24010; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; MCGEOCH DJ, 1990, NUCLEIC ACIDS RES, V18, P4105, DOI 10.1093/nar/18.14.4105; Moroz OV, 2004, J MOL BIOL, V342, P1583, DOI 10.1016/j.jmb.2004.07.050; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mustafi D, 2003, P NATL ACAD SCI USA, V100, P5670, DOI 10.1073/pnas.1031504100; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Persson R, 2001, CURR PROTEIN PEPT SC, V2, P287, DOI 10.2174/1389203013381035; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; STEITZ TA, 1993, CURR OPIN STRUC BIOL, V3, P31, DOI 10.1016/0959-440X(93)90198-T; Tellez-Sanz R, 2007, BIOCHIMIE, V89, P972, DOI 10.1016/j.biochi.2007.03.007; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	33	29	29	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.224873	http://dx.doi.org/10.1074/jbc.M111.224873			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454646	Green Published, hybrid			2022-12-27	WOS:000290022800084
J	Grechi, J; Marinho-Carvalho, M; Zancan, P; Cinelli, LP; Gomes, AMO; Rodrigues, ML; Nimrichter, L; Sola-Penna, M				Grechi, Juliana; Marinho-Carvalho, Monica; Zancan, Patricia; Cinelli, Leonardo Paes; Gomes, Andre M. O.; Rodrigues, Marcio L.; Nimrichter, Leonardo; Sola-Penna, Mauro			Glucuronoxylomannan from Cryptococcus neoformans Down-regulates the Enzyme 6-Phosphofructo-1-kinase of Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT MUSCLE PHOSPHOFRUCTOKINASE; BREAST-CANCER CELLS; SKELETAL-MUSCLE; CAPSULAR POLYSACCHARIDES; CELLULAR-DISTRIBUTION; EXTRACELLULAR VESICLES; ALVEOLAR MACROPHAGES; GLYCOLYTIC-ENZYMES; SELF-ASSOCIATION; IN-VIVO	The encapsulated yeast Cryptococcus neoformans is the causative agent of cryptococosis, an opportunistic life-threatening infection. C. neoformans is coated by a polysaccharide capsule mainly composed of glucuronoxylomannan (GXM). GXM is considered a key virulence factor of this pathogen. The present work aimed at evaluating the effects of GXM on the key glycolytic enzyme, 6-phosphofructo-1-kinase (PFK). GXM inhibited PFK activity in cultured murine macrophages in both dose-and time-dependent manners, which occurred in parallel to cell viability decrease. The polysaccharide also inhibited purified PFK, promoting a decrease on the enzyme affinity for its substrates. In macrophages GXM and PFK partially co-localized, suggesting that internalized polysaccharide directly may interact with this enzyme. The mechanism of PFK inhibition involved dissociation of tetramers into weakly active dimers, as revealed by fluorescence spectroscopy. Allosteric modulators of the enzyme able to stabilize its tetrameric conformation attenuated the inhibition promoted by GXM. Altogether, our results suggest that the mechanism of GXM-induced cell death involves the inhibition of the glycolytic flux.	[Grechi, Juliana; Rodrigues, Marcio L.; Nimrichter, Leonardo] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Lab Estudos Integrados Bioquim Microbiana, BR-21941590 Rio De Janeiro, Brazil; [Grechi, Juliana; Marinho-Carvalho, Monica; Sola-Penna, Mauro] Univ Fed Rio de Janeiro, Fac Farm, Lab Enzimol & Controle Metab, BR-21941590 Rio De Janeiro, Brazil; [Zancan, Patricia] Univ Fed Rio de Janeiro, Fac Farm, Lab Oncobiol Mol, BR-21941590 Rio De Janeiro, Brazil; [Gomes, Andre M. O.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil; [Cinelli, Leonardo Paes] Univ Fed Rio de Janeiro, Fac Farm, BR-27930560 Macae, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Nimrichter, L (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Lab Estudos Integrados Bioquim Microbiana, BR-21941590 Rio De Janeiro, Brazil.	nimrichter1@yahoo.com; maurosp@ufrj.br	Zancan, Patricia/Q-6281-2016; Rodrigues, Marcio/J-3727-2013; de Carvalho, Mônica Mesquita Marinho/ABC-7373-2020; Sola-Penna, Mauro/E-8221-2011; Gomes, Andre M.O./C-4009-2014; Nimrichter, Leonardo/L-3545-2014	Zancan, Patricia/0000-0002-0503-028X; Rodrigues, Marcio/0000-0002-6081-3439; Sola-Penna, Mauro/0000-0001-9796-6829; Gomes, Andre M.O./0000-0003-1052-8004; Nimrichter, Leonardo/0000-0001-9281-6856	Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Companhade Aperfeicoamento de Pessoal de Nivel Superior/Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ	Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Companhade Aperfeicoamento de Pessoal de Nivel Superior/Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from the Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (to L.N., M.L.R., M.S.-P., and P.Z.).; Supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.; Supported by Companhade Aperfeicoamento de Pessoal de Nivel Superior/Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ.	Alvarez M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-16; Alvarez M, 2006, CURR BIOL, V16, P2161, DOI 10.1016/j.cub.2006.09.061; Alves GG, 2003, MOL GENET METAB, V78, P302, DOI 10.1016/S1096-7192(03)00037-4; Barbosa FM, 2007, CLIN VACCINE IMMUNOL, V14, P94, DOI 10.1128/CVI.00296-06; BOLANOS B, 1989, J LEUKOCYTE BIOL, V46, P521, DOI 10.1002/jlb.46.6.521; BULMER GS, 1975, INFECT IMMUN, V11, P73, DOI 10.1128/IAI.11.1.73-79.1975; Cai GZ, 1997, BIOPHYS CHEM, V64, P199, DOI 10.1016/S0301-4622(96)02232-6; CASADEVALL A, 1992, J IMMUNOL METHODS, V154, P27, DOI 10.1016/0022-1759(92)90209-C; CEPPI ED, 1992, BIOCHEM J, V284, P761, DOI 10.1042/bj2840761; Chang ZL, 2006, INFECT IMMUN, V74, P144, DOI 10.1128/IAI.74.1.144-151.2006; Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146; Chiapello LS, 2008, INT IMMUNOL, V20, P1527, DOI 10.1093/intimm/dxn112; Coelho WS, 2007, MOL GENET METAB, V92, P364, DOI 10.1016/j.ymgme.2007.07.010; Da Silva D, 2010, ARCH BIOCHEM BIOPHYS, V496, P53, DOI 10.1016/j.abb.2010.01.013; DISCHE Z, 1947, J BIOL CHEM, V167, P189; Ellerbroek PM, 2004, CURR MED CHEM, V11, P253, DOI 10.2174/0929867043456188; Fonseca FL, 2009, FUNGAL GENET BIOL, V46, P496, DOI 10.1016/j.fgb.2009.03.003; Frases S, 2009, P NATL ACAD SCI USA, V106, P1228, DOI 10.1073/pnas.0808995106; Grijpstra J, 2009, EUKARYOT CELL, V8, P1165, DOI 10.1128/EC.00013-09; Heiss C, 2009, CARBOHYD RES, V344, P915, DOI 10.1016/j.carres.2009.03.003; HESTERBERG LK, 1981, BIOCHEMISTRY-US, V20, P2974, DOI 10.1021/bi00513a040; HESTERBERG LK, 1980, BIOCHEMISTRY-US, V19, P2030, DOI 10.1021/bi00551a004; KOZEL TR, 1988, REV INFECT DIS, V10, pS436; KOZEL TR, 1982, J IMMUNOL, V129, P1675; KOZEL TR, 1976, INFECT IMMUN, V14, P62, DOI 10.1128/IAI.14.1.62-67.1976; Leite TC, 2007, BIOCHEM J, V408, P123, DOI 10.1042/BJ20070687; Li Shu Shun, 2010, Proc Am Thorac Soc, V7, P186, DOI 10.1513/pats.200907-063AL; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTHER MA, 1986, J BIOL CHEM, V261, P1753; LUTHER MA, 1983, BIOCHEMISTRY-US, V22, P5494, DOI 10.1021/bi00293a007; LUTHER MA, 1986, BIOCHEMISTRY-US, V25, P7931, DOI 10.1021/bi00372a022; Maia J.C.C., 1983, GENES ANTIGENES PARA, P146; Marcondes MC, 2010, ARCH BIOCHEM BIOPHYS, V497, P62, DOI 10.1016/j.abb.2010.03.013; Marinho-Carvalho MM, 2006, MOL GENET METAB, V87, P253, DOI 10.1016/j.ymgme.2005.11.002; Marinho-Carvalho MM, 2009, BBA-PROTEINS PROTEOM, V1794, P1175, DOI 10.1016/j.bbapap.2009.02.006; McClelland EE, 2006, INFECT IMMUN, V74, P1500, DOI 10.1128/IAI.74.3.1500-1504.2006; McFadden DC, 2006, J BIOL CHEM, V281, P1868, DOI 10.1074/jbc.M509465200; Meira DD, 2005, MOL GENET METAB, V84, P354, DOI 10.1016/j.ymgme.2004.11.012; MITCHELL TG, 1972, INFECT IMMUN, V5, P491, DOI 10.1128/IAI.5.4.491-498.1972; Monari C, 2005, J INFECT DIS, V191, P127, DOI 10.1086/426511; Monari C, 2008, CELL MICROBIOL, V10, P2129, DOI 10.1111/j.1462-5822.2008.01196.x; Monari C, 2009, J IMMUNOL, V183, P191, DOI 10.4049/jimmunol.0804144; Mukherjee S, 1996, J INFECT DIS, V173, P1222, DOI 10.1093/infdis/173.5.1222; Nimrichter L, 2007, EUKARYOT CELL, V6, P1400, DOI 10.1128/EC.00122-07; Nosanchuk Joshua D, 2008, Commun Integr Biol, V1, P37; Oliveira DL, 2010, INFECT IMMUN, V78, P1601, DOI 10.1128/IAI.01171-09; OROSZ F, 1988, MOL PHARMACOL, V33, P678; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pelli AA, 2010, MICRON, V41, P660, DOI 10.1016/j.micron.2010.03.001; Penso J, 1998, EUR J PHARMACOL, V342, P113, DOI 10.1016/S0014-2999(97)01507-0; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Prado M, 2009, MEM I OSWALDO CRUZ, V104, P513, DOI 10.1590/S0074-02762009000300019; Rais B, 2000, BBA-PROTEIN STRUCT M, V1479, P303, DOI 10.1016/S0167-4838(00)00047-9; Real-Hohn A, 2010, BIOCHIMIE, V92, P538, DOI 10.1016/j.biochi.2010.01.023; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; Rodrigues ML, 2009, MED MYCOL, V47, P783, DOI 10.3109/13693780902788621; Silva APP, 2004, AN ACAD BRAS CIENC, V76, P541, DOI 10.1590/S0001-37652004000300008; Sola-Penna M, 2002, J BIOCHEM BIOPH METH, V50, P129, DOI 10.1016/S0165-022X(01)00180-4; Sola-Penna M, 2008, IUBMB LIFE, V60, P605, DOI 10.1002/iub.97; Sola-Penna M, 2010, IUBMB LIFE, V62, P791, DOI 10.1002/iub.393; Spitz GA, 2009, BIOCHEM PHARMACOL, V77, P46, DOI 10.1016/j.bcp.2008.09.020; TAYLOR RL, 1972, BIOCHEMISTRY-US, V11, P1383, DOI 10.1021/bi00758a009; Tucker SC, 2002, P NATL ACAD SCI USA, V99, P3165, DOI 10.1073/pnas.052702799; Vecchiarelli A, 2000, MED MYCOL, V38, P407, DOI 10.1080/mmy.38.6.407.417; Vecchiarelli Anna, 2010, Front Biosci (Schol Ed), V2, P256; Vertessy BG, 1997, BIOCHEMISTRY-US, V36, P2051, DOI 10.1021/bi9623441; Villena SN, 2008, CELL MICROBIOL, V10, P1274, DOI 10.1111/j.1462-5822.2008.01125.x; Yauch LE, 2006, PLOS PATHOG, V2, P1060, DOI 10.1371/journal.ppat.0020120; Yauch LE, 2005, INFECT IMMUN, V73, P8429, DOI 10.1128/IAI.73.12.8429-8432.2005; Zancan P, 2005, MOL GENET METAB, V86, P401, DOI 10.1016/j.ymgme.2005.06.011; Zancan P, 2005, MOL GENET METAB, V86, P392, DOI 10.1016/j.ymgme.2005.07.005; Zancan P, 2008, IUBMB LIFE, V60, P526, DOI 10.1002/iub.58; Zancan P, 2007, ARCH BIOCHEM BIOPHYS, V467, P275, DOI 10.1016/j.abb.2007.08.032; Zancan P, 2007, BIOCHEM PHARMACOL, V73, P1520, DOI 10.1016/j.bcp.2007.01.018; Zancan P, 2010, MOL GENET METAB, V100, P372, DOI 10.1016/j.ymgme.2010.04.006; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0	77	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14820	14829		10.1074/jbc.M110.177030	http://dx.doi.org/10.1074/jbc.M110.177030			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21388964	hybrid, Green Published			2022-12-27	WOS:000289788300012
J	Venkatesha, SH; Yu, H; Rajaiah, R; Tong, L; Moudgil, KD				Venkatesha, Shivaprasad H.; Yu, Hua; Rajaiah, Rajesh; Tong, Li; Moudgil, Kamal D.			Celastrus-derived Celastrol Suppresses Autoimmune Arthritis by Modulating Antigen-induced Cellular and Humoral Effector Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHEUMATOID-ARTHRITIS; TERMINAL DETERMINANTS; T-H-17 CELLS; HEAT-SHOCK-PROTEIN-65; MYCOBACTERIAL; ANGIOGENESIS; DISABILITY; ANTIBODIES; INDUCTION; CYTOKINES	Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovial inflammation and articular damage. Proinflammatory cytokines, antibodies, and matrix-degrading enzymes orchestrate the pathogenic events in autoimmune arthritis. Accordingly, these mediators of inflammation are the targets of several anti-arthritic drugs. However, the prolonged use of such drugs is associated with severe adverse reactions. This limitation has necessitated the search for less toxic natural plant products that possess anti-arthritic activity. Furthermore, it is imperative that the mechanism of action of such products be explored before they can be recommended for further preclinical testing. Using the rat adjuvant-induced arthritis model of human RA, we demonstrate that celastrol derived from Celastrus has potent anti-arthritic activity. This suppression of arthritis is mediated via modulation of the key proinflammatory cytokines (IL-17, IL-6, and IFN-gamma) in response to the disease-related antigens, of the IL-6/IL-17-related transcription factor STAT3, of antibodies directed against cyclic citrullinated peptides and Bhsp65, and of the activity of matrix metalloproteinase-9 and phospho-ERK. Most of the clinical and mechanistic attributes of celastrol are similar to those of Celastrus extract. Several studies have addressed the antitumor activity of celastrol. Our study highlights the anti-arthritic activity of Celastrus-derived celastrol and the underlying mechanisms. These results provide a strong rationale for further testing and validation of the use of celastrol and the natural plant extract from Celastrus as an adjunct (with conventional drugs) or alternative modality for the treatment of RA.	[Venkatesha, Shivaprasad H.; Yu, Hua; Rajaiah, Rajesh; Moudgil, Kamal D.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Moudgil, Kamal D.] Univ Maryland, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21201 USA; [Tong, Li] So Med Univ, Sch Tradit Chinese Med, Guangzhou 510510, Guangdong, Peoples R China	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Southern Medical University - China	Moudgil, KD (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, 685 W Baltimore St,HSF-1,Suite 380, Baltimore, MD 21201 USA.	kmoud001@umaryland.edu	Venkatesha, Shivaprasad/S-3141-2016; Rajaiah, Rajesh/A-3403-2012; Rajaiah, rajesh/ABA-5509-2021; yu, hua/F-8948-2012		National Institutes of Health [R01AT004321]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported, in whole or in part, by National Institutes of Health Grant R01AT004321.	Backman CL, 2004, CURR OPIN RHEUMATOL, V16, P148, DOI 10.1097/00002281-200403000-00014; Barnes Patricia M, 2004, Adv Data, P1; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Chang YH, 2008, CLIN BIOCHEM, V41, P955, DOI 10.1016/j.clinbiochem.2008.04.012; Durai M, 2004, J IMMUNOL, V172, P2795, DOI 10.4049/jimmunol.172.5.2795; Eck SM, 2009, J AUTOIMMUN, V33, P214, DOI 10.1016/j.jaut.2009.09.011; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; Gaffen Sarah L, 2009, Curr Rheumatol Rep, V11, P365; Gorman CL, 2008, BEST PRACT RES CL RH, V22, P221, DOI 10.1016/j.berh.2008.01.003; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hembry Rosalind M., 2007, V135, P227; Hu HY, 2009, J CARDIOVASC PHARM, V54, P240, DOI 10.1097/FJC.0b013e3181b21472; Jung HW, 2007, EXP MOL MED, V39, P715, DOI 10.1038/emm.2007.78; Kageyama-Yahara N, 2010, BIOL PHARM BULL, V33, P142, DOI 10.1248/bpb.33.142; Kim DH, 2009, EUR J CLIN INVEST, V39, P819, DOI 10.1111/j.1365-2362.2009.02186.x; Kim HR, 2006, J IMMUNOL, V177, P6634, DOI 10.4049/jimmunol.177.10.6634; Kim Y, 2009, EUR J PHARMACOL, V612, P131, DOI 10.1016/j.ejphar.2009.03.071; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kremers HM, 2004, J RHEUMATOL, V31, P2366; Lainer-Carr D, 2007, NAT CLIN PRACT RHEUM, V3, P434, DOI 10.1038/ncprheum0559; Lipsky PE, 2005, HARRISONS PRINCIPLES, P1968; Luo DQ, 2005, PEST MANAG SCI, V61, P85, DOI 10.1002/ps.953; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Moudgil KD, 1997, J EXP MED, V185, P1307, DOI 10.1084/jem.185.7.1307; Pajulo OT, 1999, WOUND REPAIR REGEN, V7, P453, DOI 10.1046/j.1524-475X.1999.00453.x; Pruijn GJM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2903; Quiding-Jarbrink M, 2001, INFECT IMMUN, V69, P5661, DOI 10.1128/IAI.69.9.5661-5670.2001; Rajaiah R, 2011, J BIOL CHEM, V286, P2817, DOI 10.1074/jbc.M110.187013; Scott DL, 2003, CLIN EXP RHEUMATOL, V21, pS20; Shen CL, 2011, OSTEOPOROSIS INT, V22, P327, DOI 10.1007/s00198-010-1209-2; Song YW, 2010, QJM-INT J MED, V103, P139, DOI 10.1093/qjmed/hcp165; Stiel D, 2000, Am J Ther, V7, P91, DOI 10.1097/00045391-200007020-00006; Taibi DM, 2003, FAM COMMUNITY HEALTH, V26, P41, DOI 10.1097/00003727-200301000-00006; Tong L, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2268; Uysal H, 2010, IMMUNOL REV, V233, P9, DOI 10.1111/j.0105-2896.2009.00853.x; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Venkatesha SH, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/986797; Venkatesha SH, 2011, BIOORGAN MED CHEM, V19, P21, DOI 10.1016/j.bmc.2010.10.053; Weir MR, 2002, CLEV CLIN J MED, V69, P53; WOOLEY PH, 1988, METHOD ENZYMOL, V162, P361; Wu SH, 2004, J CHROMATOGR A, V1028, P171, DOI 10.1016/j.chroma.2003.11.072; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yu H, 2011, ARTHRITIS RHEUM-US, V63, P981, DOI 10.1002/art.30219	45	89	93	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15138	15146		10.1074/jbc.M111.226365	http://dx.doi.org/10.1074/jbc.M111.226365			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21402700	hybrid, Green Published			2022-12-27	WOS:000289788300045
J	Solomon, IH; Khatri, N; Biasini, E; Massignan, T; Huettner, JE; Harris, DA				Solomon, Isaac H.; Khatri, Natasha; Biasini, Emiliano; Massignan, Tania; Huettner, James E.; Harris, David A.			An N-terminal Polybasic Domain and Cell Surface Localization Are Required for Mutant Prion Protein Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; CULTURED-CELLS; SYNAPTIC PLASTICITY; ANCHORED PROTEINS; SCRAPIE ISOFORM; TRANSGENIC MICE; BETA OLIGOMERS; WILD-TYPE; PRP; DISEASE	There is evidence that alterations in the normal physiological activity of PrPC contribute to prion-induced neurotoxicity. This mechanism has been difficult to investigate, however, because the normal function of PrPC has remained obscure, and there are no assays available to measure it. We recently reported that cells expressing PrP deleted for residues 105-125 exhibit spontaneous ionic currents and hypersensitivity to certain classes of cationic drugs. Here, we utilize cell culture assays based on these two phenomena to test how changes in PrP sequence and/or cellular localization affect the functional activity of the protein. We report that the toxic activity of Delta 105-125 PrP requires localization to the plasma membrane and depends on the presence of a polybasic amino acid segment at the N terminus of PrP. Several different deletions spanning the central region as well as three disease-associated point mutations also confer toxic activity on PrP. The sequence domains identified in our study are also critical for PrPSc formation, suggesting that common structural features may govern both the functional activity of PrPC and its conversion to PrPSc.	[Solomon, Isaac H.; Khatri, Natasha; Biasini, Emiliano; Massignan, Tania; Harris, David A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Huettner, James E.] Washington Univ, Dept Cell Biol & Physiol, Sch Med, St Louis, MO 63110 USA	Boston University; Washington University (WUSTL)	Harris, DA (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,K225, Boston, MA 02118 USA.	daharris@bu.edu	Huettner, James E/C-5219-2012; Biasini, Emiliano/A-3147-2011	Biasini, Emiliano/0000-0002-3927-6341; massignan, tania/0000-0002-6176-2696; Harris, David/0000-0002-6985-5790	National Institutes of Health [NS052526, NS040975, NS30888, NS063547]; Washington University [T32GM007200]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200, T32GM008541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS063547, R01NS030888, R01NS040975, R01NS065244, R01NS052526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS052526 and NS040975 (to D. A. H.) and NS30888 (to J. E. H.).; Supported by National Institutes of Health Pre-doctoral Fellowship NS063547 and the Medical Scientist Training Program at Washington University (National Institutes of Health Grant T32GM007200).	Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Baumann F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006707; Biasini E, 2010, BIOCHEM J, V430, P477, DOI 10.1042/BJ20100615; BOLTON DC, 1991, J VIROL, V65, P3667, DOI 10.1128/JVI.65.7.3667-3675.1991; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Christensen HM, 2009, J NEUROCHEM, V108, P44, DOI 10.1111/j.1471-4159.2008.05719.x; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Fuhrmann M, 2006, J NEUROCHEM, V98, P1876, DOI 10.1111/j.1471-4159.2006.04011.x; GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619; Hajj GNM, 2007, J CELL SCI, V120, P1915, DOI 10.1242/jcs.03459; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; HAY B, 1987, MOL CELL BIOL, V7, P914, DOI 10.1128/MCB.7.2.914; Herms JW, 2001, NEUROBIOL DIS, V8, P324, DOI 10.1006/nbdi.2000.0369; HOBMAN TC, 1995, MOL BIOL CELL, V6, P7, DOI 10.1091/mbc.6.1.7; Hooper NM, 2008, BIOCHEM SOC T, V36, P1272, DOI 10.1042/BST0361272; HORNSHAW MP, 1995, BIOCHEM BIOPH RES CO, V207, P621, DOI 10.1006/bbrc.1995.1233; Huettner JE, 2006, STEM CELLS, V24, P1654, DOI 10.1634/stemcells.2005-0003; Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Kourie JI, 2003, J MEMBRANE BIOL, V193, P35, DOI 10.1007/s00232-002-2005-5; Kourie JI, 2002, EUR BIOPHYS J BIOPHY, V31, P409, DOI 10.1007/s00249-002-0242-2; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Lorenz H, 2002, J BIOL CHEM, V277, P8508, DOI 10.1074/jbc.M110197200; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Maglio LE, 2004, MOL BRAIN RES, V131, P58, DOI 10.1016/j.molbrainres.2004.08.004; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Massignan T, 2011, METHODS, V53, P214, DOI 10.1016/j.ymeth.2010.11.005; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Myrdal SE, 2005, HEARING RES, V204, P170, DOI 10.1016/j.heares.2005.02.005; Myrdal SE, 2005, HEARING RES, V204, P156, DOI 10.1016/j.heares.2005.02.002; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005285; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2004, PRION BIOL DIS; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Rodriguez MM, 2005, NEUROLOGY, V64, P1455, DOI 10.1212/01.WNL.0000158618.39527.93; Sandoval RM, 2000, AM J PHYSIOL-RENAL, V279, pF884, DOI 10.1152/ajprenal.2000.279.5.F884; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SHYNG SL, 1995, J BIOL CHEM, V270, P14793, DOI 10.1074/jbc.270.24.14793; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; Wadia JS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003314; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Wilding TJ, 2005, J NEUROSCI, V25, P9470, DOI 10.1523/JNEUROSCI.2826-05.2005; YOST CS, 1990, NATURE, V343, P669, DOI 10.1038/343669a0; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200	72	45	45	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14724	14736		10.1074/jbc.M110.214973	http://dx.doi.org/10.1074/jbc.M110.214973			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21385869	Green Published, hybrid			2022-12-27	WOS:000289556200091
J	Colleran, A; Ryan, A; O'Gorman, A; Mureau, C; Liptrot, C; Dockery, P; Fearnhead, H; Egan, LJ				Colleran, Amy; Ryan, Aideen; O'Gorman, Angela; Mureau, Coralie; Liptrot, Catherine; Dockery, Peter; Fearnhead, Howard; Egan, Laurence J.			Autophagosomal I kappa B alpha Degradation Plays a Role in the Long Term Control of Tumor Necrosis Factor-alpha-induced Nuclear Factor-kappa B (NF-kappa B) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL PANETH CELLS; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; FAMILY-MEMBERS; CROHN-DISEASE; ACTIVATION; KINASE; INHIBITOR; PHOSPHORYLATION	Transcription factor NF-kappa B is persistently activated in many chronic inflammatory diseases and cancers. The short term regulation of NF-kappa B is well understood, but little is known about the mechanisms of its long term activation. We studied the effect of a single application of TNF-alpha on NF-kappa B activity for up to 48 h in intestinal epithelial cells. Results show that NF-kappa B remained persistently activated up to 48 h after TNF-alpha and that the long term activation of NF-kappa B was accompanied by a biphasic degradation of I kappa B alpha. The first phase of I kappa B alpha degradation was proteasome-dependent, but the second was not. Further investigation showed that TNF-alpha stimulated formation of autophagosomes in intestinal epithelial cells and that I kappa B alpha co-localized with autophagosomal vesicles. Pharmacological or genetic blockade of autophagosome formation or the inhibition of lysosomal proteases decreased TNF-alpha-induced degradation of I kappa B alpha and lowered NF-kappa B target gene expression. Together, these findings indicate a role of autophagy in the control of long term NF-kappa B activity. Because abnormalities in autophagy have been linked to ineffective innate immunity, we propose that alterations in NF-kappa B may mediate this effect.	[Colleran, Amy; Ryan, Aideen; O'Gorman, Angela; Mureau, Coralie; Fearnhead, Howard; Egan, Laurence J.] Natl Univ Ireland, Dept Pharmacol & Therapeut, Galway, Ireland; [Liptrot, Catherine; Dockery, Peter] Natl Univ Ireland, Sch Med, Dept Anat, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Egan, LJ (corresponding author), Univ Hosp Galway, Inst Clin Sci, Newcastle Rd, Galway, Ireland.	laurence.egan@nuigalway.ie	Ryan, Aideen/H-3909-2019; Fearnhead, Howard O/D-4826-2012; Liptrot, Catherine/D-7056-2012	Ryan, Aideen/0000-0002-5831-6783; Liptrot, Catherine/0000-0003-3882-8084; Fearnhead, Howard/0000-0002-8054-9794; Dockery, Peter/0000-0001-5103-6589	Science Foundation Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland.	Artis D, 2002, J IMMUNOL, V169, P4481, DOI 10.4049/jimmunol.169.8.4481; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Barkett M, 1997, J BIOL CHEM, V272, P29419, DOI 10.1074/jbc.272.47.29419; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2009, AUTOPHAGY, V5, P250, DOI 10.4161/auto.5.2.7560; Chen F, 1997, ARCH BIOCHEM BIOPHYS, V342, P383, DOI 10.1006/abbi.1997.0132; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Copetti T, 2009, AUTOPHAGY, V5, P858, DOI 10.4161/auto.8822; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Elewaut D, 1999, J IMMUNOL, V163, P1457; Erdman SE, 2001, J IMMUNOL, V166, P1443, DOI 10.4049/jimmunol.166.3.1443; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Howard CV, 2005, UNBIASED STEREOLOGY; Jobin C, 1997, J IMMUNOL, V158, P226; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Khalkhali-Ellis Z, 2008, J CELL BIOCHEM, V105, P208, DOI 10.1002/jcb.21814; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lin RT, 1996, MOL CELL BIOL, V16, P1401; Lind DS, 2001, SURGERY, V130, P363, DOI 10.1067/msy.2001.116672; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Neurath MF, 1998, ANN NY ACAD SCI, V859, P149, DOI 10.1111/j.1749-6632.1998.tb11119.x; Ozes ON, 1999, NATURE, V401, P82; Qing GL, 2007, CELL RES, V17, P520, DOI 10.1038/cr.2007.47; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Romieu-Mourez R, 2002, CANCER RES, V62, P6770; Rosenstiel P, 2009, ADV EXP MED BIOL, V653, P35; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tam WF, 2001, MOL CELL BIOL, V21, P4837, DOI 10.1128/MCB.21.14.4837-4846.2001; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0; Yuan H, 2009, AM J PHYSIOL-HEART C, V296, pH470, DOI 10.1152/ajpheart.01051.2008; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	46	49	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22886	22893		10.1074/jbc.M110.199950	http://dx.doi.org/10.1074/jbc.M110.199950			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21454695	Green Published, hybrid			2022-12-27	WOS:000292025000023
J	Muller, P; Ahmad, M				Mueller, Pavel; Ahmad, Margaret			Light-activated Cryptochrome Reacts with Molecular Oxygen to Form a Flavin-Superoxide Radical Pair Consistent with Magnetoreception	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED ELECTRON-TRANSFER; BLUE-LIGHT; CHEMICAL MAGNETORECEPTION; DNA PHOTOLYASE; PHOTORECEPTOR; MECHANISM; COFACTOR; COMPASS; BIRDS; MODEL	Cryptochromes are flavin-based photoreceptors occurring throughout the biological kingdom, which regulate growth and development in plants and are involved in the entrainment of circadian rhythms of both plants and animals. A number of recent theoretical works suggest that cryptochromes might also be the receptors responsible for the sensing of the magnetic field of the earth (e.g. in insects, migratory birds, or migratory fish). Cryptochromes undergo forward light-induced reactions involving electron transfer to excited state flavin to generate radical intermediates, which correlate with biological activity. Here, we give evidence of a mechanism for the reverse reaction, namely dark reoxidation of protein-bound flavin in Arabidopsis thaliana cryptochrome (AtCRY1) by molecular oxygen that involves formation of a spin-correlated FADH(center dot)-superoxide radical pair. Formation of analogous radical pairs in animal cryptochromes might enable them to function as magnetoreceptors.	[Mueller, Pavel; Ahmad, Margaret] Univ Paris 06, F-75005 Paris, France; [Mueller, Pavel] CEA, Inst Biol & Technol Saclay, Lab Photocatalyse & Biohydrogene, F-91191 Gif Sur Yvette, France; [Ahmad, Margaret] Penn State Univ, Media, PA 19063 USA	UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Ahmad, M (corresponding author), Univ Paris 06, Casier 156,4 Pl Jussieu, F-75005 Paris, France.	margaret.ahmad@upmc.fr	Müller, Pavel/I-8299-2012	Müller, Pavel/0000-0002-3245-0810; Ahmad, Margaret/0000-0003-4524-5813	National Science Foundation [0848311]; Human Frontiers; Agence Nationale de la Recherche	National Science Foundation(National Science Foundation (NSF)); Human Frontiers; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by National Science Foundation Grant 0848311 (to M. A.), a grant from Human Frontiers (to M. A. and T. Ritz), and a grant from the Agence Nationale de la Recherche (to M. A., K. Brettel, and F. Rouyer).	Balland V, 2009, J AM CHEM SOC, V131, P426, DOI 10.1021/ja806540j; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Brazard J, 2010, J AM CHEM SOC, V132, P4935, DOI 10.1021/ja1002372; Brettel K, 2010, CURR OPIN STRUC BIOL, V20, P693, DOI 10.1016/j.sbi.2010.07.003; Burney S, 2009, FEBS LETT, V583, P1427, DOI 10.1016/j.febslet.2009.03.040; CHAVES I, 2011, ANN REV PLA IN PRESS; Clausen MR, 2010, J AGR FOOD CHEM, V58, P481, DOI 10.1021/jf903470p; Devlin PF, 2000, PLANT CELL, V12, P2499, DOI 10.1105/tpc.12.12.2499; Everett SA, 1996, BIOCHEM J, V317, P17, DOI 10.1042/bj3170017; Fujiwara K, 2006, INT J ENVIRON AN CH, V86, P337, DOI 10.1080/03067310500352312; GAMPP H, 1985, TALANTA, V32, P257, DOI 10.1016/0039-9140(85)80077-1; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Gegear RJ, 2010, NATURE, V463, P804, DOI 10.1038/nature08719; Giovani B, 2003, NAT STRUCT BIOL, V10, P489, DOI 10.1038/nsb933; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; Hogben HJ, 2009, CHEM PHYS LETT, V480, P118, DOI 10.1016/j.cplett.2009.08.051; Kao YT, 2008, J AM CHEM SOC, V130, P7695, DOI 10.1021/ja801152h; Langenbacher T, 2009, J AM CHEM SOC, V131, P14274, DOI 10.1021/ja901628y; Liedvogel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001106; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Liu B, 2010, CURR OPIN PLANT BIOL, V13, P578, DOI 10.1016/j.pbi.2010.09.005; Maeda K, 2008, NATURE, V453, P387, DOI 10.1038/nature06834; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657, DOI 10.1146/annurev.ph.48.030186.003301; RAO PS, 1973, BIOCHEM BIOPH RES CO, V51, P468, DOI 10.1016/0006-291X(73)91280-1; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Rodgers CT, 2009, P NATL ACAD SCI USA, V106, P353, DOI 10.1073/pnas.0711968106; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Song SH, 2007, J BIOL CHEM, V282, P17608, DOI 10.1074/jbc.M702874200; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; vanVickle-Chavez SJ, 2007, J BIOL CHEM, V282, P10561, DOI 10.1074/jbc.M609314200; Yoshii T, 2009, PLOS BIOL, V7, P813, DOI 10.1371/journal.pbio.1000086; Zeugner A, 2005, J BIOL CHEM, V280, P19437, DOI 10.1074/jbc.C500077200	38	108	111	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21033	21040		10.1074/jbc.M111.228940	http://dx.doi.org/10.1074/jbc.M111.228940			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21467031	hybrid, Green Published			2022-12-27	WOS:000291464700002
J	Franzmann, TM; Czekalla, A; Walter, SG				Franzmann, Titus M.; Czekalla, Anna; Walter, Stefan G.			Regulatory Circuits of the AAA plus Disaggregase Hsp104	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE HSP104; PROTEIN DISAGGREGATION; AGGREGATED PROTEINS; SACCHAROMYCES-CEREVISIAE; CONFORMATIONAL-CHANGES; THERMUS-THERMOPHILUS; PRION PROPAGATION; ATPASE ACTIVITY; BINDING-SITES; TUMOR-ANTIGEN	Yeast Hsp104 is an AAA+ chaperone that rescues proteins from the aggregated state. Six protomers associate to form the functional hexamer. Each protomer contains two AAA+ modules, NBD1 and NBD2. Hsp104 converts energy provided by ATP into mechanical force used to thread polypeptides through its axial channel, thereby disrupting protein aggregates. But how the action of its 12 AAA+ domains is co-ordinated to catalyze disaggregation remained unexplained. Here, we identify a sophisticated allosteric network consisting of three distinct pathways that senses the nucleotide state of AAA+ modules and transmits this information across the Hsp104 hexamer. As a result of this communication, NBD1 and NBD2 each adopt two distinct conformations (relaxed and tense) that are reciprocally regulated. The key element in the network is the NBD1-ATP state that enables Hsp104 to switch from a barely active [(T)(R)] state to a highly active [(R)(T)] state. This concerted switch involves both cis and trans protomer interactions and provides Hsp104 with the mechanistic scaffold to catalyze disaggregation. It prepares the chaperone for polypeptide binding and activates NBD2 to generate the power strokes required to resolve protein aggregates. ATP hydrolysis in NBD1 resolves the high affinity [(R)(T)] state and switches the chaperone back into the low affinity [(T)(R)] state. Our model integrates previously unexplained observations and provides the first comprehensive map of nucleotide-related allosteric signals in a class-1 AAA+ protein.	[Franzmann, Titus M.; Czekalla, Anna; Walter, Stefan G.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Walter, SG (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N Univ, Ann Arbor, MI 48109 USA.	sgwalter@umich.edu	Franzmann, Titus M/D-1962-2011	Franzmann, Titus/0000-0002-4281-7209				Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Barends TRM, 2010, CURR OPIN STRUC BIOL, V20, P46, DOI 10.1016/j.sbi.2009.12.014; Beinker P, 2005, J BIOL CHEM, V280, P37965, DOI 10.1074/jbc.M506672200; Beinker P, 2002, J BIOL CHEM, V277, P47160, DOI 10.1074/jbc.M207853200; Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; Bendz H, 2007, J BIOL CHEM, V282, P31688, DOI 10.1074/jbc.M704129200; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bosl B, 2006, J STRUCT BIOL, V156, P139, DOI 10.1016/j.jsb.2006.02.004; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Cha SS, 2010, EMBO J, V29, P3520, DOI 10.1038/emboj.2010.226; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; Haslberger T, 2010, BIOCHEM CELL BIOL, V88, P63, DOI [10.1139/O09-118, 10.1139/o09-118]; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Osorio H, 2003, EUR J BIOCHEM, V270, P1578, DOI 10.1046/j.1432-1033.2003.03529.x; PARSELL DA, 1991, NATURE, V353, P270, DOI 10.1038/353270a0; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schaupp A, 2007, J MOL BIOL, V370, P674, DOI 10.1016/j.jmb.2007.04.070; Schirmer EC, 2001, P NATL ACAD SCI USA, V98, P914, DOI 10.1073/pnas.031568098; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; Schlieker C, 2004, FEBS LETT, V578, P351, DOI 10.1016/j.febslet.2004.11.051; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Watanabe YH, 2002, J BIOL CHEM, V277, P5804, DOI 10.1074/jbc.M109349200; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wendler P, 2009, MOL CELL, V34, P81, DOI 10.1016/j.molcel.2009.02.026; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026	46	37	37	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17992	18001		10.1074/jbc.M110.216176	http://dx.doi.org/10.1074/jbc.M110.216176			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454552	hybrid, Green Published			2022-12-27	WOS:000290585200061
J	Haag, AF; Wehmeier, S; Muszynski, A; Kerscher, B; Fletcher, V; Berry, SH; Hold, GL; Carlson, RW; Ferguson, GP				Haag, Andreas F.; Wehmeier, Silvia; Muszynski, Artur; Kerscher, Bernhard; Fletcher, Vivien; Berry, Susan H.; Hold, Georgina L.; Carlson, Russell W.; Ferguson, Gail P.			Biochemical Characterization of Sinorhizobium meliloti Mutants Reveals Gene Products Involved in the Biosynthesis of the Unusual Lipid A Very Long-chain Fatty Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHIZOBIUM-MELILOTI; LEGUME SYMBIOSIS; ACPXL MUTANT; LIPOPOLYSACCHARIDE; BACTERIA; NODULES; PROTEIN; FORM; EXOPOLYSACCHARIDE; DEFICIENT	Sinorhizobium meliloti forms a symbiosis with the legume alfalfa, whereby it differentiates into a nitrogen-fixing bacteroid. The lipid A species of S. meliloti are modified with very long-chain fatty acids (VLCFAs), which play a central role in bacteroid development. A six-gene cluster was hypothesized to be essential for the biosynthesis of VLCFA-modified lipid A. Previously, two cluster gene products, AcpXL and LpxXL, were found to be essential for S. meliloti lipid A VLCFA biosynthesis. In this paper, we show that the remaining four cluster genes are all involved in lipid A VLCFA biosynthesis. Therefore, we have identified novel gene products involved in the biosynthesis of these unusual lipid modifications. By physiological characterization of the cluster mutant strains, we demonstrate the importance of this gene cluster in the legume symbiosis and for growth in the absence of salt. Bacterial LPS species modified with VLCFAs are substantially less immunogenic than Escherichia coli LPS species, which lack VLCFAs. However, we show that the VLCFA modifications do not suppress the immunogenicity of S. meliloti LPS or affect the ability of S. meliloti to induce fluorescent plant defense molecules within the legume. Because VLCFA-modified lipids are produced by other rhizobia and mammalian pathogens, these findings will also be important in understanding the function and biosynthesis of these unusual fatty acids in diverse bacterial species.	[Haag, Andreas F.; Wehmeier, Silvia; Fletcher, Vivien; Berry, Susan H.; Hold, Georgina L.; Ferguson, Gail P.] Univ Aberdeen, Inst Med Sci, Sch Med & Dent, Aberdeen AB25 2ZD, Scotland; [Muszynski, Artur; Carlson, Russell W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University of Aberdeen; University System of Georgia; University of Georgia	Ferguson, GP (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med & Dent, Foresterhill, Aberdeen AB25 2ZD, Scotland.	g.ferguson@abdn.ac.uk	Kerscher, Bernhard G R/B-1907-2015; Haag, Andreas F/R-8775-2019; Hold, Georgina Louise/AAG-9923-2020; Wehmeier, Silvia/T-3815-2019	Kerscher, Bernhard G R/0000-0001-9300-7401; Haag, Andreas F/0000-0002-6783-0231; Hold, Georgina Louise/0000-0001-7573-3397; Muszynski, Artur/0000-0003-3497-9977; Wehmeier, Silvia/0000-0002-9824-0859	Biotechnology and Biological Sciences Research Council [BB/D000564/1]; Medical Research Council [G0501107]; Department of Energy [DE-FG02-09ER20097]; IMS; BBSRC [BB/D000564/1] Funding Source: UKRI; MRC [G0501107] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Energy(United States Department of Energy (DOE)); IMS; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Biotechnology and Biological Sciences Research Council Grant BB/D000564/1 and Medical Research Council New Investigator Grant G0501107 (to G. P. F.). Structural analysis was supported in part by Department of Energy Grant DE-FG02-09ER20097 (to the Complex Carbohydrate Research Center).; Supported by an IMS Ph.D. studentship.	Ardissone S., 2011, J BACTERIOL IN PRESS; Beck S, 2008, MICROBIOL-SGM, V154, P1258, DOI 10.1099/mic.0.2007/014894-0; BHAT UR, 1994, J BIOL CHEM, V269, P14402; BHAT UR, 1991, INT J SYST BACTERIOL, V41, P213; Campbell GRO, 2002, P NATL ACAD SCI USA, V99, P3938, DOI 10.1073/pnas.062425699; Ferguson GP, 2005, MOL MICROBIOL, V56, P68, DOI 10.1111/j.1365-2958.2005.04536.x; Ferguson GP, 2004, P NATL ACAD SCI USA, V101, P5012, DOI 10.1073/pnas.0307137101; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Galkiewicz JP, 2008, APPL ENVIRON MICROB, V74, P7828, DOI 10.1128/AEM.01303-08; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; Gudlavalleti SK, 2003, J BIOL CHEM, V278, P3957, DOI 10.1074/jbc.M210491200; Haag AF, 2009, J BACTERIOL, V191, P4681, DOI 10.1128/JB.00318-09; Hold GL, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P371, DOI 10.1007/978-3-7091-0733-1_12; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; LEIGH JA, 1985, P NATL ACAD SCI USA, V82, P6231, DOI 10.1073/pnas.82.18.6231; MEADE HM, 1982, J BACTERIOL, V149, P114, DOI 10.1128/JB.149.1.114-122.1982; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; MOHAN S, 1994, J BIOL CHEM, V269, P32896; Muszynski A, 2011, GLYCOBIOLOGY, V21, P55, DOI 10.1093/glycob/cwq131; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; REUHS BL, 1994, MOL PLANT MICROBE IN, V7, P240, DOI 10.1094/MPMI-7-0240; Sambrook J., 1989, MOL CLONING, pA1; Scheidle H, 2005, NEW PHYTOL, V165, P559, DOI 10.1111/j.1469-8137.2004.01214.x; Schild S, 2005, J BIOL CHEM, V280, P25936, DOI 10.1074/jbc.M501259200; Serrania J, 2008, J BIOTECHNOL, V135, P309, DOI 10.1016/j.jbiotec.2008.04.011; Sharypova LA, 2003, J BIOL CHEM, V278, P12946, DOI 10.1074/jbc.M209389200; Tsukushi Y, 2004, J ENDOTOXIN RES, V10, P25, DOI 10.1179/096805104225003799; Vandenplas ML, 2002, J BIOL CHEM, V277, P41811, DOI 10.1074/jbc.M205252200; Vanderlinde EM, 2009, MICROBIOL-SGM, V155, P3055, DOI 10.1099/mic.0.025031-0; Vedam V, 2006, J BACTERIOL, V188, P2126, DOI 10.1128/JB.188.6.2126-2133.2006; Vedam V, 2004, MOL PLANT MICROBE IN, V17, P283, DOI 10.1094/MPMI.2004.17.3.283; Wells DH, 2002, MOL MICROBIOL, V43, P1115, DOI 10.1046/j.1365-2958.2002.02826.x; YORK WS, 1986, METHOD ENZYMOL, V118, P3; Zhang YH, 2007, BIOORGAN MED CHEM, V15, P4800, DOI 10.1016/j.bmc.2007.05.012	36	17	19	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17455	17466		10.1074/jbc.M111.236356	http://dx.doi.org/10.1074/jbc.M111.236356			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454518	Green Published, hybrid			2022-12-27	WOS:000290585200007
J	Piao, JH; Hasegawa, M; Heissig, B; Hattori, K; Takeda, K; Iwakura, Y; Okumura, K; Inohara, N; Nakano, H				Piao, Jiang-Hu; Hasegawa, Mizuho; Heissig, Beate; Hattori, Koichi; Takeda, Kazuyoshi; Iwakura, Yoichiro; Okumura, Ko; Inohara, Naohiro; Nakano, Hiroyasu			Tumor Necrosis Factor Receptor-associated Factor (TRAF) 2 Controls Homeostasis of the Colon to Prevent Spontaneous Development of Murine Inflammatory Bowel Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTESTINAL INFLAMMATION; CELL-DEATH; ACTIVATION; MICE; PATHWAY; DEFICIENCY; DEFENSINS; RESPONSES; COLITIS	Fine-tuning of host cell responses to commensal bacteria plays a crucial role in maintaining homeostasis of the gut. Here, we show that tumor necrosis factor receptor-associated factor (Traf)2(-/-) mice spontaneously developed severe colitis and succumbed within 3 weeks after birth. Histological analysis revealed that apoptosis of colonic epithelial cells was enhanced, and B cells diffusely infiltrated into the submucosal layer of the colon of Traf2(-/-) mice. Expression of proinflammatory cytokines, including Tnfa, Il17a, and Ifng, was up-regulated, whereas expression of antimicrobial peptides was down-regulated in the colon of Traf2(-/-) mice. Moreover, a number of IL-17-producing helper T cells were increased in the colonic lamina propria of Traf2(-/-) mice. These cellular alterations resulted in drastic changes in the colonic microbiota of Traf2(-/-) mice compared with Traf2(+/+) mice. Treatment of Traf2(-/-) mice with antibiotics ameliorated colitis along with down-regulation of proinflammatory cytokines and prolonged survival, suggesting that the altered colonic microbiota might contribute to exacerbation of colitis. Finally, deletion of Tnfr1, but not Il17a, dramatically ameliorated colitis in Traf2(-/-) mice by preventing apoptosis of colonic epithelial cells, down-regulation of proinflammatory cytokines, and restoration of wild-type commensal bacteria. Together, TRAF2 plays a crucial role in controlling homeostasis of the colon.	[Piao, Jiang-Hu; Takeda, Kazuyoshi; Okumura, Ko; Nakano, Hiroyasu] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan; [Piao, Jiang-Hu] Juntendo Univ, Sch Med, Sportol Ctr, Bunkyo Ku, Tokyo 1138421, Japan; [Okumura, Ko] Juntendo Univ, Sch Med, Atopy Res Ctr, Bunkyo Ku, Tokyo 1138421, Japan; [Piao, Jiang-Hu] Ningxia Med Univ, Basic Med Sci Coll, Dept Immunol, Xingqing Qu 750004, Yinchuan, Peoples R China; [Hasegawa, Mizuho; Inohara, Naohiro] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Heissig, Beate] Univ Tokyo, Frontier Res Initiat, Minato Ku, Tokyo 1088639, Japan; [Heissig, Beate; Hattori, Koichi] Univ Tokyo, Dept Stem Cell Regulat, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Tokyo 1088639, Japan; [Iwakura, Yoichiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Juntendo University; Juntendo University; Juntendo University; Ningxia Medical University; University of Michigan System; University of Michigan; University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Nakano, H (corresponding author), Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	hnakano@juntendo.ac.jp	Heissig, Beate/AAF-6771-2021; Hattori, Koichi/AAF-6862-2021; Iwakura, Yoichiro/E-5457-2011	Heissig, Beate/0000-0002-0348-5934; Iwakura, Yoichiro/0000-0002-9934-5775; Nakano, Hiroyasu/0000-0003-4843-1427	Ministry of Education, Culture, Sports, Science and Technology; Promotion and Mutual Aid Corporation for Private Schools of Japan; Japan Society for the Promotion of Science; Scientific Research on Innovative Areas, Ministry of Education, Culture, Sports, Science and Technology, Japan; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research [23659404, 23300355] Funding Source: KAKEN; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018503] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Scientific Research on Innovative Areas, Ministry of Education, Culture, Sports, Science and Technology, Japan; Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by grants-in-aid for "High-Tech Research Center" project for private universities, matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology, the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan, Scientific Research B and C from Japan Society for the Promotion of Science, Scientific Research on Innovative Areas, Ministry of Education, Culture, Sports, Science and Technology, Japan, Takeda Science Foundation, and Astellas Foundation for Research on Metabolic Disorders.	Broglie P, 2010, J BIOL CHEM, V285, P2333, DOI 10.1074/jbc.M109.090522; Corthesy B, 2007, J IMMUNOL, V178, P27, DOI 10.4049/jimmunol.178.1.27; De Jong YP, 2000, GASTROENTEROLOGY, V119, P715, DOI 10.1053/gast.2000.16485; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Hasegawa M, 2010, INFECT IMMUN, V78, P639, DOI 10.1128/IAI.01043-09; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakano H, 2006, CELL DEATH DIFFER, V13, P730, DOI 10.1038/sj.cdd.4401830; Nakano H, 1999, P NATL ACAD SCI USA, V96, P9803, DOI 10.1073/pnas.96.17.9803; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Piao JH, 2007, J IMMUNOL, V178, P2272, DOI 10.4049/jimmunol.178.4.2272; Shi JS, 2007, J IMMUNOL, V179, P1245, DOI 10.4049/jimmunol.179.2.1245; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wehkamp J, 2005, NAT CLIN PRACT GASTR, V2, P406, DOI 10.1038/ncpgasthep0265; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	28	24	25	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17879	17888		10.1074/jbc.M111.221853	http://dx.doi.org/10.1074/jbc.M111.221853			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21393251	Green Published, hybrid			2022-12-27	WOS:000290585200051
J	Sato, M; Hiraoka, M; Suzuki, H; Bai, YZ; Kurotani, R; Yokoyama, U; Okumura, S; Cismowski, MJ; Lanier, SM; Ishikawa, Y				Sato, Motohiko; Hiraoka, Masahiro; Suzuki, Hiroko; Bai, Yunzhe; Kurotani, Reiko; Yokoyama, Utako; Okumura, Satoshi; Cismowski, Mary J.; Lanier, Stephen M.; Ishikawa, Yoshihiro			Identification of Transcription Factor E3 (TFE3) as a Receptor-independent Activator of G alpha(16) GENE REGULATION BY NUCLEAR G alpha SUBUNIT AND ITS ACTIVATOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE DEAFNESS DFNB29; G-PROTEIN; BETA-GAMMA; CARDIAC-HYPERTROPHY; SIGNAL-TRANSDUCTION; PRESSURE-OVERLOAD; RGS PROTEINS; LOCALIZATION; GI-ALPHA-3; MODULATORS	Receptor-independent G-protein regulators provide diverse mechanisms for signal input to G-protein-based signaling systems, revealing unexpected functional roles for G-proteins. As part of a broader effort to identify disease-specific regulators for heterotrimeric G-proteins, we screened for such proteins in cardiac hypertrophy using a yeast-based functional screen of mammalian cDNAs as a discovery platform. We report the identification of three transcription factors belonging to the same family, transcription factor E3 (TFE3), microphthalmia-associated transcription factor, and transcription factor EB, as novel receptor-independent activators of G-protein signaling selective for G alpha(16). TFE3 and G alpha(16) were both up-regulated in cardiac hypertrophy initiated by transverse aortic constriction. In protein interaction studies in vitro, TFE3 formed a complex with G alpha(16) but not with G alpha(i3) or G alpha(s). Although increased expression of TFE3 in heterologous systems had no influence on receptor-mediated G alpha(16) signaling at the plasma membrane, TFE3 actually translocated G alpha(16) to the nucleus, leading to the induction of claudin 14 expression, a key component of membrane structure in cardiomyocytes. The induction of claudin 14 was dependent on both the accumulation and activation of G alpha(16) by TFE3 in the nucleus. These findings indicate that TFE3 and G alpha(16) are up-regulated under pathologic conditions and are involved in a novel mechanism of transcriptional regulation via the relocalization and activation of G alpha(16).	[Okumura, Satoshi; Ishikawa, Yoshihiro] Yokohama City Univ, Sch Med, Cardiovasc Res Inst, Yokohama, Kanagawa 2360004, Japan; [Cismowski, Mary J.] Nationwide Childrens Hosp, Res Inst, Ctr Cardiovasc & Pulm Res, Columbus, OH 43205 USA; [Lanier, Stephen M.] Med Univ S Carolina, Dept Pharmacol, Charleston, SC 29425 USA	Yokohama City University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Medical University of South Carolina	Ishikawa, Y (corresponding author), Yokohama City Univ, Sch Med, Cardiovasc Res Inst, Yokohama, Kanagawa 2360004, Japan.	yishikaw@med.yokohama-cu.ac.jp	Yokoyama, Utako/AAD-1404-2022; Cismowski, Mary/E-2897-2011	Yokoyama, Utako/0000-0003-1803-0155; Lanier, Stephen/0000-0002-2740-7607	National Institutes of Health [NS24821, DA025896]; Yokohama Foundation for Advancement of Medical Science [18599006, 20590212]; Yokohama City University, Japan [K18017, K19021]; Ministry of Health Labor and Welfare; Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Cosmetology Research Foundation; Kitsuen Research Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science; Mitsubishi Pharma Research Foundation; Ichiro Kanehara Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024821, R29NS024821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025896] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21590936] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yokohama Foundation for Advancement of Medical Science; Yokohama City University, Japan; Ministry of Health Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Cosmetology Research Foundation; Kitsuen Research Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Mitsubishi Pharma Research Foundation; Ichiro Kanehara Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants NS24821 and DA025896 (both to S. M. L.). This work was also supported by Grants-in-aid for Scientific Research (C) 18599006 and 20590212, the Yokohama Foundation for Advancement of Medical Science, and Strategic Research Project Grants K18017 and K19021 from Yokohama City University, Japan (all to M. S.) and by grants from the Ministry of Health Labor and Welfare; Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Cosmetology Research Foundation; and Kitsuen Research Foundation (all to Y.I.).; Supported by the Takeda Science Foundation, the NOVARTIS Foundation (Japan) for the Promotion of Science, the Mitsubishi Pharma Research Foundation, The Ichiro Kanehara Foundation, and the Mochida Memorial Foundation for Medical and Pharmaceutical Research.	Ben-Yosef T, 2003, HUM MOL GENET, V12, P2049, DOI 10.1093/hmg/ddg210; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P772, DOI 10.1016/j.bbamem.2006.12.002; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Blumer JB, 2006, EUR J CELL BIOL, V85, P1233, DOI 10.1016/j.ejcb.2006.08.002; Burchett SA, 2003, J NEUROCHEM, V87, P551, DOI 10.1046/j.1471-4159.2003.02047.x; Cismowski MJ, 2006, SEMIN CELL DEV BIOL, V17, P334, DOI 10.1016/j.semcdb.2006.03.003; Cismowski MJ, 2002, METHOD ENZYMOL, V344, P153; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Giannone F, 2010, J MOL ENDOCRINOL, V44, P259, DOI 10.1677/JME-09-0134; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Heasley LE, 1996, MOL CELL BIOL, V16, P648; Hendriks-Balk MC, 2008, EUR J PHARMACOL, V585, P278, DOI 10.1016/j.ejphar.2008.02.088; HEPLER JR, 2005, SCI STKE, pPE38; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Hu YH, 2010, MOL BIOL REP, V37, P3381, DOI 10.1007/s11033-009-9926-3; Huang J., 2006, UCSD NATURE MOL PAGE, DOI [10.1038/mp.a000972.01, DOI 10.1038/MP.A000972.01]; HUGHES MJ, 1993, J BIOL CHEM, V268, P20687; IRVINE RF, 2002, SCI STKE, pRE13; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Mays TA, 2008, J MOL CELL CARDIOL, V45, P81, DOI 10.1016/j.yjmcc.2008.04.005; Miyamori H, 2001, J BIOL CHEM, V276, P28204, DOI 10.1074/jbc.M103083200; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Riddle EL, 2005, CIRC RES, V96, P401, DOI 10.1161/01.RES.0000158287.49872.4e; Rogers JH, 1999, J CLIN INVEST, V104, P567, DOI 10.1172/JCI6713; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sanford Jamie L, 2005, J Mol Cell Cardiol, V38, P323, DOI 10.1016/j.yjmcc.2004.11.025; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Sato M, 1996, J BIOL CHEM, V271, P30052, DOI 10.1074/jbc.271.47.30052; SATO M, 1995, J BIOL CHEM, V270, P15269, DOI 10.1074/jbc.270.25.15269; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Sato Motohiko, 2010, Pathophysiology, V17, P89, DOI 10.1016/j.pathophys.2009.03.011; Sato M, 2009, J BIOL CHEM, V284, P31431, DOI 10.1074/jbc.M109.014068; Shu FJ, 2007, CELL SIGNAL, V19, P163, DOI 10.1016/j.cellsig.2006.06.002; Spiegelberg BD, 2007, CURR OPIN GENET DEV, V17, P40, DOI 10.1016/j.gde.2006.12.002; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Tshori S, 2006, J CLIN INVEST, V116, P2673, DOI 10.1172/JCI27643; Tsukita S, 2002, CURR OPIN CELL BIOL, V14, P531, DOI 10.1016/S0955-0674(02)00362-9; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8; WILKIE TM, 1991, P NATL ACAD SCI USA, V88, P10049, DOI 10.1073/pnas.88.22.10049; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; WU DQ, 1995, J BIOL CHEM, V270, P16008, DOI 10.1074/jbc.270.27.16008; Zhou J, 1998, EUR J IMMUNOL, V28, P1645, DOI 10.1002/(SICI)1521-4141(199805)28:05<1645::AID-IMMU1645>3.0.CO;2-D	51	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17766	17776		10.1074/jbc.M111.219816	http://dx.doi.org/10.1074/jbc.M111.219816			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454667	hybrid, Green Published			2022-12-27	WOS:000290585200040
J	Liu, JY; Zhang, DY; Luo, WJ; Yu, YH; Yu, JX; Li, JX; Zhang, XH; Zhang, BL; Chen, JY; Wu, XR; Rosas-Acosta, G; Huang, CS				Liu, Jinyi; Zhang, Dongyun; Luo, Wenjing; Yu, Yonghui; Yu, Jianxiu; Li, Jingxia; Zhang, Xinhai; Zhang, Baolin; Chen, Jingyuan; Wu, Xue-Ru; Rosas-Acosta, German; Huang, Chuanshu			X-linked Inhibitor of Apoptosis Protein (XIAP) Mediates Cancer Cell Motility via Rho GDP Dissociation Inhibitor (RhoGDI)-dependent Regulation of the Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOHISTOCHEMICAL DETECTION; ACTIN POLYMERIZATION; EXPRESSION; DEGRADATION; METASTASIS; IAPS; MIGRATION; RECEPTOR; GTPASES; TARGET	X-linked inhibitor of apoptosis protein (XIAP) overexpression has been found to be associated with malignant cancer progression and aggression in individuals with many types of cancers. However, the molecular basis of XIAP in the regulation of cancer cell biological behavior remains largely unknown. In this study, we found that a deficiency of XIAP expression in human cancer cells by either knock-out or knockdown leads to a marked reduction in beta-actin polymerization and cytoskeleton formation. Consistently, cell migration and invasion were also decreased in XIAP-deficient cells compared with parental wildtype cells. Subsequent studies demonstrated that the regulation of cell motility by XIAP depends on its interaction with the Rho GDP dissociation inhibitor (RhoGDI) via the XIAP RING domain. Furthermore, XIAP was found to negatively regulate RhoGDI SUMOylation, which might affect its activity in controlling cell motility. Collectively, our studies provide novel insights into the molecular mechanisms by which XIAP regulates cancer invasion and offer a further theoretical basis for setting XIAP as a potential prognostic marker and specific target for treatment of cancers with metastatic properties.	[Liu, Jinyi; Zhang, Dongyun; Yu, Yonghui; Yu, Jianxiu; Li, Jingxia; Zhang, Xinhai; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY 10987 USA; [Liu, Jinyi] Third Mil Med Univ, Prevent Med Coll, Dept Hyg Toxicol, Chongqing 400038, Peoples R China; [Luo, Wenjing; Chen, Jingyuan] Fourth Mil Med Univ, Dept Occupat & Environm Hlth Sci, Xian 710032, Shanxi, Peoples R China; [Zhang, Baolin] US FDA, Div Therapeut Prot, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Rosas-Acosta, German] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Liu, Jinyi] Third Mil Med Univ, Prevent Med Coll, Toxicogenom Lab, Chongqing 400038, Peoples R China	New York University; Army Medical University; Air Force Military Medical University; US Food & Drug Administration (FDA); New York University; New York University; University of Texas System; University of Texas El Paso; Army Medical University	Huang, CS (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	chuanshu.huang@nyumc.org	Yu, Jianxiu/A-7214-2012; Yu, Yonghui/AAZ-4093-2021	Wu, Xue-Ru/0000-0001-6058-6291; Huang, Chuanshu/0000-0003-4133-5096	National Institutes of Health, NCI [CA112557]; NIEHS [ES000260]; New York University Urology Center of Excellence;  [ES012451];  [ES010344]; NATIONAL CANCER INSTITUTE [R01CA112557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI098976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010344, P30ES000260, R01ES012451] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); New York University Urology Center of Excellence; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA112557 from NCI and Grants ES012451, ES010344, and ES000260 from NIEHS. This work was also supported by the New York University Urology Center of Excellence.	Akyurek N, 2006, CANCER-AM CANCER SOC, V107, P1844, DOI 10.1002/cncr.22219; Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303; Burstein DE, 2008, ANN DIAGN PATHOL, V12, P85, DOI 10.1016/j.anndiagpath.2007.04.008; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Chan AY, 1998, J CELL SCI, V111, P199; Cummins JM, 2004, CANCER RES, V64, P3006, DOI 10.1158/0008-5472.CAN-04-0046; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DIAKONOVA M, 1995, J CELL SCI, V108, P2499; Disanza A, 2005, CELL MOL LIFE SCI, V62, P955, DOI 10.1007/s00018-004-4472-6; Dogan T, 2008, NAT CELL BIOL, V10, P1447, DOI 10.1038/ncb1804; Entschladen F, 2004, LANCET ONCOL, V5, P254, DOI 10.1016/S1470-2045(04)01431-7; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fong WG, 2000, GENOMICS, V70, P113, DOI 10.1006/geno.2000.6364; Gordon GJ, 2007, J PATHOL, V211, P447, DOI 10.1002/path.2121; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Jordan BWM, 2001, J BIOL CHEM, V276, P39985, DOI 10.1074/jbc.C100171200; Kleinberg L, 2007, HUM PATHOL, V38, P986, DOI 10.1016/j.humpath.2006.12.013; Kleinberg L, 2007, CANCER, V109, P228, DOI 10.1002/cncr.22426; Kluger HM, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-6; LEE HK, 1994, INT REV EXP PATHOL, V35, P39; Lewis J, 2004, J BIOL CHEM, V279, P9023, DOI 10.1074/jbc.M312891200; Li Bin, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1746; Li M, 2007, CHINESE MED J-PEKING, V120, P469, DOI 10.1097/00029330-200703020-00007; Luo WJ, 2008, J BIOL CHEM, V283, P8624, DOI 10.1074/jbc.M707860200; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Mizutani Y, 2007, INT J ONCOL, V30, P919; Morizane Y, 2005, J BIOCHEM, V137, P125, DOI 10.1093/jb/mvi029; Nagi C, 2007, ANN DIAGN PATHOL, V11, P402, DOI 10.1016/j.anndiagpath.2006.12.012; Nemoto T, 2004, EXP MOL PATHOL, V76, P253, DOI 10.1016/j.yexmp.2004.01.001; Ouyang WM, 2009, J CELL PHYSIOL, V218, P205, DOI 10.1002/jcp.21590; Pal S, 2010, J VIROL METHODS, V163, P498, DOI 10.1016/j.jviromet.2009.11.010; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Rouleau C, 2006, MOL CANCER THER, V5, P219, DOI 10.1158/1535-7163.MCT-05-0289; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Shi YH, 2008, HEPATOLOGY, V48, P497, DOI 10.1002/hep.22393; Song L, 2007, MOL CELL BIOL, V27, P2713, DOI 10.1128/MCB.00657-06; Song L, 2006, J CELL BIOL, V175, P607, DOI 10.1083/jcb.200602149; Staiger CJ, 2006, CURR OPIN PLANT BIOL, V9, P554, DOI 10.1016/j.pbi.2006.09.013; Taniuchi S, 1999, PEDIATR INT, V41, P37; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Wilkinson JC, 2008, MOL CELL BIOL, V28, P237, DOI 10.1128/MCB.01065-07; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yang L, 2003, CANCER RES, V63, P6815; Zhang BL, 2006, DRUG RESIST UPDATE, V9, P134, DOI 10.1016/j.drup.2006.06.001; Zhang BL, 2005, CANCER RES, V65, P6054, DOI 10.1158/0008-5472.CAN-05-0175; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448	51	65	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.176982	http://dx.doi.org/10.1074/jbc.M110.176982			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21402697	Green Published, hybrid			2022-12-27	WOS:000290022800003
J	Makino, R; Park, S; Obayashi, E; Iizuka, T; Hori, H; Shiro, Y				Makino, Ryu; Park, Sam-yon; Obayashi, Eiji; Iizuka, Tetsutaro; Hori, Hiroshi; Shiro, Yoshitugu			Oxygen Binding and Redox Properties of the Heme in Soluble Guanylate Cyclase IMPLICATIONS FOR THE MECHANISM OF LIGAND DISCRIMINATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; ABSORPTION FINE-STRUCTURE; SPERM WHALE MYOGLOBIN; NITRIC-OXIDE; CARBON-MONOXIDE; BOVINE LUNG; COBALT MYOGLOBINS; SMOOTH-MUSCLE; CYCLIC-GMP; ACTIVATION	Soluble guanylate cyclase is an NO-sensing hemoprotein that serves as a NO receptor in NO-mediated signaling pathways. It has been believed that this enzyme displays no measurable affinity for O-2, thereby enabling the selective NO sensing in aerobic environments. Despite the physiological significance, the reactivity of the enzyme-heme for O-2 has not been examined in detail. In this paper we demonstrated that the high spin heme of the ferrous enzyme converted to a low spin oxyheme (Fe2+-O-2) when frozen at 77 K in the presence of O-2. The ligation of O-2 was confirmed by EPR analyses using cobalt-substituted enzyme. The oxy form was produced also under solution conditions at -7 degrees C, with the extremely low affinity for O-2. The low O-2 affinity was not caused by a distal steric protein effect and by rupture of the Fe2+-proximal His bond as revealed by extended x-ray absorption fine structure. The midpoint potential of the enzyme-heme was +187 mV, which is the most positive among high spin protoheme-hemoproteins. This observation implies that the electron density of the ferrous heme iron is relatively low by comparison to those of other hemoproteins, presumably due to the weak Fe2+-proximal His bond. Based on our results, we propose that the weak Fe2+-proximal His bond is a key determinant for the low O-2 affinity of the heme moiety of soluble guanylate cyclase.	[Makino, Ryu] Rikkyo Univ, Coll Sci, Dept Life Sci, Toshima Ku, Tokyo 1718501, Japan; [Park, Sam-yon; Obayashi, Eiji] Yokohama City Univ, Prot Design Lab, Yokohama, Kanagawa 2300045, Japan; [Iizuka, Tetsutaro; Shiro, Yoshitugu] RIKEN, Harima Inst Spring 8, Mikazuki, Hyogo 6795148, Japan; [Hori, Hiroshi] Osaka Univ, Ctr Quantum Sci & Technol Extreme Condit, Osaka 5608531, Japan	Rikkyo University; Yokohama City University; RIKEN; Osaka University	Makino, R (corresponding author), Rikkyo St Pauls Univ, Coll Sci, Dept Life Sci, Toshima Ku, Nishi Ikebukuro 3-34-1, Tokyo 1718501, Japan.	rmakino@rikkyo.ne.jp	Shiro, Yoshitsugu Y/J-3757-2014	Shiro, Yoshitsugu Y/0000-0003-0695-8327	Rikkyo University; Ministry of Culture, Education, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [21245041] Funding Source: KAKEN	Rikkyo University(Rikkyo University); Ministry of Culture, Education, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Frontier Project "Life Adaptation Strategies to Environmental Changes" of Rikkyo University and grants-in-aid from the Ministry of Culture, Education, Sports, Science, and Technology of Japan (to R. M.).	BINSTED N, 1992, BIOCHEMISTRY-US, V31, P12117, DOI 10.1021/bi00163a021; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; COLLMAN JP, 1983, J AM CHEM SOC, V105, P3052, DOI 10.1021/ja00348a019; Deinum G, 1996, BIOCHEMISTRY-US, V35, P1540; Derbyshire ER, 2007, J BIOL CHEM, V282, P35741, DOI 10.1074/jbc.M705557200; Derbyshire ER, 2010, J BIOL CHEM, V285, P17471, DOI 10.1074/jbc.M109.098269; Derbyshire ER, 2005, BIOCHEMISTRY-US, V44, P16257, DOI 10.1021/bi0515671; EISENBERGER P, 1978, NATURE, V274, P30, DOI 10.1038/274030a0; Evans JP, 2009, BIOCHEMISTRY-US, V48, P8920, DOI 10.1021/bi9011258; FALK JE, 1964, PORPHYRINS METALLOPO, P67; FAULKNER KM, 1995, J BIOL CHEM, V270, P13604, DOI 10.1074/jbc.270.23.13604; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GERZER R, 1981, EUR J BIOCHEM, V116, P479, DOI 10.1111/j.1432-1033.1981.tb05361.x; Gullotti M, 2007, INORG CHEM, V46, P8971, DOI 10.1021/ic700852c; HAGIHARA B, 1971, J BIOCHEM-TOKYO, V69, P355, DOI 10.1093/oxfordjournals.jbchem.a129474; HORI H, 1982, J BIOL CHEM, V257, P3636; Hu XH, 2008, J BIOL CHEM, V283, P20968, DOI 10.1074/jbc.M801501200; Huang SH, 2007, BIOCHEMISTRY-US, V46, P15115, DOI 10.1021/bi701771r; HUMBERT P, 1990, EUR J BIOCHEM, V190, P273, DOI 10.1111/j.1432-1033.1990.tb15572.x; IGNARRO LJ, 1985, ANNU REV PHARMACOL, V25, P171, DOI 10.1146/annurev.pharmtox.25.1.171; IGNARRO LJ, 1982, P NATL ACAD SCI-BIOL, V79, P2870, DOI 10.1073/pnas.79.9.2870; IKEDASAITO M, 1977, J BIOL CHEM, V252, P4882; KAMISAKI Y, 1986, J BIOL CHEM, V261, P7236; LI TS, 1994, BIOCHEMISTRY-US, V33, P1433, DOI 10.1021/bi00172a021; Makino R, 2003, J BIOL CHEM, V278, P11130, DOI 10.1074/jbc.M209026200; Makino R, 1999, J BIOL CHEM, V274, P7714, DOI 10.1074/jbc.274.12.7714; MAKINO R, 1974, ARCH BIOCHEM BIOPHYS, V165, P485, DOI 10.1016/0003-9861(74)90274-4; Marti MA, 2006, J INORG BIOCHEM, V100, P761, DOI 10.1016/j.jinorgbio.2005.12.009; Martin E, 2006, J BIOL CHEM, V281, P27836, DOI 10.1074/jbc.M601078200; MIMS MP, 1983, J BIOL CHEM, V258, P4219; Miyatake H, 1999, J BIOL CHEM, V274, P23176, DOI 10.1074/jbc.274.33.23176; MONCADA S, 1991, EUR J CLIN INVEST, V21, P361, DOI 10.1111/j.1365-2362.1991.tb01383.x; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Obayashi E, 1997, J AM CHEM SOC, V119, P7807, DOI 10.1021/ja9637816; OBERTING WA, 1990, INORG CHEM, V29, P2633; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Rich AM, 1998, J AM CHEM SOC, V120, P10827, DOI 10.1021/ja980253g; SEYBERT DW, 1977, J BIOL CHEM, V252, P4225; STETZKOWSKI F, 1979, J BIOL CHEM, V254, P1351; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; STONE JR, 1995, BIOCHEM BIOPH RES CO, V207, P572, DOI 10.1006/bbrc.1995.1226; TRAYLOR TG, 1993, J AM CHEM SOC, V115, P810, DOI 10.1021/ja00055a075; Tsujimura S, 2005, ANAL BIOCHEM, V337, P325, DOI 10.1016/j.ab.2004.11.017; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; WALDMAN SA, 1987, PHARMACOL REV, V39, P163; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; Yang F, 1996, J MOL BIOL, V256, P762, DOI 10.1006/jmbi.1996.0123; Yazawa S, 2006, J BIOL CHEM, V281, P21763, DOI 10.1074/jbc.M508983200; YONETANI T, 1974, J BIOL CHEM, V249, P682; Zhao Y, 1997, BIOCHEMISTRY-US, V36, P15959, DOI 10.1021/bi971825x	52	26	26	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.177576	http://dx.doi.org/10.1074/jbc.M110.177576			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21385878	hybrid, Green Published			2022-12-27	WOS:000290022800007
J	Hong, J; Bae, S; Jhun, H; Lee, S; Choi, J; Kang, T; Kwak, A; Hong, K; Kim, E; Jo, S; Kim, S				Hong, Jaewoo; Bae, Suyoung; Jhun, Hyunjhung; Lee, Siyoung; Choi, Jida; Kang, Taebong; Kwak, Areum; Hong, Kwangwon; Kim, Eunsom; Jo, Seunghyun; Kim, Soohyun			Identification of Constitutively Active Interleukin 33 (IL-33) Splice Variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR ACCESSORY PROTEIN; RHEUMATOID-ARTHRITIS; CYTOKINE PRODUCTION; BINDING-PROTEIN; HUMAN BASOPHILS; GROWTH-FACTOR; ST2; IL-18; FAMILY; GENE	IL-33/IL-1F11 is a new member of the IL-1 family ligand and provokesThelper-type immune responses. IL-33 is the ligand of ST2 and IL-1 receptor accessory protein (IL-1RAcP) that triggers nuclear factor-kappa light chain enhancer of activated B cells (NF-kappa B) and MAPK signaling. We discovered a novel short splice variant of IL-33 that was termed spIL-33. The new spIL-33 lacks exon 3 containing a proposed caspase-1 cleavage site. We isolated spIL-33 cDNA from the Huh7 human hepatocarcinoma cell line and expressed the recombinant spIL-33 protein in Escherichia coli. The recombinant spIL-33 and pro-IL-33 were not cleaved by caspase-1, unlike IL-18 (IL-1F4). The recombinant spIL-33 was constitutively active, and spIL-33-induced inflammatory cytokine production was caspase-1-independent in HMC-1 and Raw 264.7 cells. The recombinant spIL-33 induced the phosphorylation of IL-1 receptor-associated kinase (IRAK1), NF-kappa B, p38 MAPK, p44/42 MAPK, and JNK in a time- and dose-dependent manner. Anti-ST2 monoclonal antibody specifically blocked the spIL-33-induced cytokine production. In this study, we identified and characterized a new IL-33 splice variant, which was a constitutively active IL-33 isoform. The existence of constitutively active spIL-33 suggests that the biological activity of IL-33 could be triggered by diverse stimulations during immune responses. Further investigation of the spIL-33 expression pattern may contribute to understanding the involvement of IL-33 in inflammatory disorders.	[Hong, Jaewoo; Bae, Suyoung; Jhun, Hyunjhung; Lee, Siyoung; Choi, Jida; Kang, Taebong; Kwak, Areum; Hong, Kwangwon; Kim, Eunsom; Jo, Seunghyun; Kim, Soohyun] Konkuk Univ, Lab Cytokine Immunol, Med Immunol Ctr, Seoul 143701, South Korea	Konkuk University; Konkuk University Medical Center	Kim, S (corresponding author), Konkuk Univ, Lab Cytokine Immunol, Med Immunol Ctr, 1 Hwayang Dong, Seoul 143701, South Korea.	soohyun@konkuk.ac.kr		Hong, Jaewoo/0000-0003-3456-3672; kang, tae-bong/0000-0003-1441-9470	Korean government [R33-2008-000-10022-0, KRF-2008-313-C00644]; Ministry of Health & Welfare, Republic of Korea [A100460]	Korean government(Korean Government); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by National Research Foundation Grants WCU R33-2008-000-10022-0 and KRF-2008-313-C00644 funded by the Korean government and the Korea Healthcare Technology R&D Project Grant A100460 from the Ministry of Health & Welfare, Republic of Korea.	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Allakhverdi Z, 2009, J ALLERGY CLIN IMMUN, V123, P472, DOI 10.1016/j.jaci.2008.10.022; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; BAGGIOLINI M, 1978, AGENTS ACTIONS, V8, P3, DOI 10.1007/BF01972395; BERGERS G, 1994, EMBO J, V13, P1176, DOI 10.1002/j.1460-2075.1994.tb06367.x; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.3.CO;2-U; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Bufler P, 2002, P NATL ACAD SCI USA, V99, P13723, DOI 10.1073/pnas.212519099; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Csernok E, 1996, CLIN EXP IMMUNOL, V105, P104, DOI 10.1046/j.1365-2249.1996.d01-715.x; Dinarello CA, 2004, CURR OPIN PHARMACOL, V4, P378, DOI 10.1016/j.coph.2004.03.010; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Haibel H, 2005, ANN RHEUM DIS, V64, P296, DOI 10.1136/ard.2004.023176; Han SY, 2002, J BIOL CHEM, V277, P47167, DOI 10.1074/jbc.M204270200; Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033; Hayakawa M, 2009, BIOCHEM BIOPH RES CO, V387, P218, DOI 10.1016/j.bbrc.2009.07.018; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Kim SH, 2000, P NATL ACAD SCI USA, V97, P1190, DOI 10.1073/pnas.97.3.1190; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; KLEMENZ R, 1989, P NATL ACAD SCI USA, V86, P5708, DOI 10.1073/pnas.86.15.5708; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Kriventseva EV, 2003, TRENDS GENET, V19, P124, DOI 10.1016/S0168-9525(03)00023-4; Kumar S, 2002, CYTOKINE, V18, P61, DOI 10.1006/cyto.2002.0873; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Lamkanfi M, 2009, IMMUNITY, V31, P5, DOI 10.1016/j.immuni.2009.06.011; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Meazza R, 1996, ONCOGENE, V12, P2187; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Nishimura H, 1998, J IMMUNOL, V160, P936; Novick D, 2006, P NATL ACAD SCI USA, V103, P3316, DOI 10.1073/pnas.0511206103; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Ohno T, 2009, J IMMUNOL, V183, P7890, DOI 10.4049/jimmunol.0802449; PADRINES M, 1994, FEBS LETT, V352, P231, DOI 10.1016/0014-5793(94)00952-X; Palmer G, 2008, CYTOKINE, V42, P358, DOI 10.1016/j.cyto.2008.03.008; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Philips AV, 2000, CELL MOL LIFE SCI, V57, P235, DOI 10.1007/PL00000687; Pufe T, 2001, ARTHRITIS RHEUM, V44, P1082, DOI 10.1002/1529-0131(200105)44:5<1082::AID-ANR188>3.0.CO;2-X; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; ROBACHEGALLEA S, 1995, J BIOL CHEM, V270, P23688, DOI 10.1074/jbc.270.40.23688; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Senn KA, 2000, EUR J IMMUNOL, V30, P1929, DOI 10.1002/1521-4141(200007)30:7&lt;1929::AID-IMMU1929&gt;3.0.CO;2-1; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Sugawara S, 2001, J IMMUNOL, V167, P6568, DOI 10.4049/jimmunol.167.11.6568; Sullivan BM, 2009, IMMUNITY, V30, P12, DOI 10.1016/j.immuni.2008.12.006; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Suzukawa M, 2008, LAB INVEST, V88, P1245, DOI 10.1038/labinvest.2008.82; Tagaya Y, 1997, P NATL ACAD SCI USA, V94, P14444, DOI 10.1073/pnas.94.26.14444; TOMINAGA S, 1992, BIOCHIM BIOPHYS ACTA, V1171, P215, DOI 10.1016/0167-4781(92)90125-J; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; TOMINAGA S, 1991, BIOCHIM BIOPHYS ACTA, V1090, P1, DOI 10.1016/0167-4781(91)90029-L; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Trajkovic V, 2004, CYTOKINE GROWTH F R, V15, P87, DOI 10.1016/j.cytogfr.2004.02.004; Verri WA, 2010, ANN RHEUM DIS, V69, P1697, DOI 10.1136/ard.2009.122655	66	58	60	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20078	20086		10.1074/jbc.M111.219089	http://dx.doi.org/10.1074/jbc.M111.219089			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21454686	Green Published, hybrid			2022-12-27	WOS:000291027700084
J	Ori, A; Wilkinson, MC; Fernig, DG				Ori, Alessandro; Wilkinson, Mark C.; Fernig, David G.			A Systems Biology Approach for the Investigation of the Heparin/Heparan Sulfate Interactome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; EXTRACELLULAR-MATRIX; PROTEIN-PROTEIN; BINDING SITES; GENE ONTOLOGY; DOMAIN; GLYCOSAMINOGLYCANS; EXPRESSION; EVOLUTION; IDENTIFICATION	A large body of evidence supports the involvement of heparan sulfate (HS) proteoglycans in physiological processes such as development and diseases including cancer and neurodegenerative disorders. The role of HS emerges from its ability to interact and regulate the activity of a vast number of extracellular proteins including growth factors and extracellular matrix components. A global view on how protein-HS interactions influence the extracellular proteome and, consequently, cell function is currently lacking. Here, we systematically investigate the functional and structural properties that characterize HS-interacting proteins and the network they form. We collected 435 human proteins interacting with HS or the structurally related heparin by integrating literature-derived and affinity proteomics data. We used this data set to identify the topological features that distinguish the heparin/HS-interacting network from the rest of the extracellular proteome and to analyze the enrichment of gene ontology terms, pathways, and domain families in heparin/HS-binding proteins. Our analysis revealed that heparin/HS-binding proteins form a highly interconnected network, which is functionally linked to physiological and pathological processes that are characteristic of higher organisms. Therefore, we then investigated the existence of a correlation between the expansion of domain families characteristic of the heparin/HS interactome and the increase in biological complexity in the metazoan lineage. A strong positive correlation between the expansion of the heparin/HS interactome and biosynthetic machinery and organism complexity emerged. The evolutionary role of HS was reinforced by the presence of a rudimentary HS biosynthetic machinery in a unicellular organism at the root of the metazoan lineage.	[Fernig, David G.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England; [Fernig, David G.] Univ Liverpool, Ctr Glycobiol, Liverpool L69 7ZB, Merseyside, England	University of Liverpool; University of Liverpool	Fernig, DG (corresponding author), Univ Liverpool, Inst Integrat Biol, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	dgfernig@liv.ac.uk	Ori, Alessandro/B-7067-2011; Fernig, David G/A-3590-2008; Ori, Alessandro/M-8586-2019	Ori, Alessandro/0000-0002-3046-0871; Fernig, David G/0000-0003-4875-4293; Ori, Alessandro/0000-0002-3046-0871; Wilkinson, Mark/0000-0003-3109-6888	European Commission; Cancer and Polio Research Fund Laboratories; North West Cancer Research Fund	European Commission(European CommissionEuropean Commission Joint Research Centre); Cancer and Polio Research Fund Laboratories; North West Cancer Research Fund	This work was supported by the European Commission Marie Curie Early Stage Training Program MolFun (to A. O.), the Cancer and Polio Research Fund Laboratories, and the North West Cancer Research Fund (to D. G. F.).	Abedin M, 2008, SCIENCE, V319, P946, DOI 10.1126/science.1151084; Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bandyopadhyay S, 2006, GENOME RES, V16, P428, DOI 10.1101/gr.4526006; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Beltrao P, 2007, PLOS COMPUT BIOL, V3, P258, DOI 10.1371/journal.pcbi.0030025; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Bornemann DJ, 2008, DEVELOPMENT, V135, P1039, DOI 10.1242/dev.017061; Chautard E, 2009, BIOINFORMATICS, V25, P690, DOI 10.1093/bioinformatics/btp025; Chen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004947; Chen Y, 2008, MOL CELLS, V26, P415; Clarris HJ, 1997, J NEUROCHEM, V68, P1164; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; DeAngelis PL, 2002, ANAT RECORD, V268, P317, DOI 10.1002/ar.10163; Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661; ErsdalBadju E, 1997, J BIOL CHEM, V272, P19393, DOI 10.1074/jbc.272.31.19393; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fraser HB, 2006, CURR OPIN GENET DEV, V16, P637, DOI 10.1016/j.gde.2006.09.001; Freilich S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-247; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huxley-Jones J, 2009, INT J EXP PATHOL, V90, P95, DOI 10.1111/j.1365-2613.2008.00637.x; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; INGHAM KC, 1990, BIOCHEM J, V272, P605, DOI 10.1042/bj2720605; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Julenius K, 2006, MOL BIOL EVOL, V23, P2039, DOI 10.1093/molbev/msl081; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kappler J, 2000, BIOCHEM BIOPH RES CO, V271, P287, DOI 10.1006/bbrc.2000.2583; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kim BT, 2001, P NATL ACAD SCI USA, V98, P7176, DOI 10.1073/pnas.131188498; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kitagawa H, 2007, J BIOL CHEM, V282, P8533, DOI 10.1074/jbc.M611107200; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuang ZH, 2006, J MOL BIOL, V364, P690, DOI 10.1016/j.jmb.2006.09.006; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Lee JS, 2004, NAT REV GENET, V5, P923, DOI 10.1038/nrg1490; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lyon M, 1997, J BIOL CHEM, V272, P18000, DOI 10.1074/jbc.272.29.18000; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Medeiros GF, 2000, BBA-GEN SUBJECTS, V1475, P287, DOI 10.1016/S0304-4165(00)00079-9; Mine S, 2002, BIOCHEMISTRY-US, V41, P78, DOI 10.1021/bi011299g; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Ori A, 2009, MOL CELL PROTEOMICS, V8, P2256, DOI 10.1074/mcp.M900031-MCP200; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rastegar-Lari G, 2002, BIOCHEMISTRY-US, V41, P6668, DOI 10.1021/bi020044f; Ritty TM, 2003, BIOCHEM J, V375, P425, DOI 10.1042/BJ20030649; Sachchidanand, 2002, J BIOL CHEM, V277, P50629, DOI 10.1074/jbc.M208956200; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao CH, 2006, J BIOL CHEM, V281, P31689, DOI 10.1074/jbc.M604502200; Shen L, 1999, THROMB HAEMOSTASIS, V82, P72, DOI 10.1055/s-0037-1614632; STEPHENS RW, 1992, BIOCHEMISTRY-US, V31, P7572, DOI 10.1021/bi00148a019; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Thompson SM, 2010, BIRTH DEFECTS RES C, V90, P32, DOI 10.1002/bdrc.20169; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tucker CL, 2001, TRENDS CELL BIOL, V11, P102, DOI 10.1016/S0962-8924(00)01902-4; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; TURNBULL JE, 1991, BIOCHEM J, V273, P553, DOI 10.1042/bj2730553; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Uniewicz KA, 2008, FRONT BIOSCI-LANDMRK, V13, P4339, DOI 10.2741/3008; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Wei G, 2000, J BIOL CHEM, V275, P27733; Yamada S, 2007, GLYCOBIOLOGY, V17, P886, DOI 10.1093/glycob/cwm051; Yu HN, 2005, BBA-GEN SUBJECTS, V1726, P168, DOI 10.1016/j.bbagen.2005.08.003; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391	83	164	168	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19892	19904		10.1074/jbc.M111.228114	http://dx.doi.org/10.1074/jbc.M111.228114			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21454685	Green Published, hybrid			2022-12-27	WOS:000291027700069
J	Zavala, LE; Pardo-Lopez, L; Canton, PE; Gomez, I; Soberon, M; Bravo, A				Enrique Zavala, Luis; Pardo-Lopez, Liliana; Emiliano Canton, Pablo; Gomez, Isabel; Soberon, Mario; Bravo, Alejandra			Domains II and III of Bacillus thuringiensis Cry1Ab Toxin Remain Exposed to the Solvent after Insertion of Part of Domain I into the Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC PRE-PORE; MANDUCA-SEXTA; DELTA-ENDOTOXIN; PROTEIN TOXINS; FORMING DOMAIN; MUTANTS; MIDGUT; ORGANIZATION; BINDING	Bacillus thuringiensis produces insecticidal proteins named Cry toxins, that are used commercially for the control of economical important insect pests. These are pore-forming toxins that interact with different receptors in the insect gut, forming pores in the apical membrane causing cell burst and insect death. Elucidation of the structure of the membrane-inserted toxin is important to fully understand its mechanism of action. One hypothesis proposed that the hairpin of alpha-helices 4-5 of domain I inserts into the phospholipid bilayer, whereas the rest of helices of domain I are spread on the membrane surface in an umbrella-like conformation. However, a second hypothesis proposed that the three domains of the Cry toxin insert into the bilayer without major conformational changes. In this work we constructed single Cys Cry1Ab mutants that remain active against Manduca sexta larvae and labeled them with different fluorescent probes that have different responses to solvent polarity. Different soluble quenchers as well as a membrane-bound quencher were used to compare the properties of the soluble and brush border membrane-inserted forms of Cry1Ab toxin. The fluorescence and quenching analysis presented here, revealed that domains II and III of the toxin remain in the surface of the membrane and only a discrete region of domain I is inserted into the lipid bilayer, supporting the umbrella model of toxin insertion.	[Enrique Zavala, Luis; Pardo-Lopez, Liliana; Emiliano Canton, Pablo; Gomez, Isabel; Soberon, Mario; Bravo, Alejandra] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Bravo, A (corresponding author), Apdo Postal 510-3, Cuernavaca 62250, Morelos, Mexico.	bravo@ibt.unam.mx	Ojeda, Pablo Emiliano Cantón/AAH-1044-2021; de la Parra, Maria Alejandra Bravo/R-6740-2017	Ojeda, Pablo Emiliano Cantón/0000-0002-9463-2441; Bravo, Alejandra/0000-0002-7573-7475; Pardo Lopez, Liliana/0000-0002-8927-1733	DGAPA/UNAM [IN206209-3, IN218409]; CONACyT [128883, 81679-Q]	DGAPA/UNAM(Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported in part through Grants IN206209-3 and IN218409 from DGAPA/UNAM and CONACyT Grants 128883 and 81679-Q.	ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; BRAVO A, 2005, COMPREHENSIVE MOL IN, V4, P175; Bravo A, 2010, INSECT CONTROL, P248; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3265, DOI 10.1021/bi026696l; Cobb BA, 2000, J BIOL CHEM, V275, P6664, DOI 10.1074/jbc.275.9.6664; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; Gazit E, 1998, P NATL ACAD SCI USA, V95, P12289, DOI 10.1073/pnas.95.21.12289; Gerber D, 2000, J BIOL CHEM, V275, P23602, DOI 10.1074/jbc.M002596200; Girard F, 2009, BBA-BIOMEMBRANES, V1788, P575, DOI 10.1016/j.bbamem.2008.11.001; Girard F, 2008, APPL ENVIRON MICROB, V74, P2565, DOI 10.1128/AEM.00094-08; Huang SJ, 2004, ELECTROPHORESIS, V25, P779, DOI 10.1002/elps.200305723; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Kumar ASM, 1999, J BACTERIOL, V181, P6103; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Loseva OI, 2001, BIOCHEMISTRY-US, V40, P14143, DOI 10.1021/bi010171w; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Munoz-Garay C, 2006, J MEMBRANE BIOL, V212, P61, DOI 10.1007/s00232-006-0003-8; Munoz-Garay C, 2009, BBA-BIOMEMBRANES, V1788, P2229, DOI 10.1016/j.bbamem.2009.06.014; Nair MS, 2008, J BIOL CHEM, V283, P26324, DOI 10.1074/jbc.M802895200; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Pardo-Lopez L, 2006, BIOCHEMISTRY-US, V45, P10329, DOI 10.1021/bi060297z; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Penefsky H S, 1979, Methods Enzymol, V56, P527; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Rausell C, 2004, J BIOL CHEM, V279, P55168, DOI 10.1074/jbc.M406279200; Rausell C, 2004, BIOCHEMISTRY-US, V43, P166, DOI 10.1021/bi035527d; Rodriguez-Almazan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005545; Schwartz JL, 1997, FEBS LETT, V410, P397, DOI 10.1016/S0014-5793(97)00626-1; SHAHROKH Z, 1991, J BIOL CHEM, V266, P12082; Soberon M, 2009, CELL MOL LIFE SCI, V66, P1337, DOI 10.1007/s00018-008-8330-9; Spruijt RB, 1996, BIOCHEMISTRY-US, V35, P10383, DOI 10.1021/bi960410t; Taveecharoenkool T., 2010, PMC BIOPHYS, V3, P1; Vachon V, 2004, APPL ENVIRON MICROB, V70, P6123, DOI 10.1128/AEM.70.10.6123-6130.2004; Vachon V, 2002, BIOCHEMISTRY-US, V41, P6178, DOI 10.1021/bi011572e; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Zhuang MB, 2002, J BIOL CHEM, V277, P13863, DOI 10.1074/jbc.M110057200	40	16	18	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19109	19117		10.1074/jbc.M110.202994	http://dx.doi.org/10.1074/jbc.M110.202994			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21464133	Green Published, hybrid			2022-12-27	WOS:000290785700080
J	Dong, AW; Gupta, A; Pai, RK; Tun, M; Lowe, AW				Dong, Aiwen; Gupta, Aparna; Pai, Reetesh K.; Tun, May; Lowe, Anson W.			The Human Adenocarcinoma-associated Gene, AGR2, Induces Expression of Amphiregulin through Hippo Pathway Co-activator YAP1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGAN SIZE CONTROL; HUMAN HOMOLOG; CELL; CANCER; PROTEIN; REGENERATION; DROSOPHILA; GROWTH; EGFR; AUTOCRINE	Anterior Gradient Homolog 2 (AGR2) is expressed by the normal intestine and by most human adenocarcinomas, including those derived from the esophagus, pancreas, lung, breast, ovary, and prostate. Xenografts of human adenocarcinoma cell lines in nude mice previously demonstrated that AGR2 supports tumor growth. In addition, AGR2 is able to induce in vitro a transformed phenotype in fibroblast and epithelial cell lines. The mechanism underlying the growth promoting effects of AGR2 is unknown. The present study shows that AGR2 induces expression of amphiregulin (AREG), a growth promoting EGFR ligand. Induced AREG expression in adenocarcinoma cells is able to rescue the transformed phenotype that is lost when AGR2 expression is reduced. Additional experiments demonstrate that AGR2 induction of AREG is mediated by activation of the Hippo signaling pathway co-activator, YAP1. Thus AGR2 promotes growth by regulating the Hippo and EGF receptor signaling pathways.	[Dong, Aiwen; Gupta, Aparna; Tun, May; Lowe, Anson W.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Pai, Reetesh K.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Lowe, Anson W.] Stanford Univ, Stanford Digest Dis Ctr, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Lowe, AW (corresponding author), Alway Bldg,Rm M211,300 Pasteur Dr, Stanford, CA 94305 USA.	lowe@stanford.edu	Dong, Aiwen/B-1258-2013	Dong, Aiwen/0000-0003-4931-3633	National Institutes of Health [DK063624]; Stanford University Digestive Disease Center [DK56339]; Stanford Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063624, P30DK056339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University Digestive Disease Center; Stanford Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK063624 (to A. W. L.), DK56339 (Stanford University Digestive Disease Center), and the Stanford Cancer Center.	Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5; AKAGI M, 1995, CANCER, V75, P1460, DOI 10.1002/1097-0142(19950315)75:6+<1460::AID-CNCR2820751513>3.0.CO;2-L; Alvarez H, 2008, CANCER BIOL THER, V7, P1753; Baldys A, 2009, BIOCHEMISTRY-US, V48, P1462, DOI 10.1021/bi801771g; BANKSSCHLEGEL SP, 1985, CANCER RES, V45, P1187; Berasain C, 2005, GASTROENTEROLOGY, V128, P424, DOI 10.1053/j.gastro.2004.11.006; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Boonstra JJ, 2010, JNCI-J NATL CANCER I, V102, P271, DOI 10.1093/jnci/djp499; Bostwick DG, 2004, PROSTATE, V58, P164, DOI 10.1002/pros.10322; Brown CL, 1998, J BIOL CHEM, V273, P17258, DOI 10.1074/jbc.273.27.17258; Brown CL, 2001, J BIOL CHEM, V276, P29538, DOI 10.1074/jbc.M102114200; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Castillo J, 2006, CANCER RES, V66, P6129, DOI 10.1158/0008-5472.CAN-06-0404; COX AD, 1994, METHOD ENZYMOL, V238, P277; D'Antonio A, 2002, INT J ONCOL, V21, P941; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; EBERT M, 1994, CANCER RES, V54, P3959; Edgell TA, 2010, CLIN SCI, V118, P717, DOI 10.1042/CS20090537; Fritzsche FR, 2007, HISTOL HISTOPATHOL, V22, P703, DOI 10.14670/HH-22.703; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; JOHNSON GR, 1992, J CELL BIOL, V118, P741, DOI 10.1083/jcb.118.3.741; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu D, 2005, CANCER RES, V65, P3796, DOI 10.1158/0008-5472.CAN-04-3823; Lowe AW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000323; Ma L, 1999, ONCOGENE, V18, P6513, DOI 10.1038/sj.onc.1203042; MartinezLacaci I, 1996, J CELL PHYSIOL, V169, P497, DOI 10.1002/(SICI)1097-4652(199612)169:3<497::AID-JCP10>3.0.CO;2-3; Persson S, 2005, MOL PHYLOGENET EVOL, V36, P734, DOI 10.1016/j.ympev.2005.04.002; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Rockett JC, 1997, BRIT J CANCER, V75, P258, DOI 10.1038/bjc.1997.42; SAEKI T, 1992, CANCER RES, V52, P3467; Schuger L, 1996, DEVELOPMENT, V122, P1759; Shao JY, 2010, ENDOCRINOLOGY, V151, P3728, DOI 10.1210/en.2010-0319; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Stern KA, 2008, BIOCHEM J, V410, P585, DOI 10.1042/BJ20071505; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; Wang Z, 2008, CANCER RES, V68, P492, DOI 10.1158/0008-5472.CAN-07-2930; Willmarth NE, 2006, J BIOL CHEM, V281, P37728, DOI 10.1074/jbc.M606532200; Yotsumoto F, 2008, BIOCHEM BIOPH RES CO, V365, P555, DOI 10.1016/j.bbrc.2007.11.015; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang JS, 2005, GENE CHROMOSOME CANC, V43, P249, DOI 10.1002/gcc.20188; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhu H, 2007, CANCER LETT, V245, P303, DOI 10.1016/j.canlet.2006.01.020	52	72	75	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18301	18310		10.1074/jbc.M110.215707	http://dx.doi.org/10.1074/jbc.M110.215707			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454516	Green Published, hybrid			2022-12-27	WOS:000290585200090
J	Andrikopoulos, P; Fraser, SP; Patterson, L; Ahmad, Z; Burcu, H; Ottaviani, D; Diss, JKJ; Box, C; Eccles, SA; Djamgoz, MBA				Andrikopoulos, Petros; Fraser, Scott P.; Patterson, Lisa; Ahmad, Zahida; Burcu, Hakan; Ottaviani, Diego; Diss, James K. J.; Box, Carol; Eccles, Suzanne A.; Djamgoz, Mustafa B. A.			Angiogenic Functions of Voltage-gated Na+ Channels in Human Endothelial Cells MODULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; HUMAN UMBILICAL VEIN; BREAST-CANCER CELLS; RAT PROSTATE-CANCER; SODIUM-CHANNEL; IN-VITRO; NA+-CA2+ EXCHANGE; SPLICE VARIANT; CA2+ CHANNELS; DNA-SYNTHESIS	Voltage-gated sodium channel (VGSC) activity has previously been reported in endothelial cells (ECs). However, the exact isoforms of VGSCs present, their mode(s) of action, and potential role(s) in angiogenesis have not been investigated. The main aims of this study were to determine the role of VGSC activity in angiogenic functions and to elucidate the potentially associated signaling mechanisms using human umbilical vein endothelial cells (HUVECs) as a model system. Real-time PCR showed that the primary functional VGSC alpha- and beta-subunit isoforms in HUVECs were Nav1.5, Nav1.7, VGSC beta 1, and VGSC beta 3. Western blots verified that VGSC alpha proteins were expressed in HUVECs, and immunohistochemistry revealed VGSC alpha expression in mouse aortic ECs in vivo. Electrophysiological recordings showed that the channels were functional and suppressed by tetrodotoxin (TTX). VGSC activity modulated the following angiogenic properties of HUVECs: VEGF-induced proliferation or chemotaxis, tubular differentiation, and substrate adhesion. Interestingly, different aspects of angiogenesis were controlled by the different VGSC isoforms based on TTX sensitivity and effects of siRNA-mediated gene silencing. Additionally, we show for the first time that TTX-resistant (TTX-R) VGSCs (Nav1.5) potentiate VEGF-induced ERK1/2 activation through the PKC alpha-B-RAF signaling axis. We postulate that this potentiation occurs through modulation of VEGF-induced HUVEC depolarization and [Ca2+](i). We conclude that VGSCs regulate multiple angiogenic functions and VEGF signaling in HUVECs. Our results imply that targeting VGSC expression/activity could be a novel strategy for controlling angiogenesis.	[Diss, James K. J.; Djamgoz, Mustafa B. A.] Univ London Imperial Coll Sci Technol & Med, Neurosci Solut Canc Res Grp, Div Cell & Mol Biol, London SW7 2AZ, England; [Andrikopoulos, Petros; Patterson, Lisa; Ahmad, Zahida; Burcu, Hakan; Ottaviani, Diego; Box, Carol; Eccles, Suzanne A.] Inst Canc Res, McElwain Labs, Canc Res UK Canc Therapeut Unit, Sutton SM2 5NG, Surrey, England	Imperial College London; Cancer Research UK; University of London; Institute of Cancer Research - UK	Andrikopoulos, P (corresponding author), Queen Marys Univ London, Barts & London Sch Med, William Harvey Res Inst, London EC1M 6BQ, England.	p.andrikopoulos@qmul.ac.uk; m.djamgoz@imperial.ac.uk	Andrikopoulos, Petros/G-2519-2011; Andrikopoulos, Petros/N-7724-2019; Diss, James K/C-5994-2008	Andrikopoulos, Petros/0000-0002-1555-3498; Diss, James K/0000-0003-4988-257X; Box, Carol/0000-0002-8919-8724	British Heart Foundation [FS/06/22]; National Health Service; Royal Marsden Hospital Head and Neck Cancer Research Trust; Cancer Research UK [C309/A8274]; Institute of Cancer Research; Cancer Research UK [11566] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); National Health Service; Royal Marsden Hospital Head and Neck Cancer Research Trust; Cancer Research UK(Cancer Research UK); Institute of Cancer Research; Cancer Research UK(Cancer Research UK)	This work was supported by British Heart Foundation Studentship FS/06/22 (to P. A.). Additional support was provided by the Pro Cancer Research Fund. The NIHR Biomedical Research Centre was supported by the National Health Service.; Supported by the Royal Marsden Hospital Head and Neck Cancer Research Trust.; Supported by Cancer Research UK Grant C309/A8274 and The Institute of Cancer Research.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Black JA, 2008, ANN NEUROL, V64, P644, DOI 10.1002/ana.21527; Borg JJ, 2002, J PHARMACOL EXP THER, V303, P282, DOI 10.1124/jpet.102.038901; Brackenbury WJ, 2007, BREAST CANCER RES TR, V101, P149, DOI 10.1007/s10549-006-9281-1; Brackenbury WJ, 2006, J PHYSIOL-LONDON, V573, P343, DOI 10.1113/jphysiol.2006.106906; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carrithers MD, 2009, J BIOL CHEM, V284, P8114, DOI 10.1074/jbc.M801892200; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chen CH, 2006, CIRC RES, V99, P787, DOI 10.1161/01.RES.0000247758.34085.a6; Chioni AM, 2009, INT J BIOCHEM CELL B, V41, P1216, DOI 10.1016/j.biocel.2008.11.001; Dawson NS, 2006, FASEB J, V20, P991, DOI 10.1096/fj.05-3923fje; Diss JKJ, 2001, PROSTATE, V48, P165, DOI 10.1002/pros.1095; Doanes AM, 1999, BIOCHEM BIOPH RES CO, V255, P545, DOI 10.1006/bbrc.1999.0227; Eccles SA, 2004, INT J DEV BIOL, V48, P583, DOI 10.1387/ijdb.041820se; Eccles Suzanne A., 2009, V467, P159, DOI 10.1007/978-1-59745-241-0_9; EPPS DE, 1994, CHEM PHYS LIPIDS, V69, P137, DOI 10.1016/0009-3084(94)90035-3; Fraser SP, 2003, J CELL PHYSIOL, V195, P479, DOI 10.1002/jcp.10312; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gillet L, 2009, J BIOL CHEM, V284, P8671, DOI 10.1074/jbc.M806891200; Gliki G, 2001, BIOCHEM J, V353, P503, DOI 10.1042/0264-6021:3530503; GORDIENKO DV, 1994, PFLUG ARCH EUR J PHY, V428, P91, DOI 10.1007/BF00374756; Gosling M, 1998, J BIOL CHEM, V273, P21084, DOI 10.1074/jbc.273.33.21084; HE P, 1994, J APPL PHYSIOL, V76, P2288, DOI 10.1152/jappl.1994.76.6.2288; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; House CD, 2010, CANCER RES, V70, P6957, DOI 10.1158/0008-5472.CAN-10-1169; Isner JM, 2002, NATURE, V415, P234, DOI 10.1038/415234a; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Larbig R, 2010, J PHYSIOL-LONDON, V588, P3266, DOI 10.1113/jphysiol.2010.187708; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Liang GH, 2008, PFLUG ARCH EUR J PHY, V457, P67, DOI 10.1007/s00424-008-0490-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier SKG, 2003, P NATL ACAD SCI USA, V100, P3507, DOI 10.1073/pnas.2627986100; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Meadows KN, 2001, J BIOL CHEM, V276, P49289, DOI 10.1074/jbc.M108069200; Ng SW, 2008, J BIOL CHEM, V283, P31348, DOI 10.1074/jbc.M804942200; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Palmer CP, 2008, EUR BIOPHYS J BIOPHY, V37, P359, DOI 10.1007/s00249-007-0219-2; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Platel JC, 2005, P NATL ACAD SCI USA, V102, P19174, DOI 10.1073/pnas.0504540102; Putney J W Jr, 2001, Mol Interv, V1, P84; Qu YS, 1996, J GEN PHYSIOL, V108, P375, DOI 10.1085/jgp.108.5.375; Sanderson S, 2006, MOL CANCER THER, V5, P522, DOI 10.1158/1535-7163.MCT-05-0439; Semenza GL, 2006, CIRC RES, V98, P1115, DOI 10.1161/01.RES.0000223485.43020.9e; Shigekawa M, 2001, CIRC RES, V88, P864, DOI 10.1161/hh0901.090298; Smitherman KA, 2001, J MEMBRANE BIOL, V181, P125, DOI 10.1007/s00232-001-0016-2; Stamboulian S, 2010, J NEUROSCI, V30, P1637, DOI 10.1523/JNEUROSCI.4872-09.2010; Szewczyk MM, 2007, J CELL MOL MED, V11, P129, DOI 10.1111/j.1582-4934.2007.00010.x; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Teubl M, 1999, J BIOL CHEM, V274, P29529, DOI 10.1074/jbc.274.41.29529; Traub O, 1999, J BIOL CHEM, V274, P20144, DOI 10.1074/jbc.274.29.20144; Walsh KB, 1998, AM J PHYSIOL-HEART C, V274, pH506, DOI 10.1152/ajpheart.1998.274.2.H506; Wang AH, 2002, CIRC RES, V90, P609, DOI 10.1161/01.RES.0000012503.30315.E8; Wilsher N, 2007, DRUG METAB DISPOS, V35, P1017, DOI 10.1124/dmd.106.014498; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006; Zeng HY, 2001, J BIOL CHEM, V276, P32714, DOI 10.1074/jbc.M103130200	60	73	79	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16846	16860		10.1074/jbc.M110.187559	http://dx.doi.org/10.1074/jbc.M110.187559			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21385874	Green Published, hybrid			2022-12-27	WOS:000290301900034
J	Fecto, F; Shi, Y; Huda, R; Martina, M; Siddique, T; Deng, HX				Fecto, Faisal; Shi, Yong; Huda, Rafiq; Martina, Marco; Siddique, Teepu; Deng, Han-Xiang			Mutant TRPV4-mediated Toxicity Is Linked to Increased Constitutive Function in Axonal Neuropathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; SENSORY NEUROPATHY; HEREDITARY MOTOR; TRPV4; CALCIUM; DISEASE; DISORDERS; MUTATIONS; HMSN2C; GENE	Mutations in TRPV4 have been linked to three distinct axonal neuropathies. However, the pathogenic mechanism underlying these disorders remains unclear. Both gain and loss of calcium channel activity of the mutant TRPV4 have been suggested. Here, we show that the three previously reported TRPV4 mutant channels have a physiological localization and display an increased calcium channel activity, leading to increased cytotoxicity in three different cell types. Patch clamp experiments showed that cells expressing mutant TRPV4 have much larger whole-cell currents than those expressing the wild-type TRPV4 channel. Single channel recordings showed that the mutant channels have higher open probability, due to a modification of gating, and no change in single-channel conductance. These data support the hypothesis that a "gain of function" mechanism, possibly leading to increased intracellular calcium influx, underlies the pathogenesis of the TRPV4-linked axonal neuropathies, and may have immediate implications for designing rational therapies.	[Fecto, Faisal; Shi, Yong; Siddique, Teepu; Deng, Han-Xiang] Northwestern Univ, Feinberg Sch Med, Div Neuromuscular Med, Davee Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA; [Fecto, Faisal; Huda, Rafiq; Martina, Marco; Siddique, Teepu] Northwestern Univ, Feinberg Sch Med, Interdept Neurosci Program, Chicago, IL 60611 USA; [Huda, Rafiq; Martina, Marco] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Siddique, Teepu] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Deng, HX (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Neuromuscular Med, Davee Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA.	h-deng@northwestern.edu	Siddique, Teepu/AAT-8166-2021	Huda, Rafiq/0000-0002-6814-9966; martina, marco/0000-0002-9648-2918; Deng, Han-Xiang/0000-0002-0030-8465; Siddique, Teepu/0000-0001-7293-9146; Fecto, Faisal/0000-0002-7587-8024	NINDS [NS050641]; NHLBI [HL095731]; National Institutes of Health [T32 AG20506, T32 MH067564]; Les Turner ALS Foundation; Vena E. Schaff ALS Research Fund; Harold Post Research Professorship; Herbert and Florence C. Wenske Foundation; David C. Asselin MD Memorial Fund; Help America Foundation; Les Turner ALS Foundation/Herbert C. Wenske Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH067564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020506] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Les Turner ALS Foundation; Vena E. Schaff ALS Research Fund; Harold Post Research Professorship; Herbert and Florence C. Wenske Foundation; David C. Asselin MD Memorial Fund; Help America Foundation; Les Turner ALS Foundation/Herbert C. Wenske Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by NINDS Grant NS050641, NHLBI Grant HL095731, and Grants T32 AG20506 and T32 MH067564 from the National Institutes of Health. This work was also supported by the Les Turner ALS Foundation, the Vena E. Schaff ALS Research Fund, the Harold Post Research Professorship, the Herbert and Florence C. Wenske Foundation, the David C. Asselin MD Memorial Fund, the Help America Foundation, and the Les Turner ALS Foundation/Herbert C. Wenske Foundation Professorship.	Auer-Grumbach M, 2010, NAT GENET, V42, P160, DOI 10.1038/ng.508; DELONG R, 1992, ARCH NEUROL-CHICAGO, V49, P905, DOI 10.1001/archneur.1992.00530330027010; Dempster J., 1993, COMPUTER ANAL ELECTR; Deng HX, 2010, NAT GENET, V42, P165, DOI 10.1038/ng.509; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; DYCK PJ, 1994, ANN NEUROL, V35, P608, DOI 10.1002/ana.410350515; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; FARBER JL, 1981, LIFE SCI, V29, P1289, DOI 10.1016/0024-3205(81)90670-6; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Isozumi K, 1996, HUM MOL GENET, V5, P1377, DOI 10.1093/hmg/5.9.1377; Klein CJ, 2011, NEUROLOGY, V76, P887, DOI 10.1212/WNL.0b013e31820f2de3; Klein CJ, 2003, NEUROLOGY, V60, P1151, DOI 10.1212/01.WNL.0000055900.30217.EA; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; Liedtke W, 2008, ANN NY ACAD SCI, V1144, P42, DOI 10.1196/annals.1418.012; Loukin S, 2010, J BIOL CHEM, V285, P27176, DOI 10.1074/jbc.M110.143370; Marongiu R, 2009, J NEUROCHEM, V108, P1561, DOI 10.1111/j.1471-4159.2009.05932.x; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; McEntagart ME, 2005, ANN NEUROL, V57, P293, DOI 10.1002/ana.20375; Nilius B, 2010, NAT GENET, V42, P98, DOI 10.1038/ng0210-98; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; Suzuki M, 2003, J BIOL CHEM, V278, P51448, DOI 10.1074/jbc.M308212200; Wegierski T, 2009, J BIOL CHEM, V284, P2923, DOI 10.1074/jbc.M805357200; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Zimon M, 2010, BRAIN, V133, P1798, DOI 10.1093/brain/awq109	24	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17281	17291		10.1074/jbc.M111.237685	http://dx.doi.org/10.1074/jbc.M111.237685			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454511	Green Published, hybrid			2022-12-27	WOS:000290301900076
J	Horl, G; Wagner, A; Cole, LK; Malli, R; Reicher, H; Kotzbeck, P; Kofeler, H; Hofler, G; Frank, S; Bogner-Strauss, JG; Sattler, W; Vance, DE; Steyrer, E				Hoerl, Gerd; Wagner, Andrea; Cole, Laura K.; Malli, Roland; Reicher, Helga; Kotzbeck, Petra; Koefeler, Harald; Hoefler, Gerald; Frank, Sasa; Bogner-Strauss, Juliane G.; Sattler, Wolfgang; Vance, Dennis E.; Steyrer, Ernst			Sequential Synthesis and Methylation of Phosphatidylethanolamine Promote Lipid Droplet Biosynthesis and Stability in Tissue Culture and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; ADIPOSE TRIGLYCERIDE LIPASE; DIET-INDUCED OBESITY; N-METHYLTRANSFERASE; RAT-LIVER; PHOSPHATIDYLCHOLINE SYNTHESIS; PHOSPHOLIPID-COMPOSITION; ENDOPLASMIC-RETICULUM; ADIPOCYTE LIPOLYSIS; MEMBRANE-FRACTION	Triacylglycerols are stored in eukaryotic cells within lipid droplets (LD). The LD core is enwrapped by a phospholipid monolayer with phosphatidylcholine (PC), the major phospholipid, and phosphatidylethanolamine (PE), a minor component. We demonstrate that the onset of LD formation is characterized by a change in cellular PC, PE, and phosphatidylserine (PS). With induction of differentiation of 3T3-L1 fibroblasts into adipocytes, the cellular PC/PE ratio decreased concomitant with LD formation, with the most pronounced decline between confluency and day 5. The mRNA for PS synthase-1 (forms PS from PC) and PS decarboxylase (forms PE from PS) increased after day 5. Activity and protein of PE N-methyltransferase (PEMT), which produces PC by methylation of PE, are absent in 3T3-L1 fibroblasts but were induced at day 5. High fat challenge induced PEMT expression in mouse adipose tissue. PE, produced via PS decarboxylase, was the preferred substrate for methylation to PC. A PEMT-GFP fusion protein decorated the periphery of LD. PEMT knockdown in 3T3-L1 adipocytes correlated with increased basal triacylglycerol hydrolysis. Pemt(-/-) mice developed desensitization against adenosine-mediated inhibition of basal hydrolysis in adipose tissue, and adipocyte hypotrophy was observed in Pemt(-/-) animals on a high fat diet. Knock-out of PEMT in adipose tissue down-regulated PS synthase-1 mRNA, suggesting coordination between PE supply and converting pathways during LD biosynthesis. We conclude that two consecutive processes not previously related to LD biogenesis, (i) PE production via PS and (ii) PE conversion via PEMT, are implicated in LD formation and stability.	[Hoerl, Gerd; Wagner, Andrea; Malli, Roland; Reicher, Helga; Frank, Sasa; Sattler, Wolfgang; Steyrer, Ernst] Med Univ Graz, Dept Mol Biol & Biochem, Ctr Mol Med, A-8010 Graz, Austria; [Cole, Laura K.; Vance, Dennis E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Cole, Laura K.; Vance, Dennis E.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; [Kotzbeck, Petra] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Koefeler, Harald] Med Univ Graz, Med Res Ctr, A-8010 Graz, Austria; [Hoefler, Gerald] Med Univ Graz, Dept Pathol, A-8010 Graz, Austria; [Bogner-Strauss, Juliane G.] Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria	Medical University of Graz; University of Alberta; University of Alberta; University of Graz; Medical University of Graz; Medical University of Graz; Graz University of Technology	Steyrer, E (corresponding author), Med Univ Graz, Dept Mol Biol & Biochem, Ctr Mol Med, Harrachgasse 21, A-8010 Graz, Austria.	ernst.steyrer@medunigraz.at		Bogner-Strauss, Juliane/0000-0003-2459-0124; Kotzbeck, Petra/0000-0003-4039-3745; Groselj-Strele, Andrea/0000-0002-0709-5458; Kofeler, Harald/0000-0002-2725-9616; Hoerl, Gerd/0000-0002-0884-0851; Malli, Roland/0000-0001-6327-8729	Austrian Science Funds [P-15.358, F3007 SFB LIPOTOX, F3002-B05 SFB LIPTOX, P-19473]; Austrian Heart Foundation [01/08]; Franz-Lanyar Foundation (Graz, Austria) [P-308, P-323]; Austrian Ministry for Science and Research; Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; National Science and Engineering Research Council; Austrian Science Fund (FWF) [F 3007, W 901] Funding Source: researchfish	Austrian Science Funds(Austrian Science Fund (FWF)); Austrian Heart Foundation; Franz-Lanyar Foundation (Graz, Austria); Austrian Ministry for Science and Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Funds P-15.358 (to E. S.), F3007 SFB LIPOTOX (to W. S.), F3002-B05 SFB LIPTOX (to G. H.), and P-19473 (to S. F.), Austrian Heart Foundation Project 01/08 (to E. S.), Franz-Lanyar Foundation (Graz, Austria) Grants P-308 (to G. Horl) and P-323 (to E. S.), Austrian Ministry for Science and Research GEN-AU Project GOLDIII (to J. G. B.-S.), and the Canadian Institutes of Health Research (to D. E. V.).; Recipient of studentship awards from the Alberta Heritage Foundation for Medical Research and the National Science and Engineering Research Council.	Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Arikketh D, 2008, J BIOL CHEM, V283, P12888, DOI 10.1074/jbc.M800714200; Badman MK, 2007, GASTROENTEROLOGY, V132, P2103, DOI 10.1053/j.gastro.2007.03.058; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blouin CM, 2010, J LIPID RES, V51, P945, DOI 10.1194/jlr.M001016; Borglum JD, 1996, MOL CELL ENDOCRINOL, V117, P17, DOI 10.1016/0303-7207(95)03728-4; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Chang BHJ, 2007, AM J PHYSIOL-GASTR L, V292, pG1465, DOI 10.1152/ajpgi.00566.2006; Ciruela F, 2010, BBA-BIOMEMBRANES, V1798, P9, DOI 10.1016/j.bbamem.2009.10.016; Cole LK, 2010, J BIOL CHEM, V285, P11880, DOI 10.1074/jbc.M110.109843; CUI Z, 1993, J BIOL CHEM, V268, P16655; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Dowhan W, 2008, N COMP BIOC, P1, DOI 10.1016/B978-044453219-0.50003-9; FAST DG, 1995, BBA-LIPID LIPID MET, V1258, P159, DOI 10.1016/0005-2760(95)00116-T; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; HOFFMAN BB, 1986, J CLIN INVEST, V78, P185, DOI 10.1172/JCI112550; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; Kast HR, 2001, J LIPID RES, V42, P1266; KASTURI R, 1983, J BIOL CHEM, V258, P3559; Kornmann B, 2010, J CELL SCI, V123, P1389, DOI 10.1242/jcs.058636; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lehner R, 1999, BIOCHEM J, V338, P761, DOI 10.1042/0264-6021:3380761; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Liu PS, 2007, BBA-MOL CELL RES, V1773, P784, DOI 10.1016/j.bbamcr.2007.02.004; Marchesan D, 2003, J BIOL CHEM, V278, P27293, DOI 10.1074/jbc.M301430200; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Nakamura N, 2005, BIOCHEM BIOPH RES CO, V335, P117, DOI 10.1016/j.bbrc.2005.07.050; Nishimaki-Mogami T, 2002, J LIPID RES, V43, P1035, DOI 10.1194/jlr.M100354-JLR200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Ost A, 2005, J BIOL CHEM, V280, P5, DOI 10.1074/jbc.C400429200; Prattes S, 2000, J CELL SCI, V113, P2977; Rasband W. S., 1997, IMAGEJ VER 1 44; RIDGWAY ND, 1992, METHOD ENZYMOL, V209, P366; Robenek H, 2006, J CELL SCI, V119, P4215, DOI 10.1242/jcs.03191; Sattler W, 1996, LIPIDS, V31, P1303, DOI 10.1007/BF02587917; Schrader M, 2001, J HISTOCHEM CYTOCHEM, V49, P1421, DOI 10.1177/002215540104901110; SCOW RO, 1991, BRAIN RES BULL, V27, P487, DOI 10.1016/0361-9230(91)90147-C; Shields DJ, 2003, J BIOL CHEM, V278, P35826, DOI 10.1074/jbc.M306308200; Shields DJ, 2003, J BIOL CHEM, V278, P2956, DOI 10.1074/jbc.M210904200; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Steenbergen R, 2006, BBA-MOL CELL BIOL L, V1761, P313, DOI 10.1016/j.bbalip.2006.03.005; Tansey JT, 2004, IUBMB LIFE, V56, P379, DOI 10.1080/15216540400009968; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Vance DE, 2008, N COMP BIOC, P213, DOI 10.1016/B978-044453219-0.50010-6; VANCE JE, 1986, J BIOL CHEM, V261, P4486; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; VERKADE HJ, 1993, J BIOL CHEM, V268, P24990; Viswanadha S, 2006, J LIPID RES, V47, P1859, DOI 10.1194/jlr.D600005-JLR200; VOELKER DR, 1989, J BIOL CHEM, V264, P8019; VOELKER DR, 1989, P NATL ACAD SCI USA, V86, P9921, DOI 10.1073/pnas.86.24.9921; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c; Zhu XN, 2003, BIOCHEM J, V370, P987, DOI 10.1042/BJ20021523; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	69	75	77	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17338	17350		10.1074/jbc.M111.234534	http://dx.doi.org/10.1074/jbc.M111.234534			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454708	Green Published, hybrid			2022-12-27	WOS:000290301900081
J	Masui, S; Vavassori, S; Fagioli, C; Sitia, R; Inaba, K				Masui, Shoji; Vavassori, Stefano; Fagioli, Claudio; Sitia, Roberto; Inaba, Kenji			Molecular Bases of Cyclic and Specific Disulfide Interchange between Human ERO1 alpha Protein and Protein-disulfide Isomerase (PDI)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; BOND FORMATION; GENERATING DISULFIDES; MISFOLDED PROTEINS; OXIDATIVE ACTIVITY; CRYSTAL-STRUCTURE; PEROXIREDOXIN-IV; HUMAN-CELLS; ERP44; FAMILY	In the endoplasmic reticulum (ER) of human cells, ERO1 alpha and protein-disulfide isomerase (PDI) constitute one of the major electron flow pathways that catalyze oxidative folding of secretory proteins. Specific and limited PDI oxidation by ERO1 alpha is essential to avoid ER hyperoxidation. To investigate how ERO1 alpha oxidizes PDI selectively among more than 20 ER-resident PDI family member proteins, we performed docking simulations and systematic biochemical analyses. Our findings reveal that a protruding beta-hairpin of ERO1 alpha specifically interacts with the hydrophobic pocket present in the redox-inactive PDI b'-domain through the stacks between their aromatic residues, leading to preferred oxidation of the C-terminal PDI a'-domain. ERO1 alpha associated preferentially with reduced PDI, explaining the stepwise disulfide shuttle mechanism, first from ERO1 alpha to PDI and then from oxidized PDI to an unfolded polypeptide bound to its hydrophobic pocket. The interaction of ERO1 alpha with ERp44, another PDI family member protein, was also analyzed. Notably, ERO1 alpha-dependent PDI oxidation was inhibited by a hyperactive ERp44 mutant that lacks the C-terminal tail concealing the substrate-binding hydrophobic regions. The potential ability of ERp44 to inhibit ERO1 alpha activity may suggest its physiological role in ER redox and protein homeostasis.	[Masui, Shoji; Inaba, Kenji] Kyushu Univ, Med Inst Bioregulat, Postgenome Sci Ctr, Div Prot Chem,Higashi Ku, Fukuoka 8128582, Japan; [Vavassori, Stefano; Fagioli, Claudio; Sitia, Roberto] Univ Vita Salute, San Raffaele Sci Inst, Div Genet & Cell Biol, I-20132 Milan, Italy	Kyushu University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Inaba, K (corresponding author), Kyushu Univ, Med Inst Bioregulat, Postgenome Sci Ctr, Div Prot Chem,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	inaba-k@bioreg.kyushu-u.ac.jp	Fagioli, Claudio/AAN-4147-2020; Sitia, Roberto/AAB-5005-2019	Fagioli, Claudio/0000-0001-9889-4695; Sitia, Roberto/0000-0001-7086-4152; Inaba, Kenji/0000-0001-8229-0467	MEXT; Yamada Science Foundation; Regione Lombardia (ASTIL); Associazione Italiana Ricerca Cancro (AIRC)	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Science Foundation; Regione Lombardia (ASTIL)(Regione Lombardia); Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by a Grant-in-aid for Young Scientists (A) from MEXT and the Yamada Science Foundation (to K. I.) and grants from Regione Lombardia (ASTIL) and Associazione Italiana Ricerca Cancro (AIRC) (to R. S.).	Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Bertoli G, 2004, J BIOL CHEM, V279, P30047, DOI 10.1074/jbc.M403192200; Byrne LJ, 2009, BIOCHEM J, V423, P209, DOI 10.1042/BJ20090565; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Chambers JE, 2010, J BIOL CHEM, V285, P29200, DOI 10.1074/jbc.M110.156596; Cortini M, 2010, TRAFFIC, V11, P651, DOI 10.1111/j.1600-0854.2010.01043.x; Denisov AY, 2009, FEBS J, V276, P1440, DOI 10.1111/j.1742-4658.2009.06884.x; Depuydt M., 2011, ANTIOXID RE IN PRESS; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Fraldi A, 2008, HUM MOL GENET, V17, P2610, DOI 10.1093/hmg/ddn161; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Inaba K, 2010, GENES CELLS, V15, P935, DOI 10.1111/j.1365-2443.2010.01434.x; Kanamori E, 2007, PROTEINS, V69, P832, DOI 10.1002/prot.21737; Karala AR, 2009, ANTIOXID REDOX SIGN, V11, P963, DOI 10.1089/ARS.2008.2326; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kodali VK, 2010, ANTIOXID REDOX SIGN, V13, P1217, DOI 10.1089/ars.2010.3098; Li WK, 2010, NATURE, V463, P507, DOI 10.1038/nature08720; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mariappan M, 2008, J BIOL CHEM, V283, P6375, DOI 10.1074/jbc.M709171200; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Nakasako M, 2010, BIOCHEMISTRY-US, V49, P6953, DOI 10.1021/bi1006089; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Saaranen MJ, 2010, ANTIOXID REDOX SIGN, V12, P15, DOI 10.1089/ars.2009.2674; Serve O, 2010, J MOL BIOL, V396, P361, DOI 10.1016/j.jmb.2009.11.049; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230; Thorpe C, 2007, J BIOL CHEM, V282, P13929, DOI 10.1074/jbc.R600037200; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tsuchiya Y, 2006, PROTEIN ENG DES SEL, V19, P421, DOI 10.1093/protein/gzl026; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Vitu E, 2010, J BIOL CHEM, V285, P18155, DOI 10.1074/jbc.M109.064931; Wang C, 2010, J BIOL CHEM, V285, P26788, DOI 10.1074/jbc.M110.107839; Wang L, 2011, BIOCHEM J, V434, P113, DOI 10.1042/BJ20101357; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Wang LK, 2008, EMBO REP, V9, P642, DOI 10.1038/embor.2008.88; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	54	53	54	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.231357	http://dx.doi.org/10.1074/jbc.M111.231357			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21398518	Green Published, hybrid			2022-12-27	WOS:000290022800065
J	Munoz, E; Valero, RA; Quintana, A; Hoth, M; Nunez, L; Villalobos, C				Munoz, Eva; Valero, Ruth A.; Quintana, Ariel; Hoth, Markus; Nunez, Lucia; Villalobos, Carlos			Nonsteroidal Anti-inflammatory Drugs Inhibit Vascular Smooth Muscle Cell Proliferation by Enabling the Ca2+-dependent Inactivation of Calcium Release-activated Calcium/Orai Channels Normally Prevented by Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STROMAL INTERACTION MOLECULE-1; CAPACITATIVE CA2+ ENTRY; NEOINTIMA FORMATION; T-LYMPHOCYTES; TRPC CHANNELS; I-CRAC; INFLUX; STIM1; SALICYLATE; STIMULATION	Abnormal vascular smooth muscle cell (VSMC) proliferation contributes to occlusive and proliferative disorders of the vessel wall. Salicylate and other nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit VSMC proliferation by an unknown mechanism unrelated to anti-inflammatory activity. In search for this mechanism, we have studied the effects of salicylate and other NSAIDs on subcellular Ca2+ homeostasis and Ca2+-dependent cell proliferation in rat aortic A10 cells, a model of neointimal VSMCs. We found that A10 cells displayed both store-operated Ca2+ entry (SOCE) and voltage-operated Ca2+ entry (VOCE), the former being more important quantitatively than the latter. Inhibition of SOCE by specific Ca2+ released-activated Ca2+ (CRAC/Orai) channels antagonists prevented A10 cell proliferation. Salicylate and other NSAIDs, including ibuprofen, indomethacin, and sulindac, inhibited SOCE and thereby Ca2+-dependent, A10 cell proliferation. SOCE, but not VOCE, induced mitochondrial Ca2+ uptake in A10 cells, and mitochondrial depolarization prevented SOCE, thus suggesting that mitochondrial Ca2+ uptake controls SOCE (but not VOCE) in A10 cells. NSAIDs depolarized mitochondria and prevented mitochondrial Ca2+ uptake, suggesting that they favor the Ca2+-dependent inactivation of CRAC/Orai channels. NSAIDs also inhibited SOCE in rat basophilic leukemia cells where mitochondrial control of CRAC/Orai is well established. NSAIDs accelerate slow inactivation of CRAC currents in rat basophilic leukemia cells under weak Ca2+ buffering conditions but not in strong Ca2+ buffer, thus excluding that NSAIDs inhibit SOCE directly. Taken together, our results indicate that NSAIDs inhibit VSMC proliferation by facilitating the Ca2+-dependent inactivation of CRAC/Orai channels which normally is prevented by mitochondria clearing of entering Ca2+.	[Munoz, Eva; Valero, Ruth A.; Nunez, Lucia; Villalobos, Carlos] Univ Valladolid, Inst Mol Biol & Genet, Toyota 47003, Japan; [Munoz, Eva; Valero, Ruth A.; Nunez, Lucia; Villalobos, Carlos] Spanish Res Council, Toyota 47003, Japan; [Quintana, Ariel; Hoth, Markus] Univ Saarland, Dept Biophys, D-66421 Homburg, Germany	Saarland University	Villalobos, C (corresponding author), Univ Valladolid, Inst Mol Biol & Genet, Toyota 47003, Japan.	carlosv@ibgm.uva.es	nunez, lucia/AAG-8018-2019; Villalobos, Carlos/M-9839-2017	Villalobos, Carlos/0000-0002-0429-3846; Hoth, Markus/0000-0001-7080-4643; Nunez, Lucia/0000-0002-9638-5747	Junta de Castilla y Leon, Spain [SAN191/VA1806, CSI12A08]; Ministerio de Ciencia e Innovacion, Spain [BFU2009-0867]; Instituto de Salud Carlos III, Spain [PI07/0766]; Deutsche Forschungsgemeinschaft [A3, Sonderforschungsbereich 530]	Junta de Castilla y Leon, Spain(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grants SAN191/VA1806, CSI12A08 from Junta de Castilla y Leon, Spain, BFU2009-0867 from Ministerio de Ciencia e Innovacion, Spain, and PI07/0766 from Instituto de Salud Carlos III, Spain, and Deutsche Forschungsgemeinschaft Grant A3 in the Sonderforschungsbereich 530.	Anderson HV, 2001, CIRCULATION, V104, P2331, DOI 10.1161/hc4401.098434; Aubart FC, 2009, MOL THER, V17, P455, DOI 10.1038/mt.2008.291; Beech DJ, 2007, BIOCHEM SOC T, V35, P890, DOI 10.1042/BST0350890; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Brooks G, 2003, J PHARM PHARMACOL, V55, P519, DOI 10.1211/002235702775; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Dietrich A, 2007, PFLUG ARCH EUR J PHY, V455, P465, DOI 10.1007/s00424-007-0314-3; Fantozzi I, 2003, AM J PHYSIOL-LUNG C, V285, pL1233, DOI 10.1152/ajplung.00445.2002; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gilabert JA, 2000, EMBO J, V19, P6401, DOI 10.1093/emboj/19.23.6401; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; Gu Qing, 2005, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V27, P87; Guibert C, 2008, PROG BIOPHYS MOL BIO, V98, P10, DOI 10.1016/j.pbiomolbio.2008.05.001; Guo RW, 2009, CARDIOVASC RES, V81, P660, DOI 10.1093/cvr/cvn338; GUTKNECHT J, 1990, J MEMBRANE BIOL, V115, P253, DOI 10.1007/BF01868640; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Khan Q, 2005, J ATHEROSCLER THROMB, V12, P185, DOI 10.5551/jat.12.185; Li J, 2008, CIRC RES, V103, pE97, DOI 10.1161/CIRCRESAHA.108.182931; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Marra DE, 2000, CIRCULATION, V102, P2124, DOI 10.1161/01.CIR.102.17.2124; Marra DE, 2001, TRENDS CARDIOVAS MED, V11, P339, DOI 10.1016/S1050-1738(01)00133-5; Montalvo GB, 2006, J BIOL CHEM, V281, P35616, DOI 10.1074/jbc.M603518200; Ng LC, 2009, J PHYSIOL-LONDON, V587, P2429, DOI 10.1113/jphysiol.2009.172254; Nunez L, 2006, J PHYSIOL-LONDON, V571, P57, DOI 10.1113/jphysiol.2005.100586; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peel SE, 2008, AM J RESP CELL MOL, V38, P744, DOI 10.1165/rcmb.2007-0395OC; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Rao RS, 1997, CARDIOVASC RES, V36, P118, DOI 10.1016/S0008-6363(97)00156-9; Ren JL, 2010, J BIOL CHEM, V285, P31829, DOI 10.1074/jbc.M109.097576; Schwarz EC, 2007, EUR J IMMUNOL, V37, P2723, DOI 10.1002/eji.200737039; Sonkusare S, 2006, VASC PHARMACOL, V44, P131, DOI 10.1016/j.vph.2005.10.005; Takahashi Y, 2007, BIOCHEM BIOPH RES CO, V361, P934, DOI 10.1016/j.bbrc.2007.07.096; Valero RA, 2008, CELL CALCIUM, V44, P259, DOI 10.1016/j.ceca.2007.12.002; Villalobos C, 2002, FASEB J, V16, DOI 10.1096/fj.01-0630com; Villalobos C, 2009, METHODS MOL BIOL, V574, P203, DOI 10.1007/978-1-60327-321-3_17; Wang YJ, 2008, CLIN EXP PHARMACOL P, V35, P1127, DOI 10.1111/j.1440-1681.2008.05018.x; Weber AA, 2000, EUR J PHARMACOL, V389, P67, DOI 10.1016/S0014-2999(99)00868-7; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	43	37	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.198952	http://dx.doi.org/10.1074/jbc.M110.198952			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21402693	Green Published, hybrid			2022-12-27	WOS:000290022800058
J	Piantadosi, CA; Withers, CM; Bartz, RR; MacGarvey, NC; Fu, P; Sweeney, TE; Welty-Wolf, KE; Suliman, HB				Piantadosi, Claude A.; Withers, Crystal M.; Bartz, Raquel R.; MacGarvey, Nancy Chou; Fu, Ping; Sweeney, Timothy E.; Welty-Wolf, Karen E.; Suliman, Hagir B.			Heme Oxygenase-1 Couples Activation of Mitochondrial Biogenesis to Anti-inflammatory Cytokine Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; HUMAN IL-10 GENE; NF-KAPPA-B; CARBON-MONOXIDE; TRANSCRIPTION FACTOR; OXIDATIVE-METABOLISM; ENDOTOXIC-SHOCK; PROTECTS MICE; INTERLEUKIN-10; INDUCTION	The induction of heme oxygenase-1 (HO-1; Hmox1) by inflammation, for instance in sepsis, is associated both with an anti-inflammatory response and with mitochondrial biogenesis. Here, we tested the idea that HO-1, acting through the Nfe2l2 (Nrf2) transcription factor, links anti-inflammatory cytokine expression to activation of mitochondrial biogenesis. HO-1 induction after LPS stimulated anti-inflammatory IL-10 and IL-1 receptor antagonist (IL-1Ra) expression in mouse liver, human HepG2 cells, and mouse J774.1 macrophages but blunted tumor necrosis factor-alpha expression. This was accompanied by nuclear Nfe2l2 accumulation and led us to identify abundant Nfe2l2 and other mitochondrial biogenesis transcription factor binding sites in the promoter regions of IL10 and IL1Ra compared with pro-inflammatory genes regulated by NF-kappa B. Mechanistically, HO-1, through its CO product, enabled these transcription factors to bind the core IL10 and IL1Ra promoters, which for IL10 included Nfe2l2, nuclear respiratory factor (NRF)-2 (Gabpa), and MEF2, and for IL1Ra, included NRF-1 and MEF2. In cells, Hmox1 or Nfe2l2 RNA silencing prevented IL-10 and IL-1Ra up-regulation, and HO-1 induction failed post-LPS in Nfe2l2-silenced cells and post-sepsis in Nfe2l2(-/-) mice. Nfe2l2(-/-) mice compared with WT mice, showed more liver damage, higher mortality, and ineffective CO rescue in sepsis. Nfe2l2(-/-) mice in sepsis also generated higher hepatic TNF-alpha mRNA levels, lower NRF-1 and PGC-1 alpha mRNA levels, and no enhancement of anti-inflammatory Il10, Socs3, or bcl-x(L) gene expression. These findings disclose a highly structured transcriptional network that couples mitochondrial biogenesis to counter-inflammation with major implications for immune suppression in sepsis.	[Piantadosi, Claude A.; MacGarvey, Nancy Chou; Welty-Wolf, Karen E.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Piantadosi, Claude A.; Bartz, Raquel R.; Fu, Ping; Suliman, Hagir B.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Piantadosi, Claude A.; Withers, Crystal M.; Sweeney, Timothy E.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Piantadosi, Claude A.; Welty-Wolf, Karen E.] Durham Vet Affairs Med Ctr, Dept Med, Durham, NC 27710 USA; [Bartz, Raquel R.] Durham Vet Affairs Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Piantadosi, CA (corresponding author), Duke Univ, Med Ctr, Dept Med, 0570 White Zone,CR 2 Bldg, Durham, NC 27710 USA.	piant001@mc.duke.edu		Sweeney, Timothy/0000-0002-3596-1093	National Institutes of Health [AI064789, GM084116]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI064789, R01AI064789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM087429, R01GM084116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI064789 and GM084116.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; Bourdi M, 2002, HEPATOLOGY, V35, P289, DOI 10.1053/jhep.2002.30956; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brandtzaeg P, 1996, J EXP MED, V184, P51, DOI 10.1084/jem.184.1.51; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Chhikara M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008139; Crouser ED, 2006, CRIT CARE MED, V34, P2439, DOI 10.1097/01.CCM.0000230240.02216.21; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Dasgupta J, 2006, ANTIOXID REDOX SIGN, V8, P1295, DOI 10.1089/ars.2006.8.1295; Deng JP, 2001, KIDNEY INT, V60, P2118, DOI 10.1046/j.1523-1755.2001.00043.x; Dhingra S, 2009, CARDIOVASC RES, V82, P59, DOI 10.1093/cvr/cvp040; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Drechsler Y, 2006, J IMMUNOL, V177, P2592, DOI 10.4049/jimmunol.177.4.2592; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kantrow SP, 1997, ARCH BIOCHEM BIOPHYS, V345, P278, DOI 10.1006/abbi.1997.0264; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; KNOLLE P, 1995, J HEPATOL, V22, P226, DOI 10.1016/0168-8278(95)80433-1; Lai CF, 1996, J BIOL CHEM, V271, P13968, DOI 10.1074/jbc.271.24.13968; Lee BS, 2006, BIOCHEM BIOPH RES CO, V343, P965, DOI 10.1016/j.bbrc.2006.03.058; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Li MH, 2007, J BIOL CHEM, V282, P28577, DOI 10.1074/jbc.M701916200; Lin CY, 2007, J HEPATOL, V46, P816, DOI 10.1016/j.jhep.2006.12.018; Liochev SI, 1997, FREE RADICAL BIO MED, V23, P668, DOI 10.1016/S0891-5849(97)00060-9; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Lowe PR, 2003, CRIT CARE MED, V31, P34, DOI 10.1097/00003246-200301000-00005; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Maines MD, 2005, ANTIOXID REDOX SIGN, V7, P1761, DOI 10.1089/ars.2005.7.1761; Mandal P, 2010, HEPATOLOGY, V51, P1420, DOI 10.1002/hep.23427; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Menezes GB, 2009, J IMMUNOL, V183, P7557, DOI 10.4049/jimmunol.0901786; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Oka SI, 2009, J MOL MED, V87, P785, DOI 10.1007/s00109-009-0471-2; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Pajkrt D, 1997, J IMMUNOL, V158, P3971; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Piantadosi CA, 2006, FREE RADICAL BIO MED, V40, P1332, DOI 10.1016/j.freeradbiomed.2005.11.020; Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Platzer C, 1999, EUR J IMMUNOL, V29, P3098, DOI 10.1002/(SICI)1521-4141(199910)29:10<3098::AID-IMMU3098>3.0.CO;2-H; Rai RM, 1997, HEPATOLOGY, V25, P889, DOI 10.1002/hep.510250417; Ramachandran B, 2008, J BIOL CHEM, V283, P11935, DOI 10.1074/jbc.M707389200; Ranatunga D, 2009, P NATL ACAD SCI USA, V106, P17123, DOI 10.1073/pnas.0904955106; Reynolds CM, 2009, FREE RADICAL BIO MED, V46, P564, DOI 10.1016/j.freeradbiomed.2008.11.007; Ricchetti GA, 2004, J LEUKOCYTE BIOL, V76, P719, DOI 10.1189/jlb.0104046; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Sarady JK, 2004, FASEB J, V18, P854, DOI 10.1096/fj.03-0643fje; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shin HD, 2000, P NATL ACAD SCI USA, V97, P14467, DOI 10.1073/pnas.97.26.14467; Siewe L, 2006, EUR J IMMUNOL, V36, P3248, DOI 10.1002/eji.200636012; Singer M, 2007, CRIT CARE MED, V35, pS441, DOI 10.1097/01.CCM.0000278049.48333.78; STANDIFORD TJ, 1995, J IMMUNOL, V155, P2222; Stumpo R, 2003, CYTOKINE, V24, P46, DOI 10.1016/S1043-4666(03)00270-9; Suliman HB, 2007, J CLIN INVEST, V117, P3730, DOI 10.1172/JCI32967; Suliman HB, 2010, J CELL SCI, V123, P2565, DOI 10.1242/jcs.064089; Suliman HB, 2010, FREE RADICAL BIO MED, V48, P736, DOI 10.1016/j.freeradbiomed.2009.12.019; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Suliman HB, 2005, FASEB J, V19, P1531, DOI 10.1096/fj.04-3500fje; Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005; Suliman HB, 2003, J BIOL CHEM, V278, P41510, DOI 10.1074/jbc.M304719200; Suliman HB, 2003, AM J RESP CRIT CARE, V167, P570, DOI 10.1164/rccm.200206-518OC; Unterberger C, 2008, MOL IMMUNOL, V45, P3230, DOI 10.1016/j.molimm.2008.02.020; VANDERPOLL T, 1995, J IMMUNOL, V155, P5397; Wang SC, 1998, J BIOL CHEM, V273, P302, DOI 10.1074/jbc.273.1.302; Wang XM, 2004, GASTROENTEROLOGY, V127, P1174, DOI 10.1053/j.gastro.2004.07.007; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Yao P, 2009, AM J PHYSIOL-GASTR L, V296, pG1318, DOI 10.1152/ajpgi.00555.2007; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang XC, 2005, J BIOL CHEM, V280, P8714, DOI 10.1074/jbc.M408092200; Ziegler-Heitbrock L, 2003, J IMMUNOL, V171, P285, DOI 10.4049/jimmunol.171.1.285	89	200	207	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.207738	http://dx.doi.org/10.1074/jbc.M110.207738			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454555	Green Published, hybrid			2022-12-27	WOS:000290022800075
J	Roumenina, LT; Radanova, M; Atanasov, BP; Popov, KT; Kaveri, SV; Lacroix-Desmazes, S; Fremeaux-Bacchi, V; Dimitrov, JD				Roumenina, Lubka T.; Radanova, Maria; Atanasov, Boris P.; Popov, Krastio T.; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien; Fremeaux-Bacchi, Veronique; Dimitrov, Jordan D.			Heme Interacts with C1q and Inhibits the Classical Complement Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; GRAPHICS PROCESSORS; PATTERN-RECOGNITION; GLOBULAR HEAD; 2 PARTS; ACTIVATION; BINDING; INFLAMMATION; ANTIBODY; DOCKING	C1q is the recognition subunit of the first component of the classical complement pathway. It participates in clearance of immune complexes and apoptotic cells as well as in defense against pathogens. Inappropriate activation of the complement contributes to cellular and tissue damage in different pathologies, urging the need for the development of therapeutic agents that are able to inhibit the complement system. In this study, we report heme as an inhibitor of C1q. Exposure of C1q to heme significantly reduced the activation of the classical complement pathway, mediated by C-reactive protein (CRP) and IgG. Interaction analyses revealed that heme reduces the binding of C1q to CRP and IgG. Furthermore, we demonstrated that the inhibition of C1q interactions results from a direct binding of heme to C1q. Formation of complex of heme with C1q caused changes in the mechanism of recognition of IgG and CRP. Taken together, our data suggest that heme is a natural negative regulator of the classical complement pathway at the level of C1q. Heme may play a role at sites of excessive tissue damage and hemolysis where large amounts of free heme are released.	[Roumenina, Lubka T.] Univ Paris 06, Ctr Rech Cordeliers, INSERM, Equipe 13,UMR S 872, F-75006 Paris, France; [Dimitrov, Jordan D.] Univ Paris 05, UMR S 872, Ctr Rech Cordeliers, INSERM,Equipe 16, F-75006 Paris, France; [Roumenina, Lubka T.; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien; Fremeaux-Bacchi, Veronique; Dimitrov, Jordan D.] INSERM, U872, F-75006 Paris, France; [Radanova, Maria] Med Univ Varna, Dept Biochem Mol Med & Nutrigen, Varna 9002, Bulgaria; [Atanasov, Boris P.] Bulgarian Acad Sci, Inst Organ Chem, Biophys Chem Grp, BU-1113 Sofia, Bulgaria; [Popov, Krastio T.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Fremeaux-Bacchi, Veronique] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv Immunol Biol, F-75908 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Medical University Varna; Bulgarian Academy of Sciences; Helmholtz Association; German Cancer Research Center (DKFZ); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Roumenina, LT (corresponding author), Univ Paris 06, Ctr Rech Cordeliers, INSERM, Equipe 13,UMR S 872, 15 Rue Ecole Med, F-75006 Paris, France.	lubka.roumenina@crc.jussieu.fr; jordan.dimitrov@crc.jussieu.fr	Radanova, Maria/AHA-8156-2022; Radanova, Maria A/A-7081-2015; Roumenina, Lubka/L-2638-2017; Roumenina, Lubka/P-5906-2019; Dimitrov, Jordan/N-2141-2014	Roumenina, Lubka/0000-0002-9940-0324; Radanova, Maria/0000-0002-0941-6139; Lacroix-Desmazes, Sebastien/0000-0001-5625-8447; Dimitrov, Jordan/0000-0001-8536-8995; Kaveri, Srini/0000-0002-0837-4053	Institut National de la Sante et de la Recherche Medicale (France); Centre National de la Recherche Scientifique (France); Universite Pierre et Marie Curie (Paris 6); French-Bulgarian Project EGIDE-Rila [19296UK]; Fondation pour le Recherche Medicale (Paris, France)	Institut National de la Sante et de la Recherche Medicale (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (France)(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie (Paris 6); French-Bulgarian Project EGIDE-Rila; Fondation pour le Recherche Medicale (Paris, France)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (France), by Centre National de la Recherche Scientifique (France), and by Universite Pierre et Marie Curie (Paris 6).; Supported by the French-Bulgarian Project EGIDE-Rila 19296UK.; Recipient of a fellowship from the Fondation pour le Recherche Medicale (Paris, France). To whom correspondence may be addressed: Equipe 16 INSERM UMR S 872, Centre de Recherche des Cordeliers, 15 rue de l'Ecole de Medecine, 75006 Paris, France. Tel.: 33-0-1-55-42-82-71; Fax: 33-0-1-55-42-82-62; E-mail: jordan.dimitrov@crc.jussieu.fr.	Agrawal A, 2001, J IMMUNOL, V166, P3998, DOI 10.4049/jimmunol.166.6.3998; Agrawal A, 2009, ADV EXP MED BIOL, V653, P98; Amzel LM, 2000, METHOD ENZYMOL, V323, P167; Arriaga SM, 1999, BBA-GEN SUBJECTS, V1473, P329, DOI 10.1016/S0304-4165(99)00201-9; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; Basiglio CL, 2007, BBA-GEN SUBJECTS, V1770, P1003, DOI 10.1016/j.bbagen.2007.03.005; Biro A, 2007, IMMUNOLOGY, V121, P40, DOI 10.1111/j.1365-2567.2007.02535.x; Bureeva S, 2005, BIOORGAN MED CHEM, V13, P1045, DOI 10.1016/j.bmc.2004.11.056; Bureeva S, 2007, BIOORGAN MED CHEM, V15, P3489, DOI 10.1016/j.bmc.2007.03.002; Castellano G, 2010, AM J PATHOL, V176, P1648, DOI 10.2353/ajpath.2010.090276; del Zoppo GJ, 1999, NAT MED, V5, P995, DOI 10.1038/12431; Dimitrov JD, 2007, SCAND J IMMUNOL, V65, P230, DOI 10.1111/j.1365-3083.2006.01893.x; Dimitrov JD, 2007, J BIOL CHEM, V282, P26696, DOI 10.1074/jbc.M702751200; Dimitrov JD, 2007, MOL IMMUNOL, V44, P1854, DOI 10.1016/j.molimm.2006.10.002; Dimitrov JD, 2009, NAT BIOTECHNOL, V27, P892, DOI 10.1038/nbt1009-892a; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; GALANAKIS DK, 1994, J CLIN INVEST, V93, P303, DOI 10.1172/JCI116960; GREEN D, 1986, THROMB HAEMOSTASIS, V56, P277; Griselli M, 1999, J EXP MED, V190, P1733, DOI 10.1084/jem.190.12.1733; JANIN J, 1995, BIOCHIMIE, V77, P497, DOI 10.1016/0300-9084(96)88166-1; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Ji SR, 2006, ARTERIOSCL THROM VAS, V26, P935, DOI 10.1161/01.ATV.0000206211.21895.73; Kang YH, 2009, ADV EXP MED BIOL, V653, P117; Kantardjiev AA, 2006, NUCLEIC ACIDS RES, V34, pW43, DOI 10.1093/nar/gkl165; Kantardjiev AA, 2009, NUCLEIC ACIDS RES, V37, pW422, DOI 10.1093/nar/gkp336; Kirschfink M, 2001, Expert Opin Pharmacother, V2, P1073, DOI 10.1517/14656566.2.7.1073; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; MORGAN WT, 1985, BIOCHEMISTRY-US, V24, P1496, DOI 10.1021/bi00327a031; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Pawluczkowycz AW, 2007, J IMMUNOL, V179, P5543, DOI 10.4049/jimmunol.179.8.5543; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Roos A, 2002, IMMUNOBIOLOGY, V205, P595, DOI 10.1078/0171-2985-00157; Roos A, 2001, J IMMUNOL, V167, P7052, DOI 10.4049/jimmunol.167.12.7052; Roumenina LT, 2006, BIOCHEMISTRY-US, V45, P4093, DOI 10.1021/bi052646f; Roumenina LT, 2005, BIOCHEMISTRY-US, V44, P14097, DOI 10.1021/bi051186n; Roumenina L, 2007, J MOL RECOGNIT, V20, P405, DOI 10.1002/jmr.853; SEARS DA, 1970, J CLIN INVEST, V49, P5, DOI 10.1172/JCI106222; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Weiser MR, 1996, J EXP MED, V183, P2343, DOI 10.1084/jem.183.5.2343	54	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.206136	http://dx.doi.org/10.1074/jbc.M110.206136			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454703	Green Published, hybrid			2022-12-27	WOS:000290022800083
J	Garbers, C; Janner, N; Chalaris, A; Moss, ML; Floss, DM; Meyer, D; Koch-Nolte, F; Rose-John, S; Scheller, J				Garbers, Christoph; Jaenner, Nathalie; Chalaris, Athena; Moss, Marcia L.; Floss, Doreen M.; Meyer, Doerte; Koch-Nolte, Friedrich; Rose-John, Stefan; Scheller, Juergen			Species Specificity of ADAM10 and ADAM17 Proteins in Interleukin-6 (IL-6) Trans-signaling and Novel Role of ADAM10 in Inducible IL-6 Receptor Shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; L-SELECTIN; INTESTINAL INFLAMMATION; ECTODOMAIN; DISINTEGRIN; CLEAVAGE; INACTIVATION; DEFICIENCY; COMPONENTS; EXPRESSION	Hypomorphic ADAM17(ex/ex) mice showed defects in mucosal regeneration due to inefficient enhanced GFR shedding. ADAM17 is the main sheddase of interleukin-6 receptor (IL-6R) to induce IL-6 trans-signaling. However, serum levels of soluble murine IL-6R were not reduced in ADAM17ex/ex mice, and murine ADAM17 was not the major sheddase of murine IL-6R. Shedding of murine IL-6R by murine ADAM17 was rescued in chimeric murine IL-6R proteins containing any extracellular domain but not the transmembrane and intracellular domain of human IL-6R. Apoptosis is a physiological stimulus of ADAM17-mediated shedding of human IL-6R. Even though apoptosis induced IL-6R shedding in mice, the responsible protease was identified as ADAM10. ADAM10 also was identified as protease responsible for ionomycin-induced shedding of murine and human IL-6R. However, in ADAM10-deficient murine embryonic fibroblasts, compensatory shedding of human IL-6R was mediated by ADAM17, but loss of ADAM10-mediated shedding of murine IL-6R was compensated by an as-yet-unidentified protease. Finally, we identified physiological purinergic P2X7 receptor stimulation as a novel inducer of murine and human IL-6R shedding solely mediated by ADAM10. In conclusion, we describe an unexpected species specificity of ADAM10 and ADAM17 and identified ADAM10 as novel inducible sheddase of IL-6R in mice and humans, which might have consequences for the interpretation of phenotypes from ADAM17- and ADAM10-deficient mice.	[Garbers, Christoph; Jaenner, Nathalie; Chalaris, Athena; Meyer, Doerte; Rose-John, Stefan; Scheller, Juergen] Univ Kiel, Inst Biochem, D-2300 Kiel, Germany; [Moss, Marcia L.] BioZyme Inc, Apex, NC 27523 USA; [Floss, Doreen M.; Scheller, Juergen] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Dusseldorf, Germany; [Koch-Nolte, Friedrich] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany	University of Kiel; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Rose-John, S (corresponding author), Univ Kiel, Inst Biochem, Olshausenstr 40, D-2300 Kiel, Germany.	rosejohn@biochem.uni-kiel.de; jscheller@uni-duesseldorf.de	Garbers, Christoph/D-9932-2015; Scheller, Jürgen/K-5290-2015; Rose-John, Stefan/A-7998-2010	Garbers, Christoph/0000-0003-4939-6950; Rose-John, Stefan/0000-0002-7519-3279; Koch-Nolte, Friedrich/0000-0003-1730-6674	Deutsche Forschungsgemeinschaft (Bonn, Germany) [SFB877, A2]; Cluster of Excellence "Inflammation at Interfaces"	Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Bonn, Germany; SFB877 Project A2) and by the Cluster of Excellence "Inflammation at Interfaces."	Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; CHALARIS A, 2011, EUR J CELL BIOL; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Dethlefsen SM, 1998, J CELL BIOCHEM, V69, P143, DOI 10.1002/(SICI)1097-4644(19980501)69:2<143::AID-JCB5>3.0.CO;2-S; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Gu B, 1998, BLOOD, V92, P946; Hamaoka M, 2010, J BIOCHEM, V148, P55, DOI 10.1093/jb/mvq033; Hansen HP, 2004, FASEB J, V18, P893, DOI 10.1096/fj.03-0901fje; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Horiuchi K, 2009, J IMMUNOL, V182, P2093, DOI 10.4049/jimmunol.0802491; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Jones SA, 1998, EUR J IMMUNOL, V28, P3514, DOI 10.1002/(SICI)1521-4141(199811)28:11<3514::AID-IMMU3514>3.3.CO;2-K; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; Klaus C, 2004, BLOOD, V103, P4514, DOI 10.1182/blood-2003-12-4165; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; McFarland-Mancini MM, 2010, J IMMUNOL, V184, P7219, DOI 10.4049/jimmunol.0901929; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; MULLBERG J, 1994, J IMMUNOL, V152, P4958; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Rabe B, 2008, BLOOD, V111, P1021, DOI 10.1182/blood-2007-07-102137; Reiss K, 2006, J BIOL CHEM, V281, P21735, DOI 10.1074/jbc.M602663200; Rose-John S, 2007, EXPERT OPIN THER TAR, V11, P613, DOI 10.1517/14728222.11.5.613; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Scholz F, 2007, J INVEST DERMATOL, V127, P1444, DOI 10.1038/sj.jid.5700751; Schwarz N, 2009, PURINERG SIGNAL, V5, P139, DOI 10.1007/s11302-009-9135-5; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Vollmer P, 1996, INFECT IMMUN, V64, P3646, DOI 10.1128/IAI.64.9.3646-3651.1996; Walev I, 1996, P NATL ACAD SCI USA, V93, P7882, DOI 10.1073/pnas.93.15.7882; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200	39	146	147	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14804	14811		10.1074/jbc.M111.229393	http://dx.doi.org/10.1074/jbc.M111.229393			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21454673	Green Published, hybrid			2022-12-27	WOS:000289788300010
J	Westhofen, P; Watzka, M; Marinova, M; Hass, M; Kirfel, G; Muller, J; Bevans, CG; Muller, CR; Oldenburg, J				Westhofen, Philipp; Watzka, Matthias; Marinova, Milka; Hass, Moritz; Kirfel, Gregor; Mueller, Jens; Bevans, Carville G.; Mueller, Clemens R.; Oldenburg, Johannes			Human Vitamin K 2,3-Epoxide Reductase Complex Subunit 1-like 1 (VKORC1L1) Mediates Vitamin K-dependent Intracellular Antioxidant Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROQUINONES REDUCED FORMS; XENOBIOTIC RECEPTOR SXR; EPOXIDE-REDUCTASE; ENDOPLASMIC-RETICULUM; OSTEOBLASTIC CELLS; ACTIVE-SITE; DEFICIENCY; PROTEIN; WARFARIN; QUINONE	Human vitamin K 2,3-epoxide reductase complex subunit 1-like 1 (VKORC1L1), expressed in HEK 293T cells and localized exclusively to membranes of the endoplasmic reticulum, was found to support both vitamin K 2,3-epoxide reductase (VKOR) and vitamin K reductase enzymatic activities. Michaelis-Menten kinetic parameters for dithiothreitol-driven VKOR activity were: K-m (mu M) = 4.15 (vitamin K-1 epoxide) and 11.24 (vitamin K-2 epoxide); V-max (nmol.mg(-1).hr(-1)) = 2.57 (vitamin K-1 epoxide) and 13.46 (vitamin K-2 epoxide). Oxidative stress induced by H2O2 applied to cultured cells up-regulated VKORC1L1 expression and VKOR activity. Cell viability under conditions of no induced oxidative stress was increased by the presence of vitamins K-1 and K-2 but not ubinquinone-10 and was specifically dependent on VKORC1L1 expression. Intracellular reactive oxygen species levels in cells treated with 2,3-dimethoxy-1,4-naphthoquinone were mitigated in a VKORC1L1 expression-dependent manner. Intracellular oxidative damage to membrane intrinsic proteins was inversely dependent on VKORC1L1 expression and the presence of vitamin K-1. Taken together, our results suggest that VKORC1L1 is responsible for driving vitamin K-mediated intracellular antioxidation pathways critical to cell survival.	[Westhofen, Philipp; Watzka, Matthias; Marinova, Milka; Hass, Moritz; Mueller, Jens; Bevans, Carville G.; Oldenburg, Johannes] Univ Clin Bonn, Inst Expt Hematol & Transfus Med, D-53127 Bonn, Germany; [Kirfel, Gregor] Univ Bonn, Inst Cell Biol, D-53121 Bonn, Germany; [Mueller, Clemens R.] Univ Wurzburg, Biozentrum Hubland, Inst Human Genet, D-97074 Wurzburg, Germany	University of Bonn; University of Bonn; University of Wurzburg	Oldenburg, J (corresponding author), Univ Clin Bonn, Inst Expt Hematol & Transfus Med, Sigmund Freud Str 25, D-53127 Bonn, Germany.	johannes.oldenburg@ukb.uni-bonn.de	Oldenburg, Johannes/ABB-7817-2020; Bevans, Carville/C-6651-2009; Müller, Jens/A-8264-2012	Bevans, Carville/0000-0001-7389-2124; Müller, Jens/0000-0001-7713-9631; Oldenburg, Johannes/0000-0002-1585-4100	National Genome Research Net Cardiovascular Diseases, Germany [BMBF/DLR-01GS0424/NHK-S12T21]	National Genome Research Net Cardiovascular Diseases, Germany	This work was supported by Grant BMBF/DLR-01GS0424/NHK-S12T21 from the National Genome Research Net Cardiovascular Diseases, Germany.	Allewalt JP, 2006, APPL ENVIRON MICROB, V72, P544, DOI 10.1128/AEM.72.1.544-550.2006; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Berkner KL, 2008, VITAM HORM, V78, P131, DOI 10.1016/S0083-6729(07)00007-6; Bhaya D, 2007, ISME J, V1, P703, DOI 10.1038/ismej.2007.46; Chu PH, 2006, P NATL ACAD SCI USA, V103, P19308, DOI 10.1073/pnas.0609401103; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Fregin A, 2002, BLOOD, V100, P3229, DOI 10.1182/blood-2002-03-0698; Goodstadt L, 2004, TRENDS BIOCHEM SCI, V29, P289, DOI 10.1016/j.tibs.2004.04.004; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Gutteridge JMC, 2010, BIOCHEM BIOPH RES CO, V393, P561, DOI 10.1016/j.bbrc.2010.02.071; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; HILDEBRANDT EF, 1984, ARCH BIOCHEM BIOPHYS, V228, P480, DOI 10.1016/0003-9861(84)90014-6; Horie-Inoue K, 2008, J BONE MINER METAB, V26, P9, DOI 10.1007/s00774-007-0792-6; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200; Jin DY, 2007, BIOCHEMISTRY-US, V46, P7279, DOI 10.1021/bi700527j; KISHI T, 1993, CLIN INVESTIGATOR, V71, pS71; Landriscina M, 2009, ANTIOXID REDOX SIGN, V11, P2701, DOI 10.1089/ars.2009.2692; Li JR, 2003, J NEUROSCI, V23, P5816; Li WK, 2010, NATURE, V463, P507, DOI 10.1038/nature08720; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma Q, 2010, PHARMACOL THERAPEUT, V125, P376, DOI 10.1016/j.pharmthera.2009.11.004; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; MUKAI K, 1993, BIOCHIM BIOPHYS ACTA, V1157, P313, DOI 10.1016/0304-4165(93)90115-O; MUKAI K, 1992, J BIOL CHEM, V267, P22277; Oldenburg J, 2000, THROMB HAEMOSTASIS, V84, P937; Oldenburg J, 2006, ANTIOXID REDOX SIGN, V8, P347, DOI 10.1089/ars.2006.8.347; Rost S, 2005, THROMB HAEMOSTASIS, V94, P780, DOI 10.1160/TH05-02-0082; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Schaafhausen A, 2011, THROMB HAEMOSTASIS, V105, P285, DOI 10.1160/TH10-07-0483; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Schulman S, 2010, P NATL ACAD SCI USA, V107, P15027, DOI 10.1073/pnas.1009972107; Sly LM, 2008, J IMMUNOL, V181, P3850, DOI 10.4049/jimmunol.181.6.3850; Spohn G, 2009, THROMB HAEMOSTASIS, V101, P1044, DOI 10.1160/TH09-03-0204; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki Y, 2009, MOL IMMUNOL, V46, P2200, DOI 10.1016/j.molimm.2009.04.013; Tabb MM, 2003, J BIOL CHEM, V278, P43919, DOI 10.1074/jbc.M303136200; Tanaka T, 2006, CELL CYCLE, V5, P2671, DOI 10.4161/cc.5.22.3472; Tishler M, 1940, J AM CHEM SOC, V62, P2866, DOI 10.1021/ja01867a066; Vervoort LMT, 1997, BIOCHEM PHARMACOL, V54, P871, DOI 10.1016/S0006-2952(97)00254-2; Wajih N, 2007, J BIOL CHEM, V282, P2626, DOI 10.1074/jbc.M608954200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Watzka M, 2011, J THROMB HAEMOST, V9, P109, DOI 10.1111/j.1538-7836.2010.04095.x	47	65	73	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15085	15094		10.1074/jbc.M110.210971	http://dx.doi.org/10.1074/jbc.M110.210971			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21367861	hybrid, Green Published			2022-12-27	WOS:000289788300039
J	Yu, Y; Richardson, DR				Yu, Yu; Richardson, Des R.			Cellular Iron Depletion Stimulates the JNK and p38 MAPK Signaling Transduction Pathways, Dissociation of ASK1-Thioredoxin, and Activation of ASK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EFFECTIVE ANTIPROLIFERATIVE AGENTS; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; STRESS-INDUCED PHOSPHORYLATION; ISONICOTINOYL HYDRAZONE CLASS; SELECTIVE ANTITUMOR-ACTIVITY; PROTEIN-KINASE; MOLECULAR-MECHANISMS; CYCLE PROGRESSION; GENE-EXPRESSION; UP-REGULATION	The role of signaling pathways in the regulation of cellular iron metabolism is becoming increasingly recognized. Iron chelation is used for the treatment of iron overload but also as a potential strategy for cancer therapy, because iron depletion results in cell cycle arrest and apoptosis. This study examined potential signaling pathways affected by iron depletion induced by desferrioxamine (DFO) or di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT). Both chelators affected multiple molecules in the mitogen-activated protein kinase (MAPK) pathway, including a number of dual specificity phosphatases that directly de-phosphorylate MAPKs. Examination of the phosphorylation of major MAPKs revealed that DFO and Dp44mT markedly increased phosphorylation of stress-activated protein kinases, JNK and p38, without significantly affecting the extracellular signal-regulated kinase (ERK). Redox-inactive DFO-iron complexes did not affect phosphorylation of JNK or p38, whereas the redox-active Dp44mT-iron complex significantly increased the phosphorylation of these kinases similarly to Dp44mT alone. Iron or N-acetylcysteine supplementation reversed Dp44mT-induced up-regulation of phospho-JNK, but only iron was able to reverse the effect of DFO on JNK. Both iron chelators significantly reduced ASK1-thioredoxin complex formation, resulting in the increased phosphorylation of ASK1, which activates the JNK and p38 pathways. Thus, dissociation of ASK1 could serve as an important signal for the phosphorylation of JNK and p38 activation observed after iron chelation. Phosphorylation of JNK and p38 likely play an important role in mediating the cell cycle arrest and apoptosis induced by iron depletion.	[Richardson, Des R.] Univ Sydney, Dept Pathol, Iron Metab & Chelat Program, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Iron Metab & Chelat Program, Blackburn Bldg,D06, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au	Yu, Yu/AAD-7947-2019	Yu, Yu/0000-0002-0209-0586; Richardson, Des/0000-0003-0960-6415; Richardson, Des/0000-0002-5506-3274	National Health and Medical Research Council of Australia; Australian Research Council; University of Sydney; Cancer Institute New South Wales	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); University of Sydney(University of Sydney); Cancer Institute New South Wales	This work was supported in part by a Senior Principal Research Fellowship, Project Grants from the National Health and Medical Research Council of Australia, and a Discovery Grant from the Australian Research Council (to D. R. R.).; Supported by Ph.D. scholarships from the University of Sydney (University Postgraduate Award) and Cancer Institute New South Wales.	Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Antosiewicz J, 2007, FREE RADICAL BIO MED, V43, P265, DOI 10.1016/j.freeradbiomed.2007.04.023; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bardwell L, 2006, METHODS, V40, P213, DOI 10.1016/j.ymeth.2006.06.008; Beerepoot LV, 1996, CANCER RES, V56, P3747; BLATT J, 1987, CANCER RES, V47, P1749; BRODIE C, 1993, CANCER RES, V53, P3968; Buss JL, 2003, CURR MED CHEM, V10, P1021, DOI 10.2174/0929867033457638; CANO E, 1994, MOL CELL BIOL, V14, P7352, DOI 10.1128/MCB.14.11.7352; Choi SC, 2003, FREE RADICAL BIO MED, V35, P1171, DOI 10.1016/S0891-5849(03)00503-3; Clerk A, 1997, BIOCHEM J, V325, P801, DOI 10.1042/bj3250801; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; Darnell G, 1999, BLOOD, V94, P781, DOI 10.1182/blood.V94.2.781.414k32_781_792; Deb S, 2009, BIOMETALS, V22, P855, DOI 10.1007/s10534-009-9214-7; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; DONFRANCESCO A, 1990, CANCER RES, V50, P4929; ESTROV Z, 1987, BLOOD, V69, P757; Fu D, 2007, BLOOD, V110, P752, DOI 10.1182/blood-2007-03-076737; FUKUCHI K, 1994, FEBS LETT, V350, P139, DOI 10.1016/0014-5793(94)00755-1; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Gomez MA, 2010, J BIOL CHEM, V285, P24620, DOI 10.1074/jbc.M110.107037; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HILETI D, 1995, BRIT J HAEMATOL, V89, P181, DOI 10.1111/j.1365-2141.1995.tb08927.x; Jansson PJ, 2010, J INORG BIOCHEM, V104, P1224, DOI 10.1016/j.jinorgbio.2010.07.012; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kalinowski DS, 2007, J MED CHEM, V50, P3716, DOI 10.1021/jm070445z; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kim BS, 2002, CELL IMMUNOL, V220, P96, DOI 10.1016/S0008-8749(03)00031-5; Kim BM, 2008, TOXICOL APPL PHARM, V228, P24, DOI 10.1016/j.taap.2007.11.022; Kulp KS, 1996, EXP CELL RES, V229, P60, DOI 10.1006/excr.1996.0343; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; LUCAS JJ, 1995, BLOOD, V86, P2268, DOI 10.1182/blood.V86.6.2268.bloodjournal8662268; Mardini L, 2010, BIOCHEM J, V432, P145, DOI 10.1042/BJ20100541; Matsuzawa A, 2001, J BIOCHEM-TOKYO, V130, P1; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Noulsri E, 2009, AM J HEMATOL, V84, P170, DOI 10.1002/ajh.21350; Nurtjahja-Tjendraputra E, 2007, BLOOD, V109, P4045, DOI 10.1182/blood-2006-10-047753; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; Rahmanto YS, 2007, CARCINOGENESIS, V28, P2172, DOI 10.1093/carcin/bgm096; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rao VA, 2009, CANCER RES, V69, P948, DOI 10.1158/0008-5472.CAN-08-1437; RICHARDSON D, 1994, CANCER RES, V54, P685; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; RICHARDSON DR, 1990, BIOCHIM BIOPHYS ACTA, V1053, P1, DOI 10.1016/0167-4889(90)90018-9; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Saletta F, 2010, MOL PHARMACOL, V77, P443, DOI 10.1124/mol.109.061028; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SELIG RA, 1993, ANTICANCER RES, V13, P721; Seo GS, 2006, FREE RADICAL BIO MED, V40, P1502, DOI 10.1016/j.freeradbiomed.2005.12.020; Simonart T, 2000, J INVEST DERMATOL, V115, P893, DOI 10.1046/j.1523-1747.2000.00119.x; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wenger RH, 1998, CANCER RES, V58, P5678; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Wilkinson MG, 2000, FASEB J, V14, P2147, DOI 10.1096/fj.00-0102rev; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; YU Y, 2011, MOL PHARM IN PRESS; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zhong DS, 2008, CANCER RES, V68, P7270, DOI 10.1158/0008-5472.CAN-08-1484; Zhu T, 2000, J BIOL CHEM, V275, P2103, DOI 10.1074/jbc.275.3.2103	64	78	78	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15413	15427		10.1074/jbc.M111.225946	http://dx.doi.org/10.1074/jbc.M111.225946			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21378396	Green Published, hybrid			2022-12-27	WOS:000289788300071
J	Horowitz, S; Yesselman, JD; Al-Hashimi, HM; Trievel, RC				Horowitz, Scott; Yesselman, Joseph D.; Al-Hashimi, Hashim M.; Trievel, Raymond C.			Direct Evidence for Methyl Group Coordination by Carbon-Oxygen Hydrogen Bonds in the Lysine Methyltransferase SET7/9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTER-DOT-O; ADENOSYL-L-METHIONINE; S-ADENOSYLMETHIONINE SYNTHETASE; MOLECULAR-ORBITAL METHODS; PRODUCT SPECIFICITY; CATALYTIC MECHANISM; ACTIVE-SITE; NMR-SPECTROSCOPY; 1ST-ROW ELEMENTS; STRUCTURAL BASIS	SET domain lysine methyltransferases (KMTs) are S-adenosylmethionine (AdoMet)-dependent enzymes that catalyze the site-specific methylation of lysyl residues in histone and nonhistone proteins. Based on crystallographic and cofactor binding studies, carbon-oxygen (CH center dot center dot center dot O) hydrogen bonds have been proposed to coordinate the methyl groups of AdoMet and methyllysine within the SET domain active site. However, the presence of these hydrogen bonds has only been inferred due to the uncertainty of hydrogen atom positions in x-ray crystal structures. To experimentally resolve the positions of the methyl hydrogen atoms, we used NMR H-1 chemical shift coupled with quantum mechanics calculations to examine the interactions of the AdoMet methyl group in the active site of the human KMT SET7/9. Our results indicated that at least two of the three hydrogens in the AdoMet methyl group engage in CH center dot center dot center dot O hydrogen bonding. These findings represent direct, quantitative evidence of CH center dot center dot center dot O hydrogen bond formation in the SET domain active site and suggest a role for these interactions in catalysis. Furthermore, thermodynamic analysis of AdoMet binding indicated that these interactions are important for cofactor binding across SET domain enzymes.	[Trievel, Raymond C.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Al-Hashimi, Hashim M.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Horowitz, Scott; Yesselman, Joseph D.; Al-Hashimi, Hashim M.] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Trievel, RC (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	rtrievel@umich.edu	Yesselman, Joseph/AAH-9031-2020	Horowitz, Scott/0000-0002-1148-0105	National Institutes of Health [R01-GM073839, P41 RR001081, T32-GM008270]; National Science Foundation [MCB 0644278]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008270, R01GM073839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01-GM073839 (to R. C. T.) and a National Science Foundation CAREER award (MCB 0644278) (to H. M. A.). The UCSF Chimera package is developed and distributed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR001081).; Supported by National Institutes of Health Training Grant T32-GM008270 in Molecular Biophysics.	Afonin AV, 2009, MAGN RESON CHEM, V47, P105, DOI 10.1002/mrc.2358; Afonin AV, 2002, MAGN RESON CHEM, V40, P114, DOI 10.1002/mrc.969; Albert M, 2010, SEMIN CELL DEV BIOL, V21, P209, DOI 10.1016/j.semcdb.2009.10.007; Ash EL, 2000, P NATL ACAD SCI USA, V97, P10371, DOI 10.1073/pnas.97.19.10371; Bach RD, 2002, J PHYS CHEM B, V106, P4325, DOI 10.1021/jp020029k; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BENEVIDES JM, 1988, BIOCHEMISTRY-US, V27, P3868, DOI 10.1021/bi00410a051; BINKLEY JS, 1980, J AM CHEM SOC, V102, P939, DOI 10.1021/ja00523a008; Bond CS, 1999, STRUCTURE, V7, P81, DOI 10.1016/S0969-2126(99)80011-2; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; CHIRLIAN LE, 1987, J COMPUT CHEM, V8, P894, DOI 10.1002/jcc.540080616; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Cordier F, 2003, J AM CHEM SOC, V125, P15750, DOI 10.1021/ja038616m; Couture JF, 2006, J BIOL CHEM, V281, P19280, DOI 10.1074/jbc.M602257200; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Del Rizzo PA, 2010, J BIOL CHEM, V285, P31849, DOI 10.1074/jbc.M110.114587; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEREWENDA Z, 1995, FASEB J, V9, pA1246; DEREWENDA ZS, 1994, J MOL BIOL, V241, P83, DOI 10.1006/jmbi.1994.1475; DESIRAJU GR, 1991, ACCOUNTS CHEM RES, V24, P290, DOI 10.1021/ar00010a002; Desiraju GR, 1996, ACCOUNTS CHEM RES, V29, P441, DOI 10.1021/ar950135n; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frisch M.J., 2016, GAUSSIAN16 REV B01; Ghosh A, 1999, J MOL BIOL, V294, P1149, DOI 10.1006/jmbi.1999.3323; Goddard T. D., 2006, SPARKY 3; Guo HB, 2007, P NATL ACAD SCI USA, V104, P8797, DOI 10.1073/pnas.0702981104; Harris R. K., 1983, NUCL MAGNETIC RESONA; Hu P, 2006, J AM CHEM SOC, V128, P1272, DOI 10.1021/ja056153+; Hu P, 2008, J AM CHEM SOC, V130, P3806, DOI 10.1021/ja075896n; Iwig DF, 2004, BIOCHEMISTRY-US, V43, P13496, DOI 10.1021/bi048693+; Jacobs SA, 2002, NAT STRUCT BIOL, V9, P833, DOI 10.1038/nsb861; Jiang L, 2002, J BIOL CHEM, V277, P37732, DOI 10.1074/jbc.M204514200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KRIMM S, 1967, SCIENCE, V158, P530, DOI 10.1126/science.158.3800.530-c; Kwon T, 2003, EMBO J, V22, P292, DOI 10.1093/emboj/cdg025; Liu H, 2002, J MOL BIOL, V322, P955, DOI 10.1016/S0022-2836(02)00876-8; MARKHAM GD, 1980, J BIOL CHEM, V255, P9082; Markham GD, 2002, BIOCHEMISTRY-US, V41, P7636, DOI 10.1021/bi025682c; Meyer P, 2000, EMBO J, V19, P3520, DOI 10.1093/emboj/19.14.3520; MIERTUS S, 1981, CHEM PHYS, V55, P117, DOI 10.1016/0301-0104(81)85090-2; Mizuno K, 1998, J CHEM PHYS, V109, P9502, DOI 10.1063/1.477612; NOSE S, 1986, PHYS REV B, V33, P339, DOI 10.1103/PhysRevB.33.339; PARK J, 1995, BIOORG MED CHEM LETT, V5, P2203, DOI 10.1016/0960-894X(95)00384-6; Peralta JE, 1999, J MOL STRUC-THEOCHEM, V491, P23, DOI 10.1016/S0166-1280(99)00027-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pradhan S, 2009, EPIGENETICS, V4, P282; Qingzhong L., 2007, J MOL STRUC-THEOCHEM, V847, P68; Quinn JR, 2007, J AM CHEM SOC, V129, P934, DOI 10.1021/ja066341f; RAMACHANDRAN GN, 1965, BIOCHIM BIOPHYS ACTA, V109, P314, DOI 10.1016/0926-6585(65)90119-6; Ratajczyk T, 2005, ANGEW CHEM INT EDIT, V44, P1230, DOI 10.1002/anie.200461383; Sarkhel S, 2004, PROTEINS, V54, P247, DOI 10.1002/prot.10567; Schalk-Hihi C, 1999, BIOCHEMISTRY-US, V38, P2542, DOI 10.1021/bi9822933; Scheiner S, 2005, J PHYS CHEM B, V109, P16132, DOI 10.1021/jp053416d; Scheiner S, 2000, J MOL STRUC-THEOCHEM, V500, P441, DOI 10.1016/S0166-1280(00)00375-4; Scheiner S, 2010, INT J QUANTUM CHEM, V110, P2775, DOI 10.1002/qua.22756; Scheiner S, 2009, J PHYS CHEM B, V113, P10421, DOI 10.1021/jp9035138; Seeger K, 2005, BIOCHEMISTRY-US, V44, P6208, DOI 10.1021/bi047749x; Sheppard D, 2010, J AM CHEM SOC, V132, P7709, DOI 10.1021/ja101691s; Sigalov M, 2005, J ORG CHEM, V70, P92, DOI 10.1021/jo048592h; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Sukumar N, 2010, P NATL ACAD SCI USA, V107, P6817, DOI 10.1073/pnas.0912672107; Trievel RC, 2003, NAT STRUCT BIOL, V10, P545, DOI 10.1038/nsb946; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; WOLINSKI K, 1990, J AM CHEM SOC, V112, P8251, DOI 10.1021/ja00179a005; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yates JR, 2005, J AM CHEM SOC, V127, P10216, DOI 10.1021/ja051019a; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zhang X, 2007, BIOCHEMISTRY-US, V46, P14838, DOI 10.1021/bi7014579	72	49	50	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18658	18663		10.1074/jbc.M111.232876	http://dx.doi.org/10.1074/jbc.M111.232876			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454678	Green Published, hybrid			2022-12-27	WOS:000290785700038
J	MacDonald, MJ; Longacre, MJ; Stoker, SW; Kendrick, M; Thonpho, A; Brown, LJ; Hasan, NM; Jitrapakdee, S; Fukao, T; Hanson, MS; Fernandez, LA; Odorico, J				MacDonald, Michael J.; Longacre, Melissa J.; Stoker, Scott W.; Kendrick, Mindy; Thonpho, Ansaya; Brown, Laura J.; Hasan, Noaman M.; Jitrapakdee, Sarawut; Fukao, Toshiyuki; Hanson, Matthew S.; Fernandez, Luis A.; Odorico, Jon			Differences between Human and Rodent Pancreatic Islets LOW PYRUVATE CARBOXYLASE, ATP CITRATE LYASE, AND PYRUVATE CARBOXYLATION AND HIGH GLUCOSE-STIMULATED ACETOACETATE IN HUMAN PANCREATIC ISLETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCEROL PHOSPHATE DEHYDROGENASE; ACETYL-COA CARBOXYLASE; INSULIN-SECRETION; MALIC ENZYME; BETA-CELLS; REGULATED ANAPLEROSIS; METHYL SUCCINATE; GENE-EXPRESSION; RAT; MOUSE	Anaplerosis, the net synthesis in mitochondria of citric acid cycle intermediates, and cataplerosis, their export to the cytosol, have been shown to be important for insulin secretion in rodent beta cells. However, human islets may be different. We observed that the enzyme activity, protein level, and relative mRNA level of the key anaplerotic enzyme pyruvate carboxylase (PC) were 80-90% lower in human pancreatic islets compared with islets of rats and mice and the rat insulinoma cell line INS-1 832/13. Activity and protein of ATP citrate lyase, which uses anaplerotic products in the cytosol, were 60-75% lower in human islets than in rodent islets or the cell line. In line with the lower PC, the percentage of glucose-derived pyruvate that entered mitochondrial metabolism via carboxylation in human islets was only 20-30% that in rat islets. This suggests human islets depend less on pyruvate carboxylation than rodent models that were used to establish the role of PC in insulin secretion. Human islets possessed high levels of succinyl-CoA:3-ketoacid-CoA transferase, an enzyme that forms acetoacetate in the mitochondria, and acetoacetyl-CoA synthetase, which uses acetoacetate to form acyl-CoAs in the cytosol. Glucose-stimulated human islets released insulin similarly to rat islets but formed much more acetoacetate. beta-Hydroxybutyrate augmented insulin secretion in human islets. This information supports previous data that indicate beta cells can use a pathway involving succinyl-CoA: 3-ketoacid-CoA transferase and acetoacetyl-CoA synthetase to synthesize and use acetoacetate and suggests human islets may use this pathway more than PC and citrate to form cytosolic acyl-CoAs.	[MacDonald, Michael J.; Longacre, Melissa J.; Stoker, Scott W.; Kendrick, Mindy; Thonpho, Ansaya; Brown, Laura J.; Hasan, Noaman M.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Thonpho, Ansaya; Jitrapakdee, Sarawut] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Fukao, Toshiyuki] Gifu Univ, Dept Pediat, Gifu 5011194, Japan; [Fukao, Toshiyuki] Gifu Univ, Med Informat Sci Div, Univ Grad Sch, Gifu 5011194, Japan; [Hanson, Matthew S.; Fernandez, Luis A.; Odorico, Jon] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; Mahidol University; Gifu University; Gifu University; University of Wisconsin System; University of Wisconsin Madison	MacDonald, MJ (corresponding author), Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA.	mjmacdon@wisc.edu		MacDonald, Michael/0000-0002-0201-9245	National Institutes of Health [DK28348]; Nowlin Family Trust of the Lutheran Community Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028348, R55DK028348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nowlin Family Trust of the Lutheran Community Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK28348. This work was also supported by the Nowlin Family Trust of the Lutheran Community Foundation.	BERNE C, 1975, J HISTOCHEM CYTOCHEM, V23, P660, DOI 10.1177/23.9.240882; Brown LJ, 2009, J BIOL CHEM, V284, P35359, DOI 10.1074/jbc.M109.040394; BRUN T, 1993, J BIOL CHEM, V268, P18905; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; FERNANDEZALVAREZ J, 1994, DIABETOLOGIA, V37, P177, DOI 10.1007/s001250050090; Flamez D, 2002, DIABETES, V51, P2018, DOI 10.2337/diabetes.51.7.2018; GIROIX MH, 1991, DIABETES, V40, P227, DOI 10.2337/diabetes.40.2.227; Gong QM, 2000, J BIOL CHEM, V275, P38012, DOI 10.1074/jbc.M004078200; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Hasan NM, 2002, GENE, V296, P221, DOI 10.1016/S0378-1119(02)00865-X; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Hasan NM, 2010, ARCH BIOCHEM BIOPHYS, V499, P62, DOI 10.1016/j.abb.2010.05.007; Henquin JC, 2006, DIABETES, V55, P3470, DOI 10.2337/db06-0868; IKEDA T, 1987, ARCH BIOCHEM BIOPHYS, V257, P140, DOI 10.1016/0003-9861(87)90552-2; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; KELLEHER JK, 1985, ANAL BIOCHEM, V151, P55, DOI 10.1016/0003-2697(85)90052-1; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; Kim A, 2009, ISLETS, V1, P129, DOI 10.4161/isl.1.2.9480; Koza RA, 1996, ARCH BIOCHEM BIOPHYS, V336, P97, DOI 10.1006/abbi.1996.0536; Kutlu B, 2009, PHYSIOL GENOMICS, V39, P72, DOI 10.1152/physiolgenomics.00063.2009; LANOUE K, 1970, J BIOL CHEM, V245, P102; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Lehmann R, 2007, DIABETES, V56, P594, DOI 10.2337/db06-0779; Li CH, 2008, J BIOL CHEM, V283, P17238, DOI 10.1074/jbc.M709235200; LOUIS NA, 1992, J BIOL CHEM, V267, P2287; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; MacDonald MJ, 2008, BBA-GEN SUBJECTS, V1780, P966, DOI 10.1016/j.bbagen.2008.03.017; MacDonald MJ, 2008, ARCH BIOCHEM BIOPHYS, V470, P153, DOI 10.1016/j.abb.2007.11.017; MacDonald MJ, 2008, AM J PHYSIOL-CELL PH, V294, pC442, DOI 10.1152/ajpcell.00368.2007; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; MacDonald MJ, 2007, J BIOL CHEM, V282, P6043, DOI 10.1074/jbc.M606652200; MacDonald MJ, 2009, ARCH BIOCHEM BIOPHYS, V488, P100, DOI 10.1016/j.abb.2009.07.004; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P201, DOI 10.1006/abbi.1993.1028; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1993, METABOLISM, V42, P1229, DOI 10.1016/0026-0495(93)90118-8; MACDONALD MJ, 1992, HORM METAB RES, V24, P158, DOI 10.1055/s-2007-1003284; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MacDonald MJ, 2003, METABOLISM, V52, P993, DOI 10.1016/S0026-0495(03)00149-5; MacDonald MJ, 2003, BBA-GEN SUBJECTS, V1619, P77, DOI 10.1016/S0304-4165(02)00443-9; MacDonald MJ, 1996, DIABETES, V45, P1626, DOI 10.2337/diabetes.45.11.1626; MACDONALD MJ, 1981, ENDOCRINOLOGY, V108, P1899, DOI 10.1210/endo-108-5-1899; MacDonald MJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE302, DOI 10.1152/ajpendo.00041.2002; MACDONALD MJ, 1981, J BIOL CHEM, V256, P8287; MACDONALD MJ, 1982, ARCH BIOCHEM BIOPHYS, V213, P643, DOI 10.1016/0003-9861(82)90594-X; MacDonald MJ, 2001, MOL CELL BIOCHEM, V220, P117, DOI 10.1023/A:1010821821921; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; MacDonald MJ, 1996, DIABETES, V45, P886, DOI 10.2337/diabetes.45.7.886; MACDONALD MJ, 1991, J BIOL CHEM, V266, P22392; MACDONALD MJ, 1990, CANCER RES, V50, P7203; MACDONALD MJ, 1983, J CLIN ENDOCR METAB, V57, P662, DOI 10.1210/jcem-57-3-662; MALAISSE WJ, 1990, AM J PHYSIOL, V259, pE117, DOI 10.1152/ajpendo.1990.259.1.E117; Newgard CB, 2002, DIABETES, V51, pS389, DOI 10.2337/diabetes.51.2007.S389; Ni QH, 2008, ANAL CHEM, V80, P3539, DOI 10.1021/ac800406f; OSTENSON CG, 1993, DIABETOLOGIA, V36, P722, DOI 10.1007/BF00401142; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Pisania A, 2010, LAB INVEST, V90, P1661, DOI 10.1038/labinvest.2010.124; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Simpson NE, 2006, DIABETOLOGIA, V49, P1338, DOI 10.1007/s00125-006-0216-5; SRERE PA, 1974, LIFE SCI, V15, P1695, DOI 10.1016/0024-3205(74)90172-6; Sunyakumthorn P, 2005, BIOCHEM BIOPH RES CO, V329, P188, DOI 10.1016/j.bbrc.2005.01.108; WALTER P, 1966, J BIOL CHEM, V241, P2523; WHITEHOUSE S, 1974, BIOCHEM J, V141, P761, DOI 10.1042/bj1410761; Xu J, 2008, DIABETOLOGIA, V51, P2022, DOI 10.1007/s00125-008-1130-9; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	73	68	68	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18383	18396		10.1074/jbc.M111.241182	http://dx.doi.org/10.1074/jbc.M111.241182			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454710	hybrid, Green Published			2022-12-27	WOS:000290785700011
J	Mangialavori, I; Villamil-Giraldo, AM; Pignataro, MF; Ferreira-Gomes, M; Caride, AJ; Rossi, JPFC				Mangialavori, Irene; Maria Villamil-Giraldo, Ana; Pignataro, Maria F.; Ferreira-Gomes, Mariela; Caride, Ariel J.; Rossi, Juan Pablo F. C.			Plasma Membrane Calcium Pump (PMCA) Differential Exposure of Hydrophobic Domains after Calmodulin and Phosphatidic Acid Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOACTIVATABLE PHOSPHOLIPIDIC PROBE; POLYACRYLAMIDE-GEL-ELECTROPHORESIS; FLUORESCENCE ENERGY-TRANSFER; HUMAN-ERYTHROCYTE MEMBRANES; LIPID-BINDING REGION; CA2+ PUMP; CA-2+ PUMP; SARCOPLASMIC-RETICULUM; MONOCLONAL-ANTIBODIES; CRYSTAL-STRUCTURE	The exposure of the plasma membrane calcium pump (PMCA) to the surrounding phospholipids was assessed by measuring the incorporation of the photoactivatable phosphatidylcholine analog [I-125]TID-PC/16 to the protein. In the presence of Ca2+ both calmodulin (CaM) and phosphatidic acid (PA) greatly decreased the incorporation of [I-125] TID-PC/16 to PMCA. Proteolysis of PMCA with V8 protease results in three main fragments: N, which includes transmembrane segments M1 and M2; M, which includes M3 and M4; and C, which includes M5 to M10. CaM decreased the level of incorporation of [I-125] TID-PC/16 to fragments M and C, whereas phosphatidic acid decreased the incorporation of [I-125] TID-PC/16 to fragments N and M. This suggests that the conformational changes induced by binding of CaM or PA extend to the adjacent transmembrane domains. Interestingly, this result also denotes differences between the active conformations produced by CaM and PA. To verify this point, we measured resonance energy transfer between PMCA labeled with eosin isothiocyanate at the ATP-binding site and the phospholipid RhoPE included in PMCA micelles. CaM decreased the efficiency of the energy transfer between these two probes, whereas PA did not. This result indicates that activation by CaM increases the distance between the ATP-binding site and the membrane, but PA does not affect this distance. Our results disclose main differences between PMCA conformations induced by CaM or PA and show that those differences involve transmembrane regions.	[Mangialavori, Irene; Maria Villamil-Giraldo, Ana; Pignataro, Maria F.; Ferreira-Gomes, Mariela; Rossi, Juan Pablo F. C.] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Caride, Ariel J.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Mayo Clinic	Villamil-Giraldo, AM (corresponding author), Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	am.villamil.giraldo@umontreal.ca; jprossi@qb.ffyb.uba.ar	Mangialavori, Irene/GLU-8182-2022	Mangialavori, Irene/0000-0003-3187-3130; Rossi, Juan Pablo/0000-0001-7087-844X	National Institutes of Health, Fogarty International Center [R03TW006837]; Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad de Buenos Aires Ciencia y Tecnica (Argentina); FOGARTY INTERNATIONAL CENTER [R03TW006837] Funding Source: NIH RePORTER	National Institutes of Health, Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires Ciencia y Tecnica (Argentina); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by, in whole or in part, by National Institutes of Health, Fogarty International Center Grant R03TW006837. This work was also supported by Agencia Nacional de Promocion Cientifica y Tecnologica, Consejo Nacional de Investigaciones Cientificas y Tecnicas, and Universidad de Buenos Aires Ciencia y Tecnica (Argentina).	ADAMO HP, 1992, J BIOL CHEM, V267, P14244; BALL EH, 1986, ANAL BIOCHEM, V155, P23, DOI 10.1016/0003-2697(86)90218-6; Bredeston LM, 2004, J BIOL CHEM, V279, P41619, DOI 10.1074/jbc.M403116200; Brini M, 2010, J BIOL CHEM, V285, P30779, DOI 10.1074/jbc.M110.140475; BRODIN P, 1992, EUR J BIOCHEM, V204, P939, DOI 10.1111/j.1432-1033.1992.tb16715.x; BRUNNER J, 1981, BIOCHEMISTRY-US, V20, P7174, DOI 10.1021/bi00528a019; BRUNNER J, 1993, ANNU REV BIOCHEM, V62, P483, DOI 10.1146/annurev.bi.62.070193.002411; Caride AJ, 1999, J BIOL CHEM, V274, P35227, DOI 10.1074/jbc.274.49.35227; Caride AJ, 1996, BIOCHEM J, V316, P353, DOI 10.1042/bj3160353; CASTELLO PR, 1994, BIOCHEM BIOPH RES CO, V201, P194, DOI 10.1006/bbrc.1994.1688; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Corradi GR, 2007, J BIOL CHEM, V282, P35440, DOI 10.1074/jbc.M703377200; Donnet C, 1998, J MEMBRANE BIOL, V163, P217, DOI 10.1007/s002329900385; ENYEDI A, 1989, J BIOL CHEM, V264, P12313; ENYEDI A, 1987, J BIOL CHEM, V262, P6425; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; FALCHETTO R, 1991, J BIOL CHEM, V266, P2930; Filomatori CV, 2003, J BIOL CHEM, V278, P22265, DOI 10.1074/jbc.M302657200; FILOTEO AG, 1987, J BIOL CHEM, V262, P6526; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; FILOTEO AG, 1992, J BIOL CHEM, V267, P11800; Fiske CH, 1925, J BIOL CHEM, V66, P375; FUNG BKK, 1978, BIOCHEMISTRY-US, V17, P5241, DOI 10.1021/bi00617a025; GATTO C, 1993, AM J PHYSIOL, V264, pC1577, DOI 10.1152/ajpcell.1993.264.6.C1577; Giraldo AMV, 2006, FEBS LETT, V580, P607, DOI 10.1016/j.febslet.2005.12.078; GRAF E, 1981, ARCH BIOCHEM BIOPHYS, V210, P257, DOI 10.1016/0003-9861(81)90187-9; HOEKSTRA D, 1982, BIOCHEMISTRY-US, V21, P1055, DOI 10.1021/bi00534a036; JAMES P, 1988, J BIOL CHEM, V263, P2905; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Levi V, 2000, FEBS LETT, V483, P99, DOI 10.1016/S0014-5793(00)02093-7; Liyanage MR, 2009, ANAL BIOCHEM, V385, P1, DOI 10.1016/j.ab.2008.10.022; Mangialavori I, 2010, J BIOL CHEM, V285, P123, DOI 10.1074/jbc.M109.076679; Mangialavori I, 2009, J BIOL CHEM, V284, P4823, DOI 10.1074/jbc.M806912200; MUNKONGE F, 1988, BIOCHEMISTRY-US, V27, P6800, DOI 10.1021/bi00418a023; NIGGLI V, 1979, J BIOL CHEM, V254, P9955; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Padanyi R, 2003, J BIOL CHEM, V278, P35798, DOI 10.1074/jbc.M305794200; PAPP S, 1987, BIOPHYS J, V51, P205, DOI 10.1016/S0006-3495(87)83326-X; Pinto FD, 2002, J BIOL CHEM, V277, P12784, DOI 10.1074/jbc.M111055200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; VORHERR T, 1990, BIOCHEMISTRY-US, V29, P355, DOI 10.1021/bi00454a008; WEBER T, 1995, J AM CHEM SOC, V117, P3084, DOI 10.1021/ja00116a013; Ye YZ, 2005, BIOINFORMATICS, V21, P2362, DOI 10.1093/bioinformatics/bti353; ZVARITCH E, 1990, BIOCHEMISTRY-US, V29, P8070, DOI 10.1021/bi00487a012	49	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18397	18404		10.1074/jbc.M110.210088	http://dx.doi.org/10.1074/jbc.M110.210088			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454645	hybrid, Green Published			2022-12-27	WOS:000290785700012
J	Webb, KJ; Al-Hadid, Q; Zurita-Lopez, CI; Young, BD; Lipson, RS; Clarke, SG				Webb, Kristofor J.; Al-Hadid, Qais; Zurita-Lopez, Cecilia I.; Young, Brian D.; Lipson, Rebecca S.; Clarke, Steven G.			The Ribosomal L1 Protuberance in Yeast Is Methylated on a Lysine Residue Catalyzed by a Seven-beta-strand Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SET DOMAIN METHYLTRANSFERASE; PROTEIN-ARGININE METHYLTRANSFERASE; ION EXCHANGE CHROMATOGRAPHY; POSTTRANSLATIONAL MODIFICATIONS; SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; ESCHERICHIA-COLI; AMINO-ACIDS; IDENTIFICATION; SUBUNIT	Modification of proteins of the translational apparatus is common in many organisms. In the yeast Saccharomyces cerevisiae, we provide evidence for the methylation of Rpl1ab, a well conserved protein forming the ribosomal L1 protuberance of the large subunit that functions in the release of tRNA from the exit site. We show that the intact mass of Rpl1ab is 14 Da larger than its calculated mass with the previously described loss of the initiator methionine residue and N-terminal acetylation. We determined that the increase in mass of yeast Rpl1ab is consistent with the addition of a methyl group to lysine 46 using top-down mass spectrometry. Lysine modification was confirmed by detecting H-3-N-epsilon-monomethyllysine in hydrolysates of Rpl1ab purified from yeast cells radiolabeled in vivo with S-adenosyl-L-[methyl-H-3] methionine. Mass spectrometric analysis of intact Rpl1ab purified from 37 deletion strains of known and putative yeast methyltransferases revealed that only the deletion of the YLR137W gene, encoding a seven-beta-strand methyltransferase, results in the loss of the + 14-Da modification. We expressed the YLR137W gene as a His-tagged protein in Escherichia coli and showed that it catalyzes N-epsilon-monomethyllysine formation within Rpl1ab on ribosomes from the Delta YLR137W mutant strain lacking the methyltransferase activity but not from wild-type ribosomes. We also showed that the His-tagged protein could catalyze monomethyllysine formation on a 16-residue peptide corresponding to residues 38-53 of Rpl1ab. We propose that the YLR137W gene be given the standard name RKM5 (ribosomal lysine (K) methyltransferase 5). Orthologs of RKM5 are found only in fungal species, suggesting a role unique to their survival.	[Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu	Zurita-Lopez, Cecilia I./AAC-6509-2020	Webb, Kristofor/0000-0001-8111-9756	National Institutes of Health [GM026020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026020, R01GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM026020.	Arnold RJ, 1999, ANAL BIOCHEM, V269, P105, DOI 10.1006/abio.1998.3077; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Botting CH, 2010, ARCHAEA, V2010, DOI 10.1155/2010/106341; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; CAVALLIUS J, 1993, BIOCHIM BIOPHYS ACTA, V1163, P75, DOI 10.1016/0167-4838(93)90281-U; Chern MK, 2002, J BIOL CHEM, V277, P15345, DOI 10.1074/jbc.M111379200; CLARKE S, 1984, METHOD ENZYMOL, V106, P330; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; Demirci H, 2008, STRUCTURE, V16, P1059, DOI 10.1016/j.str.2008.03.016; Febbraio F, 2004, J BIOL CHEM, V279, P10185, DOI 10.1074/jbc.M308520200; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; GOTTSCHLING H, 1962, NATURE, V196, P829, DOI 10.1038/196829a0; GUERIN MF, 1989, BIOCHIMIE, V71, P805, DOI 10.1016/0300-9084(89)90043-6; KLEENE SJ, 1977, J BIOL CHEM, V252, P3214; KLEIN PD, 1967, ANAL CHEM, V39, P1276, DOI 10.1021/ac60255a005; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; LHOEST J, 1990, PROTEIN METHYLATION, P155; Lipson RS, 2010, ARCH BIOCHEM BIOPHYS, V500, P137, DOI 10.1016/j.abb.2010.05.023; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Nevskaya N, 2006, J MOL BIOL, V355, P747, DOI 10.1016/j.jmb.2005.10.084; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Nikulin A, 2003, NAT STRUCT BIOL, V10, P104, DOI 10.1038/nsb886; Odintsova TI, 2003, J PROTEIN CHEM, V22, P249, DOI 10.1023/A:1025068419698; Olsson I, 2007, EXP CELL RES, V313, P1778, DOI 10.1016/j.yexcr.2007.03.007; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; PETITJEAN A, 1995, MOL CELL BIOL, V15, P5071; Petrossian T, 2009, EPIGENOMICS-UK, V1, P163, DOI 10.2217/EPI.09.3; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Polevoda B, 2000, J BIOL CHEM, V275, P20508, DOI 10.1074/jbc.M001891200; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Porras-Yakushi TR, 2007, J BIOL CHEM, V282, P12368, DOI 10.1074/jbc.M611896200; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Porras-Yakushi TR, 2005, J BIOL CHEM, V280, P34590, DOI 10.1074/jbc.M507672200; Ren JQ, 2010, J BIOL CHEM, V285, P12695, DOI 10.1074/jbc.M110.103911; RICE RH, 1977, BIOCHIM BIOPHYS ACTA, V492, P316, DOI 10.1016/0005-2795(77)90082-4; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; Schubert HL, 2003, BIOCHEMISTRY-US, V42, P5592, DOI 10.1021/bi034026p; Shirai A, 2010, J BIOL CHEM, V285, P22448, DOI 10.1074/jbc.M110.132274; Sledz P, 2010, PROTEIN SCI, V19, P1395, DOI 10.1002/pro.420; Swiercz R, 2007, J BIOL CHEM, V282, P16917, DOI 10.1074/jbc.M609778200; Tooley CES, 2010, NATURE, V466, P1125, DOI 10.1038/nature09343; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; VANET A, 1994, MOL MICROBIOL, V14, P947, DOI 10.1111/j.1365-2958.1994.tb01330.x; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Webb KJ, 2008, J BIOL CHEM, V283, P35561, DOI 10.1074/jbc.M806006200; Williamson NA, 1997, EUR J BIOCHEM, V246, P786, DOI 10.1111/j.1432-1033.1997.00786.x	50	25	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18405	18413		10.1074/jbc.M110.200410	http://dx.doi.org/10.1074/jbc.M110.200410			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21460220	Green Published, hybrid			2022-12-27	WOS:000290785700013
J	Guo, LL; Chen, ZY; Cox, BE; Amarnath, V; Epand, RF; Epand, RM; Davies, SS				Guo, Lilu; Chen, Zhongyi; Cox, Brian E.; Amarnath, Venkataraman; Epand, Raquel F.; Epand, Richard M.; Davies, Sean S.			Phosphatidylethanolamines Modified by gamma-Ketoaldehyde (gamma KA) Induce Endoplasmic Reticulum Stress and Endothelial Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAVENGER RECEPTOR CD36; ER STRESS; OXIDIZED PHOSPHOLIPIDS; LIPID-PEROXIDATION; COVALENT BINDING; HYDROXY-ALKENALS; ALDEHYDES; CELLS; INFLAMMATION; APOPTOSIS	Peroxidation of plasma lipoproteins has been implicated in the endothelial cell activation and monocyte adhesion that initiate atherosclerosis, but the exact mechanisms underlying this activation remain unclear. Lipid peroxidation generates lipid aldehydes, including the gamma-ketoaldehydes (gamma KA), also termed isoketals or isolevuglandins, that readily modify the amine headgroup of phosphatidylethanolamine (PE). We hypothesized that aldehyde modification of PE could mediate some of the proinflammatory effects of lipid peroxidation. We found that PE modified by gamma KA (gamma KA-PE) induced THP-1 monocyte adhesion to human umbilical cord endothelial cells. gamma KA-PE also induced expression of adhesion molecules and increased MCP-1 and IL-8 mRNA in human umbilical cord endothelial cells. To determine the structural requirements for gamma KA-PE activity, we tested several related compounds. PE modified by 4-oxo-pentanal induced THP-1 adhesion, but N-glutaroyl-PE and C18:0N-acyl-PE did not, suggesting that an N-pyrrole moiety was essential for cellular activity. As the N-pyrrole headgroup might distort the membrane, we tested the effect of the pyrrole-PEs on membrane parameters. gamma KA-PE and 4-oxo-pentanal significantly reduced the temperature for the liquid crystalline to hexagonal phase transition in artificial bilayers, suggesting that these pyrrole-PE markedly altered membrane curvature. Additionally, fluorescently labeled gamma KA-PE rapidly internalized to the endoplasmic reticulum (ER); gamma KA-PE induced C/EBP homologous protein CHOP and BiP expression and p38 MAPK activity, and inhibitors of ER stress reduced gamma KA-PE-induced C/EBP homologous protein CHOP and BiP expression as well as EC activation, consistent with gamma KA-PE inducing ER stress responses that have been previously linked to inflammatory chemokine expression. Thus, gamma KA-PE is a potential mediator of the inflammation induced by lipid peroxidation.	[Guo, Lilu; Chen, Zhongyi; Cox, Brian E.; Davies, Sean S.] Vanderbilt Univ, Div Clin Pharmacol, Nashville, TN 37232 USA; [Amarnath, Venkataraman] Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA; [Davies, Sean S.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Epand, Raquel F.; Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Serv, Hamilton, ON L8N 3Z5, Canada	Vanderbilt University; Vanderbilt University; Vanderbilt University; McMaster University	Davies, SS (corresponding author), 2222 Pierce Ave,506A RRB, Nashville, TN 37232 USA.	sean.davies@vanderbilt.edu	, Richard/R-2316-2019	, Richard/0000-0002-9602-9558; Davies, Sean/0000-0001-9879-8062	National Institutes of Health [OD003137-01, UL1 RR024975]; Vanderbilt Department of Pharmacology; Heart and Stroke Foundation of Ontario [T6915]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Department of Pharmacology; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants OD003137-01 (to S. S. D.) and UL1 RR024975 (to Vanderbilt Institute for Clinical and Translation Research). This work was also supported by Vanderbilt Department of Pharmacology (to S. S. D.) and Heart and Stroke Foundation of Ontario Grant T6915 (to R. M. E.).	Amarnath V, 2005, SYNTHETIC COMMUN, V35, P397, DOI 10.1081/SCC-200048945; Amarnath V, 2004, CHEM RES TOXICOL, V17, P410, DOI 10.1021/tx0300535; Bach D, 2009, CHEM PHYS LIPIDS, V161, P95, DOI 10.1016/j.chemphyslip.2009.07.006; Bacot S, 2003, J LIPID RES, V44, P917, DOI 10.1194/jlr.M200450-JLR200; Bacot S, 2007, J LIPID RES, V48, P816, DOI 10.1194/jlr.M600340-JLR200; Balasubramanian K, 2001, BIOCHEMISTRY-US, V40, P8672, DOI 10.1021/bi010841y; Bernoud-Hubac N, 2004, FREE RADICAL BIO MED, V37, P1604, DOI 10.1016/j.freeradbiomed.2004.07.031; Berry KAZ, 2007, CHEM RES TOXICOL, V20, P1342, DOI 10.1021/tx700102n; BHUYAN KC, 1986, MECH AGEING DEV, V34, P289, DOI 10.1016/0047-6374(86)90080-1; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Epand RF, 2009, BBA-BIOMEMBRANES, V1788, P1967, DOI 10.1016/j.bbamem.2009.06.015; EPAND RM, 1985, BIOCHEMISTRY-US, V24, P7092, DOI 10.1021/bi00346a011; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Go YM, 2007, AM J PATHOL, V171, P1670, DOI 10.2353/ajpath.2007.070218; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; Guichardant M, 1998, FREE RADICAL BIO MED, V25, P1049, DOI 10.1016/S0891-5849(98)00149-X; Guichardant M, 2002, PROSTAG LEUKOTR ESS, V67, P147, DOI 10.1054/plef.2002.0412; Guo LL, 2010, ANAL BIOCHEM, V405, P236, DOI 10.1016/j.ab.2010.06.027; Haberzettl P, 2009, TOXICOL APPL PHARM, V234, P14, DOI 10.1016/j.taap.2008.09.019; Hidalgo FJ, 2004, ANAL BIOCHEM, V334, P155, DOI 10.1016/j.ab.2004.08.001; Hidalgo FJ, 2008, FOOD CHEM TOXICOL, V46, P43, DOI 10.1016/j.fct.2007.05.035; Hill GE, 1998, ATHEROSCLEROSIS, V141, P107, DOI 10.1016/S0021-9150(98)00153-1; Jiao P, 2011, OBESITY, V19, P483, DOI 10.1038/oby.2010.200; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; KILGORE KS, 1995, J IMMUNOL, V155, P1434; Lee JY, 2004, EUR J BIOCHEM, V271, P1339, DOI 10.1111/j.1432-1033.2004.04042.x; Lee YY, 2010, BIOCHEM BIOPH RES CO, V397, P735, DOI 10.1016/j.bbrc.2010.06.022; Li W, 2009, FREE RADICAL BIO MED, V47, P1539, DOI 10.1016/j.freeradbiomed.2009.09.003; Miyazawa T, 2012, AMINO ACIDS, V42, P1163, DOI 10.1007/s00726-010-0772-3; Moretto N, 2009, AM J PHYSIOL-LUNG C, V296, pL839, DOI 10.1152/ajplung.90570.2008; Nitti M, 2002, BIOCHEM BIOPH RES CO, V294, P547, DOI 10.1016/S0006-291X(02)00512-0; NJOROGE FG, 1987, CARBOHYD RES, V167, P211; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okada T, 2003, J BIOL CHEM, V278, P31024, DOI 10.1074/jbc.M300923200; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; PRIVALOV G, 1995, ANAL BIOCHEM, V232, P79, DOI 10.1006/abio.1995.9957; Razinkov VI, 1998, J GEN PHYSIOL, V112, P409, DOI 10.1085/jgp.112.4.409; Sanson M, 2009, CIRC RES, V104, P328, DOI 10.1161/CIRCRESAHA.108.183749; SAYRE LM, 1993, CHEM RES TOXICOL, V6, P19, DOI 10.1021/tx00031a002; Settles EI, 2010, BIOPHYS J, V99, P1539, DOI 10.1016/j.bpj.2010.06.059; Shanmugam N, 2008, DIABETES, V57, P879, DOI 10.2337/db07-1204; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Stadelmann-Ingrand S, 2004, CHEM PHYS LIPIDS, V131, P93, DOI 10.1016/j.chemphyslip.2004.04.008; Sullivan CB, 2010, J LIPID RES, V51, P999, DOI 10.1194/jlr.M001040; Tabas I, 2009, ANTIOXID REDOX SIGN, V11, P2333, DOI [10.1089/ars.2009.2469, 10.1089/ARS.2009.2469]; West JD, 2005, CHEM RES TOXICOL, V18, P1642, DOI 10.1021/tx050211n; Yamawaki H, 2008, AM J PHYSIOL-CELL PH, V295, pC1510, DOI 10.1152/ajpcell.00252.2008; Zhang WH, 2003, CHEM RES TOXICOL, V16, P512, DOI 10.1021/tx020105a	53	42	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18170	18180		10.1074/jbc.M110.213470	http://dx.doi.org/10.1074/jbc.M110.213470			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454544	Green Published, hybrid			2022-12-27	WOS:000290585200077
J	Kim, HG; Hwang, SY; Aaronson, SA; Mandinova, A; Lee, SW				Kim, Hyung-Gu; Hwang, So-Young; Aaronson, Stuart A.; Mandinova, Anna; Lee, Sam W.			DDR1 Receptor Tyrosine Kinase Promotes Prosurvival Pathway through Notch1 Activation (Publication with Expression of Concern. See vol. 292, pg. 7162, 2017) (Publication with Expression of Concern. See vol. 292, pg. 7162, 2017) (Withdrawn Publication. See vol. 294, pg. 18950, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							DISCOIDIN DOMAIN RECEPTOR-1; SOMATIC MUTATIONS; HUMAN HOMOLOG; TARGET GENE; APOPTOSIS; EXPRESSION; CELLS; P53; OVEREXPRESSION; DISTINCT	DDR1 (discoidin domain receptor tyrosine kinase 1) kinase s highly expressed in a variety of human cancers and occasionally mutated in lung cancer and leukemia. It is now clear that aberrant signaling through the DDR1 receptor is closely associated with various steps of tumorigenesis, although little is known about the molecular mechanism(s) underlying the role of DDR1 in cancer. Besides the role of DDR1 in tumorigenesis, we previously identified DDR1 kinase as a transcriptional target of tumor suppressor p53. DDR1 is functionally activated as determined by its tyrosine phosphorylation, in response to p53-dependent DNA damage. In this study, we report the characterization of the Notch1 protein as an interacting partner of DDR1 receptor, as determined by tandem affinity protein purification. Upon ligand-mediated DDR1 kinase activation, Notch1 was activated, bound to DDR1, and activated canonical Notch1 targets, including Hes1 and Hey2. Moreover, DDR1 ligand (collagen I) treatment significantly increased the active form of Notch1 receptor in the nuclear fraction, whereas DDR1 knockdown cells show little or no increase of the active form of Notch1 in the nuclear fraction, suggesting a novel intracellular mechanism underlying autocrine activation of wild-type Notch signaling through DDR1. DDR1 activation suppressed genotoxic-mediated cell death, whereas Notch1 inhibition by a gamma-secretase inhibitor, DAPT, enhanced cell death in response to stress. Moreover, the DDR1 knockdown cancer cells showed the reduced transformed phenotypes in vitro and in vivo xenograft studies. The results suggest that DDR1 exerts prosurvival effect, at least in part, through the functional interaction with Notch1.	[Kim, Hyung-Gu; Hwang, So-Young; Mandinova, Anna; Lee, Sam W.] Massachusetts Gen Hosp, CBRC, Charlestown, MA 02129 USA; [Kim, Hyung-Gu; Hwang, So-Young; Mandinova, Anna; Lee, Sam W.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Aaronson, Stuart A.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA	Harvard University; Massachusetts General Hospital; Harvard University; Icahn School of Medicine at Mount Sinai	Lee, SW (corresponding author), Massachusetts Gen Hosp, CBRC, Bldg 149,13th St, Charlestown, MA 02129 USA.	swlee@partners.org			National Institutes of Health [CA127247, CA80058, CA097216]; NATIONAL CANCER INSTITUTE [R01CA097216, P01CA080058, R01CA127247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA127247, CA80058, and CA097216.	Allenspach EJ, 2002, CANCER BIOL THER, V1, P466, DOI 10.4161/cbt.1.5.159; ALVES F, 1995, ONCOGENE, V10, P609; ASTER J, 1994, COLD SPRING HARB SYM, V59, P125, DOI 10.1101/SQB.1994.059.01.016; Brown L, 2007, EMBO J, V26, P3410, DOI 10.1038/sj.emboj.7601779; Chiaretti S, 2005, CLIN CANCER RES, V11, P7209, DOI 10.1158/1078-0432.CCR-04-2165; Das S, 2006, CANCER RES, V66, P8123, DOI 10.1158/0008-5472.CAN-06-1215; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Ford CE, 2007, BRIT J CANCER, V96, P808, DOI 10.1038/sj.bjc.6603614; Garber K, 2007, J NATL CANCER I, V99, P1284, DOI 10.1093/jnci/djm148; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Guentchev M, 2006, EUR J NEUROSCI, V23, P2289, DOI 10.1111/j.1460-9568.2006.04766.x; Heinzelmann-Schwarz VA, 2004, CLIN CANCER RES, V10, P4427, DOI 10.1158/1078-0432.CCR-04-0073; Jang MS, 2000, CURR OPIN MOL THER, V2, P55; JOHNSON JD, 1993, P NATL ACAD SCI USA, V90, P10891, DOI 10.1073/pnas.90.22.10891; Kim JW, 2005, P NATL ACAD SCI USA, V102, P14308, DOI 10.1073/pnas.0501600102; Klinakis A, 2006, P NATL ACAD SCI USA, V103, P9262, DOI 10.1073/pnas.0603371103; L'hote CGML, 2001, FASEB J, V15, P234, DOI 10.1096/fj.01-0414fje; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; MacKenzie F, 2004, J BIOL CHEM, V279, P11657, DOI 10.1074/jbc.M312102200; Mandinova A, 2008, EMBO J, V27, P1243, DOI 10.1038/emboj.2008.45; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Nair P, 2003, J VIROL, V77, P7106, DOI 10.1128/JVI.77.12.7106-7112.2003; Nemoto T, 1997, PATHOBIOLOGY, V65, P195, DOI 10.1159/000164123; Oishi K, 2004, DEV BIOL, V276, P172, DOI 10.1016/j.ydbio.2004.08.039; Ongusaha PP, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161938; Ongusaha PP, 2003, EMBO J, V22, P1289, DOI 10.1093/emboj/cdg129; Oswald F, 1998, MOL CELL BIOL, V18, P2077, DOI 10.1128/MCB.18.4.2077; Park HS, 2007, ONCOL REP, V18, P1435; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Schlessinger J, 1997, CELL, V91, P869, DOI 10.1016/S0092-8674(00)80477-8; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Small D, 2001, J BIOL CHEM, V276, P32022, DOI 10.1074/jbc.M100933200; Tomasson MH, 2008, BLOOD, V111, P4797, DOI 10.1182/blood-2007-09-113027; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel W, 1999, FASEB J, V13, pS77, DOI 10.1096/fasebj.13.9001.s77; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Weiner HL, 2000, NEUROSURGERY, V47, P1400, DOI 10.1097/00006123-200012000-00028; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; ZERLIN M, 1993, ONCOGENE, V8, P2731	47	67	79	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17672	17681		10.1074/jbc.M111.236612	http://dx.doi.org/10.1074/jbc.M111.236612			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21398698	Green Published, hybrid			2022-12-27	WOS:000290585200031
J	Matthes, F; Wolte, P; Bockenhoff, A; Huwel, S; Schulz, M; Hyden, P; Fogh, J; Gieselmann, V; Galla, HJ; Matzner, U				Matthes, Frank; Woelte, Philipp; Boeckenhoff, Annika; Huewel, Sabine; Schulz, Mareike; Hyden, Pia; Fogh, Jens; Gieselmann, Volkmar; Galla, Hans-Joachim; Matzner, Ulrich			Transport of Arylsulfatase A across the Blood-Brain Barrier in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME-REPLACEMENT-THERAPY; MOUSE MODEL; ENDOTHELIAL-CELLS; GENTAMICIN; STORAGE; DELIVERY; SYSTEM; ENDOCYTOSIS; CORRECTS; PEPTIDE	Enzyme replacement therapy is an option to treat lysosomal storage diseases caused by functional deficiencies of lysosomal hydrolases as intravenous injection of therapeutic enzymes can correct the catabolic defect within many organ systems. However, beneficial effects on central nervous system manifestations are very limited because the blood-brain barrier (BBB) prevents the transfer of enzyme from the circulation to the brain parenchyma. Preclinical studies in mouse models of metachromatic leukodystrophy, however, showed that arylsulfatase A (ASA) is able to cross the BBB to some extent, thus reducing lysosomal storage in brain microglial cells. The present study aims to investigate the routing of ASA across the BBB and to improve the transfer in vitro using a well established cell culture model consisting of primary porcine brain capillary endothelial cells cultured on Transwell filter inserts. Passive apical-to-basolateral ASA transfer was observed, which was not saturable up to high ASA concentrations. No active transport could be determined. The passive transendothelial transfer was, however, charge-dependent as reduced concentrations of negatively charged monosaccharides in the N-glycans of ASA or the addition of polycations increased basolateral ASA levels. Adsorptive transcytosis is therefore considered to be the major transport pathway. Partial inhibition of the transcellular ASA transfer by mannose 6-phosphate indicated a second route depending on the insulin-like growth factor II/mannose 6-phosphate receptor, MPR300. We conclude that cationization of ASA and an increase of the mannose 6-phosphate content of the enzyme may promote blood-to-brain transfer of ASA, thus leading to an improved therapeutic efficacy of enzyme replacement therapy behind the BBB.	[Matthes, Frank; Boeckenhoff, Annika; Gieselmann, Volkmar; Matzner, Ulrich] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [Woelte, Philipp; Huewel, Sabine; Schulz, Mareike; Galla, Hans-Joachim] Univ Munster, Inst Biochem, D-48149 Munster, Germany; [Hyden, Pia; Fogh, Jens] Zymenex AS, DK-3400 Hillerod, Denmark	University of Bonn; University of Munster	Matzner, U (corresponding author), Nussallee 11, D-53115 Bonn, Germany.	matzner@ibmb.uni-bonn.de		Matthes, Frank/0000-0002-5115-8831	"Eva Luise und Horst Kohler Stiftung fur Menschen mit Seltenen Erkrankungen," Germany; International Graduate School Biotech-Pharma of North-Rhine West-phalia, Germany	"Eva Luise und Horst Kohler Stiftung fur Menschen mit Seltenen Erkrankungen," Germany; International Graduate School Biotech-Pharma of North-Rhine West-phalia, Germany	This work was supported by research grants from the "Eva Luise und Horst Kohler Stiftung fur Menschen mit Seltenen Erkrankungen," Germany, and the International Graduate School Biotech-Pharma of North-Rhine West-phalia, Germany.	BAUM H, 1959, CLIN CHIM ACTA, V4, P453, DOI 10.1016/0009-8981(59)90119-6; Beck M, 2010, IUBMB LIFE, V62, P33, DOI 10.1002/iub.284; Blanz J, 2008, HUM MOL GENET, V17, P3437, DOI 10.1093/hmg/ddn237; Desnick RJ, 2002, NAT REV GENET, V3, P954, DOI 10.1038/nrg963; Dunder U, 2000, FASEB J, V14, P361, DOI 10.1096/fasebj.14.2.361; Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9; GIURGEAMARION L, 1986, TOXICOL APPL PHARM, V86, P271, DOI 10.1016/0041-008X(86)90058-X; Greiner-Tollersrud Ole Kristian, 2005, P60; Grubb JH, 2008, P NATL ACAD SCI USA, V105, P2616, DOI 10.1073/pnas.0712147105; Herve F, 2008, AAPS J, V10, P455, DOI 10.1208/s12248-008-9055-2; KUMAGAI AK, 1987, J BIOL CHEM, V262, P15214; Lischper M, 2010, BRAIN RES, V1326, P114, DOI 10.1016/j.brainres.2010.02.054; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Matzner U, 2005, HUM MOL GENET, V14, P1139, DOI 10.1093/hmg/ddi126; Matzner U, 2000, GENE THER, V7, P805, DOI 10.1038/sj.gt.3301150; Matzner U, 2009, MOL THER, V17, P600, DOI 10.1038/mt.2008.305; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Mitsunaga-Nakatsubo K, 2009, DEV GENES EVOL, V219, P281, DOI 10.1007/s00427-009-0289-5; Mitsunaga-Nakatsubo K, 2009, MED MOL MORPHOL, V42, P63, DOI 10.1007/s00795-009-0447-x; Pohl S, 2009, BIOL CHEM, V390, P521, DOI 10.1515/BC.2009.076; Polito VA, 2009, AM J HUM GENET, V85, P296, DOI 10.1016/j.ajhg.2009.07.011; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Segrest J P, 1971, Biochem Biophys Res Commun, V44, P390; Roces DP, 2004, HUM MOL GENET, V13, P1979, DOI 10.1093/hmg/ddh220; Sarrazin S, 2010, MOL THER, V18, P1268, DOI 10.1038/mt.2010.78; Schroder S, 2010, GLYCOBIOLOGY, V20, P248, DOI 10.1093/glycob/cwp171; SILVERBLATT FJ, 1979, KIDNEY INT, V15, P335, DOI 10.1038/ki.1979.45; Skopicki HA, 1996, AM J PHYSIOL-RENAL, V270, pF531, DOI 10.1152/ajprenal.1996.270.3.F531; Sorribas V, 2001, KIDNEY INT, V59, P1024, DOI 10.1046/j.1523-1755.2001.0590031024.x; STEVENS RL, 1975, J BIOL CHEM, V250, P2495; Storch Stephan, 2005, P17; TRIGUERO D, 1989, P NATL ACAD SCI USA, V86, P4761, DOI 10.1073/pnas.86.12.4761; Urayama A, 2007, P NATL ACAD SCI USA, V104, P12873, DOI 10.1073/pnas.0705611104; Vagedes P, 2002, BIOPHYS J, V83, P3066, DOI 10.1016/S0006-3495(02)75311-3; Vogler C, 2005, P NATL ACAD SCI USA, V102, P14777, DOI 10.1073/pnas.0506892102; von Wedel-Parlow M, 2009, J NEUROCHEM, V111, P111, DOI 10.1111/j.1471-4159.2009.06305.x; VONFIGURA K, 2001, METABOLIC MOL BASES, P3695	37	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17487	17494		10.1074/jbc.M110.189381	http://dx.doi.org/10.1074/jbc.M110.189381			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454621	Green Published, hybrid			2022-12-27	WOS:000290585200010
J	Mireuta, M; Hancock, MA; Pollak, M				Mireuta, Matei; Hancock, Mark A.; Pollak, Michael			Binding between Insulin-like Growth Factor 1 and Insulin-like Growth Factor-binding Protein 3 Is Not Influenced by Glucose or 2-Deoxy-D-glucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOF MASS-SPECTROMETRY; NONCOVALENT COMPLEXES; METABOLIC BLOCK; 2-DEOXYGLUCOSE; BIOSENSOR; INHIBITION; SYSTEM; CANCER	A recent report (Zhong, D., Xiong, L., Liu, T., Liu, X., Liu, X., Chen, J., Sun, S. Y., Khuri, F. R., Zong, Y., Zhou, Q., and Zhou, W. (2009) J. Biol. Chem. 284, 23225-23233) details that 2-deoxy-D-glucose (2-DG), a well known inhibitor of glycolysis and a candidate antineoplastic agent, also induces insulin-like growth factor 1 receptor (IGF-1R) signaling through the inhibition of insulin-like growth factor 1-insulin-like growth factor-binding protein 3 (IGF-1-IGFBP-3) complex formation. Zhong et al. hypothesized that disrupted IGF-1/IGFBP-3 binding by 2-DG led to increased free IGF-1 concentrations and, consequently, activation of IGF-1R downstream pathways. Because their report suggests unprecedented off-target effects of 2-DG, this has profound implications for the fields of metabolism and oncology. Using ELISA, surface plasmon resonance, and novel "intensity-fading" mass spectrometry, we now provide a detailed characterization of complex formation between IGF-1 and IGFBP-3. All three of these independent methods demonstrated that there was no effect of glucose or 2-DG on the interaction between IGF-1 and IGFBP-3. Furthermore, we show examples of 2-DG exposure associated with reduced rather than increased IGF-1R and AKT activation, providing further evidence against a 2-DG increase in IGF-1R activation by IGF-1-IGFBP-3 complex disruption.	[Mireuta, Matei; Pollak, Michael] Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Mireuta, Matei; Pollak, Michael] Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Hancock, Mark A.] McGill Univ, Sheldon Biotechnol Ctr, Montreal, PQ H3A 2B4, Canada	McGill University; Lady Davis Institute; McGill University; McGill University	Pollak, M (corresponding author), 3755 Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	michael.pollak@mcgill.ca	Pollak, Michael/G-9094-2011	Pollak, Michael/0000-0003-3047-0604	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank the Genome Quebec and Lady Davis Institute Clinical Proteomics Facility for their assistance with mass spectrometry experiments. Sheldon Biotechnology Centre is supported by a research resource grant from the Canadian Institutes of Health Research.	Beattie J, 2008, MOL CELL BIOCHEM, V307, P221, DOI 10.1007/s11010-007-9601-8; Bolbach G, 2005, CURR PHARM DESIGN, V11, P2535, DOI 10.2174/1381612054546923; CHEN W, 1992, BIOCHIMIE, V74, P867, DOI 10.1016/0300-9084(92)90070-U; Collett-Solberg PF, 2000, ENDOCRINE, V12, P121, DOI 10.1385/ENDO:12:2:121; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Laviola L, 2007, CURR PHARM DESIGN, V13, P663, DOI 10.2174/138161207780249146; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Levitt RJ, 2005, BIOCHEM BIOPH RES CO, V336, P1056, DOI 10.1016/j.bbrc.2005.08.229; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Singh DH, 2005, STRAHLENTHER ONKOL, V181, P507, DOI 10.1007/s00066-005-1320-z; Vorwerk P, 2002, ENDOCRINOLOGY, V143, P1677, DOI 10.1210/en.143.5.1677; WICK AN, 1955, P SOC EXP BIOL MED, V89, P579; WICK AN, 1957, J BIOL CHEM, V224, P963; Yanes O, 2007, NAT PROTOC, V2, P119, DOI 10.1038/nprot.2006.487; Yanes O, 2006, J PROTEOME RES, V5, P2711, DOI 10.1021/pr060202f; Zhong DS, 2008, MOL CANCER THER, V7, P809, DOI 10.1158/1535-7163.MCT-07-0559; Zhong DS, 2009, J BIOL CHEM, V284, P23225, DOI 10.1074/jbc.M109.005280	21	8	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16567	16573		10.1074/jbc.M110.213033	http://dx.doi.org/10.1074/jbc.M110.213033			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21388950	Green Published, hybrid			2022-12-27	WOS:000290301900005
J	Townley, RA; Bulow, HE				Townley, Robert A.; Buelow, Hannes E.			Genetic Analysis of the Heparan Modification Network in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATE 6-O-SULFOTRANSFERASE; IN-VIVO; SUBSTRATE-SPECIFICITY; LIGAND-BINDING; FINE-STRUCTURE; BIOSYNTHESIS; GLYCOSAMINOGLYCANS; ACID; 2-O-SULFOTRANSFERASE; PROTEOGLYCANS	Heparan sulfates (HS) are highly modified sugar polymers in multicellular organisms that function in cell adhesion and cellular responses to protein signaling. Functionally distinct, cell type-dependent HS modification patterns arise as the result of a conserved network of enzymes that catalyze deacetylations, sulfations, and epimerizations in specific positions of the sugar residues. To understand the genetic interactions of the enzymes during the HS modification process, we have measured the composition of HS purified from mutant strains of Caenorhabditis elegans. From these measurements we have developed a genetic network model of HS modification. We find the interactions to be highly recursive positive feed-forward and negative feedback loops. Our genetic analyses show that the HS C-5 epimerase hse-5, the HS 2-O-sulfotransferase hst-2, or the HS 6-O-sulfotransferase hst-6 inhibit N-sulfation. In contrast, hse-5 stimulates both 2-O- and 6-O-sulfation and, hst-2 and hst-6 inhibit 6-O- and 2-O-sulfation, respectively. The effects of hst-2 and hst-6 on N-sulfation, 6-O-sulfation, and 2-O-sulfation appear largely dependent on hse-5 function. This core of regulatory interactions is further modulated by 6-O-endosulfatase activity (sul-1). 47% of all 6-O-sulfates get removed from HS and this editing process is dependent on hst-2, thereby providing additional negative feedback between 2-O- and 6-O-sulfation. These findings suggest that the modification patterns are highly sensitive to the relative composition of the HS modification enzymes. Our comprehensive genetic analysis forms the basis of understanding the HS modification network in metazoans.	[Townley, Robert A.; Buelow, Hannes E.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Buelow, Hannes E.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Bulow, HE (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	hannes.buelow@einstein.yu.edu		Townley, Robert/0000-0002-9347-2431	National Institutes of Health [5R01HD055380, RC1GM090825, 5T32NS07098]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM090825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01HD055380 and RC1GM090825 (to H. E. B.) and 5T32NS07098 (to R. A. T.).	Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; Bhattacharya R, 2009, J CELL SCI, V122, P4492, DOI 10.1242/jcs.050732; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bulow HE, 2008, CURR BIOL, V18, P1978, DOI 10.1016/j.cub.2008.11.023; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Bulow HE, 2002, P NATL ACAD SCI USA, V99, P6346, DOI 10.1073/pnas.092128099; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Clement A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000136; Dejima K, 2010, J BIOL CHEM, V285, P24717, DOI 10.1074/jbc.M109.088229; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Frese MA, 2009, J BIOL CHEM, V284, P28033, DOI 10.1074/jbc.M109.035808; Guimond SE, 2009, J BIOL CHEM, V284, P25714, DOI 10.1074/jbc.M109.032755; Habuchi H, 2003, BIOCHEM J, V371, P131, DOI 10.1042/BJ20021259; Habuchi H, 2000, J BIOL CHEM, V275, P2859, DOI 10.1074/jbc.275.4.2859; Habuchi H, 2007, J BIOL CHEM, V282, P15578, DOI 10.1074/jbc.M607434200; JACOBSSON I, 1984, J BIOL CHEM, V259, P1056; JACOBSSON I, 1980, J BIOL CHEM, V255, P5094; Jemth P, 2003, J BIOL CHEM, V278, P24371, DOI 10.1074/jbc.M212155200; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; KATO M, 1994, J BIOL CHEM, V269, P18881; Kinnunen T, 2005, P NATL ACAD SCI USA, V102, P1507, DOI 10.1073/pnas.0401591102; Kobayashi M, 1996, J BIOL CHEM, V271, P7645, DOI 10.1074/jbc.271.13.7645; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Li FC, 2011, J CELL BIOL, V192, P691, DOI 10.1083/jcb.201008087; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nagai N, 2004, J CELL SCI, V117, P3331, DOI 10.1242/jcs.01191; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; SHWORAK NW, 1993, HAEMOSTASIS, V23, P161; Smeds E, 2010, GLYCOBIOLOGY, V20, P1274, DOI 10.1093/glycob/cwq089; Stanford KI, 2010, J BIOL CHEM, V285, P286, DOI 10.1074/jbc.M109.063701; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Tveit H, 2005, J BIOL CHEM, V280, P29596, DOI 10.1074/jbc.M503691200; Yamada S, 1999, FEBS LETT, V459, P327, DOI 10.1016/S0014-5793(99)01286-7; Zako M, 2003, J BIOL CHEM, V278, P13561, DOI 10.1074/jbc.M209658200	44	22	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16824	16831		10.1074/jbc.M111.227926	http://dx.doi.org/10.1074/jbc.M111.227926			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454666	hybrid, Green Published			2022-12-27	WOS:000290301900032
J	Zhang, YH; Yan, WS; Chen, XB				Zhang, Yanhong; Yan, Wensheng; Chen, Xinbin			Mutant p53 Disrupts MCF-10A Cell Polarity in Three-dimensional Culture via Epithelial-to-mesenchymal Transitions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LI-FRAUMENI-SYNDROME; WILD-TYPE P53; GAIN; MUTATIONS; APOPTOSIS; SUPPRESSION; RESISTANCE; SURVIVAL; INVASION; BINDING	Mutant p53 is not only deficient in tumor suppression but also acquires additional activity, called gain of function. Mutant p53 gain of function is recapitulated in knock-in mice that carry one null allele and one mutant allele of the p53 gene. These knock-in mice develop aggressive tumors compared with p53-null mice. Recently, we and others showed that tumor cells carrying a mutant p53 are addicted to the mutant for cell survival and resistance to DNA damage. To further define mutant p53 gain of function, we used the MCF-10A three-dimensional model of mammary morphogenesis. MCF-10A cells in three-dimensional culture undergo a series of morphological changes and form polarized and growth-arrested spheroids with hollow lumen, which resembles normal glandular architectures in vivo. Here, we found that endogenous wild-type p53 in MCF-10A cells was not required for acinus formation, but knockdown of endogenous wild-type p53 (p53-KD) led to partial clearance of cells in the lumen due to decreased apoptosis. Consistent with this, p53-KD altered expression patterns of the cell adhesion molecule E-cadherin, the cytoskeletal marker beta-catenin, and the extracellular matrix protein laminin V. We also found that ectopic expression of the mutant G245S led to a phenotype similar to p53-KD, whereas a combination of ectopic expression of siRNA-resistant G245S with p53-KD led to a less cleared lumen. In contrast, ectopic expression of mutant R248W, R175H, and R273H disrupted normal acinus architectures with filled lumen and led to formation of irregular and multiacinus structures regardless of p53-KD. In addition, these mutants altered normal expression patterns and/or levels of E-cadherin, beta-catenin, laminin V, and tight junction marker ZO-1. Furthermore, epithelial-to-mesenchymal transitions (EMT) markers, Snail, Slug, and Twist, were highly induced by mutant p53 and/or p53-KD. Together, we postulate that EMT represents a mutant p53 gain of function and mutant p53 alters cell polarity via EMT.	[Zhang, Yanhong; Yan, Wensheng; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu	qiao, zhixin/I-3408-2012		National Institutes of Health [CA121137]; NATIONAL CANCER INSTITUTE [P30CA093373, R01CA121137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA121137.	Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Danes CG, 2008, CANCER RES, V68, P1760, DOI 10.1158/0008-5472.CAN-07-3177; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Feigin ME, 2009, CURR OPIN CELL BIOL, V21, P694, DOI 10.1016/j.ceb.2009.07.003; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; MERLO GR, 1995, J CELL BIOL, V128, P1185, DOI 10.1083/jcb.128.6.1185; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; ROLLEY N, 1995, ONCOGENE, V11, P763; Sarig R, 2010, J EXP MED, V207, P2127, DOI 10.1084/jem.20100797; Seewaldt VL, 2001, J CELL BIOL, V155, P471, DOI 10.1083/jcb.200011001; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Yan WS, 2008, CANCER RES, V68, P6789, DOI 10.1158/0008-5472.CAN-08-0810; Yan WS, 2010, J BIOL CHEM, V285, P14229, DOI 10.1074/jbc.M109.097253; Yan WS, 2009, J BIOL CHEM, V284, P12178, DOI 10.1074/jbc.M900994200; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	29	61	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.214585	http://dx.doi.org/10.1074/jbc.M110.214585			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454711	hybrid, Green Published			2022-12-27	WOS:000290022800061
J	Kitano, E; Hayashi, A; Kanai, D; Shinmyozu, K; Nakayama, J				Kitano, Erina; Hayashi, Aki; Kanai, Daigo; Shinmyozu, Kaori; Nakayama, Jun-ichi			Roles of Fission Yeast Grc3 Protein in Ribosomal RNA Processing and Heterochromatic Gene Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMODOMAIN PROTEIN; HISTONE H3; LOCALIZATION; TRANSCRIPTION; ORGANIZATION; METHYLATION; INTERACT; EXPORT; DAMAGE; HCLP1	Grc3 is an evolutionarily conserved protein. Genome-wide budding yeast studies suggest that Grc3 is involved in rRNA processing. In the fission yeast Schizosaccharomyces pombe, Grc3 was identified as a factor exhibiting distinct nuclear dot localization, yet its exact physiological function remains unknown. Here, we show that S. pombe Grc3 is required for both rRNA processing and heterochromatic gene silencing. Cytological analysis revealed that Grc3 nuclear dots correspond to heterochromatic regions and that some Grc3 is also present in the nucleolar peripheral region. Depleting the heterochromatic proteins Swi6 or Clr4 abolished heterochromatic localization of Grc3 and resulted in its preferential accumulation in the peri-nucleolar region, suggesting its dynamic association with these nuclear compartments. Cells expressing mutant grc3 showed defects in 25 S rRNA maturation and in heterochromatic gene silencing. Protein analysis of Grc3-containing complexes led to the identification of Las1 and components of the IPI complex (Rix1, Ipi1, and Crb3). All of these Grc3-interacting proteins showed a dynamic nuclear localization similar to that observed for Grc3, and those conditional mutants showed defects in both rRNA processing and silencing of centromeric transcripts. Our data suggest that Grc3 functions cooperatively with Las1 and the IPI complex in both ribosome biogenesis and heterochromatin assembly.	[Nakayama, Jun-ichi] RIKEN, Ctr Dev Biol, Lab Chromatin Dynam, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Shinmyozu, Kaori] RIKEN, Ctr Dev Biol, Prote Support Unit, Kobe, Hyogo 6500047, Japan; [Kitano, Erina] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 6578501, Japan; [Kanai, Daigo; Nakayama, Jun-ichi] Kwansei Gakuin Univ, Grad Sch Sci & Technol, Dept Biosci, Sanda 6691337, Japan	RIKEN; RIKEN; Kobe University; Kwansei Gakuin University	Nakayama, J (corresponding author), RIKEN, Ctr Dev Biol, Lab Chromatin Dynam, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	jnakayam@cdb.riken.jp	Nakayama, Jun-ichi/C-6003-2011	Nakayama, Jun-ichi/0000-0002-5597-8239; Hayashi, Aki/0000-0003-1953-1664	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kobe University; Grants-in-Aid for Scientific Research [22115513] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kobe University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.; Supported by the Global Center of Excellence (G-COE) program of Kobe University.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Braglia P, 2010, EMBO REP, V11, P758, DOI 10.1038/embor.2010.130; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Castle CD, 2010, MOL CELL BIOL, V30, P4404, DOI 10.1128/MCB.00358-10; de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895; Ding DQ, 2000, GENES CELLS, V5, P169, DOI 10.1046/j.1365-2443.2000.00317.x; DOSEFF AI, 1995, GENETICS, V141, P857; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; El-Moghazy AN, 2000, YEAST, V16, P277, DOI 10.1002/(SICI)1097-0061(200002)16:3<277::AID-YEA524>3.0.CO;2-G; Galani K, 2004, J BIOL CHEM, V279, P55411, DOI 10.1074/jbc.M406876200; Gould KL, 2004, METHODS, V33, P239, DOI 10.1016/j.ymeth.2003.11.019; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hayashi A, 2009, GENES CELLS, V14, P217, DOI 10.1111/j.1365-2443.2008.01264.x; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Jain R, 2009, RNA, V15, P923, DOI 10.1261/rna.1492809; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; MinvielleSebastia L, 1997, P NATL ACAD SCI USA, V94, P7897, DOI 10.1073/pnas.94.15.7897; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noble CG, 2007, NUCLEIC ACIDS RES, V35, P87, DOI 10.1093/nar/gkl1010; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Ramirez A, 2008, RNA, V14, P1737, DOI 10.1261/rna.1142908; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Sadaie M, 2008, MOL CELL BIOL, V28, P6973, DOI 10.1128/MCB.00791-08; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Sydorskyy Y, 2003, MOL CELL BIOL, V23, P2042, DOI 10.1128/MCB.23.6.2042-2054.2003; Taricani L, 2006, MOL BIOL CELL, V17, P3456, DOI 10.1091/mbc.E06-01-0056; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777	44	19	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15391	15402		10.1074/jbc.M110.201343	http://dx.doi.org/10.1074/jbc.M110.201343			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21385875	hybrid, Green Published			2022-12-27	WOS:000289788300069
J	Sekimoto, T; Miyamoto, Y; Arai, S; Yoneda, Y				Sekimoto, Toshihiro; Miyamoto, Yoshimi; Arai, Shouko; Yoneda, Yoshihiro			Importin alpha Protein Acts as a Negative Regulator for Snail Protein Nuclear Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; ZINC-FINGER; TUMOR PROGRESSION; REPRESSOR SNAIL; BREAST-CANCER; BETA; LOCALIZATION; PHOSPHORYLATION	Snail, a zinc finger-containing transcriptional regulator, migrates into the nucleus where it controls gene expression. We demonstrated previously that importin beta 1 directly recognizes the zinc finger domain of Snail and transports it into the nucleus. Here, using in vitro and in vivo assays, we show that importin alpha, an adaptor protein for importin beta 1, negatively regulates the nuclear import of Snail mediated by importin beta 1. In vitro binding assays indicated that importin alpha interacted with the zinc finger domain of Snail to compete with the binding of importin beta 1 and that Snail did not form a ternary complex with importin alpha/importin beta 1. Overexpression of importin alpha in A549 cells reduced the endogenous Snail protein level, which was restored by inhibitors of the proteasome and glycogen synthase kinase 3 beta. Furthermore, knockdown of importin alpha by siRNA treatment increased the endogenous Snail protein level in several cancer cell lines. This study provides a novel regulatory mechanism of the nuclear protein import process by importin alpha and gives an implication to control Snail activity by inhibiting its nuclear localization.	[Sekimoto, Toshihiro; Yoneda, Yoshihiro] Osaka Univ, Grad Sch Med, Dept Biochem, Osaka 5650871, Japan; [Miyamoto, Yoshimi; Arai, Shouko; Yoneda, Yoshihiro] Osaka Univ, Grad Sch Frontier Biosci, Dept Frontier Biosci, Osaka 5650871, Japan; [Miyamoto, Yoshimi; Arai, Shouko; Yoneda, Yoshihiro] Osaka Univ, Japan Sci & Technol Agcy, Osaka 5650871, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST); Osaka University	Yoneda, Y (corresponding author), 1-3 Yamada Oka, Osaka 5650871, Japan.	yyoneda@anat3.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; JST; Grants-in-Aid for Scientific Research [23657130] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and JST, CREST.	Nieto MA, 2009, INT J DEV BIOL, V53, P1541, DOI 10.1387/ijdb.072410mn; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Forwood JK, 2010, STRUCTURE, V18, P1171, DOI 10.1016/j.str.2010.06.015; Forwood JK, 2002, BIOCHEMISTRY-US, V41, P9333, DOI 10.1021/bi025548s; Hajra KM, 2002, CANCER RES, V62, P1613; Harreman MT, 2003, J BIOL CHEM, V278, P5854, DOI 10.1074/jbc.M210951200; Ito T, 2010, BIOCHEM BIOPH RES CO, V403, P161, DOI 10.1016/j.bbrc.2010.10.036; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; Ko H, 2007, CELLS TISSUES ORGANS, V185, P66, DOI 10.1159/000101305; Kotera I, 2005, EMBO J, V24, P942, DOI 10.1038/sj.emboj.7600587; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Mingot JM, 2009, J CELL SCI, V122, P1452, DOI 10.1242/jcs.041749; Nagoshi E, 1999, MOL BIOL CELL, V10, P2221, DOI 10.1091/mbc.10.7.2221; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Poser I, 2001, J BIOL CHEM, V276, P24661, DOI 10.1074/jbc.M011224200; Quadrini KJ, 2002, J BIOL CHEM, V277, P32243, DOI 10.1074/jbc.M205677200; Sekimoto T, 2004, EMBO J, V23, P1934, DOI 10.1038/sj.emboj.7600198; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wu YD, 2009, J BIOL CHEM, V284, P640, DOI 10.1074/jbc.M806916200; Yamasaki H, 2005, GENES CELLS, V10, P455, DOI 10.1111/j.1365-2443.2005.00850.x; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yang ZB, 2005, CANCER RES, V65, P3179, DOI 10.1158/0008-5472.CAN-04-3480; Ying M, 2007, BBA-MOL CELL RES, V1773, P804, DOI 10.1016/j.bbamcr.2007.03.006; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	36	17	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15126	15131		10.1074/jbc.M110.213579	http://dx.doi.org/10.1074/jbc.M110.213579			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21454664	hybrid, Green Published			2022-12-27	WOS:000289788300043
J	Dong, XY; Guo, P; Sun, XD; Li, QN; Dong, JT				Dong, Xue-Yuan; Guo, Peng; Sun, Xiaodong; Li, Qunna; Dong, Jin-Tang			Estrogen Up-regulates ATBF1 Transcription but Causes Its Protein Degradation in Estrogen Receptor-alpha-positive Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; EPITHELIAL-CELLS; PROSTATE-CANCER; MENSTRUAL-CYCLE; PROGESTERONE-RECEPTOR; GASTRIC-CANCER; HEALTHY WOMEN; MAMMARY-GLAND; C-MYC; ACTIVATION	The proper level of estrogen-estrogen receptor (ER) signaling is important for the maintenance of epithelial homeostasis in the breast. In a previous study we demonstrated that ATBF1, which has been suggested as a tumor suppressor in breast cancer, inhibited estrogen-mediated cell proliferation by selectively competing with AIB1 for binding to the ER. However, the expression of ATBF1 mRNA was shown to positively correlate with ER in breast cancer specimens. We, therefore, examined whether estrogen regulates ATBF1. We demonstrated that estrogen up-regulated the transcription of ATBF1, which was mediated by the direct binding of the ER onto the ATBF1 promoter, and that a half-estrogen-responsive element in the ATBF1 promoter was essential for ER direct binding. Furthermore, we found that estrogen at lower levels increased, but at higher levels decreased the expression of ATBF1 protein, which involved the degradation of ATBF1 protein by the estrogen-responsive proteasome system. ATBF1 protein levels fluctuate with estrogen levels. Although lower levels of estrogen increased ATBF1 protein expression, ATBF1 still inhibited cell proliferation caused by lower levels of estrogen. These findings not only reveal an autoregulatory feedback loop between ATBF1 and estrogen-ER signaling but also suggest that ATBF1 plays a role in both the maintenance of breast epithelial homeostasis and breast tumorigenesis caused by elevated estrogen levels.	Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Dong, JT (corresponding author), 1365-C Clifton Rd, Atlanta, GA 30322 USA.	j.dong@emory.edu	guo, peng/AAG-4052-2019; Guo, Peng/GWC-0572-2022	Dong, Jin-Tang/0000-0003-2349-5782; Guo, Peng/0000-0002-4575-8443	National Institutes of Health [CA85560]; Department of Defense [W81XWH-08-1-0328]; Georgia Cancer Coalition Award [GCC130042]; NATIONAL CANCER INSTITUTE [R01CA085560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Georgia Cancer Coalition Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA85560 (to J.-T.D.). This work was also supported by Department of Defense Grant W81XWH-08-1-0328 and Georgia Cancer Coalition Award GCC130042 (both to X.-Y.D.).	Anderson E, 2004, J MAMMARY GLAND BIOL, V9, P3, DOI 10.1023/B:JOMG.0000023584.01750.16; Anderson E, 1998, J MAMMARY GLAND BIOL, V3, P23, DOI 10.1023/A:1018718117113; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Berns A, 2010, NATURE, V468, P519, DOI 10.1038/468519a; Bocchinfuso WP, 1997, J MAMMARY GLAND BIOL, V2, P323, DOI 10.1023/A:1026339111278; BRUNNER N, 1993, CANCER RES, V53, P3229; Burger A, 2006, NEOPLASIA, V8, P689, DOI 10.1593/neo.06469; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cho YG, 2007, CLIN CANCER RES, V13, P4355, DOI 10.1158/1078-0432.CCR-07-0619; Clarke RB, 2006, MATURITAS, V54, P327, DOI 10.1016/j.maturitas.2006.06.002; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Cleton-Jansen AM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-105; Cottone E, 2001, INT J BIOL MARKER, V16, P151, DOI 10.1177/172460080101600301; Dong XY, 2008, HUM MOL GENET, V17, P1031, DOI 10.1093/hmg/ddm375; Dong XY, 2006, CANCER RES, V66, P6998, DOI 10.1158/0008-5472.CAN-06-0411; Dong XY, 2010, J BIOL CHEM, V285, P32801, DOI 10.1074/jbc.M110.128330; DUBIK D, 1992, ONCOGENE, V7, P1587; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Farage MA, 2009, OBSTET GYNECOL SURV, V64, P58, DOI 10.1097/OGX.0b013e3181932a37; Fereshteh MP, 2008, CANCER RES, V68, P3697, DOI 10.1158/0008-5472.CAN-07-6702; Ferguson AT, 1997, CRIT REV ONCOGENESIS, V8, P29, DOI 10.1615/CritRevOncog.v8.i1.20; Frietze S, 2008, CANCER RES, V68, P301, DOI 10.1158/0008-5472.CAN-07-1983; Guo P, 2009, J BIOL CHEM, V284, P28243, DOI 10.1074/jbc.M109.036160; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Guo P, 2009, J BIOL CHEM, V284, P6071, DOI 10.1074/jbc.M806270200; Hartel A, 2003, J STEROID BIOCHEM, V84, P231, DOI 10.1016/S0960-0760(03)00033-5; INOUE S, 1993, P NATL ACAD SCI USA, V90, P11117, DOI 10.1073/pnas.90.23.11117; Jamerson MH, 2000, ONCOGENE, V19, P1065, DOI 10.1038/sj.onc.1203268; Kai K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-262; Kaspar P, 1999, J BIOL CHEM, V274, P14422, DOI 10.1074/jbc.274.20.14422; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Kim CJ, 2008, HISTOPATHOLOGY, V52, P552, DOI 10.1111/j.1365-2559.2008.02980.x; Kimura N, 2008, J MOL ENDOCRINOL, V40, P75, DOI 10.1677/JME-07-0108; Lahusen T, 2009, BREAST CANCER RES TR, V116, P225, DOI 10.1007/s10549-009-0405-2; Lemieux P, 1996, J STEROID BIOCHEM, V56, P87, DOI 10.1016/0960-0760(95)00269-3; Li H, 2002, GYNECOL ONCOL, V84, P216, DOI 10.1006/gyno.2001.6498; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; Mori Y, 2007, INT J CANCER, V121, P241, DOI 10.1002/ijc.22654; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; Nojiri S, 2004, BIOCHEM BIOPH RES CO, V314, P97, DOI 10.1016/j.bbrc.2003.12.054; Ochsner SA, 2009, CANCER RES, V69, P23, DOI 10.1158/0008-5472.CAN-08-3492; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004; Russo J, 1999, BREAST CANCER RES TR, V53, P217, DOI 10.1023/A:1006186719322; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Soderqvist G, 1997, AM J OBSTET GYNECOL, V176, P123, DOI 10.1016/S0002-9378(97)80024-5; SODERQVIST G, 1993, AM J OBSTET GYNECOL, V168, P874; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528; Sun XD, 2007, J CANCER RES CLIN, V133, P103, DOI 10.1007/s00432-006-0148-y; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Xu JY, 2006, PROSTATE, V66, P1082, DOI 10.1002/pros.20430; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; ZAJCHOWSKI DA, 1993, CANCER RES, V53, P5004; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang ZH, 2005, CLIN CANCER RES, V11, P193	60	26	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13879	13890		10.1074/jbc.M110.187849	http://dx.doi.org/10.1074/jbc.M110.187849			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21367855	hybrid, Green Published			2022-12-27	WOS:000289556200011
J	Li, YY; Sun, LY; Zhang, Y; Wang, DD; Wang, F; Liang, J; Gui, B; Shang, YF				Li, Yanyan; Sun, Luyang; Zhang, Yu; Wang, Dandan; Wang, Feng; Liang, Jing; Gui, Bin; Shang, Yongfeng			The Histone Modifications Governing TFF1 Transcription Mediated by Estrogen Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ACTIVATED PROTEIN-KINASE; ALPHA-AMANITIN; GENE-EXPRESSION; REGULATED TRANSCRIPTION; NUCLEAR RECEPTORS; TERMINAL DOMAIN; TFIIH KINASE; SRC FAMILY; PHOSPHORYLATION	Transcription regulation by histone modifications is a major contributing factor to the structural and functional diversity in biology. These modifications are encrypted as histone codes or histone languages and function to establish and maintain heritable epigenetic codes that define the identity and the fate of the cell. Despite recent advances revealing numerous histone modifications associated with transcription regulation, how such modifications dictate the process of transcription is not fully understood. Here we describe spatial and temporal analyses of the histone modifications that are introduced during estrogen receptor alpha (ER alpha)-activated transcription. We demonstrated that aborting RNA polymerase II caused a disruption of the histone modifications that are associated with transcription elongation but had a minimal effect on modifications deposited during transcription initiation. We also found that the histone H3S10 phosphorylation mark is catalyzed by mitogen-and stress-activated protein kinase 1 (MSK1) and is recognized by a 14-3-3 zeta/14-3-3 epsilon heterodimer through its interaction with H3K4 trimethyltransferase SMYD3 and the p52 subunit of TFIIH. We showed that H3S10 phosphorylation is a prerequisite for H3K4 trimethylation. In addition, we demonstrated that SET8/PR-Set7/KMT5A is required for ER alpha-regulated transcription and its catalyzed H4K20 monomethylation is implicated in both transcription initiation and elongation. Our experiments provide a relatively comprehensive analysis of histone modifications associated with ER alpha-regulated transcription and define the biological meaning of several key components of the histone code that governs ER alpha-regulated transcription.	[Li, Yanyan; Sun, Luyang; Zhang, Yu; Wang, Dandan; Wang, Feng; Liang, Jing; Gui, Bin; Shang, Yongfeng] Peking Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100191, Peoples R China; [Shang, Yongfeng] Tianjin Med Univ, Tianjin 300070, Peoples R China	Peking University; Tianjin Medical University	Shang, YF (corresponding author), Peking Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, Key Lab Carcinogenesis & Translat Res,Minist Educ, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.				National Natural Science Foundation of China [30830032, 30921062]; Ministry of Science and Technology of China [2011CB504204, 2007CB914503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Grants 30830032 and 30921062 (to Y.S.) from the National Natural Science Foundation of China and Grants 2011CB504204 and 2007CB914503 (973 Program) (to Y.S.) from the Ministry of Science and Technology of China.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Benvenisti-Zarom L, 2006, NEUROSCI LETT, V398, P230, DOI 10.1016/j.neulet.2006.01.003; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Carascossa S, 2010, GENE DEV, V24, P708, DOI 10.1101/gad.568410; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Couture JF, 2006, CURR OPIN STRUC BIOL, V16, P753, DOI 10.1016/j.sbi.2006.10.002; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Duan Q, 2008, J BIOL CHEM, V283, P33585, DOI 10.1074/jbc.M803312200; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Frigo DE, 2006, MOL ENDOCRINOL, V20, P971, DOI 10.1210/me.2004-0075; Fukuda A, 2000, Tanpakushitsu Kakusan Koso, V45, P1505; Glass CK, 2000, GENE DEV, V14, P121; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; HANSEN JC, 1992, BIOCHEMISTRY-US, V31, P7977, DOI 10.1021/bi00149a032; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hong SW, 2009, P NATL ACAD SCI USA, V106, P14276, DOI 10.1073/pnas.0903642106; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Ivaldi MS, 2007, GENE DEV, V21, P2818, DOI 10.1101/gad.1604007; Jones PA, 2008, NATURE, V454, P711, DOI 10.1038/454711a; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Ke QD, 2008, CARCINOGENESIS, V29, P1276, DOI 10.1093/carcin/bgn084; KEDINGER C, 1970, BIOCHEM BIOPH RES CO, V38, P165, DOI 10.1016/0006-291X(70)91099-5; Kim HG, 2008, CANCER RES, V68, P2538, DOI 10.1158/0008-5472.CAN-07-6597; Kim H, 2009, J BIOL CHEM, V284, P19867, DOI 10.1074/jbc.M109.021485; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Lee DY, 2006, J BIOL CHEM, V281, P8476, DOI 10.1074/jbc.M511093200; Lee JS, 2007, MUTAT RES-FUND MOL M, V618, P130, DOI 10.1016/j.mrfmmm.2006.08.014; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Qi C, 2002, J BIOL CHEM, V277, P28624, DOI 10.1074/jbc.M201053200; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Rodicker F, 1999, GENE EXPRESSION, V8, P165; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Seval Y, 2006, J CLIN ENDOCR METAB, V91, P2349, DOI 10.1210/jc.2005-2132; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Sun XJ, 2004, J BIOL CHEM, V279, P32839, DOI 10.1074/jbc.M402522200; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/0968-0004(96)10046-3; Tang GQ, 2009, P NATL ACAD SCI USA, V106, P22175, DOI 10.1073/pnas.0906979106; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Tshuikina M, 2008, GENE, V410, P259, DOI 10.1016/j.gene.2007.12.013; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wilson BJ, 2010, MOL ENDOCRINOL, V24, P1349, DOI 10.1210/me.2009-0441; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhang Y, 2007, EMBO J, V26, P2645, DOI 10.1038/sj.emboj.7601710; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	79	44	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13925	13936		10.1074/jbc.M111.223198	http://dx.doi.org/10.1074/jbc.M111.223198			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21378170	hybrid, Green Published			2022-12-27	WOS:000289556200015
J	Kennedy, EM; Daddacha, W; Slater, R; Gavegnano, C; Fromentin, E; Schinazi, RF; Kim, B				Kennedy, Edward M.; Daddacha, Waaqo; Slater, Rebecca; Gavegnano, Christina; Fromentin, Emilie; Schinazi, Raymond F.; Kim, Baek			Abundant Non-canonical dUTP Found in Primary Human Macrophages Drives Its Frequent Incorporation by HIV-1 Reverse Transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; URACIL-DNA GLYCOSYLASE; ESCHERICHIA-COLI; VIRAL-INFECTION; DNTP BINDING; POLYMERASE-I; FIDELITY; ENZYME; REPLICATION; SEQUENCE	Terminally differentiated/non-dividing macrophages contain extremely low cellular dNTP concentrations (20-40 nM), compared with activated CD4(+) T cells (2-5 mu M). However, our LC-MS/MS study revealed that the non-canonical dUTP concentration (2.9 mu M) is similar to 60 times higher than TTP in macrophages, whereas the concentrations of dUTP and TTP in dividing human primary lymphocytes are very similar. Specifically, we evaluated the contribution of HIV-1 reverse transcriptase to proviral DNA uracilation under the physiological conditions found in HIV-1 target cells. Indeed, biochemical simulation of HIV-1 reverse transcription demonstrates that HIV-1 RT efficiently incorporates dUTP in the macrophage nucleotide pools but not in the T cell nucleotide pools. Measurement of both pre-steady state and steady state kinetic parameters of dUTP incorporation reveals minimal selectivity of HIV-1 RT for TTP over dUTP, implying that the cellular dUTP/TTP ratio determines the frequency of HIV-1 RT-mediated dUTP incorporation. The RT of another lentivirus, simian immunodeficiency virus, also displays efficient dUTP incorporation in the dNTP/dUTP pools found in macrophages but not in T cells. Finally, 2',3'-dideoxyuridine was inhibitory to HIV-1 proviral DNA synthesis in macrophages but not in T cells. The data presented demonstrates that the non-canonical dUTP was abundant relative to TTP, and efficiently incorporated during HIV-1 reverse transcription, particularly in non-dividing macrophages.	[Kennedy, Edward M.; Daddacha, Waaqo; Slater, Rebecca; Kim, Baek] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Gavegnano, Christina; Fromentin, Emilie; Schinazi, Raymond F.] Emory Univ, Sch Med, Dept Pediat, Ctr AIDS Res,Lab Biochem Pharmacol, Decatur, GA 30033 USA; [Gavegnano, Christina; Fromentin, Emilie; Schinazi, Raymond F.] Vet Affairs Med Ctr, Decatur, GA 30033 USA	University of Rochester; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Kim, B (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu	Schinazi, Raymond F/B-6777-2017	Kennedy, Edward/0000-0002-2817-4809	National Institutes of Health [AI049781, T32 AI007362, 1R01-RR-025996-01A1, 2P30-AI-050409]; Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049781, R56AI049781, P30AI050409, T32AI007362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI049781 (to B. K.), T32 AI007362 (to E. M. K.), 1R01-RR-025996-01A1 (to R. F. S.), and 2P30-AI-050409 (to R. F. S.). This work was also supported by a grant from the Department of Veterans Affairs (to R. F. S.).	Abergel C, 1999, J VIROL, V73, P751, DOI 10.1128/JVI.73.1.751-753.1999; Aquaro S, 1998, J BIOL REG HOMEOS AG, V12, P23; Astatke M, 1998, J MOL BIOL, V278, P147, DOI 10.1006/jmbi.1998.1672; BEBENEK K, 1990, J BIOL CHEM, V265, P13878; BJORKLUND S, 1990, BIOCHEMISTRY-US, V29, P5452; Bjornberg O, 2003, J BIOL CHEM, V278, P20667, DOI 10.1074/jbc.M213010200; Bouhamdan M, 1996, J VIROL, V70, P697, DOI 10.1128/JVI.70.2.697-704.1996; BRYNOLF K, 1978, CELL, V13, P573, DOI 10.1016/0092-8674(78)90330-6; Chen RX, 2002, J GEN VIROL, V83, P2339, DOI 10.1099/0022-1317-83-10-2339; Chugh P, 2007, J MOL BIOL, V366, P67, DOI 10.1016/j.jmb.2006.11.011; DEVCHAND PR, 1993, NUCLEIC ACIDS RES, V21, P3437, DOI 10.1093/nar/21.15.3437; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Diamond TL, 2001, J BIOL CHEM, V276, P23624, DOI 10.1074/jbc.M102496200; DUBE DK, 1979, BIOCHIM BIOPHYS ACTA, V561, P369, DOI 10.1016/0005-2787(79)90145-X; ELDER JH, 1992, J VIROL, V66, P1791, DOI 10.1128/JVI.66.3.1791-1794.1992; ELHAJJ HH, 1988, J BACTERIOL, V170, P1069, DOI 10.1128/jb.170.3.1069-1075.1988; Fromentin E, 2010, ANAL CHEM, V82, P1982, DOI 10.1021/ac902737j; GADSDEN MH, 1993, EMBO J, V12, P4425, DOI 10.1002/j.1460-2075.1993.tb06127.x; Graciet JCG, 1998, NUCLEOS NUCLEOT NUCL, V17, P711, DOI 10.1080/07328319808004670; Horowitz RW, 1997, BIOCHEM PHARMACOL, V54, P635, DOI 10.1016/S0006-2952(97)00259-1; Jamburuthugoda VK, 2008, J BIOL CHEM, V283, P9206, DOI 10.1074/jbc.M710149200; Jamburuthugoda VK, 2006, J BIOL CHEM, V281, P13388, DOI 10.1074/jbc.M600291200; Kaiser SM, 2006, J VIROL, V80, P875, DOI 10.1128/JVI.80.2.875-882.2006; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kennedy EM, 2009, BIOCHEMISTRY-US, V48, P11161, DOI 10.1021/bi9010122; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEGRICE SFJ, 1991, EMBO J, V10, P3905, DOI 10.1002/j.1460-2075.1991.tb04960.x; LINDAHL T, 1977, J BIOL CHEM, V252, P3286; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; Mansky LM, 2000, J VIROL, V74, P7039, DOI 10.1128/JVI.74.15.7039-7047.2000; MCGEOCH DJ, 1990, NUCLEIC ACIDS RES, V18, P4105, DOI 10.1093/nar/18.14.4105; MCINTOSH EM, 1992, P NATL ACAD SCI USA, V89, P8020, DOI 10.1073/pnas.89.17.8020; Montaner LJ, 2006, J LEUKOCYTE BIOL, V80, P961, DOI 10.1189/jlb.0806488; MOSBAUGH DW, 1988, NUCLEIC ACIDS RES, V16, P5645, DOI 10.1093/nar/16.12.5645; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; PRESTON VG, 1984, VIROLOGY, V138, P58, DOI 10.1016/0042-6822(84)90147-8; Priet S, 2005, MOL CELL, V17, P479, DOI 10.1016/j.molcel.2005.01.016; Priet S, 2003, VIROLOGY, V307, P283, DOI 10.1016/S0042-6822(02)00073-9; Santos-Velazquez J, 2008, J VIROL, V82, P8235, DOI 10.1128/JVI.00088-08; Sire J, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-45; Skasko M, 2005, J BIOL CHEM, V280, P12190, DOI 10.1074/jbc.M412859200; Skasko M, 2008, J VIROL, V82, P7716, DOI 10.1128/JVI.00120-08; Skasko M, 2009, BIOCHEMISTRY-US, V48, P5389, DOI 10.1021/bi900346m; STRAHLER JR, 1993, P NATL ACAD SCI USA, V90, P4991, DOI 10.1073/pnas.90.11.4991; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; Toth J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706230200; Traut T., 1994, MOL CELL BIOCHEM, V140, P1573; TYE BK, 1978, P NATL ACAD SCI USA, V75, P233, DOI 10.1073/pnas.75.1.233; Weiss KK, 2000, BIOCHEMISTRY-US, V39, P10684, DOI 10.1021/bi000788y; Weiss KK, 2004, BIOCHEMISTRY-US, V43, P4490, DOI 10.1021/bi035258r; Weiss KK, 2002, J BIOL CHEM, V277, P22662, DOI 10.1074/jbc.M200202200; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171	54	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25047	25055		10.1074/jbc.M111.234047	http://dx.doi.org/10.1074/jbc.M111.234047			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21454906	Green Published, hybrid			2022-12-27	WOS:000292547900053
J	Renzi, F; Zhang, XL; Rice, WJ; Torres-Arancivia, C; Gomez-Llorente, Y; Diaz, R; Ahn, K; Yu, CJ; Li, YM; Sisodia, SS; Ubarretxena-Belandia, I				Renzi, Fabiana; Zhang, Xulun; Rice, William J.; Torres-Arancivia, Celia; Gomez-Llorente, Yacob; Diaz, Ruben; Ahn, Kwangwook; Yu, Chunjiang; Li, Yue-Ming; Sisodia, Sangram S.; Ubarretxena-Belandia, Iban			Structure of gamma-Secretase and Its Trimeric Pre-activation Intermediate by Single-particle Electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL PEPTIDE PEPTIDASE; ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; INTRAMEMBRANE PROTEASE; TRANSGENIC MODELS; MEMBRANE-PROTEINS; C-TERMINUS; COMPLEX; PRESENILIN-1; NICASTRIN	The gamma-secretase membrane protein complex is responsible for proteolytic maturation of signaling precursors and catalyzes the final step in the production of the amyloid beta-peptides implicated in the pathogenesis of Alzheimer disease. The incorporation of PEN-2 (presenilin enhancer 2) into a pre-activation intermediate, composed of the catalytic subunit presenilin and the accessory proteins APH-1 (anterior pharynx-defective 1) and nicastrin, triggers the endoproteolysis of presenilin and results in an active tetrameric gamma-secretase. We have determined the three-dimensional reconstruction of a mature and catalytically active gamma-secretase using single-particle cryo-electron microscopy. gamma-Secretase has a cup-like shape with a lateral belt of similar to 40-50 angstrom in height that encloses a water-accessible internal chamber. Active site labeling with a gold-coupled transition state analog inhibitor suggested that the gamma-secretase active site faces this chamber. Comparison with the structure of a trimeric pre-activation intermediate suggested that the incorporation of PEN-2 might contribute to the maturation of the active site architecture.	[Zhang, Xulun; Sisodia, Sangram S.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Renzi, Fabiana; Torres-Arancivia, Celia; Gomez-Llorente, Yacob; Ubarretxena-Belandia, Iban] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Renzi, Fabiana] Univ Roma Tor Vergata, I-00185 Rome, Italy; [Rice, William J.; Diaz, Ruben] New York Struct Biol Ctr, New York, NY 10027 USA; [Torres-Arancivia, Celia] CUNY, Grad Ctr, New York, NY 10016 USA; [Ahn, Kwangwook; Li, Yue-Ming] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Yu, Chunjiang] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA	University of Chicago; Icahn School of Medicine at Mount Sinai; University of Rome Tor Vergata; City University of New York (CUNY) System; Memorial Sloan Kettering Cancer Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Sisodia, SS (corresponding author), Univ Chicago, Dept Neurobiol, 947 E 58th St,MC0926, Chicago, IL 60637 USA.	ssisodia@bsd.uchicago.edu; iban.ubarretxena@mssm.edu	Gomez-Llorente, Yacob/E-5631-2013; LI, Yue/GRS-8071-2022; Yu, Chunjiang/E-9419-2012; Ubarretxena-Belandia, Iban/AAA-8939-2019	Rice, William/0000-0002-5187-255X	National Institutes of Health [R01 AG027854-01A1, R01 AG026660]; European Community; Alzheimer's Association [IIRG-06-26572]; American Health Assistance Foundation; National Science Foundation [MCB-0546087]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027854, R01AG026660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); Alzheimer's Association(Alzheimer's Association); American Health Assistance Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG027854-01A1 (to S. S. S.) and R01 AG026660 (to Y.-M. L.). This work was also supported by a Marie Curie International outgoing fellowship within the 7th European Community Framework Program (to F. R.), Alzheimer's Association Grant IIRG-06-26572 (to S. S. S.), the American Health Assistance Foundation (to Y.-M. L.), and National Science Foundation Grant MCB-0546087 (to I. U.-B.). S. S. Sisodia discloses that he is a paid consultant of Neuropharma Inc. and Eisai Research Labs Inc. but does not hold shares in any company that is a maker or owner of a Food and Drug Administration-regulated drug or device.	Bergman A, 2004, J BIOL CHEM, V279, P45564, DOI 10.1074/jbc.M407717200; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Capell A, 2003, J BIOL CHEM, V278, P52519, DOI 10.1074/jbc.C300435200; Crystal AS, 2003, J BIOL CHEM, V278, P20117, DOI 10.1074/jbc.M213107200; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Edbauer D, 2004, J BIOL CHEM, V279, P37311, DOI 10.1074/jbc.M406228200; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; Fortna RR, 2004, J BIOL CHEM, V279, P3685, DOI 10.1074/jbc.M310505200; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Hasegawa H, 2004, J BIOL CHEM, V279, P46455, DOI 10.1074/jbc.M406289200; Henricson A, 2005, FEBS J, V272, P2727, DOI 10.1111/j.1742-4658.2005.04691.x; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Hu Y, 2003, J CELL BIOL, V161, P685, DOI 10.1083/jcb.200304014; Kaether C, 2006, NEURODEGENER DIS, V3, P275, DOI 10.1159/000095267; Kern J, 2007, PHOTOSYNTH RES, V92, P389, DOI 10.1007/s11120-007-9173-1; Kim SH, 2005, J BIOL CHEM, V280, P1992, DOI 10.1074/jbc.M412404200; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Knappenberger KS, 2004, BIOCHEMISTRY-US, V43, P6208, DOI 10.1021/bi036072v; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Leal-Pinto E, 2010, J BIOL CHEM, V285, P39790, DOI 10.1074/jbc.M110.151373; Lee SF, 2004, J BIOL CHEM, V279, P4144, DOI 10.1074/jbc.M309745200; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Marabini R, 1996, J STRUCT BIOL, V116, P237, DOI 10.1006/jsbi.1996.0036; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Morais VA, 2003, J BIOL CHEM, V278, P43284, DOI 10.1074/jbc.M305685200; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Periz G, 2004, J NEUROSCI RES, V77, P309, DOI 10.1002/jnr.20203; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Price DL, 1998, SCIENCE, V282, P1079, DOI 10.1126/science.282.5391.1079; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Shirotani K, 2003, J BIOL CHEM, V278, P16474, DOI 10.1074/jbc.C300095200; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Sloane PD, 2002, ANNU REV PUBL HEALTH, V23, P213, DOI 10.1146/annurev.publhealth.23.100901.140525; Steiner H, 1999, J BIOL CHEM, V274, P7615, DOI 10.1074/jbc.274.12.7615; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Torres-Arancivia C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013072; Ubarretxena-Belandia I, 2001, CURR OPIN STRUC BIOL, V11, P370, DOI 10.1016/S0959-440X(00)00217-7; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Weipoltshammer K, 2000, HISTOCHEM CELL BIOL, V114, P489; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	76	30	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21440	21449		10.1074/jbc.M110.193326	http://dx.doi.org/10.1074/jbc.M110.193326			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21454611	hybrid, Green Published			2022-12-27	WOS:000291464700042
J	Manzanares, D; Gonzalez, C; Ivonnet, P; Chen, RS; Valencia-Gattas, M; Conner, GE; Larsson, HP; Salathe, M				Manzanares, Dahis; Gonzalez, Carlos; Ivonnet, Pedro; Chen, Ren-Shiang; Valencia-Gattas, Monica; Conner, Gregory E.; Larsson, H. Peter; Salathe, Matthias			Functional Apical Large Conductance, Ca2+-activated, and Voltage-dependent K+ Channels Are Required for Maintenance of Airway Surface Liquid Volume	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNEL; CILIARY BEAT FREQUENCY; CANINE TRACHEAL EPITHELIUM; SMOOTH-MUSCLE-CELLS; PHASIC SHEAR-STRESS; BETA-SUBUNIT; CHLORIDE SECRETION; ARACHIDONIC-ACID; MEMBRANE STRETCH; ION-TRANSPORT	Large conductance, Ca2+-activated, and voltage-dependent K+ (BK) channels control a variety of physiological processes in nervous, muscular, and renal epithelial tissues. In bronchial airway epithelia, extracellular ATP-mediated, apical increases in intracellular Ca2+ are important signals for ion movement through the apical membrane and regulation of water secretion. Although other, mainly basolaterally expressed K+ channels are recognized as modulators of ion transport in airway epithelial cells, the role of BK in this process, especially as a regulator of airway surface liquid volume, has not been examined. Using patch clamp and Ussing chamber approaches, this study reveals that BK channels are present and functional at the apical membrane of airway epithelial cells. BK channels open in response to ATP stimulation at the apical membrane and allow K+ flux to the airway surface liquid, whereas no functional BK channels were found basolaterally. Ion transport modeling supports the notion that apically expressed BK channels are part of an apical loop current, favoring apical Cl- efflux. Importantly, apical BK channels were found to be critical for the maintenance of adequate airway surface liquid volume because continuous inhibition of BK channels or knockdown of KCNMA1, the gene coding for the BK alpha subunit (KCNMA1), lead to airway surface dehydration and thus periciliary fluid height collapse revealed by low ciliary beat frequency that could be fully rescued by addition of apical fluid. Thus, apical BK channels play an important, previously unrecognized role in maintaining adequate airway surface hydration.	[Manzanares, Dahis; Ivonnet, Pedro; Conner, Gregory E.; Salathe, Matthias] Univ Miami, Div Pulm & Crit Care, Miami, FL 33136 USA; [Gonzalez, Carlos; Chen, Ren-Shiang; Larsson, H. Peter] Univ Miami, Dept Physiol & Biophys, Miami, FL 33136 USA; [Valencia-Gattas, Monica; Conner, Gregory E.] Univ Miami, Dept Cell Biol & Anat, Miami, FL 33136 USA; [Gonzalez, Carlos] Univ Valparaiso, Ctr Interdisciplinario Neurociencia, Valparaiso, Chile	University of Miami; University of Miami; University of Miami; Universidad de Valparaiso	Salathe, M (corresponding author), 1600 NW 10th Ave,RMSB 7063, Miami, FL 33136 USA.	msalathe@med.miami.edu	Chen, Renshiang/GYD-4500-2022; Gonzalez, Carlos/V-7628-2019; Conner, Gregory/AAI-1285-2021	Conner, Gregory/0000-0003-2217-2252; Salathe, Matthias/0000-0001-9092-4861	NHLBI, National Institutes of Health [HL-089399, HL-060644, HL-095920, AR32805, HL-066125]; American Heart Association [10GRNT4150069]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089399, R01HL095920, R01HL060644, R01HL066125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032805, R37AR032805] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by NHLBI, National Institutes of Health Grants HL-089399 and HL-060644 (to M. S.), HL-095920 (to H. P. L.), AR32805 (to R.-S.C.), and HL-066125 (to G. E. C.). This work was also supported by American Heart Association Grant 10GRNT4150069 (to H. P. L.).	Begenisich T, 1998, J MEMBRANE BIOL, V163, P77, DOI 10.1007/s002329900372; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Bernard K, 2003, J MEMBRANE BIOL, V196, P15, DOI 10.1007/s00232-003-0621-3; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Button B, 2008, RESP PHYSIOL NEUROBI, V163, P189, DOI 10.1016/j.resp.2008.04.020; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Clarke LL, 1997, AM J PHYSIOL-LUNG C, V272, pL1084, DOI 10.1152/ajplung.1997.272.6.L1084; COOK DI, 1989, J MEMBRANE BIOL, V110, P139, DOI 10.1007/BF01869469; Cotton CU, 2000, AM J RESP CELL MOL, V23, P270, DOI 10.1165/ajrcmb.23.3.f198; Davis CW, 2008, RESP PHYSIOL NEUROBI, V163, P208, DOI 10.1016/j.resp.2008.05.015; Faria D, 2009, PFLUG ARCH EUR J PHY, V457, P1373, DOI 10.1007/s00424-008-0606-2; Fernandez-Fernandez JM, 2002, AM J PHYSIOL-CELL PH, V283, pC1705, DOI 10.1152/ajpcell.00245.2002; Fernandez-Fernandez JM, 2008, PFLUG ARCH EUR J PHY, V457, P149, DOI 10.1007/s00424-008-0516-3; Fragoso MA, 2004, J PHYSIOL-LONDON, V561, P183, DOI 10.1113/jphysiol.2004.071548; GALIETTA LJV, 1994, PFLUG ARCH EUR J PHY, V426, P534, DOI 10.1007/BF00378531; Gattas MV, 2009, FREE RADICAL BIO MED, V47, P1450, DOI 10.1016/j.freeradbiomed.2009.08.017; Hammami S, 2009, J PHYSIOL-LONDON, V587, P2225, DOI 10.1113/jphysiol.2008.163550; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; KIRBER MT, 1992, FEBS LETT, V297, P24, DOI 10.1016/0014-5793(92)80319-C; Kreda SM, 2007, J PHYSIOL-LONDON, V584, P245, DOI 10.1113/jphysiol.2007.139840; Lazarowski ER, 2009, CURR OPIN PHARMACOL, V9, P262, DOI 10.1016/j.coph.2009.02.004; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Lieb T, 2002, J PHYSIOL-LONDON, V538, P633, DOI 10.1113/jphysiol.2001.013222; Liu B, 2009, BBA-BIOMEMBRANES, V1788, P2174, DOI 10.1016/j.bbamem.2009.07.016; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Lu T, 2005, DIABETES, V54, P2155, DOI 10.2337/diabetes.54.7.2155; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Mall M, 2003, PEDIATR RES, V53, P608, DOI 10.1203/01.PDR.0000057204.51420.DC; Mall M, 2000, AM J RESP CELL MOL, V23, P283, DOI 10.1165/ajrcmb.23.3.4060; Morimoto T, 2007, MOL PHARMACOL, V71, P1075, DOI 10.1124/mol.106.031146; Moser SL, 2008, J MEMBRANE BIOL, V221, P153, DOI 10.1007/s00232-008-9093-9; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2009, J BIOL CHEM, V284, P15916, DOI 10.1074/jbc.M808021200; Nlend MC, 2002, AM J RESP CELL MOL, V27, P436, DOI 10.1165/rcmb.2002-0012OC; Orio P, 2005, J GEN PHYSIOL, V125, P395, DOI 10.1085/jgp.200409236; Orio P, 2002, NEWS PHYSIOL SCI, V17, P156, DOI 10.1152/nips.01387.2002; Paradiso AM, 2001, J GEN PHYSIOL, V117, P53, DOI 10.1085/jgp.117.1.53; Ransford GA, 2009, AM J RESP CELL MOL, V41, P525, DOI 10.1165/rcmb.2008-0367OC; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; RUGOLO M, 1993, J BIOL CHEM, V268, P24779; Salathe M, 1999, J PHYSIOL-LONDON, V520, P851, DOI 10.1111/j.1469-7793.1999.00851.x; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Schmid A, 2006, J CELL SCI, V119, P4176, DOI 10.1242/jcs.03181; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Sun X, 2007, J NEUROPHYSIOL, V97, P62, DOI 10.1152/jn.00700.2006; Sun XP, 2004, J PHYSIOL-LONDON, V557, P207, DOI 10.1113/jphysiol.2003.060509; Sweet TB, 2009, J GEN PHYSIOL, V133, P139, DOI 10.1085/jgp.200810129; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Tarran R, 2001, J GEN PHYSIOL, V118, P223, DOI 10.1085/jgp.118.2.223; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; WELSH MJ, 1983, J CLIN INVEST, V71, P1392, DOI 10.1172/JCI110892; WELSH MJ, 1983, J MEMBRANE BIOL, V71, P209, DOI 10.1007/BF01875462; Willumsen NJ, 1989, AM J PHYSIOL, V256, pC1054, DOI 10.1152/ajpcell.1989.256.5.C1054; Xia XM, 2003, J GEN PHYSIOL, V121, P125, DOI 10.1085/jgp.20028667; Xia XM, 2000, J NEUROSCI, V20, P4890; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhou XB, 2010, P NATL ACAD SCI USA, V107, P8005, DOI 10.1073/pnas.0912029107	63	57	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19830	19839		10.1074/jbc.M110.185074	http://dx.doi.org/10.1074/jbc.M110.185074			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21454692	hybrid, Green Published			2022-12-27	WOS:000291027700064
J	Guo, NX; Woeller, CF; Feldon, SE; Phipps, RP				Guo, Naxin; Woeller, Collynn F.; Feldon, Steven E.; Phipps, Richard P.			Peroxisome Proliferator-activated Receptor gamma Ligands Inhibit Transforming Growth Factor-beta-induced, Hyaluronan-dependent, T Cell Adhesion to Orbital Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-ASSOCIATED OPHTHALMOPATHY; GRAVES OPHTHALMOPATHY; PPAR-GAMMA; TGF-BETA; EXTRACELLULAR-MATRIX; MESANGIAL CELLS; EYE DISEASE; LUNG INJURY; EXPRESSION; CD44	Thyroid eye disease is characterized by the infiltration of leukocytes and accumulation of hyaluronan (HA) in orbital tissue. Inflamed orbital tissue expands in size due to excessive HA and to the formation of scar tissue (fibrosis) and/or adipose accumulation. Transforming growth factor beta (TGF-beta) acts as a key inducer of fibrosis by enhancing extracellular matrix production. Treatment of primary human orbital fibroblasts with TGF-beta led to significant increases in both HA synthesis and secretion. TGF-beta also strongly induced hyaluronan synthase 1 (HAS1) and HAS2 mRNA levels, which increased 50- and 6-fold, respectively. Remarkably, the addition of the peroxisome proliferator-activated receptor (PPAR gamma) ligands pioglitazone (Pio) or rosiglitazone (Rosi) to TGF-beta-treated orbital fibroblasts attenuated HA synthesis and reduced HAS1 and HAS2 mRNA levels. The attenuation of TGF-beta function by Pio and Rosi was independent of PPAR gamma activity. Furthermore, Pio and Rosi treatment inhibited TGF-beta-induced T cell adhesion to orbital fibroblasts. Our findings demonstrate that TGF-beta plays an important role in HA synthesis and in the inflammatory response by enhancing or facilitating inflammatory cell infiltration and adhesion to orbital tissue. Pio and Rosi exhibit anti-fibrotic and anti-inflammatory activity and may be useful in treating thyroid eye disease.	[Woeller, Collynn F.; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14642 USA; [Guo, Naxin; Feldon, Steven E.; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Flaum Eye Inst, Rochester, NY 14642 USA; [Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Lung Biol & Dis Program, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Phipps, RP (corresponding author), Univ Rochester, Sch Med & Dent, Dept Environm Med, Box 850,601 Elmwood Ave, Rochester, NY 14642 USA.	Richard_Phipps@urmc.rochester.edu	Woeller, Collynn/U-3877-2019	Feldon, Steven/0000-0003-0603-9312; Woeller, Collynn/0000-0001-7197-5057	National Institutes of Health, NEI [EY017123]; Research to Prevent Blindness Foundation; NIEHS, National Institutes of Health [ES07026]; NATIONAL EYE INSTITUTE [R01EY017123] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY017123 from NEI. This work was also supported by a Research to Prevent Blindness Foundation grant.; Supported by NIEHS, National Institutes of Health Training Grant ES07026.	Acharya PS, 2008, J CELL SCI, V121, P1393, DOI 10.1242/jcs.021683; Aniszewski JP, 2000, J CLIN ENDOCR METAB, V85, P776, DOI 10.1210/jc.85.2.776; Antonelli A, 2006, J CLIN ENDOCR METAB, V91, P614, DOI 10.1210/jc.2005-1689; Antonelli A, 2009, J CLIN ENDOCR METAB, V94, P1803, DOI 10.1210/jc.2008-2450; Aoki Y, 2009, RESPIRATION, V77, P311, DOI 10.1159/000168676; Asman P, 2003, ACTA OPHTHALMOL SCAN, V81, P437, DOI 10.1034/j.1600-0420.2003.00147.x; Baglole CJ, 2005, METH MOLEC MED, V117, P115; Bahn RS, 2010, NEW ENGL J MED, V362, P726, DOI 10.1056/NEJMra0905750; Bahn RS, 2002, THYROID, V12, P193, DOI 10.1089/105072502753600124; BAHN RS, 1993, NEW ENGL J MED, V329, P1468; Bartley GB, 1996, AM J OPHTHALMOL, V121, P284, DOI 10.1016/S0002-9394(14)70276-4; Burgess HA, 2005, AM J PHYSIOL-LUNG C, V288, pL1146, DOI 10.1152/ajplung.00383.2004; Cheng HC, 2008, MOL VIS, V14, P95; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Dorkhan M, 2006, CLIN ENDOCRINOL, V65, P35, DOI 10.1111/j.1365-2265.2006.02542.x; Feldon SE, 2005, INVEST OPHTH VIS SCI, V46, P3913, DOI 10.1167/iovs.05-0605; FELDON SE, 1982, ARCH OPHTHALMOL-CHIC, V100, P1266, DOI 10.1001/archopht.1982.01030040244006; Feldon SE, 2006, AM J PATHOL, V169, P1183, DOI 10.2353/ajpath.2006.060434; Ferguson HE, 2009, AM J RESP CELL MOL, V41, P722, DOI 10.1165/rcmb.2009-0006OC; Fuchshofer R, 2005, INVEST OPHTH VIS SCI, V46, P568, DOI 10.1167/iovs.04-0649; Funderburgh JL, 2001, J BIOL CHEM, V276, P44173, DOI 10.1074/jbc.M107596200; Guo BL, 2004, DIABETES, V53, P200, DOI 10.2337/diabetes.53.1.200; Guo NX, 2007, J BIOL CHEM, V282, P12475, DOI 10.1074/jbc.M609280200; Guo NX, 2010, J BIOL CHEM, V285, P15794, DOI 10.1074/jbc.M109.074534; Han R, 2006, ENDOCRINOLOGY, V147, P13, DOI 10.1210/en.2005-1018; HEUFELDER AE, 1992, EUR J CLIN INVEST, V22, P529, DOI 10.1111/j.1365-2362.1992.tb01501.x; HEUFELDER AE, 1993, MED KLIN, V88, P181; HEUFELDER AE, 1994, INVEST OPHTH VIS SCI, V35, P120; HodgeDufour J, 1997, J IMMUNOL, V159, P2492; Jenkins RH, 2004, J BIOL CHEM, V279, P41453, DOI 10.1074/jbc.M401678200; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; KORDUCKI JM, 1992, INVEST OPHTH VIS SCI, V33, P2037; Koumas L, 2003, AM J PATHOL, V163, P1291, DOI 10.1016/S0002-9440(10)63488-8; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Lee Seongmu, 2007, BMC Ophthalmol, V7, P8, DOI 10.1186/1471-2415-7-8; Lehmann GM, 2008, PPAR RES, V2008, DOI 10.1155/2008/895901; Lehmann GM, 2008, THYROID, V18, P959, DOI 10.1089/thy.2007.0407; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Levin F, 2005, ARCH OPHTHALMOL-CHIC, V123, P119, DOI 10.1001/archopht.123.1.119; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; MOURITS MP, 1989, BRIT J OPHTHALMOL, V73, P639, DOI 10.1136/bjo.73.8.639; OHYA T, 1970, BIOCHIM BIOPHYS ACTA, V198, P607, DOI 10.1016/0005-2744(70)90139-7; Saika S, 2007, AM J PHYSIOL-CELL PH, V293, pC75, DOI 10.1152/ajpcell.00332.2006; Sime PJ, 2008, J INVEST MED, V56, P534, DOI 10.2310/JIM.0b013e31816464e9; Skoog T, 2006, EXP DERMATOL, V15, P775, DOI 10.1111/j.1600-0625.2006.00460.x; Smith TJ, 2004, J CLIN ENDOCR METAB, V89, P5076, DOI 10.1210/jc.2004-0716; Smith TJ, 2002, J CLIN ENDOCR METAB, V87, P385, DOI 10.1210/jc.87.1.385; SMITH TJ, 1995, J CLIN ENDOCR METAB, V80, P2620, DOI 10.1210/jc.80.9.2620; Starkey K, 2003, J CLIN ENDOCR METAB, V88, P55, DOI 10.1210/jc.2002-020987; Stuhlmeier KM, 2004, J BIOL CHEM, V279, P8753, DOI 10.1074/jbc.M303945200; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; van Steensel L, 2009, INVEST OPHTH VIS SCI, V50, P3091, DOI 10.1167/iovs.08-2443; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang HS, 2005, J CELL BIOCHEM, V95, P256, DOI 10.1002/jcb.20405; WEETMAN AP, 1989, CLIN EXP IMMUNOL, V75, P222; Yamanaka O, 2009, INVEST OPHTH VIS SCI, V50, P187, DOI 10.1167/iovs.08-2282; Zhang GY, 2010, J PLAST RECONSTR AES, V63, P1209, DOI 10.1016/j.bjps.2009.06.032	61	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18856	18867		10.1074/jbc.M110.179317	http://dx.doi.org/10.1074/jbc.M110.179317			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454487	hybrid, Green Published			2022-12-27	WOS:000290785700058
J	Fu, J; Li, LN; Bouvier, M				Fu, Jie; Li, Lenong; Bouvier, Marlene			Adenovirus E3-19K Proteins of Different Serotypes and Subgroups Have Similar, Yet Distinct, Immunomodulatory Functions toward Major Histocompatibility Class I Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM LUMENAL DOMAIN; CELL-SURFACE EXPRESSION; ENDOPLASMIC-RETICULUM; E3/19K PROTEIN; E3-GP19K PROTEIN; DOWN-REGULATION; T-LYMPHOCYTES; TYPE-2; GLYCOPROTEIN; ANTIGENS	Our understanding of the mechanism by which the E3-19K protein from adenovirus (Ad) targets major histocompatibility complex (MHC) class I molecules for retention in the endoplasmic reticulum is derived largely from studies of Ad serotype 2 (subgroup C). It is not well understood to what extent observations on the Ad2 E3-19K/MHC I association can be generalized to E3-19K proteins of other serotypes and subgroups. The low levels of amino acid sequence homology between E3-19K proteins suggest that these proteins are likely to manifest distinct MHC I binding properties. This information is important as the E3-19K/MHC I interaction is thought to play a critical role in enabling Ads to cause persistent infections. Here, we characterized interaction between E3-19K proteins of serotypes 7 and 35 (subgroup B), 5 (subgroup C), 37 (subgroup D), and 4 (subgroup E) and a panel of HLA-A, -B, and -C molecules using native gel, surface plasmon resonance (SPR), and flow cytometry. Results show that all E3-19K proteins exhibited allele specificity toward HLA-A and -B molecules; this was less evident for Ad37 E3-19K. The allele specificity for HLA-A molecules was remarkably similar for different serotypes of subgroup B as well as subgroup C. Interestingly, all E3-19K proteins characterized also exhibited MHC I locus specificity. Importantly, we show that Lys(91) in the conserved region of Ad2 E3-19K targets the C terminus of the alpha 2-helix (MHC residue 177) on MHC class I molecules. From our data, we propose a model of interaction between E3-19K and MHC class I molecules.	[Fu, Jie; Li, Lenong; Bouvier, Marlene] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bouvier, M (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, M-C 790,835 S Wolcott Ave, Chicago, IL 60612 USA.	mbouvier@uic.edu			National Institutes of Health from NIAID [AI045070]; University of Illinois at Chicago, Center for Clinical and Translational Science from the NCRR [UL1RR029879]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045070, R01AI045070] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Illinois at Chicago, Center for Clinical and Translational Science from the NCRR; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI045070 from NIAID. This work was also supported by University of Illinois at Chicago, Center for Clinical and Translational Science Award UL1RR029879 from the NCRR.	ANDERSSON M, 1987, J IMMUNOL, V138, P3960; ANDERSSON M, 1985, CELL, V43, P215, DOI 10.1016/0092-8674(85)90026-1; BEIER DC, 1994, J IMMUNOL, V152, P3862; BURGERT HG, 1985, CELL, V41, P987, DOI 10.1016/S0092-8674(85)80079-9; BURGERT HG, 1987, P NATL ACAD SCI USA, V84, P1356, DOI 10.1073/pnas.84.5.1356; Burgert HG, 2002, CURR TOP MICROBIOL, V269, P273; BURGERT HG, 1987, EMBO J, V6, P2019, DOI 10.1002/j.1460-2075.1987.tb02466.x; CHALLBERG SS, 1981, VIROLOGY, V114, P196, DOI 10.1016/0042-6822(81)90265-8; CHATTERJEE D, 1984, P NATL ACAD SCI-BIOL, V81, P6039, DOI 10.1073/pnas.81.19.6039; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; COX JH, 1990, SCIENCE, V247, P715, DOI 10.1126/science.2137259; COX JH, 1991, J EXP MED, V174, P1629, DOI 10.1084/jem.174.6.1629; Deryckere F, 1996, J VIROL, V70, P2832, DOI 10.1128/JVI.70.5.2832-2841.1996; FEUERBACH D, 1994, J IMMUNOL, V153, P1626; FLOMENBERG P, 1994, MOL IMMUNOL, V31, P1277, DOI 10.1016/0161-5890(94)90078-7; Flomenberg P, 1996, J VIROL, V70, P6314, DOI 10.1128/JVI.70.9.6314-6322.1996; FLOMENBERG P, 1994, J INFECT DIS, V169, P775, DOI 10.1093/infdis/169.4.775; FLOMENBERG P, 1992, J VIROL, V66, P4778, DOI 10.1128/JVI.66.8.4778-4783.1992; FOX JP, 1969, AM J EPIDEMIOL, V89, P25, DOI 10.1093/oxfordjournals.aje.a120913; FOX JP, 1977, AM J EPIDEMIOL, V105, P362, DOI 10.1093/oxfordjournals.aje.a112394; Fu J, 2009, 2ND EUROPEAN CONGRESS OF IMMUNOLOGY (ECI), P123; Fu J, 2011, MOL IMMUNOL, V48, P532, DOI 10.1016/j.molimm.2010.10.017; GABATHULER R, 1990, J VIROL, V64, P3679, DOI 10.1128/JVI.64.8.3679-3685.1990; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; GINSBERG HS, 1989, P NATL ACAD SCI USA, V86, P3823, DOI 10.1073/pnas.86.10.3823; GREEN M, 1979, VIROLOGY, V93, P481, DOI 10.1016/0042-6822(79)90251-4; HERMISTON TW, 1993, VIROLOGY, V197, P593, DOI 10.1006/viro.1993.1633; HERMISTON TW, 1993, J VIROL, V67, P5289, DOI 10.1128/JVI.67.9.5289-5298.1993; HIERHOLZER JC, 1992, CLIN MICROBIOL REV, V5, P262, DOI 10.1128/CMR.5.3.262-274.1992; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; KRILOV LR, 1990, REV INFECT DIS, V12, P303; KVIST S, 1978, P NATL ACAD SCI USA, V75, P5674, DOI 10.1073/pnas.75.11.5674; Li LN, 2002, ACTA CRYSTALLOGR D, V58, P1195, DOI 10.1107/S0907444902007928; Liu H, 2005, J VIROL, V79, P13317, DOI 10.1128/JVI.79.21.13317-13325.2005; Liu H, 2007, J IMMUNOL, V178, P4567, DOI 10.4049/jimmunol.178.7.4567; McSharry BP, 2008, J VIROL, V82, P4585, DOI 10.1128/JVI.02251-07; PAABO S, 1987, CELL, V50, P311, DOI 10.1016/0092-8674(87)90226-1; RAWLE FC, 1989, J IMMUNOL, V143, P2031; SESTER M, 1994, J VIROL, V68, P5423, DOI 10.1128/JVI.68.9.5423-5432.1994; SEVERINSSON L, 1986, J IMMUNOL, V137, P1003; TANAKA Y, 1988, VIROLOGY, V165, P357, DOI 10.1016/0042-6822(88)90580-6; WADELL G, 1984, CURR TOP MICROBIOL, V110, P191; WOLD WSM, 1989, MOL BIOL MED, V6, P433; Yokoyama WM, 1998, CURR OPIN IMMUNOL, V10, P298, DOI 10.1016/S0952-7915(98)80168-4; ZAHRADNIK JM, 1980, AM J MED, V68, P725, DOI 10.1016/0002-9343(80)90262-4	45	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17631	17639		10.1074/jbc.M110.212050	http://dx.doi.org/10.1074/jbc.M110.212050			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454588	Green Published, hybrid			2022-12-27	WOS:000290585200026
J	Hu, W; Ross, J; Geng, TY; Brice, SE; Cowart, LA				Hu, Wei; Ross, Jessica; Geng, Tuoyu; Brice, Sarah E.; Cowart, L. Ashley			Differential Regulation of Dihydroceramide Desaturase by Palmitate versus Monounsaturated Fatty Acids IMPLICATIONS FOR INSULIN RESISTANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CELLS; PROTEIN-KINASE-C; SPHINGOLIPID METABOLISM; CELLULAR-RESPONSES; CERAMIDE SYNTHASES; SPHINGOSINE KINASE; ACCUMULATION; DIACYLGLYCEROL; INVOLVEMENT; DISEASE	Much data implicate saturated fatty acids in deleterious processes associated with obesity, diabetes, and the metabolic syndrome. Many of these changes may be due to aberrant generation of bioactive lipids when saturated fatty acid availability to tissues is increased. On the other hand, studies are emerging that implicate the monounsaturated fatty acid oleate in protection from saturated fat mediated toxicity; however, the mechanisms are not well understood. Our data demonstrate a novel role for palmitate in increasing mRNA encoding DES1, which is the enzyme responsible for generating ceramide from its precursor dihydroceramide and thus controls synthesis of the bioactive lipid ceramide. Moreover, co-treatment with oleate prevented the increase in ceramide, and this occurred through attenuation of the increase in message and activity of DES1. Knockdown of DES1 also protected from palmitate-induced insulin resistance, and overexpression of this enzyme ameliorated the protective effect of oleate. Together, these findings provide insight into the mechanisms of oleate-mediated protection against metabolic disease and provide novel evidence for fatty acid-mediated regulation of a key enzyme of ceramide biosynthesis.	[Hu, Wei; Ross, Jessica; Geng, Tuoyu; Brice, Sarah E.; Cowart, L. Ashley] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29403 USA; [Cowart, L. Ashley] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29403 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Cowart, LA (corresponding author), 114 Doughty St,Strom Thurmond Bldg,Rm 423, Charleston, SC 29403 USA.	cowartl@musc.edu			Department of Veterans Affairs; National Institutes of Health COBRE in Lipidomics and Pathobiology at the Medical University of South Carolina; Centers of Biomedical Research Excellence in Lipidomics in Pathobiology (NIH) [P20RR017077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM072643] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health COBRE in Lipidomics and Pathobiology at the Medical University of South Carolina; Centers of Biomedical Research Excellence in Lipidomics in Pathobiology (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Merit Award from the Department of Veterans Affairs (to L. A. C.) and the National Institutes of Health COBRE in Lipidomics and Pathobiology at the Medical University of South Carolina (to L. A. C.). Lipidomics were supported by the Centers of Biomedical Research Excellence in Lipidomics in Pathobiology (NIH P20RR017077).	Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Arana L, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-15; BERKOWITZ D, 1966, J AMER MED ASSOC, V197, P77, DOI 10.1001/jama.197.2.77; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chavez JA, 2005, J BIOL CHEM, V280, P20148, DOI 10.1074/jbc.M412769200; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Cowart LA, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.3; Das SK, 2010, J LIPID RES, V51, P2121, DOI 10.1194/jlr.M004275; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Frangioudakis G, 2010, ENDOCRINOLOGY, V151, P4187, DOI 10.1210/en.2010-0250; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; Geeraert L, 1997, BIOCHEM J, V327, P125, DOI 10.1042/bj3270125; Ghosh N, 2007, ENDOCRINOLOGY, V148, P1359, DOI 10.1210/en.2006-0750; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hansen BC, 1999, ANN NY ACAD SCI, V892, P1, DOI 10.1111/j.1749-6632.1999.tb07782.x; Henique C, 2010, J BIOL CHEM, V285, P36818, DOI 10.1074/jbc.M110.170431; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu W, 2009, J LIPID RES, V50, P1852, DOI 10.1194/jlr.M800635-JLR200; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Kadotani A, 2009, AM J PHYSIOL-ENDOC M, V297, pE1291, DOI 10.1152/ajpendo.00293.2009; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Kraegen EW, 2008, CURR OPIN LIPIDOL, V19, P235, DOI 10.1097/01.mol.0000319118.44995.9a; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lee JS, 2006, J APPL PHYSIOL, V100, P1467, DOI 10.1152/japplphysiol.01438.2005; Mao CG, 2003, J BIOL CHEM, V278, P31184, DOI 10.1074/jbc.M303875200; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Michel C, 1997, FEBS LETT, V416, P153, DOI 10.1016/S0014-5793(97)01187-3; Miyazaki M, 2001, J BIOL CHEM, V276, P39455, DOI 10.1074/jbc.M106442200; Moro C, 2009, J CLIN ENDOCR METAB, V94, P3440, DOI 10.1210/jc.2009-0053; Mullen KL, 2009, AM J PHYSIOL-REG I, V296, pR243, DOI 10.1152/ajpregu.90774.2008; OBEID LM, 1995, J CELL BIOCHEM, V58, P191, DOI 10.1002/jcb.240580208; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pickersgill L, 2007, J BIOL CHEM, V282, P12583, DOI 10.1074/jbc.M611157200; Roden M, 2004, NEWS PHYSIOL SCI, V19, P92, DOI 10.1152/nips.01459.2003; Sabin MA, 2007, J CELL PHYSIOL, V211, P244, DOI 10.1002/jcp.20922; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Schmitz-Peiffer C, 2002, ANN NY ACAD SCI, V967, P146; Schulze H, 2000, METHOD ENZYMOL, V311, P22; Sell H, 2008, AM J PHYSIOL-ENDOC M, V294, pE1070, DOI 10.1152/ajpendo.00529.2007; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; SPRINGER ML, 1997, CURRENT PROTOCOLS HU; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Turpin SM, 2009, J PHYSIOL-LONDON, V587, P1593, DOI 10.1113/jphysiol.2008.166033; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Ye Jianping, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P65; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	61	58	59	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16596	16605		10.1074/jbc.M110.186916	http://dx.doi.org/10.1074/jbc.M110.186916			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454530	Green Published, hybrid			2022-12-27	WOS:000290301900008
J	Liu, SL; Needham, KM; May, JR; Nolen, BJ				Liu, Su-Ling; Needham, Karen M.; May, Jordan R.; Nolen, Brad J.			Mechanism of a Concentration-dependent Switch between Activation and Inhibition of Arp2/3 Complex by Coronin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FILAMENT NETWORK FORMATION; BINDING PROTEIN CORONIN; ACTIN-FILAMENT; FISSION YEAST; F-ACTIN; CONFORMATIONAL-CHANGES; WASP/SCAR PROTEINS; BRANCH FORMATION; DISTINCT ROLES; CROSS-LINKING	Arp2/3 complex is a key actin filament nucleator that assembles branched actin networks in response to cellular signals. The activity of Arp2/3 complex is regulated by both activating and inhibitory proteins. Coronins make up a large class of actin-binding proteins previously shown to inhibit Arp2/3 complex. Although coronins are known to play a role in controlling actin dynamics in diverse processes, including endocytosis and cell motility, the precise mechanism by which they regulate Arp2/3 complex is unclear. We conducted a detailed biochemical analysis of budding yeast coronin, Crn1, and found that it not only inhibits Arp2/3 complex but also activates it. We mapped regions required for activation and found that Crn1 contains a sequence called CA, which is conserved in WASp/Scar proteins, the prototypical activators of Arp2/3 complex. Point mutations in CA abolished activation of Arp2/3 complex by Crn1 in vitro. Confocal microscopy and quantitative actin patch tracking showed that these mutants had defective endocytic actin patch dynamics in Saccharomyces cerevisiae, indicating that activation of Arp2/3 complex by coronin is required for normal actin dynamics in vivo. The switch between the dual modes of regulation by Crn1 is controlled by concentration, and low concentrations of Crn1 enhance filament binding by Arp2/3 complex, whereas high concentrations block binding. Our data support a direct tethering recruitment model for activation of Arp2/3 complex by Crn1 and suggest that Crn1 indirectly inhibits Arp2/3 complex by blocking it from binding actin filaments.	Univ Oregon, Dept Chem, Eugene, OR 97403 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Nolen, BJ (corresponding author), 1229 Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	bnolen@uoregon.edu		Nolen, Brad/0000-0002-0224-9980	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant (to B. J. N).	Achard V, 2010, CURR BIOL, V20, P423, DOI 10.1016/j.cub.2009.12.056; Beltzner CC, 2008, J BIOL CHEM, V283, P7135, DOI 10.1074/jbc.M705894200; Berro J, 2010, MOL BIOL CELL, V21, P2905, DOI 10.1091/mbc.E10-06-0494; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; D'Agostino JL, 2005, GENETICS, V171, P35, DOI 10.1534/genetics.105.040634; Dayel MJ, 2004, PLOS BIOL, V2, P476, DOI 10.1371/journal.pbio.0020091; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Evangelista M, 2000, J CELL BIOL, V148, P353, DOI 10.1083/jcb.148.2.353; Footer MJ, 2008, J BIOL CHEM, V283, P23852, DOI 10.1074/jbc.M803448200; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; Galkin VE, 2008, J MOL BIOL, V376, P607, DOI 10.1016/j.jmb.2007.12.007; Galletta BJ, 2008, PLOS BIOL, V6, P72, DOI 10.1371/journal.pbio.0060001; Gandhi M, 2010, J BIOL CHEM, V285, P34899, DOI 10.1074/jbc.M110.171496; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Goley ED, 2010, P NATL ACAD SCI USA, V107, P8159, DOI 10.1073/pnas.0911668107; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kammerer RA, 2005, P NATL ACAD SCI USA, V102, P13891, DOI 10.1073/pnas.0502390102; Lin MC, 2010, J CELL SCI, V123, P1329, DOI 10.1242/jcs.065698; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; Nolen BJ, 2008, J BIOL CHEM, V283, P26490, DOI 10.1074/jbc.M802607200; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2010, ANAL BIOCHEM, V407, P89, DOI 10.1016/j.ab.2010.07.017; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Rodal AA, 2003, CURR BIOL, V13, P1000, DOI 10.1016/S0960-9822(03)00383-X; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Uruno T, 2003, J BIOL CHEM, V278, P26086, DOI 10.1074/jbc.M301997200; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Wen KK, 2005, J BIOL CHEM, V280, P24168, DOI 10.1074/jbc.M502024200; Yamakita Y, 2003, J BIOL CHEM, V278, P17937, DOI 10.1074/jbc.M208739200	55	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17039	17046		10.1074/jbc.M111.219964	http://dx.doi.org/10.1074/jbc.M111.219964			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454476	Green Published, hybrid			2022-12-27	WOS:000290301900054
J	Dmitriev, OY; Bhattacharjee, A; Nokhrin, S; Uhlemann, EME; Lutsenko, S				Dmitriev, Oleg Y.; Bhattacharjee, Ashima; Nokhrin, Sergiy; Uhlemann, Eva-Maria E.; Lutsenko, Svetlana			Difference in Stability of the N-domain Underlies Distinct Intracellular Properties of the E1064A and H1069Q Mutants of Copper-transporting ATPase ATP7B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSON-DISEASE PROTEIN; NUCLEOTIDE-BINDING DOMAIN; MUTATIONS; EXPRESSION	Wilson disease (WD) is a disorder of copper metabolism caused by mutations in the Cu-transporting ATPase ATP7B. WD is characterized by significant phenotypic variability, the molecular basis of which is poorly understood. The E1064A mutation in the N-domain of ATP7B was previously shown to disrupt ATP binding. We have now determined, by NMR, the structure of the N-domain containing this mutation and compared properties of E1064A and H1069Q, another mutant with impaired ATP binding. The E1064A mutation does not change the overall fold of the N-domain. However, the position of the alpha 1,alpha 2-helical hairpin (alpha-HH) that houses Glu(1064) and His(1069) is altered. The alpha-HH movement produces a more open structure compared with the wild-type ATP-bound form and misaligns ATP coordinating residues, thus explaining complete loss of ATP binding. In the cell, neither the stability nor targeting of ATP7B-E1064A to the trans-Golgi network differs significantly from the wild type. This is in a contrast to the H1069Q mutation within the same alpha-HH, which greatly destabilizes protein both in vitro and in cells. The difference between two mutants can be linked to a lower stability of the alpha-HH in the H1069Q variant at the physiological temperature. We conclude that the structural stability of the N-domain rather than the loss of ATP binding plays a defining role in the ability of ATP7B to reach the trans-Golgi network, thus contributing to phenotypic variability in WD.	[Dmitriev, Oleg Y.; Nokhrin, Sergiy; Uhlemann, Eva-Maria E.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Bhattacharjee, Ashima; Lutsenko, Svetlana] Johns Hopkins Univ, Dept Physiol, Baltimore, MD 21205 USA	University of Saskatchewan; Johns Hopkins University	Dmitriev, OY (corresponding author), 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	oleg.dmitriev@usask.ca; lutsenko@jhmi.edu	Dmitriev, Oleg/AAB-7830-2019		Canadian Institutes of Health Research; Saskatchewan Health Research Foundation; National Institutes of Health [R01 DK071865, P01GM067166]; NSF; United States Department of Agriculture; University of Wisconsin; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); University of Wisconsin; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from Canadian Institutes of Health Research and Saskatchewan Health Research Foundation (to O. Y. D.). This work was also supported in part by National Institutes of Health Grants R01 DK071865 and P01GM067166 (to S. L.). The study also made use of the National Magnetic Resonance Facility at Madison, which is supported by funding from National Institutes of Health, NSF, United States Department of Agriculture, and the University of Wisconsin.	Banci L, 2010, J BIOL CHEM, V285, P2537, DOI 10.1074/jbc.M109.054262; Caca K, 2001, J HEPATOL, V35, P575, DOI 10.1016/S0168-8278(01)00219-7; Cauza E, 2000, WIEN KLIN WOCHENSCHR, V112, P576; Das SK, 2006, NAT CLIN PRACT NEURO, V2, P482, DOI 10.1038/ncpneuro0291; Dmitriev O, 2006, P NATL ACAD SCI USA, V103, P5302, DOI 10.1073/pnas.0507416103; Folhoffer Aniko, 2003, Orvosi Hetilap, V144, P2509; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Huster D, 2003, GASTROENTEROLOGY, V124, P335, DOI 10.1053/gast.2003.50066; Kalinsky H, 1998, HUM MUTAT, V11, P145, DOI 10.1002/(SICI)1098-1004(1998)11:2<145::AID-HUMU7>3.3.CO;2-F; Liu L, 2009, ACTA CRYSTALLOGR E, V65, pO2776, DOI 10.1107/S1600536809039646; Lubben M, 2007, J MOL BIOL, V369, P368, DOI 10.1016/j.jmb.2007.03.029; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Morgan CT, 2004, J BIOL CHEM, V279, P36363, DOI 10.1074/jbc.M404553200; Payne AS, 1998, P NATL ACAD SCI USA, V95, P10854, DOI 10.1073/pnas.95.18.10854; Rodriguez-Granillo A, 2008, J MOL BIOL, V383, P1097, DOI 10.1016/j.jmb.2008.07.065; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Stapelbroek JM, 2004, J HEPATOL, V41, P758, DOI 10.1016/j.jhep.2004.07.017; Tsivkovskii R, 2003, J BIOL CHEM, V278, P13302, DOI 10.1074/jbc.M300034200; Tsuda T, 2009, EMBO J, V28, P1782, DOI 10.1038/emboj.2009.143; van den Berghe PVE, 2009, HEPATOLOGY, V50, P1783, DOI 10.1002/hep.23209	20	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.198101	http://dx.doi.org/10.1074/jbc.M110.198101			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21398519	Green Published, hybrid			2022-12-27	WOS:000290022800073
J	Saino, H; Ukita, Y; Ago, H; Irikura, D; Nisawa, A; Ueno, G; Yamamoto, M; Kanaoka, Y; Lam, BK; Austen, KF; Miyano, M				Saino, Hiromichi; Ukita, Yoko; Ago, Hideo; Irikura, Daisuke; Nisawa, Atsushi; Ueno, Go; Yamamoto, Masaki; Kanaoka, Yoshihide; Lam, Bing K.; Austen, K. Frank; Miyano, Masashi			The Catalytic Architecture of Leukotriene C-4 Synthase with Two Arginine Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; IN-VIVO; PROTEIN; 5-LIPOXYGENASE; GENERATION; IDENTIFICATION; PURIFICATION; REQUIREMENT; RECOGNITION; ANTAGONIST	Leukotriene (LT) C-4 and its metabolites, LTD4 and LTE4, are involved in the pathobiology of bronchial asthma. LTC4 synthase is the nuclear membrane-embedded enzyme responsible for LTC4 biosynthesis, catalyzing the conjugation of two substrates that have considerably different water solubility; that amphipathic LTA(4) as a derivative of arachidonic acid and a water-soluble glutathione (GSH). A previous crystal structure revealed important details of GSH binding and implied a GSH activating function for Arg-104. In addition, Arg-31 was also proposed to participate in the catalysis based on the putative LTA(4) binding model. In this study enzymatic assay with mutant enzymes demonstrates that Arg-104 is required for the binding and activation of GSH and that Arg-31 is needed for catalysis probably by activating the epoxide group of LTA(4).	[Saino, Hiromichi; Ukita, Yoko; Ago, Hideo; Irikura, Daisuke; Miyano, Masashi] RIKEN SPring 8 Ctr, Harima Inst, Struct Biophys Lab, Sayo, Hyogo 6795148, Japan; [Nisawa, Atsushi; Ueno, Go; Yamamoto, Masaki] RIKEN SPring 8 Ctr, Harima Inst, Res Infrastruct Grp, Sayo, Hyogo 6795148, Japan; [Kanaoka, Yoshihide; Lam, Bing K.; Austen, K. Frank] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Kanaoka, Yoshihide; Lam, Bing K.; Austen, K. Frank] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	RIKEN; RIKEN; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Ago, H (corresponding author), RIKEN SPring 8 Ctr, Harima Inst, Struct Biophys Lab, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	ago@spring8.or.jp; miyano@spring8.or.jp	Yamamoto, Masaki/B-7844-2015; Miyano, Masashi/R-2785-2016	Yamamoto, Masaki/0000-0002-1311-1768; Miyano, Masashi/0000-0003-2253-6175; Ago, Hideo/0000-0002-9040-488X	National Institutes of Health [AI31599, HL36110, HL82695, HL90630]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [A-12]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090630, K08HL003611, P01HL036110, R01HL082695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI031599, U01AI031599, P01AI031599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI31599, HL36110, and HL82695 (to B. K. L.) and HL90630 (to Y. K.). This work was supported in part by a grant-in-aid for Scientific Research in the Global Center of Excellence program (A-12) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H. A.).	Adachi S, 2001, NUCL INSTRUM METH A, V467, P711, DOI 10.1016/S0168-9002(01)00472-7; Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrett NA, 2009, J IMMUNOL, V182, P1119, DOI 10.4049/jimmunol.182.2.1119; Beller TC, 2004, P NATL ACAD SCI USA, V101, P3047, DOI 10.1073/pnas.0400235101; Bresell A, 2005, FEBS J, V272, P1688, DOI 10.1111/j.1742-4658.2005.04596.x; CARRIER DJ, 1988, PROSTAG LEUKOTR ESS, V34, P27, DOI 10.1016/0952-3278(88)90021-X; CHEN WJ, 1988, BIOCHEMISTRY-US, V27, P647, DOI 10.1021/bi00402a023; CLARK JD, 1990, P NATL ACAD SCI USA, V87, P7708, DOI 10.1073/pnas.87.19.7708; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; DAHLEN SE, 1981, P NATL ACAD SCI-BIOL, V78, P3887, DOI 10.1073/pnas.78.6.3887; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; DONNELLY AL, 1995, AM J RESP CRIT CARE, V151, P1734, DOI 10.1164/ajrccm.151.6.7767514; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P12552, DOI 10.1021/bi001396u; Habib GM, 2003, FASEB J, V17, P1313, DOI 10.1096/fj.02-0899fje; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Hoff RH, 2000, BIOCHEMISTRY-US, V39, P46, DOI 10.1021/bi991570i; ISRAEL E, 1990, NEW ENGL J MED, V323, P1740, DOI 10.1056/NEJM199012203232505; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Kim DC, 2006, J IMMUNOL, V176, P4440, DOI 10.4049/jimmunol.176.7.4440; KNAPP HR, 1990, NEW ENGL J MED, V323, P1745, DOI 10.1056/NEJM199012203232506; KRILIS S, 1983, J CLIN INVEST, V71, P909, DOI 10.1172/JCI110845; LAM BK, 1994, P NATL ACAD SCI USA, V91, P7663, DOI 10.1073/pnas.91.16.7663; Lam BK, 1997, J BIOL CHEM, V272, P13923, DOI 10.1074/jbc.272.21.13923; LEWIS RA, 1980, P NATL ACAD SCI-BIOL, V77, P3710, DOI 10.1073/pnas.77.6.3710; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Lynch KR, 1999, NATURE, V399, P789; MACGLASHAN DW, 1986, J IMMUNOL, V136, P2231; MACGLASHAN DW, 1982, J CLIN INVEST, V70, P747, DOI 10.1172/JCI110670; Maekawa A, 2008, P NATL ACAD SCI USA, V105, P16695, DOI 10.1073/pnas.0808993105; MANNING PJ, 1990, NEW ENGL J MED, V323, P1736, DOI 10.1056/NEJM199012203232504; MAYCOCK AL, 1982, J BIOL CHEM, V257, P3911; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Pacor ML, 2001, CLIN EXP ALLERGY, V31, P1607, DOI 10.1046/j.1365-2222.2001.01189.x; Paruchuri S, 2008, J BIOL CHEM, V283, P16477, DOI 10.1074/jbc.M705822200; Paruchuri S, 2009, J EXP MED, V206, P2543, DOI 10.1084/jem.20091240; RADMARK O, 1980, J BIOL CHEM, V255, P1828; ROUZER CA, 1985, P NATL ACAD SCI USA, V82, P6040, DOI 10.1073/pnas.82.18.6040; ROUZER CA, 1980, P NATL ACAD SCI-BIOL, V77, P4928, DOI 10.1073/pnas.77.8.4928; SALA A, 1990, J BIOL CHEM, V265, P21771; Schmidt- Krey I, 2004, STRUCTURE, V12, P2009, DOI 10.1016/j.str.2004.08.008; Shi ZZ, 2001, MOL CELL BIOL, V21, P5389, DOI 10.1128/MCB.21.16.5389-5395.2001; Silva PJ, 2010, J PHYS CHEM B, V114, P8994, DOI 10.1021/jp100961s; Silva PJ, 2005, J PHYS CHEM B, V109, P18195, DOI 10.1021/jp051792s; SMITH CM, 1991, AM REV RESPIR DIS, V144, P1411, DOI 10.1164/ajrccm/144.6.1411; SOTER NA, 1983, J INVEST DERMATOL, V80, P115, DOI 10.1111/1523-1747.ep12531738; STEINER EC, 1963, J AM CHEM SOC, V85, P3054, DOI 10.1021/ja00902a062; Ueno Go, 2006, Journal of Structural and Functional Genomics, V7, P15, DOI 10.1007/s10969-005-9005-5; WARDLAW AJ, 1989, J ALLERGY CLIN IMMUN, V84, P19, DOI 10.1016/0091-6749(89)90173-5; WEISS JW, 1982, SCIENCE, V216, P196, DOI 10.1126/science.7063880; WELLER PF, 1983, P NATL ACAD SCI-BIOL, V80, P7626, DOI 10.1073/pnas.80.24.7626; WOODS JW, 1993, J EXP MED, V178, P1935, DOI 10.1084/jem.178.6.1935; YOSHIMOTO T, 1988, J CLIN INVEST, V81, P866, DOI 10.1172/JCI113396	55	30	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.150177	http://dx.doi.org/10.1074/jbc.M110.150177			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454538	Green Published, hybrid			2022-12-27	WOS:000290022800077
J	Tolino, LA; Okumura, S; Kashlan, OB; Carattino, MD				Tolino, Lindsey A.; Okumura, Sora; Kashlan, Ossama B.; Carattino, Marcelo D.			Insights into the Mechanism of Pore Opening of Acid-sensing Ion Channel 1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGE; EXTRACELLULAR DOMAIN; DESENSITIZATION; KINETICS; SITES	Acid-sensing ion channels (ASICs) are trimeric cation channels that undergo activation and desensitization in response to extracellular acidification. The underlying mechanism coupling proton binding in the extracellular region to pore gating is unknown. Here we probed the reactivity toward methanethiosulfonate (MTS) reagents of channels with cysteine-substituted residues in the outer vestibule of the pore of ASIC1a. We found that positively-charged MTS reagents trigger pore opening of G428C. Scanning mutagenesis of residues in the region preceding the second transmembrane spanning domain indicated that the MTSET-modified side chain of Cys at position 428 interacts with Tyr-424. This interaction was confirmed by double-mutant cycle analysis. Strikingly, Y424C-G428C monomers were associated by intersubunit disulfide bonds and were insensitive to MTSET. Despite the spatial constraints introduced by these intersubunit disulfide bonds in the outer vestibule of the pore, Y424C-G428C transitions between the resting, open, and desensitized states in response to extracellular acidification. This finding suggests that the opening of the ion conductive pathway involves coordinated rotation of the second transmembrane-spanning domains.	[Tolino, Lindsey A.; Okumura, Sora; Kashlan, Ossama B.; Carattino, Marcelo D.] Univ Pittsburgh, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carattino, MD (corresponding author), S828 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	mdc4@pitt.edu			National Institutes of Health [R01 DK084060, DK078734]; American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084060, K01DK078734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grants R01 DK084060 (to M. D. C.) and DK078734 (to O. B. K.) from the National Institutes of Health.; Supported by a Carl W. Gottschalk award from the American Society of Nephrology.	Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Kusama N, 2010, J BIOL CHEM, V285, P17425, DOI 10.1074/jbc.M109.091561; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Passero CJ, 2009, J BIOL CHEM, V284, P36473, DOI 10.1074/jbc.M109.055418; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Sluka KA, 2009, CURR OPIN DRUG DISC, V12, P693; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Vemana S, 2004, J GEN PHYSIOL, V123, P21, DOI 10.1085/jgp.200308916; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Yu MJ, 2006, MOL CELL PROTEOMICS, V5, P2131, DOI 10.1074/mcp.M600177-MCP200; Zha XM, 2009, P NATL ACAD SCI USA, V106, P3573, DOI 10.1073/pnas.0813402106	29	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.202366	http://dx.doi.org/10.1074/jbc.M110.202366			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21388961	hybrid, Green Published			2022-12-27	WOS:000290022800068
J	Sato, K; Miyoshi, F; Yokota, K; Araki, Y; Asanuma, Y; Akiyama, Y; Yoh, K; Takahashi, S; Aburatani, H; Mimura, T				Sato, Kojiro; Miyoshi, Fumihiko; Yokota, Kazuhiro; Araki, Yasuto; Asanuma, Yu; Akiyama, Yuji; Yoh, Keigyou; Takahashi, Satoru; Aburatani, Hiroyuki; Mimura, Toshihide			Marked Induction of c-Maf Protein during Th17 Cell Differentiation and Its Implication in Memory Th Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; ROR-GAMMA-T; TGF-BETA; CUTTING EDGE; T-H-17 CELLS; INTESTINAL INFLAMMATION; HELPER-CELLS; T(H)17 CELLS; IFN-GAMMA; EXPRESSION	Until recently, effector T helper (Th) cells have been classified into two subsets, Th1 and Th2 cells. Since the discovery of Th17 cells, which produce IL-17, much attention has been given to Th17 cells, mainly because they have been implicated in the pathogenesis of various inflammatory diseases. We have performed transcriptome analysis combined with factor analysis and revealed that the expression level of c-Maf, which is considered to be important for Th2 differentiation, increases significantly during the course of Th17 differentiation. The IL-23 receptor (IL-23R), which is important for Th17 cells, is among putative transcriptional targets of c-Maf. Interestingly, the analysis of c-Maf transgenic Th cells revealed that the overexpression of c-Maf did not lead to the acceleration of the early stage of Th17 differentiation but rather to the expansion of memory phenotype cells, particularly with Th1 and Th17 traits. Consistently, mouse wild-type memory Th cells expressed higher mRNA levels of c-Maf, IL-23R, IL-17, and IFN-gamma than control cells; in contrast, Maf(-/-) memory Th cells expressed lower mRNA levels of those molecules. Thus, we propose that c-Maf is important for the development of memory Th cells, particularly memory Th17 cells and Th1 cells.	[Sato, Kojiro; Miyoshi, Fumihiko; Yokota, Kazuhiro; Araki, Yasuto; Asanuma, Yu; Akiyama, Yuji; Mimura, Toshihide] Saitama Med Univ, Fac Med, Dept Rheumatol & Appl Immunol, Saitama 3500495, Japan; [Yoh, Keigyou] Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Clin Sci, Tsukuba, Ibaraki 3058575, Japan; [Takahashi, Satoru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Anat & Embryol, Tsukuba, Ibaraki 3058575, Japan; [Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med, Dept Canc Syst Biol, Tokyo 1538904, Japan	Saitama Medical University; University of Tsukuba; University of Tsukuba; University of Tokyo	Sato, K (corresponding author), Morohongo 38, Moroyama, Saitama 3500495, Japan.	satok@saitama-med.ac.jp	Mimura, Toshihide/AAV-2844-2020	Sato, Kojiro/0000-0003-4105-3726	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation; Kanae Foundation for the Promotion of Medical Science; Uehara Memorial Foundation; Kato Memorial Bioscience Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation(Naito Memorial Foundation); Kanae Foundation for the Promotion of Medical Science; Uehara Memorial Foundation(Uehara Memorial Foundation); Kato Memorial Bioscience Foundation	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and grants from the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Naito Foundation, the Kanae Foundation for the Promotion of Medical Science, Uehara Memorial Foundation, and the Kato Memorial Bioscience Foundation.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Boniface K, 2010, J IMMUNOL, V185, P679, DOI 10.4049/jimmunol.1000366; GAJEWSKI TF, 1988, J IMMUNOL, V140, P4245; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Kajihara M, 2003, BIOCHEM BIOPH RES CO, V312, P831, DOI 10.1016/j.bbrc.2003.10.196; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Kim Y, 2005, J BIOL CHEM, V280, P32905, DOI 10.1074/jbc.M505820200; KO LJ, 1991, MOL CELL BIOL, V11, P2778, DOI 10.1128/MCB.11.5.2778; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Morito N, 2006, CANCER RES, V66, P812, DOI 10.1158/0008-5472.CAN-05-2154; Nishihara M, 2007, INT IMMUNOL, V19, P695, DOI 10.1093/intimm/dxm045; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Shin HCK, 1999, CYTOKINE, V11, P257, DOI 10.1006/cyto.1998.0433; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Takatori H, 2005, J IMMUNOL, V174, P3734, DOI 10.4049/jimmunol.174.6.3734; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Weigmann B, 2004, J IMMUNOL, V173, P3446, DOI 10.4049/jimmunol.173.5.3446; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123; Yamamoto T, 2006, GENES CELLS, V11, P575, DOI 10.1111/j.1365-2443.2006.00965.x; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yang Y, 2005, J IMMUNOL, V174, P2720, DOI 10.4049/jimmunol.174.5.2720; Zhu YC, 2004, J IMMUNOL, V173, P2918, DOI 10.4049/jimmunol.173.5.2918	42	33	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14963	14971		10.1074/jbc.M111.218867	http://dx.doi.org/10.1074/jbc.M111.218867			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21402704	Green Published, hybrid			2022-12-27	WOS:000289788300026
J	Street, VA; Li, J; Robbins, CA; Kallman, JC				Street, Valerie A.; Li, Jin; Robbins, Carol A.; Kallman, Jeremy C.			A DNA Variant within the MYO7A Promoter Regulates YY1 Transcription Factor Binding and Gene Expression Serving as a Potential Dominant DFNA11 Auditory Genetic Modifier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; MOUSE INNER-EAR; MYOSIN-VIIA; HEARING IMPAIRMENT; LOW-FREQUENCY; IDENTIFICATION; MUTATION; COCHLEA; CELL; SHAKER-1	Mutations within MYO7A can lead to recessive and dominant forms of inherited hearing loss. We previously identified a large pedigree (referred to as the HL2 family) with hearing loss that first impacts the low and mid frequencies segregating a dominant MYO7A mutation in exon 17 at DNA residue G2164C. The MYO7A(G2164C) mutation predicts a nonconservative glycine-to-arginine (G722R) amino acid substitution at a highly conserved glycine residue. The degree of low and mid frequency hearing loss varies markedly in the family, suggesting the presence of a genetic modifier that either rescues or exacerbates the primary MYO7A(G2164C) mutation. Here we describe a single nucleotide polymorphism (SNP) T/C at position -4128 in the wild-type MYO7A promoter allele that sorts with the degree of hearing loss severity in the pedigree. Electrophoretic mobility shift assay analysis indicates that the SNP differentially regulates the binding of the YY1 transcription factor with the T-4128 allele creating an YY1 binding site. Immunocytochemistry demonstrates that Yy1 is expressed in hair cell nuclei within the cochlea. Given that Myo7a is also expressed in cochlear hair cells, Yy1 shows the appropriate localization to regulate Myo7a transcription within the inner ear. YY1 appears to be acting as a transcriptional repressor as the MYO7A promoter allele containing the T-4128 SNP drives 41 and 46% less reporter gene expression compared with the C-4128 SNP in the ARPE-19 and HeLa cell lines, respectively. The T-4128 SNP may be contributing to the severe hearing loss phenotype in the HL2 pedigree by reducing expression of the wild-type MYO7A allele.	[Street, Valerie A.; Li, Jin; Robbins, Carol A.; Kallman, Jeremy C.] Univ Washington, Dept Otolaryngol Head & Neck Surg, VM Bloedel Hearing Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Street, VA (corresponding author), Univ Washington, HNS Dept, VM Bloedel Hearing Res Ctr, Seattle, WA 98195 USA.	vastreet@u.washington.edu			National Institutes of Health [DC04945, P30 DC04661]; V. M. Bloedel Hearing Research Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004661, R03DC004945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V. M. Bloedel Hearing Research Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC04945 (to V. A. S.) and P30 DC04661 (to the V. M. Bloedel Core). This work was also supported by a grant from the V. M. Bloedel Hearing Research Center (to V. A. S.).	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boeda B, 2001, HUM MOL GENET, V10, P1581, DOI 10.1093/hmg/10.15.1581; Bolz Hanno, 2004, Hum Mutat, V24, P274, DOI 10.1002/humu.9272; Daudet N, 2009, DEV BIOL, V326, P86, DOI 10.1016/j.ydbio.2008.10.033; Di Leva F, 2006, AUDIOL NEURO-OTOL, V11, P157, DOI 10.1159/000091199; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Hasson T, 1997, CELL MOTIL CYTOSKEL, V37, P127, DOI 10.1002/(SICI)1097-0169(1997)37:2<127::AID-CM5>3.0.CO;2-5; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; He Y, 2008, J NEUROCHEM, V106, P1493, DOI 10.1111/j.1471-4159.2008.05486.x; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Jin ZH, 2003, TOHOKU J EXP MED, V200, P137, DOI 10.1620/tjem.200.137; Kallman JC, 2008, OTOL NEUROTOL, V29, P860, DOI 10.1097/MAO.0b013e3181825651; Knipper M, 1998, DEVELOPMENT, V125, P3709; Lu ZJ, 2008, DEV NEUROBIOL, V68, P1059, DOI 10.1002/dneu.20635; Luijendijk MWJ, 2004, HUM GENET, V115, P149, DOI 10.1007/s00439-004-1137-3; MARTINEZMONEDER.R, 2006, ASS RES OT MIDW M BA, P285; Masotti C, 2005, GENE, V359, P44, DOI 10.1016/j.gene.2005.06.004; Miyazaki H, 2006, DEV GROWTH DIFFER, V48, P429, DOI 10.1111/j.1440-169x.2006.00879.x; Oesterle EC, 2008, JARO-J ASSOC RES OTO, V9, P65, DOI 10.1007/s10162-007-0106-7; Roberson DW, 2002, HEARING RES, V172, P62, DOI 10.1016/S0378-5955(02)00512-9; Rylski M, 2008, NEUROCHEM RES, V33, P2556, DOI 10.1007/s11064-008-9757-y; Sage C, 2000, HEARING RES, V150, P70, DOI 10.1016/S0378-5955(00)00183-0; Street VA, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013557; STREET VA, 1995, GENOMICS, V29, P123, DOI 10.1006/geno.1995.1222; Tamagawa Y, 2000, ADV OTO-RHINO-LARYNG, V56, P103	27	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15278	15286		10.1074/jbc.M111.228304	http://dx.doi.org/10.1074/jbc.M111.228304			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21378158	hybrid, Green Published			2022-12-27	WOS:000289788300059
J	Oh, CS; Martin, GB				Oh, Chang-Sik; Martin, Gregory B.			Tomato 14-3-3 Protein TFT7 Interacts with a MAP Kinase Kinase to Regulate Immunity-associated Programmed Cell Death Mediated by Diverse Disease Resistance Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE REGULATOR; DOCKING SITES; RECOGNITION; CASCADES; PATHWAY; SYSTEM; GENES; FORM	Programmed cell death (PCD) associated with immunity is triggered when a plant disease resistance (R) protein recognizes a corresponding pathogen virulence protein. In tomato, detection by the host Pto kinase of the Pseudomonas syringae proteins AvrPto or AvrPtoB causes localized PCD. Previously, we reported that both MAPKKK alpha (mitogen-activated protein kinase kinase kinase) and the tomato 14-3-3 protein 7 (TFT7) positively regulate Pto-mediated PCD in tomato and Nicotiana benthamiana. In addition, in contrast to MAPKKK alpha, TFT7 is required for PCD mediated by four other R proteins. Here we investigate why TFT7 is required for PCD induced by diverse R proteins in plants. We discovered that a MAPKK, SlMKK2, which acts downstream of SlMAPKKK alpha, also interacts with TFT7 in plant cells. Gene silencing experiments revealed that the orthologous genes of both SlMKK2 and TFT7 in N. benthamiana are required for PCD mediated by the same set of R proteins. SlMKK2 and its orthologs contain a 14-3-3 binding site in their N terminus, and Thr(33) in this site is required for interaction with TFT7 in vivo. Like the structurally similar human 14-3-3 is an element of protein, TFT7 forms a homodimer in vivo. Because TFT7 interacts with both SlMAPKKK alpha and SlMKK2 and also forms a homodimer, we propose that TFT7 may coordinately recruit these client proteins for efficient signal transfer, leading to PCD induction.	[Oh, Chang-Sik; Martin, Gregory B.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Oh, Chang-Sik] Kyung Hee Univ, Dept Hort Biotechnol, Yongin 446701, South Korea; [Martin, Gregory B.] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research; Kyung Hee University; Cornell University	Martin, GB (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	gbm7@cornell.edu	Martin, Gregory B/F-6262-2011	Martin, Gregory B/0000-0003-0044-6830	Israel-USA Binational Agriculture Research and Development Fund [IS-4159-08C]	Israel-USA Binational Agriculture Research and Development Fund	This work was supported by grant IS-4159-08C from the Israel-USA Binational Agriculture Research and Development Fund.	Bardwell AJ, 2009, J BIOL CHEM, V284, P13165, DOI 10.1074/jbc.M900080200; Bendahmane A, 2000, PLANT J, V21, P73, DOI 10.1046/j.1365-313x.2000.00654.x; BRIDGES D, 2005, SCI STKE RE, V10, P2; Brigneti G, 2004, PLANT J, V39, P264, DOI 10.1111/j.1365-313X.2004.02122.x; Chaudhri M, 2003, BIOCHEM BIOPH RES CO, V300, P679, DOI 10.1016/S0006-291X(02)02902-9; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; Day B, 2005, PLANT CELL, V17, P1292, DOI 10.1105/tpc.104.030163; del Pozo O, 2004, EMBO J, V23, P3072, DOI 10.1038/sj.emboj.7600283; Ekengren SK, 2003, PLANT J, V36, P905, DOI 10.1046/j.1365-313X.2003.01944.x; Fritz A, 2006, J BIOL CHEM, V281, P6236, DOI 10.1074/jbc.M509249200; Gutierrez JR, 2010, PLANT J, V61, P507, DOI 10.1111/j.1365-313X.2009.04078.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jin HL, 2002, DEV CELL, V3, P291, DOI 10.1016/S1534-5807(02)00205-8; Jin HL, 2003, PLANT J, V33, P719, DOI 10.1046/j.1365-313X.2003.01664.x; Kang HG, 2010, PLANT CELL, V22, P918, DOI 10.1105/tpc.109.071662; Kiegerl S, 2000, PLANT CELL, V12, P2247, DOI 10.1105/tpc.12.11.2247; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Melech-Bonfil S, 2010, PLANT J, V64, P379, DOI 10.1111/j.1365-313X.2010.04333.x; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Oh CS, 2011, TRENDS PLANT SCI, V16, P132, DOI 10.1016/j.tplants.2010.11.001; Oh CS, 2010, PLANT CELL, V22, P260, DOI 10.1105/tpc.109.070664; Oh CS, 2010, PLANT PATHOLOGY J, V26, P1, DOI 10.5423/PPJ.2010.26.1.001; Peart JR, 2002, P NATL ACAD SCI USA, V99, P10865, DOI 10.1073/pnas.152330599; Pedley KF, 2005, CURR OPIN PLANT BIOL, V8, P541, DOI 10.1016/j.pbi.2005.07.006; Pedley KF, 2004, J BIOL CHEM, V279, P49229, DOI 10.1074/jbc.M410323200; Rentel MC, 2008, P NATL ACAD SCI USA, V105, P1091, DOI 10.1073/pnas.0711215105; Roberts MR, 2003, TRENDS PLANT SCI, V8, P218, DOI 10.1016/S1360-1385(03)00056-6; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Sacco MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000564; Sehnke PC, 2002, PLANT CELL, V14, pS339, DOI 10.1105/tpc.010430; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; van Doorn WG, 2005, TRENDS PLANT SCI, V10, P117, DOI 10.1016/j.tplants.2005.01.006; Velasquez A.C., 2009, J VIS EXP, V28, P1292; Yang KY, 2001, P NATL ACAD SCI USA, V98, P741, DOI 10.1073/pnas.98.2.741; Yang XH, 2009, PLANT J, V60, P539, DOI 10.1111/j.1365-313X.2009.03978.x; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103	42	57	59	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14129	14136		10.1074/jbc.M111.225086	http://dx.doi.org/10.1074/jbc.M111.225086			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21378171	hybrid, Green Published			2022-12-27	WOS:000289556200036
J	Gottesfeld, JM				Gottesfeld, Joel M.			Introduction to the Thematic Minireview Series on Epigenetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Gottesfeld, JM (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jgottesfeld@asbmb.org		Gottesfeld, Joel/0000-0002-4643-5777				Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127	1	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18345	18346		10.1074/jbc.R111.243527	http://dx.doi.org/10.1074/jbc.R111.243527			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454488	Green Published, hybrid			2022-12-27	WOS:000290785700005
J	Ruan, WJ; Lehmann, E; Thomm, M; Kostrewa, D; Cramer, P				Ruan, Wenjie; Lehmann, Elisabeth; Thomm, Michael; Kostrewa, Dirk; Cramer, Patrick			Evolution of Two Modes of Intrinsic RNA Polymerase Transcript Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR TFIIS; STRUCTURAL BASIS; SUBUNIT; FIDELITY; MECHANISM; COMPLEX; ARCHITECTURE; TERMINATION; RESOLUTION; REQUIRES	During gene transcription, the RNA polymerase (Pol) active center can catalyze RNA cleavage. This intrinsic cleavage activity is strong for Pol I and Pol III but very weak for Pol II. The reason for this difference is unclear because the active centers of the polymerases are virtually identical. Here we show that Pol II gains strong cleavage activity when the C-terminal zinc ribbon domain (C-ribbon) of subunit Rpb9 is replaced by its counterpart from the Pol III subunit C11. X-ray analysis shows that the C-ribbon has detached from its site on the Pol II surface and is mobile. Mutagenesis indicates that the C-ribbon transiently inserts into the Pol II pore to complement the active center. This mechanism is also used by transcription factor IIS, a factor that can bind Pol II and induce strong RNA cleavage. Together with published data, our results indicate that Pol I and Pol III contain catalytic C-ribbons that complement the active center, whereas Pol II contains a non-catalytic C-ribbon that is immobilized on the enzyme surface. Evolution of the Pol II system may have rendered mRNA transcript cleavage controllable by the dissociable factor transcription factor IIS to enable promoter-proximal gene regulation and elaborate 3'-processing and transcription termination.	[Ruan, Wenjie; Lehmann, Elisabeth; Kostrewa, Dirk; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Ruan, Wenjie; Lehmann, Elisabeth; Kostrewa, Dirk; Cramer, Patrick] Univ Munich, Ctr Integrated Prot Sci Munich CIPSM, Dept Biochem, D-81377 Munich, Germany; [Thomm, Michael] Univ Regensburg, Inst Mikrobiol, D-93053 Regensburg, Germany	University of Munich; University of Munich; University of Regensburg	Cramer, P (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de	Ruan, Wenjie/W-3957-2019	Ruan, Wenjie/0000-0002-8311-8738	Deutsche Forschungsgemeinschaft (DFG) [Th422/11-1, SFB646, TR5, FOR1068]; Nanosystems Initiative Munich; Elitenetzwerk Bayern; Jung-Stiftung; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Nanosystems Initiative Munich; Elitenetzwerk Bayern; Jung-Stiftung; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	Supported by grants from Deutsche Forschungsgemeinschaft (DFG) Forschergruppe "Regulation und Mechanismus der Ribosomenbiogenese" (Grant Th422/11-1).; Supported by grants from the DFG, SFB646, TR5, FOR1068, Nanosystems Initiative Munich, the Elitenetzwerk Bayern, the Jung-Stiftung, and the Fonds der Chemischen Industrie. To whom correspondence should be addressed. Tel.: 49-89-2180-76951; Fax: 49-89-2180-76999; E-mail: cramer@LMB.uni-muenchen.de.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Alic N, 2007, P NATL ACAD SCI USA, V104, P10400, DOI 10.1073/pnas.0704116104; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Dengl S, 2009, J BIOL CHEM, V284, P21270, DOI 10.1074/jbc.M109.013847; Fernandez-Tornero C, 2010, EMBO J, V29, P3762, DOI 10.1038/emboj.2010.266; Hausner W, 2000, J BIOL CHEM, V275, P12393, DOI 10.1074/jbc.275.17.12393; Hemming SA, 2000, J BIOL CHEM, V275, P2288, DOI 10.1074/jbc.275.4.2288; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Kusser AG, 2008, J MOL BIOL, V376, P303, DOI 10.1016/j.jmb.2007.08.066; Lange U, 2004, MOL MICROBIOL, V52, P1133, DOI 10.1111/j.1365-2958.2004.04039.x; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Palangat M, 2005, P NATL ACAD SCI USA, V102, P15036, DOI 10.1073/pnas.0409405102; Prescott EM, 2004, P NATL ACAD SCI USA, V101, P6068, DOI 10.1073/pnas.0401393101; QIAN XQ, 1993, NATURE, V365, P277, DOI 10.1038/365277a0; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Spitalny P, 2008, MOL MICROBIOL, V67, P958, DOI 10.1111/j.1365-2958.2007.06084.x; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Thuillier V, 1996, EMBO J, V15, P618, DOI 10.1002/j.1460-2075.1996.tb00394.x; Walmacq C, 2009, J BIOL CHEM, V284, P19601, DOI 10.1074/jbc.M109.006908; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729	34	54	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18701	18707		10.1074/jbc.M111.222273	http://dx.doi.org/10.1074/jbc.M111.222273			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454497	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000290785700043
J	Guo, X; Shen, S; Song, SS; He, S; Cui, Y; Xing, GC; Wang, J; Yin, YX; Fan, LB; He, FC; Zhang, LQ				Guo, Xing; Shen, Shan; Song, Shanshan; He, Shan; Cui, Yu; Xing, Guichun; Wang, Jian; Yin, Yuxin; Fan, Libin; He, Fuchu; Zhang, Lingqiang			The E3 Ligase Smurf1 Regulates Wolfram Syndrome Protein Stability at the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; UBIQUITIN LIGASES; DIDMOAD SYNDROME; WFS1 GENE; DEGRADATION; STRESS; EXPRESSION; P53; ACTIVATION; POLARITY	The HECT-type ubiquitin ligase (E3) Smad ubiquitination regulatory factor 1 (Smurf1) targets various substrates, including Smad1/5, RhoA, Prickle 1, MEKK2, and JunB for degradation and thereby regulates adult bone formation and embryonic development. Here, we identify the endoplasmic reticulum (ER)-localized Wolfram syndrome protein (WFS1) as a specific degradation substrate of Smurf1. Mutations in the WFS1 gene cause Wolfram syndrome, an autosomal recessive disorder characterized by diabetes mellitus and optic atrophy. WFS1 negatively regulates the ER stress response, and WFS1 deficiency in mice increases ER stress and triggers apoptosis. We show that Smurf1 interacts with WFS1 at the ER and promotes the ubiquitination and proteasomal degradation of WFS1. A C-terminal luminal region in WFS1, including residues 667-700, is involved in this degradation. Wild-type WFS1 as well as a subset of WFS1 mutants that include this degron region are susceptible to Smurf1-mediated degradation. By contrast, pathophysiological deletion mutants of WFS1 lacking the degron, such as W648X, Y660X, and Q667X, are resistant to degradation by Smurf1. Depletion of Smurf1 by RNA interference results in increased WFS1 and decreased ATF6 alpha levels. Furthermore, we show that ER stress induces Smurf1 degradation and WFS1 up-regulation. These findings reveal for the first time that Smurf1 targets an ER-localized protein for degradation and that Smurf1 is regulated by ER stress.	[Guo, Xing; Song, Shanshan; He, Shan; Cui, Yu; Xing, Guichun; Wang, Jian; He, Fuchu; Zhang, Lingqiang] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China; [Shen, Shan; Fan, Libin; Zhang, Lingqiang] Anhui Med Univ, Dept Biol, Hefei 230032, Anhui, Peoples R China; [Shen, Shan; Fan, Libin; Zhang, Lingqiang] Anhui Med Univ, Cell Biol Lab, Hefei 230032, Anhui, Peoples R China; [Yin, Yuxin] Peking Univ, Sch Basic Med Sci, Dept Pathol, Beijing 100191, Peoples R China; [Guo, Xing; Song, Shanshan; He, Fuchu] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Med Genet, Beijing 100730, Peoples R China; [Guo, Xing; Song, Shanshan; He, Fuchu] Peking Union Med Coll, Beijing 100730, Peoples R China	Academy of Military Medical Sciences - China; Anhui Medical University; Anhui Medical University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	He, FC (corresponding author), Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, 27 Taiping Rd, Beijing 100850, Peoples R China.	hefc@nic.bmi.ac.cn; zhanglq@nic.bmi.ac.cn			National Basic Research Programs [2011CB910602, 2007CB914601, 2010CB912202]; National Natural Science Foundation [30830029]; National Key Technologies R&D Program for New Drugs [2009ZX09503-002, 2009ZX09301-002]	National Basic Research Programs(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program for New Drugs(National Key Technology R&D Program)	This work was supported by National Basic Research Programs 2011CB910602, 2007CB914601, and 2010CB912202, National Natural Science Foundation Projects (30830029), and National Key Technologies R&D Program for New Drugs (2009ZX09503-002, 2009ZX09301-002).	Barrett TG, 1997, J MED GENET, V34, P838, DOI 10.1136/jmg.34.10.838; BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678; Hofmann S, 2006, FEBS LETT, V580, P4000, DOI 10.1016/j.febslet.2006.06.036; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li S, 2010, MOL CELL BIOCHEM, V338, P11, DOI 10.1007/s11010-009-0315-y; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nie J, 2010, J BIOL CHEM, V285, P22816, DOI 10.1074/jbc.M110.126920; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Tajima Y, 2003, J BIOL CHEM, V278, P10716, DOI 10.1074/jbc.M212663200; Takeda K, 2001, HUM MOL GENET, V10, P477, DOI 10.1093/hmg/10.5.477; Ueda K, 2005, EUR J ENDOCRINOL, V153, P167, DOI 10.1530/eje.1.01945; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wolfram DJ, 1938, P MAYO CLIN, V13, P715; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; Yamaguchi S, 2004, BIOCHEM BIOPH RES CO, V325, P250, DOI 10.1016/j.bbrc.2004.10.017; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Zhao L, 2010, J BONE MINER RES, V25, P1246, DOI 10.1002/jbmr.28; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	30	51	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18037	18047		10.1074/jbc.M111.225615	http://dx.doi.org/10.1074/jbc.M111.225615			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454619	hybrid, Green Published			2022-12-27	WOS:000290585200065
J	Marques, JC; Lamosa, P; Russell, C; Ventura, R; Maycock, C; Semmelhack, MF; Miller, ST; Xavier, KB				Marques, Joao C.; Lamosa, Pedro; Russell, Caitlin; Ventura, Rita; Maycock, Christopher; Semmelhack, Martin F.; Miller, Stephen T.; Xavier, Karina B.			Processing the Interspecies Quorum-sensing Signal Autoinducer-2 (AI-2) CHARACTERIZATION OF PHOSPHO-(S)-4,5-DIHYDROXY-2,3-PENTANEDIONE ISOMERIZATION BY LsrG PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; LUXS; COMMUNICATION; METABOLISM; EXPRESSION; AL-2	The molecule (S)-4,5-dihydroxy-2,3-pentanedione (DPD) is produced by many different species of bacteria and is the precursor of the signal molecule autoinducer-2 (AI-2). AI-2 mediates interspecies communication and facilitates regulation of bacterial behaviors such as biofilm formation and virulence. A variety of bacterial species have the ability to sequester and process the AI-2 present in their environment, thereby interfering with the cell-cell communication of other bacteria. This process involves the AI-2-regulated lsr operon, comprised of the Lsr transport system that facilitates uptake of the signal, a kinase that phosphorylates the signal to phospho-DPD (P-DPD), and enzymes (like LsrG) that are responsible for processing the phosphorylated signal. Because P-DPD is the intracellular inducer of the lsr operon, enzymes involved in P-DPD processing impact the levels of Lsr expression. Here we show that LsrG catalyzes isomerization of P-DPD into 3,4,4-trihydroxy-2-pentanone-5-phosphate. We present the crystal structure of LsrG, identify potential catalytic residues, and determine which of these residues affects P-DPD processing in vivo and in vitro. We also show that an lsrG deletion mutant accumulates at least 10 times more P-DPD than wild type cells. Consistent with this result, we find that the lsrG mutant has increased expression of the lsr operon and an altered profile of AI-2 accumulation and removal. Understanding of the biochemical mechanisms employed by bacteria to quench signaling of other species can be of great utility in the development of therapies to control bacterial behavior.	[Marques, Joao C.; Lamosa, Pedro; Ventura, Rita; Maycock, Christopher; Xavier, Karina B.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780 Oeiras, Portugal; [Marques, Joao C.; Xavier, Karina B.] Inst Gulbenkian Ciencias, P-2780 Oeiras, Portugal; [Russell, Caitlin; Miller, Stephen T.] Swarthmore Coll, Dept Chem & Biochem, Swarthmore, PA 19081 USA; [Maycock, Christopher] Univ Lisbon, Dept Quim & Bioquim, Fac Ciencias, P-1749 Lisbon, Portugal; [Semmelhack, Martin F.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Universidade Nova de Lisboa; Instituto Gulbenkian de Ciencia; Swarthmore College; Universidade de Lisboa; Princeton University	Miller, ST (corresponding author), 500 Coll Ave, Swarthmore, PA 19081 USA.	smiller1@swarthmore.edu; kxavier@igc.gulbenkian.pt	Maycock, Christopher/Z-3471-2019; Ventura, Rita/B-8011-2008; Maycock, Christopher/H-9875-2012; Xavier, Karina/B-9425-2008	Maycock, Christopher/0000-0002-6687-4435; Ventura, Rita/0000-0002-6854-7278; Maycock, Christopher/0000-0002-6687-4435; Xavier, Karina/0000-0001-5210-1434; marques, joao/0000-0003-0972-1149; Lamosa, Pedro/0000-0002-3003-1516	National Institutes of Health [AI074041]; Fundacao para a Ciencia e Tecnologia (Portugal) [PPCDT/DG/BIA/82010/2006]; Camille and Henry Dreyfus Foundation; Swarthmore College; Programa Operacional Ciencia e Inovacao (POCTI); Fundacao para a Ciencia e Tecnologia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI074041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Camille and Henry Dreyfus Foundation; Swarthmore College; Programa Operacional Ciencia e Inovacao (POCTI); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant of AI074041 (to S. T. M.). This work was also supported by the Fundacao para a Ciencia e Tecnologia (PPCDT/DG/BIA/82010/2006, Portugal (to K. B. X.) and by the Camille and Henry Dreyfus Foundation and Swarthmore College (to S. T. M.).; We thank Frederick M. Hughson (Princeton University) and Helena Santos (Instituto Tecnologia Quimica e Biologica) for critically reading the manuscript. We thank Ana R. Neves and Teresa Catarino for precious help in optimizing the NMR conditions and preparing the anaerobic samples, respectively. The NMR spectrometers are part of The National NMR Network (REDE/1517/RMN/2005), supported by "Programa Operacional Ciencia e Inovacao (POCTI) 2010" and Fundacao para a Ciencia e Tecnologia. We acknowledge National BioResource Project (Japan):E. coli for providing strain JCM62.	Adams MA, 2005, J BIOL CHEM, V280, P8358, DOI 10.1074/jbc.M412637200; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ascenso OS, 2011, BIOORGAN MED CHEM, V19, P1236, DOI 10.1016/j.bmc.2010.12.036; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; DAMITIO J, 1992, J AM CHEM SOC, V114, P3081, DOI 10.1021/ja00034a049; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Dong YH, 2007, PHILOS T R SOC B, V362, P1201, DOI 10.1098/rstb.2007.2045; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Federle MJ, 2009, CONTRIB MICROBIOL, V16, P18, DOI 10.1159/000219371; Fetzner S, 2010, APPL MICROBIOL BIOT, V86, P791, DOI 10.1007/s00253-010-2455-0; Grocholski T, 2010, BIOCHEMISTRY-US, V49, P934, DOI 10.1021/bi901985b; Hardie KR, 2008, NAT REV MICROBIOL, V6, P635, DOI 10.1038/nrmicro1916; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Leadbetter JR, 2000, J BACTERIOL, V182, P6921, DOI 10.1128/JB.182.24.6921-6926.2000; Lowery CA, 2008, CHEM SOC REV, V37, P1337, DOI 10.1039/b702781h; Lyon GJ, 2004, PEPTIDES, V25, P1389, DOI 10.1016/j.peptides.2003.11.026; Matheus C. K., 1999, BIOCHEMISTRY-US, P280; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereira CS, 2009, J BACTERIOL, V191, P6975, DOI 10.1128/JB.00976-09; Pereira CS, 2008, MOL MICROBIOL, V70, P1223, DOI 10.1111/j.1365-2958.2008.06477.x; Rajamani S, 2007, BIOCHEMISTRY-US, V46, P3990, DOI 10.1021/bi602479e; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Roy V, 2010, ACS CHEM BIOL, V5, P223, DOI 10.1021/cb9002738; Sambrook J., 2001, MOL CLONING LAB MANU; SANTOS H, 1986, FEBS LETT, V194, P73, DOI 10.1016/0014-5793(86)80054-0; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; Silhavy T. J., 1984, EXPT GENE FUSIONS, P107; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; Surette MG, 1999, MOL MICROBIOL, V31, P585, DOI 10.1046/j.1365-2958.1999.01199.x; Taga ME, 2003, MOL MICROBIOL, V50, P1411, DOI 10.1046/j.1365-2958.2003.03781.x; Taga ME, 2001, MOL MICROBIOL, V42, P777, DOI 10.1046/j.1365-2958.2001.02669.x; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Wang L, 2005, J BACTERIOL, V187, P8350, DOI 10.1128/JB.187.24.8350-8360.2005; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Xavier KB, 2007, ACS CHEM BIOL, V2, P128, DOI 10.1021/cb600444h; Xavier KB, 2005, NATURE, V437, P750, DOI 10.1038/nature03960; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Xavier KB, 2005, J BACTERIOL, V187, P238, DOI 10.1128/JB.187.1.238-248.2005; Xue T, 2009, CELL RES, V19, P1258, DOI 10.1038/cr.2009.91; Yang F, 2005, FEBS LETT, V579, P3713, DOI 10.1016/j.febslet.2005.05.060	50	42	43	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18331	18343		10.1074/jbc.M111.230227	http://dx.doi.org/10.1074/jbc.M111.230227			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454635	hybrid, Green Published			2022-12-27	WOS:000290585200093
J	Mazur, O; Zimmer, J				Mazur, Olga; Zimmer, Jochen			Apo- and Cellopentaose-bound Structures of the Bacterial Cellulose Synthase Subunit BcsZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-BONDING SYSTEM; SYNCHROTRON X-RAY; ACETOBACTER-XYLINUM; CRYSTAL-STRUCTURE; ENDO-BETA-1,4-GLUCANASE; BIOSYNTHESIS; MECHANISM	Cellulose, a very abundant extracellular polysaccharide, is synthesized in a finely tuned process that involves the activity of glycosyl-transferases and hydrolases. The cellulose microfibril consists of bundles of linear beta-1,4-glucan chains that are synthesized inside the cell; however, the mechanism by which these polymers traverse the cell membrane is currently unknown. In Gram-negative bacteria, the cellulose synthase complex forms a trans-envelope complex consisting of at least four subunits. Although three of these subunits account for the synthesis and translocation of the polysaccharide, the fourth subunit, BcsZ, is a periplasmic protein with endo-beta-1,4-glucanase activity. BcsZ belongs to family eight of glycosyl-hydrolases, and its activity is required for optimal synthesis and membrane translocation of cellulose. In this study we report two crystal structures of BcsZ from Escherichia coli. One structure shows the wild-type enzyme in its apo form, and the second structure is for a catalytically inactive mutant of BcsZ in complex with the substrate cellopentaose. The structures demonstrate that BcsZ adopts an (alpha/alpha)(6)-barrel fold and that it binds four glucan moieties of cellopentaose via highly conserved residues exclusively on the nonreducing side of its catalytic center. Thus, the BcsZ-cellopentaose structure most likely represents a posthydrolysis state in which the newly formed nonreducing end has already left the substrate binding pocket while the enzyme remains attached to the truncated polysaccharide chain. We further show that BcsZ efficiently degrades beta-1,4-glucans in in vitro cellulase assays with carboxymethyl-cellulose as substrate.	[Mazur, Olga; Zimmer, Jochen] Univ Virginia, Dept Mol Physiol & Biol Phys, Ctr Membrane Biol, Charlottesville, VA 22908 USA	University of Virginia	Zimmer, J (corresponding author), 480 Ray C Hunt Dr,Snyder Bldg, Charlottesville, VA 22908 USA.	jochen_zimmer@virginia.edu		Zimmer, Jochen/0000-0002-8423-2882	University of Virginia, School of Medicine; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]	University of Virginia, School of Medicine; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by start-up funds from the University of Virginia, School of Medicine (to J. Z.). Data were collected at the Southeast Regional Collaborative Access Team (SER-CAT) 22-ID and 22-BM beamlines at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	ALONI Y, 1982, P NATL ACAD SCI-BIOL, V79, P6448, DOI 10.1073/pnas.79.21.6448; Alzari PM, 1996, STRUCTURE, V4, P265, DOI 10.1016/S0969-2126(96)00031-7; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BUREAU TE, 1987, P NATL ACAD SCI USA, V84, P6985, DOI 10.1073/pnas.84.20.6985; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Gray MC, 2003, APPL BIOCHEM BIOTECH, V105, P179, DOI 10.1385/ABAB:105:1-3:179; Guerin DMA, 2002, J MOL BIOL, V316, P1061, DOI 10.1006/jmbi.2001.5404; Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149; Ito F., 2004, J APPL GLYCOSCI, V51, P297, DOI [10.5458/jag.51.297, DOI 10.5458/JAG.51.297]; Kawano S, 2002, J BIOSCI BIOENG, V94, P275, DOI 10.1263/jbb.94.275; Koo HM, 1998, BIOSCI BIOTECH BIOCH, V62, P2257, DOI 10.1271/bbb.62.2257; LEVER M, 1973, BIOCHEM MED METAB B, V7, P274, DOI 10.1016/0006-2944(73)90083-5; Ly HD, 1999, ANNU REV BIOCHEM, V68, P487, DOI 10.1146/annurev.biochem.68.1.487; Maloney VJ, 2010, PLANT BIOTECHNOL J, V8, P294, DOI 10.1111/j.1467-7652.2009.00483.x; MATTHYSSE AG, 1995, J BACTERIOL, V177, P1076, DOI 10.1128/jb.177.4.1076-1081.1995; Molhoj M, 2002, PLANT CELL PHYSIOL, V43, P1399, DOI 10.1093/pcp/pcf163; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pointing Stephen B., 1999, Fungal Diversity, V2, P17; Rabinovich ML, 2002, BIOCHEMISTRY-MOSCOW+, V67, P850, DOI 10.1023/A:1019958419032; Romling U, 2002, RES MICROBIOL, V153, P205, DOI 10.1016/S0923-2508(02)01316-5; Saxena IM, 2005, ANN BOT-LONDON, V96, P9, DOI 10.1093/aob/mci155; SAXENA IM, 1994, J BACTERIOL, V176, P5735, DOI 10.1128/JB.176.18.5735-5752.1994; Saxena IM, 2001, PHYTOCHEMISTRY, V57, P1135, DOI 10.1016/S0031-9422(01)00048-6; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; STANDAL R, 1994, J BACTERIOL, V176, P665, DOI 10.1128/jb.176.3.665-672.1994; Yasutake Y, 2006, PROTEINS, V64, P1069, DOI 10.1002/prot.21052; Zhang YHP, 2009, METHODS MOL BIOL, V581, P213, DOI 10.1007/978-1-60761-214-8_14	39	60	60	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17601	17606		10.1074/jbc.M111.227660	http://dx.doi.org/10.1074/jbc.M111.227660			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454578	Green Published			2022-12-27	WOS:000290585200023
J	Tenhaken, R; Voglas, E; Cock, JM; Neu, V; Huber, CG				Tenhaken, Raimund; Voglas, Elena; Cock, J. Mark; Neu, Volker; Huber, Christian G.			Characterization of GDP-mannose Dehydrogenase from the Brown Alga Ectocarpus siliculosus Providing the Precursor for the Alginate Polymer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-GLUCOSE DEHYDROGENASE; PSEUDOMONAS-AERUGINOSA; KEY ENZYME; MATRIX POLYSACCHARIDES; BIOSYNTHESIS; PURIFICATION; EVOLUTION; RESIDUES; SEQUENCE; GENOME	Alginate is a major cell wall polymer of brown algae. The precursor for the polymer is GDP-mannuronic acid, which is believed to be derived from a four-electron oxidation of GDPmannose through the enzyme GDP-mannose dehydrogenase (GMD). So far no eukaryotic GMD has been biochemically characterized. We have identified a candidate gene in the Ectocarpus siliculosus genome and expressed it as a recombinant protein in Escherichia coli. The GMD from Ectocarpus differs strongly from related enzymes in bacteria and is as distant to the bacterial proteins as it is to the group of UDP-glucose dehydrogenases. It lacks the C-terminal similar to 120 amino acid domain present in bacterial GMDs, which is believed to be involved in catalysis. The GMD from brown algae is highly active at alkaline pH and contains a catalytic Cys residue, sensitive to heavy metals. The product GDP-mannuronic acid was analyzed by HPLC and mass spectroscopy. The K-m for GDP-mannose was 95 mu M, and 86 mu M for NAD(+). No substrate other than GDP-mannose was oxidized by the enzyme. In gel filtration experiments the enzyme behaved as a dimer. The Ectocarpus GMD is stimulated by salts even at low molar concentrations as a possible adaptation to marine life. It is rapidly inactivated at temperatures above 30 degrees C.	[Tenhaken, Raimund; Voglas, Elena] Salzburg Univ, Dept Cell Biol, Div Plant Physiol, A-5020 Salzburg, Austria; [Cock, J. Mark] Marine Plants & Biomol Stn, Algal Genet Grp, F-29682 Roscoff, France; [Neu, Volker; Huber, Christian G.] Salzburg Univ, Dept Mol Biol, Div Chem & Bioanalyt, A-5020 Salzburg, Austria	Salzburg University; Salzburg University	Tenhaken, R (corresponding author), Salzburg Univ, Dept Cell Biol, Div Plant Physiol, Hellbrunnerstr 34, A-5020 Salzburg, Austria.	raimund.tenhaken@sbg.ac.at	Tenhaken, Raimund/O-6556-2019; Huber, Christian G./E-5445-2011	Tenhaken, Raimund/0000-0002-6764-4826; Huber, Christian G./0000-0001-8358-1880; Cock, J. Mark/0000-0002-2650-0383				Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; DERETIC V, 1987, J BACTERIOL, V169, P351, DOI 10.1128/jb.169.1.351-358.1987; Draget K. I., 2002, BIOPOLYMERS POLYSACC, VII, P215; Ge X, 2004, EUR J BIOCHEM, V271, P14, DOI 10.1046/j.1432-1033.2003.03876.x; Hinterberg B, 2002, PLANT PHYSIOL BIOCH, V40, P1011, DOI 10.1016/S0981-9428(02)01465-1; Klinghammer M, 2007, J EXP BOT, V58, P3609, DOI 10.1093/jxb/erm209; KLOAREG B., 1988, OCEANOGR MAR BIOL, V26, P259; LIN TY, 1966, J BIOL CHEM, V241, P5284; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; Naught LE, 2002, BIOCHEMISTRY-US, V41, P9637, DOI 10.1021/bi025862m; Nyvall P, 2003, PLANT PHYSIOL, V133, P726, DOI 10.1104/pp.103.025981; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; ROYCHOUDHURY S, 1989, J BIOL CHEM, V264, P9380; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; SKJAKBRAEK G, 1986, CARBOHYD RES, V154, P239; Snook CF, 2003, BIOCHEMISTRY-US, V42, P4658, DOI 10.1021/bi027328k	19	22	22	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16707	16715		10.1074/jbc.M111.230979	http://dx.doi.org/10.1074/jbc.M111.230979			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454608	Green Published, hybrid			2022-12-27	WOS:000290301900018
J	Lyzogubov, VV; Tytarenko, RG; Liu, J; Bora, NS; Bora, PS				Lyzogubov, Valeriy V.; Tytarenko, Ruslana G.; Liu, Juan; Bora, Nalini S.; Bora, Puran S.			Polyethylene Glycol (PEG)-induced Mouse Model of Choroidal Neovascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT MEMBRANE ATTACK; GROWTH-FACTOR SECRETION; MACULAR DEGENERATION; ALTERNATIVE PATHWAY; FACTOR-H; TARGETED INHIBITOR; ACTIVATION; VEGF; CELLS; RPE	In this study, we describe a new method for inducing choroidal neovascularization (CNV) in C57BL/6 mice, an animal model of wet age-related macular degeneration (AMD). AMD is a disease that causes central blindness in humans. We injected PEG-8 subretinally in different doses (0.125-2 mg) to induce CNV. After PEG-8 injection, we examined CNV at several time points (days 3-42). We also used Western blotting, immunohistochemistry, and ELISA to examine the complement component C3 split products, C9, VEGF, TGF-beta 2, and basic FGF. As early as day 1 after treatment, we found that a single subretinal injection of 1 mg of PEG-8 increased the C3 split products and the C9, TGF-beta 2, and basic FGF levels in the retinal pigment epithelium-choroid tissue. By day 3 after PEG-8 injection, the intraocular activation of the complement system caused induction and progression of CNV, including new vessels penetrating the Bruch's membrane. At day 5 after PEG-8 injection, we observed a fully developed CNV and retinal degeneration. Thus, in this study, we present a new, inexpensive, and accelerated mouse model of CNV that may be useful to study AMD.	[Lyzogubov, Valeriy V.; Tytarenko, Ruslana G.; Liu, Juan; Bora, Nalini S.; Bora, Puran S.] Univ Arkansas Med Sci, Dept Ophthalmol, Jones Eye Inst, Pat & Willard Walker Eye Res Ctr, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Bora, PS (corresponding author), Univ Arkansas Med Sci, Dept Ophthalmol, Jones Eye Inst, Pat & Willard Walker Eye Res Ctr, 4301 W Markham St,Slot 523-7, Little Rock, AR 72205 USA.	pbora@uams.edu		Bora, Puran/0000-0003-4781-1217	University of Arkansas for Medical Sciences; Pat and Willard Walker Eye Research Center	University of Arkansas for Medical Sciences; Pat and Willard Walker Eye Research Center	This work was supported in part by grants from the University of Arkansas for Medical Sciences and the Pat and Willard Walker Eye Research Center.	Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; [Anonymous], 2006, INT J TOXICOL, V25, P121, DOI 10.1080/10915810600964642; Baba T, 2010, AM J PATHOL, V176, P3085, DOI 10.2353/ajpath.2010.090989; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Bora NS, 2006, J IMMUNOL, V177, P1872, DOI 10.4049/jimmunol.177.3.1872; Bora NS, 2010, J BIOL CHEM, V285, P33826, DOI 10.1074/jbc.M110.153130; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; Campochiaro PA, 2000, J CELL PHYSIOL, V184, P301, DOI 10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H; Cao JT, 2010, INVEST OPHTH VIS SCI, V51, P6009, DOI 10.1167/iovs.09-4956; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Edwards Albert O., 2007, Angiogenesis, V10, P119, DOI 10.1007/s10456-007-9064-2; ELIZABETH RP, 2006, EXP EYE RES, V82, P741, DOI DOI 10.1016/J.EXER.2005.10.012; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; HALPERIN JA, 1993, J CLIN INVEST, V91, P1974, DOI 10.1172/JCI116418; Hamada I, 2008, MOL IMMUNOL, V46, P225, DOI 10.1016/j.molimm.2008.08.276; Huang YX, 2008, J IMMUNOL, V181, P8068, DOI 10.4049/jimmunol.181.11.8068; Itaya M, 2007, INVEST OPHTH VIS SCI, V48, P5677, DOI 10.1167/iovs.07-0156; KILLINGSWORTH MC, 1995, GRAEF ARCH CLIN EXP, V233, P313, DOI 10.1007/BF00200479; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lassota N, 2008, ACTA OPHTHALMOL, V86, P495, DOI [10.1111/j.1600-0420.2007.01127.x, 10.1111/j.1755-3768.2008.01412.x]; Li WB, 2010, MED SCI MONITOR, V16, pBR17; Lyzogubov VV, 2010, AM J PATHOL, V177, P1870, DOI 10.2353/ajpath.2010.091168; Moghimi SM, 2006, J LIPOSOME RES, V16, P167, DOI 10.1080/08982100600848801; Montezuma SR, 2009, SEMIN OPHTHALMOL, V24, P52, DOI 10.1080/08820530902800017; MORGAN BP, 1989, BIOCHEM J, V264, P1; Palarasah Y, 2010, J IMMUNOL METHODS, V362, P142, DOI 10.1016/j.jim.2010.09.024; Pawliuk R., 2001, WIPO Patent Application, Patent No. [WO/2001/087312, 2001087312]; Ramo K, 2008, INVEST OPHTH VIS SCI, V49, P4126, DOI 10.1167/iovs.08-2025; Rohrer B, 2009, INVEST OPHTH VIS SCI, V50, P3056, DOI 10.1167/iovs.08-2222; Saint-Geniez M, 2006, INVEST OPHTH VIS SCI, V47, P3135, DOI 10.1167/iovs.05-1229; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Shen WY, 2001, ANTISENSE NUCLEIC A, V11, P257, DOI 10.1089/108729001317022250; Sonoda S, 2010, AGING-US, V2, P28, DOI 10.18632/aging.100111; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; YAMAOKA T, 1995, J PHARM SCI, V84, P349, DOI 10.1002/jps.2600840316; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zhao L, 2007, MOL VIS, V13, P873	39	39	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.204701	http://dx.doi.org/10.1074/jbc.M110.204701			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454496	Green Published, hybrid			2022-12-27	WOS:000290022800062
J	Chen, YL; Li, X; Ye, QQ; Tian, J; Jing, RM; Xie, ZJ				Chen, Yiliang; Li, Xin; Ye, Qiqi; Tian, Jiang; Jing, Runming; Xie, Zijian			Regulation of alpha 1 Na/K-ATPase Expression by Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PICK TYPE-C; NA+/K+-ATPASE; SIGNAL-TRANSDUCTION; MEMBRANE TRAFFICKING; CARDIAC MYOCYTES; PROTEIN-KINASES; PLASMA-MEMBRANE; CELL-GROWTH; ANNEXIN-II; NA,K-ATPASE	We have reported that alpha 1 Na/K-ATPase regulates the trafficking of caveolin-1 and consequently alters cholesterol distribution in the plasma membrane. Here, we report the reciprocal regulation of alpha 1 Na/K-ATPase by cholesterol. Acute exposure of LLC-PK1 cells to methyl beta-cyclodextrin led to parallel decreases in cellular cholesterol and the expression of alpha 1 Na/K-ATPase. Cholesterol repletion fully reversed the effect of methyl beta-cyclodextrin. Moreover, inhibition of intracellular cholesterol trafficking to the plasma membrane by compound U18666A had the same effect on alpha 1 Na/K-ATPase. Similarly, the expression of alpha 1, but not alpha 2 and alpha 3, Na/K-ATPase was significantly reduced in the target organs of Niemann-Pick type C mice where the intracellular cholesterol trafficking is blocked. Mechanistically, decreases in the plasma membrane cholesterol activated Src kinase and stimulated the endocytosis and degradation of alpha 1 Na/K-ATPase through Src- and ubiquitination-dependent pathways. Thus, the new findings, taken together with what we have already reported, revealed a previously unrecognized feed-forward mechanism by which cells can utilize the Src-dependent interplay among Na/K-ATPase, caveolin-1, and cholesterol to effectively alter the structure and function of the plasma membrane.	[Xie, Zijian] Univ Toledo, Dept Physiol & Pharmacol, Coll Med, Toledo, OH 43614 USA; [Li, Xin; Jing, Runming] Huazhong Univ Sci & Technol, Dept Pediat, Union Hosp, Wuhan 430074, Hubei, Peoples R China	University System of Ohio; University of Toledo; Huazhong University of Science & Technology	Xie, ZJ (corresponding author), Univ Toledo, Dept Physiol & Pharmacol, Coll Med, 3000 Arlington Ave, Toledo, OH 43614 USA.	zi-jian.xie@utoledo.edu		Chen, Yiliang/0000-0001-9786-8305	National Institutes of Health [HL-36573, GM 78565]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-36573 and GM 78565.	Abi-Mosleh L, 2009, P NATL ACAD SCI USA, V106, P19316, DOI 10.1073/pnas.0910916106; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; CHEN M, 1995, BBA-MOL BASIS DIS, V1272, P101, DOI 10.1016/0925-4439(95)00073-D; Chen YL, 2009, J BIOL CHEM, V284, P14881, DOI 10.1074/jbc.M109.003574; CORNELIUS F, 1995, BBA-BIOMEMBRANES, V1235, P205, DOI 10.1016/0005-2736(95)80006-2; Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g; Dada LA, 2007, CELL SIGNAL, V19, P1893, DOI 10.1016/j.cellsig.2007.04.013; DELUISE M, 1980, NEW ENGL J MED, V303, P1017, DOI 10.1056/NEJM198010303031801; Desfrere L, 2009, P NATL ACAD SCI USA, V106, P2212, DOI 10.1073/pnas.0809253106; Garver WS, 2007, J CELL BIOCHEM, V101, P498, DOI 10.1002/jcb.21200; Garver WS, 1999, BBA-MOL BASIS DIS, V1453, P193, DOI 10.1016/S0925-4439(98)00101-X; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hailstones D, 1998, J LIPID RES, V39, P369; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Khanna S, 2007, J BIOL CHEM, V282, P23482, DOI 10.1074/jbc.M611269200; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kometiani P, 1998, J BIOL CHEM, V273, P15249, DOI 10.1074/jbc.273.24.15249; Lange Y, 2002, J LIPID RES, V43, P198; Lange Y, 1998, J BIOL CHEM, V273, P18915, DOI 10.1074/jbc.273.30.18915; Lange Y, 1999, J LIPID RES, V40, P2264; Lecuona E, 2009, AM J RESP CELL MOL, V41, P671, DOI 10.1165/rcmb.2008-0365OC; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Li ZC, 2009, J BIOL CHEM, V284, P21066, DOI 10.1074/jbc.M109.013821; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; LINGREL JB, 1992, J BIOENERG BIOMEMBR, V24, P263; Liu J, 2004, KIDNEY INT, V66, P227, DOI 10.1111/j.1523-1755.2004.00723.x; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Park EK, 2009, J PATHOL, V218, P337, DOI 10.1002/path.2531; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Raghu H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-647; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Uittenbogaard A, 2002, J BIOL CHEM, V277, P4925, DOI 10.1074/jbc.M109278200; URAYAMA O, 1989, J BIOL CHEM, V264, P8271; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Xie ZJ, 1999, J BIOL CHEM, V274, P19323, DOI 10.1074/jbc.274.27.19323; Yu SP, 2003, BIOCHEM PHARMACOL, V66, P1601, DOI 10.1016/S0006-2952(03)00531-8; Zhang M, 2009, BIOSCIENCE REP, V29, P193, DOI 10.1042/BSR20090032	43	34	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15517	15524		10.1074/jbc.M110.204396	http://dx.doi.org/10.1074/jbc.M110.204396			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21362623	hybrid, Green Published			2022-12-27	WOS:000289788300079
J	Koehler, C; Carlier, L; Veggi, D; Balducci, E; Di Marcello, F; Ferrer-Navarro, M; Pizza, M; Daura, X; Soriani, M; Boelens, R; Bonvin, AMJJ				Koehler, Christian; Carlier, Ludovic; Veggi, Daniele; Balducci, Enrico; Di Marcello, Federica; Ferrer-Navarro, Mario; Pizza, Mariagrazia; Daura, Xavier; Soriani, Marco; Boelens, Rolf; Bonvin, Alexandre M. J. J.			Structural and Biochemical Characterization of NarE, an Iron-containing ADP-ribosyltransferase from Neisseria meningitidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERTUSSIS TOXIN; PROTEIN STRUCTURES; CRYSTAL-STRUCTURE; BINDING SITE; RIBOSYLATION; SEQUENCE; HADDOCK; C-13	NarE is a 16 kDa protein identified from Neisseria meningitidis, one of the bacterial pathogens responsible for meningitis. NarE belongs to the family of ADP-ribosyltransferases (ADPRT) and catalyzes the transfer of ADP-ribose moieties to arginine residues in target protein acceptors. Many pathogenic bacteria utilize ADP-ribosylating toxins to modify and alter essential functions of eukaryotic cells. NarE is further the first ADPRT which could be shown to bind iron through a Fe-S center, which is crucial for the catalytic activity. Here we present the NMR solution structure of NarE, which shows structural homology to other ADPRTs. Using NMR titration experiments we could identify from Chemical Shift Perturbation data both the NAD binding site, which is in perfect agreement with a consensus sequence analysis between different ADPRTs, as well as the iron coordination site, which consists of 2 cysteines and 2 histidines. This atypical iron coordination is also capable to bind zinc. These results could be fortified by site-directed mutagenesis of the catalytic region, which identified two functionally crucial residues. We could further identify a main interaction region of NarE with antibodies using two complementary methods based on antibody immobilization, proteolytic digestion, and mass spectrometry. This study combines structural and functional features of NarE providing for the first time a characterization of an iron-dependent ADPRT.	[Koehler, Christian; Carlier, Ludovic; Boelens, Rolf; Bonvin, Alexandre M. J. J.] Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Ferrer-Navarro, Mario; Daura, Xavier] Univ Autonoma Barcelona, Inst Biotechnol & Biomed, Bellaterra 08193, Barcelona, Spain; [Veggi, Daniele; Di Marcello, Federica; Pizza, Mariagrazia; Soriani, Marco] Novartis Vaccines & Diagnost, I-53100 Siena, Italy; [Daura, Xavier] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Spain; [Balducci, Enrico] Univ Camerino, Sch Biosci & Biotechnol, I-62032 Camerino, Italy	Utrecht University; Autonomous University of Barcelona; Novartis; ICREA; University of Camerino	Bonvin, AMJJ (corresponding author), Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	a.m.j.j.bonvin@uu.nl	Daura, Xavier/C-9275-2009; Bonvin, Alexandre M.J.J./A-5420-2009; Boelens, Rolf/B-4702-2009	Daura, Xavier/0000-0001-9235-6730; Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Boelens, Rolf/0000-0002-6939-8913; SORIANI, Marco/0000-0002-9752-5844; Carlier, Ludovic/0000-0002-9036-6561; Balducci, Enrico/0000-0001-6147-9033; Ferrer-Navarro, Mario/0000-0001-9990-914X	European Union [LSHB-CT-2006-037325]; eNMR Project [213010]; National GRID Initiatives of Italy, Germany; The Netherlands; ICREA Funding Source: Custom	European Union(European Commission); eNMR Project; National GRID Initiatives of Italy, Germany; The Netherlands(Netherlands Government); ICREA(ICREA)	This project was supported by funding under the Sixth Research Framework Programme of the European Union (Ref. LSHB-CT-2006-037325, BacAbs). The eNMR Project (European FP7 e-Infrastructure Grant, Contract no. 213010), supported by the National GRID Initiatives of Italy, Germany, and The Netherlands.	Althaus F R, 1987, Mol Biol Biochem Biophys, V37, P1; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bonvin Alexandre M. J. J., 2010, Journal of Structural and Functional Genomics, V11, P1, DOI 10.1007/s10969-010-9084-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carlier L, 2011, BIOMOL NMR ASSIGN, V5, P35, DOI 10.1007/s12104-010-9261-6; CLORE GM, 1991, PROG NUCL MAG RES SP, V23, P43, DOI 10.1016/0079-6565(91)80002-J; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Del Vecchio M, 2009, J BIOL CHEM, V284, P33040, DOI 10.1074/jbc.M109.057547; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Genco CA, 2010, NEISSERIA: MOLECULAR MECHANISMS OF PATHOGENESIS, P1; Goddard T. D., SPARKY 3; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; GUENTERT P, 2004, AUTOMATED NMR PROTEI, P353; Hazes B, 1996, J MOL BIOL, V258, P661, DOI 10.1006/jmbi.1996.0277; Hill DJ, 2010, CLIN SCI, V118, P547, DOI 10.1042/CS20090513; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jobling MG, 2001, J BACTERIOL, V183, P4024, DOI 10.1128/JB.183.13.4024-4032.2001; Kato-Murayama M, 2005, J MOL BIOL, V348, P295, DOI 10.1016/j.jmb.2005.02.049; KAY LE, 1990, J AM CHEM SOC, V112, P888, DOI 10.1021/ja00158a070; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu Q, 2009, J BIOL CHEM, V284, P27637, DOI 10.1074/jbc.M109.031005; LOCHT C, 1986, SCIENCE, V232, P1258, DOI 10.1126/science.3704651; Masignani V, 2004, INT J MED MICROBIOL, V293, P471, DOI 10.1078/1438-4221-00296; Masignani V, 2003, MOL MICROBIOL, V50, P1055, DOI 10.1046/j.1365-2958.2003.03770.x; MERRITT EA, 1994, MOL MICROBIOL, V13, P745, DOI 10.1111/j.1365-2958.1994.tb00467.x; MONTELIONE GT, 1992, J AM CHEM SOC, V114, P10974, DOI 10.1021/ja00053a051; MOSS J, 1981, P NATL ACAD SCI-BIOL, V78, P4809, DOI 10.1073/pnas.78.8.4809; MOSS J, 1976, P NATL ACAD SCI USA, V73, P4424, DOI 10.1073/pnas.73.12.4424; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Peter JF, 2001, ANAL CHEM, V73, P4012, DOI 10.1021/ac010258n; PIZZA M, 1989, SCIENCE, V246, P497, DOI 10.1126/science.2683073; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Singer AU, 2004, STRUCTURE, V12, P1669, DOI 10.1016/j.str.2004.06.023; Soriani M, 2010, J BIOL CHEM, V285, P30126, DOI 10.1074/jbc.M110.118513; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; XU YR, 1994, J BIOL CHEM, V269, P9993	39	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14842	14851		10.1074/jbc.M110.193623	http://dx.doi.org/10.1074/jbc.M110.193623			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21367854	Green Published, hybrid			2022-12-27	WOS:000289788300014
J	Shiose, S; Chen, Y; Okano, K; Roy, S; Kohno, H; Tang, J; Pearlman, E; Maeda, T; Palczewski, K; Maeda, A				Shiose, Satomi; Chen, Yu; Okano, Kiichiro; Roy, Sanhita; Kohno, Hideo; Tang, Johnny; Pearlman, Eric; Maeda, Tadao; Palczewski, Krzysztof; Maeda, Akiko			Toll-like Receptor 3 Is Required for Development of Retinopathy Caused by Impaired All-trans-retinal Clearance in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT FACTOR-H; MACULAR DEGENERATION; GEOGRAPHIC ATROPHY; INNATE IMMUNITY; MESSENGER-RNA; AGE; RISK; VARIANT; SUSCEPTIBILITY; COMMON	Chronic inflammation is an important component that contributes to many age-related neurodegenerative diseases, including macular degeneration. Here, we report a role for toll-like receptor 3 (TLR3) in cone-rod dystrophy (CORD) of mice lacking ATP-binding cassette transporter 4 (ABCA4) and retinol dehydrogenase 8 (RDH8), proteins critical for all-trans-retinal clearance in the retina. Increased expression of toll-like receptor-signaling elements and inflammatory changes were observed in Rdh8(-/-) Abca4(-/-) eyes by RNA expression analysis. Unlike 3-month-old Rdh8(-/-) Abca4(-/-) mice that developed CORD, 6-month-old Tlr3(-/-) Rdh8(-/-) Abca4(-/-) mice did not evidence an abnormal retinal phenotype. Light-induced retinal degeneration in Tlr3(-/-) Rdh8(-/-) Abca4(-/-) mice was milder than that in Rdh8(-/-) Abca4(-/-) mice, and a 2-fold increased TLR3 expression was detected in light-illuminated retinas of Rdh8(-/-) Abca4(-/-) mice compared with nonilluminated retinas. Poly(I-C), a TLR3 ligand, caused caspase-8-independent cellular apoptosis. Whereas poly(I-C) induced retinal cell death in Rdh8(-/-) Abca4(-/-) and WT mice both in vivo and ex vivo, this was not seen in mice lacking Tlr3. Far fewer invasive macrophage/microglialcells in the subretinal space and weaker activation of Muller glial cells were exhibited by Tlr3(-/-) Rdh8(-/-) Abca4(-/-) mice compared with Rdh8(-/-) Abca4(-/-) mice at 3 and 6 months of age, indicating that loss of TLR3 inhibits local inflammation in the retina. Both poly(I-C) and endogenous products emanating from dying/dead retinal cells induced NF-kappa B and IRF3 activation. These findings demonstrate that endogenous products from degenerating retina stimulate TLR3 that causes cellular apoptosis and retinal inflammation and that loss of TLR3 protects mice from CORD.	[Palczewski, Krzysztof; Maeda, Akiko] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Maeda, Akiko] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Sch Med, Cleveland, OH 44106 USA; [Tang, Johnny] Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu; aam19@case.edu		ROY, SANHITA/0000-0002-0407-8177	National Institutes of Health [K08EY019031, K08EY019880, EY009339, EY021126, P30 EY11373]; Veterans Affairs Medical Center; Research to Prevent Blindness Foundation; Foundation Fighting Blindness; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [R24EY021126, P30EY011373, K08EY019031, K08EY019880, R01EY009339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Medical Center; Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness(European Commission); Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants K08EY019031, K08EY019880, EY009339, EY021126, and P30 EY11373. This work was also supported by a Veterans Affairs Medical Center career development grant, Research to Prevent Blindness Foundation, Foundation Fighting Blindness, and the Ohio Lions Eye Research Foundation.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 2009, NEW ENGL J MED, V360, P2252; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Arora A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-1; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Cho YE, 2009, INVEST OPHTH VIS SCI, V50, P5614, DOI 10.1167/iovs.09-3688; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Deleidi M, 2010, J NEUROSCI, V30, P16091, DOI 10.1523/JNEUROSCI.2400-10.2010; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Edwards AO, 2008, INVEST OPHTH VIS SCI, V49, P1652, DOI 10.1167/iovs.07-1378; Edwards AO, 2009, NEW ENGL J MED, V360, P2254; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; EILAT D, 1994, MOL IMMUNOL, V31, P1377, DOI 10.1016/0161-5890(94)90154-6; Fiala M, 2007, P NATL ACAD SCI USA, V104, P12849, DOI 10.1073/pnas.0701267104; Ginsberg SD, 1999, ANN NEUROL, V45, P174, DOI 10.1002/1531-8249(199902)45:2<174::AID-ANA7>3.0.CO;2-E; Glenn JV, 2009, INVEST OPHTH VIS SCI, V50, P441, DOI 10.1167/iovs.08-1724; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Johnson AC, 2008, J BIOL CHEM, V283, P3988, DOI 10.1074/jbc.M707264200; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Kam JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013127; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Kumar MV, 2004, J NEUROIMMUNOL, V153, P7, DOI 10.1016/j.jneuroim.2004.04.018; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lewin AS, 2009, NEW ENGL J MED, V360, P2251, DOI 10.1056/NEJMc082233; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liew G, 2009, NEW ENGL J MED, V360, P2252; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2010, P NATL ACAD SCI USA, V107, P8428, DOI 10.1073/pnas.1000640107; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Ryan D, 2006, MOL VIS, V12, P1175; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Shen DF, 2006, OPHTHALMIC RES, V38, P71, DOI 10.1159/000090266; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Sparrow JR, 2001, INVEST OPHTH VIS SCI, V42, P1356; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Vives-Bauza C, 2008, J BIOL CHEM, V283, P24770, DOI 10.1074/jbc.M800706200; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Weber A, 2010, CELL DEATH DIFFER, V17, P942, DOI 10.1038/cdd.2009.190; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yoneda K, 2008, INT J ONCOL, V33, P929, DOI 10.3892/ijo_00000080; Zareparsi S, 2005, HUM MOL GENET, V14, P1449, DOI 10.1093/hmg/ddi154	68	44	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15543	15555		10.1074/jbc.M111.228551	http://dx.doi.org/10.1074/jbc.M111.228551			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21383019	Green Published, hybrid			2022-12-27	WOS:000289788300082
J	Vitrac, H; Bogdanov, M; Heacock, P; Dowhan, W				Vitrac, Heidi; Bogdanov, Mikhail; Heacock, Phil; Dowhan, William			Lipids and Topological Rules of Membrane Protein Assembly BALANCE BETWEEN LONG AND SHORT RANGE LIPID-PROTEIN INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-COMPOSITION; TOPOGENIC SIGNALS; CYSTEINE RESIDUES; TRANSPORT PROTEIN; LACTOSE PERMEASE; CHARGED RESIDUES; PLASMA-MEMBRANE; ATP SYNTHASE	The N-terminal six-transmembrane domain (TM) bundle of lactose permease of Escherichia coli is uniformly inverted when assembled in membranes lacking phosphatidylethanolamine (PE). Inversion is dependent on the net charge of cytoplasmically exposed protein domains containing positive and negative residues, net charge of the membrane surface, and low hydrophobicity of TM VII acting as a molecular hinge between the two halves of lactose permease (Bogdanov, M., Xie, J., Heacock, P., and Dowhan, W. (2008) J. Cell Biol. 182, 925-935). Net neutral lipids suppress the membrane translocation potential of negatively charged amino acids, thus increasing the cytoplasmic retention potential of positively charged amino acids. Herein, TM organization of sucrose permease (CscB) and phenylalanine permease (PheP) as a function of membrane lipid composition was investigated to extend these principles to other proteins. For CscB, topological dependence on PE only becomes evident after a significant increase in the net negative charge of the cytoplasmic surface of the N-terminal TM bundle. High negative charge is required to overcome the thermodynamic block to inversion due to the high hydrophobicity of TM VII. Increasing the positive charge of the cytoplasmic surface of the N-terminal TM hairpin of PheP, which is misoriented in PE-lacking cells, favors native orientation in the absence of PE. PheP and CscB also display co-existing dual topologies dependent on changes in the charge balance between protein domains and the membrane lipids. Therefore, the topology of both permeases is dependent on PE. However, CscB topology is governed by thermodynamic balance between opposing lipid-dependent electrostatic and hydrophobic interactions.	[Vitrac, Heidi; Bogdanov, Mikhail; Heacock, Phil; Dowhan, William] Univ Texas Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Bogdanov, M (corresponding author), Univ Texas Med Sch, Dept Biochem & Mol Biol, 6431 Fannin St,Suite 6-200, Houston, TX 77030 USA.	Mikhail.V.Bogdanov@uth.tmc.edu; William.Dowhan@uth.tmc.edu	Bogdanov, Mikhail/J-3695-2017; Vitrac, Heidi/R-7117-2018	Vitrac, Heidi/0000-0002-8858-4914	National Institutes of Health [GM R37 20478]; John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM R37 20478 (to W.D.). This work was also supported by a grant from the John Dunn Research Foundation (to W.D.).	BELTZER JP, 1991, J BIOL CHEM, V266, P973; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Bogdanov M, 2010, P NATL ACAD SCI USA, V107, P15057, DOI 10.1073/pnas.1006286107; Bogdanov M, 2010, METHODS MOL BIOL, V619, P79, DOI 10.1007/978-1-60327-412-8_5; Bogdanov M, 2009, J BIOL CHEM, V284, P9637, DOI 10.1074/jbc.R800081200; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Dowhan W, 2009, J LIPID RES, V50, pS305, DOI 10.1194/jlr.R800041-JLR200; DUNLOP J, 1995, EMBO J, V14, P3609, DOI 10.1002/j.1460-2075.1995.tb00030.x; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Granseth E, 2005, J MOL BIOL, V346, P377, DOI 10.1016/j.jmb.2004.11.036; Gulshan K, 2010, MOL BIOL CELL, V21, P443, DOI 10.1091/mbc.E09-06-0519; Guo DP, 1996, J BIOL CHEM, V271, P30829, DOI 10.1074/jbc.271.48.30829; Guo Y, 2010, J BIOL CHEM, V285, P39564, DOI 10.1074/jbc.M110.177055; Junne T, 2010, MOL BIOL CELL, V21, P1662, DOI 10.1091/mbc.E10-01-0060; LEE E, 1994, J BIOL CHEM, V269, P28822; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Monne M, 2005, FEBS J, V272, P28, DOI 10.1111/j.1432-1033.2004.04394.x; Nakamura H, 2000, BIOSCI BIOTECH BIOCH, V64, P167, DOI 10.1271/bbb.64.167; NILSSON IM, 1990, CELL, V62, P1135, DOI 10.1016/0092-8674(90)90390-Z; Opekarova M, 2002, BBA-BIOMEMBRANES, V1564, P9, DOI 10.1016/S0005-2736(02)00455-8; Rutz C, 1999, J BIOL CHEM, V274, P33757, DOI 10.1074/jbc.274.47.33757; Sahin-Toth M, 2000, BIOCHEMISTRY-US, V39, P6164, DOI 10.1021/bi000124o; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; Soekarjo M, 1996, BIOCHEMISTRY-US, V35, P1232, DOI 10.1021/bi951087h; STEITZ TA, 1982, BIOPHYS J, V37, P124, DOI 10.1016/S0006-3495(82)84633-X; vanKlompenburg W, 1997, EMBO J, V16, P4261, DOI 10.1093/emboj/16.14.4261; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; White SH, 2005, BIOCHEM SOC T, V33, P1012, DOI 10.1042/BST0331012; Wikstrom M, 2004, J BIOL CHEM, V279, P10484, DOI 10.1074/jbc.M310183200; Wikstrom M, 2009, J BIOL CHEM, V284, P954, DOI 10.1074/jbc.M804482200; Xie J, 2006, J BIOL CHEM, V281, P19172, DOI 10.1074/jbc.M602565200; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200; Zhu QS, 1999, J BIOL CHEM, V274, P27898, DOI 10.1074/jbc.274.39.27898	47	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15182	15194		10.1074/jbc.M110.214387	http://dx.doi.org/10.1074/jbc.M110.214387			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21454589	hybrid, Green Published			2022-12-27	WOS:000289788300050
J	Huang, TT; Wang, YM; Yin, J; Du, YH; Tao, MF; Xu, J; Chen, WQ; Lin, SJ; Deng, ZX				Huang, Tingting; Wang, Yemin; Yin, Jun; Du, Yanhua; Tao, Meifeng; Xu, Jing; Chen, Wenqing; Lin, Shuangjun; Deng, Zixin			Identification and Characterization of the Pyridomycin Biosynthetic Gene Cluster of Streptomyces pyridomyceticus NRRL B-2517	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; PRISTINAMYCIN I BIOSYNTHESIS; MBTH-LIKE PROTEINS; BACILLUS-SUBTILIS; ADENYLATION DOMAINS; NATURAL-PRODUCTS; ASSEMBLY-LINE; POLYKETIDE; ENZYME; PRISTINAESPIRALIS	Pyridomycin is a structurally unique antimycobacterial cyclodepsipeptide containing rare 3-(3-pyridyl)-L-alanine and 2-hydroxy-3-methylpent-2-enoic acid moieties. The biosynthetic gene cluster for pyridomycin has been cloned and identified from Streptomyces pyridomyceticus NRRL B-2517. Sequence analysis of a 42.5-kb DNA region revealed 26 putative open reading frames, including two nonribosomal peptide synthetase (NRPS) genes and a polyketide synthase gene. A special feature is the presence of a polyketide synthase-type ketoreductase domain embedded in an NRPS. Furthermore, we showed that PyrA functioned as an NRPS adenylation domain that activates 3-hydroxypicolinic acid and transfers it to a discrete peptidyl carrier protein, PyrU, which functions as a loading module that initiates pyridomycin biosynthesis in vivo and in vitro. PyrA could also activate other aromatic acids, generating three pyridomycin analogues in vivo.	[Huang, Tingting; Wang, Yemin; Yin, Jun; Du, Yanhua; Tao, Meifeng; Xu, Jing; Chen, Wenqing; Lin, Shuangjun; Deng, Zixin] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Huang, Tingting; Wang, Yemin; Yin, Jun; Du, Yanhua; Tao, Meifeng; Xu, Jing; Chen, Wenqing; Lin, Shuangjun; Deng, Zixin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lin, SJ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, 1954 Huashan Rd, Shanghai 200030, Peoples R China.	linsj@sjtu.edu.cn		Chen, Wenqing/0000-0003-2557-8960	Ministry of Science and Technology of China; National Science Foundation of China	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China 973 and 863 programs and the National Science Foundation of China.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Bruntner C, 1998, EUR J BIOCHEM, V254, P347, DOI 10.1046/j.1432-1327.1998.2540347.x; Cane DE, 1997, CHEM REV, V97, P2463, DOI 10.1021/cr970097g; Cheng YQ, 2006, CHEMBIOCHEM, V7, P471, DOI 10.1002/cbic.200500425; deCrecyLagard V, 1997, J BACTERIOL, V179, P705, DOI 10.1128/jb.179.3.705-713.1997; Dewick P. M, 2002, MED NATURAL PRODUCTS, P307; DEWICK PM, 1995, NAT PROD REP, V12, P579, DOI 10.1039/np9951200579; Du L, 2001, Curr Opin Drug Discov Devel, V4, P215; Du LH, 2001, METAB ENG, V3, P78, DOI 10.1006/mben.2000.0171; Ehling-Schulz M, 2005, APPL ENVIRON MICROB, V71, P105, DOI 10.1128/AEM.71.1.105-113.2005; Felnagle EA, 2010, BIOCHEMISTRY-US, V49, P8815, DOI 10.1021/bi1012854; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; FOSTER JW, 1980, MICROBIOL REV, V44, P83, DOI 10.1128/MMBR.44.1.83-105.1980; Gehring AM, 1997, BIOCHEMISTRY-US, V36, P8495, DOI 10.1021/bi970453p; Grunewald J, 2006, MICROBIOL MOL BIOL R, V70, P121, DOI 10.1128/MMBR.70.1.121-146.2006; Ishikawa J, 1999, FEMS MICROBIOL LETT, V174, P251, DOI 10.1111/j.1574-6968.1999.tb13576.x; KELLER U, 1992, J BIOL CHEM, V267, P11745; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KINOSHITA M, 1989, TETRAHEDRON LETT, V30, P7419, DOI 10.1016/S0040-4039(00)70713-1; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Lin SJ, 2009, P NATL ACAD SCI USA, V106, P4183, DOI 10.1073/pnas.0808880106; MAEDA K, 1957, J ANTIBIOT, V10, P94; MAEDA KENJI, 1953, JOUR ANTIBIOTICS [TOKYO], V6, P140; Magarvey NA, 2006, ACS CHEM BIOL, V1, P766, DOI 10.1021/cb6004307; Magarvey NA, 2006, J AM CHEM SOC, V128, P10698, DOI 10.1021/ja0640187; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Mast Y, 2011, MICROB BIOTECHNOL, V4, P192, DOI 10.1111/j.1751-7915.2010.00213.x; May JJ, 2001, J BIOL CHEM, V276, P7209, DOI 10.1074/jbc.M009140200; Molnar I, 2000, CHEM BIOL, V7, P97, DOI 10.1016/S1074-5521(00)00075-2; NAKANO MM, 1992, MOL GEN GENET, V232, P313, DOI 10.1007/BF00280011; Namwat W, 2002, J BACTERIOL, V184, P4811, DOI 10.1128/JB.184.17.4811-4818.2002; Namwat W, 2002, GENE, V286, P283, DOI 10.1016/S0378-1119(02)00424-9; OGAWARA H, 1968, CHEM PHARM BULL, V16, P679; OGAWARA H, 1968, BIOCHEMISTRY-US, V7, P3296, DOI 10.1021/bi00849a037; Olsen JG, 1999, FEBS LETT, V460, P46, DOI 10.1016/S0014-5793(99)01303-4; Orsburn BC, 2010, MOL MICROBIOL, V75, P178, DOI 10.1111/j.1365-2958.2009.06975.x; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Ramaswamy AV, 2007, J NAT PROD, V70, P1977, DOI 10.1021/np0704250; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHLUMBOHM W, 1990, J BIOL CHEM, V265, P2156; Schmoock G, 2005, J BIOL CHEM, V280, P4339, DOI 10.1074/jbc.M411026200; Shen B, 2001, J IND MICROBIOL BIOT, V27, P378, DOI 10.1038/sj.jim.7000194; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Thibaut D, 1997, J BACTERIOL, V179, P697, DOI 10.1128/jb.179.3.697-704.1997; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; Waters B, 2002, J ANTIBIOT, V55, P407, DOI 10.7164/antibiotics.55.407; Weber T, 2000, STRUCT FOLD DES, V8, P407, DOI 10.1016/S0969-2126(00)00120-9; Wolpert M, 2007, MICROBIOL-SGM, V153, P1413, DOI 10.1099/mic.0.2006/002998-0; YUAN L, 1983, ANTIBIOTICS, V8, P380; Zaleta-Rivera K, 2006, BIOCHEMISTRY-US, V45, P2561, DOI 10.1021/bi052085s; Zhang WJ, 2010, BIOCHEMISTRY-US, V49, P9946, DOI 10.1021/bi101539b	58	40	44	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20648	20657		10.1074/jbc.M110.180000	http://dx.doi.org/10.1074/jbc.M110.180000			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21454714	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000291267600051
J	Dong, L; Vecchio, AJ; Sharma, NP; Jurban, BJ; Malkowski, MG; Smith, WL				Dong, Liang; Vecchio, Alex J.; Sharma, Narayan P.; Jurban, Brice J.; Malkowski, Michael G.; Smith, William L.			Human Cyclooxygenase-2 Is a Sequence Homodimer That Functions as a Conformational Heterodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN-H SYNTHASE; ARACHIDONIC-ACID; SUBCELLULAR-LOCALIZATION; PROTEIN-DEGRADATION; MOLECULAR-GRAPHICS; GENETIC-VARIANTS; FATTY-ACIDS; CROSS-TALK; CRYSTALLOGRAPHY; BINDING	Prostaglandin endoperoxide H synthases 1 and 2, also known as cyclooxygenases (COXs) 1 and 2, convert arachidonic acid (AA) to prostaglandin endoperoxide H-2. Prostaglandin endoperoxide H synthases are targets of nonspecific nonsteroidal anti-inflammatory drugs and COX-2-specific inhibitors called coxibs. PGHS-2 is a sequence homodimer. Each monomer has a peroxidase and a COX active site. We find that human PGHS-2 functions as a conformational heterodimer having a catalytic monomer (E-cat) and an allosteric monomer (E-allo). Heme binds tightly only to the peroxidase site of E-cat, whereas substrates, as well as certain inhibitors (e.g. celecoxib), bind the COX site of E-cat. E-cat is regulated by E-allo in a manner dependent on what ligand is bound to E-allo. Substrate and nonsubstrate fatty acids (FAs) and some COX inhibitors (e. g. naproxen) preferentially bind to the COX site of E-allo. AA can bind to E-cat and E-allo, but the affinity of AA for E-allo is 25 times that for E-cat. Palmitic acid, an efficacious stimulator of human PGHS-2, binds only E-allo in palmitic acid/murine PGHS-2 co-crystals. Nonsubstrate FAs can potentiate or attenuate actions of COX inhibitors depending on the FA and whether the inhibitor binds E-cat or E-allo. Our studies suggest that the concentration and composition of the free FA pool in the environment in which PGHS-2 functions in cells, the FA tone, is a key factor regulating PGHS-2 activity and its responses to COX inhibitors. We suggest that differences in FA tone occurring with different diets will likely affect both baseline prostanoid synthesis and responses to COX inhibitors.	[Dong, Liang; Sharma, Narayan P.; Jurban, Brice J.; Smith, William L.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Vecchio, Alex J.; Malkowski, Michael G.] SUNY Buffalo, Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Vecchio, Alex J.; Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA	University of Michigan System; University of Michigan; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Smith, WL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	smithww@umich.edu	Malkowski, Michael G/G-4939-2011	Malkowski, Michael G/0000-0003-1025-0014; Vecchio, Alex/0000-0002-4222-7874; Malkowski, Michael/0000-0002-1203-7463	National Institutes of Health [GM 068848, GM 077176]; National Science Foundation [DMR-0225180]; National Institutes of Health, NCRR [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068848, R01GM077176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 068848 (to W. L. S.) and GM 077176 (to M. G. M.). This work was based on research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by National Science Foundation Award DMR-0225180, using the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by National Institutes of Health Award RR-01646 from NCRR.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burian M, 2005, PHARMACOL THERAPEUT, V107, P139, DOI 10.1016/j.pharmthera.2005.02.004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Duncan T, 1999, J LIPID RES, V40, P1222; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gorski J, 1998, MOL CELL BIOCHEM, V178, P113, DOI 10.1023/A:1006820907955; Grosser T, 2010, ANNU REV MED, V61, P17, DOI 10.1146/annurev-med-011209-153129; HAMBERG M, 1967, J BIOL CHEM, V242, P5336; Huber WJ, 2008, ANAL BIOCHEM, V373, P167, DOI 10.1016/j.ab.2007.10.010; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; KULMACZ RJ, 1984, J BIOL CHEM, V259, P6358; KULMACZ RJ, 1985, J BIOL CHEM, V260, P2572; LAGARDE M, 1984, BIOMED BIOCHIM ACTA, V43, pS319; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lapicque F, 2000, CLIN PHARMACOKINET, V39, P369, DOI 10.2165/00003088-200039050-00005; Liu JY, 2007, J BIOL CHEM, V282, P18233, DOI 10.1074/jbc.M701235200; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Mathias RA, 2010, J LIPID RES, V51, P2766, DOI 10.1194/jlr.M008359; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muth-Selbach US, 1999, ANESTHESIOLOGY, V91, P231, DOI 10.1097/00000542-199907000-00032; OTTO JC, 1994, J BIOL CHEM, V269, P19868; PERCIVAL MD, 1994, ARCH BIOCHEM BIOPHYS, V315, P111, DOI 10.1006/abbi.1994.1478; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Rimon G, 2010, P NATL ACAD SCI USA, V107, P28, DOI 10.1073/pnas.0909765106; ROLLINS TE, 1980, J BIOL CHEM, V255, P4872; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sharma NP, 2010, MOL PHARMACOL, V77, P979, DOI 10.1124/mol.109.063115; Sidhu RS, 2010, BIOCHEMISTRY-US, V49, P7069, DOI 10.1021/bi1003298; Simopoulos AP, 2010, EXP BIOL MED, V235, P785, DOI 10.1258/ebm.2010.009298; Smith WL, 2008, TRENDS BIOCHEM SCI, V33, P27, DOI 10.1016/j.tibs.2007.09.013; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Spencer AG, 1999, J BIOL CHEM, V274, P32936, DOI 10.1074/jbc.274.46.32936; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Thuresson ED, 2001, J BIOL CHEM, V276, P10358, DOI 10.1074/jbc.M009378200; Tsai AL, 2010, ARCH BIOCHEM BIOPHYS, V493, P103, DOI 10.1016/j.abb.2009.08.019; Tsai AL, 2002, J BIOL CHEM, V277, P38311, DOI 10.1074/jbc.M206961200; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xiao GS, 1998, J BIOL CHEM, V273, P6801, DOI 10.1074/jbc.273.12.6801; Yu Y, 2005, J CLIN INVEST, V115, P986, DOI 10.1172/JCI23683; Yu Y, 2007, J BIOL CHEM, V282, P1498, DOI 10.1074/jbc.M609930200; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200	54	77	81	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19035	19046		10.1074/jbc.M111.231969	http://dx.doi.org/10.1074/jbc.M111.231969			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21467029	hybrid, Green Published			2022-12-27	WOS:000290785700074
J	Winkler, DD; Luger, K				Winkler, Duane D.; Luger, Karolin			The Histone Chaperone FACT: Structural Insights and Mechanisms for Nucleosome Reorganization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RNA-POLYMERASE-II; TRANSCRIPTION ELONGATION-FACTORS; N-TERMINAL DOMAIN; SACCHAROMYCES-CEREVISIAE; IN-VIVO; DNA-REPLICATION; CHD1 INTERACTS; YEAST FACT; CHROMATIN; COMPLEX	Changes in chromatin architecture induced by epigenetic mechanisms are essential for normal cellular processes such as gene expression, DNA repair, and cellular division. Compact chromatin presents a barrier to these processes and is highly regulated by epigenetic markers binding to components of the nucleosome. Histone modifications directly influence chromatin dynamics and facilitate recruitment of additional factors such as chromatin remodelers and histone chaperones. One member of this last class of factors, FACT (facilitates chromatin transcription), is categorized as a histone chaperone critical for nucleosome reorganization during replication, transcription, and DNA repair. Significant discoveries regarding the role of histone chaperones and specifically FACT have come over the past dozen years from a number of independent laboratories. Here, we review the structural and biophysical basis for FACT-mediated nucleosome reorganization and discuss up-to-date models for FACT function.	[Luger, Karolin] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Howard Hughes Medical Institute	Luger, K (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	karolin.luger@colostate.edu		SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331; Winkler, Duane D./0000-0003-1045-0323	National Institutes of Health [1P01GM088409-01A1]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM088409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1P01GM088409-01A1. This work was also supported by the Howard Hughes Medical Institute (to D. D. W. and K. L.). This is the fourth article in the Thematic Minireview Series on Epigenetics. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Biswas D, 2005, MOL CELL BIOL, V25, P5812, DOI 10.1128/MCB.25.14.5812-5822.2005; Brewster NK, 1998, J BIOL CHEM, V273, P21972, DOI 10.1074/jbc.273.34.21972; Brewster NK, 2001, MOL CELL BIOL, V21, P3491, DOI 10.1128/MCB.21.10.3491-3502.2001; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chang CH, 1997, J BIOL CHEM, V272, P23427, DOI 10.1074/jbc.272.37.23427; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2002, GENETICS, V162, P1557; Formosa T, 2008, MOL BIOSYST, V4, P1085, DOI 10.1039/b812136b; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Huang JY, 2006, NUCLEIC ACIDS RES, V34, P2398, DOI 10.1093/nar/gkl241; JACKSON V, 1990, BIOCHEMISTRY-US, V29, P719, DOI 10.1021/bi00455a019; Kasai N, 2005, J BIOMOL NMR, V32, P83, DOI 10.1007/s10858-005-3662-3; Keller DM, 2002, J BIOL CHEM, V277, P50206, DOI 10.1074/jbc.M209820200; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kelley DE, 1999, CHROMOSOMA, V108, P10, DOI 10.1007/s004120050347; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Masse JE, 2002, J MOL BIOL, V323, P263, DOI 10.1016/S0022-2836(02)00938-5; McBryant SJ, 2010, CELL RES, V20, P519, DOI 10.1038/cr.2010.35; Moreira JMA, 2000, EMBO J, V19, P6804, DOI 10.1093/emboj/19.24.6804; Morillo-Huesca M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000964; Ner SS, 2001, J BIOL CHEM, V276, P37569, DOI 10.1074/jbc.M105635200; O'Donnell AF, 2004, NUCLEIC ACIDS RES, V32, P5894, DOI 10.1093/nar/gkh922; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Philpott A, 2000, SEMIN CELL DEV BIOL, V11, P7, DOI 10.1006/scdb.1999.0346; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; Rhoades AR, 2004, MOL CELL BIOL, V24, P3907, DOI 10.1128/MCB.24.9.3907-3917.2004; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rondon AG, 2004, EMBO REP, V5, P47, DOI 10.1038/sj.embor.7400045; Ruone S, 2003, J BIOL CHEM, V278, P45288, DOI 10.1074/jbc.M307291200; Schlesinger MB, 2000, GENETICS, V155, P1593; Shi XM, 1996, MOL CELL BIOL, V16, P669; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Tsunaka Y, 2009, J BIOL CHEM, V284, P24610, DOI 10.1074/jbc.M109.001958; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Woodcock CL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000596; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002	58	145	146	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18369	18374		10.1074/jbc.R110.180778	http://dx.doi.org/10.1074/jbc.R110.180778			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454601	Green Published, hybrid			2022-12-27	WOS:000290785700009
J	Kuda, O; Jenkins, CM; Skinner, JR; Moon, SH; Su, X; Gross, RW; Abumrad, NA				Kuda, Ondrej; Jenkins, Christopher M.; Skinner, James R.; Moon, Sung Ho; Su, Xiong; Gross, Richard W.; Abumrad, Nada A.			CD36 Protein Is Involved in Store-operated Calcium Flux, Phospholipase A2 Activation, and Production of Prostaglandin E2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; ENDOPLASMIC-RETICULUM STRESS; MECHANISM-BASED DISCRIMINATION; SCAVENGER RECEPTOR CD36; HAMSTER OVARY CELLS; CYTOSOLIC PHOSPHOLIPASE; FATTY-ACID; TYROSINE KINASES; CYCLOOXYGENASE-2 GENE; ENDOTHELIAL-CELLS	The scavenger receptor FAT/CD36 contributes to the inflammation associated with diabetes, atherosclerosis, thrombosis, and Alzheimer disease. Underlying mechanisms include CD36 promotion of oxidative stress and its signaling to stress kinases. Here we document an additional mechanism for the role of CD36 in inflammation. CD36 regulates membrane calcium influx in response to endoplasmic reticulum (ER) stress, release of arachidonic acid (AA) from cellular membranes by cytoplasmic phospholipase A(2)alpha (cPLA(2)alpha) and contributes to the generation of proinflammatory eicosanoids. CHO cells stably expressing human CD36 released severalfold more AA and prostaglandin E-2 (PGE(2)), a major product of AA metabolism by cyclooxygenases, in response to thapsigargin-induced ER stress as compared with control cells. Calcium influx after ER calcium release resulted in phosphorylation of cPLA(2) and its translocation to membranes in a CD36-dependent manner. Peritoneal macrophages from CD36(-/-) mice exhibited diminished calcium transients and reduced AA release after thapsigargin or UTP treatment with decreased ERK1/2 and cPLA(2) phosphorylation. However, PGE(2) production was unexpectedly enhanced in CD36(-/-) macrophages, which probably resulted from a large induction of cyclooxygenase 2 mRNA and protein. The data demonstrate participation of CD36 in membrane calcium influx in response to ER stress or purinergic receptor stimulation resulting in AA liberation for PGE(2) formation. Collectively, these results identify a mechanism contributing to the pleiotropic proinflammatory effects of CD36 and suggest that its targeted inhibition may reduce the acute inflammatory response.	[Kuda, Ondrej; Skinner, James R.; Su, Xiong; Abumrad, Nada A.] Washington Univ, Sch Med, Ctr Human Nutr, Dept Med, St Louis, MO 63110 USA; [Jenkins, Christopher M.; Moon, Sung Ho; Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Abumrad, NA (corresponding author), Washington Univ, Sch Med, Ctr Human Nutr, Dept Med, Campus Box 8031, St Louis, MO 63110 USA.	NAbumrad@DOM.wustl.edu	Kuda, Ondrej/B-7990-2012	Kuda, Ondrej/0000-0001-7034-4536	National Institutes of Health (NIH) [P01 HL057278, R01 DK33301, DK56351, DK 56341, R01 HL-41250]; NIH, NHLBI [T32 HL-007275]; American Heart Association [835140N]; Nutrition and Obesity Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275, R01HL041250, P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033301, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Nutrition and Obesity Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants P01 HL057278, R01 DK33301, DK56351, and R01 HL-41250 and NIH, NHLBI, Training Grant T32 HL-007275 (to J.S.). This work was also supported by American Heart Association Scientist Development Grant 835140N (to X. S.).; We thank Dr. Dmitri Samovski for help with the microscopy and Terri Pietka and the Adipocyte Biology and Molecular Nutrition Core (supported by National Institutes of Health Grant DK 56341; Nutrition and Obesity Research Center) for valuable technical assistance.	ALONSO F, 1986, BIOCHIM BIOPHYS ACTA, V878, P273, DOI 10.1016/0005-2760(86)90156-6; Babnigg G, 1997, J BIOL CHEM, V272, P29434, DOI 10.1074/jbc.272.47.29434; Balboa MA, 1997, J BIOL CHEM, V272, P8576, DOI 10.1074/jbc.272.13.8576; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; BULL HA, 1994, FEBS LETT, V351, P41, DOI 10.1016/0014-5793(94)00814-0; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; Cipollone F, 2004, JAMA-J AM MED ASSOC, V291, P2221, DOI 10.1001/jama.291.18.2221; Cubells L, 2008, J BIOL CHEM, V283, P10174, DOI 10.1074/jbc.M706618200; Degagne E, 2009, J IMMUNOL, V183, P4521, DOI 10.4049/jimmunol.0803977; Dickenson JM, 1998, BRIT J PHARMACOL, V124, P1491, DOI 10.1038/sj.bjp.0701977; Dimitrov T, 1997, J VIROL, V71, P2830, DOI 10.1128/JVI.71.4.2830-2837.1997; El-Yassimi A, 2008, J BIOL CHEM, V283, P12949, DOI 10.1074/jbc.M707478200; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Furuyashiki T, 2009, CURR OPIN PHARMACOL, V9, P31, DOI 10.1016/j.coph.2008.12.010; GARCIA M, 1994, BIOCHEM PHARMACOL, V48, P1735, DOI 10.1016/0006-2952(94)90459-6; Geijsen N, 2000, FEBS LETT, V471, P83, DOI 10.1016/S0014-5793(00)01373-9; Ghomashchi F, 2001, BBA-BIOMEMBRANES, V1513, P160, DOI 10.1016/S0005-2736(01)00349-2; Gijon MA, 1999, J LEUKOCYTE BIOL, V65, P330, DOI 10.1002/jlb.65.3.330; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Golej DL, 2011, J LIPID RES, V52, P782, DOI 10.1194/jlr.M013292; Haeggstrom JZ, 2010, BIOCHEM BIOPH RES CO, V396, P135, DOI 10.1016/j.bbrc.2010.03.140; Hamar P, 2004, P NATL ACAD SCI USA, V101, P14883, DOI 10.1073/pnas.0406421101; Handberg A, 2008, STROKE, V39, P3092, DOI 10.1161/STROKEAHA.108.517128; Handberg A, 2006, CIRCULATION, V114, P1169, DOI 10.1161/CIRCULATIONAHA.106.626135; HARMON CM, 1991, J MEMBRANE BIOL, V121, P261, DOI 10.1007/BF01951559; Harper MT, 2010, PLATELETS, V21, P445, DOI 10.3109/09537104.2010.483295; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Hefner Y, 2000, J BIOL CHEM, V275, P37542, DOI 10.1074/jbc.M003395200; Hirabayashi T, 1999, J BIOL CHEM, V274, P5163, DOI 10.1074/jbc.274.8.5163; Hirano K, 2003, TRENDS CARDIOVAS MED, V13, P136, DOI 10.1016/S1050-1738(03)00026-4; Hirao A, 1997, EMBO J, V16, P2342, DOI 10.1093/emboj/16.9.2342; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; Kim KB, 2004, PROTEOMICS, V4, P3527, DOI 10.1002/pmic.200401001; Kohsaka S, 2008, ATHEROSCLEROSIS, V196, P926, DOI 10.1016/j.atherosclerosis.2007.02.010; Konheim YL, 2003, HUM GENET, V113, P377, DOI 10.1007/s00439-003-1000-y; Le Foll C, 2009, AM J PHYSIOL-REG I, V297, pR655, DOI 10.1152/ajpregu.00223.2009; Lee H, 2001, J BIOL CHEM, V276, P35150, DOI 10.1074/jbc.M104530200; Lin WW, 1998, BRIT J PHARMACOL, V123, P1173, DOI 10.1038/sj.bjp.0701705; Lipsky RH, 1997, RECEPT SIGNAL TRANS, V7, P1; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Love-Gregory L, 2011, HUM MOL GENET, V20, P193, DOI 10.1093/hmg/ddq449; Ma XW, 2004, HUM MOL GENET, V13, P2197, DOI 10.1093/hmg/ddh233; Maulon L, 2001, ONCOGENE, V20, P1964, DOI 10.1038/sj.onc.1204266; Millanvoye-Van Brussel E, 1999, J VASC RES, V36, P235, DOI 10.1159/000025647; Moon SH, 2008, J BIOL CHEM, V283, P33975, DOI 10.1074/jbc.M805817200; Mounier CM, 2004, J BIOL CHEM, V279, P25024, DOI 10.1074/jbc.M313019200; Murakami M, 2004, PROG LIPID RES, V43, P3, DOI 10.1016/S0163-7827(03)00037-7; Newcomer ME, 2010, J BIOL CHEM, V285, P25109, DOI 10.1074/jbc.R110.125880; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Pereira C, 2009, EUR J GASTROEN HEPAT, V21, P76, DOI 10.1097/MEG.0b013e32830ce7ba; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Poeckel D, 2010, CARDIOVASC RES, V86, P243, DOI 10.1093/cvr/cvq016; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rudock ME, 2009, ATHEROSCLEROSIS, V203, P459, DOI 10.1016/j.atherosclerosis.2008.07.018; Rutkai I, 2009, CARDIOVASC RES, V83, P148, DOI 10.1093/cvr/cvp098; Sampson MJ, 2003, ATHEROSCLEROSIS, V167, P129, DOI 10.1016/S0021-9150(02)00421-5; Santovito D, 2009, CURR OPIN LIPIDOL, V20, P402, DOI 10.1097/MOL.0b013e32832fa22c; Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010; Shimizu M, 2009, CELL SIGNAL, V21, P440, DOI 10.1016/j.cellsig.2008.11.014; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Smith J, 2008, J BIOL CHEM, V283, P13578, DOI 10.1074/jbc.M800008200; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Sun JF, 2009, AM J PHYSIOL-HEART C, V296, pH1344, DOI 10.1152/ajpheart.01246.2008; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Taylor AA, 2001, ENDOCRIN METAB CLIN, V30, P983, DOI 10.1016/S0889-8529(05)70223-1; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Vazquez G, 2004, J BIOL CHEM, V279, P40521, DOI 10.1074/jbc.M405280200; Zhu XD, 2002, J LEUKOCYTE BIOL, V72, P1046	78	65	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17785	17795		10.1074/jbc.M111.232975	http://dx.doi.org/10.1074/jbc.M111.232975			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454644	hybrid, Green Published			2022-12-27	WOS:000290585200042
J	Taschler, U; Radner, FPW; Heier, C; Schreiber, R; Schweiger, M; Schoiswohl, G; Preiss-Landl, K; Jaeger, D; Reiter, B; Koefeler, HC; Wojciechowski, J; Theussl, C; Penninger, JM; Lass, A; Haemmerle, G; Zechner, R; Zimmermann, R				Taschler, Ulrike; Radner, Franz P. W.; Heier, Christoph; Schreiber, Renate; Schweiger, Martina; Schoiswohl, Gabriele; Preiss-Landl, Karina; Jaeger, Doris; Reiter, Birgit; Koefeler, Harald C.; Wojciechowski, Jacek; Theussl, Christian; Penninger, Josef M.; Lass, Achim; Haemmerle, Guenter; Zechner, Rudolf; Zimmermann, Robert			Monoglyceride Lipase Deficiency in Mice Impairs Lipolysis and Attenuates Diet-induced Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; HORMONE-SENSITIVE LIPASE; ENDOCANNABINOID SYSTEM; MONOACYLGLYCEROL LIPASE; LIPOPROTEIN-LIPASE; ENERGY-METABOLISM; TISSUE; OBESITY; 2-ARACHIDONOYLGLYCEROL; TRIACYLGLYCEROL	Monoglyceride lipase (MGL) influences energy metabolism by at least two mechanisms. First, it hydrolyzes monoacylglycerols (MG) into fatty acids and glycerol. These products can be used for energy production or synthetic reactions. Second, MGL degrades 2-arachidonoyl glycerol (2-AG), the most abundant endogenous ligand of cannabinoid receptors (CBR). Activation of CBR affects energy homeostasis by central orexigenic stimuli, by promoting lipid storage, and by reducing energy expenditure. To characterize the metabolic role of MGL in vivo, we generated an MGL-deficient mouse model (MGL-ko). These mice exhibit a reduction in MG hydrolase activity and a concomitant increase in MG levels in adipose tissue, brain, and liver. In adipose tissue, the lack of MGL activity is partially compensated by hormone-sensitive lipase. Nonetheless, fasted MGL-ko mice exhibit reduced plasma glycerol and triacylglycerol, as well as liver triacylglycerol levels indicative for impaired lipolysis. Despite a strong elevation of 2-AG levels, MGL-ko mice exhibit normal food intake, fat mass, and energy expenditure. Yet mice lacking MGL show a pharmacological tolerance to the CBR agonist CP 55,940 suggesting that the elevated 2-AG levels are functionally antagonized by desensitization of CBR. Interestingly, however, MGL-ko mice receiving a high fat diet exhibit significantly improved glucose tolerance and insulin sensitivity in comparison with wild-type controls despite equal weight gain. In conclusion, our observations implicate that MGL deficiency impairs lipolysis and attenuates diet-induced insulin resistance. Defective degradation of 2-AG does not provoke cannabinoid-like effects on feeding behavior, lipid storage, and energy expenditure, which may be explained by desensitization of CBR.	[Taschler, Ulrike; Radner, Franz P. W.; Heier, Christoph; Schreiber, Renate; Schweiger, Martina; Schoiswohl, Gabriele; Preiss-Landl, Karina; Jaeger, Doris; Lass, Achim; Haemmerle, Guenter; Zechner, Rudolf; Zimmermann, Robert] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Reiter, Birgit; Koefeler, Harald C.] Med Univ Graz, Med Res Ctr, A-8010 Graz, Austria; [Wojciechowski, Jacek; Theussl, Christian; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	University of Graz; Medical University of Graz; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Zimmermann, R (corresponding author), Graz Univ, Inst Mol Biosci, Heinrichstr 31A, A-8010 Graz, Austria.	robert.zimmermann@uni-graz.at	Penninger, Josef M/I-6860-2013; Lass, Achim/C-3332-2008	Penninger, Josef M/0000-0002-8194-3777; Lass, Achim/0000-0002-8190-7151; Kofeler, Harald/0000-0002-2725-9616; Schoiswohl, Gabriele/0000-0002-7346-2834; Schreiber, Renate/0000-0002-3475-157X; Zechner, Rudolf/0000-0001-5483-1182; Heier, Christoph/0000-0001-6858-408X; Schweiger, Martina/0000-0002-3419-1007; Radner, Franz/0000-0003-3466-0181; Zimmermann, Robert/0000-0002-7354-870X; Taschler, Ulrike/0000-0001-9000-1602; Haemmerle, Guenter/0000-0001-9900-5896	Austrian Science Funds [P21296]; DK Molecular Enzymology Grant [W901-B05 DK]; Austrian Federal Ministry for Science and Research; Austrian Science Fund (FWF) [F 3002, Z 136, P 21296, W 901] Funding Source: researchfish	Austrian Science Funds(Austrian Science Fund (FWF)); DK Molecular Enzymology Grant(Austrian Science Fund (FWF)); Austrian Federal Ministry for Science and Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Funds, Project P21296, the DK Molecular Enzymology Grant W901-B05 DK, and by the Austrian Federal Ministry for Science and Research, Project "GOLD-Genomics of Lipid-associated Disorders" in the framework of the Austrian Genome Project "GEN-AU Genome Research in Austria."	Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Chanda PK, 2010, MOL PHARMACOL, V78, P996, DOI 10.1124/mol.110.068304; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Di Marzo V, 2008, DIABETOLOGIA, V51, P1356, DOI 10.1007/s00125-008-1048-2; Di Marzo V, 2009, PHARMACOL RES, V60, P77, DOI 10.1016/j.phrs.2009.02.010; Fiskerstrand T, 2010, AM J HUM GENET, V87, P410, DOI 10.1016/j.ajhg.2010.08.002; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Goldberg IJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD388, DOI 10.2741/Goldberg; Haemmerle G, 2002, J BIOL CHEM, V277, P12946, DOI 10.1074/jbc.M108640200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Heier C, 2010, BBA-MOL CELL BIOL L, V1801, P1063, DOI 10.1016/j.bbalip.2010.06.001; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Karlsson M, 1997, J BIOL CHEM, V272, P27218, DOI 10.1074/jbc.272.43.27218; Karlsson M, 2000, PROTEIN EXPRES PURIF, V18, P286, DOI 10.1006/prep.1999.1194; Kienesberger PC, 2009, J BIOL CHEM, V284, P30218, DOI 10.1074/jbc.M109.047787; Kunos G, 2008, J BIOL CHEM, V283, P33021, DOI 10.1074/jbc.R800012200; Leite CE, 2009, PHARMACOL REP, V61, P217, DOI 10.1016/S1734-1140(09)70025-8; Lichtman AH, 2005, HANDB EXP PHARMACOL, V168, P691; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Lowe ME, 1997, ANNU REV NUTR, V17, P141, DOI 10.1146/annurev.nutr.17.1.141; Maccarrone M, 2010, ANNU REV NUTR, V30, P423, DOI 10.1146/annurev.nutr.012809.104701; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Rodriguez JA, 2010, BBA-MOL CELL BIOL L, V1801, P77, DOI 10.1016/j.bbalip.2009.09.020; Ruby MA, 2008, P NATL ACAD SCI USA, V105, P14561, DOI 10.1073/pnas.0807232105; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sugiura T, 2006, PROG LIPID RES, V45, P405, DOI 10.1016/j.plipres.2006.03.003; TORNQVIST H, 1974, J LIPID RES, V15, P291; TORNQVIST H, 1976, J BIOL CHEM, V251, P813; Wiley JL, 2005, BRIT J PHARMACOL, V145, P293, DOI 10.1038/sj.bjp.0706157; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	39	184	190	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17467	17477		10.1074/jbc.M110.215434	http://dx.doi.org/10.1074/jbc.M110.215434			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454566	hybrid, Green Published			2022-12-27	WOS:000290585200008
J	Bojja, RS; Andrake, MD; Weigand, S; Merkel, G; Yarychkivska, O; Henderson, A; Kummerling, M; Skalka, AM				Bojja, Ravi S.; Andrake, Mark D.; Weigand, Steven; Merkel, George; Yarychkivska, Olya; Henderson, Adam; Kummerling, Marissa; Skalka, Anna Marie			Architecture of a Full-length Retroviral Integrase Monomer and Dimer, Revealed by Small Angle X-ray Scattering and Chemical Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-VIRUS INTEGRASE; DNA-BINDING DOMAIN; C-TERMINAL DOMAIN; INHIBITORY MONOCLONAL-ANTIBODY; REFINED SOLUTION STRUCTURE; HIV-1 INTEGRASE; CATALYTIC DOMAIN; CRYSTAL-STRUCTURE; TYPE-1 INTEGRASE; ACTIVE-SITE	We determined the size and shape of full-length avian sarcoma virus (ASV) integrase (IN) monomers and dimers in solution using small angle x-ray scattering. The low resolution data obtained establish constraints for the relative arrangements of the three component domains in both forms. Domain organization within the small angle x-ray envelopes was determined by combining available atomic resolution data for individual domains with results from cross-linking coupled with mass spectrometry. The full-length dimer architecture so revealed is unequivocally different from that proposed from x-ray crystallographic analyses of two-domain fragments, in which interactions between the catalytic core domains play a prominent role. Core-core interactions are detected only in cross-linked IN tetramers and are required for concerted integration. The solution dimer is stabilized by C-terminal domain (CTD-CTD) interactions and by interactions of the N-terminal domain in one subunit with the core and CTD in the second subunit. These results suggest a pathway for formation of functional IN-DNA complexes that has not previously been considered and possible strategies for preventing such assembly.	[Bojja, Ravi S.; Andrake, Mark D.; Merkel, George; Yarychkivska, Olya; Henderson, Adam; Kummerling, Marissa; Skalka, Anna Marie] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA; [Weigand, Steven] Northwestern Univ, Dupont NW Dow Collaborat Access Team, Synchrotron Res Ctr, Argonne, IL 60439 USA	Fox Chase Cancer Center; Northwestern University	Skalka, AM (corresponding author), Fox Chase Canc Ctr, Inst Canc Res, 333 Cottman Ave, Philadelphia, PA 19111 USA.	AM_Skalka@fccc.edu	Weigand, Steven/G-6181-2015	Weigand, Steven/0000-0003-3137-0672	National Institutes of Health [AI40385, CA71515, CA006927]; Commonwealth of Pennsylvania; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA071515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI40385, CA71515, and CA006927. This work was also supported by an appropriation from the Commonwealth of Pennsylvania.; We thank Drs. Richard Katz, Eileen Jaffe, and Roland Dunbrack for critical comments and helpful discussions and Marie Estes for valuable help in preparing our manuscript. Dr. Peter Cherepanov generously provided a plasmid that expresses PFV IN protein, advice for its preparation, and PFV intasome coordinates prior to publication. Dr. Zimei Bu performed some preliminary SAXS analyses at the Fox Chase Cancer Center, and Dr. S. Seeholzer provided advice for our mass spectrometry analyses. Molecular modeling was performed with the help of the Fox Chase Molecular Modeling Facility and mass spectrometry analyses benefited from assistance of Dr. Yibai Chen in the Fox Chase Biotechnology and Biochemistry Facility. Sequences of all expression plasmid constructs were verified by the Fox Chase DNA Sequencing Facility. Use of APS was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences Grant DE-AC02-06CH11357.	Al-Mawsawi LQ, 2008, VIROLOGY, V377, P353, DOI 10.1016/j.virol.2008.04.030; ANDRAKE MD, 1995, J BIOL CHEM, V270, P29299, DOI 10.1074/jbc.270.49.29299; Baker NM, 2011, NUCLEIC ACIDS RES, V39, P755, DOI 10.1093/nar/gkq799; Bao KK, 2003, J BIOL CHEM, V278, P1323, DOI 10.1074/jbc.C200550200; Bujacz G, 1997, J BIOL CHEM, V272, P18161, DOI 10.1074/jbc.272.29.18161; BUJACZ G, 1995, J MOL BIOL, V253, P333, DOI 10.1006/jmbi.1995.0556; Bujacz G, 1996, STRUCTURE, V4, P89, DOI 10.1016/S0969-2126(96)00012-3; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Chen ZG, 2000, J MOL BIOL, V296, P521, DOI 10.1006/jmbi.1999.3451; Coleman J, 1999, J BIOL CHEM, V274, P32842, DOI 10.1074/jbc.274.46.32842; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Eijkelenboom APAM, 1997, CURR BIOL, V7, P739, DOI 10.1016/S0960-9822(06)00332-0; Eijkelenboom APAM, 2000, J BIOMOL NMR, V18, P119, DOI 10.1023/A:1008342312269; Eijkelenboom APAM, 1999, PROTEINS, V36, P556, DOI 10.1002/(SICI)1097-0134(19990901)36:4<556::AID-PROT18>3.0.CO;2-6; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; ELLISON V, 1995, J BIOL CHEM, V270, P3320, DOI 10.1074/jbc.270.7.3320; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Gao YG, 1998, NAT STRUCT BIOL, V5, P782, DOI 10.1038/1822; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Gupta K, 2010, J BIOL CHEM, V285, P20303, DOI 10.1074/jbc.M110.114413; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Hojrup P., 1990, GEN PROTEIN MASS ANA, P61; Ilavsky J, 2009, J APPL CRYSTALLOGR, V42, P347, DOI 10.1107/S0021889809002222; Jaskolski M, 2009, FEBS J, V276, P2926, DOI 10.1111/j.1742-4658.2009.07009.x; JENKINS TM, 1995, P NATL ACAD SCI USA, V92, P6057, DOI 10.1073/pnas.92.13.6057; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; JONES KS, 1992, J BIOL CHEM, V267, P16037; Karki RG, 2004, J COMPUT AID MOL DES, V18, P739, DOI 10.1007/s10822-005-0365-5; KATZ RA, 1990, CELL, V63, P87, DOI 10.1016/0092-8674(90)90290-U; Kessl JJ, 2009, MOL PHARMACOL, V76, P824, DOI 10.1124/mol.109.058883; Lawrence SH, 2008, CHEM BIOL, V15, P586, DOI 10.1016/j.chembiol.2008.04.012; Lee SP, 1997, BIOCHEMISTRY-US, V36, P173, DOI 10.1021/bi961849o; LevyMintz P, 1996, J VIROL, V70, P8821, DOI 10.1128/JVI.70.12.8821-8832.1996; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Lins RD, 2000, BIOPOLYMERS, V53, P308, DOI 10.1002/(SICI)1097-0282(20000405)53:4<308::AID-BIP3>3.0.CO;2-H; Liu QA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-244; Lo Conte L, 1999, J MOL BIOL, V285, P2177; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; Moreau K, 2003, EUR J BIOCHEM, V270, P4426, DOI 10.1046/j.1432-1033.2003.03833.x; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Podtelezhnikov AA, 2003, BIOPOLYMERS, V68, P110, DOI 10.1002/bip.10217; Ramcharan J, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-34; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; VANGENT DC, 1993, EMBO J, V12, P3261, DOI 10.1002/j.1460-2075.1993.tb05995.x; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wriggers W, 2001, J STRUCT BIOL, V133, P193, DOI 10.1006/jsbi.2000.4350; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Yi JZ, 2002, J BIOL CHEM, V277, P12164, DOI 10.1074/jbc.M105072200; Yi JZ, 2000, J BIOL CHEM, V275, P38739, DOI 10.1074/jbc.M005499200; Zhao Z, 2008, J BIOL CHEM, V283, P5632, DOI 10.1074/jbc.M705241200; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659	65	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17047	17059		10.1074/jbc.M110.212571	http://dx.doi.org/10.1074/jbc.M110.212571			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454648	hybrid, Green Published			2022-12-27	WOS:000290301900055
J	Sucharitakul, J; Wongnate, T; Chaiyen, P				Sucharitakul, Jeerus; Wongnate, Thanyaporn; Chaiyen, Pimchai			Hydrogen Peroxide Elimination from C4a-hydroperoxyflavin in a Flavoprotein Oxidase Occurs through a Single Proton Transfer from Flavin N5 to a Peroxide Leaving Group	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRANOSE 2-OXIDASE; OXYGEN ACTIVATION; HYDRIDE TRANSFER; MECHANISM; ENZYME; STABILIZATION; OXIDATION; PROTEIN; MONOOXYGENASES; INTERMEDIATE	C4a-hydroperoxyflavin is found commonly in the reactions of flavin-dependent monooxygenases, in which it plays a key role as an intermediate that incorporates an oxygen atom into substrates. Only recently has evidence for its involvement in the reactions of flavoprotein oxidases been reported. Previous studies of pyranose 2-oxidase (P2O), an enzyme catalyzing the oxidation of pyranoses using oxygen as an electron acceptor to generate oxidized sugars and hydrogen peroxide (H2O2), have shown that C4a-hydroperoxyflavin forms in P2O reactions before it eliminates H2O2 as a product (Sucharitakul, J., Prongjit, M., Haltrich, D., and Chaiyen, P. (2008) Biochemistry 47, 84858490). In this report, the solvent kinetic isotope effects (SKIE) on the reaction of reduced P2O with oxygen were investigated using transient kinetics. Our results showed that D2O has a negligible effect on the formation of C4a-hydroperoxyflavin. The ensuing step of H2O2 elimination from C4a-hydroperoxyflavin was shown to be modulated by an SKIE of 2.8 +/- 0.2, and a proton inventory analysis of this step indicates a linear plot. These data suggest that a single-proton transfer process causes SKIE at the H2O2 elimination step. Double and single mixing stopped-flow experiments performed in H2O buffer revealed that reduced flavin specifically labeled with deuterium at the flavin N5 position generated kinetic isotope effects similar to those found with experiments performed with the enzyme pre-equilibrated in D2O buffer. This suggests that the proton at the flavin N5 position is responsible for the SKIE and is the proton-in-flight that is transferred during the transition state. The mechanism of H2O2 elimination from C4a-hydroperoxyflavin is consistent with a single proton transfer from the flavin N5 to the peroxide leaving group, possibly via the formation of an intramolecular hydrogen bridge.	[Sucharitakul, Jeerus] Chulalongkorn Univ, Fac Dent, Dept Biochem, Bangkok 10300, Thailand; [Wongnate, Thanyaporn; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Wongnate, Thanyaporn; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Ctr Excellence Prot Struct & Funct, Bangkok 10400, Thailand	Chulalongkorn University; Mahidol University; Mahidol University	Chaiyen, P (corresponding author), Rama 6 Rd, Bangkok 10400, Thailand.	scpcy@mahidol.ac.th	Chaiyen, Pimchai/R-5052-2019	Chaiyen, Pimchai/0000-0002-8533-1604	Thailand Research Fund [BRG5480001, MRG5380240]; Faculty of Science, Mahidol University; National Research University; Ratchadaphiseksomphot Endowment Fund [HR1166I]; Chulalongkorn University; National Science and Technology Development Agency	Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; National Research University; Ratchadaphiseksomphot Endowment Fund; Chulalongkorn University(Chulalongkorn University); National Science and Technology Development Agency	This work was supported by The Thailand Research Fund Grants BRG5480001 (to P. C.) and MRG5380240 (to J. S.) and grants from the Faculty of Science, Mahidol University (to P. C.), from the National Research University Project of Commission on Higher Education and the Ratchadaphiseksomphot Endowment Fund (HR1166I), Chulalongkorn University (to J. S.), and from National Science and Technology Development Agency (to T. W.). This work was presented at the Gordon Research Conference 2010 (July 19-23) at Waterville Valley Resort, NH, Enzymes, Co-enzymes & Metabolic Pathways.	Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; BRUICE TC, 1984, ISRAEL J CHEM, V24, P54; Chaiyen P, 2010, ARCH BIOCHEM BIOPHYS, V493, P62, DOI 10.1016/j.abb.2009.08.021; Cook P. F., 1991, ENZYME MECH ISOTOPE, P74; DANNEEL HJ, 1993, EUR J BIOCHEM, V214, P795, DOI 10.1111/j.1432-1033.1993.tb17982.x; EBERLEIN G, 1982, J AM CHEM SOC, V104, P1449, DOI 10.1021/ja00369a061; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; EVANS MG, 1949, T FARADAY SOC, V45, P224, DOI 10.1039/tf9494500224; Fitzpatrick PF, 2001, ACCOUNTS CHEM RES, V34, P299, DOI 10.1021/ar0000511; Francisco WA, 1998, BIOCHEMISTRY-US, V37, P2596, DOI 10.1021/bi972266x; Gadda G, 2008, BIOCHEMISTRY-US, V47, P13745, DOI 10.1021/bi801994c; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; Klinman JP, 2007, ACCOUNTS CHEM RES, V40, P325, DOI 10.1021/ar6000507; Kujawa M, 2006, J BIOL CHEM, V281, P35104, DOI 10.1074/jbc.M604718200; Leitner C, 1998, APPL BIOCHEM BIOTECH, V70-2, P237, DOI 10.1007/BF02920140; Macheroux Peter, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091/6/26; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; MERENYI G, 1991, J AM CHEM SOC, V113, P3146, DOI 10.1021/ja00008a051; Orru R, 2010, J BIOL CHEM, V285, P35021, DOI 10.1074/jbc.M110.161372; Orville AM, 2009, BIOCHEMISTRY-US, V48, P720, DOI 10.1021/bi801918u; Palfey B. A., 1995, ACTIVE OXYGEN BIOCH, P37, DOI DOI 10.1007/978-94-011-0609-2_2; Palfey B. A., 1998, COMPREHENSIVE BIOL C, VIII, P83; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Pazmino DET, 2010, J BIOTECHNOL, V146, P9, DOI 10.1016/j.jbiotec.2010.01.021; Pennati A, 2011, BIOCHEMISTRY-US, V50, P1, DOI 10.1021/bi101387w; Pitsawong W, 2010, J BIOL CHEM, V285, P9697, DOI 10.1074/jbc.M109.073247; POMPON D, 1980, EUR J BIOCHEM, V104, P479, DOI 10.1111/j.1432-1033.1980.tb04450.x; Pozzi MH, 2010, ARCH BIOCHEM BIOPHYS, V498, P83, DOI 10.1016/j.abb.2010.04.015; Prongjit M, 2009, BIOCHEMISTRY-US, V48, P4170, DOI 10.1021/bi802331r; Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881; Rungsrisuriyachai K, 2010, BIOCHEMISTRY-US, V49, P2483, DOI 10.1021/bi901796a; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Schowen KB, 2000, BBA-BIOENERGETICS, V1458, P43, DOI 10.1016/S0005-2728(00)00059-1; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; Sobrado P, 2003, BIOCHEMISTRY-US, V42, P15208, DOI 10.1021/bi035546n; Spadiut O, 2010, FEBS J, V277, P2892, DOI 10.1111/j.1742-4658.2010.07705.x; Su QJ, 1999, BIOCHEMISTRY-US, V38, P8572, DOI 10.1021/bi990044o; Sucharitakul J, 2008, BIOCHEMISTRY-US, V47, P8485, DOI 10.1021/bi801039d; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Sucharitakul J, 2010, BIOCHEMISTRY-US, V49, P3753, DOI 10.1021/bi100187b; Tan TC, 2010, J MOL BIOL, V402, P578, DOI 10.1016/j.jmb.2010.08.011; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; VENKATASUBBAN KS, 1984, CRC CR REV BIOCH MOL, V17, P1, DOI 10.3109/10409238409110268	44	40	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16900	16909		10.1074/jbc.M111.222976	http://dx.doi.org/10.1074/jbc.M111.222976			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454569	Green Published, hybrid			2022-12-27	WOS:000290301900039
J	Wang, H; Bei, L; Shah, CA; Horvath, E; Eklund, EA				Wang, Hao; Bei, Ling; Shah, Chirag A.; Horvath, Elizabeth; Eklund, Elizabeth A.			HoxA10 Influences Protein Ubiquitination by Activating Transcription of ARIH2, the Gene Encoding Triad1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNDIFFERENTIATED MYELOID CELLS; HUMAN HEMATOPOIETIC-CELLS; BONE-MARROW-CELLS; HOMEOBOX GENE; DNA-BINDING; IN-VITRO; EXPRESSION; LEUKEMIA; DIFFERENTIATION; SUBPOPULATIONS	HoxA10 is a homeodomain transcription factor that is maximally expressed in myeloid progenitor cells. An increase in HoxA10 expression correlates with poor prognosis in human acute myeloid leukemia (AML). Consistent with this scenario, HoxA10 overexpression in murine bone marrow induces a myeloproliferative neoplasm that advances AML over time. Despite the importance of HoxA10 for leukemogenesis, few genuine HoxA10 target genes have been identified. The current study identified ARIH2, the gene encoding Triad1, as a HoxA10 target gene. We identified two distinct HoxA10-binding cis elements in the ARIH2 promoter and determined that HoxA10 activates these cis elements in myeloid cells. Triad1 has E3 ubiquitin ligase activity, and we found that HoxA10-overexpressing myeloid cells exhibited a Triad1-dependent increase in protein ubiquitination. Therefore, these studies have identified the regulation of protein ubiquitination as a novel function of Hox transcription factors. Forced overexpression of Triad1 has been show previously to inhibit colony formation by myeloid progenitor cells. In contrast, HoxA10-overexpressing myeloid progenitor cells exhibited increased proliferation in response to low doses of various cytokines. We found that Triad1 knockdown further increased cytokine-induced proliferation in HoxA10-overexpressing cells. Therefore, these studies have identified a HoxA10 target gene that antagonizes the overall influence of overexpressed HoxA10 on myeloproliferation. This result suggests that the consequences of HoxA10 overexpression reflect a balance between the target genes that facilitate and antagonize proliferation. These results have implications for understanding the mechanisms of leukemogenesis in AML with Hox overexpression.	[Wang, Hao; Bei, Ling; Shah, Chirag A.; Horvath, Elizabeth; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Wang, Hao; Bei, Ling; Shah, Chirag A.; Horvath, Elizabeth; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Bei, Ling; Horvath, Elizabeth; Eklund, Elizabeth A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Super St,Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu	Shah, Chirag/C-6770-2011	Wang, Hao/0000-0003-2131-0377	National Institutes of Health [R01-HL87717]; Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL87717. This work was also supported by a Veterans Affairs Merit Review award (to E. A. E.).	ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bei L, 2007, J BIOL CHEM, V282, P16846, DOI 10.1074/jbc.M609744200; Bjornsson JM, 2001, BLOOD, V98, P3301, DOI 10.1182/blood.V98.12.3301; Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Camos M, 2006, CANCER RES, V66, P6947, DOI 10.1158/0008-5472.CAN-05-4601; Compendia Biosciences, ONC 4 4; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Eklund EA, 2002, J BIOL CHEM, V277, P36878, DOI 10.1074/jbc.M203917200; Eklund EA, 2000, J BIOL CHEM, V275, P20117, DOI 10.1074/jbc.M907915199; Gabellini D, 2003, EMBO J, V22, P3715, DOI 10.1093/emboj/cdg340; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; LAWRENCE HJ, 1995, EXP HEMATOL, V23, P1160; Lindsey S, 2005, J IMMUNOL, V175, P5269, DOI 10.4049/jimmunol.175.8.5269; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; LOWNEY P, 1991, NUCLEIC ACIDS RES, V19, P3443, DOI 10.1093/nar/19.12.3443; Lu YF, 2003, J BIOL CHEM, V278, P47792, DOI 10.1074/jbc.M305885200; Marteijn JA, 2009, LEUKEMIA, V23, P1480, DOI 10.1038/leu.2009.57; Marteijn JAF, 2005, BLOOD, V106, P4114, DOI 10.1182/blood-2005-04-1450; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Shah CA, 2011, J BIOL CHEM, V286, P3161, DOI 10.1074/jbc.M110.183251; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Van der Reijden BA, 1999, PROTEIN SCI, V8, P1557, DOI 10.1110/ps.8.7.1557; Wang H, 2007, J BIOL CHEM, V282, P16164, DOI 10.1074/jbc.M610556200; Wang H, 2009, J BIOL CHEM, V284, P2549, DOI 10.1074/jbc.M804704200; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Zhang Y, 2003, EMBO J, V22, P6057, DOI 10.1093/emboj/cdg577; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	37	24	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16832	16845		10.1074/jbc.M110.213975	http://dx.doi.org/10.1074/jbc.M110.213975			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454682	Green Published, hybrid			2022-12-27	WOS:000290301900033
J	Cross, B; Chen, LH; Cheng, Q; Li, BZ; Yuan, ZM; Chen, JD				Cross, Brittany; Chen, Lihong; Cheng, Qian; Li, Baozong; Yuan, Zhi-Min; Chen, Jiandong			Inhibition of p53 DNA Binding Function by the MDM2 Protein Acidic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOREGULATORY FEEDBACK LOOP; MANTLE-CELL LYMPHOMA; EMBRYONIC LETHALITY; TUMOR-SUPPRESSOR; CORE DOMAIN; IN-VIVO; MDM2-DEFICIENT MICE; NUCLEAR EXPORT; UBIQUITINATION; GENE	MDM2 regulates p53 predominantly by promoting p53 ubiquitination. However, ubiquitination-independent mechanisms of MDM2 have also been implicated. Here we show that MDM2 inhibits p53 DNA binding activity in vitro and in vivo. MDM2 binding promotes p53 to adopt a mutant-like conformation, losing reactivity to antibody Pab1620, while exposing the Pab240 epitope. The acidic domain of MDM2 is required to induce p53 conformational change and inhibit p53 DNA binding. Alternate reading frame binding to the MDM2 acidic domain restores p53 wild type conformation and rescues DNA binding activity. Furthermore, histone methyl transferase SUV39H1 binding to the MDM2 acidic domain also restores p53 wild type conformation and allows p53-MDM2-SUV39H1 complex to bind DNA. These results provide further evidence for an ubiquitination-independent mechanism of p53 regulation by MDM2 and reveal how MDM2-interacting repressors gain access to p53 target promoters and repress transcription. Furthermore, we show that the MDM2 inhibitor Nutlin cooperates with the proteasome inhibitor Bortezomib by stimulating p53 DNA binding and transcriptional activity, providing a rationale for combination therapy using proteasome and MDM2 inhibitors.	[Cross, Brittany; Chen, Lihong; Cheng, Qian; Li, Baozong; Chen, Jiandong] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Yuan, Zhi-Min] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiat Oncol, San Antonio, TX 78229 USA	H Lee Moffitt Cancer Center & Research Institute; University of Texas System; University of Texas Health San Antonio	Chen, JD (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	Jiandong.chen@moffitt.org	li, baozong/K-4176-2012; Li, Baozong/ABD-4742-2020		National Institutes of Health [CA109636, CA141244, CA118210]; NATIONAL CANCER INSTITUTE [P01CA118210, R01CA109636, P30CA076292, R01CA141244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA109636, CA141244, and CA118210.	Arva NC, 2005, J BIOL CHEM, V280, P26776, DOI 10.1074/jbc.M505203200; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Blattner C, 2002, MOL CELL BIOL, V22, P6170, DOI 10.1128/MCB.22.17.6170-6182.2002; Bothner B, 2001, J MOL BIOL, V314, P263, DOI 10.1006/jmbi.2001.5110; Bottger A, 1997, J MOL BIOL, V269, P744, DOI 10.1006/jmbi.1997.1078; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Brooks CL, 2007, J BIOL CHEM, V282, P22804, DOI 10.1074/jbc.M700961200; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Burch L, 2004, J MOL BIOL, V337, P129, DOI 10.1016/j.jmb.2004.01.017; Burch LR, 2000, FEBS LETT, V472, P93, DOI 10.1016/S0014-5793(00)01427-7; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Chen LH, 2010, EMBO J, V29, P2538, DOI 10.1038/emboj.2010.140; Cheng Q, 2009, EMBO J, V28, P3857, DOI 10.1038/emboj.2009.294; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Francoz S, 2006, P NATL ACAD SCI USA, V103, P3232, DOI 10.1073/pnas.0508476103; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; Grier JD, 2006, MOL CELL BIOL, V26, P192, DOI 10.1128/MCB.26.1.192-198.2006; Hansen S, 1996, J BIOL CHEM, V271, P3917; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hideshima Teru, 2003, Rev Clin Exp Hematol, V7, P191; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kulikov R, 2005, MOL CELL BIOL, V25, P7170, DOI 10.1128/MCB.25.16.7170-7180.2005; Li BZ, 2010, CELL CYCLE, V9, P1411, DOI 10.4161/cc.9.7.11255; LUNA RMD, 1995, NATURE, V378, P203; Maetens M, 2007, BLOOD, V109, P2630, DOI 10.1182/blood-2006-03-013656; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Ooi MG, 2009, CLIN CANCER RES, V15, P7153, DOI 10.1158/1078-0432.CCR-09-1071; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Phillips A, 2010, J BIOL CHEM, V285, P29111, DOI 10.1074/jbc.M110.129726; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Saha MN, 2010, CANCER BIOL THER, V9, P936, DOI 10.4161/cbt.9.11.11882; Sasaki M, 2007, J BIOL CHEM, V282, P14626, DOI 10.1074/jbc.M610514200; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Sivakolundu SG, 2008, J MOL BIOL, V384, P240, DOI 10.1016/j.jmb.2008.09.019; Soussi T, 2000, HUM MUTAT, V15, P105, DOI 10.1002/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G; Soussi T, 2006, NAT REV CANCER, V6, P83, DOI 10.1038/nrc1783; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Tabe Y, 2009, CLIN CANCER RES, V15, P933, DOI 10.1158/1078-0432.CCR-08-0399; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Wang XJ, 2004, FEBS LETT, V561, P195, DOI 10.1016/S0014-5793(04)00168-1; Wawrzynow B, 2007, J BIOL CHEM, V282, P32603, DOI 10.1074/jbc.M702767200; White DE, 2006, CANCER RES, V66, P3463, DOI 10.1158/0008-5472.CAN-05-1381; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; ZAUBERMAN A, 1993, EMBO J, V12, P2799, DOI 10.1002/j.1460-2075.1993.tb05941.x; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	63	43	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.228981	http://dx.doi.org/10.1074/jbc.M111.228981			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454483	hybrid, Green Published			2022-12-27	WOS:000290022800042
J	Graham, SJL; Dziadek, MA; Johnstone, LS				Graham, Sarah J. L.; Dziadek, Marie A.; Johnstone, Lorna S.			A Cytosolic STIM2 Preprotein Created by Signal Peptide Inefficiency Activates ORAI1 in a Store-independent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; NF-KAPPA-B; ENDOPLASMIC-RETICULUM; CRAC CHANNEL; C-REL; BIOCHEMICAL-PROPERTIES; CELL-DEVELOPMENT; FACTOR-I; T-CELLS; CALMODULIN	Calcium (Ca2+) influx through the plasma membrane store-operated Ca2+ channel ORAI1 is controlled by Ca2+ sensors of the stromal interaction molecule (STIM) family. STIM1 responds to endoplasmic reticulum (ER) Ca2+ store depletion by redistributing and activating ORAI1 from regions of the ER juxtaposed to the plasma membrane. Unlike STIM1, STIM2 can regulate ORAI1 in a store-dependent and store-independent manner, but the mechanism by which this is achieved is unknown. Here we find that STIM2 is translated from a highly conserved methionine residue and is directed to the ER by an incredibly long 101-amino acid signal peptide. We find that although the majority of the total STIM2 population resides on the ER membrane, a second population escapes ER targeting to accumulate as a full-length preprotein in the cytosol, signal peptide intact. Unlike STIM2, preSTIM2 localizes to the inner leaflet of the plasma membrane where it interacts with ORAI1 to regulate basal Ca2+ concentration and Ca2+-dependent gene transcription in a store-independent manner. Furthermore, a third protein comprising a fragment of the STIM2 signal peptide is released from the ER membrane into the cytosol where it regulates gene transcription in a Ca2+-independent manner. This study establishes a new model for STIM2-mediated regulation of ORAI1 in which two distinct proteins, STIM2 and preSTIM2, control store-dependent and store-independent modes of ORAI1 activation.	[Graham, Sarah J. L.; Johnstone, Lorna S.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Dziadek, Marie A.] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia	University of Auckland; University of New South Wales Sydney	Johnstone, LS (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1142, New Zealand.	lorna.johnstone@vodafone.co.nz		Graham, Sarah/0000-0002-3021-5542	Health Research Council; Auckland Medical Research Foundation; Lottery Health in New Zealand	Health Research Council; Auckland Medical Research Foundation; Lottery Health in New Zealand	This work was supported by the Health Research Council, Auckland Medical Research Foundation, and Lottery Health in New Zealand.	Antonsson A, 2003, MOL CELL BIOL, V23, P1418, DOI 10.1128/MCB.23.4.1418-1427.2003; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Bae JS, 2003, BIOCHEM BIOPH RES CO, V305, P1094, DOI 10.1016/S0006-291X(03)00869-6; Ballabio E, 2004, CELL MOL LIFE SCI, V61, P1069, DOI 10.1007/s00018-004-4016-0; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; Bird GS, 2009, CURR BIOL, V19, P1724, DOI 10.1016/j.cub.2009.08.022; Bopp T, 2005, J EXP MED, V201, P181, DOI 10.1084/jem.20041538; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Byun-McKay SA, 2007, TRENDS ECOL EVOL, V22, P338, DOI 10.1016/j.tree.2007.05.002; Darbellay B, 2010, J BIOL CHEM, V285, P22437, DOI 10.1074/jbc.M110.118984; Deenick EK, 2010, EUR J IMMUNOL, V40, P677, DOI 10.1002/eji.201040298; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Edin S, 2010, MOL IMMUNOL, V47, P2057, DOI 10.1016/j.molimm.2010.04.005; Ercan E, 2009, TRAFFIC, V10, P1802, DOI 10.1111/j.1600-0854.2009.00995.x; Golde TE, 2009, SEMIN CELL DEV BIOL, V20, P225, DOI 10.1016/j.semcdb.2009.02.003; Graham SJL, 2009, DIFFERENTIATION, V77, P239, DOI 10.1016/j.diff.2008.10.013; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Hughes K, 2001, J BIOL CHEM, V276, P36008, DOI 10.1074/jbc.M106125200; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Johanson RA, 2000, J NEUROSCI, V20, P2860; Johnstone LS, 2010, J CELL MOL MED, V14, P1890, DOI 10.1111/j.1582-4934.2010.01097.x; Kanazawa Y, 2008, NEUROSCIENCE, V154, P473, DOI 10.1016/j.neuroscience.2008.03.044; Kilic A, 2010, EUR J CELL BIOL, V89, P449, DOI 10.1016/j.ejcb.2010.02.001; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Lemberg MK, 2004, FEBS LETT, V564, P213, DOI 10.1016/S0014-5793(04)00192-9; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lipskaia L, 2009, PFLUG ARCH EUR J PHY, V457, P673, DOI 10.1007/s00424-007-0428-7; Malli R, 2008, J CELL SCI, V121, P3133, DOI 10.1242/jcs.034496; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; Mariotti M, 2000, J BIOL CHEM, V275, P24047, DOI 10.1074/jbc.M001928200; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; MATTILA PS, 1990, EMBO J, V9, P4425, DOI 10.1002/j.1460-2075.1990.tb07893.x; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Oritani K, 1996, J CELL BIOL, V134, P771, DOI 10.1083/jcb.134.3.771; Pani B, 2009, P NATL ACAD SCI USA, V106, P20087, DOI 10.1073/pnas.0905002106; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Parvez S, 2008, FASEB J, V22, P752, DOI 10.1096/fj.07-9449com; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Rosso L, 2008, PLOS BIOL, V6, P1281, DOI 10.1371/journal.pbio.0060140; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Shaffer KL, 2005, DEV CELL, V9, P545, DOI 10.1016/j.devcel.2005.09.001; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Vang KB, 2010, J IMMUNOL, V184, P4074, DOI 10.4049/jimmunol.0903933; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Visekruna A, 2010, EUR J IMMUNOL, V40, P671, DOI 10.1002/eji.200940260; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Wedel B, 2007, J PHYSIOL-LONDON, V579, P679, DOI 10.1113/jphysiol.2006.125641; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900	63	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.206946	http://dx.doi.org/10.1074/jbc.M110.206946			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21383014	Green Published, hybrid			2022-12-27	WOS:000290022800057
J	Miller, LJ; Chen, Q; Lam, PCH; Pinon, DI; Sexton, PM; Abagyan, R; Dong, MQ				Miller, Laurence J.; Chen, Quan; Lam, Polo C. -H.; Pinon, Delia I.; Sexton, Patrick M.; Abagyan, Ruben; Dong, Maoqing			Refinement of Glucagon-like Peptide 1 Docking to Its Intact Receptor Using Mid-region Photolabile Probes and Molecular Modeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; CORTICOTROPIN-RELEASING-FACTOR; PHOTOAFFINITY CROSS-LINKING; PARATHYROID-HORMONE PTH; AMINO-TERMINAL REGION; 3RD EXTRACELLULAR LOOP; SECRETIN RECEPTOR; CALCITONIN RECEPTOR; AGONIST-BINDING; SPATIAL APPROXIMATION	The glucagon-like peptide 1 (GLP1) receptor is an important drug target within the B family of G protein-coupled receptors. Its natural agonist ligand, GLP1, has incretin-like actions and the receptor is a recognized target for management of type 2 diabetes mellitus. Despite recent solution of the structure of the amino terminus of the GLP1 receptor and several close family members, the molecular basis for GLP1 binding to and activation of the intact receptor remains unclear. We previously demonstrated molecular approximations between amino-and carboxyl-terminal residues of GLP1 and its receptor. In this work, we study spatial approximations with the mid-region of this peptide to gain insights into the orientation of the intact receptor and the ligand-receptor complex. Wehave prepared two new photolabile probes incorporating a p-benzoyl-L-phenylalanine into positions 16 and 20 of GLP1(7-36). Both probes bound to the GLP1 receptor specifically and with high affinity. These were each fully efficacious agonists, stimulating cAMP accumulation in receptor-bearing CHO cells in a concentration-dependent manner. Each probe specifically labeled a single receptor site. Protease cleavage and radiochemical sequencing identified receptor residue Leu(141) above transmembrane segment one as its site of labeling for the position 16 probe, whereas the position 20 probe labeled receptor residue Trp(297) within the second extracellular loop. Establishing ligand residue approximation with this loop region is unique among family members and may help to orient the receptor amino-terminal domain relative to its helical bundle region.	[Miller, Laurence J.; Chen, Quan; Pinon, Delia I.; Dong, Maoqing] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; [Lam, Polo C. -H.; Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92037 USA; [Lam, Polo C. -H.; Abagyan, Ruben] Molsoft LLC, La Jolla, CA 92037 USA; [Sexton, Patrick M.] Monash Univ, Drug Discovery Biol Lab, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Sexton, Patrick M.] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia	Mayo Clinic; Mayo Clinic Phoenix; University of California System; University of California San Diego; Monash University; Monash University	Miller, LJ (corresponding author), 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu; dongmq@mayo.edu	Sexton, Patrick M/B-1319-2008	Sexton, Patrick M/0000-0001-8902-2473	National Institutes of Health [DK46577]; American Diabetes Association [1-08-RA-42]; Australian National Health and Medical Research Council (NHMRC) [APP1002180]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046577, R56DK046577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK46577, American Diabetes Association Grant 1-08-RA-42, and Australian National Health and Medical Research Council (NHMRC) Grant APP1002180.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Adams AE, 1998, MOL ENDOCRINOL, V12, P1673, DOI 10.1210/me.12.11.1673; ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Al-Sabah S, 2003, FEBS LETT, V553, P342, DOI 10.1016/S0014-5793(03)01043-3; Assil-Kishawi I, 2002, J BIOL CHEM, V277, P32558, DOI 10.1074/jbc.M204964200; Bergwitz C, 1997, J BIOL CHEM, V272, P28861, DOI 10.1074/jbc.272.46.28861; Bisello A, 1998, J BIOL CHEM, V273, P22498, DOI 10.1074/jbc.273.35.22498; CAO YJ, 1995, BIOCHEM BIOPH RES CO, V212, P673, DOI 10.1006/bbrc.1995.2021; Carter PH, 1999, J BIOL CHEM, V274, P31955, DOI 10.1074/jbc.274.45.31955; Ceraudo E, 2008, MOL ENDOCRINOL, V22, P147, DOI 10.1210/me.2007-0361; Ceraudo E, 2008, J MOL NEUROSCI, V36, P245, DOI 10.1007/s12031-008-9073-7; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; Chorev M, 2002, RECEPTOR CHANNEL, V8, P219, DOI 10.1080/10606820213685; COUVINEAU A, 1995, BIOCHEM BIOPH RES CO, V206, P246, DOI 10.1006/bbrc.1995.1034; Dautzenberg FM, 2002, MOL PHARMACOL, V61, P1132, DOI 10.1124/mol.61.5.1132; de Maturana RL, 2004, PROTEIN PEPTIDE LETT, V11, P15, DOI 10.2174/0929866043478491; Dong MQ, 2008, MOL PHARMACOL, V74, P413, DOI 10.1124/mol.108.047209; Dong MQ, 2008, MOL ENDOCRINOL, V22, P1489, DOI 10.1210/me.2008-0025; Dong MQ, 2007, MOL PHARMACOL, V72, P280, DOI 10.1124/mol.107.035402; Dong MQ, 2010, J BIOL CHEM, V285, P9919, DOI 10.1074/jbc.M109.089730; Dong MQ, 2009, J BIOL CHEM, V284, P21839, DOI 10.1074/jbc.M109.011924; Dong MQ, 2004, J BIOL CHEM, V279, P31177, DOI 10.1074/jbc.M404113200; Dong MQ, 2004, J BIOL CHEM, V279, P2894, DOI 10.1074/jbc.M310407200; Dong MQ, 2004, J BIOL CHEM, V279, P1167, DOI 10.1074/jbc.M305719200; Dong MQ, 1999, J BIOL CHEM, V274, P903, DOI 10.1074/jbc.274.2.903; Estall JL, 2006, CURR PHARM DESIGN, V12, P1731, DOI 10.2174/138161206776873671; Gaylinn BD, 2002, RECEPTOR CHANNEL, V8, P155, DOI 10.1080/10606820213679; Gensure RC, 2003, MOL ENDOCRINOL, V17, P2647, DOI 10.1210/me.2003-0275; Gensure RC, 2001, J BIOL CHEM, V276, P28650, DOI 10.1074/jbc.M100717200; Gourlet P, 1996, PEPTIDES, V17, P825, DOI 10.1016/0196-9781(96)00107-6; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Graziano MP, 1996, RECEPTOR CHANNEL, V4, P9; Greenberg Z, 2000, BIOCHEMISTRY-US, V39, P8142, DOI 10.1021/bi000195n; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Holtmann MH, 1996, J BIOL CHEM, V271, P14944, DOI 10.1074/jbc.271.25.14944; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Ji ZS, 1997, J BIOL CHEM, V272, P24393, DOI 10.1074/jbc.272.39.24393; JUPPNER H, 1994, ENDOCRINOLOGY, V134, P879, DOI 10.1210/en.134.2.879; Koth CM, 2010, BIOCHEMISTRY-US, V49, P1862, DOI 10.1021/bi901848m; Kraetke O, 2005, BIOCHEMISTRY-US, V44, P15569, DOI 10.1021/bi0507027; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE CW, 1995, MOL ENDOCRINOL, V9, P1269, DOI 10.1210/me.9.10.1269; Liaw CW, 1997, MOL ENDOCRINOL, V11, P980, DOI 10.1210/me.11.7.980; Lin F, 2009, J MOL MODEL, V15, P53, DOI 10.1007/s00894-008-0372-2; Mann RJ, 2010, PEPTIDES, V31, P2289, DOI 10.1016/j.peptides.2010.09.015; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Olde B, 1998, J MOL NEUROSCI, V11, P127, DOI 10.1385/JMN:11:2:127; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Pham V, 2004, J BIOL CHEM, V279, P6720, DOI 10.1074/jbc.M307214200; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Runge S, 2003, J BIOL CHEM, V278, P28005, DOI 10.1074/jbc.M301085200; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Stroop SD, 1996, ENDOCRINOLOGY, V137, P4752, DOI 10.1210/en.137.11.4752; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; Tan YV, 2006, J BIOL CHEM, V281, P12792, DOI 10.1074/jbc.M513305200; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; Tokuyama Y, 2004, DIABETES RES CLIN PR, V66, P63, DOI 10.1016/j.diabres.2004.02.004; ULRICH CD, 1993, GASTROENTEROLOGY, V105, P1534, DOI 10.1016/0016-5085(93)90162-6; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Wittelsberger A, 2006, BIOCHEMISTRY-US, V45, P2027, DOI 10.1021/bi051833a; Zang MW, 2003, MOL PHARMACOL, V63, P993, DOI 10.1124/mol.63.5.993; Zhou AT, 1997, P NATL ACAD SCI USA, V94, P3644, DOI 10.1073/pnas.94.8.3644	71	46	46	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.217901	http://dx.doi.org/10.1074/jbc.M110.217901			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454562	Green Published, hybrid			2022-12-27	WOS:000290022800030
J	Wei, ZK; Peterson, JM; Wong, GW				Wei, Zhikui; Peterson, Jonathan M.; Wong, G. William			Metabolic Regulation by C1q/TNF-related Protein-13 (CTRP13) ACTIVATION OF AMP-ACTIVATED PROTEIN KINASE AND SUPPRESSION OF FATTY ACID-INDUCED JNK SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; CRYSTAL-STRUCTURE; COLLAGENOUS DOMAIN; ADIPOSE-TISSUE; ADIPONECTIN; EXPRESSION; GLUCOSE; FAMILY; GENE; MICE	Members of the C1q/TNF family play important and diverse roles in the immune, endocrine, skeletal, vascular, and sensory systems. Here, we identify and characterize CTRP13, a new and extremely conserved member of the C1q/TNF family. CTRP13 is preferentially expressed by adipose tissue and the brain in mice and predominantly by adipose tissue in humans. Within mouse adipose tissue, CTRP13 is largely expressed by cells of the stromal vascular compartment. Due to sexually dimorphic expression patterns, female mice have higher transcript and circulating CTRP13 levels than males. CTRP13 transcript and circulating levels are elevated in obese male mice, suggesting a potential role in energy metabolism. The insulin-sensitizing drug rosiglitazone also increases the expression of CTRP13 in adipocytes, which correlates with the insulin-sensitizing action of CTRP13. In a heterologous expression system, CTRP13 is secreted as a disulfide-linked oligomeric protein. When co-expressed, CTRP13 forms heteromeric complexes with a closely related family member, CTRP10. This heteromeric association does not involve conserved N-terminal Cys residues. Functional studies using purified recombinant protein demonstrated that CTRP13 is an adipokine that promotes glucose uptake in adipocytes, myotubes, and hepatocytes via activation of the AMPK signaling pathway. CTRP13 also ameliorates lipid-induced insulin resistance in hepatocytes through suppression of the SAPK/JNK stress signaling that impairs the insulin signaling pathway. Further, CTRP13 reduces glucose output in hepatocytes by inhibiting the mRNA expression of gluconeogenic enzymes, glucose-6-phosphatase and the cytosolic form of phosphoenolpyruvate carboxykinase. These results provide the first functional characterization of CTRP13 and establish its importance in glucose homeostasis.	[Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 855 N Wolfe St, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Peterson, Jonathan M./H-3122-2019	Peterson, Jonathan M./0000-0002-9873-3880; Wong, G. William/0000-0002-5286-6506; Wei, Zhikui/0000-0002-2311-9800	National Institutes of Health [DK084171, F32DK084607]; American Heart Association [SDG2260721, PRE3790034]; Baltimore Diabetes Research and Training Center [P60DK079637]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171, F32DK084607, P30DK079637, P60DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Baltimore Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK084171 (to G. W. W.). This work was also supported in part by American Heart Association Grant SDG2260721 and Baltimore Diabetes Research and Training Center Grant P60DK079637.; Supported by American Heart Association Fellowship PRE3790034.; Supported by National Institutes of Health National Research Service Award F32DK084607.	Akiyama H, 2007, MOL CELL BIOCHEM, V304, P243, DOI 10.1007/s11010-007-9506-6; Ayyagari R, 2005, INVEST OPHTH VIS SCI, V46, P3363, DOI 10.1167/iovs.05-0159; Bao DS, 2005, J NEUROCHEM, V95, P618, DOI 10.1111/j.1471-4159.2005.03385.x; Bogin O, 2002, STRUCTURE, V10, P165, DOI 10.1016/S0969-2126(02)00697-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briggs DB, 2009, BIOCHEMISTRY-US, V48, P12345, DOI 10.1021/bi9015555; Cheng A, 2006, BIOESSAYS, V28, P231, DOI 10.1002/bies.20375; Colombatti A, 2000, MATRIX BIOL, V19, P289, DOI 10.1016/S0945-053X(00)00074-3; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Davis Kathryn E, 2008, Biochem J, V416, pe7, DOI 10.1042/BJ20082033; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; GERSHONI JM, 1985, ANAL BIOCHEM, V146, P59, DOI 10.1016/0003-2697(85)90395-1; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; HAYWARD CPM, 1991, BLOOD, V77, P2556; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Iglesias MA, 2002, DIABETES, V51, P2886, DOI 10.2337/diabetes.51.10.2886; Iijima T, 2007, EUR J NEUROSCI, V25, P1049, DOI 10.1111/j.1460-9568.2007.05361.x; Iijima T, 2010, EUR J NEUROSCI, V31, P1606, DOI 10.1111/j.1460-9568.2010.07202.x; Illidge C, 2001, INT J BIOCHEM CELL B, V33, P521, DOI 10.1016/S1357-2725(01)00013-9; Jeon JH, 2008, FASEB J, V22, P1502, DOI 10.1096/fj.07-9412com; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Koide T, 2000, J BIOL CHEM, V275, P27957; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kvansakul M, 2003, MATRIX BIOL, V22, P145, DOI 10.1016/S0945-053X(02)00119-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lasser G, 2006, BLOOD, V107, P423, DOI 10.1182/blood-2005-04-1425; Lee W, 2010, FEBS LETT, V584, P968, DOI 10.1016/j.febslet.2010.01.040; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mongiat M, 2000, J BIOL CHEM, V275, P25471, DOI 10.1074/jbc.M001426200; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Park SY, 2009, J BIOL CHEM, V284, P27780, DOI 10.1074/jbc.M109.005611; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Peterson JM, 2009, BIOCHEM BIOPH RES CO, V388, P360, DOI 10.1016/j.bbrc.2009.08.014; REID KBM, 1976, BIOCHEM J, V155, P19, DOI 10.1042/bj1550019; Richards AA, 2006, MOL ENDOCRINOL, V20, P1673, DOI 10.1210/me.2005-0390; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; SHETTY M, 1993, J BIOL CHEM, V268, P17225; Shetty S, 2009, TRENDS PHARMACOL SCI, V30, P234, DOI 10.1016/j.tips.2009.02.004; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Suzuki S, 2007, FEBS LETT, V581, P809, DOI 10.1016/j.febslet.2007.01.046; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang Y, 2006, J BIOL CHEM, V281, P16391, DOI 10.1074/jbc.M513907200; WEINSTEIN IB, 1975, CANCER RES, V35, P253; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yano W, 2008, ENDOCR J, V55, P515, DOI 10.1507/endocrj.K08E-093; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	72	102	113	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.201087	http://dx.doi.org/10.1074/jbc.M110.201087			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21378161	hybrid, Green Published			2022-12-27	WOS:000290022800005
J	Sakamoto, T; Niiya, D; Seiki, M				Sakamoto, Takeharu; Niiya, Daigo; Seiki, Motoharu			Targeting the Warburg Effect That Arises in Tumor Cells Expressing Membrane Type-1 Matrix Metalloproteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; CANCER-CELLS; PERICELLULAR PROTEOLYSIS; TRANSCRIPTIONAL ACTIVITY; GLUCOSE-METABOLISM; BASEMENT-MEMBRANE; PRECURSOR PROTEIN; PYRUVATE-KINASE; GROWTH-FACTOR; MT1-MMP	Hypoxia inducible factor-1 (HIF-1) is a key transcription factor required for cellular adaptation to hypoxia, although its physiological roles and activation mechanisms during normoxia have not been studied sufficiently. The Warburg effect, which is a hallmark of malignant tumors that is characterized by increased activity of aerobic glycolysis, accompanies activation of HIF-1 during normoxia. Besides tumor cells that have multiple genetic and epigenetic alterations, normal macrophages also use glycolysis for ATP production by depending upon elevated HIF-1 activity even during normoxia. We recently found that activity of factor inhibiting HIF-1 (FIH-1) is specifically suppressed in macrophages by a nonproteolytic activity of membrane type-1 matrix metalloproteinase (MT1-MMP/MMP-14). Thus, MT1-MMP expressed in macrophages plays a significant role in regulating HIF-1 activity during normoxia. In the light of this finding, we examined here whether MT1-MMP contributes to the Warburg effect of tumor cells. All the tumor cell lines that express MT1-MMP exhibit increased glycolytic activity, and forced expression of MT1-MMP in MT1-MMP-negative tumor cells is sufficient to induce the Warburg effect. The cytoplasmic tail of MT1-MMP mediates the stimulation of aerobic glycolysis by increasing the expression of HIF-1 target genes. Specific intervention of the MT1-MMP-mediated activation of HIF-1 in tumor cells retarded tumor growth in mice. Systemic administration of a membrane-penetrating form of the cytoplasmic tail peptide in mice to inhibit HIF-1 activation competitively also exhibited a therapeutic effect on tumors.	[Sakamoto, Takeharu; Niiya, Daigo; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo, Japan	University of Tokyo	Seiki, M (corresponding author), 4-6-1 Shirokanedai,Minato Ku, Tokyo 1088639, Japan.	mseiki@ims.u-tokyo.ac.jp	Sakamoto, Takeharu/Y-6062-2019; Seiki, Motoharu/K-9443-2015	Sakamoto, Takeharu/0000-0002-1225-1902; 	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science and Technology of Japan	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Specific Coordination Fund for Promoting Science (to T. S.) and by a grant-in-aid for scientific research (S) on priority areas, the "Integrative Research toward the Conquest of Cancer," from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M. S.).	Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dang CV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe75; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Guess CM, 2009, MATRIX BIOL, V28, P445, DOI 10.1016/j.matbio.2009.07.008; Han JB, 2008, J CELL SCI, V121, P2217, DOI 10.1242/jcs.019745; Hill K, 2003, J BIOL CHEM, V278, P36032, DOI 10.1074/jbc.M301632200; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koshikawa N, 2010, CANCER RES, V70, P6093, DOI 10.1158/0008-5472.CAN-10-0346; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; MICHL J, 1976, J EXP MED, V144, P1465, DOI 10.1084/jem.144.6.1465; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Polette M, 2005, CANCER RES, V65, P7691, DOI 10.1158/0008-5472.CAN-04-4230; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Pulyaeva H, 1997, CLIN EXP METASTAS, V15, P111, DOI 10.1023/A:1018444609098; Rogelj B, 2006, BRAIN RES REV, V52, P305, DOI 10.1016/j.brainresrev.2006.04.005; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Sakamoto T, 2009, J BIOL CHEM, V284, P30350, DOI 10.1074/jbc.M109.019216; Sakamoto T, 2009, GENES CELLS, V14, P617, DOI 10.1111/j.1365-2443.2009.01293.x; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Seiki M, 2003, CANCER SCI, V94, P569, DOI 10.1111/j.1349-7006.2003.tb01484.x; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Tanahashi H, 1999, BIOCHEM BIOPH RES CO, V255, P663, DOI 10.1006/bbrc.1999.0265; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WARBURG O, 1930, METABOLISM TUMORS, P327; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yana I, 2007, J CELL SCI, V120, P1607, DOI 10.1242/jcs.000679	58	53	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14691	14704		10.1074/jbc.M110.188714	http://dx.doi.org/10.1074/jbc.M110.188714			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21372132	Green Published, hybrid			2022-12-27	WOS:000289556200088
J	Yu, Q; Zhang, XM; Bi, X				Yu, Qun; Zhang, Xinmin; Bi, Xin			Roles of Chromatin Remodeling Factors in the Formation and Maintenance of Heterochromatin Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONALLY SILENT CHROMATIN; POSITION-EFFECT VARIEGATION; LINKING NUMBER CHANGE; SACCHAROMYCES-CEREVISIAE; SIR COMPLEX; LOCUS HML; YEAST; ACETYLATION; PROTEIN; DNA	Heterochromatin consists of highly ordered nucleosomes with characteristic histone modifications. There is evidence implicating chromatin remodeling proteins in heterochromatin formation, but their exact roles are not clear. We demonstrate in Saccharomyces cerevisiae that the Fun30p and Isw1p chromatin remodeling factors are similarly required for transcriptional silencing at the HML locus, but they differentially contribute to the structure and stability of HML heterochromatin. In the absence of Fun30p, only a partially silenced structure is established at HML. Such a structure resembles fully silenced heterochromatin in histone modifications but differs markedly from both fully silenced and derepressed chromatin structures regarding nucleosome arrangement. This structure likely represents an intermediate state of heterochromatin that can be converted by Fun30p to the mature state. Moreover, Fun30p removal reduces the rate of de novo establishment of heterochromatin, suggesting that Fun30p assists the silencing machinery in forming heterochromatin. We also find evidence suggesting that Fun30p functions together with, or after, the action of the silencing machinery. On the other hand, Isw1p is dispensable for the formation of heterochromatin structure but is instead critically required for maintaining its stability. Therefore, chromatin remodeling proteins may rearrange nucleosomes during the formation of heterochromatin or serve to stabilize/maintain heterochromatin structure.	[Yu, Qun; Zhang, Xinmin; Bi, Xin] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Zhang, Xinmin] Jilin Univ, Sch Pharmaceut Sci, Changchun 130021, Jilin, Peoples R China	University of Rochester; Jilin University	Bi, X (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	xinbi@mail.rochester.edu			National Institutes of Health [GM62484]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62484 (to X. B.).	Awad S, 2010, J BIOL CHEM, V285, P9477, DOI 10.1074/jbc.M109.082149; Bassett AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002099; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Bi X, 1997, MOL CELL BIOL, V17, P7077, DOI 10.1128/MCB.17.12.7077; Bi X, 1999, GENE DEV, V13, P1089, DOI 10.1101/gad.13.9.1089; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; Cheng TH, 1998, P NATL ACAD SCI USA, V95, P5521, DOI 10.1073/pnas.95.10.5521; Chiu YH, 2003, GENETICS, V165, P115; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Corona DFV, 2007, PLOS BIOL, V5, P2011, DOI 10.1371/journal.pbio.0050232; Cuperus G, 2002, GENETICS, V162, P633; de la Cruz X, 2005, BIOESSAYS, V27, P164, DOI 10.1002/bies.20176; Dillon N, 2004, BIOL CELL, V96, P631, DOI 10.1016/j.biolcel.2004.06.003; Dror V, 2004, MOL CELL BIOL, V24, P8227, DOI 10.1128/MCB.24.18.8227-8235.2004; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Holmes SG, 1996, GENE DEV, V10, P1021, DOI 10.1101/gad.10.8.1021; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Katan-Khaykovich Y, 2005, EMBO J, V24, P2138, DOI 10.1038/sj.emboj.7600692; KENT NA, 1993, NUCLEIC ACIDS RES, V21, P4653, DOI 10.1093/nar/21.19.4653; Lau A, 2002, GENE DEV, V16, P2935, DOI 10.1101/gad.764102; Lejeune E, 2007, CURR BIOL, V17, P1219, DOI 10.1016/j.cub.2007.06.028; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Martins-Taylor K, 2004, GENETICS, V168, P65, DOI 10.1534/genetics.103.020149; Mellor J, 2004, BBA-GENE STRUCT EXPR, V1677, P100, DOI 10.1016/j.bbaexp.2003.10.014; MILLER AM, 1984, NATURE, V312, P247, DOI 10.1038/312247a0; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; Neves-Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008111; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; NORTON VG, 1990, J BIOL CHEM, V265, P19848; PARK EC, 1990, MOL CELL BIOL, V10, P4932, DOI 10.1128/MCB.10.9.4932; Ravindra A, 1999, MOL CELL BIOL, V19, P7944; Roy N, 2000, CURR BIOL, V10, P111, DOI 10.1016/S0960-9822(00)00298-0; Rudner AD, 2005, MOL CELL BIOL, V25, P4514, DOI 10.1128/MCB.25.11.4514-4528.2005; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Ryan MP, 1999, METHOD ENZYMOL, V304, P376; Santos-Rosa H, 2004, J BIOL CHEM, V279, P47506, DOI 10.1074/jbc.M407949200; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; THOMPSON JS, 1994, MOL CELL BIOL, V14, P446, DOI 10.1128/MCB.14.1.446; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Van Leeuwen F, 2002, METHOD ENZYMOL, V350, P165, DOI 10.1016/S0076-6879(02)50962-9; VOLKERT FC, 1986, CELL, V46, P541, DOI 10.1016/0092-8674(86)90879-2; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Weiss K, 1998, MOL CELL BIOL, V18, P5392, DOI 10.1128/MCB.18.9.5392; Yu Q, 2006, J MOL BIOL, V356, P1082, DOI 10.1016/j.jmb.2005.11.089	50	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14659	14669		10.1074/jbc.M110.183269	http://dx.doi.org/10.1074/jbc.M110.183269			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21388962	hybrid, Green Published			2022-12-27	WOS:000289556200085
J	Joubert, MK; Luo, QZ; Nashed-Samuel, Y; Wypych, J; Narhi, LO				Joubert, Marisa K.; Luo, Quanzhou; Nashed-Samuel, Yasser; Wypych, Jette; Narhi, Linda O.			Classification and Characterization of Therapeutic Antibody Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE TOLERANT MICE; STRUCTURAL-CHARACTERIZATION; MONOCLONAL-ANTIBODY; PROTEIN AGGREGATION; HEMOPHILIA-A; FACTOR-VIII; WILD-TYPE; IMMUNOGENICITY; PARTICLES; PATHWAY	A host of diverse stress techniques was applied to a monoclonal antibody (IgG(2)) to yield protein particles with varying attributes and morphologies. Aggregated solutions were evaluated for percent aggregation, particle counts, size distribution, morphology, changes in secondary and tertiary structure, surface hydrophobicity, metal content, and reversibility. Chemical modifications were also identified in a separate report (Luo, Q., Joubert, M. K., Stevenson, R., Narhi, L. O., and Wypych, J. (2011) J. Biol. Chem. 286, 25134-25144). Aggregates were categorized into seven discrete classes, based on the traits described. Several additional molecules (from the IgG(1) and IgG(2) subtypes as well as intravenous IgG) were stressed and found to be defined with the same classification system. The mechanism of protein aggregation and the type of aggregate formed depends on the nature of the stress applied. Different IgG molecules appear to aggregate by a similar mechanism under the same applied stress. Aggregates created by harsh mechanical stress showed the largest number of subvisible particles, and the class generated by thermal stress displayed the largest number of visible particles. Most classes showed a disruption of the higher order structure, with the degree of disorder depending on the stress process. Particles in all classes (except thermal stress) were at least partially reversible upon dilution in pH 5 buffer. High copper content was detected in isolated metal-catalyzed aggregates, a stress previously shown to produce immunogenic aggregates. In conclusion, protein aggregates can be a very heterogeneous population, whose qualities are the result of the type of stress that was experienced.	[Joubert, Marisa K.; Nashed-Samuel, Yasser; Narhi, Linda O.] Amgen Inc, Dept Formulat & Analyt Resources, Thousand Oaks, CA 91320 USA; [Luo, Quanzhou; Wypych, Jette] Amgen Inc, Dept Analyt & Formulat Sci, Thousand Oaks, CA 91320 USA	Amgen; Amgen	Joubert, MK (corresponding author), 1 Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	mjoubert@amgen.com; lnarhi@amgen.com						[Anonymous], 2004, INT ALPH 2B, V2, P1812; Arvinte T., 2007, BIOWORLD EUR, V1, P6; Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; Baszkin A, 2001, J COLLOID INTERF SCI, V239, P1, DOI 10.1006/jcis.2001.7521; Braun A, 1997, PHARMACEUT RES, V14, P1472, DOI 10.1023/A:1012193326789; Carpenter JF, 2009, J PHARM SCI-US, V98, P1201, DOI 10.1002/jps.21530; Carpenter ML, 2000, METH MOL B, V148, P491; Chackerian B, 2002, J IMMUNOL, V169, P6120, DOI 10.4049/jimmunol.169.11.6120; Chang SH, 2005, COLLOID SURFACE B, V41, P1, DOI 10.1016/j.colsurfb.2004.10.015; Chen S, 2010, PROTEIN SCI, V19, P1191, DOI 10.1002/pro.396; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; De Groot AS, 2007, TRENDS IMMUNOL, V28, P482, DOI 10.1016/j.it.2007.07.011; Demeule B, 2006, EUR J PHARM BIOPHARM, V62, P121, DOI 10.1016/j.ejpb.2005.08.008; Denis J, 2007, VIROLOGY, V363, P59, DOI 10.1016/j.virol.2007.01.011; DINTZIS HM, 1976, P NATL ACAD SCI USA, V73, P3671, DOI 10.1073/pnas.73.10.3671; Eakins M. N., 2010, PHARM OUTSOURCING, V11, P10; European Directorate for the Quality of Medicines and Healthcare, 2010, PART CONT SUBV PART; European Directorate for the Quality of Medicines and Healthcare, 2010, PART CONT VIS PART; Fesinmeyer RM, 2009, PHARM RES-DORDR, V26, P903, DOI 10.1007/s11095-008-9792-z; Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148; Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2; Foguel B, 2004, BIOCHEMISTRY-US, V43, P11361; Fradkin AH, 2009, J PHARM SCI-US, V98, P3247, DOI 10.1002/jps.21834; Frare E, 2009, J MOL BIOL, V387, P17, DOI 10.1016/j.jmb.2009.01.049; Friede M, 2005, ADV DRUG DELIVER REV, V57, P325, DOI 10.1016/j.addr.2004.10.001; Gulseren I, 2007, ULTRASON SONOCHEM, V14, P173, DOI 10.1016/j.ultsonch.2005.07.006; Hari SB, 2010, BIOCHEMISTRY-US, V49, P9328, DOI 10.1021/bi100841u; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Hawe A, 2009, EUR J PHARM SCI, V38, P79, DOI 10.1016/j.ejps.2009.06.001; He F, 2010, J PHARM SCI-US, V99, P2598, DOI 10.1002/jps.22036; Hermeling S, 2006, J PHARM SCI-US, V95, P1084, DOI 10.1002/jps.20599; Hermeling S, 2005, PHARM RES-DORDR, V22, P1997, DOI 10.1007/s11095-005-8177-9; Huang CT, 2009, J PHARM SCI-US, V98, P3058, DOI 10.1002/jps.21575; Jiang Y., 2011, J PHARM SCI IN PRESS; Jiang YJ, 2009, J PHARM SCI-US, V98, P4695, DOI 10.1002/jps.21778; Juarez J, 2009, BIOPHYS J, V96, P2353, DOI 10.1016/j.bpj.2008.12.3901; Kessler M, 2006, NEPHROL DIAL TRANSPL, V21, P9, DOI 10.1093/ndt/gfl476; Kiese S, 2008, J PHARM SCI-US, V97, P4347, DOI 10.1002/jps.21328; Knapp JZ, 2000, PDA J PHARM SCI TECH, V54, P218; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Krishnan S, 2009, BIOPHYS J, V96, P199, DOI 10.1016/j.bpj.2008.10.002; Lahendro B., 2008, ONDRUGDELIVERY, P24; Li CH, 2009, CURR PHARM BIOTECHNO, V10, P391, DOI 10.2174/138920109788488950; Lindgren M, 2005, BIOPHYS J, V88, P4200, DOI 10.1529/biophysj.104.049700; Luo QZ, 2011, J BIOL CHEM, V286, P25134, DOI 10.1074/jbc.M110.160440; Maas C, 2007, J BIOL CHEM, V282, P2229, DOI 10.1074/jbc.M605984200; Mahler HC, 2009, J PHARM SCI-US, V98, P2909, DOI 10.1002/jps.21566; Morefield GL, 2005, VACCINE, V23, P1588, DOI 10.1016/j.vaccine.2004.07.050; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Narhi LO, 2009, CURR PHARM BIOTECHNO, V10, P373, DOI 10.2174/138920109788488905; Purohit VS, 2006, J PHARM SCI-US, V95, P358, DOI 10.1002/jps.20529; Randolph TW, 2002, BBA-PROTEIN STRUCT M, V1595, P224, DOI 10.1016/S0167-4838(01)00346-6; Reipert BM, 2007, BRIT J HAEMATOL, V136, P12, DOI 10.1111/j.1365-2141.2006.06359.x; Rosenberg A., 2009, 13 S INT REG AN SCI, P23; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Seaver S, 2008, BIOQUALITY, V13, P3; Silva JL, 2006, BBA-PROTEINS PROTEOM, V1764, P443, DOI 10.1016/j.bbapap.2005.11.012; Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1; Singh SK, 2010, J PHARM SCI-US, V99, P3302, DOI 10.1002/jps.22097; Souillac PO, 2005, J PHARM SCI-US, V94, P2069, DOI 10.1002/jps.20423; United States Pharmacopeia, 2010, 34NF USP; Valente JJ, 2005, CURR PHARM BIOTECHNO, V6, P427, DOI 10.2174/138920105775159313; Wang W, 2010, INT J PHARMACEUT, V390, P89, DOI 10.1016/j.ijpharm.2010.02.025	63	229	240	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25118	25133		10.1074/jbc.M110.160457	http://dx.doi.org/10.1074/jbc.M110.160457			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21454532	Green Published, hybrid			2022-12-27	WOS:000292547900060
J	Salonikidis, PS; Niebert, M; Ullrich, T; Bao, GB; Zeug, A; Richter, DW				Salonikidis, Petrus S.; Niebert, Marcus; Ullrich, Tim; Bao, Guobin; Zeug, Andre; Richter, Diethelm W.			An Ion-insensitive cAMP Biosensor for Long Term Quantitative Ratiometric Fluorescence Resonance Energy Transfer (FRET) Measurements under Variable Physiological Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR PH; EPAC ACTIVATION; CELL-DEATH; PROTEIN; MICRODOMAINS; CALMODULIN; MECHANISM; NEURONS; SENSORS; THERMODYNAMICS	Ratiometric measurements with FRET-based biosensors in living cells using a single fluorescence excitation wavelength are often affected by a significant ion sensitivity and the aggregation behavior of the FRET pair. This is an important problem for quantitative approaches. Here we report on the influence of physiological ion concentration changes on quantitative ratiometric measurements by comparing different FRET pairs for a cAMP-detecting biosensor. We exchanged the enhanced CFP/enhanced YFP FRET pair of an established Epac1-based biosensor by the fluorophores mCerulean/mCitrine. In the case of enhanced CFP/enhanced YFP, we showed that changes in proton, and (to a lesser extent) chloride ion concentrations result in incorrect ratiometric FRET signals, which may exceed the dynamic range of the biosensor. Calcium ions have no direct, but an indirect pH-driven effect by mobilizing protons. These ion dependences were greatly eliminated when mCerulean/mCitrine fluorophores were used. For such advanced FRET pairs the biosensor is less sensitive to changes in ion concentration and allows consistent cAMP concentration measurements under different physiological conditions, as occur in metabolically active cells. In addition, we verified that the described FRET pair exchange increased the dynamic range of the FRET efficiency response. The time window for stable experimental conditions was also prolonged by a faster biosensor expression rate in transfected cells and a greatly reduced tendency to aggregate, which reduces cytotoxicity. These properties were verified in functional tests in single cells co-expressing the biosensor and the 5-HT1A receptor.	[Salonikidis, Petrus S.; Niebert, Marcus; Ullrich, Tim; Richter, Diethelm W.] Univ Gottingen, Dept Neuro & Sensory Physiol, D-37073 Gottingen, Germany; [Bao, Guobin] Univ Gottingen, Dept Neurophysiol & Cellular Biophys, D-37073 Gottingen, Germany; [Zeug, Andre] Hannover Med Sch, Dept Cellular Neurophysiol, D-30625 Hannover, Germany; [Salonikidis, Petrus S.; Niebert, Marcus; Richter, Diethelm W.] Deutsch Forsch Gemeinschaft Res Ctr Mol Physiol B, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen; Hannover Medical School	Salonikidis, PS (corresponding author), Humboldtallee 23, D-37073 Gottingen, Germany.	psaloni@gwdg.de	Zeug, Andre/X-3208-2019	Zeug, Andre/0000-0001-9858-5841	Deutsche Forschungsgemeinschaft through the Research Center for Molecular Physiology of the Brain [FZT 103]	Deutsche Forschungsgemeinschaft through the Research Center for Molecular Physiology of the Brain	This work was supported by the Deutsche Forschungsgemeinschaft through the Research Center for Molecular Physiology of the Brain (FZT 103)/Cluster of Excellence 171.	BALLANYI K, 1994, NEUROREPORT, V6, P33, DOI 10.1097/00001756-199412300-00010; Burnashev N, 2005, CELL CALCIUM, V37, P489, DOI 10.1016/j.ceca.2005.01.003; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; FLOGEL U, 1994, NMR BIOMED, V7, P157, DOI 10.1002/nbm.1940070402; GORES GJ, 1989, J CLIN INVEST, V83, P386, DOI 10.1172/JCI113896; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; HARTLEY Z, 1993, J NEUROSCI, V13, P4690; Heine M, 2002, PFLUG ARCH EUR J PHY, V443, P418, DOI 10.1007/s004240100690; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Koivumaki JT, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001067; KRAUSE KH, 1991, J BIOL CHEM, V266, P9453; Lakowicz R. J., 2006, PRINCIPLES FLUORESCE, P443; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; MILOS M, 1986, BIOCHEMISTRY-US, V25, P6279, DOI 10.1021/bi00368a067; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Muller M, 2000, NEUROSCIENCE, V97, P33, DOI 10.1016/S0306-4522(00)00025-7; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Papoucheva E, 2004, J BIOL CHEM, V279, P3280, DOI 10.1074/jbc.M308177200; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Patterson G, 2001, J CELL SCI, V114, P837; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Ponimaskin EG, 2007, FRONT NEUROSCI, P19; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Robertson RM, 2010, NEUROREPORT, V21, P943, DOI 10.1097/WNR.0b013e32833e332d; Salonikidis PS, 2008, BIOPHYS J, V95, P5412, DOI 10.1529/biophysj.107.125666; Schoenmakers T. J., 1992, BIOTECHNIQUES, V12, P876; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; SELLERS P, 1991, BIOPHYS CHEM, V39, P199, DOI 10.1016/0301-4622(91)85022-I; Shahrezaei V, 2004, BIOPHYS J, V87, P2352, DOI 10.1529/biophysj.104.043380; Thevenaz P, 2007, MICROSC RES TECHNIQ, V70, P135, DOI 10.1002/jemt.20393; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; Wlodarczyk J, 2008, BIOPHYS J, V94, P986, DOI 10.1529/biophysj.107.111773; Woehler A, 2010, BIOPHYS J, V99, P2344, DOI 10.1016/j.bpj.2010.07.053; Woehler Andrew, 2009, Curr Mol Pharmacol, V2, P237; Yao H, 2004, CELL CALCIUM, V36, P247, DOI 10.1016/j.ceca.2004.02.013; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	46	28	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23419	23431		10.1074/jbc.M111.236869	http://dx.doi.org/10.1074/jbc.M111.236869			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21454618	hybrid, Green Published			2022-12-27	WOS:000292025000073
J	Eathiraj, S; Palma, R; Hirschi, M; Volckova, E; Nakuci, E; Castro, J; Chen, CR; Chan, TCK; France, DS; Ashwell, MA				Eathiraj, Sudharshan; Palma, Rocio; Hirschi, Marscha; Volckova, Erika; Nakuci, Enkeleda; Castro, Jennifer; Chen, Chang-Rung; Chan, Thomas C. K.; France, Dennis S.; Ashwell, Mark A.			A Novel Mode of Protein Kinase Inhibition Exploiting Hydrophobic Motifs of Autoinhibited Kinases DISCOVERY OF ATP-INDEPENDENT INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMAL SHIFT ASSAYS; TYROSINE KINASE; ACTIVATION STATE; AUTOPHOSPHORYLATION; MECHANISMS; BINDING; REVEALS; DOMAIN; FGFR2	Protein kinase inhibitors with enhanced selectivity can be designed by optimizing binding interactions with less conserved inactive conformations because such inhibitors will be less likely to compete with ATP for binding and therefore may be less impacted by high intracellular concentrations of ATP. Analysis of the ATP-binding cleft in a number of inactive protein kinases, particularly in the autoinhibited conformation, led to the identification of a previously undisclosed non-polar region in this cleft. This ATP-incompatible hydrophobic region is distinct from the previously characterized hydrophobic allosteric back pocket, as well as the main pocket. Generalized hypothetical models of inactive kinases were constructed and, for the work described here, we selected the fibroblast growth factor receptor (FGFR) tyrosine kinase family as a case study. Initial optimization of a FGFR2 inhibitor identified from a library of commercial compounds was guided using structural information from the model. We describe the inhibitory characteristics of this compound in biophysical, biochemical, and cell-based assays, and have characterized the binding mode using x-ray crystallographic studies. The results demonstrate, as expected, that these inhibitors prevent activation of the autoinhibited conformation, retain full inhibitory potency in the presence of physiological concentrations of ATP, and have favorable inhibitory activity in cancer cells. Given the widespread regulation of kinases by autoinhibitory mechanisms, the approach described herein provides a new paradigm for the discovery of inhibitors by targeting inactive conformations of protein kinases.	[Eathiraj, Sudharshan; Palma, Rocio; Hirschi, Marscha; Volckova, Erika; Nakuci, Enkeleda; Castro, Jennifer; Chen, Chang-Rung; Chan, Thomas C. K.; France, Dennis S.; Ashwell, Mark A.] ArQule Inc, Woburn, MA 01801 USA		Ashwell, MA (corresponding author), 19 Presidential Way, Woburn, MA 01801 USA.	mashwell@arqule.com			NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NIBIB NIH HHS [P30 EB009998] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Bae JH, 2010, P NATL ACAD SCI USA, V107, P2866, DOI 10.1073/pnas.0914157107; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Cheetham GMT, 2004, CURR OPIN STRUC BIOL, V14, P700, DOI 10.1016/j.sbi.2004.10.011; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Cowan-Jacob SW, 2009, CURR OPIN CELL BIOL, V21, P280, DOI 10.1016/j.ceb.2009.01.012; Dubreuil P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007258; Eathiraj S, 2011, J BIOL CHEM, V286, P20666, DOI 10.1074/jbc.M110.213801; Engh RA, 2002, PHARMACOL THERAPEUT, V93, P99, DOI 10.1016/S0163-7258(02)00180-8; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Frantz B, 1998, BIOCHEMISTRY-US, V37, P13846, DOI 10.1021/bi980832y; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Gajiwala KS, 2009, P NATL ACAD SCI USA, V106, P1542, DOI 10.1073/pnas.0812413106; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Hubbard SR, 2002, FRONT BIOSCI, V7, pD330, DOI 10.2741/hubbard; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; Karni R, 2003, FEBS LETT, V537, P47, DOI 10.1016/S0014-5793(03)00069-3; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kufareva I, 2008, J MED CHEM, V51, P7921, DOI 10.1021/jm8010299; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; Lee T, 2005, J MOL BIOL, V353, P600, DOI 10.1016/j.jmb.2005.08.029; Lew ED, 2007, P NATL ACAD SCI USA, V104, P19802, DOI 10.1073/pnas.0709905104; Lew ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000021; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Montalban AG, 2008, BIOORG MED CHEM LETT, V18, P5456, DOI 10.1016/j.bmcl.2008.09.028; Munshi N, 2010, MOL CANCER THER, V9, P1544, DOI 10.1158/1535-7163.MCT-09-1173; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Peterson JR, 2004, J CELL BIOCHEM, V93, P68, DOI 10.1002/jcb.20184; Ravindranathan KP, 2010, J MED CHEM, V53, P1662, DOI 10.1021/jm901386e; Richards MW, 2009, MOL CELL, V36, P560, DOI 10.1016/j.molcel.2009.09.038; Szwaya J, 2007, J BIOMOL SCREEN, V12, P159, DOI 10.1177/1087057106297787; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wodicka LM, 2010, CHEM BIOL, V17, P1241, DOI 10.1016/j.chembiol.2010.09.010; Wong TW, 2006, CLIN CANCER RES, V12, P6186, DOI 10.1158/1078-0432.CCR-06-0642; Zhao BG, 2008, PROTEIN SCI, V17, P1791, DOI 10.1110/ps.036590.108	44	41	46	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20677	20687		10.1074/jbc.M110.213736	http://dx.doi.org/10.1074/jbc.M110.213736			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21454610	Green Published, hybrid			2022-12-27	WOS:000291267600054
J	Bruck, I; Kaplan, DL				Bruck, Irina; Kaplan, Daniel L.			Origin Single-stranded DNA Releases Sld3 Protein from the Mcm2-7 Complex, Allowing the GINS Tetramer to Bind the Mcm2-7 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE PROGRESSION; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; REPLICATION ORIGINS; CHROMOSOME-REPLICATION; PHOSPHORYLATION; DPB11; CDC45; ASSOCIATION; INTERACTS	The replication fork helicase in eukaryotic cells is comprised of Cdc45, Mcm2-7, and GINS (CMG complex). In budding yeast, Sld3, Sld2, and Dpb11 are required for the initiation of DNA replication, but Sld3 and Dpb11 do not travel with the replication fork. Sld3 and Cdc45 bind to early replication origins during the G(1) phase of the cell cycle, whereas Sld2, GINS, polymerase epsilon, and Dpb11 form a transient preloading complex that associates with origins during S phase. We show here that Sld3 binds tightly to origin single-stranded DNA (ssDNA). CDK-phosphorylated Sld3 binds to origin ssDNA with similar high affinity. Origin ssDNA does not disrupt the interaction between Sld3 and Dpb11, and origin ssDNA does not disrupt the interaction between Sld3 and Cdc45. However, origin ssDNA substantially disrupts the interaction between Sld3 and Mcm2-7. GINS and Sld3 compete with one another for binding to Mcm2-7. However, in a mixture of Sld3, GINS, and Mcm2-7, origin ssDNA inhibits the interaction between Sld3 and Mcm2-7, whereas origin ssDNA promotes the association between GINS and Mcm2-7. We also show that origin single-stranded DNA promotes the formation of the CMG complex. We conclude that origin single-stranded DNA releases Sld3 from Mcm2-7, allowing GINS to bind Mcm2-7.	[Bruck, Irina; Kaplan, Daniel L.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Kaplan, DL (corresponding author), VU Stn B,Box 35-1634, Nashville, TN 37235 USA.	Daniel.Kaplan@Vanderbilt.edu		Kaplan, Daniel/0000-0003-2760-7745	American Cancer Society [RSG-08-124-01-CCG]; Vanderbilt University; Vanderbilt Ingram Cancer Center	American Cancer Society(American Cancer Society); Vanderbilt University; Vanderbilt Ingram Cancer Center	This work was supported by American Cancer Society Research Scholar Grant RSG-08-124-01-CCG (to D. L. K.), a Vanderbilt University Discovery grant (to D. L. K.), and a Vanderbilt Ingram Cancer Center grant (to D. L. K.).	ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Araki H, 2010, CURR OPIN CELL BIOL, V22, P766, DOI 10.1016/j.ceb.2010.07.015; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bruck I, 2011, J BIOL CHEM, V286, P14157, DOI 10.1074/jbc.M111.218305; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; Gai DH, 2010, CURR OPIN STRUC BIOL, V20, P756, DOI 10.1016/j.sbi.2010.08.009; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Geraghty DS, 2000, J BIOL CHEM, V275, P18011, DOI 10.1074/jbc.M909787199; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; HUANG RY, 1993, EMBO J, V12, P4521, DOI 10.1002/j.1460-2075.1993.tb06141.x; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; KANTER D, 2010, NUCL ACIDS RES; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Labib K, 2007, TRENDS CELL BIOL, V17, P271, DOI 10.1016/j.tcb.2007.04.002; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lydeard JR, 2010, GENE DEV, V24, P1133, DOI 10.1101/gad.1922610; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; NATALE DA, 1993, NUCLEIC ACIDS RES, V21, P555, DOI 10.1093/nar/21.3.555; NEWLON CS, 1993, CURR OPIN GENET DEV, V3, P752, DOI 10.1016/S0959-437X(05)80094-2; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; Yardimci H, 2010, MOL CELL, V40, P834, DOI 10.1016/j.molcel.2010.11.027; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	43	25	27	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18602	18613		10.1074/jbc.M111.226332	http://dx.doi.org/10.1074/jbc.M111.226332			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21460226	hybrid, Green Published			2022-12-27	WOS:000290785700032
J	Zhang, XM; Tan, FL; Brovkovych, V; Zhang, YK; Skidgel, RA				Zhang, Xianming; Tan, Fulong; Brovkovych, Viktor; Zhang, Yongkang; Skidgel, Randal A.			Cross-talk between Carboxypeptidase M and the Kinin B1 Receptor Mediates a New Mode of G Protein-coupled Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE PRODUCTION; MEMBRANE-BOUND CARBOXYPEPTIDASE; SPONTANEOUSLY HYPERTENSIVE-RATS; CONVERTING-ENZYME INHIBITORS; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; B-1 RECEPTORS; BRADYKININ B1; ENKEPHALIN CONVERTASE; INTERNATIONAL UNION	G protein-coupled receptor (GPCR) signaling is affected by formation of GPCR homo-or heterodimers, but GPCR regulation by other cell surface proteins is not well understood. We reported that the kinin B1 receptor (B1R) heterodimerizes with membrane carboxypeptidase M (CPM), facilitating receptor signaling via CPM-mediated conversion of bradykinin or kallidin to des-Arg kinin B1R agonists. Here, we found that a catalytically inactive CPM mutant that still binds substrate (CPM-E264Q) also facilitates efficient B1R signaling by B2 receptor agonists bradykinin or kallidin. This response required co-expression of B1R and CPM-E264Q in the same cell, was disrupted by antibody that dissociates CPM from B1R, and was not found with a CPM-E264Q-B1R fusion protein. An additional mutation that reduced the affinity of CPM for C-terminal Arg and increased the affinity for C-terminal Lys inhibited the B1R response to bradykinin (with C-terminal Arg) but generated a response to Lys(9)-bradykinin. CPM-E264Q-mediated activation of B1Rs by bradykinin resulted in increased intramolecular fluorescence resonance energy transfer (FRET) in a B1R FRET construct, similar to that generated directly by a B1R agonist. In cytokine-treated human lung microvascular endothelial cells, disruption of B1R-CPM heterodimers inhibited B1R-dependent NO production stimulated by bradykinin and blocked the increased endothelial permeability caused by treatment with bradykinin and pyrogallol (a superoxide generator). Thus, CPM and B1Rs on cell membranes form a critical complex that potentiates B1R signaling. Kinin peptide binding to CPM causes a conformational change in the B1R leading to intracellular signaling and reveals a new mode of GPCR activation by a cell surface peptidase.	[Zhang, Xianming; Tan, Fulong; Brovkovych, Viktor; Zhang, Yongkang; Skidgel, Randal A.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Skidgel, RA (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol MC 868, 835 S Wolcott, Chicago, IL 60612 USA.	rskidgel@uic.edu	zhang, xian/GYA-0290-2022		National Institutes of Health [DK41431, HL60678]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK041431, R56DK041431, R01DK041431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK41431 and HL60678.; Recipient of an American Heart Association postdoctoral fellowship.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Aloy P, 2001, J BIOL CHEM, V276, P16177, DOI 10.1074/jbc.M011457200; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Brovkovych V, 1999, J PHARMACEUT BIOMED, V19, P135, DOI 10.1016/S0731-7085(98)00090-9; Brovkovych V, 2011, J CELL MOL MED, V15, P258, DOI 10.1111/j.1582-4934.2009.00992.x; Campos MM, 2006, TRENDS PHARMACOL SCI, V27, P646, DOI 10.1016/j.tips.2006.10.007; Chen ZL, 2006, FASEB J, V20, P2261, DOI 10.1096/fj.06-6113com; Couture R, 2004, EUR J PHARMACOL, V500, P467, DOI 10.1016/j.ejphar.2004.07.045; DEDDISH PA, 1989, BIOCHEM J, V261, P289, DOI 10.1042/bj2610289; Deiteren K, 2009, CLIN CHIM ACTA, V399, P24, DOI 10.1016/j.cca.2008.10.003; Emanueli C, 2002, CIRCULATION, V105, P360, DOI 10.1161/hc0302.102142; Eng FJ, 1998, J BIOL CHEM, V273, P8382, DOI 10.1074/jbc.273.14.8382; Erdos EG, 2010, HYPERTENSION, V55, P214, DOI 10.1161/HYPERTENSIONAHA.109.144600; FRICKER LD, 1983, BIOCHEM BIOPH RES CO, V111, P994, DOI 10.1016/0006-291X(83)91398-0; Ha SN, 2006, BIOCHEMISTRY-US, V45, P14355, DOI 10.1021/bi060673f; Hadkar V, 2004, AM J PHYSIOL-LUNG C, V287, pL35, DOI 10.1152/ajplung.00346.2003; Hagiwara M, 2004, HYPERTENS RES, V27, P399, DOI 10.1291/hypres.27.399; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Ignjatovic T, 2004, MOL PHARMACOL, V66, P1310, DOI 10.1124/mol.104.001990; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Kakoki M, 2007, P NATL ACAD SCI USA, V104, P7576, DOI 10.1073/pnas.0701617104; Keil C, 2007, J MOL BIOL, V366, P504, DOI 10.1016/j.jmb.2006.11.025; Kenakin TP, 2008, MOL PHARMACOL, V74, P541, DOI 10.1124/mol.108.050062; Kenakin TP, 2009, TRENDS PHARMACOL SCI, V30, P460, DOI 10.1016/j.tips.2009.06.007; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kuhr F, 2010, NEUROPEPTIDES, V44, P145, DOI 10.1016/j.npep.2009.12.004; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Marcic B, 2000, J BIOL CHEM, V275, P16110, DOI 10.1074/jbc.M909490199; McGwire GB, 1997, LIFE SCI, V60, P715, DOI 10.1016/S0024-3205(96)00642-X; Merino VF, 2008, J MOL MED, V86, P791, DOI 10.1007/s00109-008-0345-z; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Moniwa N, 2006, BIOL CHEM, V387, P203, DOI 10.1515/BC.2006.027; NAGAE A, 1993, AM J RESP CELL MOL, V9, P221, DOI 10.1165/ajrcmb/9.2.221; NAGAE A, 1992, J NEUROCHEM, V59, P2201; Nakanishi J, 2006, BIOCHEM BIOPH RES CO, V343, P1191, DOI 10.1016/j.bbrc.2006.03.064; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Parenti A, 2001, FASEB J, V15, P1487, DOI 10.1096/fj.00-0503fje; Paria BC, 2004, AM J PHYSIOL-LUNG C, V287, pL1303, DOI 10.1152/ajplung.00240.2004; Pesquero JB, 2006, BIOL CHEM, V387, P119, DOI 10.1515/BC.2006.017; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; PLUMMER TH, 1981, BIOCHEM BIOPH RES CO, V98, P448, DOI 10.1016/0006-291X(81)90860-3; Qian YM, 1999, J BIOL CHEM, V274, P11582, DOI 10.1074/jbc.274.17.11582; Reverter D, 2004, J MOL BIOL, V338, P257, DOI 10.1016/j.jmb.2004.02.058; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Sangsree S, 2003, AM J PHYSIOL-HEART C, V284, pH1959, DOI 10.1152/ajpheart.00036.2003; Schremmer-Danninger E, 1998, BIOCHEM BIOPH RES CO, V243, P246, DOI 10.1006/bbrc.1997.7999; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Sittipunt C, 2001, AM J RESP CRIT CARE, V163, P503, DOI 10.1164/ajrccm.163.2.2004187; Skidgel RA, 2006, BIOL CHEM, V387, P159, DOI 10.1515/BC.2006.021; Skidgel RA, 1998, IMMUNOL REV, V161, P129, DOI 10.1111/j.1600-065X.1998.tb01577.x; SKIDGEL RA, 1989, J BIOL CHEM, V264, P2236; SKIDGEL RA, 1995, METHOD ENZYMOL, V248, P653; SKIDGEL RA, 1984, BIOCHEM PHARMACOL, V33, P3471, DOI 10.1016/0006-2952(84)90122-9; Skidgel RA, 2007, INT IMMUNOPHARMACOL, V7, P1888, DOI 10.1016/j.intimp.2007.07.014; TAN FL, 1995, METHOD ENZYMOL, V248, P663; TAN FL, 1989, J BIOL CHEM, V264, P13165; Tan FL, 2003, BIOCHEM J, V370, P567, DOI 10.1042/BJ20021495; Tan FL, 1997, BIOCHEM J, V327, P81, DOI 10.1042/bj3270081; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Wang LY, 2009, J PHARMACOL EXP THER, V331, P340, DOI 10.1124/jpet.109.156380; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Zhang XM, 2008, J BIOL CHEM, V283, P7994, DOI 10.1074/jbc.M709837200; Zhang YK, 2007, J BIOL CHEM, V282, P32453, DOI 10.1074/jbc.M706242200	64	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18547	18561		10.1074/jbc.M110.214940	http://dx.doi.org/10.1074/jbc.M110.214940			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454694	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000290785700027
J	Arai, N; Kagawa, W; Saito, K; Shingu, Y; Mikawa, T; Kurumizaka, H; Shibata, T				Arai, Naoto; Kagawa, Wataru; Saito, Kengo; Shingu, Yoshinori; Mikawa, Tsutomu; Kurumizaka, Hitoshi; Shibata, Takehiko			Vital Roles of the Second DNA-binding Site of Rad52 Protein in Yeast Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; COLI RECA PROTEIN; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; GENETIC-RECOMBINATION; BREAK REPAIR; MEDIATOR FUNCTION; JOINT MOLECULES; CIRCULAR DNA; EXCHANGE	RecA/Rad51 proteins are essential in homologous DNA recombination and catalyze the ATP-dependent formation of D-loops from a single-stranded DNA and an internal homologous sequence in a double-stranded DNA. RecA and Rad51 require a "recombination mediator" to overcome the interference imposed by the prior binding of single-stranded binding protein/replication protein A to the single-stranded DNA. Rad52 is the prototype of recombination mediators, and the human Rad52 protein has two distinct DNA-binding sites: the first site binds to single-stranded DNA, and the second site binds to either double-or single-stranded DNA. We previously showed that yeast Rad52 extensively stimulates Rad51-catalyzed D-loop formation even in the absence of replication protein A, by forming a 2: 1 stoichiometric complex with Rad51. However, the precise roles of Rad52 and Rad51 within the complex are unknown. In the present study, we constructed yeast Rad52 mutants in which the amino acid residues corresponding to the second DNA-binding site of the human Rad52 protein were replaced with either alanine or aspartic acid. We found that the second DNA-binding site is important for the yeast Rad52 function in vivo. Rad51-Rad52 complexes consisting of these Rad52 mutants were defective in promoting the formation of D-loops, and the ability of the complex to associate with double-stranded DNA was specifically impaired. Our studies suggest that Rad52 within the complex associates with double-stranded DNA to assist Rad51-mediated homologous pairing.	[Arai, Naoto] Nihon Univ, Coll Bioresource Sci, Dept Appl Biol Sci, Fujisawa, Kanagawa 2520880, Japan; [Kagawa, Wataru; Saito, Kengo; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, Tokyo 1628480, Japan; [Shingu, Yoshinori; Mikawa, Tsutomu; Shibata, Takehiko] RIKEN Adv Sci Inst, Cellular & Mol Biol Lab, Wako, Saitama 3510198, Japan; [Shingu, Yoshinori; Mikawa, Tsutomu; Shibata, Takehiko] Yokohama City Univ, Grad Sch Nanobiosci, Dept Supramol Biol, Tsurumi Ku, Kanagawa 2300045, Japan; [Mikawa, Tsutomu] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	Nihon University; Waseda University; RIKEN; Yokohama City University; RIKEN	Arai, N (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Appl Biol Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	narai@brs.nihon-u.ac.jp; tshibata@postman.riken.go.jp	Mikawa, Tsutomu/E-6510-2013	Mikawa, Tsutomu/0000-0003-2325-5084; Kurumizaka, Hitoshi/0000-0001-7412-3722; Kagawa, Wataru/0000-0002-8801-6589; SAITO, Kengo/0000-0002-8714-6285	Ministry of Education, Culture, Science, Sports and Technology of Japan [21113004, 19570168]; Nihon University [08-125]; Grants-in-Aid for Scientific Research [22310119, 21113001, 10J02699] Funding Source: KAKEN	Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nihon University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research on Innovative Areas 21113004, Scientific Research (C) 19570168, from the Ministry of Education, Culture, Science, Sports and Technology of Japan and by Nihon University Individual Research Grant 08-125.	ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Arai N, 2005, J BIOL CHEM, V280, P32218, DOI 10.1074/jbc.M507521200; Bai Y, 1999, GENETICS, V153, P1117; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; CHOW SA, 1985, P NATL ACAD SCI USA, V82, P5646, DOI 10.1073/pnas.82.17.5646; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; CUNNINGHAM RP, 1980, CELL, V20, P223, DOI 10.1016/0092-8674(80)90250-0; de Mayolo AA, 2006, NUCLEIC ACIDS RES, V34, P2587, DOI 10.1093/nar/gkl280; Enomoto R, 2004, J BIOL CHEM, V279, P35263, DOI 10.1074/jbc.M402481200; Gupta RC, 1997, P NATL ACAD SCI USA, V94, P463, DOI 10.1073/pnas.94.2.463; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kagawa W, 2008, J BIOL CHEM, V283, P24264, DOI 10.1074/jbc.M802204200; KAHN R, 1981, P NATL ACAD SCI-BIOL, V78, P4786, DOI 10.1073/pnas.78.8.4786; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Lee MH, 2005, J BIOL CHEM, V280, P40980, DOI 10.1074/jbc.M505896200; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; LIU JH, 1995, EMBO J, V14, P4599, DOI 10.1002/j.1460-2075.1995.tb00139.x; LUISIDELUCA C, 1995, J BACTERIOL, V177, P566, DOI 10.1128/jb.177.3.566-572.1995; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; Mazloum N, 2008, P NATL ACAD SCI USA, V105, P524, DOI 10.1073/pnas.0707031105; MCENTEE K, 1980, P NATL ACAD SCI-BIOL, V77, P857, DOI 10.1073/pnas.77.2.857; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; Mcllwraith MJ, 2008, MOL CELL, V29, P510, DOI 10.1016/j.molcel.2007.11.037; Mortensen UH, 2002, GENETICS, V161, P549; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Nimonkar AV, 2009, P NATL ACAD SCI USA, V106, P3077, DOI 10.1073/pnas.0813247106; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; SCOTT JF, 1977, P NATL ACAD SCI USA, V74, P193, DOI 10.1073/pnas.74.1.193; Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563; Seitz EM, 1998, GENE DEV, V12, P1248, DOI 10.1101/gad.12.9.1248; Seong C, 2008, J BIOL CHEM, V283, P12166, DOI 10.1074/jbc.M800763200; Shi I, 2009, J BIOL CHEM, V284, P33275, DOI 10.1074/jbc.M109.057752; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P5100, DOI 10.1073/pnas.76.10.5100; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; SHIBATA T, 1980, P NATL ACAD SCI-BIOL, V77, P2606, DOI 10.1073/pnas.77.5.2606; SHIBATA T, 1981, J BIOL CHEM, V256, P7565; SHIBATA T, 1982, J BIOL CHEM, V257, P370; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TSANG SS, 1985, BIOCHEMISTRY-US, V24, P3226, DOI 10.1021/bi00334a023; Wu Y, 2008, J BIOL CHEM, V283, P14883, DOI 10.1074/jbc.M801097200	53	14	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17607	17617		10.1074/jbc.M110.216739	http://dx.doi.org/10.1074/jbc.M110.216739			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454474	Green Published, hybrid			2022-12-27	WOS:000290585200024
J	Lee, DW; Selamoglu, N; Lanciano, P; Cooley, JW; Forquer, I; Kramer, DM; Daldal, F				Lee, Dong-Woo; Selamoglu, Nur; Lanciano, Pascal; Cooley, Jason W.; Forquer, Isaac; Kramer, David M.; Daldal, Fevzi			Loss of a Conserved Tyrosine Residue of Cytochrome b Induces Reactive Oxygen Species Production by Cytochrome bc(1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL-COMPLEX-III; IRON-SULFUR PROTEIN; ELECTRON-TRANSFER; RHODOBACTER-CAPSULATUS; Q(O) SITE; Q-CYCLE; UBIHYDROQUINONE OXIDATION; DOMAIN MOVEMENT; PLASMODIUM-FALCIPARUM; SUPEROXIDE-PRODUCTION	Production of reactive oxygen species (ROS) induces oxidative damages, decreases cellular energy conversion efficiencies, and induces metabolic diseases in humans. During respiration, cytochrome bc(1) efficiently oxidizes hydroquinone to quinone, but how it performs this reaction without any leak of electrons to O-2 to yield ROS is not understood. Using the bacterial enzyme, here we show that a conserved Tyr residue of the cytochrome b subunit of cytochrome bc(1) is critical for this process. Substitution of this residue with other amino acids decreases cytochrome bc(1) activity and enhances ROS production. Moreover, the Tyr to Cys mutation cross-links together the cytochrome b and iron-sulfur subunits and renders the bacterial enzyme sensitive to O-2 by oxidative disruption of its catalytic [2Fe-2S] cluster. Hence, this Tyr residue is essential in controlling unproductive encounters between O-2 and catalytic intermediates at the quinol oxidation site of cytochrome bc(1) to prevent ROS generation. Remarkably, the same Tyr to Cys mutation is encountered in humans with mitochondrial disorders and in Plasmodium species that are resistant to the anti-malarial drug atovaquone. These findings illustrate the harmful consequences of this mutation in human diseases.	[Lee, Dong-Woo; Selamoglu, Nur; Lanciano, Pascal; Cooley, Jason W.; Daldal, Fevzi] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Forquer, Isaac; Kramer, David M.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	University of Pennsylvania; Washington State University	Daldal, F (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	fdaldal@sas.upenn.edu	Kramer, David M/B-9588-2016	Kramer, David M/0000-0003-2181-6888	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038237] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM038237] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; ATTAASAFOADJEI E, 1991, P NATL ACAD SCI USA, V88, P492, DOI 10.1073/pnas.88.2.492; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Cape JL, 2006, TRENDS PLANT SCI, V11, P46, DOI 10.1016/j.tplants.2005.11.007; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Crofts AR, 1999, P NATL ACAD SCI USA, V96, P10021, DOI 10.1073/pnas.96.18.10021; Crofts AR, 2000, BBA-BIOENERGETICS, V1459, P456, DOI 10.1016/S0005-2728(00)00184-5; Darrouzet E, 2000, P NATL ACAD SCI USA, V97, P4567, DOI 10.1073/pnas.97.9.4567; Darrouzet E, 2002, J BIOL CHEM, V277, P3464, DOI 10.1074/jbc.M107973200; Darrouzet E, 2001, TRENDS BIOCHEM SCI, V26, P445, DOI 10.1016/S0968-0004(01)01897-7; DAVIDSON E, 1987, J MOL BIOL, V195, P13, DOI 10.1016/0022-2836(87)90323-8; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Esser L, 2006, P NATL ACAD SCI USA, V103, P13045, DOI 10.1073/pnas.0601149103; Fisher N, 2004, J BIOL CHEM, V279, P12951, DOI 10.1074/jbc.M313866200; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; Kolling DJ, 2007, STRUCTURE, V15, P29, DOI 10.1016/j.str.2006.11.012; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; Lee DW, 2008, J BIOL CHEM, V283, P13973, DOI 10.1074/jbc.M800091200; Lesnefsky EJ, 2003, ARCH BIOCHEM BIOPHYS, V420, P287, DOI 10.1016/j.abb.2003.09.046; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MarinGarcia J, 1996, BIOCHEM MOL BIOL INT, V40, P487; Mather MW, 2005, J BIOL CHEM, V280, P27458, DOI 10.1074/jbc.M502319200; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; Onder O, 2008, MOL CELL PROTEOMICS, V7, P875, DOI 10.1074/mcp.M700433-MCP200; Onder O, 2006, MOL CELL PROTEOMICS, V5, P1426, DOI 10.1074/mcp.M600099-MCP200; Onder O, 2010, ADV EXP MED BIOL, V675, P179, DOI 10.1007/978-1-4419-1528-3_11; Osyczka A, 2005, TRENDS BIOCHEM SCI, V30, P176, DOI 10.1016/j.tibs.2005.02.001; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Poyton RO, 2009, TRENDS ENDOCRIN MET, V20, P332, DOI 10.1016/j.tem.2009.04.001; Snyder CH, 2000, J BIOL CHEM, V275, P13535, DOI 10.1074/jbc.275.18.13535; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Srivastava IK, 1999, MOL MICROBIOL, V33, P704, DOI 10.1046/j.1365-2958.1999.01515.x; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Valkova-Valchanova MB, 1998, BIOCHEMISTRY-US, V37, P16242, DOI 10.1021/bi981651z; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x; Wenz T, 2007, J BIOL CHEM, V282, P3977, DOI 10.1074/jbc.M606482200; Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	48	35	36	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18139	18148		10.1074/jbc.M110.214460	http://dx.doi.org/10.1074/jbc.M110.214460			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454570	hybrid, Green Published			2022-12-27	WOS:000290585200074
J	Li, S; Tsalkova, T; White, MA; Mei, FC; Liu, T; Wang, D; Woods, VL; Cheng, XD				Li, Sheng; Tsalkova, Tamara; White, Mark A.; Mei, Fang C.; Liu, Tong; Wang, Daphne; Woods, Virgil L., Jr.; Cheng, Xiaodong			Mechanism of Intracellular cAMP Sensor Epac2 Activation cAMP-INDUCED CONFORMATIONAL CHANGES IDENTIFIED BY AMIDE HYDROGEN/DEUTERIUM EXCHANGE MASS SPECTROMETRY (DXMS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; MASS-SPECTROMETRY; CYCLIC-AMP; SUBCELLULAR-LOCALIZATION; PHOSPHOLIPASE A(2); DEUTERIUM-EXCHANGE; DOMAIN; RAP1; EXOCYTOSIS; COMPLEX	Epac2, a guanine nucleotide exchange factor, regulates a wide variety of intracellular processes in response to second messenger cAMP. In this study, we have used peptide amide hydrogen/deuterium exchange mass spectrometry to probe the solution structural and conformational dynamics of full-length Epac2 in the presence and absence of cAMP. The results support a mechanism in which cAMP-induced Epac2 activation is mediated by a major hinge motion centered on the C terminus of the second cAMP binding domain. This conformational change realigns the regulatory components of Epac2 away from the catalytic core, making the later available for effector binding. Furthermore, the interface between the first and second cAMP binding domains is highly dynamic, providing an explanation of how cAMP gains access to the ligand binding sites that, in the crystal structure, are seen to be mutually occluded by the other cAMP binding domain. Moreover, cAMP also induces conformational changes at the ionic latch/hairpin structure, which is directly involved in RAP1 binding. These results suggest that in addition to relieving the steric hindrance imposed upon the catalytic lobe by the regulatory lobe, cAMP may also be an allosteric modulator directly affecting the interaction between Epac2 and RAP1. Finally, cAMP binding also induces significant conformational changes in the dishevelled/Egl/pleckstrin (DEP) domain, a conserved structural motif that, although missing from the active Epac2 crystal structure, is important for Epac subcellular targeting and in vivo functions.	[Li, Sheng; Liu, Tong; Wang, Daphne; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Li, Sheng; Liu, Tong; Wang, Daphne; Woods, Virgil L., Jr.] Univ Calif San Diego, Biomed Sci Grad program, La Jolla, CA 92093 USA; [Tsalkova, Tamara; White, Mark A.; Mei, Fang C.; Cheng, Xiaodong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Tsalkova, Tamara; Mei, Fang C.; Cheng, Xiaodong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Woods, VL (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	vwoods@ucsd.edu; xcheng@utmb.edu	Cheng, Xiaodong/O-8176-2019; White, Mark Andrew/B-1723-2012	Cheng, Xiaodong/0000-0002-3479-1694; White, Mark Andrew/0000-0003-1057-4203	National Institutes of Health [GM066170, GM020501, NS070899 GM093325, RR029388]; NIEHS [ES06676]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020501, R01GM093325, R01GM066170, F32GM020501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM066170 (to X. C. and V. L. W.) and GM020501, NS070899 GM093325 and RR029388 (V. L. W.) and NIEHS Center Grant ES06676 (to X. C.).	Brock M, 2007, J BIOL CHEM, V282, P32256, DOI 10.1074/jbc.M706231200; Burke JE, 2009, J AM CHEM SOC, V131, P8083, DOI 10.1021/ja900098y; Burns-Hamuro LL, 2005, PROTEIN SCI, V14, P2982, DOI 10.1110/ps.051687305; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Hsu S, 2009, BIOCHEMISTRY-US, V48, P9891, DOI 10.1021/bi9008853; Hsu YH, 2008, J BIOL CHEM, V283, P9820, DOI 10.1074/jbc.M708143200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Liu C, 2010, MOL CELL BIOL, V30, P3956, DOI 10.1128/MCB.00242-10; Mei FC, 2005, MOL BIOSYST, V1, P325, DOI 10.1039/b511267b; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Niimura M, 2009, J CELL PHYSIOL, V219, P652, DOI 10.1002/jcp.21709; Nijholt IM, 2008, CELL SIGNAL, V20, P1715, DOI 10.1016/j.cellsig.2008.05.001; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Ponsioen B, 2009, MOL CELL BIOL, V29, P2521, DOI 10.1128/MCB.01630-08; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P245, DOI 10.1016/S0968-0004(96)30027-3; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rehmann H, 2003, J BIOL CHEM, V278, P23508, DOI 10.1074/jbc.M301680200; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Tsalkova T, 2011, ASSAY DRUG DEV TECHN, V9, P88, DOI 10.1089/adt.2010.0338; Tsalkova T, 2009, J BIOL CHEM, V284, P23644, DOI 10.1074/jbc.M109.024950; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Wong L, 2004, J MOL BIOL, V341, P93, DOI 10.1016/j.jmb.2004.05.060; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	32	53	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17889	17897		10.1074/jbc.M111.224535	http://dx.doi.org/10.1074/jbc.M111.224535			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454623	Green Published, hybrid			2022-12-27	WOS:000290585200052
J	Melchior-Becker, A; Dai, G; Ding, ZP; Schafer, L; Schrader, J; Young, MF; Fischer, JW				Melchior-Becker, Ariane; Dai, Guang; Ding, Zhaoping; Schaefer, Liliana; Schrader, Juergen; Young, Marian F.; Fischer, Jens W.			Deficiency of Biglycan Causes Cardiac Fibroblasts to Differentiate into a Myofibroblast Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX TURNOVER; COLLAGEN GEL CONTRACTION; TGF-BETA; TARGETED DISRUPTION; DECORIN; TISSUE; EXPRESSION; RECEPTOR; SMAD7	Myocardial infarction (MI) is followed by extracellular matrix (ECM) remodeling, which is on the one hand required for the healing response and the formation of stable scar tissue. However, on the other hand, ECM remodeling can lead to fibrosis and decreased ventricular compliance. The small leucine-rich proteoglycan (SLRP), biglycan (bgn), has been shown to be critically involved in these processes. During post-infarct remodeling cardiac fibroblasts differentiate into myofibroblasts which are the main cell type mediating ECM remodeling. The aim of the present study was to characterize the role of bgn in modulating the phenotype of cardiac fibroblasts. Cardiac fibroblasts were isolated from hearts of wild-type (WT) versus bgn(-/0) mice. Phenotypic characterization of the bgn(-/0) fibroblasts revealed increased proliferation. Importantly, this phenotype of bgn(-/0) fibroblasts was abolished to the WT level by reconstitution of biglycan in the ECM. TGF-beta receptor II expression and phosphorylation of SMAD2 were increased. Furthermore, indicative of a myofibroblast phenotype bgn(-/0) fibroblasts were characterized by increased alpha-smooth muscle actin (alpha-SMA) incorporated into stress fibers, increased formation of focal adhesions, and increased contraction of collagen gels. Administration of neutralizing antibodies to TGF-beta reversed the pro-proliferative, myofibroblastic phenotype. In vivo post-MI alpha-SMA, TGF-beta receptor II expression, and SMAD2 phosphorylation were markedly increased in bgn(-/0) mice. Collectively, the data suggest that bgn deficiency promotes myofibroblast differentiation and proliferation in vitro and in vivo likely due to increased responses to TGF-beta and SMAD2 signaling.	[Melchior-Becker, Ariane; Dai, Guang; Fischer, Jens W.] Univ Dusseldorf, Inst Pharmakol & Klin Pharmakol, Univ Klinikum Dusseldorf, D-40225 Dusseldorf, Germany; [Ding, Zhaoping; Schrader, Juergen] Univ Dusseldorf, Inst Herz & Kreislaufphysiol, D-40225 Dusseldorf, Germany; [Schaefer, Liliana] Klinikum JW Goethe Univ, Pharmazentrum Frankfurt, Inst Allgemeine Pharmakol & Toxikol ZAFES, D-60590 Frankfurt, Germany; [Young, Marian F.] NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Goethe University Frankfurt; Goethe University Frankfurt Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Fischer, JW (corresponding author), Univ Dusseldorf, Inst Pharmakol & Klin Pharmakol, Univ Klinikum Dusseldorf, Moorenstr 5, D-40225 Dusseldorf, Germany.	jens.fischer@uni-duesseldorf.de		Schaefer, Liliana/0000-0002-3318-3005; Young, Marian F/0000-0003-0929-8854	Deutsche Forschungsgemeinschaft [GRK 1089]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000379] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Deutsche Forschungsgemeinschaft Grant GRK 1089.	Acharya PS, 2008, J CELL SCI, V121, P1393, DOI 10.1242/jcs.021683; BERSCHNEIDER HM, 1992, J CLIN INVEST, V89, P484, DOI 10.1172/JCI115610; BERSCHNEIDER HM, 1992, ANN NY ACAD SCI, V664, P140, DOI 10.1111/j.1749-6632.1992.tb39756.x; Bochaton-Piallat ML, 2000, INVEST OPHTH VIS SCI, V41, P2336; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Campbell Patrick H., 2008, Molecular & Cellular Biomechanics, V5, P27; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Cunnington RH, 2009, CAN J PHYSIOL PHARM, V87, P764, DOI 10.1139/Y09-076; Dai G, 2007, AM J PATHOL, V171, P1451, DOI 10.2353/ajpath.2007.070136; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Dobaczewski M, 2006, CELL TISSUE RES, V324, P475, DOI 10.1007/s00441-005-0144-6; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Edlund S, 2005, MOL CELL BIOL, V25, P1475, DOI 10.1128/MCB.25.4.1475-1488.2005; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Embree MC, 2010, AM J PATHOL, V176, P812, DOI 10.2353/ajpath.2010.090450; Ferdous Z, 2007, J BIOL CHEM, V282, P35887, DOI 10.1074/jbc.M705180200; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hinterleitner TA, 1996, AM J PHYSIOL-CELL PH, V271, pC1262, DOI 10.1152/ajpcell.1996.271.4.C1262; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Huebener P, 2008, J IMMUNOL, V180, P2625, DOI 10.4049/jimmunol.180.4.2625; Inkson CA, 2009, CELLS TISSUES ORGANS, V189, P153, DOI 10.1159/000151377; Jarvelainen H, 2004, ARTERIOSCL THROM VAS, V24, P67, DOI 10.1161/01.ATV.0000107026.98626.3b; JONES PA, 1979, P NATL ACAD SCI USA, V76, P353, DOI 10.1073/pnas.76.1.353; Kalmes M, 2006, BIOL CHEM, V387, P1201, DOI 10.1515/BC.2006.148; Kitaya K, 2009, J LEUKOCYTE BIOL, V85, P391, DOI 10.1189/jlb.0908535; Kresse H, 1997, J BIOL CHEM, V272, P18404, DOI 10.1074/jbc.272.29.18404; Kresse H, 2001, J BIOL CHEM, V276, P13411, DOI 10.1074/jbc.M009321200; Landstrom M, 2000, CURR BIOL, V10, P535, DOI 10.1016/S0960-9822(00)00470-X; Leurs C, 2003, HUM GENE THER, V14, P509, DOI 10.1089/104303403764539305; Lijnen P, 2003, J RENIN-ANGIO-ALDO S, V4, P113, DOI 10.3317/jraas.2003.011; Lijnen P, 2003, METHOD FIND EXP CLIN, V25, P79, DOI 10.1358/mf.2003.25.2.723680; Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4; Marzoll A., 2009, J CELL MOL IN PRESS; Masters KSB, 2005, J BIOMAT SCI-POLYM E, V16, P659, DOI 10.1163/1568562053783722; Mazars A, 2001, J BIOL CHEM, V276, P36797, DOI 10.1074/jbc.M101672200; Nagy N, 2010, BASIC RES CARDIOL, V105, P29, DOI 10.1007/s00395-009-0051-1; PETERKOFSKY B, 1972, BIOCHEM BIOPH RES CO, V49, P1343, DOI 10.1016/0006-291X(72)90614-6; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Reinboth B, 2002, J BIOL CHEM, V277, P3950, DOI 10.1074/jbc.M109540200; Rock K., 2010, DERMATOLOGY IN PRESS; Schaefer L, 2004, AM J PATHOL, V165, P383, DOI 10.1016/S0002-9440(10)63305-6; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schaefer L, 2003, J BIOL CHEM, V278, P26227, DOI 10.1074/jbc.M210574200; SCHWARZ RI, 1977, P NATL ACAD SCI USA, V74, P4453, DOI 10.1073/pnas.74.10.4453; Shimizu-Hirota R, 2004, CIRC RES, V94, P1067, DOI 10.1161/01.RES.0000126049.79800.CA; Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8; Sun Y, 1996, J MOL CELL CARDIOL, V28, P851, DOI 10.1006/jmcc.1996.0080; Tang Y, 2008, J BIOL CHEM, V283, P23956, DOI 10.1074/jbc.M800351200; Tiede K, 2010, BASIC RES CARDIOL, V105, P99, DOI 10.1007/s00395-009-0049-8; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vernon RB, 2002, IN VITRO CELL DEV-AN, V38, P97, DOI 10.1290/1071-2690(2002)038<0097:AIMFTC>2.0.CO;2; Webber J, 2009, AM J PATHOL, V175, P148, DOI 10.2353/ajpath.2009.080837; Weber CK, 2001, GASTROENTEROLOGY, V121, P657, DOI 10.1053/gast.2001.27222; Weis SM, 2005, MATRIX BIOL, V24, P313, DOI 10.1016/j.matbio.2005.05.003; WELCH MP, 1990, J CELL BIOL, V110, P133, DOI 10.1083/jcb.110.1.133; Westermann D, 2008, CIRCULATION, V117, P1269, DOI 10.1161/CIRCULATIONAHA.107.714147; WILBORN J, 1995, AM J PHYSIOL-LUNG C, V268, pL294, DOI 10.1152/ajplung.1995.268.2.L294; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; WILLEMS IEMG, 1994, AM J PATHOL, V145, P868; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Young MF, 2002, GLYCOCONJUGATE J, V19, P257, DOI 10.1023/A:1025336114352; Yu Q, 2000, GENE DEV, V14, P163; Zamilpa R, 2010, J MOL CELL CARDIOL, V48, P558, DOI 10.1016/j.yjmcc.2009.06.012; ZERN MA, 1985, EXP CELL RES, V160, P307, DOI 10.1016/0014-4827(85)90178-8; Zhang Z, 2009, BURNS, V35, P527, DOI 10.1016/j.burns.2008.08.021	67	59	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17365	17375		10.1074/jbc.M110.192682	http://dx.doi.org/10.1074/jbc.M110.192682			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454527	Green Published, hybrid			2022-12-27	WOS:000290301900084
J	Chan, D; Citro, A; Cordy, JM; Shen, GC; Wolozin, B				Chan, Diane; Citro, Allison; Cordy, Joanna M.; Shen, Grace C.; Wolozin, Benjamin			Rac1 Protein Rescues Neurite Retraction Caused by G2019S Leucine-rich Repeat Kinase 2 (LRRK2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; RHO GTPASES; ACTIVATION; EXPRESSION; EZRIN/RADIXIN/MOESIN; PHOSPHORYLATION; VULNERABILITY; MITOCHONDRIA; PATHOGENESIS	Mutations in leucine-rich repeat kinase 2 (LRRK2) are currently the most common genetic cause of familial late-onset Parkinson disease, which is clinically indistinguishable from idiopathic disease. The most common pathological mutation in LRRK2, G2019S LRRK2, is known to cause neurite retraction. However, molecular mechanisms underlying regulation of neurite length by LRRK2 are unknown. Here, we demonstrate a novel interaction between LRRK2 and the Rho GTPase, Rac1, which plays a critical role in actin cytoskeleton remodeling necessary for the maintenance of neurite morphology. LRRK2 binds strongly to endogenous or expressed Rac1, while showing weak binding to Cdc42 and no binding to RhoA. Co-expression with LRRK2 increases Rac1 activity, as shown by increased binding to the p21-activated kinase, which modulates actin cytoskeletal dynamics. LRRK2 constructs carrying mutations that inactivate the kinase or GTPase activities do not activate Rac1. Interestingly, LRRK2 does not increase levels of membrane-bound Rac1 but dramatically changes the cellular localization of Rac1, causing polarization, which is augmented further when LRRK2 is co-expressed with constitutively active Rac1. Four different disease-related mutations in LRRK2 altered binding to Rac1, with the G2019S and R1441C LRRK2 mutations attenuating Rac1 binding and the Y1699C and I2020T LRRK2 mutations increasing binding. Co-expressing Rac1 in SH-SY5Y cells rescues the G2019S mutant phenotype of neurite retraction. We hypothesize that pathological mutations in LRRK2 attenuates activation of Rac1, causing disassembly of actin filaments, leading to neurite retraction. The interactions between LRRK2 and Rho GTPases provide a novel pathway through which LRRK2 might modulate cellular dynamics and contribute to the pathophysiology of Parkinson disease.	[Chan, Diane; Citro, Allison; Cordy, Joanna M.; Shen, Grace C.; Wolozin, Benjamin] Boston Univ, Sch Med, Dept Pharmacol, Boston, MA 02118 USA; [Wolozin, Benjamin] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	Boston University; Boston University	Wolozin, B (corresponding author), Boston Univ, Sch Med, Dept Pharmacol, 72 E Concord St,R-614, Boston, MA 02118 USA.	bwolozin@bu.edu		Chan, Diane/0000-0003-3765-190X	National Institutes of Health [NIEHS ES15567, NINDS NS41786, 066108, NINDS NS066658]; Alzheimer Association and Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041786, R01NS060872, F30NS066658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association and Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NIEHS ES15567 and NINDS NS41786 and 066108 (to B. W.) and NINDS NS066658 (to D. C.). This work was also supported by the Alzheimer Association and Michael J. Fox Foundation (to B. W.).	Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Biskup S, 2008, J NEUROL, V255, P8, DOI 10.1007/s00415-008-5005-2; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Carballo-Carbajal I, 2010, CELL SIGNAL, V22, P821, DOI 10.1016/j.cellsig.2010.01.006; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2009, BBA-MOL BASIS DIS, V1792, P585, DOI 10.1016/j.bbadis.2009.06.001; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2007, J NEUROCHEM, V102, P93, DOI 10.1111/j.1471-4159.2007.04523.x; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Haebig K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013762; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ho CCY, 2009, J NEUROSCI, V29, P1011, DOI 10.1523/JNEUROSCI.5175-08.2009; Hsu CH, 2010, NEURODEGENER DIS, V7, P68, DOI 10.1159/000285509; Hsu CH, 2010, J NEUROCHEM, V112, P1593, DOI 10.1111/j.1471-4159.2010.06568.x; Hughes SC, 2007, CURR OPIN CELL BIOL, V19, P51, DOI 10.1016/j.ceb.2006.12.004; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Klein CL, 2009, J NEUROCHEM, V111, P703, DOI 10.1111/j.1471-4159.2009.06358.x; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Kreis P, 2009, CELL SIGNAL, V21, P384, DOI 10.1016/j.cellsig.2008.11.001; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008730; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Linseman DA, 2008, FRONT BIOSCI-LANDMRK, V13, P657, DOI 10.2741/2710; Liou AKF, 2008, NEUROBIOL DIS, V32, P116, DOI 10.1016/j.nbd.2008.06.016; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Ogita H, 2006, METHOD ENZYMOL, V406, P415, DOI 10.1016/S0076-6879(06)06030-7; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Saha S, 2009, J NEUROSCI, V29, P9210, DOI 10.1523/JNEUROSCI.2281-09.2009; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Taylor JP, 2006, TRENDS MOL MED, V12, P76, DOI 10.1016/j.molmed.2005.12.004; Ved R, 2005, J BIOL CHEM, V280, P42655, DOI 10.1074/jbc.M505910200; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Watabe-Uchida M, 2006, J NEUROSCI, V26, P10633, DOI 10.1523/JNEUROSCI.4084-06.2006; White LR, 2007, J NEUROSCI RES, V85, P1288, DOI 10.1002/jnr.21240	53	88	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.234005	http://dx.doi.org/10.1074/jbc.M111.234005			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454543	hybrid, Green Published			2022-12-27	WOS:000290022800054
J	Wang, HB; Xiao, LQ; Kazanietz, MG				Wang, HongBin; Xiao, Liqing; Kazanietz, Marcelo G.			p23/Tmp21 Associates with Protein Kinase C delta(PKC delta) and Modulates Its Apoptotic Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; ESTER-INDUCED APOPTOSIS; C-DELTA; PHORBOL ESTER; PKC-DELTA; SUBCELLULAR-LOCALIZATION; TRANSMEMBRANE PROTEIN; DIFFERENTIAL LOCALIZATION; DEPENDENT BINDING; GOLGI-COMPLEX	There is emerging evidence that C1 domains, motifs originally identified in PKC isozymes and responsible for binding of phorbol esters and diacylglycerol, interact with the Golgi/endoplasmic reticulum protein p23 (Tmp21). In this study, we investigated whether PKC delta, a kinase widely implicated in apoptosis and inhibition of cell cycle progression, associates with p23 and determined the potential functional implications of this interaction. Using a yeast two-hybrid approach, we found that the PKC delta C1b domain associates with p23 and identified two key residues (Asp(245) and Met(266)) implicated in this interaction. Interestingly, silencing p23 from LNCaP prostate cancer cells using RNAi markedly enhanced PKC delta-dependent apoptosis and activation of PKC delta downstream effectors ROCK and JNK by phorbol 12-myristate 13-acetate. Moreover, translocation of PKC delta to the plasma membrane by phorbol 12-myristate 13-acetate was enhanced in p23-depleted LNCaP cells. Notably, a PKC delta mutant that failed to interact with p23 triggered a strong apoptotic response when expressed in LNCaP cells. In summary, our data compellingly support the concept that C1 domains have dual roles both in lipid and protein associations and provide strong evidence that p23 acts as an anchoring protein that retains PKC delta at the perinuclear region, thus limiting the availability of this kinase for activation in response to stimuli.	[Wang, HongBin; Xiao, Liqing; Kazanietz, Marcelo G.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Wang, HB (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 1238 Biomed Res Bldg,2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	hongbin@mail.med.upenn.edu; marcelog@upenn.edu	wang, hongbin/E-5541-2011		National Institutes of Health [RO1-CA89202]; NATIONAL CANCER INSTITUTE [R01CA089202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-CA89202 from (to M. G. K.).	Anilkumar N, 2003, EMBO J, V22, P5390, DOI 10.1093/emboj/cdg521; Blass M, 2002, MOL CELL BIOL, V22, P182, DOI 10.1128/MCB.22.1.182-195.2002; Blumberg PM, 2008, CURR DRUG TARGETS, V9, P641, DOI 10.2174/138945008785132376; Bogi K, 1998, CANCER RES, V58, P1423; Caino MC, 2011, J BIOL CHEM, V286, P11254, DOI 10.1074/jbc.M110.194332; Caloca MJ, 1999, P NATL ACAD SCI USA, V96, P11854, DOI 10.1073/pnas.96.21.11854; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Caloca MJ, 1997, J BIOL CHEM, V272, P26488, DOI 10.1074/jbc.272.42.26488; Caloca MJ, 2001, J BIOL CHEM, V276, P18303, DOI 10.1074/jbc.M011368200; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Chen D, 2004, J BIOL CHEM, V279, P4829, DOI 10.1074/jbc.M311196200; Chen D, 2007, J BIOL CHEM, V282, P33776, DOI 10.1074/jbc.M703320200; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Colon-Gonzalez F, 2008, J BIOL CHEM, V283, P35247, DOI 10.1074/jbc.M806264200; Csukai M, 1999, PHARMACOL RES, V39, P253, DOI 10.1006/phrs.1998.0418; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Fikaris AJ, 2005, J BIOL CHEM, V280, P32107, DOI 10.1074/jbc.M504432200; Fucini RV, 2002, MOL BIOL CELL, V13, P621, DOI 10.1091/mbc.01-11-0547; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Gavrielides MV, 2006, CANCER RES, V66, P11792, DOI 10.1158/0008-5472.CAN-06-1139; Gomel R, 2007, MOL CANCER RES, V5, P627, DOI 10.1158/1541-7786.MCR-06-0255; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Kajimoto T, 2004, J BIOL CHEM, V279, P12668, DOI 10.1074/jbc.M312350200; Lagory EL, 2010, J BIOL CHEM, V285, P1879, DOI 10.1074/jbc.M109.055392; Lim JH, 2009, CARCINOGENESIS, V30, P729, DOI 10.1093/carcin/bgn265; Majoul I, 2001, DEV CELL, V1, P139, DOI 10.1016/S1534-5807(01)00004-1; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Nguyen TA, 2004, J BIOL CHEM, V279, P52714, DOI 10.1074/jbc.M403040200; Panaretakis T, 2005, MOL BIOL CELL, V16, P3821, DOI 10.1091/mbc.E04-10-0862; Perego C, 2002, BIOCHEM BIOPH RES CO, V294, P127, DOI 10.1016/S0006-291X(02)00448-5; Pu YM, 2006, J BIOL CHEM, V281, P33773, DOI 10.1074/jbc.M606560200; Qi X, 2008, J CELL SCI, V121, P804, DOI 10.1242/jcs.024653; Rojo M, 2000, J CELL SCI, V113, P1043; Rojo M, 1997, J CELL BIOL, V139, P1119, DOI 10.1083/jcb.139.5.1119; Schultz A, 2004, J BIOL CHEM, V279, P31750, DOI 10.1074/jbc.M313017200; Schultz A, 2003, CELL DEATH DIFFER, V10, P662, DOI 10.1038/sj.cdd.4401235; Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239; STAMNES MA, 1995, P NATL ACAD SCI USA, V92, P8011, DOI 10.1073/pnas.92.17.8011; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Sumitomo M, 2002, J CLIN INVEST, V109, P827, DOI 10.1172/JCI200214146; Sunesson L, 2008, J BIOL CHEM, V283, P16653, DOI 10.1074/jbc.M710436200; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Torgersen ML, 2007, J BIOL CHEM, V282, P16317, DOI 10.1074/jbc.M610886200; von Burstin VA, 2010, MOL PHARMACOL, V78, P325, DOI 10.1124/mol.110.064741; Wang H, 2006, BIOCHEM SOC T, V34, P855, DOI 10.1042/BST0340855; Wang HB, 2002, J BIOL CHEM, V277, P4541, DOI 10.1074/jbc.M107150200; Wang HB, 2006, EMBO J, V25, P2062, DOI 10.1038/sj.emboj.7601098; Wang HB, 2010, MOL BIOL CELL, V21, P1398, DOI 10.1091/mbc.E09-08-0735; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; WATANABE T, 1992, P NATL ACAD SCI USA, V89, P10159, DOI 10.1073/pnas.89.21.10159; Xiao LQ, 2009, J BIOL CHEM, V284, P29365, DOI 10.1074/jbc.M109.007971; Zhao LY, 1999, J BIOL CHEM, V274, P14198, DOI 10.1074/jbc.274.20.14198	54	32	32	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.227991	http://dx.doi.org/10.1074/jbc.M111.227991			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454541	hybrid, Green Published			2022-12-27	WOS:000290022800023
J	Wang, L; Liu, YT; Hao, R; Chen, L; Chang, ZJ; Wang, HR; Wang, ZX; Wu, JW				Wang, Le; Liu, Yi-Tong; Hao, Rui; Chen, Lei; Chang, Zhijie; Wang, Hong-Rui; Wang, Zhi-Xin; Wu, Jia-Wei			Molecular Mechanism of the Negative Regulation of Smad1/5 Protein by Carboxyl Terminus of Hsc70-interacting Protein (CHIP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE CHIP; TGF-BETA SUPERFAMILY; MEDIATED DEGRADATION; SIGNALING PATHWAY; OSTEOBLAST DIFFERENTIATION; STRUCTURAL BASIS; QUALITY-CONTROL; BMP PATHWAY; CHAPERONE; TARGETS	The transforming growth factor-beta (TGF-beta) superfamily of ligands signals along two intracellular pathways, Smad2/3-mediated TGF-beta/activin pathway and Smad1/5/8-mediated bone morphogenetic protein pathway. The C terminus of Hsc70-interacting protein (CHIP) serves as an E3 ubiquitin ligase to mediate the degradation of Smad proteins and many other signaling proteins. However, the molecular mechanism for CHIP-mediated down-regulation of TGF-beta signaling remains unclear. Here we show that the extreme C-terminal sequence of Smad1 plays an indispensable role in its direct association with the tetratricopeptide repeat (TPR) domain of CHIP. Interestingly, Smad1 undergoes CHIP-mediated polyubiquitination in the absence of molecular chaperones, and phosphorylation of the C-terminal SXS motif of Smad1 enhances the interaction and ubiquitination. We also found that CHIP preferentially binds to Smad1/5 and specifically disrupts the core signaling complex of Smad1/5 and Smad4. We determined the crystal structures of CHIP-TPR in complex with the phosphorylated/pseudophosphorylated Smad1 peptides and with an Hsp70/Hsc70 C-terminal peptide. Structural analyses and subsequent biochemical studies revealed that the distinct CHIP binding affinities of Smad1/5 or Smad2/3 result from the nonconservative hydrophobic residues at R-Smad C termini. Unexpectedly, the C-terminal peptides from Smad1 and Hsp70/Hsc70 bind in the same groove of CHIP-TPR, and heat shock proteins compete with Smad1/5 for CHIP interaction and concomitantly suppress, rather than facilitate, CHIP-mediated Smad ubiquitination. Thus, we conclude that CHIP inhibits the signaling activities of Smad1/5 by recruiting Smad1/5 from the functional R-/Co-Smad complex and further promoting the ubiquitination/degradation of Smad1/5 in a chaperone-independent manner.	[Wang, Le; Liu, Yi-Tong; Hao, Rui; Chen, Lei; Wang, Zhi-Xin; Wu, Jia-Wei] Tsinghua Univ, MOE Key Lab Bioinformat, Sch Life Sci, Beijing 100084, Peoples R China; [Chang, Zhijie] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Sch Med, Beijing 100084, Peoples R China; [Wang, Hong-Rui] Xiamen Univ, MOE Key Lab Cell Biol & Tumor Cell Engn, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China	Tsinghua University; Tsinghua University; Xiamen University	Wu, JW (corresponding author), Tsinghua Univ, MOE Key Lab Bioinformat, Sch Life Sci, Beijing 100084, Peoples R China.	jiaweiwu@mail.tsinghua.edu.cn	wang, zhixin/GZH-2500-2022; Chang, Zhijie/AAH-8109-2019	Chang, Zhijie/0000-0003-1567-3227; Wang, Hong-Rui/0000-0002-2916-8849; Wang, Le/0000-0002-8687-239X	Ministry of Science and Technology of China [2007CB914400, 2011CB910803]; National Natural Science Foundation of China [31070643]; Tsinghua University [09THZ02235]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University	This work was supported in part by Ministry of Science and Technology of China Grants 2007CB914400 and 2011CB910803, National Natural Science Foundation of China Grant 31070643, and Tsinghua University Grant 09THZ02235.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Belova L, 2006, BIOCHEM J, V400, P235, DOI 10.1042/BJ20060905; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Chen HB, 2006, GENE DEV, V20, P648, DOI 10.1101/gad.1384706; Cliff MJ, 2006, STRUCTURE, V14, P415, DOI 10.1016/j.str.2005.12.009; Daviau A, 2006, J BIOL CHEM, V281, P31467, DOI 10.1074/jbc.M607612200; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; Duan XY, 2006, J BIOL CHEM, V281, P36526, DOI 10.1074/jbc.M605169200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; Li LY, 2004, MOL CELL BIOL, V24, P856, DOI 10.1128/MCB.24.2.856-864.2004; Li RF, 2007, J MOL BIOL, V374, P777, DOI 10.1016/j.jmb.2007.09.082; Li XN, 2008, J CELL BIOL, V181, P959, DOI 10.1083/jcb.200711044; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Masaki M, 2005, CIRCULATION, V111, P2752, DOI 10.1161/CIRCULATIONAHA.104.490946; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pardali E, 2009, FRONT BIOSCI-LANDMRK, V14, P4848, DOI 10.2741/3573; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Xin H, 2005, J BIOL CHEM, V280, P20842, DOI 10.1074/jbc.M412275200; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yamamoto N, 1997, BIOCHEM BIOPH RES CO, V238, P574, DOI 10.1006/bbrc.1997.7325; Zhang CL, 2005, AM J PHYSIOL-HEART C, V288, pH2836, DOI 10.1152/ajpheart.01122.2004; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	47	53	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.201814	http://dx.doi.org/10.1074/jbc.M110.201814			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454478	Green Published, hybrid			2022-12-27	WOS:000290022800029
J	Xia, Y; Lundback, AK; Sahaf, N; Nordlund, G; Brzezinski, P; Eshaghi, S				Xia, Yu; Lundbaeck, Anna-Karin; Sahaf, Newsha; Nordlund, Gustav; Brzezinski, Peter; Eshaghi, Said			Co2+ Selectivity of Thermotoga maritima CorA and Its Inability to Regulate Mg2+ Homeostasis Present a New Class of CorA Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNESIUM TRANSPORT; SALMONELLA-TYPHIMURIUM; CRYSTAL-STRUCTURE; HYPERTHERMOPHILIC BACTERIUM; ALKALINE-PHOSPHATASE; ANGSTROM RESOLUTION; STABILITY; SYSTEM; HOMOTETRAMER; CLONING	CorA is a family of divalent cation transporters ubiquitously present in bacteria and archaea. Although CorA can transport both Mg2+ and Co2+ almost equally well, its main role has been suggested to be that of primary Mg2+ transporter of prokaryotes and hence the regulator of Mg2+ homeostasis. The reason is that the affinity of CorA for Co2+ is relatively low and thus considered non-physiological. Here, we show that Thermotoga maritima CorA (TmCorA) is incapable of regulating the Mg2+ homeostasis and therefore cannot be the primary Mg2+ transporter of T. maritima. Further, our in vivo experiments confirm that TmCorA is a highly selective Co2+ transporter, as it selects Co2+ over Mg2+ at > 100 times lower concentrations. In addition, we present data that show TmCorA to be extremely thermostable in the presence of Co2+. Mg2+ could not stabilize the protein to the same extent, even at high concentrations. We also show that addition of Co2+, but not Mg2+, specifically induces structural changes to the protein. Altogether, these data show that TmCorA has the role of being the transporter of Co2+ but not Mg2+. The physiological relevance and requirements of Co2+ in T. maritima is discussed and highlighted. We suggest that CorA may have different roles in different organisms. Such functional diversity is presumably a reflection of minor, but important structural differences within the CorA family that regulate the gating, substrate selection, and transport.	[Xia, Yu; Lundbaeck, Anna-Karin; Sahaf, Newsha; Eshaghi, Said] Nanyang Technol Univ, Sch Biol Sci, Singapore 138673, Singapore; [Nordlund, Gustav; Brzezinski, Peter] Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Stockholm University	Eshaghi, S (corresponding author), 61 Biopolis Dr, Singapore 138673, Singapore.	Said.Eshaghi@ntu.edu.sg			Nanyang Technological University; National Research Foundation (NRF); Biomedical Research Council (BMRC) of Singapore; Swedish Research Council; Center for Biomembrane Research at Stockholm University; Knut and Alice Wallenberg Foundation	Nanyang Technological University(Nanyang Technological University); National Research Foundation (NRF); Biomedical Research Council (BMRC) of Singapore(Agency for Science Technology & Research (A*STAR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Center for Biomembrane Research at Stockholm University; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by grants from Nanyang Technological University, the National Research Foundation (NRF) and Biomedical Research Council (BMRC) of Singapore, the Swedish Research Council, the Center for Biomembrane Research at Stockholm University, and the Knut and Alice Wallenberg Foundation.	Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Cannio R, 2004, EXTREMOPHILES, V8, P117, DOI 10.1007/s00792-003-0370-3; Chakrabarti N, 2010, BIOPHYS J, V98, P784, DOI 10.1016/j.bpj.2009.11.009; Epting KL, 2005, FEBS J, V272, P1454, DOI 10.1111/j.1742-4658.2005.04577.x; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; HMIEL SP, 1989, J BACTERIOL, V171, P4742, DOI 10.1128/jb.171.9.4742-4751.1989; HMIEL SP, 1986, J BACTERIOL, V168, P1444, DOI 10.1128/jb.168.3.1444-1450.1986; Hogbom M, 2004, SCIENCE, V305, P245, DOI 10.1126/science.1098419; Holden JF, 2003, CURR OPIN CHEM BIOL, V7, P160, DOI 10.1016/S1367-5931(03)00026-7; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; Jorge CD, 2007, EXTREMOPHILES, V11, P115, DOI 10.1007/s00792-006-0021-6; Kehres D G, 1998, Microb Comp Genomics, V3, P151, DOI 10.1089/omi.1.1998.3.151; Kehres DG, 2002, BIOMETALS, V15, P261, DOI 10.1023/A:1016078832697; Llanos J, 2000, CURR MICROBIOL, V41, P201, DOI 10.1007/s002840010119; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Majava V, 2008, FEBS J, V275, P4583, DOI 10.1111/j.1742-4658.2008.06601.x; Nakajima M, 2003, ARCH BIOCHEM BIOPHYS, V415, P87, DOI 10.1016/S0003-9861(03)00222-4; Niegowski D, 2007, CELL MOL LIFE SCI, V64, P2564, DOI 10.1007/s00018-007-7174-z; Payandeh J, 2008, J BIOL CHEM, V283, P11721, DOI 10.1074/jbc.M707889200; Payandeh J, 2006, EMBO J, V25, P3762, DOI 10.1038/sj.emboj.7601269; SCHUMANN J, 1991, FEBS LETT, V282, P122, DOI 10.1016/0014-5793(91)80459-G; Smith RL, 1998, J BACTERIOL, V180, P2788, DOI 10.1128/JB.180.10.2788-2791.1998; Smith RL, 1998, MICROBIOL-SGM, V144, P1835, DOI 10.1099/00221287-144-7-1835; SMITH RL, 1995, J BACTERIOL, V177, P1638, DOI 10.1128/jb.177.6.1638-1640.1995; SNAVELY MD, 1989, J BACTERIOL, V171, P4761, DOI 10.1128/jb.171.9.4761-4766.1989; Song SH, 2008, APPL MICROBIOL BIOT, V81, P485, DOI 10.1007/s00253-008-1633-9; Spraggon G, 2004, PROTEINS, V55, P1078, DOI 10.1002/prot.20034; Sterner R, 1996, PROTEIN SCI, V5, P2000, DOI 10.1002/pro.5560051006; Svidova S., 2010, BIOCH BIOPH IN PRESS; Tan KM, 2009, PROTEIN SCI, V18, P2043, DOI 10.1002/pro.215; Tetin SY, 2000, METHODS, V20, P341, DOI 10.1006/meth.1999.0927; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wang J, 2005, BIOCHEMISTRY-US, V44, P8378, DOI 10.1021/bi050155p; Wang SZ, 2006, J BIOL CHEM, V281, P26813, DOI 10.1074/jbc.M602342200; Warren MA, 2004, J BACTERIOL, V186, P4605, DOI 10.1128/JB.186.14.4605-4612.2004; Wojciechowski CL, 2002, PROTEIN SCI, V11, P903, DOI 10.1110/ps.4260102	38	21	22	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.222166	http://dx.doi.org/10.1074/jbc.M111.222166			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454699	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000290022800089
J	Yoon, S; Choi, MH; Chang, MS; Baik, JH				Yoon, Sehyoun; Choi, Mi-hyun; Chang, Min Seok; Baik, Ja-Hyun			Wnt5a-Dopamine D2 Receptor Interactions Regulate Dopamine Neuron Development via Extracellular Signal-regulated Kinase (ERK) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; DISHEVELLED PHOSPHORYLATION; SUBVENTRICULAR ZONE; 2 ISOFORMS; CELLS; WNT-5A; D-3; STIMULATION; EXPRESSION; SURVIVAL	The dopamine D2 receptor (D2R) plays an important role in mesencephalic dopaminergic neuronal development, particularly coupled with extracellular signal-regulated kinase (ERK) activation. Wnt5a protein is known to regulate the development of dopaminergic neurons. We analyzed the effect of Wnt5a on dopaminergic neuron development in mesencephalic primary cultures from wild-type (WT) and D2R knock-out (D2R(-/-)) mice. Treatment with Wnt5a increased the number and neuritic length of dopamine neurons in primary mesencephalic neuronal cultures from WT mice, but not from D2R(-/-) mice. The effect of Wnt5a was completely blocked by treatment with D2R antagonist or inhibitors of MAPK or EGFR. Wnt5a-mediated ERK activation in mesencephalic neuronal cultures was inhibited by treatment of D2R antagonist and EGFR inhibitors in WT mice. However, these regulations were not observed for D2R(-/-) mice. Co-immunoprecipitation and displacement of [H-3] spiperone from D2R by Wnt5a demonstrated that Wnt5a could bind with D2R. This interaction was confirmed by GST pulldown assays demonstrating that the domain including transmembrane domain 4, second extracellular loop, and transmembrane domain 5 of D2R binds to Wnt5a. These results suggest that the interaction between D2R and Wnt5a has an important role in dopamine neuron development in association with EGFR and the ERK pathway.	[Baik, Ja-Hyun] Korea Univ, Sch Life Sci & Biotechnol, Mol Neurobiol Lab, Seoul 136701, South Korea	Korea University	Baik, JH (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Mol Neurobiol Lab, Seoul 136701, South Korea.	jahyunb@korea.ac.kr	soler, martha maricel m gomez/L-6025-2014	soler, martha maricel m gomez/0000-0002-4412-8108; Yoon, Sehyoun/0000-0001-6545-3615	Korea Healthcare Technology RD Project [A084139]; Ministry of Education, Science and Technology, the Republic of Korea [2009K001254, 2010K000814]; Korea University; Seoul Scholarship Foundation	Korea Healthcare Technology RD Project; Ministry of Education, Science and Technology, the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea University; Seoul Scholarship Foundation	This work was supported in part by a research grant from the Korea Healthcare Technology R&D Project A084139, Grants 2009K001254 and 2010K000814 from the Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Education, Science and Technology, the Republic of Korea, and by a Korea University grant.; Supported by a Hi Seoul Science (Humanities) fellowship from the Seoul Scholarship Foundation.	Abe Y, 2009, NEUROSCIENCE, V161, P95, DOI 10.1016/j.neuroscience.2009.03.022; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; An JJ, 2003, MOL CELL ENDOCRINOL, V206, P49, DOI 10.1016/S0303-7207(03)00236-3; Andersson ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003517; Arenas E, 2005, ANN NY ACAD SCI, V1049, P51, DOI 10.1196/annals.1334.007; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; CASPER D, 1991, J NEUROSCI RES, V30, P372, DOI 10.1002/jnr.490300213; CASPER D, 1994, J NEUROCHEM, V62, P2166; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Choi EY, 1999, BIOCHEM BIOPH RES CO, V256, P33, DOI 10.1006/bbrc.1999.0286; Civenni G, 2003, EMBO REP, V4, P166, DOI 10.1038/sj.embor.embor735; Collo G, 2008, EUR J NEUROSCI, V28, P1231, DOI 10.1111/j.1460-9568.2008.06423.x; GROVES PM, 1975, SCIENCE, V190, P522, DOI 10.1126/science.242074; Inoue H, 2007, P NATL ACAD SCI USA, V104, P14430, DOI 10.1073/pnas.0700901104; Kim HS, 2006, J NEUROCHEM, V99, P458, DOI 10.1111/j.1471-4159.2006.04108.x; Kim KS, 2010, J BIOL CHEM, V285, P8905, DOI 10.1074/jbc.M109.079590; Kim SJ, 2004, MOL ENDOCRINOL, V18, P640, DOI 10.1210/me.2003-0066; Kim SY, 2008, EXP NEUROL, V214, P69, DOI 10.1016/j.expneurol.2008.07.014; Kim SY, 2006, J NEUROSCI, V26, P4567, DOI 10.1523/JNEUROSCI.5236-05.2006; Lindvall O, 2009, TRENDS PHARMACOL SCI, V30, P260, DOI 10.1016/j.tips.2009.03.001; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; MEIERGERD SM, 1993, J NEUROCHEM, V61, P764; Moses D, 2006, EXP NEUROL, V199, P209, DOI 10.1016/j.expneurol.2006.02.120; O'Keeffe GC, 2009, P NATL ACAD SCI USA, V106, P8754, DOI 10.1073/pnas.0803955106; Perlmann T, 2004, CELL TISSUE RES, V318, P45, DOI 10.1007/s00441-004-0974-7; Perrone-Capano C, 2000, NEUROSCI BIOBEHAV R, V24, P119, DOI 10.1016/S0149-7634(99)00054-8; Riddle R, 2003, DEV BRAIN RES, V147, P3, DOI 10.1016/j.devbrainres.2003.09.010; Ryu JH, 2006, J BIOL CHEM, V281, P22039, DOI 10.1074/jbc.M601804200; Schulte G, 2005, J NEUROCHEM, V92, P1550, DOI 10.1111/j.1471-4159.2004.03022.x; Shimogori T, 2004, J COMP NEUROL, V473, P496, DOI 10.1002/cne.20135; Simon HH, 2003, ANN NY ACAD SCI, V991, P36; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Sutton LP, 2007, J NEUROCHEM, V102, P153, DOI 10.1111/j.1471-4159.2007.04527.x; SWARZENSKI BC, 1994, P NATL ACAD SCI USA, V91, P649, DOI 10.1073/pnas.91.2.649; Van Kampen JM, 2006, J NEUROSCI, V26, P7272, DOI 10.1523/JNEUROSCI.0837-06.2006; Van Kampen JM, 2005, NEUROSCIENCE, V136, P381, DOI 10.1016/j.neuroscience.2005.07.054; Van Kampen JM, 2004, EUR J NEUROSCI, V19, P2377, DOI 10.1111/j.0953-816X.2004.03342.x; Winner B, 2009, EXP NEUROL, V219, P543, DOI 10.1016/j.expneurol.2009.07.013; Yamada M, 1997, PROG NEUROBIOL, V51, P19, DOI 10.1016/S0301-0082(96)00046-9	39	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.188078	http://dx.doi.org/10.1074/jbc.M110.188078			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454669	hybrid, Green Published			2022-12-27	WOS:000290022800004
J	Gregg, KJ; Zandberg, WF; Hehemann, JH; Whitworth, GE; Deng, LH; Vocadlo, DJ; Boraston, AB				Gregg, Katie J.; Zandberg, Wesley F.; Hehemann, Jan-Hendrik; Whitworth, Garrett E.; Deng, Lehua; Vocadlo, David J.; Boraston, Alisdair B.			Analysis of a New Family of Widely Distributed Metal-independent alpha-Mannosidases Provides Unique Insight into the Processing of N-Linked Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EVOLUTIONARY CONSERVATION; SUBSTRATE-SPECIFICITY; MECHANISTIC INSIGHTS; SEQUENCE; OLIGOSACCHARIDES; ACCURACY; SOFTWARE; QUALITY; MAFFT; MEGA	The modification of N-glycans by alpha-mannosidases is a process that is relevant to a large number of biologically important processes, including infection by microbial pathogens and colonization by microbial symbionts. At present, the described mannosidases specific for alpha 1,6-mannose linkages are very limited in number. Through structural and functional analysis of two sequence-related enzymes, one from Streptococcus pneumoniae (SpGH125) and one from Clostridium perfringens (CpGH125), a new glycoside hydrolase family, GH125, is identified and characterized. Analysis of SpGH125 and CpGH125 reveal them to have exo-alpha 1,6-mannosidase activity consistent with specificity for N-linked glycans having their alpha 1,3-mannose branches removed. The x-ray crystal structures of SpGH125 and CpGH125 obtained in apo-, inhibitor-bound, and substrate-Bound forms provide both mechanistic and molecular insight into how these proteins, which adopt an (alpha/alpha)(6)-fold, recognize and hydrolyze the alpha 1,6-mannosidic bond by an inverting, metal-independent catalytic mechanism. A phylogenetic analysis of GH125 proteins reveals this to be a relatively large and widespread family found frequently in bacterial pathogens, bacterial human gut symbionts, and a variety of fungi. Based on these studies we predict this family of enzymes will primarily comprise such exo-alpha 1,6-mannosidases.	[Gregg, Katie J.; Hehemann, Jan-Hendrik; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Zandberg, Wesley F.; Whitworth, Garrett E.; Deng, Lehua; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	University of Victoria; Simon Fraser University	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca	Vocadlo, David J/E-5508-2014; Zandberg, Wesley/AAX-5568-2021	Vocadlo, David J/0000-0001-6897-5558; Boraston, Alisdair/0000-0001-6417-0592; Hehemann, Jan-Hendrik/0000-0002-8700-2564	Canadian Institutes of Health Research [FRN 86610]; Natural Sciences and Engineering Research Council (NSERC) of Canada; NSERC; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	This work was supported in part by Canadian Institutes of Health Research Grant FRN 86610 (to D. J. V. and A. B. B.).; Supported by a doctoral fellowship from the Natural Sciences and Engineering Research Council (NSERC) of Canada.; Supported by a doctoral fellowship from the NSERC.; We thank Dr. Michael Suits for critical reading of the manuscript and Professor Geert-Jan Boons, CCRC, University of Georgia, for the kind gift of the methyl-S-(alpha-D-mannopyranosyl)-(1-6)-alpha-D-mannopyranose. We also thank the beamline staff at the Stanford Synchrotron Research Laboratory BL9-2 and the Canadian Light Source CMCF1. The Canadian Light Source is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P6240, DOI 10.1021/bi0101695; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charlwood J, 1998, ANAL BIOCHEM, V262, P197, DOI 10.1006/abio.1998.2803; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evangelista RA, 1996, ELECTROPHORESIS, V17, P347, DOI 10.1002/elps.1150170210; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Guttman A, 1996, ANAL BIOCHEM, V233, P234, DOI 10.1006/abio.1996.0034; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Higgins MA, 2009, J BIOL CHEM, V284, P26161, DOI 10.1074/jbc.M109.024067; Homer KA, 2001, J CLIN MICROBIOL, V39, P995, DOI 10.1128/JCM.39.3.995-1001.2001; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; King SJ, 2010, MOL ORAL MICROBIOL, V25, P15, DOI 10.1111/j.2041-1014.2009.00564.x; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEGLER G, 1984, CARBOHYD RES, V128, P61, DOI 10.1016/0008-6215(84)85084-3; Mizuno M, 2004, J BIOL CHEM, V279, P10575, DOI 10.1074/jbc.M310771200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nei M., 2000, MOL EVOLUTION PHYLOG; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Park C, 2005, J BIOL CHEM, V280, P37204, DOI 10.1074/jbc.M508930200; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Scaman CH, 1996, GLYCOBIOLOGY, V6, P265, DOI 10.1093/glycob/6.3.265; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Suits MDL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009006; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Whitworth GE, 2010, GLYCOBIOLOGY, V20, P287, DOI 10.1093/glycob/cwp173; Zhong W, 2008, J AM CHEM SOC, V130, P8975, DOI 10.1021/ja711248y; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	45	49	51	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15586	15596		10.1074/jbc.M111.223172	http://dx.doi.org/10.1074/jbc.M111.223172			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21388958	Green Published, hybrid			2022-12-27	WOS:000289788300086
J	Duvernay, MT; Wang, H; Dong, CM; Guidry, JJ; Sackett, DL; Wu, GY				Duvernay, Matthew T.; Wang, Hong; Dong, Chunmin; Guidry, Jesse J.; Sackett, Dan L.; Wu, Guangyu			alpha(2B)-Adrenergic Receptor Interaction with Tubulin Controls Its Transport from the Endoplasmic Reticulum to the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; 3RD INTRACELLULAR LOOP; ANGIOTENSIN-II RECEPTORS; TO-GOLGI TRANSPORT; C-TERMINAL TAIL; G-BETA-GAMMA; ALPHA(2)-ADRENERGIC RECEPTORS; ANTEROGRADE TRANSPORT; MUSCARINIC RECEPTORS; MEMBRANE TRAFFICKING	It is well recognized that the C terminus (CT) plays a crucial role in modulating G protein-coupled receptor (GPCR) transport from the endoplasmic reticulum (ER) to the cell surface. However the molecular mechanisms that govern CT-dependent ER export remain elusive. To address this issue, we used alpha(2B)-adrenergic receptor (alpha(2B)-AR) as a model GPCR to search for proteins interacting with the CT. By using peptide-conjugated affinity matrix combined with proteomics and glutathione S-transferase fusion protein pull-down assays, we identified tubulin directly interacting with the alpha(2B)-AR CT. The interaction domains weremappedto the acidic CT of tubulin and the basic Arg residues in the alpha(2B)-AR CT, particularly Arg-437, Arg-441, and Arg-446. More importantly, mutation of these Arg residues to disrupt tubulin interaction markedly inhibited alpha(2B)-AR transport to the cell surface and strongly arrested the receptor in the ER. These data provide the first evidence indicating that the alpha(2B)-AR C-terminal Arg cluster mediates its association with tubulin to coordinate its ER-to-cell surface traffic and suggest a novel mechanism of GPCR export through physical contact with microtubules.	[Wu, Guangyu] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Duvernay, Matthew T.; Wang, Hong; Dong, Chunmin; Guidry, Jesse J.; Wu, Guangyu] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Wang, Hong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Sackett, Dan L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Integrat & Med Biophys, Program Phys Biol, NIH, Bethesda, MD 20892 USA	University System of Georgia; Augusta University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tongji University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Wu, GY (corresponding author), Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.	guwu@georgiahealth.edu		Guidry, Jessie/0000-0002-5601-0430	National Institutes of Health [R01GM076167, P20RR018766]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM076167 (to G. W.) and P20RR018766 Principal Investigator: Daniel R. Kapusta, and by Intramural Research Funds of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (to D. L. S.).	Achour L, 2009, BLOOD, V113, P1938, DOI 10.1182/blood-2008-02-141275; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Chen CG, 2006, J BIOL CHEM, V281, P7983, DOI 10.1074/jbc.M509805200; Chen Y, 2009, J BIOL CHEM, V284, P1673, DOI 10.1074/jbc.M808303200; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Ciruela F, 2001, J NEUROCHEM, V76, P750, DOI 10.1046/j.1471-4159.2001.00099.x; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; DeGraff JL, 2002, J BIOL CHEM, V277, P43247, DOI 10.1074/jbc.M207495200; Dong C, 2008, CELL SIGNAL, V20, P1035, DOI 10.1016/j.cellsig.2008.01.014; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Dong CM, 2006, J BIOL CHEM, V281, P38543, DOI 10.1074/jbc.M605734200; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Dong CM, 2010, J PHARMACOL EXP THER, V333, P174, DOI 10.1124/jpet.109.161489; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; Duvernay MT, 2009, TRAFFIC, V10, P552, DOI 10.1111/j.1600-0854.2009.00890.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Filipeanu CM, 2006, MOL PHARMACOL, V69, P1571, DOI 10.1124/mol.105.019984; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; Gaborik Z, 1998, FEBS LETT, V428, P147, DOI 10.1016/S0014-5793(98)00511-0; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Knipling L, 1999, CELL MOTIL CYTOSKEL, V43, P63, DOI 10.1002/(SICI)1097-0169(1999)43:1<63::AID-CM7>3.0.CO;2-Z; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; MIZUNO M, 1994, J CELL SCI, V107, P1321; Morello JP, 2001, ANNU REV PHYSIOL, V63, P607, DOI 10.1146/annurev.physiol.63.1.607; Narishige T, 1999, J BIOL CHEM, V274, P9692, DOI 10.1074/jbc.274.14.9692; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Popova JS, 2004, J BIOL CHEM, V279, P30410, DOI 10.1074/jbc.M402871200; POPOVA JS, 1994, J BIOL CHEM, V269, P21748; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Ralston E, 2001, J NEUROSCI, V21, P875, DOI 10.1523/JNEUROSCI.21-03-00875.2001; Robert J, 2005, J BIOL CHEM, V280, P2300, DOI 10.1074/jbc.M410655200; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; SARASTE J, 1991, J CELL SCI, V100, P415; Sarma T, 2003, FASEB J, V17, P848, DOI 10.1096/fj.02-0730com; Sato H, 1997, J CELL BIOL, V139, P963, DOI 10.1083/jcb.139.4.963; Saugstad JA, 2002, J NEUROCHEM, V80, P980, DOI 10.1046/j.0022-3042.2002.00778.x; Saunders C, 2000, MOL PHARMACOL, V57, P44; Saunders C, 1997, J BIOL CHEM, V272, P19035, DOI 10.1074/jbc.272.30.19035; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Simon V, 2006, J BIOL CHEM, V281, P40310, DOI 10.1074/jbc.M603858200; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Stojanovic A, 2002, RECEPTOR CHANNEL, V8, P33, DOI 10.1080/10606820212137; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; Tetsuka M, 2004, ENDOCRINOLOGY, V145, P3712, DOI 10.1210/en.2003-1638; Themmen APN, 1996, EUR J ENDOCRINOL, V134, P533, DOI 10.1530/eje.0.1340533; Uemura K, 2004, CURR ALZHEIMER RES, V1, P1, DOI 10.2174/1567205043480528; Venkatesan S, 2001, J BIOL CHEM, V276, P40133, DOI 10.1074/jbc.M105722200; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Wu GY, 2000, J BIOL CHEM, V275, P9026, DOI 10.1074/jbc.275.12.9026; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Zhang XP, 2009, J PHARMACOL EXP THER, V330, P109, DOI 10.1124/jpet.109.153460; Zhou FG, 2006, CELL SIGNAL, V18, P318, DOI 10.1016/j.cellsig.2005.05.014	62	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14080	14089		10.1074/jbc.M111.222323	http://dx.doi.org/10.1074/jbc.M111.222323			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357695	hybrid, Green Published			2022-12-27	WOS:000289556200031
J	Griffiths, GS; Grundl, M; Leychenko, A; Reiter, S; Young-Robbins, SS; Sulzmaier, FJ; Caliva, MJ; Ramos, JW; Matter, ML				Griffiths, Genevieve S.; Grundl, Melanie; Leychenko, Anna; Reiter, Silke; Young-Robbins, Shirley S.; Sulzmaier, Florian J.; Caliva, Maisel J.; Ramos, Joe W.; Matter, Michelle L.			Bit-1 Mediates Integrin-dependent Cell Survival through Activation of the NF kappa B Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; RIBOSOMAL S6 KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; OSTEOCLAST SURVIVAL; BCL-2 EXPRESSION; APOPTOSIS; PROTEIN; FIBRONECTIN; MECHANISMS; TRANSCRIPTION	Loss of properly regulated cell death and cell survival pathways can contribute to the development of cancer and cancer metastasis. Cell survival signals are modulated by many different receptors, including integrins. Bit-1 is an effector of anoikis (cell death due to loss of attachment) in suspended cells. The anoikis function of Bit-1 can be counteracted by integrin-mediated cell attachment. Here, we explored integrin regulation of Bit-1 in adherent cells. We show that knockdown of endogenous Bit-1 in adherent cells decreased cell survival and re-expression of Bit-1 abrogated this effect. Furthermore, reduction of Bit-1 promoted both staurosporine and serum-deprivation induced apoptosis. Indeed knockdown of Bit-1 in these cells led to increased apoptosis as determined by caspase-3 activation and positive TUNEL staining. Bit-1 expression protected cells from apoptosis by increasing phospho-I kappa B levels and subsequently bcl-2 gene transcription. Protection from apoptosis under serum-free conditions correlated with bcl-2 transcription and Bcl-2 protein expression. Finally, Bit-1-mediated regulation of bcl-2 was dependent on focal adhesion kinase, PI3K, and AKT. Thus, we have elucidated an integrin-controlled pathway in which Bit-1 is, in part, responsible for the survival effects of cell-ECM interactions.	[Griffiths, Genevieve S.; Grundl, Melanie; Leychenko, Anna; Reiter, Silke; Matter, Michelle L.] Univ Hawaii Manoa, Ctr Cardiovasc Res & Cell & Mol Biol, Honolulu, HI 96813 USA; [Leychenko, Anna; Sulzmaier, Florian J.] Univ Hawaii Manoa, John A Burns Sch Med Mol Biosci & Bioengn, Honolulu, HI 96813 USA; [Young-Robbins, Shirley S.; Sulzmaier, Florian J.; Caliva, Maisel J.; Ramos, Joe W.] Univ Hawaii Manoa, Univ Hawaii Canc Ctr, Honolulu, HI 96813 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa	Matter, ML (corresponding author), John A Burns Sch Med, Cardiovasc Res Ctr, 651 Ilalo St, Honolulu, HI 96813 USA.	matter@hawaii.edu	Ramos, Joe/G-4074-2010; Matter, Michelle/GSN-9703-2022	Ramos, Joe/0000-0002-9708-2115; Matter, Michelle/0000-0002-5988-9663	National Institutes of Health [NCRR P20-RR016453, R01-GM088266]; The Robert C. Perry Fund [20061479]; Department of Defense [05245002]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Robert C. Perry Fund; Department of Defense(United States Department of Defense); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants NCRR P20-RR016453 (to M. L. M.) and R01-GM088266 (to J. W. R.). This work was also supported by The Robert C. Perry Fund Grant 20061479 (to M. L. M.), and the Department of Defense Grant 05245002 (to J. W. R.).	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; BAUER JS, 1992, J CELL BIOL, V116, P477, DOI 10.1083/jcb.116.2.477; Biliran H, 2008, J BIOL CHEM, V283, P28029, DOI 10.1074/jbc.M803139200; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Cheresh DA, 2008, ONCOGENE, V27, P6285, DOI 10.1038/onc.2008.304; CLARKE AS, 1995, J BIOL CHEM, V270, P22673, DOI 10.1074/jbc.270.39.22673; Cohen LA, 2005, CURR CANCER DRUG TAR, V5, P629, DOI 10.2174/156800905774932798; de Pereda JM, 2004, J BIOL CHEM, V279, P8111, DOI 10.1074/jbc.M311449200; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Ghoda L, 1997, J BIOL CHEM, V272, P21281, DOI 10.1074/jbc.272.34.21281; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Grosjean J, 2006, BIOCHEM BIOPH RES CO, V340, P984, DOI 10.1016/j.bbrc.2005.12.095; Huang D, 2007, AM J PHYSIOL-CELL PH, V292, pC1339, DOI 10.1152/ajpcell.00144.2006; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Kairouz-Wahbe R, 2008, P NATL ACAD SCI USA, V105, P1528, DOI 10.1073/pnas.0711357105; Kurland JF, 2001, J BIOL CHEM, V276, P45380, DOI 10.1074/jbc.M108294200; Lee BH, 2005, J CELL BIOCHEM, V95, P1214, DOI 10.1002/jcb.20488; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; Matter ML, 1998, J CELL BIOL, V141, P1019, DOI 10.1083/jcb.141.4.1019; OBrien V, 1996, EXP CELL RES, V224, P208, DOI 10.1006/excr.1996.0130; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schouten GJ, 1997, EMBO J, V16, P3133, DOI 10.1093/emboj/16.11.3133; Schwartz MA, 2001, TRENDS CELL BIOL, V11, P466, DOI 10.1016/S0962-8924(01)02152-3; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161; ZHANG ZH, 1993, J CELL BIOL, V122, P235, DOI 10.1083/jcb.122.1.235; Zhao-Yang Z, 2008, CANCER LETT, V266, P209, DOI 10.1016/j.canlet.2008.02.054	37	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14713	14723		10.1074/jbc.M111.228387	http://dx.doi.org/10.1074/jbc.M111.228387			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21383007	Green Published, hybrid			2022-12-27	WOS:000289556200090
J	Montanier, CY; Correia, MAS; Flint, JE; Zhu, YP; Basle, A; Mckee, LS; Prates, JAM; Polizzi, SJ; Coutinho, PM; Lewis, RJ; Henrissat, B; Fontes, CMGA; Gilbert, HJ				Montanier, Cedric Y.; Correia, Marcia A. S.; Flint, James E.; Zhu, Yanping; Basle, Arnaud; McKee, Lauren S.; Prates, Jose A. M.; Polizzi, Samuel J.; Coutinho, Pedro M.; Lewis, Richard J.; Henrissat, Bernard; Fontes, Carlos M. G. A.; Gilbert, Harry J.			A Novel, Noncatalytic Carbohydrate-binding Module Displays Specificity for Galactose-containing Polysaccharides through Calcium-mediated Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; CLOSTRIDIUM-THERMOCELLUM; DOMAINS; COMPLEX; FAMILY; PROTEIN; DISTRIBUTIONS; CELLULOSOMES; GLUCANS; SITE	The enzymic degradation of plant cell walls plays a central role in the carbon cycle and is of increasing environmental and industrial significance. The catalytic modules of enzymes that catalyze this process are generally appended to noncatalytic carbohydrate-binding modules (CBMs). CBMs potentiate the rate of catalysis by bringing their cognate enzymes into intimate contact with the target substrate. A powerful plant cell wall-degrading system is the Clostridium thermocellum multienzyme complex, termed the "cellulosome." Here, we identify a novel CBM (CtCBM62) within the large C. thermocellum cellulosomal protein Cthe_2193 (defined as CtXyl5A), which establishes a new CBM family. Phylogenetic analysis of CBM62 members indicates that a circular permutation occurred within the family. CtCBM62 binds to D-galactose and L-arabinopyranose in either anomeric configuration. The crystal structures of CtCBM62, in complex with oligosaccharides containing alpha- and beta-galactose residues, show that the ligand-binding site in the beta-sandwich protein is located in the loops that connect the two beta-sheets. Specificity is conferred through numerous interactions with the axial O4 of the target sugars, a feature that distinguishes galactose and arabinose from the other major sugars located in plant cell walls. CtCBM62 displays tighter affinity for multivalent ligands compared with molecules containing single galactose residues, which is associated with precipitation of these complex carbohydrates. These avidity effects, which confer the targeting of polysaccharides, are mediated by calcium-dependent oligomerization of the CBM.	[Zhu, Yanping; Prates, Jose A. M.; Fontes, Carlos M. G. A.] Univ Tecn Lisboa, Ctr Invest Interdisciplinar Sanidade Anim, Fac Med Vet, P-1300477 Lisbon, Portugal; [Montanier, Cedric Y.; Correia, Marcia A. S.; Flint, James E.; Zhu, Yanping; Basle, Arnaud; McKee, Lauren S.; Lewis, Richard J.; Gilbert, Harry J.] Newcastle Univ, Inst Cell & Mol Biosci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Coutinho, Pedro M.; Henrissat, Bernard] Univ Aix Marseille 1, CNRS, UMR6098, F-13288 Marseille, France; [Coutinho, Pedro M.; Henrissat, Bernard] Univ Aix Marseille 2, CNRS, UMR6098, F-13288 Marseille, France; [Zhu, Yanping; McKee, Lauren S.; Gilbert, Harry J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Polizzi, Samuel J.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Universidade de Lisboa; Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Fontes, CMGA (corresponding author), Univ Tecn Lisboa, Ctr Invest Interdisciplinar Sanidade Anim, Fac Med Vet, Ave Univ Tecn, P-1300477 Lisbon, Portugal.	cafontes@fmv.utl.pt; h.j.gilbert@newcastle.ac.uk	McKee, Lauren/A-2782-2013; Montanier, Cédric/P-7727-2019; Henrissat, Bernard/J-2475-2012; Correia, Márcia/D-2077-2013; Prates, José A M/K-9934-2013	McKee, Lauren/0000-0002-3372-8773; Montanier, Cédric/0000-0002-8205-7160; Henrissat, Bernard/0000-0002-3434-8588; Correia, Márcia/0000-0003-0636-8095; Prates, José A M/0000-0003-1032-5987; Fontes, Carlos/0000-0002-1219-9753; Basle, Arnaud/0000-0002-4899-3086; lewis, richard/0000-0003-2641-8643; Flint, James/0000-0003-2923-7813	Fundacao para a Ciencia e Tecnologia (Portugal) [PTDC/BIAPRO/69732/2006];  [SFRH/BD/16731/2004]; Biotechnology and Biological Sciences Research Council [BB/C005074/1] Funding Source: researchfish	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grants PTDC/BIAPRO/69732/2006 from Fundacao para a Ciencia e Tecnologia (Portugal) and SFRH/BD/16731/2004 (to M. C.).	Abbott DW, 2009, BIOCHEMISTRY-US, V48, P10395, DOI 10.1021/bi9013424; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Black GW, 1997, J BIOTECHNOL, V57, P59, DOI 10.1016/S0168-1656(97)00089-8; Bolam DN, 2001, BIOCHEMISTRY-US, V40, P2468, DOI 10.1021/bi002564l; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2002, MOL MICROBIOL, V43, P187, DOI 10.1046/j.1365-2958.2002.02730.x; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2006, J BIOL CHEM, V281, P35263, DOI 10.1074/jbc.M607620200; Brett CT, 1996, PHYSL BIOCH PLANT CE; Brown PH, 2007, BIOMACROMOLECULES, V8, P2011, DOI 10.1021/bm070193j; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; CORREIA AS, 2011, J BIOL CHEM, V286; Correia MAS, 2010, BIOCHEMISTRY-US, V49, P6193, DOI 10.1021/bi1006139; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; Dvortsov IA, 2009, MICROBIOL-SGM, V155, P2442, DOI 10.1099/mic.0.026930-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, DATA COLLECTION PROC, P114; FERREIRA LMA, 1990, BIOCHEM J, V269, P261, DOI 10.1042/bj2690261; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Freelove ACJ, 2001, J BIOL CHEM, V276, P43010, DOI 10.1074/jbc.M107143200; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Henshaw J, 2006, J BIOL CHEM, V281, P17099, DOI 10.1074/jbc.M600702200; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Jamal-Talabani S, 2004, STRUCTURE, V12, P1177, DOI 10.1016/j.str.2004.04.022; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lindqvist Y, 1997, CURR OPIN STRUC BIOL, V7, P422, DOI 10.1016/S0959-440X(97)80061-9; Lo WC, 2009, NUCLEIC ACIDS RES, V37, pD328, DOI 10.1093/nar/gkn679; MAYER F, 1987, APPL ENVIRON MICROB, V53, P2785, DOI 10.1128/AEM.53.12.2785-2792.1987; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy T, 1998, FEBS LETT, V429, P312, DOI 10.1016/S0014-5793(98)00625-5; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Pell G, 2003, BIOCHEMISTRY-US, V42, P9316, DOI 10.1021/bi0347510; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Raghothama S, 2000, BIOCHEMISTRY-US, V39, P978, DOI 10.1021/bi992163+; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shatalov AA, 1999, CARBOHYD RES, V320, P93, DOI 10.1016/S0008-6215(99)00136-6; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; van Bueren AL, 2005, J BIOL CHEM, V280, P530, DOI 10.1074/jbc.M410113200; Vijayan M, 1999, CURR OPIN STRUC BIOL, V9, P707, DOI 10.1016/S0959-440X(99)00034-2	50	28	29	2	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22499	22509		10.1074/jbc.M110.217372	http://dx.doi.org/10.1074/jbc.M110.217372			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21454512	Green Published, hybrid			2022-12-27	WOS:000291719900058
J	Spiller, MP; Stirling, CJ				Spiller, Michael P.; Stirling, Colin J.			Preferential Targeting of a Signal Recognition Particle-dependent Precursor to the Ssh1p Translocon in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; PROTEIN TRANSLOCATION; SACCHAROMYCES-CEREVISIAE; ER MEMBRANE; IN-VIVO; SEC63P; RIBOSOME; INSERTION; COMPLEX; DOMAIN	Protein translocation across the endoplasmic reticulum membrane occurs via a "translocon" channel formed by the Sec61p complex. In yeast, two channels exist: the canonical Sec61p channel and a homolog called Ssh1p. Here, we used trapped translocation intermediates to demonstrate that a specific signal recognition particle-dependent substrate, Sec71p, is targeted exclusively to Ssh1p. Strikingly, we found that, in the absence of Ssh1p, precursor could be successfully redirected to canonical Sec61p, demonstrating that the normal targeting reaction must involve preferential sorting to Ssh1p. Our data therefore demonstrate that Ssh1p is the primary translocon for Sec71p and reveal a novel sorting mechanism at the level of the endoplasmic reticulum membrane enabling precursors to be directed to distinct translocons. Interestingly, the Ssh1p-dependent translocation of Sec71p was found to be dependent upon Sec63p, demonstrating a previously unappreciated functional interaction between Sec63p and the Ssh1p translocon.	[Spiller, Michael P.; Stirling, Colin J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Stirling, CJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	colin.stirling@manchester.ac.uk						Abell BM, 2004, EMBO J, V23, P2755, DOI 10.1038/sj.emboj.7600281; ADELMAN MR, 1973, J CELL BIOL, V56, P206, DOI 10.1083/jcb.56.1.206; Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; FELDHEIM D, 1993, MOL BIOL CELL, V4, P931, DOI 10.1091/mbc.4.9.931; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Helmers J, 2003, J BIOL CHEM, V278, P23686, DOI 10.1074/jbc.C300180200; HIGH S, 1993, J CELL BIOL, V121, P743, DOI 10.1083/jcb.121.4.743; HIGH S, 1993, J BIOL CHEM, V268, P26745; Jermy AJ, 2006, J BIOL CHEM, V281, P7899, DOI 10.1074/jbc.M511402200; Jiang Y, 2008, J CELL BIOL, V180, P1149, DOI 10.1083/jcb.200707196; Kabani M, 2000, MOL CELL BIOL, V20, P6923, DOI 10.1128/MCB.20.18.6923-6934.2000; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; LYMAN SK, 1995, J CELL BIOL, V131, P1163, DOI 10.1083/jcb.131.5.1163; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Steel GJ, 2002, BIOCHEMISTRY-US, V41, P11914, DOI 10.1021/bi026105r; STIRLING CJ, 1992, NATURE, V356, P534, DOI 10.1038/356534a0; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Wilkinson BM, 1997, J MEMBRANE BIOL, V155, P189, DOI 10.1007/s002329900171; Wilkinson BM, 2001, DEV CELL, V1, P401, DOI 10.1016/S1534-5807(01)00043-0; Willer M, 2003, BIOCHEMISTRY-US, V42, P7171, DOI 10.1021/bi034395l; Wittke S, 1999, MOL BIOL CELL, V10, P2519, DOI 10.1091/mbc.10.8.2519; Wittke S, 2002, MOL BIOL CELL, V13, P2223, DOI 10.1091/mbc.01-10-0518; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262	35	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					21953	21960		10.1074/jbc.M111.219568	http://dx.doi.org/10.1074/jbc.M111.219568			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21454595	Green Published, hybrid			2022-12-27	WOS:000291719900002
J	Bibert, S; Liu, CC; Figtree, GA; Garcia, A; Hamilton, EJ; Marassi, FM; Sweadner, KJ; Cornelius, F; Geering, K; Rasmussen, HH				Bibert, Stephanie; Liu, Chia-Chi; Figtree, Gemma A.; Garcia, Alvaro; Hamilton, Elisha J.; Marassi, Francesca M.; Sweadner, Kathleen J.; Cornelius, Flemming; Geering, Kaethi; Rasmussen, Helge H.			FXYD Proteins Reverse Inhibition of the Na+-K+ Pump Mediated by Glutathionylation of Its beta(1) Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-POTASSIUM PUMP; SHARK RECTAL GLANDS; OXIDATIVE MODIFICATION; PHOSPHOLEMMAN FXYD1; CRYSTAL-STRUCTURE; CARDIAC MYOCYTES; PROSTATE-CANCER; XENOPUS OOCYTES; ALPHA-SUBUNIT; MICE LACKING	The seven members of the FXYD protein family associate with the Na+-K+ pump and modulate its activity. We investigated whether conserved cysteines in FXYD proteins are susceptible to glutathionylation and whether such reactivity affects Na+-K+ pump function in cardiac myocytes and Xenopus oocytes. Glutathionylation was detected by immunoblotting streptavidin precipitate from biotin-GSH loaded cells or by a GSH antibody. Incubation of myocytes with recombinant FXYD proteins resulted in competitive displacement of native FXYD1. Myocyte and Xenopus oocyte pump currents were measured with whole-cell and two-electrode voltage clamp techniques, respectively. Native FXYD1 in myocytes and FXYD1 expressed in oocytes were susceptible to glutathionylation. Mutagenesis identified the specific cysteine in the cytoplasmic terminal that was reactive. Its reactivity was dependent on flanking basic amino acids. We have reported that Na+-K(+)pump beta(1) subunit glutathionylation induced by oxidative signals causes pump inhibition in a previous study. In the present study, we found that beta(1) subunit glutathionylation and pump inhibition could be reversed by exposing myocytes to exogenous wild-type FXYD3. A cysteine-free FXYD3 derivative had no effect. Similar results were obtained with wild-type and mutant FXYD proteins expressed in oocytes. Glutathionylation of the beta(1) subunit was increased in myocardium from FXYD1(-/-) mice. In conclusion, there is a dependence of Na+-K+ pump regulation on reactivity of two specifically identified cysteines on separate components of the multimeric Na+-K+ pump complex. By facilitating deglutathionylation of the beta(1) subunit, FXYD proteins reverse oxidative inhibition of the Na+-K+ pump and play a dynamic role in its regulation.	[Bibert, Stephanie; Geering, Kaethi] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; [Liu, Chia-Chi; Figtree, Gemma A.; Garcia, Alvaro; Hamilton, Elisha J.; Rasmussen, Helge H.] Univ Sydney, Kolling Inst, N Shore Heart Res Grp, St Leonards, NSW 2065, Australia; [Figtree, Gemma A.; Garcia, Alvaro; Rasmussen, Helge H.] Royal N Shore Hosp, Dept Cardiol, St Leonards, NSW 2065, Australia; [Marassi, Francesca M.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Sweadner, Kathleen J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Sweadner, Kathleen J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Cornelius, Flemming] Aarhus Univ, Dept Physiol & Biophys, DK-8000 Aarhus, Denmark	University of Lausanne; University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Aarhus University	Rasmussen, HH (corresponding author), Royal N Shore Hosp, Dept Cardiol, St Leonards, NSW 2065, Australia.	helge.rasmussen@sydney.edu.au	Cornelius, Flemming/C-1912-2019; Hamilton, Elisha/F-8187-2010; Garcia, Alvaro/E-6573-2015	Cornelius, Flemming/0000-0003-1566-0020; Hamilton, Elisha/0000-0002-1892-352X; Garcia, Alvaro/0000-0002-1159-4567; Bibert, Stephanie/0000-0001-5170-7506; Rasmussen, Helge/0000-0003-2409-4083	North Shore Heart Research Foundation; National Health and Medical Research Council (Australia) [633252]; National Institutes of Health [CA082864, R01 NS050696]; Medical Foundation (University of Sydney); The Danish Medical Research Council; Danish Agency for Science, Technology and Innovation; Swiss National Science Foundation [3100A0-107513]; NATIONAL CANCER INSTITUTE [R01CA082864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050696] Funding Source: NIH RePORTER	North Shore Heart Research Foundation; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Foundation (University of Sydney)(University of Sydney); The Danish Medical Research Council(Danish Medical Research Council); Danish Agency for Science, Technology and Innovation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by a grant from the North Shore Heart Research Foundation, National Health and Medical Research Council (Australia) Project Grant 633252, and Grant CA082864 from the National Institutes of Health (to F. M. M.).; Supported by the Medical Foundation (University of Sydney).; Supported by National Institutes of Health Grant R01 NS050696.; Supported by The Danish Medical Research Council and Danish Agency for Science, Technology and Innovation.; Supported by Swiss National Science Foundation Grant 3100A0-107513.	Arimochi J, 2007, BIOL PHARM BULL, V30, P648, DOI 10.1248/bpb.30.648; Bibert S, 2008, J BIOL CHEM, V283, P476, DOI 10.1074/jbc.M705830200; Bossuyt J, 2005, CIRC RES, V97, P558, DOI 10.1161/01.RES.0000181172.27931.c3; Bundgaard H, 2010, CIRCULATION, V122, P2699, DOI 10.1161/CIRCULATIONAHA.110.964619; Cornelius F, 2005, BIOCHEMISTRY-US, V44, P13051, DOI 10.1021/bi0504456; Cornelius F, 2003, NEWS PHYSIOL SCI, V18, P119, DOI 10.1152/nips.01434.2003; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Dempski RE, 2006, J BIOL CHEM, V281, P36338, DOI 10.1074/jbc.M604788200; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; GEERING K, 1989, AM J PHYSIOL, V257, pC851, DOI 10.1152/ajpcell.1989.257.5.C851; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Grzmil M, 2004, INT J ONCOL, V24, P97; Hansen RE, 2005, BIOCHEMISTRY-US, V44, P5899, DOI 10.1021/bi0500372; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Hashemy SI, 2007, J BIOL CHEM, V282, P14428, DOI 10.1074/jbc.M700927200; Horisberger JD, 2004, J BIOL CHEM, V279, P29542, DOI 10.1074/jbc.M400585200; Huang YT, 2004, BIOCHEM PHARMACOL, V67, P727, DOI 10.1016/j.bcp.2003.10.013; JAUNIN P, 1992, J BIOL CHEM, V267, P577; Jia LG, 2005, AM J PHYSIOL-HEART C, V288, pH1982, DOI 10.1152/ajpheart.00142.2004; Jones DH, 2005, J BIOL CHEM, V280, P19003, DOI 10.1074/jbc.M500697200; Kuster GM, 2010, FREE RADICAL BIO MED, V48, P1182, DOI 10.1016/j.freeradbiomed.2010.01.038; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; Liochev SI, 2007, FREE RADICAL BIO MED, V42, P1465, DOI 10.1016/j.freeradbiomed.2007.02.015; Mahmmoud YA, 2000, J BIOL CHEM, V275, P35969, DOI 10.1074/jbc.M005168200; Mahmmoud YA, 2005, J BIOL CHEM, V280, P27776, DOI 10.1074/jbc.M503150200; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Moens AL, 2009, J MOL CELL CARDIOL, V47, P576, DOI 10.1016/j.yjmcc.2009.06.005; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Pani G, 2009, ANTIOXID REDOX SIGN, V11, P2791, DOI 10.1089/ars.2009.2739; PRESTI CF, 1985, J BIOL CHEM, V260, P3860; Rasmussen HH, 2010, TRENDS CARDIOVAS MED, V20, P85, DOI 10.1016/j.tcm.2010.06.002; Shattock MJ, 2009, CURR OPIN PHARMACOL, V9, P160, DOI 10.1016/j.coph.2008.12.015; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Starke DW, 2003, J BIOL CHEM, V278, P14607, DOI 10.1074/jbc.M210434200; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Teriete P, 2007, BIOCHEMISTRY-US, V46, P6774, DOI 10.1021/bi700391b; White CN, 2008, AM J PHYSIOL-CELL PH, V294, pC572, DOI 10.1152/ajpcell.00242.2007; White CN, 2010, J BIOL CHEM, V285, P13712, DOI 10.1074/jbc.M109.090225; White CN, 2009, AM J PHYSIOL-CELL PH, V296, pC693, DOI 10.1152/ajpcell.00648.2008; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Zhang XQ, 2009, AM J PHYSIOL-CELL PH, V296, pC911, DOI 10.1152/ajpcell.00196.2008	44	69	81	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18562	18572		10.1074/jbc.M110.184101	http://dx.doi.org/10.1074/jbc.M110.184101			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454534	Green Published, hybrid			2022-12-27	WOS:000290785700028
J	Lim, KG; Tonelli, F; Li, ZG; Lu, XQ; Bittman, R; Pyne, S; Pyne, NJ				Lim, Keng G.; Tonelli, Francesca; Li, Zaiguo; Lu, Xuequan; Bittman, Robert; Pyne, Susan; Pyne, Nigel J.			FTY720 Analogues as Sphingosine Kinase 1 Inhibitors ENZYME INHIBITION KINETICS, ALLOSTERISM, PROTEASOMAL DEGRADATION, AND ACTIN REARRANGEMENT IN MCF-7 BREAST CANCER CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT PROSTATE-CANCER; PROTEIN-COUPLED RECEPTORS; TUMOR-GROWTH; 1-PHOSPHATE RECEPTORS; MAMMALIAN-CELLS; IN-VITRO; SPHINGOSINE-1-PHOSPHATE; ANGIOGENESIS; EXPRESSION; DISCOVERY	Sphingosine kinase 1 (SK1) catalyzes the conversion of sphingosine to the bioactive lipid sphingosine 1-phosphate. We have previously demonstrated that FTY720 and (S)-FTY720 vinylphosphonate are novel inhibitors of SK1 activity. Here, we show that (S)-FTY720 vinylphosphonate binds to a putative allosteric site in SK1 contingent on formation of the enzyme-sphingosine complex. We report that SK1 is an oligomeric protein (minimally a dimer) containing noncooperative catalytic sites and that the allosteric site exerts an autoinhibition of the catalytic site. A model is proposed in which (S)-FTY720 vinylphosphonate binding to and stabilization of the allosteric site might enhance the autoinhibitory effect on SK1 activity. Further evidence for the existence of allosteric site(s) in SK1 was demonstrated by data showing that two new FTY720 analogues (a conjugate of sphingosine with a fluorophore and (S)-FTY720 regioisomer) increased SK1 activity, suggesting relief of autoinhibition of SK1 activity. Comparisons with the SK1 inhibitor, SKi or siRNA knockdown of SK1 indicated that (S)-FTY720 vinylphosphonate and FTY720 behave as typical SK1 inhibitors in preventing sphingosine 1-phosphate-stimulated rearrangement of actin in MCF-7 cells. These findings are discussed in relation to the anticancer properties of SK1 inhibitors.	[Lim, Keng G.; Tonelli, Francesca; Pyne, Susan; Pyne, Nigel J.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Cell Biol Grp, Glasgow G4 0RE, Lanark, Scotland; [Li, Zaiguo; Lu, Xuequan; Bittman, Robert] CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA	University of Strathclyde; City University of New York (CUNY) System; Queens College NY (CUNY)	Pyne, NJ (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Cell Biol Grp, 161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland.	n.j.pyne@strath.ac.uk	Pyne, Susan/AAF-5001-2019	Pyne, Susan/0000-0002-6608-9584; Tonelli, Francesca/0000-0002-4600-6630; Pyne, Nigel/0000-0002-5657-4578	National Institutes of Health [HL083187]; Strathclyde University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL083187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Strathclyde University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL083187 (to R. B.). This work was also supported by two Strathclyde University scholarships (to K. G. L. and F. T.).	Alderton F, 2001, J BIOL CHEM, V276, P28578, DOI 10.1074/jbc.M102771200; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Azuma H, 2002, CANCER RES, V62, P1410; Azuma H, 2003, J UROLOGY, V169, P2372, DOI 10.1097/01.ju.0000064938.32318.91; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Chua CW, 2005, INT J CANCER, V117, P1039, DOI 10.1002/ijc.21243; Cortes A, 2001, BIOCHEM J, V357, P263, DOI 10.1042/0264-6021:3570263; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; French KJ, 2003, CANCER RES, V63, P5962; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Ho JWY, 2005, MOL CANCER THER, V4, P1430, DOI 10.1158/1535-7163.MCT-05-0021; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Long JS, 2010, MOL CELL BIOL, V30, P3827, DOI 10.1128/MCB.01133-09; Loveridge C, 2010, J BIOL CHEM, V285, P38841, DOI 10.1074/jbc.M110.127993; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Pitson SM, 2001, FEBS LETT, V509, P169; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Tonelli F, 2010, CELL SIGNAL, V22, P1536, DOI 10.1016/j.cellsig.2010.05.022; Ubai T, 2007, ANTICANCER RES, V27, P75; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Watson C, 2010, AM J PATHOL, V177, P2205, DOI 10.2353/ajpath.2010.100220; Yokota S, 2004, FEBS LETT, V578, P106, DOI 10.1016/j.febslet.2004.10.081	30	98	108	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18633	18640		10.1074/jbc.M111.220756	http://dx.doi.org/10.1074/jbc.M111.220756			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21464128	Green Published, hybrid			2022-12-27	WOS:000290785700035
J	Overton, JD; Leibel, RL				Overton, John D.; Leibel, Rudolph L.			Mahoganoid and Mahogany Mutations Rectify the Obesity of the Yellow Mouse by Effects on Endosomal Traffic of MC4R Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGOUTI-RELATED PROTEIN; MELANOCYTE-STIMULATING-HORMONE; MELANOCORTIN-4 RECEPTOR; IN-VITRO; MUTANT MICE; COAT COLOR; ATTRACTIN; MAHOGUNIN; NEURODEGENERATION; GENE	The ubiquitous overexpression of agouti-signaling protein (ASP), a paracrine-signaling molecule that regulates pigment-type switching in the hair follicle of the mouse, is responsible for the obesity and yellow pelage of the Yellow mouse (Ay). Mahogany (Attractin, Atrn/mg) and mahoganoid (Mahogunin Ring Finger-1, Mgrn1/md) are mutations epistatic to Ay. These mutations have been described as suppressors of ASP action, blocking its antagonizing effects on the melanocortin 1 and 4 receptors (MC1R and MC4R) in the skin and the brain, respectively, via unknown mechanisms. Here, we describe the molecular bases for the md- and mg-dependent rescue of the Ay phenotype at the MC4R. We show that overexpression of ASP inhibits the rise in cAMP levels in response to alpha-melanocyte-stimulating hormone, an MC4R agonist, by blocking ligand binding and by directing MC4R trafficking to the lysosome. Loss-of-function of either attractin or MGRN1 blocks ASP-dependent MC4R degradation and promotes increased trafficking of internalized MC4R to the cell surface, but it does not restore alpha-melanocyte-stimulating hormone-dependent cAMP signaling. We propose that MGRN1 and attractin are components of an evolutionarily conserved receptor trafficking pathway and that the md- and mg mutations rescue the Ay phenotypes by a primarily cAMP-independent mechanism promoting trafficking of MC4R and likely MC1R away from the lysosome toward the cell surface.	Columbia Univ, Div Mol Genet, Dept Pediat, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; Columbia Univ, Inst Human Nutr, New York, NY 10032 USA	Columbia University; Columbia University	Overton, JD (corresponding author), Yale Univ, Dept Genet, Howard Hughes Med Inst, New Haven, CT 06519 USA.	john.overton@yale.edu; rl232@columbia.edu			National Institutes of Health [R01-DK52431, P30-DK26687]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, R01DK052431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01-DK52431 and P30-DK26687.	Abdel-Malek ZA, 2001, CELL MOL LIFE SCI, V58, P434, DOI 10.1007/PL00000868; Artigas RA, 2008, J CLIN ENDOCR METAB, V93, P3097, DOI 10.1210/jc.2008-0048; Azouz A, 2007, EXP CELL RES, V313, P761, DOI 10.1016/j.yexcr.2006.11.018; Bagher P, 2006, PIGM CELL RES, V19, P635, DOI 10.1111/j.1600-0749.2006.00340.x; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Barsh GS, 1999, ANN NY ACAD SCI, V885, P143; Barsh GS, 2002, J RECEPT SIGNAL TR R, V22, P63, DOI 10.1081/RRS-120014588; Breit A, 2006, J BIOL CHEM, V281, P37447, DOI 10.1074/jbc.M605982200; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Chai BX, 2003, PEPTIDES, V24, P603, DOI 10.1016/S0196-9781(03)00104-9; Chakrabarti O, 2009, CELL, V137, P1136, DOI 10.1016/j.cell.2009.03.042; Chen WB, 1997, CELL, V91, P789, DOI 10.1016/S0092-8674(00)80467-5; Cota CD, 2006, DEV DYNAM, V235, P3438, DOI 10.1002/dvdy.20992; Creemers JWM, 2006, ENDOCRINOLOGY, V147, P1621, DOI 10.1210/en.2005-1373; Duke-Cohan JS, 2004, J ENVIRON PATHOL TOX, V23, P1, DOI 10.1615/JEnvPathToxOncol.v23.i1.10; Duke-Cohan JS, 1998, P NATL ACAD SCI USA, V95, P11336, DOI 10.1073/pnas.95.19.11336; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; GANTZ I, 1993, J BIOL CHEM, V268, P15174; Gao ZH, 2003, J PHARMACOL EXP THER, V307, P870, DOI 10.1124/jpet.103.055525; Gunn TM, 1999, NATURE, V398, P152, DOI 10.1038/18217; Gunn TM, 2001, GENETICS, V158, P1683; Haqq AM, 2003, BIOCHEM J, V376, P595, DOI 10.1042/BJ20031241; He L, 2003, SCIENCE, V299, P710, DOI 10.1126/science.1079694; He L, 2001, NAT GENET, V27, P40, DOI 10.1038/83741; Hida T, 2009, PIGM CELL MELANOMA R, V22, P623, DOI 10.1111/j.1755-148X.2009.00582.x; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jackson PJ, 2006, CHEM BIOL, V13, P1297, DOI 10.1016/j.chembiol.2006.10.006; Jiao J, 2009, BBA-MOL BASIS DIS, V1792, P1027, DOI 10.1016/j.bbadis.2009.08.009; Jiao J, 2009, GENESIS, V47, P524, DOI 10.1002/dvg.20529; Kim BY, 2007, MOL BIOL CELL, V18, P1129, DOI 10.1091/mbc.E06-09-0787; LANE PRISCILLA W., 1960, JOUR HEREDITY, V51, P228; LANE PW, 1960, MOUSE NEWS LETT, V22, P35; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Lubrano-Berthelier C, 2003, HUM MOL GENET, V12, P145, DOI 10.1093/hmg/ddg016; MICHAUD EJ, 1993, GENE DEV, V7, P1203, DOI 10.1101/gad.7.7a.1203; MILLAR SE, 1995, DEVELOPMENT, V121, P3223; Miller KA, 1997, GENETICS, V146, P1407; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; MILLIGAN G, 1995, TRENDS PHARMACOL SCI, V16, P10, DOI 10.1016/S0165-6147(00)88963-4; Mohammad S, 2007, J BIOL CHEM, V282, P4963, DOI [10.1074/jbc.m608283200, 10.1074/jbc.M608283200]; Nagle DL, 1999, NATURE, V398, P148, DOI 10.1038/18210; Ollmann MM, 1999, J BIOL CHEM, V274, P15837, DOI 10.1074/jbc.274.22.15837; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Ollmann MM, 1998, GENE DEV, V12, P316, DOI 10.1101/gad.12.3.316; Oshikawa J, 2003, AM J PHYSIOL-CELL PH, V285, pC567, DOI 10.1152/ajpcell.00422.2002; Paz J, 2007, NEUROBIOL AGING, V28, P1446, DOI 10.1016/j.neurobiolaging.2006.06.014; Perez-Oliva AB, 2009, J BIOL CHEM, V284, P31714, DOI 10.1074/jbc.M109.028100; Phan LK, 2002, J CLIN INVEST, V110, P1449, DOI 10.1172/JC1200216131; Phan LK, 2006, AM J PHYSIOL-ENDOC M, V291, pE611, DOI 10.1152/ajpendo.00034.2006; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Shinyama H, 2003, ENDOCRINOLOGY, V144, P1301, DOI 10.1210/en.2002-220931; Siegrist W, 1996, BIOCHEM BIOPH RES CO, V218, P171, DOI 10.1006/bbrc.1996.0030; STAR RA, 1995, P NATL ACAD SCI USA, V92, P8016, DOI 10.1073/pnas.92.17.8016; Sun K, 2007, NEUROBIOL AGING, V28, P1840, DOI 10.1016/j.neurobiolaging.2007.07.012; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Van der Ploeg LHT, 2002, P NATL ACAD SCI USA, V99, P11381, DOI 10.1073/pnas.172378699; Walker WP, 2007, GENESIS, V45, P744, DOI 10.1002/dvg.20351; ZHOU A, 1993, J BIOL CHEM, V268, P1763	61	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18914	18929		10.1074/jbc.M111.224592	http://dx.doi.org/10.1074/jbc.M111.224592			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21460229	Green Published, hybrid			2022-12-27	WOS:000290785700063
J	Hao, F; Pysz, MA; Curry, KJ; Haas, KN; Seedhouse, SJ; Black, AR; Black, JD				Hao, Fang; Pysz, Marybeth A.; Curry, Kathryn J.; Haas, Kristin N.; Seedhouse, Steven J.; Black, Adrian R.; Black, Jennifer D.			Protein Kinase C alpha Signaling Regulates Inhibitor of DNA Binding 1 in the Intestinal Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; CELL-CYCLE ARREST; ID PROTEINS; COLON CARCINOGENESIS; INCREASED EXPRESSION; DIFFERENTIATION ID1; GROWTH-FACTOR; CANCER CELLS; STEM-CELLS; ACTIVATION	Increasing evidence supports a role forPKC alpha in growth arrest and tumor suppression in the intestinal epithelium. In contrast, the Id1 transcriptional repressor has pro-proliferative and tumorigenic properties in this tissue. Here, we identify Id1 as a novel target of PKC alpha signaling. Using a highly specific antibody and a combined morphological/biochemical approach, we establish that Id1 is a nuclear protein restricted to proliferating intestinal crypt cells. A relationship between PKC alpha and Id1 was supported by the demonstration that (a) down-regulation of Id1 at the crypt/villus junction coincides with PKC alpha activation, and (b) loss ofPKC alpha in intestinal tumors is associated with increased levels of nuclear Id1. Manipulation of PKC alpha activity in IEC-18 nontransformed intestinal crypt cells determined that PKC alpha suppresses Id1 mRNA and protein via an Erk-dependent mechanism. PKC alpha, but not PKC delta, also inhibited Id1 expression in colon cancer cells. Id1 was found to regulate cyclin D1 levels in IEC-18 and colon cancer cells, pointing to a role for Id1 suppression in the antiproliferative/tumor suppressive activities of PKC alpha. Notably, Id1 expression was elevated in the intestinal epithelium of PKC alpha-knock-out mice, confirming that PKC alpha regulates Id1 in vivo. A wider role for PKC alpha in control of inhibitor of DNA binding factors is supported by its ability to down-regulate Id2 and Id3 in IEC-18 cells, although their suppression is more modest than that of Id1. This study provides the first demonstrated link between a specific PKC isozyme and inhibitor of DNA binding factors, and it points to a role for a PKC alpha -> 3 Erk (sic) Id1 -> cyclin D1 signaling axis in the maintenance of intestinal homeostasis.	[Hao, Fang; Pysz, Marybeth A.; Curry, Kathryn J.; Haas, Kristin N.; Seedhouse, Steven J.; Black, Adrian R.; Black, Jennifer D.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Black, JD (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Elm & Carlton St, Buffalo, NY 14263 USA.	jennifer.black@roswellpark.org			National Institutes of Health [DK60632, DK54909, CA16056, CA113048]; NATIONAL CANCER INSTITUTE [F32CA113048, P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054909, R56DK060632, R01DK060632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK60632, DK54909, and CA16056 and Postdoctoral Fellowship CA113048 (to M. A. P.).	Akakura S, 2010, CELL CYCLE, V9, P4656, DOI 10.4161/cc.9.23.13974; Alani RM, 2001, P NATL ACAD SCI USA, V98, P7812, DOI 10.1073/pnas.141235398; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Black JD, 2001, GASTROENTEROLOGY, V120, P1868, DOI 10.1053/gast.2001.25287; Black JD, 2000, FRONT BIOSCI-LANDMRK, V5, pD406, DOI 10.2741/Black; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Caldon CE, 2008, CANCER RES, V68, P3026, DOI 10.1158/0008-5472.CAN-07-3079; Cameron AJ, 2008, INT J CANCER, V123, P769, DOI 10.1002/ijc.23560; Chaudhary J, 2005, BIOL REPROD, V72, P1205, DOI 10.1095/biolreprod.104.035717; Chaudhary J, 2001, ENDOCRINOLOGY, V142, P1727, DOI 10.1210/en.142.5.1727; Ciarrocchi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001338; Clark JA, 2004, J BIOL CHEM, V279, P9233, DOI 10.1074/jbc.M312268200; de Lau W, 2007, FRONT BIOSCI-LANDMRK, V12, P471, DOI 10.2741/2076; Detjen KM, 2000, J CELL SCI, V113, P3025; Dupasquier S, 2009, J CELL SCI, V122, P2191, DOI 10.1242/jcs.036483; Fields Alan P, 2003, Methods Mol Biol, V233, P539; Fields AP, 2007, PHARMACOL RES, V55, P487, DOI 10.1016/j.phrs.2007.04.015; FLINT N, 1991, BIOCHEM J, V280, P331, DOI 10.1042/bj2800331; Fong S, 2004, TRENDS MOL MED, V10, P387, DOI 10.1016/j.molmed.2004.06.008; Frey MR, 2000, J CELL BIOL, V151, P763, DOI 10.1083/jcb.151.4.763; Frey MR, 1997, J BIOL CHEM, V272, P9424; Garcia-Bermejo ML, 2002, J BIOL CHEM, V277, P645, DOI 10.1074/jbc.M107639200; Gil-Bazo I, 2010, CLIN TRANSL ONCOL, V12, P69, DOI 10.1007/s12094-010-0470-3; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Hizli AA, 2006, J BIOL CHEM, V281, P14596, DOI 10.1074/jbc.M601959200; Howarth GS, 2003, GROWTH FACTORS, V21, P79, DOI 10.1080/08977190310001605779; Israel MA, 1999, CANCER RES, V59, p1726S; Jedlicka P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-197; Jones JM, 2006, J NEUROSCI, V26, P550, DOI 10.1523/JNEUROSCI.3859-05.2006; KAHLRAINER P, 1994, CARCINOGENESIS, V15, P779, DOI 10.1093/carcin/15.4.779; KahlRainer P, 1996, GASTROENTEROLOGY, V110, P1753, DOI 10.1053/gast.1996.v110.pm8964400; Kebebew E, 2000, SURGERY, V128, P952, DOI 10.1067/msy.2000.111082; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; Kress TR, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-1; Lee JY, 2009, ONCOGENE, V28, P824, DOI 10.1038/onc.2008.451; Lee JM, 2010, MOL CELL, V37, P183, DOI 10.1016/j.molcel.2009.12.022; Leow CC, 2004, CANCER RES, V64, P6050, DOI 10.1158/0008-5472.CAN-04-0290; Ling MT, 2006, DIFFERENTIATION, V74, P481, DOI 10.1111/j.1432-0436.2006.00083.x; Ling MT, 2004, CARCINOGENESIS, V25, P517, DOI 10.1093/carcin/bgh047; Lingbeck JM, 2005, ONCOGENE, V24, P6376, DOI 10.1038/sj.onc.1208789; Lingbeck JM, 2008, FASEB J, V22, P1694, DOI 10.1096/fj.07-095000; Lowery JW, 2010, AM J PHYSIOL-REG I, V299, pR1463, DOI 10.1152/ajpregu.00866.2009; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; Meteoglu I, 2009, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-69; Nair R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011947; Nakashima A, 2005, J BIOL CHEM, V280, P37660, DOI 10.1074/jbc.M504612200; Norton JD, 2000, J CELL SCI, V113, P3897; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Ozeki M, 2007, J NEUROSCI RES, V85, P515, DOI 10.1002/jnr.21133; Pache G, 2006, AM J PHYSIOL-RENAL, V291, pF654, DOI 10.1152/ajprenal.00214.2004; Paoni NF, 2003, PHYSIOL GENOMICS, V15, P228, DOI 10.1152/physiolgenomics.00078.2003; Peddada S, 2006, HUM MOL GENET, V15, P2003, DOI 10.1093/hmg/ddl124; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Perk J, 2006, CANCER RES, V66, P10870, DOI 10.1158/0008-5472.CAN-06-2643; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Pysz MA, 2009, EXP CELL RES, V315, P1415, DOI 10.1016/j.yexcr.2009.02.002; QUARONI A, 1981, J NATL CANCER I, V67, P1353; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Santiskulvong C, 2007, CELL SIGNAL, V19, P1348, DOI 10.1016/j.cellsig.2007.01.006; SAXON ML, 1994, J CELL BIOL, V126, P747, DOI 10.1083/jcb.126.3.747; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Slosberg ED, 1999, ONCOGENE, V18, P6658, DOI 10.1038/sj.onc.1203083; Swarbrick A, 2005, ONCOGENE, V24, P381, DOI 10.1038/sj.onc.1208188; Ushio K, 2009, MOL CANCER RES, V7, P1179, DOI 10.1158/1541-7786.MCR-08-0289; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Verstovsek G, 1998, GASTROENTEROLOGY, V115, P75, DOI 10.1016/S0016-5085(98)70367-1; Vinals F, 2004, EMBO J, V23, P3527, DOI 10.1038/sj.emboj.7600360; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wice BM, 1998, J BIOL CHEM, V273, P25310, DOI 10.1074/jbc.273.39.25310; Wilson JW, 2001, CANCER RES, V61, P8803; Yang DH, 2009, CIRC RES, V104, P372, DOI 10.1161/CIRCRESAHA.108.185405; Yeh JJ, 2009, MOL CANCER THER, V8, P834, DOI 10.1158/1535-7163.MCT-08-0972; Zhang X, 2004, BRIT J CANCER, V91, P2042, DOI 10.1038/sj.bjc.6602254; Zhao ZR, 2008, ONCOL REP, V19, P419	80	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18104	18117		10.1074/jbc.M110.208488	http://dx.doi.org/10.1074/jbc.M110.208488			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454537	Green Published, hybrid			2022-12-27	WOS:000290585200071
J	Ozeki, C; Sawai, Y; Shibata, T; Kohno, T; Okamoto, K; Yokota, J; Tashiro, F; Tanuma, S; Sakai, R; Kawase, T; Kitabayashi, I; Taya, Y; Ohki, R				Ozeki, Chikako; Sawai, Yuichiro; Shibata, Tatsuhiro; Kohno, Takashi; Okamoto, Koji; Yokota, Jun; Tashiro, Fumio; Tanuma, Sei-ichi; Sakai, Ryuichi; Kawase, Tatsuya; Kitabayashi, Issay; Taya, Yoichi; Ohki, Rieko			Cancer Susceptibility Polymorphism of p53 at Codon 72 Affects Phosphorylation and Degradation of p53 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO72 HOMOZYGOUS GENOTYPE; P53-DEPENDENT APOPTOSIS; TGF-BETA; ASSOCIATION; EXPRESSION; PATHWAY; DOMAIN; CELLS; RISK	The common polymorphism of p53 at codon 72, either encoding proline or arginine, has drawn attention as a genetic factor associated with clinical outcome or cancer risk for the last 2 decades. We now show that these two polymorphic variants differ in protein structure, especially within the N-terminal region and, as a consequence, differ in post-translational modification at the N terminus. The arginine form (p53-72R) shows significantly enhanced phosphorylation at Ser-6 and Ser-20 compared with the proline form (p53-72P). We also show diminished Mdm2-mediated degradation of p53-72R compared with p53-72P, which is at least partly brought about by higher levels of phosphorylation at Ser-20 in p53-72R. Furthermore, enhanced p21 expression in p53-72R-expressing cells, which is dependent on phosphorylation at Ser-6, was demonstrated. Differential p21 expression between the variants was also observed upon activation of TGF-beta signaling. Collectively, we demonstrate a novel molecular difference and simultaneously suggest a difference in the tumor-suppressing function of the variants.	[Ozeki, Chikako; Okamoto, Koji; Kawase, Tatsuya; Taya, Yoichi; Ohki, Rieko] Natl Canc Ctr, Div Radiobiol, Chuo Ku, Tokyo 1040045, Japan; [Ozeki, Chikako; Kitabayashi, Issay] Natl Canc Ctr, Div Mol Oncol, Chuo Ku, Tokyo 1040045, Japan; [Shibata, Tatsuhiro] Natl Canc Ctr, Div Canc Genom, Chuo Ku, Tokyo 1040045, Japan; [Kohno, Takashi; Yokota, Jun] Natl Canc Ctr, Div Biol, Chuo Ku, Tokyo 1040045, Japan; [Okamoto, Koji] Natl Canc Ctr, Early Oncogenesis Res Project, Chuo Ku, Tokyo 1040045, Japan; [Sakai, Ryuichi; Ohki, Rieko] Natl Canc Ctr, Growth Factor Div, Chuo Ku, Tokyo 1040045, Japan; [Sawai, Yuichiro; Ohki, Rieko] Natl Canc Ctr, Div Canc Biol, Chuo Ku, Tokyo 1040045, Japan; [Ozeki, Chikako; Tanuma, Sei-ichi] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Biochem, Noda, Chiba 2708510, Japan; [Sawai, Yuichiro; Tashiro, Fumio; Kawase, Tatsuya] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Noda, Chiba 2708510, Japan; [Taya, Yoichi] Natl Univ Singapore, Canc Sci Inst Singapore, Ctr Life Sci 02 07, Singapore 117456, Singapore; [Taya, Yoichi] Natl Univ Singapore, Dept Biochem, Ctr Life Sci 02 07, Singapore 117456, Singapore	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Tokyo University of Science; Tokyo University of Science; National University of Singapore; National University of Singapore	Taya, Y (corresponding author), Natl Canc Ctr, Div Radiobiol, Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan.	csiyt@nus.edu.sag; rohki@ncc.go.jp	Kitabayashi, Issay/G-2204-2017; Shibata, Tatsuhiro/AAO-1278-2021; Sakai, Ryuichi/R-7741-2017; Shibata, Tatsuhiro/ABA-8234-2020	Sakai, Ryuichi/0000-0001-6833-1103; Kitabayashi, Issay/0000-0002-8409-0407	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare Japan; National Institute of Biomedical Innovation; New Energy and Industrial Technology Development Organization; Hayashi Memorial Foundation for Female Natural Scientists; Sagawa Foundation for Promoting Cancer Research; Takeda Science Foundation; Kobayashi Foundation for Cancer Research; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Grants-in-Aid for Scientific Research [23501271] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists); Sagawa Foundation for Promoting Cancer Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); Kobayashi Foundation for Cancer Research(Kobayashi Foundation for Cancer Research); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to R. O., T. K., and Y. T.), grants-in-aid for the Third Term Comprehensive Ten-year Strategy for Cancer Control from the Ministry of Health, Labor, and Welfare Japan (to T. S., J. Y., and Y. T.), Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (to T. S., T. K., and J. Y.), New Energy and Industrial Technology Development Organization (to R. O.), research grants from Hayashi Memorial Foundation for Female Natural Scientists (to R. O.), the Sagawa Foundation for Promoting Cancer Research (to R. O.), Takeda Science Foundation (to R. O.), Kobayashi Foundation for Cancer Research (to R. O.), and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to R. O.).	Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boldrini L, 2008, ONCOL REP, V19, P771; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Fan R, 2000, CANCER EPIDEM BIOMAR, V9, P1037; HARRIS N, 1986, MOL CELL BIOL, V6, P4650, DOI 10.1128/MCB.6.12.4650; Kawase T, 2008, ONCOGENE, V27, P3797, DOI 10.1038/onc.2008.32; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; MATLASHEWSKI GJ, 1987, MOL CELL BIOL, V7, P961, DOI 10.1128/MCB.7.2.961; Murphy ME, 2006, CELL DEATH DIFFER, V13, P916, DOI 10.1038/sj.cdd.4401907; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Ohki R, 2007, CANCER SCI, V98, P189, DOI 10.1111/j.1349-7006.2006.00375.x; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; Phang BH, 2007, ONCOGENE, V26, P2964, DOI 10.1038/sj.onc.1210112; Sakiyama T, 2005, INT J CANCER, V114, P730, DOI 10.1002/ijc.20790; Shibata T, 2005, CLIN CANCER RES, V11, P6177, DOI 10.1158/1078-0432.CCR-05-0293; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Su L, 2003, LUNG CANCER-J IASLC, V40, P259, DOI 10.1016/S0169-5002(03)00081-3; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tommiska J, 2005, CLIN CANCER RES, V11, P5098, DOI 10.1158/1078-0432.CCR-05-0173; Unger T, 1999, ONCOGENE, V18, P3205, DOI 10.1038/sj.onc.1202656; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Xu Y, 2003, CELL DEATH DIFFER, V10, P1213, DOI 10.1038/sj.cdd.4401292; Zilfou JT, 2001, MOL CELL BIOL, V21, P3974, DOI 10.1128/MCB.21.12.3974-3985.2001	26	21	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18251	18260		10.1074/jbc.M110.208587	http://dx.doi.org/10.1074/jbc.M110.208587			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454683	Green Published, hybrid			2022-12-27	WOS:000290585200085
J	Sweadner, KJ; Pascoa, JL; Salazar, CA; Arystarkhova, E				Sweadner, Kathleen J.; Pascoa, Jennifer L.; Salazar, Cynthia A.; Arystarkhova, Elena			Post-transcriptional Control of Na,K-ATPase Activity and Cell Growth by a Splice Variant of FXYD2 Protein with Modified mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-TRANSPORT REGULATORS; SODIUM-POTASSIUM PUMP; NA+-K+-ATPASE; GAMMA-SUBUNIT; ENDOPLASMIC-RETICULUM; RENAL NA,K-ATPASE; TRANSMEMBRANE PROTEINS; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS; KINASE-C	In kidney, FXYD proteins regulate Na,K-ATPase in a nephron segment-specific way. FXYD2 is the most abundant renal FXYD but is not expressed in most renal cell lines unless induced by hypertonicity. Expression by transfection of FXYD2a or FXYD2b splice variants in NRK-52E cells reduces the apparent Na+ affinity of the Na, K-ATPase and slows the cell proliferation rate. Based on RT-PCR, mRNAs for both splice variants were expressed in wild type NRK-52E cells as low abundance species. DNA sequencing of the PCR products revealed a base alteration from C to T in FXYD2b but not FXYD2a from both untreated and hypertonicity-treated NRK-52E cells. The 172C -> T sequence change exposed a cryptic KKXX endoplasmic reticulum retrieval signal via a premature stop codon. The truncation affected trafficking of FXYD2b and its association with Na,K-ATPase and blocked its effect on enzyme kinetics and cell growth. The data may be explained by altered splicing or selective RNA editing of FXYD2b, a supplementary process that would ensure that it was inactive even if transcribed and translated, in these cells that normally express only FXYD2a. 172C -> T mutation was also identified after mutagenesis of FXYD2b by error-prone PCR coupled with a selection for cell proliferation. Furthermore, the error-prone PCR alone introduced the mutation with high frequency, implying a structural peculiarity. The data confirm truncation of FXYD2b as a potential mechanism to regulate the amount of FXYD2 at the cell surface to control activity of Na,K-ATPase and cell growth.	[Arystarkhova, Elena] Massachusetts Gen Hosp, Dept Neurosurg, Lab Membrane Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Arystarkhova, E (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, Lab Membrane Biol, Edwards 410,55 Fruit St, Boston, MA 02114 USA.	aristarkhova@helix.mgh.harvard.edu			National Institutes of Health [HL036271, NS045083, NS050696]; American Recovery and Reinvestment Act [NS050696]; Harvard Medical School 50th Anniversary Scholars in Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050696, R21NS045083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; Harvard Medical School 50th Anniversary Scholars in Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL036271, NS045083, and NS050696 and an American Recovery and Reinvestment Act supplement to Grant NS050696. This work was also supported by a grant from the Harvard Medical School 50th Anniversary Scholars in Medicine Margaret H. Walter and Daughters Fellowship in memory of Carl W. Walter, M. D., '32.	Arystarkhova E, 1999, J BIOL CHEM, V274, P33183, DOI 10.1074/jbc.274.47.33183; Arystarkhova E, 2003, ANN NY ACAD SCI, V986, P416, DOI 10.1111/j.1749-6632.2003.tb07223.x; Arystarkhova E, 2002, J BIOL CHEM, V277, P10162, DOI 10.1074/jbc.M111552200; Arystarkhova E, 2002, AM J PHYSIOL-RENAL, V282, pF393, DOI 10.1152/ajprenal.00146.2001; Arystarkhova E, 2007, AM J PHYSIOL-CELL PH, V292, pC1179, DOI 10.1152/ajpcell.00328.2006; Beguin P, 1997, EMBO J, V16, P4250, DOI 10.1093/emboj/16.14.4250; Bibert S, 2008, J BIOL CHEM, V283, P476, DOI 10.1074/jbc.M705830200; Bibert S, 2006, J BIOL CHEM, V281, P39142, DOI 10.1074/jbc.M605221200; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; Capasso JM, 2001, P NATL ACAD SCI USA, V98, P13414, DOI 10.1073/pnas.231309198; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Choi YS, 1997, ARCH BIOCHEM BIOPHYS, V344, P165, DOI 10.1006/abbi.1997.0183; Colina C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000540; COLLINS JH, 1987, BIOCHEMISTRY-US, V26, P8665, DOI 10.1021/bi00400a026; Crambert G, 2004, J BIOL CHEM, V279, P30888, DOI 10.1074/jbc.M313494200; Donnet C, 2001, J BIOL CHEM, V276, P7357, DOI 10.1074/jbc.M009131200; FELSENFELD DP, 1988, J BIOL CHEM, V263, P10932; Feschenko MS, 1997, J BIOL CHEM, V272, P17726, DOI 10.1074/jbc.272.28.17726; FORBUSH B, 1978, BIOCHEMISTRY-US, V17, P3667, DOI 10.1021/bi00610a037; Fuller W, 2009, AM J PHYSIOL-CELL PH, V296, pC1346, DOI 10.1152/ajpcell.00523.2008; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Ino Y, 2002, P NATL ACAD SCI USA, V99, P365, DOI 10.1073/pnas.012425299; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jones DH, 2005, J BIOL CHEM, V280, P19003, DOI 10.1074/jbc.M500697200; Jorgensen P L, 1974, Methods Enzymol, V32, P277; Kuster B, 2000, J BIOL CHEM, V275, P18441, DOI 10.1074/jbc.M001411200; Laughery MD, 2003, J BIOL CHEM, V278, P34794, DOI 10.1074/jbc.M302899200; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Lindzen M, 2003, J BIOL CHEM, V278, P18738, DOI 10.1074/jbc.M213253200; Lubarski I, 2005, J BIOL CHEM, V280, P37717, DOI 10.1074/jbc.M506397200; Lubarski I, 2007, AM J PHYSIOL-RENAL, V293, pF1818, DOI 10.1152/ajprenal.00367.2007; Meier JC, 2005, NAT NEUROSCI, V8, P736, DOI 10.1038/nn1467; MERCER RW, 1993, J CELL BIOL, V121, P579, DOI 10.1083/jcb.121.3.579; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morton MJ, 2010, J BIOL CHEM, V285, P33737, DOI 10.1074/jbc.M110.141119; Murphy GJ, 2006, NAT MED, V12, P1093, DOI 10.1038/nm1376; Pihakaski-Maunsbach K, 2008, ACTA HISTOCHEM CYTOC, V41, P105, DOI 10.1267/ahc.08018; Pihakaski-Maunsbach K, 2006, AM J PHYSIOL-RENAL, V291, pF1033, DOI 10.1152/ajprenal.00086.2006; Pu HX, 2002, J BIOL CHEM, V277, P20270, DOI 10.1074/jbc.M201009200; Pu HX, 2001, J BIOL CHEM, V276, P20370, DOI 10.1074/jbc.M010836200; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SWEADNER KJ, 1985, J BIOL CHEM, V260, P9016; Sweadner KJ, 2000, BIOCHEM BIOPH RES CO, V279, P196, DOI 10.1006/bbrc.2000.3907; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Thanaraj TA, 2001, NUCLEIC ACIDS RES, V29, P2581, DOI 10.1093/nar/29.12.2581; Wetzel RK, 2004, J BIOL CHEM, V279, P41750, DOI 10.1074/jbc.M405622200; Zouzoulas A, 2005, J MEMBRANE BIOL, V204, P49, DOI 10.1007/s00232-005-0746-7	50	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18290	18300		10.1074/jbc.M111.241901	http://dx.doi.org/10.1074/jbc.M111.241901			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21460224	hybrid, Green Published			2022-12-27	WOS:000290585200089
J	Dejima, K; Kanai, MI; Akiyama, T; Levings, DC; Nakato, H				Dejima, Katsufumi; Kanai, Makoto I.; Akiyama, Takuya; Levings, Daniel C.; Nakato, Hiroshi			Novel Contact-dependent Bone Morphogenetic Protein (BMP) Signaling Mediated by Heparan Sulfate Proteoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE; DROSOPHILA GLYPICAN; DALLY-LIKE; GRADIENT FORMATION; CORE PROTEIN; DPP; RANGE; HEDGEHOG; DIFFERENTIATION; DIVISION	We previously proposed a model that DALLY, a Drosophila glypican, acts as a trans co-receptor to regulate BMP signaling in the germ line stem cell niche. To investigate the molecular mechanisms of contact-dependent BMP signaling, we developed novel in vitro assay systems to monitor trans signaling using Drosophila S2 cells. Using immunoblot-based as well as single-cell assay systems, we present evidence that Drosophila glypicans indeed enhance BMP signaling in trans in a contact-dependent manner in vitro. Our analysis showed that heparan sulfate modification is required for the trans co-receptor activity of DALLY. Two BMP-like molecules, Decapentaplegic (DPP) and Glass bottom boat, can mediate trans signaling through a heparan sulfate proteoglycan co-receptor in S2 cells. The in vitro systems reflect the molecular characteristics of heparan sulfate proteoglycan functions observed previously in vivo, such as ligand specificity and biphasic activity dependent on the ligand dosage. In addition, experiments using a DALLY-coated surface suggested that DALLY regulates DPP signaling in trans by its effect on the stability of DPP protein on the surface of the contacting cells. Our findings provide the molecular foundation for novel contact-dependent signaling, which defines the physical space of the stem cell niche in vivo.	[Dejima, Katsufumi; Kanai, Makoto I.; Akiyama, Takuya; Levings, Daniel C.; Nakato, Hiroshi] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Nakato, H (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 321 Church St SE, Minneapolis, MN 55455 USA.	nakat003@umn.edu		Levings, Daniel/0000-0002-8678-0794	National Institutes of Health [R01 HD042769]; American Heart Association; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [23770262] Funding Source: KAKEN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by National Institutes of Health Grant R01 HD042769. This work was also supported by the American Heart Association (to H. N.) and a Uehara Memorial Foundation Postdoctoral Fellowship (to K. D.).	Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; BUNCH TA, 1992, DEVELOPMENT, V116, P239; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Guo Z, 2009, DEVELOPMENT, V136, P3627, DOI 10.1242/dev.036939; Hacker U, 1997, DEVELOPMENT, V124, P3565; Hayashi Y, 2009, J CELL BIOL, V187, P473, DOI 10.1083/jcb.200904118; Irie A, 2003, BIOCHEM BIOPH RES CO, V308, P858, DOI 10.1016/S0006-291X(03)01500-6; Jackson SM, 1997, DEVELOPMENT, V124, P4113; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200; Jortikka L, 1997, CELL SIGNAL, V9, P47, DOI 10.1016/S0898-6568(96)00094-0; Kasevayuth K, 2004, BIOCHEM BIOPH RES CO, V324, P205, DOI 10.1016/j.bbrc.2004.09.036; Kirkpatrick CA, 2004, DEV CELL, V7, P513, DOI 10.1016/j.devcel.2004.08.004; Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; Kornberg TB, 2007, CURR OPIN GENET DEV, V17, P264, DOI 10.1016/j.gde.2007.05.010; Kramer KL, 2002, DEV CELL, V2, P115, DOI 10.1016/S1534-5807(01)00107-1; Kuo WJ, 2010, MOL BIOL CELL, V21, P4028, DOI 10.1091/mbc.E10-04-0348; Maeda N, 1996, DEVELOPMENT, V122, P647; Miller AF, 2000, J BIOL CHEM, V275, P17937, DOI 10.1074/jbc.275.24.17937; NAKATO H, 1995, DEVELOPMENT, V121, P3687; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Serpe M, 2008, DEV CELL, V14, P940, DOI 10.1016/j.devcel.2008.03.023; Shimmi O, 2003, DEVELOPMENT, V130, P4673, DOI 10.1242/dev.00684; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200; Takeo S, 2005, DEV BIOL, V284, P204, DOI 10.1016/j.ydbio.2005.05.014; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Williams EH, 2010, P NATL ACAD SCI USA, V107, P5869, DOI 10.1073/pnas.1001777107; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yan D, 2010, DEVELOPMENT, V137, P2033, DOI 10.1242/dev.045740; Yan D, 2009, DEV CELL, V17, P470, DOI 10.1016/j.devcel.2009.09.001; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	39	51	52	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17103	17111		10.1074/jbc.M110.208082	http://dx.doi.org/10.1074/jbc.M110.208082			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454551	hybrid, Green Published			2022-12-27	WOS:000290301900060
J	Pena, A; Ripoll-Rozada, J; Zunzunegui, S; Cabezon, E; de la Cruz, F; Arechaga, I				Pena, Alejandro; Ripoll-Rozada, Jorge; Zunzunegui, Sandra; Cabezon, Elena; de la Cruz, Fernando; Arechaga, Ignacio			Autoinhibitory Regulation of TrwK, an Essential VirB4 ATPase in Type IV Secretion Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; MULTIPLE SEQUENCE ALIGNMENT; DEPENDENT PROTEIN-KINASE; INCW PLASMID R388; BACTERIAL CONJUGATION; STRUCTURE PREDICTION; PATHOGENIC BACTERIA; CARBOXYL-TERMINUS; DOMAIN; MECHANISM	Type IV secretion systems (T4SS) mediate the transfer of DNA and protein substrates to target cells. TrwK, encoded by the conjugative plasmid R388, is a member of the VirB4 family, comprising the largest and most conserved proteins of T4SS. In a previous work we demonstrated that TrwK is able to hydrolyze ATP. Here, based on the structural homology of VirB4 proteins with the DNA-pumping ATPase TrwB coupling protein, we generated a series of variants of TrwK where fragments of the C-terminal domain were sequentially truncated. Surprisingly, the in vitro ATPase activity of these TrwK variants was much higher than that of the wild-type enzyme. Moreover, addition of a synthetic peptide containing the amino acid residues comprising this C-terminal region resulted in the specific inhibition of the TrwK variants lacking such domain. These results indicate that the C-terminal end of TrwK plays an important regulatory role in the functioning of the T4SS.	[Arechaga, Ignacio] Univ Cantabria, Dept Biol Mol, Fac Med, Santander 39011, Spain; UC IDICAN CSIC, Inst Biomed & Biotecnol Cantabria IBBTEC, Santander 39011, Spain	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Arechaga, I (corresponding author), Univ Cantabria, Dept Biol Mol, Fac Med, Santander 39011, Spain.	arechagai@unican.es	Cabezon, Elena/K-5874-2014; de la Cruz, Fernando/L-2812-2014; Ripoll Rozada, Jorge/L-1574-2016; Rozada, Jorge Ripoll/AAA-8049-2020; Arechaga, Ignacio/K-2198-2014	de la Cruz, Fernando/0000-0003-4758-6857; Ripoll Rozada, Jorge/0000-0001-7235-317X; Rozada, Jorge Ripoll/0000-0001-7235-317X; Arechaga, Ignacio/0000-0002-1342-9370; Pena, Alejandro/0000-0001-5674-7064; Cabezon, Elena/0000-0002-6177-5016	Ministerio de Ciencia e Innovacion (MCINN, Spain) [BFU2008-00806, BFU2008-00995/BMC]; Instituto de Salud Carlos III (Spain) [RD06/0008/1012]; European VI Framework Program [LSHM-CT-2005_019023]; MCINN	Ministerio de Ciencia e Innovacion (MCINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); European VI Framework Program; MCINN(European Commission)	This work was supported by the Ministerio de Ciencia e Innovacion (MCINN, Spain) Grants BFU2008-00806 and BFU2008-00995/BMC, RD06/0008/1012 from Instituto de Salud Carlos III (Spain) and LSHM-CT-2005_019023 from the European VI Framework Program.; Supported by a predoctoral fellowship from the MCINN.	Arechaga I, 2008, J BACTERIOL, V190, P5472, DOI 10.1128/JB.00321-08; Baekgaard L, 2005, J BIOENERG BIOMEMBR, V37, P369, DOI 10.1007/s10863-005-9473-0; Baron C, 2002, MOL MICROBIOL, V43, P1359, DOI 10.1046/j.1365-2958.2002.02816.x; BERGER BR, 1993, J BACTERIOL, V175, P1723, DOI 10.1128/JB.175.6.1723-1734.1993; BOLLAND S, 1990, J BACTERIOL, V172, P5795, DOI 10.1128/jb.172.10.5795-5802.1990; Burns DL, 2003, CURR OPIN MICROBIOL, V6, P29, DOI 10.1016/S1369-5274(02)00006-1; Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Curran AC, 2000, J BIOL CHEM, V275, P30301, DOI 10.1074/jbc.M002047200; Durand E, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-4; Durand E, 2010, J BACTERIOL, V192, P2315, DOI 10.1128/JB.01384-09; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; ENYEDI A, 1993, J BIOL CHEM, V268, P17120; Fernandez-Lopez R, 2006, FEMS MICROBIOL REV, V30, P942, DOI 10.1111/j.1574-6976.2006.00042.x; Fischer W, 2002, INT J MED MICROBIOL, V292, P159, DOI 10.1078/1438-4221-00199; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Hackney DD, 2000, NAT CELL BIOL, V2, P257, DOI 10.1038/35010525; Hwang I, 2000, P NATL ACAD SCI USA, V97, P6224, DOI 10.1073/pnas.97.11.6224; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kerr JE, 2010, J BACTERIOL, V192, P4923, DOI 10.1128/JB.00557-10; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; Malmstrom S, 2000, PLANT PHYSIOL, V122, P517, DOI 10.1104/pp.122.2.517; Matilla I, 2010, J BIOL CHEM, V285, P17537, DOI 10.1074/jbc.M109.084137; Middleton R, 2005, P NATL ACAD SCI USA, V102, P1685, DOI 10.1073/pnas.0409399102; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moncalian G, 1999, J BIOL CHEM, V274, P36117, DOI 10.1074/jbc.274.51.36117; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Owen BAL, 2002, J BIOL CHEM, V277, P7086, DOI 10.1074/jbc.M111450200; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PORTILLO F, 1989, FEBS LETT, V247, P381, DOI 10.1016/0014-5793(89)81375-4; Rabel C, 2003, J BACTERIOL, V185, P1045, DOI 10.1128/JB.185.3.1045-1058.2003; Rangrez AY, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-10; Reddy LG, 1999, BIOPHYS J, V76, P3058, DOI 10.1016/S0006-3495(99)77458-8; Rivas S, 1997, J BIOL CHEM, V272, P25583, DOI 10.1074/jbc.272.41.25583; Sambrook J., 2002, MOL CLONING LAB MANU; SANCHEZ VE, 1993, J BIOL CHEM, V268, P17889; Seiler S, 2000, NAT CELL BIOL, V2, P333, DOI 10.1038/35014022; SMITH MK, 1992, J BIOL CHEM, V267, P1761; Tato I, 2005, P NATL ACAD SCI USA, V102, P8156, DOI 10.1073/pnas.0503402102; Tato I, 2007, J BIOL CHEM, V282, P25569, DOI 10.1074/jbc.M703464200; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; WALKER JE, 1994, CURR OPIN STRUC BIOL, V4, P912, DOI 10.1016/0959-440X(94)90274-7; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waters V L, 1999, Front Biosci, V4, pD433, DOI 10.2741/Waters; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157; Yeo HJ, 2000, MOL CELL, V6, P1461, DOI 10.1016/S1097-2765(00)00142-8; Yonekura H, 2006, BIOCHEM BIOPH RES CO, V343, P420, DOI 10.1016/j.bbrc.2006.02.169; ZU YL, 1995, J BIOL CHEM, V270, P202, DOI 10.1074/jbc.270.1.202	55	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17376	17382		10.1074/jbc.M110.208942	http://dx.doi.org/10.1074/jbc.M110.208942			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454654	Green Published, hybrid			2022-12-27	WOS:000290301900085
J	Sikora, AE; Zielke, RA; Lawrence, DA; Andrews, PC; Sandkvist, M				Sikora, Aleksandra E.; Zielke, Ryszard A.; Lawrence, Daniel A.; Andrews, Philip C.; Sandkvist, Maria			Proteomic Analysis of the Vibrio cholerae Type II Secretome Reveals New Proteins, Including Three Related Serine Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; OUTER-MEMBRANE; SUBCELLULAR-LOCALIZATION; PROTEOLYTIC ACTIVATION; LEGIONELLA-PNEUMOPHILA; GENETIC-ANALYSIS; BACTERIAL; HOST; TOXIN; EXPRESSION	The type II secretion (T2S) system is responsible for extracellular secretion of a broad range of proteins, including toxins and degradative enzymes that play important roles in the pathogenesis and life cycle of many Gram-negative bacteria. In Vibrio cholerae, the etiological agent of cholera, the T2S machinery transports cholera toxin, which induces profuse watery diarrhea, a hallmark of this life-threatening disease. Besides cholera toxin, four other proteins have been shown to be transported by the T2S machinery, including hemagglutinin protease, chitinase, GbpA, and lipase. Here, for the first time, we have applied proteomic approaches, including isotope tagging for relative and absolute quantification coupled with multidimensional liquid chromatography and tandem mass spectrometry, to perform an unbiased and comprehensive analysis of proteins secreted by the T2S apparatus of the V. cholerae El Tor strain N16961 under standard laboratory growth conditions. This analysis identified 16 new putative T2S substrates, including sialidase, several proteins participating in chitin utilization, two aminopeptidases, TagA-related protein, cytolysin, RbmC, three hypothetical proteins encoded by VCA0583, VCA0738, and VC2298, and three serine proteases VesA, VesB, and VesC. Focusing on the initial characterization of VesA, VesB, and VesC, we have confirmed enzymatic activities and T2S-dependent transport for each of these proteases. In addition, analysis of single, double, and triple protease knock-out strains indicated that VesA is the primary protease responsible for processing the A subunit of cholera toxin during in vitro growth of the V. cholerae strain N16961.	[Sikora, Aleksandra E.; Sandkvist, Maria] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Zielke, Ryszard A.] Univ Michigan, Dept Mol Dev & Cellular Biol, Ann Arbor, MI 48109 USA; [Lawrence, Daniel A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Andrews, Philip C.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sandkvist, M (corresponding author), Univ Michigan, Dept Microbiol & Immunol, 1150 W Med Ctr Dr,3726 Med Sci Bldg 2, Ann Arbor, MI 48109 USA.	mariasan@umich.edu	Sikora, Aleksandra E/HGD-6641-2022	Lawrence, Daniel/0000-0003-3126-1935; Andrews, Philip/0000-0001-6843-5420	National Institutes of Health from NIAID [R01AI081705]; NHLBI [HL55374, HL54710, HL089407]; National Institutes of Health [1-U54-AI-057153]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089407, R01HL055374, P01HL054710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI081705] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI081705 from NIAID (to M. S.) and Grants HL55374, HL54710, and HL089407 from NHLBI (to D. A. L.).; We acknowledge membership within and support from the Region V "Great Lakes" Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research program supported by National Institutes of Health Award 1-U54-AI-057153.	Adav SS, 2010, J PROTEOME RES, V9, P3932, DOI 10.1021/pr100148j; Adav SS, 2010, J PROTEOME RES, V9, P3016, DOI 10.1021/pr901174z; Angelichio MJ, 1999, INFECT IMMUN, V67, P3733, DOI 10.1128/IAI.67.8.3733-3739.1999; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhowmick R, 2007, J APPL MICROBIOL, V103, P97, DOI 10.1111/j.1365-2672.2006.03253.x; BOOTH BA, 1984, INFECT IMMUN, V45, P558, DOI 10.1128/IAI.45.3.558-560.1984; Broza M, 2001, NATURE, V412, P40, DOI 10.1038/35083691; Bumann D, 2002, INFECT IMMUN, V70, P3396, DOI 10.1128/IAI.70.7.3396-3403.2002; Caldwell RB, 2004, APPL ENVIRON MICROB, V70, P610, DOI 10.1128/AEM.70.1.610-612.2004; Camberg JL, 2005, J BACTERIOL, V187, P249, DOI 10.1128/JB.187.1.249-256.2005; Camberg JL, 2007, EMBO J, V26, P19, DOI 10.1038/sj.emboj.7601481; Chen XQ, 2010, J PROTEOME RES, V9, P885, DOI 10.1021/pr900784c; Cianciotto NP, 2009, FUTURE MICROBIOL, V4, P797, DOI 10.2217/FMB.09.53; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Connell TD, 1998, J BACTERIOL, V180, P5591, DOI 10.1128/JB.180.21.5591-5600.1998; Cottingham KL, 2003, FRONT ECOL ENVIRON, V1, P80, DOI 10.1890/1540-9295(2003)001[0080:EMAHPT]2.0.CO;2; Coulthurst SJ, 2008, J BIOL CHEM, V283, P23739, DOI 10.1074/jbc.M801829200; Davis BM, 2000, SCIENCE, V288, P333, DOI 10.1126/science.288.5464.333; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; DENFERT C, 1989, J BIOL CHEM, V264, P17462; DENFERT C, 1987, EMBO J, V6, P3531, DOI 10.1002/j.1460-2075.1987.tb02679.x; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Evans FF, 2008, ENVIRON MICROBIOL, V10, P1101, DOI 10.1111/j.1462-2920.2007.01545.x; Evans FF, 2007, J PROTEOME RES, V6, P967, DOI 10.1021/pr060416x; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; FINKELSTEIN RA, 1983, P NATL ACAD SCI-BIOL, V80, P1092, DOI 10.1073/pnas.80.4.1092; GALEN JE, 1992, INFECT IMMUN, V60, P406, DOI 10.1128/IAI.60.2.406-415.1992; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gill D M, 1977, Adv Cyclic Nucleotide Res, V8, P85; GILL DM, 1979, J INFECT DIS, V139, P674, DOI 10.1093/infdis/139.6.674; GORDON VM, 1994, INFECT IMMUN, V62, P333, DOI 10.1128/IAI.62.2.333-340.1994; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Halpern M, 2003, APPL ENVIRON MICROB, V69, P4200, DOI 10.1128/AEM.69.7.4200-4204.2003; HEDSTROM L, 2002, CURR PROTOC PROTEIN, V21; HIRST TR, 1987, P NATL ACAD SCI USA, V84, P7418, DOI 10.1073/pnas.84.21.7418; Horstman AL, 2002, J BIOL CHEM, V277, P32538, DOI 10.1074/jbc.M203740200; IWANAGA M, 1985, J CLIN MICROBIOL, V22, P405, DOI 10.1128/JCM.22.3.405-408.1985; Jermyn WS, 2002, MICROBIOL-SGM, V148, P3681, DOI 10.1099/00221287-148-11-3681; Jha G, 2005, MOL PLANT MICROBE IN, V18, P891, DOI 10.1094/MPMI-18-0891; Johnson TL, 2007, J BACTERIOL, V189, P9082, DOI 10.1128/JB.01256-07; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Kaffarnik FAR, 2009, MOL CELL PROTEOMICS, V8, P145, DOI 10.1074/mcp.M800043-MCP200; Kanjilal S, 2010, J BACTERIOL, V192, P4300, DOI 10.1128/JB.00182-10; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Lantz MS, 1997, J PERIODONTAL RES, V32, P126, DOI 10.1111/j.1600-0765.1997.tb01393.x; Lathem WW, 2002, MOL MICROBIOL, V45, P277, DOI 10.1046/j.1365-2958.2002.02997.x; Lencer WI, 1997, J BIOL CHEM, V272, P15562, DOI 10.1074/jbc.272.24.15562; Li XB, 2007, GLYCOBIOLOGY, V17, P1377, DOI 10.1093/glycob/cwm096; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Lory S, 1998, CURR OPIN MICROBIOL, V1, P27, DOI 10.1016/S1369-5274(98)80139-2; Lybarger SR, 2009, J BACTERIOL, V191, P3149, DOI 10.1128/JB.01701-08; Maeda H, 1996, MICROBIOL IMMUNOL, V40, P685, DOI 10.1111/j.1348-0421.1996.tb01129.x; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; MENARD R, 1993, J BACTERIOL, V175, P5899; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; Moustafa I, 2004, J BIOL CHEM, V279, P40819, DOI 10.1074/jbc.M404965200; NALIN DR, 1979, INFECT IMMUN, V25, P768, DOI 10.1128/IAI.25.2.768-770.1979; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; OVERBYE LJ, 1993, GENE, V132, P101, DOI 10.1016/0378-1119(93)90520-D; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Sack DA, 2006, NEW ENGL J MED, V355, P649, DOI 10.1056/NEJMp068144; Saier MH, 2006, J MEMBRANE BIOL, V214, P75, DOI 10.1007/s00232-006-0049-7; SANDKVIST M, 1993, GENE, V123, P81, DOI 10.1016/0378-1119(93)90543-C; Sandkvist M, 1997, J BACTERIOL, V179, P6994, DOI 10.1128/jb.179.22.6994-7003.1997; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shi L, 2008, J BACTERIOL, V190, P5512, DOI 10.1128/JB.00514-08; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Sikora AE, 2007, J BACTERIOL, V189, P8484, DOI 10.1128/JB.00583-07; Sikora AE, 2009, J BACTERIOL, V191, P5398, DOI 10.1128/JB.00092-09; Silva AJ, 2006, INFECT IMMUN, V74, P2072, DOI 10.1128/IAI.74.4.2072-2079.2006; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Stewart CR, 2009, J BACTERIOL, V191, P1537, DOI 10.1128/JB.01531-08; Syngkon A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013122; TAYLOR RK, 1989, J BACTERIOL, V171, P1870, DOI 10.1128/jb.171.4.1870-1878.1989; Toma C, 1996, INFECT IMMUN, V64, P4495, DOI 10.1128/IAI.64.11.4495-4500.1996; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Xicohtencatl-Cortes J, 2006, MOL CELL PROTEOMICS, V5, P2374, DOI 10.1074/mcp.M600228-MCP200; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zalewska-Piatek B, 2008, J BACTERIOL, V190, P5044, DOI 10.1128/JB.00224-08; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	86	79	79	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16555	16566		10.1074/jbc.M110.211078	http://dx.doi.org/10.1074/jbc.M110.211078			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21385872	Green Published, hybrid			2022-12-27	WOS:000290301900004
J	Wu, Y; Wei, S; Van Doren, SR; Brew, K				Wu, Ying; Wei, Shuo; Van Doren, Steven R.; Brew, Keith			Entropy Increases from Different Sources Support the High-affinity Binding of the N-terminal Inhibitory Domains of Tissue Inhibitors of Metalloproteinases to the Catalytic Domains of Matrix Metalloproteinases-1 and-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTION; CRYSTAL-STRUCTURE; HEAT-CAPACITY; 1-MATRIX METALLOPROTEINASE; ESCHERICHIA-COLI; POTENT INHIBITOR; TIMP-1; COMPLEX; SPECIFICITY; SURFACE	The avid binding of tissue inhibitors of metalloproteinases (TIMPs) to matrix metalloproteinases (MMPs) is crucial for the regulation of pericellular and extracellular proteolysis. The interactions of the catalytic domain (cd) of MMP-1 with the inhibitory domains of TIMP-1 and TIMP-2 (N-TIMPs) and MMP-3cd with N-TIMP-2 have been characterized by isothermal titration calorimetry and compared with published data for the N-TIMP-1/MMP-3cd interaction. All interactions are largely driven by increases in entropy but there are significant differences in the profiles for the interactions of both N-TIMPs with MMP-1cd as compared with MMP-3cd; the enthalpy change ranges from small for MMP-1cd to highly unfavorable for MMP-3cd (-0.1 +/- 0.7 versus 6.0 +/- 0.5 kcal mol(-1)). The heat capacity change (Delta C-p) of binding to MMP-1cd (temperature dependence of Delta H) is large and negative (-210 +/- 20 cal K-1 mol(-1)), indicating a large hydrophobic contribution, whereas the Delta C-p values for the binding to MMP-3cd are much smaller (-53 +/- 3 cal K-1 mol(-1)), and some of the entropy increase may arise from increased conformational entropy. Apart from differences in ionization effects, it appears that the properties of the MMPmay have a predominant influence in the thermodynamic profiles for these N-TIMP/MMP interactions.	[Wu, Ying; Wei, Shuo; Brew, Keith] Florida Atlantic Univ, Dept Basic Sci, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA; [Van Doren, Steven R.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	State University System of Florida; Florida Atlantic University; University of Missouri System; University of Missouri Columbia	Brew, K (corresponding author), Florida Atlantic Univ, Dept Basic Sci, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA.	kbrew@fau.edu	Brew, Keith/A-6746-2009; Brew, Keith/W-1643-2019	Brew, Keith/0000-0003-1306-1032; Wei, Shuo/0000-0001-8203-4922; Van Doren, Steven/0000-0003-2838-4598	National Institutes of Health [R01 AR40994, R01GM57289]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR40994 (to K. B.) and R01GM57289 (to S. R. V. D.).	Arumugam S, 2003, J MOL BIOL, V327, P719, DOI 10.1016/S0022-2836(03)00180-3; Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1; Baker BM, 1998, METHOD ENZYMOL, V295, P294; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Butler GS, 1999, J BIOL CHEM, V274, P20391, DOI 10.1074/jbc.274.29.20391; Chen LY, 1999, J MOL BIOL, V293, P545, DOI 10.1006/jmbi.1999.3147; Cho S, 2010, BIOCHEMISTRY-US, V49, P9256, DOI 10.1021/bi1008968; Cooper A, 2007, BIOCHEM SOC T, V35, P1547, DOI 10.1042/BST0351547; Cooper A, 2005, BIOPHYS CHEM, V115, P89, DOI 10.1016/j.bpc.2004.12.011; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; FU L, 1992, P NATL ACAD SCI USA, V89, P9335, DOI 10.1073/pnas.89.19.9335; Goldberg RN, 2002, J PHYS CHEM REF DATA, V31, P231, DOI 10.1063/1.1416902; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Grimsley GR, 2009, PROTEIN SCI, V18, P247, DOI 10.1002/pro.19; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; Higashi S, 1999, J BIOL CHEM, V274, P10497, DOI 10.1074/jbc.274.15.10497; Holman CM, 1999, BIOCHEMISTRY-US, V38, P677, DOI 10.1021/bi9822170; Huang W, 1996, FEBS LETT, V384, P155, DOI 10.1016/0014-5793(96)00304-3; Huang W, 1997, J BIOL CHEM, V272, P22086, DOI 10.1074/jbc.272.35.22086; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Janin J, 1996, PROTEINS, V24, pR1, DOI 10.1002/prot.340240402; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Lee MH, 2004, J BIOL CHEM, V279, P17562, DOI 10.1074/jbc.M312589200; Lee MH, 2003, J BIOL CHEM, V278, P40224, DOI 10.1074/jbc.M305678200; Lim NH, 2010, BIOCHEM J, V431, P113, DOI 10.1042/BJ20100725; Maskos K, 2007, J MOL BIOL, V366, P1222, DOI 10.1016/j.jmb.2006.11.072; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Meng Q, 1999, J BIOL CHEM, V274, P10184, DOI 10.1074/jbc.274.15.10184; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rapti M, 2008, BIOCHEM J, V411, P433, DOI 10.1042/BJ20071430; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Van Doren SR, 2008, BIOPOLYMERS, V89, P960, DOI 10.1002/bip.21043; Wei S, 2005, J BIOL CHEM, V280, P32877, DOI 10.1074/jbc.C500220200; Wei S, 2003, BIOCHEMISTRY-US, V42, P12200, DOI 10.1021/bi035358x; Wei S, 2003, J BIOL CHEM, V278, P9831, DOI 10.1074/jbc.M211793200; Williamson RA, 1999, J BIOL CHEM, V274, P37226, DOI 10.1074/jbc.274.52.37226; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Yu YB, 2001, BIOPHYS J, V81, P1632, DOI 10.1016/S0006-3495(01)75817-1	43	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16891	16899		10.1074/jbc.M111.222307	http://dx.doi.org/10.1074/jbc.M111.222307			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454617	hybrid, Green Published			2022-12-27	WOS:000290301900038
J	Cenik, B; Sephton, CF; Dewey, CM; Xian, XD; Wei, SG; Yu, K; Niu, WZ; Coppola, G; Coughlin, SE; Lee, SE; Dries, DR; Almeida, S; Geschwind, DH; Gao, FB; Miller, BL; Farese, RV; Posner, BA; Yu, G; Herz, J				Cenik, Basar; Sephton, Chantelle F.; Dewey, Colleen M.; Xian, Xunde; Wei, Shuguang; Yu, Kimberley; Niu, Wenze; Coppola, Giovanni; Coughlin, Sarah E.; Lee, Suzee E.; Dries, Daniel R.; Almeida, Sandra; Geschwind, Daniel H.; Gao, Fen-Biao; Miller, Bruce L.; Farese, Robert V., Jr.; Posner, Bruce A.; Yu, Gang; Herz, Joachim			Suberoylanilide Hydroxamic Acid (Vorinostat) Up-regulates Progranulin Transcription RATIONAL THERAPEUTIC APPROACH TO FRONTOTEMPORAL DEMENTIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; LOBAR DEGENERATION; HDAC INHIBITORS; IN-VITRO; RESVERATROL; MUTATIONS; DISEASE; VIVO; ACETYLATION; ACTIVATION	Progranulin (GRN) haploinsufficiency is a frequent cause of familial frontotemporal dementia, a currently untreatable progressive neurodegenerative disease. By chemical library screening, we identified suberoylanilide hydroxamic acid (SAHA), a Food and Drug Administration-approved histone deacetylase inhibitor, as an enhancer of GRN expression. SAHA dose-dependently increased GRN mRNA and protein levels in cultured cells and restored near-normal GRN expression in haploinsufficient cells from human subjects. Although elevation of secreted progranulin levels through a post-transcriptional mechanism has recently been reported, this is, to the best of our knowledge, the first report of a small molecule enhancer of progranulin transcription. SAHA has demonstrated therapeutic potential in other neurodegenerative diseases and thus holds promise as a first generation drug for the prevention and treatment of frontotemporal dementia.	[Dries, Daniel R.; Yu, Gang; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Cenik, Basar; Xian, Xunde; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Wei, Shuguang; Posner, Bruce A.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Coppola, Giovanni; Geschwind, Daniel H.] Univ Calif Los Angeles, Program Neurogenet, Dept Neurol, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Coughlin, Sarah E.; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Lee, Suzee E.; Miller, Bruce L.] Univ Calif San Francisco, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Almeida, Sandra; Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Massachusetts System; University of Massachusetts Worcester	Yu, G (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	gang.yu@utsouthwestern.edu; joachim.herz@utsouthwestern.edu	Lee, Suzee/AAG-2393-2019; Coughlin, Sarah/ABG-7079-2020; Xian, Xunde/B-9490-2012	Xian, Xunde/0000-0003-3059-1254; DRIES, DANIEL/0000-0002-0530-5212; Yu, Kimberley/0000-0002-3993-923X	National Institutes of Health; Consortium for Frontotemporal Dementia Research; California Institute for Regenerative Medicine; National Cell Repository for Alzheimer's Disease; Ted Nash Long Life Foundation; Welch Foundation; Humboldt Foundation; American Health Assistance Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, R01AG029547, P01AG019724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Frontotemporal Dementia Research; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Cell Repository for Alzheimer's Disease; Ted Nash Long Life Foundation; Welch Foundation(The Welch Foundation); Humboldt Foundation(Alexander von Humboldt Foundation); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health, the Consortium for Frontotemporal Dementia Research, the California Institute for Regenerative Medicine, the National Cell Repository for Alzheimer's Disease, the Ted Nash Long Life Foundation, the Welch Foundation, the Humboldt Foundation, and the American Health Assistance Foundation.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bhandari V, 1996, BIOCHEM J, V319, P441, DOI 10.1042/bj3190441; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Calamini B, 2010, BIOCHEM J, V429, P273, DOI 10.1042/BJ20091857; Capell A, 2011, J NEUROSCI, V31, P1885, DOI 10.1523/JNEUROSCI.5757-10.2011; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Eriksen JL, 2008, J NEUROCHEM, V104, P287, DOI 10.1111/j.1471-4159.2007.04968.x; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Finkelstein RA, 2010, J SURG RES, V163, P146, DOI 10.1016/j.jss.2010.04.024; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hahnen E, 2006, J NEUROCHEM, V98, P193, DOI 10.1111/j.1471-4159.2006.03868.x; Halili MA, 2010, J LEUKOCYTE BIOL, V87, P1103, DOI 10.1189/jlb.0509363; Heltweg B, 2004, J MED CHEM, V47, P5235, DOI 10.1021/jm0497592; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hodges JR, 2003, NEUROLOGY, V61, P349, DOI 10.1212/01.WNL.0000078928.20107.52; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Jiao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010551; Kai L, 2010, INT J CANCER, V126, P1538, DOI 10.1002/ijc.24928; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kirshner HS, 2010, CURR NEUROL NEUROSCI, V10, P504, DOI 10.1007/s11910-010-0145-z; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Lin HS, 2007, BRIT J PHARMACOL, V150, P862, DOI 10.1038/sj.bjp.0707165; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; MA PTS, 1986, P NATL ACAD SCI USA, V83, P8370, DOI 10.1073/pnas.83.21.8370; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Tang BL, 2010, BRAIN RES BULL, V81, P359, DOI 10.1016/j.brainresbull.2009.12.007; Tang W., 2011, SCIENCE IN PRESS; van Swieten JC, 2008, LANCET NEUROL, V7, P965, DOI 10.1016/S1474-4422(08)70194-7; Vingtdeux V, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S6; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; Watamoto K, 2003, ONCOGENE, V22, P9176, DOI 10.1038/sj.onc.1206902; Yang JQ, 2009, J BIOL CHEM, V284, P27042, DOI 10.1074/jbc.M109.047340; Yin D, 2007, CLIN CANCER RES, V13, P1045, DOI 10.1158/1078-0432.CCR-06-1261; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhang F, 2010, EUR J PHARMACOL, V636, P1, DOI 10.1016/j.ejphar.2010.03.043	45	112	118	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.193433	http://dx.doi.org/10.1074/jbc.M110.193433			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454553	hybrid, Green Published			2022-12-27	WOS:000290022800050
J	Gandini, MA; Sandoval, A; Gonzalez-Ramirez, R; Mori, Y; de Waard, M; Felix, R				Gandini, Mara A.; Sandoval, Alejandro; Gonzalez-Ramirez, Ricardo; Mori, Yasuo; de Waard, Michel; Felix, Ricardo			Functional Coupling of Rab3-interacting Molecule 1 (RIM1) and L-type Ca2+ Channels in Insulin Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELL; GATED CALCIUM-CHANNELS; INTERACTING MOLECULE; SUBUNIT INTERACTION; RAB3 EFFECTOR; SECRETION; EXOCYTOSIS; INACTIVATION; CA(V)1.2; SNAP-25	Insulin release by pancreatic beta-cells is regulated by diverse intracellular signals, including changes in Ca2+ concentration resulting from Ca2+ entry through voltage-gated (Ca-V) channels. It has been reported that the Rab3 effector RIM1 acts as a functional link between neuronal Ca-V channels and the machinery for exocytosis. Here, we investigated whether RIM1 regulates recombinant and native L-type Ca-V channels (that play a key role in hormone secretion) and whether this regulation affects insulin release. Whole-cell patch clamp currents were recorded from HEK-293 and insulinoma RIN-m5F cells. RIM1 and Ca-V channel expression was identified by RT-PCR and Western blot. RIM1-Ca-V channel interaction was determined by co-immunoprecipitation. Knockdown of RIM1 and Ca-V channel subunit expression were performed using small interference RNAs. Insulin release was assessed by ELISA. Co-expression of Ca(V)1.2 and Ca(V)1.3 L-type channels with RIM1 in HEK-293 cells revealed that RIM1 may not determine the availability of L-type Ca-V channels but decreases the rate of inactivation of the whole cell currents. Co-immunoprecipitation experiments showed association of the Ca-V beta auxiliary subunit with RIM1. The lack of Ca-V beta expression suppressed channel regulation by RIM1. Similar to the heterologous system, an increase of current inactivation was observed upon knockdown of endogenous RIM1. Co-immunoprecipitation showed association of Ca-V beta and RIM1 in insulin-secreting RIN-m5F cells. Knockdown of RIM1 notably impaired high K+-stimulated insulin secretion in the RIN-m5F cells. These data unveil a novel functional coupling between RIM1 and the L-type Ca-V channels via the Ca-V beta auxiliary subunit that contribute to determine insulin secretion.	[Gandini, Mara A.; Felix, Ricardo] CINVESTAV, IPN, Natl Polytech Inst, Dept Cell Biol,Ctr Res & Adv Studies, Mexico City 07300, DF, Mexico; [Sandoval, Alejandro] Univ Nacl Autonoma Mexico, Sch Med FES Iztacala, Tlalnepantla 54090, Mexico; [Gonzalez-Ramirez, Ricardo] Dr Manuel Gea Gonzalez Gen Hosp, Dept Mol Biol & Histocompatibil, Mexico City 14080, DF, Mexico; [Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan; [de Waard, Michel] INSERM, Grenoble Inst Neurosci, U836, Grenoble, France; [de Waard, Michel] Univ Grenoble 1, F-38042 Grenoble, France	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Kyoto University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Felix, R (corresponding author), CINVESTAV, IPN, Natl Polytech Inst, Dept Cell Biol,Ctr Res & Adv Studies, Ave IPN 2508, Mexico City 07300, DF, Mexico.	rfelix@cell.cinvestav.mx	De Waard, Michel/G-7406-2014; Felix, Ricardo/A-6989-2008; González-Ramírez, Ricardo/O-1792-2014	De Waard, Michel/0000-0002-2782-9615; Felix, Ricardo/0000-0002-5383-7176; González-Ramírez, Ricardo/0000-0003-1399-8036; Gandini, Maria/0000-0003-4399-1679; Sandoval, Alejandro/0000-0002-8558-6033	Consejo Nacional de Ciencia y Tenologia (Conacyt, Mexico); PAPIIT-UNAM [IN210708]; Conacyt and Instituto de Ciencia y Tecnologia del Distrito Federal (ICyTDF, Mexico)	Consejo Nacional de Ciencia y Tenologia (Conacyt, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Conacyt and Instituto de Ciencia y Tecnologia del Distrito Federal (ICyTDF, Mexico)	This work was supported in part by grants from Consejo Nacional de Ciencia y Tenologia (Conacyt, Mexico) (to R. F.) and from PAPIIT-UNAM (Grant IN210708) (to A. S.). This work was also supported by doctoral and post-doctoral fellowships from Conacyt and Instituto de Ciencia y Tecnologia del Distrito Federal (ICyTDF, Mexico) (to M. G. and R. G.-R., respectively).	Andrade A, 2009, CELL CALCIUM, V46, P282, DOI 10.1016/j.ceca.2009.08.006; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Avila G, 2004, CELL MOL NEUROBIOL, V24, P317, DOI 10.1023/B:CEMN.0000022765.52109.26; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Felix R, 2005, J RECEPT SIG TRANSD, V25, P57, DOI 10.1081/RRS-200068102; Gebhart M, 2010, MOL CELL NEUROSCI, V44, P246, DOI 10.1016/j.mcn.2010.03.011; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Hering S, 2000, J PHYSIOL-LONDON, V528, P237, DOI 10.1111/j.1469-7793.2000.t01-1-00237.x; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Hiriart M, 2008, AM J PHYSIOL-ENDOC M, V295, pE1298, DOI 10.1152/ajpendo.90493.2008; Iezzi M, 2000, FEBS LETT, V474, P66, DOI 10.1016/S0014-5793(00)01572-6; Jacobo SMP, 2009, J PHARMACOL EXP THER, V330, P283, DOI 10.1124/jpet.109.150672; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Karunasekara Y, 2009, EUR BIOPHYS J BIOPHY, V39, P75, DOI 10.1007/s00249-009-0467-4; Khanna R, 2006, NEUROSCIENCE, V140, P1201, DOI 10.1016/j.neuroscience.2006.04.053; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; Liu HY, 1996, J NEUROSCI, V16, P7557; Mears D, 2004, J MEMBRANE BIOL, V200, P57, DOI 10.1007/s00232-004-0692-9; Miki Takafumi, 2007, Channels (Austin), V1, P144; Safayhi H, 1997, MOL ENDOCRINOL, V11, P619, DOI 10.1210/me.11.5.619; Sandoval A, 2007, CELL MOL NEUROBIOL, V27, P901, DOI 10.1007/s10571-007-9210-9; Sandoval A, 2007, J NEUROSCI, V27, P3317, DOI 10.1523/JNEUROSCI.4566-06.2007; SATIN LS, 1995, ENDOCRINOLOGY, V136, P4589, DOI 10.1210/en.136.10.4589; Schulla V, 2003, EMBO J, V22, P3844, DOI 10.1093/emboj/cdg389; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Stanley EF, 2003, EUR J NEUROSCI, V18, P2403, DOI 10.1046/j.1460-9568.2003.02948.x; Uriu Y, 2010, J BIOL CHEM, V285, P21750, DOI 10.1074/jbc.M110.101311; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Wong FK, 2010, J NEUROCHEM, V112, P463, DOI 10.1111/j.1471-4159.2009.06466.x; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x	39	25	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.187757	http://dx.doi.org/10.1074/jbc.M110.187757			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21402706	hybrid, Green Published			2022-12-27	WOS:000290022800015
J	Obrador, E; Benlloch, M; Pellicer, JA; Asensi, M; Estrela, JM				Obrador, Elena; Benlloch, Maria; Pellicer, Jose A.; Asensi, Miguel; Estrela, Jose M.			Intertissue Flow of Glutathione (GSH) as a Tumor Growth-promoting Mechanism INTERLEUKIN 6 INDUCES GSH RELEASE FROM HEPATOCYTES IN METASTATIC B16 MELANOMA-BEARING MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B16 MELANOMA-CELLS; GAMMA-GLUTAMYL-TRANSPEPTIDASE; LIVER PARENCHYMAL-CELLS; MOUSE-LIVER; RAT-LIVER; IN-VITRO; MULTIDRUG-RESISTANCE; METASTATIC MELANOMA; CANCER-CHEMOTHERAPY; REDUCED GLUTATHIONE	B16 melanoma F10 (B16-F10) cells with high glutathione (GSH) content show high metastatic activity in vivo. An intertissue flow of GSH, where the liver is the main reservoir, can increase GSH content in metastatic cells and promote their growth. We have studied here possible tumor-derived molecular signals that could activate GSH release from hepatocytes. GSH efflux increases in hepatocytes isolated from mice bearing liver or lung metastases, thus suggesting a systemic mechanism. Fractionation of serum-free conditioned medium from cultured B16-F10 cells and monoclonal antibody-induced neutralization techniques facilitated identification of interleukin (IL)-6 as a tumor-derived molecule promoting GSH efflux in hepatocytes. IL-6 activates GSH release through a methionine-sensitive/organic anion transporter polypeptide 1- and multidrug resistance protein 1-independent channel located on the sinusoidal site of hepatocytes. Specific siRNAs were used to knock down key factors in the main signaling pathways activated by IL-6, which revealed a STAT3-dependent mechanism. Our results show that IL-6 (mainly of tumor origin in B16-F10-bearing mice) may facilitate GSH release from hepatocytes and its interorgan transport to metastatic growing foci.	[Estrela, Jose M.] Univ Valencia, Dept Physiol, Fac Med & Odontol, Valencia 46010, Spain; [Benlloch, Maria] San Vicente Martir Catholic Univ, Fac Expt Sci, Valencia, Spain	University of Valencia; Universidad Catolica de Valencia San Vicente Martir	Estrela, JM (corresponding author), Univ Valencia, Dept Physiol, Fac Med & Odontol, 15 Av Blasco Ibanez, Valencia 46010, Spain.	jose.m.estrela@uv.es	OBRADOR, ELENA/H-4069-2015; Estrela, Jose/H-4449-2015; Miralles, Miguel A Asensi/I-2756-2015; MARTINEZ, ANTONIO PELLICER/C-4832-2015	OBRADOR, ELENA/0000-0002-5934-5543; Estrela, Jose/0000-0002-2540-9190; Miralles, Miguel A Asensi/0000-0003-1922-7777; 	Ministerio de Ciencia e Innovacion, Spain [SAF2009-07729, IPT-010000-2010-21]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by Ministerio de Ciencia e Innovacion, Spain, Grants SAF2009-07729 and IPT-010000-2010-21.	Anasagasti MJ, 1998, HEPATOLOGY, V27, P1249, DOI 10.1002/hep.510270510; ANDERSON ME, 1980, J BIOL CHEM, V255, P9530; ASENSI M, 1994, ANAL BIOCHEM, V217, P323, DOI 10.1006/abio.1994.1126; Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; Ballatori N, 1998, SEMIN LIVER DIS, V18, P377, DOI 10.1055/s-2007-1007171; Ballatori N, 2009, MOL ASPECTS MED, V30, P13, DOI 10.1016/j.mam.2008.08.004; BANNAI S, 1986, J MEMBRANE BIOL, V89, P1, DOI 10.1007/BF01870891; Benlloch M, 2005, J BIOL CHEM, V280, P6950, DOI 10.1074/jbc.M408531200; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carretero J, 2001, J BIOL CHEM, V276, P25775, DOI 10.1074/jbc.M101148200; Carretero J, 1999, CLIN EXP METASTAS, V17, P567, DOI 10.1023/A:1006725226078; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DENEKE SM, 1989, AM J PHYSIOL, V257, pL163, DOI 10.1152/ajplung.1989.257.4.L163; Emmenegger U, 2010, NATURE, V468, P637, DOI 10.1038/468637a; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; FernandezCheca JC, 1996, AM J PHYSIOL-GASTR L, V270, pG969, DOI 10.1152/ajpgi.1996.270.6.G969; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; FIDLER IJ, 1990, CANCER RES, V50, P6130; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; GARDELL SJ, 1980, FEBS LETT, V122, P171, DOI 10.1016/0014-5793(80)80430-3; Garibotto G, 2003, AM J PHYSIOL-ENDOC M, V284, pE757, DOI 10.1152/ajpendo.00403.2002; Geier A, 2005, AM J PHYSIOL-GASTR L, V289, pG831, DOI 10.1152/ajpgi.00307.2004; Green RM, 1996, GASTROENTEROLOGY, V111, P193, DOI 10.1053/gast.1996.v111.pm8698199; GRIFFITH OW, 1979, P NATL ACAD SCI USA, V76, P5606, DOI 10.1073/pnas.76.11.5606; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; GROEN AK, 1982, EUR J BIOCHEM, V122, P87, DOI 10.1111/j.1432-1033.1982.tb05851.x; HANIGAN MH, 1995, CARCINOGENESIS, V16, P181, DOI 10.1093/carcin/16.2.181; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hochwald SN, 1996, J NATL CANCER I, V88, P193, DOI 10.1093/jnci/88.3-4.193; Ilkovitch D, 2008, EXP DERMATOL, V17, P977, DOI 10.1111/j.1600-0625.2008.00779.x; Karras JG, 2000, CELL IMMUNOL, V202, P124, DOI 10.1006/cimm.2000.1661; Kovalovich K, 2001, J BIOL CHEM, V276, P26605, DOI 10.1074/jbc.M100740200; Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614; Leu JI, 2001, MOL CELL BIOL, V21, P414, DOI 10.1128/MCB.21.2.414-424.2001; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; LI L, 1991, CANCER RES, V51, P245; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; MEISTER A, 1983, SCIENCE, V220, P472, DOI 10.1126/science.6836290; MEISTER A, 1991, PHARMACOL THERAPEUT, V51, P155, DOI 10.1016/0163-7258(91)90076-X; Meredith MJ, 1998, BIOCHEM BIOPH RES CO, V248, P458, DOI 10.1006/bbrc.1998.8998; Morgan ET, 2008, DRUG METAB DISPOS, V36, P205, DOI 10.1124/dmd.107.018747; New LS, 2008, J CHROMATOGR SCI, V46, P209, DOI 10.1093/chromsci/46.3.209; Obrador E, 2002, HEPATOLOGY, V35, P74, DOI 10.1053/jhep.2002.30277; OBrien ML, 1996, EUR J CANCER, V32A, P967, DOI 10.1016/0959-8049(96)00051-2; OOKHTENS M, 1994, AM J PHYSIOL, V266, pR979, DOI 10.1152/ajpregu.1994.266.3.R979; Ookhtens M, 1998, SEMIN LIVER DIS, V18, P313, DOI 10.1055/s-2007-1007167; Orr FW, 2000, J PATHOL, V190, P310, DOI 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P; Ortega A, 2003, J BIOL CHEM, V278, P39591, DOI 10.1074/jbc.M303753200; Renton KW, 2004, CURR DRUG METAB, V5, P235, DOI 10.2174/1389200043335559; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Siewert E, 2004, BIOCHEM BIOPH RES CO, V322, P232, DOI 10.1016/j.bbrc.2004.07.102; Singh A, 2006, BIOTECHNOL BIOENG, V95, P850, DOI 10.1002/bit.21026; SINGH B, 1983, ACTA PHYSIOL SCAND, V117, P497, DOI 10.1111/j.1748-1716.1983.tb07218.x; Slaviero KA, 2003, LANCET ONCOL, V4, P224, DOI 10.1016/S1470-2045(03)01034-9; STACKPOLE CW, 1995, CLIN EXP METASTAS, V13, P105, DOI 10.1007/BF00133615; TERRADEZ P, 1993, BIOCHEM J, V292, P477, DOI 10.1042/bj2920477; van der Kolk DM, 1999, ADV EXP MED BIOL, V457, P187; Vee ML, 2009, DRUG METAB DISPOS, V37, P685, DOI DOI 10.1124/DMD.108.023630; Wang Y, 2010, CANCER LETT, V295, P110, DOI 10.1016/j.canlet.2010.02.019; Weiss L, 1990, Adv Cancer Res, V54, P159, DOI 10.1016/S0065-230X(08)60811-8; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang HQ, 2005, METHOD ENZYMOL, V401, P468, DOI 10.1016/S0076-6879(05)01028-1	67	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.196261	http://dx.doi.org/10.1074/jbc.M110.196261			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21393247	hybrid, Green Published			2022-12-27	WOS:000290022800011
J	San Luis, B; Sondgeroth, B; Nassar, N; Carpino, N				San Luis, Boris; Sondgeroth, Ben; Nassar, Nicolas; Carpino, Nick			Sts-2 Is a Phosphatase That Negatively Regulates Zeta-associated Protein (ZAP)-70 and T Cell Receptor Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHATASES; DOMAIN; UBIQUITIN; TULA; IDENTIFICATION; ENDOCYTOSIS; SUBSTRATE; KINASES; ZAP-70; BINDS	T cell activity is controlled in large part by the T cell receptor (TCR). The TCR detects the presence of foreign pathogens and activates the T cell-mediated immune reaction. Numerous intracellular signaling pathways downstream of the TCR are involved in the process of T cell activation. Negative regulation of these pathways helps prevent excessive and deleterious T cell responses. Two homologous proteins, Sts-1 and Sts-2, have been shown to function as critical negative regulators of TCR signaling. The phosphoglycerate mutase-like domain of Sts-1 (Sts-1(PGM)) has a potent phosphatase activity that contributes to the suppression of TCR signaling. The function of Sts-2(PGM) as a phosphatase has been less clear, principally because its intrinsic enzyme activity has been difficult to detect. Here, we demonstrate that Sts-2 regulates the level of tyrosine phosphorylation on targets within T cells, among them the critical T cell tyrosine kinase Zap-70. Utilizing new phosphorylated substrates, we demonstrate that Sts-2(PGM) has clear, albeit weak, phosphatase activity. We further pinpoint Sts-2 residues Glu-481, Ser-552, and Ser-582 as specificity determinants, in that an Sts-2(PGM) triple mutant in which these three amino acids are altered to their counterparts in Sts-1(PGM) has substantially increased activity. Our results suggest that the phosphatase activities of both suppressor of TCR signaling homologues cooperate in a similar but independent fashion to help set the threshold for TCR-induced T cell activation.	[San Luis, Boris; Carpino, Nick] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Sondgeroth, Ben; Nassar, Nicolas] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Carpino, N (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Rm 160 Life Sci Bldg, Stony Brook, NY 11794 USA.	ncarpino@notes.cc.sunysb.edu			National Institutes of Health, NIAID [R21AI075176, R01AI080892, CA-115611]; Stony Brook University [LI07]; Arthritis Foundation; Department of Defense [NF060060]; NATIONAL CANCER INSTITUTE [R01CA115611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080892, R21AI075176] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Stony Brook University; Arthritis Foundation; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AI075176 and R01AI080892 from NIAID and CA-115611 (to N. N.). This work was also supported by Stony Brook University, Grant LI07 from the Arthritis Foundation (to N. C.), and Department of Defense Grant NF060060 (to N. N.).	Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Agrawal R, 2008, J CELL BIOCHEM, V104, P953, DOI 10.1002/jcb.21678; Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Carpino N, 2002, MOL CELL BIOL, V22, P7491, DOI 10.1128/MCB.22.21.7491-7500.2002; Carpino N, 2009, MOL IMMUNOL, V46, P3224, DOI 10.1016/j.molimm.2009.08.015; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chen XW, 2010, J BIOL CHEM, V285, P31268, DOI 10.1074/jbc.M110.114181; Chen YT, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.04C042; Chen YT, 2009, BIOCHEMISTRY-US, V48, P1681, DOI 10.1021/bi802219n; Collingwood TS, 2007, J BIOL CHEM, V282, P30920, DOI 10.1074/jbc.M706870200; Feshchenko EA, 2004, ONCOGENE, V23, P4690, DOI 10.1038/sj.onc.1207627; Gottlin EB, 1996, J BIOL CHEM, V271, P27445, DOI 10.1074/jbc.271.44.27445; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Huang YP, 2004, J BIOL CHEM, V279, P28827, DOI 10.1074/jbc.R400012200; Huang Z, 1999, J BIOMOL SCREEN, V4, P327, DOI 10.1177/108705719900400608; Huston DP, 1997, JAMA-J AM MED ASSOC, V278, P1804, DOI 10.1001/jama.278.22.1804; Jedrzejas MJ, 2000, PROG BIOPHYS MOL BIO, V73, P263, DOI 10.1016/S0079-6107(00)00007-9; Kleinman H, 2006, ACTA CRYSTALLOGR F, V62, P218, DOI 10.1107/S1744309106003320; Kowanetz K, 2004, J BIOL CHEM, V279, P32786, DOI 10.1074/jbc.M403759200; Mikhailik A, 2007, MOL CELL, V27, P486, DOI 10.1016/j.molcel.2007.06.015; Raguz J, 2007, FEBS LETT, V581, P4767, DOI 10.1016/j.febslet.2007.08.077; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Siegel J N, 1991, Semin Immunol, V3, P325; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Tsygankov AY, 2008, IUBMB LIFE, V60, P224, DOI 10.1002/iub.36; Tsygankov AY, 2009, CELL MOL LIFE SCI, V66, P2949, DOI 10.1007/s00018-009-0071-x; Wadham C, 2003, MOL BIOL CELL, V14, P2520, DOI 10.1091/mbc.E02-09-0577; WANG H, 2010, COLD SPRING HARB PER, V2, P1; Wang QP, 1999, BBA-PROTEIN STRUCT M, V1431, P14, DOI 10.1016/S0167-4838(99)00042-4; Wang ZX, 1998, MOL CELL BIOL, V18, P590, DOI 10.1128/MCB.18.1.590	34	44	44	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.177634	http://dx.doi.org/10.1074/jbc.M110.177634			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21393235	Green Published, hybrid			2022-12-27	WOS:000290022800034
J	Salomonsson, E; Thijssen, VL; Griffioen, AW; Nilsson, UJ; Leffler, H				Salomonsson, Emma; Thijssen, Victor L.; Griffioen, Arjan W.; Nilsson, Ulf J.; Leffler, Hakon			The Anti-angiogenic Peptide Anginex Greatly Enhances Galectin-1 Binding Affinity for Glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOSACCHARIDE SPECIFICITY; FLUORESCENCE POLARIZATION; LIGAND INTERACTIONS; CELL-SURFACE; TOLERANCE; LATTICES; THERAPY	Angiogenesis is a key event in cancer progression and therefore a promising target in cancer treatment. Galectin-1, a beta-galactoside binding lectin, is up-regulated in the endothelium of tumors of different origin and has been shown to be the target for anginex, a powerful anti-angiogenic peptide with anti-tumor activity. Here we show that when bound to anginex, galectin-1 binds various glycoproteins with hundred-to thousand-fold higher affinity. Anginex also interacts with galectin-2, -7, -8N, and -9N but not with galectin-3, -4, or -9C.	[Salomonsson, Emma; Leffler, Hakon] Lund Univ, Microbiol Sect, Inst Lab Med, SE-22362 Lund, Sweden; [Thijssen, Victor L.; Griffioen, Arjan W.] Vrije Univ Amsterdam Med Ctr, Angiogenesis Lab, Canc Ctr Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Nilsson, Ulf J.] Lund Univ, Div Organ Chem, SE-22100 Lund, Sweden	Lund University; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Lund University	Leffler, H (corresponding author), Lund Univ, Microbiol Sect, Inst Lab Med, Solvegatan 23, SE-22362 Lund, Sweden.	Hakon.Leffler@med.lu.se	Nilsson, Ulf J./L-3219-2014; Thijssen, Victor LJL/B-2792-2009; Leffler, Hakon/A-2416-2019	Nilsson, Ulf J./0000-0001-5815-9522; Thijssen, Victor LJL/0000-0002-6146-1842; Leffler, Hakon/0000-0003-4482-8945	Lund University Research School in Pharmaceutical Sciences; Swedish Research Council [2009-5656, 2009-5326]; Dutch Cancer Society [UM2008-4101, VU2009-4358]	Lund University Research School in Pharmaceutical Sciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by grants from the Lund University Research School in Pharmaceutical Sciences, the Swedish Research Council Grants 2009-5656 (to H. L.) and 2009-5326 (to U.J.N.), and Dutch Cancer Society Grants UM2008-4101 and VU2009-4358 (to V.L.T. and A.W.G.).	Arroyo MM, 2007, BBA-PROTEINS PROTEOM, V1774, P645, DOI 10.1016/j.bbapap.2007.03.007; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Carlsson S, 2007, GLYCOBIOLOGY, V17, P663, DOI 10.1093/glycob/cwm026; Cederfur C, 2008, GLYCOBIOLOGY, V18, P384, DOI 10.1093/glycob/cwn015; Cumpstey I, 2008, CHEM-EUR J, V14, P4233, DOI 10.1002/chem.200701932; Dam TK, 2005, BIOCHEMISTRY-US, V44, P12564, DOI 10.1021/bi051144z; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Griffioen AW, 2001, BIOCHEM J, V354, P233, DOI 10.1042/0264-6021:3540233; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Le Mercier M, 2010, BRAIN PATHOL, V20, P17, DOI 10.1111/j.1750-3639.2009.00270.x; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; Nishi N, 2008, GLYCOBIOLOGY, V18, P1065, DOI 10.1093/glycob/cwn089; Oberg CT, 2003, BIOCONJUGATE CHEM, V14, P1289, DOI 10.1021/bc034130j; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Salomonsson E, 2010, BIOCHEMISTRY-US, V49, P9518, DOI 10.1021/bi1009584; Salomonsson E, 2010, J BIOL CHEM, V285, P35079, DOI 10.1074/jbc.M109.098160; Sorme P, 2004, ANAL BIOCHEM, V334, P36, DOI 10.1016/j.ab.2004.06.042; Thijssen VL, 2010, CANCER RES, V70, P6216, DOI 10.1158/0008-5472.CAN-09-4150; Thijssen VLJL, 2007, BLOOD, V110, P2819, DOI 10.1182/blood-2007-03-077792; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; van der Schaft DWJ, 2002, FASEB J, V16, P1991, DOI 10.1096/fj.02-0509fje	23	32	33	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13801	13804		10.1074/jbc.C111.229096	http://dx.doi.org/10.1074/jbc.C111.229096			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21372130	Green Published, hybrid			2022-12-27	WOS:000289556200002
J	Xu, B; Zeng, DQ; Wu, YA; Zheng, R; Gu, L; Lin, XA; Hua, XX; Jin, GH				Xu, Bin; Zeng, De-quan; Wu, Yuan; Zheng, Rong; Gu, Le; Lin, Xiao; Hua, Xianxin; Jin, Guang-Hui			Tumor Suppressor Menin Represses Paired Box Gene 2 Expression via Wilms Tumor Suppressor Protein-Polycomb Group Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE COMPLEX; KIDNEY DEVELOPMENT; TARGET GENES; ES CELLS; WT1; CANCER; GROWTH; PAX-2; METHYLATION; PROMOTER	Tumor suppressor menin, the product of the MEN1 gene, plays a key role in controlling histone 3 lysine 4 trimethylation (H3K4me3) and gene transcription, which can regulate proliferation, apoptosis, and differentiation. However, little is known as to whether menin controls gene expression and cell proliferation and survival via regulating Polycomb group (PcG) protein complex/H3K27me3. Here we show that menin specifically represses transcription factor Paired box gene 2 (Pax2) through PcG-mediated H3K27me3 and Wilms tumor suppressor protein (WT1), a zinc finger domain-containing DNA-binding protein. Menin does not directly bind to the Pax2 locus, instead, it up-regulates WT1 expression. WT1 recruits PcG complex to the Pax2 promoter and represses expression of Pax2 through PcG-dependent H3K27me3. Moreover, WT1 also interacts with DNA methyltransferase 1 (DNMT1), and recruits DNMT1 to the Pax2 promoter, resulting in hypermethylation of CpG in the Pax2 promoter. Together, these studies have uncovered a novel epigenetic mechanism whereby menin regulates H3K27me3 and promoter DNA methylation via WT1 and suggest that WT1 protein plays an important, yet previously unappreciated role in regulating the function of the menin/PcG axis, H3K27 methylation, and DNA methylation, resulting in repression of gene transcription.	[Xu, Bin; Zeng, De-quan; Wu, Yuan; Zheng, Rong; Gu, Le; Lin, Xiao; Jin, Guang-Hui] Xiamen Univ, Dept Basic Med Sci, Coll Med, Xiamen 361005, Fujian, Peoples R China; [Hua, Xianxin] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA	Xiamen University; University of Pennsylvania	Jin, GH (corresponding author), Daxue Rd 168, Xiamen 361005, Fujian, Peoples R China.	ghjin@xmu.edu.cn			National Natural Science Foundation of China [30701003, 81071926]; Natural Science Foundation of Xiamen [3502Z20104001]; fundamental research funds for the central universities [2010121106]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097555] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Xiamen; fundamental research funds for the central universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Natural Science Foundation of China Grants 30701003 and 81071926 ( to G.-H.J.), Natural Science Foundation of Xiamen Grant 3502Z20104001 ( to G.-H.J.), and fundamental research funds for the central universities grant 2010121106 ( to G.-H.J.).	Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; Feng ZJ, 2010, ONCOGENE, V29, P5416, DOI 10.1038/onc.2010.282; Flock G, 2002, MOL ENDOCRINOL, V16, P2349, DOI 10.1210/me.2002-0149; Gao SB, 2009, ONCOGENE, V28, P4095, DOI 10.1038/onc.2009.273; GERMAN MS, 1992, MOL CELL BIOL, V12, P1777, DOI 10.1128/MCB.12.4.1777; Goode DK, 2009, DEV DYNAM, V238, P2951, DOI 10.1002/dvdy.22146; Hartkamp J, 2010, MOL CELL, V37, P159, DOI 10.1016/j.molcel.2009.12.023; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jin SH, 2010, J CLIN INVEST, V120, P593, DOI 10.1172/JCI38030; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; La P, 2004, ENDOCRINOLOGY, V145, P3443, DOI 10.1210/en.2004-0124; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Metsuyanim S, 2008, STEM CELLS, V26, P1808, DOI 10.1634/stemcells.2007-0322; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; NAKAGAMA H, 1995, MOL CELL BIOL, V15, P1489; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Ritz-Laser B, 2000, J BIOL CHEM, V275, P32708, DOI 10.1074/jbc.M005704200; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; RUPPRECHT HD, 1994, J BIOL CHEM, V269, P6198; RYAN G, 1995, DEVELOPMENT, V121, P867; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Schnepp RW, 2006, CANCER RES, V66, P5707, DOI 10.1158/0008-5472.CAN-05-4518; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Stuart RO, 2001, P NATL ACAD SCI USA, V98, P5649, DOI 10.1073/pnas.091110798; Thakur A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-11; Thiel AT, 2010, CANCER CELL, V17, P148, DOI 10.1016/j.ccr.2009.12.034; Torres M, 1995, DEVELOPMENT, V121, P4057; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wellik DM, 2002, GENE DEV, V16, P1423, DOI 10.1101/gad.993302; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Zaiko M, 2004, EUR J ENDOCRINOL, V150, P389, DOI 10.1530/eje.0.1500389	45	29	29	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13937	13944		10.1074/jbc.M110.197830	http://dx.doi.org/10.1074/jbc.M110.197830			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21378168	Green Published, hybrid			2022-12-27	WOS:000289556200016
J	Metzger, F; Sajid, W; Saenger, S; Staudenmaier, C; van der Poel, C; Sobottka, B; Schuler, A; Sawitzky, M; Poirier, R; Tuerck, D; Schick, E; Schaubmar, A; Hesse, F; Amrein, K; Loetscher, H; Lynch, GS; Hoeflich, A; De Meyts, P; Schoenfeld, HJ				Metzger, Friedrich; Sajid, Waseem; Saenger, Stefanie; Staudenmaier, Christian; van der Poel, Chris; Sobottka, Bettina; Schuler, Angelika; Sawitzky, Mandy; Poirier, Raphael; Tuerck, Dietrich; Schick, Eginhard; Schaubmar, Andreas; Hesse, Friederike; Amrein, Kurt; Loetscher, Hansruedi; Lynch, Gordon S.; Hoeflich, Andreas; De Meyts, Pierre; Schoenfeld, Hans-Joachim			Separation of Fast from Slow Anabolism by Site-specific PEGylation of Insulin-like Growth Factor I (IGF-I)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING; MECASERMIN RINFABATE; DIABETES-MELLITUS; TRANSGENIC MICE; HYPERTROPHY; DIFFERENTIATION; COMPLEX; CELLS; OVEREXPRESSION; RESISTANCE	Insulin-like growth factor I (IGF-I) has important anabolic and homeostatic functions in tissues like skeletal muscle, and a decline in circulating levels is linked with catabolic conditions. Whereas IGF-I therapies for musculoskeletal disorders have been postulated, dosing issues and disruptions of the homeostasis have so far precluded clinical application. We have developed a novel IGF-I variant by site-specific addition of polyethylene glycol (PEG) to lysine 68 (PEG-IGF-I). In vitro, this modification decreased the affinity for the IGF-I and insulin receptors, presumably through decreased association rates, and slowed down the association to IGF-I-binding proteins, selectively limiting fast but maintaining sustained anabolic activity. Desirable in vivo effects of PEG-IGF-I included increased half-life and recruitment of IGF-binding proteins, thereby reducing risk of hypoglycemia. PEG-IGF-I was equipotent to IGF-I in ameliorating contraction-induced muscle injury in vivo without affecting muscle metabolism as IGF-I did. The data provide an important step in understanding the differences of IGF-I and insulin receptor contribution to the in vivo activity of IGF-I. In addition, PEG-IGF-I presents an innovative concept for IGF-I therapy in diseases with indicated muscle dysfunction.	[Metzger, Friedrich; Saenger, Stefanie; Staudenmaier, Christian; Sobottka, Bettina; Schuler, Angelika; Poirier, Raphael; Tuerck, Dietrich; Schick, Eginhard; Amrein, Kurt; Loetscher, Hansruedi; Schoenfeld, Hans-Joachim] Roche pRED, CH-4070 Basel, Switzerland; [Sajid, Waseem; De Meyts, Pierre] Hagedorn Res Inst, Receptor Syst Biol Lab, DK-2820 Gentofte, Denmark; [van der Poel, Chris; Lynch, Gordon S.] Univ Melbourne, Dept Physiol, Basic & Clin Myol Lab, Melbourne, Vic 3010, Australia; [Sawitzky, Mandy; Hoeflich, Andreas] FBN, Leibniz Inst Farm Anim Biol, Lab Mouse Genet, D-18196 Dummerstorf, Germany; [Schaubmar, Andreas; Hesse, Friederike] Roche pRED, D-82377 Penzberg, Germany	Roche Holding; Novo Nordisk; Hagedorn Research Institute; University of Melbourne; Forschungsinstitut fur Nutztierbiologie (FBN)	Metzger, F (corresponding author), F Hoffmann La Roche Ltd, CNS Discovery Res, Bldg 68-410, CH-4070 Basel, Switzerland.	friedrich.metzger@roche.com	Lynch, Gordon/G-9553-2015	Lynch, Gordon/0000-0001-9220-9810; Hoeflich, Andreas/0000-0003-2018-2836; Sobottka, Bettina/0000-0002-0890-5248; De Meyts, Pierre/0000-0001-6214-0824	Roche	Roche(Roche Holding)	This work was supported in part by a Roche Postdoctoral Fellowship (to C. v. d. P.).	Baudry A, 2001, FEBS LETT, V488, P174, DOI 10.1016/S0014-5793(00)02435-2; BAYNE ML, 1989, J BIOL CHEM, V264, P11004; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cheetham TD, 1997, CLIN ENDOCRINOL, V46, P415, DOI 10.1046/j.1365-2265.1997.1320953.x; Clemmons DR, 2000, J CLIN ENDOCR METAB, V85, P1518, DOI 10.1210/jc.85.4.1518; Clemmons DR, 1998, MOL CELL ENDOCRINOL, V140, P19, DOI 10.1016/S0303-7207(98)00024-0; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Conti E., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P258, DOI 10.2174/187152508785909456; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; De Meyts P, 2009, ANN NY ACAD SCI, V1160, P45, DOI 10.1111/j.1749-6632.2009.03837.x; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; Diehl D, 2004, CANCER RES, V64, P1600, DOI 10.1158/0008-5472.CAN-03-2844; DREJER K, 1991, DIABETES, V40, P1488, DOI 10.2337/diabetes.40.11.1488; Duttaroy A, 2005, DIABETES, V54, P251, DOI 10.2337/diabetes.54.1.251; Epa VC, 2006, PROTEIN ENG DES SEL, V19, P377, DOI 10.1093/protein/gzl022; Fang Peng, 2004, Novartis Found Symp, V262, P215; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gauguin L, 2008, J BIOL CHEM, V283, P20821, DOI 10.1074/jbc.M802620200; GERMAINLEE EL, 1992, BIOCHEM J, V281, P413, DOI 10.1042/bj2810413; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gregorevic P, 2002, AM J PATHOL, V161, P2263, DOI 10.1016/S0002-9440(10)64502-6; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Hoeflich A, 1999, ENDOCRINOLOGY, V140, P5488, DOI 10.1210/en.140.12.5488; Hoeflich A, 2008, GROWTH HORM IGF RES, V18, P181, DOI 10.1016/j.ghir.2008.01.003; Jain A, 2008, CRIT REV THER DRUG, V25, P403, DOI 10.1615/CritRevTherDrugCarrierSyst.v25.i5.10; Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218; Kemp SF, 2007, DRUG TODAY, V43, P149, DOI 10.1358/dot.2007.43.3.1079876; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; KNUSEL B, 1990, J NEUROSCI, V10, P558; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Palsgaard J, 2009, GROWTH HORM IGF RES, V19, P168, DOI 10.1016/j.ghir.2008.09.004; Philippou A., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P208; QUINN LS, 1993, EXP CELL RES, V208, P504, DOI 10.1006/excr.1993.1273; Ranke MB, 2005, TRENDS ENDOCRIN MET, V16, P190, DOI 10.1016/j.tem.2005.03.011; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sajid W, 2009, BIOCHEMISTRY-US, V48, P11283, DOI 10.1021/bi901269j; Saukkonen T, 2004, J CLIN ENDOCR METAB, V89, P4634, DOI 10.1210/jc.2004-0243; Schertzer JD, 2006, AM J PHYSIOL-ENDOC M, V291, pE499, DOI 10.1152/ajpendo.00101.2006; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; SVRZIC D, 1990, BIOCHEM BIOPH RES CO, V172, P54, DOI 10.1016/S0006-291X(05)80172-X; VACCARELLO MA, 1993, J CLIN ENDOCR METAB, V77, P273, DOI 10.1210/jc.77.1.273; Vashisth H, 2010, J MOL BIOL, V400, P645, DOI 10.1016/j.jmb.2010.05.025; Wheatcroft SB, 2007, DIABETES, V56, P285, DOI 10.2337/db06-0436; Williams RM, 2008, EXPERT OPIN DRUG MET, V4, P311, DOI [10.1517/17425255.4.3.311, 10.1517/17425255.4.3.311 ]; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; ZHANG WG, 1994, J BIOL CHEM, V269, P10609	48	37	38	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19501	19510		10.1074/jbc.M110.172189	http://dx.doi.org/10.1074/jbc.M110.172189			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21460230	hybrid, Green Published			2022-12-27	WOS:000291027700033
J	Sheng, JZ; Liu, RP; Xu, YM; Liu, J				Sheng, Juzheng; Liu, Renpeng; Xu, Yongmei; Liu, Jian			The Dominating Role of N-Deacetylase/N-Sulfotransferase 1 in Forming Domain Structures in Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHESIS; SPECIFICITY; EXPRESSION; MEMBER	Heparan sulfate (HS) is a highly sulfated polysaccharide participated in essential physiological functions from regulating cell growth to blood coagulation. HS contains sulfated domains known as N-S domains and low sulfate domains known as N-Ac domains. The distribution of the domain structures is likely governed by the action of glucosaminyl N-deacetylase/N-sulfotransferase (NDST). Here, we sought to determine the substrate specificity of NDST using model substrates and recombinant NDST protein. We discovered that NDST-1 carries out the modification in a highly ordered fashion. The enzyme sulfates the substrate from the nonreducing end toward the reducing end consecutively, leading to the product with a cluster of N-sulfo glucosamine residues. Furthermore, a preexisting N-sulfo glucosamine residue prevents the action of NDST-1 at the residues immediately located at the nonreducing end, allowing the formation of an N-Ac domain. Our results provide the long sought evidence for understanding the formation of sulfated versus nonsulfated domains in the HS isolated from cells and tissues. The study demonstrates the regulating role of NDST-1 in mapping the sulfation patterns of HS.	[Sheng, Juzheng; Liu, Renpeng; Xu, Yongmei; Liu, Jian] Univ N Carolina, Div Med Chem & Nat Prod, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Liu, J (corresponding author), Univ N Carolina, Div Med Chem & Nat Prod, Eshelman Sch Pharm, Rm 303,Beard Hall, Chapel Hill, NC 27599 USA.	jian_liu@unc.edu	Sheng, Juzheng/G-2693-2013; Liu, Renpeng/G-1625-2011	Sheng, Juzheng/0000-0003-2856-9162; 	National Institutes of Health [AI50050, HL094463, HL096972, AI074775]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096972, R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050050, R21AI074775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI50050, HL094463, HL096972, and AI074775.	Aikawa J, 1999, J BIOL CHEM, V274, P2690, DOI 10.1074/jbc.274.5.2690; Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Chen M, 2006, BIOCHEMISTRY-US, V45, P12358, DOI 10.1021/bi060844g; Crawford BE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010691; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Duncan MB, 2006, BIOCHEM BIOPH RES CO, V339, P1232, DOI 10.1016/j.bbrc.2005.11.142; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; Forsberg E, 2001, J CLIN INVEST, V108, P175, DOI 10.1172/JCI13561; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Li JP, 2001, J BIOL CHEM, V276, P20069, DOI 10.1074/jbc.M011783200; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Pallerla SR, 2008, J BIOL CHEM, V283, P16885, DOI 10.1074/jbc.M709774200; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Rong JH, 2001, BIOCHEMISTRY-US, V40, P5548, DOI 10.1021/bi002926p; Saribas AS, 2004, GLYCOBIOLOGY, V14, P1217, DOI 10.1093/glycob/cwh129; Sigulinsky C, 2010, CARBOHYD RES, V345, P250, DOI 10.1016/j.carres.2009.10.024; Sismey-Ragatz AE, 2007, J BIOL CHEM, V282, P28321, DOI 10.1074/jbc.M701599200; Staples GO, 2010, J BIOL CHEM, V285, P18336, DOI 10.1074/jbc.M110.101592; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233	28	55	56	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19768	19776		10.1074/jbc.M111.224311	http://dx.doi.org/10.1074/jbc.M111.224311			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21454625	Green Published, hybrid			2022-12-27	WOS:000291027700059
J	Henderson, A; Erales, J; Hoyt, MA; Coffino, P				Henderson, Allen; Erales, Jenny; Hoyt, Martin A.; Coffino, Philip			Dependence of Proteasome Processing Rate on Substrate Unfolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							26 S PROTEASOME; MULTIUBIQUITIN-CHAIN-BINDING; ORNITHINE-DECARBOXYLASE; DIHYDROFOLATE-REDUCTASE; DEGRADATION MACHINE; SACCHAROMYCES-CEREVISIAE; MECHANICAL STABILITY; STRUCTURAL ELEMENTS; PROTEIN; CLPXP	Protein degradation by eukaryotic proteasomes is a multi-step process involving substrate recognition, ATP-dependent unfolding, translocation into the proteolytic core particle, and finally proteolysis. To date, most investigations of proteasome function have focused on the first and the last steps in this process. Here we examine the relationship between the stability of a folded protein domain and its degradation rate. Test proteins were targeted to the proteasome independently of ubiquitination by directly tethering them to the protease. Degradation kinetics were compared for test protein pairs whose stability was altered by either point mutation or ligand binding, but were otherwise identical. In both intact cells and in reactions using purified proteasomes and substrates, increased substrate stability led to an increase in substrate turnover time. The steady-state time for degradation ranged from similar to 5 min (dihydrofolate reductase) to 40 min (I27 domain of titin). ATP turnover was 110/min./proteasome, and was not markedly changed by substrate. Proteasomes engage tightly folded substrates in multiple iterative rounds of ATP hydrolysis, a process that can be rate-limiting for degradation.	[Henderson, Allen; Erales, Jenny; Hoyt, Martin A.; Coffino, Philip] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94127 USA	University of California System; University of California San Francisco	Coffino, P (corresponding author), 513 Parnassus Ave,Room S-430, San Francisco, CA 94143 USA.	Philip.Coffino@ucsf.edu		Coffino, Philip/0000-0003-0344-5083	National Institutes of Health [GM45335, GM074760, 5T32 CA09043]; NATIONAL CANCER INSTITUTE [T32CA009043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045335, R01GM074760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM45335 and GM074760 (to P. C.) and National Institutes of Health Training Grant 5T32 CA09043 (to A. H.).	Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034; Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028; Bajorek M, 2004, CELL MOL LIFE SCI, V61, P1579, DOI 10.1007/s00018-004-4131-y; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Chen H, 2002, J BIOL CHEM, V277, P45957, DOI 10.1074/jbc.M206799200; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fowler SB, 2001, STRUCTURE, V9, P355, DOI 10.1016/S0969-2126(01)00596-2; Fowler SB, 2002, J MOL BIOL, V322, P841, DOI 10.1016/S0022-2836(02)00805-7; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Hoffman L, 1996, J BIOL CHEM, V271, P32538, DOI 10.1074/jbc.271.51.32538; Hoskins JR, 2000, P NATL ACAD SCI USA, V97, P8892, DOI 10.1073/pnas.97.16.8892; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; Hoyt MA, 2003, J BIOL CHEM, V278, P12135, DOI 10.1074/jbc.M211802200; Hoyt MA, 2006, EMBO J, V25, P1720, DOI 10.1038/sj.emboj.7601058; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Klingenberg O, 1996, BIOCHEM J, V313, P647, DOI 10.1042/bj3130647; Koodathingal P, 2009, J BIOL CHEM, V284, P18674, DOI 10.1074/jbc.M900783200; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Li HB, 2000, P NATL ACAD SCI USA, V97, P6527, DOI 10.1073/pnas.120048697; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Li H, 2007, ORG BIOMOL CHEM, V5, P3399, DOI 10.1039/b710321m; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Salvador N, 2000, J BIOL CHEM, V275, P27447; Sears C, 1998, J BIOL CHEM, V273, P1409, DOI 10.1074/jbc.273.3.1409; Shin Y, 2009, P NATL ACAD SCI USA, V106, P19340, DOI 10.1073/pnas.0910484106; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Sone T, 2004, J BIOL CHEM, V279, P28807, DOI 10.1074/jbc.M403165200; Takeuchi J, 2008, BIOCHEM J, V410, P401, DOI 10.1042/BJ20071239; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2000, CELL, V101, P341, DOI 10.1016/S0092-8674(00)80843-0; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Zhang MS, 2004, J BIOL CHEM, V279, P20959, DOI 10.1074/jbc.M314043200; Zhang MS, 2004, J BIOL CHEM, V279, P8635, DOI 10.1074/jbc.M310449200	52	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17495	17502		10.1074/jbc.M110.212027	http://dx.doi.org/10.1074/jbc.M110.212027			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454622	Green Published, hybrid			2022-12-27	WOS:000290585200011
J	Le Pennec, S; Mirebeau-Prunier, D; Boutet-Bouzamondo, N; Jacques, C; Guillotin, D; Lauret, E; Houlgatte, R; Malthiery, Y; Savagner, F				Le Pennec, Soazig; Mirebeau-Prunier, Delphine; Boutet-Bouzamondo, Nathalie; Jacques, Caroline; Guillotin, Delphine; Lauret, Emilie; Houlgatte, Remi; Malthiery, Yves; Savagner, Frederique			Nitric Oxide and Calcium Participate in the Fine Regulation of Mitochondrial Biogenesis in Follicular Thyroid Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; PGC-1-RELATED COACTIVATOR; SKELETAL-MUSCLE; GAMMA COACTIVATOR-1-ALPHA; INDUCIBLE COACTIVATOR; RESPIRATORY-CHAIN; RECEPTOR-ALPHA; EXPRESSION; TRANSCRIPTION; SYNTHASE	Members of the peroxisome proliferator-activated receptor gamma coactivator-1 family (i.e. PGC-1 alpha, PGC-1 beta, and the PGC-1-related coactivator (PRC)) are key regulators of mitochondrial biogenesis and function. These regulators serve as mediators between environmental or endogenous signals and the transcriptional machinery governing mitochondrial biogenesis. The FTC-133 and RO82 W-1 follicular thyroid carcinoma cell lines, which present significantly different numbers of mitochondria, metabolic mechanisms, and expression levels of PRC and PGC-1 alpha, may employ retrograde signaling in response to respiratory dysfunction. Nitric oxide (NO) and calcium have been hypothesized to participate in this activity. We investigated the effects of the S-nitroso-N-acetyl-DL-penicillamine-NO donor, on the expression of genes involved in mitochondrial biogenesis and cellular metabolic functions in FTC-133 and RO82 W-1 cells by measuring lactate dehydrogenase and cytochrome c oxidase (COX) activities. We studied the action of ionomycin and 1,2-bis(2-aminophenoxy)ethane-N, N, N', N'-tetraacetic acid-acetoxymethyl ester (BAPTA/AM) (i.e. a calcium ionophore and a cytosolic calcium chelator) on whole genome expression and mitochondrial biogenesis in RO82 W-1 cells. COX activity and the dynamics of endoplasmic reticulum and mitochondrial networks were analyzed in regard to calcium-modulating treatments. In the FTC-133 and RO82 W-1 cells, the mitochondrial biogenesis induced by NO was mainly related to PRC expression as a retrograde mitochondrial signaling. Ionomycin diminished COX activity and negatively regulated PRC-mediated mitochondrial biogenesis in RO82 W-1 cells, whereas BAPTA/AM produced the opposite effects with a reorganization of the mitochondrial network. This is the first demonstration that NO and calcium regulate mitochondrial biogenesis through the PRC pathway in thyroid cell lines.	[Savagner, Frederique] CHU Angers, INSERM, UMR 694, Biochim Lab, F-49033 Angers, France; [Le Pennec, Soazig; Mirebeau-Prunier, Delphine; Jacques, Caroline; Guillotin, Delphine; Lauret, Emilie; Malthiery, Yves; Savagner, Frederique] Univ Angers, F-49033 Angers, France; [Houlgatte, Remi; Savagner, Frederique] Inst Thorax, INSERM, UMR915, F-44007 Nantes, France; [Houlgatte, Remi] Univ Nantes, F-44035 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite	Savagner, F (corresponding author), CHU Angers, INSERM, UMR 694, Biochim Lab, 4 Rue Larrey, F-49033 Angers, France.	frederique.savagner@univ-angers.fr	Prunier, Delphine/K-3301-2015; Houlgatte, Remi/P-3020-2017; LE PENNEC, Soazig/H-3817-2017	Guillotin, Delphine/0000-0002-2464-6848	Region Pays de la Loire (Ciblage Moleculare et Applications Therapeutiques)	Region Pays de la Loire (Ciblage Moleculare et Applications Therapeutiques)(Region Pays de la Loire)	This work was supported by grants from the Region Pays de la Loire (Ciblage Moleculare et Applications Therapeutiques).	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53; Bender E, 2000, FEBS LETT, V466, P130, DOI 10.1016/S0014-5793(99)01773-1; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Calderon-Cortes E, 2008, MITOCHONDRION, V8, P262, DOI 10.1016/j.mito.2008.04.005; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Freyssenet D, 2004, AM J PHYSIOL-CELL PH, V286, pC1053, DOI 10.1152/ajpcell.00418.2003; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Guha M, 2010, BBA-BIOENERGETICS, V1797, P1055, DOI 10.1016/j.bbabio.2010.02.008; HARRIS DA, 1991, BIOCHEM J, V280, P561, DOI 10.1042/bj2800561; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Lopez-Rios F, 2007, CANCER RES, V67, P9013, DOI 10.1158/0008-5472.CAN-07-1678; McConell GK, 2010, J APPL PHYSIOL, V108, P589, DOI 10.1152/japplphysiol.00377.2009; Mercy L, 2005, FEBS J, V272, P5031, DOI 10.1111/j.1742-4658.2005.04913.x; Mirebeau-Prunier D, 2010, FEBS J, V277, P713, DOI 10.1111/j.1742-4658.2009.07516.x; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; MORENOSANCHEZ R, 1985, J BIOL CHEM, V260, P2554; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Ojuka EO, 2003, FASEB J, V17, P675, DOI 10.1096/fj.02-0951com; Ojuka EO, 2002, AM J PHYSIOL-ENDOC M, V283, pE1040, DOI 10.1152/ajpendo.00242.2002; Papa S, 1996, FEBS LETT, V379, P299, DOI 10.1016/0014-5793(95)01532-9; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Raharijaona M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007964; Rustin P, 2004, METHOD ENZYMOL, V382, P81; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Soriano FX, 2006, DIABETES, V55, P1783, DOI 10.2337/db05-0509; Sumi D, 2003, P NATL ACAD SCI USA, V100, P14451, DOI 10.1073/pnas.2235590100; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vercauteren K, 2008, J BIOL CHEM, V283, P12102, DOI 10.1074/jbc.M710150200; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	38	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18229	18239		10.1074/jbc.M110.217521	http://dx.doi.org/10.1074/jbc.M110.217521			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454643	hybrid, Green Published			2022-12-27	WOS:000290585200083
J	Huang, H; Ishida, H; Yamniuk, AP; Vogel, HJ				Huang, Hao; Ishida, Hiroaki; Yamniuk, Aaron P.; Vogel, Hans J.			Solution Structures of Ca2+-CIB1 and Mg2+-CIB1 and Their Interactions with the Platelet Integrin alpha IIb Cytoplasmic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT PROTEINS; LIQUID-CRYSTALLINE PHASE; CALCIUM-BINDING PROTEIN; NMR-SPECTROSCOPY; CHEMICAL-SHIFT; EF-HAND; BIOLOGICAL MACROMOLECULES; CONFORMATIONAL-CHANGES; SECONDARY STRUCTURE; DIPOLAR COUPLINGS	The calcium-and integrin-binding protein 1 (CIB1) is a ubiquitous Ca2+-binding protein and a specific binding partner for the platelet integrin alpha IIb cytoplasmic domain, which confers the key role of CIB1 in hemostasis. CIB1 is also known to be involved in apoptosis, embryogenesis, and the DNA damage response. In this study, the solution structures of both Ca(2+)CIB1 and Mg2+-CIB1 were determined using solution-state NMR spectroscopy. The methyl groups of Ile, Leu, and Val were selectively protonated to compensate for the loss of protons due to deuteration. The solution structure of Ca2+-CIB1 possesses smaller opened EF-hands in its C-domain compared with available crystal structures. Ca2+-CIB1 and Mg2+-CIB1 have similar structures, but the N-lobe of Mg2+-CIB1 is slightly more opened than that of Ca2+-CIB1. Additional NMR experiments, such as chemical shift perturbation and methyl group solvent accessibility as measured by a nitroxide surface probe, were carried out to further characterize the structures of Ca2+-CIB1 and Mg2+-CIB1 as well as their interactions with the integrin alpha IIb cytoplasmic domain. NMR measurements of backbone amide proton slow motion (microsecond to millisecond) dynamics confirmed that the C-terminal helix of Ca2+-CIB1 is displaced upon alpha IIb binding. The EF-hand III of both Ca2+-CIB1 and Mg2+-CIB1 was identified to be directly involved in the interaction of CIB1 with alpha IIb. Together, these data illustrate that CIB1 behaves quite differently from related EF-hand regulatory calcium-binding proteins, such as calmodulin or neuronal calcium sensor proteins.	[Huang, Hao; Ishida, Hiroaki; Yamniuk, Aaron P.; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada	University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Biochem Res Grp, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca			Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported in part by the Canadian Institutes of Health Research.; Recipient of an Alberta Heritage Foundation for Medical Research Studentship award.; Recipient of a scientist award from the Alberta Heritage Foundation for Medical Research. To whom correspondence should be addressed: Dept. of Biological Sciences, University of Calgary, 2500 University Dr. NW, Calgary, Alberta T2N 1N4, Canada. Tel.: 403-220-6006; Fax: 403-289-9311; E-mail:vogel@ucalgary.ca.	BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Barry WT, 2002, J BIOL CHEM, V277, P28877, DOI 10.1074/jbc.M202983200; Blamey CJ, 2005, PROTEIN SCI, V14, P1214, DOI 10.1110/ps.041270805; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Chou JJ, 2000, J BIOMOL NMR, V18, P217, DOI 10.1023/A:1026563923774; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Das R, 2006, J AM CHEM SOC, V128, P8406, DOI 10.1021/ja060046d; DeNofrio JC, 2008, THROMB HAEMOSTASIS, V100, P847, DOI 10.1160/TH08-06-0351; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Heineke J, 2010, NAT MED, V16, P872, DOI 10.1038/nm.2181; HOWARTH JW, 1995, PROTEIN SCI, V4, P671; Huang H, 2010, PROTEIN SCI, V19, P475, DOI 10.1002/pro.325; Hwang PM, 2000, J MOL RECOGNIT, V13, P83, DOI 10.1002/(SICI)1099-1352(200003/04)13:2<83::AID-JMR491>3.0.CO;2-A; Ishida H, 2008, J BIOL CHEM, V283, P14619, DOI 10.1074/jbc.M801398200; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Kay LE, 2005, J MAGN RESON, V173, P193, DOI 10.1016/j.jmr.2004.11.021; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Leisner TM, 2007, CURR OPIN HEMATOL, V14, P255, DOI 10.1097/MOH.0b013e3280dce543; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; Li CM, 2009, J BIOL CHEM, V284, P2472, DOI 10.1074/jbc.M806513200; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Mulder FAA, 2000, BIOCHEMISTRY-US, V39, P12614, DOI 10.1021/bi001351t; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Ohki SY, 1997, BIOCHEMISTRY-US, V36, P4309, DOI 10.1021/bi962759m; Orban T, 2010, STRUCTURE, V18, P116, DOI 10.1016/j.str.2009.11.008; Ottiger M, 1998, J AM CHEM SOC, V120, P12334, DOI 10.1021/ja9826791; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Park CJ, 2005, NUCLEIC ACIDS RES, V33, P4172, DOI 10.1093/nar/gki736; Pennestri M, 2007, J BIOL CHEM, V282, P667, DOI 10.1074/jbc.M607016200; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; RICHARDS FM, 1988, PROTEINS, V3, P71, DOI 10.1002/prot.340030202; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Stabler SM, 1999, J CELL BIOL, V145, P1277, DOI 10.1083/jcb.145.6.1277; Tsuboi S, 2002, J BIOL CHEM, V277, P1919, DOI 10.1074/jbc.M110643200; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Weljie AM, 2003, PROTEIN SCI, V12, P228, DOI 10.1110/ps.0226203; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yamniuk AP, 2008, BIOCHEMISTRY-US, V47, P1696, DOI 10.1021/bi701494m; Yamniuk AP, 2007, BIOCHEMISTRY-US, V46, P7088, DOI 10.1021/bi700200z; Yamniuk AP, 2006, J BIOL CHEM, V281, P26455, DOI 10.1074/jbc.M603963200; Yamniuk AP, 2009, PROTEIN SCI, V18, P1128, DOI 10.1002/pro.104; Yamniuk AP, 2005, PROTEIN SCI, V14, P1429, DOI 10.1110/ps.041312805; Yamniuk AP, 2004, BIOCHEMISTRY-US, V43, P2558, DOI 10.1021/bi035432b; Yamniuk AP, 2006, CALCIUM BINDING PROT, V1, P150; Yang DW, 1999, J BIOMOL NMR, V14, P333, DOI 10.1023/A:1008314803561; Yang DW, 2004, J AM CHEM SOC, V126, P3710, DOI 10.1021/ja039102q; Yoon KW, 2009, P NATL ACAD SCI USA, V106, P17389, DOI 10.1073/pnas.0812259106; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	57	17	19	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17181	17192		10.1074/jbc.M110.179028	http://dx.doi.org/10.1074/jbc.M110.179028			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21388953	Green Published, hybrid			2022-12-27	WOS:000290301900067
J	Orban, T; Palczewska, G; Palczewski, K				Orban, Tivadar; Palczewska, Grazyna; Palczewski, Krzysztof			Retinyl Ester Storage Particles (Retinosomes) from the Retinal Pigmented Epithelium Resemble Lipid Droplets in Other Tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-RELATED PROTEIN; LEBER CONGENITAL AMAUROSIS; VISUAL CYCLE; ENDOPLASMIC-RETICULUM; MOUSE MODEL; VERTEBRATE RETINA; FATTY-ACID; CELLS; RPE65; ACYLTRANSFERASE	Levels of many hydrophobic cellular substances are tightly regulated because of their potential cytotoxicity. These compounds tend to self-aggregate in cytoplasmic storage depots termed lipid droplets/bodies that have well defined structures that contain additional components, including cholesterol and various proteins. Hydrophobic substances in these structures become mobilized in a specific and regulated manner as dictated by cellular requirements. Retinal pigmented epithelial cells in the eye produce retinyl ester-containing lipid droplets named retinosomes. These esters are mobilized to replenish the visual chromophore, 11-cis-retinal, and their storage ensures proper visual function despite fluctuations in dietary vitamin A intake. But it remains unclear whether retinosomes are structures specific to the eye or similar to lipid droplets in other organs/tissues that contain substances other than retinyl esters. Thus, we initially investigated the production of these lipid droplets in experimental cell lines expressing lecithin: retinol acyltransferase, a key enzyme involved in formation of retinyl ester-containing retinosomes from all-trans-retinol. We found that retinosomes and oleate-derived lipid droplets form and co-localize concomitantly, indicating their intrinsic structural similarities. Next, we isolated native retinosomes from bovine retinal pigmented epithelium and found that their protein and hydrophobic small molecular constituents were similar to those of lipid droplets reported for other experimental cell lines and tissues. These unexpected findings suggest a common mechanism for lipid droplet formation that exhibits broad chemical specificity for the hydrophobic substances being stored.	[Orban, Tivadar; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Palczewska, Grazyna] Polgenix Inc, Cleveland, OH 44106 USA	Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu			National Institutes of Health [EY009339, EY021126, EY020715, P30 EY11373]; State of Ohio Department of Development [09-004]; Klaus Tschira Foundation, Heidelberg, Germany; NATIONAL EYE INSTITUTE [P30EY011373, R01EY009339, R24EY021126, R43EY020715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Ohio Department of Development; Klaus Tschira Foundation, Heidelberg, Germany; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY009339, EY021126, EY020715, and P30 EY11373. This work was also supported by TECH 09-004 from the State of Ohio Department of Development and Third Frontier Commission, European Life Scientist Organization sponsored by the Klaus Tschira Foundation, Heidelberg, Germany.	Atshaves BP, 2000, J BIOL CHEM, V275, P36852, DOI 10.1074/jbc.M003434200; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Batten ML, 2005, PLOS MED, V2, P1177, DOI 10.1371/journal.pmed.0020333; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Beller M, 2010, FEBS LETT, V584, P2176, DOI 10.1016/j.febslet.2010.03.022; Bereta G, 2008, BIOCHEMISTRY-US, V47, P9856, DOI 10.1021/bi800905v; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Blouin CM, 2010, J LIPID RES, V51, P945, DOI 10.1194/jlr.M001016; BOK D, 1993, J CELL SCI, P189; Bozza PT, 2009, BBA-MOL CELL BIOL L, V1791, P540, DOI 10.1016/j.bbalip.2009.01.005; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; CHRISTIANSEN K, 1972, BIOCHIM BIOPHYS ACTA, V260, P449, DOI 10.1016/0005-2760(72)90060-4; CUSHMAN SW, 1970, J CELL BIOL, V46, P326, DOI 10.1083/jcb.46.2.326; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; FLANNERY JG, 1990, EXP EYE RES, V51, P717, DOI 10.1016/0014-4835(90)90057-2; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; Guo XJ, 2000, CARCINOGENESIS, V21, P1925, DOI 10.1093/carcin/21.11.1925; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; HENAULT MA, 1993, ANAT REC, V237, P466, DOI 10.1002/ar.1092370405; Imanishi Y, 2004, J CELL BIOL, V166, P447, DOI 10.1083/jcb.200405110; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Imanishi Y, 2008, J BIOL CHEM, V283, P25091, DOI 10.1074/jbc.M802981200; Imanishi Y, 2010, METHODS MOL BIOL, V652, P247, DOI 10.1007/978-1-60327-325-1_14; Jagerstrom S, 2009, CELL BIOL INT, V33, P934, DOI 10.1016/j.cellbi.2009.06.011; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang HF, 2007, BBA-MOL CELL BIOL L, V1771, P66, DOI 10.1016/j.bbalip.2006.10.004; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; KASURINEN J, 1992, BIOCHEM BIOPH RES CO, V187, P1594, DOI 10.1016/0006-291X(92)90485-4; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lieber JG, 1996, J CELL SCI, V109, P3047; Liu PS, 2007, BBA-MOL CELL RES, V1773, P784, DOI 10.1016/j.bbamcr.2007.02.004; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Maeda A, 2006, BIOCHEMISTRY-US, V45, P4210, DOI 10.1021/bi052382x; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; MCGOOKEY DJ, 1983, J CELL BIOL, V97, P1156, DOI 10.1083/jcb.97.4.1156; Moise AR, 2007, BIOCHEMISTRY-US, V46, P4449, DOI 10.1021/bi7003069; Moise AR, 2007, J BIOL CHEM, V282, P2081, DOI 10.1074/jbc.M608315200; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; MORIWAKI H, 1988, J LIPID RES, V29, P1523; Palczewska G, 2010, NAT MED, V16, P1444, DOI 10.1038/nm.2260; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Palczewski K, 2010, TRENDS PHARMACOL SCI, V31, P284, DOI 10.1016/j.tips.2010.03.001; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Rinia HA, 2008, BIOPHYS J, V95, P4908, DOI 10.1529/biophysj.108.137737; Robenek MJ, 2004, FASEB J, V18, P866, DOI 10.1096/fj.03-0782fje; Russell TD, 2008, J LIPID RES, V49, P206, DOI 10.1194/jlr.M700396-JLR200; SAARI JC, 1988, J BIOL CHEM, V263, P8084; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Uhlenhuth E, 1916, J EXP MED, V24, P689, DOI 10.1084/jem.24.6.689; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Van Hooser JP, 2002, J BIOL CHEM, V277, P19173, DOI 10.1074/jbc.M112384200; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; Wang HJ, 2010, MOL BIOL CELL, V21, P1991, DOI 10.1091/mbc.E09-05-0364; Wingerath T, 1997, ANAL CHEM, V69, P3855, DOI 10.1021/ac970463w; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Wongsiriroj N, 2008, J BIOL CHEM, V283, P13510, DOI 10.1074/jbc.M800777200; Wu CC, 2000, ELECTROPHORESIS, V21, P3470, DOI 10.1002/1522-2683(20001001)21:16<3470::AID-ELPS3470>3.3.CO;2-7; Xie XS, 2006, SCIENCE, V312, P228, DOI 10.1126/science.1127566; Yamaguchi T, 2009, BBA-MOL CELL BIOL L, V1791, P519, DOI 10.1016/j.bbalip.2008.10.012	82	57	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17248	17258		10.1074/jbc.M110.195198	http://dx.doi.org/10.1074/jbc.M110.195198			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454509	hybrid, Green Published			2022-12-27	WOS:000290301900073
J	Jara-Oseguera, A; Ishida, IG; Rangel-Yescas, GE; Espinosa-Jalapa, N; Perez-Guzman, JA; Elias-Vinas, D; Le Lagadec, R; Rosenbaum, T; Islas, LD				Jara-Oseguera, Andres; Ishida, Itzel G.; Rangel-Yescas, Gisela E.; Espinosa-Jalapa, Noel; Perez-Guzman, Jose A.; Elias-Vinas, David; Le Lagadec, Ronan; Rosenbaum, Tamara; Islas, Leon D.			Uncoupling Charge Movement from Channel Opening in Voltage-gated Potassium Channels by Ruthenium Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAKER K+ CHANNELS; GATING CURRENTS; CARBON-MONOXIDE; ION CHANNELS; ACTIVATION PATHWAY; SENSING DOMAINS; S4-S5 LINKER; PORE DOMAINS; KV CHANNELS; S5 SEGMENT	The Kv2.1 channel generates a delayed-rectifier current in neurons and is responsible for modulation of neuronal spike frequency and membrane repolarization in pancreatic beta-cells and cardiomyocytes. As with other tetrameric voltage-activated K+-channels, it has been proposed that each of the four Kv2.1 voltage-sensing domains activates independently upon depolarization, leading to a final concerted transition that causes channel opening. The mechanism by which voltage-sensor activation is coupled to the gating of the pore is still not understood. Here we show that the carbon-monoxide releasing molecule 2 (CORM-2) is an allosteric inhibitor of the Kv2.1 channel and that its inhibitory properties derive from the CORM-2 ability to largely reduce the voltage dependence of the opening transition, uncoupling voltage-sensor activation from the concerted opening transition. We additionally demonstrate that CORM-2 modulates Shaker K+-channels in a similar manner. Our data suggest that the mechanism of inhibition by CORM-2 may be common to voltage-activated channels and that this compound should be a useful tool for understanding the mechanisms of electromechanical coupling.	[Jara-Oseguera, Andres; Ishida, Itzel G.; Rangel-Yescas, Gisela E.; Islas, Leon D.] Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Mexico City 04510, DF, Mexico; [Espinosa-Jalapa, Noel; Le Lagadec, Ronan] Univ Nacl Autonoma Mexico, Inst Quim, Dept Quim Inorgan, Mexico City 04510, DF, Mexico; [Perez-Guzman, Jose A.; Elias-Vinas, David] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Dept Neurodesarrollo & Fisiol, Mexico City 04510, DF, Mexico; [Rosenbaum, Tamara] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Secc Bioelect, Dept Ingn Elect, Mexico City 07360, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Islas, LD (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Mexico City 04510, DF, Mexico.	islas@liceaga.facmed.unam.mx	Le Lagadec, Ronan/J-4035-2015; Islas, Leon D/AAW-9845-2020; Le Lagadec, Ronan/ABE-6445-2020	Le Lagadec, Ronan/0000-0002-5679-2081; Islas, Leon D/0000-0002-7461-5214; Rangel-Yescas, Gisela Edith/0000-0003-2766-6040; Rosenbaum, Tamara/0000-0002-4791-3195; Espinosa Jalapa, Noel Angel/0000-0003-2425-2707; Jara Oseguera, Andres/0000-0001-5921-9320	Consejo Nacional de Ciencia y Tecnologia [48990]; Direccion General de Asuntos del Personal Academico-PAPIIT [IN209209]; Instituto de Ciencia y Tecnologia del Distrito Federal [PIFUTP09-262]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico-PAPIIT; Instituto de Ciencia y Tecnologia del Distrito Federal	This study was supported by Consejo Nacional de Ciencia y Tecnologia Grant 48990, Direccion General de Asuntos del Personal Academico-PAPIIT Grant IN209209, and Instituto de Ciencia y Tecnologia del Distrito Federal Grant PIFUTP09-262 (to L. D. I.).	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; ALESSIO E, 1995, INORG CHEM, V34, P4722, DOI 10.1021/ic00123a004; ALESSIO E, 1988, INORG CHEM, V27, P4099, DOI 10.1021/ic00296a006; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Armstrong CM, 2001, BIOPHYS J, V81, P895, DOI 10.1016/S0006-3495(01)75749-9; Bezanilla F, 2005, IEEE T NANOBIOSCI, V4, P34, DOI 10.1109/TNB.2004.842463; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Brindell M, 2007, EUR J INORG CHEM, P2353, DOI 10.1002/ejic.200600987; Caprini M, 2005, J BIOL CHEM, V280, P18253, DOI 10.1074/jbc.M413389200; Claydon TW, 2007, J PHARMACOL EXP THER, V320, P162, DOI 10.1124/jpet.106.110411; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; EVANS IP, 1973, J CHEM SOC DALTON, P204, DOI 10.1039/dt9730000204; GOLDIN AL, 1992, METHOD ENZYMOL, V207, P266; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Holmgren M, 1996, J GEN PHYSIOL, V108, P195, DOI 10.1085/jgp.108.3.195; Hou SW, 2008, P NATL ACAD SCI USA, V105, P4039, DOI 10.1073/pnas.0800304105; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Kanevsky M, 1999, J GEN PHYSIOL, V114, P215, DOI 10.1085/jgp.114.2.215; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048; Lai HC, 2005, NEURON, V47, P395, DOI 10.1016/j.neuron.2005.06.019; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; LOPATIN AN, 1994, J GEN PHYSIOL, V103, P203, DOI 10.1085/jgp.103.2.203; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Muroi Y, 2009, J GEN PHYSIOL, V133, P1, DOI 10.1085/jgp.200810103; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; PEROZO E, 1992, BIOPHYS J, V62, P160, DOI 10.1016/S0006-3495(92)81802-7; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; Roux B, 2006, NEURON, V52, P568, DOI 10.1016/j.neuron.2006.11.002; Sack JT, 2006, J GEN PHYSIOL, V128, P119, DOI 10.1085/jgp.200609492; Sakmann B., 1995, SINGLE CHANNEL RECOR, P483; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Scholle A, 2004, J MEMBRANE BIOL, V198, P103, DOI 10.1007/s00232-004-0664-0; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SHAO XM, 1993, NEURON, V11, P343, DOI 10.1016/0896-6273(93)90189-X; Shieh CC, 1997, J GEN PHYSIOL, V109, P767, DOI 10.1085/jgp.109.6.767; SIGG D, 1994, BIOPHYS J, V66, pA136; SIGWORTH FJ, 1992, METHOD ENZYMOL, V207, P746; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Sigworth FJ, 2007, BIOPHYS J, V93, P2981, DOI 10.1529/biophysj.107.115741; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; Sukhareva M, 2003, J GEN PHYSIOL, V122, P541, DOI 10.1085/jgp.200308905; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; TAGLIALATELA M, 1993, P NATL ACAD SCI USA, V90, P4758, DOI 10.1073/pnas.90.10.4758; Tao X, 2008, J MOL BIOL, V382, P24, DOI 10.1016/j.jmb.2008.06.085; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Wilkinson WJ, 2009, BRIT J PHARMACOL, V158, P862, DOI 10.1111/j.1476-5381.2009.00354.x; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Yang YS, 2004, J GEN PHYSIOL, V124, P163, DOI 10.1085/jgp.200409057; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	72	24	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.198010	http://dx.doi.org/10.1074/jbc.M110.198010			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454671	Green Published, hybrid			2022-12-27	WOS:000290022800079
J	Qi, TY; Tang, W; Wang, L; Zhai, L; Guo, LJ; Zeng, XL				Qi, Tianyang; Tang, Wen; Wang, Ling; Zhai, Lei; Guo, Lijing; Zeng, Xianlu			G-actin Participates in RNA Polymerase II-dependent Transcription Elongation by Recruiting Positive Transcription Elongation Factor b (P-TEFb)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROMODOMAIN PROTEIN BRD4; C-TERMINAL DOMAIN; NUCLEAR ACTIN; GENE-EXPRESSION; CDK9/CYCLIN T1; BETA-ACTIN; HIV-1 TAT; 7SK SNRNA; MYOSIN-I; HNRNP-U	Actin is a key regulator of RNA polymerase (Pol) II-dependent transcription. Positive transcription elongation factor b (P-TEFb), a Cdk9/cyclin T1 heterodimer, has been reported to play a critical role in transcription elongation. However, the relationship between actin and P-TEFb is still not clear. In this study, actin was found to interact with Cdk9, a catalytic subunit of P-TEFb, in elongation complexes. Using immunofluorescence and immunoprecipitation assays, Cdk9 was found to bind to G-actin through the conserved Thr-186 in the T-loop. Overexpression and in vitro kinase assays showed that G-actin promotes P-TEFb-dependent phosphorylation of the Pol II C-terminal domain. An in vitro transcription experiment revealed that the interaction between G-actin and Cdk9 stimulated Pol II transcription elongation. ChIP and immobilized template assays indicated that actin recruited Cdk9 to a transcriptional template in vivo and in vitro. Using cytokine IL-6-inducible p21 gene expression system, we revealed that actin recruited Cdk9 to endogenous gene. Moreover, overexpression of actin and Cdk9 increased histone H3 acetylation and acetylized histone H3 binding to a transcriptional template through the interaction with histone acetyltransferase, p300. Taken together, our results suggested that actin participates in transcription elongation by recruiting Cdk9 for phosphorylation of the Pol II C-terminal domain, and the actin-Cdk9 interaction promotes chromatin remodeling.	[Zeng, Xianlu] NE Normal Univ, Key Lab Mol Epigenet MOE, Changchun 130024, Jilin, Peoples R China; NE Normal Univ, Inst Cytol & Genet, Changchun 130024, Jilin, Peoples R China	Northeast Normal University - China; Northeast Normal University - China	Zeng, XL (corresponding author), NE Normal Univ, Key Lab Mol Epigenet MOE, Changchun 130024, Jilin, Peoples R China.	zengx779@nenu.edu.cn	Zhai, Lei/AAJ-1301-2020	Zhai, Lei/0000-0002-3886-2154	National Basic Research Program of China [2005CB522404]; National Natural Science Foundation of China [90608021]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (Grant 2005CB522404) and the National Natural Science Foundation of China (Grant 90608021).	Arndt KM, 2003, TRENDS GENET, V19, P543, DOI 10.1016/j.tig.2003.08.008; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen RC, 2004, J BIOL CHEM, V279, P4153, DOI 10.1074/jbc.M310044200; Choi CH, 2003, NATURE, V424, P965, DOI 10.1038/nature01899; CORDEN JL, 1990, TRENDS BIOCHEM SCI, V15, P383, DOI 10.1016/0968-0004(90)90236-5; Dvir A, 1997, P NATL ACAD SCI USA, V94, P9006, DOI 10.1073/pnas.94.17.9006; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; Fong YW, 2000, MOL CELL BIOL, V20, P5897, DOI 10.1128/MCB.20.16.5897-5907.2000; Grummt I, 2006, CURR OPIN GENET DEV, V16, P191, DOI 10.1016/j.gde.2006.02.001; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Hu P, 2004, GENE DEV, V18, P3010, DOI 10.1101/gad.1250804; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jockusch BM, 2006, TRENDS CELL BIOL, V16, P391, DOI 10.1016/j.tcb.2006.06.006; Jones KA, 1997, GENE DEV, V11, P2593, DOI 10.1101/gad.11.20.2593; Kameoka S, 2004, EMBO J, V23, P1782, DOI 10.1038/sj.emboj.7600187; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Mayeda A, 1999, METH MOL B, V118, P309; McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101; Mellor J, 2005, MOL CELL, V19, P147, DOI 10.1016/j.molcel.2005.06.023; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Obrdlik A, 2008, MOL CELL BIOL, V28, P6342, DOI 10.1128/MCB.00766-08; OBRIEN T, 1994, NATURE, V370, P75, DOI 10.1038/370075a0; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pederson T, 2002, J STRUCT BIOL, V140, P3, DOI 10.1016/S1047-8477(02)00528-2; Percipalle P, 2006, J CELL BIOL, V172, P967, DOI 10.1083/jcb.200512083; Percipalle P, 2003, P NATL ACAD SCI USA, V100, P6475, DOI 10.1073/pnas.1131933100; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Simone C, 2002, ONCOGENE, V21, P4158, DOI 10.1038/sj.onc.1205511; Sjolinder M, 2005, GENE DEV, V19, P1871, DOI 10.1101/gad.339405; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; Sunagawa Y, 2010, J BIOL CHEM, V285, P9556, DOI 10.1074/jbc.M109.070458; Vieu E, 2006, NAT CELL BIOL, V8, P650, DOI 10.1038/ncb0706-650; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Ye J, 2008, GENE DEV, V22, P322, DOI 10.1101/gad.455908; Yik JHN, 2004, MOL CELL BIOL, V24, P5094, DOI 10.1128/MCB.24.12.5094-5105.2004; Yoo YD, 2007, J BIOL CHEM, V282, P7616, DOI 10.1074/jbc.M607596200; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5; ZHOU QA, 1995, EMBO J, V14, P321, DOI 10.1002/j.1460-2075.1995.tb07006.x	53	40	40	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15171	15181		10.1074/jbc.M110.184374	http://dx.doi.org/10.1074/jbc.M110.184374			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21378166	Green Published, hybrid			2022-12-27	WOS:000289788300049
J	Vial, C; Gutierrez, J; Santander, C; Cabrera, D; Brandan, E				Vial, Cecilia; Gutierrez, Jaime; Santander, Cristian; Cabrera, Daniel; Brandan, Enrique			Decorin Interacts with Connective Tissue Growth Factor (CTGF)/CCN2 by LRR12 Inhibiting Its Biological Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE DIFFERENTIATION; DERMATAN SULFATE PROTEOGLYCAN; MESSENGER-RNA EXPRESSION; HEPATIC STELLATE CELLS; FACTOR GENE-EXPRESSION; FACTOR-BETA; TGF-BETA; LUNG FIBROSIS; TRANSFORMING GROWTH-FACTOR-BETA-1	Fibrotic disorders are the end point of many chronic diseases in different tissues, where an accumulation of the extracellular matrix occurs, mainly because of the action of the connective tissue growth factor (CTGF/CCN2). Little is known about how this growth factor activity is regulated. We found that decorin null myoblasts are more sensitive to CTGF than wild type myoblasts, as evaluated by the accumulation of fibronectin or collagen III. Decorin added exogenously negatively regulated CTGF pro-fibrotic activity and the induction of actin stress fibers. Using co-immunoprecipitation and in vitro interaction assays, decorin and CTGF were shown to interact in a saturable manner with a K-d of 4.4 nM. This interaction requires the core protein of decorin. Experiments using the deletion mutant decorin indicated that the leucine-rich repeats (LRR) 10-12 are important for the interaction with CTGF and the negative regulation of the cytokine activity, moreover, a peptide derived from the LRR12 was able to inhibit CTGF-decorin complex formation and CTGF activity. Finally, we showed that CTGF specifically induced the synthesis of decorin, suggesting a mechanism of autoregulation. These results suggest that decorin interacts with CTGF and regulates its biological activity.	[Vial, Cecilia; Gutierrez, Jaime; Santander, Cristian; Cabrera, Daniel; Brandan, Enrique] Pontificia Univ Catolica Chile, Ctr Regulac Celular & Patol, Ctr Regenerac & Envejecimiento, Dept Biol Celular & Mol,MIFAB, Santiago, Chile	Pontificia Universidad Catolica de Chile	Brandan, E (corresponding author), Pontificia Univ Catolica Chile, Ctr Regulac Celular & Patol, Ctr Regenerac & Envejecimiento, Dept Biol Celular & Mol,MIFAB, Casilla 114-D, Santiago, Chile.	ebrandan@bio.puc.cl	CABRERA, DANIEL/AAR-5027-2020; Vial, Maria Cecilia/GVS-4266-2022; Brandan, Enrique/A-7063-2017	CABRERA, DANIEL/0000-0001-9634-725X; Vial, Cecilia/0000-0002-0399-6144; Brandan, Enrique/0000-0002-6820-5059	FONDAP-Biomedicine [13980001]; CARE [PFB12/2007]; FONDECYT [103193, 21050032, MDA 89419]; Fundacion Chilena para Biologia Celular Proyecto [MF-100]	FONDAP-Biomedicine(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); CARE; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fundacion Chilena para Biologia Celular Proyecto	This work was supported by Research Grants FONDAP-Biomedicine 13980001, CARE PFB12/2007, FONDECYT 103193 (to C. V.) and 21050032 (to J. G.), MDA 89419, and Fundacion Chilena para Biologia Celular Proyecto MF-100.	Abraham D, 2008, RHEUMATOLOGY, V47, pV8, DOI 10.1093/rheumatology/ken278; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Alvarez K, 2002, J CELL BIOCHEM, V85, P703, DOI 10.1002/jcb.10184; Bernasconi P, 1999, NEUROMUSCULAR DISORD, V9, P28, DOI 10.1016/S0960-8966(98)00093-5; BOLSTER MB, 1993, BAILLIERE CLIN RHEUM, V7, P79, DOI 10.1016/S0950-3579(05)80269-9; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; BRANDAN E, 1991, EUR J CELL BIOL, V55, P209; BRANDAN E, 1992, J NEUROSCI RES, V32, P51, DOI 10.1002/jnr.490320107; Brandan E, 2006, J BIOL CHEM, V281, P31562, DOI 10.1074/jbc.M602919200; Brandan E, 2008, MATRIX BIOL, V27, P700, DOI 10.1016/j.matbio.2008.07.004; Caceres S, 2000, EUR J CELL BIOL, V79, P173, DOI 10.1078/S0171-9335(04)70020-5; Casar JC, 2004, DEV BIOL, V268, P358, DOI 10.1016/j.ydbio.2003.12.025; Chen YL, 2004, MOL BIOL CELL, V15, P5635, DOI 10.1091/mbc.E04-06-0490; Cicha I, 2009, BIOFACTORS, V35, P200, DOI 10.1002/biof.30; Cossu G, 2007, TRENDS MOL MED, V13, P520, DOI 10.1016/j.molmed.2007.10.003; Costacurta A, 2002, J CLIN LAB ANAL, V16, P178, DOI 10.1002/jcla.10038; De Winter P, 2008, GROWTH FACTORS, V26, P80, DOI 10.1080/08977190802025602; Denton CP, 2001, CURR OPIN RHEUMATOL, V13, P505, DOI 10.1097/00002281-200111000-00010; Droguett R, 2006, MATRIX BIOL, V25, P332, DOI 10.1016/j.matbio.2006.04.004; Droppelmann CA, 2009, J BIOL CHEM, V284, P13551, DOI 10.1074/jbc.M807352200; Fadic R, 2006, J CELL MOL MED, V10, P758, DOI 10.1111/j.1582-4934.2006.tb00435.x; Faust SM, 2009, J IMMUNOL, V183, P7307, DOI 10.4049/jimmunol.0902736; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852; Giri SN, 2003, ANNU REV PHARMACOL, V43, P73, DOI 10.1146/annurev.pharmtox.43.100901.135740; Giri SN, 1997, BIOCHEM PHARMACOL, V54, P1205, DOI 10.1016/S0006-2952(97)00343-2; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; IGARASHI A, 1995, J INVEST DERMATOL, V105, P280, DOI 10.1111/1523-1747.ep12318465; Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Jedsadayanmata A, 1999, J BIOL CHEM, V274, P24321, DOI 10.1074/jbc.274.34.24321; Kireeva ML, 1997, EXP CELL RES, V233, P63, DOI 10.1006/excr.1997.3548; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; Larrain J, 2000, DEVELOPMENT, V127, P821; Lasky JA, 1998, AM J PHYSIOL-LUNG C, V275, pL365, DOI 10.1152/ajplung.1998.275.2.L365; Leask A, 2004, J INVEST DERMATOL, V122, P1, DOI 10.1046/j.0022-202X.2003.22133.x; Leask A, 2007, CARDIOVASC RES, V74, P207, DOI 10.1016/j.cardiores.2006.07.012; Leask Andrew, 2009, Front Biosci (Elite Ed), V1, P115; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Li Y, 2007, MOL THER, V15, P1616, DOI 10.1038/sj.mt.6300250; Lopez-Casillas F, 2003, J BIOL CHEM, V278, P382, DOI 10.1074/jbc.M208520200; Miyazono K, 2000, J CELL SCI, V113, P1101; Nguyen TQ, 2008, J AM SOC NEPHROL, V19, P2098, DOI 10.1681/ASN.2007111261; Nishida T, 2000, J CELL PHYSIOL, V184, P197, DOI 10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R; Paradis V, 2002, LAB INVEST, V82, P767, DOI 10.1097/01.LAB.0000017365.18894.D3; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Ramamurthy P, 1996, J BIOL CHEM, V271, P19578, DOI 10.1074/jbc.271.32.19578; RAMPOLDI E, 1986, EUR J CELL BIOL, V42, P27; Riquelme C, 2001, J BIOL CHEM, V276, P3589, DOI 10.1074/jbc.M004602200; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; SCHMIDT G, 1991, BIOCHEM J, V280, P411, DOI 10.1042/bj2800411; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Schonherr E, 1998, ARCH BIOCHEM BIOPHYS, V355, P241, DOI 10.1006/abbi.1998.0720; SCHWARZ K, 1990, J BIOL CHEM, V265, P22023; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Segarini PR, 2001, J BIOL CHEM, V276, P40659, DOI 10.1074/jbc.M105180200; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Sun G, 2008, J NEUROL SCI, V267, P48, DOI 10.1016/j.jns.2007.09.043; SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712; Vial C, 2008, J CELL PHYSIOL, V215, P410, DOI 10.1002/jcp.21324; Weber IT, 1996, J BIOL CHEM, V271, P31767, DOI 10.1074/jbc.271.50.31767; Wickert L, 2002, BIOCHEM BIOPH RES CO, V295, P330, DOI 10.1016/S0006-291X(02)00669-1; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Zhu J, 2007, J BIOL CHEM, V282, P25852, DOI 10.1074/jbc.M704146200; ZIYADEH FN, 1993, AM J KIDNEY DIS, V22, P736, DOI 10.1016/S0272-6386(12)80440-9	74	85	88	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24242	24252		10.1074/jbc.M110.189365	http://dx.doi.org/10.1074/jbc.M110.189365			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21454550	hybrid, Green Published			2022-12-27	WOS:000292294900066
J	He, J; Scott, JL; Heroux, A; Roy, S; Lenoir, M; Overduin, M; Stahelin, RV; Kutateladze, TG				He, Ju; Scott, Jordan L.; Heroux, Annie; Roy, Siddhartha; Lenoir, Marc; Overduin, Michael; Stahelin, Robert V.; Kutateladze, Tatiana G.			Molecular Basis of Phosphatidylinositol 4-Phosphate and ARF1 GTPase Recognition by the FAPP1 Pleckstrin Homology (PH) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; FYVE DOMAIN; MEMBRANE; BINDING; PROTEINS; ACIDIFICATION; PTDINS(4)P; MECHANISM; APOPTOSIS; SOFTWARE	Four-phosphate-adaptor protein 1 (FAPP1) regulates secretory transport from the trans-Golgi network (TGN) to the plasma membrane. FAPP1 is recruited to the Golgi through binding of its pleckstrin homology (PH) domain to phosphatidylinositol 4-phosphate (PtdIns(4) P) and a small GTPase ADP-ribosylation factor 1 (ARF1). Despite the critical role of FAPP1 in membrane trafficking, the molecular basis of its dual function remains unclear. Here, we report a 1.9 angstrom resolution crystal structure of the FAPP1 PH domain and detail the molecular mechanisms of the PtdIns(4) P and ARF1 recognition. The FAPP1 PH domain folds into a seven-stranded beta-barrel capped by an beta-helix at one edge, whereas the opposite edge is flanked by three loops and the beta 4 and beta 7 strands that form a lipid-binding pocket within the beta-barrel. The ARF1-binding site is located on the outer side of the beta-barrel as determined by NMR resonance perturbation analysis, mutagenesis, and measurements of binding affinities. The two binding sites have little overlap, allowing FAPP1 PH to associate with both ligands simultaneously and independently. Binding to PtdIns(4) P is enhanced in an acidic environment and is required for membrane penetration and tubulation activity of FAPP1, whereas the GTP-bound conformation of the GTPase is necessary for the interaction with ARF1. Together, these findings provide structural and biochemical insight into the multivalent membrane anchoring by the PH domain that may augment affinity and selectivity of FAPP1 toward the TGN membranes enriched in both PtdIns(4) P and GTP-bound ARF1.	[Scott, Jordan L.; Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [He, Ju; Roy, Siddhartha; Kutateladze, Tatiana G.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Scott, Jordan L.; Stahelin, Robert V.] Univ Notre Dame, Walther Ctr Canc Res, Notre Dame, IN 46556 USA; [Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Heroux, Annie] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Lenoir, Marc; Overduin, Michael] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England	University of Notre Dame; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Notre Dame; Walther Cancer Institute; Indiana University System; Indiana University South Bend; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Birmingham	Stahelin, RV (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	rstaheli@iupui.edu; Tatiana.Kutateladze@ucdenver.edu	Overduin, Michael/AAG-3632-2020; Stahelin, Robert/L-3567-2019	Overduin, Michael/0000-0002-3114-6585; Kutateladze, Tatiana/0000-0001-7375-6990; Stahelin, Robert/0000-0001-5443-7863; Lenoir, Marc/0000-0001-7410-2323	National Institutes of Health [GM071424, CA95144]; American Heart Association; Indiana University Biomedical Research; American Cancer Society; Cancer Research UK; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health [P41RR012408]; Biotechnology and Biological Sciences Research Council [BBS/B/10714] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA095144] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075762, R01GM071424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Indiana University Biomedical Research; American Cancer Society(American Cancer Society); Cancer Research UK(Cancer Research UK); Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM071424 and CA95144 and the American Heart Association (to T. G. K.). This work was also supported by grants from Indiana University Biomedical Research and the American Cancer Society (to R. V. S.) and Cancer Research UK (to M. O.).; We thank Y. Gedle, M. Lemmon, C. Musselman, E. Odintsova, and R. Zhao for discussions and helping with experiments and R. Prekeris and S. Wakatsuki for providing cDNAs of wild type and ARF1 Q71L. X-ray crystallographic data were collected at beamline X25 of the NSLS. Financial support for NSLS comes from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and from the National Center for Research Resources of the National Institutes of Health (Grant P41RR012408).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Bunney TD, 2009, MOL CELL, V34, P223, DOI 10.1016/j.molcel.2009.02.023; Cao XW, 2009, P NATL ACAD SCI USA, V106, P21121, DOI 10.1073/pnas.0911789106; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Donaldson Julie G, 2008, Biochem J, V414, pe1, DOI 10.1042/BJ20081438; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; GOTTLIEB RA, 1995, P NATL ACAD SCI USA, V92, P5965, DOI 10.1073/pnas.92.13.5965; He J, 2008, J LIPID RES, V49, P1807, DOI 10.1194/jlr.M800150-JLR200; He J, 2009, PROTEINS, V76, P852, DOI 10.1002/prot.22392; Hom RA, 2007, J MOL BIOL, V373, P412, DOI 10.1016/j.jmb.2007.08.016; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Lee SA, 2006, J BIOL CHEM, V281, P37091, DOI 10.1074/jbc.M608610200; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lenoir M, 2010, EMBO REP, V11, P279, DOI 10.1038/embor.2010.28; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Menetrey J, 2007, EMBO J, V26, P1953, DOI 10.1038/sj.emboj.7601634; MOOLENAAR WH, 1983, NATURE, V304, P645, DOI 10.1038/304645a0; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; SCHULDINER S, 1982, P NATL ACAD SCI-BIOL, V79, P7778, DOI 10.1073/pnas.79.24.7778; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Thangaraju M, 1999, J BIOL CHEM, V274, P29549, DOI 10.1074/jbc.274.41.29549; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; ZEUZEM S, 1992, P NATL ACAD SCI USA, V89, P6619, DOI 10.1073/pnas.89.14.6619	38	62	64	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18650	18657		10.1074/jbc.M111.233015	http://dx.doi.org/10.1074/jbc.M111.233015			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454700	Green Published, hybrid			2022-12-27	WOS:000290785700037
J	Radu, RA; Hu, J; Yuan, Q; Welch, DL; Makshanoff, J; Lloyd, M; McMullen, S; Travis, GH; Bok, D				Radu, Roxana A.; Hu, Jane; Yuan, Quan; Welch, Darcy L.; Makshanoff, Jacob; Lloyd, Marcia; McMullen, Stephen; Travis, Gabriel H.; Bok, Dean			Complement System Dysregulation and Inflammation in the Retinal Pigment Epithelium of a Mouse Model for Stargardt Macular Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-H POLYMORPHISM; C-REACTIVE PROTEIN; OXIDATIVE DAMAGE; HUMAN-DISEASE; RIM PROTEIN; LIPOFUSCIN; A2E; ABCR; RISK; GENE	Accumulation of vitamin A-derived lipofuscin fluorophores in the retinal pigment epithelium (RPE) is a pathologic feature of recessive Stargardt macular dystrophy, a blinding disease caused by dysfunction or loss of the ABCA4 transporter in rods and cones. Age-related macular degeneration, a prevalent blinding disease of the elderly, is strongly associated with mutations in the genes for complement regulatory proteins (CRP), causing chronic inflammation of the RPE. Here we explore the possible relationship between lipofuscin accumulation and complement activation in vivo. Using the abca4(-/-) mouse model for recessive Stargardt, we investigated the role of lipofuscin fluorophores (A2E-lipofuscin) on oxidative stress and complement activation. We observed higher expression of oxidative-stress genes and elevated products of lipid peroxidation in eyes from abca4(-/-) versus wild-type mice. We also observed higher levels of complement-activation products in abca4(-/-) RPE cells. Unexpectedly, expression of multiple CRPs, which protect cells from attack by the complement system, were lower in abca4(-/-) versus wildtype RPE. To test whether acute exposure of healthy RPE cells to A2E-lipofuscin affects oxidative stress and expression of CRPs, we fed cultured fetal-derived human RPE cells with rod outer segments from wild-type or abca4(-/-) retinas. In contrast to RPE cells in abca4(-/-) mice, human RPE cells exposed to abca4(-/-) rod outer segments adaptively increased expression of both oxidative-stress and CRP genes. These results suggest that A2E accumulation causes oxidative stress, complement activation, and down-regulation of protective CRP in the Stargardt mouse model. Thus, Stargardt disease and age-related macular degeneration may both be caused by chronic inflammation of the RPE.	[Radu, Roxana A.; Hu, Jane; Yuan, Quan; Welch, Darcy L.; Makshanoff, Jacob; Lloyd, Marcia; McMullen, Stephen; Travis, Gabriel H.; Bok, Dean] Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Bok, Dean] Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Bok, Dean] Univ Calif Los Angeles, Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Radu, RA (corresponding author), Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Dept Ophthalmol, 100 Stein Plaza, Los Angeles, CA 90095 USA.	radu@jsei.ucla.edu	yuan, quan/GZM-5597-2022; Radu, Roxana A./K-8924-2019; Travis, Gabriel Harvey/AIF-1062-2022	Travis, Gabriel Harvey/0000-0003-4020-9493; Radu, Roxana/0000-0002-5064-6403	National Institutes of Health [EY00331, R24 EY017404]; American Health Assistance Foundation; Macula Vision Research Foundation; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R01EY011713, R24EY017404, P30EY000331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation; Macula Vision Research Foundation; Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY00331 (NEI; to D. B.) and R24 EY017404. This work was also supported by grants from the American Health Assistance Foundation (to R. A. R.), the Macula Vision Research Foundation (to D. B. and G. H. T.), and the Foundation Fighting Blindness (to D. B. and G. H. T.).	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Avalle LB, 2004, EXP EYE RES, V78, P895, DOI 10.1016/j.exer.2003.10.023; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bither P P, 1988, J Am Optom Assoc, V59, P106; Booij JC, 2010, PROG RETIN EYE RES, V29, P1, DOI 10.1016/j.preteyeres.2009.08.003; Boon CJF, 2008, VISION RES, V48, P2569, DOI 10.1016/j.visres.2008.01.010; Cideciyan AV, 2004, HUM MOL GENET, V13, P525, DOI 10.1093/hmg/ddh048; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P2327; Dillon J, 2004, EXP EYE RES, V79, P537, DOI 10.1016/j.exer.2004.06.024; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hecker LA, 2010, HUM MOL GENET, V19, P209, DOI 10.1093/hmg/ddp472; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hu J, 2001, MOL VIS, V7, P14; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Johnson PT, 2006, P NATL ACAD SCI USA, V103, P17456, DOI 10.1073/pnas.0606234103; Kapphahn RJ, 2006, EXP EYE RES, V83, P165, DOI 10.1016/j.exer.2005.11.017; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kurth I, 2007, MOL CELL BIOL, V27, P1370, DOI 10.1128/MCB.01486-06; LI B, 1993, J IMMUNOL, V151, P4295; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Maugeri A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079; Okubo A, 1999, INVEST OPHTH VIS SCI, V40, P443; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Radu RA, 2004, P NATL ACAD SCI USA, V101, P5928, DOI 10.1073/pnas.0308302101; Radu RA, 2008, INVEST OPHTH VIS SCI, V49, P3821, DOI 10.1167/iovs.07-1470; Richards A, 2007, ADV IMMUNOL, V96, P141, DOI 10.1016/S0065-2776(07)96004-6; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P774, DOI 10.1001/archopht.123.6.774; Shen JK, 2007, HISTOL HISTOPATHOL, V22, P1301, DOI 10.14670/HH-22.1301; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P3859, DOI 10.1167/iovs.05-0672; Wang Z, 2006, PHOTOCHEM PHOTOBIOL, V82, P474, DOI 10.1562/2005-10-21-RA-725; Wang Z, 2006, PHOTOCHEM PHOTOBIOL, V82, P1251, DOI 10.1562/2006-04-01-RA-864; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Yang P, 2009, INVEST OPHTH VIS SCI, V50, P3473, DOI 10.1167/iovs.08-3202; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; YOUNG B, 1991, PATHOLOGY, V23, P118, DOI 10.3109/00313029109060809; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; YOUNG RW, 1987, SURV OPHTHALMOL, V31, P291, DOI 10.1145/1165387.275645; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103; Zhou J, 2009, INVEST OPHTH VIS SCI, V50, P1392, DOI 10.1167/iovs.08-2868	51	108	112	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18593	18601		10.1074/jbc.M110.191866	http://dx.doi.org/10.1074/jbc.M110.191866			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21464132	Green Published, hybrid			2022-12-27	WOS:000290785700031
J	Pike, GM; Madden, BJ; Melder, DC; Charlesworth, MC; Federspiel, MJ				Pike, Gennett M.; Madden, Benjamin J.; Melder, Deborah C.; Charlesworth, M. Cristine; Federspiel, Mark J.			Simple, Automated, High Resolution Mass Spectrometry Method to Determine the Disulfide Bond and Glycosylation Patterns of a Complex Protein SUBGROUP A AVIAN SARCOMA AND LEUKOSIS VIRUS ENVELOPE GLYCOPROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-CAPTURE DISSOCIATION; MEMBRANE-FUSION PROTEIN; EBOLA-VIRUS; RECEPTOR-BINDING; LOW PH; CELLULAR RECEPTOR; INFECTION; IDENTIFICATION; SUBUNIT; CHICKEN	Enveloped viruses must fuse the viral and cellular membranes to enter the cell. Understanding how viral fusion proteins mediate entry will provide valuable information for antiviral intervention to combat associated disease. The avian sarcoma and leukosis virus envelope glycoproteins, trimers composed of surface (SU) and transmembrane heterodimers, break the fusion process into several steps. First, interactions between SU and a cell surface receptor at neutral pH trigger an initial conformational change in the viral glycoprotein trimer followed by exposure to low pH enabling additional conformational changes to complete the fusion of the viral and cellular membranes. Here, we describe the structural characterization of the extracellular region of the subgroup A avian sarcoma and leukosis viruses envelope glycoproteins, SUATM129 produced in chicken DF-1 cells. We developed a simple, automated method for acquiring high resolution mass spectrometry data using electron capture dissociation conditions that preferentially cleave the disulfide bond more readily than the peptide backbone amide bonds that enabled the identification of disulfide-linked peptides. Seven of nine disulfide bonds were definitively assigned; the remaining two bonds were assigned to an adjacent pair of cysteine residues. The first cysteine of surface and the last cysteine of the transmembrane form a disulfide bond linking the heterodimer. The surface glycoprotein contains a free cysteine at residue 38 previously reported to be critical for virus entry. Eleven of 13 possible SUATM129 N-linked glycosylation sites were modified with carbohydrate. This study demonstrates the utility of this simple yet powerful method for assigning disulfide bonds in a complex glycoprotein.	[Pike, Gennett M.; Melder, Deborah C.; Federspiel, Mark J.] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Madden, Benjamin J.; Charlesworth, M. Cristine] Mayo Clin, Mayo Prote Res Ctr, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Federspiel, MJ (corresponding author), Mayo Clin, Dept Mol Med, 200 1st St SW, Rochester, MN 55905 USA.	federspiel.mark@mayo.edu		Federspiel, Mark/0000-0002-3713-186X	National Institutes of Health [AI48682]; Mayo Clinic; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI48682. This work was also supported by the Mayo Clinic.	Adkins HB, 1997, P NATL ACAD SCI USA, V94, P11617, DOI 10.1073/pnas.94.21.11617; Adkins HB, 2000, J VIROL, V74, P3572, DOI 10.1128/JVI.74.8.3572-3578.2000; Barnard RJO, 2003, CURR TOP MICROBIOL, V281, P107; BATES P, 1993, CELL, V74, P1043, DOI 10.1016/0092-8674(93)90726-7; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Brojatsch J, 1996, CELL, V87, P845, DOI 10.1016/S0092-8674(00)81992-3; COFFIN JM, 1992, CURR TOP MICROBIOL, V176, P143; Damico R, 2000, J VIROL, V74, P6469, DOI 10.1128/JVI.74.14.6469-6475.2000; Einfeld DA, 1997, J VIROL, V71, P2383, DOI 10.1128/JVI.71.3.2383-2389.1997; Elleder D, 2005, J VIROL, V79, P10408, DOI 10.1128/JVI.79.16.10408-10419.2005; FEDERSPIEL MJ, 1989, VIROLOGY, V173, P167, DOI 10.1016/0042-6822(89)90232-8; Gallaher WR, 1996, CELL, V85, P477, DOI 10.1016/S0092-8674(00)81248-9; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hernandez LD, 1997, J CELL BIOL, V139, P1455, DOI 10.1083/jcb.139.6.1455; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Holmen SL, 1999, J VIROL, V73, P10051, DOI 10.1128/JVI.73.12.10051-10060.1999; Holmen SL, 2000, VIROLOGY, V273, P364, DOI 10.1006/viro.2000.0424; Holmen SL, 2001, J VIROL, V75, P726, DOI 10.1128/JVI.75.2.726-737.2001; Hunter E., 1997, P71; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Kvaratskhelia M, 2004, VIROLOGY, V326, P171, DOI 10.1016/j.virol.2004.05.020; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Malashkevich VN, 1999, P NATL ACAD SCI USA, V96, P2662, DOI 10.1073/pnas.96.6.2662; Markosyan RM, 2004, BIOPHYS J, V87, P3291, DOI 10.1529/biophysj.104.047696; Matsuyama S, 2004, J VIROL, V78, P8201, DOI 10.1128/JVI.78.15.8201-8209.2004; Melikyan GB, 2005, P NATL ACAD SCI USA, V102, P8728, DOI 10.1073/pnas.0501864102; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Ochsenbauer-Jambor C, 2002, J VIROL, V76, P7518, DOI 10.1128/JVI.76.15.7518-7527.2002; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998; Schaefer-Klein J, 1998, VIROLOGY, V248, P305, DOI 10.1006/viro.1998.9291; Smith JG, 2007, PLOS PATHOG, V3, P1971, DOI 10.1371/journal.ppat.0030198; Smith JG, 2004, J VIROL, V78, P1403, DOI 10.1128/JVI.78.3.1403-1410.2004; Swanstrom R., 1997, P263; Tamm LK, 2003, BBA-BIOMEMBRANES, V1614, P14, DOI 10.1016/S0005-2736(03)00159-7; Weiss R. A., 1992, RETROVIRIDAE, P1; Weissenhorn W, 1998, P NATL ACAD SCI USA, V95, P6032, DOI 10.1073/pnas.95.11.6032; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; YOUNG JAT, 1993, J VIROL, V67, P1811, DOI 10.1128/JVI.67.4.1811-1816.1993; YOUNG JAT, 2001, FIELDS VIROLOGY, P87; Zubarev RA, 2004, CURR OPIN BIOTECH, V15, P12, DOI 10.1016/j.copbio.2003.12.002; Zubarev RA, 2000, ANAL CHEM, V72, P563, DOI 10.1021/ac990811p	43	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17954	17967		10.1074/jbc.M111.229377	http://dx.doi.org/10.1074/jbc.M111.229377			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454567	hybrid, Green Published			2022-12-27	WOS:000290585200058
J	Potez, S; Luginbul, M; Monastyrskaya, K; Hostettler, A; Draeger, A; Babiychuk, EB				Potez, Sarah; Luginbuehl, Miriam; Monastyrskaya, Katia; Hostettler, Andrea; Draeger, Annette; Babiychuk, Eduard B.			Tailored Protection against Plasmalemmal Injury by Annexins with Different Ca2+ Sensitivities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE REPAIR; INWARD VESICULATION; LIPID MICRODOMAINS; STREPTOLYSIN-O; LIVING CELLS; A1; DYNAMICS; FAMILY; ENDOCYTOSIS; EXOCYTOSIS	The annexins, a family of Ca2+- and lipid-binding proteins, are involved in a range of intracellular processes. Recent findings have implicated annexin A1 in the resealing of plasmalemmal injuries. Here, we demonstrate that another member of the annexin protein family, annexin A6, is also involved in the repair of plasmalemmal lesions induced by a bacterial pore-forming toxin, streptolysin O. An injury-induced elevation in the intracellular concentration of Ca2+ ([Ca2+](i)) triggers plasmalemmal repair. The highly Ca2+-sensitive annexin A6 responds faster than annexin A1 to [Ca2+](i) elevation. Correspondingly, a limited plasmalemmal injury can be promptly countered by annexin A6 even without the participation of annexin A1. However, its high Ca2+ sensitivity makes annexin A6 highly amenable to an unproductive binding to the uninjured plasmalemma; during an extensive injury accompanied by a massive elevation in [Ca2+](i), its active pool is severely depleted. In contrast, annexin A1 with a much lower Ca2+ sensitivity is ineffective at the early stages of injury; however, it remains available for the repair even at high [Ca2+](i). Our findings highlight the role of the annexins in the process of plasmalemmal repair; a number of annexins with different Ca2+-sensitivities provide a cell with the means to react promptly to a limited injury in its early stages and, at the same time, to withstand a sustained injury accompanied by the continuous formation of plasmalemmal lesions.	[Potez, Sarah; Luginbuehl, Miriam; Monastyrskaya, Katia; Hostettler, Andrea; Draeger, Annette; Babiychuk, Eduard B.] Univ Bern, Inst Anat, Dept Cell Biol, CH-3012 Bern, Switzerland	University of Bern	Babiychuk, EB (corresponding author), Univ Bern, Inst Anat, Dept Cell Biol, Baltzerstr 2, CH-3012 Bern, Switzerland.	edik@ana.unibe.ch	Babiychuk, Eduard/AAV-7223-2021	Monastyrskaya, Katia/0000-0003-2042-1139; Babiychuk, Eduard/0000-0003-1786-0085	Swiss National Science Foundation [3100A0-121980/1, 320030_128064/1]; National Research Programme [NRP 53, 405340-104679/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Research Programme	This work was supported by Swiss National Science Foundation Grants 3100A0-121980/1 (to E. B. B.) and 320030_128064/1 (to A. D.) and the National Research Programme Grant NRP 53 "Musculoskeletal Health-Chronic Pain" 405340-104679/1 (to A. D.).	Babiychuk EB, 2011, CELL DEATH DIFFER, V18, P80, DOI 10.1038/cdd.2010.81; Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Babiychuk EB, 2008, TRAFFIC, V9, P1757, DOI 10.1111/j.1600-0854.2008.00800.x; Babiychuk EB, 2006, BIOCHEM J, V397, P407, DOI 10.1042/BJ20060056; Buckingham JC, 1997, MOL MED TODAY, V3, P296, DOI 10.1016/S1357-4310(97)88908-3; Chasserot-Golaz S, 2005, MOL BIOL CELL, V16, P1108, DOI 10.1091/mbc.E04-07-0627; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Grewal T, 2009, CELL SIGNAL, V21, P847, DOI 10.1016/j.cellsig.2009.01.031; Idone V, 2008, TRENDS CELL BIOL, V18, P552, DOI 10.1016/j.tcb.2008.09.001; John CD, 2008, CURR OPIN PHARMACOL, V8, P765, DOI 10.1016/j.coph.2008.09.005; Lambert O, 1997, J MOL BIOL, V272, P42, DOI 10.1006/jmbi.1997.1183; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Monastyrskaya K, 2007, CELL CALCIUM, V41, P207, DOI 10.1016/j.ceca.2006.06.008; Monastyrskaya K, 2009, CELL MOL LIFE SCI, V66, P2623, DOI 10.1007/s00018-009-0027-1; Monastyrskaya K, 2009, J BIOL CHEM, V284, P17227, DOI 10.1074/jbc.M109.004457; MORGAN BP, 1986, CELL CALCIUM, V7, P399, DOI 10.1016/0143-4160(86)90042-4; Morgan RO, 1997, CELL MOL LIFE SCI, V53, P508, DOI 10.1007/s000180050064; Moskovich O, 2007, J BIOL CHEM, V282, P29977, DOI 10.1074/jbc.M703742200; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rescher U, 2008, PFLUG ARCH EUR J PHY, V455, P575, DOI 10.1007/s00424-007-0313-4; Schapire AL, 2009, TRENDS PLANT SCI, V14, P645, DOI 10.1016/j.tplants.2009.09.004; Skrahina T, 2008, EXP CELL RES, V314, P1039, DOI 10.1016/j.yexcr.2007.11.015; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Thiery J, 2010, BLOOD, V115, P1582, DOI 10.1182/blood-2009-10-246116; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759	32	76	78	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17982	17991		10.1074/jbc.M110.187625	http://dx.doi.org/10.1074/jbc.M110.187625			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454475	Green Published, hybrid			2022-12-27	WOS:000290585200060
J	Treberg, JR; Brand, MD				Treberg, Jason R.; Brand, Martin D.			A Model of the Proton Translocation Mechanism of Complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; IRON-SULFUR CLUSTERS; SUPEROXIDE-PRODUCTION; HEART-MITOCHONDRIA; ESCHERICHIA-COLI; ELECTRON; REDOX; GENERATION; MEMBRANE; MATRIX	Despite decades of speculation, the proton pumping mechanism of complex I (NADH-ubiquinone oxidoreductase) is unknown and continues to be controversial. Recent descriptions of the architecture of the hydrophobic region of complex I have resolved one vital issue: this region appears to have multiple proton transporters that are mechanically interlinked. Thus, transduction of conformational changes to drive the transmembrane transporters linked by a "connecting rod" during the reduction of ubiquinone (Q) can account for two or three of the four protons pumped per NADH oxidized. The remaining proton(s) must be pumped by direct coupling at the Q-binding site. Here, we present a mixed model based on a crucial constraint: the strong dependence on the pH gradient across the membrane (Delta pH) of superoxide generation at the Q-binding site of complex I. This model combines direct and indirect coupling mechanisms to account for the pumping of the four protons. It explains the observed properties of the semiquinone in the Q-binding site, the rapid superoxide production from this site during reverse electron transport, its low superoxide production during forward electron transport except in the presence of inhibitory Q-analogs and high protonmotive force, and the strong dependence of both modes of superoxide production on Delta pH.	[Treberg, Jason R.; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Treberg, JR (corresponding author), 8001 Redwood Blvd, Novato, CA 94945 USA.	jtreberg@mun.ca	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153; Treberg, Jason/0000-0001-5112-7325	National Institutes of Health [P01 AG025901, PL1 AG032118, R01 AG033542]; Ellison Medical Foundation [AG-SS-2288-09]; NATIONAL INSTITUTE ON AGING [P01AG025901, R01AG033542, PL1AG032118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported, in whole or in part, by National Institutes of Health Grants P01 AG025901, PL1 AG032118, and R01 AG033542. This work was also supported by The Ellison Medical Foundation Grant AG-SS-2288-09.	Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Birrell JA, 2010, FEBS LETT, V584, P4247, DOI 10.1016/j.febslet.2010.09.017; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; Brandt U, 1997, BBA-BIOENERGETICS, V1318, P79, DOI 10.1016/S0005-2728(96)00141-7; BRANDT U, 2006, BIOCHEM J, V75, P473; Dutton PL, 1998, BBA-BIOENERGETICS, V1364, P245, DOI 10.1016/S0005-2728(98)00031-0; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Esterhazy D, 2008, BIOCHEMISTRY-US, V47, P3964, DOI 10.1021/bi702243b; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lambert AJ, 2008, FEBS LETT, V582, P1711, DOI 10.1016/j.febslet.2008.04.030; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Liu SS, 1997, BIOSCIENCE REP, V17, P259, DOI 10.1023/A:1027328510931; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Magnitsky S, 2002, J BIOENERG BIOMEMBR, V34, P193, DOI 10.1023/A:1016083419979; Medvedev ES, 2010, BBA-BIOENERGETICS, V1797, P1665, DOI 10.1016/j.bbabio.2010.05.011; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1901, DOI 10.1016/j.bbabio.2010.05.012; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1891, DOI 10.1016/j.bbabio.2010.06.010; Ohnishi ST, 2005, J BIOENERG BIOMEMBR, V37, P1, DOI 10.1007/s10863-005-4117-y; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Ohnishi T, 2010, FEBS LETT, V584, P4131, DOI 10.1016/j.febslet.2010.08.039; POZZAN T, 1979, J BIOL CHEM, V254, P200; RICH PR, 1984, BIOCHIM BIOPHYS ACTA, V768, P53, DOI 10.1016/0304-4173(84)90007-7; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Treberg JR, 2010, FEBS J, V277, P2766, DOI 10.1111/j.1742-4658.2010.07693.x; Verkhovskaya ML, 2008, P NATL ACAD SCI USA, V105, P3763, DOI 10.1073/pnas.0711249105; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Zwicker K, 2006, J BIOL CHEM, V281, P23013, DOI 10.1074/jbc.M603442200	39	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17579	17584		10.1074/jbc.M111.227751	http://dx.doi.org/10.1074/jbc.M111.227751			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454533	hybrid, Green Published			2022-12-27	WOS:000290585200020
J	Zaharieva, I; Wichmann, JM; Dau, H				Zaharieva, Ivelina; Wichmann, Joerg M.; Dau, Holger			Thermodynamic Limitations of Photosynthetic Water Oxidation at High Proton Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING CENTER; II MEMBRANE-PARTICLES; PHOTOSYSTEM-II; PH-DEPENDENCE; MANGANESE COMPLEX; ELECTRON-TRANSFER; DIOXYGEN FORMATION; KINETIC-ANALYSIS; REACTION CYCLE; EVOLUTION	In oxygenic photosynthesis, solar energy drives the oxidation of water catalyzed by a Mn4Ca complex bound to the proteins of Photosystem II. Four protons are released during one turnover of the water oxidation cycle (S-state cycle), implying thermodynamic limitations at low pH. For proton concentrations ranging from 1 nM (pH 9) to 1 mM (pH 3), we have characterized the low-pH limitations using a new experimental approach: a specific pH-jump protocol combined with time-resolved measurement of the delayed chlorophyll fluorescence after nanosecond flash excitation. Effective pK values were determined for low-pH inhibition of the light-induced S-state transitions: pK(1) = 3.3 +/- 0.3, pK(2) = 3.5 +/- 0.2, and pK(3) approximate to pK(4) = 4.6 +/- 0.2. Alkaline inhibition was not observed. An extension of the classical Kok model facilitated assignment of these four pK values to specific deprotonation steps in the reaction cycle. Our results provide important support to the extended S-state cycle model and criteria needed for assessment of quantum chemical calculations of the mechanism of water oxidation. They also imply that, in intact organisms, the pH in the lumen compartment can hardly drop below 5, thereby limiting the Delta pH contribution to the driving force of ATP synthesis.	[Zaharieva, Ivelina; Wichmann, Joerg M.; Dau, Holger] Free Univ Berlin, Fachbereich Phys, D-14195 Berlin, Germany	Free University of Berlin	Dau, H (corresponding author), Free Univ Berlin, Fachbereich Phys, Arnimallee 14, D-14195 Berlin, Germany.	holger.dau@fu-berlin.de	Zaharieva, Ivelina S/H-6119-2012	Zaharieva, Ivelina S/0000-0002-4745-5307; Dau, Holger/0000-0001-6482-7494	Deutsche Forschungsgemeinschaft (Berlin) [SFB 498]; UniCat Cluster of Excellence (Unifying Concepts in Catalysis, Berlin); German Ministry of Education and Research [03SF0318C, 03SF0355D]; European Union [SOLAR-H2 516510]; Alexander-von-Humboldt Foundation	Deutsche Forschungsgemeinschaft (Berlin)(German Research Foundation (DFG)); UniCat Cluster of Excellence (Unifying Concepts in Catalysis, Berlin); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported in part by the Deutsche Forschungsgemeinschaft (SFB 498, Berlin), the UniCat Cluster of Excellence (Unifying Concepts in Catalysis, Berlin), the German Ministry of Education and Research (Bio-H<INF>2</INF>, 03SF0318C; and H<INF>2</INF> Design Cell, 03SF0355D), and the European Union (SOLAR-H2 516510).; Supported by a fellowship from the Alexander-von-Humboldt Foundation.	[Anonymous], 2002, PHOTOSYNTHETICA; Avenson TJ, 2005, P NATL ACAD SCI USA, V102, P9709, DOI 10.1073/pnas.0503952102; Bernat G, 2002, BIOCHEMISTRY-US, V41, P5830, DOI 10.1021/bi011691u; Brudvig GW, 2008, COORDIN CHEM REV, V252, P231, DOI 10.1016/j.ccr.2007.08.028; Buchta J, 2007, BBA-BIOENERGETICS, V1767, P565, DOI 10.1016/j.bbabio.2007.04.003; Clausen J, 2004, NATURE, V430, P480, DOI 10.1038/nature02676; Dau H, 2006, SCIENCE, V312, P1471; DAU H, 1989, PHOTOSYNTH RES, V20, P59, DOI 10.1007/BF00028622; Dau H, 2001, BBA-BIOENERGETICS, V1503, P24, DOI 10.1016/S0005-2728(00)00230-9; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Dau H, 2007, BBA-BIOENERGETICS, V1767, P472, DOI 10.1016/j.bbabio.2007.02.022; Dau H, 2007, PHOTOSYNTH RES, V92, P327, DOI 10.1007/s11120-007-9141-9; Dau H, 2010, CHEMCATCHEM, V2, P724, DOI 10.1002/cctc.201000126; Dau H, 2009, ACCOUNTS CHEM RES, V42, P1861, DOI 10.1021/ar900225y; de Wijn R, 2001, BIOCHEMISTRY-US, V40, P5821, DOI 10.1021/bi002824z; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Grabolle M, 2005, BBA-BIOENERGETICS, V1708, P209, DOI 10.1016/j.bbabio.2005.03.007; Grabolle M, 2007, PHYSIOL PLANTARUM, V131, P50, DOI 10.1111/j.1399-3054.2007.00941.x; Gust D, 2009, ACCOUNTS CHEM RES, V42, P1890, DOI 10.1021/ar900209b; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; Haumann M, 2005, BIOCHEMISTRY-US, V44, P1894, DOI 10.1021/bi048697e; Haumann M, 1997, PHOTOSYNTH RES, V51, P193, DOI 10.1023/A:1005861917596; Haumann M, 2008, P NATL ACAD SCI USA, V105, P17384, DOI 10.1073/pnas.0802596105; Heinze I, 1996, BER BUNSEN PHYS CHEM, V100, P2008, DOI 10.1002/bbpc.19961001214; Herrero C, 2008, COORDIN CHEM REV, V252, P456, DOI 10.1016/j.ccr.2007.09.002; JOLIOT P, 1968, BIOCHIM BIOPHYS ACTA, V153, P625, DOI 10.1016/0005-2728(68)90190-4; Junge W, 2002, PHILOS T ROY SOC B, V357, P1407, DOI 10.1098/rstb.2002.1137; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Kolling DRJ, 2009, BIOCHEMISTRY-US, V48, P1381, DOI 10.1021/bi801774f; KRISHTALIK LI, 1986, BIOCHIM BIOPHYS ACTA, V849, P162, DOI 10.1016/0005-2728(86)90107-6; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Magnuson A, 2009, ACCOUNTS CHEM RES, V42, P1899, DOI 10.1021/ar900127h; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; McEvoy JP, 2004, PHYS CHEM CHEM PHYS, V6, P4754, DOI 10.1039/b407500e; MESSINGER J, 1994, BIOCHEMISTRY-US, V33, P10896, DOI 10.1021/bi00202a008; RAPPAPORT F, 1994, BBA-BIOENERGETICS, V1184, P178, DOI 10.1016/0005-2728(94)90222-4; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Schiller H, 2000, J PHOTOCH PHOTOBIO B, V55, P138, DOI 10.1016/S1011-1344(00)00036-1; Shevela D, 2011, P NATL ACAD SCI USA, V108, P3602, DOI 10.1073/pnas.1014249108; Siegbahn PEM, 2009, ACCOUNTS CHEM RES, V42, P1871, DOI 10.1021/ar900117k; Siegbahn PEM, 2009, DALTON T, P5832, DOI 10.1039/b903007g; Siegbahn PEM, 2008, CHEM-EUR J, V14, P8290, DOI 10.1002/chem.200800445; Sproviero EM, 2008, J AM CHEM SOC, V130, P6728, DOI 10.1021/ja801979n; Suzuki H, 2005, BIOCHEMISTRY-US, V44, P1708, DOI 10.1021/bi0483312; Takizawa K, 2007, BBA-BIOENERGETICS, V1767, P1233, DOI 10.1016/j.bbabio.2007.07.006; Zaharieva I., 2011, ENERGY ENV SCI  0303, DOI [10.1039/c1030ee00815j, DOI 10.1039/C1030EE00815J]; ZANKEL KL, 1971, BIOCHIM BIOPHYS ACTA, V245, P373, DOI 10.1016/0005-2728(71)90156-3	48	33	34	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18222	18228		10.1074/jbc.M111.237941	http://dx.doi.org/10.1074/jbc.M111.237941			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21464129	hybrid, Green Published			2022-12-27	WOS:000290585200082
J	Zhang, DX; Jiang, PP; Xu, QQ; Zhang, XT				Zhang, Dingxiao; Jiang, Pingping; Xu, Qinqin; Zhang, Xiaoting			Arginine and Glutamate-rich 1 (ARGLU1) Interacts with Mediator Subunit 1 (MED1) and Is Required for Estrogen Receptor-mediated Gene Transcription and Breast Cancer Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ACTIVATED PROTEIN-KINASE; COACTIVATOR COMPLEX; NUCLEAR RECEPTORS; DEPENDENT TRANSCRIPTION; TRAP/MEDIATOR-SUBUNIT; TRAP220; EXPRESSION; PHOSPHORYLATION; MECHANISMS	Estrogen receptor is a nuclear receptor superfamily member of transcriptional activators that regulate gene expression by recruiting diverese transcriptional coregulators. The Mediator complex is a central transcriptional coactivator complex that acts as a bridge between transcriptional activators and RNA polymerase II. MED1 (Mediator subunit 1) is the key Mediator subunit that directly interacts with estrogen receptor to mediate its functions both in vitro and in vivo. Interestingly, our previous biochemical analyses indicated that MED1 exists only in a subpopulation of the Mediator complex that is enriched with a number of distinct Mediator subunits and RNA polymerase II. Here, we report ARGLU1 as a MED1/Mediator-associated protein. We found that ARGLU1 (arginine and glutamate rich 1) not only colocalizes with MED1 in the nucleus, but also directly interacts with a far C-terminal region of MED1. Reporter assays indicate that ARGLU1 is able to cooperate with MED1 to regulate estrogen receptor-mediated gene transcription. Importantly, ARGLU1 is recruited, in a ligand-dependent manner, to endogenous estrogen receptor target gene promoters and is required for their expression. Furthermore, by ChIP-reChIP assay, we confirm that ARGLU1 and MED1 colocalize on the same estrogen receptor target gene promoter upon estrogen induction. Moreover, we found that depletion of ARGLU1 significantly impairs the growth, as well as anchorage-dependent and -independent colony formation of breast cancer cells. Taken together, these results establish ARGLU1 as a new MED1-interacting protein required for estrogen-dependent gene transcription and breast cancer cell growth.	[Zhang, Dingxiao; Jiang, Pingping; Xu, Qinqin; Zhang, Xiaoting] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA; [Jiang, Pingping; Xu, Qinqin] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	University System of Ohio; University of Cincinnati; Zhejiang University	Zhang, XT (corresponding author), 3125 Eden Ave, Cincinnati, OH 45267 USA.	zhangxt@ucmail.uc.edu	Xu, Qinqin/I-2202-2019; Zhang, Dingxiao/A-1902-2016	JIANG, PINGPING/0000-0002-4975-4861; Zhang, Dingxiao/0000-0001-8505-8831	National Institutes of Health from the United States Public Health Service [DK P30 DK078392]; University of Cincinnati Cancer Center Start-up and Pilot; American Heart Association; Ride Cincinnati Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; University of Cincinnati Cancer Center Start-up and Pilot; American Heart Association(American Heart Association); Ride Cincinnati Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK P30 DK078392 from the United States Public Health Service, University of Cincinnati Cancer Center Start-up and Pilot Grants, American Heart Association Beginning Grant-in-aid, and a Ride Cincinnati Award (to X. Z.).	Acevedo ML, 2004, MOL CELL, V13, P725, DOI 10.1016/S1097-2765(04)00121-2; Acevedo ML, 2003, MOL CELL BIOL, V23, P335, DOI 10.1128/MCB.23.1.335-348.2003; Baek HJ, 2002, MOL CELL BIOL, V22, P2842, DOI 10.1128/MCB.22.8.2842-2852.2002; Baek HJ, 2006, J BIOL CHEM, V281, P15172, DOI 10.1074/jbc.M601983200; Belakavadi M, 2008, MOL CELL BIOL, V28, P3932, DOI 10.1128/MCB.02191-07; Blazek E, 2005, CHROMOSOMA, V113, P399, DOI 10.1007/s00412-005-0329-5; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Burakov D, 2000, J BIOL CHEM, V275, P20928, DOI 10.1074/jbc.M002013200; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Crawford SE, 2002, J BIOL CHEM, V277, P3585, DOI 10.1074/jbc.M107995200; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Ge K, 2008, MOL CELL BIOL, V28, P1081, DOI 10.1128/MCB.00967-07; Glass CK, 2000, GENE DEV, V14, P121; Gordon DF, 2006, MOL ENDOCRINOL, V20, P1073, DOI 10.1210/me.2005-0115; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jiang PP, 2010, P NATL ACAD SCI USA, V107, P6765, DOI 10.1073/pnas.1001814107; Johnson KM, 2002, GENE DEV, V16, P1852, DOI 10.1101/gad.995702; Kang YK, 2002, P NATL ACAD SCI USA, V99, P2642, DOI 10.1073/pnas.261715899; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luoh SW, 2002, CANCER GENET CYTOGEN, V136, P43, DOI 10.1016/S0165-4608(01)00657-4; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Malik S, 2004, MOL CELL BIOL, V24, P8244, DOI 10.1128/MCB.24.18.8244-8254.2004; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Misra P, 2002, J BIOL CHEM, V277, P48745, DOI 10.1074/jbc.M208829200; Pandey PK, 2005, MOL CELL BIOL, V25, P10695, DOI 10.1128/MCB.25.24.10695-10710.2005; Ren YS, 2000, MOL CELL BIOL, V20, P5433, DOI 10.1128/MCB.20.15.5433-5446.2000; Roeder RG, 1998, COLD SPRING HARB SYM, V63, P201, DOI 10.1101/sqb.1998.63.201; Roeder RG, 2003, NAT MED, V9, P1239, DOI 10.1038/nm938; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Stumpf M, 2006, P NATL ACAD SCI USA, V103, P18504, DOI 10.1073/pnas.0604494103; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Warnmark A, 2001, J BIOL CHEM, V276, P23397, DOI 10.1074/jbc.M011651200; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015; Zhu YJ, 1999, P NATL ACAD SCI USA, V96, P10848, DOI 10.1073/pnas.96.19.10848	44	40	42	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17746	17754		10.1074/jbc.M110.206029	http://dx.doi.org/10.1074/jbc.M110.206029			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454576	Green Published, hybrid			2022-12-27	WOS:000290585200038
J	Bonacci, G; Schopfer, FJ; Batthyany, CI; Rudolph, TK; Rudolph, V; Khoo, NKH; Kelley, EE; Freeman, BA				Bonacci, Gustavo; Schopfer, Francisco J.; Batthyany, Carlos I.; Rudolph, Tanja K.; Rudolph, Volker; Khoo, Nicholas K. H.; Kelley, Eric E.; Freeman, Bruce A.			Electrophilic Fatty Acids Regulate Matrix Metalloproteinase Activity and Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-GAMMA; ATHEROSCLEROTIC PLAQUE STABILITY; NITRIC-OXIDE; CYSTEINE SWITCH; NITROLINOLEIC ACID; SIGNALING PATHWAY; NITROGEN-DIOXIDE; MECHANISM; PEROXYNITRITE; INFLAMMATION	Nitro-fatty acids (NO2-FA) are electrophilic signaling mediators formed by reactions of nitric oxide and nitrite. NO2-FA exert anti-inflammatory signaling actions through post-translational protein modifications. We report that nitro-oleic acid (OA-NO2) stimulates proMMP-7 and proMMP-9 proteolytic activity via adduction of the conserved cysteine switch domain thiolate. Biotin-labeled OA-NO2 showed this adduction occurs preferentially with latent forms of MMP, confirming a role for thiol alkylation by OA-NO2 in MMP activation. In addition to regulating pro-MMP activation, MMP expression was modulated by OA-NO2 via activation of peroxisome proliferator-activated receptor-gamma. MMP-9 transcription was decreased in phorbol 12-myristate 13-acetate-stimulated THP-1 macrophages to an extent similar to that induced by the peroxisome proliferator-activated receptor-gamma agonist Rosiglitazone. This was affirmed using a murine model of atherosclerosis, ApoE(-/-) mice, where in vivo OA-NO2 administration suppressed MMP expression in atherosclerotic lesions. These findings reveal that electrophilic fatty acid derivatives can serve as effectors during inflammation, first by activating pro-MMP proteolytic activity via alkylation of the cysteine switch domain, and then by transcriptionally inhibiting MMP expression, thereby limiting the further progression of inflammatory processes.	[Bonacci, Gustavo; Schopfer, Francisco J.; Rudolph, Tanja K.; Rudolph, Volker; Khoo, Nicholas K. H.; Freeman, Bruce A.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Kelley, Eric E.] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15213 USA; [Rudolph, Tanja K.; Rudolph, Volker] Univ Heart Ctr Hamburg, Dept Cardiol, D-20246 Hamburg, Germany; [Batthyany, Carlos I.] Inst Pasteur, Montevideo 11400, Uruguay	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Hamburg; University Medical Center Hamburg-Eppendorf; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Freeman, BA (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Thomas E Starzl Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15213 USA.	freerad@pitt.edu	Schopfer, Francisco Jose/AAE-8125-2020; Freeman, Bruce A/H-9342-2012; Schopfer, Francisco/AAW-6505-2021	Schopfer, Francisco Jose/0000-0001-9526-695X; Batthyany, Carlos/0000-0002-0627-1982	National Institutes of Health [R01 HL58115, R01 HL64937]; American Diabetes Association [7-08-JF-52]; American Heart Association [0665418U]; Deutsche Herzstiftung; Complexa, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058115, R01HL064937, R37HL058115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); Deutsche Herzstiftung; Complexa, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL58115 and R01 HL64937 (to B. A. F.), American Diabetes Association Grant 7-08-JF-52 (to F. J. S.), American Heart Association Grant 0665418U (to F. J. S.), and a grant from the Deutsche Herzstiftung (to V. R.). B. A. F. acknowledges financial interest in Complexa, Inc.	Alexander RL, 2006, BIOCHEMISTRY-US, V45, P7889, DOI 10.1021/bi0605639; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2009, FREE RADICAL BIO MED, V46, P989, DOI 10.1016/j.freeradbiomed.2008.11.021; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; Casella L, 2002, ENVIRON HEALTH PERSP, V110, P709, DOI 10.1289/ehp.02110s5709; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Deshmukh HS, 2008, AM J RESP CELL MOL, V38, P446, DOI 10.1165/rcmb.2006-0339OC; Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003; Ferreira AM, 2009, BIOCHEM J, V417, P223, DOI 10.1042/BJ20080701; Fu XY, 2003, J BIOL CHEM, V278, P28403, DOI 10.1074/jbc.M304739200; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Ichikawa T, 2008, ENDOCRINOLOGY, V149, P4086, DOI 10.1210/en.2007-1639; Jain K, 2008, FREE RADICAL BIO MED, V45, P269, DOI 10.1016/j.freeradbiomed.2008.04.015; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Kansanen E, 2009, J BIOL CHEM, V284, P33233, DOI 10.1074/jbc.M109.064873; Lemaitre Vincent, 2006, Birth Defects Research, V78, P1, DOI 10.1002/bdrc.20065; Lin D, 2008, CHEM RES TOXICOL, V21, P2361, DOI 10.1021/tx800248x; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; McCarthy SM, 2008, BIOCHEMISTRY-US, V47, P5832, DOI 10.1021/bi702496v; Nadtochiy SM, 2009, CARDIOVASC RES, V82, P333, DOI 10.1093/cvr/cvn323; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Newby AC, 2007, TRENDS CARDIOVAS MED, V17, P253, DOI 10.1016/j.tcm.2007.09.001; Newby AC, 2009, THROMB HAEMOSTASIS, V101, P1006, DOI 10.1160/TH08-07-0469; O'Donnell VB, 1999, CHEM RES TOXICOL, V12, P83, DOI 10.1021/tx980207u; Okamoto T, 2001, J BIOL CHEM, V276, P29596, DOI 10.1074/jbc.M102417200; Okamoto T, 1997, ARCH BIOCHEM BIOPHYS, V342, P261, DOI 10.1006/abbi.1997.0127; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rudolph TK, 2010, ARTERIOSCL THROM VAS, V30, P938, DOI 10.1161/ATVBAHA.109.201582; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Rudolph V, 2009, CIRC RES, V105, P511, DOI 10.1161/CIRCRESAHA.109.202077; Rudolph V, 2009, J BIOL CHEM, V284, P1461, DOI 10.1074/jbc.M802298200; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007	44	42	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.225029	http://dx.doi.org/10.1074/jbc.M111.225029			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454668	Green Published, hybrid			2022-12-27	WOS:000290022800047
J	Hennen, E; Czopka, T; Faissner, A				Hennen, Eva; Czopka, Tim; Faissner, Andreas			Structurally Distinct LewisX Glycans Distinguish Subpopulations of Neural Stem/Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; MONOCLONAL-ANTIBODY; RADIAL GLIA; NEURITE OUTGROWTH; ADHESION MOLECULE; NEURONAL LINEAGE; PRECURSOR CELL; ANTIGEN; ASTROCYTES	There is increasing evidence that the stem and progenitor cell population that builds the central nervous system is very heterogeneous. Stem cell markers with the potential to divide this cell pool into subpopulations with distinct characteristics are sparse. We were looking for new cell type-specific antigens to further subdivide the progenitor pool. Here, we introduce the novel monoclonal antibody clone 5750. We show that it specifically labels cell surfaces of neural stem and progenitor cells. When 5750-expressing cells were isolated by fluorescence-activated cell sorting from embryonic mouse brains, the sorted population showed increased neurosphere forming capacity and multipotency. Neurospheres generated from 5750-positive cells could self-renew and remained multipotent even after prolonged passaging. Carbohydrate binding assays revealed that the 5750 antibody specifically binds to LewisX-related carbohydrates. Interestingly, we found that the LewisX epitope recognized by clone 5750 differs from those detected by other anti-LewisX antibody clones like 487(LeX), SSEA-1(LeX), and MMA(LeX). Our data further reveal that individual anti-LewisX clones can be successfully used to label and deplete different subpopulations of neural cells in vivo and in vitro. In conclusion, we present a new tool for the isolation and characterization of neural subpopulations and provide insights into the complexity of cell surface glycosylation.	[Hennen, Eva; Czopka, Tim; Faissner, Andreas] Ruhr Univ Bochum, Dept Cell Morphol & Mol Neurobiol, D-44780 Bochum, Germany; [Hennen, Eva] Ruhr Univ Bochum, Int Grad Sch Neurosci, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Faissner, A (corresponding author), Ruhr Univ Bochum, Dept Cell Morphol & Mol Neurobiol, Univ Str 150,NDEF 05-593, D-44780 Bochum, Germany.	Andreas.Faissner@rub.de	Faissner, Andreas/A-5314-2008	Faissner, Andreas/0000-0002-2211-8259	Consortium for Functional Glycomics [GM62116]; International Graduate School of Neuroscience; Deutsche Forschungsgemeinschaft [GSC 98/1]; Federal Ministry of Education and Research (Federal Ministry of Education and Research); Land Nordrhein Westfalen; stem cell network North Rhine Westphalia; Ruhr-University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Consortium for Functional Glycomics; International Graduate School of Neuroscience; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research (Federal Ministry of Education and Research); Land Nordrhein Westfalen; stem cell network North Rhine Westphalia; Ruhr-University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Consortium for Functional Glycomics Grant GM62116.; Supported by the Ph.D. program of the International Graduate School of Neuroscience and the Research School at the Ruhr-University supported by Deutsche Forschungsgemeinschaft Grant GSC 98/1.; Supported by the Deutsche Forschungsgemeinschaft, the Federal Ministry of Education and Research (Federal Ministry of Education and Research), the Land Nordrhein Westfalen, the stem cell network North Rhine Westphalia, and the Ruhr-University for part of this work.	Allendoerfer KL, 1999, DEV BIOL, V211, P208, DOI 10.1006/dbio.1999.9308; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Brito C, 2007, J NEUROSCI RES, V85, P1260, DOI 10.1002/jnr.21230; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Czopka T, 2009, CELL TISSUE RES, V338, P161, DOI 10.1007/s00441-009-0868-9; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; EGGENS I, 1989, J BIOL CHEM, V264, P9476; EISENBARTH GS, 1979, P NATL ACAD SCI USA, V76, P4913, DOI 10.1073/pnas.76.10.4913; FAISSNER A, 1985, EMBO J, V4, P3105, DOI 10.1002/j.1460-2075.1985.tb04052.x; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; FAISSNER A, 1990, NEURON, V5, P627, DOI 10.1016/0896-6273(90)90217-4; FENDERSON BA, 1984, J EXP MED, V160, P1591, DOI 10.1084/jem.160.5.1591; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; Garwood J, 1999, J NEUROSCI, V19, P3888; HANJAN SNS, 1982, CLIN IMMUNOL IMMUNOP, V23, P172, DOI 10.1016/0090-1229(82)90106-4; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Imura T, 2006, GLIA, V53, P277, DOI 10.1002/glia.20281; Jirmanova L, 1999, INT J DEV BIOL, V43, P555; KRUSE J, 1985, NATURE, V316, P146, DOI 10.1038/316146a0; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; Lieberoth A, 2009, J NEUROSCI, V29, P6677, DOI 10.1523/JNEUROSCI.4361-08.2009; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MILNER R, 1994, DEVELOPMENT, V120, P3497; Nishihara S, 2003, GLYCOBIOLOGY, V13, P445, DOI 10.1093/glycob/cwg048; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Pellegrini W, 2007, HAEMATOL-HEMATOL J, V92, P708, DOI 10.3324/haematol.11002; RAFF MC, 1983, J NEUROSCI, V3, P1289; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Strathmann FG, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-33; STREIT A, 1990, J NEUROCHEM, V55, P1494, DOI 10.1111/j.1471-4159.1990.tb04931.x; Streit A, 1996, J NEUROCHEM, V66, P834; STREIT A, 1993, J CELL BIOL, V120, P799, DOI 10.1083/jcb.120.3.799; SUDOU A, 1995, J BIOCHEM-TOKYO, V117, P271, DOI 10.1093/jb/117.2.271; von Holst A, 2006, J NEUROSCI, V26, P4082, DOI 10.1523/JNEUROSCI.0422-06.2006; Yagi H, 2010, GLYCOBIOLOGY, V20, P976, DOI 10.1093/glycob/cwq054; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x	43	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.201095	http://dx.doi.org/10.1074/jbc.M110.201095			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21385876	hybrid, Green Published			2022-12-27	WOS:000290022800070
J	Kawahara, H; Okada, Y; Imai, T; Iwanami, A; Mischel, PS; Okano, H				Kawahara, Hironori; Okada, Yohei; Imai, Takao; Iwanami, Akio; Mischel, Paul S.; Okano, Hideyuki			Musashi1 Cooperates in Abnormal Cell Lineage Protein 28 (Lin28)-mediated Let-7 Family MicroRNA Biogenesis in Early Neural Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; POSTTRANSCRIPTIONAL REGULATION; REGULATED EXPRESSION; IN-VITRO; LIN28; LIN-28; MATURATION; LOCALIZATION; MARKER	Musashi1 (Msi1) is an RNA-binding protein that is highly expressed in neural stem/progenitor cells (NS/PCs) as well as in other tissue stem cells. Msi1 binds to the 3'-UTR of its target mRNAs in NS/PCs, prevents their translation, and interferes with NS/PC differentiation. We previously showed that Msi1 competes with eIF4G to bind poly(A)-binding protein and inhibits assembly of the 80 S ribosome. Here we show that Msi1 works in concert with Lin28 to regulate post-transcriptional microRNA (miRNA) biogenesis in the cropping step, which occurs in the nucleus. Lin28 and its binding partner terminal uridylyltransferase 4 (TUT4) are known to maintain embryonic stem cell pluripotency by blocking let-7 miRNA biogenesis at the dicing step. Interestingly, we found that during early neural differentiation of embryonic stem cells, Msi1 enhanced the localization of Lin28 to the nucleus and also inhibited the nuclear cropping step of another let-7 family miRNA, miR98. These results suggest that Msi1 can influence stem cell maintenance and differentiation by controlling the subcellular localization of proteins involved in miRNA biogenesis, as well as by regulating the translation of its target mRNA.	[Kawahara, Hironori; Okada, Yohei; Imai, Takao; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan; [Okada, Yohei] Keio Univ, Sch Med, Kanrinmaru Project, Shinjuku Ku, Tokyo 1608582, Japan; [Iwanami, Akio; Mischel, Paul S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Iwanami, Akio; Mischel, Paul S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Keio University; Keio University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Okano, H (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan.	hidokano@a2.keio.jp	Okano, Hideyuki/I-7584-2019; Imai, Takao/L-1232-2013; Okada, Yohei/L-1662-2013		Japan Society for the Promotion of Science; Japanese Ministry of Education, Sports and Culture of Japan (MEXT); Keio University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Sports and Culture of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Keio University	This work was supported by the Funding Program for World-Leading Innovative R&D on Science and Technology from Japan Society for the Promotion of Science and by grants from the Japanese Ministry of Education, Sports and Culture of Japan (MEXT) (to H. O.) (the Leading Project for Realization of Regenerative Medicine) and (to H. K.) (Grant-in-aid for Young Scientists (B)) and a Keio University grant-in-aid for the encouragement of young medical scientists.	Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V139, P28, DOI 10.1016/j.cell.2009.09.013; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kanemura Y, 2001, DIFFERENTIATION, V68, P141, DOI 10.1046/j.1432-0436.2001.680208.x; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lee Y, 2007, METHOD ENZYMOL, V427, P89, DOI 10.1016/S0076-6879(07)27005-3; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Okano H, 2002, J CELL SCI, V115, P1355; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Shiohama A, 2007, EXP CELL RES, V313, P4196, DOI 10.1016/j.yexcr.2007.07.020; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Toda M, 2001, GLIA, V34, P1, DOI 10.1002/glia.1034; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang XY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-221; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	43	64	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.199166	http://dx.doi.org/10.1074/jbc.M110.199166			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21378162	hybrid, Green Published			2022-12-27	WOS:000290022800052
J	Peng, HJ; Henkels, KM; Mahankali, M; Dinauer, MC; Gomez-Cambronero, J				Peng, Hong-Juan; Henkels, Karen M.; Mahankali, Madhu; Dinauer, Mary C.; Gomez-Cambronero, Julian			Evidence for Two CRIB Domains in Phospholipase D2 (PLD2) That the Enzyme Uses to Specifically Bind to the Small GTPase Rac2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; ADP-RIBOSYLATION FACTOR; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PLASMA-MEMBRANE; CELL-MIGRATION; RHO-GTPASES; KINASE-C; CDC42; D1; ACTIVATION	Phospholipase D (PLD) and small GTPases are vital to cell signaling. We report that the Rac2 and the PLD2 isoforms exist in the cell as a lipase-GTPase complex that enables the two proteins to elicit their respective functionalities. A strong association between the two molecules was demonstrated by co-immunoprecipitation and was confirmed in living cells by FRET with CFP-Rac2 and YFP-PLD2 fluorescent chimeras. We have identified the amino acids in PLD2 that define a specific binding site to Rac2. This site is composed of two CRIB (Cdc42-and Rac-interactive binding) motifs that we have named "CRIB-1" and "CRIB-2" in and around the PH domain in PLD2. Deletion mutants PLD2-Delta CRIB-1/2 negate co-immunoprecipitation with Rac2 and diminish the FRET signal in living cells. The PLD2-Rac2 association was further confirmed in vitro using affinity-purified recombinant proteins. Binding was saturable with an apparent K-d of 3 nM and was diminished with PLD2-Delta CRIB mutants. Furthermore, PLD2 bound more efficiently to Rac2-GTP than to Rac2-GDP or to a GDP-constitutive Rac2-N17 mutant. Increasing concentrations of recombinant Rac2 in vitro and in vivo during cell adhesion inhibit PLD2. Conversely, Rac2 activity is increased in the presence of PLD2-WT but not in PLD2-Delta CRIB. We propose that in activated cells PLD2 affects Rac2 in an initial positive feedback, but as Rac2-GTP accumulates in the cell, this constitutes a "termination signal" leading to PLD2 inactivation.	[Peng, Hong-Juan; Henkels, Karen M.; Mahankali, Madhu; Gomez-Cambronero, Julian] Wright State Univ, Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Dinauer, Mary C.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat Hematol Oncol, Indianapolis, IN 46202 USA	University System of Ohio; Wright State University Dayton; Indiana University System; Indiana University Bloomington	Gomez-Cambronero, J (corresponding author), Wright State Univ, Sch Med, Dept Biochem & Mol Biol, 3640 Colonel Glenn Highway, Dayton, OH 45435 USA.	julian.cambronero@wright.edu	Peng, Hongjuan/GYV-5462-2022	Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health [HL056653]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL056653, R01HL056653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL056653 (to J. G.-C.).	Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Bi EF, 1999, CURR BIOL, V9, pR160, DOI 10.1016/S0960-9822(99)80102-X; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bompard G, 2003, J CELL SCI, V116, P2519, DOI 10.1242/jcs.00448; Brown FD, 1998, CURR BIOL, V8, P835, DOI 10.1016/S0960-9822(98)70326-4; BROWN HA, 1995, J BIOL CHEM, V270, P14935, DOI 10.1074/jbc.270.25.14935; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chae YC, 2008, MOL BIOL CELL, V19, P3111, DOI 10.1091/mbc.E07-04-0337; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; Dinauer MC, 2003, CURR OPIN HEMATOL, V10, P8, DOI 10.1097/00062752-200301000-00003; Du GW, 2009, MOL BIOL CELL, V20, P200, DOI 10.1091/mbc.E08-06-0555; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; Du GW, 2000, MOL BIOL CELL, V11, P4359, DOI 10.1091/mbc.11.12.4359; Faugaret D, 2011, BIOCHEM PHARMACOL, V81, P144, DOI 10.1016/j.bcp.2010.09.014; Freiss G, 2004, B CANCER, V91, P325; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Hiroyama M, 2005, J CELL PHYSIOL, V202, P608, DOI 10.1002/jcp.20156; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Jones D, 1999, BBA-MOL CELL BIOL L, V1439, P229, DOI 10.1016/S1388-1981(99)00097-9; Kurz T, 2004, J MOL CELL CARDIOL, V36, P225, DOI 10.1016/j.yjmcc.2003.11.008; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; MANSER E, 1995, J BIOL CHEM, V270, P25070, DOI 10.1074/jbc.270.42.25070; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARTIN GA, 1995, EMBO J, V14, P4385, DOI 10.1002/j.1460-2075.1995.tb00113.x; McDermott M, 2004, BIOCHEM CELL BIOL, V82, P225, DOI 10.1139/o03-079; Mohseni M, 2009, CELL ADHES MIGR, V3, P191, DOI 10.4161/cam.3.2.7375; Olivo C, 2000, ONCOGENE, V19, P1428, DOI 10.1038/sj.onc.1203440; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Powner DJ, 2002, FEBS LETT, V531, P62, DOI 10.1016/S0014-5793(02)03410-5; Powner DJ, 2002, MOL BIOL CELL, V13, P1252, DOI 10.1091/mbc.01-05-0235; Rivero F, 2002, J MUSCLE RES CELL M, V23, P737, DOI 10.1023/A:1024423611223; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Schmidt M, 1996, J BIOL CHEM, V271, P2422, DOI 10.1074/jbc.271.5.2422; Schmidt M, 1999, J BIOL CHEM, V274, P14648, DOI 10.1074/jbc.274.21.14648; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; SINGER WD, 1995, J BIOL CHEM, V270, P14944, DOI 10.1074/jbc.270.25.14944; Weernink PAO, 2004, J BIOL CHEM, V279, P7840, DOI 10.1074/jbc.M312737200; Yamazaki M, 1999, J BIOL CHEM, V274, P6035, DOI 10.1074/jbc.274.10.6035	46	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.206672	http://dx.doi.org/10.1074/jbc.M110.206672			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21378159	Green Published, hybrid			2022-12-27	WOS:000290022800069
J	Tafel, AA; Wu, L; McHugh, PJ				Tafel, Agnieszka A.; Wu, Leonard; McHugh, Peter J.			Human HEL308 Localizes to Damaged Replication Forks and Unwinds Lagging Strand Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINK REPAIR; SENSITIVITY PROTEIN MUS308; FANCONI-ANEMIA PROTEIN; DNA HELICASE; HOMOLOGOUS RECOMBINATION; IN-VITRO; SULFOLOBUS-TOKODAII; POLYMERASE; FANCD2; REGRESSION	HEL308 is a superfamily II DNA helicase, conserved from archaea through to humans. HEL308 family members were originally isolated by their similarity to the Drosophila melanogaster Mus308 protein, which contributes to the repair of replication-blocking lesions such as DNA interstrand cross-links. Biochemical studies have established that human HEL308 is an ATP-dependent enzyme that unwinds DNA with a 3' to 5' polarity, but little else is know about its mechanism. Here, we show that GFP-tagged HEL308 localizes to replication forks following camptothecin treatment. Moreover, HEL308 colocalizes with two factors involved in the repair of damaged forks by homologous recombination, Rad51 and FANCD2. Purified HEL308 requires a 3' single-stranded DNA region to load and unwind duplex DNA structures. When incubated with substrates that model stalled replication forks, HEL308 preferentially unwinds the parental strands of a structure that models a fork with a nascent lagging strand, and the unwinding action of HEL308 is specifically stimulated by human replication protein A. Finally, we show that HEL308 appears to target and unwind from the junction between single-stranded to double-stranded DNA on model fork structures. Together, our results suggest that one role for HEL308 at sites of blocked replication might be to open up the parental strands to facilitate the loading of subsequent factors required for replication restart.	[Tafel, Agnieszka A.; Wu, Leonard; McHugh, Peter J.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	McHugh, PJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	peter.mchugh@imm.ox.ac.uk		McHugh, Peter/0000-0002-8679-4627	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK grants (to P. J. M. and L. W.).	Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Bernstein KA, 2010, ANNU REV GENET, V44, P393, DOI 10.1146/annurev-genet-102209-163602; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Blastyak A, 2010, MOL CELL BIOL, V30, P684, DOI 10.1128/MCB.00863-09; BOYD JB, 1990, GENETICS, V125, P813; Cadman CJ, 2006, J MOL BIOL, V362, P18, DOI 10.1016/j.jmb.2006.06.032; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Fujikane R, 2006, GENES CELLS, V11, P99, DOI 10.1111/j.1365-2443.2006.00925.x; Fujikane R, 2005, J BIOL CHEM, V280, P12351, DOI 10.1074/jbc.M413417200; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; Guy CP, 2005, NUCLEIC ACIDS RES, V33, P3678, DOI 10.1093/nar/gki685; Harris PV, 1996, MOL CELL BIOL, V16, P5764; Hussain S, 2004, HUM MOL GENET, V13, P1241, DOI 10.1093/hmg/ddh135; Li Z, 2008, J BACTERIOL, V190, P3006, DOI 10.1128/JB.01662-07; Liu YL, 2010, DNA REPAIR, V9, P325, DOI 10.1016/j.dnarep.2010.01.006; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Lu SH, 2008, BIOCHEM BIOPH RES CO, V376, P369, DOI 10.1016/j.bbrc.2008.08.150; Machwe A, 2005, J BIOL CHEM, V280, P23397, DOI 10.1074/jbc.M414130200; MacKay C, 2009, BIOCHEM BIOPH RES CO, V390, P187, DOI 10.1016/j.bbrc.2009.08.151; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Marini F, 2003, J BIOL CHEM, V278, P32014, DOI 10.1074/jbc.M305646200; Marini F, 2002, J BIOL CHEM, V277, P8716, DOI 10.1074/jbc.M110271200; Moldovan GL, 2010, MOL CELL BIOL, V30, P1088, DOI 10.1128/MCB.01124-09; Muzzini DM, 2008, DNA REPAIR, V7, P941, DOI 10.1016/j.dnarep.2008.03.021; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rossi ML, 2010, DNA REPAIR, V9, P331, DOI 10.1016/j.dnarep.2009.12.011; Seki M, 2003, NUCLEIC ACIDS RES, V31, P6117, DOI 10.1093/nar/gkg814; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Woodman IL, 2011, DNA REPAIR, V10, P306, DOI 10.1016/j.dnarep.2010.12.001; Woodman IL, 2009, BIOCHEM SOC T, V37, P74, DOI 10.1042/BST0370074; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Yoshimura M, 2006, MOL CELL, V24, P115, DOI 10.1016/j.molcel.2006.07.032	36	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.228189	http://dx.doi.org/10.1074/jbc.M111.228189			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21398521	Green Published, hybrid			2022-12-27	WOS:000290022800024
J	Garalde, DR; Simon, CA; Dahl, JM; Wang, H; Akeson, M; Lieberman, KR				Garalde, Daniel R.; Simon, Christopher A.; Dahl, Joseph M.; Wang, Hongyun; Akeson, Mark; Lieberman, Kate R.			Distinct Complexes of DNA Polymerase I (Klenow Fragment) for Base and Sugar Discrimination during Nucleotide Substrate Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGES; ANGSTROM RESOLUTION; ELECTRONIC CONTROL; CRYSTAL-STRUCTURES; KINETIC MECHANISM; STRUCTURAL BASIS; ACTIVE-SITE; NANOPORE; MOLECULES; REPLICATION	During each catalytic cycle, DNA polymerases select deoxyribonucleoside triphosphate (dNTP) substrates complementary to a templating base with high fidelity from a pool that includes noncomplementary dNTPs and both complementary and noncomplementary ribonucleoside triphosphates (rNTPs). The Klenow fragment of Escherichia coli DNA polymerase I (KF) achieves this through a series of conformational transitions that precede the chemical step of phosphodiester bond formation. Kinetic evidence from fluorescence and FRET experiments indicates that discrimination of the base and sugar moieties of the incoming nucleotide occurs in distinct, sequential steps during the selection pathway. Here we show that KF-DNA complexes formed with complementary rNTPs or with noncomplementary nucleotides can be distinguished on the basis of their properties when captured in an electric field atop the alpha-hemolysin nanopore. The average nanopore dwell time of KF-DNA complexes increased as a function of complementary rNTP concentration. The increase was less than that promoted by complementary dNTP, indicating that the rNTP complexes are more stable than KF-DNA binary complexes but less stable than KF-DNA-dNTP ternary complexes. KF-DNA-rNTP complexes could also be distinguished from KF-DNA-dNTP complexes on the basis of ionic current amplitude. In contrast to complementary rNTPs, noncomplementary dNTPs and rNTPs diminished the average nanopore dwell time of KF-DNA complexes in a concentration-dependent manner, suggesting that binding of a noncomplementary nucleotide keeps the KF-DNA complex in a less stable state. These results imply that nucleotide selection proceeds through a series of complexes of increasing stability in which substrates with the correct moiety promote the forward transitions.	[Dahl, Joseph M.; Akeson, Mark; Lieberman, Kate R.] Univ Calif Santa Cruz, Baskin Sch Engn, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Garalde, Daniel R.] Univ Calif Santa Cruz, Baskin Sch Engn, Dept Comp Engn, Santa Cruz, CA 95064 USA; [Simon, Christopher A.; Wang, Hongyun] Univ Calif Santa Cruz, Baskin Sch Engn, Dept Appl Math & Stat, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Lieberman, KR (corresponding author), Univ Calif Santa Cruz, Baskin Sch Engn, Dept Biomol Engn, 1156 High St,MS SOE2, Santa Cruz, CA 95064 USA.	lieberman@biology.ucsc.edu	Akeson, Mark/HCH-3046-2022		National Institutes of Health from the NHGRI [1RC2HG005553]; National Institutes of Health from the NIGMS [1R01GM087484-01A2]; National Science Foundation [DMS-0719361]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087484] Funding Source: NIH RePORTER	National Institutes of Health from the NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RC2HG005553 from the NHGRI (to M. A.) and 1R01GM087484-01A2 from the NIGMS (to K. R. L. and M. A.).; Supported in part by National Science Foundation Grant DMS-0719361.	Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; Benner S, 2007, NAT NANOTECHNOL, V2, P718, DOI 10.1038/nnano.2007.344; Bermek O, 2011, J BIOL CHEM, V286, P3755, DOI 10.1074/jbc.M110.167593; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Cockroft SL, 2008, J AM CHEM SOC, V130, P818, DOI 10.1021/ja077082c; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; Datta K, 2010, P NATL ACAD SCI USA, V107, P17980, DOI 10.1073/pnas.1012277107; DeLucia AM, 2006, J BIOL CHEM, V281, P27286, DOI 10.1074/jbc.M604393200; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Dzantiev L, 1999, J BIOL CHEM, V274, P3279, DOI 10.1074/jbc.274.6.3279; Dzantiev L, 2001, BIOCHEMISTRY-US, V40, P3215, DOI 10.1021/bi002569i; Gyarfas B, 2009, ACS NANO, V3, P1457, DOI 10.1021/nn900303g; Hurt N, 2009, J AM CHEM SOC, V131, P3772, DOI 10.1021/ja809663f; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Lieberman KR, 2010, J AM CHEM SOC, V132, P17961, DOI 10.1021/ja1087612; Minnick DT, 2002, P NATL ACAD SCI USA, V99, P1194, DOI 10.1073/pnas.032457899; Olasagasti F, 2010, NAT NANOTECHNOL, V5, P798, DOI [10.1038/nnano.2010.177, 10.1038/NNANO.2010.177]; Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; SAVAGE LJ, 1976, ANN STAT, V4, P441, DOI 10.1214/aos/1176343456; Stengel G, 2007, BIOCHEMISTRY-US, V46, P12289, DOI 10.1021/bi700755m; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Vercoutere W, 2001, NAT BIOTECHNOL, V19, P248, DOI 10.1038/85696; Wilson NA, 2009, ACS NANO, V3, P995, DOI 10.1021/nn9000897	31	20	25	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14480	14492		10.1074/jbc.M111.218750	http://dx.doi.org/10.1074/jbc.M111.218750			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21362617	hybrid, Green Published			2022-12-27	WOS:000289556200069
J	Gentile, MA; Melchiorre, S; Emolo, C; Moschioni, M; Gianfaldoni, C; Pancotto, L; Ferlenghi, I; Scarselli, M; Pansegrau, W; Veggi, D; Merola, M; Cantini, F; Ruggiero, P; Banci, L; Masignani, V				Gentile, Maria Antonietta; Melchiorre, Sara; Emolo, Carla; Moschioni, Monica; Gianfaldoni, Claudia; Pancotto, Laura; Ferlenghi, Ilaria; Scarselli, Maria; Pansegrau, Werner; Veggi, Daniele; Merola, Marcello; Cantini, Francesca; Ruggiero, Paolo; Banci, Lucia; Masignani, Vega			Structural and Functional Characterization of the Streptococcus pneumoniae RrgB Pilus Backbone D1 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCUS; MAGNETIC-RESONANCE RELAXATION; GRAM-POSITIVE BACTERIA; MODEL-FREE APPROACH; ISOPEPTIDE BONDS; CORYNEBACTERIUM-DIPHTHERIAE; STABILIZING ISOPEPTIDE; OTITIS-MEDIA; UCSF CHIMERA; PROTEIN NMR	Streptococcus pneumoniae expresses on its surface adhesive pili, involved in bacterial attachment to epithelial cells and virulence. The pneumococcal pilus is composed of three proteins, RrgA, RrgB, and RrgC, each stabilized by intramolecular isopeptide bonds and covalently polymerized by means of intermolecular isopeptide bonds to form an extended fiber. RrgB is the pilus scaffold subunit and is protective in vivo in mouse models of sepsis and pneumonia, thus representing a potential vaccine candidate. The crystal structure of a major RrgB C-terminal portion featured an organization into three independently folded protein domains (D2-D4), whereas the N-terminal D1 domain (D1) remained unsolved. We have tested the four single recombinant RrgB domains in active and passive immunization studies and show that D1 is the most effective, providing a level of protection comparable with that of the full-length protein. To elucidate the structural features of D1, we solved the solution structure of the recombinant domain by NMR spectroscopy. The spectra analysis revealed that D1 has many flexible regions, does not contain any intramolecular isopeptide bond, and shares with the other domains an Ig-like fold. In addition, we demonstrated, by site-directed mutagenesis and complementation in S. pneumoniae, that the D1 domain contains the Lys residue (Lys-183) involved in the formation of the intermolecular isopeptide bonds and pilus polymerization. Finally, we present a model of the RrgB protein architecture along with the mapping of two surface-exposed linear epitopes recognized by protective antisera.	[Cantini, Francesca; Banci, Lucia] Univ Florence, Magnet Resonance Ctr, Dept Chem, I-50019 Sesto Fiorentino, Italy; [Gentile, Maria Antonietta; Melchiorre, Sara; Emolo, Carla; Moschioni, Monica; Gianfaldoni, Claudia; Pancotto, Laura; Ferlenghi, Ilaria; Scarselli, Maria; Pansegrau, Werner; Veggi, Daniele; Merola, Marcello; Ruggiero, Paolo; Masignani, Vega] Novartis Vaccines & Diagnost Res Ctr, I-53100 Siena, Italy; [Merola, Marcello] Univ Naples Federico II, I-80126 Naples, Italy	University of Florence; Novartis; University of Naples Federico II	Banci, L (corresponding author), Univ Florence, Magnet Resonance Ctr, Dept Chem, Via L Sacconi 6, I-50019 Sesto Fiorentino, Italy.	banci@cerm.unifi.it; vega.masignani@novartis.com	Cantini, Francesca/O-1220-2015	Cantini, Francesca/0000-0003-0526-6732; BANCI, LUCIA/0000-0003-0562-5774	Ministero dell'Istruzione, dell'Universita e della Ricerca (Fondi per gli Investimenti della Ricerca di Base-Proteomica) [RBRN07BMCT]; Integrated Structural Biology Infrastructure for Europ [211252]	Ministero dell'Istruzione, dell'Universita e della Ricerca (Fondi per gli Investimenti della Ricerca di Base-Proteomica)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Integrated Structural Biology Infrastructure for Europ	This work was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca (Fondi per gli Investimenti della Ricerca di Base-Proteomica RBRN07BMCT) and Integrated Structural Biology Infrastructure for Europe Contract 211252. Because some of the authors are employees of Novartis Vaccines, there are competing financial interests.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; ACHEN MG, 1986, GENE, V45, P45, DOI 10.1016/0378-1119(86)90130-7; Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; El Mortaji L, 2010, J BIOL CHEM, V285, P12405, DOI 10.1074/jbc.M109.082776; Falker S, 2008, MOL MICROBIOL, V70, P595, DOI 10.1111/j.1365-2958.2008.06396.x; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fletcher MA, 2007, VACCINE, V25, P2507, DOI 10.1016/j.vaccine.2006.09.027; Gianfaldoni C, 2007, INFECT IMMUN, V75, P1059, DOI 10.1128/IAI.01400-06; Goddard TD, 2005, STRUCTURE, V13, P473, DOI 10.1016/j.str.2005.01.006; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Guttilla IK, 2009, J BACTERIOL, V191, P5603, DOI 10.1128/JB.00627-09; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Holm L, 1996, METHOD ENZYMOL, V266, P653; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Melegaro A, 2004, EPIDEMIOL INFECT, V132, P433, DOI 10.1017/S0950268804001980; Melegaro A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-90; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Millar EV, 2009, PEDIATR INFECT DIS J, V28, P711, DOI 10.1097/INF.0b013e3181a06303; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Moschioni M, 2010, INFECT IMMUN, V78, P5033, DOI 10.1128/IAI.00601-10; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; PEARLMAN AD, 1995, COMP PHYS COMMUN, V91, P1; Pelton SI, 2009, PEDIATR INFECT DIS J, V28, pS133, DOI 10.1097/INF.0b013e3181b6d81a; Pezzicoli A, 2008, J INFECT DIS, V198, P890, DOI 10.1086/591182; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Ryan MW, 2000, LARYNGOSCOPE, V110, P961, DOI 10.1097/00005537-200006000-00014; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4	55	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14588	14597		10.1074/jbc.M110.202739	http://dx.doi.org/10.1074/jbc.M110.202739			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21367860	Green Published, hybrid			2022-12-27	WOS:000289556200078
J	Markiv, A; Peiris, D; Curley, GP; Odell, M; Dwek, MV				Markiv, Anatoliy; Peiris, Diluka; Curley, G. Paul; Odell, Mark; Dwek, Miriam V.			Identification, Cloning, and Characterization of Two N-Acetylgalactosamine-binding Lectins from the Albumen Gland of Helix pomatia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-REACTIVE HEMAGGLUTININ; BREAST-CANCER; HPA-BINDING; GEL-ELECTROPHORESIS; AGGLUTININ; SEPARATION; TUMOR; GLYCOSYLATION; PURIFICATION; INVOLVEMENT	Helix pomatia agglutinin (HPA), the lectin from the albumen gland of the Roman snail, has been used in histochemical studies relating glycosylation changes to the metastatic potential of solid tumors. To facilitate the use of HPA in a clinical (diagnostic) setting, detailed analysis of the lectin, including cloning and recombinant production of HPA, is required. A combination of isoelectric focusing, amino acid sequence analysis, and cloning revealed two polypeptides in native HPA preparations (HPAI and HPAII), both consistent with GalNAc-binding lectins of the H-type family. Pairwise sequence alignment showed that HPAI and HPAII share 54% sequence identity whereas molecular modeling using SWISS-MODEL suggests they are likely to adopt similar tertiary structure. The inherent heterogeneity of native HPA highlighted the need for production of functional recombinant protein; this was addressed by preparing His-thioredoxin-tagged fusion products in Escherichia coli Rosettagami B (DE3) cells. The recombinant lectins agglutinated human blood group A erythrocytes whereas their oligosaccharide specificity, evaluated using glycan microarrays, showed that they predominantly bind glycans with terminal alpha-GalNAc residues. Surface plasmon resonance with immobilized GalNAc-BSA confirmed that recombinant HPAI and HPAII bind strongly with this ligand (K-d = 0.60 nM and 2.00 nM, respectively) with a somewhat higher affinity to native HPA (K-d = 7.67 nM). Recombinant HPAII also bound the breast cancer cells of breast cancer tissue specimens in a manner similar to native lectin. The recombinant HPA described here shows important potential for future studies of cancer cell glycosylation and as a reagent for cancer prognostication.	[Markiv, Anatoliy; Peiris, Diluka; Curley, G. Paul; Odell, Mark; Dwek, Miriam V.] Univ Westminster, Sch Life Sci, Dept Mol & Appl Biosci, London W1W 6UW, England	Roehampton University; University of Westminster	Dwek, MV (corresponding author), Univ Westminster, Sch Life Sci, Dept Mol & Appl Biosci, 115 New Cavendish St, London W1W 6UW, England.	m.v.dwek@westminster.ac.uk		Dwek, Miriam/0000-0001-7184-2932; Markiv, Anatoliy/0000-0002-5307-0104	University of Westminster	University of Westminster	Supported by a University of Westminster Cavendish scholarship.	Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Brooks SA, 2003, ACTA HISTOCHEM, V105, P205, DOI 10.1078/0065-1281-00705; BROOKS SA, 1991, LANCET, V338, P71, DOI 10.1016/0140-6736(91)90071-V; Brooks SA, 2000, HISTOL HISTOPATHOL, V15, P143, DOI 10.14670/HH-15.143; CHOMCZYNSKI P, 1995, ANAL BIOCHEM, V225, P163, DOI 10.1006/abio.1995.1126; Dwek MV, 2004, CURR CANCER DRUG TAR, V4, P425, DOI 10.2174/1568009043332899; Gorg A, 1999, ELECTROPHORESIS, V20, P712; HAMMARST.S, 1969, BIOCHEMISTRY-US, V8, P2696, DOI 10.1021/bi00835a002; HAMMARSTROM S, 1972, EUR J BIOCHEM, V25, P274, DOI 10.1111/j.1432-1033.1972.tb01694.x; HAMMARSTROM S, 1974, ANN NY ACAD SCI, V234, P183, DOI 10.1111/j.1749-6632.1974.tb53031.x; HAMMARSTROM S, 1972, Scandinavian Journal of Immunology, V1, P295, DOI 10.1111/j.1365-3083.1972.tb03295.x; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Kudo T, 2002, J BIOL CHEM, V277, P47724, DOI 10.1074/jbc.M205839200; LEATHEM AJ, 1987, LANCET, V1, P1054; Lisgarten JN, 2000, ACTA CRYSTALLOGR D, V56, P109, DOI 10.1107/S0907444999007957; MARKIV A, 2008, THESIS U WESTMINSTER; Okuyama T, 1998, CANCER-AM CANCER SOC, V82, P1468, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1468::AID-CNCR6>3.0.CO;2-5; Oyelaran O, 2009, J PROTEOME RES, V8, P3529, DOI 10.1021/pr9002245; Renwrantz L, 2009, J MOLLUS STUD, V75, P41, DOI 10.1093/mollus/eyn037; Sanchez JF, 2006, J BIOL CHEM, V281, P20171, DOI 10.1074/jbc.M603452200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHUMACHER U, 1994, CANCER-AM CANCER SOC, V74, P3104, DOI 10.1002/1097-0142(19941215)74:12<3104::AID-CNCR2820741207>3.0.CO;2-0; Schumacher U, 1997, HISTOCHEM J, V29, P677, DOI 10.1023/A:1026404832394; TAKATSU A, 1971, JPN J EXP MED, V41, P411; Taylor KE, 2007, IMMUNOLOGY, V120, P404, DOI 10.1111/j.1365-2567.2006.02516.x; Terasawa K, 1996, CANCER RES, V56, P2229; UHLENBRU.G, 1967, NATURE, V213, P76, DOI 10.1038/213076a0; VRETBLAD P, 1979, BIOCHIM BIOPHYS ACTA, V579, P52, DOI 10.1016/0005-2795(79)90086-2	29	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20260	20266		10.1074/jbc.M110.184515	http://dx.doi.org/10.1074/jbc.M110.184515			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21372134	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000291267600013
J	Yoshii, SR; Kishi, C; Ishihara, N; Mizushima, N				Yoshii, Saori R.; Kishi, Chieko; Ishihara, Naotada; Mizushima, Noboru			Parkin Mediates Proteasome-dependent Protein Degradation and Rupture of the Outer Mitochondrial Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN-CELLS; PERMEABILITY TRANSITION; AUTOPHAGOSOME FORMATION; PREPROTEIN TRANSLOCASE; ENDOPLASMIC-RETICULUM; TNF-ALPHA; MITOPHAGY; DISEASE; MITOFUSIN; PINK1	Upon mitochondrial depolarization, Parkin, a Parkinson disease-related E3 ubiquitin ligase, translocates from the cytosol to mitochondria and promotes their degradation by mitophagy, a selective type of autophagy. Here, we report that in addition to mitophagy, Parkin mediates proteasome-dependent degradation of outer membrane proteins such as Tom20, Tom40, Tom70, and Omp25 of depolarized mitochondria. By contrast, degradation of the inner membrane and matrix proteins largely depends on mitophagy. Furthermore, Parkin induces rupture of the outer membrane of depolarized mitochondria, which also depends on proteasomal activity. Upon induction of mitochondrial depolarization, proteasomes are recruited to mitochondria in the perinuclear region. Neither proteasome-dependent degradation of outer membrane proteins nor outer membrane rupture is required for mitophagy. These results suggest that Parkin regulates degradation of outer and inner mitochondrial membrane proteins differently through proteasome-and mitophagy-dependent pathways.	[Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, Tokyo 1138519, Japan; [Ishihara, Naotada] Kurume Univ, Inst Life Sci, Dept Prot Biochem, Kurume, Fukuoka 8390864, Japan	Tokyo Medical & Dental University (TMDU); Kurume University	Mizushima, N (corresponding author), Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	nmizu.phy2@tmd.ac.jp	Yoshii, Saori/M-6170-2016; Mizushima, Noboru/C-3635-2009	Yoshii, Saori/0000-0002-0814-4776; Mizushima, Noboru/0000-0002-6258-6444; Ishihara, Naotada/0000-0002-6305-7149	Ministry of Education, Culture, Sports, Science and Technology, Japan; Takeda Science Foundation; Funding Program for Next Generation World-Leading Researchers	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to N. I. and N. M.), the Takeda Science Foundation (to N. M.), and the Funding Program for Next Generation World-Leading Researchers (to N. I. and N. M.).	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Angermuller S, 1998, J HISTOCHEM CYTOCHEM, V46, P1175, DOI 10.1177/002215549804601009; Chan N. C., 2011, HUM MOL GEN IN PRESS; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Chu CT, 2010, HUM MOL GENET, V19, pR28, DOI 10.1093/hmg/ddq143; Cohen MMJ, 2008, MOL BIOL CELL, V19, P2457, DOI 10.1091/mbc.E08-02-0227; Dickson DW, 2009, LANCET NEUROL, V8, P1150, DOI 10.1016/S1474-4422(09)70238-8; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Feldmann G, 2000, HEPATOLOGY, V31, P674, DOI 10.1002/hep.510310318; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hamazaki J, 2007, MOL CELL BIOL, V27, P6629, DOI 10.1128/MCB.00509-07; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Ishihara N, 1998, J BIOCHEM-TOKYO, V123, P722; Iwahashi J, 1997, J BIOL CHEM, V272, P18467, DOI 10.1074/jbc.272.29.18467; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Nakagawa T, 2007, GENES CELLS, V12, P709, DOI 10.1111/j.1365-2443.2007.01086.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Neutzner A, 2008, ANN NY ACAD SCI, V1147, P242, DOI 10.1196/annals.1427.012; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Suzuki H, 2002, J CELL SCI, V115, P1895; Suzuki H, 2000, J BIOL CHEM, V275, P37930, DOI 10.1074/jbc.M006558200; Takeda K, 2010, P NATL ACAD SCI USA, V107, P3540, DOI 10.1073/pnas.0911055107; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tanaka A, 2010, FEBS LETT, V584, P1386, DOI 10.1016/j.febslet.2010.02.060; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Yonashiro R, 2009, MOL BIOL CELL, V20, P4524, DOI 10.1091/mbc.E09-02-0112; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zhu JH, 2010, J ALZHEIMERS DIS, V20, pS325, DOI 10.3233/JAD-2010-100363; Zischka H, 2008, ANAL CHEM, V80, P5051, DOI 10.1021/ac800173r; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	58	441	451	2	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19630	19640		10.1074/jbc.M110.209338	http://dx.doi.org/10.1074/jbc.M110.209338			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21454557	Green Published, hybrid			2022-12-27	WOS:000291027700046
J	Chen, ZX; Riggs, AD				Chen, Zhao-xia; Riggs, Arthur D.			DNA Methylation and Demethylation in Mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DE-NOVO METHYLATION; MATERNAL GENOMIC IMPRINTS; ZYGOTIC PATERNAL GENOME; PRIMORDIAL GERM-CELLS; GLYCOSYLASE ACTIVITY; HISTONE H3; METHYLTRANSFERASE DNMT3A; MAINTENANCE METHYLATION; MOUSE; GENE	Cell type-specific DNA methylation patterns are established during mammalian development and maintained in adult somatic cells. Understanding how these patterns of 5-methylcytosine are established and maintained requires the elucidation of mechanisms for both DNA methylation and demethylation. The enzymes involved in the de novo methylation of DNA and the maintenance of the resulting methylation patterns have been fairly well characterized. However, important remaining challenges are to understand how DNA methylation systems function in vivo and in the context of chromatin. In addition, the enzymes and mechanisms for demethylation remain to be elucidated. There is still no consensus as to how active enzymatic demethylation is achieved in mammalian cells, but recent studies implicate base excision repair for genome-wide DNA demethylation in germ cells and early embryos.	[Chen, Zhao-xia; Riggs, Arthur D.] Beckman Res Inst City Hope, Div Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Riggs, AD (corresponding author), Beckman Res Inst City Hope, Div Biol, Duarte, CA 91010 USA.	ariggs@coh.org		Riggs, Arthur/0000-0002-8184-5288				Aapola U, 2000, GENOMICS, V65, P293, DOI 10.1006/geno.2000.6168; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; BIRD A, 2002, CYTOGENET CELL GENET, V16, P9; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; CANNON SV, 1988, BIOCHEM BIOPH RES CO, V151, P1173, DOI 10.1016/S0006-291X(88)80489-3; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Chen ZX, 2005, J CELL BIOCHEM, V95, P902, DOI 10.1002/jcb.20447; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Engel N, 2009, EPIGENETICS-US, V4, P98, DOI 10.4161/epi.4.2.7858; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Ferguson-Smith AC, 2007, NATURE, V449, P148, DOI 10.1038/449148a; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Glass JL, 2009, MAMM GENOME, V20, P633, DOI 10.1007/s00335-009-9232-3; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hata K, 2002, DEVELOPMENT, V129, P1983; Hodges E, 2009, GENOME RES, V19, P1593, DOI 10.1101/gr.095190.109; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Jurkowska RZ, 2008, NUCLEIC ACIDS RES, V36, P6656, DOI 10.1093/nar/gkn747; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Riggs AD, 2004, P NATL ACAD SCI USA, V101, P4, DOI 10.1073/pnas.0307781100; Rountree MR, 2010, HEREDITY, V105, P38, DOI 10.1038/hdy.2010.44; Santos F, 2004, REPRODUCTION, V127, P643, DOI 10.1530/rep.1.00221; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zhu B, 2000, NUCLEIC ACIDS RES, V28, P4157, DOI 10.1093/nar/28.21.4157; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	87	268	281	1	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18347	18353		10.1074/jbc.R110.205286	http://dx.doi.org/10.1074/jbc.R110.205286			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454628	hybrid, Green Published			2022-12-27	WOS:000290785700006
J	Sun, Y; Perera, J; Rubin, BP; Huang, JT				Sun, Yin; Perera, Juanita; Rubin, Brian P.; Huang, Jiaoti			SYT-SSX1 (Synovial Sarcoma Translocated) Regulates PIASy Ligase Activity to Cause Overexpression of NCOA3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR COACTIVATOR; POLYMERASE CHAIN-REACTION; KAPPA-B ACTIVATION; PROSTATE-CANCER; TRANSCRIPTIONAL ACTIVITY; GENOTOXIC STRESS; DIAGNOSTIC-TOOL; ONCOPROTEIN SYT; RAR-ALPHA; AIB1	Chromosomal translocations are a major source of genetic abnormalities causally linked to certain malignancies. Synovial sarcoma is an aggressive soft tissue tumor characterized by a chromosomal translocation between chromosome 18 and X, generating oncoproteins such as SYT-SSX1 and SYT-SSX2. The molecular mechanism underlying the oncogenic potential of SYT-SSX1/2 is not clear. Here we show that SYT-SSX1 leads to up-regulation of NCOA3, a protein critical for the formation of various cancers. The increase of NCOA3 is essential for SYT-SSX1-mediated synovial sarcoma formation. SYT-SSX1 does so by increasing the sumoylation of NCOA3 through interaction with a SUMO E3 ligase, PIASy, as well as the sumoylation of NEMO. NEMO has also been shown to physically interact with NCOA3. Increased sumoylation of NCOA3 leads to its increased steady state level and nuclear localization. Our findings represent the first example that an oncoprotein directly regulates substrate modification by a SUMO E3 ligase, and leads to overexpression of a protein essential for tumor formation. Such a mechanistic finding provides an opportunity to design specific therapeutic interventions to treat synovial sarcoma.	[Rubin, Brian P.] Cleveland Clin Fdn, Dept Anat Pathol & Mol Genet, Taussig Canc Ctr, Cleveland, OH 44195 USA; [Rubin, Brian P.] Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; [Sun, Yin; Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Broad Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90095 USA; [Perera, Juanita] Univ Rochester, Dept Biomed Genet, Rochester, NY 14620 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Rochester	Rubin, BP (corresponding author), Cleveland Clin Fdn, Dept Anat Pathol & Mol Genet, Taussig Canc Ctr, L25, Cleveland, OH 44195 USA.	yinsun@mednet.ucla.edu; jiaotihuang@mednet.ucla.edu		Huang, Jiaoti/0000-0003-1195-1998	National Institutes of Health [R01 CA093848]; American Cancer Society [RSG-07-092-01-TBE]; Dept. of Defense [PC061456]; UCLA SPORE in prostate cancer; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA093848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Dept. of Defense(United States Department of Defense); UCLA SPORE in prostate cancer; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA093848 (to Y. S.). This work was also supported by Grants from the American Cancer Society (RSG-07-092-01-TBE), Dept. of Defense Prostate Cancer Research Program (PC061456), a developmental research award from UCLA SPORE in prostate cancer (PI: R. Reiter) and a challenge award from the Prostate Cancer Foundation (PI: O. Witte) (to J. H.).	Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Chung ACK, 2007, CANCER RES, V67, P5965, DOI 10.1158/0008-5472.CAN-06-3168; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; CREW AJ, 1995, EMBO J, V14, P2333, DOI 10.1002/j.1460-2075.1995.tb07228.x; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; DELEEUW B, 1995, HUM MOL GENET, V4, P1097, DOI 10.1093/hmg/4.6.1097; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; dos Santos NR, 2001, GENE CHROMOSOME CANC, V30, P1, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1056>3.0.CO;2-G; Eid JE, 2000, CELL, V102, P839, DOI 10.1016/S0092-8674(00)00072-6; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Glaeser M, 2001, HORM METAB RES, V33, P121, DOI 10.1055/s-2001-14938; Gnanapragasam VJ, 2001, BRIT J CANCER, V85, P1928, DOI 10.1054/bjoc.2001.2179; Gocke CB, 2005, J BIOL CHEM, V280, P5004, DOI 10.1074/jbc.M411718200; Guillou L, 2001, HUM PATHOL, V32, P105, DOI 10.1053/hupa.2001.21130; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Hiraga H, 1998, DIAGN MOL PATHOL, V7, P102, DOI 10.1097/00019606-199804000-00007; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Iwasaki T, 2005, ENDOCRINOLOGY, V146, P3892, DOI 10.1210/en.2004-1513; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Kato H, 2002, J BIOL CHEM, V277, P5498, DOI 10.1074/jbc.M108702200; Kawai A, 2004, CANCER LETT, V204, P105, DOI 10.1016/j.canlet.2003.09.031; Kim KI, 2006, MOL CELLS, V22, P247; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Ladanyi M, 2000, HUM PATHOL, V31, P532, DOI 10.1053/hp.2000.6706; Ladanyi M, 2001, ONCOGENE, V20, P5755, DOI 10.1038/sj.onc.1204601; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; LIMON J, 1986, CANCER GENET CYTOGEN, V23, P87, DOI 10.1016/0165-4608(86)90152-4; List HJ, 2001, BREAST CANCER RES TR, V68, P21, DOI 10.1023/A:1017910924390; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Mani A, 2006, CANCER RES, V66, P8680, DOI 10.1158/0008-5472.CAN-06-0557; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Palapattu GS, 2009, PROSTATE, V69, P787, DOI 10.1002/pros.20928; Panagopoulos I, 2001, GENE CHROMOSOME CANC, V31, P362, DOI 10.1002/gcc.1155; Perani M, 2005, J BIOL CHEM, V280, P42863, DOI 10.1074/jbc.M502963200; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Poteat HT, 1995, CANCER GENET CYTOGEN, V84, P76, DOI 10.1016/0165-4608(95)00090-9; Pretto D, 2006, ONCOGENE, V25, P3661, DOI 10.1038/sj.onc.1209413; Sakakura C, 2000, INT J CANCER, V89, P217; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Skytting B, 1999, J NATL CANCER I, V91, P974, DOI 10.1093/jnci/91.11.974; SMITH S, 1987, CANCER GENET CYTOGEN, V26, P179, DOI 10.1016/0165-4608(87)90147-6; Sun Y, 2006, ONCOGENE, V25, P1042, DOI 10.1038/sj.onc.1209143; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Willeke F, 1998, EUR J CANCER, V34, P2087, DOI 10.1016/S0959-8049(98)00240-8; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Wuerzberger-Davis SM, 2007, ONCOGENE, V26, P641, DOI 10.1038/sj.onc.1209815; Yi P, 2008, MOL CELL, V29, P465, DOI 10.1016/j.molcel.2007.12.030; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zheng LX, 2004, P NATL ACAD SCI USA, V101, P135, DOI 10.1073/pnas.2136685100; Zhu J, 2005, CANCER CELL, V7, P143, DOI 10.1016/j.ccr.2005.01.005	58	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18623	18632		10.1074/jbc.M110.176693	http://dx.doi.org/10.1074/jbc.M110.176693			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454665	hybrid, Green Published			2022-12-27	WOS:000290785700034
J	Zaidi, SK; Young, DW; Montecino, M; van Wijnen, AJ; Stein, JL; Lian, JB; Stein, GS				Zaidi, Sayyed K.; Young, Daniel W.; Montecino, Martin; van Wijnen, Andre J.; Stein, Janet L.; Lian, Jane B.; Stein, Gary S.			Bookmarking the Genome: Maintenance of Epigenetic Information	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACUTE MYELOGENOUS LEUKEMIA; TRANSCRIPTION FACTORS; DNA METHYLATION; GENE-EXPRESSION; X-CHROMOSOME; ASYMMETRIC SEGREGATION; HISTONE METHYLATION; BINDING PROTEINS; 21 TRANSLOCATION; SMALL RNAS	Mitotic inheritance of gene function is obligatory to sustain biological control. Emerging evidence suggests that epigenetic mechanisms are linked to transmission of cell fate, lineage commitment, and maintenance of cellular phenotype in progeny cells. Mechanisms of epigenetic memory include gene silencing by DNA methylation, transcriptional regulation by histone modifications, regulation of gene expression by noncoding small RNA molecules, and retention of regulatory machinery on target gene loci for activation and repression. We will focus on the regulatory implications of epigenetic memory for physiological control and for the onset and progression of disease.	[Zaidi, Sayyed K.; Young, Daniel W.; van Wijnen, Andre J.; Stein, Janet L.; Lian, Jane B.; Stein, Gary S.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Zaidi, Sayyed K.; Young, Daniel W.; van Wijnen, Andre J.; Stein, Janet L.; Lian, Jane B.; Stein, Gary S.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA; [Montecino, Martin] Univ Andres Bello, Fac Ciencias Biol, Ctr Invest Biomed, Santiago, Chile; [Montecino, Martin] Univ Andres Bello, Fac Med, Santiago, Chile	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Universidad Andres Bello; Universidad Andres Bello	Stein, GS (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA.	gary.stein@umassmed.edu	van Wijnen, Andre J./AAG-3578-2019; Zaidi, Sayyed Kaleem/I-5596-2019	van Wijnen, Andre J./0000-0002-4458-0946; Zaidi, Sayyed Kaleem/0000-0001-6664-5168	National Institutes of Health [P01 AR048818, P01 CA082834, 5 P30 DK32520]; NATIONAL CANCER INSTITUTE [P01CA082834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069, P01AR048818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AR048818, P01 CA082834, and 5 P30 DK32520. This is the second article in the Thematic Minireview Series on Epigenetics. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Ali SA, 2008, P NATL ACAD SCI USA, V105, P6632, DOI 10.1073/pnas.0800970105; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bakshi R, 2008, J CELL SCI, V121, P3981, DOI 10.1242/jcs.033431; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernards A, 2005, GROWTH FACTORS, V23, P143, DOI 10.1080/08977190500130480; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Bruserud O, 2007, CURR PHARM BIOTECHNO, V8, P388, DOI 10.2174/138920107783018417; Cao A, 2002, PEDIATR RES, V51, P415, DOI 10.1203/00006450-200204000-00003; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; Costa FF, 2008, GENE, V410, P9, DOI 10.1016/j.gene.2007.12.008; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; ELICEIRI GL, 1974, CELL, V3, P11, DOI 10.1016/0092-8674(74)90031-2; ERICKSON P, 1992, BLOOD, V80, P1825; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GOLD M, 1963, BIOCHEM BIOPH RES CO, V11, P107, DOI 10.1016/0006-291X(63)90075-5; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Goodrich JA, 2006, NAT REV MOL CELL BIO, V7, P612, DOI 10.1038/nrm1946; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; GROUDINE M, 1982, CELL, V30, P131, DOI 10.1016/0092-8674(82)90019-8; GURDON J. B., 1964, ADVANCE MORPHO GENESIS, V4, P1; GUTIERRE.RM, 1967, SCIENCE, V157, P1324, DOI 10.1126/science.157.3794.1324; He SH, 2006, J CELL SCI, V119, P1063, DOI 10.1242/jcs.02829; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Herranz Michel, 2006, Clin Transl Oncol, V8, P242, DOI 10.1007/BF02664934; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; Januschke J, 2008, ONCOGENE, V27, P6994, DOI 10.1038/onc.2008.349; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; John S, 1998, BIOESSAYS, V20, P275, DOI 10.1002/(SICI)1521-1878(199804)20:4<275::AID-BIES1>3.3.CO;2-6; Johnston CM, 1998, CELL, V94, P809, DOI 10.1016/S0092-8674(00)81739-0; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Krauss V, 2008, GENETICA, V133, P93, DOI 10.1007/s10709-007-9184-z; Ladurner AG, 2003, MOL CELL, V12, P1, DOI 10.1016/S1097-2765(03)00284-3; Lande-Diner L, 2005, NAT REV GENET, V6, P648, DOI 10.1038/nrg1639; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; MARTEGANI E, 1992, EMBO J, V11, P2151, DOI 10.1002/j.1460-2075.1992.tb05274.x; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; MCGHEE JD, 1981, CELL, V27, P45, DOI 10.1016/0092-8674(81)90359-7; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; McNeil S, 1999, P NATL ACAD SCI USA, V96, P14882, DOI 10.1073/pnas.96.26.14882; Mellor J, 2008, CURR OPIN GENET DEV, V18, P116, DOI 10.1016/j.gde.2007.12.005; MEYERS S, 1993, MOL CELL BIOL, V13, P6336, DOI 10.1128/MCB.13.10.6336; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Ng RK, 2008, CELL CYCLE, V7, P1173, DOI 10.4161/cc.7.9.5791; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; NUCIFORA G, 1993, BLOOD, V81, P883; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Peterson LF, 2004, ONCOGENE, V23, P4255, DOI 10.1038/sj.onc.1207727; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sarge KD, 2005, TRENDS BIOCHEM SCI, V30, P605, DOI 10.1016/j.tibs.2005.09.004; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Spencer CA, 2000, J CELL BIOL, V150, P13, DOI 10.1083/jcb.150.1.13; Stancheva I, 2005, BIOCHEM CELL BIOL, V83, P385, DOI 10.1139/o05-043; STEVELY WS, 1966, BIOCHEM J, V100, pC20, DOI 10.1042/bj1000020C; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Thorpe PH, 2008, COLD SH Q B, V73, P81, DOI 10.1101/sqb.2008.73.010; Tucker KL, 1996, P NATL ACAD SCI USA, V93, P12920, DOI 10.1073/pnas.93.23.12920; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WHITELAW E, 1990, MOL CELL BIOL, V10, P6596, DOI 10.1128/MCB.10.12.6596; Xin L, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-31; Yoon B, 2005, MOL CELL BIOL, V25, P11184, DOI 10.1128/MCB.25.24.11184-11190.2005; Yoon BJ, 2002, NAT GENET, V30, P92, DOI 10.1038/ng795; Young DW, 2007, P NATL ACAD SCI USA, V104, P3189, DOI 10.1073/pnas.0611419104; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Zaidi SK, 2007, NAT REV CANCER, V7, P454, DOI 10.1038/nrc2149; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827; Zaidi SK, 2003, P NATL ACAD SCI USA, V100, P14852, DOI 10.1073/pnas.2533076100; Zeng CM, 1997, P NATL ACAD SCI USA, V94, P6746, DOI 10.1073/pnas.94.13.6746; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	91	59	66	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18355	18361		10.1074/jbc.R110.197061	http://dx.doi.org/10.1074/jbc.R110.197061			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454629	hybrid, Green Published			2022-12-27	WOS:000290785700007
J	Antonenko, YN; Avetisyan, AV; Cherepanov, DA; Knorre, DA; Korshunova, GA; Markova, OV; Ojovan, SM; Perevoshchikova, IV; Pustovidko, AV; Rokitskaya, TI; Severina, II; Simonyan, RA; Smirnova, EA; Sobko, AA; Sumbatyan, NV; Severin, FF; Skulachev, VP				Antonenko, Yuri N.; Avetisyan, Armine V.; Cherepanov, Dmitry A.; Knorre, Dmitry A.; Korshunova, Galina A.; Markova, Olga V.; Ojovan, Silvia M.; Perevoshchikova, Irina V.; Pustovidko, Antonina V.; Rokitskaya, Tatyana I.; Severina, Inna I.; Simonyan, Ruben A.; Smirnova, Ekaterina A.; Sobko, Alexander A.; Sumbatyan, Natalia V.; Severin, Fedor F.; Skulachev, Vladimir P.			Derivatives of Rhodamine 19 as Mild Mitochondria-targeted Cationic Uncouplers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPHOBIC ION INTERACTIONS; LIPID BILAYER MEMBRANES; FATTY-ACIDS; PLASTOQUINONE DERIVATIVES; OXIDATIVE-PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; LIPOPHILIC DICATIONS; INTERRUPT EXECUTION; YEAST; MECHANISM	A limited decrease in mitochondrial membrane potential can be beneficial for cells, especially under some pathological conditions, suggesting that mild uncouplers (protonophores) causing such an effect are promising candidates for therapeutic uses. The great majority of protonophores are weak acids capable of permeating across membranes in their neutral and anionic forms. In the present study, protonophorous activity of a series of derivatives of cationic rhodamine 19, including dodecylrhodamine (C(12)R1) and its conjugate with plastoquinone (SkQR1), was revealed using a variety of assays. Derivatives of rhodamine B, lacking dissociable protons, showed no protonophorous properties. In planar bilayer lipid membranes, separating two compartments differing in pH, diffusion potential of H+ ions was generated in the presence of C(12)R1 and SkQR1. These compounds induced pH equilibration in liposomes loaded with the pH probe pyranine. C(12)R1 and SkQR1 partially stimulated respiration of rat liver mitochondria in State 4 and decreased their membrane potential. Also, C(12)R1 partially stimulated respiration of yeast cells but, unlike the anionic protonophore FCCP, did not suppress their growth. Loss of function of mitochondrial DNA in yeast (grande-petite transformation) is known to cause a major decrease in the mitochondrial membrane potential. We found that petite yeast cells are relatively more sensitive to the anionic uncouplers than to C(12)R1 compared with grande cells. Together, our data suggest that rhodamine 19-based cationic protonophores are self-limiting; their uncoupling activity is maximal at high membrane potential, but the activity decreases membrane potentials, which causes partial efflux of the uncouplers from mitochondria and, hence, prevents further membrane potential decrease.	[Antonenko, Yuri N.; Avetisyan, Armine V.; Cherepanov, Dmitry A.; Knorre, Dmitry A.; Korshunova, Galina A.; Markova, Olga V.; Ojovan, Silvia M.; Perevoshchikova, Irina V.; Pustovidko, Antonina V.; Rokitskaya, Tatyana I.; Severina, Inna I.; Simonyan, Ruben A.; Smirnova, Ekaterina A.; Sobko, Alexander A.; Severin, Fedor F.; Skulachev, Vladimir P.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia; [Sumbatyan, Natalia V.] Moscow MV Lomonosov State Univ, Fac Chem, Moscow 119991, Russia; [Skulachev, Vladimir P.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow 119991, Russia; [Skulachev, Vladimir P.] Moscow MV Lomonosov State Univ, Inst Mitoengn, Moscow 119991, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; Lomonosov Moscow State University; Lomonosov Moscow State University	Antonenko, YN (corresponding author), Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Leninskie Gory 1, Moscow 119991, Russia.	antonen@genebee.msu.ru; skulach@belozersky.msu.ru	Ruben, Simonyan/F-6493-2015; Cherepanov, Dmitry A./R-8391-2016; Severin, Fedor/AAD-5444-2019; Rokitskaya, Tatyana/J-3541-2013; Skulachev, Vladimir P/J-4164-2012; Antonenko, Yuri N/K-1323-2013; Knorre, Dmitry/D-8478-2012; Avetisyan, Armine/O-2426-2014; Sumbatyan, Nataliya V./B-2902-2015; Markova, Olga/J-5261-2013; Sumbatyan, Natalia/AAI-4474-2021	Ruben, Simonyan/0000-0003-0252-1216; Cherepanov, Dmitry A./0000-0001-6286-4638; Skulachev, Vladimir P/0000-0003-4886-2243; Knorre, Dmitry/0000-0001-7468-6963; Sumbatyan, Natalia/0000-0001-9361-7314; Severin, Fedor/0000-0001-6703-1256; Rokitskaya, Tatyana/0000-0002-7719-1875; Avetisyan, Armine/0000-0002-3882-2013; Skulachev, Vladimir/0000-0001-5141-7517	Russian Foundation for Basic Research [09-04-00890]; Institute of Mitoengineering, Moscow State University; Rostok Group of A.V. Chikunov	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Institute of Mitoengineering, Moscow State University; Rostok Group of A.V. Chikunov	This work was supported in part by Russian Foundation for Basic Research Grant 09-04-00890; the Institute of Mitoengineering, Moscow State University; and the Rostok Group of A.V. Chikunov.	ANDREYEV AY, 1988, FEBS LETT, V226, P265, DOI 10.1016/0014-5793(88)81436-4; ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x; Antonenko YN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1273, DOI 10.1134/S0006297908120018; Avnir Y, 2005, ANAL BIOCHEM, V347, P34, DOI 10.1016/j.ab.2005.09.026; Bakeeva LE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1288, DOI 10.1134/S000629790812002X; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Blaikie FH, 2006, BIOSCIENCE REP, V26, P231, DOI 10.1007/s10540-006-9018-8; BLAUSTEIN RO, 1988, BIOCHIM BIOPHYS ACTA, V946, P221, DOI 10.1016/0005-2736(88)90396-3; BORISOVA MP, 1974, J MEMBRANE BIOL, V18, P243, DOI 10.1007/BF01870115; Chen Y, 1999, J BIOL CHEM, V274, P18364, DOI 10.1074/jbc.274.26.18364; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Duvvuri M, 2004, J BIOL CHEM, V279, P32367, DOI 10.1074/jbc.M400735200; Fetisova EK, 2010, FEBS LETT, V584, P562, DOI 10.1016/j.febslet.2009.12.002; FLEWELLING RF, 1986, BIOPHYS J, V49, P541, DOI 10.1016/S0006-3495(86)83664-5; FLEWELLING RF, 1986, BIOPHYS J, V49, P531, DOI 10.1016/S0006-3495(86)83663-3; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Hallstrom TC, 2000, J BIOL CHEM, V275, P37347, DOI 10.1074/jbc.M007338200; Harper J A, 2001, Obes Rev, V2, P255, DOI 10.1046/j.1467-789X.2001.00043.x; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Johnson  D., 1967, METHOD ENZYMOL, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9; KAMP F, 1992, P NATL ACAD SCI USA, V89, P11367, DOI 10.1073/pnas.89.23.11367; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kyrychenko A, 2010, CHEM PHYS LETT, V485, P95, DOI 10.1016/j.cplett.2009.12.015; Lanni A, 2003, FEBS LETT, V543, P5, DOI 10.1016/S0014-5793(03)00320-X; LARIS PC, 1975, BIOCHIM BIOPHYS ACTA, V376, P415, DOI 10.1016/0005-2728(75)90163-2; LEBLANC OH, 1971, J MEMBRANE BIOL, V4, P227, DOI 10.1007/BF02431973; LIBERMAN EA, 1970, BIOCHIM BIOPHYS ACTA, V216, P30, DOI 10.1016/0005-2728(70)90156-8; LIBERMAN EA, 1969, BIOPHYSICS-USSR, V14, P477; Lou PH, 2007, BIOCHEM J, V407, P129, DOI 10.1042/BJ20070606; MCLAUGHLIN SGA, 1980, PHYSIOL REV, V60, P825, DOI 10.1152/physrev.1980.60.3.825; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; NAGAMUNE H, 1993, BIOCHIM BIOPHYS ACTA, V1141, P231, DOI 10.1016/0005-2728(93)90047-J; Nedergaard J, 2003, EXP PHYSIOL, V88, P65, DOI 10.1113/eph8802502; Pandit SA, 2008, LANGMUIR, V24, P6858, DOI 10.1021/la8004135; Petit PX, 1996, CYTOMETRY, V23, P28, DOI 10.1002/(SICI)1097-0320(19960101)23:1<28::AID-CYTO5>3.0.CO;2-I; PICKAR AD, 1978, J MEMBRANE BIOL, V44, P353, DOI 10.1007/BF01944229; Plotnikov EY, 2011, BBA-MOL BASIS DIS, V1812, P77, DOI 10.1016/j.bbadis.2010.09.008; Plotnikov EY, 2010, BIOCHEMISTRY-MOSCOW+, V75, P145, DOI 10.1134/S0006297910020045; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; RAYMOND M, 1994, MOL CELL BIOL, V14, P277, DOI 10.1128/MCB.14.1.277; Rokitskaya TI, 2008, J MEMBRANE BIOL, V224, P9, DOI 10.1007/s00232-008-9124-6; Rokitskaya TI, 2010, BBA-BIOMEMBRANES, V1798, P1698, DOI 10.1016/j.bbamem.2010.05.018; Ross MF, 2006, BIOCHEM J, V400, P199, DOI 10.1042/BJ20060919; SCHWALLER MA, 1995, J BIOL CHEM, V270, P22709, DOI 10.1074/jbc.270.39.22709; Severin FF, 2010, P NATL ACAD SCI USA, V107, P663, DOI 10.1073/pnas.0910216107; Severina II, 2007, BBA-BIOENERGETICS, V1767, P1164, DOI 10.1016/j.bbabio.2007.05.010; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; SKULACHEV VP, 1967, NATURE, V216, P718, DOI 10.1038/216718a0; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; SLONIMSKI PP, 1968, BIOCHEM BIOPH RES CO, V30, P232, DOI 10.1016/0006-291X(68)90440-3; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SUN XC, 1992, J BIOL CHEM, V267, P19147; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291	56	66	77	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17831	17840		10.1074/jbc.M110.212837	http://dx.doi.org/10.1074/jbc.M110.212837			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454507	Green Published, hybrid			2022-12-27	WOS:000290585200046
J	Murali, S; Leong, DFM; Lee, JJL; Cool, SM; Nurcombe, V				Murali, Sadasivam; Leong, Denise F. M.; Lee, Jaslyn J. L.; Cool, Simon M.; Nurcombe, Victor			Comparative Assessment of the Effects of Gender-specific Heparan Sulfates on Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; IDURONATE 2-SULFATE RESIDUES; CHEMICALLY-MODIFIED HEPARINS; FLAVOBACTERIUM-HEPARINUM; SUBSTRATE-SPECIFICITY; PURIFICATION; DEGRADATION; SACCHARIDES; COMPLEXES; MARROW	We compare here the structural and functional properties of heparan sulfate (HS) chains from both male or female adult mouse liver through a combination of molecular sieving, enzymatic cleavage, and strong anion exchange-HPLC. The results demonstrated that male and female HS chains are significantly different by a number of parameters; size determination showed that HS chain lengths were similar to 100 and similar to 22 kDa, comprising 30-40 and 6-8 disaccharide repeats, respectively. Enzymatic depolymerization and disaccharide composition analyses also demonstrated significant differences in domain organization and fine structure. N-Unsubstituted glucosamine(Delta HexA-GlcNH(3)(+), Delta HexA-GlcNH(3)(+)(6S), Delta HexA(2S)-GlcNH(3)(+), and N-acetylglucosamine (Delta HexA-GlcNAc) are the predominant disaccharides in male mouse liver HS. However, N-sulfated glucosamine (Delta HexA-GlcNSO(3)) is the predominant disaccharide found in female liver. These structurally different male and female liver HS forms exert differential effects on human mesenchymal cell proliferation and subsequent osteogenic differentiation. The present study demonstrates the potential usefulness of gender-specific liver HS for the manipulation of human mesenchymal cell properties, including expansion, multipotentiality, and subsequent matrix mineralization. Our results suggest that HS chains show both tissue-and gender-specific differences in biochemical composition that directly reflect their biological activity.	[Murali, Sadasivam; Leong, Denise F. M.; Lee, Jaslyn J. L.; Cool, Simon M.; Nurcombe, Victor] Inst Med Biol, Stem Cells & Tissue Repair Grp, Singapore 138648, Singapore; [Cool, Simon M.; Nurcombe, Victor] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Orthopaed Surg, Singapore 119074, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore	Nurcombe, V (corresponding author), Inst Med Biol, Stem Cells & Tissue Repair Grp, 8A Biomed Grove,06-06 Immunos, Singapore 138648, Singapore.	victor.nurcombe@imb.a-star.edu.sg	Cool, Simon/W-1257-2018; Cool, Simon McKenzie/AAG-4346-2021	Cool, Simon/0000-0001-8543-3056; 	Biomedical Research Council A*STAR (Agency for Science Technology and Research), Singapore; Institute of Medical Biology, Singapore	Biomedical Research Council A*STAR (Agency for Science Technology and Research), Singapore(Agency for Science Technology & Research (A*STAR)); Institute of Medical Biology, Singapore	This work was supported by the Biomedical Research Council A*STAR (Agency for Science Technology and Research), Singapore, and the Institute of Medical Biology, Singapore.	Berry D, 2004, BIOCHEM BIOPH RES CO, V314, P994, DOI 10.1016/j.bbrc.2003.12.188; Brickman YG, 1998, J BIOL CHEM, V273, P4350, DOI 10.1074/jbc.273.8.4350; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; DESAI UR, 1993, BIOCHEMISTRY-US, V32, P8140, DOI 10.1021/bi00083a012; Dombrowski C, 2009, STEM CELLS DEV, V18, P661, DOI 10.1089/scd.2008.0157; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Gennero L, 2010, CELL BIOCHEM FUNCT, V28, P178, DOI 10.1002/cbf.1630; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; HOVINGH P, 1970, J BIOL CHEM, V245, P6170; Jackson RA, 2007, J CELL PHYSIOL, V210, P38, DOI 10.1002/jcp.20813; Jastrebova N, 2010, J BIOL CHEM, V285, P26842, DOI 10.1074/jbc.M109.093542; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; LINDBLOM A, 1990, GLYCOCONJUGATE J, V7, P545, DOI 10.1007/BF01189076; LINHARDT RJ, 1990, BIOCHEMISTRY-US, V29, P2611, DOI 10.1021/bi00462a026; LINKER A, 1960, BIOCHIM BIOPHYS ACTA, V43, P366, DOI 10.1016/0006-3002(60)90460-1; LOHSE DL, 1992, J BIOL CHEM, V267, P24347; Lyon M, 2000, J BIOL CHEM, V275, P4599, DOI 10.1074/jbc.275.7.4599; LYON M, 1994, J BIOL CHEM, V269, P11208; Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787; MOFFAT CF, 1991, EUR J BIOCHEM, V202, P531, DOI 10.1111/j.1432-1033.1991.tb16405.x; MOFFAT CF, 1991, EUR J BIOCHEM, V197, P449, DOI 10.1111/j.1432-1033.1991.tb15931.x; NADER HB, 1990, J BIOL CHEM, V265, P16807; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; PERLIN AS, 1971, CARBOHYD RES, V18, P185, DOI 10.1016/S0008-6215(00)80341-9; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pye DA, 1999, J BIOL CHEM, V274, P13456, DOI 10.1074/jbc.274.19.13456; Rhomberg AJ, 1998, P NATL ACAD SCI USA, V95, P12232, DOI 10.1073/pnas.95.21.12232; Robinson CJ, 2005, J BIOL CHEM, V280, P42274, DOI 10.1074/jbc.M505720200; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Toida T, 1997, BIOCHEM J, V322, P499, DOI 10.1042/bj3220499; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; TURNBULL JE, 1990, BIOCHEM J, V265, P715, DOI 10.1042/bj2650715; TURNBULL JE, 1991, BIOCHEM J, V277, P297, DOI 10.1042/bj2770297; TURNBULL JE, 1991, BIOCHEM J, V273, P553, DOI 10.1042/bj2730553; WALKER A, 1994, J BIOL CHEM, V269, P931; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1; Wei Z, 2005, J BIOL CHEM, V280, P15742, DOI 10.1074/jbc.M501102200; Wu ZLL, 2005, J BIOL CHEM, V280, P33749, DOI 10.1074/jbc.M505677200; Yang LF, 2005, ATHEROSCLEROSIS, V179, P79, DOI 10.1016/j.atherosclerosis.2004.10.035; Zhang JH, 2009, COMPUT MED IMAG GRAP, V33, P602, DOI 10.1016/j.compmedimag.2009.06.002	46	12	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17755	17765		10.1074/jbc.M110.148874	http://dx.doi.org/10.1074/jbc.M110.148874			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454472	hybrid, Green Published			2022-12-27	WOS:000290585200039
J	Ardestani, A; Sauter, NS; Paroni, F; Dharmadhikari, G; Cho, JH; Lupi, R; Marchetti, P; Oberholzer, J; Conte, JK; Maedler, K				Ardestani, Amin; Sauter, Nadine S.; Paroni, Federico; Dharmadhikari, Gitanjali; Cho, Jae-Hyoung; Lupi, Roberto; Marchetti, Piero; Oberholzer, Jose; Conte, Julie Kerr; Maedler, Kathrin			Neutralizing Interleukin-1 beta (IL-1 beta) Induces beta-Cell Survival by Maintaining PDX1 Protein Nuclear Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR PDX-1; PANCREATIC DUODENAL HOMEOBOX-1; TYPE-2 DIABETES-MELLITUS; INSULIN MESSENGER-RNA; RECEPTOR ANTAGONIST; OXIDATIVE STRESS; NLRP3 INFLAMMASOME; C57BL/6J MICE; HUMAN ISLETS; GLUCOSE	The transcription factor PDX1 plays a critical role during beta-cell development and in glucose-induced insulin gene transcription in adult beta-cells. Acute glucose exposure leads to translocalization of PDX1 to the nucleoplasm, whereas under conditions of oxidative stress, PDX1 shuttles from the nucleus to the cytosol. Here we show that cytosolic PDX1 expression correlated with beta-cell failure in diabetes. In isolated islets from patients with type 2 diabetes and from diabetic mice, we found opposite regulation of insulin and PDX1 mRNA; insulin was decreased in diabetes, but PDX1 was increased. This suggests that elevated PDX1 mRNA levels may be insufficient to regulate insulin. In diabetic islets, PDX1 protein was localized in the cytosol, whereas in non-diabetic controls, PDX1 was in the nucleus. In contrast, overexpression of either IL-1 receptor antagonist or shuttling-deficient PDX1 restored beta-cell survival and function and PDX1 nuclear localization. Our results show that nuclear localization of PDX1 is essential for a functional beta-cell and provides a novel mechanism of the protective effect of IL-1 receptor antagonist on beta-cell survival and function.	[Ardestani, Amin; Paroni, Federico; Dharmadhikari, Gitanjali; Maedler, Kathrin] Univ Bremen, Islet Biol Lab, Ctr Biomol Interact Bremen 28355, D-28359 Bremen, Germany; [Sauter, Nadine S.] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Cho, Jae-Hyoung] Catholic Univ Korea, Coll Med, Kangnam St Marys Hosp, Dept Endocrinol, Seoul 449050, South Korea; [Lupi, Roberto; Marchetti, Piero] Azienda Osped Univ Pisana, Metab Unit, Dept Endocrinol & Kidney, I-56124 Pisa, Italy; [Oberholzer, Jose] Univ Illinois, Div Transplantat, Chicago, IL USA; [Conte, Julie Kerr] Univ Lille, INSERM, F-59021 Lille, France	University of Bremen; University of Basel; Catholic University of Korea; Catholic University Korea Hospital; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Maedler, K (corresponding author), Univ Bremen, Islet Biol Lab, Ctr Biomol Interact Bremen, Leobener Str NW2,Rm B2080, D-28359 Bremen, Germany.	kmaedler@uni-bremen.de	Marchetti, Piero/J-7439-2013; Maedler, Kathrin/ABE-3022-2021	Marchetti, Piero/0000-0003-4907-0635; Maedler, Kathrin/0000-0002-7436-1197	Deutsche Forschungsgemeinschaft [MA4172/1-1]; Juvenile Diabetes Research Foundation [40-2011-9]; European Research Council [260336]; National Center for Research Resources (NCRR); NIDDK, National Institutes of Health; European Consortium for Islet Transplantation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Research Council(European Research Council (ERC)European Commission); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); European Consortium for Islet Transplantation	This work was supported by Deutsche Forschungsgemeinschaft Emmy Noether Programm Grant MA4172/1-1, Juvenile Diabetes Research Foundation Grant 40-2011-9, and European Research Council Grant 260336.; We thank Dr. Ingo Leibiger for the PDX1 plasmids, Dr. Chris Wright for the PDX1 antibody, Jennifer Bergemann and Anke Meyer for excellent assistance, Madhura Panse for the analysis of PDX1 in isolated islets, Silvia Del Guerra for the islet RNA preparation, and the National Disease Research Interchange for providing human pancreatic sections. Human islets were provided through the Islet Cell Resource Consortium (administered by the Administrative and Bioinformatics Coordination Center (ABCC) and supported by the National Center for Research Resources (NCRR); NIDDK, National Institutes of Health; and the Juvenile Diabetes Research Foundation) and through the European Consortium for Islet Transplantation Islets for Research Distribution Program.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Briaud I, 2002, DIABETES, V51, P662, DOI 10.2337/diabetes.51.3.662; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Donath MY, 2010, CELL METAB, V12, P427, DOI 10.1016/j.cmet.2010.10.002; Donath MY, 2010, TRENDS ENDOCRIN MET, V21, P261, DOI 10.1016/j.tem.2009.12.010; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Ehses JA, 2008, BIOCHEM SOC T, V36, P340, DOI 10.1042/BST0360340; EIZIRIK DL, 1991, DIABETOLOGIA, V34, P445, DOI 10.1007/BF00403185; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Elrick LJ, 2001, DIABETES, V50, P2244, DOI 10.2337/diabetes.50.10.2244; Glas R, 2009, DIABETOLOGIA, V52, P1579, DOI 10.1007/s00125-009-1349-0; Guillemain G, 2004, BIOCHEM J, V378, P219, DOI 10.1042/BJ20031549; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Hansotia T, 2007, J CLIN INVEST, V117, P143, DOI 10.1172/JCI25483; Harmon JS, 2009, ENDOCRINOLOGY, V150, P4855, DOI 10.1210/en.2009-0708; Heitmeier MR, 2001, J BIOL CHEM, V276, P11151, DOI 10.1074/jbc.M009159200; Hirsch E, 1996, P NATL ACAD SCI USA, V93, P11008, DOI 10.1073/pnas.93.20.11008; Igoillo-Esteve M, 2010, DIABETOLOGIA, V53, P1395, DOI 10.1007/s00125-010-1707-y; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; KAISER N, 1991, ENDOCRINOLOGY, V129, P2067, DOI 10.1210/endo-129-4-2067; Kajimoto Y, 1997, J CLIN INVEST, V100, P1840, DOI 10.1172/JCI119712; Kaneto H, 2005, CURR DIABETES REV, V1, P65, DOI 10.2174/1573399052952613; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kawamori D, 2003, DIABETES, V52, P2896, DOI 10.2337/diabetes.52.12.2896; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kushner JA, 2002, J CLIN INVEST, V109, P1193, DOI 10.1172/JCI200214439; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Leibowitz G, 2001, DIABETES, V50, P1799, DOI 10.2337/diabetes.50.8.1799; Liu AH, 2006, FEBS LETT, V580, P6701, DOI 10.1016/j.febslet.2006.11.021; Macfarlane WM, 2000, DIABETES, V49, P418, DOI 10.2337/diabetes.49.3.418; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; Maedler K, 2008, FASEB J, V22, P1905, DOI 10.1096/fj.07-101824; Maedler K, 2006, DIABETES, V55, P2455, DOI 10.2337/db05-1586; Maedler K, 2009, EXPERT OPIN BIOL TH, V9, P1177, DOI 10.1517/14712590903136688; Mandrup-Poulsen T, 2010, NAT IMMUNOL, V11, P881, DOI 10.1038/ni1010-881; MANDRUPPOULSEN T, 1985, ALLERGY, V40, P424, DOI 10.1111/j.1398-9995.1985.tb02681.x; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McKinnon CM, 2001, DIABETOLOGIA, V44, P1203, DOI 10.1007/s001250100628; Meng ZX, 2009, ENDOCRINOLOGY, V150, P5284, DOI 10.1210/en.2009-0671; Moede T, 1999, FEBS LETT, V461, P229, DOI 10.1016/S0014-5793(99)01446-5; Mulder H, 2000, METABOLISM, V49, P1518, DOI 10.1053/meta.2000.18511; O'Connor JC, 2005, J IMMUNOL, V174, P4991, DOI 10.4049/jimmunol.174.8.4991; Oberholzer J, 2000, TRANSPLANTATION, V69, P1115, DOI 10.1097/00007890-200003270-00016; Osborn O, 2008, CYTOKINE, V44, P141, DOI 10.1016/j.cyto.2008.07.004; Owyang AM, 2010, ENDOCRINOLOGY, V151, P2515, DOI 10.1210/en.2009-1124; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Rafiq I, 1998, J BIOL CHEM, V273, P23241, DOI 10.1074/jbc.273.36.23241; Reers C, 2009, EUR J ENDOCRINOL, V160, P185, DOI 10.1530/EJE-08-0596; Robertson RP, 2006, CURR OPIN PHARMACOL, V6, P615, DOI 10.1016/j.coph.2006.09.002; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Schulthess FT, 2009, CELL METAB, V9, P125, DOI 10.1016/j.cmet.2009.01.003; Stoffers DA, 1998, J CLIN INVEST, V102, P232, DOI 10.1172/JCI2242; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Storling J, 2005, ENDOCRINOLOGY, V146, P3026, DOI 10.1210/en.2005-0036; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735; Zangen DH, 1997, DIABETES, V46, P258, DOI 10.2337/diabetes.46.2.258; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	69	25	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17144	17155		10.1074/jbc.M110.210526	http://dx.doi.org/10.1074/jbc.M110.210526			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21393239	hybrid, Green Published			2022-12-27	WOS:000290301900064
J	Jinwal, UK; Trotter, JH; Abisambra, JF; Koren, J; Lawson, LY; Vestal, GD; O'Leary, JC; Johnson, AG; Jin, Y; Jones, JR; Li, QY; Weeber, EJ; Dickey, CA				Jinwal, Umesh K.; Trotter, Justin H.; Abisambra, Jose F.; Koren, John, III; Lawson, Lisa Y.; Vestal, Grant D.; O'Leary, John C., III; Johnson, Amelia G.; Jin, Ying; Jones, Jeffrey R.; Li, Qingyou; Weeber, Edwin J.; Dickey, Chad A.			The Hsp90 Kinase Co-chaperone Cdc37 Regulates Tau Stability and Phosphorylation Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; PROTEIN; COCHAPERONE; CHIP; BETA; AGGREGATION; COMPLEX; MODEL; HEAT-SHOCK-PROTEIN-90; NEURODEGENERATION	The microtubule-associated protein tau, which becomes hyperphosphorylated and pathologically aggregates in a number of these diseases, is extremely sensitive to manipulations of chaperone signaling. For example, Hsp90 inhibitors can reduce the levels of tau in transgenic mouse models of tauopathy. Because of this, we hypothesized that a number of Hsp90 accessory proteins, termed co-chaperones, could also affect tau stability. Perhaps by identifying these co-chaperones, new therapeutics could be designed to specifically target these proteins and facilitate tau clearance. Here, we report that the co-chaperone Cdc37 can regulate aspects of tau pathogenesis. We found that suppression of Cdc37 destabilized tau, leading to its clearance, whereas Cdc37 overexpression preserved tau. Cdc37 was found to co-localize with tau in neuronal cells and to physically interact with tau from human brain. Moreover, Cdc37 levels significantly increased with age. Cdc37 knockdown altered the phosphorylation profile of tau, an effect that was due in part to reduced tau kinase stability, specifically Cdk5 and Akt. Conversely, GSK3 beta and Mark2 were unaffected by Cdc37 modulation. Cdc37 overexpression prevented whereas Cdc37 suppression potentiated tau clearance following Hsp90 inhibition. Thus, Cdc37 can regulate tau in two ways: by directly stabilizing it via Hsp90 and by regulating the stability of distinct tau kinases. We propose that changes in the neuronal levels or activity of Cdc37 could dramatically alter the kinome, leading to profound changes in the tau phosphorylation signature, altering its proteotoxicity and stability.	[Jinwal, Umesh K.; Abisambra, Jose F.; Koren, John, III; Lawson, Lisa Y.; Vestal, Grant D.; O'Leary, John C., III; Johnson, Amelia G.; Jin, Ying; Jones, Jeffrey R.; Li, Qingyou; Dickey, Chad A.] Univ S Florida, Dept Mol Med, USF Hlth Byrd Alzheimers Inst, Tampa, FL 33613 USA; [Trotter, Justin H.; Li, Qingyou; Weeber, Edwin J.] Univ S Florida, Dept Mol Pharmacol & Physiol, USF Hlth Byrd Alzheimers Inst, Tampa, FL 33613 USA; [Jinwal, Umesh K.] Univ S Florida, Coll Pharm, USF Hlth Byrd Alzheimers Inst, Tampa, FL 33613 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Dickey, CA (corresponding author), Univ S Florida, Dept Mol Med, Alzheimers Inst, Tampa, FL 33613 USA.	cdickey@health.usf.edu	Abisambra, Jose/V-6860-2019; Weeber, Edwin J/A-5396-2012; Dickey, Chad A/H-4441-2011; Abisambra, Joe/AAP-3269-2020; Trotter, Justin H/I-6458-2012	Abisambra, Jose/0000-0001-6341-679X; Jones, Jeffrey/0000-0002-7570-2571; Koren, John/0000-0002-6017-1763; Lawson, Lisa/0000-0002-4436-5357	National Institutes of Health, NIA [AG031291]; Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research; CurePSP; Alzheimer's Association [IIRG-09-130689, NIRG-10-174517]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG030128, R00AG031291, K99AG031291] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research; CurePSP; Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG031291 from NIA. This work was also supported by the Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research, CurePSP, and Alzheimer's Association Grants IIRG-09-130689 and NIRG-10-174517.	Abisambra JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008556; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Carrettiero DC, 2009, J NEUROSCI, V29, P2151, DOI 10.1523/JNEUROSCI.4660-08.2009; Cicero S, 2005, J NEUROSCI, V25, P9658, DOI 10.1523/JNEUROSCI.1773-05.2005; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dickey CA, 2006, FASEB J, V20, P753, DOI 10.1096/fj.05-5343fje; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Dolan PJ, 2010, J BIOL CHEM, V285, P21978, DOI 10.1074/jbc.M110.110940; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; FRAUTSCHY SA, 1991, P NATL ACAD SCI USA, V88, P8362, DOI 10.1073/pnas.88.19.8362; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Guillozet-Bongaarts AL, 2005, NEUROBIOL AGING, V26, P1015, DOI 10.1016/j.neurobiolaging.2004.09.019; Hardy J, 2006, J NEUROCHEM, V97, P1690, DOI 10.1111/j.1471-4159.2006.03979.x; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hatakeyama S, 2004, J NEUROCHEM, V91, P299, DOI 10.1111/j.1471-4159.2004.02713.x; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jinwal UK, 2010, J BIOL CHEM, V285, P16798, DOI 10.1074/jbc.M110.113753; Jinwal UK, 2010, J NEUROSCI, V30, P591, DOI 10.1523/JNEUROSCI.4815-09.2010; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Kim D, 2005, FRONT BIOSCI-LANDMRK, V10, P975, DOI 10.2741/1592; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2004, DALTON T, P1189, DOI 10.1039/b400269e; Kinoshita E, 2008, PROTEOMICS, V8, P2994, DOI 10.1002/pmic.200800243; Kinoshita-Kikuta E, 2007, MOL CELL PROTEOMICS, V6, P356, DOI 10.1074/mcp.T600044-MCP200; Lalioti V, 2010, CELL CYCLE, V9, P284, DOI 10.4161/cc.9.2.10466; Luo WJ, 2007, P NATL ACAD SCI USA, V104, P9511, DOI 10.1073/pnas.0701055104; Marx A, 2010, FASEB J, V24, P1637, DOI 10.1096/fj.09-148064; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; Mukaetova-Ladinska EB, 2000, AM J PATHOL, V157, P623, DOI 10.1016/S0002-9440(10)64573-7; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pei JJ, 2003, ACTA NEUROPATHOL, V105, P381, DOI 10.1007/s00401-002-0657-y; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Shimura H, 2004, J BIOL CHEM, V279, P17957, DOI 10.1074/jbc.M400351200; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Smith JR, 2009, ONCOGENE, V28, P157, DOI 10.1038/onc.2008.380; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298	50	48	51	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16976	16983		10.1074/jbc.M110.182493	http://dx.doi.org/10.1074/jbc.M110.182493			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21367866	hybrid, Green Published			2022-12-27	WOS:000290301900047
J	Kutz, WE; Wang, LW; Bader, HL; Majors, AK; Iwata, K; Traboulsi, EI; Sakai, LY; Keene, DR; Apte, SS				Kutz, Wendy E.; Wang, Lauren W.; Bader, Hannah L.; Majors, Alana K.; Iwata, Kazushi; Traboulsi, Elias I.; Sakai, Lynn Y.; Keene, Douglas R.; Apte, Suneel S.			ADAMTS10 Protein Interacts with Fibrillin-1 and Promotes Its Deposition in Extracellular Matrix of Cultured Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEILL-MARCHESANI-SYNDROME; MARFAN-SYNDROME; ECTOPIA LENTIS; MOUSE MODEL; MICROFIBRILS; MUTATIONS; METALLOPROTEASES; FAMILY; GLYCOPROTEIN; PATHOGENESIS	Autosomal recessive and autosomal dominant forms of Weill-Marchesani syndrome, an inherited connective tissue disorder, are caused by mutations in ADAMTS10 (encoding a secreted metalloprotease) and FBN1 (encoding fibrillin-1, which forms tissue microfibrils), respectively, yet they are clinically indistinguishable. This genetic connection prompted investigation of a potential functional relationship between ADAMTS10 and fibrillin-1. Specifically, fibrillin-1 was investigated as a potential ADAMTS10 binding partner and substrate, and the role of ADAMTS10 in influencing microfibril biogenesis was addressed. Using ligand affinity blotting and surface plasmon resonance, recombinant ADAMTS10 was found to bind to fibrillin-1 with a high degree of specificity and with high affinity. Two sites of ADAMTS10 binding to fibrillin-1 were identified, one toward the N terminus and another in the C-terminal half of fibrillin-1. Confocal microscopy and immunoelectron microscopy localized ADAMTS10 to fibrillin-1-containing microfibrils in human tissues. Furin-activated ADAMTS10 could cleave fibrillin-1, but innate resistance of ADAMTS10 zymogen to propeptide excision by furin was observed, suggesting that, unless activated, ADAMTS10 is an inefficient fibrillinase. To investigate the role of ADAMTS10 in microfibril biogenesis, fetal bovine nuchal ligament cells were cultured in the presence or absence of ADAMTS10. Exogenously added ADAMTS10 led to accelerated fibrillin-1 microfibril biogenesis. Conversely, fibroblasts obtained from a Weill-Marchesani syndrome patient with ADAMTS10 mutations deposited fibrillin-1 microfibrils sparsely compared with unaffected control cells. Taken together, these findings suggest that ADAMTS10 participates in microfibril biogenesis rather than in fibrillin-1 turnover.	[Kutz, Wendy E.; Wang, Lauren W.; Bader, Hannah L.; Iwata, Kazushi; Apte, Suneel S.] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA; [Majors, Alana K.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Traboulsi, Elias I.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44195 USA; [Sakai, Lynn Y.; Keene, Douglas R.] Shriners Hosp Children, Portland, OR 97201 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Apte, SS (corresponding author), Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, ND20,9500 Euclid Ave, Cleveland, OH 44195 USA.	aptes@ccf.org	Traboulsi, Elias/AAY-7443-2020	Apte, Suneel/0000-0001-8441-1226	NIAMS [AR53890, EY21151, T32 AR050959, T32 HL007914-08]; National Marfan Foundation; NATIONAL EYE INSTITUTE [R01EY021151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050959, R01AR053890] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Marfan Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR53890 from the NIAMS and Grant EY21151 (to S. S. A.) and Postdoctoral Training Grants T32 AR050959 (to W. E. K.; training program in orthopedics; principal investigator, Joseph P. Iannotti) and T32 HL007914-08 (to H. L. B.; training program in vascular biology and pathology; principal investigator, Edward Plow). This work was also supported by a grant from the National Marfan Foundation.	Ahram D, 2009, AM J HUM GENET, V84, P274, DOI 10.1016/j.ajhg.2009.01.007; Apte SS, 2004, INT J BIOCHEM CELL B, V36, P981, DOI 10.1016/j.biocel.2004.01.014; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Cain SA, 2006, PROTEOMICS, V6, P111, DOI 10.1002/pmic.200401340; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; Faivre L, 2003, AM J MED GENET A, V123A, P204, DOI 10.1002/ajmg.a.20289; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Farias FHG, 2010, INVEST OPHTH VIS SCI, V51, P4716, DOI 10.1167/iovs.09-5142; Greene VB, 2010, OPHTHALMIC GENET, V31, P47, DOI 10.3109/13816810903567604; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hall NG, 2003, MATRIX BIOL, V22, P501, DOI 10.1016/S0945-053X(03)00075-1; Hanssen E, 2001, MATRIX BIOL, V20, P77, DOI 10.1016/S0945-053X(01)00122-6; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Koo BH, 2007, J BIOL CHEM, V282, P16146, DOI 10.1074/jbc.M610161200; Koo BH, 2010, J BIOL CHEM, V285, P197, DOI 10.1074/jbc.M109.039677; Kutz WE, 2008, HUM MUTAT, V29, P1425, DOI 10.1002/humu.20797; Le Goff C, 2006, DEVELOPMENT, V133, P1587, DOI 10.1242/dev.02308; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Pyeritz RE, 2000, ANNU REV MED, V51, P481, DOI 10.1146/annurev.med.51.1.481; Ramirez F, 2004, PHYSIOL GENOMICS, V19, P151, DOI 10.1152/physiolgenomics.00092.2004; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Somerville RPT, 2004, J BIOL CHEM, V279, P51208, DOI 10.1074/jbc.M409036200; SPENCE MJ, 1995, SOMAT CELL MOLEC GEN, V21, P1, DOI 10.1007/BF02255818; Tsutsui K, 2010, J BIOL CHEM, V285, P4870, DOI 10.1074/jbc.M109.076919	36	100	103	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17156	17167		10.1074/jbc.M111.231571	http://dx.doi.org/10.1074/jbc.M111.231571			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21402694	Green Published, hybrid			2022-12-27	WOS:000290301900065
J	Norrgard, MA; Hellman, U; Mannervik, B				Norrgard, Malena A.; Hellman, Ulf; Mannervik, Bengt			Cys-X Scanning for Expansion of Active-site Residues and Modulation of Catalytic Functions in a Glutathione Transferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; ENZYME PROMISCUITY; ESCHERICHIA-COLI; GENETIC-CODE; MECHANISM; EVOLUTION; MUTAGENESIS; MUTATIONS; SELECTIVITY; ACTIVATION	We propose Cys-X scanning as a semisynthetic approach to engineer the functional properties of recombinant proteins. As in the case of Ala scanning, key residues in the primary structure are identified, and one of them is replaced by Cys via site-directed mutagenesis. The thiol of the residue introduced is subsequently modified by alternative chemical reagents to yield diverse Cys-X mutants of the protein. This chemical approach is orthogonal to Ala or Cys scanning and allows the expansion of the repertoire of amino acid side chains far beyond those present in natural proteins. In its present application, we have introduced Cys-X residues in human glutathione transferase (GST) M2-2, replacing Met-212 in the substrate-binding site. To achieve selectivity of the modifications, the Cys residues in the wild-type enzyme were replaced by Ala. A suite of simple substitutions resulted in a set of homologous Met derivatives ranging from normethionine to S-heptyl-cysteine. The chemical modifications were validated by HPLC and mass spectrometry. The derivatized mutant enzymes were assayed with alternative GST substrates representing diverse chemical reactions: aromatic substitution, epoxide opening, transnitrosylation, and addition to an ortho-quinone. The Cys substitutions had different effects on the alternative substrates and differentially enhanced or suppressed catalytic activities depending on both the Cys-X substitution and the substrate assayed. As a consequence, the enzyme specificity profile could be changed among the alternative substrates. The procedure lends itself to large-scale production of Cys-X modified protein variants.	[Norrgard, Malena A.; Mannervik, Bengt] Uppsala Univ, Dept Biochem & Organ Chem, Biomed Ctr, SE-75123 Uppsala, Sweden; [Hellman, Ulf] Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, SE-75123 Uppsala, Sweden; [Mannervik, Bengt] Stockholm Univ, Dept Neurochem, SE-10691 Stockholm, Sweden	Uppsala University; Ludwig Institute for Cancer Research; Uppsala University; Stockholm University	Mannervik, B (corresponding author), Uppsala Univ, Dept Biochem & Organ Chem, Biomed Ctr, Box 576, SE-75123 Uppsala, Sweden.	Bengt.Mannervik@biorg.uu.se			Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council.	Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; BJORNESTEDT R, 1995, J BIOL CHEM, V270, P29705; Blikstad C, 2008, BBA-GEN SUBJECTS, V1780, P1458, DOI 10.1016/j.bbagen.2008.07.007; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dagnino-Subiabre A, 2000, BIOCHEM BIOPH RES CO, V274, P32, DOI 10.1006/bbrc.2000.3087; Davidson VL, 2011, MOL BIOSYST, V7, P29, DOI 10.1039/c005311b; DeSantis G, 1999, CURR OPIN BIOTECH, V10, P324, DOI 10.1016/S0958-1669(99)80059-7; DeSantis G, 1999, BIOORGAN MED CHEM, V7, P1381, DOI 10.1016/S0968-0896(99)00068-1; Dourado DFAR, 2008, CHEM-EUR J, V14, P9591, DOI 10.1002/chem.200800946; Dourado DFAR, 2010, J PHYS CHEM B, V114, P12972, DOI 10.1021/jp1053875; Eklund BI, 2006, MOL PHARMACOL, V70, P747, DOI 10.1124/mol.106.025288; Emren LO, 2006, P NATL ACAD SCI USA, V103, P10866, DOI 10.1073/pnas.0604030103; Grahn E, 2006, ACTA CRYSTALLOGR D, V62, P197, DOI 10.1107/S0907444905039296; Hegazy U. M., 2009, AMINO ACIDS PEPTIDES, V2, P379; Hegazy UM, 2006, CHEM BIOL, V13, P929, DOI 10.1016/j.chembiol.2006.07.005; Hult K, 2007, TRENDS BIOTECHNOL, V25, P231, DOI 10.1016/j.tibtech.2007.03.002; Ivarsson Y, 2003, J BIOL CHEM, V278, P8733, DOI 10.1074/jbc.M211776200; Ivarsson Y, 2007, BBA-GEN SUBJECTS, V1770, P1374, DOI 10.1016/j.bbagen.2007.06.002; Jemth P., 1999, CURRENT PROTOCOLS TO, P641; Jestin JL, 2005, RES MICROBIOL, V156, P961, DOI 10.1016/j.resmic.2005.09.004; Johansson AS, 1999, PROTEIN EXPRES PURIF, V17, P105, DOI 10.1006/prep.1999.1117; JOHNSON WW, 1993, J BIOL CHEM, V268, P11508; Josephy PD, 2006, MOL TOXICOLOGY, P333; KANAYA E, 1990, BIOCHEM BIOPH RES CO, V173, P1194, DOI 10.1016/S0006-291X(05)80912-X; Kauffman S.A., 1993, ORIGINS ORDER; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kiss G, 2010, PROTEIN SCI, V19, P1760, DOI 10.1002/pro.462; Kubo Y, 1998, FEBS LETT, V435, P69, DOI 10.1016/S0014-5793(98)01038-2; Lien S, 2001, J BIOL CHEM, V276, P35599, DOI 10.1074/jbc.M103789200; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Lu Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-102; Manning TC, 1996, J IMMUNOL METHODS, V192, P125, DOI 10.1016/0022-1759(96)00048-8; Nath A, 2008, BIOCHEMISTRY-US, V47, P157, DOI 10.1021/bi701448p; Nilsson LO, 2000, P NATL ACAD SCI USA, V97, P9408, DOI 10.1073/pnas.150084897; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Norrgard MA, 2006, P NATL ACAD SCI USA, V103, P4876, DOI 10.1073/pnas.0600849103; Nuccetelli M, 1998, BIOCHEM BIOPH RES CO, V252, P184, DOI 10.1006/bbrc.1998.9575; Pettersson PL, 2002, J BIOL CHEM, V277, P30019, DOI 10.1074/jbc.M204485200; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; SAHINTOTH M, 1993, PROTEIN SCI, V2, P1024, DOI 10.1002/pro.5560020615; Sella G, 2006, J MOL EVOL, V63, P297, DOI 10.1007/s00239-004-0176-7; Simons P C, 1981, Methods Enzymol, V77, P235; SINGER TP, 1984, METHOD ENZYMOL, V106, P369; Theorell H, 1941, J AM CHEM SOC, V63, P1804, DOI 10.1021/ja01852a005; Thorn KS, 2001, BIOINFORMATICS, V17, P284, DOI 10.1093/bioinformatics/17.3.284; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang Q, 2009, CHEM BIOL, V16, P323, DOI 10.1016/j.chembiol.2009.03.001; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; WIDERSTEN M, 1995, J MOL BIOL, V250, P115, DOI 10.1006/jmbi.1995.0362; Wright SK, 2001, J BIOL CHEM, V276, P31151, DOI 10.1074/jbc.M100892200	51	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16871	16878		10.1074/jbc.M111.230078	http://dx.doi.org/10.1074/jbc.M111.230078			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454564	Green Published, hybrid			2022-12-27	WOS:000290301900036
J	Chambers, JW; LoGrasso, PV				Chambers, Jeremy W.; LoGrasso, Philip V.			Mitochondrial c-Jun N-terminal Kinase (JNK) Signaling Initiates Physiological Changes Resulting in Amplification of Reactive Oxygen Species Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; P38 MAPK; ARSENIC TRIOXIDE; SAB SH3BP5; ACTIVATION; TRANSDUCTION; APOPTOSIS; SUPEROXIDE; COMPLEX; PROTEIN	The JNK signaling cascade is critical for cellular responses to a variety of environmental and cellular stimuli. Although gene expression aspects of JNK signal transduction are well studied, there are minimal data on the physiological impact of JNK signaling. To bridge this gap, we investigated how JNK impacted physiology in HeLa cells. We observed that inhibition of JNK activity and JNK silencing with siRNA reduced the level of reactive oxygen species (ROS) generated during anisomycin-induced stress in HeLa cells. Silencing p38 had no significant impact on ROS generation under anisomycin stress. Moreover, JNK signaling mediated amplification of ROS production during stress. Mitochondrial superoxide production was shown to be the source of JNK-induced ROS amplification, as an NADPH oxidase inhibitor demonstrated little impact on JNK-mediated ROS generation. Using mitochondrial isolation from JNK null fibroblasts and targeting the mitochondrial scaffold of JNK, Sab, we demonstrated that mitochondrial JNK signaling was responsible for mitochondrial superoxide amplification. These results suggest that cellular stress altered mitochondria, causing JNK to translocate to the mitochondria and amplify up to 80% of the ROS generated largely by Complex I. This work demonstrates that a sequence of events exist for JNK mitochondrial signaling whereby ROS activates JNK, thereby affecting mitochondrial physiology, which can have effects on cell survival and death.	[LoGrasso, Philip V.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute	LoGrasso, PV (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA.	lograsso@scripps.edu		Chambers, Jeremy/0000-0002-6143-3091	National Institutes of Health [NS057153]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS057153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS057153 (to P. V. L.).	Anuradha CD, 2001, FREE RADICAL BIO MED, V31, P367, DOI 10.1016/S0891-5849(01)00591-3; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Bagowski CP, 2003, CURR BIOL, V13, P315, DOI 10.1016/S0960-9822(03)00083-6; Cao DX, 2005, J CELL BIOCHEM, V96, P810, DOI 10.1002/jcb.20563; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dougherty CJ, 2004, FASEB J, V18, P1060, DOI 10.1096/fj.04-1505com; Forkink M, 2010, BBA-BIOENERGETICS, V1797, P1034, DOI 10.1016/j.bbabio.2010.01.022; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Hawkins BJ, 2007, MOL BIOL CELL, V18, P2002, DOI 10.1091/mbc.E06-09-0830; Horbinski C, 2005, FREE RADICAL BIO MED, V38, P2, DOI 10.1016/j.freeradbiomed.2004.09.030; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; Ito Y, 2001, CELL DEATH DIFFER, V8, P794, DOI 10.1038/sj.cdd.4400886; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kamenecka T, 2010, J MED CHEM, V53, P419, DOI 10.1021/jm901351f; Kang YH, 2008, ONCOL REP, V20, P637, DOI 10.3892/or_00000053; Kang YH, 2008, J CELL PHYSIOL, V217, P23, DOI 10.1002/jcp.21470; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kim MJ, 2008, FEBS J, V275, P2096, DOI 10.1111/j.1742-4658.2008.06363.x; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Kristiansen M, 2010, J NEUROSCI, V30, P10820, DOI 10.1523/JNEUROSCI.2824-10.2010; Lee JJ, 2010, ONCOGENE, V29, P561, DOI 10.1038/onc.2009.355; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Pallotti F, 2007, METHOD CELL BIOL, V80, P3, DOI 10.1016/S0091-679X(06)80001-4; Patel VB, 2007, FREE RADICAL BIO MED, V43, P1499, DOI 10.1016/j.freeradbiomed.2007.08.004; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Soberanes S, 2009, J BIOL CHEM, V284, P2176, DOI 10.1074/jbc.M808844200; Soubannier V, 2009, BBA-MOL CELL RES, V1793, P154, DOI 10.1016/j.bbamcr.2008.07.008; STOLK J, 1994, AM J RESP CELL MOL, V11, P95, DOI 10.1165/ajrcmb.11.1.8018341; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wiltshire C, 2004, BIOCHEM SOC T, V32, P1075, DOI 10.1042/BST0321075; Wiltshire C, 2002, BIOCHEM J, V367, P577, DOI 10.1042/BJ20020553; Zhao Y, 2009, MOL CELL NEUROSCI, V41, P186, DOI 10.1016/j.mcn.2009.02.012; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x	48	134	138	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.223602	http://dx.doi.org/10.1074/jbc.M111.223602			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454558	hybrid, Green Published			2022-12-27	WOS:000290022800045
J	Dahlback, M; Jorgensen, LM; Nielsen, MA; Clausen, TM; Ditlev, SB; Resende, M; Pinto, VV; Arnot, DE; Theander, TG; Salanti, A				Dahlback, Madeleine; Jorgensen, Lars M.; Nielsen, Morten A.; Clausen, Thomas M.; Ditlev, Sisse B.; Resende, Mafalda; Pinto, Vera V.; Arnot, David E.; Theander, Thor G.; Salanti, Ali			The Chondroitin Sulfate A-binding Site of the VAR2CSA Protein Involves Multiple N-terminal Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; PREGNANCY-ASSOCIATED MALARIA; VARIANT SURFACE-ANTIGENS; PLASMODIUM-FALCIPARUM; PARASITE ADHESION; ANTIBODIES; ADHERENCE; GENE; IDENTIFICATION; PROTEOGLYCANS	Malaria during pregnancy is a major health problem for African women. The disease is caused by Plasmodium falciparum malaria parasites, which accumulate in the placenta by adhering to chondroitin sulfate A (CSA). The interaction between infected erythrocytes and the placental receptor is mediated by a parasite expressed protein named VAR2CSA. Avaccine protecting pregnant women against placental malaria should induce antibodies inhibiting the interaction between VAR2CSA and CSA. Much effort has been put into defining the part of the 350 kDa VAR2CSA protein that is responsible for binding. It has been shown that full-length recombinant VAR2CSA binds specifically to CSA with high affinity, however to date no sub-fragment of VAR2CSA has been shown to interact with CSA with similar affinity or specificity. In this study, we used a biosensor technology to examine the binding properties of a panel of truncated VAR2CSA proteins. The experiments indicate that the core of the CSA-binding site is situated in three domains, DBL2X-CIDRPAM and a flanking domain, located in the N-terminal part of VAR2CSA. Furthermore, recombinant VAR2CSA subfragments containing this region elicit antibodies with high parasite adhesion blocking activity in animal immunization experiments.	[Dahlback, Madeleine] Univ Copenhagen, Ctr Med Parasitol, Fac Hlth Sci,CSS, Inst Int Hlth Immunol & Microbiol,Dept Int Hlth I, DK-1014 Copenhagen K, Denmark; [Dahlback, Madeleine; Jorgensen, Lars M.; Nielsen, Morten A.; Clausen, Thomas M.; Ditlev, Sisse B.; Resende, Mafalda; Pinto, Vera V.; Arnot, David E.; Theander, Thor G.; Salanti, Ali] Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, CSS, DK-1014 Copenhagen K, Denmark; [Arnot, David E.] Univ Edinburgh, Inst Immunol & Infect Res, Ashworth Lab, Edinburgh EH9 3JT, Midlothian, Scotland	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Edinburgh	Dahlback, M (corresponding author), Univ Copenhagen, Ctr Med Parasitol, Fac Hlth Sci,CSS, Inst Int Hlth Immunol & Microbiol,Dept Int Hlth I, Oster Farimagsgade 5 A, DK-1014 Copenhagen K, Denmark.	dahlback@sund.ku.dk; salanti@sund.ku.dk	Theander, Thor/F-6714-2015; Arnot, David/S-1984-2019	Theander, Thor/0000-0002-3509-7514; Arnot, David/0000-0002-3027-1130; Nielsen, Morten Agertoug/0000-0003-2668-4992; Salanti, Ali/0000-0003-2207-5575; Ditlev, Sisse Bolm/0000-0003-4417-9711	Danish Council for Independent Research/Medical Sciences [271-07-0696]; Seventh Framework Programme [201222, 200889]; Bill and Melinda Gates Foundation [47029 (PMI2)]; VTU [07-017766]; University of Copenhagen; Danish National Research Foundation	Danish Council for Independent Research/Medical Sciences(Det Frie Forskningsrad (DFF)); Seventh Framework Programme(European Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); VTU; University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was funded in part by the Danish Council for Independent Research/Medical Sciences (FSS) Grant 271-07-0696, the Seventh Framework Programme ([FP7/2007-2013]) under Grant Agreements 201222 (PreMalStruct) and 200889 (STOPPAM), and the Bill and Melinda Gates Foundation, Grant 47029 (PMI2). This study also received Proof-of-Concept Funding from VTU, Grant 07-017766, support from University of Copenhagen Program of Excellence (Membrane Topology and Quaternary Structure of Key Parasite Proteins Involved in P. falciparum Malaria Pathogenesis and Immunity), and a Grant for a Visiting Professorship from the Danish National Research Foundation (to D. E. A.).	Achur RN, 2000, J BIOL CHEM, V275, P40344, DOI 10.1074/jbc.M006398200; Alkhalil A, 2000, J BIOL CHEM, V275, P40357, DOI 10.1074/jbc.M006399200; Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Brown A, 2010, CURR OPIN STRUC BIOL, V20, P560, DOI 10.1016/j.sbi.2010.06.008; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Dahlback M, 2010, TRENDS PARASITOL, V26, P230, DOI 10.1016/j.pt.2010.02.002; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Haase RN, 2006, INFECT IMMUN, V74, P3035, DOI 10.1128/IAI.74.5.3035-3038.2006; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Howell DPG, 2008, MOL MICROBIOL, V67, P78, DOI 10.1111/j.1365-2958.2007.06019.x; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; Magistrado PA, 2011, VACCINE, V29, P437, DOI 10.1016/j.vaccine.2010.10.080; Nielsen MA, 2007, EXP PARASITOL, V117, P1, DOI 10.1016/j.exppara.2007.03.002; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Oleinikov AV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000386; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Resende M, 2009, INT J PARASITOL, V39, P1195, DOI 10.1016/j.ijpara.2009.02.022; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; Singh K, 2010, J BIOL CHEM, V285, P24855, DOI 10.1074/jbc.M110.118612; Smith JD, 1998, MOL BIOCHEM PARASIT, V97, P133, DOI 10.1016/S0166-6851(98)00145-5; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; Staalsoe T, 2001, J INFECT DIS, V184, P618, DOI 10.1086/322809; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vogt AM, 2003, BLOOD, V101, P2405, DOI 10.1182/blood-2002-07-2016	37	62	65	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.191510	http://dx.doi.org/10.1074/jbc.M110.191510			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21398524	Green Published, hybrid			2022-12-27	WOS:000290022800031
J	Chen, CG; Wang, YL; Huang, P; Liu-Chen, LY				Chen, Chongguang; Wang, Yulin; Huang, Peng; Liu-Chen, Lee-Yuan			Effects of C-terminal Modifications of GEC1 Protein and gamma-Aminobutyric Acid Type A (GABA(A)) Receptor-associated Protein (GABARAP), Two Microtubule-associated Proteins, on kappa Opioid Receptor Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-TRANSPORT MODULATOR; GABA(A)-RECEPTOR-ASSOCIATED PROTEIN; AUTOPHAGIC VESICLES; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; DOWN-REGULATION; BINDING; GATE-16; LOCALIZATION; TRAFFICKING	We demonstrated previously that GEC1, a member of the microtubule-associated protein (MAP) family, bound to the human kappa opioid receptor (hKOPR) and promoted hKOPR cell surface expression by facilitating its trafficking along the secretory pathway. GABA(A) receptor-associated protein (GABARAP), a GEC1 analog, also enhanced KOPR expression, but to a lesser extent. The MAP family proteins undergo cleavage of their C-terminal residue(s), and the exposed conserved glycine forms conjugates with phosphatidylethanolamine, which associate with membranes. Here, we examined whether such modifications were required for GEC1 and GABARAP to enhance hKOPR expression. When transiently transfected into CHO or Neuro2A cells, GEC1 and GABARAP were cleaved at the C termini. G116A mutation alone or combined with deletion of Lys(117) in GEC1 (GEC1-A) or Leu(117) in GABARAP (GABARAP-A) blocked their C-terminal cleavage, indicating that the conserved Gly(116) is necessary for C-terminal modification. The two GEC1 mutants enhanced hKOPR expression to similar extents as the wildtype GEC1; however, the two GABARAP mutants did not. Immunofluorescence studies showed that HA-GEC1, HA-GEC1-A, and HA-GABARAP were distributed in a punctate manner and co-localized with KOPR-EGFP in the Golgi apparatus, whereas HA-GABARAP-A did not. Pulldown assay of GST-KOPR-C-tail with HA-GEC1 or HA-GABARAP revealed that GEC1 had stronger association with KOPR-C-tail than GABARAP. These results suggest that because of its stronger binding for hKOPR, GEC1 is able to be recruited by hKOPR sufficiently without membrane association via its C-terminal modification; however, due to its weaker affinity for the hKOPR, GABARAP appears to require C-terminal modifications to enhance KOPR expression.	[Chen, Chongguang; Wang, Yulin; Huang, Peng; Liu-Chen, Lee-Yuan] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Liu-Chen, LY (corresponding author), Temple Univ, Sch Med, Dept Pharmacol, 3420 N Broad St, Philadelphia, PA 19140 USA.	lliuche@temple.edu			National Institutes of Health [R01 DA17302, P30 DA13429]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA013429, R01DA017302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DA17302 and P30 DA13429.	Alam J, 2010, REGUL PEPTIDES, V159, P78, DOI 10.1016/j.regpep.2009.09.002; Bavro VN, 2002, EMBO REP, V3, P183, DOI 10.1093/embo-reports/kvf026; Beardsley PM, 2005, PSYCHOPHARMACOLOGY, V183, P118, DOI 10.1007/s00213-005-0167-4; Carlezon WA, 2006, J PHARMACOL EXP THER, V316, P440, DOI 10.1124/jpet.105.092304; Chakrama FZ, 2010, AUTOPHAGY, V6, P495, DOI 10.4161/auto.6.4.11819; Chen CG, 2006, J BIOL CHEM, V281, P7983, DOI 10.1074/jbc.M509805200; Chen Y, 2009, J BIOL CHEM, V284, P1673, DOI 10.1074/jbc.M808303200; Chen ZW, 2007, J NEUROSCI, V27, P6655, DOI 10.1523/JNEUROSCI.0919-07.2007; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Cook JL, 2008, CIRC RES, V102, P1539, DOI 10.1161/CIRCRESAHA.108.176594; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; Green F, 2002, FEBS LETT, V518, P101, DOI 10.1016/S0014-5793(02)02655-8; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kittler JT, 2001, MOL CELL NEUROSCI, V18, P13, DOI 10.1006/mcne.2001.1005; Knight D, 2002, J BIOL CHEM, V277, P5556, DOI 10.1074/jbc.M109753200; Knoll AT, 2007, J PHARMACOL EXP THER, V323, P838, DOI 10.1124/jpet.107.127415; LAFNEZ S, 2010, FASEB J, V24, P1958; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Leil TA, 2004, J NEUROSCI, V24, P11429, DOI 10.1523/JNEUROSCI.3355-04.2004; Li J, 2002, MOL PHARMACOL, V61, P73, DOI 10.1124/mol.61.1.73; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Liu-Chen LY, 2004, LIFE SCI, V75, P511, DOI 10.1016/j.lfs.2003.10.041; Mansuy V, 2004, BIOCHEM BIOPH RES CO, V325, P639, DOI 10.1016/j.bbrc.2004.10.072; Nemos C, 2003, MOL BRAIN RES, V119, P216, DOI 10.1016/j.molbrainres.2003.09.011; O'Sullivan GA, 2005, EUR J NEUROSCI, V22, P2644, DOI 10.1111/j.1460-9568.2005.04448.x; Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; PELLERIN I, 1993, MOL CELL ENDOCRINOL, V90, pR17, DOI 10.1016/0303-7207(93)90161-C; Reining SC, 2009, AM J PHYSIOL-RENAL, V296, pF1118, DOI 10.1152/ajprenal.90492.2008; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2003, BIOCHEM BIOPH RES CO, V300, P637, DOI 10.1016/S0006-291X(02)02907-8; Tanida I, 2006, FEBS J, V273, P2553, DOI 10.1111/j.1742-4658.2006.05260.x; Wang HB, 2000, J NEUROCHEM, V75, P644, DOI 10.1046/j.1471-4159.2000.0750644.x; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Wang Y, 2006, NEUROSCIENCE, V140, P1265, DOI 10.1016/j.neuroscience.2006.03.013; Wikstrom B, 2005, J AM SOC NEPHROL, V16, P3742, DOI 10.1681/ASN.2005020152; Xin YR, 2001, GENOMICS, V74, P408, DOI 10.1006/geno.2001.6555; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Zhang FQ, 2002, J PHARMACOL EXP THER, V302, P1184, DOI 10.1124/jpet.302.3.1184	44	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15106	15115		10.1074/jbc.M111.230896	http://dx.doi.org/10.1074/jbc.M111.230896			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21388957	hybrid, Green Published			2022-12-27	WOS:000289788300041
J	Flynn, GE; Zagotta, WN				Flynn, Galen E.; Zagotta, William N.			Molecular Mechanism Underlying Phosphatidylinositol 4,5-Bisphosphate-induced Inhibition of SpIH Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-GATED CHANNELS; HCN PACEMAKER CHANNELS; PHYSIOLOGICAL-FUNCTION; CATION CHANNELS; TERMINAL REGION; ION CHANNELS; K+ CHANNEL; VOLTAGE; MODULATION; FAMILY	Many ion channels have been shown to be regulated by the membrane signaling phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2). Here, we demonstrate that the binding of PIP2 to SpIH, a sea urchin hyperpolarization-activated cyclic nucleotide-gated ion channel (HCN), has a dual effect: potentiation and inhibition. The potentiation is observed as a shift in the voltage dependence of activation to more depolarized voltages. The inhibition is observed as a reduction in the currents elicited by the partial agonist cGMP. These two effects were separable and arose from PIP2 binding to two different regions. Deletion of the C-terminal region of SpIH removed PIP2-induced inhibition but not the PIP2-induced shift in voltage dependence. Mutating key positively charged amino acids in the C-terminal region adjacent to the membrane selectively disrupted PIP2-induced inhibition, suggesting a direct interaction between PIP2 in the membrane and amino acids in the C-terminal region that stabilizes the closed state relative to the open state in HCN channels.	[Flynn, Galen E.; Zagotta, William N.] Univ Washington, Dept Physiol & Biophys, Howard Hughes Med Inst, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Dept Physiol & Biophys, Howard Hughes Med Inst, POB 357290, Seattle, WA 98195 USA.	zagotta@u.washington.edu			National Institutes of Health from NEI [EY10329]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER	National Institutes of Health from NEI; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY10329 from NEI (to W. N. Z.). This work was also supported by the Howard Hughes Medical Institute.	Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Bian JS, 2007, PFLUG ARCH EUR J PHY, V455, P105, DOI 10.1007/s00424-007-0292-5; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; DiFrancesco D, 2006, PROG BIOPHYS MOL BIO, V90, P13, DOI 10.1016/j.pbiomolbio.2005.05.001; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Kornev AP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000056; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 1999, CELL PHYSIOL BIOCHEM, V9, P179, DOI 10.1159/000016315; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Pian P, 2007, PFLUG ARCH EUR J PHY, V455, P125, DOI 10.1007/s00424-007-0295-2; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Shin KS, 2004, NEURON, V41, P737, DOI 10.1016/S0896-6273(04)00083-2; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Vemana S, 2004, J GEN PHYSIOL, V123, P21, DOI 10.1085/jgp.200308916; Viscomi C, 2001, J BIOL CHEM, V276, P29930, DOI 10.1074/jbc.M103971200; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Womack KB, 2000, J NEUROSCI, V20, P2792; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005	32	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15535	15542		10.1074/jbc.M110.214650	http://dx.doi.org/10.1074/jbc.M110.214650			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21383006	hybrid, Green Published			2022-12-27	WOS:000289788300081
J	Heimbach, L; Li, ZW; Berkowitz, P; Zhao, ML; Li, N; Rubenstein, DS; Diaz, LA; Liu, Z				Heimbach, Lisa; Li, Zhuowei; Berkowitz, Paula; Zhao, Minglang; Li, Ning; Rubenstein, David S.; Diaz, Luis A.; Liu, Zhi			The C5a Receptor on Mast Cells Is Critical for the Autoimmune Skin-blistering Disease Bullous Pemphigoid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT ACTIVATION; HERPES-GESTATIONIS; ALTERNATE-PATHWAY; ANTIGEN BPAG2; PROTEIN; INHIBITION; MOUSE; CLONING; CDNA; ANTIBODIES	Bullous pemphigoid (BP) is an autoimmune skin-blistering disease characterized by the presence of autoantibodies against the hemidesmosomal proteins BP230 and BP180. In the IgG passive transfer mouse model of BP, subepidermal blistering is triggered by anti-BP180 antibodies and depends on the complement system, mast cell (MC) degranulation, and neutrophil infiltration. In this study, we have identified the signaling events that connect the activation of the complement system and MC degranulation. We found that mice deficient in MCs or the C5a receptor (C5aR) injected with pathogenic anti-BP180 IgG failed to develop subepidermal blisters and exhibited a drastic reduction in p38 MAPK phosphorylation compared with WT mice. Local reconstitution with MCs from WT but not C5aR-deficient mice restored high levels of p38 MAPK phosphorylation and subepidermal blistering in MC-deficient mice. Local injection of recombinant C5a induced phosphorylation of p38 MAPK in WT but not MC-deficient mice. Cultured mouse MCs treated with recombinant C5a exhibited a significant increase in p38 MAPK phosphorylation and MC degranulation. Taken together, these data demonstrate that C5a interacts with C5aR on MCs and that this C5a-C5aR interaction triggers activation of the p38 MAPK pathway, subsequent MC degranulation, and ultimately BP blistering.	[Heimbach, Lisa; Li, Zhuowei; Berkowitz, Paula; Zhao, Minglang; Li, Ning; Rubenstein, David S.; Diaz, Luis A.; Liu, Zhi] Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27599 USA; [Heimbach, Lisa; Liu, Zhi] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Liu, Z (corresponding author), Univ N Carolina, Dept Dermatol, Rm 422,116 Manning Dr, Chapel Hill, NC 27599 USA.	zhiliu@med.unc.edu		Diaz, Luis/0000-0002-7079-8914	National Institutes of Health [AI40768, AI61430, AR052109, AR053313, AI49427]; United States Public Health Service [AR32599, AR32081]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040768, R01AI040768, R01AI049427, R56AI049427, R01AI061430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR032081, R01AR032599, R03AR053313, K01AR052109, R01AR032081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI40768 and AI61430 (to Z.L.), AR052109 and AR053313 (to N.L.), AI49427 (to D.S.R.), and AR32599 and AR32081 (to L.A.D.) from the United States Public Health Service.	Adcock IM, 2006, EUR J PHARMACOL, V533, P118, DOI 10.1016/j.ejphar.2005.12.054; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Chen RY, 2002, J IMMUNOL, V169, P3987, DOI 10.4049/jimmunol.169.7.3987; Chen RY, 2001, J CLIN INVEST, V108, P1151, DOI 10.1172/jci11494; Church MK, 1999, ANN ALLERG ASTHMA IM, V83, P471, DOI 10.1016/S1081-1206(10)62853-0; Cohen P, 2009, CURR OPIN CELL BIOL, V21, P317, DOI 10.1016/j.ceb.2009.01.015; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; FUREDER W, 1995, J IMMUNOL, V155, P3152; GALLI SJ, 1987, AM J PATHOL, V127, P191; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; GIUDICE GJ, 1992, J INVEST DERMATOL, V99, P243, DOI 10.1111/1523-1747.ep12616580; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; HOPKINSON SB, 1992, J INVEST DERMATOL, V99, P264, DOI 10.1111/1523-1747.ep12616615; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; JORDON RE, 1975, J INVEST DERMATOL, V65, P162, DOI 10.1111/1523-1747.ep12598113; JORDON RE, 1967, J AMER MED ASSOC, V200, P751, DOI 10.1001/jama.200.9.751; JORDON RE, 1975, CLIN IMMUNOL IMMUNOP, V3, P307, DOI 10.1016/0090-1229(75)90017-3; Kalesnikoff J, 2002, J IMMUNOL, V168, P4737, DOI 10.4049/jimmunol.168.9.4737; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; la Sala A, 2005, J IMMUNOL, V175, P2994, DOI 10.4049/jimmunol.175.5.2994; LAWRENCE ID, 1987, J IMMUNOL, V139, P3062; LEVER WF, 1953, MEDICINE, V32, P1; LI KH, 1993, J BIOL CHEM, V268, P8825; LI KH, 1992, J INVEST DERMATOL, V99, P258, DOI 10.1111/1523-1747.ep12616611; Liu Z, 1997, J CLIN INVEST, V100, P1256, DOI 10.1172/JCI119639; LIU Z, 1995, J CLIN INVEST, V95, P1539, DOI 10.1172/JCI117826; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; LIU Z, 1992, J BIOL CHEM, V267, P15829; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; MULLIGAN MS, 1993, J IMMUNOL, V150, P5585; Nelson KC, 2006, J CLIN INVEST, V116, P2892, DOI 10.1172/JCI17891; NISHIZAWA Y, 1993, J BIOCHEM-TOKYO, V113, P493, DOI 10.1093/oxfordjournals.jbchem.a124072; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Perez OA, 2009, DRUG AGING, V26, P833, DOI 10.2165/11316810-000000000-00000; PROVOST TT, 1973, J CLIN INVEST, V52, P1779, DOI 10.1172/JCI107359; Rousseau S, 2006, CELL SIGNAL, V18, P1897, DOI 10.1016/j.cellsig.2006.02.006; Ryan JJ, 1998, J IMMUNOL, V161, P6915; Schett G, 2008, ANN RHEUM DIS, V67, P909, DOI 10.1136/ard.2007.074278; STANLEY JR, 1984, J INVEST DERMATOL, V82, P108, DOI 10.1111/1523-1747.ep12259224; STANLEY JR, 1981, CELL, V24, P897, DOI 10.1016/0092-8674(81)90115-X; STANLEY JR, 1999, DERMATOLOGY GEN MED, P666; TANAKA T, 1990, J INVEST DERMATOL, V94, P617, DOI 10.1111/1523-1747.ep12876200; WERSHIL BK, 1987, J IMMUNOL, V139, P2605; WERSHIL BK, 1991, J CLIN INVEST, V87, P446, DOI 10.1172/JCI115016; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	50	55	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15003	15009		10.1074/jbc.M111.221036	http://dx.doi.org/10.1074/jbc.M111.221036			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21393236	Green Published, hybrid			2022-12-27	WOS:000289788300030
J	McDonagh, B; Padilla, CA; Pedrajas, JR; Barcena, JA				McDonagh, Brian; Alicia Padilla, C.; Rafael Pedrajas, Jose; Antonio Barcena, Jose			Biosynthetic and Iron Metabolism Is Regulated by Thiol Proteome Changes Dependent on Glutaredoxin-2 and Mitochondrial Peroxiredoxin-1 in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST UROPORPHYRINOGEN DECARBOXYLASE; OXIDATIVE STRESS; MASS-SPECTROMETRY; FERRIC REDUCTASE; REDOX REGULATION; ENZYMES; EXPRESSION; PROTEINS; BIOLOGY; GENES	Redoxins are involved in maintenance of thiol redox homeostasis, but their exact sites of action are only partly known. We have applied a combined redox proteomics and transcriptomics experimental strategy to discover specific functions of two interacting redoxins: dually localized glutaredoxin 2 (Grx2p) and mitochondrial peroxiredoxin 1 (Prx1p). We have identified 139 proteins showing differential postranslational thiol redox modifications when the cells do not express Grx2p, Prx1p, or both and have mapped the precise cysteines involved in each case. Some of these modifications constitute functional switches that affect metabolic and signaling pathways as the primary effect, leading to gene transcription remodeling as the secondary adaptive effect as demonstrated by a parallel high throughput gene expression analysis. The results suggest that in the absence of Grx2p, the metabolic flow toward nucleotide and aromatic amino acid biosynthesis is slowed down by redox modification of the key enzymes Rpe1p (D-ribulose-5-phosphate 3-epimerase), Tkl1p (transketolase) and Aro4p (3-deoxy-D-arabino-heptulosonate-7-phosphate synthase). The glycolytic mainstream is then diverted toward carbohydrate storage by induction of trehalose and glycogen biosynthesis genes. Porphyrin biosynthesis may also be compromised by inactivation of the redox-sensitive cytosolic enzymes Hem12p (uroporphyrinogen decarboxylase) and Sam1p (S-adenosyl methionine synthetase) and a battery of respiratory genes sensitive to low heme levels are induced. Genes of the Aft1p-dependent iron regulon were induced specifically in the absence of Prx1p despite optimal mitochondrial Fe-S biogenesis, suggesting dysfunction of the mitochondria to the cytosol signaling pathway. Strikingly, requirement of Grx2p for these events places dithiolic Grx2 in the framework of iron metabolism.	[McDonagh, Brian; Alicia Padilla, C.; Antonio Barcena, Jose] Univ Cordoba, Dept Biochem & Mol Biol, E-14071 Cordoba, Spain; [McDonagh, Brian; Alicia Padilla, C.; Antonio Barcena, Jose] Univ Cordoba, Cordoba Maimonides Inst Biomed Res IMIBIC, E-14071 Cordoba, Spain; [Rafael Pedrajas, Jose] Univ Jaen, Unit Mol Signaling & Antioxidant Syst Plants, Dept Expt Biol, Jaen 23071, Spain	Universidad de Cordoba; Universidad de Cordoba; Universidad de Jaen	Barcena, JA (corresponding author), Campus Rabanales,Ed Severo Ochoa,Pl 1, Cordoba 14071, Spain.	ja.barcena@uco.es	Pedrajas, José Rafael/M-9758-2015; Bárcena, José Antonio/I-2622-2015; Padilla, C. Alicia/H-4736-2015; McDonagh, Brian/I-1903-2015	Pedrajas, José Rafael/0000-0003-1998-0638; Bárcena, José Antonio/0000-0002-5626-5943; Padilla, C. Alicia/0000-0002-9503-8284; McDonagh, Brian/0000-0003-2534-4427	Andalusian Government [P06-CVI-01611]; Spanish Government [BFU2006-02990, BFU2009-08004]	Andalusian Government; Spanish Government(Spanish GovernmentEuropean Commission)	This work was supported by Andalusian Government Grant P06-CVI-01611 and Spanish Government Grants BFU2006-02990 and BFU2009-08004.	Abid MR, 1997, BIOL SIGNAL, V6, P157; Alberola TM, 2004, INT MICROBIOL, V7, P199; Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; Binley KM, 1999, YEAST, V15, P1459, DOI 10.1002/(SICI)1097-0061(199910)15:14<1459::AID-YEA472>3.0.CO;2-A; Boisnard S, 2009, EUKARYOT CELL, V8, P1429, DOI 10.1128/EC.00106-09; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Coles SJ, 2009, BIOCHEMISTRY-US, V48, P645, DOI 10.1021/bi801805h; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Crisp RJ, 2003, J BIOL CHEM, V278, P45499, DOI 10.1074/jbc.M307229200; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; DiFlumeri C, 1997, CAN J MICROBIOL, V43, P792; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; FELIX F, 1990, EUR J BIOCHEM, V188, P393, DOI 10.1111/j.1432-1033.1990.tb15416.x; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gstaiger M, 2009, NAT REV GENET, V10, P617, DOI 10.1038/nrg2633; Hazelwood LA, 2009, APPL ENVIRON MICROB, V75, P6876, DOI 10.1128/AEM.01464-09; He YX, 2009, PROTEINS, V76, P249, DOI 10.1002/prot.22403; Helmstaedt K, 2005, P NATL ACAD SCI USA, V102, P9784, DOI 10.1073/pnas.0504238102; Jin C, 2003, J BIOL CHEM, V278, P14698, DOI 10.1074/jbc.M300593200; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Klomsiri C, 2011, ANTIOXID REDOX SIGN, V14, P1065, DOI 10.1089/ars.2010.3376; Le Moan N, 2006, J BIOL CHEM, V281, P10420, DOI 10.1074/jbc.M513346200; Lewinska A, 2006, REDOX REP, V11, P231, DOI 10.1179/135100006X154987; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; LOWRY CV, 1988, MOL CELL BIOL, V8, P4651, DOI 10.1128/MCB.8.11.4651; Lushchak V, 2005, ARCH BIOCHEM BIOPHYS, V441, P35, DOI 10.1016/j.abb.2005.06.010; Malmstrom J, 2007, CURR OPIN BIOTECH, V18, P378, DOI 10.1016/j.copbio.2007.07.005; MartinezChantar ML, 1996, FEBS LETT, V397, P293, DOI 10.1016/S0014-5793(96)01201-X; McDonagh B, 2005, AQUAT TOXICOL, V73, P315, DOI 10.1016/j.aquatox.2005.03.020; McDonagh B, 2009, J PROTEOMICS, V72, P677, DOI 10.1016/j.jprot.2009.01.023; Molina MM, 2004, J BIOL CHEM, V279, P51923, DOI 10.1074/jbc.M410219200; Moore RE, 2002, J AM SOC MASS SPECTR, V13, P378, DOI 10.1016/S1044-0305(02)00352-5; Nilsson T, 2010, NAT METHODS, V7, P681, DOI 10.1038/nmeth0910-681; PARKS LW, 1995, LIPIDS, V30, P227, DOI 10.1007/BF02537825; Pedrajas JR, 2000, J BIOL CHEM, V275, P16296, DOI 10.1074/jbc.275.21.16296; Porras P, 2006, J BIOL CHEM, V281, P16551, DOI 10.1074/jbc.M600790200; Porras P, 2010, BBA-PROTEINS PROTEOM, V1804, P839, DOI 10.1016/j.bbapap.2009.12.012; Pedrajas JR, 2010, ANTIOXID REDOX SIGN, V13, P249, DOI 10.1089/ars.2009.2950; Rahier A, 2008, BIOCHEM J, V414, P247, DOI 10.1042/BJ20080292; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rintala E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-461; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Stenbaek A, 2010, PHYTOCHEMISTRY, V71, P853, DOI 10.1016/j.phytochem.2010.03.022; Unnikrishnan I, 2003, J BIOL CHEM, V278, P26450, DOI 10.1074/jbc.M211808200; Vernis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004376; Viladevall L, 2004, J BIOL CHEM, V279, P43614, DOI 10.1074/jbc.M403606200; Wallace MA, 2004, J BIOL CHEM, V279, P32055, DOI 10.1074/jbc.M403590200; Wang QY, 2010, J BIOL CHEM, V285, P10408, DOI 10.1074/jbc.M109.085787; Wilson WA, 2002, MOL CELL PROTEOMICS, V1, P232, DOI 10.1074/mcp.M100024-MCP200; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	56	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15565	15576		10.1074/jbc.M110.193102	http://dx.doi.org/10.1074/jbc.M110.193102			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21385868	Green Published, hybrid			2022-12-27	WOS:000289788300084
J	Nakatsu, Y; Sakoda, H; Kushiyama, A; Zhang, J; Ono, H; Fujishiro, M; Kikuchi, T; Fukushima, T; Yoneda, M; Ohno, H; Horike, N; Kanna, M; Tsuchiya, Y; Kamata, H; Nishimura, F; Isobe, T; Ogihara, T; Katagiri, H; Oka, Y; Takahashi, S; Kurihara, H; Uchida, T; Asano, T				Nakatsu, Yusuke; Sakoda, Hideyuki; Kushiyama, Akifumi; Zhang, Jun; Ono, Hiraku; Fujishiro, Midori; Kikuchi, Takako; Fukushima, Toshiaki; Yoneda, Masayasu; Ohno, Haruya; Horike, Nanao; Kanna, Machi; Tsuchiya, Yoshihiro; Kamata, Hideaki; Nishimura, Fusanori; Isobe, Toshiaki; Ogihara, Takehide; Katagiri, Hideki; Oka, Yoshitomo; Takahashi, Shin-ichiro; Kurihara, Hiroki; Uchida, Takafumi; Asano, Tomoichiro			Peptidyl-prolyl Cis/Trans Isomerase NIMA-interacting 1 Associates with Insulin Receptor Substrate-1 and Enhances Insulin Actions and Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOCYTE DIFFERENTIATION; TRANSCRIPTIONAL ACTIVITY; DEPENDENT INTERACTION; BINDING-PROTEIN; CYCLOSPORINE-A; MICE LACKING; PIN1; PHOSPHORYLATION; RESISTANCE; DOMAIN	Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 (Pin1) is a unique enzyme that associates with the pSer/Thr-Pro motif and catalyzes cis-trans isomerization. We identified Pin1 in the immunoprecipitates of overexpressed IRS-1 with myc and FLAG tags in mouse livers and confirmed the association between IRS-1 and Pin1 by not only overexpression experiments but also endogenously in the mouse liver. The analysis using deletion-and point-mutated Pin1 and IRS-1 constructs revealed the WW domain located in the N terminus of Pin1 and Ser-434 in the SAIN (Shc and IRS-1 NPXY binding) domain of IRS-1 to be involved in their association. Subsequently, we investigated the role of Pin1 in IRS-1 mediation of insulin signaling. The overexpression of Pin1 in HepG2 cells markedly enhanced insulin-induced IRS-1 phosphorylation and its downstream events: phosphatidylinositol 3-kinase binding with IRS-1 and Akt phosphorylation. In contrast, the treatment of HepG2 cells with Pin1 siRNA or the Pin1 inhibitor Juglone suppressed these events. In good agreement with these in vitro data, Pin1 knock-out mice exhibited impaired insulin signaling with glucose intolerance, whereas adenoviral gene transfer of Pin1 into the ob/ob mouse liver mostly normalized insulin signaling and restored glucose tolerance. In addition, it was also demonstrated that Pin1 plays a critical role in adipose differentiation, making Pin1 knock-out mice resistant to diet-induced obesity. Importantly, Pin1 expression was shown to be up-regulated in accordance with nutrient conditions such as food intake or a high-fat diet. Taken together, these observations indicate that Pin1 binds to IRS-1 and thereby markedly enhances insulin action, essential for adipogenesis.	[Nakatsu, Yusuke; Zhang, Jun; Fukushima, Toshiaki; Yoneda, Masayasu; Ohno, Haruya; Kanna, Machi; Tsuchiya, Yoshihiro; Kamata, Hideaki; Asano, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, Hiroshima 7348553, Japan; [Sakoda, Hideyuki; Ono, Hiraku; Fujishiro, Midori; Kikuchi, Takako] Univ Tokyo, Dept Internal Med, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Tokyo 1000006, Japan; [Nishimura, Fusanori] Hiroshima Univ, Grad Sch Biomed Sci, Dept Dent Sci Hlth Promot, Hiroshima 7348553, Japan; [Isobe, Toshiaki] Tokyo Metropolitan Univ, Ctr Prior Areas, Tokyo 1920397, Japan; [Ogihara, Takehide; Katagiri, Hideki; Oka, Yoshitomo] Tohoku Univ, Grad Sch Med, Div Mol Metab & Diabet, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kurihara, Hiroki] Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metab, Bunkyo Ku, Tokyo 1130033, Japan; [Takahashi, Shin-ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Biol, Sendai, Miyagi 1130033, Japan	Hiroshima University; University of Tokyo; Asahi Life Foundation; Hiroshima University; Tokyo Metropolitan University; Tohoku University; University of Tokyo; University of Tokyo; Tohoku University	Asano, T (corresponding author), Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	asano-tky@umin.ac.jp	Kamata, Hideaki/N-3907-2017; Kushiyama, Akifumi/W-5988-2019; Isobe, Toshiaki/Q-9279-2017; 祐介, 中津/AAP-8396-2020; Kanna, Machi/D-7028-2011; Kushiyama, Akifumi/A-6386-2011	Kushiyama, Akifumi/0000-0003-1385-7487; Kanna, Machi/0000-0001-9841-433X; Kushiyama, Akifumi/0000-0003-1385-7487; Nakatsu, Yusuke/0000-0003-3279-1276; Takahashi, Shin-Ichiro/0000-0002-2323-2010; Kurihara, Hiroki/0000-0002-6476-5593; Ohno, Haruya/0000-0001-5400-1162; Uchida, Takafumi/0000-0003-3665-4906	Grants-in-Aid for Scientific Research [22780249] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jiang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006884; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; KUNZ J, 1993, TRENDS BIOCHEM SCI, V18, P334, DOI 10.1016/0968-0004(93)90069-Y; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 1999, NATURE, V399, P784; Lufei C, 2007, ONCOGENE, V26, P7656, DOI 10.1038/sj.onc.1210567; Morino K, 2008, DIABETES, V57, P2644, DOI 10.2337/db06-0454; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakatsu Y, 2010, J BIOL CHEM, V285, P33018, DOI 10.1074/jbc.M110.137836; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Pirola L, 2004, DIABETOLOGIA, V47, P170, DOI 10.1007/s00125-003-1313-3; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Takahashi K, 2008, CELL MOL LIFE SCI, V65, P359, DOI 10.1007/s00018-007-7270-0; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; Winkler KE, 2000, SCIENCE, V287, P1644, DOI 10.1126/science.287.5458.1644; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yenush L, 1996, J BIOL CHEM, V271, P24300, DOI 10.1074/jbc.271.39.24300; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	43	51	52	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20812	20822		10.1074/jbc.M110.206904	http://dx.doi.org/10.1074/jbc.M110.206904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21454638	Green Published, hybrid			2022-12-27	WOS:000291267600066
J	Jimenez, S; Torres, M; Vizuete, M; Sanchez-Varo, R; Sanchez-Mejias, E; Trujillo-Estrada, L; Carmona-Cuenca, I; Caballero, C; Ruano, D; Gutierrez, A; Vitorica, J				Jimenez, Sebastian; Torres, Manuel; Vizuete, Marisa; Sanchez-Varo, Raquel; Sanchez-Mejias, Elisabeth; Trujillo-Estrada, Laura; Carmona-Cuenca, Irene; Caballero, Cristina; Ruano, Diego; Gutierrez, Antonia; Vitorica, Javier			Age-dependent Accumulation of Soluble Amyloid beta (A beta) Oligomers Reverses the Neuroprotective Effect of Soluble Amyloid Precursor Protein-alpha (sAPP alpha) by Modulating Phosphatidylinositol 3-Kinase (PI3K)/Akt-GSK-3 beta Pathway in Alzheimer Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P75 NEUROTROPHIN RECEPTOR; GLYCOGEN-SYNTHASE KINASE-3; TRANSGENIC MICE; INSULIN-RECEPTOR; NERVOUS-SYSTEM; IN-VIVO; TAU-HYPERPHOSPHORYLATION; SIGNALING PATHWAY; DISEASE; BRAIN	Neurotrophins, activating the PI3K/Akt signaling pathway, control neuronal survival and plasticity. Alterations in NGF, BDNF, IGF-1, or insulin signaling are implicated in the pathogenesis of Alzheimer disease. We have previously characterized a bigenic PS1 x APP transgenic mouse displaying early hippocampal A beta deposition (3 to 4 months) but late (17 to 18 months) neurodegeneration of pyramidal cells, paralleled to the accumulation of soluble A beta oligomers. We hypothesized that PI3K/Akt/GSK-3 beta signaling pathway could be involved in this apparent age-dependent neuroprotective/neurodegenerative status. In fact, our data demonstrated that, as compared with age-matched nontransgenic controls, the Ser-9 phosphorylation of GSK-3 beta was increased in the 6-month PS1 x APP hippocampus, whereas in aged PS1 x APP animals (18 months), GSK-3 beta phosphorylation levels displayed a marked decrease. Using N2a and primary neuronal cell cultures, we demonstrated that soluble amyloid precursor protein-alpha (sAPP alpha), the predominant APP-derived fragment in young PS1 x APP mice, acting through IGF-1 and/or insulin receptors, activated the PI3K/Akt pathway, phosphorylated the GSK-3 beta activity, and in consequence, exerted a neuroprotective action. On the contrary, several oligomeric A beta forms, present in the soluble fractions of aged PS1 x APP mice, inhibited the induced phosphorylation of Akt/GSK-3 beta and decreased the neuronal survival. Furthermore, synthetic A beta oligomers blocked the effect mediated by different neurotrophins (NGF, BDNF, insulin, and IGF-1) and sAPP alpha, displaying high selectivity for NGF. In conclusion, the age-dependent appearance of APP-derived soluble factors modulated the PI3K/Akt/GSK-3 beta signaling pathway through the major neurotrophin receptors. sAPP alpha stimulated and A beta oligomers blocked the prosurvival signaling. Our data might provide insights into the selective vulnerability of specific neuronal groups in Alzheimer disease.	[Jimenez, Sebastian; Torres, Manuel; Vizuete, Marisa; Carmona-Cuenca, Irene; Caballero, Cristina; Ruano, Diego; Vitorica, Javier] Univ Seville, Dept Bioquim & Biol Mol, Fac Farm, E-41012 Seville, Spain; [Sanchez-Varo, Raquel; Sanchez-Mejias, Elisabeth; Trujillo-Estrada, Laura; Gutierrez, Antonia] Univ Malaga, Fac Ciencias, Dept Biol Celular Genet & Fisiol, E-29071 Malaga, Spain; [Jimenez, Sebastian; Torres, Manuel; Vizuete, Marisa; Sanchez-Varo, Raquel; Sanchez-Mejias, Elisabeth; Trujillo-Estrada, Laura; Carmona-Cuenca, Irene; Caballero, Cristina; Ruano, Diego; Gutierrez, Antonia; Vitorica, Javier] Ctr Invest Biomed Red Sobre Enfermedades Neurodeg, Seville 41013, Spain; [Jimenez, Sebastian; Torres, Manuel; Vizuete, Marisa; Carmona-Cuenca, Irene; Caballero, Cristina; Ruano, Diego; Vitorica, Javier] Univ Seville, CSIC, Inst Biomed Sevilla Hosp Univ Virgen Rocio, Seville 41013, Spain	University of Sevilla; Universidad de Malaga; CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla	Vitorica, J (corresponding author), Univ Seville, Dept Bioquim & Biol Mol, Fac Farm, E-41012 Seville, Spain.	vitorica@us.es	IBIS, ALZHEIMER/O-9867-2015; Sanchez-Varo, Raquel/AAC-8881-2022; CABALLERO, DIEGO RUANO/I-4471-2014; Sanchez-Varo, Raquel/AAS-1465-2020; Jimenez, Sebastian Jimenez S/K-6168-2017; Torres, Manuel/F-7963-2016	CABALLERO, DIEGO RUANO/0000-0001-6131-3033; Sanchez-Varo, Raquel/0000-0001-5296-9786; Jimenez, Sebastian Jimenez S/0000-0002-9151-7587; Torres, Manuel/0000-0002-5076-8486; Trujillo-Estrada, Laura/0000-0001-6696-4505; Gutierrez Perez, Antonia/0000-0002-6264-6152; Vitorica Ferrandez, Javier/0000-0002-0641-7902; Vizuete Chacon, Maria Luisa/0000-0001-5114-9428	Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III, Spain) [PS09/00151, PS09/00099, PS09/00848]; Junta de Andalucia (Spain) [CTS-4795, SAS PI-0496/2009]; Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas; Formacion de Proferorado Universitario (FPU) Program (Spain)	Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III, Spain)(Instituto de Salud Carlos III); Junta de Andalucia (Spain)(Junta de Andalucia); Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas; Formacion de Proferorado Universitario (FPU) Program (Spain)(Spanish Government)	This work was supported in part by Grants PS09/00151 (to J. V.), PS09/00099 (to A. G.), and PS09/00848 (to D. R.) from the Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III, Spain) and by Grants CTS-4795 (to J. V.) and SAS PI-0496/2009 (to A. G.) from Junta de Andalucia (Spain).; Recipient of a contract from the Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas.; Recipient of a Ph.D. fellowship from the Formacion de Proferorado Universitario (FPU) Program (Spain).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Araujo F, 1996, J BIOL CHEM, V271, P27902, DOI 10.1074/jbc.271.44.27902; Baglietto-Vargas D, 2010, J ALZHEIMERS DIS, V21, P119, DOI 10.3233/JAD-2010-100066; Balaraman Y, 2006, CELL MOL LIFE SCI, V63, P1226, DOI 10.1007/s00018-005-5597-y; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Blanchard V, 2003, EXP NEUROL, V184, P247, DOI 10.1016/S0014-4886(03)00252-8; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; Braithwaite SP, 2010, NEUROBIOL DIS, V39, P311, DOI 10.1016/j.nbd.2010.04.015; Caballero C, 2007, J NEUROSCI RES, V85, P787, DOI 10.1002/jnr.21172; Capsoni S, 2002, MOL CELL NEUROSCI, V21, P15, DOI 10.1006/mcne.2002.1163; Capsoni S, 2010, P NATL ACAD SCI USA, V107, P12299, DOI 10.1073/pnas.1007181107; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Cole GM, 2007, EXP GERONTOL, V42, P10, DOI 10.1016/j.exger.2006.08.009; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Engel T, 2006, J NEUROSCI, V26, P5083, DOI 10.1523/JNEUROSCI.0604-06.2006; Ernfors P, 2003, TRENDS NEUROSCI, V26, P171, DOI 10.1016/S0166-2236(03)00064-X; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hongisto V, 2003, MOL CELL BIOL, V23, P6027, DOI 10.1128/MCB.23.17.6027-6036.2003; Houeland G, 2010, J NEUROSCI, V30, P13089, DOI 10.1523/JNEUROSCI.0457-10.2010; Hoyer S, 1998, J NEURAL TRANSM-SUPP, P187; Jimenez S, 2008, J NEUROSCI, V28, P11650, DOI 10.1523/JNEUROSCI.3024-08.2008; Karlnoski R, 2007, NEUROBIOL DIS, V25, P179, DOI 10.1016/j.nbd.2006.09.007; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009; Kojro E, 2006, FASEB J, V20, P512, DOI 10.1096/fj.05-4812fje; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Malm TM, 2007, J NEUROSCI, V27, P3712, DOI 10.1523/JNEUROSCI.0059-07.2007; Masliah E, 1997, NEUROSCIENCE, V78, P135, DOI 10.1016/S0306-4522(96)00553-2; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Moreno-Gonzalez I, 2009, J ALZHEIMERS DIS, V18, P755, DOI 10.3233/JAD-2009-1192; Mufson Elliott J, 2008, Expert Rev Neurother, V8, P1703, DOI 10.1586/14737175.8.11.1703; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Ramos B, 2006, NEUROBIOL AGING, V27, P1658, DOI 10.1016/j.neurobiolaging.2005.09.022; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Rockenstein E, 2007, J NEUROSCI, V27, P1981, DOI 10.1523/JNEUROSCI.4321-06.2007; RUANO D, 1992, J NEUROCHEM, V58, P485, DOI 10.1111/j.1471-4159.1992.tb09747.x; Scali C, 2006, NEUROBIOL DIS, V24, P254, DOI 10.1016/j.nbd.2006.06.016; Schulte-Herbruggen O, 2008, CURR ALZHEIMER RES, V5, P38; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Su Y, 2004, BIOCHEMISTRY-US, V43, P6899, DOI 10.1021/bi035627j; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Woodgett JR, 2005, NAT IMMUNOL, V6, P751, DOI 10.1038/ni0805-751; Xie L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0001.2002; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com; Zhao WQ, 2009, J BIOL CHEM, V284, P18742, DOI 10.1074/jbc.M109.011015	62	141	152	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18414	18425		10.1074/jbc.M110.209718	http://dx.doi.org/10.1074/jbc.M110.209718			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21460223	Green Published, hybrid			2022-12-27	WOS:000290785700014
J	Jung, SR; Kuok, ITD; Couron, D; Rizzo, N; Margineantu, DH; Hockenbery, DM; Kim, F; Sweet, IR				Jung, Seung-Ryoung; Kuok, Iok Teng Denise; Couron, Drew; Rizzo, Norma; Margineantu, Daciana H.; Hockenbery, David M.; Kim, Francis; Sweet, Ian R.			Reduced Cytochrome c Is an Essential Regulator of Sustained Insulin Secretion by Pancreatic Islets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELLS; CALCIUM-CHANNELS; MITOCHONDRIAL SIGNAL; OXYGEN-CONSUMPTION; B-CELLS; PYRUVATE-CARBOXYLASE; MOUSE ISLETS; GLUCOSE; APOPTOSOME; RELEASE	Influx of calcium is an essential but insufficient signal in sustained nutrient-stimulated insulin secretion, and increased metabolic rate of the beta cell is also required. The aim of the study was to test the hypothesis that the reduced state of cytochrome c is a metabolic co-factor necessary for insulin secretion, over and above its participation in the ATP-generating function of electron transport/oxidative phosphorylation. We found that nutrient stimulation of insulin secretion by isolated rat islets was strongly correlated with reduced cytochrome c, and agents that acutely and specifically reduced cytochrome c led to increased insulin secretion, even in the face of decreased oxygen consumption and calcium influx. In contrast, neither sites 1 nor 4 of the electron transport chain were both necessary and essential for the stimulation of insulin secretion to occur. Importantly, stimulation of islets with glucose, alpha-ketoisocaproate, or glyceraldehyde resulted in the appearance of cytochrome c in the cytosol, suggesting a pathway for the regulation of exocytotic machinery by reduction of cytochrome c. The data suggest that the metabolic factor essential for sustained calcium-stimulated insulin secretion to occur is linked to reduction and translocation of cytochrome c.	[Jung, Seung-Ryoung; Kuok, Iok Teng Denise; Couron, Drew; Rizzo, Norma; Kim, Francis; Sweet, Ian R.] Univ Washington, Diabet & Obes Ctr, Dept Med, Seattle, WA 98195 USA; [Margineantu, Daciana H.; Hockenbery, David M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Sweet, IR (corresponding author), Univ Washington, Diabet & Obes Ctr, Dept Med, Box 358055,815 Mercer St, Seattle, WA 98195 USA.	isweet@u.washington.edu			National Institutes of Health [DK17047]; National Science Foundation [IIP-0750508]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK17047 (a DERC Islet Core and an R24 seed grant supplement) and National Science Foundation Grant IIP-0750508.	Aizawa T, 1992, Endocr Regul, V26, P159; Bao Q, 2007, MOL CELL, V25, P181, DOI 10.1016/j.molcel.2006.12.013; BOKVIST K, 1995, EMBO J, V14, P50, DOI 10.1002/j.1460-2075.1995.tb06974.x; Bratanova-Tochkova TK, 2002, DIABETES, V51, pS83, DOI 10.2337/diabetes.51.2007.S83; Brown GC, 2008, BBA-BIOENERGETICS, V1777, P877, DOI 10.1016/j.bbabio.2008.03.024; Cain K, 2001, J BIOL CHEM, V276, P41985, DOI 10.1074/jbc.M107419200; CAVINATO AG, 1990, ANAL CHEM, V62, P1977, DOI 10.1021/ac00217a015; Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; Deeney JT, 2000, SEMIN CELL DEV BIOL, V11, P267, DOI 10.1006/scdb.2000.0175; DENTON RM, 1985, AM J PHYSIOL, V249, pE543, DOI 10.1152/ajpendo.1985.249.6.E543; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; Gao Z, 2003, ENDOCRINOLOGY, V144, P1949, DOI 10.1210/en.2002-0072; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; GEMBAL M, 1993, J CLIN INVEST, V91, P871, DOI 10.1172/JCI116308; Gilbert M, 2008, J BIOL CHEM, V283, P24334, DOI 10.1074/jbc.M802097200; GRODSKY GM, 1966, DIABETES, V15, P910, DOI 10.2337/diab.15.12.910; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; HENQUIN JC, 1994, DIABETES METAB, V20, P132; Ishihara H, 2000, IUBMB LIFE, V49, P391; Ishiyama N, 2006, AM J PHYSIOL-ENDOC M, V290, pE540, DOI 10.1152/ajpendo.00032.2005; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jung SR, 2009, AM J PHYSIOL-ENDOC M, V297, pE717, DOI 10.1152/ajpendo.00282.2009; KASHIWAGURA T, 1984, J CELL PHYSIOL, V120, P13, DOI 10.1002/jcp.1041200103; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Malaisse WJ, 1999, BBA-MOL CELL RES, V1451, P255, DOI 10.1016/S0167-4889(99)00099-3; MALAISSELAGAE F, 1984, BIOCHEM BIOPH RES CO, V123, P1062, DOI 10.1016/S0006-291X(84)80241-7; MATSCHINSKY FM, 1986, J BIOL CHEM, V261, P14057; Matsumoto S, 1999, TRANSPLANTATION, V67, pS220, DOI 10.1097/00007890-199904150-00880; Pan ZH, 1999, CELL DEATH DIFFER, V6, P683, DOI 10.1038/sj.cdd.4400544; Pi JB, 2010, TOXICOL APPL PHARM, V244, P77, DOI 10.1016/j.taap.2009.05.025; Prentki M, 1996, EUR J ENDOCRINOL, V134, P272, DOI 10.1530/eje.0.1340272; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Ravier MA, 1999, DIABETES, V48, P2374, DOI 10.2337/diabetes.48.12.2374; SATIN LS, 1995, ENDOCRINOLOGY, V136, P4589, DOI 10.1210/en.136.10.4589; Satin LS, 2000, ENDOCRINE, V13, P251, DOI 10.1385/ENDO:13:3:251; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P661, DOI 10.1089/152091502320798303; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P67, DOI 10.1089/15209150252924111; Sweet IR, 2005, TRANSPLANTATION, V80, P1003, DOI 10.1097/01.tp.0000178381.35014.37; Sweet IR, 2004, BIOCHEM BIOPH RES CO, V314, P976, DOI 10.1016/j.bbrc.2003.12.182; Sweet IR, 2004, DIABETES, V53, P401, DOI 10.2337/diabetes.53.2.401; Sweet IR, 1996, AM J PHYSIOL-ENDOC M, V271, pE606, DOI 10.1152/ajpendo.1996.271.3.E606; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302; Zhou YP, 2000, AM J PHYSIOL-ENDOC M, V278, pE340, DOI 10.1152/ajpendo.2000.278.2.E340	55	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17422	17434		10.1074/jbc.M110.202820	http://dx.doi.org/10.1074/jbc.M110.202820			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21393241	Green Published, hybrid			2022-12-27	WOS:000290585200004
J	Lavery, DN; Villaronga, MA; Walker, MM; Patel, A; Belandia, B; Bevan, CL				Lavery, Derek N.; Villaronga, M. Angeles; Walker, Marjorie M.; Patel, Anup; Belandia, Borja; Bevan, Charlotte L.			Repression of Androgen Receptor Activity by HEYL, a Third Member of the Hairy/Enhancer-of-split-related Family of Notch Effectors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; COFACTOR P44; CYCLIN D1; DOMAIN; NUCLEAR; TARGET; PROLIFERATION; COREPRESSOR	The Hairy/Enhancer-of-split-related with YRPW-like motif (HEY) family of proteins are transcriptional repressors and downstream effectors of Notch signaling. We previously reported that HEY1 and HEY2 selectively repress androgen receptor (AR) signaling in mammalian cell lines and have shown that in human tissue HEY1 is excluded from the nuclei in prostate cancer but not benign prostatic hyperplasia. We have now characterized a third member of this family, HEYL, which is a more potent repressor of AR activity. HEYL interacted with and repressed AR activation function-1 domain and competitively inhibited SRC1e activation of AR transcriptional activity. Using a cell line inducibly expressing exogenous HEYL, we showed that HEYL represses endogenous AR-regulated genes and reduces androgen-dependent prostate cancer cell growth. Using a transrepression assay, we identified both trichostatin-sensitive and -insensitive domains within HEYL; however, analysis of endogenous AR target genes suggested that HEYL represses AR activity through histone deacetylase I/II-independent mechanisms. Immunohistochemical analyses of tissue indicated that, in a fashion similar to that previously reported for HEY1, HEYL is excluded from the nuclei in prostate cancer but not adjacent benign tissue. This suggests that nuclear exclusion of HEY proteins may be an important step in the progression of prostate cancer.	[Lavery, Derek N.; Bevan, Charlotte L.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Androgen Signalling Lab, London W12 0NN, England; [Walker, Marjorie M.] Univ London Imperial Coll Sci Technol & Med, Ctr Pathol, Div Med, London W2 1NY, England; [Villaronga, M. Angeles; Belandia, Borja] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Dept Canc Biol, Madrid 28029, Spain; [Patel, Anup] Imperial Coll Healthcare Trust, St Marys Hosp, Dept Urol, London W2 1NY, England	Imperial College London; Imperial College London; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Imperial College London	Bevan, CL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Inst Reprod & Dev Biol, Androgen Signalling Lab, London W12 0NN, England.	charlotte.bevan@imperial.ac.uk	Belandia, Borja/H-1509-2015; Bevan, Charlotte L/K-2276-2012; Walker, Marjorie Mary/F-6504-2013; Bevan, Charlotte/T-7769-2019; Lavery, Derek/C-6706-2011	Belandia, Borja/0000-0003-2448-206X; Bevan, Charlotte L/0000-0002-7533-0552; 	Cancer Research UK [C11509/A8570, C11509/A12426]; Ministerio de Ciencia e Innovacion [SAF2007-62642, SAF2010-21013]	Cancer Research UK(Cancer Research UK); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by Cancer Research UK Grants C11509/A8570 and C11509/A12426 and Ministerio de Ciencia e Innovacion Grants SAF2007-62642 and SAF2010-21013.	Agoulnik IU, 2003, J BIOL CHEM, V278, P31136, DOI 10.1074/jbc.M305153200; Belandia B, 2005, MOL CELL BIOL, V25, P1425, DOI 10.1128/MCB.25.4.1425-1436.2005; Belandia Borja, 2006, Nucl Recept Signal, V4, pe001; BRINKMANN AO, 1989, J STEROID BIOCHEM, V34, P307, DOI 10.1016/0022-4731(89)90098-8; Brinkmann AO, 1999, J STEROID BIOCHEM, V69, P307, DOI 10.1016/S0960-0760(99)00049-7; Brooke GN, 2008, ONCOGENE, V27, P2941, DOI 10.1038/sj.onc.1210955; Brooke GN, 2009, CURR GENOMICS, V10, P18, DOI 10.2174/138920209787581307; Burd CJ, 2005, MOL ENDOCRINOL, V19, P607, DOI 10.1210/me.2004-0266; Burd CJ, 2006, ENDOCR-RELAT CANCER, V13, P979, DOI 10.1677/erc.1.01115; Castella P, 2000, MOL CELL BIOL, V20, P6170, DOI 10.1128/MCB.20.16.6170-6183.2000; Chin MT, 2000, J BIOL CHEM, V275, P6381, DOI 10.1074/jbc.275.9.6381; Christiaens V, 2002, J BIOL CHEM, V277, P49230, DOI 10.1074/jbc.M209322200; Dart DA, 2009, ENDOCR-RELAT CANCER, V16, P1157, DOI 10.1677/ERC-09-0028; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Dotzlaw H, 2002, MOL ENDOCRINOL, V16, P661, DOI 10.1210/me.16.4.661; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Fischer A, 2002, COLD SPRING HARB SYM, V67, P63, DOI 10.1101/sqb.2002.67.63; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; Gamble SC, 2007, ONCOGENE, V26, P1757, DOI 10.1038/sj.onc.1209967; Gamble SC, 2004, ONCOGENE, V23, P2996, DOI 10.1038/sj.onc.1207444; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gobinet J, 2001, BIOCHEMISTRY-US, V40, P15369, DOI 10.1021/bi011384o; He B, 2002, MOL GENET METAB, V75, P293, DOI 10.1016/S1096-7192(02)00009-4; Hodgson MC, 2005, J BIOL CHEM, V280, P6511, DOI 10.1074/jbc.M408972200; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; Kalkhoven E, 1998, EMBO J, V17, P232, DOI 10.1093/emboj/17.1.232; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lavery DN, 2005, BIOCHEM J, V391, P449, DOI 10.1042/BJ20050872; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Loy CJ, 2003, P NATL ACAD SCI USA, V100, P4562, DOI 10.1073/pnas.0736237100; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng Y, 2008, P NATL ACAD SCI USA, V105, P5236, DOI 10.1073/pnas.0712262105; Petre CE, 2002, J BIOL CHEM, V277, P2207, DOI 10.1074/jbc.M106399200; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Schiewer MJ, 2009, ONCOGENE, V28, P1016, DOI 10.1038/onc.2008.446; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Verrijdt G, 2003, MOL GENET METAB, V78, P175, DOI 10.1016/S1096-7192(03)00003-9; Villaronga MA, 2010, ONCOGENE, V29, P411, DOI 10.1038/onc.2009.309; Villaronga MA, 2008, CURR CANCER DRUG TAR, V8, P566, DOI 10.2174/156800908786241096; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yu X, 2001, MOL CELL BIOL, V21, P4614, DOI 10.1128/MCB.21.14.4614-4625.2001; Zhou LR, 2006, J MOL ENDOCRINOL, V37, P283, DOI 10.1677/jme.1.02062	46	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17796	17808		10.1074/jbc.M110.198655	http://dx.doi.org/10.1074/jbc.M110.198655			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454491	Green Published, hybrid			2022-12-27	WOS:000290585200043
J	Seron, K; Couturier, C; Belouzard, S; Bacart, J; Monte, D; Corset, L; Bocquet, O; Dam, J; Vauthier, V; Lecoeur, C; Bailleul, B; Hoflack, B; Froguel, P; Jockers, R; Rouille, Y				Seron, Karin; Couturier, Cyril; Belouzard, Sandrine; Bacart, Johan; Monte, Didier; Corset, Laetitia; Bocquet, Olivier; Dam, Julie; Vauthier, Virginie; Lecoeur, Cecile; Bailleul, Bernard; Hoflack, Bernard; Froguel, Philippe; Jockers, Ralf; Rouille, Yves			Endospanins Regulate a Postinternalization Step of the Leptin Receptor Endocytic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; CELL-SURFACE; EXPRESSION; INTERNALIZATION; TRAFFICKING; ACTIVATION; MECHANISMS; TRANSPORT; ISOFORMS; VECTORS	Endospanin-1 is a negative regulator of the cell surface expression of leptin receptor (OB-R), and endospanin-2 is a homologue of unknown function. We investigated the mechanism for endospanin-1 action in regulating OB-R cell surface expression. Here we show that endospanin-1 and -2 are small integral membrane proteins that localize in endosomes and the trans-Golgi network. Antibody uptake experiments showed that both endospanins are transported to the plasma membrane and then internalized into early endosomes but do not recycle back to the trans-Golgi network. Overexpression of endospanin-1 or endospanin-2 led to a decrease of OB-R cell surface expression, whereas shRNA-mediated depletion of each protein increased OB-R cell surface expression. This increased cell surface expression was not observed with OB-Ra mutants defective in endocytosis or with transferrin and EGF receptors. Endospanin-1 or endospanin-2 depletion did not change the internalization rate of OB-Ra but slowed down its lysosomal degradation. Thus, both endospanins are regulators of postinternalization membrane traffic of the endocytic pathway of OB-R.	[Rouille, Yves] Inst Pasteur, INSERM, CNRS, CIIL,UMR8204,U1019, F-59021 Lille, France; [Seron, Karin; Couturier, Cyril; Belouzard, Sandrine; Bacart, Johan; Monte, Didier; Corset, Laetitia; Bocquet, Olivier; Lecoeur, Cecile; Bailleul, Bernard; Froguel, Philippe; Rouille, Yves] Univ Lille Nord France, F-59021 Lille, France; [Couturier, Cyril; Dam, Julie; Vauthier, Virginie; Jockers, Ralf] Univ Paris 05, Dept Cell Biol, CNRS, Inst Cochin,UMR 8104, F-75014 Paris, France; [Couturier, Cyril; Dam, Julie; Vauthier, Virginie; Jockers, Ralf] INSERM, U1016, F-75014 Paris, France; [Monte, Didier] CNRS, UMR 8161, F-59021 Lille, France; [Bailleul, Bernard] INSERM, U1011, F-59021 Lille, France; [Hoflack, Bernard] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Genom Med, London SW7 2AZ, England; [Seron, Karin; Couturier, Cyril; Bacart, Johan; Monte, Didier; Corset, Laetitia; Bocquet, Olivier; Lecoeur, Cecile; Froguel, Philippe] CNRS, UMR 8199, F-59021 Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Technische Universitat Dresden; Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Rouille, Y (corresponding author), Inst Pasteur, INSERM, CNRS, CIIL,UMR8204,U1019, Batiment IBL,1 Rue Prof Calmette,BP 447, F-59021 Lille, France.	yves.rouille@ibl.fr	Couturier, Cyril CC/I-3020-2016; Couturier, Cyril/ABG-9063-2020; Belouzard, Sandrine/O-8527-2016; Rouillé, Yves/P-2405-2016; Seron, Karin/O-8481-2016; Jockers, Ralf/Q-2100-2019; FROGUEL, Philippe/O-6799-2017; Jockers, Ralf/P-2272-2017; Dam, Julie/O-1625-2018; Belouzard, Sandrine/AAX-1584-2021; HOFLACK, Bernard/AAZ-6668-2020	Belouzard, Sandrine/0000-0002-9972-4054; Seron, Karin/0000-0002-9667-133X; Jockers, Ralf/0000-0002-4354-1750; FROGUEL, Philippe/0000-0003-2972-0784; Jockers, Ralf/0000-0002-4354-1750; Dam, Julie/0000-0001-6871-2678; Belouzard, Sandrine/0000-0002-9972-4054; Babin, Laetitia/0000-0002-9912-7321; Rouille, Yves/0000-0003-0788-9271; monte, didier/0000-0002-0613-6203	CNRS; INSERM; Region Nord-Pas de Calais	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission)	This research was supported in part by grants from CNRS (Programme Biologie Cellulaire), INSERM (Programme National de Recherche sur le Diabete), and the Region Nord-Pas de Calais.	Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Bailleul B, 1997, NUCLEIC ACIDS RES, V25, P2752, DOI 10.1093/nar/25.14.2752; Barr VA, 1999, J BIOL CHEM, V274, P21416, DOI 10.1074/jbc.274.30.21416; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bates SH, 2003, TRENDS ENDOCRIN MET, V14, P447, DOI 10.1016/j.tem.2003.10.003; Belgareh-Touze N, 2002, MOL BIOL CELL, V13, P1694, DOI 10.1091/mbc.01-12-0597; Belouzard S, 2006, EMBO J, V25, P932, DOI 10.1038/sj.emboj.7600989; Belouzard S, 2004, J BIOL CHEM, V279, P28499, DOI 10.1074/jbc.M400508200; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; CHU G, 1987, NUCLEIC ACIDS RES, V15, P1311, DOI 10.1093/nar/15.3.1311; Conchon S, 1999, EMBO J, V18, P3934, DOI 10.1093/emboj/18.14.3934; Couturier C, 2003, J BIOL CHEM, V278, P26604, DOI 10.1074/jbc.M302002200; Couturier C, 2007, P NATL ACAD SCI USA, V104, P19476, DOI 10.1073/pnas.0706671104; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; HORN M, 1994, BIOCHEM J, V301, P69, DOI 10.1042/bj3010069; Huang Y, 2001, BBA-GENE STRUCT EXPR, V1517, P327, DOI 10.1016/S0167-4781(00)00266-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindell K, 2001, MOL CELL ENDOCRINOL, V172, P37, DOI 10.1016/S0303-7207(00)00382-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Puertollano R, 1999, J CELL BIOL, V145, P141, DOI 10.1083/jcb.145.1.141; Sanders CR, 2001, BIOCHEMISTRY-US, V40, P9453, DOI 10.1021/bi010894f; Sato K, 2003, MOL BIOL CELL, V14, P3605, DOI 10.1091/mbc.E02-12-0777; Schluter C, 2008, MOL BIOL CELL, V19, P1282, DOI 10.1091/mbc.E07-07-0659; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Touvier T, 2009, J CLIN INVEST, V119, P3830, DOI 10.1172/JCI34997; Uotani S, 1999, DIABETES, V48, P279, DOI 10.2337/diabetes.48.2.279; Zabeau L, 2003, FEBS LETT, V546, P45, DOI 10.1016/S0014-5793(03)00440-X	32	34	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17968	17981		10.1074/jbc.M111.224857	http://dx.doi.org/10.1074/jbc.M111.224857			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454707	Green Published, hybrid			2022-12-27	WOS:000290585200059
J	Smith, AJ; Dai, HM; Correia, C; Takahashi, R; Lee, SH; Schmitz, I; Kaufmann, SH				Smith, Alyson J.; Dai, Haiming; Correia, Cristina; Takahashi, Rie; Lee, Sun-Hee; Schmitz, Ingo; Kaufmann, Scott H.			Noxa/Bcl-2 Protein Interactions Contribute to Bortezomib Resistance in Human Lymphoid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME INHIBITOR PS-341; CHRONIC LYMPHOCYTIC-LEUKEMIA; BCL-2 FAMILY-MEMBERS; ACUTE MYELOGENOUS LEUKEMIA; TRAIL-INDUCED APOPTOSIS; MANTLE-CELL; BH3-ONLY PROTEINS; BH3 DOMAINS; FOLLICULAR LYMPHOMA; MEDIATED APOPTOSIS	Previous studies have suggested that the BH3 domain of the proapoptotic Bcl-2 family member Noxa only interacts with the anti-apoptotic proteins Mcl-1 and A1 but not Bcl-2. In view of the similarity of the BH3 binding domains of these anti-apoptotic proteins as well as recent evidence that studies of isolated BH3 domains can potentially underestimate the binding between full-length Bcl-2 family members, we examined the interaction of full-length human Noxa with anti-apoptotic human Bcl-2 family members. Surface plasmon resonance using bacterially expressed proteins demonstrated that Noxa binds with mean dissociation constants (K-D) of 3.4 nM for Mcl-1, 70 nM for Bcl-x(L), and 250 nM for wild type human Bcl-2, demonstrating selectivity but not absolute specificity of Noxa for Mcl-1. Further analysis showed that the Noxa/Bcl-2 interaction reflected binding between the Noxa BH3 domain and the Bcl-2 BH3 binding groove. Analysis of proteins expressed in vivo demonstrated that Noxa and Bcl-2 can be pulled down together from a variety of cells. Moreover, when compared with wild type Bcl-2, certain lymphoma-derived Bcl-2 mutants bound Noxa up to 20-fold more tightly in vitro, pulled down more Noxa from cells, and protected cells against killing by transfected Noxa to a greater extent. When killing by bortezomib (an agent whose cytotoxicity in Jurkat T-cell leukemia cells is dependent on Noxa) was examined, apoptosis was enhanced by the Bcl-2/Bcl-x(L) antagonist ABT-737 or by Bcl-2 down-regulation and diminished by Bcl-2 overexpression. Collectively, these observations not only establish the ability of Noxa and Bcl-2 to interact but also identify Bcl-2 overexpression as a potential mechanism of bortezomib resistance.	[Dai, Haiming; Correia, Cristina; Kaufmann, Scott H.] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA; [Smith, Alyson J.; Lee, Sun-Hee; Kaufmann, Scott H.] Mayo Clin, Dept Mol Pharmacol, Rochester, MN 55905 USA; [Takahashi, Rie] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Schmitz, Ingo] Otto VonGuericke Univ Magdegurg, Inst Mol & Clin Immunol, Lab Syst Oriented Immunol & Inflammat Res, D-38124 Braunschweig, Germany; [Schmitz, Ingo] Helmholtz Ctr Infect Res, Div Immune Control, D-38124 Braunschweig, Germany	Mayo Clinic; Mayo Clinic; Mayo Clinic; Otto von Guericke University; Helmholtz Association; Helmholtz-Center for Infection Research	Kaufmann, SH (corresponding author), Mayo Clin, Div Oncol Res, Gonda 19-212,200 1st St SW, Rochester, MN 55905 USA.	Kaufmann.scott@mayo.edu	Schmitz, Ingo/G-2093-2013	Schmitz, Ingo/0000-0002-5360-0419; Kaufmann, Scott/0000-0002-4900-7145; Dai, Haiming/0000-0002-0484-7407; Correia, Cristina/0000-0002-9464-7555	National Institutes of Health [R01 CA69008]; Leukemia and Lymphoma Society [6125-10]; Mayo Foundation for Education and Research; NATIONAL CANCER INSTITUTE [R01CA069008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Mayo Foundation for Education and Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 CA69008. This work was also supported by Leukemia and Lymphoma Society Grant 6125-10 as well as predoctoral fellowships from the Mayo Foundation for Education and Research (to A.J.S. and S.-H. L.).	Adams J, 2001, SEMIN ONCOL, V28, P613, DOI 10.1053/sonc.2001.28609; Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Akhtar RS, 2006, J NEUROSCI, V26, P7257, DOI 10.1523/JNEUROSCI.0196-06.2006; Baou M, 2010, HAEMATOL-HEMATOL J, V95, P1510, DOI 10.3324/haematol.2010.022368; Blum KA, 2007, LEUKEMIA LYMPHOMA, V48, P1313, DOI 10.1080/10428190701411458; Brooks AD, 2010, MOL CANCER RES, V8, P729, DOI 10.1158/1541-7786.MCR-10-0022; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chauhan D, 2007, ONCOGENE, V26, P2374, DOI 10.1038/sj.onc.1210028; Chauhan D, 2005, ANNU REV PHARMACOL, V45, P465, DOI 10.1146/annurev.pharmtox.45.120403.100037; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen SQ, 2010, CANCER RES, V70, P4318, DOI 10.1158/0008-5472.CAN-09-4428; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; CHENLEVY Z, 1989, MOL CELL BIOL, V9, P701, DOI 10.1128/MCB.9.2.701; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chittenden T, 2002, CANCER CELL, V2, P165, DOI 10.1016/S1535-6108(02)00128-9; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Conticello C, 2007, J CLIN ENDOCR METAB, V92, P1938, DOI 10.1210/jc.2006-2157; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dai HM, 2009, J BIOL CHEM, V284, P18311, DOI 10.1074/jbc.M109.004770; Du H, 2011, J BIOL CHEM, V286, P491, DOI 10.1074/jbc.M110.167148; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Fribley AM, 2006, J BIOL CHEM, V281, P31440, DOI 10.1074/jbc.M604356200; Gerecitano J, 2009, BRIT J HAEMATOL, V146, P652, DOI 10.1111/j.1365-2141.2009.07775.x; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Hagenbuchner J, 2010, J BIOL CHEM, V285, P6904, DOI 10.1074/jbc.M109.038331; HARLOW E, 1988, ANTIBODIES LAB MANUA, P522; Hideshima T, 2003, BLOOD, V101, P1530, DOI 10.1182/blood-2002-08-2543; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Jung Laura, 2004, Oncology (Williston Park), V18, P4; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kabore AF, 2006, APOPTOSIS, V11, P1175, DOI 10.1007/s10495-006-8048-9; Kandasamy K, 2008, MOL CANCER THER, V7, P1091, DOI 10.1158/1535-7163.MCT-07-2368; Karp JE, 2009, BLOOD, V113, P4841, DOI 10.1182/blood-2008-08-172726; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Kaufmann SH, 1996, J NATL CANCER I, V88, P734, DOI 10.1093/jnci/88.11.734; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Le SB, 2007, J BIOL CHEM, V282, P8860, DOI 10.1074/jbc.M611777200; Lesinski GB, 2008, CANCER RES, V68, P8351, DOI 10.1158/0008-5472.CAN-08-0426; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; Lopez H, 2010, J BIOL CHEM, V285, P15016, DOI 10.1074/jbc.M109.086231; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Meng XW, 2010, J BIOL CHEM, V285, P888, DOI 10.1074/jbc.M109.057638; Meng XW, 2003, J BIOL CHEM, V278, P47326, DOI 10.1074/jbc.M304793200; Mesa RA, 2005, BLOOD, V106, P318, DOI 10.1182/blood-2004-09-3523; Michalak EM, 2009, CELL DEATH DIFFER, V16, P684, DOI 10.1038/cdd.2008.195; Naik E, 2007, J CELL BIOL, V176, P415, DOI 10.1083/jcb.200608070; NGAN BY, 1988, NEW ENGL J MED, V318, P1638, DOI 10.1056/NEJM198806233182502; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; O'Connor OA, 2010, CLIN CANCER RES, V16, P719, DOI 10.1158/1078-0432.CCR-08-2647; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Okumura K, 2008, CLIN CANCER RES, V14, P8132, DOI 10.1158/1078-0432.CCR-08-1665; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pahler JC, 2003, CLIN CANCER RES, V9, P4570; Paoluzzi L, 2010, CLIN CANCER RES, V16, P554, DOI 10.1158/1078-0432.CCR-09-1937; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Rao R, 2010, CLIN CANCER RES, V16, P4742, DOI 10.1158/1078-0432.CCR-10-0529; REED JC, 1993, LEUKEMIA LYMPHOMA, V10, P157, DOI 10.3109/10428199309145877; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Samraj AK, 2006, J BIOL CHEM, V281, P29652, DOI 10.1074/jbc.M603487200; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; SETO M, 1988, EMBO J, V7, P123, DOI 10.1002/j.1460-2075.1988.tb02791.x; Sub KS, 2008, FUTURE ONCOL, V4, P149, DOI 10.2217/14796694.4.2.149; Troch M, 2009, HAEMATOL-HEMATOL J, V94, P738, DOI 10.3324/haematol.2008.001537; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Voortman J, 2007, MOL CANCER THER, V6, P2103, DOI 10.1158/1535-7163.MCT-07-0167; Wei AH, 2008, LEUKEMIA LYMPHOMA, V49, P657, DOI 10.1080/10428190801942378; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wright JJ, 2010, CLIN CANCER RES, V16, P4094, DOI 10.1158/1078-0432.CCR-09-2882; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zinzani PL, 2007, J CLIN ONCOL, V25, P4293, DOI 10.1200/JCO.2007.11.4207	89	70	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17682	17692		10.1074/jbc.M110.189092	http://dx.doi.org/10.1074/jbc.M110.189092			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454712	Green Published, hybrid			2022-12-27	WOS:000290585200032
J	Feltham, R; Bettjeman, B; Budhidarmo, R; Mace, PD; Shirley, S; Condon, SM; Chunduru, SK; McKinlay, MA; Vaux, DL; Silke, J; Day, CL				Feltham, Rebecca; Bettjeman, Bodhi; Budhidarmo, Rhesa; Mace, Peter D.; Shirley, Sarah; Condon, Stephen M.; Chunduru, Srinivas K.; McKinlay, Mark A.; Vaux, David L.; Silke, John; Day, Catherine L.			Smac Mimetics Activate the E3 Ligase Activity of cIAP1 Protein by Promoting RING Domain Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; UBIQUITIN-CONJUGATING ENZYME; ALPHA-DEPENDENT APOPTOSIS; IAP ANTAGONISTS; CELL-SURVIVAL; TNF-ALPHA; ALLOSTERIC ACTIVATION; CRYSTAL-STRUCTURES; SIGNALING COMPLEX; INHIBITOR	The inhibitor of apoptosis (IAP) proteins are important ubiquitin E3 ligases that regulate cell survival and oncogenesis. The cIAP1 and cIAP2 paralogs bear three N-terminal baculoviral IAP repeat (BIR) domains and a C-terminal E3 ligase RING domain. IAP antagonist compounds, also known as Smac mimetics, bind the BIR domains of IAPs and trigger rapid RING-dependent autoubiquitylation, but the mechanism is unknown. We show that RING dimerization is essential for the E3 ligase activity of cIAP1 and cIAP2 because monomeric RING mutants could not interact with the ubiquitin-charged E2 enzyme and were resistant to Smac mimetic-induced autoubiquitylation. Unexpectedly, the BIR domains inhibited cIAP1 RING dimerization, and cIAP1 existed predominantly as an inactive monomer. However, addition of either mono-or bivalent Smac mimetics relieved this inhibition, thereby allowing dimer formation and promoting E3 ligase activation. In contrast, the cIAP2 dimer was more stable, had higher intrinsic E3 ligase activity, and was not highly activated by Smac mimetics. These results explain how Smac mimetics promote rapid destruction of cIAP1 and suggest mechanisms for activating cIAP1 in other pathways.	[Bettjeman, Bodhi; Budhidarmo, Rhesa; Mace, Peter D.; Shirley, Sarah; Day, Catherine L.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand; [Feltham, Rebecca; Vaux, David L.; Silke, John] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Condon, Stephen M.; Chunduru, Srinivas K.; McKinlay, Mark A.] TetraLog Pharmaceut, Malvern, PA 19355 USA	University of Otago; La Trobe University	Day, CL (corresponding author), Univ Otago, Dept Biochem, Dunedin 9054, New Zealand.	catherine.day@otago.ac.nz	Silke, John/B-7622-2008; Vaux, David L/C-7249-2013	Silke, John/0000-0002-7611-5774; Vaux, David L/0000-0003-2703-1651; Mace, Peter/0000-0003-2175-9537; Day, Catherine/0000-0003-1571-4367; Feltham, Rebecca/0000-0001-8376-6869	National Health and Medical Research Council (NHMRC) [461221, 356256, 433013, 541901, 541902]; Marsden Fund (New Zealand); Genesis Oncology Trust; Health Research Council of New Zealand	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Marsden Fund (New Zealand)(Royal Society of New ZealandMarsden Fund (NZ)); Genesis Oncology Trust; Health Research Council of New Zealand(Health Research Council of New Zealand)	Supported by National Health and Medical Research Council (NHMRC) Program Grant 461221.; Supported by NHMRC Grants 356256, 433013, 461221, 541901, and 541902.; Supported by the Marsden Fund (New Zealand), Genesis Oncology Trust, and Health Research Council of New Zealand. To whom correspondence should be addressed. Tel.: 64-3-479-7871; Fax: 64-3-479-7866; E-mail: catherine.day@otago.ac.nz.	Barbash O, 2008, CANCER CELL, V14, P68, DOI 10.1016/j.ccr.2008.05.017; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Blankenship JW, 2009, BIOCHEM J, V417, P149, DOI 10.1042/BJ20081885; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cheng Q, 2009, EMBO J, V28, P3857, DOI 10.1038/emboj.2009.294; Cheung HH, 2008, MOL BIOL CELL, V19, P2729, DOI 10.1091/mbc.E08-01-0107; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Feltham R, 2010, J BIOL CHEM, V285, P17525, DOI 10.1074/jbc.M109.087635; Flygare JA, 2010, EXPERT OPIN THER PAT, V20, P251, DOI 10.1517/13543770903567077; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Huang A, 2009, J MOL BIOL, V385, P507, DOI 10.1016/j.jmb.2008.10.044; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Knipscheer P, 2007, CURR OPIN STRUC BIOL, V17, P665, DOI 10.1016/j.sbi.2007.09.001; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Mace PD, 2010, CELL DEATH DIFFER, V17, P46, DOI 10.1038/cdd.2009.45; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; McDonald ER, 2004, P NATL ACAD SCI USA, V101, P6170, DOI 10.1073/pnas.0307459101; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Serniwka SA, 2009, BIOCHEMISTRY-US, V48, P12169, DOI 10.1021/bi901686j; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Vucic D, 2007, CLIN CANCER RES, V13, P5995, DOI 10.1158/1078-0432.CCR-07-0729; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhang CJ, 2007, J MOL BIOL, V366, P1115, DOI 10.1016/j.jmb.2006.11.096; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	52	118	121	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17015	17028		10.1074/jbc.M111.222919	http://dx.doi.org/10.1074/jbc.M111.222919			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21393245	Green Published, hybrid			2022-12-27	WOS:000290301900052
J	Ge, ZQ; Wang, HY; Parthun, MR				Ge, Zhongqi; Wang, Huanyu; Parthun, Mark R.			Nuclear Hat1p Complex (NuB4) Components Participate in DNA Repair-linked Chromatin Reassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE HAT1P; STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; ACETYLATION SITES; CHAPERONE ASF1; LYSINE 56; IN-VIVO; S-PHASE; H3; YEAST	Chromatin is disassembled and reassembled during DNA repair. To assay chromatin reassembly accompanying DNA double strand break repair, ChIP analysis can be used to monitor the presence of histone H3 near the lesion. The chromatin assembly factor Asf1p, as well as the acetylation of histone H3 lysine 56, have been shown to promote chromatin reassembly when DNA double strand break repair is complete. Using Gal-HO-mediated double strand break repair, we have tested each of the components of the nuclear Hat1p-containing type B histone acetyltransferase complex (NuB4) and have found that they can affect repair-linked chromatin reassembly but that their contributions are not equivalent. In particular, deletion of the catalytic subunit, Hat1p, caused a significant defect in chromatin reassembly. In addition, loss of the histone chaperone Hif1p, when combined with an allele of H3 that mutates lysines 14 and 23 to arginine, has a pronounced effect on chromatin reassembly that is similar to that observed in an asf1 Delta. The role of Hat1p and Hif1p is at least partially redundant with the role of Asf1p. Consistent with a more prominent role for Hif1p in chromatin reassembly than either Hat1p or Hat2p, Hif1p exists in complex(es) independent of Hat1p and Hat2p and influences the activity of an H3-specific histone acetyltransferase activity. Our data directly demonstrate the role of the nuclear HAT1 complex (NuB4) components in DNA repair-linked chromatin reassembly.	[Ge, Zhongqi; Wang, Huanyu; Parthun, Mark R.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Ge, ZQ (corresponding author), 357 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	Parthun.1@osu.edu	Wang, Huanyu/W-3145-2019	Wang, Huanyu/0000-0002-5982-6371	National Institutes of Health [GM62970]; Ohio State University Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62970 (to M. R. P.).; Supported by a Pelotonia Predoctoral Fellowship from the Ohio State University Comprehensive Cancer Center.	Adams A, 1997, METHODS YEAST GENETI; Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Ai X, 2004, MOL CELL, V14, P195, DOI 10.1016/S1097-2765(04)00184-4; ANNUNZIATO AT, 1983, J BIOL CHEM, V258, P2675; Annunziato AT, 2000, GENE EXPRESSION, V9, P37; Barman HK, 2008, BIOCHEM BIOPH RES CO, V373, P624, DOI 10.1016/j.bbrc.2008.06.100; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Benson LJ, 2007, J BIOL CHEM, V282, P836, DOI 10.1074/jbc.M607464200; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; Campos EI, 2010, GENE DEV, V24, P1334, DOI 10.1101/gad.1946810; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; CHICOINE LG, 1986, J BIOL CHEM, V261, P1071; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Durairaj G, 2010, J BIOL CHEM, V285, P30472, DOI 10.1074/jbc.M110.113225; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; HABER JE, 1995, BIOESSAYS, V17, P609, DOI 10.1002/bies.950170707; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; JACKSON V, 1976, J MOL BIOL, V104, P471, DOI 10.1016/0022-2836(76)90282-5; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Kelly TJ, 2000, MOL CELL BIOL, V20, P7051, DOI 10.1128/MCB.20.19.7051-7058.2000; KLEFF S, 1995, J BIOL CHEM, V270, P24674, DOI 10.1074/jbc.270.42.24674; Korber P, 2006, J BIOL CHEM, V281, P5539, DOI 10.1074/jbc.M513340200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Osley MA, 2006, TRENDS GENET, V22, P671, DOI 10.1016/j.tig.2006.09.007; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; Poveda A, 2004, J BIOL CHEM, V279, P16033, DOI 10.1074/jbc.M314228200; Qin S, 2006, MOL CELL BIOL, V26, P3649, DOI 10.1128/MCB.26.9.3649-3658.2006; Qin S, 2002, MOL CELL BIOL, V22, P8353, DOI 10.1128/MCB.22.23.8353-8365.2002; Ruiz-Garcia AB, 1998, J BIOL CHEM, V273, P12599, DOI 10.1074/jbc.273.20.12599; RUIZCARRILLO A, 1975, SCIENCE, V190, P117, DOI 10.1126/science.1166303; Selth L, 2007, J BIOL CHEM, V282, P12358, DOI 10.1074/jbc.C700012200; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Tsukuda Toyoko, 2009, Methods, V48, P40, DOI 10.1016/j.ymeth.2009.02.007; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Ye JX, 2005, MOL CELL, V18, P123, DOI 10.1016/j.molcel.2005.02.031; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6	55	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16790	16799		10.1074/jbc.M110.216846	http://dx.doi.org/10.1074/jbc.M110.216846			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454479	hybrid, Green Published			2022-12-27	WOS:000290301900028
J	Broser, M; Glockner, C; Gabdulkhakov, A; Guskov, A; Buchta, J; Kern, J; Muh, F; Dau, H; Saenger, W; Zouni, A				Broser, Matthias; Gloeckner, Carina; Gabdulkhakov, Azat; Guskov, Albert; Buchta, Joachim; Kern, Jan; Mueh, Frank; Dau, Holger; Saenger, Wolfram; Zouni, Athina			Structural Basis of Cyanobacterial Photosystem II Inhibition by the Herbicide Terbutryn	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC REACTION-CENTER; OXYGEN-EVOLVING COMPLEX; RHODOPSEUDOMONAS-VIRIDIS; ELECTRON-TRANSFER; BINDING NICHE; MODEL; CHLORIDE; RESISTANCE; ENERGETICS; RESOLUTION	Herbicides that target photosystem II (PSII) compete with the native electron acceptor plastoquinone for binding at the Q(B) site in the D1 subunit and thus block the electron transfer from Q(A) to Q(B). Here, we present the first crystal structure of PSII with a bound herbicide at a resolution of 3.2 angstrom. The crystallized PSII core complexes were isolated from the thermophilic cyanobacterium Thermosynechococcus elongatus. The used herbicide terbutryn is found to bind via at least two hydrogen bonds to the Q(B) site similar to photosynthetic reaction centers in anoxygenic purple bacteria. Herbicide binding to PSII is also discussed regarding the influence on the redox potential of Q(A), which is known to affect photoinhibition. We further identified a second and novel chloride position close to the water-oxidizing complex and in the vicinity of the chloride ion reported earlier (Guskov, A., Kern, J., Gabdulkhakov, A., Broser, M., Zouni, A., and Saenger, W. (2009) Nat. Struct. Mol. Biol. 16, 334-342). This discovery is discussed in the context of proton transfer to the lumen.	[Gabdulkhakov, Azat; Guskov, Albert; Saenger, Wolfram] Free Univ Berlin, Inst Chem & Biochem Kristallog, D-14195 Berlin, Germany; [Broser, Matthias; Gloeckner, Carina; Kern, Jan; Mueh, Frank; Zouni, Athina] Tech Univ Berlin, Inst Chem, Max Volmer Lab Biophys Chem, D-10623 Berlin, Germany; [Buchta, Joachim; Dau, Holger] Free Univ Berlin, Fachbereich Phys, D-14195 Berlin, Germany	Free University of Berlin; Technical University of Berlin; Free University of Berlin	Saenger, W (corresponding author), Free Univ Berlin, Inst Chem & Biochem Kristallog, D-14195 Berlin, Germany.	saenger@chemie.fu-berlin.de; athina.zouni@tu-berlin.de	Guskov, Albert/G-1286-2016; Gabdulkhakov, Azat/H-4343-2013; Kern, Jan/G-2586-2013	Guskov, Albert/0000-0003-2340-2216; Gabdulkhakov, Azat/0000-0003-1016-5936; Dau, Holger/0000-0001-6482-7494; Kern, Jan/0000-0002-7272-1603	Deutsche Forschungsgemeinschaft [Sfb 498, A4, C6, C7]; center of excellence on Unifying Concepts in Catalysis [B1]; Russian Academy of Science on Molecular and Cellular Biology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); center of excellence on Unifying Concepts in Catalysis; Russian Academy of Science on Molecular and Cellular Biology	This work was supported by the Deutsche Forschungsgemeinschaft within the framework of Sfb 498 (projects A4, C6, and C7) and the center of excellence on Unifying Concepts in Catalysis (UniCat, project B1), coordinated by the Technische Universitat Berlin. The crystallographic part of this work was supported in part by the Program of the Russian Academy of Science on Molecular and Cellular Biology.	AJLANI G, 1989, PLANT MOL BIOL, V13, P469, DOI 10.1007/BF00027307; Barber J, 2004, PHYS CHEM CHEM PHYS, V6, P4737, DOI 10.1039/b407981g; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchta J, 2007, BBA-BIOENERGETICS, V1767, P565, DOI 10.1016/j.bbabio.2007.04.003; CLARK LC, 1956, T AM SOC ART INT ORG, V2, P41; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V726, P149, DOI 10.1016/0304-4173(83)90004-6; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; DEISENHOFER J, 1984, J MOL BIOL, V180, P385, DOI 10.1016/S0022-2836(84)80011-X; DEISENHOFER J, 1989, SCIENCE, V245, P1463, DOI 10.1126/science.245.4925.1463; EGNER U, 1993, BIOCHIM BIOPHYS ACTA, V1142, P106, DOI 10.1016/0005-2728(93)90091-S; EGNER U, 1992, EUR J BIOCHEM, V206, P685, DOI 10.1111/j.1432-1033.1992.tb16974.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gabdulkhakov A, 2009, STRUCTURE, V17, P1223, DOI 10.1016/j.str.2009.07.010; GLEITER HM, 1993, PHOTOSYNTH RES, V35, P41, DOI 10.1007/BF02185410; Grabolle M, 2005, BBA-BIOENERGETICS, V1708, P209, DOI 10.1016/j.bbabio.2005.03.007; Guskov A, 2010, CHEMPHYSCHEM, V11, P1160, DOI 10.1002/cphc.200900901; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; HIRSCHBERG J, 1983, SCIENCE, V222, P1346, DOI 10.1126/science.222.4630.1346; Ishikita H, 2006, BIOCHEMISTRY-US, V45, P2063, DOI 10.1021/bi051615h; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Katona G, 2005, NAT STRUCT MOL BIOL, V12, P630, DOI 10.1038/nsmb948; Kawakami K, 2009, P NATL ACAD SCI USA, V106, P8567, DOI 10.1073/pnas.0812797106; Kern J, 2005, BBA-BIOENERGETICS, V1706, P147, DOI 10.1016/j.bbabio.2004.10.007; Kern J, 2007, PHOTOSYNTH RES, V94, P183, DOI 10.1007/s11120-007-9201-1; Krieger-Liszkay A, 1998, BIOCHEMISTRY-US, V37, P17339, DOI 10.1021/bi9822628; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Krivanek R, 2007, BBA-BIOENERGETICS, V1767, P520, DOI 10.1016/j.bbabio.2007.02.013; Lancaster CRD, 1999, J MOL BIOL, V286, P883, DOI 10.1006/jmbi.1998.2532; Lancaster CRD, 2000, J BIOL CHEM, V275, P39364, DOI 10.1074/jbc.M008225200; Lancaster CRD, 2008, PRIMARY PROCESSES 2, P5, DOI 10.1039/9781847558169-00005; Lindberg K, 1996, BIOCHEMISTRY-US, V35, P14259, DOI 10.1021/bi961244s; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MICHEL H, 1988, BIOCHEMISTRY-US, V27, P1, DOI 10.1021/bi00401a001; MICHEL H, 1986, EMBO J, V5, P2445, DOI 10.1002/j.1460-2075.1986.tb04520.x; Murray JW, 2008, ENERG ENVIRON SCI, V1, P161, DOI 10.1039/b810067p; Oettmeier W, 1999, CELL MOL LIFE SCI, V55, P1255, DOI 10.1007/s000180050370; OETTMEIER W, 1992, TOPICS PHOTOSYNTHESI, V11, P349; Olesen K, 2003, BIOCHEMISTRY-US, V42, P2025, DOI 10.1021/bi026175y; Petrouleas V, 2005, ADV PHOTO RESPIRAT, V22, P177; Reifler MJ, 2001, J MOL RECOGNIT, V14, P157, DOI 10.1002/jmr.529; Renger G, 2005, ADV PHOTO RESPIRAT, V22, P139; Renger G., 2008, PRIMARY PROCESSES 2, P57, DOI [10.1039/9781847558169-00057, DOI 10.1039/9781847558169-00057]; Renger G, 2008, PRIMARY PROCESSES 2, P237; Renger G, 2007, PHOTOSYNTH RES, V92, P407, DOI 10.1007/s11120-007-9185-x; Rutherford AW, 2001, TRENDS BIOCHEM SCI, V26, P648, DOI 10.1016/S0968-0004(01)01953-3; Sakurai I, 2006, J BIOCHEM, V140, P201, DOI 10.1093/jb/mvj141; SOBOLEV V, 1995, PROTEINS, V21, P214, DOI 10.1002/prot.340210304; Sproviero EM, 2007, CURR OPIN STRUC BIOL, V17, P173, DOI 10.1016/j.sbi.2007.03.015; Takahashi R, 2010, BIOCHEMISTRY-US, V49, P5445, DOI 10.1021/bi100639q; Takahashi R, 2009, BIOCHEMISTRY-US, V48, P8994, DOI 10.1021/bi901195e; Takano A, 2008, PHOTOSYNTH RES, V98, P159, DOI 10.1007/s11120-008-9302-5; TIETJEN KG, 1991, PESTIC SCI, V31, P65, DOI 10.1002/ps.2780310108; TREBST A, 1987, Z NATURFORSCH C, V42, P742; Trebst A, 2007, PHOTOSYNTH RES, V92, P217, DOI 10.1007/s11120-007-9213-x; vanVliet P, 1996, BIOCHEMISTRY-US, V35, P1829, DOI 10.1021/bi9514471; Wydrzynski T. J., 2005, PHOTOSYSTEM; Zimmermann K, 2006, BBA-BIOENERGETICS, V1757, P106, DOI 10.1016/j.bbabio.2005.12.002; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	59	64	86	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.215970	http://dx.doi.org/10.1074/jbc.M110.215970			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21367867	Green Published, hybrid			2022-12-27	WOS:000290022800036
J	Crane, JM; Lam, C; Rossi, A; Gupta, T; Bennett, JL; Verkman, AS				Crane, Jonathan M.; Lam, Chiwah; Rossi, Andrea; Gupta, Tripta; Bennett, Jeffrey L.; Verkman, A. S.			Binding Affinity and Specificity of Neuromyelitis Optica Autoantibodies to Aquaporin-4 M1/M23 Isoforms and Orthogonal Arrays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSENSITIVE WATER CHANNEL; BRAIN EDEMA; MICE; ANTIBODY; PARTICLES; MIGRATION; DYNAMICS; CLONING; INJURY; CELLS	Autoantibodies against astrocyte water channel aquaporin-4 (AQP4) are highly specific for the neuroinflammatory disease neuromyelitis optica (NMO). We measured the binding of NMO autoantibodies to AQP4 in human astrocyte-derived U87MG cells expressing M1 and/or M23 AQP4, or M23 mutants that do not form orthogonal array of particles (OAPs). Binding affinity was quantified by two-color fluorescence ratio imaging of cells stained with NMO serum or a recombinant monoclonal NMO autoantibody (NMO-rAb), together with a C terminus anti-AQP4 antibody. NMO-rAb titrations showed binding with dissociation constants down to 44 +/- 7 nM. Different NMO-rAbs and NMO patient sera showed a wide variation in NMO-IgG binding to M1 versus M23 AQP4. Differences in binding affinity rather than stoichiometry accounted for M1 versus M23 binding specificity, with consistently greater affinity of NMO-IgG binding to M23 than M1 AQP4. Binding and OAP measurements in cells expressing different M1: M23 ratios or AQP4 mutants indicated that the differential binding of NMO-IgG to M1 versus M23 was due to OAP assembly rather than to differences in the M1 versus M23 N termini. Purified Fab fragments of NMO-IgG showed similar patterns of AQP4 isoform binding, indicating that structural changes in the AQP4 epitope upon array assembly, and not bivalent cross-linking of whole IgG, result in the greater binding affinity to OAPs. Our study establishes a quantitative assay of NMO-IgG binding to AQP4 and indicates remarkable, OAP-dependent heterogeneity in NMO autoantibody binding specificity.	[Crane, Jonathan M.; Rossi, Andrea; Gupta, Tripta; Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Crane, Jonathan M.; Rossi, Andrea; Gupta, Tripta; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Lam, Chiwah; Bennett, Jeffrey L.] Univ Colorado Denver, Dept Neurol, Aurora, CO 80045 USA; [Lam, Chiwah; Bennett, Jeffrey L.] Univ Colorado Denver, Dept Ophthalmol, Aurora, CO 80045 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu		Rossi, Andrea/0000-0001-5863-6448	National Institutes of Health [EY13574, EB00415, DK35124, HL73856, DK86125, DK72517]; Guthy-Jackson Charitable Foundation; National Multiple Sclerosis Society [NMSSRG4320]; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086125, R01DK035124, R37DK035124, P30DK072517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guthy-Jackson Charitable Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY13574, EB00415, DK35124, HL73856, DK86125, and DK72517 (to A. S. V.). This work was also supported by grants from the Guthy-Jackson Charitable Foundation (to A. S. V. and J. L. B.) and Grant NMSSRG4320 from the National Multiple Sclerosis Society (to J. L. B.).	Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Binder DK, 2006, ACTA NEUROCHIR SUPPL, V96, P389; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Crane JM, 2008, MOL BIOL CELL, V19, P3369, DOI 10.1091/mbc.E08-03-0322; Crane JM, 2008, BIOPHYS J, V94, P702, DOI 10.1529/biophysj.107.115121; Crane JM, 2009, J BIOL CHEM, V284, P35850, DOI 10.1074/jbc.M109.071670; Crane JM, 2009, J CELL SCI, V122, P813, DOI 10.1242/jcs.042341; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Harris LJ, 1998, J MOL BIOL, V275, P861, DOI 10.1006/jmbi.1997.1508; HASEGAWA H, 1994, J BIOL CHEM, V269, P5497; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; Jarius S, 2008, BRAIN, V131, P3072, DOI 10.1093/brain/awn240; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Kinoshita M, 2010, BIOCHEM BIOPH RES CO, V394, P205, DOI 10.1016/j.bbrc.2010.02.157; LANDIS DMD, 1974, J CELL BIOL, V60, P316, DOI 10.1083/jcb.60.1.316; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Lu DC, 2008, FASEB J, V22, P3216, DOI 10.1096/fj.07-104836; Lu MQ, 1996, P NATL ACAD SCI USA, V93, P10908, DOI 10.1073/pnas.93.20.10908; Mader S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010455; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Padmawar P, 2005, NAT METHODS, V2, P825, DOI 10.1038/NMETH801; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SOSNICK TR, 1992, BIOCHEMISTRY-US, V31, P1779, DOI 10.1021/bi00121a028; Tajima M, 2010, J BIOL CHEM, V285, P8163, DOI 10.1074/jbc.M109.093948; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; WOLBURG H, 1995, J BRAIN RES, V36, P239; YANG BX, 1995, J BIOL CHEM, V270, P22907, DOI 10.1074/jbc.270.39.22907	39	137	146	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.227298	http://dx.doi.org/10.1074/jbc.M111.227298			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454592	Green Published, hybrid			2022-12-27	WOS:000290022800088
J	Lei, X; Shi, FJ; Basu, D; Huq, A; Routhier, S; Day, R; Jin, WJ				Lei, Xia; Shi, Fujun; Basu, Debapriya; Huq, Afroza; Routhier, Sophie; Day, Robert; Jin, Weijun			Proteolytic Processing of Angiopoietin-like Protein 4 by Proprotein Convertases Modulates Its Inhibitory Effects on Lipoprotein Lipase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL LIPASE; INTERACTS; ANGPTL4; OLIGOMERIZATION; METABOLISM; MIGRATION; INSIGHTS; PLASMA; TISSUE; DOMAIN	Angiopoietin-like protein 4 (ANGPTL4) has been associated with a variety of diseases. It is known as an endogenous inhibitor of lipoprotein lipase (LPL), and it modulates lipid deposition and energy homeostasis. ANGPTL4 is cleaved by unidentified protease(s), and the biological importance of this cleavage event is not fully understood with respect to its inhibitory effect on LPL activity. Here, we show that ANGPTL4 appears on the cell surface as the full-length form, where it can be released by heparin treatment in culture and in vivo. ANGPTL4 protein is then proteolytically cleaved into several forms by proprotein convertases (PCs). Several PCs, including furin, PC5/6, paired basic amino acid-cleaving enzyme 4, and PC7, are able to cleave human ANGPTL4 at a consensus site. PC-specific inhibitors block the processing of ANGPTL4. Blockage of ANGPTL4 cleavage reduces its inhibitory effects on LPL activity and decreases its ability to raise plasma triglyceride levels. In summary, the cleavage of ANGPTL4 by these PCs modulates its inhibitory effect on LPL activity.	[Jin, Weijun] SUNY Hlth Sci Ctr, Dept Cell Biol, BSB, Brooklyn, NY 11203 USA; [Routhier, Sophie; Day, Robert] Univ Sherbrooke, Fac Med Sci Sante, Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Sherbrooke	Jin, WJ (corresponding author), SUNY Hlth Sci Ctr, Dept Cell Biol, BSB, 2-106,450 Clarkson Ave, Brooklyn, NY 11203 USA.	weijun.jin@downstate.edu	Basu, Debapriya/AAS-3752-2020	Basu, Debapriya/0000-0002-5312-8169; SHI, FUJUN/0000-0003-1863-7686	National Institutes of Health, NHLBI [HL081861, HL55323, HL08186104S1]; Canadian Institutes of Health Research; Fonds de la Recherche en Sante du Quebec; Ministere du Developpement Economique, de l'Innovation et de l'Exportation du Quebec; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL055323, R01HL081861, R01HL055323] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Ministere du Developpement Economique, de l'Innovation et de l'Exportation du Quebec; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL081861, HL55323, and HL08186104S1 from the NHLBI. This work was also supported by research grants from the Canadian Institutes of Health Research, Fonds de la Recherche en Sante du Quebec, and the Ministere du Developpement Economique, de l'Innovation et de l'Exportation du Quebec (to R. D.).	Adachi H, 2009, BIOCHEM BIOPH RES CO, V379, P806, DOI 10.1016/j.bbrc.2008.12.018; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; Folsom AR, 2008, METABOLISM, V57, P1591, DOI 10.1016/j.metabol.2008.06.016; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Goh YY, 2010, AM J PATHOL, V177, P2791, DOI 10.2353/ajpath.2010.100129; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; Hermann LM, 2005, CLIN IMMUNOL, V115, P93, DOI 10.1016/j.clim.2004.12.002; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Jin WJ, 2005, J BIOL CHEM, V280, P36551, DOI 10.1074/jbc.M502264200; Jin WJ, 2003, CIRC RES, V92, P644, DOI 10.1161/01.RES.0000064502.47539.6D; Li C, 2009, CURR OPIN LIPIDOL, V20, P357, DOI 10.1097/MOL.0b013e32832dd55a; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Liu J, 2010, J BIOL CHEM, V285, P27561, DOI 10.1074/jbc.M110.144279; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; McCoy MG, 2002, J LIPID RES, V43, P921; Miida T, 2010, CURR OPIN LIPIDOL, V21, P70, DOI 10.1097/MOL.0b013e328333269e; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Welm AL, 2008, CELL, V133, P27, DOI 10.1016/j.cell.2008.03.012; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yang YH, 2008, ARTERIOSCL THROM VAS, V28, P835, DOI 10.1161/ATVBAHA.107.157776; Yin W, 2009, J BIOL CHEM, V284, P13213, DOI 10.1074/jbc.M900553200	31	94	102	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.217638	http://dx.doi.org/10.1074/jbc.M110.217638			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21398697	hybrid, Green Published			2022-12-27	WOS:000290022800014
J	Wiseman, DA; Kalwat, MA; Thurmond, DC				Wiseman, Dean A.; Kalwat, Michael A.; Thurmond, Debbie C.			Stimulus-induced S-Nitrosylation of Syntaxin 4 Impacts Insulin Granule Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE PRODUCTION; BETA-CELL DYSFUNCTION; PROTEIN-KINASE-C; TYROSINE PHOSPHORYLATION; PANCREATIC-ISLETS; GLUT4 TRANSLOCATION; OXIDATIVE STRESS; 3T3L1 ADIPOCYTES; MEMBRANE-FUSION; SECRETION	Glucose-stimulated insulin release from pancreatic islet beta-cells involves increased levels of reactive oxygen and nitrogen species. Although this is normal, under pathophysiological conditions such as chronic hyperglycemia and inflammation, insulin exocytosis fails, and yet the mechanistic reason for failure is unclear. Hypothesizing that exocytotic proteins might be targets of S-nitrosylation, with their dysfunction under conditions of nitrosative stress serving as a mechanistic basis for insulin secretory dysfunction, we identified the t-SNARE protein Syntaxin 4 as a target of modification by S-nitrosylation. The cellular content of S-nitrosylated Syntaxin 4 peaked acutely, within 5 min of glucose stimulation in both human islets and MIN6 beta-cells, corresponding to the time at which Syntaxin 4 activation was detectable. S-Nitrosylation was mapped to Syntaxin 4 residue Cys(141), located within the Hc domain predicted to increase accessibility for v-SNARE interaction. A C141S-Syntaxin 4 mutant resisted S-nitrosylation induced in vitro by the nitric oxide donor compound S-nitroso-L-glutathione, failed to exhibit glucose-induced activation and VAMP2 binding, and failed to potentiate insulin release akin to that of wild-type Syntaxin 4. Strikingly, S-nitrosylation of Syntaxin 4 could be induced by acute treatment with inflammatory cytokines (TNF alpha, IL-1 beta, and IFN gamma), coordinate with inappropriate Syntaxin 4 activation and insulin release in the absence of the glucose stimulus, consistent with nitrosative stress and dysfunctional exocytosis, preceding the cell dysfunction and death associated with more chronic stimulation (24 h). Taken together, these data indicate a significant role for reactive nitrogen species in the insulin exocytosis mechanism in beta-cells and expose a potential pathophysiological exploitation of this mechanism to underlie dysfunctional exocytosis.	[Wiseman, Dean A.; Thurmond, Debbie C.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Basic Diabet Res Grp, Indianapolis, IN 46202 USA; [Kalwat, Michael A.; Thurmond, Debbie C.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Thurmond, DC (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Basic Diabet Res Grp, 635 Barnhill Dr,MS2031, Indianapolis, IN 46202 USA.	dthurmon@iupui.edu	Kalwat, Michael A/H-3184-2013; Kalwat, Michael/GRJ-4422-2022	Kalwat, Michael A/0000-0002-8349-9470; Wiseman, Dean/0000-0002-5831-2862	National Institutes of Health [K01 DK087811, F32 HL090198, R01 DK067912, DK76614]; American Heart Association [T32 DK64466]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL090198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067912, T32DK064466, K01DK087811, R01DK076614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K01 DK087811 and F32 HL090198 (to D. A. W.) and R01 DK067912 and DK76614 (to D. C. T.) and National Institutes of Health and American Heart Association Predoctoral Fellowship T32 DK64466 (to M. A. K.).	Arnush M, 1998, J IMMUNOL, V160, P2684; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; CETKOVICCVRLJE M, 1994, CYTOKINE, V6, P399, DOI 10.1016/1043-4666(94)90064-7; Chen GL, 2003, FEBS LETT, V534, P54, DOI 10.1016/S0014-5793(02)03774-2; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P8992, DOI 10.1073/pnas.90.19.8992; CORBETT JA, 1992, DIABETES, V41, P897, DOI 10.2337/diabetes.41.8.897; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Goh CS, 2002, J MOL BIOL, V324, P177, DOI 10.1016/S0022-2836(02)01038-0; Gray JP, 2010, TOXICOL MECH METHOD, V20, P167, DOI 10.3109/15376511003695181; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jewell JL, 2008, J BIOL CHEM, V283, P21734, DOI 10.1074/jbc.M710445200; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Ke B, 2007, J BIOL CHEM, V282, P21786, DOI 10.1074/jbc.M701661200; Koeck T, 2009, ARCH BIOCHEM BIOPHYS, V484, P221, DOI 10.1016/j.abb.2009.01.021; Laffranchi R, 1995, BIOCHEM BIOPH RES CO, V217, P584, DOI 10.1006/bbrc.1995.2815; LEAHY JL, 1990, DIABETES CARE, V13, P992, DOI 10.2337/diacare.13.9.992; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Meffert MK, 1996, NEURON, V16, P1229, DOI 10.1016/S0896-6273(00)80149-X; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Nakada S, 2003, PFLUG ARCH EUR J PHY, V447, P305, DOI 10.1007/s00424-003-1176-y; Nakata M, 2003, PANCREAS, V27, P209, DOI 10.1097/00006676-200310000-00001; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; Nili U, 2006, NEUROSCIENCE, V143, P487, DOI 10.1016/j.neuroscience.2006.08.014; Oh E, 2006, J BIOL CHEM, V281, P17624, DOI 10.1074/jbc.M601581200; Palmer ZJ, 2008, BIOCHEM J, V413, P479, DOI 10.1042/BJ20080069; Prior IA, 2000, BBA-GEN SUBJECTS, V1475, P281, DOI 10.1016/S0304-4165(00)00078-7; Rizzo MA, 2003, J CELL BIOL, V161, P243, DOI 10.1083/jcb.200301063; Sadoul K, 1997, J BIOL CHEM, V272, P33023, DOI 10.1074/jbc.272.52.33023; Schmelzle K, 2006, DIABETES, V55, P2171, DOI 10.2337/db06-0148; Scott JA, 2004, ANN NY ACAD SCI, V1031, P204, DOI 10.1196/annals.1331.020; Smukler SR, 2002, DIABETES, V51, P3450, DOI 10.2337/diabetes.51.12.3450; SPINAS GA, 1988, ACTA ENDOCRINOL-COP, V119, P307, DOI 10.1530/acta.0.1190307; Spinas GA, 1998, DIABETOLOGIA, V41, P292, DOI 10.1007/s001250050906; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Spurlin BA, 2004, DIABETES, V53, P2223, DOI 10.2337/diabetes.53.9.2223; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Thomas HE, 2002, DIABETES, V51, P311, DOI 10.2337/diabetes.51.2.311; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Umahara M, 2008, ENDOCRINOLOGY, V149, P40, DOI 10.1210/en.2006-1549; VINCENT SR, 1992, SCIENCE, V258, P1376; Watanabe M, 2005, MOL BIOL CELL, V16, P4519, DOI 10.1091/mbc.E05-03-0252; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; Wu JJ, 2001, J SURG RES, V101, P190, DOI 10.1006/jsre.2001.6285	56	43	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.214031	http://dx.doi.org/10.1074/jbc.M110.214031			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21393240	Green Published, hybrid			2022-12-27	WOS:000290022800072
J	Fuhs, SR; Insel, PA				Fuhs, Stephen R.; Insel, Paul A.			Caveolin-3 Undergoes SUMOylation by the SUMO E3 Ligase PIASy SUMOYLATION AFFECTS G-PROTEIN-COUPLED RECEPTOR DESENSITIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; HUMAN BETA(1)-ADRENERGIC RECEPTOR; TYROSINE-PHOSPHATASE 1B; SKELETAL-MUSCLE CELLS; ESCHERICHIA-COLI; ADENYLYL-CYCLASE; LIPID RAFTS; BETA(2)-ADRENERGIC RECEPTOR; CARDIAC MYOCYTES; NUCLEAR EXPORT	Caveolin (Cav) proteins in the plasma membrane have numerous binding partners, but the determinants of these interactions are poorly understood. We show here that Cav-3 has a small ubiquitin-like modifier (SUMO) consensus motif (psi KX(D/E, where psi is a hydrophobic residue)) near the scaffolding domain and that Cav-3 is SUMOylated in a manner that is enhanced by the SUMO E3 ligase PIASy (protein inhibitor of activated STAT-y). Site-directed mutagenesis revealed that the consensus site lysine is the preferred SUMOylation site but that mutation of all lysines is required to abolish SUMOylation. Co-expression of a SUMOylation-deficient mutant of Cav-3 with beta-adrenergic receptors (beta ARs) alters the expression level of beta(2)ARs but not beta(1)ARs following agonist stimulation, thus implicating Cav-3 SUMOylation in the mechanisms for beta(2)AR but not beta(1)AR desensitization. Expression of endothelial nitric-oxide synthase (NOS3) was not altered by the SUMOylation-deficient mutant. Thus, SUMOylation is a covalent modification of caveolins that influence the regulation of certain signaling partners.	[Insel, Paul A.] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Insel, PA (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA.	pinsel@ucsd.edu			National Institutes of Health [HL091071, GM066232, HL066941]; University of California at San Diego; Molecular Pharmacology through NIGMS, National Institutes of Health [T32 GM007752]; PhRMA Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091071, P01HL066941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066232, T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at San Diego; Molecular Pharmacology through NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PhRMA Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL091071, GM066232, and HL066941 (to P.A.I.).; Supported in part by the University of California at San Diego Graduate Training Program in Cellular and Molecular Pharmacology through NIGMS, National Institutes of Health, Grant T32 GM007752 as well as a PhRMA Foundation predoctoral fellowship in pharmacology/toxicology.	Albor A, 2006, J BIOL CHEM, V281, P25850, DOI 10.1074/jbc.M601655200; Bartholomew JN, 2009, CANCER RES, V69, P2878, DOI 10.1158/0008-5472.CAN-08-2857; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Blomster HA, 2009, MOL CELL PROTEOMICS, V8, P1382, DOI 10.1074/mcp.M800551-MCP200; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Conrotto P, 2007, J PROTEOME RES, V6, P287, DOI 10.1021/pr060427q; Dadke S, 2007, NAT CELL BIOL, V9, P80, DOI 10.1038/ncb1522; De Arcangelis V, 2009, J BIOL CHEM, V284, P33824, DOI 10.1074/jbc.M109.020388; DIBNER MD, 1981, J BIOL CHEM, V256, P7343; Fecchi K, 2006, FASEB J, V20, P705, DOI 10.1096/fj.05-4661fje; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Gocke CB, 2005, J BIOL CHEM, V280, P5004, DOI 10.1074/jbc.M411718200; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Ihara M, 2005, MOL CELL BIOL, V25, P3506, DOI 10.1128/MCB.25.9.3506-3518.2005; Imoto S, 2008, BIOCHEM BIOPH RES CO, V370, P359, DOI 10.1016/j.bbrc.2008.03.116; Kang JS, 2008, NAT CELL BIOL, V10, P654, DOI 10.1038/ncb1728; Lamb ME, 2002, BIOCHEMISTRY-US, V41, P14340, DOI 10.1021/bi020231d; Lee H, 2006, BIOCHEMISTRY-US, V45, P234, DOI 10.1021/bi051560j; Li X, 2010, BIOCHEM J, V428, P55, DOI 10.1042/BJ20091672; Liang W, 2004, J BIOL CHEM, V279, P46882, DOI 10.1074/jbc.M406501200; Liang W, 2003, J BIOL CHEM, V278, P39773, DOI 10.1074/jbc.M304482200; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; Martin N, 2008, MOL CELL BIOL, V28, P2771, DOI 10.1128/MCB.01210-07; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Meek DW, 2003, MOL CANCER RES, V1, P1017; Mencia M, 2004, PROTEIN EXPRES PURIF, V37, P409, DOI 10.1016/j.pep.2004.07.001; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Ostrom RS, 2004, J BIOL CHEM, V279, P19846, DOI 10.1074/jbc.M313440200; Ostrom RS, 2001, J BIOL CHEM, V276, P42063, DOI 10.1074/jbc.M105348200; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; Rodriguez-Munoz M, 2007, NEUROPSYCHOPHARMACOL, V32, P842, DOI 10.1038/sj.npp.1301184; Sabourin T, 2002, MOL PHARMACOL, V61, P546, DOI 10.1124/mol.61.3.546; Saitoh Hisato, 2009, V497, P211, DOI 10.1007/978-1-59745-566-4_14; Santibanez JF, 2008, CARDIOVASC RES, V77, P791, DOI 10.1093/cvr/cvm097; Scheschonka A, 2007, TRENDS NEUROSCI, V30, P85, DOI 10.1016/j.tins.2007.01.003; Schwartz EA, 2005, BIOCHEM J, V390, P199, DOI 10.1042/BJ20041182; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shcherbakova OG, 2007, J CELL BIOL, V176, P521, DOI 10.1083/jcb.200604167; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Smythe GM, 2003, J CELL SCI, V116, P4739, DOI 10.1242/jcs.00806; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Werner Andreas, 2009, V497, P187, DOI 10.1007/978-1-59745-566-4_12; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wyatt D, 2011, J BIOL CHEM, V286, P3884, DOI 10.1074/jbc.M110.152116; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Yang ML, 2006, J BIOL CHEM, V281, P8264, DOI 10.1074/jbc.M510364200; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383	61	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14830	14841		10.1074/jbc.M110.214270	http://dx.doi.org/10.1074/jbc.M110.214270			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21362625	hybrid, Green Published			2022-12-27	WOS:000289788300013
J	He, C; Murthy, S; McCormick, ML; Spitz, DR; Ryan, AJ; Carter, AB				He, Chao; Murthy, Shubha; McCormick, Michael L.; Spitz, Douglas R.; Ryan, Alan J.; Carter, A. Brent			Mitochondrial Cu,Zn-Superoxide Dismutase Mediates Pulmonary Fibrosis by Augmenting H2O2 Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPPER CHAPERONE CCS; SUPEROXIDE-DISMUTASE; INTERMEMBRANE SPACE; GENE-EXPRESSION; LUNG-DISEASE; ANTIOXIDANT ENZYMES; HEART-MITOCHONDRIA; S-NITROSYLATION; ASBESTOS; INHALATION	The release of H2O2 from alveolar macrophages has been linked to the development of pulmonary fibrosis, but little is known about its source or mechanism of production. We found that alveolar macrophages from asbestosis patients spontaneously produce high levels of H2O2 and have high expression of Cu,Zn-superoxide dismutase (SOD). Because Cu,Zn-SOD is found in the mitochondrial intermembrane space (IMS), we hypothesized that mitochondrial Cu,Zn-SOD-mediated H2O2 generation contributed to pulmonary fibrosis. Asbestos-induced translocation of Cu,Zn-SOD to the IMS was unique to macrophages and dependent on functional mitochondrial respiration and the presence of at least one of the conserved cysteines required for disulfide bond formation. These conserved cysteine residues were also necessary for enzyme activation and H2O2 generation. Cu,Zn-SOD-mediated H2O2 generation was inhibited by knockdown of the iron-sulfur protein, Rieske, in complex III. The role of Cu,Zn-SOD was biologically relevant in that Cu,Zn-SOD-/- mice generated significantly less H2O2 and had less oxidant stress in bronchoalveolar lavage fluid and lung parenchyma. Furthermore, Cu,Zn-SOD-/- mice did not develop pulmonary fibrosis, and knockdown of Cu,Zn-SOD in monocytes attenuated collagen I deposition by lung fibroblasts. Our findings demonstrate a novel mechanism for the pathogenesis of pulmonary fibrosis where the antioxidant enzyme Cu,Zn-SOD translocates to the mitochondrial IMS to increase H2O2 generation in alveolar macrophages.	[He, Chao; McCormick, Michael L.; Spitz, Douglas R.; Carter, A. Brent] Univ Iowa, Carver Coll Med, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Murthy, Shubha; Ryan, Alan J.; Carter, A. Brent] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [He, Chao; McCormick, Michael L.; Spitz, Douglas R.; Carter, A. Brent] Univ Iowa, Carver Coll Med, Grad Program Free Rad & Radiat Biol, Iowa City, IA 52242 USA; [Carter, A. Brent] Univ Iowa, Coll Publ Hlth, Dept Human Toxicol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Carter, AB (corresponding author), Univ Iowa, Carver Coll Med, Dept Radiat Oncol, C33 GH, Iowa City, IA 52242 USA.	brent-carter@uiowa.edu		Spitz, Douglas/0000-0002-1254-8765	National Institutes of Health [ES015981, ES014871, P30 CA086862]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014871, R01ES015981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES015981, ES014871 (to A. B. C.), and P30 CA086862 (to University of Iowa Cancer Center).	ANDERSON ME, 1985, TISSUE GLUTATHIONE; Attfield M. D., 2004, Morbidity and Mortality Weekly Report, V53, P627; AUWERX JH, 1989, BLOOD, V74, P1807; BITTERMAN PB, 1986, J CLIN INVEST, V77, P700, DOI 10.1172/JCI112364; BROOKSBANK BWL, 1984, DEV BRAIN RES, V16, P37, DOI 10.1016/0165-3806(84)90060-9; Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; Carter AB, 2004, AM J RESP CELL MOL, V31, P43, DOI 10.1165/rcmb.2003-0377OC; Carter KB, 2000, J BIOL CHEM, V275, P27858; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; FRIDOVICH I, 1986, ANNU REV PHYSIOL, V48, P693; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; GILLIARD N, 1994, J CLIN INVEST, V93, P2608, DOI 10.1172/JCI117273; Goldsteins G, 2008, J BIOL CHEM, V283, P8446, DOI 10.1074/jbc.M706111200; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Guo CJ, 2008, PLOS BIOL, V6, P2414, DOI 10.1371/journal.pbio.0060266; HANCE AJ, 1985, J IMMUNOL, V134, P284; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Inarrea P, 2005, BIOCHEM J, V387, P203, DOI 10.1042/BJ20041683; Ischiropoulos H, 2005, TOXICOLOGY, V208, P299, DOI 10.1016/j.tox.2004.11.018; JANSSEN YMW, 1990, FREE RADICAL RES COM, V11, P53, DOI 10.3109/10715769009109667; JANSSEN YMW, 1992, J BIOL CHEM, V267, P10625; Kamp DW, 1999, THORAX, V54, P638, DOI 10.1136/thx.54.7.638; Krombach F, 1996, EUR RESPIR J, V9, P984, DOI 10.1183/09031936.96.09050984; Marden JJ, 2007, J CLIN INVEST, V117, P2913, DOI 10.1172/JCI31265; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; MOSSMAN BT, 1989, ENVIRON HEALTH PERSP, V81, P91, DOI 10.2307/3430811; MOSSMAN BT, 1990, AM REV RESPIR DIS, V141, P1266, DOI 10.1164/ajrccm/141.5_Pt_1.1266; Murthy S, 2010, J BIOL CHEM, V285, P25062, DOI 10.1074/jbc.M109.099655; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; OBERLEY LW, 1984, METHOD ENZYMOL, V105, P457; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Panduri V, 2004, AM J PHYSIOL-LUNG C, V286, pL1220, DOI 10.1152/ajplung.00371.2003; PANUS PC, 1993, FREE RADICAL BIO MED, V14, P217, DOI 10.1016/0891-5849(93)90013-K; ROM WN, 1987, AM REV RESPIR DIS, V136, P1429, DOI 10.1164/ajrccm/136.6.1429; Soberanes S, 2009, J BIOL CHEM, V284, P2176, DOI 10.1074/jbc.M808844200; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Tephly LA, 2007, AM J PHYSIOL-LUNG C, V293, pL1143, DOI 10.1152/ajplung.00114.2007; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Venkatachalam P, 2008, ONCOGENE, V27, P20, DOI 10.1038/sj.onc.1210634	42	51	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15597	15607		10.1074/jbc.M110.187377	http://dx.doi.org/10.1074/jbc.M110.187377			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21393238	Green Published, hybrid			2022-12-27	WOS:000289788300087
J	Sagane, K; Umemura, M; Ogawa-Mitsuhashi, K; Tsukahara, K; Yoko-o, T; Jigami, Y				Sagane, Koji; Umemura, Mariko; Ogawa-Mitsuhashi, Kaoru; Tsukahara, Kappei; Yoko-o, Takehiko; Jigami, Yoshifumi			Analysis of Membrane Topology and Identification of Essential Residues for the Yeast Endoplasmic Reticulum Inositol Acyltransferase Gwt1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR BIOSYNTHESIS; ACYL-COENZYME-A; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; PROTEINS; ACYLATION; ER; PALMITOYLTRANSFERASE; MUTAGENESIS; EXPRESSION	Glycosylphosphatidylinositol (GPI) is a post-translational modification that anchors cell surface proteins to the plasma membrane, and GPI modifications occur in all eukaryotes. Biosynthesis of GPI starts on the cytoplasmic face of the endoplasmic reticulum (ER) membrane, and GPI precursors flip from the cytoplasmic side to the luminal side of the ER, where biosynthesis of GPI precursors is completed. Gwt1p and PIG-W are inositol acyltransferases that transfer fatty acyl chains to the inositol moiety of GPI precursors in yeast and mammalian cells, respectively. To ascertain whether flipping across the ER membrane occurs before or after inositol acylation of GPI precursors, we identified essential residues of PIG-W and Gwt1p and determined the membrane topology of Gwt1p. Guided by algorithm-based predictions of membrane topology, we experimentally identified 13 transmembrane domains in Gwt1p. We found that Gwt1p, PIG-W, and their orthologs shared four conserved regions and that these four regions in Gwt1p faced the luminal side of the ER membrane. Moreover, essential residues of Gwt1p and PIG-W faced the ER lumen or were near the luminal edge of transmembrane domains. The membrane topology of Gwt1p suggested that inositol acylation occurred on the luminal side of the ER membrane. Rather than stimulate flipping of the GPI precursor across the ER membrane, inositol acylation of GPI precursors may anchor the precursors to the luminal side of the ER membrane, preventing flip-flops.	[Tsukahara, Kappei] Eisai & Co Ltd, Next Generat Syst Core Funct Unit, Eisai Prod Creat Syst, Tsukuba, Ibaraki 3002635, Japan; [Umemura, Mariko; Yoko-o, Takehiko; Jigami, Yoshifumi] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Higashi Ku, Tsukuba, Ibaraki 3058566, Japan; [Umemura, Mariko] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo 1920392, Japan	Eisai Co Ltd; National Institute of Advanced Industrial Science & Technology (AIST); Tokyo University of Pharmacy & Life Sciences	Tsukahara, K (corresponding author), Eisai & Co Ltd, Next Generat Syst Core Funct Unit, Eisai Prod Creat Syst, 5-1-3 Tokodai, Tsukuba, Ibaraki 3002635, Japan.	k-tsukahara@hhc.eisai.co.jp; t.yoko-o@aist.go.jp	Yoko-o, Takehiko/L-7093-2018	Yoko-o, Takehiko/0000-0003-0291-8299; Sagane, Koji/0000-0001-5814-3037				Abe H, 2003, GLYCOBIOLOGY, V13, P87, DOI 10.1093/glycob/cwg014; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Bosson R, 2006, MOL BIOL CELL, V17, P2636, DOI 10.1091/mbc.E06-02-0104; Caro LHP, 1997, YEAST, V13, P1477, DOI 10.1002/(SICI)1097-0061(199712)13:15<1477::AID-YEA184>3.0.CO;2-L; Chen R, 1998, P NATL ACAD SCI USA, V95, P9512, DOI 10.1073/pnas.95.16.9512; COSTELLO LC, 1992, J BIOL CHEM, V267, P8599; Fujita M, 2008, BBA-GEN SUBJECTS, V1780, P410, DOI 10.1016/j.bbagen.2007.08.009; Fujita M, 2006, MOL BIOL CELL, V17, P5253, DOI 10.1091/mbc.E06-08-0715; Gilstring CF, 2000, J BIOL CHEM, V275, P31488, DOI 10.1074/jbc.M005047200; Guo ZM, 2001, J LIPID RES, V42, P1282; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; HIROSE S, 1992, J BIOL CHEM, V267, P5272; HYMAN R, 1988, TRENDS GENET, V4, P5, DOI 10.1016/0168-9525(88)90120-5; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Kajiwara K, 2008, MOL BIOL CELL, V19, P2069, DOI 10.1091/mbc.E07-08-0740; Kinoshita T, 1995, ADV IMMUNOL, V60, P57, DOI 10.1016/S0065-2776(08)60584-2; KINOSHITA T, 2000, BIOCHIM BIOPHYS ACTA, V4, P405; LEIDICH SD, 1994, J BIOL CHEM, V269, P10193; Lu XH, 2002, J BIOL CHEM, V277, P711, DOI 10.1074/jbc.M109427200; Maeda Y, 2001, EMBO J, V20, P250, DOI 10.1093/emboj/20.1.250; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Murakami Y, 2003, MOL BIOL CELL, V14, P4285, DOI 10.1091/mbc.E03-03-0193; Nakamoto K, 2010, BIOORG MED CHEM LETT, V20, P4624, DOI 10.1016/j.bmcl.2010.06.005; Nakamura N, 1997, J BIOL CHEM, V272, P15834, DOI 10.1074/jbc.272.25.15834; Ogawa-Mitsuhashi K, 2009, YEAST, V26, P587, DOI 10.1002/yea.1708; Okamoto M, 2006, J BIOL CHEM, V281, P4013, DOI 10.1074/jbc.M504684200; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; SIKORSKI RS, 1989, GENETICS, V122, P19; SIPOS G, 1994, EMBO J, V13, P2789, DOI 10.1002/j.1460-2075.1994.tb06572.x; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Treber M, 2003, J BIOL CHEM, V278, P11145, DOI 10.1074/jbc.M210566200; Tsukahara K, 2003, MOL MICROBIOL, V48, P1029, DOI 10.1046/j.1365-2958.2003.03481.x; Umemura M, 2003, J BIOL CHEM, V278, P23639, DOI 10.1074/jbc.M301044200; URAKAZE M, 1992, J BIOL CHEM, V267, P6459; VIDUGIRIENE J, 1993, J CELL BIOL, V121, P987, DOI 10.1083/jcb.121.5.987; Vishwakarma RA, 2005, CHEM COMMUN, P453, DOI 10.1039/b413196g; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Watanabe R, 1996, J BIOL CHEM, V271, P26868, DOI 10.1074/jbc.271.43.26868	38	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14649	14658		10.1074/jbc.M110.193490	http://dx.doi.org/10.1074/jbc.M110.193490			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21367863	hybrid, Green Published			2022-12-27	WOS:000289556200084
J	Trusca, VG; Fuior, EV; Florea, IC; Kardassis, D; Simionescu, M; Gafencu, AV				Trusca, Violeta Georgeta; Fuior, Elena Valeria; Florea, Irina Cristina; Kardassis, Dimitris; Simionescu, Maya; Gafencu, Anca Violeta			Macrophage-specific Up-regulation of Apolipoprotein E Gene Expression by STAT1 Is Achieved via Long Range Genomic Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-DEFICIENT MICE; BONE-MARROW-TRANSPLANTATION; HIGH-DENSITY LIPOPROTEIN; TRANSGENIC MICE; APOE GENE; IN-VIVO; C-I; III HYPERLIPOPROTEINEMIA; CONTROL REGION; LDL RECEPTOR	In atherogenesis, macrophage-derived apolipoprotein E (apoE) has an athero-protective role by a mechanism that is not fully understood. We investigated the regulatory mechanisms involved in the modulation of apoE expression in macrophages. The experiments showed that the promoters of all genes of the apoE/apoCI/apoCIV/apoCII gene cluster are enhanced by multienhancer 2 (ME. 2), a regulatory region that is located 15.9 kb downstream of the apoE gene. ME. 2 interacts with the apoE promoter in a macrophage-specific manner. Transient transfections in RAW 264.7 macrophages showed that the activity of ME. 2 was strongly decreased by deletion of either 87 bp from the 5' end or 131 bp from the 3' end. We determined that the minimal fragment of this promoter that can be activated by ME. 2 is the proximal -100/+73 region. The analysis of the deletion mutants of ME. 2 revealed the importance of the 5' end of ME.2 in apoE promoter transactivation. Chromatin conformational capture assays demonstrated that both ME. 2 and ME. 1 physically interacted with the apoE promoter in macrophages. Our data showed that phorbol 12-myristate 13-acetate-induced differentiation of macrophages is accompanied by a robust induction of apoE and STAT1 expression. In macrophages (but not in hepatocytes), STAT1 up-regulated apoE gene expression via ME.2. The STAT1 binding site was located in the 174-182 region of ME.2. In conclusion, the specificity of the interactions between the two multienhancers (ME.1 and ME.2) and the apoE promoter indicates that these distal regulatory elements play an important role in the modulation of apoE gene expression in a cell-specific manner.	[Gafencu, Anca Violeta] Acad Romana, Inst Cellular Biol & Pathol, Sector 5, Bucharest 050568, Romania; [Kardassis, Dimitris] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71003, Crete, Greece; [Kardassis, Dimitris] Univ Crete, Sch Med, Iraklion 71003, Crete, Greece	Romanian Academy of Sciences; Nicolae Simionescu Institute of Cellular Biology & Pathology; Foundation for Research & Technology - Hellas (FORTH); University of Crete	Gafencu, AV (corresponding author), Acad Romana, Inst Cellular Biol & Pathol, Sector 5, Nicolae Simionescu 8,BP Hasdeu St, Bucharest 050568, Romania.	anca.gafencu@icbp.ro	Trusca, Violeta/AAS-9472-2021; Gafencu, Anca/AAP-8707-2020; Simionescu, Maya/C-4794-2011; Trusca, Violeta Georgeta I/H-5562-2013; Gafencu, Anca/C-3323-2011; Fuior, Elena/AAP-2673-2020	Gafencu, Anca/0000-0002-1290-1346; Fuior, Elena/0000-0001-9166-8417; Simionescu, Maya/0000-0003-2077-0400; Bivol (Trusca), Violeta Georgeta/0000-0003-2980-3811	CNCSIS-UEFISCSU [1307]; Romanian Academy;  [989/2009]	CNCSIS-UEFISCSU(Consiliul National al Cercetarii Stiintifice (CNCS)); Romanian Academy(Romanian Academy of Sciences); 	This work was financed by CNCSIS-UEFISCSU project 1307 (PNII-IDEI), contract 989/2009, and by the Romanian Academy.	Ali K, 2005, CIRC RES, V97, P922, DOI 10.1161/01.RES.0000187467.67684.43; ALLAN CM, 1995, J BIOL CHEM, V270, P26278, DOI 10.1074/jbc.270.44.26278; ALLAN CM, 1995, GENOMICS, V28, P291, DOI 10.1006/geno.1995.1144; Allan CM, 1997, J BIOL CHEM, V272, P29113, DOI 10.1074/jbc.272.46.29113; AUWERX JH, 1988, BIOCHEMISTRY-US, V27, P2651, DOI 10.1021/bi00408a003; BASHEERUDDIN K, 1994, BBA-GENE STRUCT EXPR, V1218, P235, DOI 10.1016/0167-4781(94)90021-3; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BELLOSTA S, 1995, J CLIN INVEST, V96, P2170, DOI 10.1172/JCI118271; BRAND K, 1993, J CLIN INVEST, V91, P2031, DOI 10.1172/JCI116425; CLADARAS C, 1987, J BIOL CHEM, V262, P2310; DANIELSSON B, 1978, FEBS LETT, V86, P299, DOI 10.1016/0014-5793(78)80584-5; DAS HK, 1985, J BIOL CHEM, V260, P6240; Davignon J, 2005, ARTERIOSCL THROM VAS, V25, P267, DOI 10.1161/01.ATV.0000154570.50696.2c; Eagleton MJ, 2010, J VASC SURG, V51, P951, DOI 10.1016/j.jvs.2009.11.075; Fazio S, 1997, P NATL ACAD SCI USA, V94, P4647, DOI 10.1073/pnas.94.9.4647; Gafencu AV, 2007, J BIOL CHEM, V282, P21776, DOI 10.1074/jbc.M611422200; Garcia MA, 1996, J NEUROSCI, V16, P7550; GHISELLI G, 1981, SCIENCE, V214, P1239, DOI 10.1126/science.6795720; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Grainger DJ, 2004, J IMMUNOL, V173, P6366, DOI 10.4049/jimmunol.173.10.6366; GREEN PHR, 1979, J CLIN INVEST, V64, P233, DOI 10.1172/JCI109444; Grehan S, 2001, J INVEST DERMATOL, V116, P77, DOI 10.1046/j.1523-1747.2001.00213.x; Grehan S, 2001, J NEUROSCI, V21, P812, DOI 10.1523/JNEUROSCI.21-03-00812.2001; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; INNERARITY TL, 1978, BIOCHEMISTRY-US, V17, P1440, DOI 10.1021/bi00601a013; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; LAUER SJ, 1988, J BIOL CHEM, V263, P7277; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; MAHLEY RW, 1983, BIOCHIM BIOPHYS ACTA, V737, P197, DOI 10.1016/0304-4157(83)90001-1; Mak PA, 2002, J BIOL CHEM, V277, P31900, DOI 10.1074/jbc.M202993200; Manea A, 2008, ARTERIOSCL THROM VAS, V28, P878, DOI 10.1161/ATVBAHA.108.163592; MYKLEBOST O, 1988, HUM GENET, V78, P244, DOI 10.1007/BF00291670; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; OLAISEN B, 1982, HUM GENET, V62, P233, DOI 10.1007/BF00333526; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Raffai RL, 2005, ARTERIOSCL THROM VAS, V25, P436, DOI 10.1161/01.ATV.0000152613.83243.12; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Salero E, 2003, BIOCHEM J, V370, P979, DOI 10.1042/BJ20021142; Salero E, 2001, J BIOL CHEM, V276, P1881, DOI 10.1074/jbc.M007008200; Sasaki H, 2009, J MED INVESTIG, V56, P33, DOI 10.2152/jmi.56.33; SCHAEFER EJ, 1979, LIPIDS, V14, P511, DOI 10.1007/BF02533471; SCHAEFER EJ, 1986, J CLIN INVEST, V78, P1206, DOI 10.1172/JCI112704; Shih SJ, 2000, J BIOL CHEM, V275, P31567, DOI 10.1074/jbc.M005468200; SHORE VG, 1973, BIOCHEMISTRY-US, V12, P502, DOI 10.1021/bi00727a022; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; SIMONET WS, 1991, J BIOL CHEM, V266, P8651; SMIT M, 1988, HUM GENET, V78, P90, DOI 10.1007/BF00291243; SMITH JD, 1988, J BIOL CHEM, V263, P8300; VanEck M, 1997, ARTERIOSCL THROM VAS, V17, P3117, DOI 10.1161/01.ATV.17.11.3117; vonEckardstein A, 1996, CURR OPIN LIPIDOL, V7, P308, DOI 10.1097/00041433-199610000-00009; WU AL, 1980, AM J CLIN NUTR, V33, P582, DOI 10.1093/ajcn/33.3.582; Zannis VI, 2001, CURR OPIN LIPIDOL, V12, P181, DOI 10.1097/00041433-200104000-00012; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	57	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13891	13904		10.1074/jbc.M110.179572	http://dx.doi.org/10.1074/jbc.M110.179572			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21372127	hybrid, Green Published			2022-12-27	WOS:000289556200012
J	Warfel, NA; Niederst, M; Stevens, MW; Brennan, PM; Frame, MC; Newton, AC				Warfel, Noel A.; Niederst, Matt; Stevens, Michael W.; Brennan, Paul M.; Frame, Margaret C.; Newton, Alexandra C.			Mislocalization of the E3 Ligase, beta-Transducin Repeat-containing Protein 1 (beta-TrCP1), in Glioblastoma Uncouples Negative Feedback between the Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase 1 (PHLPP1) and Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRCP-UBIQUITIN LIGASE; PHOSPHORYLATION-DEPENDENT INTERACTION; KAPPA-B-ALPHA; TUMOR-SUPPRESSOR; BREAST-CANCER; WNT PATHWAY; CATENIN; EXPRESSION; MUTATIONS; REVEALS	The PH domain leucine-rich repeat protein phosphatase, PHLPP, plays a central role in controlling the amplitude of growth factor signaling by directly dephosphorylating and thereby inactivating Akt. The cellular levels of PHLPP1 have recently been shown to be enhanced by its substrate, activated Akt, via modulation of a phosphodegron recognized by the E3 ligase beta-TrCP1, thus providing a negative feedback loop to tightly control cellular Akt output. Here we show that this feedback loop is lost in aggressive glioblastoma but not less aggressive astrocytoma. Overexpression and pharmacological studies reveal that loss of the feedback loop does not result from a defect in PHLPP1 protein or in the upstream kinases that control its phosphodegron. Rather, the defect arises from altered localization of beta-TrCP1; in astrocytoma cell lines and in normal brain tissue the E3 ligase is predominantly cytoplasmic, whereas in glioblastoma cell lines and patient-derived tumor neurospheres, the E3 ligase is confined to the nucleus and thus spatially separated from PHLPP1, which is cytoplasmic. Restoring the localization of beta-TrCP1 to the cytosol of glioblastoma cells rescues the ability of Akt to regulate PHLPP1 stability. Additionally, we show that the degradation of another beta-TrCP1 substrate, beta-catenin, is impaired and accumulates in the cytosol of glioblastoma cell lines. Our findings reveal that the cellular localization of beta-TrCP1 is altered in glioblastoma, resulting in dysregulation of PHLPP1 and other substrates such as beta-catenin.	[Warfel, Noel A.; Niederst, Matt; Stevens, Michael W.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Warfel, Noel A.; Niederst, Matt] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Brennan, Paul M.; Frame, Margaret C.] Univ Edinburgh, Edinburgh Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XR, Midlothian, Scotland	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Edinburgh	Newton, AC (corresponding author), 9500 Gilman Dr,MC 0721, La Jolla, CA 92093 USA.	anewton@ucsd.edu		Warfel, Noel/0000-0001-6410-9011; Brennan, Paul/0000-0002-7347-830X	National Institutes of Health [GM067946]; Department of Defense; University of California; Molecular Pharmacology through NIGMS, National Institutes of Health Institutional [T32 GM007752]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067946, T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); University of California(University of California System); Molecular Pharmacology through NIGMS, National Institutes of Health Institutional(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067946 (to A. C. N.). This work was also supported by Department of Defense Breast Cancer Research Program Award BC093021 (to N. W.).; Supported in part by the University of California at San Diego Graduate Training Program in Cellular and Molecular Pharmacology through NIGMS, National Institutes of Health Institutional Training Grant T32 GM007752.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Al-Mayhani TMF, 2009, J NEUROSCI METH, V176, P192, DOI 10.1016/j.jneumeth.2008.07.022; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Davis M, 2002, GENE DEV, V16, P439, DOI 10.1101/gad.218702; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gaspar C, 2008, AM J PATHOL, V172, P1363, DOI 10.2353/ajpath.2008.070851; Gilbertson RJ, 2004, LANCET ONCOL, V5, P209, DOI 10.1016/S1470-2045(04)01424-X; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hasselblatt P, 2008, ONCOGENE, V27, P6102, DOI 10.1038/onc.2008.211; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Joazeiro CAP, 2000, SCIENCE, V289, P2061, DOI 10.1126/science.289.5487.2061; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; LIU C, 2010, CLIN EXP ME IN PRESS; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mantovani F, 2003, J BIOL CHEM, V278, P42477, DOI 10.1074/jbc.M302799200; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ohta T, 2001, CANCER RES, V61, P1347; Ougolkov A, 2004, JNCI-J NATL CANCER I, V96, P1161, DOI 10.1093/jnci/djh219; Ouillette P, 2008, CANCER RES, V68, P1012, DOI 10.1158/0008-5472.CAN-07-3105; Park WS, 1999, CANCER RES, V59, P4257; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Pu P, 2009, CANCER GENE THER, V16, P351, DOI 10.1038/cgt.2008.78; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seo E, 2009, CELL SIGNAL, V21, P43, DOI 10.1016/j.cellsig.2008.09.009; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Utsuki S, 2002, J NEURO-ONCOL, V57, P187, DOI 10.1023/A:1015720220602; Vogt PK, 2007, TRENDS BIOCHEM SCI, V32, P342, DOI 10.1016/j.tibs.2007.05.005; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yano H, 2000, NEUROL RES, V22, P650; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Yokota N, 2002, INT J CANCER, V101, P198, DOI 10.1002/ijc.10559	61	36	38	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19777	19788		10.1074/jbc.M111.237081	http://dx.doi.org/10.1074/jbc.M111.237081			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21454620	Green Published, hybrid			2022-12-27	WOS:000291027700060
J	Furukawa, Y; Kaneko, K; Watanabe, S; Yamanaka, K; Nukina, N				Furukawa, Yoshiaki; Kaneko, Kumi; Watanabe, Shoji; Yamanaka, Koji; Nukina, Nobuyuki			A Seeding Reaction Recapitulates Intracellular Formation of Sarkosyl-insoluble Transactivation Response Element (TAR) DNA-binding Protein-43 Inclusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; C-TERMINAL FRAGMENTS; NEURODEGENERATIVE DISEASES; NEURONAL INCLUSIONS; AMYLOID FORMATION; TDP-43; MUTATIONS; AGGREGATION; PROGRANULIN	The transactivation response element (TAR) DNA-binding protein-43 (TDP-43) is a nuclear protein that normally regulates transcription and splicing. Abnormal accumulation of insoluble inclusions containing TDP-43 has been recently reported in the affected tissues of amyotrophic lateral sclerosis (ALS) patients. Here, we show that intracellular aggregation of TDP-43 can be triggered by transduction of fibrillar aggregates prepared from in vitro functional TDP-43. Sarkosyl is found to be incapable of solubilizing those intracellularly seeded aggregates of TDP-43, which is consistent with the observation that TDP-43 inclusions in ALS patients are sarkosyl-insoluble. In addition, intracellular seeding in our cell models reproduces ubiquitination of TDP-43 aggregates, which is another prominent feature of TDP-43 inclusions in ALS patients. Although it has been so far difficult to initiate disease-associated changes of TDP-43 using cultured cell models, we propose that a seeding reaction is a key to construct a model to monitor TDP-43 pathologies.	[Furukawa, Yoshiaki; Kaneko, Kumi; Nukina, Nobuyuki] RIKEN Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan; [Watanabe, Shoji; Yamanaka, Koji] RIKEN Brain Sci Inst, Lab Motor Neuron Dis, Wako, Saitama 3510198, Japan; [Furukawa, Yoshiaki] Keio Univ, Dept Chem, Kanagawa 2238522, Japan	RIKEN; RIKEN; Keio University	Furukawa, Y (corresponding author), 3-14-1 Hiyoshi, Kanagawa 2238522, Japan.	furukawa@chem.keio.ac.jp; nukina@brain.riken.jp	Furukawa, Yoshiaki/F-2871-2014; Yamanaka, Koji/H-5806-2011; Nukina, Nobuyuki/GPP-6265-2022; Yamanaka, Koji/ABD-1034-2020	Furukawa, Yoshiaki/0000-0002-1918-372X; Yamanaka, Koji/0000-0003-4655-0035; Yamanaka, Koji/0000-0003-4655-0035	Ministry of Education, Culture, Sports, Science and Technology of Japan [22240037, 22110004, 22770162, 21390274]; Core Research for Evolutional Science and Technology of Japan Science and Technology Agency; Japanese Health and Labor Sciences Research Grant; Strategic Research Program for Brain Science; Naito Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Japanese Health and Labor Sciences Research Grant; Strategic Research Program for Brain Science; Naito Foundation(Naito Memorial Foundation)	This work was supported by Grants-in-Aid 22240037 (to N. N.), 22110004 for Scientific Research on Innovative Areas (to N. N.), 22770162 (to Y. F.), and 21390274 (to K. Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from Core Research for Evolutional Science and Technology of Japan Science and Technology Agency (to K. Y.) a Japanese Health and Labor Sciences Research Grant (to K. Y.), a Strategic Research Program for Brain Science (to N. N.), and a grant from the Naito Foundation (to Y. F.).	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Furukawa Y, 2010, J BIOL CHEM, V285, P22221, DOI 10.1074/jbc.M110.113597; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lin WL, 2008, ACTA NEUROPATHOL, V116, P205, DOI 10.1007/s00401-008-0408-9; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	36	181	186	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18664	18672		10.1074/jbc.M111.231209	http://dx.doi.org/10.1074/jbc.M111.231209			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454603	Green Published, hybrid			2022-12-27	WOS:000290785700039
J	Cheng, H; Mohammed, F; Nam, G; Chen, Y; Qi, JX; Garner, LI; Allen, RL; Yan, JH; Willcox, BE; Gao, GF				Cheng, Hao; Mohammed, Fiyaz; Nam, Gol; Chen, Yong; Qi, Jianxun; Garner, Lee I.; Allen, Rachel L.; Yan, Jinghua; Willcox, Benjamin E.; Gao, George F.			Crystal Structure of Leukocyte Ig-like Receptor LILRB4 (ILT3/LIR-5/CD85k) A MYELOID INHIBITORY RECEPTOR INVOLVED IN IMMUNE TOLERANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; ACTIVATING RECEPTOR; SUPPRESSOR-CELLS; ILT3; COMPLEX; MOLECULES; LIR-1; RESPONSES; FAMILY	The myeloid inhibitory receptor LILRB4 (also called ILT3, LIR-5, CD85k), a member of the leukocyte immunoglobulin-like receptors (LILRs/LIRs), is an important mediator of immune tolerance. Up-regulated on tolerogenic dendritic cells, it has been shown to modulate immune responses via induction of T cell anergy and differentiation of CD8(+) T suppressor cells and may play a role in establishing immune tolerance in cancer. Consequently, characterizing the molecular mechanisms involved in LILRB4 function and in particular its structure and ligands is a key aim but has remained elusive to date. Here we describe the production, crystallization, and structure of the LILRB4 ectodomain to 1.7 angstrom using an expression strategy involving engineering of an additional disulfide bond in the D2 domain to enhance protein stability. LILRB4 comprises two immunoglobulin domains similar in structure to other LILRs; however, the D2 domain, which is most closely related to the D4 domains of other family members, contains 3(10) helices not previously observed. At the D1-D2 interface, reduced interdomain contacts resulted in an obtuse interdomain angle of similar to 107 degrees. Comparison with MHC class I binding Group 1 LILRs suggests LILRB4 is both conformationally and electrostatically unsuited to MHC ligation, consistent with LILRB4 status as a Group 2 LILR likely to bind novel non-MHC class I ligands. Finally, examination of the LILRB4 surface highlighted distinctive surface patches on the D1 domain and D1D2 hinge region, which may be involved in ligand binding. These findings will facilitate our attempts to precisely define the role of LILRB4 in the regulation of immune tolerance.	[Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Cheng, Hao; Nam, Gol; Chen, Yong; Gao, George F.] Chinese Acad Sci, Grad Univ, Beijing 100149, Peoples R China; [Mohammed, Fiyaz; Garner, Lee I.; Willcox, Benjamin E.] Univ Birmingham, Sch Canc Sci, Birmingham CRUK Canc Ctr, Birmingham B15 2TT, W Midlands, England; [Allen, Rachel L.] Univ London, Div Cellular & Mol Med, Ctr Infect, London, England; [Qi, Jianxun; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Birmingham; University of London; Chinese Academy of Sciences	Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	gaof@im.ac.cn	Gao, George Fu/ABD-5229-2021; Qi, Jianxun/ABF-1646-2021	Allen, Rachel/0000-0001-9834-8475	Ministry of Science and Technology of China (MOST) [2010CB911902]; National Natural Science Foundation of China [31030030]; Biotechnology and Biological Sciences Research Council [BB/E009417/1]; National Natural Science Foundation of China Innovative Research Group [81021003]; BBSRC [BB/E009417/1] Funding Source: UKRI	Ministry of Science and Technology of China (MOST)(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Natural Science Foundation of China Innovative Research Group; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by grants from Ministry of Science and Technology of China (MOST, 973 Project 2010CB911902) and National Natural Science Foundation of China Grant 31030030.; The laboratory work of B. E. W. is supported by Biotechnology and Biological Sciences Research Council project grant funding (Grant BB/E009417/1).; A leading principal investigator of the National Natural Science Foundation of China Innovative Research Group (Grant 81021003). To whom correspondence should be addressed: CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China. Tel.: 86-10-64807688; Fax: 86-1064807882; E-mail: gaof@im.ac.cn.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belkaid Y, 2008, IMMUNITY, V29, P362, DOI 10.1016/j.immuni.2008.08.005; Bellon T, 2002, J IMMUNOL, V168, P3351, DOI 10.4049/jimmunol.168.7.3351; Borges L, 2003, BLOOD, V101, P1484, DOI 10.1182/blood-2002-05-1432; Borges L, 1997, J IMMUNOL, V159, P5192; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Chapman TL, 2000, IMMUNITY, V13, P727, DOI 10.1016/S1074-7613(00)00071-6; Chen Y, 2007, PROTEIN EXPRES PURIF, V56, P253, DOI 10.1016/j.pep.2007.08.010; Chen Y, 2010, PROTEIN CELL, V1, P153, DOI 10.1007/s13238-010-0022-1; Chen Y, 2009, J MOL BIOL, V386, P841, DOI 10.1016/j.jmb.2009.01.006; Colonna M, 2000, SEMIN IMMUNOL, V12, P121, DOI 10.1006/smim.2000.0214; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Dietrich J, 2000, MICROBES INFECT, V2, P323, DOI 10.1016/S1286-4579(00)00294-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanger NA, 1998, EUR J IMMUNOL, V28, P3423, DOI 10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Filaci G, 2004, HUM IMMUNOL, V65, P142, DOI 10.1016/j.humimm.2003.12.001; Foster CE, 2003, J BIOL CHEM, V278, P46081, DOI 10.1074/jbc.M308491200; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garner LI, 2006, PROTEIN EXPRES PURIF, V47, P490, DOI 10.1016/j.pep.2005.11.020; Gleissner CA, 2007, EUR J IMMUNOL, V37, P177, DOI 10.1002/eji.200636498; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim-Schulze S, 2006, J IMMUNOL, V176, P2790, DOI 10.4049/jimmunol.176.5.2790; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Liu WR, 2000, IMMUNOGENETICS, V51, P659, DOI 10.1007/s002510000183; Liu Z, 1998, INT IMMUNOL, V10, P775, DOI 10.1093/intimm/10.6.775; Manavalan JS, 2004, INT IMMUNOL, V16, P1055, DOI 10.1093/intimm/dxh107; Manavalan JS, 2003, TRANSPL IMMUNOL, V11, P245, DOI 10.1016/S0966-3274(03)00058-3; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morel E, 2008, J IMMUNOL, V181, P2368, DOI 10.4049/jimmunol.181.4.2368; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakajima H, 1999, J IMMUNOL, V162, P5; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Prod'homme V, 2007, J IMMUNOL, V178, P4473, DOI 10.4049/jimmunol.178.7.4473; Prud'homme GJ, 2004, J LEUKOCYTE BIOL, V75, P586, DOI 10.1189/jlb.0803394; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; Saulquin X, 2003, J EXP MED, V197, P933, DOI 10.1084/jem.20021624; Saverino D, 2000, J IMMUNOL, V165, P3742, DOI 10.4049/jimmunol.165.7.3742; Sayos J, 2004, BIOCHEM BIOPH RES CO, V324, P640, DOI 10.1016/j.bbrc.2004.09.097; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Shiroishi M, 2006, J BIOL CHEM, V281, P19536, DOI 10.1074/jbc.M603076200; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Suciu-Foca N, 2005, INT IMMUNOPHARMACOL, V5, P7, DOI 10.1016/j.intimp.2004.09.003; Suciu-Foca N, 2007, CELL IMMUNOL, V248, P59, DOI 10.1016/j.cellimm.2007.01.013; Suciu-Foca N, 2007, J IMMUNOL, V178, P7432, DOI 10.4049/jimmunol.178.11.7432; Svajger U, 2008, INT IMMUNOPHARMACOL, V8, P997, DOI 10.1016/j.intimp.2008.03.006; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vlad G, 2008, HUM IMMUNOL, V69, P681, DOI 10.1016/j.humimm.2008.08.286; Volz A, 2001, IMMUNOL REV, V181, P39, DOI 10.1034/j.1600-065X.2001.1810103.x; Willcox BE, 1999, PROTEIN SCI, V8, P2418; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Willcox Benjamin E, 2002, BMC Struct Biol, V2, P6, DOI 10.1186/1472-6807-2-6; Young NT, 2001, IMMUNOGENETICS, V53, P270, DOI 10.1007/s002510100332	66	29	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18013	18025		10.1074/jbc.M111.221028	http://dx.doi.org/10.1074/jbc.M111.221028			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454581	Green Published, hybrid			2022-12-27	WOS:000290585200063
J	Lacroix, J; Halaszovich, CR; Schreiber, DN; Leitner, MG; Bezanilla, F; Oliver, D; Villalba-Galea, CA				Lacroix, Jerome; Halaszovich, Christian R.; Schreiber, Daniela N.; Leitner, Michael G.; Bezanilla, Francisco; Oliver, Dominik; Villalba-Galea, Carlos A.			Controlling the Activity of a Phosphatase and Tensin Homolog (PTEN) by Membrane Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PTEN; CI-VSP; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PLASMA-MEMBRANE; XENOPUS-OOCYTES; VOLTAGE SENSOR; LIVING CELLS; CHANNEL; PROTEIN; PIP2	The recently discovered voltage-sensitive phosphatases (VSPs) hydrolyze phosphoinositides upon depolarization of the membrane potential, thus representing a novel principle for the transduction of electrical activity into biochemical signals. Here, we demonstrate the possibility to confer voltage sensitivity to cytosolic enzymes. By fusing the tumor suppressor PTEN to the voltage sensor of the prototypic VSP from Ciona intestinalis, Ci-VSP, we generated chimeric proteins that are voltage-sensitive and display PTEN-like enzymatic activity in a strictly depolarization-dependent manner in vivo. Functional coupling of the exogenous enzymatic activity to the voltage sensor is mediated by a phospholipid-binding motif at the interface between voltage sensor and catalytic domains. Our findings reveal that the main domains of VSPs and related phosphoinositide phosphatases are intrinsically modular and define structural requirements for coupling of enzymatic activity to a voltage sensor domain. A key feature of this prototype of novel engineered voltage-sensitive enzymes, termed Ci-VSPTEN, is the novel ability to switch enzymatic activity of PTEN rapidly and reversibly. We demonstrate that experimental control of Ci-VSPTEN can be obtained either by electrophysiological techniques or more general techniques, using potassium-induced depolarization of intact cells. Thus, Ci-VSPTEN provides a novel approach for studying the complex mechanism of activation, cellular control, and pharmacology of this important tumor suppressor. Moreover, by inducing temporally precise perturbation of phosphoinositide concentrations, Ci-VSPTEN will be useful for probing the role and specificity of these messengers in many cellular processes and to analyze the timing of phosphoinositide signaling.	[Halaszovich, Christian R.; Schreiber, Daniela N.; Leitner, Michael G.; Oliver, Dominik] Univ Marburg, Inst Physiol & Pathophysiol, D-35037 Marburg, Germany; [Lacroix, Jerome; Bezanilla, Francisco] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Villalba-Galea, Carlos A.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA	Philipps University Marburg; University of Chicago; Virginia Commonwealth University	Oliver, D (corresponding author), Univ Marburg, Inst Physiol & Pathophysiol, Deutschhausstr 1-2, D-35037 Marburg, Germany.	oliverd@staff.uni-marburg.de; cavillalbaga@vcu.edu	Halaszovich, Christian/I-7231-2012; Leitner, Michael G./D-7887-2014; Leitner, Michael/N-8793-2019; Oliver, Dominik/F-5845-2013	Leitner, Michael G./0000-0002-3259-6481; Leitner, Michael/0000-0002-3259-6481; Oliver, Dominik/0000-0002-8368-0923; Villalba-Galea, Carlos A./0000-0002-6489-4651	National Institutes of Health [GM030376]; Deutsche Forschungsgemeinschaft [SFB593 TPA12]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030376, R01GM030376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM030376 (to F. B.). This work was also supported by Deutsche Forschungsgemeinschaft Grant SFB593 TPA12 (to D. O.).	Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Cha A, 1998, METHOD ENZYMOL, V296, P566; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Denning G, 2007, ONCOGENE, V26, P3930, DOI 10.1038/sj.onc.1210175; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P99, DOI 10.1085/jgp.200910345; Finkbeiner S, 1998, J NEUROBIOL, V37, P171, DOI 10.1002/(SICI)1097-4695(199810)37:1<171::AID-NEU13>3.0.CO;2-H; Halaszovich CR, 2009, J BIOL CHEM, V284, P2106, DOI 10.1074/jbc.M803543200; Haucke V, 2005, BIOCHEM SOC T, V33, P1285, DOI 10.1042/BST0331285; Hossain MI, 2008, J BIOL CHEM, V283, P18248, DOI 10.1074/jbc.M706184200; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; Kimber WA, 2002, BIOCHEM J, V361, P525, DOI 10.1042/0264-6021:3610525; Kingsbury TJ, 2007, J NEUROCHEM, V103, P761, DOI 10.1111/j.1471-4159.2007.04801.x; Kohout SC, 2008, NAT STRUCT MOL BIOL, V15, P106, DOI 10.1038/nsmb1320; Kohout SC, 2010, NAT CHEM BIOL, V6, P369, DOI 10.1038/nchembio.349; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Liu Y, 2010, PROG LIPID RES, V49, P201, DOI 10.1016/j.plipres.2009.12.001; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Pagliarini DJ, 2004, J BIOL CHEM, V279, P38590, DOI 10.1074/jbc.M404959200; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Redfern RE, 2008, BIOCHEMISTRY-US, V47, P2162, DOI 10.1021/bi702114w; Schaechinger TJ, 2007, P NATL ACAD SCI USA, V104, P7693, DOI 10.1073/pnas.0608583104; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Tapparel C, 2003, GENE, V323, P189, DOI 10.1016/j.gene.2003.09.038; Van der Kaay J, 1999, J BIOL CHEM, V274, P35963, DOI 10.1074/jbc.274.50.35963; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Villalba-Galea CA, 2009, J GEN PHYSIOL, V134, P5, DOI 10.1085/jgp.200910215; Walker SM, 2004, BIOCHEM J, V379, P301, DOI 10.1042/BJ20031839; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Wang YJ, 2004, J CELL BIOL, V167, P1005, DOI 10.1083/jcb.200408008; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335	48	35	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17945	17953		10.1074/jbc.M110.201749	http://dx.doi.org/10.1074/jbc.M110.201749			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454672	Green Published, hybrid			2022-12-27	WOS:000290585200057
J	Lin, MH; Yang, YL; Chen, YP; Hua, KF; Lu, CP; Sheu, F; Lin, GH; Tsay, SS; Liang, SM; Wu, SH				Lin, Miao-Hsia; Yang, Yu-Liang; Chen, Yen-Po; Hua, Kuo-Feng; Lu, Chun-Ping; Sheu, Fuu; Lin, Guang-Huey; Tsay, San-San; Liang, Shu-Mei; Wu, Shih-Hsiung			A Novel Exopolysaccharide from the Biofilm of Thermus aquaticus YT-1 Induces the Immune Response through Toll-like Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTREME THERMOPHILE; CYTOKINE PRODUCTION; IN-VIVO; PATHOGEN RECOGNITION; DENDRITIC CELLS; INNATE IMMUNITY; POLYSACCHARIDES; IDENTIFICATION; MACROPHAGES; INDUCTION	Bacterial polysaccharides are known to induce the immune response in macrophages. Here we isolated a novel extracellular polysaccharide from the biofilm of Thermus aquaticus YT-1 and evaluated its structure and immunomodulatory effects. The size of this polysaccharide, TA-1, was deduced by size-exclusion chromatography as 500 kDa. GC-MS, high performance anion-exchange chromatography with pulsed amperometric detection, electrospray ionization-MS/MS, and NMR revealed the novel structure of TA-1. The polysaccharide is composed of tetrasaccharide-repeating units of galactofuranose, galactopyranose, and N-acetylgalactosamine (1: 1: 2) and lacked acidic sugars. TA-1 stimulated macrophage cells to produce the cytokines TNF-alpha and IL-6. Screening of Toll-like receptors and antibody-blocking experiments indicated that the natural receptor of TA-1 in its immunoactivity is TLR2. Recognition of TA-1 by TLR2 was confirmed by TA-1 induction of IL-6 production in peritoneal macrophages from wild-type mice but not from TLR2 (-/-) mice. TA-1, as a TLR2 agonist, could possibly be used as an adjuvant and could enhance cytokine release, which increases the immune response. Furthermore, TA-1 induced cytokine release is dependent on MyD88/TIRAP.	[Chen, Yen-Po; Liang, Shu-Mei] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Lin, Miao-Hsia; Yang, Yu-Liang; Lu, Chun-Ping; Wu, Shih-Hsiung] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Hua, Kuo-Feng] Natl Ilan Univ, Inst Biotechnol, Ilan 260, Taiwan; [Sheu, Fuu] Natl Taiwan Univ, Dept Hort, Taipei 106, Taiwan; [Lin, Guang-Huey] Tzu Chi Univ, Inst Microbiol Immunol & Mol Med, Hualien 970, Taiwan; [Tsay, San-San] Natl Taiwan Univ, Dept Life Sci, Taipei 106, Taiwan; [Tsay, San-San] Natl Taiwan Univ, Inst Plant Biol, Taipei 106, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Ilan University; National Taiwan University; Tzu Chi University; National Taiwan University; National Taiwan University	Liang, SM (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan.	smyang@gate.sinica.edu.tw; shwu@gate.sinica.edu.tw	Chen, Yen Po/GLQ-6423-2022; Lu, Chun-Ping/B-9999-2011	Chen, Yen Po/0000-0003-0621-6219; Sheu, Fuu/0000-0001-9794-3483; Liang, Shu-Mei/0000-0001-8926-4747	National Science Council and Academia Sinica, Taiwan	National Science Council and Academia Sinica, Taiwan	This work was supported by the National Science Council and Academia Sinica, Taiwan.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Albiger B, 2007, J INTERN MED, V261, P511, DOI 10.1111/j.1365-2796.2007.01821.x; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Bakker H, 2005, BIOL CHEM, V386, P657, DOI 10.1515/BC.2005.076; BROCK TD, 1970, J BACTERIOL, V104, P509, DOI 10.1128/JB.104.1.509-517.1970; BROCK TD, 1969, J BACTERIOL, V98, P289, DOI 10.1128/JB.98.1.289-297.1969; CHIEN A, 1976, J BACTERIOL, V127, P1550, DOI 10.1128/JB.127.3.1550-1557.1976; Chu SF, 2006, PLASMID, V56, P46, DOI 10.1016/j.plasmid.2006.01.005; Cohen N, 2008, J IMMUNOL, V180, P2409, DOI 10.4049/jimmunol.180.4.2409; FIDLER IJ, 1988, CIBA F SYMP, V141, P211; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Guy B, 2010, J COMP PATHOL, V141, pS133, DOI [10.1016/j.jepa.2009.09.009, 10.1016/j.jcpa.2009.09.009]; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hsu HY, 2004, J IMMUNOL, V173, P5989, DOI 10.4049/jimmunol.173.10.5989; Iwamoto M, 2005, FEBS LETT, V579, P4423, DOI 10.1016/j.febslet.2005.07.007; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kumagai Yutaro, 2008, Journal of Infection and Chemotherapy, V14, P86, DOI 10.1007/s10156-008-0596-1; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Leone S, 2006, GLYCOBIOLOGY, V16, P766, DOI 10.1093/glycob/cwj120; Maletto BA, 2005, CLIN IMMUNOL, V117, P251, DOI 10.1016/j.clim.2005.08.016; Maue AC, 2009, J IMMUNOL, V182, P6129, DOI 10.4049/jimmunol.0804226; Mojica K, 2007, J MICROBIOL METH, V71, P61, DOI 10.1016/j.mimet.2007.07.010; Nassau PM, 1996, J BACTERIOL, V178, P1047, DOI 10.1128/jb.178.4.1047-1052.1996; OKAZAKI M, 1995, BIOL PHARM BULL, V18, P1320, DOI 10.1248/bpb.18.1320; Ooi VEC, 2000, CURR MED CHEM, V7, P715; OTTERLEI M, 1991, J IMMUNOTHER, V10, P286, DOI 10.1097/00002371-199108000-00007; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Rosenberg SA, 2006, J IMMUNOTHER, V29, P313, DOI 10.1097/01.cji.0000210386.55951.c2; Schepetkin IA, 2006, INT IMMUNOPHARMACOL, V6, P317, DOI 10.1016/j.intimp.2005.10.005; SELJELID R, 1989, SCAND J IMMUNOL, V29, P181, DOI 10.1111/j.1365-3083.1989.tb01115.x; Sen G, 2005, J IMMUNOL, V175, P3084, DOI 10.4049/jimmunol.175.5.3084; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Sutherland IW, 2001, WATER SCI TECHNOL, V43, P77, DOI 10.2166/wst.2001.0345; TZIANABOS AO, 1993, SCIENCE, V262, P416, DOI 10.1126/science.8211161; van Putten JPM, 2010, IMMUNOL LETT, V128, P8, DOI 10.1016/j.imlet.2009.09.007; VERSTOVSEK S, 1992, CANCER RES, V52, P3880; WAEGHE TJ, 1983, CARBOHYD RES, V123, P281, DOI 10.1016/0008-6215(83)88484-5; Wang Q, 2006, J EXP MED, V203, P2853, DOI 10.1084/jem.20062008; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000; Weston A, 1998, TUBERCLE LUNG DIS, V78, P123, DOI 10.1016/S0962-8479(98)80005-1; Wozniak DJ, 2003, P NATL ACAD SCI USA, V100, P7907, DOI 10.1073/pnas.1231792100; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yim JH, 2005, MAR BIOTECHNOL, V7, P331, DOI 10.1007/s10126-004-0404-6	47	44	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17736	17745		10.1074/jbc.M110.200113	http://dx.doi.org/10.1074/jbc.M110.200113			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454596	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000290585200037
J	Regue, L; Sdelci, S; Bertran, MT; Caelles, C; Reverter, D; Roig, J				Regue, Laura; Sdelci, Sara; Teresa Bertran, M.; Caelles, Carme; Reverter, David; Roig, Joan			DYNLL/LC8 Protein Controls Signal Transduction through the Nek9/Nek6 Signaling Module by Regulating Nek6 Binding to Nek9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN LC8; MITOTIC SPINDLE FORMATION; NIMA-FAMILY KINASE; CELL-CYCLE ARREST; CYTOPLASMIC DYNEIN; INTERMEDIATE CHAIN; PHOSPHORYLATION; DIMERIZATION; PROGRESSION; MITOSIS	The NIMA family protein kinases Nek9/Nercc1 and the highly similar Nek6 and Nek7 form a signaling module activated in mitosis, when they are involved in the control of spindle organization and function. Here we report that Nek9, the module upstream kinase, binds to DYNLL/LC8, a highly conserved protein originally described as a component of the dynein complex. LC8 is a dimer that interacts with different proteins and has been suggested to act as a dimerization hub promoting the organization and oligomerization of partially disorganized partners. We find that the interaction of LC8 with Nek9 depends on a (K/R)XTQT motif adjacent to the Nek9 C-terminal coiled coil motif, results in Nek9 multimerization, and increases the rate of Nek9 autoactivation. LC8 binding to Nek9 is regulated by Nek9 activity through the autophosphorylation of Ser(944), a residue immediately N-terminal to the (K/R)XTQT motif. Remarkably, LC8 binding interferes with the interaction of Nek9 with its downstream partner Nek6 as well as with Nek6 activation, thus controlling both processes. Our work sheds light into the control of signal transduction through the module formed by Nek9 and Nek6/7 and uncovers a novel manner in which LC8 can regulate partner physiology by interfering with protein complex formation. We suggest that this and other LC8 functions can be specifically regulated by partner phosphorylation.	[Regue, Laura; Sdelci, Sara; Teresa Bertran, M.; Caelles, Carme; Roig, Joan] Inst Res Biomed IRB Barcelona, Program Mol Med, Cell Signaling Grp, Barcelona 08028, Spain; [Reverter, David] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Struct Biol Unit, Bellaterra 08193, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Autonomous University of Barcelona	Roig, J (corresponding author), IRB Barcelona, Cell Signaling Res Grp, Parc Cient Barcelona,C Baldiri & Reixac 10-12, Barcelona 08028, Spain.	joan.roig@irbbarcelona.org	Bertran, M. Teresa/C-4169-2019; Reverter, David/H-5360-2015; sdelci, sara/S-2243-2018; Barrufet, Laura Regue/AAB-9465-2020; Roig, Joan/E-2836-2017	Bertran, M. Teresa/0000-0002-8336-0903; Reverter, David/0000-0002-5347-0992; sdelci, sara/0000-0003-1330-4364; Barrufet, Laura Regue/0000-0003-1341-3413; Roig, Joan/0000-0002-3872-4712	Ramon y Cajal Program; Ministerio de Ciencia e Innovacion (MICINN), Spain [BFU2008-00364/BMC, BFU2008-03441/BMC]	Ramon y Cajal Program(Spanish Government); Ministerio de Ciencia e Innovacion (MICINN), Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Supported by the Ramon y Cajal Program and the Plan Nacional I + D Grant BFU2008-00364/BMC (Ministerio de Ciencia e Innovacion (MICINN), Spain).; Supported by the Ramon y Cajal Program and the Plan Nacional I + D Grant BFU2008-03441/BMC (MICINN, Spain) and institutional funds. To whom correspondence should be addressed: Cell Signaling Research Group, IRB Barcelona, Parc Cientific de Barcelona, c/Baldiri i Reixac, 10-12, 08028 Barcelona, Spain. Tel.: 34-638297563; Fax: 34-934037114; E-mail: joan.roig@irbbarcelona.org.	Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Chen YM, 2008, CELL CYCLE, V7, P3194, DOI 10.4161/cc.7.20.6815; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dick T, 1996, MOL GEN GENET, V251, P38; Dick T, 1996, MOL CELL BIOL, V16, P1966; Jeon YJ, 2010, J BIOL CHEM, V285, P28126, DOI 10.1074/jbc.M110.137190; Jung YY, 2008, J BIOL CHEM, V283, P23863, DOI 10.1074/jbc.M803072200; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; Lightcap CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006025; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Makokha M, 2002, BIOCHEMISTRY-US, V41, P4302, DOI 10.1021/bi011970h; Melixetian M, 2009, NAT CELL BIOL, V11, P1247, DOI 10.1038/ncb1969; Miki F, 2002, MOL BIOL CELL, V13, P930, DOI 10.1091/mbc.01-11-0543; Mohan PMK, 2006, PROTEIN SCI, V15, P335, DOI 10.1110/ps.051854906; Moniz LS, 2011, MOL CELL BIOL, V31, P30, DOI 10.1128/MCB.00648-10; Nassirpour R, 2010, MOL CANCER RES, V8, P717, DOI 10.1158/1541-7786.MCR-09-0291; Noguchi K, 2002, J BIOL CHEM, V277, P39655, DOI 10.1074/jbc.M204599200; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Pelegrini AL, 2010, MUTAGENESIS, V25, P447, DOI 10.1093/mutage/geq026; Phillis R, 1996, DEVELOPMENT, V122, P2955; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Richards MW, 2009, MOL CELL, V36, P560, DOI 10.1016/j.molcel.2009.09.038; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Roig J, 2005, MOL BIOL CELL, V16, P4827, DOI 10.1091/mbc.E05-04-0315; Roig J, 2002, GENE DEV, V16, P1640, DOI 10.1101/gad.972202; ROIG J, 2010, UCSD NATURE MOL PAGE, DOI DOI 10.1038/MP.A003029.01; ROIG J, 2006, SIGMA RBI HDB RECEPT, P286; Salem H, 2010, ONCOGENE, V29, P4046, DOI 10.1038/onc.2010.162; Song CY, 2008, J BIOL CHEM, V283, P4004, DOI 10.1074/jbc.M704512200; Song YJ, 2007, J BIOL CHEM, V282, P17272, DOI 10.1074/jbc.M610445200; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Wilson MJ, 2001, CELL MOTIL CYTOSKEL, V49, P229, DOI 10.1002/cm.1036; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yin MJ, 2003, J BIOL CHEM, V278, P52454, DOI 10.1074/jbc.M308080200; Yissachar N, 2006, FEBS LETT, V580, P6489, DOI 10.1016/j.febslet.2006.10.069	45	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18118	18129		10.1074/jbc.M110.209080	http://dx.doi.org/10.1074/jbc.M110.209080			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454704	hybrid, Green Published			2022-12-27	WOS:000290585200072
J	Smith, CE; Richardson, AS; Hu, YY; Bartlett, JD; Hu, JCC; Simmer, JP				Smith, Charles E.; Richardson, Amelia S.; Hu, Yuanyuan; Bartlett, John D.; Hu, Jan C-C.; Simmer, James P.			Effect of Kallikrein 4 Loss on Enamel Mineralization COMPARISON WITH MICE LACKING MATRIX METALLOPROTEINASE 20	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOMATURATION AMELOGENESIS-IMPERFECTA; NULL MOUSE ENAMEL; MESSENGER-RNA; RAT INCISORS; EXPRESSION; MMP-20; KLK4; MATURATION; MICE; MUTATION	Enamel formation depends on a triad of tissue-specific matrix proteins (amelogenin, ameloblastin, and enamelin) to help initiate and stabilize progressively elongating, thin mineral ribbons of hydroxyapatite formed during an appositional growth phase. Subsequently, these proteins are eradicated to facilitate lateral expansion of the hydroxyapatite crystallites. The purpose of this study was to investigate changes in enamel mineralization occurring in mice unable to produce kallikrein 4 (Klk4), a proteinase associated with terminal extracellular degradation of matrix proteins during the maturation stage. Mice lacking functional matrix metalloproteinase 20 (Mmp20), a proteinase associated with early cleavage of matrix proteins during the secretory stage, were also analyzed as a frame of reference. The results indicated that mice lacking Klk4 produce enamel that is normal in thickness and overall organization in terms of layers and rod/inter-rod structure, but there is a developmental defect in enamel rods where they first form near the dentinoenamel junction. Mineralization is normal up to early maturation after which the enamel both retains and gains additional proteins and is unable to mature beyond 85% mineral by weight. The outmost enamel is hard, but inner regions are soft and contain much more protein than normal. The rate of mineral acquisition overall is lower by 25%. Mice lacking functional Mmp20 produce enamel that is thin and structurally abnormal. Relatively high amounts of protein remain throughout maturation, but the enamel is able to change from 67 to 75% mineral by weight during maturation. These findings reaffirm the importance of secreted proteinases to enamel mineral acquisition.	[Smith, Charles E.] McGill Univ, Dept Anat & Cell Biol, Facil Elect Microscopy Res, Montreal, PQ H3A 2B2, Canada; [Smith, Charles E.] McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada; [Smith, Charles E.; Richardson, Amelia S.; Hu, Yuanyuan; Hu, Jan C-C.; Simmer, James P.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48108 USA; [Bartlett, John D.] Harvard Univ, Sch Dent Med, Dept Cytokine Biol, Forsyth Inst, Cambridge, MA 02142 USA; [Bartlett, John D.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Cambridge, MA 02142 USA	McGill University; McGill University; University of Michigan System; University of Michigan; Harvard University; Forsyth Institute; Harvard School of Dental Medicine; Harvard University; Harvard School of Dental Medicine	Smith, CE (corresponding author), McGill Univ, Dept Anat & Cell Biol, Facil Elect Microscopy Res, 3640 Univ St, Montreal, PQ H3A 2B2, Canada.	charles.smith@mcgill.ca	Hu, Jan C-C./F-5679-2015; Bartlett, John/L-9832-2017	Hu, Jan C-C./0000-0002-9294-0248; Bartlett, John/0000-0003-2052-6299	NIDCR, National Institutes of Health [DE019775, DE016276]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019775, R01DE016276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE016276] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE019775 and DE016276 from NIDCR.	Bartlett JD, 2004, J DENT RES, V83, P909, DOI 10.1177/154405910408301204; Bartlett JD, 2006, EUR J ORAL SCI, V114, P18, DOI 10.1111/j.1600-0722.2006.00292.x; Bei M, 2009, CURR OPIN GENET DEV, V19, P504, DOI 10.1016/j.gde.2009.09.002; Beniash E, 2006, EUR J ORAL SCI, V114, P24, DOI 10.1111/j.1600-0722.2006.00293.x; Caterina JJ, 2002, J BIOL CHEM, V277, P49598, DOI 10.1074/jbc.M209100200; Chun YHP, 2010, J DENT RES, V89, P785, DOI 10.1177/0022034510366903; Elliott J. C., 1994, STRUCTURE CHEM APATI, P259; Fukae M, 2002, J DENT RES, V81, P668, DOI 10.1177/154405910208101003; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; He B, 2010, ARCH ORAL BIOL, V55, P134, DOI 10.1016/j.archoralbio.2009.12.005; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; Hu JCC, 2002, EUR J ORAL SCI, V110, P307, DOI 10.1034/j.1600-0722.2002.21301.x; Hu JCC, 2003, CRIT REV ORAL BIOL M, V14, P387, DOI 10.1177/154411130301400602; Kim JW, 2005, J MED GENET, V42, P271, DOI 10.1136/jmg.2004.024505; Lacruz RS, 2010, CALCIFIED TISSUE INT, V86, P91, DOI 10.1007/s00223-009-9326-7; Lu Y, 2008, BIOL CHEM, V389, P695, DOI 10.1515/BC.2008.080; MCKEE MD, 1988, ARCH ORAL BIOL, V33, P413, DOI 10.1016/0003-9969(88)90199-9; MCKEE MD, 1987, ANAT REC, V218, P123, DOI 10.1002/ar.1092180205; Meredith N, 1996, ARCH ORAL BIOL, V41, P539, DOI 10.1016/0003-9969(96)00020-9; Miyazaki Y, 1998, ARCH ORAL BIOL, V43, P367, DOI 10.1016/S0003-9969(98)00014-4; Nagano T, 2003, J DENT RES, V82, P982, DOI 10.1177/154405910308201209; Nagano T, 2009, J DENT RES, V88, P823, DOI 10.1177/0022034509342694; Nylen M U, 1970, Tandlaegebladet, V74, P685; Ryu O, 2002, EUR J ORAL SCI, V110, P358, DOI 10.1034/j.1600-0722.2002.21349.x; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; Simmer J. P., 2004, P 8 INT S BIOM NIIG, P348; Simmer JP, 2009, J BIOL CHEM, V284, P19110, DOI 10.1074/jbc.M109.013623; Smith CE, 2005, J BONE MINER RES, V20, P240, DOI 10.1359/JBMR.041002; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Smith CE, 1996, ANAT REC, V245, P186, DOI 10.1002/(SICI)1097-0185(199606)245:2<186::AID-AR7>3.0.CO;2-V; Smith CE, 2009, EUR J ORAL SCI, V117, P485, DOI 10.1111/j.1600-0722.2009.00666.x; Tye CE, 2010, J DENT RES, V89, P1421, DOI 10.1177/0022034510384625; Tye CE, 2009, J DENT RES, V88, P323, DOI 10.1177/0022034509334240; WARSHAWSKY H, 1971, ANAT RECORD, V169, P559, DOI 10.1002/ar.1091690307; WEBER DF, 1968, J MORPHOL, V126, P435, DOI 10.1002/jmor.1051260405; Wright JT, 2009, CELLS TISSUES ORGANS, V189, P224, DOI 10.1159/000151378; Yamakoshi Y, 2006, EUR J ORAL SCI, V114, P45, DOI 10.1111/j.1600-0722.2006.00281.x; Yanagawa T, 2004, GENES CELLS, V9, P641, DOI 10.1111/j.1356-9597.2004.00753.x	38	51	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18149	18160		10.1074/jbc.M110.194258	http://dx.doi.org/10.1074/jbc.M110.194258			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454549	Green Published, hybrid			2022-12-27	WOS:000290585200075
J	Tatum, D; Li, SS				Tatum, Danielle; Li, Shisheng			Evidence That the Histone Methyltransferase Dot1 Mediates Global Genomic Repair by Methylating Histone H3 on Lysine 79	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCISION-REPAIR; CYCLOBUTANE PYRIMIDINE DIMERS; NUCLEOSOME CORE PARTICLE; DNA-DAMAGE CHECKPOINT; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; NONTRANSCRIBED STRAND; ACTIVE GENE; UV DAMAGE; YEAST	Global genomic repair (GGR) and transcription coupled repair (TCR) are two pathways of nucleotide excision repair (NER) that differ in the damage recognition step. How NER factors, especially GGR factors, access DNA damage in the chromatin of eukaryotic cells has been poorly understood. Dot1, a histone methyltransferase required for methylation of histone H3 lysine 79 (H3K79), has been shown to confer yeast cells with resistance to DNA-damaging agents and play a role in activation of DNA damage checkpoints. Here, we show that Dot1 and H3K79 methylation are required for GGR in both nucleosomal core regions and internucleosomal linker DNA, but play no role in TCR. H3K79 trimethylation contributes to but is not absolutely required for GGR, and lower levels of H3K79 methylation (mono- and dimethylation) also promote GGR. Our results also indicate that the roles of Dot1 and H3K79 methylation in GGR are not achieved by either activating DNA damage checkpoints or regulating the expression of the GGR-specific factor Rad16. Rather, the methylated H3K79 may serve as a docking site for the GGR machinery on the chromatin. Our studies identified a novel GGR-specific NER factor and unveiled the critical link between a covalent histone modification and GGR.	[Tatum, Danielle; Li, Shisheng] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Li, SS (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	shli@vetmed.lsu.edu	Li, Shisheng/H-9126-2012	Tatum, Danielle/0000-0002-3281-3853	National Science Foundation [MCB-0745229]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0745229.	Bostelman LJ, 2007, DNA REPAIR, V6, P383, DOI 10.1016/j.dnarep.2006.12.010; Capiaghi C, 2004, MOL CELL BIOL, V24, P6907, DOI 10.1128/MCB.24.16.6907-6918.2004; Chaudhuri S, 2009, NUCLEIC ACIDS RES, V37, P1690, DOI 10.1093/nar/gkp003; FRIEDBERG EC, 2006, DNA REPAIR MUTAGENES, P227; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Giannattasio M, 2004, EMBO J, V23, P429, DOI 10.1038/sj.emboj.7600051; Gillette TG, 2006, EMBO J, V25, P2529, DOI 10.1038/sj.emboj.7601120; Gong F, 2005, DNA REPAIR, V4, P884, DOI 10.1016/j.dnarep.2005.04.007; Gong F, 2006, NAT STRUCT MOL BIOL, V13, P902, DOI 10.1038/nsmb1152; Guzder SN, 1998, J BIOL CHEM, V273, P6292, DOI 10.1074/jbc.273.11.6292; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LeJeune D, 2009, DNA REPAIR, V8, P40, DOI 10.1016/j.dnarep.2008.08.010; Lettieri T, 2008, DNA REPAIR, V7, P734, DOI 10.1016/j.dnarep.2008.01.016; Levesque N, 2010, J BIOL CHEM, V285, P35113, DOI 10.1074/jbc.M110.116855; Li SS, 2007, DNA REPAIR, V6, P1596, DOI 10.1016/j.dnarep.2007.05.005; Li SS, 1996, CARCINOGENESIS, V17, P1549, DOI 10.1093/carcin/17.8.1549; Li SS, 2004, J BIOL CHEM, V279, P14418, DOI 10.1074/jbc.M312004200; Li SS, 1997, J MOL BIOL, V271, P31, DOI 10.1006/jmbi.1997.1154; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; Lloyd RS, 2005, MUTAT RES-FUND MOL M, V577, P77, DOI 10.1016/j.mrfmmm.2005.04.003; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Rochette PJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000926; Siede W, 1996, J BACTERIOL, V178, P5841, DOI 10.1128/jb.178.19.5841-5843.1996; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Teng Y, 2008, EMBO REP, V9, P97, DOI 10.1038/sj.embor.7401112; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; VERHAGE R, 1994, MOL CELL BIOL, V14, P6135, DOI 10.1128/MCB.14.9.6135; Waters R, 2009, DNA REPAIR, V8, P146, DOI 10.1016/j.dnarep.2008.11.001; Wellinger RE, 1997, EMBO J, V16, P5046, DOI 10.1093/emboj/16.16.5046; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102	38	48	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17530	17535		10.1074/jbc.M111.241570	http://dx.doi.org/10.1074/jbc.M111.241570			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21460225	hybrid, Green Published			2022-12-27	WOS:000290585200015
J	Zheng, YF; Ao, ZJ; Wang, BC; Jayappa, KD; Yao, XJ				Zheng, Yingfeng; Ao, Zhujun; Wang, Binchen; Jayappa, Kallesh Danappa; Yao, Xiaojian			Host Protein Ku70 Binds and Protects HIV-1 Integrase from Proteasomal Degradation and Is Required for HIV Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MURINE LEUKEMIA-VIRUS; CATALYTIC CORE DOMAIN; DNA END; PREINTEGRATION COMPLEXES; NUCLEAR IMPORT; RETROVIRAL DNA; V(D)J RECOMBINATION; MUTAGENIC ANALYSIS; CHROMATIN BINDING	HIV-1 integrase (IN) is a key viral enzymatic protein acting in several viral replication steps, including integration. IN has been shown to be an unstable protein degraded by the N-end rule pathway through the host ubiquitin-proteasome machinery. However, it is still not fully understood how this viral protein is protected from the host ubiquitin-proteasome system within cells during HIV replication. In the present study, we provide evidence that the host protein Ku70 interacts with HIV-1 IN and protects it from the Lys(48)-linked polyubiquitination proteasomal pathway. Moreover, Ku70 is able to down-regulate the overall protein polyubiquitination level within the host cells and to specifically deubiquitinate IN through their interaction. Mutagenic studies revealed that the C terminus of IN (residues 230-288) is required for IN binding to the N-terminal part of Ku70 (Ku70(1-430)), and their interaction is independent of Ku70/80 heterodimerization. Finally, knockdown of Ku70 expression in both virus-producing and target CD4(+) T cells significantly disrupted HIV-1 replication and rendered two-long terminal repeat circles and integration undetectable, indicating that Ku70 is required for both the early and the late stages of the HIV-1 life cycle. Interestingly, Ku70 was incorporated into the progeny virus in an IN-dependent way. We proposed that Ku70 may interact with IN during viral assembly and accompany HIV-1 IN upon entry into the new target cells, acting to 1) protect IN from the host defense system and 2) assist IN integration activity. Overall, this report provides another example of how HIV-1 hijacks host cellular machinery to protect the virus itself and to facilitate its replication.	[Zheng, Yingfeng; Ao, Zhujun; Wang, Binchen; Jayappa, Kallesh Danappa; Yao, Xiaojian] Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Mol Human Retrovirol, Winnipeg, MB R3E 0J9, Canada	University of Manitoba	Yao, XJ (corresponding author), Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Mol Human Retrovirol, 508-745 William Ave, Winnipeg, MB R3E 0J9, Canada.	yao2@cc.umanitoba.ca	JAYAPPA, KALLESH DANAPPA/M-6571-2018; Zheng, Yingfeng/AAE-2983-2022	JAYAPPA, KALLESH DANAPPA/0000-0002-7239-5246; Yao, Xiaojian/0000-0002-5022-1309	Canadian Institutes of Health Research (CIHR) [HOP-81180, HBF 103212]; Canadian Foundation of Innovation; Manitoba Health Research Council/Manitoba Institute of Child Health (MHRC/MICH); CIHR International Infectious Disease and Global Health; Manitoba Medical Service Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation of Innovation(Canada Foundation for Innovation); Manitoba Health Research Council/Manitoba Institute of Child Health (MHRC/MICH); CIHR International Infectious Disease and Global Health(Canadian Institutes of Health Research (CIHR)); Manitoba Medical Service Foundation	This work was supported by Canadian Institutes of Health Research (CIHR) Grants HOP-81180 and HBF 103212 and the Leaders Opportunity Fund Award from the Canadian Foundation of Innovation (to X.-J.Y.).; Recipient of studentships from the Manitoba Health Research Council/Manitoba Institute of Child Health (MHRC/MICH) and the CIHR International Infectious Disease and Global Health Training Program.; Recipient of the Basic Science Career Development Research Award from the Manitoba Medical Service Foundation.	Amsel AD, 2008, P NATL ACAD SCI USA, V105, P5117, DOI 10.1073/pnas.0706700105; Ao Z, 2004, J VIROL, V78, P3170, DOI 10.1128/JVI.78.6.3170-3177.2004; Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Ao ZJ, 2010, J VIROL, V84, P8650, DOI 10.1128/JVI.00508-10; Ao ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001995; Ao ZJ, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-62; Berthoux L, 2007, VIROLOGY, V364, P227, DOI 10.1016/j.virol.2007.02.029; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Daniel R, 2005, NAT CELL BIOL, V7, P452, DOI 10.1038/ncb0505-452; Daniel R, 2004, J VIROL, V78, P8573, DOI 10.1128/JVI.78.16.8573-8581.2004; Daniel R, 2001, MOL CELL BIOL, V21, P1164, DOI 10.1128/MCB.21.4.1164-1172.2001; Daniel R, 2001, J VIROL, V75, P3121, DOI 10.1128/JVI.75.7.3121-3128.2001; Daniel R, 1999, SCIENCE, V284, P644, DOI 10.1126/science.284.5414.644; Doherty AJ, 2001, FEBS LETT, V500, P186, DOI 10.1016/S0014-5793(01)02589-3; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Downs JA, 1999, MOL CELL BIOL, V19, P6260; Dubiel W, 1999, CURR BIOL, V9, pR554, DOI 10.1016/S0960-9822(99)80353-4; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Jeanson L, 2002, VIROLOGY, V300, P100, DOI 10.1006/viro.2002.1515; Jeanson L, 2002, J BIOL CHEM, V277, P4918, DOI 10.1074/jbc.M110830200; Jin SF, 1997, EMBO J, V16, P6874, DOI 10.1093/emboj/16.22.6874; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kiel C, 2006, J MOL BIOL, V355, P821, DOI 10.1016/j.jmb.2005.10.010; Kilzer JM, 2003, VIROLOGY, V314, P460, DOI 10.1016/S0042-6822(03)00455-0; Klinger Patricia P, 2005, Expert Rev Anti Infect Ther, V3, P61, DOI 10.1586/14787210.3.1.61; Koike M, 2001, J BIOL CHEM, V276, P11167, DOI 10.1074/jbc.M010902200; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Le Rouzic E, 2008, J BIOL CHEM, V283, P21686, DOI 10.1074/jbc.M710298200; LEE MS, 1994, P NATL ACAD SCI USA, V91, P9823, DOI 10.1073/pnas.91.21.9823; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Lin CW, 2003, J VIROL, V77, P5030, DOI 10.1128/JVI.77.8.5030-5036.2003; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Mouland AJ, 2000, J VIROL, V74, P5441, DOI 10.1128/JVI.74.12.5441-5451.2000; Mulder LCF, 2000, J BIOL CHEM, V275, P29749, DOI 10.1074/jbc.M004670200; Mulder LCF, 2002, J BIOL CHEM, V277, P27489, DOI 10.1074/jbc.M203061200; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Ott David E., 2009, V485, P15, DOI 10.1007/978-1-59745-170-3_2; Ott DE, 1998, J VIROL, V72, P2962, DOI 10.1128/JVI.72.4.2962-2968.1998; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pornillos O, 2002, TRENDS CELL BIOL, V12, P569, DOI 10.1016/S0962-8924(02)02402-9; Roe T, 1997, J VIROL, V71, P1334, DOI 10.1128/JVI.71.2.1334-1340.1997; Sadowski M, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-19; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Strack B, 2002, J VIROL, V76, P5472, DOI 10.1128/JVI.76.11.5472-5479.2002; Studamire B, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-48; Tuteja R, 2000, CRIT REV BIOCHEM MOL, V35, P1, DOI 10.1080/10409230091169177; Van Maele B, 2005, AIDS REV, V7, P26; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Wang JS, 1998, J BIOL CHEM, V273, P842, DOI 10.1074/jbc.273.2.842; Wu XT, 1996, MOL CELL BIOL, V16, P5186; Xu ZK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-102; YAO XJ, 1995, J VIROL, V69, P7032, DOI 10.1128/JVI.69.11.7032-7044.1995; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zheng YF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-68	67	52	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17722	17735		10.1074/jbc.M110.184739	http://dx.doi.org/10.1074/jbc.M110.184739			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454661	Green Published, hybrid			2022-12-27	WOS:000290585200036
J	Kang, BH; Xia, F; Pop, R; Dohi, T; Socolovsky, M; Altieri, DC				Kang, Byoung Heon; Xia, Fang; Pop, Ramona; Dohi, Takehiko; Socolovsky, Merav; Altieri, Dario C.			Developmental Control of Apoptosis by the Immunophilin Aryl Hydrocarbon Receptor-interacting Protein (AIP) Involves Mitochondrial Import of the Survivin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PITUITARY-ADENOMA PREDISPOSITION; IN-VIVO; INHIBITS APOPTOSIS; PRECURSOR PROTEINS; OUTER-MEMBRANE; CANCER; GENE; COMPLEX; IAP; DIFFERENTIATION	Survivin is a multifunctional protein with essential roles in cell division and inhibition of apoptosis, but the molecular underpinnings of its cytoprotective properties are poorly understood. Here we show that homozygous deletion of the aryl hydrocarbon receptor-interacting protein (AIP), a survivin-associated immunophilin, causes embryonic lethality in mice by embryonic day 13.5-14, increased apoptosis of Ter119(-)/CD71(-) early erythropoietic progenitors, and loss of survivin expression in its cytosolic and mitochondrial compartments in vivo. In import assays using recombinant proteins, AIP directly mediated the import of survivin to mitochondria, thus enabling its anti-apoptotic function, whereas a survivin 1-141 mutant that does not bind AIP was not imported to mitochondria and failed to inhibit apoptosis. AIP-directed mitochondrial import of survivin did not affect cell division, was independent of the organelle transmembrane potential, did not require the chaperone Heat Shock Protein 90 (Hsp90), and was inhibited by cytosolic factor(s) present in normal cells. shRNA knockdown of the mitochondrial import receptor Tom20 abolished mitochondrial import of survivin and sensitized tumor cells to apoptosis, whereas silencing of Tom70 had no effect. Therefore, an AIP-Tom20 recognition contributes to cell survival in development and cancer by mediating the mitochondrial import of survivin.	[Dohi, Takehiko; Altieri, Dario C.] Wistar Inst Anat & Biol, Ctr Canc, Philadelphia, PA 19104 USA; [Kang, Byoung Heon; Xia, Fang; Dohi, Takehiko; Altieri, Dario C.] Univ Massachusetts, Sch Med, Prostate Canc Discovery & Dev Program, Worcester, MA 01605 USA; [Kang, Byoung Heon; Xia, Fang] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Pop, Ramona; Socolovsky, Merav] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA	The Wistar Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Altieri, DC (corresponding author), Wistar Inst Anat & Biol, Ctr Canc, 3601 Spruce St, Philadelphia, PA 19104 USA.	daltieri@wistar.org	Kang, Byoung Heon/E-6165-2010	Kang, Byoung Heon/0000-0001-5902-0549; Socolovsky, Merav/0000-0001-6747-7960	National Institutes of Health [CA78810, CA140043, HL54131, HL084168, CA118005]; NATIONAL CANCER INSTITUTE [R01CA078810, P01CA140043, R01CA118005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL054131, R01HL054131, R01HL084168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA78810, CA140043, HL54131, HL084168, and CA118005.	Ach M, 2009, LEUKEMIA, V23, P712, DOI 10.1038/leu.2008.363; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Beckers A, 2007, EUR J ENDOCRINOL, V157, P371, DOI 10.1530/EJE-07-0348; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Carver LA, 1997, J BIOL CHEM, V272, P11452; Ceballos-Cancino G, 2007, ONCOGENE, V26, P7569, DOI 10.1038/sj.onc.1210560; Colnaghi R, 2006, J BIOL CHEM, V281, P33450, DOI 10.1074/jbc.C600164200; DiGiovanni R, 2007, ENDOCR PATHOL, V18, P76, DOI 10.1007/s12022-007-0010-z; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Georgitsi M, 2008, J CLIN ENDOCR METAB, V93, P4146, DOI 10.1210/jc.2008-1003; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Heliovaara E, 2009, AM J PATHOL, V175, P2501, DOI 10.2353/ajpath.2009.081131; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Kang BH, 2006, J BIOL CHEM, V281, P24721, DOI 10.1074/jbc.M603175200; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; LaPres JJ, 2000, J BIOL CHEM, V275, P6153, DOI 10.1074/jbc.275.9.6153; Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611; Leung CG, 2007, J EXP MED, V204, P1603, DOI 10.1084/jem.20062395; Li FZ, 2010, AM J PATHOL, V176, P1629, DOI 10.2353/ajpath.2010.090414; Lin BC, 2007, J BIOL CHEM, V282, P35924, DOI 10.1074/jbc.M705471200; Ma Q, 1997, J BIOL CHEM, V272, P8878; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Motz C, 2002, J MOL BIOL, V323, P729, DOI 10.1016/S0022-2836(02)00995-6; Musacchio A, 2010, SCIENCE, V330, P183, DOI 10.1126/science.1197261; Nukaya M, 2010, J BIOL CHEM, V285, P35599, DOI 10.1074/jbc.M110.132043; Ozfirat Z, 2010, MOL CELL ENDOCRINOL, V326, P71, DOI 10.1016/j.mce.2010.05.001; Pop R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000484; Raitila A, 2010, AM J PATHOL, V177, P1969, DOI 10.2353/ajpath.2010.100138; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; Small S, 2010, LEUKEMIA, V24, P1920, DOI 10.1038/leu.2010.198; Socolovsky M, 2007, PLOS BIOL, V5, P2296, DOI 10.1371/journal.pbio.0050252; Song ZY, 2003, J BIOL CHEM, V278, P23130, DOI 10.1074/jbc.M300957200; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Wilson TR, 2009, CURR CANCER DRUG TAR, V9, P307, DOI 10.2174/156800909788166547; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Xia F, 2006, CANCER RES, V66, P3392, DOI 10.1158/0008-5472.CAN-05-4537; Yano M, 2003, J CELL BIOL, V163, P45, DOI 10.1083/jcb.200305051; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zwerts F, 2007, BLOOD, V109, P4742, DOI 10.1182/blood-2006-06-028068	47	32	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16758	16767		10.1074/jbc.M110.210120	http://dx.doi.org/10.1074/jbc.M110.210120			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454573	Green Published, hybrid			2022-12-27	WOS:000290301900024
J	Liu, HB; Chen, CH; Espinoza-Lewis, RA; Jiao, Z; Sheu, I; Hu, XF; Lin, MK; Zhang, YD; Chen, YP				Liu, Hongbing; Chen, Chao-Hui; Espinoza-Lewis, Ramon A.; Jiao, Zhen; Sheu, Ivana; Hu, Xuefeng; Lin, Minkui; Zhang, Yanding; Chen, YiPing			Functional Redundancy between Human SHOX and Mouse Shox2 Genes in the Regulation of Sinoatrial Node Formation and Pacemaking Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMEOBOX GENE; TURNER-SYNDROME; SHORT-STATURE; LERI-WEILL; TARGETED MUTATION; HEART; MICE; DYSCHONDROSTEOSIS; EXPRESSION; DYSPLASIA	The homeodomain transcription factor Shox2 plays a crucial regulatory role in the development of sinoatrial node (SAN) by repressing the expression of Nkx2.5, as demonstrated by failed differentiation of SAN in Shox2 null mice. The SHOX (short stature homeobox) gene family consists of two closely related members, SHOX and SHOX2 in humans, but a SHOX ortholog does not exist in the mouse genome. These two genes exhibit overlapping and distinct expression patterns in many developing organs but whether they share functional redundancy is not known. In this study, we set to investigate possible functional redundancy between SHOX and SHOX2 in vitro and in vivo. We first showed that human SHOX and SHOX2 and mouse Shox2 possess similar transcriptional repressive activities in cell cultures, particularly the repressive effects on the Nkx2.5 promoter activity. We further created an SHOX/Shox2 knock-in mouse line (replacement of Shox2 with SHOX, referred as Shox2(KI/KI)). Mice carrying the hypomorphic Shox2(KI+Neo/KI+Neo) allele exhibit bradycardia and arrhythmia and die a few days after birth. However, mice carrying the Shox2(KI/KI) allele grow to adulthood. Physiological, histological, and molecular analyses demonstrate a fully developed SAN and normal pacemaking function in Shox2(KI/KI) mice. Our results demonstrate a functional redundancy between human SHOX and mouse Shox2 in the regulation of SAN formation and pacemaking function in addition to several other organs. The SHOX/Shox2 dose appears to be critical for normal pacemaking function.	[Liu, Hongbing; Chen, Chao-Hui; Espinoza-Lewis, Ramon A.; Sheu, Ivana; Lin, Minkui; Chen, YiPing] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Jiao, Zhen] Tulane Univ, Div Cardiol, Dept Med, New Orleans, LA 70118 USA; [Hu, Xuefeng; Zhang, Yanding; Chen, YiPing] Fujian Normal Univ, Coll Life Sci, Fujian Key Lab Dev & Neurobiol, Fuzhou 350108, Fujian Province, Peoples R China	Tulane University; Tulane University; Fujian Normal University	Chen, YP (corresponding author), Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA.	ychen@tulane.edu	Liu, Hongbing/I-4052-2014	Liu, Hongbing/0000-0002-3411-4597; Espinoza-Lewis, Ramon/0000-0003-3068-5517	National Institutes of Health [R01 DE17792]; NSF of China [30871422]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DE17792 (to Y. P. C.). This work was also supported by an NSF of China Grant 30871422 (to Y. Z.).	Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; Blaschke RJ, 1998, P NATL ACAD SCI USA, V95, P2406, DOI 10.1073/pnas.95.5.2406; Blaschke RJ, 2007, CIRCULATION, V115, P1830, DOI 10.1161/CIRCULATIONAHA.106.637819; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; Cobb J, 2006, P NATL ACAD SCI USA, V103, P4511, DOI 10.1073/pnas.0510544103; Durham D, 2002, Crit Care Resusc, V4, P35; Ellison JW, 1997, HUM MOL GENET, V6, P1341, DOI 10.1093/hmg/6.8.1341; Espinoza-Lewis RA, 2009, DEV BIOL, V327, P376, DOI 10.1016/j.ydbio.2008.12.028; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Gu SP, 2008, MECH DEVELOP, V125, P729, DOI 10.1016/j.mod.2008.04.003; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Presnell JK, 1997, HUMASONS ANIMAL TISS, P124; Puskaric S, 2010, HUM MOL GENET, V19, P4625, DOI 10.1093/hmg/ddq393; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Rao E, 2001, HUM MOL GENET, V10, P3083, DOI 10.1093/hmg/10.26.3083; Rovescalli AC, 1996, P NATL ACAD SCI USA, V93, P10691, DOI 10.1073/pnas.93.20.10691; Semina EV, 1998, HUM MOL GENET, V7, P415, DOI 10.1093/hmg/7.3.415; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; Van Mierop L H, 1970, Am J Cardiol, V25, P204, DOI 10.1016/0002-9149(70)90580-1; Yu L, 2005, DEVELOPMENT, V132, P4397, DOI 10.1242/dev.02013; Yu L, 2007, DEV BIOL, V306, P549, DOI 10.1016/j.ydbio.2007.03.518; Zinn AR, 2002, AM J MED GENET, V110, P158, DOI 10.1002/ajmg.10422	25	36	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17029	17038		10.1074/jbc.M111.234252	http://dx.doi.org/10.1074/jbc.M111.234252			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454626	Green Published, hybrid			2022-12-27	WOS:000290301900053
J	Wandhammer, M; Carletti, E; Van der Schans, M; Gillon, E; Nicolet, Y; Masson, P; Goeldner, M; Noort, D; Nachon, F				Wandhammer, Marielle; Carletti, Eugenie; Van der Schans, Marcel; Gillon, Emilie; Nicolet, Yvain; Masson, Patrick; Goeldner, Maurice; Noort, Daan; Nachon, Florian			Structural Study of the Complex Stereoselectivity of Human Butyrylcholinesterase for the Neurotoxic V-agents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ACETYLCHOLINESTERASE; PROTECTION; REACTIVATION; ENANTIOMERS	Nerve agents are chiral organophosphate compounds (OPs) that exert their acute toxicity by phosphorylating the catalytic serine of acetylcholinesterase (AChE). The inhibited cholinesterases can be reactivated using oximes, but a spontaneous time-dependent process called aging alters the adduct, leading to resistance toward oxime reactivation. Human butyrylcholinesterase (BChE) functions as a bioscavenger, protecting the cholinergic system against OPs. The stereoselectivity of BChE is an important parameter for its efficiency at scavenging the most toxic OPs enantiomer for AChE. Crystals of BChE inhibited in solution or in cristallo with racemic V-agents (VX, Russian VX, and Chinese VX) systematically show the formation of the PS adduct. In this configuration, no catalysis of aging seems possible as confirmed by the three-dimensional structures of the three conjugates incubated over a period exceeding a week. Crystals of BChE soaked in optically pure VXR-(+) and VXS-(-) solutions lead to the formation of the P-S and P-R adduct, respectively. These structural data support an in-line phosphonylation mechanism. Additionally, they show that BChE reacts with VXR-(+) in the presence of racemic mixture of V-agents, at odds with earlier kinetic results showing a moderate higher inhibition rate for VXS-(-). These combined results suggest that the simultaneous presence of both enantiomers alters the enzyme stereoselectivity. In summary, the three-dimensional data show that BChE reacts preferentially with P-R enantiomer of V-agents and does not age, in complete contrast to AChE, which is selectively inhibited by the PS enantiomer and ages.	[Wandhammer, Marielle; Carletti, Eugenie; Gillon, Emilie; Masson, Patrick; Nachon, Florian] Inst Rech Biomed Armees CRSSA, Dept Toxicol, F-38700 La Tronche, France; [Wandhammer, Marielle; Goeldner, Maurice] Fac Pharm, UMR 7199, Lab Concept & Applicat Mol Bioact, F-67400 Illkirch Graffenstaden, France; [Van der Schans, Marcel; Noort, Daan] TNO Def Secur & Safety, Business Unit Biol & Chem Protect, Res Grp Diag & Therapy, NL-2288 GJ Rijswijk, Netherlands; [Nicolet, Yvain] Inst Biol Struct, Cristallog & Cristallogenese Prot Lab, F-38027 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Netherlands Organization Applied Science Research; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Nachon, F (corresponding author), Inst Rech Biomed Armees CRSSA, Dept Toxicol, 24 Av Maquis du Gresivaudan, F-38700 La Tronche, France.	florian@nachon.net	Yvain, Nicolet/AAP-9763-2020; Masson, Patrick YM/J-3964-2013; Masson, Patrick/AAA-7213-2019	Yvain, Nicolet/0000-0002-4189-7067; Masson, Patrick YM/0000-0002-7837-3662; Masson, Patrick/0000-0002-7837-3662	Direction Generale de l'Armement [08co501, ANR-06-BLAN-0163, ANR-09-BLAN-0192]; Defense Threat Reduction Agency [CBDIF07-THER01-2-0038]	Direction Generale de l'Armement; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by Direction Generale de l'Armement under Programme d'Etude Amont Grants 08co501, ANR-06-BLAN-0163, and ANR-09-BLAN-0192 (to F. N.) and Defense Threat Reduction Agency Grant CBDIF07-THER01-2-0038 (to D. N., F. N., and M. G.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aurbek N, 2009, TOXICOLOGY, V259, P133, DOI 10.1016/j.tox.2009.02.014; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOTER HL, 1969, BIOCHEM PHARMACOL, V18, P2403, DOI 10.1016/0006-2952(69)90355-4; Carletti E, 2010, J MED CHEM, V53, P4002, DOI 10.1021/jm901853b; Carletti E, 2009, BIOCHEM J, V421, P97, DOI 10.1042/BJ20090091; Cohen O, 2006, MOL PHARMACOL, V70, P1121, DOI 10.1124/mol.106.026179; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HALL CR, 1977, J PHARM PHARMACOL, V29, P574, DOI 10.1111/j.2042-7158.1977.tb11405.x; HOLMSTEDT B, 1959, PHARMACOL REV, V11, P567; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kasten S. A., 2010, P 2010 MED DEF BIOSC; Lenz DE, 2005, CHEM-BIOL INTERACT, V157, P205, DOI 10.1016/j.cbi.2005.10.025; Li B, 2000, J NEUROCHEM, V75, P1320, DOI 10.1046/j.1471-4159.2000.751320.x; Li H, 2007, TOXICOL SCI, V100, P136, DOI 10.1093/toxsci/kfm215; Masson P, 1997, BIOCHEMISTRY-US, V36, P2266, DOI 10.1021/bi962484a; Masson P, 2010, CHEM-BIOL INTERACT, V187, P157, DOI 10.1016/j.cbi.2010.03.027; Masson P, 2010, ARCH BIOCHEM BIOPHYS, V494, P107, DOI 10.1016/j.abb.2009.12.005; Millard CB, 1999, J AM CHEM SOC, V121, P9883, DOI 10.1021/ja992704i; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nachon F, 2002, EUR J BIOCHEM, V269, P630, DOI 10.1046/j.0014-2956.2001.02692.x; Nachon F, 2011, BIOCHEM J, V434, P73, DOI 10.1042/BJ20101648; Nachon F, 2010, CHEM-BIOL INTERACT, V187, P44, DOI 10.1016/j.cbi.2010.03.053; Nicolet Y, 2003, J BIOL CHEM, V278, P41141, DOI 10.1074/jbc.M210241200; Ordentlich A, 1999, BIOCHEMISTRY-US, V38, P3055, DOI 10.1021/bi982261f; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Reiter G, 2008, J CHROMATOGR B, V873, P86, DOI 10.1016/j.jchromb.2008.08.001; Saxena A, 2006, J MOL NEUROSCI, V30, P145, DOI 10.1385/JMN:30:1:145; Silman I, 2005, CURR OPIN PHARMACOL, V5, P293, DOI 10.1016/j.coph.2005.01.014	31	33	34	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16783	16789		10.1074/jbc.M110.209569	http://dx.doi.org/10.1074/jbc.M110.209569			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454498	Green Published, hybrid			2022-12-27	WOS:000290301900027
J	Martin, J; Masri, J; Cloninger, C; Holmes, B; Artinian, N; Funk, A; Ruegg, T; Anderson, L; Bashir, T; Bernath, A; Lichtenstein, A; Gera, J				Martin, Jheralyn; Masri, Janine; Cloninger, Cheri; Holmes, Brent; Artinian, Nicholas; Funk, Alexander; Ruegg, Teresa; Anderson, Lauren; Bashir, Tariq; Bernath, Andrew; Lichtenstein, Alan; Gera, Joseph			Phosphomimetic Substitution of Heterogeneous Nuclear Ribonucleoprotein A1 at Serine 199 Abolishes AKT-dependent Internal Ribosome Entry Site-transacting Factor (ITAF) Function via Effects on Strand Annealing and Results in Mammalian Target of Rapamycin Complex 1 (mTORC1) Inhibitor Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING-PROTEINS; TRANS-ACTING FACTORS; MESSENGER-RNA; CYCLIN D1; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ENHANCED SENSITIVITY; GENE-EXPRESSION; TRANSLATION; PHOSPHORYLATION; PATHWAY	The relative activity of the AKT kinase has been demonstrated to be a major determinant of sensitivity of tumor cells to mammalian target of rapamycin (mTOR) complex 1 inhibitors. Our previous studies have shown that the multifunctional RNA-binding protein heterogeneous nuclear ribonucleoprotein (hnRNP) A1 regulates a salvage pathway facilitating internal ribosome entry site (IRES)-dependent mRNA translation of critical cellular determinants in an AKT-dependent manner following mTOR inhibitor exposure. This pathway functions by stimulating IRES-dependent translation in cells with relatively quiescent AKT, resulting in resistance to rapamycin. However, the pathway is repressed in cells with elevated AKT activity, rendering them sensitive to rapamycin-induced G(1) arrest as a result of the inhibition of global eIF-4E-mediated translation. AKT phosphorylation of hnRNP A1 at serine 199 has been demonstrated to inhibit IRES-mediated translation initiation. Here we describe a phosphomimetic mutant of hnRNP A1 (S199E) that is capable of binding both the cyclin D1 and c-MYC IRES RNAs in vitro but lacks nucleic acid annealing activity, resulting in inhibition of IRES function in dicistronic mRNA reporter assays. Utilizing cells in which AKT is conditionally active, we demonstrate that overexpression of this mutant renders quiescent AKT-containing cells sensitive to rapamycin in vitro and in xenografts. We also demonstrate that activated AKT is strongly correlated with elevated Ser(P)(199)-hnRNP A1 levels in a panel of 22 glioblastomas. These data demonstrate that the phosphorylation status of hnRNP A1 serine 199 regulates the AKT-dependent sensitivity of cells to rapamycin and functionally links IRES-transacting factor annealing activity to cellular responses to mTOR complex 1 inhibition.	[Martin, Jheralyn; Masri, Janine; Cloninger, Cheri; Holmes, Brent; Artinian, Nicholas; Funk, Alexander; Ruegg, Teresa; Anderson, Lauren; Bashir, Tariq; Bernath, Andrew; Lichtenstein, Alan; Gera, Joseph] Greater Los Angeles Vet Affairs Healthcare Syst, Dept Res & Dev, Los Angeles, CA 91343 USA; [Lichtenstein, Alan; Gera, Joseph] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90048 USA; [Lichtenstein, Alan; Gera, Joseph] Univ Calif Los Angeles, Jonnson Comprehens Canc Ctr, Los Angeles, CA 90048 USA; [Gera, Joseph] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90048 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gera, J (corresponding author), 16111 Plummer Str 151,Bldg 1,Rm C111A, Sepulveda, CA 91343 USA.	jgera@mednet.ucla.edu		Holmes, Brent/0000-0002-2768-2991; Gera, Joseph/0000-0002-2908-6894	National Institutes of Health [R01CA111448, R01CA109312]; Department of Veterans Affairs; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA109312, R01CA111448, R01CA132778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA111448 (to A. L.) and R01CA109312 (to J. G.). This work was also supported by funds from the Department of Veterans Affairs and the Department of Defense.	Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Cammas A, 2007, MOL BIOL CELL, V18, P5048, DOI 10.1091/mbc.E07-06-0603; Cammas A, 2008, BIOCHEM PHARMACOL, V76, P1395, DOI 10.1016/j.bcp.2008.05.022; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Choe G, 2003, CANCER RES, V63, P2742; COBIANCHI F, 1993, NUCLEIC ACIDS RES, V21, P949, DOI 10.1093/nar/21.4.949; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Gratton JP, 2001, J BIOL CHEM, V276, P30359, DOI 10.1074/jbc.M009698200; HAMILTON BJ, 1993, J BIOL CHEM, V268, P8881; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; HENICS T, 1994, J BIOL CHEM, V269, P5377; Holcik M, 2004, CURR CANCER DRUG TAR, V4, P299, DOI 10.2174/1568009043333005; IDRISS H, 1994, BIOCHEMISTRY-US, V33, P11382, DOI 10.1021/bi00203a037; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; King P H, 2000, Nucleic Acids Res, V28, pE20, DOI 10.1093/nar/28.7.e20; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; KUMAR A, 1990, BIOCHEMISTRY-US, V29, P10717, DOI 10.1021/bi00500a001; Le Quesne JPC, 2010, J PATHOL, V220, P140, DOI 10.1002/path.2627; Lewis SM, 2008, ONCOGENE, V27, P1033, DOI 10.1038/sj.onc.1210777; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Pedrotti S, 2010, EMBO J, V29, P1235, DOI 10.1038/emboj.2010.19; Pickering BM, 2004, MOL CELL BIOL, V24, P5595, DOI 10.1128/MCB.24.12.5595-5605.2004; PINOLROMA S, 1991, SCIENCE, V253, P312, DOI 10.1126/science.1857966; Sammons MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009301; Schultz DE, 1996, J BIOL CHEM, V271, P14134, DOI 10.1074/jbc.271.24.14134; Semler BL, 2008, TRENDS MICROBIOL, V16, P1, DOI 10.1016/j.tim.2007.11.001; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Shi YJ, 2002, CANCER RES, V62, P5027; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Svitkin YV, 1996, EMBO J, V15, P7147, DOI 10.1002/j.1460-2075.1996.tb01106.x; Yi MY, 2000, J VIROL, V74, P6459, DOI 10.1128/JVI.74.14.6459-6468.2000; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	39	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.205096	http://dx.doi.org/10.1074/jbc.M110.205096			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454539	Green Published, hybrid			2022-12-27	WOS:000290022800078
J	Law, A; Boulanger, MJ				Law, Adrienne; Boulanger, Martin J.			Defining a Structural and Kinetic Rationale for Paralogous Copies of Phenylacetate-CoA Ligases from the Cystic Fibrosis Pathogen Burkholderia cenocepacia J2315	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; AEROBIC METABOLISM; CATABOLIC PATHWAY; COENZYME; ENZYME; ACID; DLTA; PHENYLALANINE; ACTIVATION; BINDING	The phenylacetic acid (PAA) degradation pathway is the sole aerobic route for phenylacetic acid metabolism in bacteria and facilitates degradation of environmental pollutants such as styrene and ethylbenzene. The PAA pathway also is implicated in promoting Burkholderia cenocepacia infections in cystic fibrosis patients. Intriguingly, the first enzyme in the PAA pathway is present in two copies (paaK1 and paaK2), yet each subsequent enzyme is present in only a single copy. Furthermore, sequence divergence indicates that PaaK1 and PaaK2 form a unique subgroup within the adenylate-forming enzyme (AFE) superfamily. To establish a biochemical rationale for the existence of the PaaK paralogs in B. cenocepacia, we present high resolution x-ray crystal structures of a selenomethionine derivative of PaaK1 in complex with ATP and adenylated phenylacetate intermediate complexes of PaaK1 and PaaK2 in distinct conformations. Structural analysis reveals a novel N-terminal microdomain that may serve to recruit subsequent PAA enzymes, whereas a bifunctional role is proposed for the P-loop in stabilizing the C-terminal domain in conformation 2. The potential for different kinetic profiles was suggested by a structurally divergent extension of the aryl substrate pocket in PaaK1 relative to PaaK2. Functional characterization confirmed this prediction, with PaaK1 possessing a lower K-m for phenylacetic acid and better able to accommodate 3' and 4' substitutions on the phenyl ring. Collectively, these results offer detailed insight into the reaction mechanism of a novel subgroup of the AFE superfamily and provide a clear biochemical rationale for the presence of paralogous copies of PaaK of B. cenocepacia.	[Law, Adrienne; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	University of Victoria	Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	mboulang@uvic.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada; NSERC Alexander Graham Bell Canada	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Alexander Graham Bell Canada	This work was supported by a research grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada (to M. J. B.).; Supported by an NSERC Alexander Graham Bell Canada Graduate Scholarship.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bains J, 2007, J MOL BIOL, V373, P965, DOI 10.1016/j.jmb.2007.08.008; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; CORKERY DM, 1994, FEMS MICROBIOL LETT, V124, P23, DOI 10.1111/j.1574-6968.1994.tb07256.x; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Du LQ, 2008, BIOCHEMISTRY-US, V47, P11473, DOI 10.1021/bi801363b; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erb TJ, 2008, CURR MICROBIOL, V57, P27, DOI 10.1007/s00284-008-9147-3; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gulick AM, 2004, BIOCHEMISTRY-US, V43, P8670, DOI 10.1021/bi049384m; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Hunt TA, 2004, INFECT IMMUN, V72, P4010, DOI 10.1128/IAI.72.7.4010-4022.2004; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Law RJ, 2008, J BACTERIOL, V190, P7209, DOI 10.1128/JB.00481-08; LESLIE AGW, 1991, RECENT CHANGES MOSFL; MARTINEZBLANCO H, 1990, J BIOL CHEM, V265, P7084; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Mohamed ME, 2000, J BACTERIOL, V182, P286, DOI 10.1128/JB.182.2.286-294.2000; Mohamed MES, 2002, ARCH MICROBIOL, V178, P180, DOI 10.1007/s00203-002-0438-y; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Osman KT, 2009, J MOL BIOL, V388, P345, DOI 10.1016/j.jmb.2009.03.040; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Velasco A, 1998, J BACTERIOL, V180, P1063, DOI 10.1128/JB.180.5.1063-1071.1998; Wu R, 2007, BIOCHEMISTRY-US, V46, P14487, DOI 10.1021/bi701609w; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Yoder-Himes DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008724; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200; ZIEGLER K, 1989, ARCH MICROBIOL, V151, P171, DOI 10.1007/BF00414434	36	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15577	15585		10.1074/jbc.M111.219683	http://dx.doi.org/10.1074/jbc.M111.219683			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21388965	hybrid, Green Published			2022-12-27	WOS:000289788300085
J	Liu, JX; Hunter, CS; Du, AP; Ediger, B; Walp, E; Murray, J; Stein, R; May, CL				Liu, Jingxuan; Hunter, Chad S.; Du, Aiping; Ediger, Benjamin; Walp, Erik; Murray, Johanna; Stein, Roland; May, Catherine Lee			Islet-1 Regulates Arx Transcription during Pancreatic Islet alpha-Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPROVES GLUCOSE-TOLERANCE; BETA-CELL; ENDOCRINE PANCREAS; HOMEODOMAIN PROTEINS; GENE; GLUCAGON; LIM; DOMAIN; DIFFERENTIATION; INSULIN	Aristaless related homeodomain protein (Arx) specifies the formation of the pancreatic islet alpha-cell during development. This cell type produces glucagon, a major counteracting hormone to insulin in regulating glucose homeostasis in adults. However, little is known about the factors that regulate Arx transcription in the pancreas. In this study, we showed that the number of Arx(+) cells was significantly reduced in the pancreata of embryos deficient for the Islet-1 (Isl-1) transcription factor, which was also supported by the reduction in Arx mRNA levels. Chromatin immunoprecipitation analysis localized Isl-1 activator binding sites within two highly conserved noncoding regulatory regions (Re) in the Arx locus, termed Re1 (+5.6 to +6.1 kb) and Re2 (+23.6 to +24 kb). Using cell line-based transfection assays, we demonstrated that a Re1- and Re2-driven reporter was selectively activated in islet alpha-cells,a process mediated by Isl-1 in overexpression, knockdown, and site-directed mutation experiments. Moreover, Arx mRNA levels were upregulated in islet alpha-cells upon Isl-1 overexpression in vivo. Isl-1 represents the first known activator of Arx transcription in alpha-cells, here established to be acting through the conserved Re1 and Re2 control domains.	[Liu, Jingxuan; Du, Aiping; Ediger, Benjamin; Walp, Erik; Murray, Johanna; May, Catherine Lee] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [May, Catherine Lee] Univ Penn, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA; [May, Catherine Lee] Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Hunter, Chad S.; Stein, Roland] Vanderbilt Univ, Dept Mol Physiol & Biophys, Med Ctr, Nashville, TN 37232 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Vanderbilt University	May, CL (corresponding author), 3615 Civ Ctr Blvd,Room 516E, Philadelphia, PA 19104 USA.	catheril@mail.med.upenn.edu		Hunter, Chad/0000-0002-1644-447X	National Institutes of Health [DK078606, F32DK083160, T32GM07229]; JDRF [2-2007-703]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK078606, P30DK019525, R56DK078606, F32DK083160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK078606 (to C. L. M. and R. S.), F32DK083160 (to C. S. H.), T32GM07229 (to B. E.), and JDRF 2-2007-703 (to C. L. M.).	Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Burcelin R, 1996, DIABETES METAB, V22, P373; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cobos I, 2005, J COMP NEUROL, V483, P292, DOI 10.1002/cne.20405; Colasante G, 2008, J NEUROSCI, V28, P10674, DOI 10.1523/JNEUROSCI.1283-08.2008; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; DOBBS R, 1975, SCIENCE, V187, P544, DOI 10.1126/science.1089999; Du AP, 2009, DIABETES, V58, P2059, DOI 10.2337/db08-0987; Gannon M, 2000, DEVELOPMENT, V127, P2883; GERICH JE, 1975, NEW ENGL J MED, V292, P985, DOI 10.1056/NEJM197505082921901; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; Hancock AS, 2010, MOL ENDOCRINOL, V24, P1605, DOI 10.1210/me.2010-0120; Hohmeier HE, 2004, MOL CELL ENDOCRINOL, V228, P121, DOI 10.1016/j.mce.2004.04.017; Itoh M, 2010, DIFFERENTIATION, V80, P118, DOI 10.1016/j.diff.2010.05.003; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; LILJENQUIST JE, 1979, DIABETOLOGIA, V17, P139, DOI 10.1007/BF01219739; Matthews JM, 2003, EMBO REP, V4, P1132, DOI 10.1038/sj.embor.7400030; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; PICTET RL, 1972, DEV BIOL, V29, P436, DOI 10.1016/0012-1606(72)90083-8; RASKIN P, 1978, NEW ENGL J MED, V299, P433, DOI 10.1056/NEJM197808312990901; Sander M, 2000, DEVELOPMENT, V127, P5533; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; Toft I, 2002, METABOLISM, V51, P1128, DOI 10.1053/meta.2002.34702; Tuteja G, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp536; UNGER RJ, 1971, DIABETES, V20, P834, DOI 10.2337/diab.20.12.834; WANG M, 1995, J BIOL CHEM, V270, P12646, DOI 10.1074/jbc.270.21.12584; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; Yu X, 2008, P NATL ACAD SCI USA, V105, P14070, DOI 10.1073/pnas.0806993105	43	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15352	15360		10.1074/jbc.M111.231670	http://dx.doi.org/10.1074/jbc.M111.231670			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21388963	Green Published, hybrid			2022-12-27	WOS:000289788300066
J	Matsumoto, K; Shima, F; Muraoka, S; Araki, M; Hu, LZ; Ijiri, Y; Hirai, R; Liao, JL; Yoshioka, T; Kumasaka, T; Yamamoto, M; Tamura, A; Kataoka, T				Matsumoto, Kousuke; Shima, Fumi; Muraoka, Shin; Araki, Mitsugu; Hu, Lizhi; Ijiri, Yuichi; Hirai, Rina; Liao, Jingling; Yoshioka, Takashi; Kumasaka, Takashi; Yamamoto, Masaki; Tamura, Atsuo; Kataoka, Tohru			Critical Roles of Interactions among Switch I-preceding Residues and between Switch II and Its Neighboring alpha-Helix in Conformational Dynamics of the GTP-bound Ras Family Small GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACTIVATING PROTEIN; STRUCTURAL BASIS; BINDING; P21(RAS); STATE	GTP-bound forms of Ras family small GTPases exhibit dynamic equilibrium between two interconverting conformations, "inactive" state 1 and "active" state 2. A great variation exists in their state distribution; H-Ras mainly adopts state 2, whereas M-Ras predominantly adopts state 1. Our previous studies based on comparison of crystal structures representing state 1 and state 2 revealed the importance of the hydrogen-bonding interactions of two flexible effector-interacting regions, switch I and switch II, with the gamma-phosphate of GTP in establishing state 2 conformation. However, failure to obtain both state structures from a single protein hampered further analysis of state transition mechanisms. Here, we succeed in solving two crystal structures corresponding to state 1 and state 2 from a single Ras polypeptide, M-RasD41E, carrying an H-Ras-type substitution in residue 41, immediately preceding switch I, in complex with guanosine 5'-(beta,gamma-imido)triphosphate. Comparison among the two structures and other state 1 and state 2 structures of H-Ras/M-Ras reveal two new structural features playing critical roles in state dynamics; interaction of residues 31/41 (H-Ras/M-Ras) with residues 29/39 and 30/40, which induces a conformational change of switch I favoring its interaction with the gamma-phosphate, and the hydrogen-bonding interaction of switch II with its neighboring alpha-helix, alpha 3-helix, which induces a conformational change of switch II favoring its interaction with the gamma-phosphate. The importance of the latter interaction is proved by mutational analyses of the residues involved in hydrogen bonding. These results define the two novel functional regions playing critical roles during state transition.	[Matsumoto, Kousuke; Shima, Fumi; Muraoka, Shin; Hu, Lizhi; Ijiri, Yuichi; Hirai, Rina; Liao, Jingling; Kataoka, Tohru] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Araki, Mitsugu; Yoshioka, Takashi; Tamura, Atsuo] Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, Kobe, Hyogo 6578501, Japan; [Kumasaka, Takashi] Japan Synchrotron Radiat Res Inst JASRI, Sayo, Hyogo 6795198, Japan; [Muraoka, Shin; Yamamoto, Masaki] RIKEN SPring 8 Ctr, Mikazuki, Hyogo 6795148, Japan	Kobe University; Kobe University; Japan Synchrotron Radiation Research Institute; RIKEN	Kataoka, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kataoka@people.kobe-u.ac.jp	Kumasaka, Takashi/D-7428-2018; Yamamoto, Masaki/B-7844-2015; Araki, Mitsugu/C-7470-2016	Kumasaka, Takashi/0000-0001-9289-1557; Yamamoto, Masaki/0000-0002-1311-1768; Tamura, Atsuo/0000-0001-8238-8851	Ministry of Education, Science, Sports and Culture of Japan [17014061, 18057014, A08]; National Institute of Biomedical Innovation; Grants-in-Aid for Scientific Research [23390071] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research in Priority Areas 17014061 and 18057014, and Global COE Program A08 from the Ministry of Education, Science, Sports and Culture of Japan, and by a grant from the Program for Promotion of Fundamental Studies of Health Sciences 06-3 from the National Institute of Biomedical Innovation.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Corbett KD, 2001, TRENDS BIOCHEM SCI, V26, P710, DOI 10.1016/S0968-0004(01)01974-0; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fenwick RB, 2009, BIOCHEMISTRY-US, V48, P2192, DOI 10.1021/bi802129d; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; Ford B, 2009, BIOCHEMISTRY-US, V48, P11449, DOI 10.1021/bi901479b; Geyer M, 1997, NAT STRUCT BIOL, V4, P694, DOI 10.1038/nsb0997-694; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, JOINT CCP4 ESF EACBM, V26; Liao JL, 2008, BIOCHEM BIOPH RES CO, V369, P327, DOI 10.1016/j.bbrc.2008.01.169; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nicely NI, 2004, STRUCTURE, V12, P2025, DOI 10.1016/j.str.2004.08.011; O'Connor C, 2008, BIOCHEMISTRY-US, V47, P10244, DOI 10.1021/bi801076c; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Quilliam LA, 1999, J BIOL CHEM, V274, P23850, DOI 10.1074/jbc.274.34.23850; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Scheidig AJ, 1999, STRUCTURE, V7, P1311, DOI 10.1016/S0969-2126(00)80021-0; Shima F, 2010, J BIOL CHEM, V285, P22696, DOI 10.1074/jbc.M110.125161; Spoerner M, 2004, FEBS LETT, V578, P305, DOI 10.1016/j.febslet.2004.11.020; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2007, FEBS J, V274, P1419, DOI 10.1111/j.1742-4658.2007.05681.x; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Ye M, 2005, J BIOL CHEM, V280, P31267, DOI 10.1074/jbc.M505503200	32	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15403	15412		10.1074/jbc.M110.204933	http://dx.doi.org/10.1074/jbc.M110.204933			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21388959	Green Published, hybrid			2022-12-27	WOS:000289788300070
J	Shi, SJ; Ghosh, DD; Okumura, S; Carattino, MD; Kashlan, OB; Sheng, SH; Kleyman, TR				Shi, Shujie; Ghosh, D. Dipon; Okumura, Sora; Carattino, Marcelo D.; Kashlan, Ossama B.; Sheng, Shaohu; Kleyman, Thomas R.			Base of the Thumb Domain Modulates Epithelial Sodium Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; GAMMA-SUBUNIT; FURIN; ENAC; INHIBITION; ACTIVATION; RESIDUES; PEPTIDE	The activity of the epithelial sodium channel (ENaC) is modulated by multiple external factors, including proteases, cations, anions and shear stress. The resolved crystal structure of acid-sensing ion channel 1 (ASIC1), a structurally related ion channel, and mutagenesis studies suggest that the large extracellular region is involved in recognizing external signals that regulate channel gating. The thumb domain in the extracellular region of ASIC1 has a cylinder-like structure with a loop at its base that is in proximity to the tract connecting the extracellular region to the transmembrane domains. This loop has been proposed to have a role in transmitting proton-induced conformational changes within the extracellular region to the gate. We examined whether loops at the base of the thumb domains within ENaC subunits have a similar role in transmitting conformational changes induced by external Na+ and shear stress. Mutations at selected sites within this loop in each of the subunits altered channel responses to both external Na+ and shear stress. The most robust changes were observed at the site adjacent to a conserved Tyr residue. In the context of channels that have a low open probability due to retention of an inhibitory tract, mutations in the loop activated channels in a subunit-specific manner. Our data suggest that this loop has a role in modulating channel gating in response to external stimuli, and are consistent with the hypothesis that external signals trigger movements within the extracellular regions of ENaC subunits that are transmitted to the channel gate.	[Sheng, Shaohu] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Ghosh, D. Dipon] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Sheng, SH (corresponding author), Univ Pittsburgh, Dept Med, Renal Electrolyte Div, S929 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	shaohu@pitt.edu	Shi, Shujie/D-4999-2012; Sheng, Shaohu/G-7052-2016	Sheng, Shaohu/0000-0002-7198-1702; Ghosh, D. Dipon/0000-0001-6391-5767	National Institutes of Health [R01 DK051391, R01 DK054354, R01 ES014701, K01 DK078734, P30 DK079307]; American Heart Association; Howard Hughes Medical Institute; American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054354, R01DK051391, P30DK079307, K01DK078734, R37DK051391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by Grants R01 DK051391, R01 DK054354, R01 ES014701, K01 DK078734, and P30 DK079307 from the National Institutes of Health.; Supported by a postdoctoral fellowship award from the American Heart Association.; Supported by the Howard Hughes Medical Institute Undergraduate Science Education Program.; Supported by a Carl W. Gottschalk Award from the American Society of Nephrology.	Althaus M, 2007, FASEB J, V21, P2389, DOI 10.1096/fj.06-7694com; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2007, AM J PHYSIOL-RENAL, V293, pF316, DOI 10.1152/ajprenal.00455.2006; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Satlin LM, 2006, AM J PHYSIOL-RENAL, V291, pF923, DOI 10.1152/ajprenal.00192.2006; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; SHENG S, 2008, EPITHELIAL SODIUM CH; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Winarski KL, 2010, J BIOL CHEM, V285, P26088, DOI 10.1074/jbc.M110.149963	25	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14753	14761		10.1074/jbc.M110.191734	http://dx.doi.org/10.1074/jbc.M110.191734			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21367859	Green Published, hybrid			2022-12-27	WOS:000289788300004
J	David, A; Netzer, N; Strader, MB; Das, SR; Chen, CY; Gibbs, J; Pierre, P; Bennink, JR; Yewdell, JW				David, Alexandre; Netzer, Nir; Strader, Michael Brad; Das, Suman R.; Chen, Cai Yun; Gibbs, James; Pierre, Philippe; Bennink, Jack R.; Yewdell, Jonathan W.			RNA Binding Targets Aminoacyl-tRNA Synthetases to Translating Ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; MESSENGER-RNA; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; MACROMOLECULAR ASSEMBLAGE; SUBCELLULAR-DISTRIBUTION; STRESS GRANULES; SHEEP LIVER; COMPLEX; PHOSPHORYLATION	Here, we examine tRNA-aminoacyl synthetase (ARS) localization in protein synthesis. Proteomics reveals that ten of the twenty cytosolic ARSs associate with ribosomes in sucrose gradients: phenylalanyl-RS (FRS), and the 9 ARSs that form the multi-ARS complex (MSC). Using the ribopuromycylation method (RPM) for localizing intracellular translation, we show that FRS and the MSC, and to a lesser extent other ARSs, localize to translating ribosomes, most strikingly when translation is restricted to poxvirus or alphavirus factories in infected cells. Immunoproximity fluorescence indicates close proximity between MSC and the ribosome. Stress induced-translational shutdown recruits the MSC to stress-granules, a depot for mRNA and translation components. MSC binding to mRNA provides a facile explanation for its delivery to translating ribosomes and stress granules. These findings, along with the abundance of the MSC (9 x 10(6) copies per cell, roughly equimolar with ribosomes), is consistent with the idea that MSC specificity, recently reported to vary with cellular stress (Netzer, N., Goodenbour, J. M., David, A., Dittmar, K. A., Jones, R. B., Schneider, J. R., Boone, D., Eves, E. M., Rosner, M. R., Gibbs, J. S., Embry, A., Dolan, B., Das, S., Hickman, H. D., Berglund, P., Bennink, J. R., Yewdell, J. W., and Pan, T. (2009) Nature 462, 522-526) can be modulated at the level of individual mRNAs to modify decoding of specific gene products.	[Yewdell, Jonathan W.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; [Strader, Michael Brad; Chen, Cai Yun] NIMH, Lab Neurotoxicol, NIH, Bethesda, MD 20892 USA; [Pierre, Philippe] Ctr Immunol Marseille Luminy, Marseille, France	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Yewdell, JW (corresponding author), NIAID, Viral Dis Lab, NIH, Bldg 33,33 North Dr, Bethesda, MD 20892 USA.	jyewdell@nih.gov	David, Alexandre/B-2447-2013; yewdell, jyewdell@nih.gov jonathan/A-1702-2012; Das, Suman/ABB-7273-2020; David, Alexandre/AAL-2758-2021; chen, caiyun/HHY-7684-2022; Das, Suman R/C-8760-2009	David, Alexandre/0000-0003-3365-1339; Das, Suman/0000-0003-2496-9724; David, Alexandre/0000-0003-3365-1339; pierre, philippe/0000-0003-0863-8255	Division of Intramural Research, NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000542] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Division of Intramural Research, NIAID, National Institutes of Health.	BANDYOPADHYAY AK, 1971, J MOL BIOL, V60, P113, DOI 10.1016/0022-2836(71)90451-7; Blobel G, 2000, CHEMBIOCHEM, V1, P87; DUNCAN R, 1983, J BIOL CHEM, V258, P7228; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; GEELS J, 1971, ARCH BIOCHEM BIOPHYS, V144, P773, DOI 10.1016/0003-9861(71)90386-9; Griffing LR, 2010, BIOCHEM SOC T, V38, P747, DOI 10.1042/BST0380747; HAMPEL A, 1973, J MOL BIOL, V79, P285, DOI 10.1016/0022-2836(73)90006-5; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; Hovland R, 1996, INT J BIOCHEM CELL B, V28, P1089, DOI 10.1016/1357-2725(96)00059-3; Jansen RP, 1999, FASEB J, V13, P455, DOI 10.1096/fasebj.13.3.455; Kaminska M, 2009, J BIOL CHEM, V284, P13746, DOI 10.1074/jbc.M900480200; KAPPEN LS, 1973, P NATL ACAD SCI USA, V70, P22, DOI 10.1073/pnas.70.1.22; Katsafanas GC, 2007, CELL HOST MICROBE, V2, P221, DOI 10.1016/j.chom.2007.08.005; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; KELLERMANN O, 1979, EUR J BIOCHEM, V99, P541, DOI 10.1111/j.1432-1033.1979.tb13286.x; KERJAN P, 1994, BBA-GEN SUBJECTS, V1199, P293, DOI 10.1016/0304-4165(94)90009-4; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; Lelouard H, 2002, NATURE, V417, P177, DOI 10.1038/417177a; Lerner RS, 2006, RNA, V12, P775, DOI 10.1261/rna.2318906; Lev A, 2010, P NATL ACAD SCI USA, V107, P6964, DOI 10.1073/pnas.0910997107; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; McFarland MA, 2008, MOL CELL PROTEOMICS, V7, P2123, DOI 10.1074/mcp.M800116-MCP200; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; MIRANDE M, 1985, EXP CELL RES, V156, P91, DOI 10.1016/0014-4827(85)90264-2; MISETA A, 1991, J BIOL CHEM, V266, P19158; MOSYAK L, 1995, NAT STRUCT BIOL, V2, P537, DOI 10.1038/nsb0795-537; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; PAILLIEZ JP, 1984, J BIOL CHEM, V259, P5491; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; POPENKO VI, 1994, EUR J CELL BIOL, V65, P60; Potter MD, 2002, J BIOL CHEM, V277, P23314, DOI 10.1074/jbc.M202559200; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Pyhtila B, 2008, RNA, V14, P445, DOI 10.1261/rna.721108; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Remacha M, 1995, BIOCHEM CELL BIOL, V73, P959, DOI 10.1139/o95-103; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; SCHRAY B, 1991, NUCLEIC ACIDS RES, V19, P5307, DOI 10.1093/nar/19.19.5307; Slotta DJ, 2010, PROTEOMICS, V10, P3035, DOI 10.1002/pmic.200900370; SPIRIN AS, 1978, FEBS LETT, V88, P15, DOI 10.1016/0014-5793(78)80596-1; STAPULIONIS R, 1995, P NATL ACAD SCI USA, V92, P7158, DOI 10.1073/pnas.92.16.7158; Stephens SB, 2008, MOL BIOL CELL, V19, P623, DOI 10.1091/mbc.E07-07-0677; Stephens SB, 2007, METHOD ENZYMOL, V431, P47, DOI 10.1016/S0076-6879(07)31004-5; Stephens SB, 2005, MOL BIOL CELL, V16, P5819, DOI 10.1091/mbc.E05-07-0685; USSERY MA, 1977, EUR J BIOCHEM, V72, P491, DOI 10.1111/j.1432-1033.1977.tb11272.x; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008	50	60	60	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20688	20700		10.1074/jbc.M110.209452	http://dx.doi.org/10.1074/jbc.M110.209452			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21460219	Green Published, hybrid			2022-12-27	WOS:000291267600055
J	Song, CC; Rahim, RT; Davey, PC; Bednar, F; Bardi, G; Zhang, L; Zhang, N; Oppenheim, JJ; Rogers, TJ				Song, Changcheng; Rahim, Rahil T.; Davey, Penelope C.; Bednar, Filip; Bardi, Giuseppe; Zhang, Lily; Zhang, Ning; Oppenheim, Joost J.; Rogers, Thomas J.			Protein Kinase C zeta Mediates mu-Opioid Receptor-induced Cross-desensitization of Chemokine Receptor CCR5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROLOGOUS DESENSITIZATION; INDUCED CHEMOTAXIS; HUMAN-MONOCYTES; RAT ADIPOCYTES; IMMUNE-SYSTEM; PKC-ZETA; ACTIVATION; TRANSLOCATION; 3-KINASE; CELLS	We have previously shown that the mu-opioid receptor (MOR) is capable of mediating cross-desensitization of several chemokine receptors including CCR5, but the biochemical mechanism of this process has not been fully elucidated. We have carried out a series of functional and biochemical studies and found that the mechanism of MOR-induced cross-desensitization of CCR5 involves the activation of PKC zeta. Inhibition of PKC zeta by its pseudosubstrate inhibitor, or its siRNA, or dominant negative mutants suppresses the cross-desensitization of CCR5. Our results further indicate that the activation of PKC zeta is mediated through a pathway involving phosphoinositol-dependent kinase-1 (PDK1). In addition, activation of MOR elevates the phosphorylation level and kinase activity of PKC zeta. The phosphorylation of PKC zeta can be suppressed by a dominant negative mutant of PDK1. We observed that following MOR activation, the interaction between PKC zeta and PDK1 is immediately increased based on the analysis of fluorescent resonance energy transfer in cells with the expression of PKC zeta-YFP and PDK1-CFP. In addition, cells expressing PKC zeta kinase motif mutants (Lys-281, Thr-410, Thr-560) fail to exhibit full MOR-induced desensitization of CCR5 activity. Taken together, we propose that upon DAMGO treatment, MOR activates PKC zeta through a PDK1-dependent signaling pathway to induce CCR5 phosphorylation and desensitization. Because CCR5 is a highly proinflammatory receptor, and a critical coreceptor for HIV-1, these results may provide a novel approach for the development of specific therapeutic agents to treat patients with certain inflammatory diseases or AIDS.	[Song, Changcheng; Rahim, Rahil T.; Davey, Penelope C.; Bardi, Giuseppe; Zhang, Lily; Rogers, Thomas J.] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA; [Bednar, Filip] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Zhang, Ning; Oppenheim, Joost J.] NCI, Mol Immunoregulat Lab, Div Basic Sci, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Rogers, TJ (corresponding author), Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Ctr Subst Abuse Res, 3307 N Broad St, Philadelphia, PA 19140 USA.	rogerst@temple.edu	Bardi, Giuseppe/B-6452-2013; Bardi, Giuseppe/K-7057-2019	Bardi, Giuseppe/0000-0001-9662-3007; Bardi, Giuseppe/0000-0001-9662-3007	National Institutes of Health, NIDA [DA-14230, DA-25532, P01DA-23860, P30DA-13429, T32DA-07237, DA-06650]; NATIONAL CANCER INSTITUTE [ZIABC010708] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA013429, R01DA006650, T32DA007237, R01DA014230, P01DA023860, R01DA025532] Funding Source: NIH RePORTER	National Institutes of Health, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA-14230, DA-25532, P01DA-23860, P30DA-13429, T32DA-07237, and DA-06650 from NIDA.	Ali H, 1999, J BIOL CHEM, V274, P6027, DOI 10.1074/jbc.274.10.6027; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Chen CG, 2004, EUR J PHARMACOL, V483, P175, DOI 10.1016/j.ejphar.2003.10.033; Choi Y, 1999, IN VIVO, V13, P389; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Diaz-Meco MT, 2001, MOL CELL BIOL, V21, P1218, DOI 10.1128/MCB.21.4.1218-1227.2001; Eisenstein TK, 1998, J NEUROIMMUNOL, V83, P36, DOI 10.1016/S0165-5728(97)00219-1; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; GalveRoperh I, 1997, FEBS LETT, V415, P271, DOI 10.1016/S0014-5793(97)00985-X; Grimm MC, 1998, ANN NY ACAD SCI, V840, P9, DOI 10.1111/j.1749-6632.1998.tb09544.x; Grimm MC, 1998, J EXP MED, V188, P317, DOI 10.1084/jem.188.2.317; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Hu SX, 2000, J PSYCHOPHARMACOL, V14, P238, DOI 10.1177/026988110001400307; KAZANIETZ MG, 1993, MOL PHARMACOL, V44, P298; Laudanna C, 1998, J BIOL CHEM, V273, P30306, DOI 10.1074/jbc.273.46.30306; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Le YY, 2001, CLIN IMMUNOL, V99, P365, DOI 10.1006/clim.2001.5021; Macey TA, 2006, J BIOL CHEM, V281, P34515, DOI 10.1074/jbc.M604278200; Madden JJ, 1998, J NEUROIMMUNOL, V83, P57, DOI 10.1016/S0165-5728(97)00221-X; Mamidipudi V, 2002, J NEUROSCI RES, V68, P373, DOI 10.1002/jnr.10244; Mandyam CD, 2003, J PHARMACOL EXP THER, V306, P965, DOI 10.1124/jpet.103.051599; Martin P, 2005, P NATL ACAD SCI USA, V102, P9866, DOI 10.1073/pnas.0501202102; McCarthy L, 2001, DRUG ALCOHOL DEPEN, V62, P111, DOI 10.1016/S0376-8716(00)00181-2; McPherson J, 2010, MOL PHARMACOL, V78, P756, DOI 10.1124/mol.110.066613; Nasser MW, 2005, J IMMUNOL, V174, P6927, DOI 10.4049/jimmunol.174.11.6927; Noda Y, 2003, J BIOL CHEM, V278, P43516, DOI 10.1074/jbc.M306330200; PEREZCASTRILLON JL, 1992, IMMUNOPHARMACOLOGY, V23, P57, DOI 10.1016/0162-3109(92)90009-2; Peterson PK, 1998, J NEUROIMMUNOL, V83, P63, DOI 10.1016/S0165-5728(97)00222-1; Pollok-Kopp B, 2003, J BIOL CHEM, V278, P2190, DOI 10.1074/jbc.M209844200; Rubino T, 2006, MOL NEUROBIOL, V33, P199, DOI 10.1385/MN:33:3:199; RUFF MR, 1985, NEUROPEPTIDES, V5, P363, DOI 10.1016/0143-4179(85)90029-0; Sharp BM, 1998, J NEUROIMMUNOL, V83, P45, DOI 10.1016/S0165-5728(97)00220-8; Shen WP, 2000, BLOOD, V96, P2887, DOI 10.1182/blood.V96.8.2887.h8002887_2887_2894; Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Steele AD, 2002, CYTOKINE GROWTH F R, V13, P209, DOI 10.1016/S1359-6101(02)00007-2; Szabo I, 2003, J LEUKOCYTE BIOL, V74, P1074, DOI 10.1189/jlb.0203067; Szabo I, 2002, P NATL ACAD SCI USA, V99, P10276, DOI 10.1073/pnas.102327699; Szabo I, 2001, ADV EXP MED BIOL, V493, P75; TUBARO E, 1985, INT J IMMUNOPHARMACO, V7, P865, DOI 10.1016/0192-0561(85)90049-9; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Zhang N, 2003, J BIOL CHEM, V278, P12729, DOI 10.1074/jbc.M300430200	45	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20354	20365		10.1074/jbc.M110.177303	http://dx.doi.org/10.1074/jbc.M110.177303			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21454526	Green Published, hybrid			2022-12-27	WOS:000291267600023
J	Gupta-Rossi, N; Ortica, S; Meas-Yedid, V; Heuss, S; Moretti, J; Olivo-Marin, JC; Israel, A				Gupta-Rossi, Neetu; Ortica, Sara; Meas-Yedid, Vannary; Heuss, Sara; Moretti, Julien; Olivo-Marin, Jean-Christophe; Israel, Alain			The Adaptor-associated Kinase 1, AAK1, Is a Positive Regulator of the Notch Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; INTRACELLULAR DOMAIN; PLASMA-MEMBRANE; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; CELL-MIGRATION; IN-VIVO; RECEPTOR; PROTEIN; NUMB	The Notch pathway is involved in cell-cell signaling during development and adulthood from invertebrates to higher eukaryotes. Activation of the Notch receptor by its ligands relies upon a multi-step processing. The extracellular part of the receptor is removed by a metalloprotease of the ADAM family and the remaining fragment is cleaved within its transmembrane domain by a presenilin-dependent gamma-secretase activity. gamma-Secretase processing of Notch has been shown to depend upon monoubiquitination as well as clathrin-mediated endocytosis (CME). We show here that AAK1, the adaptor-associated kinase 1, directly interacts with the membrane-tethered active form of Notch released by metalloprotease cleavage. Active AAK1 acts upstream of the gamma-secretase cleavage by stabilizing both the membrane-tethered activated form of Notch and its monoubiquitinated counterpart. We propose that AAK1 acts as an adaptor for Notch interaction with components of the clathrin-mediated pathway such as Eps15b. Moreover, transfected AAK1 increases the localization of activated Notch to Rab5-positive endocytic vesicles, while AAK1 depletion or overexpression of Numb, an inhibitor of the pathway, interferes with this localization. These results suggest that after ligand-induced activation of Notch, the membrane-tethered form can be directed to different endocytic pathways leading to distinct fates.	[Gupta-Rossi, Neetu; Ortica, Sara; Heuss, Sara; Moretti, Julien; Israel, Alain] Inst Pasteur, Unite Signalisat Mol & Activat Cellulair, CNRS URA 2582, F-75724 Paris 15, France; [Meas-Yedid, Vannary; Olivo-Marin, Jean-Christophe] Inst Pasteur, Unite Anal Images Quantitat, CNRS URA 2582, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Gupta-Rossi, N (corresponding author), Inst Pasteur, Unite Signalisat Mol & Activat Cellulair, CNRS URA 2582, 25 Rue Dr Roux, F-75724 Paris 15, France.	neetu.gupta@pasteur.fr	Olivo-Marin, Jean-Christophe/K-4428-2015; Gupta-Rossi, Neetu/AAE-3117-2022	Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; Gupta-Rossi, Neetu/0000-0003-0043-264X; Moretti, Julien/0000-0002-3415-9058	EC; DIM	EC(European CommissionEuropean Commission Joint Research Centre); DIM	This work was supported in part by the Rubicon EC FP6 Grant and a DIM Stem-Pole grant (to S. O.).	Benmerah A, 1995, J CELL BIOL, V131, P1831, DOI 10.1083/jcb.131.6.1831; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; Chien CT, 1998, MOL CELL BIOL, V18, P598, DOI 10.1128/MCB.18.1.598; Childress JL, 2006, CURR BIOL, V16, P2228, DOI 10.1016/j.cub.2006.09.031; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; Conner SD, 2003, TRAFFIC, V4, P885, DOI 10.1046/j.1398-9219.2003.0142.x; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Fares H, 1999, GENETICS, V153, P1641; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Henderson DM, 2007, MOL BIOL CELL, V18, P2698, DOI 10.1091/mbc.E06-09-0831; Heuss SF, 2008, P NATL ACAD SCI USA, V105, P11212, DOI 10.1073/pnas.0800695105; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x; Jackson AP, 2003, J CELL BIOL, V163, P231, DOI 10.1083/jcb.200304079; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jha A, 2004, J BIOL CHEM, V279, P2281, DOI 10.1074/jbc.M305644200; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Morgan JR, 2000, J NEUROSCI, V20, P8667; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Owen DJ, 2000, CURR OPIN CELL BIOL, V12, P467, DOI 10.1016/S0955-0674(00)00118-6; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Roxrud I, 2008, J CELL BIOL, V180, P1205, DOI 10.1083/jcb.200708115; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Seugnet L, 1997, DEV BIOL, V192, P585, DOI 10.1006/dbio.1997.8723; Shaye DD, 2002, NATURE, V420, P686, DOI 10.1038/nature01234; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Six EM, 2004, J BIOL CHEM, V279, P55818, DOI 10.1074/jbc.M408022200; Sorensen EB, 2008, TRAFFIC, V9, P1791, DOI 10.1111/j.1600-0854.2008.00790.x; Sorensen EB, 2010, TRAFFIC, V11, P1234, DOI 10.1111/j.1600-0854.2010.01090.x; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Tokumitsu H, 2006, FEBS LETT, V580, P5797, DOI 10.1016/j.febslet.2006.09.043; Umeda A, 2000, EUR J CELL BIOL, V79, P336, DOI 10.1078/S0171-9335(04)70037-0; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Wendland B, 2002, NAT REV MOL CELL BIO, V3, P971, DOI 10.1038/nrm970; Wilkin M, 2008, DEV CELL, V15, P762, DOI 10.1016/j.devcel.2008.09.002; Windler SL, 2010, CURR BIOL, V20, P538, DOI 10.1016/j.cub.2010.01.049; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yamamoto S, 2010, CURR TOP DEV BIOL, V92, P165, DOI 10.1016/S0070-2153(10)92005-X	64	30	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18720	18730		10.1074/jbc.M110.190769	http://dx.doi.org/10.1074/jbc.M110.190769			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21464124	Green Published, hybrid			2022-12-27	WOS:000290785700045
J	Togi, S; Ikeda, O; Kamitani, S; Nakasuji, M; Sekine, Y; Muromoto, R; Nanbo, A; Oritani, K; Kawai, T; Akira, S; Matsuda, T				Togi, Sumihito; Ikeda, Osamu; Kamitani, Shinya; Nakasuji, Misa; Sekine, Yuichi; Muromoto, Ryuta; Nanbo, Asuka; Oritani, Kenji; Kawai, Taro; Akira, Shizuo; Matsuda, Tadashi			Zipper-interacting Protein Kinase (ZIPK) Modulates Canonical Wnt/beta-Catenin Signaling through Interaction with Nemo-like Kinase and T-cell Factor 4 (NLK/TCF4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; TRANSCRIPTION FACTOR; BINDING PROTEIN; SERINE/THREONINE KINASE; FUNCTIONAL INTERACTIONS; APOPTOSIS; PATHWAY; TARGET; TCF; PHOSPHORYLATION	Zipper-interacting protein kinase (ZIPK) is a widely expressed serine/threonine kinase that has been implicated in apoptosis and transcriptional regulation. Here, we identified Nemo-like kinase (NLK) as a novel ZIPK-binding partner and found that ZIPK regulates NLK-mediated repression of canonical Wnt/beta-catenin signaling. Indeed, siRNA-mediated reduction of endogenous ZIPK expression reduced Wnt/beta-catenin signaling. Furthermore, ZIPK affected the formation of NLK-T-cell factor 4 (TCF4) complex. Importantly, ZIPK siRNA treatment in human colon carcinoma cells resulted in a reduction of beta-catenin/TCF-mediated gene expression and cell growth. These results indicate that ZIPK may serve as a transcriptional regulator of canonical Wnt/beta-catenin signaling through interaction with NLK/TCF4.	[Matsuda, Tadashi] Hokkaido Univ, Dept Immunol, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Oritani, Kenji] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan; [Kawai, Taro; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan	Hokkaido University; Osaka University; Osaka University	Matsuda, T (corresponding author), Hokkaido Univ, Dept Immunol, Grad Sch Pharmaceut Sci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	tmatsuda@pharm.hokudai.ac.jp	Matsuda, Tadashi/A-3835-2012; Togi, Sumihito/ABH-6734-2020; Nanbo, Asuka/P-2478-2019; Muromoto, Ryuta/E-4203-2012; Nanbo, Asuka/C-6630-2012; Akira, Shizuo/C-3134-2009; Sekine, Yuichi/S-8813-2019	Matsuda, Tadashi/0000-0002-3089-3757; Nanbo, Asuka/0000-0001-8764-1350; Muromoto, Ryuta/0000-0002-7474-493X; Nanbo, Asuka/0000-0001-8764-1350; Sekine, Yuichi/0000-0002-2861-603X; Togi, Sumihito/0000-0002-3189-8111; Kawai, Taro/0000-0001-7510-4662	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Barre B, 2005, J BIOL CHEM, V280, P15673, DOI 10.1074/jbc.M413203200; Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Hecht A, 1999, J BIOL CHEM, V274, P18017, DOI 10.1074/jbc.274.25.18017; Ikeda O, 2008, MOL CELL BIOL, V28, P5027, DOI 10.1128/MCB.00194-08; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Kawai T, 2003, MOL CELL BIOL, V23, P6174, DOI 10.1128/MCB.23.17.6174-6186.2003; Kawai T, 1998, MOL CELL BIOL, V18, P1642, DOI 10.1128/MCB.18.3.1642; Kogel D, 1998, ONCOGENE, V17, P2645, DOI 10.1038/sj.onc.1202204; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Matsuda T, 2004, BIOCHEM BIOPH RES CO, V325, P586, DOI 10.1016/j.bbrc.2004.10.071; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; McGargill MA, 2004, IMMUNITY, V21, P781, DOI 10.1016/j.immuni.2004.10.008; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Muromoto R, 2006, J IMMUNOL, V177, P1160, DOI 10.4049/jimmunol.177.2.1160; Ohbayashi N, 2008, BIOCHEM BIOPH RES CO, V372, P708, DOI 10.1016/j.bbrc.2008.05.113; Polakis P, 2000, GENE DEV, V14, P1837; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Rottinger E, 2006, DEVELOPMENT, V133, P4341, DOI 10.1242/dev.02603; Sato N, 2006, IMMUNOL LETT, V103, P127, DOI 10.1016/j.imlet.2005.10.015; Sato N, 2005, INT IMMUNOL, V17, P1543, DOI 10.1093/intimm/dxh331; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Stevens C, 2009, J BIOL CHEM, V284, P334, DOI 10.1074/jbc.M805165200; Tago K, 2000, GENE DEV, V14, P1741; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Topol LL, 2009, J BIOL CHEM, V284, P3323, DOI 10.1074/jbc.M808048200; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wu YY, 2010, J BIOL CHEM, V285, P34621, DOI 10.1074/jbc.M110.148791; Yamada M, 2006, J BIOL CHEM, V281, P20749, DOI 10.1074/jbc.M602089200	33	25	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19170	19177		10.1074/jbc.M110.189829	http://dx.doi.org/10.1074/jbc.M110.189829			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454679	Green Published, hybrid			2022-12-27	WOS:000290785700086
J	Holm, J; Ferreras, M; Ipsen, H; Wurtzen, PA; Gajhede, M; Larsen, JN; Lund, K; Spangfort, MD				Holm, Jens; Ferreras, Mercedes; Ipsen, Henrik; Wurtzen, Peter A.; Gajhede, Michael; Larsen, Jorgen N.; Lund, Kaare; Spangfort, Michael D.			Epitope Grafting, Re-creating a Conformational Bet v 1 Antibody Epitope on the Surface of the Homologous Apple Allergen Mal d 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIRCH POLLEN ALLERGEN; CROSS-REACTIVITY; MAJOR ALLERGENS; IMMUNOCHEMICAL CHARACTERIZATION; MOLECULAR-BASIS; IGE-BINDING; PRU AV-1; X-RAY; AVIUM	Birch-allergic patients often experience oral allergy syndrome upon ingestion of vegetables and fruits, most prominently apple, that is caused by antibody cross-reactivity of the IgE antibodies in patients to proteins sharing molecular surface structures with the major birch pollen group 1 allergen from Betula verrucosa (Bet v 1). Still, to what extent two molecular surfaces need to be similar for clinically relevant antibody cross-reactivity to occur is unknown. Here, we describe the grafting of a defined conformational antibody epitope from Bet v 1 onto the surface of the homologous apple allergen Malus domestica group 1 (Mal d 1). Engineering of the epitope was accomplished by genetic engineering substituting amino acid residues in Mal d 1 differing between Bet v 1 and Mal d 1 within the epitope defined by the mAb BV16. The kinetic parameters characterizing the antibody binding interaction to Bet v 1 and to the mutated Mal d 1 variant, respectively, were assessed by Biacore experiments demonstrating indistinguishable binding kinetics. This demonstrates that a conformational epitope defined by a high affinity antibody-allergen interaction can successfully be grafted onto a homologous scaffold molecule without loss of epitope functionality. Furthermore, we show that increasing surface similarity to Bet v 1 of Mal d 1 variants by substitution of 6-8 residues increased the ability to trigger basophil histamine release with blood from birch-allergic patients not responding to natural Mal d 1. Conversely, reducing surface similarity to Bet v 1 of a Mal d 1 variant by substitution of three residues abolished histamine release in one patient reacting to Mal d 1.	[Holm, Jens; Ferreras, Mercedes; Ipsen, Henrik; Wurtzen, Peter A.; Larsen, Jorgen N.; Lund, Kaare; Spangfort, Michael D.] ALK ABELLO, Res Dept, DK-2970 Horsholm, Denmark; [Gajhede, Michael] Univ Copenhagen, Fac Pharmaceut Sci, Dept Med Chem, DK-2100 Copenhagen, Denmark	ALK-Abello AS; University of Copenhagen	Larsen, JN (corresponding author), ALK ABELLO, Dept Expt Immunol, Boge Alle 6-8, DK-2970 Horsholm, Denmark.	jhodk@alk-abello.com	Larsen, Jørgen Nedergaard/AAI-3423-2020	Gajhede, Michael/0000-0001-9864-2287				Aalberse RC, 2001, ALLERGY, V56, P27, DOI 10.1034/j.1398-9995.2001.00909.x; Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x; Alam R., 2009, ALLERGY ALLERGIC DIS, V1, P203; Alexander C, 2005, CLIN EXP ALLERGY, V35, P52, DOI 10.1111/j.1365-2222.2005.02143.x; AMLOT PL, 1987, CLIN ALLERGY, V17, P33, DOI 10.1111/j.1365-2222.1987.tb02317.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ausucua M, 2009, MED ORAL PATOL ORAL, V14, pE568, DOI 10.4317/medoral.14.e568; Bousquet J, 1998, ALLERGY, V53, P4; Braden BC, 1995, ANN NY ACAD SCI, V764, P315; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; EBNER C, 1991, J ALLERGY CLIN IMMUN, V88, P588, DOI 10.1016/0091-6749(91)90152-E; Flicker S, 2003, INT ARCH ALLERGY IMM, V132, P13, DOI 10.1159/000073260; Fritsch R, 1998, J ALLERGY CLIN IMMUN, V102, P679, DOI 10.1016/S0091-6749(98)70287-8; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; HANNUKSELA M, 1977, CONTACT DERMATITIS, V3, P79, DOI 10.1111/j.1600-0536.1977.tb03603.x; Holm J, 2004, J IMMUNOL, V173, P5258, DOI 10.4049/jimmunol.173.8.5258; Holm J, 2001, J CHROMATOGR B, V756, P307, DOI 10.1016/S0378-4347(01)00089-5; IPSEN H, 1985, ALLERGY, V40, P510, DOI 10.1111/j.1398-9995.1985.tb00259.x; IPSEN H, 1983, J ALLERGY CLIN IMMUN, V72, P150, DOI 10.1016/0091-6749(83)90523-7; IPSEN H, 1992, CLIN EXP ALLERGY, V22, P391, DOI 10.1111/j.1365-2222.1992.tb03101.x; Jahn-Schmid B, 2005, J ALLERGY CLIN IMMUN, V116, P213, DOI 10.1016/j.jaci.2005.04.019; Jogi R, 1998, CLIN EXP ALLERGY, V28, P1072; Larsen Jorgen Nedergaard, 2004, Clin Allergy Immunol, V18, P433; LICHTENSTEIN LM, 1968, J IMMUNOL, V101, P317; Linneberg A, 2007, CLIN EXP ALLERGY, V37, P1137, DOI 10.1111/j.1365-2222.2007.02760.x; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Neudecker P, 2003, BIOCHEM J, V376, P97, DOI 10.1042/BJ20031057; Norman PS, 1996, AM J RESP CRIT CARE, V154, P1623, DOI 10.1164/ajrccm.154.6.8970345; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; Spangfort MD, 1996, PROTEIN EXPRES PURIF, V8, P365, DOI 10.1006/prep.1996.0112; Vieths S, 2002, ANN NY ACAD SCI, V964, P47; Wiche R, 2005, BIOCHEM J, V385, P319, DOI 10.1042/BJ20040842	33	30	31	5	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17569	17578		10.1074/jbc.M110.194878	http://dx.doi.org/10.1074/jbc.M110.194878			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454600	Green Published, hybrid			2022-12-27	WOS:000290585200019
J	Hong, M; Wilkes, MC; Penheiter, SG; Gupta, SK; Edens, M; Leof, EB				Hong, Min; Wilkes, Mark C.; Penheiter, Sumedha G.; Gupta, Shiv K.; Edens, Maryanne; Leof, Edward B.			Non-Smad Transforming Growth Factor-beta Signaling Regulated by Focal Adhesion Kinase Binding the p85 Subunit of Phosphatidylinositol 3-Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; MESENCHYMAL TRANSITION; CELL-PROLIFERATION; TYROSINE KINASE; FERM DOMAIN; C-ABL; INTEGRIN; FAK; ACTIVATION; CANCER	TGF-beta modulates numerous diverse cellular phenotypes including growth arrest in epithelial cells and proliferation in fibroblasts. Although the Smad pathway is fundamental for the majority of these responses, recent evidence indicates that non-Smad pathways may also have a critical role. Here we report a novel mechanism whereby the nonreceptor tyrosine focal adhesion kinase (FAK) functions as an adaptor necessary for cell type-specific responses to TGF-beta. We show that in contrast to Smad actions, non-Smad pathways, including c-Abl, PAK2, and Akt, display an obligate requirement for FAK. Interestingly, this occurs in Src null SYF cells and is independent of FAK tyrosine phosphorylation, kinase activity, and/or proline-rich sequences in the C-terminal FAT domain. FAK binds the phosphatidylinositol 3-kinase (PI3K) p85 regulatory subunit following TGF-beta treatment in a subset of fibroblasts but not epithelial cells and has an obligate role in TGF-beta-stimulated anchorage-independent growth and migration. Together, these results uncover a new scaffolding role for FAK as the most upstream component regulating the profibrogenic action of TGF-beta and suggest that inhibiting this interaction may be useful in treating a number of fibrotic diseases.	[Leof, Edward B.] Mayo Clin, Mayo Clin Canc Ctr, Thorac Dis Res Unit, Dept Biochem Mol Biol, Rochester, MN 55905 USA; Mayo Clin, Mayo Clin Canc Ctr, Thorac Dis Res Unit, Dept Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Leof, EB (corresponding author), Mayo Clin, Mayo Clin Canc Ctr, Thorac Dis Res Unit, Dept Biochem Mol Biol, Stabile 8-58,200 1st St SW, Rochester, MN 55905 USA.	leof.edward@mayo.edu		Wilkes, Mark/0000-0002-9600-6831	Public Health Service from the National Institute of General Medical Sciences [GM-54200, GM-55816]; Scleroderma Foundation; Mayo Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055816, R01GM054200, R37GM055816] Funding Source: NIH RePORTER	Public Health Service from the National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Scleroderma Foundation; Mayo Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service Grants GM-54200 and GM-55816 from the National Institute of General Medical Sciences, the Scleroderma Foundation, and the Mayo Foundation (to E. B. L.).	AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Berking C, 2001, CANCER RES, V61, P8306; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Davidson L, 2004, J BIOL CHEM, V279, P1980, DOI 10.1074/jbc.M309827200; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dunty JM, 2004, MOL CELL BIOL, V24, P5353, DOI 10.1128/MCB.24.12.5353-5368.2004; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Genua M, 2009, VITAM HORM, V80, P77, DOI 10.1016/S0083-6729(08)00604-3; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Korc M, 2007, AM J SURG, V194, pS84, DOI 10.1016/j.amjsurg.2007.05.004; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Lim ST, 2008, CELL CYCLE, V7, P2306, DOI 10.4161/cc.6367; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Liu SX, 2007, MOL BIOL CELL, V18, P2169, DOI 10.1091/mbc.E06-12-1121; Lohr M, 2001, CANCER RES, V61, P550; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Parsons JT, 1996, CURR OPIN CELL BIOL, V8, P146, DOI 10.1016/S0955-0674(96)80059-7; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rahimi RA, 2009, CANCER RES, V69, P84, DOI 10.1158/0008-5472.CAN-08-2146; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Walsh MF, 2009, BBA-GENE REGUL MECH, V1789, P88, DOI 10.1016/j.bbagrm.2008.11.002; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; Wilkes MC, 2006, J BIOL CHEM, V281, P27846, DOI 10.1074/jbc.M603721200; Wilkes MC, 2009, DEV CELL, V16, P433, DOI 10.1016/j.devcel.2009.01.009; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Wilkes MC, 2003, MOL CELL BIOL, V23, P8878, DOI 10.1128/MCB.23.23.8878-8889.2003; Wisniewska M, 2005, J MOL BIOL, V347, P1005, DOI 10.1016/j.jmb.2005.02.017; Yue JB, 2001, PHARMACOL THERAPEUT, V91, P1, DOI 10.1016/S0163-7258(01)00143-7; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	52	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17841	17850		10.1074/jbc.M111.233676	http://dx.doi.org/10.1074/jbc.M111.233676			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454615	Green Published, hybrid			2022-12-27	WOS:000290585200047
J	Lovelace, LL; Cooper, CL; Sodetz, JM; Lebioda, L				Lovelace, Leslie L.; Cooper, Christopher L.; Sodetz, James M.; Lebioda, Lukasz			Structure of Human C8 Protein Provides Mechanistic Insight into Membrane Pore Formation by Complement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ATTACK COMPLEX; 8TH COMPONENT; MACPF DOMAIN; BINDING-SITE; C8-GAMMA; C8-ALPHA; SUBUNIT; REVEALS; FAMILY	C8 is one of five complement proteins that assemble on bacterial membranes to form the lethal pore-like "membrane attack complex" (MAC) of complement. TheMACconsists of one C5b, C6, C7, and C8 and 12-18 molecules of C9. C8 is composed of three genetically distinct subunits, C8 alpha, C8 beta, and C8 gamma. The C6, C7, C8 alpha, C8 beta, and C9 proteins are homologous and together comprise the MAC family of proteins. All contain N- and C-terminal modules and a central 40-kDa membrane attack complex perforin (MACPF) domain that has a key role in forming the MACpore. Here, we report the 2.5A resolution crystal structure of human C8 purified from blood. This is the first structure of a MAC family member and of a human MACPF-containing protein. The structure shows the modules in C8 alpha and C8 beta are located on the periphery of C8 and not likely to interact with the target membrane. The C8 gamma subunit, a member of the lipocalin family of proteins that bind and transport small lipophilic molecules, shows no occupancy of its putative ligand-binding site. C8 alpha and C8 beta are related by a rotation of similar to 22 degrees with only a small translational component along the rotation axis. Evolutionary arguments suggest the geometry of binding between these two subunits is similar to the arrangement of C9 molecules within the MAC pore. This leads to a model of the MAC that explains how C8-C9 and C9-C9 interactions could facilitate refolding and insertion of putative MACPF transmembrane beta-hairpins to form a circular pore.	[Lovelace, Leslie L.; Cooper, Christopher L.; Sodetz, James M.; Lebioda, Lukasz] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Sodetz, JM (corresponding author), Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA.	sodetz@mail.chem.sc.edu; lebioda@mail.chem.sc.edu			National Institutes of Health [GM042898]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM042898 (to J. M. S.).	Aybar L, 2009, FISH SHELLFISH IMMUN, V27, P397, DOI 10.1016/j.fsi.2009.05.020; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brannen CL, 2007, MOL IMMUNOL, V44, P960, DOI 10.1016/j.molimm.2006.03.012; BRICKNER A, 1985, BIOCHEMISTRY-US, V24, P4603, DOI 10.1021/bi00338a019; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DEBEER T, 1995, BIOCHEMISTRY-US, V34, P11785, DOI 10.1021/bi00037a016; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DiScipio RG, 1999, MOL IMMUNOL, V36, P575, DOI 10.1016/S0161-5890(99)00073-5; DISCIPIO RG, 1991, J IMMUNOL, V147, P4239; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSER AF, 1994, TOXICOLOGY, V87, P229, DOI 10.1016/0300-483X(94)90253-4; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Hofsteenge J, 1999, J BIOL CHEM, V274, P32786, DOI 10.1074/jbc.274.46.32786; HOROWITZ N. H., 1965, P15; HOROWITZ NH, 1945, P NATL ACAD SCI USA, V31, P153, DOI 10.1073/pnas.31.6.153; Huang Y, 2006, J BIOL CHEM, V281, P27398, DOI 10.1074/jbc.M603690200; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; LEBIODA L, 1988, NATURE, V333, P683, DOI 10.1038/333683a0; Lebioda L, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P233; Lengweiler S, 1996, FEBS LETT, V380, P8, DOI 10.1016/0014-5793(95)01541-8; LOCKERT DH, 1995, J BIOL CHEM, V270, P19723, DOI 10.1074/jbc.270.34.19723; Lu HS, 2001, J BIOL CHEM, V276, P34913, DOI 10.1074/jbc.M102874200; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NG SC, 1987, BIOCHEMISTRY-US, V26, P5229, DOI 10.1021/bi00391a003; NINOMIYA H, 1992, J BIOL CHEM, V267, P13675; Ortlund E, 2002, BIOCHEMISTRY-US, V41, P7030, DOI 10.1021/bi025696i; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paakkonen K., 2006, PROTEINS, V64, P1268; Parker CL, 2002, MOL IMMUNOL, V39, P453, DOI 10.1016/S0161-5890(02)00121-9; Plumb ME, 2000, BIOCHEMISTRY-US, V39, P13078, DOI 10.1021/bi001451z; PLUMB ME, 1998, HUMAN COMPLEMENT SYS, P119; PODACK ER, 1991, ANNU REV IMMUNOL, V9, P129, DOI 10.1146/annurev.iy.09.040191.001021; Ponting CP, 1999, CURR BIOL, V9, pR911, DOI 10.1016/S0960-9822(00)80102-5; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Rossjohn J, 2007, J MOL BIOL, V367, P1227, DOI 10.1016/j.jmb.2007.01.042; ROUSSEL A, 1991, TURBO FRODO SILICON; Schreck SF, 1998, J IMMUNOL, V161, P311; Slade DJ, 2008, J MOL BIOL, V379, P331, DOI 10.1016/j.jmb.2008.03.061; Slade DJ, 2006, BIOCHEMISTRY-US, V45, P5290, DOI 10.1021/bi0601860; STECKEL EW, 1983, J BIOL CHEM, V258, P4318; STECKEL EW, 1980, J BIOL CHEM, V255, P1997; Tang LY, 2007, MOL CELL PROTEOMICS, V6, P1952, DOI 10.1074/mcp.M700120-MCP200; Teichmann SA, 2001, J MOL BIOL, V311, P693, DOI 10.1006/jmbi.2001.4912; Thai CT, 2004, J IMMUNOL, V173, P4547, DOI 10.4049/jimmunol.173.7.4547; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1297, DOI 10.1107/S1744309110023055; ZALMAN LS, 1990, MOL IMMUNOL, V27, P533, DOI 10.1016/0161-5890(90)90072-8	56	73	75	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17585	17592		10.1074/jbc.M111.219766	http://dx.doi.org/10.1074/jbc.M111.219766			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454577	Green Published			2022-12-27	WOS:000290585200021
J	Xu, DS; Meyer, F; Ehlers, E; Blasnitz, L; Zhang, LW				Xu, Dongsheng; Meyer, Florencia; Ehlers, Erica; Blasnitz, Laura; Zhang, Luwen			Interferon Regulatory Factor 4 (IRF-4) Targets IRF-5 to Regulate Epstein-Barr Virus Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; T-CELL LEUKEMIA; HUMAN B-CELLS; KAPOSIS-SARCOMA; TRANSCRIPTION FACTOR; LATENT MEMBRANE-PROTEIN-1; INDUCED APOPTOSIS; MULTIPLE-MYELOMA; GENE-EXPRESSION; DNA	The cellular interferon regulatory factor-4 (IRF-4), which is a member of IRF family, is involved in the development of multiple myeloma and Epstein-Barr virus (EBV)-mediated transformation of B lymphocytes. However, the molecular mechanism of IRF-4 in cellular transformation is unknown. We have found that knockdown of IRF-4 leads to high expression of IRF-5, a pro-apoptotic member in the IRF family. Overexpression of IRF-4 represses IRF-5 expression. Reduction of IRF-4 leads to growth inhibition, and the restoration of IRF-4 by exogenous plasmids correlates with the growth recovery and reduces IRF-5 expression. In addition, IRF-4 negatively regulates IRF-5 promoter reporter activities and binds to IRF-5 promoters in vivo and in vitro. Knockdown of IRF-5 rescues IRF-4 knockdown-mediated growth inhibition, and IRF-5 overexpression alone is sufficient to induce cellular growth inhibition of EBV-transformed cells. Therefore, IRF-5 is one of the targets of IRF-4, and IRF-4 regulates the growth of EBV-transformed cells partially through IRF-5. This work provides insight on how IRFs interact with one another to participate in viral pathogenesis and transformation.	[Xu, Dongsheng; Meyer, Florencia; Ehlers, Erica; Blasnitz, Laura; Zhang, Luwen] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Zhang, Luwen] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Zhang, LW (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Morrison Ctr 238, 4240 Fair St, Lincoln, NE 68583 USA.	lzhang2@unlnotes.unl.edu	Meyer, Florencia/V-3406-2019		National Institutes of Health [CA138213, CA108951]; NCRR [RR15635]; IDeA Networks of Biomedical Research Excellence; NATIONAL CANCER INSTITUTE [R01CA108951, R01CA138213] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); IDeA Networks of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA138213 and CA108951 and Grant RR15635 from NCRR (to L. Z.).; Supported in part by the IDeA Networks of Biomedical Research Excellence.	Acquaviva J, 2008, BLOOD, V112, P3798, DOI 10.1182/blood-2007-10-117838; Alexander L, 2000, J VIROL, V74, P3388, DOI 10.1128/JVI.74.7.3388-3398.2000; ALLDAY MJ, 1995, EMBO J, V14, P1382, DOI 10.1002/j.1460-2075.1995.tb07124.x; Altmann M, 2005, PLOS BIOL, V3, P2148, DOI 10.1371/journal.pbio.0030404; Barnes BJ, 2003, CANCER RES, V63, P6424; Bellows DS, 2002, J VIROL, V76, P2469, DOI 10.1128/JVI.76.5.2469-2479.2002; BENBASSAT H, 1977, INT J CANCER, V19, P27, DOI 10.1002/ijc.2910190105; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; Carter KL, 2002, J VIROL, V76, P10427, DOI 10.1128/JVI.76.20.10427-10436.2002; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chang Y, 1996, INFECT AGENT DIS, V5, P215; Couzinet A, 2008, P NATL ACAD SCI USA, V105, P2556, DOI 10.1073/pnas.0712295105; Della Ragione F, 2003, J BIOL CHEM, V278, P23360, DOI 10.1074/jbc.M300771200; Dourmishev LA, 2003, MICROBIOL MOL BIOL R, V67, P175, DOI 10.1128/MMBR.67.2.175-212.2003; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Frost V, 2001, J GEN VIROL, V82, P3057, DOI 10.1099/0022-1317-82-12-3057; HENDERSON A, 1983, P NATL ACAD SCI-BIOL, V80, P1987, DOI 10.1073/pnas.80.7.1987; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; HURLEY EA, 1991, J VIROL, V65, P3958, DOI 10.1128/JVI.65.7.3958-3963.1991; Jin L, 2004, J VIROL METHODS, V118, P9, DOI 10.1016/j.jviromet.2004.01.011; Kieff E., 1996, FIELDS VIROLOGY, V2, P2343; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Mamane Y, 2005, J INTERF CYTOK RES, V25, P43, DOI 10.1089/jir.2005.25.43; Mamane Y, 2002, ONCOGENE, V21, P6751, DOI 10.1038/sj.onc.1205843; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Marshall WL, 1999, J VIROL, V73, P5181, DOI 10.1128/JVI.73.6.5181-5185.1999; Martin HJ, 2007, J VIROL, V81, P9748, DOI 10.1128/JVI.01122-07; McFarland EDC, 1999, ONCOGENE, V18, P6959, DOI 10.1038/sj.onc.1203217; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Moore P., 2001, VIROLOGY, P2803; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; NGUYEN H, 1995, ONCOGENE, V11, P537; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; Ning S, 2003, J VIROL, V77, P9359, DOI 10.1128/JVI.77.17.9359-9368.2003; Nonkwelo C, 1996, J VIROL, V70, P623, DOI 10.1128/JVI.70.1.623-627.1996; Pagano JS, 1999, P ASSOC AM PHYSICIAN, V111, P573, DOI 10.1046/j.1525-1381.1999.t01-1-99220.x; Pitha PM, 1998, BIOCHIMIE, V80, P651, DOI 10.1016/S0300-9084(99)80018-2; Saito T, 1999, BIOCHEM BIOPH RES CO, V260, P329, DOI 10.1006/bbrc.1999.0911; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tanaka N, 2000, SEMIN CANCER BIOL, V10, P73, DOI 10.1006/scbi.2000.0310; TANIGUCHI T, 1995, J CANCER RES CLIN, V121, P516, DOI 10.1007/BF01197763; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; West JT, 2003, ONCOGENE, V22, P5150, DOI 10.1038/sj.onc.1206555; WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156; Xu DS, 2008, J VIROL, V82, P6251, DOI 10.1128/JVI.00163-08; Xu DS, 2007, J VIROL, V81, P6068, DOI 10.1128/JVI.02743-06; Yamagata T, 1996, MOL CELL BIOL, V16, P1283; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Zhang LW, 2004, J VIROL, V78, P12987, DOI 10.1128/JVI.78.23.12987-12995.2004; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zhang LW, 2001, SEMIN CANCER BIOL, V11, P445, DOI 10.1006/scbi.2001.0411; Zhang LW, 2001, J VIROL, V75, P12393, DOI 10.1128/JVI.75.24.12393-12401.2001; Zhang LW, 2001, J VIROL, V75, P341, DOI 10.1128/JVI.75.1.341-350.2001; Zhang LW, 2000, J VIROL, V74, P1061, DOI 10.1128/JVI.74.3.1061-1068.2000	57	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18261	18267		10.1074/jbc.M110.210542	http://dx.doi.org/10.1074/jbc.M110.210542			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454650	Green Published, hybrid			2022-12-27	WOS:000290585200086
J	Moshe, Y; Bar-On, O; Ganoth, D; Hershko, A				Moshe, Yakir; Bar-On, Ortal; Ganoth, Dvora; Hershko, Avram			Regulation of the Action of Early Mitotic Inhibitor 1 on the Anaphase-promoting Complex/Cyclosome by Cyclin-dependent Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS EGGS; POLO-LIKE KINASE-1; SCF-BETA-TRCP; AFFINITY PURIFICATION; CELL-CYCLE; DNA-REPLICATION; IN-VIVO; EMI1; COMPLEX; PHOSPHORYLATION	Cell cycle regulation is characterized by alternating activities of cyclin-dependent kinases (CDKs) and of the ubiquitin ligase anaphase promoting complex/cyclosome (APC/C). During S-phase APC/C is inhibited by early mitotic inhibitor 1 (Emi1) to allow the accumulation of cyclins A and B and to prevent re-replication. Emi1 is degraded at prophase by a Plk1-dependent pathway. Recent studies in which the degradation pathway of Emi1 was disrupted have shown that APC/C is activated at mitotic entry despite stabilization of Emi1. These results suggested the possibility of additional mechanisms other than degradation of Emi1, which release APC/C from inhibition by Emi1 upon entry into mitosis. In this study we report one such mechanism, by which the ability of Emi1 to inhibit APC/C is negatively regulated by CDKs. We show that in Plk1-inhibited cells Emi1 is stabilized and phosphorylated, that Emi1 is phosphorylated by CDKs in mitotic but not S-phase cell extracts, and that Emi1 phosphorylation by mitotic cell extracts or purified CDKs markedly reduces the ability of Emi1 to bind and to inhibit APC/C. Finally, we show that the addition of extracts from S-phase cells to extracts from mitotic cells protects Emi1 from CDK-mediated inactivation.	[Moshe, Yakir; Bar-On, Ortal; Ganoth, Dvora; Hershko, Avram] Technion Israel Inst Technol, Biochem Unit, Rappaport Fac Med, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Hershko, A (corresponding author), Technion Israel Inst Technol, Biochem Unit, Rappaport Fac Med, IL-31096 Haifa, Israel.	hershko@tx.technion.ac.il			Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This work was supported by a grant from the Israel Science Foundation (to A. H.).	Aristarkhov A, 1996, P NATL ACAD SCI USA, V93, P4294, DOI 10.1073/pnas.93.9.4294; Bernis C, 2007, EMBO REP, V8, P91, DOI 10.1038/sj.embor.7400853; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Di Fiore B, 2008, CHROMOSOMA, V117, P333, DOI 10.1007/s00412-008-0152-x; Di Fiore B, 2007, J CELL BIOL, V177, P425, DOI 10.1083/jcb.200611166; Dong XZ, 1997, GENE DEV, V11, P94, DOI 10.1101/gad.11.1.94; Eldridge AG, 2006, CELL, V124, P367, DOI 10.1016/j.cell.2005.10.038; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Golan A, 2002, J BIOL CHEM, V277, P15552, DOI 10.1074/jbc.M111476200; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hansen DV, 2007, CELL CYCLE, V6, P732, DOI 10.4161/cc.6.6.3937; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 2005, METHOD ENZYMOL, V398, P170, DOI 10.1016/S0076-6879(05)98015-4; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; Lee H, 2006, MOL CELL BIOL, V26, P5373, DOI 10.1128/MCB.00043-06; Lehman NL, 2007, AM J PATHOL, V170, P1793, DOI 10.2353/ajpath.2007.060767; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Liu JJ, 2006, J BIOL CHEM, V281, P34736, DOI 10.1074/jbc.M606607200; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; MAYER AN, 1989, BIOCHEMISTRY-US, V28, P166, DOI 10.1021/bi00427a024; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Moshe Y, 2004, P NATL ACAD SCI USA, V101, P7937, DOI 10.1073/pnas.0402442101; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; Ohe M, 2010, MOL BIOL CELL, V21, P905, DOI 10.1091/mbc.E09-11-0974; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Sudakin V, 1997, J BIOL CHEM, V272, P18051, DOI 10.1074/jbc.272.29.18051; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Wu JQ, 2008, J CELL SCI, V121, P3509, DOI 10.1242/jcs.036855; Wu JQ, 2007, P NATL ACAD SCI USA, V104, P16564, DOI 10.1073/pnas.0707537104; Wu QJ, 2007, CURR BIOL, V17, P213, DOI 10.1016/j.cub.2006.12.045	44	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16647	16657		10.1074/jbc.M111.223339	http://dx.doi.org/10.1074/jbc.M111.223339			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454540	Green Published, hybrid			2022-12-27	WOS:000290301900013
J	Zieba, BJ; Artamonov, MV; Jin, L; Momotani, K; Ho, R; Franke, AS; Neppl, RL; Stevenson, AS; Khromov, AS; Chrzanowska-Wodnicka, M; Somlyo, AV				Zieba, Bartosz J.; Artamonov, Mykhaylo V.; Jin, Li; Momotani, Ko; Ho, Ruoya; Franke, Aaron S.; Neppl, Ronald L.; Stevenson, Andra S.; Khromov, Alexander S.; Chrzanowska-Wodnicka, Magdalena; Somlyo, Avril V.			The cAMP-responsive Rap1 Guanine Nucleotide Exchange Factor, Epac, Induces Smooth Muscle Relaxation by Down-regulation of RhoA Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; ENDOTHELIAL BARRIER FUNCTION; LIGHT-CHAIN PHOSPHATASE; INDUCED CA2+ SENSITIZATION; GUINEA-PIG ILEUM; CYCLIC-AMP; MYOSIN PHOSPHATASE; SIGNALING PATHWAY; PULMONARY-ARTERY; MEDIATED INHIBITION	Agonist activation of the small GTPase, RhoA, and its effector Rho kinase leads to down-regulation of smooth muscle (SM) myosin light chain phosphatase activity, an increase in myosin light chain (RLC20) phosphorylation and force. Cyclic nucleotides can reverse this process. We report a new mechanism of cAMP-mediated relaxation through Epac, a GTP exchange factor for the small GTPase Rap1 resulting in an increase in Rap1 activity and suppression of RhoA activity. An Epac-selective cAMP analog, 8-pCPT-2'-O-Me-cAMP ("007"), significantly reduced agonist-induced contractile force, RLC20, and myosin light chain phosphatase phosphorylation in both intact and permeabilized vascular, gut, and airway SMs independently of PKA and PKG. The vasodilator PGI(2) analog, cicaprost, increased Rap1 activity and decreased RhoA activity in intact SMs. Forskolin, phosphodiesterase inhibitor isobutylmethylxanthine, and isoproterenol also significantly increased Rap1-GTP in rat aortic SM cells. The PKA inhibitor H89 was without effect on the 007-induced increase in Rap1-GTP. Lysophosphatidic acid-induced RhoA activity was reduced by treatment with 007 in WT but not Rap1B null fibroblasts, consistent with Epac signaling through Rap1B to down-regulate RhoA activity. Isoproterenol-induced increase in Rap1 activity was inhibited by silencing Epac1 in rat aortic SM cells. Evidence is presented that cooperative cAMP activation of PKA and Epac contribute to relaxation of SM. Our findings demonstrate a cAMP-mediated signaling mechanism whereby activation of Epac results in a PKA-independent, Rap1-dependent Ca2+ desensitization of force in SM through down-regulation of RhoA activity. Cyclic AMP inhibition of RhoA is mediated through activation of both Epac and PKA.	[Zieba, Bartosz J.; Artamonov, Mykhaylo V.; Jin, Li; Momotani, Ko; Ho, Ruoya; Franke, Aaron S.; Stevenson, Andra S.; Khromov, Alexander S.; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Zieba, Bartosz J.] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biochem, PL-30387 Krakow, Poland; [Chrzanowska-Wodnicka, Magdalena] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53101 USA; [Neppl, Ronald L.] Harvard Univ, Sch Med, Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA	University of Virginia; Jagiellonian University; Versiti Blood Center of Wisconsin; Harvard University; Boston Children's Hospital; Harvard Medical School	Somlyo, AV (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, POB 800736, Charlottesville, VA 22908 USA.	avs5u@virginia.edu	Neppl, Ronald L/AAW-1257-2020; Artamonov, Mykhaylo/AAD-3488-2021	Neppl, Ronald L/0000-0003-1497-6058; Artamonov, Mykhaylo/0000-0002-0848-2054; Chrzanowska, Magdalena/0000-0003-4182-2126	National Institutes of Health [R01GM086457-02, 1R01DK088905-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM086457-02 and 1R01DK088905-01 (to A. V. S.).	Birukova AA, 2008, J CELL PHYSIOL, V215, P715, DOI 10.1002/jcp.21354; Birukova AA, 2007, EXP CELL RES, V313, P2504, DOI 10.1016/j.yexcr.2007.03.036; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Carvajal JA, 2000, J CELL PHYSIOL, V184, P409, DOI 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.3.CO;2-B; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Clapp LH, 2002, AM J RESP CELL MOL, V26, P194, DOI 10.1165/ajrcmb.26.2.4695; Conner D A, 2001, Curr Protoc Mol Biol, VChapter 23, DOI 10.1002/0471142727.mb2302s51; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Gudi T, 2002, J BIOL CHEM, V277, P37382, DOI 10.1074/jbc.M204491200; HIMPENS B, 1989, J PHYSIOL-LONDON, V413, P489, DOI 10.1113/jphysiol.1989.sp017665; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Kasahara H, 2005, METH MOLEC MED, V112, P155, DOI 10.1007/978-1-59259-879-3_9; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; KITAZAWA T, 1991, P NATL ACAD SCI USA, V88, P9307, DOI 10.1073/pnas.88.20.9307; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lubomirov LT, 2006, CIRC RES, V98, P1159, DOI 10.1161/01.RES.0000219904.43852.3e; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; MONCADA S, 1983, STROKE, V14, P157, DOI 10.1161/01.STR.14.2.157; Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981; Neppl RL, 2009, J BIOL CHEM, V284, P6348, DOI 10.1074/jbc.M807040200; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Purves GI, 2009, J PHYSIOL-LONDON, V587, P3639, DOI 10.1113/jphysiol.2009.173534; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Roscioni SS, 2010, J CELL MOL IN PRESS; Sand C, 2010, THROMB HAEMOSTASIS, V103, P662, DOI 10.1160/TH09-06-0341; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Sawada N, 2001, BIOCHEM BIOPH RES CO, V280, P798, DOI 10.1006/bbrc.2000.4194; Shi GX, 2006, MOL CELL BIOL, V26, P9136, DOI 10.1128/MCB.00332-06; Sobolewski A, 2004, AM J PHYSIOL-LUNG C, V287, pL352, DOI 10.1152/ajplung.00270.2003; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; SOMLYO AP, 1989, ADV PROTEIN PHOSPHAT, V5, P181; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; Sukhanova I F, 2006, Dokl Biol Sci, V411, P441, DOI 10.1134/S0012496606060044; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Sward K, 2000, J PHYSIOL-LONDON, V522, P33, DOI 10.1111/j.1469-7793.2000.0033m.x; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Van Eyk JE, 1998, J BIOL CHEM, V273, P23433, DOI 10.1074/jbc.273.36.23433; WALSH MP, 1995, CAN J PHYSIOL PHARM, V73, P565, DOI 10.1139/y95-072; Weisbrod RM, 1998, BRIT J PHARMACOL, V125, P1695, DOI 10.1038/sj.bjp.0702233; Wittchen ES, 2005, J BIOL CHEM, V280, P11675, DOI 10.1074/jbc.M412595200; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Wu XQ, 1996, BIOCHEM BIOPH RES CO, V220, P658, DOI 10.1006/bbrc.1996.0460; Wu XQ, 1998, J BIOL CHEM, V273, P11362, DOI 10.1074/jbc.273.18.11362; Yamada T, 2005, J BIOL CHEM, V280, P33026, DOI 10.1074/jbc.M504587200; Yokoyama U, 2008, J BIOL CHEM, V283, P28702, DOI 10.1074/jbc.M804223200; Yokoyama U, 2008, AM J PHYSIOL-HEART C, V295, pH1547, DOI 10.1152/ajpheart.01317.2007; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105	68	70	75	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16681	16692		10.1074/jbc.M110.205062	http://dx.doi.org/10.1074/jbc.M110.205062			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454546	hybrid, Green Published			2022-12-27	WOS:000290301900016
J	Nath, S; Banerjee, T; Sen, D; Das, T; Roychoudhury, S				Nath, Somsubhra; Banerjee, Taraswi; Sen, Debrup; Das, Tania; Roychoudhury, Susanta			Spindle Assembly Checkpoint Protein Cdc20 Transcriptionally Activates Expression of Ubiquitin Carrier Protein UbcH10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE; CONJUGATING ENZYME; CANCER-CELLS; WD REPEAT; APC/C; OVEREXPRESSION; CARCINOMAS; P53; ANEUPLOIDY	The spindle assembly checkpoint (SAC) ensures accurate segregation of chromosomes by monitoring kinetochore attachment of spindles during mitosis. Proper progression of mitosis depends on orderly ubiquitination and subsequent degradation of various mitotic inhibitors. At the molecular level, upon removal of SAC, Cdc20 activates E3 ubiquitin ligase anaphase-promoting complex/cyclosome that, along with E2 ubiquitin-conjugating enzyme UbcH10, executes this function. Both Cdc20 and UbcH10 are overexpressed in many cancer types and are associated with defective SAC function leading to chromosomal instability. The precise mechanism of correlated overexpression of these two proteins remains elusive. We show that Cdc20 transcriptionally up-regulates UbcH10 expression. The WD40 domain of Cdc20 is required for this activity. Physical interaction between Cdc20 and anaphase-promoting complex/cyclosome-CBP/p300 complex and its subsequent recruitment to the UBCH10 promoter are involved in this transactivation process. This transcriptional regulatory function of Cdc20 was observed to be cell cycle-specific. We hypothesize that this coregulated overexpression of both proteins contributes to chromosomal instability.	[Nath, Somsubhra; Banerjee, Taraswi; Sen, Debrup; Das, Tania; Roychoudhury, Susanta] Indian Inst Chem Biol, Council Sci & Ind Res, Mol & Human Genet Div, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Roychoudhury, S (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Mol & Human Genet Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	susanta@iicb.res.in	Nath, Somsubhra/AAL-6377-2020; Banerjee, Taraswi/AAC-6093-2020; Roychoudhury, Susanta/AAD-7946-2021	Nath, Somsubhra/0000-0001-8214-1218	Department of Biotechnology [BT/PR/5524/Med/14/649/2004, BT/01/COE/05/04]; Council of Scientific and Industrial Research [IAP 001]; Council of Scientific and Industrial Research, New Delhi, India; Lady Tata Memorial Trust, Mumbai, India	Department of Biotechnology; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Lady Tata Memorial Trust, Mumbai, India	This work was supported in part by Department of Biotechnology Grants BT/PR/5524/Med/14/649/2004 and BT/01/COE/05/04 and Council of Scientific and Industrial Research Grant IAP 001 (to S. R.).; Supported by Council of Scientific and Industrial Research, New Delhi, India.; Supported by Lady Tata Memorial Trust, Mumbai, India.	Baker DJ, 2007, CELL MOL LIFE SCI, V64, P589, DOI 10.1007/s00018-007-6443-1; Banerjee T, 2009, NUCLEIC ACIDS RES, V37, P2688, DOI 10.1093/nar/gkp110; Benanti JA, 2008, MOL CELL, V32, P460, DOI 10.1016/j.molcel.2008.11.006; Berlingieri MT, 2007, ONCOGENE, V26, P2136, DOI 10.1038/sj.onc.1210010; Berlingieri MT, 2007, EUR J CANCER, V43, P2729, DOI 10.1016/j.ejca.2007.09.003; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Chan HM, 2001, J CELL SCI, V114, P2363; Chi YH, 2007, J CELL BIOCHEM, V102, P531, DOI 10.1002/jcb.21484; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Chun ACS, 2003, J BIOL CHEM, V278, P37439, DOI 10.1074/jbc.M307185200; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Fujita T, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-87; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Jeong SJ, 2004, CANCER RES, V64, P8666, DOI 10.1158/0008-5472.CAN-03-3455; Jiang L, 2010, J CANCER RES CLIN, V136, P211, DOI 10.1007/s00432-009-0651-z; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li M, 2009, J CELL BIOL, V185, P983, DOI 10.1083/jcb.200904020; Liu JH, 2006, CANCER BIOL THER, V5, P760, DOI 10.4161/cbt.5.7.3103; Manchado E, 2010, BIOCHEM SOC T, V38, P65, DOI 10.1042/BST0380065; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Mondal G, 2007, CARCINOGENESIS, V28, P81, DOI 10.1093/carcin/bgl100; Mondal G, 2006, BIOCHEM J, V396, P243, DOI 10.1042/BJ20051914; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Oikawa T, 2005, MOL CELL BIOL, V25, P4046, DOI 10.1128/MCB.25.10.4046-4061.2005; Okamoto Y, 2003, CANCER RES, V63, P4167; Pallante P, 2005, BRIT J CANCER, V93, P464, DOI 10.1038/sj.bjc.6602721; Park HY, 2007, EXP MOL MED, V39, P195, DOI 10.1038/emm.2007.22; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pines J, 2009, MOL CELL, V34, P135, DOI 10.1016/j.molcel.2009.04.006; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; van Ree JH, 2010, J CELL BIOL, V188, P83, DOI 10.1083/jcb.200906147; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wagner KW, 2004, ONCOGENE, V23, P6621, DOI 10.1038/sj.onc.1207861; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Yang Y, 2010, CURR OPIN NEUROBIOL, V20, P92, DOI 10.1016/j.conb.2009.12.004; Yoon YM, 2004, FEBS LETT, V575, P23, DOI 10.1016/j.febslet.2004.07.089; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Yuen KWY, 2005, CURR OPIN CELL BIOL, V17, P576, DOI 10.1016/j.ceb.2005.09.012	54	17	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.160671	http://dx.doi.org/10.1074/jbc.M110.160671			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454660	Green Published, hybrid			2022-12-27	WOS:000290022800006
J	Qi, XP; Nishida, J; Chaves, L; Ohmori, K; Huang, H				Qi, Xiaopeng; Nishida, Jun; Chaves, Lee; Ohmori, Keitaro; Huang, Hua			CCAAT/Enhancer-binding Protein alpha (C/EBP alpha) Is Critical for Interleukin-4 Expression in Response to Fc epsilon RI Receptor Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN IL-4 PROMOTER; T-CELLS; GENE-EXPRESSION; NUCLEAR-FACTOR; MAST-CELLS; IN-VIVO; SIGNALING PATHWAYS; IL4 GENE; C-MAF; TRANSCRIPTION	Basophils mediate many of their biological functions by producing IL-4. However, it is unknown how the Il4 gene is regulated in basophils. Here, we report that CCAAT/enhancer-binding protein alpha (C/EBP alpha), a major myeloid transcription factor, was highly expressed in basophils. We show that C/EBP alpha selectively activated Il4 promoter-luciferase reporter gene transcription in response to IgE cross-linking, but C/EBP alpha did not activate other known Th2 or mast cell enhancers. We found that the PI3K pathway and calcineurin were essential in C/EBP alpha-driven Il4 promoter-luciferase gene transcription. Our mutation analyses revealed that C/EBP alpha drove Il4 promoter-luciferase activity depending on its DNA binding domain. Mutation of the C/EBP alpha-binding site in the Il4 promoter region abolished C/EBP alpha-driven Il4 promoter-luciferase activity. Our results further showed that a mutation in nuclear factor of activated T cells (NFAT)-binding sites in the Il4 promoter also negated C/EBP alpha-driven Il4 promoter-luciferase activity. Our study demonstrates that C/EBP alpha, in cooperation with NFAT, directly regulates Il4 gene transcription.	[Qi, Xiaopeng; Nishida, Jun; Chaves, Lee; Ohmori, Keitaro; Huang, Hua] Univ Colorado, Dept Med, Div Allergy & Immunol, Natl Jewish Hlth,Denver Sch Med, Denver, CO 80206 USA; [Huang, Hua] Univ Colorado, Integrated Dept Immunol, Denver Sch Med, Denver, CO 80206 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Huang, H (corresponding author), Univ Colorado, Dept Med, Div Allergy & Immunol, Natl Jewish Hlth,Denver Sch Med, Denver, CO 80206 USA.	huangh@njhealth.org	OHMORI, Keitaro/G-1143-2013	OHMORI, Keitaro/0000-0002-0582-4880; Huang, Hua/0000-0001-7317-8983	National Institutes of Health [RO1 AI05917, RO1 AI068083]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AI05917 and RO1 AI068083 (to H. H.).	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Arock M, 2002, J LEUKOCYTE BIOL, V71, P557; Behre G, 2002, J BIOL CHEM, V277, P26293, DOI 10.1074/jbc.M202301200; DAVYDOV IV, 1995, J IMMUNOL, V155, P5273; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; ERICKSON J, 1986, MOL IMMUNOL, V23, P769, DOI 10.1016/0161-5890(86)90089-1; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; HENKEL G, 1994, P NATL ACAD SCI USA, V91, P7737, DOI 10.1073/pnas.91.16.7737; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Huang H, 1997, J IMMUNOL, V159, P3731; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Khanna-Gupta A, 2008, BLOOD CELL MOL DIS, V41, P77, DOI 10.1016/j.bcmd.2008.02.011; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Kuroda E, 2011, J IMMUNOL, V186, P323, DOI 10.4049/jimmunol.1002778; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Li-Weber M, 2003, NAT REV IMMUNOL, V3, P534, DOI 10.1038/nri1128; Li-Weber M, 1998, J IMMUNOL, V161, P1380; Liu HK, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-14; Luccioli S, 2002, J ALLERGY CLIN IMMUN, V110, P117, DOI 10.1067/mai.2002.125828; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; Mulero MC, 2009, J BIOL CHEM, V284, P9394, DOI 10.1074/jbc.M805889200; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Ohmori K, 2009, J IMMUNOL, V182, P2835, DOI 10.4049/jimmunol.0802870; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Paz-Priel I, 2005, MOL CANCER RES, V3, P585, DOI 10.1158/1541-7786.MCR-05-0111; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Radomska HS, 2006, J EXP MED, V203, P371, DOI 10.1084/jem.20052242; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; Ross SE, 2004, MOL CELL BIOL, V24, P675, DOI 10.1128/MCB.24.2.675-686.2004; SCOTT LM, 1992, BLOOD, V80, P1725; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Wang GL, 2004, GENE DEV, V18, P912, DOI 10.1101/gad.1183304; Weiss DL, 2001, IMMUNOL REV, V179, P35, DOI 10.1034/j.1600-065X.2001.790104.x; Yagi R, 2007, MOL CELL BIOL, V27, P8087, DOI 10.1128/MCB.00631-07; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zhang P, 1998, J EXP MED, V188, P1173, DOI 10.1084/jem.188.6.1173; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhang YK, 2001, J EXP MED, V194, P165, DOI 10.1084/jem.194.2.165; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	47	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.213389	http://dx.doi.org/10.1074/jbc.M110.213389			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454593	Green Published, hybrid			2022-12-27	WOS:000290022800046
J	Davies, JS; Klein, DC; Carter, DA				Davies, Jeff S.; Klein, David C.; Carter, David A.			Selective Genomic Targeting by FRA-2/FOSL2 Transcription Factor REGULATION OF THE Rgs4 GENE IS MEDIATED BY A VARIANT ACTIVATOR PROTEIN 1 (AP-1) PROMOTER SEQUENCE/CREB-BINDING PROTEIN (CBP) MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-RESPONSE-ELEMENT; ARYLALKYLAMINE N-ACETYLTRANSFERASE; RAT PINEAL-GLAND; CIRCADIAN EXPRESSION; C-JUN; GENE-EXPRESSION; PC12 CELLS; RGS4 POLYMORPHISMS; DYNAMIC EXPRESSION; ANTIGEN-2 FRA-2	FRA-2/FOSL2 is a basic region-leucine zipper motif transcription factor that is widely expressed in mammalian tissues. The functional repertoire of this factor is unclear, partly due to a lack of knowledge of genomic sequences that are targeted. Here, we identified novel, functional FRA-2 targets across the genome through expression profile analysis in a knockdown transgenic rat. In this model, a nocturnal rhythm of pineal gland FRA-2 is suppressed by a genetically encoded, dominant negative mutant protein. Bioinformatic analysis of validated sets of FRA-2-regulated and -nonregulated genes revealed that the FRA-2 regulon is limited by genomic target selection rules that, in general, transcend core cis-sequence identity. However, one variant AP-1related (AP-1R) sequence was common to a subset of regulated genes. The functional activity and protein binding partners of a candidate AP-1R sequence were determined for a novel FRA-2-repressed gene, Rgs4. FRA-2 protein preferentially associated with a proximal Rgs4 AP-1R sequence as demonstrated by ex vivo ChIP and in vitro EMSA analysis; moreover, transcriptional repression was blocked by mutation of the AP-1R sequence, where as mutation of an upstream consensus AP-1 family sequence did not affect Rgs4 expression. Nocturnal changes in protein complexes at the Rgs4 AP-1R sequence are associated with FRA-2-dependent dismissal of the co-activator, CBP; this provides a mechanistic basis for Rgs4 gene repression. These studies have also provided functional insight into selective genomic targeting by FRA-2, highlighting discordance between predicted and actual targets. Future studies should address FRA-2-Rgs4 interactions in other systems, including the brain, where FRA-2 function is poorly understood.	[Davies, Jeff S.; Carter, David A.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Klein, David C.] NICHD, Sect Neuroendocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA	Cardiff University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Carter, DA (corresponding author), Cardiff Univ, Sch Biosci, Museum Ave, Cardiff CF10 3AX, S Glam, Wales.	carterda@cardiff.ac.uk	Davies, Jeffrey S/K-1400-2019; Carter, David/A-4479-2010; Klein, David C./C-1331-2009	Davies, Jeffrey S/0000-0002-4234-0033; Carter, David/0000-0002-8419-3975; Klein, David/0000-0002-1792-5806	National Institutes of Health; Wellcome Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008836, ZIAHD008838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program (to D. C. K.). This work was also supported by the Wellcome Trust (to J. D. and D. A. C.).	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey MJ, 2009, J BIOL CHEM, V284, P7606, DOI 10.1074/jbc.M808394200; Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; Baler R, 1999, BIOL CELL, V91, P699, DOI 10.1016/S0248-4900(00)88533-0; BALER R, 1995, J BIOL CHEM, V270, P27319, DOI 10.1074/jbc.270.45.27319; Benkoussa M, 2002, MOL CELL BIOL, V22, P4522, DOI 10.1128/MCB.22.13.4522-4534.2002; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Boss V, 2001, J NEUROSCI, V21, P18, DOI 10.1523/JNEUROSCI.21-01-00018.2001; Bozec A, 2008, NATURE, V454, P221, DOI 10.1038/nature07019; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Burke Z, 1999, J NEUROCHEM, V73, P1343, DOI 10.1046/j.1471-4159.1999.0731343.x; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; CARTER DA, 1992, MOL BRAIN RES, V16, P111, DOI 10.1016/0169-328X(92)90200-U; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Chik CL, 2007, ENDOCRINOLOGY, V148, P3523, DOI 10.1210/en.2007-0166; Chorley BN, 2008, MUTAT RES-REV MUTAT, V659, P147, DOI 10.1016/j.mrrev.2008.05.001; Chowdari KV, 2008, SCHIZOPHRENIA BULL, V34, P118, DOI 10.1093/schbul/sbm042; Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Ding L, 2007, GENE, V401, P46, DOI 10.1016/j.gene.2007.07.002; Ebert PJ, 2006, NEUROSCIENCE, V142, P1145, DOI 10.1016/j.neuroscience.2006.08.011; Eferl R, 2008, P NATL ACAD SCI USA, V105, P10525, DOI 10.1073/pnas.0801414105; Engel L, 2005, NEUROSCIENCE, V132, P511, DOI 10.1016/j.neuroscience.2004.12.014; Eriksson M, 2007, J CELL PHYSIOL, V210, P538, DOI 10.1002/jcp.20907; Flammer JR, 2006, BIOCHEMISTRY-US, V45, P9615, DOI 10.1021/bi052521a; Gaildrat P, 2005, J BIOL CHEM, V280, P16851, DOI 10.1074/jbc.M414587200; Grillet N, 2003, J NEUROSCI, V23, P10613; Guberman AS, 2003, J BIOL CHEM, V278, P2317, DOI 10.1074/jbc.M205057200; Guillaumond F, 2000, J NEUROCHEM, V75, P1398, DOI 10.1046/j.1471-4159.2000.0751398.x; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Ho AK, 2007, ENDOCRINOLOGY, V148, P4592, DOI 10.1210/en.2007-0578; Hu WH, 2008, BIOCHEM J, V412, P35, DOI 10.1042/BJ20080042; Humphries A, 2004, J NEUROCHEM, V91, P946, DOI 10.1111/j.1471-4159.2004.02777.x; Iwamoto T, 2005, CYTOTECHNOLOGY, V47, P107, DOI 10.1007/s10616-005-3763-6; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KERPPOLA TK, 1993, MOL CELL BIOL, V13, P5479, DOI 10.1128/MCB.13.9.5479; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; KONRADI C, 1993, P NATL ACAD SCI USA, V90, P7005, DOI 10.1073/pnas.90.15.7005; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; Lapidot M, 2008, PLOS GENET, V4; Levitt P, 2006, BIOL PSYCHIAT, V60, P534, DOI 10.1016/j.biopsych.2006.04.028; Liu WH, 2006, P NATL ACAD SCI USA, V103, P18338, DOI 10.1073/pnas.0604560103; Maronde E, 1999, J NEUROSCI, V19, P3326; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Pepperl DJ, 1998, BIOCHEM BIOPH RES CO, V243, P52, DOI 10.1006/bbrc.1997.8056; Poirier G. L., 2008, Thalamus & Related Systems, V4, P59, DOI 10.1017/S1472928808000368; RYSECK RP, 1991, ONCOGENE, V6, P533; Sanders AR, 2008, AM J PSYCHIAT, V165, P497, DOI 10.1176/appi.ajp.2007.07101573; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Seldeen KL, 2009, BIOCHEMISTRY-US, V48, P1975, DOI 10.1021/bi802068s; Siddharthan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009722; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith M, 2001, MOL CELL BIOL, V21, P3704, DOI 10.1128/MCB.21.11.3704-3713.2001; STEHLE JH, 1993, NATURE, V365, P314, DOI 10.1038/365314a0; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun H, 2006, NUCLEIC ACIDS RES, V34, pD98, DOI 10.1093/nar/gkj096; SUZUKI T, 1991, NUCLEIC ACIDS RES, V19, P5537, DOI 10.1093/nar/19.20.5537; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; TAMOTSU S, 1995, CELL TISSUE RES, V282, P219, DOI 10.1007/s004410050474; Taymans JM, 2003, J NEUROCHEM, V84, P1118, DOI 10.1046/j.1471-4159.2003.01610.x; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Van Loo P, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r66; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wagner EF, 2010, ANN RHEUM DIS, V69, P86, DOI 10.1136/ard.2009.119396; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; Yang JQ, 2010, J BIOL CHEM, V285, P29760, DOI 10.1074/jbc.M110.121459; Yivgi-Ohana N, 2009, ENDOCRINOLOGY, V150, P977, DOI 10.1210/en.2008-0541; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zhang DS, 2005, NEUROPSYCHOPHARMACOL, V30, P1443, DOI 10.1038/sj.npp.1300680; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhou HM, 2005, DNA RES, V12, P139, DOI 10.1093/dnares/12.2.139	77	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15227	15239		10.1074/jbc.M110.201996	http://dx.doi.org/10.1074/jbc.M110.201996			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21367864	Green Published, hybrid			2022-12-27	WOS:000289788300054
J	Bruck, I; Kaplan, DL				Bruck, Irina; Kaplan, Daniel L.			GINS and Sld3 Compete with One Another for Mcm2-7 and Cdc45 Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; BUDDING YEAST; ATP-HYDROLYSIS; S-PHASE; PHOSPHORYLATION; COMPLEX; HELICASE; ASSOCIATION; PROGRESSION; CDC7-DBF4	Sld3 is essential for the initiation of DNA replication, but Sld3 does not travel with a replication fork. GINS binds to Cdc45 and Mcm2-7 to form the replication fork helicase in eukaryotes. We purified Sld3, Cdc45, GINS, and Mcm2-7 and studied their interaction and assembly into complexes. Sld3 binds tightly to Cdc45 in the presence or absence of cyclin-dependent kinase activity. Furthermore, Sld3 binds tightly to the Mcm2-7 complex, and a ternary complex forms among Cdc45, Mcm2-7, and Sld3, with a 1:1:1 stoichiometry (CMS complex). GINS binds directly to Mcm2-7, and GINS competes with Sld3 for Mcm2-7 binding. GINS also binds directly to Cdc45, and GINS competes with Sld3 for Cdc45 binding. Cdc45, Mcm2-7, and GINS form a ternary complex with a stoichiometry of 1:1:1 (CMG complex). Size exclusion data reveal that when Sld3, Cdc45, Mcm2-7, and GINS are added together, the result is a mixture of CMS and CMG complexes. The data suggest that GINS and Sld3 compete with one another for Mcm2-7 and Cdc45 binding. Our results are consistent with a model wherein GINS trades places with Sld3 at a replication origin, contributing to the activation of the replication fork helicase.	[Bruck, Irina; Kaplan, Daniel L.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Kaplan, DL (corresponding author), VU Stn B, Box 35-1634, Nashville, TN 37235 USA.	kaplan@vanderbilt.edu		Kaplan, Daniel/0000-0003-2760-7745	Vanderbilt University; American Cancer Society [RSG-08-124-01-CCG]	Vanderbilt University; American Cancer Society(American Cancer Society)	This work was supported by a Vanderbilt University Discovery grant (to D. L. K.) and American Cancer Society Research Scholar Grant RSG-08-124-01-CCG (to D. L. K.).	Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; MacNeill SA, 2010, BIOCHEM J, V425, P489, DOI 10.1042/BJ20091531; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Yardimci H, 2010, MOL CELL, V40, P834, DOI 10.1016/j.molcel.2010.11.027; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	29	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14157	14167		10.1074/jbc.M111.218305	http://dx.doi.org/10.1074/jbc.M111.218305			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21362622	Green Published, hybrid			2022-12-27	WOS:000289556200039
J	Song, PH; Groos, S; Riederer, B; Feng, Z; Krabbenhoft, A; Manns, MP; Smolka, A; Hagen, SJ; Neusch, C; Seidler, U				Song, Penghong; Groos, Stephanie; Riederer, Brigitte; Feng, Zhe; Krabbenhoeft, Anja; Manns, Michael P.; Smolka, Adam; Hagen, Susan J.; Neusch, Clemens; Seidler, Ursula			Kir4.1 Channel Expression Is Essential for Parietal Cell Control of Acid Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIR2.1 K+ CHANNELS; GASTRIC-MUCOSA; POTASSIUM CHANNELS; OXYNTIC CELLS; MEMBRANE; EZRIN; ENDOCYTOSIS; SUBUNIT; ATPASE; MICE	Kir4.1 channels were found to colocalize with the H+/K+ ATPase throughout the parietal cell (PC) acid secretory cycle. This study was undertaken to explore their functional role. Acid secretory rates, electrophysiological parameters, PC ultrastructure, and gene and protein expression were determined in gastric mucosae of 7-8-day-old Kir4.1-deficient mice and WT littermates. Kir4.1(-/-) mucosa secreted significantly more acid and initiated secretion significantly faster than WT mucosa. No change in PC number but a relative up-regulation of H+/K+ ATPase gene and protein expression (but not of other PC ion transporters) was observed. Electron microscopy revealed fully fused canalicular membranes and a lack of tubulovesicles in resting state Kir4.1(-/-) PCs, suggesting that Kir4.1 ablation may also interfere with tubulovesicle endocytosis. The role of this inward rectifier in the PC apical membrane may therefore be to balance between K+ loss via KCNQ1/KCNE2 and K+ reabsorption by the slow turnover of the H+/K+-ATPase, with consequences for K+ reabsorption, inhibition of acid secretion, and membrane recycling. Our results demonstrate that Kir4.1 channels are involved in the control of acid secretion and suggest that they may also affect secretory membrane recycling. The regulation of gastric acid secretion requires	[Song, Penghong; Riederer, Brigitte; Feng, Zhe; Krabbenhoeft, Anja; Manns, Michael P.; Seidler, Ursula] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Groos, Stephanie] Hannover Med Sch, Dept Anat 1, D-30625 Hannover, Germany; [Smolka, Adam] Med Univ S Carolina, Dept Med, Charleston, SC 29403 USA; [Hagen, Susan J.] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02115 USA; [Neusch, Clemens] Univ Gottingen, Dept Neurol, D-37075 Gottingen, Germany	Hannover Medical School; Hannover Medical School; Medical University of South Carolina; Harvard University; Beth Israel Deaconess Medical Center; University of Gottingen	Seidler, U (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	seidler.ursula@mh-hannover.de	Seidler, Ursula/HII-8049-2022	Seidler, Ursula/0000-0002-9600-2769	Deutsche Forschungsgemeinschaft [Se460/9-5, Se460/9-6]; Lower Saxony Ministry of Science and Education; Volkswagen Vorab Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Lower Saxony Ministry of Science and Education; Volkswagen Vorab Stiftung	This work was supported by Deutsche Forschungsgemeinschaft Sachbeihilfe Se460/9-5 and Se460/9-6 and by the Lower Saxony Ministry of Science and Education and the Volkswagen Vorab Stiftung (to U. S.).	Agnew BJ, 1999, J CELL SCI, V112, P2639; CLAUSEN C, 1982, SCIENCE, V217, P448, DOI 10.1126/science.217.4558.448; CLAUSEN C, 1983, BIOPHYS J, V41, P167, DOI 10.1016/S0006-3495(83)84417-8; CourtoisCoutry N, 1997, CELL, V90, P501, DOI 10.1016/S0092-8674(00)80510-3; CUPPOLETTI J, 1984, J BIOL CHEM, V259, P4952; DEBELLIS L, 1990, AM J PHYSIOL, V258, pG631, DOI 10.1152/ajpgi.1990.258.4.G631; DEBELLIS L, 1992, PFLUG ARCH EUR J PHY, V422, P253, DOI 10.1007/BF00376210; Dedek K, 2001, PFLUG ARCH EUR J PHY, V442, P896, DOI 10.1007/s004240100609; Engqvist-Goldstein AEY, 2001, J CELL BIOL, V154, P1209, DOI 10.1083/jcb.200106089; Forte JG, 2004, AM J PHYSIOL-CELL PH, V286, pC478, DOI 10.1152/ajpcell.00531.2003; Forte JG, 2010, ANNU REV PHYSIOL, V72, P273, DOI 10.1146/annurev-physiol-021909-135744; FORTE TM, 1977, GASTROENTEROLOGY, V73, P941; Fujita A, 2002, J PHYSIOL-LONDON, V540, P85, DOI 10.1113/jphysiol.2001.013439; HANZEL D, 1991, EMBO J, V10, P2363, DOI 10.1002/j.1460-2075.1991.tb07775.x; Heitzmann D, 2008, PHYSIOL REV, V88, P1119, DOI 10.1152/physrev.00020.2007; Hou JCQ, 2009, VITAM HORM, V80, P473, DOI 10.1016/S0083-6729(08)00616-X; Jain RN, 2008, J CLIN INVEST, V118, P2459, DOI 10.1172/JCI33569; Kaufhold MA, 2008, GASTROENTEROLOGY, V134, P1058, DOI 10.1053/j.gastro.2008.01.033; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Lambrecht NWG, 2005, PHYSIOL GENOMICS, V21, P81, DOI 10.1152/physiolgenomics.00212.2004; Malinowska DH, 2004, AM J PHYSIOL-CELL PH, V286, pC495, DOI 10.1152/ajpcell.00386.2003; MANGEAT P, 1990, BIOL CELL, V69, P223, DOI 10.1016/0248-4900(90)90349-8; McDaniel N, 2005, AM J PHYSIOL-GASTR L, V289, pG550, DOI 10.1152/ajpgi.00095.2005; Neusch C, 2003, CELL TISSUE RES, V311, P131, DOI 10.1007/s00441-002-0669-x; Neusch C, 2001, J NEUROSCI, V21, P5429, DOI 10.1523/JNEUROSCI.21-15-05429.2001; Nguyen NV, 2004, GASTROENTEROLOGY, V127, P145, DOI 10.1053/j.gastro.2004.04.016; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Ostrowski J, 1994, J Physiol Pharmacol, V45, P351; Ostrowski J, 1991, J Physiol Pharmacol, V42, P367; Pagliocca A, 2008, EXP PHYSIOL, V93, P1174, DOI 10.1113/expphysiol.2008.042648; PETTITT JM, 1993, IMMUNOL CELL BIOL, V71, P191, DOI 10.1038/icb.1993.21; Raiteri L, 2007, J NEUROCHEM, V103, P952, DOI 10.1111/j.1471-4159.2007.04784.x; Reimann F, 1999, CURR OPIN CELL BIOL, V11, P503, DOI 10.1016/S0955-0674(99)80073-8; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Schubert ML, 2009, CURR OPIN GASTROEN, V25, P529, DOI 10.1097/MOG.0b013e328331b62a; Smith RM, 2002, TRAFFIC, V3, P397, DOI 10.1034/j.1600-0854.2002.30603.x; Song PH, 2009, J PHYSIOL-LONDON, V587, P3955, DOI 10.1113/jphysiol.2009.173302; Spicer Z, 2000, J BIOL CHEM, V275, P21555, DOI 10.1074/jbc.M001558200; Tamura A, 2005, J CELL BIOL, V169, P21, DOI 10.1083/jcb.200410083; Thevenod F, 2002, AM J PHYSIOL-CELL PH, V283, pC651, DOI 10.1152/ajpcell.00600.2001; TSUNODA Y, 1987, FEBS LETT, V222, P149, DOI 10.1016/0014-5793(87)80209-0; UEDA S, 1989, BIOCHIM BIOPHYS ACTA, V1012, P254, DOI 10.1016/0167-4889(89)90105-5; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200; Zhou RH, 2005, J CELL SCI, V118, P4381, DOI 10.1242/jcs.02559; Zhou RH, 2003, J BIOL CHEM, V278, P35651, DOI 10.1074/jbc.M303416200	46	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14120	14128		10.1074/jbc.M110.151191	http://dx.doi.org/10.1074/jbc.M110.151191			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21367857	Green Published, hybrid			2022-12-27	WOS:000289556200035
J	Chong, BM; Russell, TD; Schaack, J; Orlicky, DJ; Reigan, P; Ladinsky, M; McManaman, JL				Chong, Brandi M.; Russell, Tanya D.; Schaack, Jerome; Orlicky, David J.; Reigan, Philip; Ladinsky, Mark; McManaman, James L.			The Adipophilin C Terminus Is a Self-folding Membrane-binding Domain That Is Important for Milk Lipid Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-RELATED PROTEIN; MAMMARY EPITHELIAL-CELLS; XANTHINE-OXIDOREDUCTASE; DROPLET FORMATION; GLOBULE-MEMBRANE; APOLIPOPROTEIN-E; SOLVENT MODELS; TIP47; GLAND; BIOGENESIS	Cytoplasmic lipid droplets (CLD) in mammary epithelial cells undergo secretion by a unique membrane envelopment process to produce milk lipids. Adipophilin (ADPH/Plin2), a member of the perilipin/PAT family of lipid droplet-associated proteins, is hypothesized to mediate CLD secretion through interactions with apical plasma membrane elements. We found that the secretion of CLD coated by truncated ADPH lacking the C-terminal region encoding a putative four-helix bundle structure was impaired relative to that of CLD coated by full-length ADPH. We used homology modeling and analyses of the solution and membrane binding properties of purified recombinant ADPHC terminus to understand how this region possibly mediates CLD secretion. Homology modeling supports the concept that the ADPH C terminus forms a four-helix bundle motif and suggests that this structure can form stable membrane bilayer interactions. Circular dichroism and protease mapping studies confirmed that the ADPH C terminus is an independently folding alpha-helical structure that is relatively resistant to urea denaturation. Liposome binding studies showed that the purified C terminus binds to phospholipid membranes through electrostatic dependent interactions, and cell culture studies documented that it localizes to the plasma membrane. Collectively, these data provide direct evidence that the ADPH C terminus forms a stable membrane binding helical structure that is important for CLD secretion. We speculate that interactions between the four-helix bundle of ADPH and membrane phospholipids may be an initial step in milk lipid secretion.	[Chong, Brandi M.; Russell, Tanya D.; Schaack, Jerome; McManaman, James L.] Univ Colorado, Grad Program Mol Biol, Div Basic Reprod Sci, Aurora, CO 80045 USA; [Chong, Brandi M.; Russell, Tanya D.; McManaman, James L.] Univ Colorado, Dept Obstet & Gynecol, Aurora, CO 80045 USA; [Schaack, Jerome] Univ Colorado, Dept Microbiol, Aurora, CO 80045 USA; [Orlicky, David J.] Univ Colorado, Dept Pathol, Aurora, CO 80045 USA; [Reigan, Philip] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Ladinsky, Mark] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder	McManaman, JL (corresponding author), 12800 E 19th Ave,Mailstop 8309, Aurora, CO 80045 USA.	jim.mcmanaman@ucdenver.edu			National Institutes of Health [2RO1-HD045962, PO1-HD38129]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD038129, R01HD045965] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD045962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants 2RO1-HD045962 and PO1-HD38129 (to J. L. M.).	Ajees AA, 2006, P NATL ACAD SCI USA, V103, P2126, DOI 10.1073/pnas.0506877103; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Chroni A, 2008, BIOCHEMISTRY-US, V47, P9071, DOI 10.1021/bi800469r; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Evans RK, 2004, J PHARM SCI-US, V93, P2458, DOI 10.1002/jps.20157; Feig M, 2004, CURR OPIN STRUC BIOL, V14, P217, DOI 10.1016/j.sbi.2004.03.009; Gao J, 1999, J BIOL CHEM, V274, P16825, DOI 10.1074/jbc.274.24.16825; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heid HW, 1996, BIOCHEM J, V320, P1025, DOI 10.1042/bj3201025; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Kirwan JP, 2010, J STRUCT BIOL, V170, P294, DOI 10.1016/j.jsb.2010.01.020; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; McManaman JL, 2007, J MAMMARY GLAND BIOL, V12, P259, DOI 10.1007/s10911-007-9053-5; McManaman JL, 2009, CLIN LIPIDOL, V4, P391, DOI 10.2217/CLP.09.15; McManaman JL, 2003, J LIPID RES, V44, P668, DOI 10.1194/jlr.C200021-JLR200; McManaman JL, 2002, J PHYSIOL-LONDON, V545, P567, DOI 10.1113/jphysiol.2002.027185; McManaman JL, 2004, ADV EXP MED BIOL, V554, P263; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Narayanaswami V, 2004, J BIOL CHEM, V279, P14273, DOI 10.1074/jbc.M313318200; Narayanaswami V, 2010, COMP BIOCHEM PHYS A, V155, P123, DOI 10.1016/j.cbpa.2009.09.009; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; Orlicky DJ, 2008, J CELL SCI, V121, P2921, DOI 10.1242/jcs.026153; Orlicky DJ, 2001, J LIPID RES, V42, P460; Reinhardt TA, 2008, J DAIRY SCI, V91, P2307, DOI 10.3168/jds.2007-0952; Robenek H, 2005, J LIPID RES, V46, P1331, DOI 10.1194/jlr.M400323-JLR200; Robenek H, 2006, J CELL SCI, V119, P4215, DOI 10.1242/jcs.03191; Robenek H, 2006, P NATL ACAD SCI USA, V103, P10385, DOI 10.1073/pnas.0600795103; Russell TD, 2008, J LIPID RES, V49, P206, DOI 10.1194/jlr.M700396-JLR200; Russell TD, 2007, J LIPID RES, V48, P1463, DOI 10.1194/jlr.M600474-JLR200; Russell TD, 2003, J VIROL, V77, P5801, DOI 10.1128/JVI.77.10.5801-5809.2003; Schaack J, 2001, VIROLOGY, V291, P101, DOI 10.1006/viro.2001.1211; Spassov VZ, 2002, J PHYS CHEM B, V106, P8726, DOI 10.1021/jp020674r; Sztalryd C, 2006, J BIOL CHEM, V281, P34341, DOI 10.1074/jbc.M602497200; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; Wu CC, 2000, ELECTROPHORESIS, V21, P3470, DOI 10.1002/1522-2683(20001001)21:16<3470::AID-ELPS3470>3.3.CO;2-7	46	29	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23254	23265		10.1074/jbc.M110.217091	http://dx.doi.org/10.1074/jbc.M110.217091			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21383012	hybrid, Green Published			2022-12-27	WOS:000292025000059
J	Correia, MAS; Mazumder, K; Bras, JLA; Firbank, SJ; Zhu, YP; Lewis, RJ; York, WS; Fontes, CMGA; Gilbert, HJ				Correia, Marcia A. S.; Mazumder, Koushik; Bras, Joana L. A.; Firbank, Susan J.; Zhu, Yanping; Lewis, Richard J.; York, William S.; Fontes, Carlos M. G. A.; Gilbert, Harry J.			Structure and Function of an Arabinoxylan-specific Xylanase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; CELL-WALL DEGRADATION; LIGAND-BINDING; H-1-NMR SPECTROSCOPY; COMPLEX; OLIGOSACCHARIDES; BIOCHEMISTRY; REFINEMENT; SEQUENCE; DOMAINS	The enzymatic degradation of plant cell walls plays a central role in the carbon cycle and is of increasing environmental and industrial significance. The enzymes that catalyze this process include xylanases that degrade xylan, a beta-1,4-xylose polymer that is decorated with various sugars. Although xylanases efficiently hydrolyze unsubstituted xylans, these enzymes are unable to access highly decorated forms of the polysaccharide, such as arabinoxylans that contain arabinofuranose decorations. Here, we show that a Clostridium thermocellum enzyme, designated CtXyl5A, hydrolyzes arabinoxylans but does not attack unsubstituted xylans. Analysis of the reaction products generated by CtXyl5A showed that all the oligosaccharides contain an O3 arabinose linked to the reducing endxylose. The crystal structure of the catalytic module(CtGH5) of CtXyl5A, appended to a family 6 noncatalytic carbohydrate-binding module (CtCBM6), showed that CtGH5 displays a canonical (alpha/beta)(8)-barrel fold with the substrate binding cleft running along the surface of the protein. The catalytic apparatus is housed in the center of the cleft. Adjacent to the -1 subsite is a pocket that could accommodate an L-arabinofuranose-linked alpha-1,3 to the active site xylose, which is likely to function as a key specificity determinant. CtCBM6, which adopts a beta-sandwich fold, recognizes the termini of xylo-and gluco-configured oligosaccharides, consistent with the pocket topology displayed by the ligand-binding site. In contrast to typical modular glycoside hydrolases, there is an extensive hydrophobic interface between CtGH5 and CtCBM6, and thus the two modules cannot function as independent entities.	[Correia, Marcia A. S.; Bras, Joana L. A.; Fontes, Carlos M. G. A.] Univ Tecn Lisboa, Fac Med Vet, Ctr Invest Interdisciplinar Sanidade Anim, P-1300477 Lisbon, Portugal; [Firbank, Susan J.; Zhu, Yanping; Lewis, Richard J.; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Mazumder, Koushik; Zhu, Yanping; York, William S.; Gilbert, Harry J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Universidade de Lisboa; Newcastle University - UK; University System of Georgia; University of Georgia	Fontes, CMGA (corresponding author), Univ Tecn Lisboa, Fac Med Vet, Ctr Invest Interdisciplinar Sanidade Anim, Ave Univ Tecn, P-1300477 Lisbon, Portugal.	cafontes@fmv.utl.pt; h.j.gilbert@newcastle.ac.uk	Correia, Márcia/D-2077-2013	Correia, Márcia/0000-0003-0636-8095; Bras, Joana/0000-0002-1141-5530; lewis, richard/0000-0003-2641-8643; Fontes, Carlos/0000-0002-1219-9753	Fundacao para a Ciencia e Tecnologia (Portugal) [PTDC/BIAPRO/69732/2006]; Office of Biological and Environmental Research in the Department of Energy Office of Science; Department of Energy [DE-FG02-96ER20220];  [SFRH/BD/16731/2004]	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Office of Biological and Environmental Research in the Department of Energy Office of Science; Department of Energy(United States Department of Energy (DOE)); 	This work was supported by Grants PTDC/BIAPRO/69732/2006 from Fundacao para a Ciencia e Tecnologia (Portugal) and SFRH/BD/16731/2004 (to M. A. S. C.), Bioenergy Science Center, United States Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science, and Department of Energy Grant DE-FG02-96ER20220.	Abbott DW, 2009, BIOCHEMISTRY-US, V48, P10395, DOI 10.1021/bi9013424; Beylot MH, 2001, BIOCHEM J, V358, P607, DOI 10.1042/0264-6021:3580607; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P6240, DOI 10.1021/bi0101695; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brett CT, 1996, PHYSL BIOCH PLANT CE; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARPITA NC, 1989, ANAL CARBOHYDRATES G, P157; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; Charnock SJ, 1997, J BIOL CHEM, V272, P2942, DOI 10.1074/jbc.272.5.2942; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; DOMON B, 1988, BIOCHEMISTRY-US, V27, P1534, DOI 10.1021/bi00405a021; Ebringerova A, 2005, ADV POLYM SCI, V186, P1, DOI 10.1007/b136816; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, DATA COLLECTION PROC, P114; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; GRUPPEN H, 1992, CARBOHYD RES, V233, P45, DOI 10.1016/S0008-6215(00)90919-4; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Hilge M, 1998, STRUCTURE, V6, P1433, DOI 10.1016/S0969-2126(98)00142-7; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; HOFFMANN RA, 1991, CARBOHYD RES, V221, P63, DOI 10.1016/0008-6215(91)80049-S; JENKINS J, 1995, FEBS LETT, V362, P281, DOI 10.1016/0014-5793(95)00252-5; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Mazumder K, 2010, CARBOHYD RES, V345, P2183, DOI 10.1016/j.carres.2010.07.034; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; MONTANIER CY, 2011, J BIOL CHEM IN PRESS, V286; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pell G, 2004, J BIOL CHEM, V279, P9597, DOI 10.1074/jbc.M312278200; Pires VMR, 2004, J BIOL CHEM, V279, P21560, DOI 10.1074/jbc.M401599200; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; van Bueren AL, 2005, J BIOL CHEM, V280, P530, DOI 10.1074/jbc.M410113200; Vrsanska M, 2007, FEBS J, V274, P1666, DOI 10.1111/j.1742-4658.2007.05710.x; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087; Williams SJ, 2000, J AM CHEM SOC, V122, P4229, DOI 10.1021/ja0002870; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yaoi K, 2007, J MOL BIOL, V370, P53, DOI 10.1016/j.jmb.2007.04.035	48	61	68	2	45	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22510	22520		10.1074/jbc.M110.217315	http://dx.doi.org/10.1074/jbc.M110.217315			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21378160	Green Published, hybrid			2022-12-27	WOS:000291719900059
J	Jin, HJ; Kanthasamy, A; Anantharam, V; Rana, A; Kanthasamy, AG				Jin, Huajun; Kanthasamy, Arthi; Anantharam, Vellareddy; Rana, Ajay; Kanthasamy, Anumantha G.			Transcriptional Regulation of Pro-apoptotic Protein Kinase C delta IMPLICATIONS FOR OXIDATIVE STRESS-INDUCED NEURONAL CELL DEATH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-3-DEPENDENT PROTEOLYTIC CLEAVAGE; BREAST-CANCER CELLS; PKC-DELTA; GENE-EXPRESSION; PARKINSONS-DISEASE; DOPAMINERGIC CELLS; PROMOTER ANALYSIS; GENOMIC STRUCTURE; PHORBOL ESTER; IN-VITRO	We previously demonstrated that protein kinase C delta (PKC delta; PKC delta) is an oxidative stress-sensitive kinase that plays a causal role in apoptotic cell death in neuronal cells. Although PKC delta activation has been extensively studied, relatively little is known about the molecular mechanisms controlling PKC delta expression. To characterize the regulation of PKC delta expression, we cloned an similar to 2-kbp 5 ' -promoter segment of the mouse Prkcd gene. Deletion analysis indicated that the noncoding exon 1 region contained multiple Sp sites, including four GC boxes and one CACCC box, which directed the highest levels of transcription in neuronal cells. In addition, an upstream regulatory region containing adjacent repressive and anti-repressive elements with opposing regulatory activities was identified within the region -712 to -560. Detailed mutagenesis studies revealed that each Sp site made a positive contribution to PKC delta promoter expression. Overexpression of Sp family proteins markedly stimulated PKC delta promoter activity without any synergistic transactivating effect. Furthermore, experiments in Sp-deficient SL2 cells indicated long isoform Sp3 as the essential activator of PKC delta transcription. Importantly, both PKC delta promoter activity and endogenous PKC delta expression in NIE115 cells and primary striatal cultures were inhibited by mithramycin A. The results from chromatin immunoprecipitation and gel shift assays further confirmed the functional binding of Sp proteins to the PKC delta promoter. Additionally, we demonstrated that overexpression of p300 or CREB-binding protein increases the PKC delta promoter activity. This stimulatory effect requires intact Sp-binding sites and is independent of p300 histone acetyltransferase activity. Finally, modulation of Sp transcriptional activity or protein level profoundly altered the cell death induced by oxidative insult, demonstrating the functional significance of Sp-dependent PKC delta gene expression. Collectively, our findings may have implications for development of new translational strategies against oxidative damage.	[Jin, Huajun; Kanthasamy, Arthi; Anantharam, Vellareddy; Kanthasamy, Anumantha G.] Iowa State Univ, Dept Biomed Sci, Parkinsons Disorder Res Lab, Iowa Ctr Adv Neurotoxicol, Ames, IA 50011 USA; [Rana, Ajay] Loyola Univ Chicago, Dept Pharmacol, Stritch Sch Med, Maywood, IL 60153 USA; [Rana, Ajay] Hines VA Med Ctr, Hines, IL 60141 USA	Iowa State University; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Kanthasamy, AG (corresponding author), Iowa State Univ, Dept Biomed Sci, Parkinsons Disorder Res Lab, Iowa Ctr Adv Neurotoxicol, 2062 Coll Vet Med Bldg, Ames, IA 50011 USA.	akanthas@iastate.edu		Kanthasamy, Anumantha/0000-0002-6454-4264; Kanthasamy, Arthi/0000-0003-4654-9907	National Institutes of Health [ES10586, NS065167, GM055835]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES10586 (to A. G. K.), NS065167 (to A. K.), and GM055835 (to A. R.).	Alonso-Escolano D, 2006, J PHARMACOL EXP THER, V318, P373, DOI 10.1124/jpet.106.103358; Ammanamanchi S, 2003, J BIOL CHEM, V278, P35775, DOI 10.1074/jbc.M305961200; Anantharam V, 2002, J NEUROSCI, V22, P1738, DOI 10.1523/JNEUROSCI.22-05-01738.2002; Balasubramanian N, 2002, LEUKEMIA RES, V26, P67, DOI 10.1016/S0145-2126(01)00098-4; Barmack NH, 2000, J COMP NEUROL, V427, P235, DOI 10.1002/1096-9861(20001113)427:2<235::AID-CNE6>3.0.CO;2-6; Battaini F, 2005, ANN NY ACAD SCI, V1057, P177, DOI 10.1196/annals.1356.011; BATTAINI F, 1995, NEUROBIOL AGING, V16, P137, DOI 10.1016/0197-4580(94)00154-5; Berry DM, 1996, J BIOL CHEM, V271, P16090, DOI 10.1074/jbc.271.27.16090; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; Bright R, 2004, J NEUROSCI, V24, P6880, DOI 10.1523/JNEUROSCI.4474-03.2004; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cataldi A, 2009, ANAT REC, V292, P1135, DOI 10.1002/ar.20936; Choi SH, 2006, CANCER RES, V66, P7261, DOI 10.1158/0008-5472.CAN-05-4177; Chou WH, 2004, J CLIN INVEST, V114, P49, DOI 10.1172/JC1200421655; Chou WH, 2005, TRENDS CARDIOVAS MED, V15, P47, DOI 10.1016/j.tcm.2005.01.003; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Evans JD, 2003, AM J CLIN PATHOL, V119, P392, DOI 10.1309/BKPC9DX98R781B87; Gavrielides MV, 2006, CANCER RES, V66, P11792, DOI 10.1158/0008-5472.CAN-06-1139; Giorgi C, 2010, ANTIOXID REDOX SIGN, V13, P1051, DOI 10.1089/ars.2009.2825; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; Hlavackova M, 2010, MOL CELL BIOCHEM, V345, P271, DOI 10.1007/s11010-010-0581-8; Horovitz-Fried M, 2006, CELL SIGNAL, V18, P183, DOI 10.1016/j.cellsig.2005.04.004; Horovitz-Fried M, 2007, CELL SIGNAL, V19, P556, DOI 10.1016/j.cellsig.2006.08.005; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kaneki M, 1999, MOL CELL BIOL, V19, P461; Kanthasamy AG, 2003, ANN NY ACAD SCI, V1010, P683, DOI 10.1196/annals.1299.125; Kanthasamy AG, 2003, ANTIOXID REDOX SIGN, V5, P609, DOI 10.1089/152308603770310275; Kanthasamy A, 2010, NEUROTOXICOLOGY, V31, P555, DOI 10.1016/j.neuro.2009.12.003; Kanthasamy AG, 2006, FREE RADICAL BIO MED, V41, P1578, DOI 10.1016/j.freeradbiomed.2006.08.016; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Kaul S, 2005, MOL BRAIN RES, V139, P137, DOI 10.1016/j.molbrainres.2005.05.022; Kaul S, 2005, J BIOL CHEM, V280, P28721, DOI 10.1074/jbc.M501092200; Kaul S, 2003, EUR J NEUROSCI, V18, P1387, DOI 10.1046/j.1460-9568.2003.02864.x; Kavurma MM, 2001, J BIOL CHEM, V276, P4964, DOI 10.1074/jbc.M009251200; Kharait S, 2006, BIOCHEM BIOPH RES CO, V343, P848, DOI 10.1016/j.bbrc.2006.03.044; Kiley SC, 1999, ONCOGENE, V18, P6748, DOI 10.1038/sj.onc.1203101; Kitazawa M, 2003, NEUROSCIENCE, V119, P945, DOI 10.1016/S0306-4522(03)00226-4; Koike K, 2006, THYROID, V16, P333, DOI 10.1089/thy.2006.16.333; Kruger JS, 2003, MOL CANCER RES, V1, P801; Kudo S, 1998, MOL CELL BIOL, V18, P5492, DOI 10.1128/MCB.18.9.5492; Kurkinen KMA, 2000, GENE, V242, P115, DOI 10.1016/S0378-1119(99)00539-9; Latchoumycandane C, 2005, J PHARMACOL EXP THER, V313, P46, DOI 10.1124/jpet.104.078469; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; LEIBERSPERGER H, 1991, J BIOL CHEM, V266, P14778; Li XH, 2010, PROSTAG OTH LIPID M, V93, P84, DOI 10.1016/j.prostaglandins.2010.06.008; Liedtke C, 2003, J BIOL CHEM, V278, P27593, DOI 10.1074/jbc.M304077200; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Soto A, 2006, J BIOL CHEM, V281, P30419, DOI 10.1074/jbc.M604868200; MacCarthy-Morrogh L, 2000, ONCOGENE, V19, P5534, DOI 10.1038/sj.onc.1203949; Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465; Mavrothalassitis G, 2000, ONCOGENE, V19, P6524, DOI 10.1038/sj.onc.1204045; Miettinen S, 1996, J NEUROSCI, V16, P6236; Morgenstern B, 1996, P NATL ACAD SCI USA, V93, P12098, DOI 10.1073/pnas.93.22.12098; Naik MU, 2000, J COMP NEUROL, V426, P243, DOI 10.1002/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8; Noti JD, 1997, J BIOL CHEM, V272, P24038, DOI 10.1074/jbc.272.38.24038; ONO Y, 1988, J BIOL CHEM, V263, P6927; Pascale A, 1998, MOL NEUROBIOL, V16, P49, DOI 10.1007/BF02740602; Pascale A, 2007, PHARMACOL RES, V55, P560, DOI 10.1016/j.phrs.2007.04.013; Peters CA, 2000, MOL CELL ENDOCRINOL, V162, P181, DOI 10.1016/S0303-7207(00)00193-3; Ponassi R, 2006, BIOCHEM PHARMACOL, V72, P1417, DOI 10.1016/j.bcp.2006.07.031; Quan TH, 1999, J BIOL CHEM, V274, P28566, DOI 10.1074/jbc.274.40.28566; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; RAY R, 1989, J CLIN INVEST, V83, P2003, DOI 10.1172/JCI114110; Reno EM, 2008, HUM PATHOL, V39, P21, DOI 10.1016/j.humpath.2007.05.023; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Rybin VO, 2007, J BIOL CHEM, V282, P23631, DOI 10.1074/jbc.M701676200; Ryu H, 2003, P NATL ACAD SCI USA, V100, P4281, DOI 10.1073/pnas.0737363100; Saito N, 1995, Nihon Yakurigaku Zasshi, V105, P127; Sapetschnig A, 2004, J BIOL CHEM, V279, P42095, DOI 10.1074/jbc.M404989200; Saur D, 2002, J BIOL CHEM, V277, P25798, DOI 10.1074/jbc.M109802200; Shanmugam M, 1999, MOL CELL ENDOCRINOL, V148, P109, DOI 10.1016/S0303-7207(98)00229-9; Sherer TB, 2002, J NEUROSCI, V22, P7006; Shin SY, 2004, J MOL BIOL, V340, P681, DOI 10.1016/j.jmb.2004.04.006; Solovyev VV, 2003, NUCLEIC ACIDS RES, V31, P3540, DOI 10.1093/nar/gkg525; Sowa Y, 1999, CANCER RES, V59, P4266; Spengler ML, 2006, J BIOL CHEM, V281, P5567, DOI 10.1074/jbc.M600035200; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Stempka L, 1999, J BIOL CHEM, V274, P8886, DOI 10.1074/jbc.274.13.8886; Sudhakar C, 2008, FEBS J, V275, P2200, DOI 10.1111/j.1742-4658.2008.06373.x; Suh KS, 2003, GENOMICS, V82, P57, DOI 10.1016/S0888-7543(03)00072-7; Sun XG, 2000, J BIOL CHEM, V275, P7470, DOI 10.1074/jbc.275.11.7470; Suske G, 2000, Methods Mol Biol, V130, P175; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suzuki T, 2000, GENES CELLS, V5, P29, DOI 10.1046/j.1365-2443.2000.00302.x; Takayama M, 2001, JPN CIRC J, V65, P1071, DOI 10.1253/jcj.65.1071; Tavares D, 1999, J BIOL CHEM, V274, P30066, DOI 10.1074/jbc.274.42.30066; Tsai JH, 2000, CANCER LETT, V161, P171, DOI 10.1016/S0304-3835(00)00597-8; Villar J, 2007, CANCER RES, V67, P10859, DOI 10.1158/0008-5472.CAN-07-2041; Vucenik I, 2005, BREAST CANCER RES TR, V91, P35, DOI 10.1007/s10549-004-6456-5; Walker GE, 2001, ENDOCRINOLOGY, V142, P3817, DOI 10.1210/en.142.9.3817; Welman A, 2007, PROTEIN SCI, V16, P2711, DOI 10.1110/ps.072874607; Whetstine JR, 2002, BIOCHEM J, V367, P629, DOI 10.1042/BJ20020512; Wu YZ, 2004, ONCOGENE, V23, P168, DOI 10.1038/sj.onc.1207003; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yang YJ, 2004, MOL CELL NEUROSCI, V25, P406, DOI 10.1016/j.mcn.2003.11.011; Zhang DH, 2007, J PHARMACOL EXP THER, V322, P913, DOI 10.1124/jpet.107.124669; Zhang DH, 2007, J NEUROSCI, V27, P5349, DOI 10.1523/JNEUROSCI.4107-06.2007	106	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19840	19859		10.1074/jbc.M110.203687	http://dx.doi.org/10.1074/jbc.M110.203687			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21467032	hybrid, Green Published			2022-12-27	WOS:000291027700065
J	Lee, IH; Song, SH; Campbell, CR; Kumar, S; Cook, DI; Dinudom, A				Lee, Il-Ha; Song, Sung-Hee; Campbell, Craig R.; Kumar, Sharad; Cook, David I.; Dinudom, Anuwat			Regulation of the Epithelial Na+ Channel by the RH Domain of G Protein-coupled Receptor Kinase, GRK2, and G alpha q/11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION-INDEPENDENT REGULATION; G-ALPHA-Q; SODIUM-CHANNELS; GLUCOSE-TRANSPORT; CYTOSOLIC NA+; SELECTIVE REGULATION; MUCIN SECRETION; GAMMA-SUBUNIT; P2 RECEPTORS; CELLS	The G protein-coupled receptor kinase (GRK2) belongs to a family of protein kinases that phosphorylates agonist-activated G protein-coupled receptors, leading to G protein-receptor uncoupling and termination of G protein signaling. GRK2 also contains a regulator of G protein signaling homology (RH) domain, which selectively interacts with alpha-subunits of the Gq/11 family that are released during G protein-coupled receptor activation. We have previously reported that kinase activity of GRK2 up-regulates activity of the epithelial sodium channel (ENaC) in a Na+ absorptive epithelium by blocking Nedd4-2-dependent inhibition of ENaC. In the present study, we report that GRK2 also regulates ENaC by a mechanism that does not depend on its kinase activity. We show that a wild-type GRK2 (wtGRK2) and a kinase-dead GRK2 mutant ((K220R)GRK2), but not a GRK2 mutant that lacks the C-terminal RH domain (Delta RH-GRK2) or a GRK2 mutant that cannot interact with G alpha q/11/14 ((D110A)GRK2), increase activity of ENaC. GRK2 up-regulates the basal activity of the channel as a consequence of its RH domain binding the alpha-subunits of Gq/11. We further found that expression of constitutively active G alpha q/11 mutants significantly inhibits activity of ENaC. Conversely, co-expression of siRNA against G alpha q/11 increases ENaC activity. The effect of G alpha q on ENaC activity is not due to change in ENaC membrane expression and is independent of Nedd4-2. These findings reveal a novel mechanism by which GRK2 and Gq/11 alpha-subunits regulate the activity ENaC.	[Lee, Il-Ha; Song, Sung-Hee; Campbell, Craig R.; Cook, David I.; Dinudom, Anuwat] Univ Sydney, Fac Med, Bosch Inst, Discipline Physiol, Sydney, NSW 2006, Australia; [Kumar, Sharad] SA Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia	University of Sydney; Centre for Cancer Biology; SA Pathology	Dinudom, A (corresponding author), Med Fdn Bldg,92-94 Parramatta Rd, Sydney, NSW 2050, Australia.	anuwat@physiol.usyd.edu.au	Kumar, Sharad/AAX-7787-2020; Campbell, Craig R/B-5983-2012	Kumar, Sharad/0000-0001-7126-9814; Campbell, Craig R/0000-0002-0843-7579	National Health and Medical Research Council of Australia [508086]; Australian Research Council [DP0774320]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council of Australia (508086) and the Australian Research Council (DP0774320).	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Arthur JW, 2006, BIOINFORMATICS, V22, P2192, DOI 10.1093/bioinformatics/btl381; Ballou LM, 2003, J BIOL CHEM, V278, P23472, DOI 10.1074/jbc.M212232200; Bengrine A, 2007, J BIOL CHEM, V282, P26884, DOI 10.1074/jbc.M611829200; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; Cook DI, 1998, EUR J MORPHOL, V36, P67; Cummins MM, 2002, PFLUG ARCH EUR J PHY, V444, P644, DOI 10.1007/s00424-002-0856-3; Dale LB, 2000, J BIOL CHEM, V275, P38213, DOI 10.1074/jbc.M006075200; Day PW, 2004, J BIOL CHEM, V279, P53643, DOI 10.1074/jbc.M401438200; Day PW, 2003, BIOCHEMISTRY-US, V42, P9176, DOI 10.1021/bi034442+; DEVIVO M, 1992, J BIOL CHEM, V267, P18263; Dhami GK, 2005, J BIOL CHEM, V280, P24420, DOI 10.1074/jbc.M501650200; Dhami GK, 2002, J BIOL CHEM, V277, P25266, DOI 10.1074/jbc.M203593200; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; DINUDOM A, 1995, J PHYSIOL-LONDON, V487, P549, DOI 10.1113/jphysiol.1995.sp020899; Dinudom A, 2004, P NATL ACAD SCI USA, V101, P11886, DOI 10.1073/pnas.0402178101; Dinudom A, 1998, P NATL ACAD SCI USA, V95, P7169, DOI 10.1073/pnas.95.12.7169; Ehre C, 2007, AM J PHYSIOL-CELL PH, V293, pC1445, DOI 10.1152/ajpcell.00051.2007; Erb L, 2006, PFLUG ARCH EUR J PHY, V452, P552, DOI 10.1007/s00424-006-0069-2; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Flores SY, 2003, PFLUG ARCH EUR J PHY, V446, P334, DOI 10.1007/s00424-003-1027-x; Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje; Freedman NJ, 1997, J BIOL CHEM, V272, P17734, DOI 10.1074/jbc.272.28.17734; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; Harvey KF, 2001, J BIOL CHEM, V276, P8597, DOI 10.1074/jbc.C000906200; Hennig B, 2008, EUR J PHARMACOL, V583, P156, DOI 10.1016/j.ejphar.2008.01.017; Hou CF, 2004, J PHARMACOL EXP THER, V309, P697, DOI 10.1124/jpet.103.060574; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Hummler E, 1999, AM J PHYSIOL-GASTR L, V276, pG567, DOI 10.1152/ajpgi.1999.276.3.G567; Imamura T, 1999, MOL CELL BIOL, V19, P6765; Kemp PA, 2004, AM J RESP CELL MOL, V31, P446, DOI 10.1165/rcmb.2003-0211OC; Komwatana P, 1998, J MEMBRANE BIOL, V162, P225, DOI 10.1007/s002329900360; Komwatana P, 1996, P NATL ACAD SCI USA, V93, P8107, DOI 10.1073/pnas.93.15.8107; KONG GH, 1994, J BIOL CHEM, V269, P13084; Kunzelmann K, 2005, FASEB J, V19, P969, DOI 10.1096/fj.04-2469fje; Lee IH, 2008, CLIN EXP PHARMACOL P, V35, P235, DOI 10.1111/j.1440-1681.2007.04844.x; Lee IH, 2007, J BIOL CHEM, V282, P29866, DOI 10.1074/jbc.M701923200; Lee IH, 2009, J BIOL CHEM, V284, P12663, DOI 10.1074/jbc.M809737200; Leipziger J, 2003, AM J PHYSIOL-RENAL, V284, pF419, DOI 10.1152/ajprenal.00075.2002; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Ma HP, 2007, PFLUG ARCH EUR J PHY, V455, P169, DOI 10.1007/s00424-007-0294-3; Matalon S, 1999, ANNU REV PHYSIOL, V61, P627, DOI 10.1146/annurev.physiol.61.1.627; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Sallese M, 2000, MOL PHARMACOL, V57, P826, DOI 10.1124/mol.57.4.826; Sanchez-Perez A, 2007, BIOCHEM BIOPH RES CO, V359, P611, DOI 10.1016/j.bbrc.2007.05.134; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; TURNHEIM K, 1991, PHYSIOL REV, V71, P429, DOI 10.1152/physrev.1991.71.2.429; Usui I, 2004, EMBO J, V23, P2821, DOI 10.1038/sj.emboj.7600297; Wang J, 2008, AM J PHYSIOL-RENAL, V295, pF843, DOI 10.1152/ajprenal.90348.2008; Willets JM, 2005, J BIOL CHEM, V280, P18950, DOI 10.1074/jbc.M412682200	58	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19259	19269		10.1074/jbc.M111.239772	http://dx.doi.org/10.1074/jbc.M111.239772			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21464134	hybrid, Green Published			2022-12-27	WOS:000291027700008
J	Nelson, DE; Laman, H				Nelson, David E.; Laman, Heike			A Competitive Binding Mechanism between Skp1 and Exportin 1 (CRM1) Controls the Localization of a Subset of F-box Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCF UBIQUITIN-LIGASE; PARKINSONIAN-PYRAMIDAL SYNDROME; CELL-CYCLE; SUBCELLULAR-LOCALIZATION; PROTEOLYSIS MACHINERY; FBXO7; PHOSPHORYLATION; COMPLEX; INHIBITOR; P27(KIP1)	SCF-type E3 ubiquitin ligases are crucial regulators of cell cycle progression. As the F-box protein is the substrate-specifying subunit of this family of ligases, their availability dictates the timing and the location of the ubiquitination of substrates. We report here our investigation into the regulation of the localization of F-box proteins, in particular Fbxo7, whose mislocalization is associated with human disease. We identified a motif in Fbxo7 that we have characterized as a functional leucine-rich nuclear export sequence (NES), and which allowed binding to the nuclear export protein, exportin 1 (CRM1). Unusually, the NES was embedded within the F-box domain, which is bound by Skp1 and enables the F-box protein to form part of an E3 ubiquitin ligase. The NES of Fbxo7 controlled its localization and was conserved in Fbxo7 homologues in other species. Skp1 binding prevented Fbxo7 from contacting CRM1. We propose that this competitive binding allowed Fbxo7 to accumulate within the nucleus starting at the G1/S transition. More than ten other F-box proteins also contain an NES at the same location in their F-box domains, indicating that this competitive binding mechanism may contribute to the regulation of a sixth of the known F-box proteins.	[Nelson, David E.; Laman, Heike] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Cambridge	Laman, H (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	hl316@cam.ac.uk	Nelson, David/AAX-5648-2021	Nelson, David/0000-0002-5034-0885; Laman, Heike/0000-0002-6089-171X	BBSRC [BB/F012764/1]; Biotechnology and Biological Sciences Research Council [BB/F012764/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the BBSRC (BB/F012764/1).	Bagui TK, 2003, MOL CELL BIOL, V23, P7285, DOI 10.1128/MCB.23.20.7285-7290.2003; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bashir T, 2010, CELL CYCLE, V9, P971, DOI 10.4161/cc.9.5.10914; Boutonnet C, 2010, CELL CYCLE, V9, P975, DOI 10.4161/cc.9.5.10915; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chang YF, 2006, BIOCHEM BIOPH RES CO, V342, P1022, DOI 10.1016/j.bbrc.2006.02.061; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Di Fonzo A, 2009, NEUROLOGY, V72, P240, DOI 10.1212/01.wnl.0000338144.10967.2b; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kirk R, 2008, J BIOL CHEM, V283, P22325, DOI 10.1074/jbc.M709900200; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Laman H, 2006, CELL CYCLE, V5, P279, DOI 10.4161/cc.5.3.2403; Laman H, 2005, EMBO J, V24, P3104, DOI 10.1038/sj.emboj.7600775; Li FN, 1997, EMBO J, V16, P5629, DOI 10.1093/emboj/16.18.5629; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Nelson G, 2002, J CELL SCI, V115, P1137; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Shojaee S, 2008, AM J HUM GENET, V82, P1375, DOI 10.1016/j.ajhg.2008.05.005; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083	25	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19804	19815		10.1074/jbc.M111.220079	http://dx.doi.org/10.1074/jbc.M111.220079			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21378169	Green Published, hybrid			2022-12-27	WOS:000291027700062
J	Stockbridge, RB; Wolfenden, R				Stockbridge, Randy B.; Wolfenden, Richard			Enhancement of the Rate of Pyrophosphate Hydrolysis by Nonenzymatic Catalysts and by Inorganic Pyrophosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; EVOLUTIONARY CONSERVATION; MANGANESE METALLOENZYMES; PHOSPHORYL TRANSFER; CRYSTAL-STRUCTURE; ENZYMES; MECHANISM; FAMILY; PROFICIENCIES; HYDROXIDE	To estimate the proficiency of inorganic pyrophosphatase as a catalyst, P-31 NMR was used to determine rate constants and thermodynamics of activation for the spontaneous hydrolysis of inorganic pyrophosphate (PPi) in the presence and absence of Mg2+ at elevated temperatures. These values were compared with rate constants and activation parameters determined for the reaction catalyzed by Escherichia coli inorganic pyrophosphatase using isothermal titration calorimetry. At 25 degrees C and pH 8.5, the hydrolysis of MgPPi2- proceeds with a rate constant of 2.8 x 10(-10) s(-1), whereas E. coli pyrophosphatase was found to have a turnover number of 570 s(-1) under the same conditions. The resulting rate enhancement (2 x 10(12)-fold) is achieved entirely by reducing the enthalpy of activation (Delta Delta H-double dagger = -16.6 kcal/mol). The presence of Mg2+ ions or the transfer of the substrate from bulk water to dimethyl sulfoxide was found to increase the rate of pyrophosphate hydrolysis by as much as similar to 10(6)-fold. Transfer to dimethyl sulfoxide accelerated PPi hydrolysis by reducing the enthalpy of activation. Mg2+ increased the rate of PPi hydrolysis by both increasing the entropy of activation and reducing the enthalpy of activation.	[Stockbridge, Randy B.; Wolfenden, Richard] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Wolfenden, R (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Genet Med Suite 3010,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	water@med.unc.edu	Wolfenden, Richard/CAH-1293-2022	Stockbridge, Randy/0000-0001-8848-3032	National Institutes of Health [GM18325]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018325, R01GM018325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM18325.	ARTHUR EM, 1996, METAL COMPLEXES AQUE; BALTSCHEFFSKY H, 1986, CHEM SCRIPTA, V26B, P259; Baykov AA, 1996, BIOCHEMISTRY-US, V35, P4655, DOI 10.1021/bi952635u; BORDWELL FG, 1988, ACCOUNTS CHEM RES, V21, P456, DOI 10.1021/ar00156a004; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Christianson DW, 1997, PROG BIOPHYS MOL BIO, V67, P217, DOI 10.1016/S0079-6107(97)88477-5; COOPERMAN BS, 1992, TRENDS BIOCHEM SCI, V17, P262, DOI 10.1016/0968-0004(92)90406-Y; COOPERMAN BS, 1982, METHOD ENZYMOL, V87, P526; COWAN JA, 1995, BIOL CHEM MAGNESIUM, P8; Dismukes GC, 1996, CHEM REV, V96, P2909, DOI 10.1021/cr950053c; Fabrichniy IP, 2007, J BIOL CHEM, V282, P1422, DOI 10.1074/jbc.M513161200; Gill R, 2005, ACTA CRYSTALLOGR D, V61, P545, DOI 10.1107/S0907444905004038; GUTZ IGR, 1992, CURTIPOT VERSION 3 5; Hagelueken G, 2006, P NATL ACAD SCI USA, V103, P7631, DOI 10.1073/pnas.0510501103; Hedlund J, 2006, FEBS J, V273, P5183, DOI 10.1111/j.1742-4658.2006.05514.x; Heikinheimo P, 1996, STRUCTURE, V4, P1491, DOI 10.1016/S0969-2126(96)00155-4; Heikinheimo P, 2001, P NATL ACAD SCI USA, V98, P3121, DOI 10.1073/pnas.061612498; Heinonen J. K., 2001, BIOL ROLE INORGANIC; JENCKS WP, 1968, HDB BIOCH, pJ150; JOSSE J, 1966, J BIOL CHEM, V241, P1948; KNIGHT WB, 1981, BIOCHEMISTRY-US, V20, P4079, DOI 10.1021/bi00517a021; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; KONSOWITZ LM, 1976, J AM CHEM SOC, V98, P1993, DOI 10.1021/ja00423a072; Lad C, 2003, P NATL ACAD SCI USA, V100, P5607, DOI 10.1073/pnas.0631607100; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Malinen AM, 2007, BIOCHEMISTRY-US, V46, P8872, DOI 10.1021/bi700564b; MARAT K, 1999, SPINWORKS VERSION 2; Merckel MC, 2001, STRUCTURE, V9, P289, DOI 10.1016/S0969-2126(01)00587-1; OSTERHELD RK, 1958, J PHYS CHEM-US, V62, P1133, DOI 10.1021/j150567a028; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Pohjanjoki P, 1998, BIOCHEMISTRY-US, V37, P1754, DOI 10.1021/bi971771r; ROBINSON RA, 1970, ELECTROLYTE SOLUTION, P363; Ronimus RS, 2001, EXTREMOPHILES, V5, P357, DOI 10.1007/s007920100215; SALMINEN T, 1995, BIOCHEMISTRY-US, V34, P782, DOI 10.1021/bi00003a011; Shintani T, 1998, FEBS LETT, V439, P263, DOI 10.1016/S0014-5793(98)01381-7; Smith RM, 1974, CRITICAL STABILITY C, V1-6; Sorensen-Stowell K, 2006, J ORG CHEM, V71, P7180, DOI 10.1021/jo060896b; Stockbridge RB, 2010, P NATL ACAD SCI USA, V107, P22102, DOI 10.1073/pnas.1013647107; Stockbridge RB, 2010, CHEM COMMUN, V46, P4306, DOI 10.1039/c0cc00229a; Stockbridge RB, 2009, J AM CHEM SOC, V131, P18248, DOI 10.1021/ja907967y; Stockbridge RB, 2009, J BIOL CHEM, V284, P22747, DOI 10.1074/jbc.M109.017806; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; WESTHEIMER FH, 1957, J PHYS CHEM-US, V60, P1668, DOI 10.1021/j150546a024; Wilcox DE, 1996, CHEM REV, V96, P2435, DOI 10.1021/cr950043b; Wolfenden R, 2006, CHEM REV, V106, P3379, DOI 10.1021/cr050311y; Zea CJ, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-15	48	28	29	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18538	18546		10.1074/jbc.M110.214510	http://dx.doi.org/10.1074/jbc.M110.214510			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21460215	Green Published, hybrid			2022-12-27	WOS:000290785700026
J	Meran, S; Luo, DD; Simpson, R; Martin, J; Wells, A; Steadman, R; Phillips, AO				Meran, Soma; Luo, Dong Dong; Simpson, Russell; Martin, John; Wells, Alan; Steadman, Robert; Phillips, Aled O.			Hyaluronan Facilitates Transforming Growth Factor-beta 1-dependent Proliferation via CD44 and Epidermal Growth Factor Receptor Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX REORGANIZATION; SMOOTH-MUSCLE-CELLS; TGF-BETA; EGF RECEPTOR; WOUND CONTRACTION; ORAL FIBROBLASTS; FIBROSIS; MIGRATION; ACTIVATION; PHENOTYPE	Fibroblast proliferation is an early feature of progressive tissue fibrosis and is largely regulated by the cytokine transforming growth factor-beta 1 (TGF-beta 1). In the oral mucosa, fibroblasts have a unique phenotype and demonstrate healing with no fibrosis/scarring. Our previous studies show that whereas dermal fibroblasts proliferate in response to TGF-beta 1, oral fibroblasts have an antiproliferative response to this cytokine. Hyaluronan (HA) was directly linked to this TGF-beta 1-dependent response. The aim of this study was to understand the underlying mechanism through which HA regulates TGF-beta-dependent responses. Using patient-matched oral and dermal fibroblasts, we show that TGF-beta 1-dependent proliferation is mediated through the HA receptor CD44, whereas the TGF-beta 1-mediated antiproliferative response is CD44-independent. Furthermore, overexpression of HAS2 (HA synthase-2) in oral cells modifies their response, and they subsequently demonstrate a proliferative, CD44-dependent response to TGF-beta 1. We also show that epidermal growth factor (EGF) and its receptor (EGFR) are essential for TGF-beta 1/HA/CD44-dependent proliferation. Increased HA levels promote EGFR and CD44 coupling, potentiating signal transduction through the MAPK/ERK pathway. Thus, in a HA-rich environment, late ERK1/2 activation results from EGFR/CD44 coupling and leads to a proliferative response to TGF-beta 1. In comparison, in a non-HA-rich environment, only early ERK1/2 activation occurs, and this is associated with an antiproliferative response to TGF-beta 1. In summary, HA facilitates TGF-beta 1-dependent fibroblast proliferation through promoting interaction between CD44 and EGFR, which then promotes specific MAPK/ERK activation, inducing cellular proliferation.	[Meran, Soma; Luo, Dong Dong; Simpson, Russell; Martin, John; Steadman, Robert; Phillips, Aled O.] Univ Wales Hosp, Inst Nephrol, Cardiff CF14 4XN, S Glam, Wales; [Wells, Alan] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA	Cardiff University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Meran, S (corresponding author), Univ Wales Hosp, Inst Nephrol, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	merans@cf.ac.uk	Steadman, Robert/O-1614-2016	Steadman, Robert/0000-0002-1303-2496; Wells, Alan/0000-0002-1637-8150				alKhateeb T, 1997, J PERIODONTOL, V68, P1063, DOI 10.1902/jop.1997.68.11.1063; ANSCHER MS, 1993, NEW ENGL J MED, V328, P1592, DOI 10.1056/NEJM199306033282203; ARMSTRONG JR, 1995, DEV BIOL, V169, P242, DOI 10.1006/dbio.1995.1141; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Beanes Steven R., 2003, Expert Reviews in Molecular Medicine, V5, P1, DOI 10.1017/S1462399403005817; Bedossa P, 2003, J PATHOL, V200, P504, DOI 10.1002/path.1397; BORDER WA, 1995, J CLIN INVEST, V96, P655, DOI 10.1172/JCI118107; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Border WA, 1997, KIDNEY INT, V51, P1388, DOI 10.1038/ki.1997.190; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; BRECHT M, 1986, BIOCHEM J, V239, P445, DOI 10.1042/bj2390445; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chen PY, 2007, BIOCHEM BIOPH RES CO, V360, P1, DOI 10.1016/j.bbrc.2007.04.211; Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x; Chipev Constantin C, 2002, BMC Dermatol, V2, P13, DOI 10.1186/1471-5945-2-13; CONNOR TB, 1989, J CLIN INVEST, V83, P1661, DOI 10.1172/JCI114065; Deng ZY, 2009, CHINESE MED J-PEKING, V122, P1449, DOI 10.3760/cma.j.issn.0366-6999.2009.12.018; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF1202, DOI 10.1152/ajprenal.00406.2005; Dong J, 2004, AM J PHYSIOL-RENAL, V287, pF1049, DOI 10.1152/ajprenal.00132.2004; EDDY AA, 1994, J AM SOC NEPHROL, V5, P1273; Ellis IR, 2007, EXP CELL RES, V313, P732, DOI 10.1016/j.yexcr.2006.11.016; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; FRANCIS GS, 1995, AM J CARDIOL, V75, pA11, DOI 10.1016/S0002-9149(99)80378-6; Funaba M, 2008, J BIOCHEM BIOPH METH, V70, P816, DOI 10.1016/j.jbbm.2007.10.001; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Hardie WD, 2008, AM J PHYSIOL-LUNG C, V294, pL1217, DOI 10.1152/ajplung.00020.2008; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Ito T, 2004, KIDNEY INT, V65, P823, DOI 10.1111/j.1523-1755.2004.00457.x; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Kim Y, 2008, J BIOL CHEM, V283, P22513, DOI 10.1074/jbc.M708319200; Knudson C. B., 2000, GLYCOFORUM; Krieg T, 1989, Recenti Prog Med, V80, P594; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Ma Frank Y, 2009, Front Biosci (Schol Ed), V1, P171, DOI 10.2741/s17; Meran S, 2008, J BIOL CHEM, V283, P6530, DOI 10.1074/jbc.M704819200; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Palyi-Krekk Z, 2008, CANCER LETT, V263, P231, DOI 10.1016/j.canlet.2008.01.014; PANDIELLA A, 1989, ONCOGENE, V4, P1299; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Poumay Yves, 2009, Folia Med (Plovdiv), V51, P5; Samarakoon R, 2008, J MOL CELL CARDIOL, V44, P527, DOI 10.1016/j.yjmcc.2007.12.006; Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; Spicer A. P., 1999, GLYCOFORUM; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Stephens P, 1996, J DENT RES, V75, P1358, DOI 10.1177/00220345960750060601; Stephens P, 2001, BRIT J DERMATOL, V144, P229, DOI 10.1046/j.1365-2133.2001.04006.x; Terzi F, 2000, J CLIN INVEST, V106, P225, DOI 10.1172/JCI8315; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Turley EA, 1999, GLYCOFORUM; van den Bogaerdt AJ, 2002, ARCH DERMATOL RES, V294, P135, DOI 10.1007/s00403-002-0305-3; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	59	87	90	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17618	17630		10.1074/jbc.M111.226563	http://dx.doi.org/10.1074/jbc.M111.226563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454519	hybrid, Green Published			2022-12-27	WOS:000290585200025
J	Nagy, P; Karton, A; Betz, A; Peskin, AV; Pace, P; O'Reilly, RJ; Hampton, MB; Radom, L; Winterbourn, CC				Nagy, Peter; Karton, Amir; Betz, Andrea; Peskin, Alexander V.; Pace, Paul; O'Reilly, Robert J.; Hampton, Mark B.; Radom, Leo; Winterbourn, Christine C.			Model for the Exceptional Reactivity of Peroxiredoxins 2 and 3 with Hydrogen Peroxide A KINETIC AND COMPUTATIONAL STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE SULFENIC ACID; BACTERIAL PEROXIREDOXIN; PEROXYNITRITE; MECHANISMS; SUBSTRATE; OXIDATION; AHPC	Peroxiredoxins (Prx) are thiol peroxidases that exhibit exceptionally high reactivity toward peroxides, but the chemical basis for this is not well understood. We present strong experimental evidence that two highly conserved arginine residues play a vital role in this activity of human Prx2 and Prx3. Point mutation of either ArgI or ArgII (in Prx3 Arg-123 and Arg-146, which are similar to 3-4 angstrom or similar to 6-7 angstrom away from the active site peroxidative cysteine (C-p), respectively) in each case resulted in a 5 orders of magnitude loss in reactivity. A further 2 orders of magnitude decrease in the second-order rate constant was observed for the double arginine mutants of both isoforms, suggesting a cooperative function for these residues. Detailed ab initio theoretical calculations carried out with the high level G4 procedure suggest strong catalytic effects of H-bond-donating functional groups to the C-p sulfur and the reactive and leaving oxygens of the peroxide in a cooperative manner. Using a guanidinium cation in the calculations to mimic the functional group of arginine, we were able to locate two transition structures that indicate rate enhancements consistent with our experimentally observed rate constants. Our results provide strong evidence for a vital role of ArgI in activating the peroxide that also involves H-bonding to ArgII. This mechanism could explain the exceptional reactivity of peroxiredoxins toward H2O2 and may have wider implications for protein thiol reactivity toward peroxides.	[Winterbourn, Christine C.] Univ Otago Christchurch, Dept Pathol, Christchurch, New Zealand; [Winterbourn, Christine C.] Univ Otago Christchurch, Natl Res Ctr Growth & Dev, Christchurch, New Zealand; [Karton, Amir; O'Reilly, Robert J.; Radom, Leo] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Karton, Amir; O'Reilly, Robert J.; Radom, Leo] Univ Sydney, ARC Ctr Excellence Free Radical Chem & Biotechnol, Sydney, NSW 2006, Australia	University of Otago; University of Otago; University of Sydney; University of Sydney	Nagy, P (corresponding author), Natl Inst Oncol, Dept Mol Immunol & Toxicol, Rath Gyorgy 7-9, H-1122 Budapest, Hungary.	peter.nagy@oncol.hu	O'Reilly, Robert/E-9421-2010; Hampton, Mark B/A-8490-2008; Nagy, Peter/C-6768-2008; O'Reilly, Robert John/AFR-4026-2022; Karton, Amir/P-1942-2019; Peskin, alexander/R-6457-2019; O'Reilly, Robert/M-2456-2015; Pace, Paul E/A-3104-2012; Karton, Amir/B-7628-2008	O'Reilly, Robert/0000-0001-6938-9999; Hampton, Mark B/0000-0002-7349-3729; Nagy, Peter/0000-0003-3393-235X; O'Reilly, Robert John/0000-0002-5000-1920; Karton, Amir/0000-0002-7981-508X; O'Reilly, Robert/0000-0002-5000-1920; Pace, Paul E/0000-0003-1855-5760; Karton, Amir/0000-0002-7981-508X; Radom, Leo/0000-0001-8249-1314	Marsden Fund; Health Research Council of New Zealand; Australian Research Council	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand); Australian Research Council(Australian Research Council)	This work was supported by the Marsden Fund, the Health Research Council of New Zealand, and the Australian Research Council.	Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Cox AG, 2009, BIOCHEMISTRY-US, V48, P6495, DOI 10.1021/bi900558g; DOLMAN D, 1975, CAN J BIOCHEM CELL B, V53, P495, DOI 10.1139/o75-069; Fourquet S, 2008, ANTIOXID REDOX SIGN, V10, P1565, DOI 10.1089/ars.2008.2049; HALL A, 2010, ANTIOXID RE IN PRESS; Hall A, 2010, J MOL BIOL, V402, P194, DOI 10.1016/j.jmb.2010.07.022; Konig J, 2003, J BIOL CHEM, V278, P24409, DOI 10.1074/jbc.M301145200; Nagy P., 2010, ADV MOL TOXICOLOGY, P183, DOI DOI 10.1016/S0012-821X(03)00488-6; Nagy P, 2007, J AM CHEM SOC, V129, P14082, DOI 10.1021/ja0737218; Nagy P, 2007, J ORG CHEM, V72, P8838, DOI 10.1021/jo701813f; Nakamura T, 2008, P NATL ACAD SCI USA, V105, P6238, DOI 10.1073/pnas.0709822105; Nakamura T, 2010, J BIOCHEM, V147, P109, DOI 10.1093/jb/mvp154; Nelson KJ, 2008, BIOCHEMISTRY-US, V47, P12860, DOI 10.1021/bi801718d; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Parsonage D, 2008, P NATL ACAD SCI USA, V105, P8209, DOI 10.1073/pnas.0708308105; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Peskin AV, 2010, BIOCHEM J, V432, P313, DOI 10.1042/BJ20101156; Sandala GM, 2010, ACCOUNTS CHEM RES, V43, P642, DOI 10.1021/ar900260c; Stacey MM, 2009, FREE RADICAL BIO MED, V47, P1468, DOI 10.1016/j.freeradbiomed.2009.08.022; Trujillo Madia, 2007, V44, P83; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9	21	86	88	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18048	18055		10.1074/jbc.M111.232355	http://dx.doi.org/10.1074/jbc.M111.232355			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21385867	Green Published, hybrid			2022-12-27	WOS:000290585200066
J	Xu, Y; Lee, M; Moeller, A; Song, S; Yoon, BY; Kim, HM; Jun, SY; Lee, K; Ha, NC				Xu, Yongbin; Lee, Minho; Moeller, Arne; Song, Saemee; Yoon, Bo-Young; Kim, Hong-Man; Jun, So-Young; Lee, Kangseok; Ha, Nam-Chul			Funnel-like Hexameric Assembly of the Periplasmic Adapter Protein in the Tripartite Multidrug Efflux Pump in Gram-negative Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION PROTEINS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; TRANSPORTER ACRB; TIP REGION; TOLC; COMPONENT; CHANNEL; CRYSTALLIZATION	Gram-negative bacteria expel diverse toxic chemicals through the tripartite efflux pumps spanning both the inner and outer membranes. The Escherichia coli AcrAB-TolC pump is the principal multidrug exporter that confers intrinsic drug tolerance to the bacteria. The inner membrane transporter AcrB requires the outer membrane factor TolC and the periplasmic adapter protein AcrA. However, it remains ambiguous how the three proteins are assembled. In this study, a hexameric model of the adapter protein was generated based on the propensity for trimerization of a dimeric unit, and this model was further validated by presenting its channel-forming property that determines the substrate specificity. Genetic, in vitro complementation, and electron microscopic studies provided evidence for the binding of the hexameric adapter protein to the outer membrane factor in an intermeshing cogwheel manner. Structural analyses suggested that the adapter covers the periplasmic region of the inner membrane transporter. Taken together, we propose an adapter bridging model for the assembly of the tripartite pump, where the adapter protein provides a bridging channel and induces the channel opening of the outer membrane factor in the intermeshing tip-to-tip manner.	[Lee, Minho; Song, Saemee; Kim, Hong-Man; Lee, Kangseok] Chung Ang Univ, Res Ctr Biomol & Biosyst, Dept Life Sci, Program BK21, Seoul 156756, South Korea; [Moeller, Arne] Scripps Res Inst, Natl Resource Automated Mol Microscopy, La Jolla, CA 92037 USA; [Xu, Yongbin; Yoon, Bo-Young; Jun, So-Young; Ha, Nam-Chul] Pusan Natl Univ, Res Inst Drug Dev, Pusan 609735, South Korea; [Xu, Yongbin; Yoon, Bo-Young; Jun, So-Young; Ha, Nam-Chul] Pusan Natl Univ, Coll Pharm, Dept Mfg Pharm, Pusan 609735, South Korea	Chung Ang University; Scripps Research Institute; Pusan National University; Pusan National University	Lee, K (corresponding author), Chung Ang Univ, Res Ctr Biomol & Biosyst, Dept Life Sci, Program BK21, Seoul 156756, South Korea.	kangseok@cau.ac.kr; hnc@pusan.ac.kr	Lee, Minho/AAK-4109-2021	Lee, Minho/0000-0002-8404-5702; Moeller, Arne/0000-0003-1101-5366	National Research Foundation [NRF-2010-0016052]; National Research Program of Korea [20100002201]; Joint Center for Innovation in Membrane Protein Production for Structure Determination [RFA-RM-08-019]; National Institutes of Health through the NCRR P41 [RR17573, P41]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197] Funding Source: NIH RePORTER	National Research Foundation; National Research Program of Korea; Joint Center for Innovation in Membrane Protein Production for Structure Determination; National Institutes of Health through the NCRR P41(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Research Foundation Grant NRF-2010-0016052 (to N.-C. H.) and Pioneer Research Center Program Grant 20100002201 from the National Research Program of Korea (to K. L.).; Recipient of Grant RFA-RM-08-019 from the Joint Center for Innovation in Membrane Protein Production for Structure Determination.; We thank Erica Jacovetty for assistance with EM data collection. EM imaging was performed at the National Resource for Automated Molecular Microscopy, which is supported by National Institutes of Health Grant RR17573 through the NCRR P41 program.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Avila-Sakar AJ, 2001, J STRUCT BIOL, V136, P81, DOI 10.1006/jsbi.2001.4418; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; De Angelis F, 2010, P NATL ACAD SCI USA, V107, P11038, DOI 10.1073/pnas.1003908107; Gerken H, 2004, MOL MICROBIOL, V54, P620, DOI 10.1111/j.1365-2958.2004.04301.x; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gristwood T, 2008, MOL MICROBIOL, V69, P418, DOI 10.1111/j.1365-2958.2008.06291.x; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Husain F, 2004, J BACTERIOL, V186, P8533, DOI 10.1128/JB.186.24.8533-8536.2004; Kim HM, 2010, J BACTERIOL, V192, P4498, DOI 10.1128/JB.00334-10; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lewis K, 2000, CURR BIOL, V10, pR678, DOI 10.1016/S0960-9822(00)00682-5; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Mima T, 2007, J BACTERIOL, V189, P7600, DOI 10.1128/JB.00850-07; Misra R, 2009, BBA-PROTEINS PROTEOM, V1794, P817, DOI 10.1016/j.bbapap.2009.02.017; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Nikaido H, 1999, CURR OPIN INFECT DIS, V12, P529, DOI 10.1097/00001432-199912000-00001; Nikaido H, 2001, J MOL MICROB BIOTECH, V3, P215; Piao S, 2008, ACTA CRYSTALLOGR F, V64, P391, DOI 10.1107/S1744309108008701; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Takatsuka Y, 2009, J BACTERIOL, V191, P1729, DOI 10.1128/JB.01441-08; Tamura N, 2005, BIOCHEMISTRY-US, V44, P11115, DOI 10.1021/bi050452u; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Tikhonova EB, 2009, P NATL ACAD SCI USA, V106, P16416, DOI 10.1073/pnas.0906601106; Trepout S, 2010, BBA-BIOMEMBRANES, V1798, P1953, DOI 10.1016/j.bbamem.2010.06.019; Weeks JW, 2010, MOL MICROBIOL, V75, P1468, DOI 10.1111/j.1365-2958.2010.07068.x; Xu Y, 2011, J BIOL CHEM, V286, P13541, DOI 10.1074/jbc.M110.202598; Xu YB, 2010, BIOCHEM BIOPH RES CO, V394, P962, DOI 10.1016/j.bbrc.2010.03.097; Xu Y, 2009, BIOCHEMISTRY-US, V48, P5218, DOI 10.1021/bi900415t; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190	37	49	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17910	17920		10.1074/jbc.M111.238535	http://dx.doi.org/10.1074/jbc.M111.238535			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454662	hybrid, Green Published			2022-12-27	WOS:000290585200054
J	Doseth, B; Visnes, T; Wallenius, A; Ericsson, I; Sarno, A; Pettersen, HS; Flatberg, A; Catterall, T; Slupphaug, G; Krokan, HE; Kavli, B				Doseth, Berit; Visnes, Torkild; Wallenius, Anders; Ericsson, Ida; Sarno, Antonio; Pettersen, Henrik Sahlin; Flatberg, Arnar; Catterall, Tara; Slupphaug, Geir; Krokan, Hans E.; Kavli, Bodil			Uracil-DNA Glycosylase in Base Excision Repair and Adaptive Immunity SPECIES DIFFERENCES BETWEEN MAN AND MOUSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-SWITCH RECOMBINATION; UNG GENE; SOMATIC HYPERMUTATION; DEFICIENT MICE; CYTOTOXICITY; REPLICATION; CELLS; 5-FLUOROURACIL; RECOGNITION; SPECIFICITY	Genomic uracil is a DNA lesion but also an essential key intermediate in adaptive immunity. In B cells, activation-induced cytidine deaminase deaminates cytosine to uracil (U:G mispairs) in Ig genes to initiate antibody maturation. Uracil-DNA glycosylases (UDGs) such as uracil N-glycosylase (UNG), single strand-selective monofunctional uracil-DNA glycosylase 1 (SMUG1), and thymine-DNA glycosylase remove uracil from DNA. Gene-targeted mouse models are extensively used to investigate the role of these enzymes in DNA repair and Ig diversification. However, possible species differences in uracil processing in humans and mice are yet not established. To address this, we analyzed UDG activities and quantities in human and mouse cell lines and in splenic B cells from Ung(+/+) and Ung(-/-) backcrossed mice. Interestingly, human cells displayed similar to 15-fold higher total uracil excision capacity due to higher levels of UNG. In contrast, SMUG1 activity was similar to 8-fold higher in mouse cells, constituting similar to 50% of the total U:G excision activity compared with less than 1% in human cells. In activated B cells, both UNG and SMUG1 activities were at levels comparable with those measured for mouse cell lines. Moreover, SMUG1 activity per cell was not down-regulated after activation. We therefore suggest that SMUG1 may work as a weak backup activity for UNG2 during class switch recombination in Ung(-/-) mice. Our results reveal significant species differences in genomic uracil processing. These findings should be taken into account when mouse models are used in studies of uracil DNA repair and adaptive immunity.	[Doseth, Berit; Visnes, Torkild; Wallenius, Anders; Ericsson, Ida; Sarno, Antonio; Pettersen, Henrik Sahlin; Flatberg, Arnar; Catterall, Tara; Slupphaug, Geir; Krokan, Hans E.; Kavli, Bodil] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Fac Med, N-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Kavli, B (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Fac Med, POB 8905, N-7491 Trondheim, Norway.	bodil.kavli@ntnu.no	Pettersen, Henrik Sahlin/B-9901-2011; Visnes, Torkild/H-3242-2017; Slupphaug, Geir/AAN-3794-2020; kavli, bodil/ABC-8889-2020	Visnes, Torkild/0000-0003-1047-988X; Sarno, Antonio/0000-0002-9308-8018; Slupphaug, Geir/0000-0002-7498-3500; Pettersen, Henrik Sahlin/0000-0003-3219-0577	Research Council of Norway; Norwegian Cancer Association; St. Olavs's Hospital in Trondheim, Norway; Svanhild and Arne Must Fund for Medical Research	Research Council of Norway(Research Council of Norway); Norwegian Cancer Association; St. Olavs's Hospital in Trondheim, Norway; Svanhild and Arne Must Fund for Medical Research	This work was supported by The Research Council of Norway (National Program for Research in Functional Genomics); The Norwegian Cancer Association; the Cancer Fund at St. Olavs's Hospital in Trondheim, Norway; and The Svanhild and Arne Must Fund for Medical Research.	Akbari M, 2004, NUCLEIC ACIDS RES, V32, P5486, DOI 10.1093/nar/gkh872; An Q, 2007, CANCER RES, V67, P940, DOI 10.1158/0008-5472.CAN-06-2960; Andersen S, 2005, DNA REPAIR, V4, P1432, DOI 10.1016/j.dnarep.2005.08.004; Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444; Begum NA, 2007, J BIOL CHEM, V282, P731, DOI 10.1074/jbc.M607439200; Cappelli E, 2001, CARCINOGENESIS, V22, P387, DOI 10.1093/carcin/22.3.387; Cseresnyes Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-88; Dhillon KK, 2010, DNA REPAIR, V9, P11, DOI 10.1016/j.dnarep.2009.09.013; Di Noia JM, 2007, J EXP MED, V204, P3209, DOI 10.1084/jem.20071768; GOWER JC, 1996, CHAPMANHALL CRC MONO, V54; Hagen L, 2008, EMBO J, V27, P51, DOI 10.1038/sj.emboj.7601958; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hardeland U, 2007, NUCLEIC ACIDS RES, V35, P3859, DOI 10.1093/nar/gkm337; Haug T, 1998, NUCLEIC ACIDS RES, V26, P1449, DOI 10.1093/nar/26.6.1449; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Jolliffe I. T., 2002, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kavli B, 2005, J EXP MED, V201, P2011, DOI 10.1084/jem.20050042; Kavli B, 2002, J BIOL CHEM, V277, P39926, DOI 10.1074/jbc.M207107200; Krokan HE, 2001, PROG NUCLEIC ACID RE, V68, P365; Kunz C, 2009, PLOS BIOL, V7, P967, DOI 10.1371/journal.pbio.1000091; Kvaloy K, 2001, MUTAT RES-DNA REPAIR, V461, P325, DOI 10.1016/S0921-8777(00)00063-X; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; MOSBAUGH DW, 1994, PROG NUCLEIC ACID RE, V48, P315, DOI 10.1016/S0079-6603(08)60859-4; Nilsen H, 2000, NUCLEIC ACIDS RES, V28, P2277, DOI 10.1093/nar/28.12.2277; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Nilsen H, 2003, ONCOGENE, V22, P5381, DOI 10.1038/sj.onc.1206860; NISSENMEYER J, 1987, CANCER RES, V47, P2251; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Pettersen HS, 2007, NUCLEIC ACIDS RES, V35, P3879, DOI 10.1093/nar/gkm372; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Scaramozzino N, 2003, NUCLEIC ACIDS RES, V31, P4950, DOI 10.1093/nar/gkg672; Shen HM, 2006, J IMMUNOL, V177, P5386, DOI 10.4049/jimmunol.177.8.5386; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Turner DP, 2006, CANCER RES, V66, P7686, DOI 10.1158/0008-5472.CAN-05-4488; Visnes T, 2008, DNA REPAIR, V7, P1869, DOI 10.1016/j.dnarep.2008.07.012	37	38	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16669	16680		10.1074/jbc.M111.230052	http://dx.doi.org/10.1074/jbc.M111.230052			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454529	Green Published, hybrid			2022-12-27	WOS:000290301900015
J	Kavuri, SM; Geserick, P; Berg, D; Dimitrova, DP; Feoktistova, M; Siegmund, D; Gollnick, H; Neumann, M; Wajant, H; Leverkus, M				Kavuri, Shyam M.; Geserick, Peter; Berg, Daniela; Dimitrova, Diana Panayotova; Feoktistova, Maria; Siegmund, Daniela; Gollnick, Harald; Neumann, Manfred; Wajant, Harald; Leverkus, Martin			Cellular FLICE-inhibitory Protein (cFLIP) Isoforms Block CD95-and TRAIL Death Receptor-induced Gene Induction Irrespective of Processing of Caspase-8 or cFLIP in the Death-inducing Signaling Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; INDUCED APOPTOSIS; FAMILY-MEMBERS; LONG FORM; TNF-ALPHA; ACTIVATION; CELLS; KERATINOCYTES; FAS	Death receptors (DRs) induce apoptosis but also stimulate proinflammatory "non-apoptotic" signaling (e. g. NF-kappa B and mitogen-activated protein kinase (MAPK) activation) and inhibit distinct steps of DR-activated maturation of procaspase-8. To examine whether isoforms of cellular FLIP (cFLIP) or its cleavage products differentially regulate DR signaling, we established HaCaT cells expressing cFLIP(S), cFLIP(L), or mutants of cFLIP(L) (cFLIP(D376N) and cFLIP(p43)). cFLIP variants blocked TRAIL- and CD95L-induced apoptosis, but the cleavage pattern of caspase-8 in the death inducing signaling complex was different: cFLIP(L) induced processing of caspase-8 to the p43/41 fragments irrespective of cFLIP cleavage. cFLIP(S) or cFLIP(p43) blocked procaspase-8 cleavage. Analyzing non-apoptotic signaling pathways, we found that TRAIL and CD95L activate JNK and p38 within 15 min. cFLIP variants and different caspase inhibitors blocked late death ligand-induced JNK or p38 MAPK activation suggesting that these responses are secondary to cell death. cFLIP isoforms/mutants also blocked death ligand-mediated gene induction of CXCL-8 (IL-8). Knockdown of caspase-8 fully suppressed apoptotic and non-apoptotic signaling. Knockdown of cFLIP isoforms in primary human keratinocytes enhanced CD95L- and TRAIL-induced NF-kappa B activation, and JNK and p38 activation, underscoring the regulatory role of cFLIP for these DR-mediated signals. Whereas the presence of caspase-8 is critical for apoptotic and non-apoptotic signaling, cFLIP isoforms are potent inhibitors of TRAIL- and CD95L-induced apoptosis, NF-kappa B activation, and the late JNK and p38 MAPK activation. cFLIP-mediated inhibition of CD95 and TRAIL DR could be of crucial importance during keratinocyte skin carcinogenesis and for the activation of innate and/or adaptive immune responses triggered by DR activation in the skin.	[Kavuri, Shyam M.; Geserick, Peter; Dimitrova, Diana Panayotova; Feoktistova, Maria; Leverkus, Martin] Heidelberg Univ, Dept Dermatol Venereol & Allergol, Sect Mol Dermatol, Med Fac Mannheim, D-68167 Mannheim, Germany; [Kavuri, Shyam M.; Geserick, Peter; Dimitrova, Diana Panayotova; Feoktistova, Maria; Gollnick, Harald; Leverkus, Martin] Otto VonGuericke Univ Magdegurg, Lab Expt Dermatol, Dept Dermatol & Venereol, D-39120 Magdeburg, Germany; [Berg, Daniela; Siegmund, Daniela; Wajant, Harald] Univ Wurzburg, Dept Mol Internal Med, Med Clin & Polyclin 2, D-97080 Wurzburg, Germany; [Neumann, Manfred] Univ Tubingen, Inst Pathol, Dept Mol Pathol, D-72076 Tubingen, Germany	Ruprecht Karls University Heidelberg; Otto von Guericke University; University of Wurzburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Leverkus, M (corresponding author), Heidelberg Univ, Dept Dermatol Venereol & Allergol, Sect Mol Dermatol, Med Fac Mannheim, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	martin.leverkus@medma.uni-heidelberg.de	Feoktistova, Maria/HHN-5423-2022; Wajant, Harald/A-3020-2017	Wajant, Harald/0000-0002-2005-3949	Deutsche Forschungsgemeinschaft [Le 953/5-1, Le 953/6-1]; Deutsche Forschungsgemeinschaft Graduiertenkolleg [1167]; Wilhelm-Sander-Stiftung [2008.072.1]; Deutsche Krebshilfe [106849]; Center of Excellence Dermatology Mannheim of Baden-Wurttemberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft Graduiertenkolleg(German Research Foundation (DFG)); Wilhelm-Sander-Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe); Center of Excellence Dermatology Mannheim of Baden-Wurttemberg	This work was supported by Deutsche Forschungsgemeinschaft Grants Le 953/5-1 and Le 953/6-1, Deutsche Forschungsgemeinschaft Graduiertenkolleg 1167, Wilhelm-Sander-Stiftung Grant 2008.072.1, and Deutsche Krebshilfe Grant 106849 (to M. L.). S. M. K. and M. F. were supported by the "Center of Excellence Dermatology Mannheim of Baden-Wurttemberg."	Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Azoitei N, 2005, J NEUROCHEM, V93, P1487, DOI 10.1111/j.1471-4159.2005.03148.x; Banno T, 2005, J BIOL CHEM, V280, P18973, DOI 10.1074/jbc.M411758200; Berg D, 2007, CELL DEATH DIFFER, V14, P2021, DOI 10.1038/sj.cdd.4402213; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Choi C, 2001, CANCER RES, V61, P3084; Devin A, 2003, EMBO REP, V4, P623, DOI 10.1038/sj.embor.embor854; Diessenbacher P, 2008, J INVEST DERMATOL, V128, P1134, DOI 10.1038/sj.jid.5701141; Dohrman A, 2005, J IMMUNOL, V174, P5270, DOI 10.4049/jimmunol.174.9.5270; Duckett Colin S, 2005, Biochem J, V385, pe1; Ehrenschwender M, 2010, CELL DEATH DIFFER, V17, P1435, DOI 10.1038/cdd.2010.36; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Farley SM, 2006, J INVEST DERMATOL, V126, P2438, DOI 10.1038/sj.jid.5700477; Fricker N, 2010, J CELL BIOL, V190, P377, DOI 10.1083/jcb.201002060; Geserick P, 2008, ONCOGENE, V27, P3211, DOI 10.1038/sj.onc.1210985; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; Goebeler M, 2001, BLOOD, V97, P46, DOI 10.1182/blood.V97.1.46; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Harper N, 2001, J BIOL CHEM, V276, P34743, DOI 10.1074/jbc.M105693200; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Kerstan A, 2009, EXP DERMATOL, V18, P893, DOI 10.1111/j.1600-0625.2009.00919.x; Kim HS, 2005, CANCER RES, V65, P6111, DOI 10.1158/0008-5472.CAN-05-0472; Krammer PH, 2007, ADV CANCER RES, V97, P111, DOI 10.1016/S0065-230X(06)97005-5; Kreuz S, 2004, J CELL BIOL, V166, P369, DOI 10.1083/jcb.200401036; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Leverkus M, 2000, CANCER RES, V60, P553; Leverkus M, 2003, J INVEST DERMATOL, V121, P149, DOI 10.1046/j.1523-1747.2003.12332.x; Leverkus M, 2003, MOL CELL BIOL, V23, P777, DOI 10.1128/MCB.23.3.777-790.2003; Leverkus M, 2008, EXP DERMATOL, V17, P614, DOI 10.1111/j.1600-0625.2008.00728.x; Leverkus M, 2006, J INVEST DERMATOL, V126, P91, DOI 10.1038/sj.jid.5700012; Martinon F, 2000, FEBS LETT, V468, P134, DOI 10.1016/S0014-5793(00)01212-6; Matta H, 2003, J BIOL CHEM, V278, P52406, DOI 10.1074/jbc.M307308200; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mueller MM, 2001, AM J PATHOL, V159, P1567, DOI 10.1016/S0002-9440(10)62541-2; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Schmidt M, 2000, J BIOL CHEM, V275, P41011, DOI 10.1074/jbc.M003716200; Schmidt M, 2010, J CELL MOL MED, V14, P1760, DOI 10.1111/j.1582-4934.2009.00823.x; Siegmund D, 2007, CELL SIGNAL, V19, P1172, DOI 10.1016/j.cellsig.2006.12.008; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Sun QM, 2003, J BIOL CHEM, V278, P52437, DOI 10.1074/jbc.M304199200; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Trauzold A, 2006, ONCOGENE, V25, P7434, DOI 10.1038/sj.onc.1209719; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Wachter T, 2004, J BIOL CHEM, V279, P52824, DOI 10.1074/jbc.M409554200; Wicovsky A, 2007, J BIOL CHEM, V282, P2174, DOI 10.1074/jbc.M606167200; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; Wu YT, 2011, CELL DEATH DIFFER, V18, P26, DOI 10.1038/cdd.2010.72; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Zhang LQ, 2009, J MOL BIOL, V389, P495, DOI 10.1016/j.jmb.2009.04.054	66	70	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16631	16646		10.1074/jbc.M110.148585	http://dx.doi.org/10.1074/jbc.M110.148585			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454681	Green Published, hybrid			2022-12-27	WOS:000290301900012
J	Kirchdoerfer, RN; Garner, AL; Flack, CE; Mee, JM; Horswill, AR; Janda, KD; Kaufmann, GF; Wilson, IA				Kirchdoerfer, Robert N.; Garner, Amanda L.; Flack, Caralyn E.; Mee, Jenny M.; Horswill, Alexander R.; Janda, Kim D.; Kaufmann, Gunnar F.; Wilson, Ian A.			Structural Basis for Ligand Recognition and Discrimination of a Quorum-quenching Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-PI INTERACTIONS; STAPHYLOCOCCUS-AUREUS; RECEPTOR RECOGNITION; MAXIMUM-LIKELIHOOD; VIRULENCE; IDENTIFICATION; INHIBITION; REFINEMENT; ACTIVATION; EXPRESSION	In the postantibiotic era, available treatment options for severe bacterial infections caused by methicillin-resistant Staphylococcus aureus have become limited. Therefore, new and innovative approaches are needed to combat such life-threatening infections. Virulence factor expression in S. aureus is regulated in a cell density-dependent manner using "quorum sensing," which involves generation and secretion of autoinducing peptides (AIPs) into the surrounding environment to activate a bacterial sensor kinase at a particular threshold concentration. Mouse monoclonal antibody AP4-24H11 was shown previously to blunt quorum sensing-mediated changes in gene expression in vitro and protect mice from a lethal dose of S. aureus by sequestering the AIP signal. We have elucidated the crystal structure of the AP4-24H11 Fab in complex with AIP-4 at 2.5 angstrom resolution to determine its mechanism of ligand recognition. A key Glu(H95) provides much of the binding specificity through formation of hydrogen bonds with each of the four amide nitrogens in the AIP-4 macrocyclic ring. Importantly, these structural data give clues as to the interactions between the cognate staphylococcal AIP receptors AgrC and the AIPs, as AP4-24H11.AIP-4 binding recapitulates features that have been proposed for AgrC-AIP recognition. Additionally, these structural insights may enable the engineering of AIP cross-reactive antibodies or quorum quenching vaccines for use in active or passive immunotherapy for prevention or treatment of S. aureus infections.	[Kirchdoerfer, Robert N.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Garner, Amanda L.; Mee, Jenny M.; Janda, Kim D.; Kaufmann, Gunnar F.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Garner, Amanda L.; Mee, Jenny M.; Janda, Kim D.; Kaufmann, Gunnar F.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Janda, Kim D.; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Janda, Kim D.] Scripps Res Inst, Worm Inst Res & Med, La Jolla, CA 92037 USA; [Flack, Caralyn E.; Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Iowa	Kaufmann, GF (corresponding author), 10550 N Torrey Pines Rd,BCC578, La Jolla, CA 92037 USA.	kaufmann@scripps.edu; wilson@scripps.edu		Flack, Caralyn/0000-0001-9200-4575	National Institutes of Health [AI078921, AI080715, AI042266, CA058896]; Skaggs Institute; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078921, R01AI042266, R37AI042266, R01AI080715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants AI078921 (to A. R. H.), AI080715 (to G. F. K.), and AI042266 and CA058896 (to I. A. W.). This work was also supported by The Skaggs Institute (to I. A. W. and K. D. J.). The Advanced Photon Source at Argonne National Laboratory is supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences Contract DE-AC02-06CH11357. This is Paper 20569 from The Scripps Research Institute.	Abhinandan KR, 2008, MOL IMMUNOL, V45, P3832, DOI 10.1016/j.molimm.2008.05.022; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Chen LC, 2009, J MICROBIOL, V47, P572, DOI 10.1007/s12275-009-0004-2; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Debler EW, 2007, J MOL BIOL, V368, P1392, DOI 10.1016/j.jmb.2007.02.081; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Geisinger E, 2008, J BIOL CHEM, V283, P8930, DOI 10.1074/jbc.M710227200; Gruber K, 1999, BIOCHEMISTRY-US, V38, P7062, DOI 10.1021/bi990210s; HARLOW E, 1988, ANTIBODIES LAB MANUA, P626; Jensen RO, 2008, J MOL BIOL, V381, P300, DOI 10.1016/j.jmb.2008.06.018; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Kaufmann GF, 2008, EXPERT OPIN BIOL TH, V8, P719, DOI 10.1517/14712598.8.6.719 ; Kaufmann GF, 2011, METHODS MOL BIOL, V692, P299, DOI 10.1007/978-1-60761-971-0_22; Koenig RL, 2004, J BACTERIOL, V186, P7549, DOI 10.1128/JB.186.22.7549-7555.2004; LEBEAU C, 1994, J BACTERIOL, V176, P5534, DOI 10.1128/JB.176.17.5534-5536.1994; Lyon GJ, 2000, P NATL ACAD SCI USA, V97, P13330, DOI 10.1073/pnas.97.24.13330; MARKS JD, 1991, EUR J IMMUNOL, V21, P985, DOI 10.1002/eji.1830210419; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; McDowell P, 2001, MOL MICROBIOL, V41, P503, DOI 10.1046/j.1365-2958.2001.02539.x; Morfeldt E, 1996, MOL MICROBIOL, V21, P1227, DOI 10.1046/j.1365-2958.1996.751447.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakayama J, 2009, ANTIMICROB AGENTS CH, V53, P580, DOI 10.1128/AAC.00995-08; NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park J, 2007, CHEM BIOL, V14, P1119, DOI 10.1016/j.chembiol.2007.08.013; Projan SJ, 2006, CURR OPIN PHARMACOL, V6, P473, DOI 10.1016/j.coph.2006.04.005; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; Suga H, 2003, CURR OPIN CHEM BIOL, V7, P586, DOI 10.1016/j.cbpa.2003.08.001; Thoendel M, 2009, J BIOL CHEM, V284, P21828, DOI 10.1074/jbc.M109.031757; Wright JS, 2005, J BACTERIOL, V187, P5585, DOI 10.1128/JB.187.16.5585-5594.2005; Wright JS, 2004, P NATL ACAD SCI USA, V101, P16168, DOI 10.1073/pnas.0404039101; Zhang LS, 2002, J BIOL CHEM, V277, P34736, DOI 10.1074/jbc.M205367200	48	43	48	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17351	17358		10.1074/jbc.M111.231258	http://dx.doi.org/10.1074/jbc.M111.231258			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454495	Green Published, hybrid			2022-12-27	WOS:000290301900082
J	Leverrier, P; Declercq, JP; Denoncin, K; Vertommen, D; Hiniker, A; Cho, SH; Collet, JF				Leverrier, Pauline; Declercq, Jean-Paul; Denoncin, Katleen; Vertommen, Didier; Hiniker, Annie; Cho, Seung-Hyun; Collet, Jean-Francois			Crystal Structure of the Outer Membrane Protein RcsF, a New Substrate for the Periplasmic Protein-disulfide Isomerase DsbC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; SIGNALING PATHWAY; CAPSULE SYNTHESIS; PHOSPHORELAY; BOND; REGULATOR; BIOSYNTHESIS; ENVELOPE; STRESS; SYSTEM	The bacterial Rcs phosphorelay is a stress-induced defense mechanism that controls the expression of numerous genes, including those for capsular polysaccharides, motility, and virulence factors. It is a complex multicomponent system that includes the histidine kinase (RcsC) and the response regulator (RcsB) and also auxiliary proteins such as RcsF. RcsF is an outer membrane lipoprotein that transmits signals from the cell surface to RcsC. The physiological signals that activate RcsF and how RcsF interacts with RcsC remain unknown. Here, we report the three-dimensional structure of RcsF. The fold of the protein is characterized by the presence of a central 4-stranded beta sheet, which is conserved in several other proteins, including the copper-binding domain of the amyloid precursor protein. RcsF, which contains four conserved cysteine residues, presents two nonconsecutive disulfides between Cys(74) and Cys(118) and between Cys(109) and Cys(124), respectively. These two disulfides are not functionally equivalent; the Cys(109)-Cys(124) disulfide is particularly important for the assembly of an active RcsF. Moreover, we show that formation of the nonconsecutive disulfides of RcsF depends on the periplasmic disulfide isomerase DsbC. We trapped RcsF in a mixed disulfide complex with DsbC, and we show that deletion of dsbC prevents the activation of the Rcs phosphorelay by signals that function through RcsF. The three-dimensional structure of RcsF provides the structural basis to understand how this protein triggers the Rcs signaling cascade.	[Leverrier, Pauline; Denoncin, Katleen; Vertommen, Didier; Cho, Seung-Hyun; Collet, Jean-Francois] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium; [Leverrier, Pauline; Denoncin, Katleen; Cho, Seung-Hyun; Collet, Jean-Francois] Catholic Univ Louvain, Welbio Walloon Excellence Life Sci & Biotechnol, B-1200 Brussels, Belgium; [Declercq, Jean-Paul] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium; [Hiniker, Annie] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Universite Catholique Louvain; Universite Catholique Louvain; WELBIO; Universite Catholique Louvain; Princeton University	Collet, JF (corresponding author), 75-39 Av Hippocrate, B-1200 Brussels, Belgium.	jfcollet@uclouvain.be	Collet, Jean Francois/F-2105-2010	Vertommen, Didier/0000-0001-7648-8282; Leverrier, Pauline/0000-0003-2465-8491; Collet, Jean-Francois/0000-0001-8069-7036; cho, seung-hyun/0000-0002-5548-4239	Belgian Science Policy, Network [P6/05]; Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique; European Community [RII3-CT-2004-506008]	Belgian Science Policy, Network(Belgian Federal Science Policy Office); Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); European Community(European Commission)	This work was supported by the Interuniversity Attraction Pole Programme-Belgian Science Policy, Network P6/05 (to J.-F. C.), and by grants from the Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (to J.-F. C.).; We thank Asma Boujtat and Steve Calberson for technical assistance and Matthieu Depuydt for critical reading of the manuscript. We thank the European Community for Access to Research Infrastructure Action of the Improving Human Potential Programme to the EMBL Hamburg Outstation, Contract RII3-CT-2004-506008.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Beck T, 2008, ACTA CRYSTALLOGR D, V64, P1179, DOI 10.1107/S0907444908030266; Berkmen M, 2005, J BIOL CHEM, V280, P11387, DOI 10.1074/jbc.M411774200; Bieger B, 2003, STRUCTURE, V11, P375, DOI 10.1016/S0969-2126(03)00048-0; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Callewaert L, 2009, J BACTERIOL, V191, P1979, DOI 10.1128/JB.01549-08; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Castanie-Cornet MP, 2006, J BACTERIOL, V188, P4264, DOI 10.1128/JB.00004-06; Chen J, 1999, J BIOL CHEM, V274, P19601, DOI 10.1074/jbc.274.28.19601; Clarke DJ, 2010, FUTURE MICROBIOL, V5, P1173, DOI 10.2217/FMB.10.83; Clarke DJ, 2002, J BACTERIOL, V184, P1204, DOI 10.1128/jb.184.4.1204-1208.2002; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Denoncin K, 2010, J BIOL CHEM, V285, P29425, DOI 10.1074/jbc.M110.119321; Depuydt M., 2011, ANTIOXID RE IN PRESS; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farris C, 2010, J BACTERIOL, V192, P4894, DOI 10.1128/JB.00505-10; GERVAIS FG, 1992, J BACTERIOL, V174, P8016, DOI 10.1128/JB.174.24.8016-8022.1992; GOTTESMAN S, 1985, J BACTERIOL, V162, P1111, DOI 10.1128/JB.162.3.1111-1119.1985; Grininger M, 2009, J BIOL CHEM, V284, P13068, DOI 10.1074/jbc.M808063200; Hagiwara D, 2003, J BACTERIOL, V185, P5735, DOI 10.1128/JB.185.19.5735-5746.2003; Hiniker A, 2003, BIOCHEMISTRY-US, V42, P1179, DOI 10.1021/bi027141t; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang YH, 2006, RES MICROBIOL, V157, P206, DOI 10.1016/j.resmic.2005.11.005; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Kelm O, 1997, MOL GEN GENET, V256, P72, DOI 10.1007/s004380050547; Kong GKW, 2007, J MOL BIOL, V367, P148, DOI 10.1016/j.jmb.2006.12.041; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; Leverrier P, 2010, PROTEOMICS, V10, P771, DOI 10.1002/pmic.200900461; MacRitchie DM, 2008, ADV EXP MED BIOL, V631, P80, DOI 10.1007/978-0-387-78885-2_6; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Majdalani N, 2005, J BACTERIOL, V187, P6770, DOI 10.1128/JB.187.19.6770-6778.2005; Miller JH, 1992, SHORT COURSE BACTERI, P221; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Politzer P, 2007, J MOL MODEL, V13, P305, DOI 10.1007/s00894-006-0154-7; Politzer P, 2010, PHYS CHEM CHEM PHYS, V12, P7748, DOI 10.1039/c004189k; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; PROUVOST AF, 2008, THESIS U SCI TECHNOL; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Singh P, 2008, ANAL CHEM, V80, P8799, DOI 10.1021/ac801646f; STOUT V, 1991, J BACTERIOL, V173, P1738, DOI 10.1128/jb.173.5.1738-1747.1991; STOUT V, 1990, J BACTERIOL, V172, P659, DOI 10.1128/jb.172.2.659-669.1990; STOUT V, 1994, RES MICROBIOL, V145, P389, DOI 10.1016/0923-2508(94)90086-8; Takeda S, 2001, MOL MICROBIOL, V40, P440, DOI 10.1046/j.1365-2958.2001.02393.x; Vertommen D, 2008, MOL MICROBIOL, V67, P336, DOI 10.1111/j.1365-2958.2007.06030.x; Wehland M, 2000, J BIOL CHEM, V275, P7013, DOI 10.1074/jbc.275.10.7013; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wouters MA, 2010, ANTIOXID REDOX SIGN, V12, P53, DOI [10.1089/ars.2009.2510, 10.1089/ARS.2009.2510]	56	45	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16734	16742		10.1074/jbc.M111.224865	http://dx.doi.org/10.1074/jbc.M111.224865			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454485	Green Published, hybrid			2022-12-27	WOS:000290301900021
J	Dauletbaev, N; Eklove, D; Mawji, N; Iskandar, M; Di Marco, S; Gallouzi, IE; Lands, LC				Dauletbaev, Nurlan; Eklove, Daniel; Mawji, Nadir; Iskandar, Michele; Di Marco, Sergio; Gallouzi, Imed-Eddine; Lands, Larry C.			Down-regulation of Cytokine-induced Interleukin-8 Requires Inhibition of p38 Mitogen-activated Protein Kinase (MAPK) via MAPK Phosphatase 1-dependent and -independent Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRONCHIAL EPITHELIAL-CELLS; NF-KAPPA-B; TRANSMEMBRANE CONDUCTANCE REGULATOR; OBSTRUCTIVE PULMONARY-DISEASE; LOWER AIRWAY INFLAMMATION; INNATE IMMUNE-RESPONSES; HIGH-DOSE IBUPROFEN; CYSTIC-FIBROSIS; IL-8 PRODUCTION; LUNG-DISEASE	Down-regulation of overabundant interleukin (IL)-8 present in cystic fibrosis (CF) airways could ease excessive neutrophil burden and its deleterious consequences for the lung. IL-8 production in airway epithelial cells, stimulated with e. g. inflammatory cytokines IL-1 beta and tumor necrosis factor (TNF)-alpha, is regulated by several signaling pathways including nuclear factor (NF)-kappa B and p38 mitogen-activated protein kinase (MAPK). We previously demonstrated that the anti-inflammatory drugs dexamethasone and ibuprofen suppress NF-kappa B; however, only dexamethasone down-regulates cytokine-induced IL-8, highlighting the importance of non-NF-kappa B mechanisms. Here, we tested the hypothesis that down-regulation of cytokine-induced IL-8 requires modulation of the MAPK phosphatase (MKP)-1/p38 MAPK/mRNA stability pathway. The effects of dexamethasone (5 nM) and ibuprofen (480 mu M) on this pathway and IL-8 were studied in CF (CFTE29o-, CFBE41o-) and non-CF (1HAEo-) airway epithelial cells. We observed that dexamethasone, but not ibuprofen, destabilizes IL-8 mRNA and up-regulates MKP-1mRNA. Further, siRNA silencing of MKP-1, via p38 MAPK, leads to IL-8 overproduction and diminishes the anti-IL-8 potential of dexamethasone. However, MKP-1 overexpression does not significantly alter IL-8 production. By contrast, direct inhibition of p38 MAPK (inhibitor SB203580) efficiently suppresses IL-8 with potency comparable with dexamethasone. Similar to dexamethasone, SB203580 decreases IL-8mRNA stability. Dexamethasone does not affect p38 MAPK activation, which excludes its effects upstream of p38 MAPK. In conclusion, normal levels of MKP-1 are necessary for a full anti-IL-8 potential of pharmacological agents; however, efficient pharmacological down-regulation of cytokine-induced IL-8 also requires direct effects on p38 MAPK and mRNA stability independently of MKP-1.	[Dauletbaev, Nurlan; Eklove, Daniel; Mawji, Nadir; Iskandar, Michele; Lands, Larry C.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3H 1P3, Canada; [Di Marco, Sergio; Gallouzi, Imed-Eddine] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Dauletbaev, Nurlan; Lands, Larry C.] McGill Univ, Ctr Hlth, Div Resp Med, Montreal Childrens Hosp, Montreal, PQ H3H 1P3, Canada	McGill University; McGill University; McGill University	Dauletbaev, N (corresponding author), McGill Univ, Ctr Hlth, Div Resp Med, Montreal Childrens Hosp, D-380,2300 Tupper St, Montreal, PQ H3H 1P3, Canada.	nurlan.dauletbaev@muhc.mcgill.ca; larry.lands@muhc.mcgill.ca	Iskandar, Michele M./U-6627-2019	Di Marco, Sergio/0000-0002-4039-0600	Canadian Cystic Fibrosis Foundation; BREATHE Initiative	Canadian Cystic Fibrosis Foundation; BREATHE Initiative	The work was supported by grants from the Canadian Cystic Fibrosis Foundation and its BREATHE Initiative.	Abraham SM, 2006, BIOCHEM SOC T, V34, P1018, DOI 10.1042/BST0341018; Aoki Y, 1998, AM J PHYSIOL-LUNG C, V274, pL1030, DOI 10.1152/ajplung.1998.274.6.L1030; Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Armstrong DS, 1997, AM J RESP CRIT CARE, V156, P1197, DOI 10.1164/ajrccm.156.4.96-11058; AUERBACH HS, 1985, LANCET, V2, P686; BALOUGH K, 1995, PEDIATR PULM, V20, P63, DOI 10.1002/ppul.1950200203; Banner KH, 2009, J CYST FIBROS, V8, P1, DOI 10.1016/j.jcf.2008.10.002; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Becker MN, 2004, AM J RESP CRIT CARE, V169, P645, DOI 10.1164/rccm.200207-765OC; Bhattacharyya S, 2011, J BIOL CHEM, V286, P11604, DOI 10.1074/jbc.M110.198390; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Bhavsar P, 2010, EUR RESPIR J, V35, P750, DOI 10.1183/09031936.00071309; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Chang MMJ, 2001, AM J PHYSIOL-LUNG C, V280, pL107, DOI 10.1152/ajplung.2001.280.1.L107; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; CHENG K, 2000, COCHRANE DB SYST REV; Chmiel JF, 2002, CLIN REV ALLERG IMMU, V23, P5, DOI 10.1385/CRIAI:23:1:005; Dauletbaev N, 2004, J Cyst Fibros, V3, P119, DOI 10.1016/j.jcf.2004.03.005; Dauletbaev N, 2010, RESPIRATION, V79, P234, DOI 10.1159/000255342; Dechecchi MC, 2007, AM J RESP CELL MOL, V36, P615, DOI 10.1165/rcmb.2006-0200OC; Di Marco S, 2005, MOL CELL BIOL, V25, P6533, DOI 10.1128/MCB.25.15.6533-6545.2005; Eickmeier O, 2010, CYTOKINE, V50, P152, DOI 10.1016/j.cyto.2010.02.004; EIGEN H, 1995, J PEDIATR-US, V126, P515, DOI 10.1016/S0022-3476(95)70343-8; Elizur A, 2008, CHEST, V133, P489, DOI 10.1378/chest.07-1631; Escotte S, 2003, EUR RESPIR J, V21, P574, DOI 10.1183/09031936.03.00031803; GREALLY P, 1994, ARCH DIS CHILD, V71, P35, DOI 10.1136/adc.71.1.35; Gruenert D C, 2004, J Cyst Fibros, V3 Suppl 2, P191, DOI 10.1016/j.jcf.2004.05.040; Hallows KR, 2006, J BIOL CHEM, V281, P4231, DOI 10.1074/jbc.M511029200; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Humlicek AL, 2007, J IMMUNOL, V178, P6395, DOI 10.4049/jimmunol.178.10.6395; Issa R, 2007, J IMMUNOL, V178, P7366, DOI 10.4049/jimmunol.178.11.7366; Jacquot J, 2008, EXPERT REV MOL DIAGN, V8, P359, DOI 10.1586/14737159.8.4.359; John G, 2010, AM J RESP CELL MOL, V42, P424, DOI 10.1165/rcmb.2008-0408OC; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Konstan MW, 2008, CURR OPIN PULM MED, V14, P567, DOI 10.1097/MCP.0b013e32831311e8; Konstan MW, 2002, ADV DRUG DELIVER REV, V54, P1409, DOI 10.1016/S0169-409X(02)00146-1; KONSTAN MW, 1995, NEW ENGL J MED, V332, P848, DOI 10.1056/NEJM199503303321303; Kube D, 2001, AM J PHYSIOL-LUNG C, V280, pL493, DOI 10.1152/ajplung.2001.280.3.L493; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; KUNZELMANN K, 1993, AM J RESP CELL MOL, V8, P522, DOI 10.1165/ajrcmb/8.5.522; KWON OJ, 1994, AM J PHYSIOL-LUNG C, V267, pL398, DOI 10.1152/ajplung.1994.267.4.L398; Lai HC, 2000, NEW ENGL J MED, V342, P851, DOI 10.1056/NEJM200003233421204; Lands LC, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001505.pub2; Lands LC, 2007, J PEDIATR-US, V151, P249, DOI 10.1016/j.jpeds.2007.04.009; Lands LC, 2010, PHARMACEUTICALS, V3, P2213, DOI 10.3390/ph3072213; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Li LW, 2009, INT J CLIN EXP MED, V2, P48; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; McGarvey L P A, 2002, J Cyst Fibros, V1, P269, DOI 10.1016/S1569-1993(02)00098-X; Muselet-Charlier C, 2007, BIOCHEM BIOPH RES CO, V357, P402, DOI 10.1016/j.bbrc.2007.03.141; Noah TL, 1997, J INFECT DIS, V175, P638, DOI 10.1093/infdis/175.3.638; Pan NY, 2006, RESP MED, V100, P1614, DOI 10.1016/j.rmed.2005.12.003; Park HS, 1999, ANN ALLERG ASTHMA IM, V82, P371, DOI 10.1016/S1081-1206(10)63286-3; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Quante T, 2008, AM J RESP CELL MOL, V39, P208, DOI 10.1165/rcmb.2007-0014OC; Ratjen FA, 2009, RESP CARE, V54, P595, DOI 10.4187/aarc0427; RICHMANEISENSTAT JBY, 1993, AM J PHYSIOL, V264, pL413, DOI 10.1152/ajplung.1993.264.4.L413; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Roger T, 2005, EUR J IMMUNOL, V35, P3405, DOI 10.1002/eji.200535413; Rottner M, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-23; Sagel SD, 2001, AM J RESP CRIT CARE, V164, P1425, DOI 10.1164/ajrccm.164.8.2104075; Shannon J, 2008, CHEST, V133, P420, DOI 10.1378/chest.07-1881; Sloane AJ, 2005, AM J RESP CRIT CARE, V172, P1416, DOI 10.1164/rccm.200409-1215OC; Sly PD, 2009, AM J RESP CRIT CARE, V180, P146, DOI 10.1164/rccm.200901-0069OC; Smountas AA, 2004, CLIN BIOCHEM, V37, P1031, DOI 10.1016/j.clinbiochem.2004.07.008; Stecenko AA, 2001, INFLAMMATION, V25, P145, DOI 10.1023/A:1011080229374; Sutanto EN, 2011, AM J RESP CELL MOL, V44, P761, DOI 10.1165/rcmb.2010-0368OC; Sutherland ER, 2008, AM J RESP CRIT CARE, V178, P682, DOI 10.1164/rccm.200801-076OC; Sutherland ER, 2010, AM J RESP CRIT CARE, V181, P699, DOI 10.1164/rccm.200911-1710OC; Taggart C, 2000, AM J PHYSIOL-LUNG C, V278, pL33, DOI 10.1152/ajplung.2000.278.1.L33; Turpeinen T, 2010, J PHARMACOL EXP THER, V333, P310, DOI 10.1124/jpet.109.157438; van der Velden VHJ, 1998, EUR CYTOKINE NETW, V9, P269; Vij N, 2008, AM J RESP CELL MOL, V38, P176, DOI 10.1165/rcmb.2007-0197OC; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Xu YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011004	80	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.205724	http://dx.doi.org/10.1074/jbc.M110.205724			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454676	Green Published, hybrid			2022-12-27	WOS:000290022800040
J	Liu, XQ; Rajput, A; Geng, LY; Ongchin, M; Chaudhuri, A; Wang, J				Liu, Xiao-Qiong; Rajput, Ashwani; Geng, Liying; Ongchin, Melanie; Chaudhuri, Anathbandhu; Wang, Jing			Restoration of Transforming Growth Factor-beta Receptor II Expression in Colon Cancer Cells with Microsatellite Instability Increases Metastatic Potential in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLORECTAL-CANCER; TGF-BETA; CARCINOMA CELLS; MESENCHYMAL TRANSITIONS; ADJUVANT CHEMOTHERAPY; INDUCED APOPTOSIS; BH3-ONLY PROTEIN; BIM; SURVIVAL; PHOSPHORYLATION	Microsatellite instability (MSI), which occurs in 15% of colorectal cancer, has been shown to have a lower incidence of metastasis and better patient survival rates compared with microsatellite stable colorectal cancer. However, a mechanistic understanding of the basis for this difference is very limited. Here, we show that restoration of TGF beta signaling by re-expression of TGF beta receptor II in MSI colon cancer cells increased PI3K/AKT activation, conferred resistance to growth factor deprivation stress-induced apoptosis, and promoted cell motility in vitro. Treatment with a potent PI3K inhibitor (LY294002) blocked the prosurvival and promotility effects of TGF beta, indicating that TGF beta-mediated promotion of cell survival and motility is dependent upon activation of the PI3K/AKT pathway. Analysis of apoptotic effectors that are affected by TGF beta signaling indicated that Bim is an effector of TGF beta-mediated survival. In addition, TGF beta-induced down-regulation of E-cadherin contributed to the prosurvival effect of TGF beta, and restoration of TGF beta signaling in MSI colon cancer cells increased liver metastasis in an orthotopic model in vivo. Taken together, our results demonstrate that restoration of TGF beta signaling promotes cell survival, motility, and metastatic progression in MSI colon cancer cells and indicate that TGF beta receptor II mutations contribute to the favorable outcomes in colon cancer patients with MSI.	[Wang, Jing] Univ Nebraska Med Ctr, Nebraska Med Ctr 985950, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Rajput, Ashwani] Univ New Mexico, Div Surg Oncol, Dept Surg, Albuquerque, NM 87131 USA; [Ongchin, Melanie] Roswell Pk Canc Inst, Dept Surg, Buffalo, NY 14263 USA	University of Nebraska System; University of Nebraska Medical Center; University of New Mexico; Roswell Park Cancer Institute	Wang, J (corresponding author), Univ Nebraska Med Ctr, Nebraska Med Ctr 985950, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	jjwang@unmc.edu	Chaudhuri, Anathbandhu/F-2501-2017	Chaudhuri, Anathbandhu/0000-0003-4833-3077	National Institutes of Health [P20RR018759, R01CA140988-01]; NATIONAL CANCER INSTITUTE [R01CA140988] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants P20RR018759 and R01CA140988-01.	Abdel-Rahman WM, 2008, DNA REPAIR, V7, P321, DOI 10.1016/j.dnarep.2007.11.009; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bertagnolli MM, 2009, J CLIN ONCOL, V27, P1814, DOI 10.1200/JCO.2008.18.2071; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; BOYD DD, 1988, CANCER RES, V48, P2469; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fallik D, 2003, CANCER RES, V63, P5738; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Guo XN, 2007, CANCER RES, V67, P5851, DOI 10.1158/0008-5472.CAN-07-0049; Hoshino Y, 2011, J BIOCHEM, V149, P55, DOI 10.1093/jb/mvq114; Hu PPC, 1998, ENDOCR REV, V19, P349, DOI 10.1210/er.19.3.349; Ikeguchi M, 2000, SCAND J GASTROENTERO, V35, P839; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jiang W, 1997, BIOCHEMISTRY-US, V36, P14786, DOI 10.1021/bi9717892; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Losi L, 2007, ONCOL REP, V17, P1095; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Miyaki M, 1999, ONCOGENE, V18, P3098, DOI 10.1038/sj.onc.1202642; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Pino MS, 2010, GASTROENTEROLOGY, V138, P1406, DOI 10.1053/j.gastro.2009.12.010; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Shin I, 2001, MOL BIOL CELL, V12, P3328, DOI 10.1091/mbc.12.11.3328; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; SUN LZ, 1994, J BIOL CHEM, V269, P26449; SUN LZ, 1994, EXP CELL RES, V214, P215, DOI 10.1006/excr.1994.1251; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Valdes F, 2002, MOL CANCER RES, V1, P68; Wang J, 1996, J BIOL CHEM, V271, P17366, DOI 10.1074/jbc.271.29.17366; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Wang J, 2007, MOL CANCER THER, V6, P1143, DOI 10.1158/1535-7163.MCT-06-0555; Wang J, 2009, J BIOL CHEM, V284, P10912, DOI 10.1074/jbc.M809551200; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; WU SP, 1993, CELL GROWTH DIFFER, V4, P115; WU SP, 1992, J CELL BIOL, V116, P187, DOI 10.1083/jcb.116.1.187; Ye SC, 1999, CANCER RES, V59, P4725; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang BX, 2010, GASTROENTEROLOGY, V138, P969, DOI 10.1053/j.gastro.2009.11.004; Zhu B, 2010, PROSTATE, V70, P17, DOI 10.1002/pros.21033; Zhu SK, 2008, CIRCULATION, V118, P2156, DOI 10.1161/CIRCULATIONAHA.108.787200	55	20	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.221697	http://dx.doi.org/10.1074/jbc.M111.221697			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454688	Green Published, hybrid			2022-12-27	WOS:000290022800048
J	Morizane, Y; Thanos, A; Takeuchi, K; Murakami, Y; Kayama, M; Trichonas, G; Miller, J; Foretz, M; Viollet, B; Vavvas, DG				Morizane, Yuki; Thanos, Aristomenis; Takeuchi, Kimio; Murakami, Yusuke; Kayama, Maki; Trichonas, George; Miller, Joan; Foretz, Marc; Viollet, Benoit; Vavvas, Demetrios G.			AMP-activated Protein Kinase Suppresses Matrix Metalloproteinase-9 Expression in Mouse Embryonic Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IV COLLAGENASE EXPRESSION; CENTRAL-NERVOUS-SYSTEM; MURINE MAMMARY CELLS; GLUCOKINASE TRANSLOCATION; MATRIX METALLOPROTEINASES; METASTATIC PHENOTYPE; PROTEOLYTIC-ENZYMES; ENDOTHELIAL-CELLS; DEPENDENT KINASE	Matrix metalloproteinase-9 (MMP-9) plays a critical role in tissue remodeling under both physiological and pathological conditions. Although MMP-9expression is low in most cells and is tightly controlled, the mechanism of its regulation is poorly understood. We utilized mouse embryonic fibroblasts (MEFs) that were nullizygous for the catalytic alpha subunit of AMP-activated protein kinase (AMPK), which is a key regulator of energy homeostasis, to identify AMPK as a suppressor of MMP-9 expression. Total AMPK alpha deletion significantly elevated MMP-9 expression compared with wild-type (WT) MEFs, whereas single knock-out of the isoforms AMPK alpha 1 and AMPK alpha 2 caused minimal change in the level of MMP-9 expression. The suppressive role of AMPK on MMP-9 expression was mediated through both its activity and presence. The AMPK activators 5-amino-4-imidazole carboxamide riboside and A769662 suppressed MMP-9 expression in WT MEFs, and AMPK inhibition by the overexpression of dominant negative (DN) AMPK alpha elevated MMP-9 expression. However, in AMPK alpha(-/-) MEFs transduced with DN AMPK alpha, MMP-9 expression was suppressed. AMPK alpha(-/-) MEFs showed increased phosphorylation of I kappa B alpha, expression of I kappa B alpha mRNA, nuclear localization of nuclear factor-kappa B (NF-kappa B), and DNA-binding activity of NF-kappa B compared with WT. Consistently, selective NF-kappa B inhibitors BMS345541 and SM7368 decreased MMP-9 expression in AMPK alpha(-/-) MEFs. Overall, our results suggest that both AMPK alpha isoforms suppress MMP-9 expression and that both the activity and presence of AMPK alpha contribute to its function as a regulator of MMP-9 expression by inhibiting the NF-kappa B pathway.	[Morizane, Yuki; Thanos, Aristomenis; Takeuchi, Kimio; Murakami, Yusuke; Kayama, Maki; Trichonas, George; Miller, Joan; Vavvas, Demetrios G.] Harvard Univ, Sch Med, Retina Serv, Angiogenesis Lab,Massachusetts Eye & Ear Infirm,D, Boston, MA 02114 USA; [Foretz, Marc; Viollet, Benoit] Inst Cochin, INSERM, U1016, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] CNRS, UMR 8104, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, F-75014 Paris, France	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Vavvas, DG (corresponding author), 243 Charles St, Boston, MA 02114 USA.	vavvas@meei.harvard.edu	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017; FORETZ, Marc/O-7334-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032; Miller, Joan/0000-0003-2046-3996; Vavvas, Demetrios/0000-0002-8622-6478	National Institutes of Health through the NEI [EY014104]; Bacardi Fund; Research to Prevent Blindness Foundation; Lions Eye Research Fund; Onassis Foundation; Fight for Sight Grant in Aid; Harvard Ophthalmology Department; Bausch and Lomb Japan Vitreoretinal; NATIONAL EYE INSTITUTE [P30EY014104] Funding Source: NIH RePORTER	National Institutes of Health through the NEI; Bacardi Fund; Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Lions Eye Research Fund; Onassis Foundation; Fight for Sight Grant in Aid; Harvard Ophthalmology Department; Bausch and Lomb Japan Vitreoretinal; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY014104 through the NEI. This work was also supported by the Bacardi Fund (to D. G. V.), the Research to Prevent Blindness Foundation (to D. G. V.), the Lions Eye Research Fund (to D. G. V.), the Onassis Foundation (to D. G. V.), a Fight for Sight Grant in Aid (to D. G. V.), the Harvard Ophthalmology Department (to D. G. V.), and a Bausch and Lomb Japan Vitreoretinal fellowship (to Y. M. and M. K.).	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Bronner M, 2004, BIOCHEM J, V384, P295, DOI 10.1042/BJ20040955; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Foretz M, 2011, FASEB J, V25, P337, DOI 10.1096/fj.10-169383; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; GARBISA S, 1987, CANCER RES, V47, P1523; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Grossoni VC, 2007, CLIN EXP METASTAS, V24, P513, DOI 10.1007/s10585-007-9088-4; Gueron G, 2009, MOL CANCER RES, V7, P1745, DOI 10.1158/1541-7786.MCR-08-0325; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Guigas B, 2009, IUBMB LIFE, V61, P18, DOI 10.1002/iub.135; Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672; Gum R, 1997, ONCOGENE, V14, P1481, DOI 10.1038/sj.onc.1200973; Han F, 2010, J SURG RES, V159, P443, DOI 10.1016/j.jss.2009.03.079; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Himelstein BP, 1997, ONCOGENE, V14, P1995, DOI 10.1038/sj.onc.1201012; Hwang YP, 2010, BRIT J PHARMACOL, V160, P1195, DOI 10.1111/j.1476-5381.2010.00762.x; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Katerelos M, 2010, IMMUNOL CELL BIOL, V88, P754, DOI 10.1038/icb.2010.44; Kim S, 2011, CELL METAB, V13, P215, DOI 10.1016/j.cmet.2011.01.007; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Moens U, 1997, VIRUS GENES, V15, P135, DOI 10.1023/A:1007962908248; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Mukhtar MH, 2008, AM J PHYSIOL-REG I, V294, pR766, DOI 10.1152/ajpregu.00593.2007; Nair RR, 2006, J BIOL CHEM, V281, P26424, DOI 10.1074/jbc.M602703200; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Robert I, 2009, ONCOGENE, V28, P1626, DOI 10.1038/onc.2009.6; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Singh S, 1998, ANAL BIOCHEM, V265, P185, DOI 10.1006/abio.1998.2882; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; STAHL H, 1987, BIOCHIM BIOPHYS ACTA, V910, P1, DOI 10.1016/0167-4781(87)90088-1; Steinberg GR, 2010, J BIOL CHEM, V285, P37198, DOI 10.1074/jbc.M110.102434; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takagi S, 2009, CANCER RES, V69, P1502, DOI 10.1158/0008-5472.CAN-08-2635; Theodoropoulou S, 2010, FASEB J, V24, P2620, DOI 10.1096/fj.09-152546; THORGEIRSSON UP, 1985, MOL CELL BIOL, V5, P259, DOI 10.1128/MCB.5.1.259; Turnley AM, 1999, J NEUROCHEM, V72, P1707, DOI 10.1046/j.1471-4159.1999.721707.x; Urtreger AJ, 2005, MOL CARCINOGEN, V42, P29, DOI 10.1002/mc.20066; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Wang W, 2009, ACTA PHYSIOL, V196, P55, DOI 10.1111/j.1748-1716.2009.01980.x; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948	62	44	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.199398	http://dx.doi.org/10.1074/jbc.M110.199398			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21402702	Green Published, hybrid			2022-12-27	WOS:000290022800043
J	Park, JS; Wang, CZ; Han, Y; Huang, Z; Niu, L				Park, Jae-Seon; Wang, Congzhou; Han, Yan; Huang, Zhen; Niu, Li			Potent and Selective Inhibition of a Single alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Subunit by an RNA Aptamer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL-OPENING KINETICS; GLUTAMATE-OPERATED CHANNELS; LASER-PULSE PHOTOLYSIS; MOLECULAR DETERMINANT; BINDING DOMAIN; GLUR2; MECHANISM; ANTAGONISTS; NEURONS; FLIP	Inhibitors of AMPA-type glutamate ion channels are useful as biochemical probes for structure-function studies and as drug candidates for a number of neurological disorders and diseases. Here, we describe the identification of an RNA inhibitor or aptamer by an in vitro evolution approach and a characterization of its mechanism of inhibition on the sites of interaction by equilibrium binding and on the receptor channel opening rate by a laser-pulse photolysis technique. Our results show that the aptamer is a noncompetitive inhibitor that selectively inhibits the GluA2Q(flip) AMPA receptor subunit without any effect on other AMPA receptor subunits or kainate or NMDA receptors. On the GluA2 subunit, this aptamer preferentially inhibits the flip variant. Furthermore, the aptamer preferentially inhibits the closed-channel state of GluA2Q(flip) with a K-I = 1.5 mu M or by similar to 15-fold over the open-channel state. The potency and selectivity of this aptamer rival those of small molecule inhibitors. Together, these properties make this aptamer a promising candidate for the development of water-soluble, highly potent, and GluA2 subunit-selective drugs.	[Niu, Li] SUNY Albany, Dept Chem, Albany, NY 12222 USA; SUNY Albany, Neurosci Res Ctr, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Niu, L (corresponding author), SUNY Albany, Dept Chem, Albany, NY 12222 USA.	lniu@albany.edu	Han, Yan/G-6027-2014		National Institutes of Health [R01 NS060812]; Department of Defense [W81XWH-04-1-0106, GW080163]; Muscular Dystrophy Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant R01 NS060812. This work was also supported by the Department of Defense (Grants W81XWH-04-1-0106 and GW080163) and the Muscular Dystrophy Association.	Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Ahmed AH, 2009, BIOCHEMISTRY-US, V48, P3894, DOI 10.1021/bi900107m; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dixon SJ, 2009, CURR OPIN CHEM BIOL, V13, P549, DOI 10.1016/j.cbpa.2009.08.003; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; Hruby VJ, 2009, J ORG CHEM, V74, P9245, DOI 10.1021/jo901767e; Huang Z, 2007, BIOCHEMISTRY-US, V46, P12648, DOI 10.1021/bi701036p; Huang Z, 2010, BIOCHEMISTRY-US, V49, P5790, DOI 10.1021/bi100690k; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Koike M, 2000, J NEUROSCI, V20, P2166; Kuner T, 2001, J NEUROSCI, V21, P4162, DOI 10.1523/JNEUROSCI.21-12-04162.2001; Kwak S, 2005, J MOL MED, V83, P110, DOI 10.1007/s00109-004-0599-z; Li G, 2005, BIOCHEMISTRY-US, V44, P5835, DOI 10.1021/bi047413n; Li G, 2004, J BIOL CHEM, V279, P3990, DOI 10.1074/jbc.M310410200; Li G, 2003, BIOCHEMISTRY-US, V42, P12367, DOI 10.1021/bi034797t; Li G, 2003, BIOCHEMISTRY-US, V42, P12358, DOI 10.1021/bi0347961; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Lunn ML, 2003, J MED CHEM, V46, P872, DOI 10.1021/jm021020+; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marcaurelle Lisa A., 2008, V66; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Niu L, 1995, P NATL ACAD SCI USA, V92, P12008, DOI 10.1073/pnas.92.26.12008; Niu Li, 1993, Biochemistry, V32, P3831, DOI 10.1021/bi00066a001; Oguro K, 1999, J NEUROSCI, V19, P9218; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Pei WM, 2007, J BIOL CHEM, V282, P22731, DOI 10.1074/jbc.M611821200; Pei WM, 2007, BIOCHEMISTRY-US, V46, P2027, DOI 10.1021/bi062213s; Pei WM, 2009, BIOCHEMISTRY-US, V48, P3767, DOI 10.1021/bi8015907; Ritz M, 2008, BIOCHEMISTRY-US, V47, P1061, DOI 10.1021/bi700782x; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Solyom S, 2002, CURR PHARM DESIGN, V8, P913, DOI 10.2174/1381612024607081; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; Tanaka Y, 1999, NUCLEIC ACIDS RES, V27, P949, DOI 10.1093/nar/27.4.949; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Voss NR, 2005, J MOL BIOL, V346, P477, DOI 10.1016/j.jmb.2004.11.072; Weiser T, 2005, CNS NEUROL DISORD-DR, V4, P153, DOI 10.2174/1568007053544129; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WIEBOLDT R, 1994, P NATL ACAD SCI USA, V91, P8752, DOI 10.1073/pnas.91.19.8752; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Zappala M, 2001, MINI-REV MED CHEM, V1, P243, DOI 10.2174/1389557013406783; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	14	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15608	15617		10.1074/jbc.M111.229559	http://dx.doi.org/10.1074/jbc.M111.229559			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21402710	hybrid, Green Published			2022-12-27	WOS:000289788300088
J	Moshiri, H; Acoca, S; Kala, S; Najafabadi, HS; Hogues, H; Purisima, E; Salavati, R				Moshiri, Houtan; Acoca, Stephane; Kala, Smriti; Najafabadi, Hamed Shateri; Hogues, Herve; Purisima, Enrico; Salavati, Reza			Naphthalene-based RNA Editing Inhibitor Blocks RNA Editing Activities and Editosome Assembly in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL RIBONUCLEOPROTEIN COMPLEXES; URIDYLYL TRANSFERASE TUTASE; SOLVATED INTERACTION ENERGY; BOUNDARY-ELEMENT METHOD; BINDING PROTEIN; GUIDE RNA; MESSENGER-RNA; DELETION; INSERTION; LIGASE	RNA editing, catalyzed by the multiprotein editosome complex, is an essential step for the expression of most mitochondrial genes in trypanosomatid pathogens. It has been shown previously that Trypanosoma brucei RNA editing ligase 1 (TbREL1), a core catalytic component of the editosome, is essential in the mammalian life stage of these parasitic pathogens. Because of the availability of its crystal structure and absence from human, the adenylylation domain of TbREL1 has recently become the focus of several studies for designing inhibitors that target its adenylylation pocket. Here, we have studied new and existing inhibitors of TbREL1 to better understand their mechanism of action. We found that these compounds are moderate to weak inhibitors of adenylylation of TbREL1 and in fact enhance adenylylation at higher concentrations of protein. Nevertheless, they can efficiently block deadenylylation of TbREL1 in the editosome and, consequently, result in inhibition of the ligation step of RNA editing. Further experiments directly showed that the studied compounds inhibit the interaction of the editosome with substrate RNA. This was supported by the observation that not only the ligation activity of TbREL1 but also the activities of other editosome proteins such as endoribonuclease, terminal RNA uridylyltransferase, and uridylate-specific exoribonuclease, all of which require the interaction of the editosome with the substrate RNA, are efficiently inhibited by these compounds. In addition, we found that these compounds can interfere with the integrity and/or assembly of the editosome complex, opening the exciting possibility of using them to study the mechanism of assembly of the editosome components.	[Moshiri, Houtan; Acoca, Stephane; Purisima, Enrico; Salavati, Reza] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Moshiri, Houtan; Kala, Smriti; Najafabadi, Hamed Shateri; Salavati, Reza] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Najafabadi, Hamed Shateri; Salavati, Reza] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ H3G 0B1, Canada; [Hogues, Herve; Purisima, Enrico] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	McGill University; McGill University; McGill University; National Research Council Canada	Salavati, R (corresponding author), McGill Univ, Dept Biochem, McIntyre Med Bldg,3655 Promenade Sir William Osle, Montreal, PQ H3G 1Y6, Canada.	reza.salavati@mcgill.ca		Najafabadi, Hamed/0000-0003-2735-4231	Natural Sciences and Engineering Research Council of Canada [328186]; Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT) Fellowship [134818, 134790]; McGill University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT) Fellowship(FQRNT); McGill University	This work was supported in part by Natural Sciences and Engineering Research Council of Canada Grant 328186 (to R. S.).; Recipient of Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT) Fellowship 134818.; Recipient of FQRNT Fellowship 134790.; Recipient of a Lloyd Carr-Harris fellowship (McGill University).	ALLISON J, 1984, NUCLEIC ACIDS RES, V12, P9051, DOI 10.1093/nar/12.23.9051; Amaro RE, 2008, P NATL ACAD SCI USA, V105, P17278, DOI 10.1073/pnas.0805820105; Aphasizhev R, 2003, EMBO J, V22, P913, DOI 10.1093/emboj/cdg083; Aphasizhev R, 2002, CELL, V108, P637, DOI 10.1016/S0092-8674(02)00647-5; Bhat S, 2006, PROTEINS, V62, P244, DOI 10.1002/prot.20682; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Cruz-Reyes J, 2002, MOL CELL BIOL, V22, P4652, DOI 10.1128/MCB.22.13.4652-4660.2002; Cui QZ, 2008, J MOL BIOL, V379, P787, DOI 10.1016/j.jmb.2008.04.035; Delespaux V, 2007, DRUG RESIST UPDATE, V10, P30, DOI 10.1016/j.drup.2007.02.004; Denise H, 2001, BIOCHEM PHARMACOL, V61, P1, DOI 10.1016/S0006-2952(00)00477-9; Doherty AJ, 2000, NUCLEIC ACIDS RES, V28, P4051, DOI 10.1093/nar/28.21.4051; Domingo GJ, 2003, EUKARYOT CELL, V2, P569, DOI 10.1128/EC.2.3.569-577.2003; Durrant JD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000803; Ernst NL, 2003, MOL CELL, V11, P1525, DOI 10.1016/S1097-2765(03)00185-0; Gao GH, 2010, PROTIST, V161, P489, DOI 10.1016/j.protis.2010.01.001; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; GORINGER HU, 1994, P NATL ACAD SCI USA, V91, P1776, DOI 10.1073/pnas.91.5.1776; Guo XM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008913; Igo RP, 2000, MOL CELL BIOL, V20, P8447, DOI 10.1128/MCB.20.22.8447-8457.2000; Igo RP, 2002, EUKARYOT CELL, V1, P112, DOI 10.1128/EC.1.1.112-118.2002; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kable ML, 1997, TRENDS BIOCHEM SCI, V22, P162, DOI 10.1016/S0968-0004(97)01041-4; Kala S, 2010, RNA, V16, P1951, DOI 10.1261/rna.2124610; Kang XD, 2005, P NATL ACAD SCI USA, V102, P1017, DOI 10.1073/pnas.0409275102; Law JA, 2008, RNA, V14, P1187, DOI 10.1261/rna.899508; McManus MT, 2001, RNA, V7, P167, DOI 10.1017/S1355838201002072; Moshiri H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq333; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Niemann M, 2008, NUCLEIC ACIDS RES, V36, P4465, DOI 10.1093/nar/gkn410; Panigrahi AK, 2003, RNA, V9, P484, DOI 10.1261/rna.2194603; Panigrahi AK, 2001, MOL CELL BIOL, V21, P380, DOI 10.1128/MCB.21.2.380-389.2001; PURISIMA EO, 1995, J COMPUT CHEM, V16, P681, DOI 10.1002/jcc.540160604; Purisima EO, 1998, J COMPUT CHEM, V19, P1494, DOI 10.1002/(SICI)1096-987X(199810)19:13<1494::AID-JCC6>3.0.CO;2-L; READ LK, 1994, MOL CELL BIOL, V14, P2629, DOI 10.1128/MCB.14.4.2629; SABATINI R, 1995, J BIOL CHEM, V270, P7233, DOI 10.1074/jbc.270.13.7233; Salavati R, 2006, RNA, V12, P819, DOI 10.1261/rna.2244106; Salavati R, 2002, MOL BIOCHEM PARASIT, V120, P23, DOI 10.1016/S0166-6851(01)00431-5; Sbicego S, 2003, EUKARYOT CELL, V2, P560, DOI 10.1128/EC.2.3.560-568.2003; Schnaufer A, 2003, MOL CELL, V12, P307, DOI 10.1016/S1097-2765(03)00286-7; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Schneider Andre, 2007, Methods Mol Biol, V372, P67, DOI 10.1007/978-1-59745-365-3_5; Seiwert SD, 1996, CELL, V84, P831, DOI 10.1016/S0092-8674(00)81062-4; Shaneh A, 2010, J MOL MODEL, V16, P61, DOI 10.1007/s00894-009-0506-1; Simpson L, 2003, RNA, V9, P265, DOI 10.1261/rna.2178403; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Swift RV, 2009, BIOCHEMISTRY-US, V48, P709, DOI 10.1021/bi8018114; Tarun SZ, 2008, RNA, V14, P347, DOI 10.1261/rna.763308; Trotter JR, 2005, MOL CELL, V20, P403, DOI 10.1016/j.molcel.2005.09.016; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P6392, DOI 10.1093/nar/gkg870	51	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14178	14189		10.1074/jbc.M110.199646	http://dx.doi.org/10.1074/jbc.M110.199646			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21378165	Green Published, hybrid			2022-12-27	WOS:000289556200041
J	Peterson, AW; Pendrak, ML; Roberts, DD				Peterson, Alexander W.; Pendrak, Michael L.; Roberts, David D.			ATP Binding to Hemoglobin Response Gene 1 Protein Is Necessary for Regulation of the Mating Type Locus in Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANOMALOUS ELECTROPHORETIC BEHAVIOR; ADENYLATE KINASE; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE-BINDING; ACIDIC PROTEIN; P-LOOP; YEAST; CHROMATOGRAPHY; MOTIF	HBR1 (hemoglobin response gene 1) is an essential gene in Candida albicans that positively regulates mating type locus MTL alpha gene expression and thereby regulates cell type-specific developmental genes. Hbr1p contains a phosphate-binding loop (P-loop), a highly conserved motif characteristic of ATP-and GTP-binding proteins. Recombinant Hbr1p was isolated in an oligomeric state that specifically bound ATP with K-d similar to 2 mu M. ATP but not ADP, AMP, GTP, or dATP specifically protected Hbr1p from proteolysis by trypsin. Site-directed mutagenesis of the highly conserved P-loop lysine (K22Q) and the less conserved glycine (G19S) decreased the binding affinity for soluble ATP and ATP immobilized through its gamma-phosphate. ATP bound somewhat more avidly than ATP gamma S to wild type and mutant Hbr1p. Although Hbr1p exhibits sequence motifs characteristic of adenylate kinases, and adenylate kinase and ATPase activities have been reported for the apparent human ortholog of Hbr1p, assays for adenylate kinase activity, autophosphorylation, and ATPase activity proved negative. Overexpression of wild type but not the mutant forms of Hbr1p restored MTl alpha 2 expression in an HBR1/hbr1 mutant, indicating that ATP binding to the P-loop is necessary for this function of Hbr1p.	[Peterson, Alexander W.; Pendrak, Michael L.; Roberts, David D.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roberts, DD (corresponding author), NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10,Rm 2A33,10 Ctr Dr, Bethesda, MD 20892 USA.	droberts@helix.nih.gov	Roberts, David D./A-9699-2008	Roberts, David D./0000-0002-2481-2981	National Institutes of Health through the National Cancer Institute Center for Cancer Research [ZIA SC 009173]; NATIONAL CANCER INSTITUTE [ZIASC009173] Funding Source: NIH RePORTER	National Institutes of Health through the National Cancer Institute Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health through the National Cancer Institute Center for Cancer Research Intramural Research Program, ZIA SC 009173.	ADAMS A, 1998, METHODS YEAST GENETI, P99; ADAMS LD, 2004, CURR PROTOC MOL BIOL, V14, P11; Alves VS, 2004, BIOCHEM BIOPH RES CO, V314, P229, DOI 10.1016/j.bbrc.2003.12.086; BEGG GE, 1999, CURRENT PROTOC PROTE, V10, P11; Bennett RJ, 2005, ANNU REV MICROBIOL, V59, P233, DOI 10.1146/annurev.micro.59.030804.121310; Care RS, 1999, MOL MICROBIOL, V34, P792, DOI 10.1046/j.1365-2958.1999.01641.x; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; DUNN B, 1992, CURR PROTOC MOL BIOL, V13, P11; Garcia-Ortega L, 2005, ELECTROPHORESIS, V26, P3407, DOI 10.1002/elps.200500261; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; Granneman S, 2005, MOL CELL BIOL, V25, P10352, DOI 10.1128/MCB.25.23.10352-10364.2005; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; Juhnke H, 2000, MOL MICROBIOL, V35, P936, DOI 10.1046/j.1365-2958.2000.01768.x; Krell T, 1998, J MOL BIOL, V278, P983, DOI 10.1006/jmbi.1998.1755; Kvaal C, 1999, INFECT IMMUN, V67, P6652; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Magee BB, 2000, SCIENCE, V289, P310, DOI 10.1126/science.289.5477.310; Meng G, 2008, BIOCHEMISTRY-MOSCOW+, V73, P38, DOI 10.1134/S0006297908010057; Miller MG, 2002, CELL, V110, P293, DOI 10.1016/S0092-8674(02)00837-1; MOORE RE, 2000, CURRENT PROTOC PROTE, V10, P11; ODA Y, 1981, J BIOCHEM-TOKYO, V89, P285, DOI 10.1093/oxfordjournals.jbchem.a133192; ODDS FC, 1988, CANDIDA CANDIDOSIS, P206; Pendrak ML, 2004, EUKARYOT CELL, V3, P764, DOI 10.1128/EC.3.3.764-775.2004; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Ramakrishnan C, 2002, PROTEIN ENG, V15, P783, DOI 10.1093/protein/15.10.783; RANDERATH K, 1964, J CHROMATOGR, V16, P111, DOI 10.1016/S0021-9673(01)82445-6; REINSTEIN J, 1990, BIOCHEMISTRY-US, V29, P7451, DOI 10.1021/bi00484a014; Ren H, 2005, P NATL ACAD SCI USA, V102, P303, DOI 10.1073/pnas.0407459102; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Santama N, 2005, J BIOL CHEM, V280, P36429, DOI 10.1074/jbc.M501982200; SANTOS MAS, 1995, NUCLEIC ACIDS RES, V23, P1481, DOI 10.1093/nar/23.9.1481; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SHERMAN F, 1991, P3; SOLL DR, 1992, CLIN MICROBIOL REV, V5, P183, DOI 10.1128/CMR.5.2.183-203.1992; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; STONE KL, 2004, CURRENT PROTOC PROTE, V13, P1; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WILLIAMS A, 1998, CURR PROTOC MOL BIOL, V10, P11; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Zhai RT, 2006, FEBS LETT, V580, P3811, DOI 10.1016/j.febslet.2006.05.074; Zhang JF, 2010, CELL MOL LIFE SCI, V67, P1907, DOI 10.1007/s00018-010-0301-2	45	1	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13914	13924		10.1074/jbc.M110.180190	http://dx.doi.org/10.1074/jbc.M110.180190			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21372131	Green Published, hybrid			2022-12-27	WOS:000289556200014
J	Boutz, DR; Collins, PJ; Suresh, U; Lu, MZ; Ramirez, CM; Fernandez-Hernando, C; Huang, YF; Abreu, RD; Le, SY; Shapiro, BA; Liu, AM; Luk, JM; Aldred, SF; Trinklein, ND; Marcotte, EM; Penalva, LOF				Boutz, Daniel R.; Collins, Patrick J.; Suresh, Uthra; Lu, Mingzhu; Ramirez, Cristina M.; Fernandez-Hernando, Carlos; Huang, Yufei; Abreu, Raquel de Sousa; Le, Shu-Yun; Shapiro, Bruce A.; Liu, Angela M.; Luk, John M.; Aldred, Shelley Force; Trinklein, Nathan D.; Marcotte, Edward M.; Penalva, Luiz O. F.			Two-tiered Approach Identifies a Network of Cancer and Liver Disease-related Genes Regulated by miR-122	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; HUMAN BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR; STIMULATED PHOSPHORYLATION; INSULIN SENSITIVITY; PYRUVATE-KINASE; MESSENGER-RNAS; IN-VIVO; MICRORNA	MicroRNAs function as important regulators of gene expression and are commonly linked to development, differentiation, and diseases such as cancer. To better understand their roles in various biological processes, identification of genes targeted by microRNAs is necessary. Although prediction tools have significantly helped with this task, experimental approaches are ultimately required for extensive target search and validation. We employed two independent yet complementary high throughput approaches to map a large set of mRNAs regulated by miR-122, a liver-specific microRNA implicated in regulation of fatty acid and cholesterol metabolism, hepatitis C infection, and hepatocellular carcinoma. The combination of luciferase reporter-based screening and shotgun proteomics resulted in the identification of 260 proteins significantly down-regulated in response to miR-122 in at least one method, 113 of which contain predicted miR-122 target sites. These proteins are enriched for functions associated with the cell cycle, differentiation, proliferation, and apoptosis. Among these miR-122-sensitive proteins, we identified a large group with strong connections to liver metabolism, diseases, and hepatocellular carcinoma. Additional analyses, including examination of consensus binding motifs for both miR-122 and target sequences, provide further insight into miR-122 function.	[Boutz, Daniel R.; Marcotte, Edward M.] Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Collins, Patrick J.; Aldred, Shelley Force; Trinklein, Nathan D.] SwitchGear Genom, Menlo Pk, CA 94025 USA; [Suresh, Uthra; Huang, Yufei; Abreu, Raquel de Sousa; Penalva, Luiz O. F.] Univ Texas Hlth Sci Ctr San Antonio, Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Lu, Mingzhu; Huang, Yufei] Univ Texas San Antonio, Dept Elect & Comp Engn, San Antonio, TX 78249 USA; [Ramirez, Cristina M.; Fernandez-Hernando, Carlos] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY 10016 USA; [Le, Shu-Yun; Shapiro, Bruce A.; Penalva, Luiz O. F.] NCI, Ctr Canc Res, Nanobiol Program, NIH, Frederick, MD 21702 USA; [Liu, Angela M.; Luk, John M.] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Liu, Angela M.; Luk, John M.] Natl Univ Singapore, Dept Pharmacol, Singapore 117597, Singapore; [Luk, John M.] Natl Univ Singapore, Dept Surg, Singapore 117597, Singapore; [Luk, John M.] Natl Univ Singapore, Canc Sci Inst, Singapore 117597, Singapore; [Marcotte, Edward M.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Penalva, Luiz O. F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Hong Kong; National University of Singapore; National University of Singapore; National University of Singapore; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio	Boutz, DR (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, 2500 Speedway,MBB 3-210, Austin, TX 78712 USA.	dboutz@mail.utexas.edu; penalva@uthscsa.edu	Huang, Yufei/AAU-2891-2021; Ramírez, Cristina/ABI-1568-2020; Ramírez, Cristina/A-6975-2016; Luk, John/A-4085-2008; Boutz, Daniel/M-4872-2013	Ramírez, Cristina/0000-0003-2589-0786; Ramírez, Cristina/0000-0003-2589-0786; Luk, John/0000-0002-6323-7940; Boutz, Daniel/0000-0001-7462-4105; Penalva, Luiz/0000-0003-4491-6769; de Sousa Abreu, Raquel/0000-0002-8211-6052; Collins, Patrick/0000-0002-7141-7503; Marcotte, Edward/0000-0001-8808-180X	National Institutes of Health [GM076536, GM067779, GM088624]; Welch Foundation [F-1515]; Packard Foundation; NCI Center for Cancer Research; Children's Cancer Research Institute; University of Texas Health Science Center at San Antonio; SwitchGear Genomics; NATIONAL CANCER INSTITUTE [ZIABC008382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088624, R01GM067779, R01GM076536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Packard Foundation(The David & Lucile Packard Foundation); NCI Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Children's Cancer Research Institute; University of Texas Health Science Center at San Antonio; SwitchGear Genomics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM076536, GM067779, and GM088624, and Grant F-1515 from the Welch Foundation and by the Packard Foundation. (to E. M. M.) and the NCI Center for Cancer Research Intramural Research Program (to the B. A. S. laboratory). This work was also supported by the Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio (to the L. O. F. P. laboratory), and by SwitchGear Genomics. N. D. T., S. F. A., and P. J. C. are employees of and hold stock in SwitchGear Genomics. SwitchGear Genomics sells 3'UTR reporter vectors commercially. SwitchGear Genomics is the owner by assignment of patents or patent applications related to the 3'UTR reporter platform.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Burchard J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.58; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Cahova M, 2007, PHYSIOL RES, V56, P1, DOI 10.33549/physiolres.930882; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Colombat M, 2003, J PATHOL, V201, P260, DOI 10.1002/path.1451; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Czech MP, 2006, NEW ENGL J MED, V354, P1194, DOI 10.1056/NEJMcibr060065; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fang YJ, 2009, INT J COLORECTAL DIS, V24, P875, DOI 10.1007/s00384-009-0725-z; Farnebo M, 2010, BIOCHEM BIOPH RES CO, V396, P85, DOI 10.1016/j.bbrc.2010.02.152; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Frayn KN, 2003, BIOCHEM SOC T, V31, P1115, DOI 10.1042/BST0311115; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hao K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-389; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; HENDRIX MJC, 1992, JNCI-J NATL CANCER I, V84, P165, DOI 10.1093/jnci/84.3.165; Hirashima M, 2009, ANAT SCI INT, V84, P95, DOI 10.1007/s12565-009-0026-1; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Hu L, 2004, ONCOGENE, V23, P298, DOI 10.1038/sj.onc.1206483; ISHIBASHI H, 1978, J BIOL CHEM, V253, P8767; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Koren S, 2007, BEST PRACT RES CL EN, V21, P621, DOI 10.1016/j.beem.2007.08.004; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Langhans W, 2003, CURR OPIN CLIN NUTR, V6, P449, DOI 10.1097/01.mco.0000078993.96795.16; Le S. Y., 1990, P 6 CONV BIOM STER S; LE SY, 1989, J THEOR BIOL, V138, P495, DOI 10.1016/S0022-5193(89)80047-5; Le SY, 2002, KNOWL-BASED SYST, V15, P243, DOI 10.1016/S0950-7051(01)00146-0; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li HG, 2005, WORLD J GASTROENTERO, V11, P1445; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu M, 2010, MOL BIOL REP, V37, P3601, DOI 10.1007/s11033-010-0009-2; Liu SJ, 2008, J AM CHEM SOC, V130, P8251, DOI 10.1021/ja711125p; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; NAGANO M, 1980, ARCH BIOCHEM BIOPHYS, V203, P271, DOI 10.1016/0003-9861(80)90177-0; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Ou L, 2006, PROTEIN EXPRES PURIF, V47, P367, DOI 10.1016/j.pep.2006.01.016; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Sanchez-Diaz Patricia, 2006, RNA Biol, V3, P101; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Shi WD, 2009, CANCER LETT, V283, P84, DOI 10.1016/j.canlet.2009.03.030; Silverman-Gavrila R, 2008, THESCIENTIFICWORLDJO, V8, P611, DOI 10.1100/tsw.2008.87; Siu YT, 2007, FEBS J, V274, P3224, DOI 10.1111/j.1742-4658.2007.05884.x; Soucek L, 2010, CURR OPIN GENET DEV, V20, P91, DOI 10.1016/j.gde.2009.11.001; Sun S, 2010, J PROTEOME RES, V9, P1923, DOI 10.1021/pr901085z; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Tsubota A, 2010, CARCINOGENESIS, V31, P504, DOI 10.1093/carcin/bgp313; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Turner CE, 2000, J CELL SCI, V113, P4139; Vadlamudi R, 1999, CANCER RES, V59, P2843; Vella MC, 2004, CHEM BIOL, V11, P1619, DOI 10.1016/j.chembiol.2004.09.010; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wu X, 2009, SCAND J GASTROENTERO, V44, P1332, DOI 10.3109/00365520903215305; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Zhai Y F, 1996, Cancer Treat Res, V83, P107; ZHAI YF, 1993, CANCER RES, V53, P2272; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	87	44	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18066	18078		10.1074/jbc.M110.196451	http://dx.doi.org/10.1074/jbc.M110.196451			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21402708	Green Published, hybrid			2022-12-27	WOS:000290585200068
J	Jones, CG; Moniodis, J; Zulak, KG; Scaffidi, A; Plummer, JA; Ghisalberti, EL; Barbour, EL; Bohlmann, J				Jones, Christopher G.; Moniodis, Jessie; Zulak, Katherine G.; Scaffidi, Adrian; Plummer, Julie A.; Ghisalberti, Emilio L.; Barbour, Elizabeth L.; Bohlmann, Joerg			Sandalwood Fragrance Biosynthesis Involves Sesquiterpene Synthases of Both the Terpene Synthase (TPS)-a and TPS-b Subfamilies, including Santalene Synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESSENTIAL-OIL; BIOLOGICAL EVALUATION; INDIAN SANDALWOOD; INSIGHTS; QUALITY; WILD	Sandalwood oil is one of the worlds most highly prized fragrances. To identify the genes and encoded enzymes responsible for santalene biosynthesis, we cloned and characterized three orthologous terpene synthase (TPS) genes SaSSy, SauSSy, and SspiSSy from three divergent sandalwood species; Santalum album, S. austrocaledonicum, and S. spicatum, respectively. The encoded enzymes catalyze the formation of alpha-, beta-, epi-beta-santalene, and alpha-exo-bergamotene from (E,E)-farnesyl diphosphate (E,E-FPP). Recombinant SaSSy was additionally tested with (Z,Z)-farnesyl diphosphate (Z,Z-FPP) and remarkably, found to produce a mixture of alpha-endo-bergamotene, alpha-santalene, (Z)-beta-farnesene, epi-beta-santalene, and beta-santalene. Additional cDNAs that encode bisabolene/bisabolol synthases were also cloned and functionally characterized from these three species. Both the santalene synthases and the bisabolene/bisabolol synthases reside in the TPS-b phylogenetic clade, which is more commonly associated with angiosperm monoterpene synthases. An orthologous set of TPS-a synthases responsible for formation of macrocyclic and bicyclic sesquiterpenes were characterized. Strict functionality and limited sequence divergence in the santalene and bisabolene synthases are in contrast to the TPS-a synthases, suggesting these compounds have played a significant role in the evolution of the Santalum genus.	[Jones, Christopher G.; Moniodis, Jessie; Zulak, Katherine G.; Plummer, Julie A.; Barbour, Elizabeth L.] Univ Western Australia Crawley, Fac Nat & Agr Sci, Sch Plant Biol M084, Crawley, WA 6009, Australia; [Scaffidi, Adrian; Ghisalberti, Emilio L.] Univ Western Australia Crawley, Sch Biomed Biomol & Chem Sci M313, Fac Life & Phys Sci, Crawley, WA 6009, Australia; [Barbour, Elizabeth L.] Forest Prod Commiss Western Australia, Rivervale, WA 6103, Australia; [Zulak, Katherine G.; Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada	University of Western Australia; University of Western Australia; University of British Columbia	Jones, CG (corresponding author), Univ Western Australia Crawley, Fac Nat & Agr Sci, Sch Plant Biol M084, Crawley, WA 6009, Australia.	christopher.jones@uwa.edu.au	Zulak, Katherine G/B-5939-2011; Scaffidi, Adrian/J-2707-2012	Zulak, Katherine G/0000-0003-0415-8975; Barbour, Elizabeth/0000-0002-3533-2422	Australian Research Council (ARC); Forest Products Commission of Western Australia (FPC) [LP0882690]; Natural Sciences and Engineering Council of Canada (NSERC)	Australian Research Council (ARC)(Australian Research Council); Forest Products Commission of Western Australia (FPC); Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Australian Research Council (ARC) and the Forest Products Commission of Western Australia (FPC) as part of linkage project LP0882690 (to J. A. P. and E. L. G.) and a Discovery Grant of the Natural Sciences and Engineering Council of Canada (NSERC) (to J. B.).	Adams R.P., 1995, IDENTIFICATION ESSEN; Aharoni A, 2004, PLANT CELL, V16, P3110, DOI 10.1105/tpc.104.023895; Applegate GB, 1990, P S SAND PAC APR 9 1, P1; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Braun NA, 2005, J ESSENT OIL RES, V17, P477, DOI 10.1080/10412905.2005.9698969; Choi HS, 2003, J AGR FOOD CHEM, V51, P2687, DOI 10.1021/jf021069o; CHUNG TY, 1993, J AGR FOOD CHEM, V41, P1693, DOI 10.1021/jf00034a033; Cyr A, 2007, J AM CHEM SOC, V129, P6684, DOI 10.1021/ja071158n; DAVIES NW, 1990, J CHROMATOGR, V503, P1, DOI 10.1016/S0021-9673(01)81487-4; de Kraker JW, 1998, PLANT PHYSIOL, V117, P1381, DOI 10.1104/pp.117.4.1381; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Howes MJR, 2004, J CHROMATOGR A, V1028, P307, DOI 10.1016/j.chroma.2003.11.093; Huang QL, 2001, BIOORGAN MED CHEM, V9, P2237, DOI 10.1016/S0968-0896(01)00072-4; Jones CG, 2009, SILVAE GENET, V58, P279, DOI 10.1515/sg-2009-0036; Jones CG, 2008, ARCH BIOCHEM BIOPHYS, V477, P121, DOI 10.1016/j.abb.2008.05.008; Jones CG, 2006, PHYTOCHEMISTRY, V67, P2463, DOI 10.1016/j.phytochem.2006.09.013; Kampranis SC, 2007, PLANT CELL, V19, P1994, DOI 10.1105/tpc.106.047779; Kollner TG, 2004, PLANT CELL, V16, P1115, DOI 10.1105/tpc.019877; Kolosova N, 2004, BIOTECHNIQUES, V36, P821, DOI 10.2144/04365ST06; Kreipl AT, 2004, PHYTOCHEMISTRY, V65, P2045, DOI 10.1016/j.phytochem.2004.05.007; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; O'Maille PE, 2004, ANAL BIOCHEM, V335, P210, DOI 10.1016/j.ab.2004.09.011; Page T, 2010, CHEM BIODIVERS, V7, P1990, DOI 10.1002/cbdv.200900382; Pala-Paul J, 2005, J CHROMATOGR A, V1074, P235, DOI 10.1016/j.chroma.2005.03.036; Paolini J, 2007, FLAVOUR FRAG J, V22, P479, DOI 10.1002/ffj.1824; Piggott MJ, 1997, FLAVOUR FRAG J, V12, P43, DOI 10.1002/(SICI)1099-1026(199701)12:1<43::AID-FFJ601>3.0.CO;2-H; Sallaud C, 2009, PLANT CELL, V21, P301, DOI 10.1105/tpc.107.057885; Shao Y, 1999, ORG LETT, V1, P627, DOI 10.1021/ol990714i; Skaltsa HD, 2003, PHYTOCHEMISTRY, V64, P743, DOI 10.1016/S0031-9422(03)00386-8; SOUTHWELL IA, 1970, PHYTOCHEMISTRY, V9, P2243, DOI 10.1016/S0031-9422(00)85393-5; Trapp SC, 2001, GENETICS, V158, P811; Valder C, 2003, J ESSENT OIL RES, V15, P178, DOI 10.1080/10412905.2003.9712106; Williams DC, 1998, BIOCHEMISTRY-US, V37, P12213, DOI 10.1021/bi980854k; Xie HB, 2000, J ORG CHEM, V65, P8552, DOI 10.1021/jo000942m	36	96	126	3	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17445	17454		10.1074/jbc.M111.231787	http://dx.doi.org/10.1074/jbc.M111.231787			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454632	hybrid, Green Published			2022-12-27	WOS:000290585200006
J	Park, SY; Jin, WZ; Woo, JR; Shoelson, SE				Park, Sang-Youn; Jin, Wanzhu; Woo, Ju Rang; Shoelson, Steven E.			Crystal Structures of Human TBC1D1 and TBC1D4 (AS160) RabGTPase-activating Protein (RabGAP) Domains Reveal Critical Elements for GLUT4 Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKT SUBSTRATE; GAP DOMAIN; MEMBRANE; MUTATION; GTPASES; RAB10	We have solved the x-ray crystal structures of the RabGAP domains of human TBC1D1 and human TBC1D4 (AS160), at 2.2 and 3.5 angstrom resolution, respectively. Like the yeast Gyp1p RabGAP domain, whose structure was solved previously in complex with mouse Rab33B, the human TBC1D1 and TBC1D4 domains both have 16 alpha-helices and no beta-sheet elements. We expected the yeast Gyp1p RabGAP/mouse Rab33B structure to predict the corresponding interfaces between cognate mammalian RabGAPs and Rabs, but found that residues were poorly conserved. We further tested the relevance of this model by Ala-scanning mutagenesis, but only one of five substitutions within the inferred binding site of the TBC1D1 RabGAP significantly perturbed catalytic efficiency. In addition, substitution of TBC1D1 residues with corresponding residues from Gyp1p did not enhance catalytic efficiency. We hypothesized that biologically relevant RabGAP/Rab partners utilize additional contacts not described in the yeast Gyp1p/mouse Rab33B structure, which we predicted using our two new human TBC1D1 and TBC1D4 structures. Ala substitution of TBC1D1 Met(930), corresponding to a residue outside of the Gyp1p/Rab33B contact, substantially reduced catalytic activity. GLUT4 translocation assays confirmed the biological relevance of our findings. Substitutions with lowest RabGAP activity, including catalytically dead RK and Met(930) and Leu(1019) predicted to perturb Rab binding, confirmed that biological activity requires contacts between cognate RabGAPs and Rabs beyond those in the yeast Gyp1p RabGAP/mouse Rab33B structure.	[Shoelson, Steven E.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Shoelson, SE (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	steven.shoelson@joslin.harvard.edu	Jin, Wanzhu/B-5699-2012	Jin, Wanzhu/0000-0002-5860-2958	National Institutes of Health [R01 DK43123, R01 DK51729, F32 DK77485, P30 DK36836]; United States Department of Energy, Division of Materials Sciences and Division of Chemical Sciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK077485, R01DK043123, P30DK036836, R01DK051729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Division of Materials Sciences and Division of Chemical Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK43123 and R01 DK51729 (to S. E. S.), F32 DK77485 (to S.-Y. P.), and P30 DK36836 (to the Joslin Diabetes Center). Data were collected at beams X29A and X12C of National Synchrotron Light Source, Brookhaven National Laboratory, which is supported by the United States Department of Energy, Division of Materials Sciences and Division of Chemical Sciences, Contract DE-AC02-98CH10886.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Cowtan K., 1994, CRYSTALLOGRAPHY, V31, P34; Dash S, 2009, P NATL ACAD SCI USA, V106, P9350, DOI 10.1073/pnas.0900909106; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Peck GR, 2006, MOL ENDOCRINOL, V20, P2576, DOI 10.1210/me.2005-0476; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rak A, 2000, EMBO J, V19, P5105, DOI 10.1093/emboj/19.19.5105; Roach WG, 2007, BIOCHEM J, V403, P353, DOI 10.1042/BJ20061798; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	23	18	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18130	18138		10.1074/jbc.M110.217323	http://dx.doi.org/10.1074/jbc.M110.217323			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454505	hybrid, Green Published			2022-12-27	WOS:000290585200073
J	Wang, YC; Yang, F; Fu, Y; Huang, XH; Wang, W; Jiang, XN; Gritsenko, MA; Zhao, R; Monore, ME; Pertz, OC; Purvine, SO; Orton, DJ; Jacobs, JM; Camp, DG; Smith, RD; Klemke, RL				Wang, Yingchun; Yang, Feng; Fu, Yi; Huang, Xiahe; Wang, Wei; Jiang, Xinning; Gritsenko, Marina A.; Zhao, Rui; Monore, Matthew E.; Pertz, Olivier C.; Purvine, Samuel O.; Orton, Daniel J.; Jacobs, Jon M.; Camp, David G., II; Smith, Richard D.; Klemke, Richard L.			Spatial Phosphoprotein Profiling Reveals a Compartmentalized Extracellular Signal-regulated Kinase Switch Governing Neurite Growth and Retraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; ABL TYROSINE KINASE; ADULT DRG NEURONS; LYSOPHOSPHATIDIC ACID; CELL-MIGRATION; ERK ACTIVATION; AXON GUIDANCE; MAP-KINASE; CYTOSKELETAL DYNAMICS; CONE GUIDANCE	Brain development and spinal cord regeneration require neurite sprouting and growth cone navigation in response to extension and collapsing factors present in the extracellular environment. These external guidance cues control neurite growth cone extension and retraction processes through intracellular protein phosphorylation of numerous cytoskeletal, adhesion, and polarity complex signaling proteins. However, the complex kinase/substrate signaling networks that mediate neuritogenesis have not been investigated. Here, we compare the neurite phosphoproteome under growth and retraction conditions using neurite purification methodology combined with mass spectrometry. More than 4000 non-redundant phosphorylation sites from 1883 proteins have been annotated and mapped to signaling pathways that control kinase/phosphatase networks, cytoskeleton remodeling, and axon/dendrite specification. Comprehensive informatics and functional studies revealed a compartmentalized ERK activation/deactivation cytoskeletal switch that governs neurite growth and retraction, respectively. Our findings provide the first system-wide analysis of the phosphoprotein signaling networks that enable neurite growth and retraction and reveal an important molecular switch that governs neuritogenesis.	[Wang, Yingchun; Wang, Wei; Jiang, Xinning; Pertz, Olivier C.; Klemke, Richard L.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Wang, Yingchun; Wang, Wei; Jiang, Xinning; Pertz, Olivier C.; Klemke, Richard L.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Yang, Feng; Gritsenko, Marina A.; Zhao, Rui; Monore, Matthew E.; Purvine, Samuel O.; Orton, Daniel J.; Jacobs, Jon M.; Camp, David G., II; Smith, Richard D.] Pacific NW Natl Lab, Environm Mol Sci Lab, Div Biol Sci, Richland, WA 99354 USA; [Wang, Yingchun; Fu, Yi; Huang, Xiahe; Wang, Wei] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China	University of California System; University of California San Diego; University of California System; University of California San Diego; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Klemke, RL (corresponding author), Univ Calif San Diego, Dept Pathol, Basic Sci Bldg 1040,9500 Gilman Dr,MC 0612, La Jolla, CA 92093 USA.	rklemke@ucsd.edu	Jiang, Xinning/F-2140-2010; Purvine, Samuel O/O-3358-2017; Smith, Richard D/J-3664-2012	Jiang, Xinning/0000-0001-6414-6226; Purvine, Samuel O/0000-0002-2257-2400; Smith, Richard D/0000-0002-2381-2349; pertz, olivier/0000-0001-8579-4919; Orton, Daniel/0000-0002-0253-6859	National Institutes of Health [GM068487, CA097022, RR018522]; Chinese Academy of Sciences; Department of Energy [DE-AC05-76RLO 1830]; NATIONAL CANCER INSTITUTE [R01CA097022] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Sciences(Chinese Academy of Sciences); Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068487 (to R. L. K.), CA097022 (to R. L. K.), and RR018522 (to R. D. S.).; Supported by the One Hundred Talents project of the Chinese Academy of Sciences.; We thank Monica Holcomb for excellent technical assistance. We also thank Dr. Andrew D. Catling (Louisiana State University Health Sciences Center, New Orleans, LA) for providing the MEK constructs and Drs. Rune Linding and Tony Pawson for assistance and advice on using NetworKIN. Portions of the research were performed in the Environmental Molecular Sciences Laboratory, a United States Department of Energy scientific user facility located at Pacific Northwest National Laboratory in Richland, WA. Pacific Northwest National Laboratory is operated by Battelle for the United States Department of Energy under Contract DE-AC05-76RLO 1830.	Alessandrini A, 1996, J BIOL CHEM, V271, P31612, DOI 10.1074/jbc.271.49.31612; Allen J, 2009, DEV BIOL, V327, P4, DOI 10.1016/j.ydbio.2008.12.013; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Barnes AP, 2008, CURR OPIN NEUROBIOL, V18, P44, DOI 10.1016/j.conb.2008.05.003; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bordt SL, 2001, BBA-MOL CELL RES, V1499, P257, DOI 10.1016/S0167-4889(00)00127-0; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Chodniewicz D, 2004, EXP CELL RES, V301, P31, DOI 10.1016/j.yexcr.2004.08.006; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; Darenfed H, 2007, CELL MOTIL CYTOSKEL, V64, P97, DOI 10.1002/cm.20168; Dehmelt L, 2007, CURR BIOL, V17, pR611, DOI 10.1016/j.cub.2007.05.059; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Dhillon AS, 2003, MOL CELL BIOL, V23, P1983, DOI 10.1128/MCB.23.6.1983-1993.2003; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Dimitropoulou A, 2000, BRAIN RES, V858, P205, DOI 10.1016/S0006-8993(00)01946-6; Ding SJ, 2008, J PROTEOME RES, V7, P4215, DOI 10.1021/pr7007785; Drees F, 2008, CURR OPIN NEUROBIOL, V18, P53, DOI 10.1016/j.conb.2008.05.007; Du XX, 2008, J PROTEOME RES, V7, P2195, DOI 10.1021/pr070510t; Eblen ST, 2004, MOL CELL BIOL, V24, P2308, DOI 10.1128/MCB.24.6.2308-2317.2004; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Ehler E, 1997, MOL CELL NEUROSCI, V9, P1, DOI 10.1006/mcne.1997.0602; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Enserink JM, 2004, J BIOL CHEM, V279, P44889, DOI 10.1074/jbc.M404599200; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Fukushima N, 2002, MOL CELL NEUROSCI, V20, P271, DOI 10.1006/mcne.2002.1123; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Giannone G, 2009, TRENDS CELL BIOL, V19, P475, DOI 10.1016/j.tcb.2009.07.001; Haeusgen W, 2009, NEUROSCIENCE, V161, P951, DOI 10.1016/j.neuroscience.2009.04.014; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Heibeck TH, 2009, J PROTEOME RES, V8, P3852, DOI 10.1021/pr900044c; Hernandez SE, 2004, CURR BIOL, V14, P691, DOI 10.1016/j.cub.2004.03.062; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Hollis ER, 2009, P NATL ACAD SCI USA, V106, P7215, DOI 10.1073/pnas.0810624106; Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X; Huang J, 2006, MOL BIOL CELL, V17, P3187, DOI 10.1091/mbc.E05-12-1122; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Jeon S, 2010, NEUROCHEM INT, V56, P810, DOI 10.1016/j.neuint.2010.03.005; Jorgensen C, 2010, CURR OPIN GENET DEV, V20, P15, DOI 10.1016/j.gde.2009.12.003; Jorgensen C, 2009, SCIENCE, V326, P1502, DOI 10.1126/science.1176615; Kain KH, 2001, J BIOL CHEM, V276, P16185, DOI 10.1074/jbc.M100095200; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kao HT, 2002, NAT NEUROSCI, V5, P431, DOI 10.1038/nn840; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Koh CG, 2006, NEUROSIGNALS, V15, P228, DOI 10.1159/000101527; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Li GN, 2008, ANN BIOMED ENG, V36, P889, DOI 10.1007/s10439-008-9486-z; Liang XQ, 2007, J AM SOC MASS SPECTR, V18, P1932, DOI 10.1016/j.jasms.2007.08.001; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Linding R, 2008, NUCLEIC ACIDS RES, V36, pD695, DOI 10.1093/nar/gkm902; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; McLeod SJ, 2004, J BIOL CHEM, V279, P12009, DOI 10.1074/jbc.M313098200; Moser K, 2006, J PROTEOME RES, V5, P98, DOI 10.1021/pr0503073; Mruthyunjaya S, 2010, BIOCHEM BIOPH RES CO, V391, P43, DOI 10.1016/j.bbrc.2009.10.158; Nakata H, 2007, BIOCHEM BIOPH RES CO, V355, P842, DOI 10.1016/j.bbrc.2007.02.045; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Nusser N, 2006, CELL SIGNAL, V18, P704, DOI 10.1016/j.cellsig.2005.06.010; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; Paglini G, 2001, EUR J BIOCHEM, V268, P1528, DOI 10.1046/j.1432-1033.2001.02023.x; Park ER, 2007, CELL SIGNAL, V19, P1488, DOI 10.1016/j.cellsig.2007.01.018; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perron JC, 1999, MOL CELL NEUROSCI, V13, P362, DOI 10.1006/mcne.1999.0753; Pertz OC, 2008, P NATL ACAD SCI USA, V105, P1931, DOI 10.1073/pnas.0706545105; PHAM CD, 1995, ONCOGENE, V10, P1683; Piper M, 2007, ADV EXP MED BIOL, V621, P134, DOI 10.1007/978-0-387-76715-4_10; Plantman S, 2008, MOL CELL NEUROSCI, V39, P50, DOI 10.1016/j.mcn.2008.05.015; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Prager-Khoutorsky M, 2009, BRAIN RES, V1251, P65, DOI 10.1016/j.brainres.2008.10.049; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Quinn CC, 2008, TRENDS CELL BIOL, V18, P597, DOI 10.1016/j.tcb.2008.09.005; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Sayas CL, 1999, J BIOL CHEM, V274, P37046, DOI 10.1074/jbc.274.52.37046; Sayas CL, 2002, BBA-MOL CELL BIOL L, V1582, P144, DOI 10.1016/S1388-1981(02)00149-X; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shelly M, 2010, SCIENCE, V327, P547, DOI 10.1126/science.1179735; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Spencer TK, 2008, MOL CELL NEUROSCI, V38, P110, DOI 10.1016/j.mcn.2008.02.005; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Suetsugu S, 2002, DEV CELL, V3, P645, DOI 10.1016/S1534-5807(02)00324-6; Tahirovic S, 2010, J NEUROSCI, V30, P6930, DOI 10.1523/JNEUROSCI.5395-09.2010; Tan CSH, 2009, PROTEOMICS, V9, P5233, DOI 10.1002/pmic.200900266; Tigyi G, 1996, J NEUROCHEM, V66, P537; To KCW, 2008, NEUROSCIENCE, V153, P645, DOI 10.1016/j.neuroscience.2008.02.043; Tucker BA, 2008, CELL SIGNAL, V20, P241, DOI 10.1016/j.cellsig.2007.10.014; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; van Horck FPG, 2004, CURR OPIN NEUROBIOL, V14, P61, DOI 10.1016/j.conb.2004.01.002; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vogelezang M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-44; Wang YC, 2007, P NATL ACAD SCI USA, V104, P8328, DOI 10.1073/pnas.0701103104; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Wu HT, 2009, BBA-MOL CELL BIOL L, V1791, P8, DOI 10.1016/j.bbalip.2008.10.004; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yamauchi J, 2006, EXP CELL RES, V312, P2954, DOI 10.1016/j.yexcr.2006.05.016; Yang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014152; Yang YC, 2006, MOL CELL BIOL, V26, P8357, DOI 10.1128/MCB.01017-06; Yasui H, 2010, FREE RADICAL RES, V44, P645, DOI 10.3109/10715761003692537; Yee KL, 2008, IET SYST BIOL, V2, P8, DOI 10.1049/iet-syb:20060058; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang XF, 2003, NEURON, V40, P931, DOI 10.1016/S0896-6273(03)00754-2	116	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18190	18201		10.1074/jbc.M111.236133	http://dx.doi.org/10.1074/jbc.M111.236133			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454597	hybrid, Green Published			2022-12-27	WOS:000290585200079
J	Georgelis, N; Tabuchi, A; Nikolaidis, N; Cosgrove, DJ				Georgelis, Nikolaos; Tabuchi, Akira; Nikolaidis, Nikolas; Cosgrove, Daniel J.			Structure-Function Analysis of the Bacterial Expansin EXLX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULOSE-BINDING DOMAIN; PROTEIN SECONDARY STRUCTURE; PLANT-CELL WALLS; CIRCULAR-DICHROISM SPECTROSCOPY; LYTIC TRANSGLYCOSYLASE-B; DEEP-WATER RICE; CLOSTRIDIUM-CELLULOVORANS; CRYSTAL-STRUCTURE; GENE-EXPRESSION; BETA-EXPANSINS	We made use of EXLX1, an expansin from Bacillus subtilis, to investigate protein features essential for its plant cell wall binding and wall loosening activities. We found that the two expansin domains, D1 and D2, need to be linked for wall extension activity and that D2 mediates EXLX1 binding to whole cell walls and to cellulose via distinct residues on the D2 surface. Binding to cellulose is mediated by three aromatic residues arranged linearly on the putative binding surface that spans D1 and D2. Mutation of these three residues to alanine eliminated cellulose binding and concomitantly eliminated wall loosening activity measured either by cell wall extension or by weakening of filter paper but hardly affected binding to whole cell walls, which is mediated by basic residues located on other D2 surfaces. Mutation of these basic residues to glutamine reduced cell wall binding but not wall loosening activities. We propose domain D2 as the founding member of a new carbohydrate binding module family, CBM63, but its function in expansin activity apparently goes beyond simply anchoring D1 to the wall. Several polar residues on the putative binding surface of domain D1 are also important for activity, most notably Asp82, whose mutation to alanine or asparagine completely eliminated wall loosening activity. The functional insights based on this bacterial expansin may be extrapolated to the interactions of plant expansins with cell walls.	[Georgelis, Nikolaos; Tabuchi, Akira; Nikolaidis, Nikolas; Cosgrove, Daniel J.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Georgelis, N (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	nug5@psu.edu	/AAE-9630-2019		United States Department of Energy, Office of Basic Energy Sciences [DE-FG02-84ER13179]	United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by United States Department of Energy Grant DE-FG02-84ER13179 from the Office of Basic Energy Sciences.	Ali MK, 2001, BIOSCI BIOTECH BIOCH, V65, P41, DOI 10.1271/bbb.65.41; Barre A, 2002, BIOCHEM BIOPH RES CO, V296, P1346, DOI 10.1016/S0006-291X(02)02091-0; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2003, J BIOL CHEM, V278, P6120, DOI 10.1074/jbc.M209554200; Boraston AB, 2000, BIOCHEMISTRY-US, V39, P11129, DOI 10.1021/bi0007728; Bras JLA, 2011, P NATL ACAD SCI USA, V108, P5237, DOI 10.1073/pnas.1015006108; Brummell DA, 1999, PLANT MOL BIOL, V39, P161, DOI 10.1023/A:1006130018931; CARPITA NC, 1984, PLANT PHYSIOL, V76, P205, DOI 10.1104/pp.76.1.205; Carpita NC, 2001, PLANT PHYSIOL, V127, P551, DOI 10.1104/pp.010146; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; Cho HT, 2000, P NATL ACAD SCI USA, V97, P9783, DOI 10.1073/pnas.160276997; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Cho HT, 1997, PLANT CELL, V9, P1661, DOI 10.1105/tpc.9.9.1661; Choi DS, 2003, PLANT CELL, V15, P1386, DOI 10.1105/tpc.011965; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 1996, BIOESSAYS, V18, P533, DOI 10.1002/bies.950180704; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davies GJ, 1995, BIOCHEMISTRY-US, V34, P16210, DOI 10.1021/bi00049a037; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; GILKES NR, 1988, J BIOL CHEM, V263, P10401; GOLDSTEIN MA, 1993, J BACTERIOL, V175, P5762, DOI 10.1128/JB.175.18.5762-5768.1993; GOLDSTEIN MA, 1994, J BACTERIOL, V176, P7328, DOI 10.1128/JB.176.23.7328-7334.1994; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; Hall M, 2010, FEBS J, V277, P1571, DOI 10.1111/j.1742-4658.2010.07585.x; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345; Jahr H, 2000, MOL PLANT MICROBE IN, V13, P703, DOI 10.1094/MPMI.2000.13.7.703; Kende H, 2004, PLANT MOL BIOL, V55, P311, DOI 10.1007/s11103-004-0158-6; Kerff F, 2008, P NATL ACAD SCI USA, V105, P16876, DOI 10.1073/pnas.0809382105; Kim ES, 2009, BIOTECHNOL BIOENG, V102, P1342, DOI 10.1002/bit.22193; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Lee Y, 2001, PLANT PHYSIOL, V127, P645, DOI 10.1104/pp.010345; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Li LC, 2003, PLANT PHYSIOL, V132, P2073, DOI 10.1104/pp.103.020024; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Linder M, 1996, J BIOL CHEM, V271, P21268, DOI 10.1074/jbc.271.35.21268; MAGLIONE G, 1992, APPL ENVIRON MICROB, V58, P3593, DOI 10.1128/AEM.58.11.3593-3597.1992; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; MCQUEENMASON S, 1994, P NATL ACAD SCI USA, V91, P6574, DOI 10.1073/pnas.91.14.6574; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; Murashima K, 2005, J BACTERIOL, V187, P7146, DOI 10.1128/JB.187.20.7146-7149.2005; Pages S, 1997, J BACTERIOL, V179, P2810, DOI 10.1128/jb.179.9.2810-2816.1997; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Reid CW, 2007, FEBS LETT, V581, P4988, DOI 10.1016/j.febslet.2007.09.037; Reid CW, 2004, FEBS LETT, V574, P73, DOI 10.1016/j.febslet.2004.08.006; Reinhardt D, 1998, PLANT CELL, V10, P1427, DOI 10.1105/tpc.10.9.1427; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Valdivia ER, 2007, PLANT PHYSIOL, V143, P1269, DOI 10.1104/pp.106.092544; Valdivia ER, 2009, SEX PLANT REPROD, V22, P141, DOI 10.1007/s00497-009-0099-y; van Straaten KE, 2005, J MOL BIOL, V352, P1068, DOI 10.1016/j.jmb.2005.07.067; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vriezen WH, 2000, PLANTA, V210, P956, DOI 10.1007/s004250050703; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Whitney SEC, 2000, PLANT J, V22, P327, DOI 10.1046/j.1365-313x.2000.00742.x; Willats WGT, 2001, J BIOL CHEM, V276, P19404, DOI 10.1074/jbc.M011242200; Wu YJ, 2001, PLANT PHYSIOL, V126, P1471, DOI 10.1104/pp.126.4.1471; Yennawar NH, 2006, P NATL ACAD SCI USA, V103, P14664, DOI 10.1073/pnas.0605979103; Zenoni S, 2004, PLANT CELL, V16, P295, DOI 10.1105/tpc.018705; Zverlov VV, 2001, MICROBIOL-SGM, V147, P621, DOI 10.1099/00221287-147-3-621	71	85	89	3	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16814	16823		10.1074/jbc.M111.225037	http://dx.doi.org/10.1074/jbc.M111.225037			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454649	Green Published, hybrid			2022-12-27	WOS:000290301900031
J	Mysliwiec, MR; Bresnick, EH; Lee, Y				Mysliwiec, Matthew R.; Bresnick, Emery H.; Lee, Youngsook			Endothelial Jarid2/Jumonji Is Required for Normal Cardiac Development and Proper Notch1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; CARDIOMYOCYTE PROLIFERATION; JUMONJI FAMILY; MOUSE EMBRYOS; TARGET GENES; MICE LACKING; TRANSCRIPTION; NEUREGULIN	Jarid2/Jumonji critically regulates developmental processes including cardiovascular development. Jarid2 knock-out mice exhibit cardiac defects including hypertrabeculation with noncompaction of the ventricular wall. However, molecular mechanisms underlying Jarid2-mediated cardiac development remain unknown. To determine the cardiac lineage-specific roles of Jarid2, we generated myocardial, epicardial, cardiac neural crest, or endothelial conditional Jarid2 knockout mice using Cre-loxP technology. Only mice with an endothelial deletion of Jarid2 recapitulate phenotypic defects observed in whole body mutants including hypertrabeculation and noncompaction of the ventricle. To identify potential targets of Jarid2, combinatorial approaches using microarray and candidate gene analyses were employed on Jarid2 knock-out embryonic hearts. Whole body or endothelial deletion of Jarid2 leads to increased endocardial Notch1 expression in the developing ventricle, resulting in increased Notch1-dependent signaling to the adjacent myocardium. Using quantitative chromatin immunoprecipitation analysis, Jarid2 was found to occupy a specific region on the endogenous Notch1 locus. We propose that failure to properly regulate Notch signaling in Jarid2 mutants likely leads to the defects in the developing ventricular chamber. The identification of Jarid2 as a potential regulator of Notch1 signaling has broad implications for many cellular processes including development, stem cell maintenance, and tumor formation.	[Mysliwiec, Matthew R.; Lee, Youngsook] Univ Wisconsin, Dept Anat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Bresnick, Emery H.] Univ Wisconsin, Wisconsin Inst Med Res, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Lee, Y (corresponding author), Univ Wisconsin, Dept Anat, Sch Med & Publ Hlth, 1300 Univ Ave,SMI 322, Madison, WI 53706 USA.	youngsooklee@wisc.edu			National Institutes of Health [HL67050, DK068634]; American Heart Association [0815663G, 0615633Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068634, R56DK068634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL67050 (to Y. L.) and DK068634 (to E. H. B.). This work was also supported by American Heart Association Grants 0815663G and 0615633Z (to M. R. M.).	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; Balciunas D, 2000, TRENDS BIOCHEM SCI, V25, P274, DOI 10.1016/S0968-0004(00)01593-0; Barth JL, 2010, DEV DYNAM, V239, P2024, DOI 10.1002/dvdy.22341; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Campa VM, 2008, J CELL BIOL, V183, P129, DOI 10.1083/jcb.200806104; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Chu JL, 2002, J BIOL CHEM, V277, P7587, DOI 10.1074/jbc.M111044200; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; Collesi C, 2008, J CELL BIOL, V183, P117, DOI 10.1083/jcb.200806091; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fiddes RJ, 1998, ONCOGENE, V16, P2803, DOI 10.1038/sj.onc.1201815; Finsterer J., 2009, INT J CARDIOL; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gerety SS, 2002, DEVELOPMENT, V129, P1397; Gitler AD, 2003, NAT GENET, V33, P75, DOI 10.1038/ng1059; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iso T, 2006, BIOCHEM BIOPH RES CO, V341, P708, DOI 10.1016/j.bbrc.2006.01.020; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iwamoto R, 2006, CELL STRUCT FUNCT, V31, P1, DOI 10.1247/csf.31.1; Johnson KD, 2006, P NATL ACAD SCI USA, V103, P15939, DOI 10.1073/pnas.0604041103; Jung J, 2005, J BIOL CHEM, V280, P30916, DOI 10.1074/jbc.M414482200; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; Kim T, 2005, BIOCHEM BIOPH RES CO, V329, P544, DOI 10.1016/j.bbrc.2005.01.154; Kim T, 2004, MOL CELL BIOL, V24, P10151, DOI 10.1128/MCB.24.23.10151-10160.2004; Kim TG, 2003, J BIOL CHEM, V278, P42247, DOI 10.1074/jbc.M307386200; Koibuchi N, 2007, CIRC RES, V100, P850, DOI 10.1161/01.RES.0000261693.13269.bf; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lee Y, 2000, CIRC RES, V86, P932, DOI 10.1161/01.RES.86.9.932; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Liu XF, 1998, P NATL ACAD SCI USA, V95, P13024, DOI 10.1073/pnas.95.22.13024; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Moore AW, 1998, MECH DEVELOP, V79, P169, DOI 10.1016/S0925-4773(98)00188-9; Mysliwiec MR, 2006, GENESIS, V44, P407, DOI 10.1002/dvg.20221; Mysliwiec MR, 2007, FEBS LETT, V581, P2633, DOI 10.1016/j.febslet.2007.05.006; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Neve RM, 2002, ONCOGENE, V21, P4567, DOI 10.1038/sj.onc.1205555; Nielsen AL, 2004, MOL CELL BIOL, V24, P5184, DOI 10.1128/MCB.24.12.5184-5196.2004; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; OKA C, 1995, DEVELOPMENT, V121, P3291; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; SATO TN, 1993, P NATL ACAD SCI USA, V90, P9355, DOI 10.1073/pnas.90.20.9355; SCHNURCH H, 1993, DEVELOPMENT, V119, P957; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shirato H, 2009, J BIOL CHEM, V284, P733, DOI 10.1074/jbc.M804994200; Shou WN, 1998, NATURE, V391, P489, DOI 10.1038/35146; Stahl M, 2006, CANCER RES, V66, P7562, DOI 10.1158/0008-5472.CAN-06-0974; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6; Sun Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003406; Takeuchi T, 1999, MECH DEVELOP, V86, P29, DOI 10.1016/S0925-4773(99)00100-8; TAKEUCHI T, 1995, GENE DEV, V9, P1211, DOI 10.1101/gad.9.10.1211; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; Talora C, 2008, BBA-MOL BASIS DIS, V1782, P489, DOI 10.1016/j.bbadis.2008.06.008; Timms JF, 2002, ONCOGENE, V21, P6573, DOI 10.1038/sj.onc.1205847; Toyoda M, 2003, DEV CELL, V5, P85, DOI 10.1016/S1534-5807(03)00189-8; Vijapurkar U, 2003, EXP CELL RES, V284, P291, DOI 10.1016/S0014-4827(02)00040-X; Vollrath AL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-280; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261	77	57	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17193	17204		10.1074/jbc.M110.205146	http://dx.doi.org/10.1074/jbc.M110.205146			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21402699	Green Published, hybrid			2022-12-27	WOS:000290301900068
J	Ryan, T; Sharma, P; Ignatchenko, A; MacLennan, DH; Kislinger, T; Gramolini, AO				Ryan, Timothy; Sharma, Parveen; Ignatchenko, Alex; MacLennan, David H.; Kislinger, Thomas; Gramolini, Anthony O.			Identification of Novel Ryanodine Receptor 1 (RyR1) Protein Interaction with Calcium Homeostasis Endoplasmic Reticulum Protein (CHERP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE CHANNEL; CENTRAL CORE DISEASE; SKELETAL-MUSCLE; MALIGNANT HYPERTHERMIA; CELL-PROLIFERATION; EXPRESSION; PHOSPHORYLATION; PHOSPHOLAMBAN; MOBILIZATION; MOUSE	The ryanodine receptor type 1 (RyR1) is a homotetrameric Ca2+ release channel located in the sarcoplasmic reticulum of skeletal muscle where it plays a role in the initiation of skeletal muscle contraction. A soluble, 6x-histidine affinity-tagged cytosolic fragment of RyR1 (amino acids 1-4243) was expressed in HEK-293 cells, and metal affinity chromatography under native conditions was used to purify the peptide together with interacting proteins. When analyzed by gel-free liquid chromatography mass spectrometry (LC-MS), 703 proteins were identified under all conditions. This group of proteins was filtered to identify putative RyR interacting proteins by removing those proteins found in only 1 RyR purification and proteins for which average spectral counts were enriched by less than 4-fold over control values. This resulted in 49 potential RyR1 interacting proteins, and 4 were selected for additional interaction studies: calcium homeostasis endoplasmic reticulum protein (CHERP), endoplasmic reticulum-Golgi intermediate compartment 53-kDa protein (LMAN1), T-complex protein, and phosphorylase kinase. Western blotting showed that only CHERP co-purified with affinity-tagged RyR1 and was eluted with imidazole. Immunofluorescence showed that endogenous CHERP co-localizes with endogenous RyR1 in the sarcoplasmic reticulum of rat soleus muscle. A combination of overexpression of RyR1 in HEK-293 cells with siRNA-mediated suppression of CHERP showed that CHERP affects Ca2+ release from the ER via RyR1. Thus, we propose that CHERP is an RyR1 interacting protein that may be involved in the regulation of excitation-contraction coupling.	[Ryan, Timothy; Sharma, Parveen; Gramolini, Anthony O.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada; [Sharma, Parveen; MacLennan, David H.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L7, Canada; [Kislinger, Thomas] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Ignatchenko, Alex; Kislinger, Thomas] Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Gramolini, AO (corresponding author), 112 Coll St, Toronto, ON M5G 1L6, Canada.	anthony.gramolini@utoronto.ca	Kislinger, Thomas/A-5934-2008	Kislinger, Thomas/0000-0003-3525-5540; Sharma, Parveen/0000-0002-5534-2417; Ignatchenko, Alexandr/0000-0002-6083-941X	Heart and Stroke Foundation of Ontario [T-6281]; Canadian Institutes of Health Research [MOP-84267, MT-3399]; Canadian Foundation for Innovation; Connaught Foundation; Heart and Stroke/Richard Lewar Centre of Cardiovascular Excellence	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Connaught Foundation(University of Toronto); Heart and Stroke/Richard Lewar Centre of Cardiovascular Excellence	This work was supported by Heart and Stroke Foundation of Ontario Grant T-6281, Canadian Institutes of Health Research Grant MOP-84267, the Canadian Foundation for Innovation, Connaught Foundation, the Heart and Stroke/Richard Lewar Centre of Cardiovascular Excellence (to A. O. G.), and Canadian Institutes of Health Research Grant MT-3399 (to D. H. M.).	Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; BEAM KG, 1989, ANN NY ACAD SCI, V560, P127, DOI 10.1111/j.1749-6632.1989.tb24090.x; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Brushia R. J., 1999, FRONT BIOSCI, V4, pD618; Chen SRW, 1997, BIOPHYS J, V73, P1904, DOI 10.1016/S0006-3495(97)78221-3; Du GG, 2002, P NATL ACAD SCI USA, V99, P16725, DOI 10.1073/pnas.012688999; Gaberc-Porekar V, 2001, J BIOCHEM BIOPH METH, V49, P335, DOI 10.1016/S0165-022X(01)00207-X; Gramolini AO, 2008, MOL CELL PROTEOMICS, V7, P519, DOI 10.1074/mcp.M700245-MCP200; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; HORWICH AL, 1993, PHILOS T R SOC B, V339, P313, DOI 10.1098/rstb.1993.0030; Hosoi E, 2001, J IMMUNOL, V167, P4887, DOI 10.4049/jimmunol.167.9.4887; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Kislinger T, 2003, MOL CELL PROTEOMICS, V2, P96, DOI 10.1074/mcp.M200074-MCP200; Kowara R, 2007, BIOCHEM BIOPH RES CO, V363, P190, DOI 10.1016/j.bbrc.2007.08.163; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LaPlante JM, 2000, BIOCHEM J, V348, P189, DOI 10.1042/0264-6021:3480189; Loke J, 1998, AM J MED, V104, P470, DOI 10.1016/S0002-9343(98)00108-9; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; O'Rourke FA, 2003, BIOCHEM J, V373, P133, DOI 10.1042/BJ20030013; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Salanova M, 2008, HISTOCHEM CELL BIOL, V130, P105, DOI 10.1007/s00418-008-0399-6; Samso M, 1998, J STRUCT BIOL, V121, P172, DOI 10.1006/jsbi.1997.3955; Sharma P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011496; SUKO J, 1993, BIOCHIM BIOPHYS ACTA, V1175, P193, DOI 10.1016/0167-4889(93)90023-I; Tong JF, 1997, J BIOL CHEM, V272, P26332, DOI 10.1074/jbc.272.42.26332; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389	32	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17060	17068		10.1074/jbc.M110.197186	http://dx.doi.org/10.1074/jbc.M110.197186			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454501	Green Published, hybrid			2022-12-27	WOS:000290301900056
J	Dogar, AM; Towbin, H; Hall, J				Dogar, Afzal M.; Towbin, Harry; Hall, Jonathan			Suppression of Latent Transforming Growth Factor (TGF)-beta 1 Restores Growth Inhibitory TGF-beta Signaling through microRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIR-200 FAMILY; MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR; PROTEOLYTIC ACTIVATION; REPRESSORS ZEB1; PATHWAYS; SMAD; TGF-BETA-1; CELLS; P53	Cancer cells secreting excess latent TGF-beta are often resistant to TGF-beta induced growth inhibition. We observed that RNAi against TGF-beta 1 led to apoptotic death in such cell lines with features that were, paradoxically, reminiscent of TGF-beta signaling activity and that included transiently enhanced SMAD2 and AKT phosphorylation. A comprehensive search in Hela cells for potential microRNA drivers of this mechanism revealed that RNAi against TGF-beta 1 led to induction of pro-apoptotic miR-34a and to a globally decreased oncomir expression. The reduced levels of the oncomirs miR-18a and miR-24 accounted for the observed derepression of two TGF-beta 1 processing factors, thrombospondin-1, and furin, respectively. Our data suggest a novel mechanism in which latent TGF-beta 1, thrombospondin 1, and furin form a microRNA-mediated regulatory feedback loop. For cells with high levels of latent TGF-beta, this provides a potentially widespread mechanism of escape from TGF-beta-mediated growth arrest at the earliest point in the signaling pathway, TGF-beta processing.	[Dogar, Afzal M.; Towbin, Harry; Hall, Jonathan] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Hall, J (corresponding author), Swiss Fed Inst Technol, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, HCI H437,Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	jonathan.hall@pharma.ethz.ch		Hall, Jonathan/0000-0003-4160-7135				ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Blakytny R, 2004, J CELL PHYSIOL, V199, P67, DOI 10.1002/jcp.10454; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DERYNCK R, 1987, CANCER RES, V47, P707; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; DISERENS AC, 1981, ACTA NEUROPATHOL, V53, P21, DOI 10.1007/BF00697180; Dumon N, 2003, J BIOL CHEM, V278, P3275, DOI 10.1074/jbc.M204623200; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P12513, DOI 10.1073/pnas.97.23.12513; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Jenkins G, 2008, INT J BIOCHEM CELL B, V40, P1068, DOI 10.1016/j.biocel.2007.11.026; JENNINGS MT, 1991, INT J CANCER, V49, P129, DOI 10.1002/ijc.2910490124; Kloth JN, 2005, CARCINOGENESIS, V26, P1493, DOI 10.1093/carcin/bgi110; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Luna C, 2011, J CELL PHYSIOL, V226, P1407, DOI 10.1002/jcp.22476; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Oren M, 2002, BIOCHEM PHARMACOL, V64, P865, DOI 10.1016/S0006-2952(02)01149-8; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26775; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; Solovyan VT, 2006, J CELL PHYSIOL, V207, P445, DOI 10.1002/jcp.20607; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Teicher BA, 2007, CLIN CANCER RES, V13, P6247, DOI 10.1158/1078-0432.CCR-07-1654; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tritschler I, 2009, INT J CANCER, V125, P530, DOI 10.1002/ijc.24443; VAN MEIR EG, 1994, CANCER RES, V54, P649; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang J, 2004, J BIOL CHEM, V279, P40237, DOI 10.1074/jbc.M401665200; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Wang Q, 2008, BLOOD, V111, P588, DOI 10.1182/blood-2007-05-092718; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wischhusen J, 2003, ONCOGENE, V22, P8233, DOI 10.1038/sj.onc.1207198; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Yao GD, 2010, MOL ENDOCRINOL, V24, P540, DOI 10.1210/me.2009-0432; Ye SC, 1999, CANCER RES, V59, P4725; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	57	25	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.208652	http://dx.doi.org/10.1074/jbc.M110.208652			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21402698	Green Published, hybrid			2022-12-27	WOS:000290022800082
J	Mullen, TD; Jenkins, RW; Clarke, CJ; Bielawski, J; Hannun, YA; Obeid, LM				Mullen, Thomas D.; Jenkins, Russell W.; Clarke, Christopher J.; Bielawski, Jacek; Hannun, Yusuf A.; Obeid, Lina M.			Ceramide Synthase-dependent Ceramide Generation and Programmed Cell Death INVOLVEMENT OF SALVAGE PATHWAY IN REGULATING POSTMITOCHONDRIAL EVENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADIATION-INDUCED APOPTOSIS; LONGEVITY ASSURANCE GENE-1; LONG-CHAIN CERAMIDE; ACID SPHINGOMYELINASE; SPHINGOLIPID METABOLISM; BCL-2 FAMILY; RESPIRATORY-CHAIN; FUMONISIN B1; PROTEIN BAK; DNA-DAMAGE	The sphingolipid ceramide has been widely implicated in the regulation of programmed cell death or apoptosis. The accumulation of ceramide has been demonstrated in a wide variety of experimental models of apoptosis and in response to a myriad of stimuli and cellular stresses. However, the detailed mechanisms of its generation and regulatory role during apoptosis are poorly understood. We sought to determine the regulation and roles of ceramide production in a model of ultraviolet light-C (UV-C)-induced programmed cell death. We found that UV-C irradiation induces the accumulation of multiple sphingolipid species including ceramide, dihydroceramide, sphingomyelin, and hexosylceramide. Late ceramide generation was also found to be regulated by Bcl-xL, Bak, and caspases. Surprisingly, inhibition of de novo synthesis using myriocin or fumonisin B1 resulted in decreased overall cellular ceramide levels basally and in response to UV-C, but only fumonisin B1 inhibited cell death, suggesting the presence of a ceramide synthase (CerS)-dependent, sphingosine-derived pool of ceramide in regulating programmed cell death. We found that this pool did not regulate the mitochondrial pathway, but it did partially regulate activation of caspase-7 and, more importantly, was necessary for late plasma membrane permeabilization. Attempting to identify the CerS responsible for this effect, we found that combined knockdown of CerS5 and CerS6 was able to decrease long-chain ceramide accumulation and plasma membrane permeabilization. These data identify a novel role for CerS and the sphingosine salvage pathway in regulating membrane permeability in the execution phase of programmed cell death.	[Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Jenkins, Russell W.; Clarke, Christopher J.; Bielawski, Jacek; Hannun, Yusuf A.; Obeid, Lina M.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Obeid, LM (corresponding author), Med Univ S Carolina, Dept Med, 114 Doughty St,Rm 603 STRB,MSC 779, Charleston, SC 29425 USA.	obeidl@musc.edu		obeid, lina/0000-0002-0734-0847	National Institutes of Health, NIEHS [5T32ES012878]; NIEHS [1 F30 ES016975-01]; NCI [R01 AG016583, P01 CA097132]; National Center for Research Resources [GM08716, C06 RR018823]; American Heart Association [081509E]; Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES016975, T32ES012878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 5T32ES012878 from the NIEHS (through the Medical University of South Carolina (MUSC) Department of Pharmaceutical Sciences training program in environmental stress signaling) and Ruth L. Kirschstein National Research Service Award 1 F30 ES016975-01 from the NIEHS (to T. D. M.), Grant R01 AG016583 (to L. M. O.), Grant P01 CA097132 from the NCI (to Y. A. H.), Medical Scientist Training Program Grant GM08716 (to R. W. J.), and Grant C06 RR018823 from the Extramural Research Facilities Program of the National Center for Research Resources (for the HPLC/MS analysis at the MUSC Lipidomics Core Facility). This work was also supported by American Heart Association Predoctoral Fellowship 081509E (to R. W. J.) and in part by a Method to Extend Research in Time award (to L. M. O.) from the Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Andrieu-Abadie N, 2002, BBA-MOL CELL BIOL L, V1585, P126, DOI 10.1016/S1388-1981(02)00332-3; Baran Y, 2007, J BIOL CHEM, V282, P10922, DOI 10.1074/jbc.M610157200; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Ch'ang HJ, 2005, NAT MED, V11, P484, DOI 10.1038/nm1237; Charruyer A, 2005, J BIOL CHEM, V280, P19196, DOI 10.1074/jbc.M412867200; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; Clarke CJ, 2006, BBA-BIOMEMBRANES, V1758, P1893, DOI 10.1016/j.bbamem.2006.06.025; Cuzzocrea S, 2008, J PHARMACOL EXP THER, V327, P45, DOI 10.1124/jpet.108.139808; Cuzzocrea S, 2009, SHOCK, V31, P634, DOI 10.1097/SHK.0b013e3181891396; Cuzzocrea S, 2009, SHOCK, V31, P170, DOI 10.1097/SHK.0b013e31817fbd4a; Dbaibo GS, 1998, J CLIN INVEST, V102, P329, DOI 10.1172/JCI1180; Dbaibo GS, 2001, FEBS LETT, V503, P7, DOI 10.1016/S0014-5793(01)02625-4; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; El-Assaad W, 1998, BIOCHEM J, V336, P735, DOI 10.1042/bj3360735; Enongene EN, 2002, TOXICOL SCI, V67, P173, DOI 10.1093/toxsci/67.2.173; Galluzzi L, 2009, BBA-BIOENERGETICS, V1787, P402, DOI 10.1016/j.bbabio.2008.09.006; Gamard CJ, 1997, J BIOL CHEM, V272, P16474, DOI 10.1074/jbc.272.26.16474; Gamen S, 1998, CELL DEATH DIFFER, V5, P241, DOI 10.1038/sj.cdd.4400344; Gouaze-Andersson V, 2006, BBA-BIOMEMBRANES, V1758, P2096, DOI 10.1016/j.bbamem.2006.08.012; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jenkins RW, 2010, J BIOL CHEM, V285, P35706, DOI 10.1074/jbc.M110.125609; Jin JF, 2008, J BIOL CHEM, V283, P26509, DOI 10.1074/jbc.M801597200; Jin JF, 2009, J LIPID RES, V50, P2389, DOI 10.1194/jlr.M900119-JLR200; Kashkar H, 2005, J BIOL CHEM, V280, P20804, DOI 10.1074/jbc.M410869200; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroesen BJ, 2001, J BIOL CHEM, V276, P13606, DOI 10.1074/jbc.M009517200; Lemasters JJ, 2005, GASTROENTEROLOGY, V129, P351, DOI 10.1053/j.gastro.2005.06.006; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Novgorodov SA, 2005, J BIOL CHEM, V280, P16096, DOI 10.1074/jbc.M411707200; Novgorodov SA, 2008, J BIOL CHEM, V283, P24707, DOI 10.1074/jbc.M801810200; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Okamoto Y, 2002, FEBS LETT, V530, P104, DOI 10.1016/S0014-5793(02)03435-X; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Sawada N, 2000, CELL DEATH DIFFER, V7, P761, DOI 10.1038/sj.cdd.4400711; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2010, J BIOL CHEM, V285, P11818, DOI 10.1074/jbc.M109.078121; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P143, DOI 10.1007/s10863-005-6567-7; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Spassieva S, 2007, METHOD ENZYMOL, V434, P233, DOI 10.1016/S0076-6879(07)34012-3; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Taha TA, 2004, J BIOL CHEM, V279, P20546, DOI 10.1074/jbc.M401259200; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tepper AD, 1999, J CLIN INVEST, V103, P971, DOI 10.1172/JCI5457; Uchida Y, 2003, J INVEST DERMATOL, V120, P662, DOI 10.1046/j.1523-1747.2003.12098.x; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Wiesner DA, 1997, J BIOL CHEM, V272, P9868; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zhang JD, 1996, P NATL ACAD SCI USA, V93, P5325, DOI 10.1073/pnas.93.11.5325	75	72	74	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.230870	http://dx.doi.org/10.1074/jbc.M111.230870			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21388949	Green Published, hybrid			2022-12-27	WOS:000290022800033
J	Wen, Y; Li, WJ; Poteet, EC; Xie, LK; Tan, C; Yan, LJ; Ju, XH; Liu, R; Qian, H; Marvin, MA; Goldberg, MS; She, H; Mao, ZX; Simpkins, JW; Yang, SH				Wen, Yi; Li, Wenjun; Poteet, Ethan C.; Xie, Luokun; Tan, Cong; Yan, Liang-Jun; Ju, Xiaohua; Liu, Ran; Qian, Hai; Marvin, Marian A.; Goldberg, Matthew S.; She, Hua; Mao, Zixu; Simpkins, James W.; Yang, Shao-Hua			Alternative Mitochondrial Electron Transfer as a Novel Strategy for Neuroprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLENE-BLUE; PARKINSONS-DISEASE; COMPLEX-I; OXIDATIVE STRESS; COENZYME Q(10); ACUTE STROKE; DOUBLE-BLIND; MODELS; INHIBITION; DAMAGE	Neuroprotective strategies, including free radical scavengers, ion channel modulators, and anti-inflammatory agents, have been extensively explored in the last 2 decades for the treatment of neurological diseases. Unfortunately, none of the neuroprotectants has been proved effective in clinical trails. In the current study, we demonstrated that methylene blue (MB) functions as an alternative electron carrier, which accepts electrons from NADH and transfers them to cytochrome c and bypasses complex I/III blockage. A de novo synthesized MB derivative, with the redox center disabled by N-acetylation, had no effect on mitochondrial complex activities. MB increases cellular oxygen consumption rates and reduces anaerobic glycolysis in cultured neuronal cells. MB is protective against various insults in vitro at low nanomolar concentrations. Our data indicate that MB has a unique mechanism and is fundamentally different from traditional antioxidants. We examined the effects of MB in two animal models of neurological diseases. MB dramatically attenuates behavioral, neurochemical, and neuropathological impairment in a Parkinson disease model. Rotenone caused severe dopamine depletion in the striatum, which was almost completely rescued by MB. MB rescued the effects of rotenone on mitochondrial complex I-III inhibition and free radical overproduction. Rotenone induced a severe loss of nigral dopaminergic neurons, which was dramatically attenuated by MB. In addition, MB significantly reduced cerebral ischemia reperfusion damage in a transient focal cerebral ischemia model. The present study indicates that rerouting mitochondrial electron transfer by MB or similar molecules provides a novel strategy for neuroprotection against both chronic and acute neurological diseases involving mitochondrial dysfunction.	[Wen, Yi; Li, Wenjun; Poteet, Ethan C.; Xie, Luokun; Tan, Cong; Yan, Liang-Jun; Ju, Xiaohua; Liu, Ran; Qian, Hai; Simpkins, James W.; Yang, Shao-Hua] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Inst Alzheimers Dis & Aging Res, Ft Worth, TX 76107 USA; [Marvin, Marian A.; Goldberg, Matthew S.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Goldberg, Matthew S.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [She, Hua; Mao, Zixu] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [She, Hua] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA	University of North Texas System; University of North Texas Health Science Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University; Emory University	Yang, SH (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Inst Alzheimers Dis & Aging Res, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	shaohua.yang@unthsc.edu	Yang, Shaohua/D-1738-2013; Goldberg, Matthew/T-7827-2019; Wen, Yi/C-6013-2009	Yan, Liang-Jun/0000-0002-5815-5430; Goldberg, Matthew/0000-0002-5172-9841; Liu, Ran/0000-0002-3882-0616	National Institutes of Health [R01NS054687, R01NS054651, P01AG22550, P01AG10485, ES015317, AG023695, NS048254]; Alzheimer's Association [NIRG57698]; Texas Garvey Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054651, R01NS048254, R01NS054687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023695, P01AG022550, P01AG010485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Texas Garvey Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS054687 (to S.-H. Y.), R01NS054651 (to S.-H. Y.), P01AG22550 (to J. W. S.), P01AG10485 (to J. W. S.), ES015317 (to Z. M.), AG023695 (to Z. M.), and NS048254 (to Z. M.). This work was also supported by Alzheimer's Association Grant NIRG57698 (to Y. W.) and Texas Garvey Foundation (to Y. W.).	Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Callaway NL, 2004, PHARMACOL BIOCHEM BE, V77, P175, DOI 10.1016/j.pbb.2003.10.007; Cassarino DS, 1997, BBA-MOL BASIS DIS, V1362, P77, DOI 10.1016/S0925-4439(97)00070-7; Chaturvedi RK, 2008, ANN NY ACAD SCI, V1147, P395, DOI 10.1196/annals.1427.027; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Demirbilek S, 2006, EUR SURG RES, V38, P35, DOI 10.1159/000091525; Dhillon Amanpreet S, 2008, J Agromedicine, V13, P37, DOI 10.1080/10599240801986215; Diener HC, 2008, STROKE, V39, P1751, DOI 10.1161/STROKEAHA.107.503334; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Furian AF, 2007, NEUROCHEM INT, V50, P164, DOI 10.1016/j.neuint.2006.07.012; Galili Y, 1997, EUR SURG RES, V29, P390, DOI 10.1159/000129548; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Gandhi S, 2005, HUM MOL GENET, V14, P2749, DOI 10.1093/hmg/ddi308; Ganguly A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011253; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Greenamyre JT, 1999, BIOCHEM SOC SYMP, V66, P85, DOI 10.1042/bss0660085; HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604; Haluzik M, 1999, ENDOCR RES, V25, P163, DOI 10.1080/07435809909066138; HRUSHESKY WJM, 1985, LANCET, V1, P565; Klintenberg R, 2003, EUR J PHARMACOL, V459, P231, DOI 10.1016/S0014-2999(02)02817-0; Ladiges W, 2010, AGING CELL, V9, P462, DOI 10.1111/j.1474-9726.2010.00579.x; Lenaz G, 2004, METHOD ENZYMOL, V382, P3; Liu DZ, 2007, J ETHNOPHARMACOL, V112, P327, DOI 10.1016/j.jep.2007.03.022; Liu WC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004597; Lohe M, 2010, J NEUROL SCI, V289, P104, DOI 10.1016/j.jns.2009.08.025; MARCZIN N, 1992, J PHARMACOL EXP THER, V263, P170; MAYER B, 1993, EUR HEART J, V14, P22; MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8; Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695; NAYLOR GJ, 1986, BIOL PSYCHIAT, V21, P915, DOI 10.1016/0006-3223(86)90265-9; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; O'Lone R, 2007, MOL ENDOCRINOL, V21, P1281, DOI 10.1210/me.2006-0497; Olanow CW, 2008, ANN NEUROL, V64, pS101, DOI 10.1002/ana.21461; Peei G, 2001, NEPHROL DIAL TRANSPL, V16, P1436, DOI 10.1093/ndt/16.7.1436; Ramsay RR, 2007, BRIT J PHARMACOL, V152, P946, DOI 10.1038/sj.bjp.0707430; Rezzani R, 2001, NEPHRON, V89, P329, DOI 10.1159/000046094; Riedel W, 2003, MOL CELL BIOCHEM, V247, P83, DOI 10.1023/A:1024142400835; ROUSLIN W, 1983, AM J PHYSIOL, V244, pH743, DOI 10.1152/ajpheart.1983.244.6.H743; Schaller B, 2004, J CEREBR BLOOD F MET, V24, P351, DOI 10.1097/00004647-200404000-00001; Seo BB, 2006, J BIOL CHEM, V281, P14250, DOI 10.1074/jbc.M600922200; Srinivasan J, 2004, BEHAV BRAIN RES, V151, P191, DOI 10.1016/j.bbr.2003.08.016; Storch A, 2007, ARCH NEUROL-CHICAGO, V64, P938, DOI 10.1001/archneur.64.7.nct60005; Testa CM, 2005, MOL BRAIN RES, V134, P109, DOI 10.1016/j.molbrainres.2004.11.007; TOKUMITSU Y, 1973, BIOCHIM BIOPHYS ACTA, V292, P310, DOI 10.1016/0005-2728(73)90038-8; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Vosler PS, 2009, STROKE, V40, P3149, DOI 10.1161/STROKEAHA.108.543769; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Yang LC, 2009, J NEUROCHEM, V109, P1427, DOI 10.1111/j.1471-4159.2009.06074.x; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106	51	194	204	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.208447	http://dx.doi.org/10.1074/jbc.M110.208447			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454572	Green Published, hybrid			2022-12-27	WOS:000290022800087
J	Tao, RY; Wei, D; Gao, HL; Liu, YL; DePinho, RA; Dong, XC				Tao, Rongya; Wei, Dan; Gao, Hanlin; Liu, Yunlong; DePinho, Ronald A.; Dong, X. Charlie			Hepatic FoxOs Regulate Lipid Metabolism via Modulation of Expression of the Nicotinamide Phosphoribosyltransferase Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; TRANSCRIPTION FACTOR FOXO1; FORKHEAD BOX O1; INSULIN ACTION; MITOCHONDRIAL-FUNCTION; DEPENDENT REGULATION; NAD BIOSYNTHESIS; CIRCADIAN-CLOCK; SIRT3; LIVER	FoxO transcription factors have been implicated in lipid metabolism; however, the underlying mechanisms are not well understood. Here, in an effort to elucidate such mechanisms, we examined the phenotypic consequences of liver-specific deletion of three members of the FoxO family: FoxO1, FoxO3, and FoxO4. These liver-specific triply null mice, designated LTKO, exhibited elevated triglycerides in the liver on regular chow diet. More remarkably, LTKO mice developed severe hepatic steatosis following placement on a high fat diet. Further analyses revealed that hepatic NAD(+) levels and Sirt1 activity were decreased in the liver of the LTKO mice relative to controls. At the mechanistic level, expression profile analyses showed that LTKO livers had significantly down-regulated expression of the nicotinamide phosphoribosyltransferase (Nampt) gene encoding the rate-limiting enzyme in the salvage pathway of NAD(+) biosynthesis. Luciferase reporter assays and chromatin immunoprecipitation analyses demonstrated that Nampt is a transcriptional target gene of FoxOs. Significantly, overexpression of Nampt gene reduced, whereas knockdown increased, hepatic triglyceride levels in vitro and in vivo. Thus, FoxOs control the Nampt gene expression and the NAD(+) signaling in the regulation of hepatic triglyceride homeostasis.	[Tao, Rongya; Wei, Dan; Dong, X. Charlie] Indiana Univ Sch Med, Ctr Med Genom, Dept Biochem & Mol Biol, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Liu, Yunlong] Indiana Univ Sch Med, Ctr Med Genom, Dept Med & Mol Genet, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Gao, Hanlin] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; City of Hope; Beckman Research Institute of City of Hope; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Dong, XC (corresponding author), Indiana Univ Sch Med, Ctr Med Genom, Dept Biochem & Mol Biol, Ctr Computat Biol & Bioinformat, 635 Barnhill Dr,MS1021D, Indianapolis, IN 46202 USA.	xcdong@iupui.edu	tao, rongya/B-8042-2014	tao, rongya/0000-0002-3316-5587; DePinho, Ronald/0000-0002-5625-577X	NIDDK [R00DK077505]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK077505] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R00DK077505 from the NIDDK.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Altomonte J, 2004, J CLIN INVEST, V114, P1493, DOI 10.1172/JCI200419992; Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Bao JJ, 2010, FREE RADICAL BIO MED, V49, P1230, DOI 10.1016/j.freeradbiomed.2010.07.009; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bruce KD, 2010, J NUTR, V140, P648, DOI 10.3945/jn.109.111179; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Dahl TB, 2010, J CLIN ENDOCR METAB, V95, P3039, DOI 10.1210/jc.2009-2148; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; FRIEBE D, 2011, DIABETOLOGI IN PRESS; Garten A, 2010, BIOCHEM BIOPH RES CO, V391, P376, DOI 10.1016/j.bbrc.2009.11.066; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Ghoshal K, 2002, MOL CELL BIOL, V22, P8302, DOI 10.1128/MCB.22.23.8302-8319.2002; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Haeusler RA, 2010, J BIOL CHEM, V285, P26861, DOI 10.1074/jbc.M110.134023; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Hsieh MC, 2010, INT J OBESITY, V34, P227, DOI 10.1038/ijo.2009.228; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2009, FRONT BIOSCI-LANDMRK, V14, P2983, DOI 10.2741/3428; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Kamagate A, 2010, ENDOCRINOLOGY, V151, P3521, DOI 10.1210/en.2009-1306; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kim JJ, 2009, DIABETES, V58, P1275, DOI 10.2337/db08-1001; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Kralisch S, 2005, J ENDOCRINOL, V185, pR1, DOI 10.1677/joe.1.06211; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; MacLaren R, 2007, DIABETES OBES METAB, V9, P490, DOI 10.1111/j.1463-1326.2006.00625.x; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Moschen AR, 2010, CURR PHARM DESIGN, V16, P1913, DOI 10.2174/138161210791208947; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nasrin N, 2010, J BIOL CHEM, V285, P31995, DOI 10.1074/jbc.M110.124164; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Shi T, 2010, J DIGEST DIS, V11, P55, DOI 10.1111/j.1751-2980.2009.00416.x; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Tanaka M, 2007, BIOCHEM BIOPH RES CO, V359, P194, DOI 10.1016/j.bbrc.2007.05.096; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Wang RH, 2010, INT J BIOL SCI, V6, P682; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; Wu ZD, 2010, J CLIN INVEST, V120, P3901, DOI 10.1172/JCI43250; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	90	101	107	1	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14681	14690		10.1074/jbc.M110.201061	http://dx.doi.org/10.1074/jbc.M110.201061			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21388966	hybrid, Green Published			2022-12-27	WOS:000289556200087
J	Zhang, Q; Chen, DD; Lin, J; Liao, RJ; Tong, W; Xu, ZN; Liu, W				Zhang, Qi; Chen, Dandan; Lin, Jun; Liao, Rijing; Tong, Wei; Xu, Zhinan; Liu, Wen			Characterization of NocL Involved in Thiopeptide Nocathiacin I Biosynthesis A [4Fe-4S] CLUSTER AND THE CATALYSIS OF A RADICAL S-ADENOSYLMETHIONINE ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAEROBIC RIBONUCLEOTIDE REDUCTASE; THIAZOLYL PEPTIDE ANTIBIOTICS; ESCHERICHIA-COLI; NOCARDIA SP; IRON; SULFUR; PROTEIN; SAM; SYNTHASE; SULFIDE	The radical S-adenosylmethionine (AdoMet) enzyme superfamily is remarkable at catalyzing chemically diverse and complex reactions. We have previously shown that NosL, which is involved in forming the indole side ring of the thiopeptide nosiheptide, is a radical AdoMet enzyme that processes L-Trp to afford 3-methyl-2-indolic acid (MIA) via an unusual fragmentation-recombination mechanism. We now report the expansion of the MIA synthase family by characterization of NocL, which is involved in nocathiacin I biosynthesis. EPR and UV-visible absorbance spectroscopic analyses demonstrated the interaction between L-Trp and the [4Fe-4S] cluster of NocL, leading to the assumption of nonspecific interaction of [4Fe-4S] cluster with other nucleophiles via the unique Fe site. This notion is supported by the finding of the heterogeneity in the [4Fe-4S] cluster of NocL in the absence of AdoMet, which was revealed by the EPR study at very low temperature. Furthermore, a free radical was observed by EPR during the catalysis, which is in good agreement with the hypothesis of a glycyl radical intermediate. Combined with the mutational analysis, these studies provide new insights into the function of the [4Fe-4S] cluster of radical AdoMet enzymes as well as the mechanism of the radical-mediated complex carbon chain rearrangement catalyzed by MIA synthase.	[Zhang, Qi; Chen, Dandan; Liao, Rijing; Liu, Wen] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Chen, Dandan; Xu, Zhinan] Zhejiang Univ, Dept Chem Engn & Biotechnol, Hangzhou 310027, Peoples R China; [Lin, Jun] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China; [Tong, Wei] Chinese Acad Sci, High Field Magnet Lab, Hefei 230031, Anhui, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Zhejiang University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Liu, W (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China.	wliu@mail.sioc.ac.cn	Chen, Dan/GRY-2691-2022	Chen, Dan/0000-0002-1570-9034; Xu, Zhinan/0000-0001-7833-026X	National Natural Science Foundation [20832009, 30525001, 20921091]; Ministry of Science and Technology [2009ZX09501-008]; National Basic Research Program ("973 Program") [2010CB833200]; Chinese Academy of Sciences [KJCX2-YW-H08, KSCX2-YW-G-06]; Science and Technology Commission of Shanghai Municipality of China [09QH1402700]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Basic Research Program ("973 Program")(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality of China(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported in part by National Natural Science Foundation Grants 20832009, 30525001, and 20921091, Ministry of Science and Technology Grant 2009ZX09501-008, National Basic Research Program ("973 Program") Grant 2010CB833200, Chinese Academy of Sciences Grants KJCX2-YW-H08 and KSCX2-YW-G-06, and Science and Technology Commission of Shanghai Municipality of China Grant 09QH1402700.	Bagley MC, 2005, CHEM REV, V105, P685, DOI 10.1021/cr0300441; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Brindley AA, 2010, FEBS LETT, V584, P2461, DOI 10.1016/j.febslet.2010.04.053; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Cheek J, 2001, J BIOL INORG CHEM, V6, P209, DOI 10.1007/s007750100210; CHIRPICH TP, 1970, J BIOL CHEM, V245, P1778; Ding Y, 2010, MOL BIOSYST, V6, P1180, DOI 10.1039/c005121g; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Frey PA, 2003, CHEM REV, V103, P2129, DOI 10.1021/cr020422m; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hanzelmann P, 2002, J BIOL CHEM, V277, P18303, DOI 10.1074/jbc.M200947200; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Himo F, 2003, CHEM REV, V103, P2421, DOI 10.1021/cr020436s; Jarrett JT, 2003, CURR OPIN CHEM BIOL, V7, P174, DOI 10.1016/S1367-5931(03)00022-X; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; JOHNSON MK, 1994, ENCY INORGANIC CHEM, V4, P1896; KENNEDY MC, 1984, J BIOL CHEM, V259, P4463; Krieger CJ, 2001, J BIOL CHEM, V276, P12924, DOI 10.1074/jbc.M009453200; Kriek M, 2007, ANGEW CHEM INT EDIT, V46, P9223, DOI 10.1002/anie.200702554; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Layer G, 2005, J BIOL CHEM, V280, P29038, DOI 10.1074/jbc.M501275200; Leet JE, 2003, J ANTIBIOT, V56, P232, DOI 10.7164/antibiotics.56.232; Lendzian F, 1996, J AM CHEM SOC, V118, P8111, DOI 10.1021/ja960917r; Li WY, 2003, J ANTIBIOT, V56, P226, DOI 10.7164/antibiotics.56.226; Liu A, 2000, J BIOL CHEM, V275, P12367, DOI 10.1074/jbc.275.17.12367; Miller JE, 2003, J AM CHEM SOC, V125, P14220, DOI 10.1021/ja037203i; Nicolet Y, 2004, NUCLEIC ACIDS RES, V32, P4015, DOI 10.1093/nar/gkh728; Sambrook J., 2001, MOL CLONING LAB MANU; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Sun XY, 1996, J BIOL CHEM, V271, P6827, DOI 10.1074/jbc.271.12.6827; Walsby CJ, 2005, INORG CHEM, V44, P727, DOI 10.1021/ic0484811; Walsby CJ, 2002, J AM CHEM SOC, V124, P3143, DOI 10.1021/ja012034s; Yu Y, 2009, ACS CHEM BIOL, V4, P855, DOI 10.1021/cb900133x; Zhang Q, 2011, NAT CHEM BIOL, V7, P154, DOI [10.1038/nchembio.512, 10.1038/NCHEMBIO.512]	38	33	34	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21287	21294		10.1074/jbc.M111.224832	http://dx.doi.org/10.1074/jbc.M111.224832			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21454624	Green Published, hybrid			2022-12-27	WOS:000291464700027
J	Wang, ZX; Patel, DJ				Wang, Zhanxin; Patel, Dinshaw J.			Combinatorial Readout of Dual Histone Modifications by Paired Chromatin-associated Modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NUCLEOSOME CORE PARTICLE; PHD FINGER; STRUCTURAL BASIS; BINDING MODULES; H3 TAIL; BROMODOMAIN; METHYLATION; LYSINE; RECOGNITION; DOMAIN	The study of histone modifications and their interaction with effector modules/proteins has attracted increasing attention in recent years. Accumulating evidence indicates that epigenetic regulation, which involves post-translational modification on histones and DNAs or the participation of RNAs, plays an important role in many cellular processes. Histone modifications can function individually but are also capable of functioning combinatorially as a pattern. Recently, much more attention has focused on interpreting combined histone patterns by their downstream effectors. Structure/function-based studies on paired module-mediated histone cross-talk have greatly enhanced our understanding of the plasticity of the "histone code" hypothesis.	[Wang, Zhanxin; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Wang, ZX (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	wangz@mskcc.org; pateld@mskcc.org						Akai Y, 2010, P NATL ACAD SCI USA, V107, P8153, DOI 10.1073/pnas.0912509107; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Chang PY, 2010, J MOL BIOL, V400, P137, DOI 10.1016/j.jmb.2010.05.005; Chatterjee C, 2010, J BIOL CHEM, V285, P11045, DOI 10.1074/jbc.R109.080291; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Fair K, 2001, MOL CELL BIOL, V21, P3589, DOI 10.1128/MCB.21.10.3589-3597.2001; Fiedler M, 2008, MOL CELL, V30, P507, DOI 10.1016/j.molcel.2008.03.011; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Grow EJ, 2010, CELL, V141, P1108, DOI 10.1016/j.cell.2010.06.013; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Koziol MJ, 2010, CURR OPIN GENET DEV, V20, P142, DOI 10.1016/j.gde.2010.03.003; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P109, DOI 10.1038/nsmb1326; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Santiveri CM, 2008, J MOL BIOL, V382, P1107, DOI 10.1016/j.jmb.2008.07.081; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Syntichaki P, 2000, NATURE, V404, P414, DOI 10.1038/35006136; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; Wang ZX, 2010, CELL, V141, P1183, DOI 10.1016/j.cell.2010.05.016; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xia ZB, 2003, P NATL ACAD SCI USA, V100, P8342, DOI 10.1073/pnas.1436338100; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zeng L, 2008, NAT STRUCT MOL BIOL, V15, P626, DOI 10.1038/nsmb.1416; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139	56	49	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18363	18368		10.1074/jbc.R111.219139	http://dx.doi.org/10.1074/jbc.R111.219139			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454653	Green Published, hybrid			2022-12-27	WOS:000290785700008
J	Brickley, K; Stephenson, FA				Brickley, Kieran; Stephenson, F. Anne			Trafficking Kinesin Protein (TRAK)-mediated Transport of Mitochondria in Axons of Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COIL DOMAIN PROTEINS; IDENTIFICATION; ANTEROGRADE; FAMILY; GRIF-1; REGULATOR; MECHANISM; SYNAPSES; DYNAMICS; MOTILITY	In neurons, the proper distribution of mitochondria is essential because of a requirement for high energy and calcium buffering during synaptic neurotransmission. The efficient, regulated transport of mitochondria along axons to synapses is therefore crucial for maintaining function. The trafficking kinesin protein (TRAK)/Milton family of proteins comprises kinesin adaptors that have been implicated in the neuronal trafficking of mitochondria via their association with the mitochondrial protein Miro and kinesin motors. In this study, we used gene silencing by targeted shRNAi and dominant negative approaches in conjunction with live imaging to investigate the contribution of endogenous TRAKs, TRAK1 and TRAK2, to the transport of mitochondria in axons of hippocampal pyramidal neurons. We report that both strategies resulted in impairing mitochondrial mobility in axonal processes. Differences were apparent in terms of the contribution of TRAK1 and TRAK2 to this transport because knockdown of TRAK1 but not TRAK2 impaired mitochondrial mobility, yet both TRAK1 and TRAK2 were shown to rescue transport impaired by TRAK1 gene knock-out. Thus, we demonstrate for the first time the pivotal contribution of the endogenous TRAK family of kinesin adaptors to the regulation of mitochondrial mobility.	[Brickley, Kieran; Stephenson, F. Anne] Univ London, Sch Pharm, London WC1N 1AX, England	University of London; University College London; University of London School of Pharmacy	Stephenson, FA (corresponding author), Univ London, Sch Pharm, 29-39 Brunswick Sq, London WC1N 1AX, England.	anne.stephenson@pharmacy.ac.uk			Biotechnology and Biological Sciences Research Council (United Kingdom); Wellcome Trust; MRC [G0800498] Funding Source: UKRI; Medical Research Council [G0800498] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council (United Kingdom).; We thank Dr. Karine Pozo for help and advice on the culturing and transfection of hippocampal pyramidal neurons. We also thank Dr. Sarah Cousins for generating the clones pTurboFP635-NMito1, pEGFP-ratTRAK1silent, and pIRES-GFPTRAK2 DN; Tom Randall for help with Fig. 5; and Dr. Carolyn Moores, Birkbeck College, London, UK for insightful discussions. We gratefully acknowledge the financial contribution from The Wellcome Trust for the purchase of the Zeiss 710 confocal microscope.	Beck M, 2002, J BIOL CHEM, V277, P30079, DOI 10.1074/jbc.M200438200; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Brickley K, 2005, J BIOL CHEM, V280, P14723, DOI 10.1074/jbc.M409095200; Cai Q, 2005, J CELL BIOL, V170, P959, DOI 10.1083/jcb.200506042; Cai Q, 2007, J NEUROSCI, V27, P7284, DOI 10.1523/JNEUROSCI.0731-07.2007; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Gilbert SL, 2006, NAT GENET, V38, P245, DOI 10.1038/ng1715; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Goslin K., 1998, CULTURING NERVE CELL, P339; Grishin A, 2006, J BIOL CHEM, V281, P30104, DOI 10.1074/jbc.M602439200; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kirk E, 2006, J CELL SCI, V119, P4689, DOI 10.1242/jcs.03249; Koutsopoulos OS, 2010, BBA-MOL CELL RES, V1803, P564, DOI 10.1016/j.bbamcr.2010.03.006; Ligon LA, 2000, J COMP NEUROL, V427, P340, DOI 10.1002/1096-9861(20001120)427:3<340::AID-CNE2>3.0.CO;2-Y; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; MacAskill AF, 2009, MOL CELL NEUROSCI, V40, P301, DOI 10.1016/j.mcn.2008.10.016; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Ojla G., 2003, BR NEUROSCI ABSTR, V17, P2612; Pozo KBK, 2011, BBA-MOL CELL RES, V1813, P269, DOI 10.1016/j.bbamcr.2010.10.011; Russo GJ, 2009, J NEUROSCI, V29, P5443, DOI 10.1523/JNEUROSCI.5417-08.2009; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Smith MJ, 2006, J BIOL CHEM, V281, P27216, DOI 10.1074/jbc.M600522200; Stephenson F. A., 2010, PROTEIN FOLDING SYNA, P105; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Webber E, 2008, J MOL BIOL, V382, P638, DOI 10.1016/j.jmb.2008.07.045; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038	32	116	119	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18079	18092		10.1074/jbc.M111.236018	http://dx.doi.org/10.1074/jbc.M111.236018			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454691	Green Published, hybrid			2022-12-27	WOS:000290585200069
J	Dang, M; Dubbin, K; D'Aiello, A; Hartmann, M; Lodish, H; Herrlich, A				Dang, Michelle; Dubbin, Karen; D'Aiello, Antonio; Hartmann, Monika; Lodish, Harvey; Herrlich, Andreas			Epidermal Growth Factor (EGF) Ligand Release by Substrate-specific A Disintegrin and Metalloproteases (ADAMs) Involves Different Protein Kinase C (PKC) Isoenzymes Depending on the Stimulus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; INTRACELLULAR MATURATION; L-SELECTIN; HB-EGF; RECEPTOR; TRANSACTIVATION; CLEAVAGE; LOCALIZATION; COMPONENTS; CLONING	The dysregulation of EGF family ligand cleavage has severe consequences for the developing as well as the adult organism. Therefore, their production is highly regulated. The limiting step is the ectodomain cleavage of membrane-bound precursors by one of several a disintegrin and metalloprotease (ADAM) metalloproteases, and understanding the regulation of cleavage is an important goal of current research. We have previously reported that in mouse lung epithelial cells, the pro-EGF ligands TGF alpha, neuregulin 1 beta (NRG), and heparin-binding EGF are differentially cleaved depending on the cleavage stimulus (Herrlich, A., Klinman, E., Fu, J., Sadegh, C., and Lodish, H. (2008) FASEB J.). In this study in mouse embryonic fibroblasts that lack different ADAMs, we show that induced cleavage of EGF ligands can involve the same substrate-specific metalloprotease but does require different stimulus-dependent signaling pathways. Cleavage was stimulated by phorbol ester (12-O-tetradecanoylphorbol-13-acetate (TPA), a mimic of diacylglycerol and PKC activator), hypertonic stress, lysophosphatidic acid (LPA)-induced G protein-coupled receptor activation, or by ionomycin-induced intracellular calcium release. Although ADAMs showed substrate preference (ADAM17, TGF alpha and heparin-binding EGF; and ADAM9, NRG), substrate cleavage differed substantially with the stimulus, and cleavage of the same substrate depended on the presence of different, sometimes multiple, PKC isoforms. For instance, classical PKC was required for TPA-induced but not hypertonic stress-induced cleavage of all EGF family ligands. Inhibition of PKC zeta enhanced NRG release upon TPA stimulation, but it blocked NRG release in response to hypertonic stress. Our results suggest a model in which substantial regulation of ectodomain cleavage occurs not only on the metalloprotease level but also on the level of the substrate or of a third protein.	[Dang, Michelle; Dubbin, Karen; D'Aiello, Antonio; Lodish, Harvey; Herrlich, Andreas] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Dang, Michelle; Lodish, Harvey] MIT, Dept Biol, Cambridge, MA 02142 USA; [Dubbin, Karen] MIT, Dept Mat Sci, Cambridge, MA 02142 USA; [D'Aiello, Antonio; Herrlich, Andreas] Harvard Univ, Sch Med, Brigham & Womens Hosp, Renal Unit, Boston, MA 02114 USA; [Hartmann, Monika] Fritz Lipman Inst Age Res, D-07745 Jena, Germany	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Herrlich, A (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	herrlich@wi.mit.edu		Dubbin, Karen/0000-0002-9495-4766	National Institutes of Health [K99-DK077731-01, 4 R00 DK077731-03]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK077731, K99DK077731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K99-DK077731-01 and 4 R00 DK077731-03.	Arribas J, 2006, CANCER METAST REV, V25, P57, DOI 10.1007/s10555-006-7889-6; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CR, 2009, EXP CELL RES, V315, P671, DOI 10.1016/j.yexcr.2008.10.011; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Herrlich A, 2008, FASEB J, V22, P4281, DOI 10.1096/fj.08-113852; Higashiyama S, 2005, BBA-PROTEINS PROTEOM, V1751, P110, DOI 10.1016/j.bbapap.2004.11.009; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Howard L, 2000, BIOCHEM J, V348, P21, DOI 10.1042/0264-6021:3480021; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Janes PW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000215; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lin JQ, 2001, J BIOL CHEM, V276, P30127, DOI 10.1074/jbc.M010237200; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lum L, 1998, J BIOL CHEM, V273, P26236, DOI 10.1074/jbc.273.40.26236; Maretzky T, 2011, ONCOGENE, V30, P611, DOI 10.1038/onc.2010.443; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Turk Benjamin E., 2009, V539, P79, DOI 10.1007/978-1-60327-003-8_5; Wang X, 2006, CELL STRUCT FUNCT, V31, P15, DOI 10.1247/csf.31.15; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; Yan YB, 2002, J CELL BIOL, V158, P221, DOI 10.1083/jcb.200112026	35	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17704	17713		10.1074/jbc.M110.187823	http://dx.doi.org/10.1074/jbc.M110.187823			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454702	Green Published, hybrid			2022-12-27	WOS:000290585200034
J	Lu, P; Hankel, IL; Hostager, BS; Swartzendruber, JA; Friedman, AD; Brenton, JL; Rothman, PB; Colgan, JD				Lu, Ping; Hankel, Isaiah L.; Hostager, Bruce S.; Swartzendruber, Julie A.; Friedman, Ann D.; Brenton, Janet L.; Rothman, Paul B.; Colgan, John D.			The Developmental Regulator Protein Gon4l Associates with Protein YY1, Co-repressor Sin3a, and Histone Deacetylase 1 and Mediates Transcriptional Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL DEVELOPMENT; GENE-EXPRESSION; N-COR; SANT DOMAIN; LINEAGE; COREPRESSOR; COMPLEX; IDENTIFICATION; RECOMBINATION; COACTIVATOR	Genetic studies involving zebrafish and mice have demonstrated that the protein Gon4l (Gon4-like) is essential for hematopoiesis. These studies also suggested that Gon4l regulates gene expression during hematopoietic development, yet the biochemical function of Gon4l has not been defined. Here, we describe the identification of factors that interact with Gon4l and may cooperate with this protein to regulate gene expression. As predicted by polypeptide sequence conservation, Gon4l interacted and co-localized with the DNA-binding protein YY1 (Yin Yang 1). Density gradient sedimentation analysis of protein lysates from mouse M12 B cells showed that Gon4l and YY1 co-sediment with the transcriptional co-repressor Sin3a and its functional partner histone deacetylase (HDAC) 1. Consistent with these results, immunoprecipitation studies showed that Gon4l associates with Sin3a, HDAC1, and YY1 as a part of complexes that form in M12 cells. Sequential immunoprecipitation studies demonstrated that Gon4l, YY1, Sin3a, and HDAC1 could all associate as components of a single complex and that a conserved domain spanning the central portion of Gon4l was required for formation of this complex. When targeted to DNA, Gon4l repressed the activity of a nearby promoter, which correlated with the ability to interact with Sin3a and HDAC1. Our data suggest that Sin3a, HDAC1, and YY1 are co-factors for Gon4l and that Gon4l may function as a platform for the assembly of complexes that regulate gene expression.	[Lu, Ping; Rothman, Paul B.; Colgan, John D.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Interdisciplinary Immunol Grad Program, Iowa City, IA 52242 USA; [Hostager, Bruce S.; Swartzendruber, Julie A.; Friedman, Ann D.; Brenton, Janet L.; Rothman, Paul B.; Colgan, John D.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Hankel, Isaiah L.; Colgan, John D.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Colgan, JD (corresponding author), 375 Newton Rd,3270 CBRB, Iowa City, IA 52242 USA.	john-colgan@uiowa.edu		Colgan, John/0000-0001-9273-2644	National Institutes of Health [R01AI067489]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI067489 (to J. D. C.).	ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Bulchand S, 2010, J CELL SCI, V123, P2697, DOI 10.1242/jcs.063172; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; DAVIDSON WF, 1988, J EXP MED, V168, P389, DOI 10.1084/jem.168.1.389; de la Cruz X, 2005, BIOESSAYS, V27, P164, DOI 10.1002/bies.20176; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Friedman L, 2000, DEV BIOL, V228, P350, DOI 10.1006/dbio.2000.9944; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; HAMANO T, 1982, J IMMUNOL, V129, P1403; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hoffmann R, 2002, GENOME RES, V12, P98, DOI 10.1101/gr.201501; Hostager BS, 2003, J BIOL CHEM, V278, P45382, DOI 10.1074/jbc.M306708200; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; Jazayeri A, 2004, P NATL ACAD SCI USA, V101, P1644, DOI 10.1073/pnas.0304797101; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kuryshev VY, 2006, GENOMICS, V88, P143, DOI 10.1016/j.ygeno.2006.02.002; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lim CH, 2009, MOL BIOL CELL, V20, P4183, DOI 10.1091/mbc.E09-02-0109; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Liu YM, 2007, BLOOD, V110, P99, DOI 10.1182/blood-2006-11-059204; Lu P, 2010, J EXP MED, V207, P1359, DOI 10.1084/jem.20100147; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mo XM, 2005, GENE DEV, V19, P2447, DOI 10.1101/gad.355405; Ohtomo T, 2007, AMINO ACIDS, V33, P645, DOI 10.1007/s00726-006-0482-z; Palko L, 2004, J CELL SCI, V117, P465, DOI 10.1242/jcs.00870; Rowland SL, 2007, J IMMUNOL, V179, P4645, DOI 10.4049/jimmunol.179.7.4645; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sen R, 2006, CURR OPIN IMMUNOL, V18, P237, DOI 10.1016/j.coi.2006.03.008; SIDEN EJ, 1979, CELL, V16, P389, DOI 10.1016/0092-8674(79)90014-X; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Wang CY, 2004, J BIOL CHEM, V279, P17750, DOI 10.1074/jbc.M310532200; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Wu S, 2009, MOL CELL BIOL, V29, P6245, DOI 10.1128/MCB.00679-09	45	26	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18311	18319		10.1074/jbc.M110.133603	http://dx.doi.org/10.1074/jbc.M110.133603			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454521	hybrid, Green Published			2022-12-27	WOS:000290585200091
J	El Bouhassani, M; Gilibert, S; Moreau, M; Saint-Charles, F; Treguier, M; Poti, F; Chapman, MJ; Le Goff, W; Lesnik, P; Huby, T				El Bouhassani, Majda; Gilibert, Sophie; Moreau, Martine; Saint-Charles, Flora; Treguier, Morgan; Poti, Francesco; Chapman, M. John; Le Goff, Wilfried; Lesnik, Philippe; Huby, Thierry			Cholesteryl Ester Transfer Protein Expression Partially Attenuates the Adverse Effects of SR-BI Receptor Deficiency on Cholesterol Metabolism and Atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORT IN-VIVO; DENSITY-LIPOPROTEIN HDL; SCAVENGER RECEPTOR; SELECTIVE UPTAKE; APOLIPOPROTEIN-E; TRANSGENIC MICE; KNOCKOUT MOUSE; LDL RECEPTOR; LIVER; MACROPHAGE	Scavenger receptor SR-BI significantly contributes to HDL cholesterol metabolism and atherogenesis in mice. However, the role of SR-BI may not be as pronounced in humans due to cholesteryl ester transfer protein (CETP) activity. To address the impact of CETP expression on the adverse effects associated with SR-BI deficiency, we cross-bred our SR-BI conditional knock-out mouse model with CETP transgenic mice. CETP almost completely restored the abnormal HDL-C distribution in SR-BI-deficient mice. However, it did not normalize the elevated plasma free to total cholesterol ratio characteristic of hepatic SR-BI deficiency. Red blood cell and platelet count abnormalities observed in mice liver deficient for SR-BI were partially restored by CETP, but the elevated erythrocyte cholesterol to phopholipid ratio remained unchanged. Complete deletion of SR-BI was associated with diminished adrenal cholesterol stores, whereas hepatic SR-BI deficiency resulted in a significant increase in adrenal gland cholesterol content. In both mouse models, CETP had no impact on adrenal cholesterol metabolism. In diet-induced atherosclerosis studies, hepatic SR-BI deficiency accelerated aortic lipid lesion formation in both CETP-expressing (4-fold) and non-CETP-expressing (8-fold) mice when compared with controls. Impaired macrophage to feces reverse cholesterol transport in mice deficient for SR-BI in liver, which was not corrected by CETP, most likely contributed by such an increase in atherosclerosis susceptibility. Finally, comparison of the atherosclerosis burden in SR-BI liver-deficient and fully deficient mice demonstrated that SR-BI exerted an atheroprotective activity in extra-hepatic tissues whether CETP was present or not. These findings support the contention that the SR-BI pathway contributes in unique ways to cholesterol metabolism and atherosclerosis susceptibility even in the presence of CETP.	[El Bouhassani, Majda; Gilibert, Sophie; Moreau, Martine; Saint-Charles, Flora; Treguier, Morgan; Poti, Francesco; Chapman, M. John; Le Goff, Wilfried; Lesnik, Philippe; Huby, Thierry] Hop Pitie, INSERM, UMR S 939, F-75013 Paris, France; [El Bouhassani, Majda; Gilibert, Sophie; Moreau, Martine; Saint-Charles, Flora; Treguier, Morgan; Poti, Francesco; Chapman, M. John; Le Goff, Wilfried; Lesnik, Philippe; Huby, Thierry] Univ Paris 06, UMR S 939, F-75013 Paris, France; [Huby, Thierry] Grp Hosp Pitie Salpetriere, Assistance Publ Hop Paris, Serv Endocrinol Metab, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite	Huby, T (corresponding author), Hop Pitie, INSERM, UMR S 939, Pavillon Benjamin Delessert,83 Blvd Hosp, F-75013 Paris, France.	thierry.huby@upmc.fr	Lesnik, Philippe/AAD-7393-2020; HUBY, Thierry/N-4820-2019; Le Goff, Wilfried/N-7593-2019; Lesnik, Philippe F/F-7803-2011; chapman, john/Y-2742-2019; Huby, Thierry/E-6768-2017; Le Goff, Wilfried/N-6326-2017; Poti, Francesco/O-6600-2016	Lesnik, Philippe/0000-0002-6909-7715; HUBY, Thierry/0000-0001-6634-551X; Le Goff, Wilfried/0000-0002-7611-9644; Huby, Thierry/0000-0001-6634-551X; Le Goff, Wilfried/0000-0002-7611-9644; Poti, Francesco/0000-0002-1708-0719	French National Institute for Health and Medical Research (INSERM); French Ministry of Research; INSERM-APHP	French National Institute for Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); INSERM-APHP(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported in part by the French National Institute for Health and Medical Research (INSERM).; Supported by a Fellowship from the French Ministry of Research.; Supported by a contrat d'interface INSERM-APHP. To whom correspondence should be addressed: INSERM UMR-S 939, Hopital de la Pitie, Pavillon Benjamin Delessert, 83 Boulevard de l'hopital, F-75013 Paris, France. Tel.: 33-1-42177860; Fax: 33-1-45828198; E-mail: thierry.huby@upmc.fr.	Braun A, 2003, P NATL ACAD SCI USA, V100, P7283, DOI 10.1073/pnas.1237725100; Brousseau ME, 2005, ARTERIOSCL THROM VAS, V25, P1057, DOI 10.1161/01.ATV.0000161928.16334.dd; Dole VS, 2008, ARTERIOSCL THROM VAS, V28, P1111, DOI 10.1161/ATVBAHA.108.162347; Gauthier A, 2005, ARTERIOSCL THROM VAS, V25, P2177, DOI 10.1161/01.ATV.0000183613.13929.13; Guo L, 2009, J BIOL CHEM, V284, P19826, DOI 10.1074/jbc.M109.020933; Harada LM, 2007, ATHEROSCLEROSIS, V191, P313, DOI 10.1016/j.atherosclerosis.2006.05.036; Harder C, 2007, ARTERIOSCL THROM VAS, V27, P858, DOI 10.1161/01.ATV.0000259357.42089.dc; Hildebrand RB, 2010, ARTERIOSCL THROM VAS, V30, P1439, DOI 10.1161/ATVBAHA.110.205153; Hoekstra M, 2009, J LIPID RES, V50, P1039, DOI 10.1194/jlr.M800410-JLR200; Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817; Huby T, 2006, J CLIN INVEST, V116, P2767, DOI 10.1172/JCI26893; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; Ji Y, 1999, J BIOL CHEM, V274, P33398, DOI 10.1074/jbc.274.47.33398; Kocher O, 2008, BBA-MOL BASIS DIS, V1782, P310, DOI 10.1016/j.bbadis.2008.02.004; Kockx M, 2007, CIRC RES, V101, P607, DOI 10.1161/CIRCRESAHA.107.157198; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Lee JY, 2007, J LIPID RES, V48, P1052, DOI 10.1194/jlr.M600417-JLR200; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Li XA, 2006, CIRC RES, V98, pE60, DOI 10.1161/01.RES.0000219310.00308.10; Ma K, 2005, ARTERIOSCL THROM VAS, V25, P149, DOI 10.1161/01.ATV.0000150414.89591.6a; MAROTTI KR, 1993, NATURE, V364, P73, DOI 10.1038/364073a0; Meurs I, 2005, EXP HEMATOL, V33, P1309, DOI 10.1016/j.exphem.2005.07.004; Out R, 2004, J LIPID RES, V45, P2088, DOI 10.1194/jlr.M400191-JLR200; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rotllan N, 2008, ATHEROSCLEROSIS, V196, P505, DOI 10.1016/j.atherosclerosis.2007.05.007; Schwartz CC, 2004, J LIPID RES, V45, P1594, DOI 10.1194/jlr.M300511-JLR200; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Sehayek E, 2008, ARTERIOSCL THROM VAS, V28, P1296, DOI 10.1161/ATVBAHA.108.165803; Stein O, 2002, ATHEROSCLEROSIS, V164, P73, DOI 10.1016/S0021-9150(02)00061-8; Tanigawa H, 2007, CIRCULATION, V116, P1267, DOI 10.1161/CIRCULATIONAHA.107.704254; Tchoua U, 2008, CARDIOVASC RES, V77, P732, DOI 10.1093/cvr/cvm087; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Vergeer M, 2011, NEW ENGL J MED, V364, P136, DOI 10.1056/NEJMoa0907687; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; WERB Z, 1983, J CELL BIOL, V97, P1113, DOI 10.1083/jcb.97.4.1113; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zanotti I, 2011, ARTERIOSCL THROM VAS, V31, P74, DOI 10.1161/ATVBAHA.110.213892; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327; Zhang YZ, 2003, CIRCULATION, V108, P661, DOI 10.1161/01.CIR.0000086981.09834.E0; Zhou HW, 2006, BBA-MOL CELL BIOL L, V1761, P1482, DOI 10.1016/j.bbalip.2006.09.008	43	39	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17227	17238		10.1074/jbc.M111.220483	http://dx.doi.org/10.1074/jbc.M111.220483			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454568	hybrid, Green Published			2022-12-27	WOS:000290301900071
J	Iida, Y; Fujimori, T; Okawa, K; Nagata, K; Wada, I; Hosokawa, N				Iida, Yasutaka; Fujimori, Tsutomu; Okawa, Katsuya; Nagata, Kazuhiro; Wada, Ikuo; Hosokawa, Nobuko			SEL1L Protein Critically Determines the Stability of the HRD1-SEL1L Endoplasmic Reticulum-associated Degradation (ERAD) Complex to Optimize the Degradation Kinetics of ERAD Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE COMPLEX; MEMBRANE-PROTEIN; QUALITY-CONTROL; RETRO-TRANSLOCATION; MISFOLDED PROTEINS; DISLOCATION; CYTOSOL; HRD1; MACHINERY; STRESS	The mammalian HRD1-SEL1L complex provides a scaffold for endoplasmic reticulum (ER)-associated degradation (ERAD), thereby connecting luminal substrates for ubiquitination at the cytoplasmic surface after their retrotranslocation through the endoplasmic reticulum membrane. In this study the stability of the mammalian HRD1-SEL1L complex was assessed by performing siRNA-mediated knockdown of each of its components. Although endogenous SEL1L is a long-lived protein, the half-life of SEL1L was greatly reduced when HRD1 is silenced. Conversely, transiently expressed SEL1L was rapidly degraded but was stabilized when HRD1 was coexpressed. This was in contrast to the yeast Hrd1p-Hrd3p, where Hrd1p is destabilized by the depletion of Hrd3p, the SEL1L homologue. Endogenous HRD1-SEL1L formed a large ERAD complex (Complex I) associating with numerous ERAD components including ERAD lectin OS-9, membrane-spanning Derlin-1/2, VIMP, and Herp, whereas transiently expressed HRD1-SEL1L formed a smaller complex (Complex II) that was associated with OS-9 but not with Derlin-1/2, VIMP, or Herp. Despite its lack of stable association with the latter components, Complex II supported the retrotranslocation and degradation of model ERAD substrates alpha 1-antitrypsin null Hong-Kong (NHK) and its variant NHK-QQQ lacking the N-glycosylation sites. NHK-QQQ was rapidly degraded when SEL1L was transiently expressed, whereas the simultaneous transfection of HRD1 diminished that effect. SEL1L unassociated with HRD1 was degraded by the ubiquitin-proteasome pathway, which suggests the involvement of a ubiquitin-ligase other than HRD1 in the rapid degradation of both SEL1L and NHK-QQQ. These results indicate that the regulation of the stability and assembly of the HRD1-SEL1L complex is critical to optimize the degradation kinetics of ERAD substrates.	[Iida, Yasutaka; Fujimori, Tsutomu; Hosokawa, Nobuko] Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Sakyo Ku, Kyoto 6068397, Japan; [Okawa, Katsuya] Kyowa Hakko Kirin Co Ltd, Drug Discovery Res Labs, Nagaizumi, Shizuoka 4118731, Japan; [Nagata, Kazuhiro] Kyoto Sangyo Univ, Fac Life Sci, Mol & Cellular Biol Lab, Kita Ku, Kyoto 6038555, Japan; [Wada, Ikuo] Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Cell Sci, Fukushima 9601295, Japan	Kyoto University; Kyowa Kirin Ltd; Kyoto Sangyo University; Fukushima Medical University	Hosokawa, N (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068397, Japan.	nobukoh@frontier.kyoto-u.ac.jp		Wada, Ikuo/0000-0001-5668-6994	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Hayashi Memorial Foundation for Female Natural Scientists	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K. N., I. W., and N. H.) and by the Hayashi Memorial Foundation for Female Natural Scientists (to N. H.).	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Francisco AB, 2010, J BIOL CHEM, V285, P13694, DOI 10.1074/jbc.M109.085340; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P651, DOI 10.1093/glycob/cwq013; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Nagasawa K, 2007, EMBO REP, V8, P483, DOI 10.1038/sj.embor.7400933; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Omura T, 2006, J NEUROCHEM, V99, P1456, DOI 10.1111/j.1471-4159.2006.04155.x; Plemper RK, 1999, J CELL SCI, V112, P4123; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tamura T, 2008, TRENDS BIOCHEM SCI, V33, P298, DOI 10.1016/j.tibs.2008.04.013; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	51	71	72	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16929	16939		10.1074/jbc.M110.215871	http://dx.doi.org/10.1074/jbc.M110.215871			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454652	Green Published, hybrid			2022-12-27	WOS:000290301900042
J	Lodder-Gadaczek, J; Becker, I; Gieselmann, V; Wang-Eckhardt, L; Eckhardt, M				Lodder-Gadaczek, Julia; Becker, Ivonne; Gieselmann, Volkmar; Wang-Eckhardt, Lihua; Eckhardt, Matthias			N-Acetylaspartylglutamate Synthetase II Synthesizes N-Acetylaspartylglutamylglutamate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-L-ASPARTATE; CENTRAL-NERVOUS-SYSTEM; ISCHEMIC BRAIN-INJURY; GLUTAMIC-ACID; HIGH-AFFINITY; RAT-BRAIN; ACETYLASPARTATE; CELLS; NAAG; CSF	N-Acetylaspartylglutamate (NAAG) is found at high concentrations in the vertebrate nervous system. NAAG is an agonist at group II metabotropic glutamate receptors. In addition to its role as a neuropeptide, a number of functions have been proposed for NAAG, including a role as a non-excitotoxic transport form of glutamate and a molecular water pump. We recently identified a NAAG synthetase (now renamed NAAG synthetase I, NAAGS-I), encoded by the ribosomal modification protein rimK-like family member B (Rimklb) gene, as a member of the ATP-grasp protein family. We show here that a structurally related protein, encoded by the ribosomal modification protein rimK-like family member A (Rimkla) gene, is another NAAG synthetase (NAAGS-II), which in addition, synthesizes the N-acetylated tripeptide N-acetylaspartylglutamylglutamate (NAAG(2)). In contrast, NAAG(2) synthetase activity was undetectable in cells expressing NAAGS-I. Furthermore, we demonstrate by mass spectrometry the presence of NAAG(2) in murine brain tissue and sciatic nerves. The highest concentrations of both, NAAG(2) and NAAG, were found in sciatic nerves, spinal cord, and the brain stem, in accordance with the expression level of NAAGS-II. To our knowledge the presence of NAAG(2) in the vertebrate nervous system has not been described before. The physiological role of NAAG(2), e.g. whether it acts as a neurotransmitter, remains to be determined.	[Lodder-Gadaczek, Julia; Becker, Ivonne; Gieselmann, Volkmar; Wang-Eckhardt, Lihua; Eckhardt, Matthias] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany	University of Bonn	Eckhardt, M (corresponding author), Nussallee 11, D-53115 Bonn, Germany.	eckhardt@uni-bonn.de						Bacich DJ, 2005, J NEUROCHEM, V95, P314, DOI 10.1111/j.1471-4159.2005.03361.x; Baslow MH, 2000, J NEUROCHEM, V75, P453, DOI 10.1046/j.1471-4159.2000.0750453.x; Baslow MH, 2010, AMINO ACIDS, V39, P1139, DOI 10.1007/s00726-010-0656-6; Baslow MH, 2010, AMINO ACIDS, V38, P51, DOI 10.1007/s00726-009-0232-0; Becker I, 2008, HISTOCHEM CELL BIOL, V129, P233, DOI 10.1007/s00418-007-0344-0; Becker I, 2010, J BIOL CHEM, V285, P29156, DOI 10.1074/jbc.M110.111765; Bischofberger J, 1996, J NEUROPHYSIOL, V76, P2089, DOI 10.1152/jn.1996.76.3.2089; Bruno V, 1998, NEUROSCIENCE, V85, P751, DOI 10.1016/S0306-4522(97)00531-9; BURLINA AP, 1994, J NEUROCHEM, V63, P1174; BURRI R, 1991, DEV NEUROSCI-BASEL, V13, P403, DOI 10.1159/000112191; CASSIDY M, 1993, J NEUROCHEM, V60, P1631, DOI 10.1111/j.1471-4159.1993.tb13385.x; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Collard F, 2010, J BIOL CHEM, V285, P29826, DOI 10.1074/jbc.M110.152629; Coyle JT, 1997, NEUROBIOL DIS, V4, P231, DOI 10.1006/nbdi.1997.0153; CURATOLO A, 1965, J NEUROCHEM, V12, P339, DOI 10.1111/j.1471-4159.1965.tb06771.x; Eckhardt M, 2000, J BIOL CHEM, V275, P2328, DOI 10.1074/jbc.275.4.2328; Ganapathy V, 2006, ADV EXP MED BIOL, V576, P67; Gehl LM, 2004, J NEUROCHEM, V90, P989, DOI 10.1111/j.1471-4159.2004.02578.x; Hamada-Kanazawa M, 2010, BIOL PHARM BULL, V33, P729, DOI 10.1248/bpb.33.729; KANG WK, 1989, MOL GEN GENET, V217, P281, DOI 10.1007/BF02464894; KOLLER KJ, 1984, J NEUROCHEM, V43, P1136, DOI 10.1111/j.1471-4159.1984.tb12854.x; Losi G, 2004, NEUROPHARMACOLOGY, V46, P490, DOI 10.1016/j.neuropharm.2003.10.007; MIYAKE M, 1981, J NEUROCHEM, V37, P1064, DOI 10.1111/j.1471-4159.1981.tb04500.x; Mochel F, 2010, NEUROLOGY, V74, P302, DOI 10.1212/WNL.0b013e3181cbcdc4; Mochel F, 2010, BBA-MOL BASIS DIS, V1802, P1112, DOI 10.1016/j.bbadis.2010.07.005; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Moffett JR, 2006, ADV EXP MED BIOL, V576, P7; MOFFETT JR, 1994, J COMP NEUROL, V347, P598, DOI 10.1002/cne.903470410; Namboodiri AMA, 2006, MOL CELL ENDOCRINOL, V252, P216, DOI 10.1016/j.mce.2006.03.016; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; ORYLAVOLLEE L, 1987, J NEUROCHEM, V48, P895, DOI 10.1111/j.1471-4159.1987.tb05601.x; Passani L, 1998, BRAIN RES, V794, P143, DOI 10.1016/S0006-8993(98)00308-4; Sambrook J., 2002, MOL CLONING LAB MANU; Sartori S, 2008, EUR J PAEDIATR NEURO, V12, P348, DOI 10.1016/j.ejpn.2007.07.011; SEKIGUCHI M, 1992, FEBS LETT, V311, P285, DOI 10.1016/0014-5793(92)81121-2; Slusher BS, 1999, NAT MED, V5, P1396, DOI 10.1038/70971; Wolf NI, 2004, NEUROLOGY, V62, P1503, DOI 10.1212/01.WNL.0000123094.13406.20; Wroblewska B, 1997, J NEUROCHEM, V69, P174; ZACZEK R, 1983, P NATL ACAD SCI-BIOL, V80, P1116, DOI 10.1073/pnas.80.4.1116	40	26	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16693	16706		10.1074/jbc.M111.230136	http://dx.doi.org/10.1074/jbc.M111.230136			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454531	Green Published, hybrid			2022-12-27	WOS:000290301900017
J	Dery, KJ; Gaur, S; Gencheva, M; Yen, Y; Shively, JE; Gaur, RK				Dery, Kenneth J.; Gaur, Shikha; Gencheva, Marieta; Yen, Yun; Shively, John E.; Gaur, Rajesh K.			Mechanistic Control of Carcinoembryonic Antigen-related Cell Adhesion Molecule-1 (CEACAM1) Splice Isoforms by the Heterogeneous Nuclear Ribonuclear Proteins hnRNP L, hnRNP A1, and hnRNP M	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT CYTOPLASMIC DOMAIN; RNA-BINDING PROTEINS; MESSENGER-RNA; CANCER-CELLS; SR PROTEINS; THERAPEUTIC TARGET; C-CAM; FAMILY; EXPRESSION; APOPTOSIS	Carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) is expressed in a variety of cell types and is implicated in carcinogenesis. Alternative splicing of CEACAM1 pre-mRNA generates two cytoplasmic domain splice variants characterized by the inclusion (L-isoform) or exclusion (S-isoform) of exon 7. Here we show that the alternative splicing of CEACAM1 pre-mRNA is regulated by novel cis elements residing in exon 7. We report the presence of three exon regulatory elements that lead to the inclusion or exclusion of exon 7 CEACAM1 mRNA in ZR75 breast cancer cells. Heterologous splicing reporter assays demonstrated that the maintenance of authentic alternative splicing mechanisms were independent of the CEACAM1 intron sequence context. We show that forced expression of these exon regulatory elements could alter CEACAM1 splicing in HEK-293 cells. Using RNA affinity chromatography, three members of the heterogeneous nuclear ribonucleoprotein family (hnRNP L, hnRNP A1, and hnRNP M) were identified. RNA immunoprecipitation of hnRNP L and hnRNP A1 revealed a binding motif located central and 3' to exon 7, respectively. Depletion of hnRNP A1 or L by RNAi in HEK-293 cells promoted exon 7 inclusion, whereas overexpression led to exclusion of the variable exon. By contrast, overexpression of hnRNP M showed exon 7 inclusion and production of CEACAM1-L mRNA. Finally, stress-induced cytoplasmic accumulation of hnRNP A1 in MDA-MB-468 cells dynamically alters the CEACAM1-S: CEACAM1: L ratio in favor of the L-isoform. Thus, we have elucidated the molecular factors that control the mechanism of splice-site recognition in the alternative splicing regulation of CEACAM1.	[Dery, Kenneth J.; Gencheva, Marieta; Shively, John E.] Beckman Res Inst City Hope, Dept Immunol, Duarte, CA 91010 USA; [Gaur, Rajesh K.] Beckman Res Inst City Hope, Dept Mol & Cellular Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Shively, JE (corresponding author), Beckman Res Inst City Hope, Dept Immunol, 1450 E Duarte Rd, Duarte, CA 91010 USA.	JShively@coh.org; rkg@caltech.edu			National Institutes of Health [CA84202]; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA84202.	Aarons CB, 2007, CLIN EXP METASTAS, V24, P201, DOI 10.1007/s10585-007-9069-7; Akerman M, 2006, NUCLEIC ACIDS RES, V34, P23, DOI 10.1093/nar/gkj408; BARNETT TR, 1993, MOL CELL BIOL, V13, P1273, DOI 10.1128/MCB.13.2.1273; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BRUMMER J, 1995, ONCOGENE, V11, P1649; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; Chen T, 2001, J LEUKOCYTE BIOL, V70, P335; Cloutier P, 2008, J BIOL CHEM, V283, P21315, DOI 10.1074/jbc.M800353200; COBIANCHI F, 1988, J BIOL CHEM, V263, P1063; Dery KJ, 2009, METHODS MOL BIOL, V555, P127, DOI 10.1007/978-1-60327-295-7_10; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Edlund M, 1998, FEBS LETT, V425, P166, DOI 10.1016/S0014-5793(98)00222-1; Expert-Bezancon A, 2004, J BIOL CHEM, V279, P38249, DOI 10.1074/jbc.M405377200; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Gangopadhyay A, 1996, ARCH BIOCHEM BIOPHYS, V334, P151, DOI 10.1006/abbi.1996.0440; Garcia-Blanco MA, 2006, PROG MOLEC, V44, P47; Gaur S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-46; Graveley BR, 1998, EMBO J, V17, P6747, DOI 10.1093/emboj/17.22.6747; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Griffith BN, 2006, BBA-GENE STRUCT EXPR, V1759, P552, DOI 10.1016/j.bbaexp.2006.10.001; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Hamilton BJ, 1999, BIOCHEM BIOPH RES CO, V261, P646, DOI 10.1006/bbrc.1999.1040; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hovhannisyan RH, 2007, J BIOL CHEM, V282, P36265, DOI 10.1074/jbc.M704188200; HSIEH JT, 1995, CANCER RES, V55, P190; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Kamma H, 1999, EXP CELL RES, V246, P399, DOI 10.1006/excr.1998.4323; Kan JLC, 1999, GENE DEV, V13, P462, DOI 10.1101/gad.13.4.462; Kim DS, 2005, RNA, V11, P1667, DOI 10.1261/rna.2162205; Kim JH, 2000, J MOL BIOL, V298, P395, DOI 10.1006/jmbi.2000.3687; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; KONARSKA MM, 1986, CELL, V46, P845, DOI 10.1016/0092-8674(86)90066-8; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Laguinge L, 2005, ANTICANCER RES, V25, P23; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Ma YL, 2009, J PROTEOME RES, V8, P4525, DOI 10.1021/pr900365e; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Matter N, 2000, J BIOL CHEM, V275, P35353, DOI 10.1074/jbc.M004692200; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; MCCUAIG K, 1992, CELL GROWTH DIFFER, V3, P165; Miriami E, 2003, NUCLEIC ACIDS RES, V31, P1974, DOI 10.1093/nar/gkg279; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Nayler O, 2000, J CELL BIOL, V150, P949, DOI 10.1083/jcb.150.5.949; Nittka S, 2004, ONCOGENE, V23, P9306, DOI 10.1038/sj.onc.1208259; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; Okunola HL, 2009, MOL CELL BIOL, V29, P5620, DOI 10.1128/MCB.01678-08; Orengo JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl967; Patry C, 2003, CANCER RES, V63, P7679; Pozzoli U, 2005, CELL MOL LIFE SCI, V62, P1579, DOI 10.1007/s00018-005-5030-6; Riethdorf L, 1997, J HISTOCHEM CYTOCHEM, V45, P957, DOI 10.1177/002215549704500705; Schumann D, 2001, J BIOL CHEM, V276, P47421, DOI 10.1074/jbc.M109110200; SHIVELY JE, 1985, CRC CR REV ONCOL-HEM, V2, P355, DOI 10.1016/S1040-8428(85)80008-1; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; Suyama M, 2010, NUCLEIC ACIDS RES, V38, P7916, DOI 10.1093/nar/gkq705; Szeszel-Fedorowicz W, 2006, J BIOL CHEM, V281, P34146, DOI 10.1074/jbc.M603825200; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407; Zahler AM, 2004, J BIOL CHEM, V279, P10077, DOI 10.1074/jbc.M312743200; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	68	39	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.204057	http://dx.doi.org/10.1074/jbc.M110.204057			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21398516	Green Published, hybrid			2022-12-27	WOS:000290022800044
J	McCusker, EC; D'Avanzo, N; Nichols, CG; Wallace, BA				McCusker, Emily C.; D'Avanzo, Nazzareno; Nichols, Colin G.; Wallace, B. A.			Simplified Bacterial "Pore" Channel Provides Insight into the Assembly, Stability, and Structure of Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTROSCOPY; DEPENDENT K+ CHANNEL; ALKALIPHILIC BACILLUS; NACHBAC; INACTIVATION; ENVIRONMENT; CHEMOTAXIS; MOTILITY; SPECTRA	Eukaryotic sodium channels are important membrane proteins involved in ion permeation, homeostasis, and electrical signaling. They are long, multidomain proteins that do not express well in heterologous systems, and hence, structure/function and biochemical studies on purified sodium channel proteins have been limited. Bacteria produce smaller, homologous tetrameric single domain channels specific for the conductance of sodium ions. They consist of N-terminal voltage sensor and C-terminal pore subdomains. We designed a functional pore-only channel consisting of the final two transmembrane helices, the intervening P-region, and the C-terminal extramembranous region of the sodium channel from the marine bacterium Silicibacter pomeroyi. This sodium "pore" channel forms a tetrameric, folded structure that is capable of supporting sodium flux in phospholipid vesicles. The pore-only channel is more thermally stable than its full-length counterpart, suggesting that the voltage sensor subdomain may destabilize the full-length channel. The pore subdomains can assemble, fold, and function independently from the voltage sensor and exhibit similar ligand-blocking characteristics as the intact channel. The availability of this simple pore-only construct should enable high-level expression for the testing of potential new ligands and enhance our understanding of the structural features that govern sodium selectivity and permeability.	[McCusker, Emily C.; Wallace, B. A.] Univ London, Birkbeck Coll, Inst Struct & Mol Biol, Dept Crystallog, London WC1E 7HX, England; [D'Avanzo, Nazzareno; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [D'Avanzo, Nazzareno; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA	University of London; Birkbeck University London; Washington University (WUSTL); Washington University (WUSTL)	Wallace, BA (corresponding author), Univ London, Birkbeck Coll, Inst Struct & Mol Biol, Dept Crystallog, Malet St, London WC1E 7HX, England.	b.wallace@mail.cryst.bbk.ac.uk	Nichols, Colin/D-6336-2012; Wallace, B A/C-3753-2008	Wallace, B A/0000-0001-9649-5092	Biotechnology and Biological Science Research Council (BBSRC); National Institutes of Health [HL54171]; BBSRC [BB/H01070X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H01070X/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER	Biotechnology and Biological Science Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a project grant from the Biotechnology and Biological Science Research Council (BBSRC) (to B. A. W.) and a BBSRC SPORT programme grant to the Membrane Protein Structure Initiative consortium (to N. Isaacs, principal investigator). This work was supported in part by National Institutes of Health Grant HL54171 (to C. G. N.).	Anderson JD, 2003, MOL CANCER THER, V2, P1149; Chakrapani S, 2010, P NATL ACAD SCI USA, V107, P5435, DOI 10.1073/pnas.0914109107; Chen ZH, 2002, J BIOL CHEM, V277, P24653, DOI 10.1074/jbc.M111862200; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fraser SP, 2005, CLIN CANCER RES, V11, P5381, DOI 10.1158/1078-0432.CCR-05-0327; Fujinami S, 2009, FUTURE MICROBIOL, V4, P1137, DOI 10.2217/FMB.09.76; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Irie K, 2010, J BIOL CHEM, V285, P3685, DOI 10.1074/jbc.M109.057455; Ito M, 2004, P NATL ACAD SCI USA, V101, P10566, DOI 10.1073/pnas.0402692101; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Klose DP, 2010, BIOINFORMATICS, V26, P2624, DOI 10.1093/bioinformatics/btq480; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Liu Y, 2009, EPILEPSY RES, V83, P66, DOI 10.1016/j.eplepsyres.2008.09.006; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mio K, 2010, PROG BIOPHYS MOL BIO, V103, P111, DOI 10.1016/j.pbiomolbio.2010.05.002; Nurani G, 2008, BIOCHEMISTRY-US, V47, P8114, DOI 10.1021/bi800645w; O'Reilly AO, 2008, MOL MEMBR BIOL, V25, P670, DOI 10.1080/09687680802508754; Powl AM, 2010, P NATL ACAD SCI USA, V107, P14064, DOI 10.1073/pnas.1001793107; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Shimomura T, 2011, J BIOL CHEM, V286, P7409, DOI 10.1074/jbc.M110.186510; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Ulmschneider MB, 2010, J AM CHEM SOC, V132, P3452, DOI 10.1021/ja909347x; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zimmer T, 2008, PROG BIOPHYS MOL BIO, V98, P120, DOI 10.1016/j.pbiomolbio.2008.10.005	34	29	29	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.C111.228122	http://dx.doi.org/10.1074/jbc.C111.228122			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454659	hybrid, Green Published			2022-12-27	WOS:000290022800076
J	Giral, H; Lanzano, L; Caldas, Y; Blaine, J; Verlander, JW; Lei, T; Gratton, E; Levi, M				Giral, Hector; Lanzano, Luca; Caldas, Yupanqui; Blaine, Judith; Verlander, Jill W.; Lei, Tim; Gratton, Enrico; Levi, Moshe			Role of PDZK1 Protein in Apical Membrane Expression of Renal Sodium-coupled Phosphate Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL TUBULE CELLS; P-I COTRANSPORTER; NAPI-IIA; TARGETED DISRUPTION; PARATHYROID-HORMONE; IMAGING MICROSCOPY; ADAPTER PROTEINS; OK CELLS; MOUSE; NHERF	The sodium-dependent phosphate (Na/P-i) transporters NaPi-2a and NaPi-2c play a major role in the renal reabsorption of P-i. The functional need for several transporters accomplishing the same role is still not clear. However, the fact that these transporters show differential regulation under dietary and hormonal stimuli suggests different roles in P-i reabsorption. The pathways controlling this differential regulation are still unknown, but one of the candidates involved is the NHERF family of scaffolding PDZ proteins. We propose that differences in the molecular interaction with PDZ proteins are related with the differential adaptation of Na/P-i transporters. Pdzk1(-/-) mice adapted to chronic low P-i diets showed an increased expression of NaPi-2a protein in the apical membrane of proximal tubules but impaired up-regulation of NaPi-2c. These results suggest an important role for PDZK1 in the stabilization of NaPi-2c in the apical membrane. We studied the specific protein-protein interactions of Na/P-i transporters with NHERF-1 and PDZK1 by FRET. FRET measurements showed a much stronger interaction of NHERF-1 with NaPi-2a than with NaPi-2c. However, both Na/P-i transporters showed similar FRET efficiencies with PDZK1. Interestingly, in cells adapted to low P-i concentrations, there were increases in NaPi-2c/PDZK1 and NaPi-2a/NHERF-1 interactions. The differential affinity of the Na/P-i transporters for NHERF-1 and PDZK1 proteins could partially explain their differential regulation and/or stability in the apical membrane. In this regard, direct interaction between NaPi-2c and PDZK1 seems to play an important role in the physiological regulation of NaPi-2c.	[Giral, Hector; Caldas, Yupanqui; Blaine, Judith; Levi, Moshe] Univ Colorado, Dept Med, Aurora, CO 80045 USA; [Lanzano, Luca; Gratton, Enrico] Univ Calif Irvine, Fluorescence Dynam Lab, Irvine, CA 92697 USA; [Verlander, Jill W.] Univ Florida, Dept Med, Div Nephrol Hypertens & Transplantat, Gainesville, FL 32610 USA; [Lei, Tim] Univ Colorado, Dept Elect Engn, Denver, CO 80202 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Irvine; State University System of Florida; University of Florida; University of Colorado System; University of Colorado Denver	Levi, M (corresponding author), Univ Colorado Denver, 12700 E 19th Ave,Res 2,Rm 7002, Aurora, CO 80045 USA.	Moshe.Levi@ucdenver.edu	Verlander, Jill/I-5991-2015	Levi, Moshe/0000-0002-6225-946X; Lanzano', Luca/0000-0001-6539-394X	National Institutes of Health [R01 DK066029, P41-RRO3155, P50-GM076516, K08 DK080989]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066029, K08DK080989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK066029 (M.L., Y.C., L.L., H.G., and E.G.), P41-RRO3155 (to E.G. and L.L.), P50-GM076516 (to E.G. and L.L.), and K08 DK080989 (to J.B.).	Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Blaine J, 2009, AM J PHYSIOL-CELL PH, V297, pC1339, DOI 10.1152/ajpcell.00260.2009; Breusegem SY, 2009, AM J PHYSIOL-RENAL, V297, pF350, DOI 10.1152/ajprenal.90765.2008; Breusegem SY, 2005, AM J PHYSIOL-RENAL, V289, pF154, DOI 10.1152/ajprenal.00331.2004; Caiolfa VR, 2007, J CELL BIOL, V179, P1067, DOI 10.1083/jcb.200702151; Capuano P, 2005, PFLUG ARCH EUR J PHY, V449, P392, DOI 10.1007/s00424-004-1351-9; Clayton AHA, 2004, J MICROSC-OXFORD, V213, P1, DOI 10.1111/j.1365-2818.2004.01265.x; COLE JA, 1989, AM J PHYSIOL, V256, pF672, DOI 10.1152/ajprenal.1989.256.4.F672; Colyer RA, 2008, MICROSC RES TECHNIQ, V71, P201, DOI 10.1002/jemt.20540; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Cunningham R, 2006, AM J PHYSIOL-RENAL, V291, pF896, DOI 10.1152/ajprenal.00036.2006; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Dobrinskikh E, 2010, AM J PHYSIOL-CELL PH, V299, pC1324, DOI 10.1152/ajpcell.00183.2010; Forster IC, 2002, PROG BIOPHYS MOL BIO, V80, P69, DOI 10.1016/S0079-6107(02)00015-9; Gisler SM, 2003, KIDNEY INT, V64, P1733, DOI 10.1046/j.1523-1755.2003.00266.x; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; GRATTON E, 1984, ANNU REV BIOPHYS BIO, V13, P105; Hernando N, 2005, J PHYSIOL-LONDON, V567, P21, DOI 10.1113/jphysiol.2005.087049; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Hoag HM, 1999, J CLIN INVEST, V104, P679, DOI 10.1172/JCI7103; Kato Y, 2006, EUR J PHARM SCI, V27, P487, DOI 10.1016/j.ejps.2005.11.006; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Lan DB, 2005, J BIOL CHEM, V280, P23390, DOI 10.1074/jbc.M502777200; Lanaspa MA, 2007, AM J PHYSIOL-RENAL, V292, pF230, DOI 10.1152/ajprenal.00075.2006; Levi M, 1996, J MEMBRANE BIOL, V154, P1, DOI 10.1007/s002329900127; LEVI M, 1994, AM J PHYSIOL-RENAL, V267, pF900, DOI 10.1152/ajprenal.1994.267.5.F900; Lotscher M, 1997, J CLIN INVEST, V99, P1302, DOI 10.1172/JCI119289; McWilliams RR, 2005, AM J PHYSIOL-CELL PH, V289, pC1042, DOI 10.1152/ajpcell.00568.2004; Miyamoto KI, 2007, AM J NEPHROL, V27, P503, DOI 10.1159/000107069; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Redford GI, 2005, J FLUORESC, V15, P805, DOI 10.1007/s10895-005-2990-8; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Segawa H, 2005, AM J PHYSIOL-RENAL, V288, pF587, DOI 10.1152/ajprenal.00097.2004; Segawa H, 2002, J BIOL CHEM, V277, P19665, DOI 10.1074/jbc.M200943200; Segawa H, 2007, AM J PHYSIOL-RENAL, V292, pF395, DOI 10.1152/ajprenal.00100.2006; Seidler U, 2009, EXP PHYSIOL, V94, P175, DOI 10.1113/expphysiol.2008.043018; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Suhling K, 2005, PHOTOCH PHOTOBIO SCI, V4, P13, DOI 10.1039/b412924p; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Villa-Bellosta R, 2008, KIDNEY INT, V73, P456, DOI 10.1038/sj.ki.5002703; Wade JB, 2003, AM J PHYSIOL-CELL PH, V285, pC1494, DOI 10.1152/ajpcell.00092.2003; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Weinman EJ, 2005, PFLUG ARCH EUR J PHY, V450, P137, DOI 10.1007/s00424-005-1384-8; Weinman EJ, 2003, AM J PHYSIOL-RENAL, V285, pF1225, DOI 10.1152/ajprenal.00215.2003; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5	47	38	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15032	15042		10.1074/jbc.M110.199752	http://dx.doi.org/10.1074/jbc.M110.199752			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21388960	hybrid, Green Published			2022-12-27	WOS:000289788300033
J	Chang, HY; Jennings, PC; Stewart, J; Verrills, NM; Jones, KT				Chang, Heng-Yu; Jennings, Phoebe C.; Stewart, Jessica; Verrills, Nicole M.; Jones, Keith T.			Essential Role of Protein Phosphatase 2A in Metaphase II Arrest and Activation of Mouse Eggs Shown by Okadaic Acid, Dominant Negative Protein Phosphatase 2A, and FTY720	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERMINAL VESICLE BREAKDOWN; CELL-CYCLE PROGRESSION; XENOPUS-LAEVIS EGGS; MEIOTIC ARREST; MICROTUBULE DYNAMICS; CYTOSTATIC FACTOR; MAPK PATHWAY; MEIOSIS-II; CHROMOSOME CONDENSATION; LYMPHOCYTIC-LEUKEMIA	Vertebrate eggs arrest at second meiotic metaphase. The fertilizing sperm causes meiotic exit through Ca2+-mediated activation of the anaphase-promoting complex/cyclosome (APC/C). Although the loss in activity of the M-phase kinase CDK1 is known to be an essential downstream event of this process, the contribution of phosphatases to arrest and meiotic resumption is less apparent, especially in mammals. Therefore, we explored the role of protein phosphatase 2A (PP2A) in mouse eggs using pharmacological inhibition and activation as well as a functionally dominant-negative catalytic PP2A subunit (dn-PP2Ac-L199P) coupled with live cell imaging. We observed that PP2A inhibition using okadaic acid induced events normally observed at fertilization: degradation of the APC/C substrates cyclin B1 and securin resulting from loss of the APC/C inhibitor Emi2. Although sister chromatids separated, chromatin remained condensed, and polar body extrusion was blocked as a result of a rapid spindle disruption, which could be ameliorated by non-degradable cyclin B1, suggesting that spindle integrity was affected by CDK1 loss. Similar cell cycle effects to okadaic acid were also observed using dominant-negative PP2Ac. Preincubation of eggs with the PP2A activator FTY720 could block many of the actions of okadaic acid, including Emi2, cyclin B1, and securin degradation and sister chromatid separation. Therefore, in conclusion, we used okadaic acid, dn-PP2Ac-L199P, and FTY720 on mouse eggs to demonstrate that PP2A is needed to for both continued metaphase arrest and successful exit from meiosis.	[Chang, Heng-Yu; Jennings, Phoebe C.; Stewart, Jessica; Verrills, Nicole M.; Jones, Keith T.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia	University of Newcastle	Jones, KT (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia.	keith.jones@newcastle.edu.au	Jones, Keith/C-9821-2013; Jones, Keith/AAA-3479-2021	Jones, Keith/0000-0002-0294-0851; Jones, Keith/0000-0002-0294-0851; Barnes, Jessica/0000-0002-5386-4123; Verrills, Nicole/0000-0002-7894-0137	Australian Research Council [DP0986217]	Australian Research Council(Australian Research Council)	This work was funded by Australian Research Council Discovery Project Grant DP0986217 (to K. T. J.).	Andersen SSL, 1997, NATURE, V389, P640, DOI 10.1038/39382; Arrighi CD, 2000, BIOL REPROD, V63, P658, DOI 10.1095/biolreprod63.2.658; BosMikich A, 1997, DEV BIOL, V182, P172, DOI 10.1006/dbio.1996.8468; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; Chang HY, 2009, DEVELOPMENT, V136, P4077, DOI 10.1242/dev.042143; Chang HY, 2004, J CELL SCI, V117, P6289, DOI 10.1242/jcs.01567; COLLEDGE WH, 1994, NATURE, V370, P65, DOI 10.1038/370065a0; DEPENNART H, 1993, DEV BIOL, V157, P170, DOI 10.1006/dbio.1993.1121; Di Agostino S, 2002, DEVELOPMENT, V129, P1715; Ducibella T, 2006, SEMIN CELL DEV BIOL, V17, P324, DOI 10.1016/j.semcdb.2006.02.010; DYBAN AP, 1993, MOL REPROD DEV, V34, P402, DOI 10.1002/mrd.1080340409; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Evans DRH, 2000, GENETICS, V156, P21; Evans DRH, 1999, J BIOL CHEM, V274, P24038, DOI 10.1074/jbc.274.34.24038; GAVIN AC, 1994, J CELL SCI, V107, P275; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; HASHIMOTO N, 1994, NATURE, V370, P68, DOI 10.1038/370068a0; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; Holland AJ, 2006, J CELL SCI, V119, P3325, DOI 10.1242/jcs.03083; Holt JE, 2010, DEVELOPMENT, V137, P1297, DOI 10.1242/dev.047555; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; Jones KT, 2005, REPRODUCTION, V130, P813, DOI 10.1530/rep.1.00710; KLINE D, 1992, DEV BIOL, V149, P80, DOI 10.1016/0012-1606(92)90265-I; KUBIAK JZ, 1993, EMBO J, V12, P3773, DOI 10.1002/j.1460-2075.1993.tb06055.x; Lane SIR, 2010, REPRODUCTION, V140, P521, DOI 10.1530/REP-10-0223; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; Liu Q, 2008, BLOOD, V111, P275, DOI 10.1182/blood-2006-10-053884; Madgwick S, 2005, J CELL SCI, V118, P3849, DOI 10.1242/jcs.02506; Madgwick S, 2004, DEV BIOL, V275, P68, DOI 10.1016/j.ydbio.2004.07.024; Madgwick S, 2006, J CELL BIOL, V174, P791, DOI 10.1083/jcb.200604140; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Matsuoka Y, 2003, BRIT J PHARMACOL, V138, P1303, DOI 10.1038/sj.bjp.0705182; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; MOOS J, 1995, BIOL REPROD, V53, P692, DOI 10.1095/biolreprod53.3.692; Nabti I, 2008, DEV BIOL, V321, P379, DOI 10.1016/j.ydbio.2008.06.036; Neviani P, 2007, J CLIN INVEST, V117, P2408, DOI 10.1172/JCI31095; Nishiyama T, 2007, NATURE, V449, P341, DOI 10.1038/nature06136; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; Nixon VL, 2000, BIOL CELL, V92, P187, DOI 10.1016/S0248-4900(00)01068-6; Ookata K, 1997, BIOCHEMISTRY-US, V36, P15873, DOI 10.1021/bi971251w; Perry ACF, 2008, EMBO REP, V9, P246, DOI 10.1038/embor.2008.22; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Phillips KP, 2002, MOL BIOL CELL, V13, P3800, DOI 10.1091/mbc.E02-04-0242; Reis A, 2006, NAT CELL BIOL, V8, P539, DOI 10.1038/ncb1406; Reis A, 2007, NAT CELL BIOL, V9, P1192, DOI 10.1038/ncb1640; Reis A, 2006, EMBO REP, V7, P1040, DOI 10.1038/sj.embor.7400772; RIME H, 1990, DEV BIOL, V141, P115, DOI 10.1016/0012-1606(90)90106-S; Roberts KG, 2010, CANCER RES, V70, P5438, DOI 10.1158/0008-5472.CAN-09-2544; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Sanhaji M, 2010, MOL CELL BIOL, V30, P2594, DOI 10.1128/MCB.00098-10; Schmidt A, 2006, J CELL SCI, V119, P1213, DOI 10.1242/jcs.02919; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shiina N, 1999, MOL BIOL CELL, V10, P597, DOI 10.1091/mbc.10.3.597; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Suzuki T, 2010, DEVELOPMENT, V137, P3281, DOI 10.1242/dev.052480; Swain JE, 2007, BIOL REPROD, V76, P628, DOI 10.1095/biolreprod.106.055798; Swain JE, 2003, MOL REPROD DEV, V65, P96, DOI 10.1002/mrd.10258; Tang WL, 2008, MOL BIOL CELL, V19, P3536, DOI 10.1091/mbc.E08-04-0417; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; Vasquez RJ, 1999, CELL MOTIL CYTOSKEL, V43, P310, DOI 10.1002/(SICI)1097-0169(1999)43:4<310::AID-CM4>3.3.CO;2-A; Vigneron S, 2009, EMBO J, V28, P2786, DOI 10.1038/emboj.2009.228; Wang L, 2008, DEV BIOL, V313, P155, DOI 10.1016/j.ydbio.2007.10.009; Wang X, 2004, REPRODUCTION, V128, P493, DOI 10.1530/rep.1.00173; Wu JQ, 2008, J CELL SCI, V121, P3509, DOI 10.1242/jcs.036855; Wu JQ, 2007, P NATL ACAD SCI USA, V104, P16564, DOI 10.1073/pnas.0707537104; Wu QJ, 2007, CURR BIOL, V17, P213, DOI 10.1016/j.cub.2006.12.045; Yang KT, 2010, MOL BIOL CELL, V21, P2371, DOI 10.1091/mbc.E10-02-0170; ZERNICKAGOETZ M, 1993, EXP CELL RES, V207, P189, DOI 10.1006/excr.1993.1179	72	28	28	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14705	14712		10.1074/jbc.M110.193227	http://dx.doi.org/10.1074/jbc.M110.193227			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21383018	hybrid, Green Published			2022-12-27	WOS:000289556200089
J	Kang, YH; Park, CH; Kim, TS; Soung, NK; Bang, JK; Kim, BY; Park, JE; Lee, KS				Kang, Young H.; Park, Chi-Hoon; Kim, Tae-Sung; Soung, Nak-Kyun; Bang, Jeong K.; Kim, Bo Y.; Park, Jung-Eun; Lee, Kyung S.			Mammalian Polo-like Kinase 1-dependent Regulation of the PBIP1-CENP-Q Complex at Kinetochores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX DOMAIN; PLK1-PBIP1 INTERACTION; PLK1 LOCALIZATION; PROTEIN-KINASE; CENP-A; POLO-LIKE-KINASE-1; CYTOKINESIS; PHOSPHORYLATION; STABILITY; REVEALS	Mammalian polo-like kinase 1 (Plk1) plays a pivotal role during M-phase progression. Plk1 localizes to specific subcellular structures through the targeting activity of the C-terminal polobox domain (PBD). Disruption of the PBD function results in improper bipolar spindle formation, chromosome missegregation, and cytokinesis defect that ultimately lead to the generation of aneuploidy. It has been shown that Plk1 recruits itself to centromeres by phosphorylating and binding to a centromere scaffold, PBIP1 (also called MLF1IP and CENP-U[ 50]) through its PBD. However, how PBIP1 itself is targeted to centromeres and what roles it plays in the regulation of Plk1-dependent mitotic events remain unknown. Here, we demonstrated that PBIP1 directly interacts with CENP-Q, and this interaction was mutually required not only for their stability but also for their centromere localization. Plk1 did not appear to interact with CENP-Q directly. However, Plk1 formed a ternary complex with PBIP1 and CENP-Q through a self-generated p-T78 motif on PBIP1. This complex formation was central for Plk1-dependent phosphorylation of PBIP1-bound CENP-Q and delocalization of the PBIP1-CENP-Q complex from mitotic centromeres. This study reveals a unique mechanism of how PBIP1 mediates Plk1-dependent phosphorylation event onto a third protein, and provides new insights into the mechanism of how Plk1 and its recruitment scaffold, PBIP1-CENP-Q complex, are localized to and delocalized from centromeres.	[Kang, Young H.; Park, Chi-Hoon; Kim, Tae-Sung; Soung, Nak-Kyun; Park, Jung-Eun; Lee, Kyung S.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Bang, Jeong K.] Korean Basic Sci Inst, Div Magnet Resonance, Ochang 363883, Chung Buk, South Korea; [Soung, Nak-Kyun; Kim, Bo Y.] Korea Res Inst Biosci & Biotechnol, Chem Biol Res Ctr, Ochang 363883, Chung Buk, South Korea	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Korea Basic Science Institute (KBSI); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, KS (corresponding author), NCI, Lab Metab, Ctr Canc Res, NIH, 9000 Rockville Pike,Bldg 37,Rm 3118, Bethesda, MD 20892 USA.	kyunglee@mail.nih.gov			NCI, National Institutes of Health [Z01 BC 010520]; Korea Basic Science Institute [T3022B]; Ministry of Education, Science and Technology of Korea; NATIONAL CANCER INSTITUTE [ZIABC010680, ZIABC011324, Z01BC010520] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Korea Basic Science Institute; Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health intramural Grant Z01 BC 010520 (to K. S. L.), the Korea Basic Science Institute's high field NMR Research Program Grant T3022B (to J. K. B.), and the World Class Institute research program of the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology of Korea (to B. Y. K.).	Amaro AC, 2010, NAT CELL BIOL, V12, P319, DOI 10.1038/ncb2033; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; de Carcer G, 2001, EMBO J, V20, P2878, DOI 10.1093/emboj/20.11.2878; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Hanissian SH, 2004, ONCOGENE, V23, P3700, DOI 10.1038/sj.onc.1207448; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; LEE KS, 1995, MOL CELL BIOL, V15, P7143; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Lee KS, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-4; Lee KS, 2008, CELL CYCLE, V7, P141, DOI 10.4161/cc.7.2.5272; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Lowery DM, 2004, CELL CYCLE, V3, P128; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Qi W, 2006, MOL BIOL CELL, V17, P3705, DOI 10.1091/mbc.E06-03-0240; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; Yun SM, 2009, NAT STRUCT MOL BIOL, V16, P876, DOI 10.1038/nsmb.1628	33	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19744	19757		10.1074/jbc.M111.224105	http://dx.doi.org/10.1074/jbc.M111.224105			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21454580	Green Published, hybrid			2022-12-27	WOS:000291027700057
J	Xiao, ZH; Wang, TT; Qin, HH; Huang, C; Feng, YM; Xia, Y				Xiao, Zhihong; Wang, Tingting; Qin, Honghua; Huang, Chao; Feng, Youmei; Xia, Yong			Endoplasmic Reticulum Ca2+ Release Modulates Endothelial Nitric-oxide Synthase via Extracellular Signal-regulated Kinase (ERK) 1/2-mediated Serine 635 Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM; CELLS; ACTIVATION; ENOS; MECHANISM; CHANNELS; PERMEABILITY; CALMODULIN; PATHWAYS; SER(635)	Endothelial nitric-oxide synthase (eNOS) plays a central role in cardiovascular regulation. eNOS function is critically modulated by Ca2+ and protein phosphorylation, but the interrelationship between intracellular Ca2+ mobilization and eNOS phosphorylation is poorly understood. Here we show that endoplasmic reticulum (ER) Ca2+ release activates eNOS by selectively promoting its Ser-635/633 (bovine/human) phosphorylation. With bovine endothelial cells, thapsigargin-induced ER Ca2+ release caused a dose-dependent increase ineNOSSer-635 phosphorylation, leading to elevated NO production. ER Ca2+ release also promoted eNOS Ser-633 phosphorylation in mouse vessels in vivo. This effect was independent of extracellular Ca2+ and selective to Ser-635 because the phosphorylation status of other eNOS sites, including Ser-1179 or Thr-497, was unaffected in thapsigargin-treated cells. Blocking ERK1/2 abolished ER Ca2+ release-induced eNOS Ser-635 phosphorylation, whereas inhibiting protein kinase A or Ca2+/calmodulin-dependent protein kinase II had no effect. Protein phosphorylation assay confirmed that ERK1/2 directly phosphorylated the eNOS Ser-635 residue in vitro. Further studies demonstrated that ER Ca2+ release-induced ERK1/2 activation mediated the enhancing action of purine or bradykinin receptor stimulation on eNOS Ser-635/633 phosphorylation in bovine/human endothelial cells. Mutating the Ser-635 to nonphosphorylatable alanine prevented ATP from activating eNOS in cells. Taken together, these studies reveal that ER Ca2+ release enhances eNOS Ser-635 phosphorylation and function via ERK1/2 activation. Because ER Ca2+ is commonly mobilized by agonists or physicochemical stimuli, the identified ER Ca2+-ERK1/2-eNOS Ser-635 phosphorylation pathway may have a broad role in the regulation of endothelial function.	[Xiao, Zhihong; Wang, Tingting; Qin, Honghua; Huang, Chao; Xia, Yong] Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Div Cardiovasc Med,Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Xiao, Zhihong; Feng, Youmei] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem, Wuhan 430030, Peoples R China	University System of Ohio; Ohio State University; Huazhong University of Science & Technology	Xia, Y (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst 605, 473 W 12th Ave, Columbus, OH 43210 USA.	yong.xia@osumc.edu	wang, tingting/AAK-2640-2020		National Institutes of Health [HL77575, HL86965]; China Scholarship Council [2008616047]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077575, R01HL086965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL77575 and HL86965.; Supported by Predoctoral Fellowship 2008616047 from the China Scholarship Council.	Ayajiki K, 1996, CIRC RES, V78, P750, DOI 10.1161/01.RES.78.5.750; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boo YC, 2003, FREE RADICAL BIO MED, V35, P729, DOI 10.1016/S0891-5849(03)00397-6; Boo YC, 2002, AM J PHYSIOL-HEART C, V283, pH1819, DOI 10.1152/ajpheart.00214.2002; Bootman MD, 2002, CURR BIOL, V12, pR563, DOI 10.1016/S0960-9822(02)01055-2; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; da Silva CG, 2009, CIRCULATION, V119, P871, DOI 10.1161/CIRCULATIONAHA.108.764571; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; KUCHAN MJ, 1994, AM J PHYSIOL, V266, pC628, DOI 10.1152/ajpcell.1994.266.3.C628; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moore TM, 1998, AM J PHYSIOL-LUNG C, V275, pL203, DOI 10.1152/ajplung.1998.275.2.L203; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Oh-Hashi K, 2006, NEUROSCI LETT, V405, P100, DOI 10.1016/j.neulet.2006.06.027; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Toma I, 2008, AM J PHYSIOL-REG I, V294, pR1769, DOI 10.1152/ajpregu.00489.2007; Wei Q, 2006, J BIOL CHEM, V281, P21652, DOI 10.1074/jbc.M602105200; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Yamamoto K, 2000, AM J PHYSIOL-HEART C, V279, pH285, DOI 10.1152/ajpheart.2000.279.1.H285	31	28	31	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20100	20108		10.1074/jbc.M111.220236	http://dx.doi.org/10.1074/jbc.M111.220236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21454579	hybrid, Green Published			2022-12-27	WOS:000291027700086
J	Jaiswal, M; Gremer, L; Dvorsky, R; Haeusler, LC; Cirstea, IC; Uhlenbrock, K; Ahmadian, MR				Jaiswal, Mamta; Gremer, Lothar; Dvorsky, Radovan; Haeusler, Lars Christian; Cirstea, Ion C.; Uhlenbrock, Katharina; Ahmadian, Mohammad Reza			Mechanistic Insights into Specificity, Activity, and Regulatory Elements of the Regulator of G-protein Signaling (RGS)-containing Rho-specific Guanine Nucleotide Exchange Factors (GEFs) p115, PDZ-RhoGEF (PRG), and Leukemia-associated RhoGEF (LARG)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; DBL FAMILY PROTEINS; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; PH DOMAINS; MONITORING INTERACTIONS; EFFICIENT ACTIVATION; FLUORESCENCE METHODS; BINDING PROTEINS; HOMOLOGY DOMAIN	The multimodular guanine nucleotide exchange factors (GEFs) of the Dbl family mostly share a tandem Dbl homology (DH) and pleckstrin homology (PH) domain organization. The function of these and other domains in the DH-mediated regulation of the GDP/GTP exchange reaction of the Rho proteins is the subject of intensive investigations. This comparative study presents detailed kinetic data on specificity, activity, and regulation of the catalytic DH domains of four GEFs, namely p115, p190, PDZ-RhoGEF (PRG), and leukemia-associated RhoGEF (LARG). We demonstrate that (i) these GEFs are specific guanine nucleotide exchange factors for the Rho isoforms (RhoA, RhoB, and RhoC) and inactive toward other members of the Rho family, including Rac1, Cdc42, and TC10. (ii) The DH domain of LARG exhibits the highest catalytic activity reported for a Dbl protein till now with a maximal acceleration of the nucleotide exchange by 10(7)-fold, which is at least as efficient as reported for GEFs specific for Ran or the bacterial toxin SopE. (iii) A novel regulatory region at the N terminus of the DH domain is involved in its association with GDP-bound RhoA monitored by a fluorescently labeled RhoA. (iv) The tandem PH domains of p115 and PRG efficiently contribute to the DH-mediated nucleotide exchange reaction. (v) In contrast to the isolated DH or DH-PH domains, a p115 fragment encompassing both the regulator of G-protein signaling and the DH domains revealed a significantly reduced GEF activity, supporting the proposed models of an intramolecular autoinhibitory mechanism for p115-like RhoGEFs.	[Jaiswal, Mamta; Gremer, Lothar; Dvorsky, Radovan; Cirstea, Ion C.; Ahmadian, Mohammad Reza] Univ Dusseldorf, Fak Med, Inst Biochem & Mol Biol 2, D-40255 Dusseldorf, Germany; [Dvorsky, Radovan; Haeusler, Lars Christian; Uhlenbrock, Katharina] Max Planck Inst Mol Physiol, Abt Strukturelle Biol, D-44227 Dortmund, Germany	Heinrich Heine University Dusseldorf; Max Planck Society	Ahmadian, MR (corresponding author), Univ Dusseldorf, Fak Med, Inst Biochem & Mol Biol 2, Univ Str 1,Gebaude 22-03, D-40255 Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	Cirstea, Ion Cristian/AAQ-7670-2020; Gremer, Lothar/H-9128-2013; jaiswal, mamta/B-8431-2012; Dvorsky, Radovan/ABE-3042-2020; jaiswal, mamta/E-5148-2016	Cirstea, Ion Cristian/0000-0003-3204-1598; Gremer, Lothar/0000-0001-7065-5027; jaiswal, mamta/0000-0002-5862-7506	Deutsche Forschungsgemeinschaft [AH 92/3-1, AH 92/5-1]; E-Rare project NSEuroNet; Forschungskommission der Medizinischen Fakultat der Heinrich-Heine-Universitat Dusseldorf [9772337-09]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); E-Rare project NSEuroNet; Forschungskommission der Medizinischen Fakultat der Heinrich-Heine-Universitat Dusseldorf	This work was supported in part by Deutsche Forschungsgemeinschaft Grants AH 92/3-1 and AH 92/5-1, by the E-Rare project NSEuroNet, and by Forschungskommission der Medizinischen Fakultat der Heinrich-Heine-Universitat Dusseldorf Grant 9772337-09.	Ahmadian Mohammad Reza, 2002, Methods Mol Biol, V189, P45; Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Aittaleb M, 2009, CELL SIGNAL, V21, P1569, DOI 10.1016/j.cellsig.2009.06.003; Alexandrov K, 2001, METHOD ENZYMOL, V329, P14; Baumeister MA, 2006, BIOCHEM J, V400, P563, DOI 10.1042/BJ20061020; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Bellanger JM, 2003, BIOL CELL, V95, P625, DOI 10.1016/j.biolcel.2003.10.002; Booden MA, 2002, MOL CELL BIOL, V22, P4053, DOI 10.1128/MCB.22.12.4053-4061.2002; Chen Z, 2011, PROTEIN SCI, V20, P107, DOI 10.1002/pro.542; Chhatriwala MK, 2007, J MOL BIOL, V368, P1307, DOI 10.1016/j.jmb.2007.02.060; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; Cierpicki T, 2009, PROTEIN SCI, V18, P2067, DOI 10.1002/pro.219; Cool RH, 1999, MOL CELL BIOL, V19, P6297; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gasmi-Seabrook GMC, 2010, J BIOL CHEM, V285, P5137, DOI 10.1074/jbc.M109.064691; Gotthardt K, 2007, BIOL CHEM, V388, P67, DOI 10.1515/BC.2007.008; Haeusler LC, 2006, METHOD ENZYMOL, V406, P1, DOI 10.1016/S0076-6879(06)06001-0; Haeusler LC, 2003, FEBS LETT, V555, P556, DOI 10.1016/S0014-5793(03)01351-6; HART MJ, 1994, J BIOL CHEM, V269, P62; Hart MJ, 1996, J BIOL CHEM, V271, P25452, DOI 10.1074/jbc.271.41.25452; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hemsath L, 2005, METHODS, V37, P173, DOI 10.1016/j.ymeth.2005.05.014; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Itzen A, 2007, J MOL BIOL, V365, P1359, DOI 10.1016/j.jmb.2006.10.096; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Karnoub AE, 2004, BREAST CANCER RES TR, V84, P61, DOI 10.1023/B:BREA.0000018427.84929.5c; Karnoub AE, 2001, NAT STRUCT BIOL, V8, P1037, DOI 10.1038/nsb719; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kraemer A, 2002, J MOL BIOL, V324, P763, DOI 10.1016/S0022-2836(02)01136-1; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Nomanbhoy T, 1999, BIOCHEMISTRY-US, V38, P15878, DOI 10.1021/bi9916832; Oleksy A, 2006, J BIOL CHEM, V281, P32891, DOI 10.1074/jbc.M606220200; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Reid T, 1999, J BIOL CHEM, V274, P33587, DOI 10.1074/jbc.274.47.33587; Reuther GW, 2001, J BIOL CHEM, V276, P27145, DOI 10.1074/jbc.M103565200; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Robbe K, 2003, J BIOL CHEM, V278, P4756, DOI 10.1074/jbc.M210412200; Rossman KL, 2003, J BIOL CHEM, V278, P18393, DOI 10.1074/jbc.M300127200; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rumenapp U, 1999, FEBS LETT, V459, P313, DOI 10.1016/S0014-5793(99)01270-3; Schiller MR, 2006, CELL SIGNAL, V18, P1834, DOI 10.1016/j.cellsig.2006.01.022; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Skowronek KR, 2004, J BIOL CHEM, V279, P37895, DOI 10.1074/jbc.M312677200; Snyder JT, 2001, J BIOL CHEM, V276, P45868, DOI 10.1074/jbc.M106731200; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Stam J C, 1999, Prog Mol Subcell Biol, V22, P51; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Swiercz JM, 2002, N-S ARCH PHARMACOL, V365, pR53; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Vazquez-Prado J, 2004, METHOD ENZYMOL, V390, P259; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; Wells CD, 2002, J BIOL CHEM, V277, P1174, DOI 10.1074/jbc.M105274200; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Whitehead LP, 1999, MOL CELL BIOL, V19, P7759; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Xiang S, 2006, J MOL BIOL, V359, P35, DOI 10.1016/j.jmb.2006.03.019; Yohe ME, 2007, J BIOL CHEM, V282, P13813, DOI 10.1074/jbc.M700185200; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zheng MY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-36; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	86	48	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18202	18212		10.1074/jbc.M111.226431	http://dx.doi.org/10.1074/jbc.M111.226431			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454492	hybrid, Green Published			2022-12-27	WOS:000290585200080
J	Lopez, D; Jimenez, M; Garcia-Calvo, M; Del Val, M				Lopez, Daniel; Jimenez, Mercedes; Garcia-Calvo, Margarita; Del Val, Margarita			Concerted Antigen Processing of a Short Viral Antigen by Human Caspase-5 and-10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-INFECTED CELLS; CD8(+) T-LYMPHOCYTES; TRIPEPTIDYL-PEPTIDASE; ENDOPLASMIC-RETICULUM; APOPTOSIS; RECOGNITION; PROTEASOMES; EPITOPE; ENZYME	The generation of peptides presented by MHC class I molecules requires the proteolytic activity of the proteasome and/or other peptidases. The processing of a short vaccinia virus-encoded antigen can take place by a proteasome-independent pathway involving initiator caspase-5 and -10, which generate antigenic peptides recognized by CD8(+) T lymphocytes. In the present study, comparing single versus double enzyme digestions by mass spectrometry analysis, both qualitative and quantitative differences in the products obtained were identified. These in vitro data suggest that each enzyme can use the degradation products of the other as substrate for new cleavages, indicating concerted endoproteolytic activity of caspase-5 and -10.	[Lopez, Daniel] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Proc Antigen Prote, E-28220 Majadahonda, Madrid, Spain; [Garcia-Calvo, Margarita] Merck Res Labs, Dept Metab Disorders & Diabet, Rahway, NJ 07065 USA; [Del Val, Margarita] Univ Autonoma Madrid, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Merck & Company; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Lopez, D (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Proc Antigen Prote, E-28220 Majadahonda, Madrid, Spain.	dlopez@isciii.es	Del Val, Margarita/E-4769-2010; López, Daniel/I-2632-2014	Del Val, Margarita/0000-0001-6769-4279; López, Daniel/0000-0003-0268-5878	European Union; Ministerio de Ciencia e Innovacion; Comunidad de Madrid; Instituto de Salud Carlos III; Programa Ramon y Cajal; FIPSE Foundation	European Union(European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Programa Ramon y Cajal(Spanish Government); FIPSE Foundation	This work was supported by grants provided by the European Union, Ministerio de Ciencia e Innovacion, Comunidad de Madrid, and Instituto de Salud Carlos III (to M. D. V.) and by Programa Ramon y Cajal and FIPSE Foundation (to D. L.).	Del Val M., 2011, CELL MOL LIFE SCI; Del-Val M, 2002, MOL IMMUNOL, V39, P235, DOI 10.1016/S0161-5890(02)00104-9; DELVAL M, 1988, J VIROL, V62, P3965, DOI 10.1128/JVI.62.11.3965-3972.1988; EGGERS M, 1995, J EXP MED, V182, P1865, DOI 10.1084/jem.182.6.1865; Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497; Gil-Torregrosa BC, 1998, J EXP MED, V188, P1105, DOI 10.1084/jem.188.6.1105; Guil S, 2006, J BIOL CHEM, V281, P39925, DOI 10.1074/jbc.M608522200; Hammer GE, 2007, IMMUNITY, V26, P397, DOI 10.1016/j.immuni.2007.04.003; Kessler JH, 2011, NAT IMMUNOL, V12, P45, DOI 10.1038/ni.1974; Kettle S, 1997, J GEN VIROL, V78, P677, DOI 10.1099/0022-1317-78-3-677; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Knuehl C, 2001, J IMMUNOL, V167, P1515, DOI 10.4049/jimmunol.167.3.1515; Lopez D, 2006, J BIOL CHEM, V281, P30315, DOI 10.1074/jbc.M605973200; Lopez D, 2010, J IMMUNOL, V184, P5193, DOI 10.4049/jimmunol.1000050; Parmentier N, 2010, NAT IMMUNOL, V11, P449, DOI 10.1038/ni.1862; Pogo BGT, 2004, INT REV IMMUNOL, V23, P61, DOI 10.1080/08830180490265547; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Samino Y, 2006, J BIOL CHEM, V281, P6358, DOI 10.1074/jbc.M512263200; Saveanu L, 2005, IMMUNOL REV, V207, P42, DOI 10.1111/j.0105-2896.2005.00313.x; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809	24	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16910	16913		10.1074/jbc.M111.234658	http://dx.doi.org/10.1074/jbc.M111.234658			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454616	Green Published, hybrid			2022-12-27	WOS:000290301900040
J	Livesey, MR; Cooper, MA; Lambert, JJ; Peters, JA				Livesey, Matthew R.; Cooper, Michelle A.; Lambert, Jeremy J.; Peters, John A.			Rings of Charge within the Extracellular Vestibule Influence Ion Permeation of the 5-HT(3)A Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; SINGLE-CHANNEL CONDUCTANCE; 5-HYDROXYTRYPTAMINE TYPE-3; STRUCTURAL DETERMINANTS; CALCIUM PERMEABILITY; 5-HT3 RECEPTORS; AMINO-ACIDS; SELECTIVITY; LOOP; DOMAIN	The determinants of single channel conductance (gamma) and ion selectivity within eukaryotic pentameric ligand-gated ion channels have traditionally been ascribed to amino acid residues within the second transmembrane domain and flanking sequences of their component subunits. However, recent evidence suggests that gamma is additionally controlled by residues within the intracellular and extracellular domains. We examined the influence of two anionic residues (Asp(113) and Asp(127)) within the extracellular vestibule of a high conductance human mutant 5-hydroxytryptamine type-3A (5-HT(3)A) receptor (5-HT(3)A(QDA)) upon gamma, modulation of the latter by extracellular Ca2+, and the permeability of Ca2+ with respect to Cs+ (P-Ca/P-Cs). Mutations neutralizing (Asp -> Asn), or reversing (Asp -> Lys), charge at the 113 locus decreased inward gamma by 46 and 58%, respectively, but outward currents were unaffected. The D127N mutation decreased inward gamma by 82% and also suppressed outward currents, whereas the D127K mutation caused loss of observable single channel currents. The forgoing mutations, except for D127K, which could not be evaluated, ameliorated suppression of inwardly directed single channel currents by extracellular Ca2+. The P-Ca/P-Cs of 3.8 previously reported for the 5-HT(3)A(QDA) construct was reduced to 0.13 and 0.06 by the D127N and D127K mutations, respectively, with lesser, but clearly significant, effects caused by the D113N (1.04) and D113K (0.60) substitutions. Charge selectivity between monovalent cations and anions (P-Na/P-Cl) was unaffected by any of the mutations examined. The data identify two key residues in the extracellular vestibule of the 5-HT(3)A receptor that markedly influence gamma, P-Ca/P-Cs, and additionally the suppression of gamma by Ca2+.	[Livesey, Matthew R.; Cooper, Michelle A.; Lambert, Jeremy J.; Peters, John A.] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Neurosci, Div Med Sci, Dundee DD1 9SY, Scotland	University of Dundee	Peters, JA (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Ctr Neurosci, Div Med Sci, Mail Box 6, Dundee DD1 9SY, Scotland.	j.a.peters@dundee.ac.uk		Livesey, Matthew/0000-0002-3441-7977	Wellcome Trust; Tenovus Scotland; Anonymous Trust	Wellcome Trust(Wellcome TrustEuropean Commission); Tenovus Scotland; Anonymous Trust	This work was supported in part by grants from the Wellcome Trust (to J. J. L. and J. A. P.) and Tenovus Scotland and the Anonymous Trust (to J. A. P.).	Absalom NL, 2009, NEUROCHEM RES, V34, P1805, DOI 10.1007/s11064-009-9971-2; Bernal JA, 2009, BBA-BIOMEMBRANES, V1788, P410, DOI 10.1016/j.bbamem.2008.11.004; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; Brams M, 2011, J BIOL CHEM, V286, P4420, DOI 10.1074/jbc.M110.188730; Brown AM, 1998, J PHYSIOL-LONDON, V507, P653, DOI 10.1111/j.1469-7793.1998.653bs.x; Carland JE, 2009, J BIOL CHEM, V284, P2023, DOI 10.1074/jbc.M806618200; DANI JA, 1986, BIOPHYS J, V49, P607, DOI 10.1016/S0006-3495(86)83688-8; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Deeb TZ, 2007, J BIOL CHEM, V282, P6172, DOI 10.1074/jbc.M607698200; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Haghighi AP, 2000, J NEUROSCI, V20, P529, DOI 10.1523/JNEUROSCI.20-02-00529.2000; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jensen ML, 2005, J NEUROCHEM, V92, P217, DOI 10.1111/j.1471-4159.2004.02883.x; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Keramidas A, 2002, J GEN PHYSIOL, V119, P393, DOI 10.1085/jgp.20028552; KIENKER P, 1994, BIOPHYS J, V66, P325, DOI 10.1016/S0006-3495(94)80781-7; Kukhtina V, 2006, J NEUROCHEM, V97, P63, DOI 10.1111/j.1471-4159.2005.03468.x; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Livesey M., 2009, P BRIT PHARM SOC; Livesey MR, 2008, J BIOL CHEM, V283, P19301, DOI 10.1074/jbc.M802406200; Meltzer RH, 2006, BIOPHYS J, V91, P1325, DOI 10.1529/biophysj.106.081455; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; O'Mara M, 2005, BIOPHYS J, V88, P3286, DOI 10.1529/biophysj.104.051664; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Peters JA, 2010, J PHYSIOL-LONDON, V588, P587, DOI 10.1113/jphysiol.2009.183137; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Sine SM, 2010, J MOL NEUROSCI, V40, P70, DOI 10.1007/s12031-009-9260-1; Song C, 2009, BBA-BIOMEMBRANES, V1788, P1466, DOI 10.1016/j.bbamem.2009.04.015; Thompson AJ, 2003, BRIT J PHARMACOL, V140, P359, DOI 10.1038/sj.bjp.0705424; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Tsetlin V, 2009, CURR OPIN PHARMACOL, V9, P306, DOI 10.1016/j.coph.2009.03.005; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041	40	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.219618	http://dx.doi.org/10.1074/jbc.M111.219618			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454663	Green Published, hybrid			2022-12-27	WOS:000290022800041
J	Streit, AK; Netter, MF; Kempf, F; Walecki, M; Rinne, S; Bollepalli, MK; Preisig-Muller, R; Renigunta, V; Daut, J; Baukrowitz, T; Sansom, MSP; Stansfeld, PJ; Decher, N				Streit, Anne K.; Netter, Michael F.; Kempf, Franca; Walecki, Magdalena; Rinne, Susanne; Bollepalli, Murali K.; Preisig-Mueller, Regina; Renigunta, Vijay; Daut, Juergen; Baukrowitz, Thomas; Sansom, Mark S. P.; Stansfeld, Phillip J.; Decher, Niels			A Specific Two-pore Domain Potassium Channel Blocker Defines the Structure of the TASK-1 Open Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACKGROUND K+ CHANNEL; MOLECULAR-BASIS; PH; BINDING; ION; INACTIVATION; SELECTIVITY; CISAPRIDE; MEMBER; HERG	Two-pore domain potassium (K-2P) channels play a key role in setting the membrane potential of excitable cells. Despite their role as putative targets for drugs and general anesthetics, little is known about the structure and the drug binding site of K-2P channels. We describe A1899 as a potent and highly selective blocker of the K-2P channel TASK-1. As A1899 acts as an open-channel blocker and binds to residues forming the wall of the central cavity, the drug was used to further our understanding of the channel pore. Using alanine mutagenesis screens, we have identified residues in both pore loops, the M2 and M4 segments, and the halothane response element to form the drug binding site of TASK-1. Our experimental data were used to validate a K-2P open-pore homology model of TASK-1, providing structural insights for future rational design of drugs targeting K-2P channels.	[Streit, Anne K.; Netter, Michael F.; Kempf, Franca; Walecki, Magdalena; Rinne, Susanne; Decher, Niels] Univ Marburg, Inst Physiol & Pathophysiol, Vegetat Physiol Grp, D-35037 Marburg, Germany; [Bollepalli, Murali K.] Univ Jena, Inst Physiol 2, D-07743 Jena, Germany; [Preisig-Mueller, Regina; Renigunta, Vijay; Daut, Juergen] Univ Marburg, Inst Physiol & Pathophysiol, Cardiovasc Cell Physiol Grp, D-35037 Marburg, Germany; [Baukrowitz, Thomas] Univ Kiel, Inst Physiol, D-24118 Kiel, Germany; [Sansom, Mark S. P.; Stansfeld, Phillip J.] Univ Oxford, Struct Bioinformat & Computat Biochem Unit, Dept Biochem, Oxford OX1 3QU, England	Philipps University Marburg; Friedrich Schiller University of Jena; Philipps University Marburg; University of Kiel; University of Oxford	Decher, N (corresponding author), Deutschhausstr 1-2, D-35037 Marburg, Germany.	decher@staff.uni-marburg.de	Decher, Niels/AAF-5002-2020; Stansfeld, Phill/C-6213-2011; Sansom, Mark S.P./C-5157-2009; Stansfeld, Phillip James/AAA-9228-2020	Stansfeld, Phill/0000-0001-8800-7669; Sansom, Mark S.P./0000-0001-6360-7959; Stansfeld, Phillip James/0000-0001-8800-7669; Baukrowitz, Thomas/0000-0003-4562-0505	Kempkes Stiftung [12/08]; Deutsche Forschungsgemeinschaft [BA-1793/5-1, DE-1482/3-1, DE-1482/2-1]; Wellcome Trust	Kempkes Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Kempkes Stiftung Grant 12/08 (to N.D.) and by Deutsche Forschungsgemeinschaft Grants BA-1793/5-1 (to T.B.), DE-1482/3-1 (to N.D. and J.D.), and DE-1482/2-1 (to N.D.).; Supported by the Wellcome Trust.	ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Ashmole I, 2001, PFLUG ARCH EUR J PHY, V442, P828, DOI 10.1007/s004240100620; Barrows B, 2009, CHANNELS, V3, P239; Bruhova I, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-5; Budde T, 2008, PFLUG ARCH EUR J PHY, V456, P1061, DOI 10.1007/s00424-008-0482-9; Chatelain FC, 2005, NEURON, V47, P833, DOI 10.1016/j.neuron.2005.08.022; Chen J, 2002, P NATL ACAD SCI USA, V99, P12461, DOI 10.1073/pnas.192367299; Czirjak G, 2000, MOL ENDOCRINOL, V14, P863, DOI 10.1210/me.14.6.863; Decher N, 2001, FEBS LETT, V492, P84, DOI 10.1016/S0014-5793(01)02222-0; Decher N, 2006, MOL PHARMACOL, V70, P1204, DOI 10.1124/mol.106.026203; Dilmac N, 2004, MOL PHARMACOL, V66, P1236, DOI 10.1124/mol.104.000893; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Faraldo-Gomez JD, 2007, J MOL BIOL, V365, P649, DOI 10.1016/j.jmb.2006.09.069; Kollewe A, 2009, J GEN PHYSIOL, V134, P53, DOI 10.1085/jgp.200910235; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lerche C, 2007, MOL PHARMACOL, V71, P1503, DOI 10.1124/mol.106.031682; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Maingret F, 2001, EMBO J, V20, P47, DOI 10.1093/emboj/20.1.47; Meadows HJ, 2001, NEUROPHARMACOLOGY, V40, P551, DOI 10.1016/S0028-3908(00)00189-1; Meuth SG, 2008, J BIOL CHEM, V283, P14559, DOI 10.1074/jbc.M800637200; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Putzke C, 2007, CARDIOVASC RES, V75, P59, DOI 10.1016/j.cardiores.2007.02.025; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Strutz-Seebohm N, 2007, CELL PHYSIOL BIOCHEM, V20, P791, DOI 10.1159/000110439; Trapp S, 2008, J NEUROSCI, V28, P8844, DOI 10.1523/JNEUROSCI.1810-08.2008; Treptow W, 2010, J AM CHEM SOC, V132, P8145, DOI 10.1021/ja102191s	29	66	72	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13977	13984		10.1074/jbc.M111.227884	http://dx.doi.org/10.1074/jbc.M111.227884			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21362619	Green Published, hybrid			2022-12-27	WOS:000289556200020
J	Toubiana, J; Rossi, AL; Grimaldi, D; Belaidouni, N; Chafey, P; Clary, G; Courtine, E; Pene, F; Mira, JP; Claessens, YE; Chiche, JD				Toubiana, Julie; Rossi, Anne-Lise; Grimaldi, David; Belaidouni, Nadia; Chafey, Philippe; Clary, Guilhem; Courtine, Emilie; Pene, Frederic; Mira, Jean-Paul; Claessens, Yann-Erick; Chiche, Jean-Daniel			IMPDHII Protein Inhibits Toll-like Receptor 2-mediated Activation of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE 5'-MONOPHOSPHATE DEHYDROGENASE; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION; NEGATIVE REGULATOR; MONOPHOSPHATE DEHYDROGENASE; INFLAMMATORY RESPONSES; PATTERN-RECOGNITION; HUMAN NEUTROPHILS; EPITHELIAL-CELLS; LIPID RAFTS	Toll-like receptor 2 (TLR2) plays an essential role in innate immunity by the recognition of a large variety of pathogen-associated molecular patterns. It induces its recruitment to lipid rafts induces the formation of a membranous activation cluster necessary to enhance, amplify, and control downstream signaling. However, the exact composition of the TLR2-mediated molecular complex is unknown. We performed a proteomic analysis in lipopeptide-stimulated THP1 and found IMPDHII protein rapidly recruited to lipid raft. Whereas IMPDHII is essential for lymphocyte proliferation, its biologic function within innate immune signal pathways has not been established yet. We report here that IMPDHII plays an important role in the negative regulation of TLR2 signaling by modulating PI3K activity. Indeed, IMPDHII increases the phosphatase activity of SHP1, which participates to the inactivation of PI3K.	[Grimaldi, David; Pene, Frederic; Mira, Jean-Paul; Claessens, Yann-Erick; Chiche, Jean-Daniel] Cochin Univ Hosp, Med Intens Care Unit, F-75014 Paris, France; [Toubiana, Julie; Rossi, Anne-Lise; Grimaldi, David; Belaidouni, Nadia; Chafey, Philippe; Clary, Guilhem; Courtine, Emilie; Pene, Frederic; Mira, Jean-Paul; Claessens, Yann-Erick; Chiche, Jean-Daniel] Paris Descartes Univ, F-75006 Paris, France; [Toubiana, Julie; Rossi, Anne-Lise; Grimaldi, David; Belaidouni, Nadia; Chafey, Philippe; Clary, Guilhem; Courtine, Emilie; Pene, Frederic; Mira, Jean-Paul; Claessens, Yann-Erick; Chiche, Jean-Daniel] CNRS, INSERM, U1016, UMR 8104, F-75014 Paris, France; [Chafey, Philippe; Clary, Guilhem] Cochin Inst, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Chiche, JD (corresponding author), Cochin Univ Hosp, Med Intens Care Unit, 27 Rue Faubourg, F-75014 Paris, France.	jean-daniel.chiche@cch.aphp.fr	Chiche, Jean-Daniel/P-5220-2017; Toubiana, Julie/AAZ-8996-2020	Chiche, Jean-Daniel/0000-0002-6433-6254; Toubiana, Julie/0000-0001-9561-669X; Pene, Frederic/0000-0003-3639-3849; Rossi, Anne-Lise/0000-0001-9991-2445	INSERM; Cochin Association for Research on Inflammation, Sepsis, and Molecular Advances (CARISMA); Assistance Publique-Hopitaux de Paris (AP-HP)-CNRS; Fondation pour la Recherche Medicale; European Society of Intensive Care Medicine (ESICM)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Cochin Association for Research on Inflammation, Sepsis, and Molecular Advances (CARISMA); Assistance Publique-Hopitaux de Paris (AP-HP)-CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Society of Intensive Care Medicine (ESICM)	This work was supported by grants from INSERM and the Cochin Association for Research on Inflammation, Sepsis, and Molecular Advances (CARISMA).; Supported by grants from Assistance Publique-Hopitaux de Paris (AP-HP)-CNRS and Fondation pour la Recherche Medicale and by the Levi Montalcini Biomedical Sciences Award from the European Society of Intensive Care Medicine (ESICM).	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Abu-Dayyeh I, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000305; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P85, DOI 10.1016/S0162-3109(00)00188-0; AlShami A, 1997, BLOOD, V89, P1035, DOI 10.1182/blood.V89.3.1035; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Brumell JH, 1997, J BIOL CHEM, V272, P875, DOI 10.1074/jbc.272.2.875; CARR SF, 1993, J BIOL CHEM, V268, P27286; Chacko GW, 1996, J IMMUNOL, V157, P2234; Colby TD, 1999, P NATL ACAD SCI USA, V96, P3531, DOI 10.1073/pnas.96.7.3531; COLLART FR, 1988, J BIOL CHEM, V263, P15769; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Franklin TJ, 1999, BIOCHEM PHARMACOL, V58, P867, DOI 10.1016/S0006-2952(99)00170-7; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Hamerman JA, 2009, IMMUNOL REV, V232, P42, DOI 10.1111/j.1600-065X.2009.00841.x; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; JACKSON RC, 1975, NATURE, V256, P331, DOI 10.1038/256331a0; Jain J, 2004, BIOCHEM PHARMACOL, V67, P767, DOI 10.1016/j.bcp.2003.09.043; Jones ML, 2004, J BIOL CHEM, V279, P40475, DOI 10.1074/jbc.M402970200; Jonsson CA, 2002, CELL IMMUNOL, V216, P93, DOI 10.1016/S0008-8749(02)00502-6; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lee J, 2006, P NATL ACAD SCI USA, V103, P1828, DOI 10.1073/pnas.0510801103; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lijeroos M, 2007, CELL SIGNAL, V19, P625, DOI 10.1016/j.cellsig.2006.08.013; Mazerolles F, 1997, EUR J IMMUNOL, V27, P2457, DOI 10.1002/eji.1830270946; Mondin M, 2007, BIOCHEM PHARMACOL, V73, P1491, DOI 10.1016/j.bcp.2006.12.025; Olsson S, 2006, MOL IMMUNOL, V43, P607, DOI 10.1016/j.molimm.2005.04.011; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poole AW, 2005, CELL SIGNAL, V17, P1323, DOI 10.1016/j.cellsig.2005.05.016; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Sattler M, 2001, J BIOL CHEM, V276, P2451, DOI 10.1074/jbc.M006250200; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Sierra SS, 2009, EMBO J, V28, P2018, DOI 10.1038/emboj.2009.158; Sintchak MD, 2000, IMMUNOPHARMACOLOGY, V47, P163, DOI 10.1016/S0162-3109(00)00193-4; Slevogt H, 2008, NAT IMMUNOL, V9, P1270, DOI 10.1038/ni.1661; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Strassheim D, 2005, J IMMUNOL, V174, P8064, DOI 10.4049/jimmunol.174.12.8064; Strassheim D, 2004, J IMMUNOL, V172, P5727, DOI 10.4049/jimmunol.172.9.5727; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Triantafilou M, 2002, J CELL SCI, V115, P2603; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Weigel G, 2002, MOL PHARMACOL, V62, P453, DOI 10.1124/mol.62.3.453; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200; Zhou DL, 2010, J LEUKOCYTE BIOL, V87, P845, DOI 10.1189/jlb.0409289	48	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23319	23333		10.1074/jbc.M110.201210	http://dx.doi.org/10.1074/jbc.M110.201210			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21460227	Green Published, hybrid			2022-12-27	WOS:000292025000064
J	Sit, RK; Radic, Z; Gerardi, V; Zhang, LM; Garcia, E; Katalinic, M; Amitai, G; Kovarik, Z; Fokin, VV; Sharpless, KB; Taylor, P				Sit, Rakesh K.; Radic, Zoran; Gerardi, Valeria; Zhang, Limin; Garcia, Edzna; Katalinic, Maja; Amitai, Gabriel; Kovarik, Zrinka; Fokin, Valery V.; Sharpless, K. Barry; Taylor, Palmer			New Structural Scaffolds for Centrally Acting Oxime Reactivators of Phosphylated Cholinesterases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; ACETYLCHOLINESTERASE; NANOPARTICLES; AGENTS	We describe here the synthesis and activity of a new series of oxime reactivators of cholinesterases (ChEs) that contain tertiary amine or imidazole protonatable functional groups. Equilibration between the neutral and protonated species at physiological pH enables the reactivators to cross the blood-brain barrier and distribute in the CNS aqueous space as dictated by interstitial and cellular pH values. Our structure-activity analysis of 134 novel compounds considers primarily imidazole aldoximes and N-substituted 2-hydroxyiminoacetamides. Reactivation capacities of novel oximes are rank ordered by their relative reactivation rate constants at 0.67 mM compared with 2-pyridinealdoxime methiodide for reactivation of four organophosphate (sarin, cyclosarin, VX, and paraoxon) conjugates of human acetylcholinesterase (hAChE). Rank order of the rates differs for reactivation of human butyrylcholinesterase (hBChE) conjugates. The 10 best reactivating oximes, predominantly hydroxyimino acetamide derivatives (for hAChE) and imidazole-containing aldoximes (for hBChE) also exhibited reasonable activity in the reactivation of tabun conjugates. Reactivation kinetics of the lead hydroxyimino acetamide reactivator of hAChE, when analyzed in terms of apparent affinity (1/K-ox) and maximum reactivation rate (k(2)), is superior to the reference uncharged reactivators monoisonitrosoacetone and 2,3-butanedione monoxime and shows potential for further refinement. The disparate pH dependences for reactivation of ChE and the general base-catalyzed oximolysis of acetylthiocholine reveal that distinct reactivator ionization states are involved in the reactivation of ChE conjugates and in conferring nucleophilic reactivity of the oxime group.	[Radic, Zoran; Gerardi, Valeria; Zhang, Limin; Garcia, Edzna; Taylor, Palmer] Univ Calif San Diego, SSPPS, La Jolla, CA 92093 USA; [Sit, Rakesh K.; Fokin, Valery V.; Sharpless, K. Barry] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Sit, Rakesh K.; Fokin, Valery V.; Sharpless, K. Barry] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Katalinic, Maja; Kovarik, Zrinka] Inst Med Res & Occupat Hlth, HR-10001 Zagreb, Croatia; [Amitai, Gabriel] Israel Inst Biol Res, Dept Pharmacol, IL-74100 Ness Ziona, Israel	University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute; Institute for Medical Research & Occupational Health (IMROH)	Taylor, P (corresponding author), Univ Calif San Diego, SSPPS, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pwtaylor@ucsd.edu		Katalinic, Maja/0000-0001-7043-4291	National Institutes of Health United States Public Health Service through the NINDS [U01 NS 058046]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058046] Funding Source: NIH RePORTER	National Institutes of Health United States Public Health Service through the NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Counter Act Program United States Public Health Service Grant U01 NS 058046 through the NINDS.	Amitai G, 2007, TOXICOLOGY, V233, P187, DOI 10.1016/j.tox.2006.09.020; Asati A, 2009, ANGEW CHEM INT EDIT, V48, P2308, DOI 10.1002/anie.200805279; Beccalli EM, 2008, J ORG CHEM, V73, P4746, DOI 10.1021/jo800621n; BODOR N, 1975, SCIENCE, V190, P155, DOI 10.1126/science.1166305; Cossrow J., 2008, U. S. Patent, Patent No. [20,090,005,359:01, 2009000535901]; Demar JC, 2010, CHEM-BIOL INTERACT, V187, P191, DOI 10.1016/j.cbi.2010.02.015; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Garcia GE, 2010, CHEM-BIOL INTERACT, V187, P199, DOI 10.1016/j.cbi.2010.02.033; HELDMAN E, 1986, CARBOHYD RES, V151, P337, DOI 10.1016/S0008-6215(00)90353-7; Kalisiak J, 2008, ORG LETT, V10, P3171, DOI 10.1021/ol8006748; Kovarik Z, 2004, BIOCHEMISTRY-US, V43, P3222, DOI 10.1021/bi036191a; Kufleitner J, 2010, J MICROENCAPSUL, V27, P594, DOI 10.3109/02652048.2010.501395; Manetsch R, 2004, J AM CHEM SOC, V126, P12809, DOI 10.1021/ja046382g; Nicolaides DN, 2005, SYNTHESIS-STUTTGART, P407, DOI 10.1055/s-20040-837285; Nozaki H, 1995, INTENS CARE MED, V21, P1032, DOI 10.1007/BF01700667; Okumura T, 1996, ANN EMERG MED, V28, P129, DOI 10.1016/S0196-0644(96)70052-5; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Sekijima Y, 1995, Rinsho Shinkeigaku, V35, P1241; Shih TM, 2003, TOXICOL APPL PHARM, V188, P69, DOI 10.1016/S0041-008X(03)00019-X; Shih TM, 2010, J MOL NEUROSCI, V40, P63, DOI 10.1007/s12031-009-9259-7; Skovira JW, 2010, CHEM-BIOL INTERACT, V187, P318, DOI 10.1016/j.cbi.2010.03.010; Stefely JA, 2010, J MED CHEM, V53, P3389, DOI 10.1021/jm1000979; Taylor P., 2011, GOODMAN GILMANS PHAR, V12th ed, P239; Wagner S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014213; Yanagisawa N, 2006, J NEUROL SCI, V249, P76, DOI 10.1016/j.jns.2006.06.007	25	109	115	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19422	19430		10.1074/jbc.M111.230656	http://dx.doi.org/10.1074/jbc.M111.230656			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21464125	Green Published, hybrid			2022-12-27	WOS:000291027700025
J	Jastrzebska, B; Palczewski, K; Golczak, M				Jastrzebska, Beata; Palczewski, Krzysztof; Golczak, Marcin			Role of Bulk Water in Hydrolysis of the Rhodopsin Chromophore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; HYDROGEN-DEUTERIUM EXCHANGE; RETINAL SCHIFF-BASE; CRYSTAL-STRUCTURE; BOVINE RHODOPSIN; ACTIVATION; RESONANCE; OPSIN; PHOTOACTIVATION; INTERMEDIATE	Rhodopsin (Rho) is a prototypical G protein-coupled receptor that changes from an inactive conformational state to a G protein-activating state as a consequence of its retinal chromophore isomerization, 11-cis-retinal -> all-trans-retinal. The photoisomerized chromophore covalently linked to Lys(296) by a Schiff base is subsequently hydrolyzed, but little is known about this reaction. Recent research indicates a significant role for tightly bound transmembrane water molecules in the Rho activation process. Atomic structures of Rho and hydroxyl radical footprinting reveal ordered waters within Rho transmembrane helices that are located close to highly conserved and functionally important receptor residues, forming a hydrogen bond network. Using O-18-labeled H2O, we now report that water from bulk solvent, but not tightly bound water, is involved in the hydrolytic release of chromophore upon Rho activation by light. Moreover, small molecules (and presumably, water) enter the Rho structure from the cytoplasmic side of the membrane. Thus, this work indicates two distinct origins of water vital for Rho function.	[Jastrzebska, Beata; Palczewski, Krzysztof; Golczak, Marcin] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu; mxg149@case.edu			National Institutes of Health [EY008061, GM079191]; NATIONAL EYE INSTITUTE [R29EY008061, R01EY008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY008061 and GM079191.	AKHTAR M, 1968, BIOCHEM J, V110, P693, DOI 10.1042/bj1100693; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BOWNDS D, 1965, NATURE, V205, P254, DOI 10.1038/205254a0; BYRN M, 1966, J AM CHEM SOC, V88, P1916, DOI 10.1021/ja00961a013; COOPER A, 1987, J AM CHEM SOC, V109, P7254, DOI 10.1021/ja00258a002; DENG H, 1994, BIOPHYS J, V66, P1129, DOI 10.1016/S0006-3495(94)80893-8; FAGER RS, 1978, VISION RES, V18, P483, DOI 10.1016/0042-6989(78)90060-3; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; GREENZAID P, 1967, J AM CHEM SOC, V89, P756, DOI 10.1021/ja00980a005; Grossfield A, 2008, J MOL BIOL, V381, P478, DOI 10.1016/j.jmb.2008.05.036; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Holger S, 2006, J BIOL CHEM, V281, P9845, DOI 10.1074/jbc.M511668200; Janz JM, 2004, J BIOL CHEM, V279, P55886, DOI 10.1074/jbc.M408766200; Jastrzebska B, 2004, J BIOL CHEM, V279, P54663, DOI 10.1074/jbc.M408691200; Lodowski DT, 2010, BIOCHEMISTRY-US, V49, P9425, DOI 10.1021/bi101502v; Ludeke S, 2005, J MOL BIOL, V353, P345, DOI 10.1016/j.jmb.2005.08.039; McBee JK, 2000, BIOCHEMISTRY-US, V39, P11370, DOI 10.1021/bi001061c; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Niu L, 2002, P NATL ACAD SCI USA, V99, P13409, DOI 10.1073/pnas.212518899; Okada T, 2000, J STRUCT BIOL, V130, P73, DOI 10.1006/jsbi.1999.4209; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P15334; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; RAFERTY CN, 1981, PHOTOCHEM PHOTOBIOL, V33, P229, DOI 10.1111/j.1751-1097.1981.tb05329.x; Rath P, 1998, BIOPHYS J, V74, P192, DOI 10.1016/S0006-3495(98)77779-3; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Sandberg MN, 2011, J AM CHEM SOC, V133, P2808, DOI 10.1021/ja1094183; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; Szundi I, 2006, BIOCHEMISTRY-US, V45, P4974, DOI 10.1021/bi0524619; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; Wang T, 2007, J AM CHEM SOC, V129, P6970, DOI 10.1021/ja0691977; YOSHIZAWA T, 1963, NATURE, V197, P1279, DOI 10.1038/1971279a0	37	42	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18930	18937		10.1074/jbc.M111.234583	http://dx.doi.org/10.1074/jbc.M111.234583			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21460218	Green Published, hybrid			2022-12-27	WOS:000290785700064
J	Boesler, C; Kruse, J; Soderbom, F; Hammann, C				Boesler, Carsten; Kruse, Janis; Soderbom, Fredrik; Hammann, Christian			Sequence and Generation of Mature Ribosomal RNA Transcripts in Dictyostelium discoideum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR SLIME-MOLD; SMALL NUCLEOLAR RNA; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE-SEQUENCE; DNA; SUBUNIT; REGIONS; GENES; 5S; POLYADENYLATION	The amoeba Dictyostelium discoideum is a well established model organism for studying numerous aspects of cellular and developmental functions. Its ribosomal RNA (rRNA) is encoded in an extrachromosomal palindrome that exists in similar to 100 copies in the cell. In this study, we have set out to investigate the sequence of the expressed rRNA. For this, we have ligated the rRNA ends and performed RT-PCR on these circular RNAs. Sequencing revealed that the mature 26 S, 17 S, 5.8 S, and 5 S rRNAs have sizes of 3741, 1871, 162, and 112 nucleotides, respectively. Unlike the published data, all mature rRNAs of the same type uniformly display the same start and end nucleotides in the analyzed AX2 strain. We show the existence of a short lived primary transcript covering the rRNA transcription unit of 17 S, 5.8 S, and 26 S rRNA. Northern blots and RT-PCR reveal that from this primary transcript two precursor molecules of the 17 S and two precursors of the 26 S rRNA are generated. We have also determined the sequences of these precursor molecules, and based on these data, we propose a model for the maturation of the rRNAs in Dictyostelium discoideum that we compare with the processing of the rRNA transcription unit of Saccharomyces cerevisiae.	[Boesler, Carsten; Kruse, Janis; Hammann, Christian] Tech Univ Darmstadt, Heisenberg Res Grp Ribogenet, D-64287 Darmstadt, Germany; [Soderbom, Fredrik] Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Mol Biol, S-75124 Uppsala, Sweden	Technical University of Darmstadt; Swedish University of Agricultural Sciences	Hammann, C (corresponding author), Schnittspahnstr 10, D-64287 Darmstadt, Germany.	hammann@bio.tu-darmstadt.de	Hammann, Christian/A-3530-2012; Hammann, Christian/AAE-7325-2020		Deutsche Forschungsgemeinschaft [HA 3459/5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Recipient of Fellowship HA 3459/5 from the Heisenberg Program of the Deutsche Forschungsgemeinschaft.	Ansel KM, 2008, NAT STRUCT MOL BIOL, V15, P523, DOI 10.1038/nsmb.1417; Aspegren A, 2004, NUCLEIC ACIDS RES, V32, P4646, DOI 10.1093/nar/gkh804; BATTSYOUNG B, 1978, P NATL ACAD SCI USA, V75, P740, DOI 10.1073/pnas.75.2.740; BATTSYOUNG B, 1977, J BIOL CHEM, V252, P3952; Bhattacharya S, 1998, PARASITOL TODAY, V14, P181, DOI 10.1016/S0169-4758(98)01222-8; Carneiro T, 2007, MOL CELL BIOL, V27, P4157, DOI 10.1128/MCB.00120-07; Chamberlain JR, 1996, NUCLEIC ACIDS RES, V24, P3158, DOI 10.1093/nar/24.16.3158; Champoux JJ, 2009, FEBS J, V276, P1506, DOI 10.1111/j.1742-4658.2009.06909.x; COCKBURN AF, 1976, CELL, V9, P605, DOI 10.1016/0092-8674(76)90043-X; COCKBURN AF, 1978, CHROMOSOMA, V70, P19, DOI 10.1007/BF00292212; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; ENGBERG J, 1976, J MOL BIOL, V104, P455, DOI 10.1016/0022-2836(76)90281-3; Faber AW, 2002, RNA, V8, P1095, DOI 10.1017/S1355838202021027; FRANKEL G, 1977, J MOL BIOL, V109, P539, DOI 10.1016/S0022-2836(77)80090-9; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gabel HW, 2008, NAT STRUCT MOL BIOL, V15, P531, DOI 10.1038/nsmb.1411; GRAINGER RM, 1980, CELL, V20, P619, DOI 10.1016/0092-8674(80)90308-6; Granneman S, 2004, MOL CELL BIOL, V24, P8600, DOI 10.1128/MCB.24.19.8600-8610.2004; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hinas A, 2006, EUKARYOT CELL, V5, P924, DOI 10.1128/EC.00065-06; HORI H, 1980, NUCLEIC ACIDS RES, V8, P5535, DOI 10.1093/nar/8.23.5535; HOSHIKAWA Y, 1983, NUCLEIC ACIDS RES, V11, P1725, DOI 10.1093/nar/11.6.1725; HUGHES JE, 1988, NUCLEIC ACIDS RES, V16, P2338, DOI 10.1093/nar/16.5.2338; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; Kuhlmann M, 2005, NUCLEIC ACIDS RES, V33, P6405, DOI 10.1093/nar/gki952; MAIZELS N, 1976, CELL, V9, P431, DOI 10.1016/0092-8674(76)90088-X; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; OZAKI T, 1984, NUCLEIC ACIDS RES, V12, P4171, DOI 10.1093/nar/12.10.4171; RUBIN GM, 1973, J MOL BIOL, V79, P521, DOI 10.1016/0022-2836(73)90403-8; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Sharma K, 1999, MOL CELL BIOL, V19, P6012; Slomovic S, 2006, NUCLEIC ACIDS RES, V34, P2966, DOI 10.1093/nar/gkl357; Sucgang R, 2003, NUCLEIC ACIDS RES, V31, P2361, DOI 10.1093/nar/gkg348; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; VOGT VM, 1976, J MOL BIOL, V106, P567, DOI 10.1016/0022-2836(76)90252-7; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Win TZ, 2006, MOL CELL BIOL, V26, P1710, DOI 10.1128/MCB.26.5.1710-1721.2006; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	42	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17693	17703		10.1074/jbc.M110.208306	http://dx.doi.org/10.1074/jbc.M110.208306			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454536	Green Published, hybrid			2022-12-27	WOS:000290585200033
J	Li, QA; Mavrodi, DV; Thomashow, LS; Roessle, M; Blankenfeldt, W				Li, Qi-Ang; Mavrodi, Dmitri V.; Thomashow, Linda S.; Roessle, Manfred; Blankenfeldt, Wulf			Ligand Binding Induces an Ammonia Channel in 2-Amino-2-desoxyisochorismate (ADIC) Synthase PhzE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHORISMATE-UTILIZING ENZYMES; ISOCHORISMATE SYNTHASE; PHENAZINE BIOSYNTHESIS; ANTHRANILATE SYNTHASE; SALICYLATE SYNTHASE; MECHANISM; PSEUDOMONAS; REFINEMENT; PROTEINS; PYRUVATE	PhzE utilizes chorismate and glutamine to synthesize 2-amino-2-desoxyisochorismate (ADIC) in the first step of phenazine biosynthesis. The PhzE monomer contains both a chorismate-converting menaquinone, siderophore, tryptophan biosynthesis (MST) and a type 1 glutamine amidotransferase (GATase1) domain connected by a 45-residue linker. We present here the crystal structure of PhzE from Burkholderia lata 383 in a ligand-free open and ligand-bound closed conformation at 2.9 and 2.1 angstrom resolution, respectively. PhzE arranges in an intertwined dimer such that the GATase1 domain of one chain provides NH3 to the MST domain of the other. This quaternary structure was confirmed by small angle x-ray scattering. Binding of chorismic acid, which was found converted to benzoate and pyruvate in the MST active centers of the closed form, leads to structural rear-rangements that establish an ammonia transport channel approximately 25 angstrom in length within each of the two MST/GATase1 functional units of the dimer. The assignment of PhzE as an ADIC synthase was confirmed by mass spectrometric analysis of the product, which was also visualized at 1.9 angstrom resolution by trapping in crystals of an inactive mutant of PhzD, an isochorismatase that catalyzes the subsequent step in phenazine biosynthesis. Unlike in some of the related anthranilate synthases, no allosteric inhibition was observed in PhzE. This can be attributed to a tryptophan residue of the protein blocking the potential regulatory site. Additional electron density in the GATase1 active center was identified as zinc, and it was demonstrated that Zn2+, Mn2+, and Ni2+ reduce the activity of PhzE.	[Li, Qi-Ang; Blankenfeldt, Wulf] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; [Mavrodi, Dmitri V.; Thomashow, Linda S.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Thomashow, Linda S.] ARS, Root Dis & Biol Control Unit, USDA, Pullman, WA 99164 USA; [Roessle, Manfred] DESY, European Mol Biol Lab Hamburg Outstn, D-22603 Hamburg, Germany	Max Planck Society; Washington State University; United States Department of Agriculture (USDA); European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Blankenfeldt, W (corresponding author), Univ Bayreuth, Lehrstuhl Biochem, Univ Str 30, D-95447 Bayreuth, Germany.	wulf.blankenfeldt@uni-bayreuth.de	Mavrodi, Dmitri/AAH-7712-2020; Mavrodi, Dmitri V./S-7894-2019; Blankenfeldt, Wulf/F-8877-2010; Mavrodi, Dmitri/J-2745-2013	Mavrodi, Dmitri V./0000-0002-9644-2094; Blankenfeldt, Wulf/0000-0001-9886-9668; Rossle, Manfred/0000-0003-4196-0430	Deutsche Forschungsgemeinschaft [BL587/1-1/2]; International Max Planck Research School in Chemical Biology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Max Planck Research School in Chemical Biology	This work was supported by Deutsche Forschungsgemeinschaft Grant BL587/1-1/2 (to W. B.).; Supported by the International Max Planck Research School in Chemical Biology.	Ashenafi M, 2008, ETHNIC DIS, V18; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; DeClue MS, 2005, J AM CHEM SOC, V127, P15002, DOI 10.1021/ja055871t; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dosselaere F, 2001, CRIT REV MICROBIOL, V27, P75, DOI 10.1080/20014091096710; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kerbarh O, 2006, J MOL BIOL, V357, P524, DOI 10.1016/j.jmb.2005.12.078; Kolappan S, 2007, BIOCHEMISTRY-US, V46, P946, DOI 10.1021/bi0608515; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonald M, 2001, J AM CHEM SOC, V123, P9459, DOI 10.1021/ja011243+; Mentel M, 2009, CHEMBIOCHEM, V10, P2295, DOI 10.1002/cbic.200900323; MOROLLO AA, 1993, P NATL ACAD SCI USA, V90, P9983, DOI 10.1073/pnas.90.21.9983; MOROLLO AA, 1993, J AM CHEM SOC, V115, P816, DOI 10.1021/ja00055a079; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Parsons JF, 2008, ACTA CRYSTALLOGR D, V64, P607, DOI 10.1107/S0907444908005477; Parsons JF, 2003, BIOCHEMISTRY-US, V42, P5684, DOI 10.1021/bi027385d; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; PIERSON LS, 1995, FEMS MICROBIOL LETT, V134, P299, DOI 10.1111/j.1574-6968.1995.tb07954.x; Raushel FM, 2003, ACCOUNTS CHEM RES, V36, P539, DOI 10.1021/ar020047k; ROEMER A, 1982, Zeitschrift fuer Naturforschung Section C Journal of Biosciences, V37, P1070; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Spraggon G, 2001, P NATL ACAD SCI USA, V98, P6021, DOI 10.1073/pnas.111150298; Sridharan S, 2010, J MOL BIOL, V397, P290, DOI 10.1016/j.jmb.2010.01.019; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1993, J APPL CRYSTALLOGR, V26, P258, DOI 10.1107/S0021889892011828; Teplyakov A, 2001, J MOL BIOL, V313, P1093, DOI 10.1006/jmbi.2001.5094; Van Lanen SG, 2008, P NATL ACAD SCI USA, V105, P494, DOI 10.1073/pnas.0708750105; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Zwahlen J, 2007, BIOCHEMISTRY-US, V46, P954, DOI 10.1021/bi060852x	38	42	45	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18213	18221		10.1074/jbc.M110.183418	http://dx.doi.org/10.1074/jbc.M110.183418			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454481	Green Published, hybrid			2022-12-27	WOS:000290585200081
J	Motamed, M; Zhang, YX; Wang, ML; Seemann, J; Kwon, HJ; Goldstein, JL; Brown, MS				Motamed, Massoud; Zhang, Yinxin; Wang, Michael L.; Seemann, Joachim; Kwon, Hyock Joo; Goldstein, Joseph L.; Brown, Michael S.			Identification of Luminal Loop 1 of Scap Protein as the Sterol Sensor That Maintains Cholesterol Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEAVAGE-ACTIVATING PROTEIN; ELEMENT-BINDING PROTEINS; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; SENSING DOMAIN; COMPETITIVE INHIBITOR; REGULATED TRANSPORT; COPII PROTEINS; ER MEMBRANES; SREBPS	Cellular cholesterol homeostasis is maintained by Scap, an endoplasmic reticulum (ER) protein with eight transmembrane helices. In cholesterol-depleted cells, Scap transports sterol regulatory element-binding proteins (SREBPs) to the Golgi, where the active fragment of SREBP is liberated by proteases so that it can activate genes for cholesterol synthesis. When ER cholesterol increases, Scap binds cholesterol, and this changes the conformation of cytosolic Loop 6, which contains the binding site for COPII proteins. The altered conformation precludes COPII binding, abrogating movement to the Golgi. Consequently, cholesterol synthesis declines. Here, we identify the cholesterol-binding site on Scap as Loop 1, a 245-amino acid sequence that projects into the ER lumen. Recombinant Loop 1 binds sterols with a specificity identical to that of the entire Scap membrane domain. When tyrosine 234 in Loop 1 is mutated to alanine, Loop 6 assumes the cholesterol-bound conformation, even in sterol-depleted cells. As a result, full-length Scap(Y234A) cannot mediate SREBP processing in transfected cells. These results indicate that luminal Loop 1 of Scap controls the conformation of cytosolic Loop 6, thereby determining whether cells produce cholesterol.	[Motamed, Massoud; Zhang, Yinxin; Wang, Michael L.; Goldstein, Joseph L.; Brown, Michael S.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Seemann, Joachim] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Kwon, Hyock Joo] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldstein, JL (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu	zhang, yinxin/D-8896-2013; Zhang, Yinxin/I-9996-2019	Zhang, Yinxin/0000-0001-5909-3676	National Institutes of Healt [HL20948, GM096070, ST32 GM08014]; Ara Parseghian Medical Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096070, T32GM008014] Funding Source: NIH RePORTER	National Institutes of Healt(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ara Parseghian Medical Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants HL20948 and GM096070.; Supported by the Ara Parseghian Medical Research Foundation.; Supported by National Institutes of Health Medical Scientist Training Program Grant ST32 GM08014.	Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Feramisco JD, 2005, P NATL ACAD SCI USA, V102, P3242, DOI 10.1073/pnas.0500206102; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Ikeda Y, 2009, J BIOL CHEM, V284, P34889, DOI 10.1074/jbc.M109.044875; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; KITA T, 1980, J CLIN INVEST, V66, P1094, DOI 10.1172/JCI109938; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; Pentchev P. G., 1995, METABOLIC MOL BASIS; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; SKALNIK DG, 1988, J BIOL CHEM, V263, P6836; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; TESSIER DC, 1991, GENE, V98, P177, DOI 10.1016/0378-1119(91)90171-7; Wei JH, 2009, NAT PROTOC, V4, P1653, DOI 10.1038/nprot.2009.160; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3	35	66	67	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18002	18012		10.1074/jbc.M111.238311	http://dx.doi.org/10.1074/jbc.M111.238311			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454655	Green Published, hybrid			2022-12-27	WOS:000290585200062
J	Shi, QL; Xu, H; Yu, HQ; Zhang, NW; Ye, YZ; Estevez, AG; Deng, HT; Gibson, GE				Shi, Qingli; Xu, Hui; Yu, Haiqiang; Zhang, Nawei; Ye, Yaozu; Estevez, Alvaro G.; Deng, Haiteng; Gibson, Gary E.			Inactivation and Reactivation of the Mitochondrial alpha-Ketoglutarate Dehydrogenase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE NITRATION; PEROXYNITRITE-TREATED PROTEINS; PROGRESSIVE SUPRANUCLEAR PALSY; DEPENDENT ENZYME CHANGES; LUNG EPITHELIAL-CELLS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; GLUTATHIONE METABOLISM; MULTIENZYME COMPLEXES	Reduced brain metabolism is an invariant feature of Alzheimer Disease (AD) that is highly correlated to the decline in brain functions. Decreased activities of key tricarboxylic acid cycle (TCA) cycle enzymes may underlie this abnormality and are highly correlated to the clinical state of the patient. The activity of the alpha-ketoglutarate dehydrogenase complex (KGDHC), an arguably rate-limiting enzyme of the TCA cycle, declines with AD, but the mechanism of inactivation and whether it can be reversed remains unknown. KGDHC consists of multiple copies of three subunits. KGDHC is sensitive to oxidative stress, which is pervasive in AD brain. The present studies tested the mechanism for the peroxynitrite-induced inactivation and subsequent reactivation of purified and cellular KGDHC. Peroxynitrite inhibited purified KGDHC activity in a dose-dependent manner and reduced subunit immunoreactivity and increased nitrotyrosine immunoreactivity. Nano-LC-MS/MS showed that the inactivation was related to nitration of specific tyrosine residues in the three subunits. GSH diminished the nitrotyrosine immunoreactivity of peroxynitrite-treated KGDHC, restored the activity and the immunoreactivity for KGDHC. Nano-LC-MS/MS showed this was related to de-nitration of specific tyrosine residues, suggesting KGDHC may have a denitrase activity. Treatment of N2a cells with peroxynitrite for 5 min followed by recovery of cells for 24 h reduced KGDHC activity and increased nitrotyrosine immunoreactivity. Increasing cellular GSH in peroxynitrite-treated cells rescued KGDHC activity to the control level. The results suggest that restoring KGDHC activity is possible and may be a useful therapeutic approach in neurodegenerative diseases.	[Shi, Qingli; Xu, Hui; Gibson, Gary E.] Weill Cornell Med Coll, Burke Med Res Inst, Dept Neurol & Neurosci, White Plains, NY 10605 USA; [Yu, Haiqiang; Zhang, Nawei; Deng, Haiteng] Rockefeller Univ, Prot Resource Ctr, New York, NY 10065 USA; [Ye, Yaozu] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Estevez, Alvaro G.] Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32827 USA	Cornell University; Rockefeller University; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of Central Florida	Gibson, GE (corresponding author), Weill Cornell Med Coll, Burke Med Res Inst, Dept Neurol & Neurosci, 785 Mamaroneck Ave, White Plains, NY 10605 USA.	ggibson@med.cornell.edu		Deng, Haiteng/0000-0001-9496-1280	National Institutes of Health [PPG AG14930]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant PPG AG14930.	Abello N, 2009, J PROTEOME RES, V8, P3222, DOI 10.1021/pr900039c; Albers DS, 2000, J NEUROCHEM, V74, P878, DOI 10.1046/j.1471-4159.2000.740878.x; Applegate MAB, 2008, BIOCHEMISTRY-US, V47, P473, DOI 10.1021/bi7017464; Au HC, 1998, EUR J BIOCHEM, V251, P164, DOI 10.1046/j.1432-1327.1998.2510164.x; Bajt ML, 2004, TOXICOL SCI, V80, P343, DOI 10.1093/toxsci/kfh151; BENSON DF, 1983, ARCH NEUROL-CHICAGO, V40, P711, DOI 10.1001/archneur.1983.04050110029003; Berg A, 1997, BIOL CHEM, V378, P617; Bian K, 2001, FREE RADICAL BIO MED, V31, P421, DOI 10.1016/S0891-5849(01)00600-1; Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474; BUTTERWORTH RF, 1990, METAB BRAIN DIS, V5, P179, DOI 10.1007/BF00997071; BUTTERWORTH RF, 1993, ALCOHOL CLIN EXP RES, V17, P1084, DOI 10.1111/j.1530-0277.1993.tb05668.x; Chen HJC, 2002, CHEM-BIOL INTERACT, V140, P199, DOI 10.1016/S0009-2797(02)00019-4; Chinopoulos C, 1999, J NEUROCHEM, V73, P220, DOI 10.1046/j.1471-4159.1999.0730220.x; Chouchani ET, 2010, BIOCHEM J, V430, P49, DOI 10.1042/BJ20100633; Dringen R, 2000, EUR J BIOCHEM, V267, P4903, DOI 10.1046/j.1432-1327.2000.01651.x; Frank RAW, 2007, J MOL BIOL, V368, P639, DOI 10.1016/j.jmb.2007.01.080; GIBSON GE, 1988, ARCH NEUROL-CHICAGO, V45, P836, DOI 10.1001/archneur.1988.00520320022009; Gibson GE, 2004, J BIOENERG BIOMEMBR, V36, P335, DOI 10.1023/B:JOBB.0000041764.45552.f3; Gibson GE, 2003, NEUROCHEM INT, V43, P129, DOI 10.1016/S0197-0186(02)00225-5; Gibson GE, 2002, FREE RADICAL BIO MED, V32, P1061, DOI 10.1016/S0891-5849(02)00802-X; Golladay SA, 1997, ENVIRON HEALTH PERSP, V105, P1273, DOI 10.2307/3433546; Gow AJ, 1996, FEBS LETT, V385, P63, DOI 10.1016/0014-5793(96)00347-X; Ischiropoulos H, 2003, BIOCHEM BIOPH RES CO, V305, P776, DOI 10.1016/S0006-291X(03)00814-3; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; Jeitner TM, 2005, J NEUROCHEM, V92, P302, DOI 10.1111/j.1471-4159.2004.02868.x; Jiao KS, 2001, ANAL BIOCHEM, V293, P43, DOI 10.1006/abio.2001.5118; Kamisaki Y, 1998, P NATL ACAD SCI USA, V95, P11584, DOI 10.1073/pnas.95.20.11584; Knapp JE, 2000, PROTEIN SCI, V9, P37; Korotchkina LG, 2001, FREE RADICAL BIO MED, V30, P992, DOI 10.1016/S0891-5849(01)00491-9; Kuo WN, 1999, MOL CELL BIOCHEM, V201, P11, DOI 10.1023/A:1007024126947; Kuo WN, 1999, BIOCHEM MOL BIOL INT, V47, P1061; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; MASTROGIACOMO F, 1993, J NEUROCHEM, V61, P2007, DOI 10.1111/j.1471-4159.1993.tb07436.x; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Miranda S, 1999, BIOCHEM BIOPH RES CO, V258, P44, DOI 10.1006/bbrc.1999.0580; MIZUNO Y, 1994, ANN NEUROL, V35, P204, DOI 10.1002/ana.410350212; Nauser T, 2001, CHEM RES TOXICOL, V14, P348, DOI 10.1021/tx000236g; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; PADMAJA S, 1993, BIOCHEM BIOPH RES CO, V195, P539, DOI 10.1006/bbrc.1993.2079; Park LCH, 1999, J NEUROCHEM, V72, P1948, DOI 10.1046/j.1471-4159.1999.0721948.x; Park LCH, 2000, ANAL BIOCHEM, V277, P86, DOI 10.1006/abio.1999.4359; Park LCH, 2001, J NEUROSCI RES, V66, P1028, DOI 10.1002/jnr.10062; Perham RN, 1998, BIOCHEM SOC T, V26, P299, DOI 10.1042/bst0260299; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; PETTIT FH, 1973, J BIOL CHEM, V248, P5282; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; RAPOPORT SI, 1991, ADV EXP MED BIOL, V291, P231; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shi Q, 2007, NEUROCHEM INT, V50, P921, DOI 10.1016/j.neuint.2007.03.010; Smallwood HS, 2007, BIOCHEMISTRY-US, V46, P10498, DOI 10.1021/bi7009713; SMITH GS, 1992, ARCH NEUROL-CHICAGO, V49, P1142, DOI 10.1001/archneur.1992.00530350056020; Smith MA, 2000, BBA-MOL BASIS DIS, V1502, P139, DOI 10.1016/S0925-4439(00)00040-5; Souza JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P169, DOI 10.1006/abbi.1999.1480; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Torreilles F, 1999, BRAIN RES REV, V30, P153, DOI 10.1016/S0165-0173(99)00014-4; Ye YZ, 2007, J BIOL CHEM, V282, P6324, DOI 10.1074/jbc.M610800200; Yeh STY, 2006, TOXICOLOGY, V223, P181, DOI 10.1016/j.tox.2006.03.019	58	53	56	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17640	17648		10.1074/jbc.M110.203018	http://dx.doi.org/10.1074/jbc.M110.203018			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454586	Green Published, hybrid			2022-12-27	WOS:000290585200027
J	Steiner, DF				Steiner, Donald F.			Adventures with Insulin in the Islets of Langerhans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROINSULIN C-PEPTIDE; AMINO-ACID-SEQUENCE; CELL-FREE SYNTHESIS; BETA-CELL; PROPROTEIN CONVERTASES; AMYLOID POLYPEPTIDE; IN-VITRO; IDENTIFICATION; GENE; RAT	Insulin is a small but beautifully organized protein with a unique two-chain structure, the first protein to be sequenced. The mechanism of its biosynthesis invited much initial speculation but was finally clarified by the discovery of proinsulin, its single-chain precursor. The rich present-day field of protein precursor processing via post-translational proteolysis within the secretory pathway arose in the early 1970s as an offshoot of studies on insulin biosynthesis, which provided a novel paradigm for the generation of many other small neuroendocrine peptides. Before long, this mechanism was also found to play a role in the production of a much wider spectrum of proteins traversing the secretory pathway (receptors, growth factors, blood-clotting components, and even many viral envelope proteins) occurring in almost all eukaryotic cells. Indeed, yeast provided a key clue in the search for the proprotein convertases, the endoproteases that work along with carboxypeptidases and other modifying enzymes, such as the amidating enzyme complex (PAM), in converting inactive or less active precursor proteins into their fully active peptide products. In this "Reflections" article, I have tried to recount the people and events in my life that led to my involvement first in basic biochemical research and then on to insulin, proinsulin, and many relevant related areas that continue to fascinate and challenge my colleagues and me, as well as many other biomedical scientists today, as diabetes mellitus increasingly threatens human health throughout our contemporary world.	[Steiner, Donald F.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Steiner, Donald F.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Steiner, DF (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	dfsteine@uchicago.edu			National Institutes of Health [DK13914, DK20595]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, R01DK013914, R37DK013914, P60DK020595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	I am indebted to many students, postdoctoral fellows, and younger collaborating colleagues who have contributed to the work from my laboratory discussed in this "Reflections" article. In particular, I would like to mention Robert Roskoski, Judy King, Lee Younger, Dennis Cunningham, Philip Oyer, Jeffrey Clark, Wolfgang Kemmler, Hiroyuki Sando, Henrik Ege, Ole Hallund, Jorgen Schlichtkrull, Lisa Heding, Jorgen Gliemann, Franco Melani, Arthur Rubenstein, Jo Borg, Simon Pilkis, Howard Tager, Ron Chance, Bruce Frank, James Peterson, Shu Jin Chan, Rosa Choy, Edward Schlenk, Sooja Cho Nehrlich, Susan Terris, Ray Carroll, Ole Madsen, Jens Hoiriis Nielsen, Sture Falkmer, Stefan Emdin, Ake Lernmark, Takahiro Kanatsuna, Cecilia Hofmann, Jon Marsh, Hisako Ohgawara, Christoph Patzelt, Dorothy Hodgkin, Guy and Eleanor Dodson, Simon Kwok, Masakazu Haneda, Kevin Docherty, John Hutton, Chris Rhodes, Philippe Halban, David Nielsen, Michael Welsh, Kishio Nanjo, Susumu Seino, Craig Blackstone, Steve Smeekens, Graeme Bell, Kenneth Polonsky, Erika Plisetskaya, Steve Duguay, Cun Ming Duan, Motoshige Miyano, Masahiro Nishi, Shinya Ohagi, Machi and Hiroto Furuta, Shinya Nagamatsu, Yasunao Yoshimasa, Jonathan Whittaker, Tadashi Hanabusa, Yves Rouille, Jeremy Paul, Mohammad Pashmforoush, Isaiah Pitman IV, Satoe Nakagawa, Lelio Orci, Louis Philipson, Gregory Lipkind, Sean Martin, Tony Oliva, An Zhou, Gene Webb, Joe Bass, Xiaorong Zhu, Takeshi Kurose, Arunangsu Dey, Jie Wang, Margaret Milewski, Jeff Stein, Iris Lindberg, Gary Thomas, Lloyd Fricker, Jens Rehfeld, Per and Gunilla Westermark, Michael Weiss, Colin Ward, Michael Lawrence, and Soo Young Park. My early mentors were Herbert S. Anker, Ph. D. (deceased), Earl A. Evans, Jr., Ph. D. (deceased), Eugene P. Kennedy, Ph. D., and Robert H. Williams, M. D. (deceased). To them all, I am greatly indebted. This article is dedicated to the memory of two special colleagues (both now deceased), Philip C. Hoffmann (pharmacology) and Eugene Goldwasser (biochemistry), who were my steadfast friends/ advisers and luncheon companions for many years. Work in my laboratory has been supported by National Institutes of Health Grants DK13914 and DK20595 and by the Howard Hughes Medical Institute. My thanks to Steve Roess and Gladys Paz for assistance with the production of this manuscript and figures.	BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Cameron A., 2001, ENZYMES, VXXII; CHAN SJ, 1976, P NATL ACAD SCI USA, V73, P1964, DOI 10.1073/pnas.73.6.1964; CHAN SJ, 1990, P NATL ACAD SCI USA, V87, P9319, DOI 10.1073/pnas.87.23.9319; CHANCE RE, 1968, SCIENCE, V161, P165, DOI 10.1126/science.161.3837.165; CHANCE RE, 1993, DIABETES CARE, V16, P133, DOI 10.2337/diacare.16.3.133; CLARK JL, 1969, P NATL ACAD SCI USA, V62, P278, DOI 10.1073/pnas.62.1.278; Czyzyk TA, 2005, DEV BIOL, V287, P301, DOI 10.1016/j.ydbio.2005.09.001; DAVIDSON HW, 1988, NATURE, V333, P93, DOI 10.1038/333093a0; DAVOREN PR, 1962, BIOCHIM BIOPHYS ACTA, V63, P150, DOI 10.1016/0006-3002(62)90347-5; Day R, 1998, J BIOL CHEM, V273, P829, DOI 10.1074/jbc.273.2.829; DOCHERTY K, 1982, ANNU REV PHYSIOL, V44, P625, DOI 10.1146/annurev.ph.44.030182.003205; DOCHERTY K, 1983, P NATL ACAD SCI-BIOL, V80, P3245, DOI 10.1073/pnas.80.11.3245; DOUGLASS J, 1984, ANNU REV BIOCHEM, V53, P665; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Eulenburg-Wiener R. V., 1938, FEARFULLY WONDERFULL; FRICKER LD, 1986, NATURE, V323, P461, DOI 10.1038/323461a0; FULLER RS, 1989, SCIENCE, V246, P482, DOI 10.1126/science.2683070; Furuta M, 1998, J BIOL CHEM, V273, P3431, DOI 10.1074/jbc.273.6.3431; HUMBEL RE, 1965, P NATL ACAD SCI USA, V53, P853, DOI 10.1073/pnas.53.4.853; JAMIESON JD, 1967, J CELL BIOL, V34, P577, DOI 10.1083/jcb.34.2.577; Jensen H., 1935, J BIOL CHEM, V108, P1; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; KEMMLER W, 1973, J BIOL CHEM, V248, P4544; KEMMLER W, 1971, J BIOL CHEM, V246, P6786; Kuliawat R, 1997, J CELL BIOL, V137, P595, DOI 10.1083/jcb.137.3.595; KUROSE T, 1994, J BIOL CHEM, V269, P29190; Louagie E, 2008, P NATL ACAD SCI USA, V105, P12319, DOI 10.1073/pnas.0800340105; Marzban L, 2006, DIABETES, V55, P2192, DOI 10.2337/db05-1566; MELANI F, 1970, P NATL ACAD SCI USA, V67, P148, DOI 10.1073/pnas.67.1.148; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; MIZUNO K, 1988, BIOCHEM BIOPH RES CO, V156, P246, DOI 10.1016/S0006-291X(88)80832-5; MORGAN HE, 1961, J BIOL CHEM, V236, P262; MURNAGHAN JH, 1967, PERSPECT BIOL MED, V10, P334; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; NISHI M, 1990, J BIOL CHEM, V265, P4173; NOLAN C, 1964, BIOCHEMISTRY-US, V3, P542, DOI 10.1021/bi00892a013; NOLAN C, 1971, J BIOL CHEM, V246, P2780; ORCI L, 1985, CELL, V42, P671, DOI 10.1016/0092-8674(85)90124-2; OYER PE, 1971, J BIOL CHEM, V246, P1375; Peinado JR, 2005, ENDOCRINOLOGY, V146, P3438, DOI 10.1210/en.2004-1289; POLONSKY K S, 1986, Diabetes Metabolism Reviews, V2, P315; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; RUBENSTEIN AH, 1969, NATURE, V224, P697, DOI 10.1038/224697a0; RUBENSTEIN AH, 1968, LANCET, V1, P1353; SACHS H, 1964, ENDOCRINOLOGY, V75, P943, DOI 10.1210/endo-75-6-943; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; SHIELDS D, 1977, P NATL ACAD SCI USA, V74, P2059, DOI 10.1073/pnas.74.5.2059; SHOELSON S, 1983, NATURE, V302, P540, DOI 10.1038/302540a0; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; Sosenko JM, 2004, DIABETES, V53, pA425; Steiner D F, 1969, Recent Prog Horm Res, V25, P207; Steiner DF, 2009, DIABETES OBES METAB, V11, P189, DOI 10.1111/j.1463-1326.2009.01106.x; Steiner D F, 1966, Vitam Horm, V24, P1; Steiner D. F., 1978, CIBA F S, V55, P229; Steiner D. F., 1970, PATHOGENESIS DIABETE, V13, P57; STEINER DF, 1967, SCIENCE, V157, P697, DOI 10.1126/science.157.3789.697; STEINER DF, 1971, J BIOL CHEM, V246, P1365; STEINER DF, 1958, BIOCHIM BIOPHYS ACTA, V30, P329, DOI 10.1016/0006-3002(58)90058-1; STEINER DF, 1967, P NATL ACAD SCI USA, V57, P473, DOI 10.1073/pnas.57.2.473; STEINER DF, 1968, DIABETES, V17, P725, DOI 10.2337/diab.17.12.725; STEINER DF, 1992, J BIOL CHEM, V267, P23435; STEINER DF, 1956, P NATL ACAD SCI USA, V42, P580, DOI 10.1073/pnas.42.9.580; STEINER DF, 1959, J BIOL CHEM, V234, P1342; STEINER DF, 1959, DIABETES, V8, P154, DOI 10.2337/diab.8.2.154; STEINER DF, 1968, P NATL ACAD SCI USA, V60, P622, DOI 10.1073/pnas.60.2.622; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; TERRIS S, 1979, CAN J BIOCHEM CELL B, V57, P459, DOI 10.1139/o79-059; TERRIS S, 1975, J BIOL CHEM, V250, P8389; TERRIS S, 1976, J CLIN INVEST, V57, P885, DOI 10.1172/JCI108365; WANG SS, 1965, J BIOL CHEM, V240, P1619; WANG SS, 1969, J BIOL CHEM, V244, P5537; WICK AN, 1958, J BIOL CHEM, V233, P296; YOUNGER LR, 1966, CANCER RES, V26, P1408; Zhang X, 2010, J NEUROCHEM, V112, P1168, DOI 10.1111/j.1471-4159.2009.06530.x; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10299, DOI 10.1073/pnas.162352799; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599; Zuhlke H, 1976, Ciba Found Symp, V41, P183	83	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17399	17421		10.1074/jbc.X111.244764	http://dx.doi.org/10.1074/jbc.X111.244764			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454641	hybrid, Green Published			2022-12-27	WOS:000290585200003
J	Liu, X; Hein, J; Richardson, SCW; Basse, PH; Toptan, T; Moore, PS; Gjoerup, OV; Chang, Y				Liu, Xi; Hein, Jennifer; Richardson, Simon C. W.; Basse, Per H.; Toptan, Tuna; Moore, Patrick S.; Gjoerup, Ole V.; Chang, Yuan			Merkel Cell Polyomavirus Large T Antigen Disrupts Lysosome Clustering by Translocating Human Vam6p from the Cytoplasm to the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMIAN-VIRUS-40 LARGE T; C-VPS COMPLEX; TUMOR-ANTIGEN; SV40-TRANSFORMED CELLS; CARCINOMA-CELLS; HOST PROTEIN; FUSION; TRANSFORMATION; BINDING; LOCALIZATION	Merkel cell polyomavirus (MCV) has been recently described as the cause for most human Merkel cell carcinomas. MCV is similar to simian virus 40 (SV40) and encodes a nuclear large T (LT) oncoprotein that is usually mutated to eliminate viral replication among tumor-derived MCV. We identified the hVam6p cytoplasmic protein involved in lysosomal processing as a novel interactor with MCV LT but not SV40 LT. hVam6p binds through its clathrin heavy chain homology domain to a unique region of MCV LT adjacent to the retinoblastoma binding site. MCV LT translocates hVam6p to the nucleus, sequestering it from involvement in lysosomal trafficking. A naturally occurring, tumor-derived mutant LT (MCV350) lacking a nuclear localization signal binds hVam6p but fails to inhibit hVam6p-induced lysosomal clustering. MCV has evolved a novel mechanism to target hVam6p that may contribute to viral uncoating or egress through lysosomal processing during virus replication.	[Liu, Xi; Hein, Jennifer; Toptan, Tuna; Moore, Patrick S.; Gjoerup, Ole V.; Chang, Yuan] Univ Pittsburgh, Canc Virol Program, Pittsburgh, PA 15213 USA; [Basse, Per H.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA; [Richardson, Simon C. W.] Univ Greenwich, Sch Sci, Dept Pharmaceut Chem & Environm Sci, Medway ME4 4TB, Kent, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Greenwich	Moore, PS (corresponding author), Univ Pittsburgh, Canc Virol Program, Pittsburgh, PA 15213 USA.	psm9@pitt.edu; ovg27@pitt.edu; yc70@pitt.edu	Richardson, Dr Simon/AAB-9516-2022; Toptan, Tuna/A-6721-2013; Moore, Patrick/GVR-8294-2022; Grabmair, Tuna Toptan/AAN-6129-2021; Toptan, Tuna/F-5503-2011; Moore, Patrick S./F-3960-2011; Richardson, Simon C/C-9049-2009; Chang, Yuan/F-4146-2011	Richardson, Dr Simon/0000-0002-7927-0649; Grabmair, Tuna Toptan/0000-0002-5399-9263; Moore, Patrick S./0000-0002-8132-858X; Richardson, Simon C/0000-0002-7927-0649; Chang, Yuan/0000-0003-1125-4041	National Institutes of Health [CA136363, CA120726, AI078926]; University of Pittsburg Cancer Institute [P30 CA047904]; Al Copeland Foundation for Merkel Cell Carcinoma Research; University of Pittsburgh; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA136363, R33CA120726, P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburg Cancer Institute; Al Copeland Foundation for Merkel Cell Carcinoma Research; University of Pittsburgh(University of Pittsburgh); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA136363, CA120726 (to P. S. M. and Y. C.), and AI078926 (to O. V. G.) and University of Pittsburg Cancer Institute Core Facility Cancer Center Support Grant (CCSG) P30 CA047904, the Al Copeland Foundation for Merkel Cell Carcinoma Research, the University of Pittsburgh EXPLORER program, and American Cancer Society Research Professorships (to P. S. M. and Y. C.).	Ali SH, 2004, J VIROL, V78, P2749, DOI 10.1128/JVI.78.6.2749-2757.2004; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; CAMPBELL KS, 1994, P NATL ACAD SCI USA, V91, P6344, DOI 10.1073/pnas.91.14.6344; Campbell KS, 1997, GENE DEV, V11, P1098, DOI 10.1101/gad.11.9.1098; Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; Cote-Martin A, 2008, J VIROL, V82, P1271, DOI 10.1128/JVI.01405-07; Cotsiki M, 2004, P NATL ACAD SCI USA, V101, P947, DOI 10.1073/pnas.0308006100; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DILWORTH SM, 1994, NATURE, V367, P87, DOI 10.1038/367087a0; Felici A, 2003, EMBO J, V22, P4465, DOI 10.1093/emboj/cdg428; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Hakki M, 2006, J VIROL, V80, P11817, DOI 10.1128/JVI.00957-06; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Laude HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001076; Li L, 2009, MOL CELL, V35, P543, DOI 10.1016/j.molcel.2009.08.010; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Mannova P, 2003, J VIROL, V77, P1672, DOI 10.1128/JVI.77.3.1672-1681.2003; Nakamura N, 1997, J BIOL CHEM, V272, P11344; Nakamura T, 2010, VIROLOGY, V398, P273, DOI 10.1016/j.virol.2009.12.024; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Peralta ER, 2010, J BIOL CHEM, V285, P16814, DOI 10.1074/jbc.M110.111633; PIPAS JM, 1992, J VIROL, V66, P3979, DOI 10.1128/JVI.66.7.3979-3985.1992; Poupon V, 2003, MOL BIOL CELL, V14, P4015, DOI 10.1091/mbc.E03-01-0040; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Qian MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000465; Richardson SCW, 2004, MOL BIOL CELL, V15, P1197, DOI 10.1091/mbc.E03-06-0358; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Shuda M, 2009, INT J CANCER, V125, P1243, DOI 10.1002/ijc.24510; Srinivasan A, 1997, MOL CELL BIOL, V17, P4761, DOI 10.1128/MCB.17.8.4761; Sukarieh R, 2010, J GEN VIROL, V91, P1224, DOI 10.1099/vir.0.018069-0; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551	38	44	44	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17079	17090		10.1074/jbc.M110.192856	http://dx.doi.org/10.1074/jbc.M110.192856			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454559	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000290301900058
J	Winkler, I; Marx, AD; Lariviere, D; Heinze, RJ; Cristovao, M; Reumer, A; Curth, U; Sixma, TK; Friedhoff, P				Winkler, Ines; Marx, Andreas D.; Lariviere, Damien; Heinze, Roger J.; Cristovao, Michele; Reumer, Annet; Curth, Ute; Sixma, Titia K.; Friedhoff, Peter			Chemical Trapping of the Dynamic MutS-MutL Complex Formed in DNA Mismatch Repair in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MSH2-MSH6; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; ATPASE ACTIVITY; PROTEIN MUTS; BINDING; RECOGNITION; DOMAIN; HYDROLYSIS; INTERFACE	The ternary complex comprising MutS, MutL, and DNA is a key intermediate in DNA mismatch repair. We used chemical cross-linking and fluorescence resonance energy transfer (FRET) to study the interaction between MutS and MutL and to shed light onto the structure of this complex. Via chemical cross-linking, we could stabilize this dynamic complex and identify the structural features of key events in DNA mismatch repair. We could show that in the complex between MutS and MutL the mismatch-binding and connector domains of MutS are in proximity to the N-terminal ATPase domain of MutL. The DNA- and nucleotide-dependent complex formation could be monitored by FRET using single cysteine variants labeled in the connector domain of MutS and the transducer domain of MutL, respectively. In addition, we could trap MutS after an ATP-induced conformational change by an intramolecular cross-link between Cys-93 of the mismatch-binding domain and Cys-239 of the connector domain.	[Winkler, Ines; Marx, Andreas D.; Heinze, Roger J.; Cristovao, Michele; Friedhoff, Peter] Univ Giessen, Inst Biochem, D-35392 Giessen, Germany; [Lariviere, Damien] Fourmentin Guilbert Sci Fdn, F-93160 Noisy Le Grand, France; [Reumer, Annet; Sixma, Titia K.] Univ Amsterdam, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Reumer, Annet; Sixma, Titia K.] Univ Amsterdam, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Curth, Ute] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Cristovao, Michele] Erasmus MC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands	Justus Liebig University Giessen; University of Amsterdam; University of Amsterdam; Hannover Medical School; Erasmus University Rotterdam; Erasmus MC	Friedhoff, P (corresponding author), Univ Giessen, Inst Biochem, Heinrich Buff Ring 58, D-35392 Giessen, Germany.	peter.friedhoff@chemie.bio.uni-giessen.de	Friedhoff, Peter/G-7905-2012	Friedhoff, Peter/0000-0003-1946-1117; Sixma, Titia K/0000-0001-6180-0632; Lariviere, Damien/0000-0002-0892-5118	European Community [HEALTH-F4-2008-223545]; Deutsche Forschungsgemeinschaft [GRK 1384]; Russian Foundation for Basic Research [RFBR-DFG 08-04-91973]	European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by European Community Seventh Framework Program FP7/2007-2013 under Grant HEALTH-F4-2008-223545 (to P. F., I. W., and R. J. H.), Deutsche Forschungsgemeinschaft Grant GRK 1384 "Enzymes and Multienzyme Complexes Acting on Nucleic Acids," and Russian Foundation for Basic Research Grant RFBR-DFG 08-04-91973 (to P. F. and A. D. M.).	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Baitinger C, 2003, J BIOL CHEM, V278, P49505, DOI 10.1074/jbc.M308738200; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; DURCHSCHLAG H, 1986, THERMODYNAMIC DATA B, P45; FENG G, 1995, BIOTECHNIQUES, V19, P956; Giron-Monzon L, 2004, J BIOL CHEM, V279, P49338, DOI 10.1074/jbc.M409307200; Gradia S, 2000, J BIOL CHEM, V275, P3922, DOI 10.1074/jbc.275.6.3922; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Hargreaves VV, 2010, J BIOL CHEM, V285, P9301, DOI 10.1074/jbc.M109.096388; Heinze RJ, 2009, NUCLEIC ACIDS RES, V37, P4453, DOI 10.1093/nar/gkp380; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jacobs-Palmer E, 2007, J MOL BIOL, V366, P1087, DOI 10.1016/j.jmb.2006.11.092; Jeong C, 2011, NAT STRUCT MOL BIOL, V18, P379, DOI 10.1038/nsmb.2009; Junop MS, 2003, DNA REPAIR, V2, P387, DOI 10.1016/S1568-7864(02)00245-8; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kato R, 2001, J MOL BIOL, V309, P227, DOI 10.1006/jmbi.2001.4752; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Kosinski J, 2005, J MOL BIOL, V351, P895, DOI 10.1016/j.jmb.2005.06.044; LAHUE RS, 1987, P NATL ACAD SCI USA, V84, P1482, DOI 10.1073/pnas.84.6.1482; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lamers MH, 2004, J BIOL CHEM, V279, P43879, DOI 10.1074/jbc.M406380200; Lamers MH, 2003, EMBO J, V22, P746, DOI 10.1093/emboj/cdg064; Larrea AA, 2010, CELL, V141, DOI 10.1016/j.cell.2010.05.002; Lebbink JHG, 2006, EMBO J, V25, P409, DOI 10.1038/sj.emboj.7600936; Lebbink JHG, 2010, J BIOL CHEM, V285, P13131, DOI 10.1074/jbc.M109.066001; Lee JY, 2005, MOL CELL, V20, P155, DOI 10.1016/j.molcel.2005.08.019; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Malkov VA, 1997, J BIOL CHEM, V272, P23811, DOI 10.1074/jbc.272.38.23811; Manelyte L, 2006, NUCLEIC ACIDS RES, V34, P5270, DOI 10.1093/nar/gkl489; Mendillo ML, 2007, J BIOL CHEM, V282, P16345, DOI 10.1074/jbc.M700858200; Mendillo ML, 2010, J BIOL CHEM, V285, P13170, DOI 10.1074/jbc.M110.108894; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Mukherjee S, 2009, BIOPHYS J, V96, pL63, DOI 10.1016/j.bpj.2009.04.012; Mukherjee S, 2009, BIOPHYS J, V96, P1707, DOI 10.1016/j.bpj.2008.10.071; Natrajan G, 2003, NUCLEIC ACIDS RES, V31, P4814, DOI 10.1093/nar/gkg677; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pillon MC, 2010, MOL CELL, V39, P145, DOI 10.1016/j.molcel.2010.06.027; Plotz G, 2006, NUCLEIC ACIDS RES, V34, P6574, DOI 10.1093/nar/gkl944; Pluciennik A, 2007, P NATL ACAD SCI USA, V104, P12709, DOI 10.1073/pnas.0705129104; Polosina YY, 2010, BIOESSAYS, V32, P51, DOI 10.1002/bies.200900089; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; Schofield MJ, 2001, J BIOL CHEM, V276, P45505, DOI 10.1074/jbc.C100449200; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stevens N, 2007, PHOTOCH PHOTOBIO SCI, V6, P909, DOI 10.1039/b702631e; Thomas E, 2002, BIOL CHEM, V383, P1459, DOI 10.1515/BC.2002.166; Toedt GH, 2003, NUCLEIC ACIDS RES, V31, P819, DOI 10.1093/nar/gkg191; Wang H, 2003, P NATL ACAD SCI USA, V100, P14822, DOI 10.1073/pnas.2433654100; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Yamamoto A, 2000, NUCLEIC ACIDS RES, V28, P3564, DOI 10.1093/nar/28.18.3564; Zhai J, 2010, P NATL ACAD SCI USA, V107, P680, DOI 10.1073/pnas.0908302107; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	61	40	41	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17326	17337		10.1074/jbc.M110.187641	http://dx.doi.org/10.1074/jbc.M110.187641			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454657	Green Published, hybrid			2022-12-27	WOS:000290301900080
J	Morris, VK; Ren, Q; Macindoe, I; Kwan, AH; Byrne, N; Sunde, M				Morris, Vanessa K.; Ren, Qin; Macindoe, Ingrid; Kwan, Ann H.; Byrne, Nolene; Sunde, Margaret			Recruitment of Class I Hydrophobins to the Air: Water Interface Initiates a Multi-step Process of Functional Amyloid Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-TENSION; IONIC LIQUIDS; SALMONELLA-ENTERITIDIS; RECOMBINANT PROTEINS; AGGREGATIVE FIMBRIAE; FUNGAL HYDROPHOBINS; RODLET LAYER; PURIFICATION; HFBI; DENATURATION	Class I fungal hydrophobins form amphipathic monolayers composed of amyloid rodlets. This is a remarkable case of functional amyloid formation in that a hydrophobic: hydrophilic interface is required to trigger the self-assembly of the proteins. The mechanism of rodlet formation and the role of the interface in this process have not been well understood. Here, we have studied the effect of a range of additives, including ionic liquids, alcohols, and detergents, on rodlet formation by two class I hydrophobins, EAS and DewA. Although the conformation of the hydrophobins in these different solutions is not altered, we observe that the rate of rodlet formation is slowed as the surface tension of the solution is decreased, regardless of the nature of the additive. These results suggest that interface properties are of critical importance for the recruitment, alignment, and structural rearrangement of the amphipathic hydrophobin monomers. This work gives insight into the forces that drive macromolecular assembly of this unique family of proteins and allows us to propose a three-stage model for the interface-driven formation of rodlets.	[Morris, Vanessa K.; Ren, Qin; Macindoe, Ingrid; Kwan, Ann H.; Sunde, Margaret] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Byrne, Nolene] Deakin Univ, Ctr Mat & Fibre Innovat, Geelong, Vic 3217, Australia	University of Sydney; Deakin University	Sunde, M (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	margaret.sunde@sydney.edu.au	Morris, Vanessa/AAS-2599-2020; Sunde, Margaret/A-5186-2016; Sunde, Margaret/ABH-2584-2020	Morris, Vanessa/0000-0003-3538-0093; Sunde, Margaret/0000-0002-0150-3203; Sunde, Margaret/0000-0002-0150-3203; Kwan, Ann/0000-0002-1506-2226	Australian Research Council [LP0776672]; Australian Postdoctoral Fellowship; National Health and Medical Research Council	Australian Research Council(Australian Research Council); Australian Postdoctoral Fellowship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council for Linkage Grant LP0776672 (to M. S. and A. H. K.), the Australian Postdoctoral Fellowship (to N. B.), and the National Health and Medical Research Council RD Wright Career Development Fellowship (to M. S.).	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Akanbi MHJ, 2010, COLLOID SURFACE B, V75, P526, DOI 10.1016/j.colsurfb.2009.09.030; Arakawa T, 2007, BIOPHYS CHEM, V131, P62, DOI 10.1016/j.bpc.2007.09.004; BEEVER RE, 1979, J BACTERIOL, V140, P1063, DOI 10.1128/JB.140.3.1063-1070.1979; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Butko P, 2001, BIOCHEM BIOPH RES CO, V280, P212, DOI 10.1006/bbrc.2000.4098; Byrne N, 2009, CHEM COMMUN, P1046, DOI 10.1039/b817590j; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Chen F, 2008, J PHYS CHEM B, V112, P8975, DOI 10.1021/jp711062a; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Fujita K, 2005, CHEM COMMUN, P4804, DOI 10.1039/b508238b; Gibson DL, 2007, MICROBIOL-SGM, V153, P1131, DOI 10.1099/mic.0.2006/000935-0; Gidalevitz D, 1999, P NATL ACAD SCI USA, V96, P2608, DOI 10.1073/pnas.96.6.2608; Greaves TL, 2008, CHEM SOC REV, V37, P1709, DOI 10.1039/b801395k; Hoernke M, 2010, BIOPHYS CHEM, V150, P64, DOI 10.1016/j.bpc.2010.02.014; Hoshino M, 2007, BBA-BIOMEMBRANES, V1768, P1886, DOI 10.1016/j.bbamem.2007.03.001; Hwang H, 2009, ANAL BIOCHEM, V386, P293, DOI 10.1016/j.ab.2008.12.019; JANCZUK B, 1995, LANGMUIR, V11, P4515, DOI 10.1021/la00011a055; Jean L, 2010, FASEB J, V24, P309, DOI 10.1096/fj.09-137653; Joensuu JJ, 2010, PLANT PHYSIOL, V152, P622, DOI 10.1104/pp.109.149021; Kalhor HR, 2009, BIOMACROMOLECULES, V10, P2468, DOI 10.1021/bm900428q; Kwan AHY, 2006, P NATL ACAD SCI USA, V103, P3621, DOI 10.1073/pnas.0505704103; Kwan AH, 2008, J MOL BIOL, V382, P708, DOI 10.1016/j.jmb.2008.07.034; Lahtinen T, 2008, PROTEIN EXPRES PURIF, V59, P18, DOI 10.1016/j.pep.2007.12.014; Li XX, 2009, COLLOID SURFACE B, V74, P370, DOI 10.1016/j.colsurfb.2009.07.039; Linder M, 2001, BIOMACROMOLECULES, V2, P511, DOI 10.1021/bm0001493; Linder MB, 2005, FEMS MICROBIOL REV, V29, P877, DOI 10.1016/j.femsre.2005.01.004; Mackay JP, 2001, STRUCTURE, V9, P83, DOI 10.1016/S0969-2126(00)00559-1; Martin M, 2006, CHEM ENG SCI, V61, P5196, DOI 10.1016/j.ces.2006.03.027; Morinaga A, 2010, BBA-PROTEINS PROTEOM, V1804, P986, DOI 10.1016/j.bbapap.2010.01.012; Niga P, 2010, LANGMUIR, V26, P8282, DOI 10.1021/la904697g; Pegram LM, 2007, J PHYS CHEM B, V111, P5411, DOI 10.1021/jp070245z; Scholtmeijer K, 2004, BIO-MED MATER ENG, V14, P447; Sen P, 2008, J PHYS CHEM B, V112, P13473, DOI 10.1021/jp8061288; STRINGER MA, 1991, GENE DEV, V5, P1161, DOI 10.1101/gad.5.7.1161; STRINGER MA, 1995, MOL MICROBIOL, V16, P33, DOI 10.1111/j.1365-2958.1995.tb02389.x; Summers CA, 2000, PROTEIN SCI, V9, P2001, DOI 10.1110/ps.9.10.2001; Sunde M, 2008, MICRON, V39, P773, DOI 10.1016/j.micron.2007.08.003; Talbot NJ, 1997, CURR BIOL, V7, pR78, DOI 10.1016/S0960-9822(06)00041-8; Talbot NJ, 2003, CURR BIOL, V13, pR696, DOI 10.1016/j.cub.2003.08.040; Valo HK, 2010, ACS NANO, V4, P1750, DOI 10.1021/nn9017558; VAZQUEZ G, 1995, J CHEM ENG DATA, V40, P611, DOI 10.1021/je00019a016; Wang X, 2005, BIOPHYS J, V88, P3434, DOI 10.1529/biophysj.104.057794; Wang XS, 2010, BIOSENS BIOELECTRON, V26, P1104, DOI 10.1016/j.bios.2010.08.024; Wessels JGH, 1996, TRENDS PLANT SCI, V1, P9, DOI 10.1016/S1360-1385(96)80017-3; Wosten HAB, 2000, BBA-REV BIOMEMBRANES, V1469, P79, DOI 10.1016/S0304-4157(00)00002-2; WOSTEN HAB, 1993, PLANT CELL, V5, P1567; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625; Xiong RQ, 2007, J MICROMECH MICROENG, V17, P1002, DOI 10.1088/0960-1317/17/5/021	49	57	60	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18					15955	15963		10.1074/jbc.M110.214197	http://dx.doi.org/10.1074/jbc.M110.214197			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454575	Green Published, hybrid			2022-12-27	WOS:000290022800035
J	Paratkar, S; Deshpande, AP; Tang, GQ; Patel, SS				Paratkar, Swaroopa; Deshpande, Aishwarya P.; Tang, Guo-Qing; Patel, Smita S.			The N-terminal Domain of the Yeast Mitochondrial RNA Polymerase Regulates Multiple Steps of Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTER RECOGNITION; SPECIFICITY FACTOR; SACCHAROMYCES-CEREVISIAE; INITIATION; PURIFICATION; ELONGATION; TRANSITION; EXPRESSION; CLEARANCE; MECHANISM	Transcription of the yeast (Saccharomyces cerevisiae) mitochondrial (mt) genome is catalyzed by nuclear-encoded proteins that include the core RNA polymerase (RNAP) subunit Rpo41 and the transcription factor Mtf1. Rpo41 is homologous to the single-subunit bacteriophage T7/T3 RNAP. Its similar to 80-kDa C-terminal domain is highly conserved among mt RNAPs, but its similar to 50-kDa N-terminal domain (NTD) is less conserved and not present in T7/T3 RNAP. To understand the role of the NTD, we have biochemically characterized a series of NTD deletion mutants of Rpo41. Our studies show that NTD regulates multiple steps of transcription initiation. Interestingly, NTD functions in an autoinhibitory manner during initiation, and its partial deletion increases the efficiency of RNA synthesis. Deletion of 1-270 amino acids (DN270) reduces abortive synthesis and increases full-length to abortive RNA ratio relative to full-length (FL) Rpo41. A larger deletion of 1-380 amino acids (DN380), decreases RNA synthesis on duplex but not on premelted promoter. We show that DN380 is defective in promoter opening near the transcription start site. Most strikingly, both DN270 and DN380 catalyze highly processive RNA synthesis on the premelted promoter, and unlike the FL Rpo41, the mutants are not inhibited by Mtf1. Both mutants show weaker interactions with Mtf1, which explains many of our results, and particularly the ability of the mutants to efficiently transition from initiation to elongation. We propose that in vivo the accessory proteins that bind NTD may modulate interactions of Rpo41 with the promoter/Mtf1 to activate and allow timely release from Mtf1 for transition into elongation.	[Paratkar, Swaroopa; Deshpande, Aishwarya P.; Tang, Guo-Qing; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Patel, SS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	patelss@umdnj.edu			National Institutes of Health [GM51966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051966, R37GM051966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51966.	Bandwar RP, 2006, J MOL BIOL, V360, P466, DOI 10.1016/j.jmb.2006.05.029; Cermakian N, 1996, NUCLEIC ACIDS RES, V24, P648, DOI 10.1093/nar/24.4.648; Cliften PF, 1997, GENE DEV, V11, P2897, DOI 10.1101/gad.11.21.2897; Dvir A, 2002, BBA-GENE STRUCT EXPR, V1577, P208, DOI 10.1016/S0167-4781(02)00453-0; GRALLA JD, 1980, BIOCHEMISTRY-US, V19, P5864, DOI 10.1021/bi00566a031; Guo Q, 2005, J BIOL CHEM, V280, P3474, DOI 10.1074/jbc.M412287200; HALLER I, 1974, P NATL ACAD SCI USA, V71, P2018, DOI 10.1073/pnas.71.5.2018; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; JAEHNING JA, 1993, MOL MICROBIOL, V8, P1, DOI 10.1111/j.1365-2958.1993.tb01197.x; JANG SH, 1991, J BIOL CHEM, V266, P22671; Kravchenko JE, 2005, NATURE, V436, P735, DOI 10.1038/nature03848; LEVENS D, 1981, J BIOL CHEM, V256, P1474; Lightowlers Robert N, 2008, Biochem J, V416, pe5, DOI 10.1042/BJ20081942; Lipinski KA, 2010, BBA-BIOENERGETICS, V1797, P1086, DOI 10.1016/j.bbabio.2009.12.019; Liu CH, 2002, J BIOL CHEM, V277, P2725, DOI 10.1074/jbc.M108856200; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; Markov DA, 2009, YEAST, V26, P423, DOI 10.1002/yea.1672; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; Matsunaga M, 2004, PROTEIN EXPRES PURIF, V35, P126, DOI 10.1016/j.pep.2003.12.022; Mooney RA, 2005, MOL CELL, V20, P335, DOI 10.1016/j.molcel.2005.10.015; Nayak D, 2009, J BIOL CHEM, V284, P13641, DOI 10.1074/jbc.M900718200; Paratkar S, 2010, J BIOL CHEM, V285, P3949, DOI 10.1074/jbc.M109.050732; Rodeheffer MS, 2003, J BIOL CHEM, V278, P18695, DOI 10.1074/jbc.M301399200; Rodeheffer MS, 2001, J BIOL CHEM, V276, P8616, DOI 10.1074/jbc.M009901200; Savkina M, 2010, J BIOL CHEM, V285, P3957, DOI 10.1074/jbc.M109.051003; SCHINKEL AH, 1987, J BIOL CHEM, V262, P12785; SCHINKEL AH, 1988, EMBO J, V7, P3255, DOI 10.1002/j.1460-2075.1988.tb03192.x; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; Shutt TE, 2010, P NATL ACAD SCI USA, V107, P12133, DOI 10.1073/pnas.0910581107; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tang GQ, 2009, P NATL ACAD SCI USA, V106, P22175, DOI 10.1073/pnas.0906979106; Tang GQ, 2009, J BIOL CHEM, V284, P5514, DOI 10.1074/jbc.M807880200; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; Wang YH, 1999, P NATL ACAD SCI USA, V96, P8046, DOI 10.1073/pnas.96.14.8046; Xu F, 2008, BIOCHEM J, V416, P15, DOI 10.1042/BJ20080847; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	38	15	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.228023	http://dx.doi.org/10.1074/jbc.M111.228023			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454631	hybrid, Green Published			2022-12-27	WOS:000290022800051
J	Wang, H; Bell, M; Sreenevasan, U; Hu, H; Liu, J; Dalen, K; Londos, C; Yamaguchi, T; Rizzo, MA; Coleman, R; Gong, DW; Brasaemle, D; Sztalryd, C				Wang, Hong; Bell, Ming; Sreenevasan, Urmilla; Hu, Hong; Liu, Jun; Dalen, Knut; Londos, Constantine; Yamaguchi, Tomohiro; Rizzo, Mark A.; Coleman, Rosalind; Gong, Dawei; Brasaemle, Dawn; Sztalryd, Carole			Unique Regulation of Adipose Triglyceride Lipase (ATGL) by Perilipin 5, a Lipid Droplet-associated Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; DIFFERENTIATION-RELATED PROTEIN; CHANARIN-DORFMAN-SYNDROME; MEDIATED LIPOLYSIS; INSULIN-RESISTANCE; ADIPOCYTES; CGI-58; MICE; OBESITY; TISSUE	Lipolysis is a critical metabolic pathway contributing to energy homeostasis through degradation of triacylglycerides stored in lipid droplets (LDs), releasing fatty acids. Neutral lipid lipases act at the oil/water interface. In mammalian cells, LD surfaces are coated with one or more members of the perilipin protein family, which serve important functions in regulating lipolysis. We investigated mechanisms by which three perilipin proteins control lipolysis by adipocyte triglyceride lipase (ATGL), a key lipase in adipocytes and non-adipose cells. Using a cell culture model, we examined interactions of ATGL and its co-lipase CGI-58 with perilipin 1 (perilipin A), perilipin 2 (adipose differentiation-related protein), and perilipin 5 (LSDP5) using multiple techniques as follows: anisotropy Forster resonance energy transfer, co-immunoprecipitation, [P-32] orthophosphate radiolabeling, and measurement of lipolysis. The results show that ATGL interacts with CGI-58 and perilipin 5; the latter is selectively expressed in oxidative tissues. Both proteins independently recruited ATGL to the LD surface, but with opposite effects; interaction of ATGL with CGI-58 increased lipolysis, whereas interaction of ATGL with perilipin 5 decreased lipolysis. In contrast, neither perilipin 1 nor 2 interacted directly with ATGL. Activation of protein kinase A (PKA) increased [P-32] orthophosphate incorporation into perilipin 5 by 2-fold, whereas neither ATGL nor CGI-58 was labeled under the incubation conditions. Cells expressing both ectopic perilipin 5 and ATGL showed a 3-fold increase in lipolysis following activation of PKA. Our studies establish perilipin 5 as a novel ATGL partner and provide evidence that the protein composition of perilipins at the LD surface regulates lipolytic activity of ATGL.	[Wang, Hong; Bell, Ming; Sreenevasan, Urmilla; Gong, Dawei; Sztalryd, Carole] Univ Maryland, Sch Med, Dept Med,Div Endocrinol, Geriatr Res Educ & Clin Ctr,Baltimore Vet Affairs, Baltimore, MD 21201 USA; [Liu, Jun] Univ Kentucky, Dept Pediat, Lexington, KY 40506 USA; [Dalen, Knut; Londos, Constantine] NIDDK, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA; [Yamaguchi, Tomohiro] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Rizzo, Mark A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Coleman, Rosalind] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Brasaemle, Dawn] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA	Geriatric Research Education & Clinical Center; University System of Maryland; University of Maryland Baltimore; University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Hyogo; University System of Maryland; University of Maryland Baltimore; University of North Carolina; University of North Carolina Chapel Hill; Rutgers State University New Brunswick	Sztalryd, C (corresponding author), Univ Maryland, Sch Med, Dept Med,Div Endocrinol, Geriatr Res Educ & Clin Ctr,Baltimore Vet Affairs, Rm 445,Howard Hall,660 W Redwood St, Baltimore, MD 21201 USA.	csztalry@grecc.umaryland.edu	Gong, Dawei/AAB-4283-2020; Dalen, Knut Tomas/C-4719-2016	Dalen, Knut Tomas/0000-0002-0270-5982	National Institutes of Health [1RO1 DK 075017, R01 DK54797]; NIDDK; American Diabetes Association [1-05-CD-17]; Geriatric Research, Education and Clinical Center; Baltimore Veterans Affairs Health Care Center; Clinical Nutrition Research Unit of Maryland [DK072488]; Grants-in-Aid for Scientific Research [23790098] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488, R01DK054797, P30DK079637, R01DK075017, R21DK067415, R01DK089178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); Geriatric Research, Education and Clinical Center; Baltimore Veterans Affairs Health Care Center; Clinical Nutrition Research Unit of Maryland; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RO1 DK 075017 (to C. S.) and R01 DK54797 (to D. B.) and by Intramural Research Programs of NIDDK. This work was also supported by Career Development Award 1-05-CD-17 from the American Diabetes Association (to C. S.), the Geriatric Research, Education and Clinical Center, Baltimore Veterans Affairs Health Care Center, and Clinical Nutrition Research Unit of Maryland Grant DK072488.	Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; DeFronzo RA, 2010, DIABETOLOGIA, V53, P1270, DOI 10.1007/s00125-010-1684-1; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Magra AL, 2006, J LIPID RES, V47, P2367, DOI 10.1194/jlr.M600157-JLR200; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726; Wang SP, 2001, OBES RES, V9, P119, DOI 10.1038/oby.2001.15; WILLIAMS ML, 1991, BIOCHIM BIOPHYS ACTA, V1096, P162, DOI 10.1016/0925-4439(91)90055-E; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2006, MOL CELL BIOCHEM, V284, P167, DOI 10.1007/s11010-005-9045-y; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	38	123	132	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.207779	http://dx.doi.org/10.1074/jbc.M110.207779			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21393244	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000290022800010
J	Xu, YR; Xia, W; Baker, D; Zhou, J; Cha, HC; Voorhees, JJ; Fisher, GJ				Xu, Yiru; Xia, Wei; Baker, Dustin; Zhou, Jin; Cha, Hyuk Chol; Voorhees, John J.; Fisher, Gary J.			Receptor-type Protein Tyrosine Phosphatase beta (RPTP-beta) Directly Dephosphorylates and Regulates Hepatocyte Growth Factor Receptor (HGFR/Met) Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR SCATTER FACTOR; SMALL-MOLECULE INHIBITOR; HUMAN ENDOTHELIAL-CELLS; C-MET; HUMAN KERATINOCYTES; TPR-MET; FACTOR/SCATTER FACTOR; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; MAP KINASES	Protein tyrosine phosphorylation is a ubiquitous, fundamental biochemical mechanism that regulates essential eukaryotic cellular functions. The level of tyrosine phosphorylation of specific proteins is finely tuned by the dynamic balance between protein tyrosine kinase and protein tyrosine phosphatase activities. Hepatocyte growth factor receptor (also known as Met), a receptor protein tyrosine kinase, is a major regulator of proliferation, migration, and survival for many epithelial cell types. Wereport here that receptor-type protein tyrosine phosphatase beta (RPTP-beta) specifically dephosphorylates Met and thereby regulates its function. Expression of RPTP-beta, but not other RPTP family members or catalytically inactive forms of RPTP-beta, reduces hepatocyte growth factor (HGF)-stimulated Met tyrosine phosphorylation in HEK293 cells. Expression of RPTP-beta in primary human keratinocytes reduces both basal and HGF-induced Met phosphorylation at tyrosine 1356 and inhibits downstream MEK1/2 and Erk activation. Furthermore, shRNA-mediated knockdown of endogenous RPTP-beta increases basal and HGF-stimulated Met phosphorylation at tyrosine 1356 in primary human keratinocytes. Purified RPTP-beta intracellular domain preferentially dephosphorylates purified Met at tyrosine 1356 in vitro. In addition, the substrate-trapping mutant of RPTP-beta specifically interacts with Met in intact cells. Expression of RPTP-beta in human primary keratinocytes reduces HGF induction of VEGF expression, proliferation, and motility. Taken together, the above data indicate that RPTP-beta is a key regulator of Met function.	[Xu, Yiru; Fisher, Gary J.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Xu, YR (corresponding author), Univ Michigan, Sch Med, Dept Dermatol, Rm 6447,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	xuyiru@umich.edu; dianemch@umich.edu	Voorhees, John/AAM-9966-2020	Voorhees, John/0000-0003-1856-785X; Baker, Dustin/0000-0002-1339-9677	National Institutes of Health [5R01 ES012920]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health 5R01 ES012920 (to G. J. F.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Bachleitner-Hofmann T, 2008, MOL CANCER THER, V7, P3499, DOI 10.1158/1535-7163.MCT-08-0374; Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141; Berra E, 2000, CANCER METAST REV, V19, P139, DOI 10.1023/A:1026506011458; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Byon JCH, 1997, P SOC EXP BIOL MED, V216, P1; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Christensen JG, 2003, CANCER RES, V63, P7345; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; FERRACINI R, 1991, J BIOL CHEM, V266, P19558; Fischer EH, 1999, ADV ENZYME REGUL, V39, P359, DOI 10.1016/S0065-2571(98)00014-4; FIXMAN ED, 1995, ONCOGENE, V10, P237; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Furge KA, 2000, ONCOGENE, V19, P5582, DOI 10.1038/sj.onc.1203859; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; GERARD R, 1995, DNA CLONING PRACTICA, P300; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; HARDER KW, 1992, CYTOGENET CELL GENET, V61, P269, DOI 10.1159/000133419; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Hornberg JJ, 2005, FEBS J, V272, P244, DOI 10.1111/j.1432-1033.2004.04404.x; Hui B, 2006, J NEUROCHEM, V97, P334, DOI 10.1111/j.1471-4159.2006.03698.x; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Jeffers M, 1996, J MOL MED-JMM, V74, P505, DOI 10.1007/BF00204976; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; KAPLAN R, 1990, P NATL ACAD SCI USA, V87, P7000, DOI 10.1073/pnas.87.18.7000; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; Li LW, 2000, SEMIN IMMUNOL, V12, P75, DOI 10.1006/smim.2000.0209; Lindner G, 2000, FASEB J, V14, P319, DOI 10.1096/fasebj.14.2.319; LONGATI P, 1994, ONCOGENE, V9, P49; Maalouf S, 2002, MOL CARCINOGEN, V34, P121, DOI 10.1002/mc.10055; Machide M, 2006, J BIOL CHEM, V281, P8765, DOI 10.1074/jbc.M512298200; MATSUMOTO K, 1991, EXP CELL RES, V196, P114, DOI 10.1016/0014-4827(91)90462-4; MAURO LJ, 1994, TRENDS BIOCHEM SCI, V19, P151, DOI 10.1016/0968-0004(94)90274-7; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; Michiels C, 2001, IUBMB LIFE, V52, P49, DOI 10.1080/15216540252774766; Moriyama T, 1998, BIOCHEM BIOPH RES CO, V249, P73, DOI 10.1006/bbrc.1998.9078; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NALDINI L, 1991, MOL CELL BIOL, V11, P1793, DOI 10.1128/MCB.11.4.1793; Nayeri F, 2006, J DERMATOL SCI, V43, P49, DOI 10.1016/j.jdermsci.2006.03.004; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Puri N, 2007, CANCER RES, V67, P3529, DOI 10.1158/0008-5472.CAN-06-4416; RUBIN JS, 1993, BIOCHIM BIOPHYS ACTA, V1155, P357, DOI 10.1016/0304-419X(93)90015-5; Sangwan V, 2008, J BIOL CHEM, V283, P34374, DOI 10.1074/jbc.M805916200; SATO C, 1995, J INVEST DERMATOL, V104, P958, DOI 10.1111/1523-1747.ep12606221; SHIMAOKA S, 1995, J CELL PHYSIOL, V165, P333, DOI 10.1002/jcp.1041650214; SORIANO JV, 1995, J CELL SCI, V108, P413; Stuart KA, 2000, INT J EXP PATHOL, V81, P17, DOI 10.1046/j.1365-2613.2000.00138.x; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; WANG Y, 1992, J BIOL CHEM, V267, P16696; WEIDNER KM, 1993, J CELL BIOL, V121, P145, DOI 10.1083/jcb.121.1.145; Wojta J, 1999, LAB INVEST, V79, P427; Xu YR, 2005, J BIOL CHEM, V280, P42694, DOI 10.1074/jbc.M507722200; Yacyshyn OK, 2009, ANGIOGENESIS, V12, P25, DOI 10.1007/s10456-008-9126-0; Yoshida S, 2003, J INVEST DERMATOL, V120, P335, DOI 10.1046/j.1523-1747.2003.12039.x; You WK, 2008, BMB REP, V41, P833, DOI 10.5483/BMBRep.2008.41.12.833; Yu J, 2000, CANCER-AM CANCER SOC, V88, P1801, DOI 10.1002/(SICI)1097-0142(20000415)88:8<1801::AID-CNCR7>3.0.CO;2-U; ZHU H, 1994, J BIOL CHEM, V269, P29943	64	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.212597	http://dx.doi.org/10.1074/jbc.M110.212597			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454675	Green Published, hybrid			2022-12-27	WOS:000290022800038
J	Yang, M; Lim, Y; Li, XJ; Zhong, JH; Zhou, XF				Yang, Miao; Lim, Yoon; Li, Xiaojiang; Zhong, Jin-Hua; Zhou, Xin-Fu			Precursor of Brain-derived Neurotrophic Factor (proBDNF) Forms a Complex with Huntingtin-associated Protein-1 (HAP1) and Sortilin That Modulates proBDNF Trafficking, Degradation, and Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVITY-DEPENDENT SECRETION; PRIMARY SENSORY NEURONS; CENTRAL-NERVOUS-SYSTEM; TRANS-GOLGI NETWORK; INTRACELLULAR TRAFFICKING; VAL66MET POLYMORPHISM; HIPPOCAMPAL-NEURONS; RETROGRADE TRANSPORT; CARBOXYPEPTIDASE-E; MUTANT HUNTINGTIN	proBDNF, a precursor of brain-derived neurotrophic factor (BDNF), is anterogradely transported and released from nerve terminals, but the mechanism underlying this process remains unclear. In this study, we report that proBDNF forms a complex with Huntingtin associated protein-1 (HAP1) and sortilin, which plays an important role in proBDNF intracellular trafficking and stabilization. The interaction of proBDNF with both HAP1A and sortilin in co-transfected HEK293 cells is confirmed by both fluorescence resonance energy transfer and co-immunoprecipitation. The frequent co-localization (>90%) of endogenous HAP1, sortilin, and proBDNF is also found in cultured cortical neurons. Mapping studies using GST pulldown and competition assays has defined the interacting region of HAP1 with proBDNF within amino acids 371-445 and the binding sequences of proBDNF to HAP1 between amino acids 65 and 90. Fluorescence recovery after photobleaching confirms the defective movement of proBDNF-containing vesicles in neurites of HAP1(-/-) neurons, which can be partially restored by reintroducing HAP1 cDNA into the neurons. However, the effect is significantly increased by simultaneously reintroducing both HAP1 and sortilin. proBDNF and HAP1 are highly co-localized with organelle markers for the Golgi network, microtubules, molecular motor, or endosomes in normal neurons, but this co-localization is reduced in HAP1(-/-) neurons. Co-immunoprecipitation and Western blot showed that sortilin stabilizes the proBDNF.HAP1 complex in co-transfected HEK293 cells, helping to prevent proBDNF degradation. Furthermore, the complex facilitates furin cleavage to release mature BDNF.	[Yang, Miao; Lim, Yoon; Zhong, Jin-Hua; Zhou, Xin-Fu] Flinders Univ S Australia, Dept Human Physiol, Adelaide, SA 5001, Australia; [Yang, Miao; Lim, Yoon; Zhong, Jin-Hua; Zhou, Xin-Fu] Flinders Univ S Australia, Ctr Neurosci, Adelaide, SA 5001, Australia; [Li, Xiaojiang] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Flinders University South Australia; Flinders University South Australia; Emory University	Zhou, XF (corresponding author), Flinders Univ S Australia, Dept Human Physiol, GPO Box 2100, Adelaide, SA 5001, Australia.	Xin-fu.zhou@flinders.edu.au	Zhou, Xiaofang/C-6169-2013; zhou, xin-fu/G-6643-2011; zhou, xin-fu/F-4119-2013	Zhou, Xiaofang/0000-0001-6343-1455; zhou, xin-fu/0000-0002-8687-0175; Lim, Yoon/0000-0003-1110-1969	National Health and Medical Research Council [375110, 488022]; NATIONAL INSTITUTE ON AGING [R01AG019206] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The project was supported by National Health and Medical Research Council Grants 375110 and 488022.	Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Butowt R, 2001, J NEUROSCI, V21, P8915, DOI 10.1523/JNEUROSCI.21-22-08915.2001; Carreno S, 2004, J CELL BIOL, V165, P781, DOI 10.1083/jcb.200403120; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; del Toro D, 2006, J NEUROSCI, V26, P12748, DOI 10.1523/JNEUROSCI.3873-06.2006; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Feng D, 2010, J MOL BIOL, V396, P967, DOI 10.1016/j.jmb.2009.12.030; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Gunawardena S, 2004, J NEUROBIOL, V58, P258, DOI 10.1002/neu.10319; Gutekunst CA, 2003, J HISTOCHEM CYTOCHEM, V51, P841, DOI 10.1177/002215540305100615; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Haubensak W, 1998, J CELL SCI, V111, P1483; HEFTI F, 1994, J NEUROBIOL, V25, P1418, DOI 10.1002/neu.480251109; Hibbert AP, 2006, MOL CELL NEUROSCI, V32, P387, DOI 10.1016/j.mcn.2006.06.001; Hilgenberg L. G., 2007, J VIS EXP, V10, p[562, 1]; Hirokawa N, 2004, CURR OPIN NEUROBIOL, V14, P564, DOI 10.1016/j.conb.2004.08.011; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Li SH, 2003, J NEUROSCI, V23, P6956; Li SH, 1998, J BIOL CHEM, V273, P19220, DOI 10.1074/jbc.273.30.19220; Li XJ, 2005, TRENDS PHARMACOL SCI, V26, P1, DOI 10.1016/j.tips.2004.11.001; Lou H, 2005, NEURON, V45, P245, DOI 10.1016/j.neuron.2004.12.037; MacQueen GM, 2001, BEHAV NEUROSCI, V115, P1145, DOI 10.1037//0735-7044.115.5.1145; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Mazella J, 2001, CELL SIGNAL, V13, P1, DOI 10.1016/S0898-6568(00)00130-3; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miller FD, 2001, NEURON, V32, P767, DOI 10.1016/S0896-6273(01)00529-3; Momose Y, 2002, ANN NEUROL, V51, P133, DOI 10.1002/ana.10079; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Park JJ, 2008, MOL CELL NEUROSCI, V39, P63, DOI 10.1016/j.mcn.2008.05.016; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rong JA, 2007, J BIOL CHEM, V282, P4748, DOI 10.1074/jbc.M609057200; Rong J, 2006, J NEUROSCI, V26, P6019, DOI 10.1523/JNEUROSCI.1251-06.2006; Sarret P, 2003, J COMP NEUROL, V461, P483, DOI 10.1002/cne.10708; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vaughan KT, 2005, BBA-MOL CELL RES, V1744, P316, DOI 10.1016/j.bbamcr.2005.05.001; Ventriglia M, 2002, MOL PSYCHIATR, V7, P136, DOI 10.1038/sj.mp.4000952; von Bartheld CS, 2001, MOL NEUROBIOL, V24, P1, DOI 10.1385/MN:24:1-3:001; Wang H, 2006, EUR J NEUROSCI, V24, P2444, DOI 10.1111/j.1460-9568.2006.05138.x; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Wu LLY, 2009, CELL ADHES MIGR, V3, P71, DOI 10.4161/cam.3.1.7511; Wu LLY, 2010, J BIOL CHEM, V285, P5614, DOI 10.1074/jbc.M109.073197; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Zala D, 2008, HUM MOL GENET, V17, P3837, DOI 10.1093/hmg/ddn281; Zhou XF, 1996, NEUROSCIENCE, V74, P945, DOI 10.1016/S0306-4522(96)00237-0; Zhou XF, 2004, J NEUROCHEM, V91, P704, DOI 10.1111/j.1471-4159.2004.02775.x; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003	73	54	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.195347	http://dx.doi.org/10.1074/jbc.M110.195347			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21357693	hybrid, Green Published			2022-12-27	WOS:000290022800066
J	Kawai, M; Breggia, AC; DeMambro, VE; Shen, XC; Canalis, E; Bouxsein, ML; Beamer, WG; Clemmons, DR; Rosen, CJ				Kawai, Masanobu; Breggia, Anne C.; DeMambro, Victoria E.; Shen, Xinchun; Canalis, Ernesto; Bouxsein, Mary L.; Beamer, Wesley G.; Clemmons, David R.; Rosen, Clifford J.			The Heparin-binding Domain of IGFBP-2 Has Insulin-like Growth Factor Binding-independent Biologic Activity in the Growing Skeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKALINE-PHOSPHATASE ACTIVITY; BETA-CATENIN; FACTOR-I; TRANSGENIC MICE; IGF-I; TRANSCRIPTIONAL ACTIVITY; EXTRACELLULAR-MATRIX; PROSTATE-CANCER; BONE TURNOVER; STEM-CELLS	Insulin-like growth factor-binding protein 2 (IGFBP-2) is a member of a family of six highly conserved IGFBPs that are carriers for the insulin-like growth factors (IGFs). IGFBP-2 levels rise during rapid neonatal growth and at the time of peak bone acquisition. In contrast, Igfbp2(-/-) mice have low bone mass accompanied by reduced osteoblast numbers, low bone formation rates, and increased PTEN expression. In the current study, we postulated that IGFBP-2 increased bone mass partly through the activity of its heparin-binding domain (HBD). We synthesized a HBD peptide specific for IGFBP-2 and demonstrated in vitro that it rescued the mineralization phenotype of Igfbp2(-/-) bone marrow stromal cells and calvarial osteoblasts. Consistent with its cellular actions, the HBD peptide ex vivo stimulated metacarpal periosteal expansion. Furthermore, administration of HBD peptide to Igfbp2(-/-) mice increased osteoblast number, suppressed marrow adipogenesis, restored trabecular bone mass, and reduced bone resorption. Skeletal rescue in the Igfbp2-/- mice was characterized by reduced PTEN expression followed by enhanced Akt phosphorylation in response to IGF-I and increased beta-catenin signaling through two mechanisms: 1) stimulation of its cytosolic accumulation and 2) increased phosphorylation of serine 552. We conclude that the HBD peptide of IGFBP-2 has anabolic activity by activating IGF-I/Akt and beta-catenin signaling pathways. These data support a growing body of evidence that IGFBP-2 is not just a transport protein but rather that it functions coordinately with IGF-I to stimulate growth and skeletal acquisition.	[Kawai, Masanobu; Breggia, Anne C.; DeMambro, Victoria E.; Rosen, Clifford J.] Maine Med Ctr, Res Inst, Ctr Clin & Translat Res, Scarborough, ME 04074 USA; [Kawai, Masanobu] Osaka Med Ctr, Dept Bone & Mineral Res, Izumi Ku, Osaka 5941101, Japan; [Kawai, Masanobu] Res Inst Maternal & Child Hlth, Izumi Ku, Osaka 5941101, Japan; [Shen, Xinchun; Clemmons, David R.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Canalis, Ernesto] St Francis Hosp & Med Ctr, Dept Res, Hartford, CT 06105 USA; [Bouxsein, Mary L.] Beth Israel Deaconess Med Ctr, Orthopaed Biomech Lab, Boston, MA 02215 USA; [Bouxsein, Mary L.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Beamer, Wesley G.] Jackson Lab, Bar Harbor, ME 04609 USA	Maine Medical Center; Osaka Medical Center for Cancer & Cardiovascular Diseases; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Saint Francis Hospital & Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Jackson Laboratory	Rosen, CJ (corresponding author), Maine Med Ctr, Res Inst, Ctr Clin & Translat Res, 81 Res Dr, Scarborough, ME 04074 USA.	ROSENC@mmc.org		Kawai, Masanobu/0000-0003-4466-1559	National Institutes of Health [AR021707]; National Institutes of Arthritis, Musculoskeletal, and Skin Disorders [AR153853]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Arthritis, Musculoskeletal, and Skin Disorders	This work was supported, in whole or in part, by National Institutes of Health Grant AR021707 (to E. C.) and National Institutes of Arthritis, Musculoskeletal, and Skin Disorders Grant AR153853 (to C. J. R.).	Amin S, 2007, J BONE MINER RES, V22, P799, DOI 10.1359/JBMR.070306; Arai T, 1996, ENDOCRINOLOGY, V137, P4571, DOI 10.1210/en.137.11.4571; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; COHEN P, 1993, J CLIN ENDOCR METAB, V76, P1031, DOI 10.1210/jc.76.4.1031; Conover CA, 2002, GROWTH HORM IGF RES, V12, P178, DOI 10.1016/S1096-6374(02)00044-8; DeMambro VE, 2008, ENDOCRINOLOGY, V149, P2051, DOI 10.1210/en.2007-1068; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Duan CM, 1999, P NATL ACAD SCI USA, V96, P15274, DOI 10.1073/pnas.96.26.15274; Eckstein F, 2002, ANAT EMBRYOL, V206, P139, DOI 10.1007/s00429-002-0282-5; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Glass DA, 2006, CURR TOP DEV BIOL, V73, P43, DOI 10.1016/S0070-2153(05)73002-7; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hedbacker K, 2010, CELL METAB, V11, P11, DOI 10.1016/j.cmet.2009.11.007; Hoeflich A, 2001, ENDOCRINOLOGY, V142, P1889, DOI 10.1210/en.142.5.1889; Hu DL, 2009, J AM GERIATR SOC, V57, P1213, DOI 10.1111/j.1532-5415.2009.02318.x; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kawai M, 2009, PEDIATR NEPHROL, V24, P1277, DOI 10.1007/s00467-008-1040-6; Khosla S, 1998, J CLIN INVEST, V101, P2165, DOI 10.1172/JCI1111; Levitt RJ, 2005, BIOCHEM BIOPH RES CO, V336, P1056, DOI 10.1016/j.bbrc.2005.08.229; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Maile LA, 2008, J CELL BIOCHEM, V105, P437, DOI 10.1002/jcb.21841; Mehrian-Shai R, 2007, P NATL ACAD SCI USA, V104, P5563, DOI 10.1073/pnas.0609139104; Palermo C, 2004, AM J PHYSIOL-ENDOC M, V286, pE648, DOI 10.1152/ajpendo.00049.2003; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Perks CM, 2007, ONCOGENE, V26, P5966, DOI 10.1038/sj.onc.1210397; Playford MP, 2000, P NATL ACAD SCI USA, V97, P12103, DOI 10.1073/pnas.210394297; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Russo VC, 1999, ENDOCRINOLOGY, V140, P3082, DOI 10.1210/en.140.7.3082; Russo VC, 1997, ENDOCRINOLOGY, V138, P4858, DOI 10.1210/en.138.11.4858; Russo VC, 2005, ENDOCRINOLOGY, V146, P4445, DOI 10.1210/en.2005-0467; Sakata T, 2004, J BONE MINER RES, V19, P436, DOI 10.1359/JBMR.0301241; Shoba LNN, 2003, J CELL BIOCHEM, V88, P1247, DOI 10.1002/jcb.10474; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Wang YM, 2006, J BONE MINER RES, V21, P1350, DOI 10.1359/JBMR.060610; Wheatcroft SB, 2007, DIABETES, V56, P285, DOI 10.2337/db06-0436; Wood TL, 2000, MOL ENDOCRINOL, V14, P1472, DOI 10.1210/me.14.9.1472; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhao G, 2000, ENDOCRINOLOGY, V141, P2674, DOI 10.1210/en.141.7.2674	47	41	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14670	14680		10.1074/jbc.M110.193334	http://dx.doi.org/10.1074/jbc.M110.193334			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21372140	Green Published, hybrid			2022-12-27	WOS:000289556200086
J	Dellis, O; Arbabian, A; Papp, B; Rowe, M; Joab, I; Chomienne, C				Dellis, Olivier; Arbabian, Atousa; Papp, Bela; Rowe, Martin; Joab, Irene; Chomienne, Christine			Epstein-Barr Virus Latent Membrane Protein 1 Increases Calcium Influx through Store-operated Channels in B Lymphoid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-LYMPHOCYTES; IP3 RECEPTORS; CA2+ ENTRY; EXPRESSION; ORAI1; INHIBITION; ACTIVATION; DEFICIENCY; MODULATION; INDUCTION	Ca2+ signaling plays an important role in B cell survival and activation and is dependent on Ca2+ trapped in the endoplasmic reticulum (ER) and on extracellular Ca2+. Epstein-Barr virus (EBV) can immortalize B cells and contributes to lymphomagenesis. Previously, we showed that the ER Ca2+ content of Burkitt lymphoma cell lines was increased following infection with immortalization-competent virus expressing the full set of EBV latency genes (B95-8). In contrast, infection with an immortalization-deficient virus (P3HR-1) not expressing LMP-1 is without effect. LMP-1 protein expression was sufficient to increase the ER Ca2+ content and to increase the cytosolic Ca2+ concentration ([Ca2+](cyt)). In this follow-up study, we showed that the resting [Ca2+](cyt) of P3HR-1-infected cells was decreased, implying that EBV not only modified the ER homeostasis but also affected the cytosolic Ca2+ homeostasis. Furthermore, even if the store-operated calcium entry (SOCE) of these cells was normal, the [Ca2+](cyt) increase after thapsigargin + CaCl2 stimulation was blunted. In contrast, the resting [Ca2+](cyt) of B95-8 infected cells was not changed, even if their SOCE was increased significantly. When expressed alone, LMP-1 induced an increase of the SOCE amplitude and the expression of the protein allowing this influx, Orai1, showing the effect of EBV on SOCE of B cells are mediated by LMP-1. However, other hitherto unidentified EBV processes, unmasked in P3HR-1 infected cells, counteract this LMP-1-dependent increase of SOCE amplitude to impair a general and potentially toxic increase of [Ca2+](i). Thus, EBV infection modifies the cellular Ca2+ homeostasis by acting on the ER and plasma membrane transporters.	[Dellis, Olivier; Arbabian, Atousa; Papp, Bela; Chomienne, Christine] Univ Paris 07, INSERM, UMR S 940, Inst Univ Hematol, Paris, France; [Dellis, Olivier] Univ Paris 11, INSERM, UMR S 757, F-91405 Orsay, France; [Rowe, Martin] Univ Birmingham, Sch Med, Sch Canc Sci, Edgbaston, England; [Joab, Irene] Univ Paris 11, INSERM, UMR S 1014, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Birmingham; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Dellis, O (corresponding author), Univ Paris 11, INSERM, UMR S 757, Rue Adeles, F-91405 Orsay, France.	olivier.dellis@inserm.fr	Rowe, Martin/B-2880-2009; Dellis, Olivier/E-8501-2011	Rowe, Martin/0000-0003-4139-7326; Dellis, Olivier/0000-0003-0377-9163; CHOMIENNE, Christine/0000-0001-5513-5752; Papp, Bela/0000-0002-5025-3087	INSERM; Association pour la Recherche contre le Cancer; Cancer Research UK, London; Medical Research Council [G9818340B] Funding Source: researchfish	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Cancer Research UK, London(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by INSERM and the Association pour la Recherche contre le Cancer.; Supported by Cancer Research UK, London.	Brouland JP, 2005, AM J PATHOL, V167, P233, DOI 10.1016/S0002-9440(10)62968-9; CALENDER A, 1987, P NATL ACAD SCI USA, V84, P8060, DOI 10.1073/pnas.84.22.8060; CHUNG SC, 1994, BRIT J PHARMACOL, V113, P861, DOI 10.1111/j.1476-5381.1994.tb17072.x; Cloonan SM, 2011, INT J CANCER, V128, P1712, DOI 10.1002/ijc.25477; Dellis O, 2002, J BIOL CHEM, V277, P6044, DOI 10.1074/jbc.M111831200; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Dellis O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-59; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; FAGGIONI A, 1986, SCIENCE, V232, P1554, DOI 10.1126/science.3012779; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Floettmann JE, 1996, VIROLOGY, V223, P29, DOI 10.1006/viro.1996.0452; Gelebart P, 2002, J BIOL CHEM, V277, P26310, DOI 10.1074/jbc.M201747200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harr MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005579; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Kawa K, 2000, INT J HEMATOL, V71, P108; Lee DY, 2008, ONCOGENE, V27, P2833, DOI 10.1038/sj.onc.1210946; Li HP, 2003, J BIOMED SCI, V10, P490, DOI 10.1159/000072376; McCarl CA, 2009, J ALLERGY CLIN IMMUN, V124, P1311, DOI 10.1016/j.jaci.2009.10.007; MENEZES J, 1975, BIOMEDICINE, V22, P276; MILLER CL, 1993, J VIROL, V67, P3087, DOI 10.1128/JVI.67.6.3087-3094.1993; Morita T, 2009, J CELL SCI, V122, P1220, DOI 10.1242/jcs.041640; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; OWEN CS, 1993, ANAL BIOCHEM, V215, P90, DOI 10.1006/abio.1993.1559; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Putney J W Jr, 2001, Mol Interv, V1, P84; Robert C, 2006, CANCER RES, V66, P6336, DOI 10.1158/0008-5472.CAN-06-0078; Scrimgeour N, 2009, J PHYSIOL-LONDON, V587, P2903, DOI 10.1113/jphysiol.2009.170662; SINCLAIR AJ, 1992, CELL GROWTH DIFFER, V3, P557; WANG F, 1990, J VIROL, V64, P3407, DOI 10.1128/JVI.64.7.3407-3416.1990; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019	35	27	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18583	18592		10.1074/jbc.M111.222257	http://dx.doi.org/10.1074/jbc.M111.222257			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454636	Green Published, hybrid			2022-12-27	WOS:000290785700030
J	Hamamura, K; Tsuji, M; Hotta, H; Ohkawa, Y; Takahashi, M; Shibuya, H; Nakashima, H; Yamauchi, Y; Hashimoto, N; Hattori, H; Ueda, M; Furukawa, K; Furukawa, K				Hamamura, Kazunori; Tsuji, Momoko; Hotta, Hiroshi; Ohkawa, Yuki; Takahashi, Masataka; Shibuya, Hidenobu; Nakashima, Hideyuki; Yamauchi, Yoshio; Hashimoto, Noboru; Hattori, Hisashi; Ueda, Minoru; Furukawa, Keiko; Furukawa, Koichi			Functional Activation of Src Family Kinase Yes Protein Is Essential for the Enhanced Malignant Properties of Human Melanoma Cells Expressing Ganglioside GD3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G(D3) SYNTHASE GENE; C-YES; CARCINOMA CELLS; DOWN-REGULATION; LIPID RAFTS; PC12 CELLS; GROWTH; CANCER; PROLIFERATION; LOCALIZATION	The possible roles of Src family kinases in the enhanced malignant properties of melanomas related to GD3 expression were analyzed. Among Src family kinases only Yes, not Fyn or Src, was functionally involved in the increased cell proliferation and invasion of GD3-expressing transfectant cells (GD3+). Yes was located upstream of p130Cas and paxillin and at an equivalent level to focal adhesion kinase. Yes underwent autophosphorylation even before serum treatment and showed stronger kinase activity in GD3+ cells than in GD3- cells following serum treatment. Coimmunoprecipitation experiments revealed that Yes bound to focal adhesion kinase or p130Cas more strongly in GD3+ cells than in GD3-cells. As a possible mechanism for the enhancing effects of GD3 on cellular phenotypes, it was shown that majority of Yes was localized in glycolipid-enriched microdomain/rafts in GD3+ cells even before serum treatment, whereas it was scarcely detected in glycolipid-enriched microdomain/rafts in GD3- cells. An in vitro kinase assay of Yes revealed that coexistence of GD3 with Yes in membranous environments enhances the kinase activity of GD3- cell-derived Yes toward enolase, p125, and Yes itself. Knock-down of GD3 synthase resulted in the alleviation of tumor phenotypes and reduced activation levels of Yes. Taken together, these results suggest a role of GD3 in the regulation of Src family kinases.	[Hamamura, Kazunori; Tsuji, Momoko; Hotta, Hiroshi; Ohkawa, Yuki; Takahashi, Masataka; Shibuya, Hidenobu; Nakashima, Hideyuki; Yamauchi, Yoshio; Hashimoto, Noboru; Furukawa, Keiko; Furukawa, Koichi] Nagoya Univ, Grad Sch Med, Showa Ku, Dept Biochem 2, Nagoya, Aichi 4660065, Japan; [Hotta, Hiroshi; Shibuya, Hidenobu; Nakashima, Hideyuki; Hattori, Hisashi; Ueda, Minoru] Nagoya Univ, Grad Sch Med, Showa Ku, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4660065, Japan; [Furukawa, Keiko] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 4878501, Japan	Nagoya University; Nagoya University; Chubu University	Furukawa, K (corresponding author), Nagoya Univ, Grad Sch Med, Showa Ku, Dept Biochem 2, 65 Tsurumai, Nagoya, Aichi 4660065, Japan.	koichi@med.nagoya-u.ac.jp	Yamauchi, Yoshio/I-7539-2014	Yamauchi, Yoshio/0000-0001-5559-4596; Hamamura, Kazunori/0000-0002-8143-338X	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT).	Barraclough J, 2007, NEOPLASIA, V9, P745, DOI 10.1593/neo.07442; Bhunia AK, 2002, J BIOL CHEM, V277, P16396, DOI 10.1074/jbc.M200877200; Birkle S, 2000, J NEUROCHEM, V74, P547, DOI 10.1046/j.1471-4159.2000.740547.x; Daniotti JL, 2002, NEUROCHEM RES, V27, P1421, DOI 10.1023/A:1021684018665; Evans SV, 1999, J MOL RECOGNIT, V12, P155, DOI 10.1002/(SICI)1099-1352(199905/06)12:3<155::AID-JMR456>3.0.CO;2-S; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Furukawa K, 2007, COMPREHENSIVE GLYCOS, V4, P149; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P143, DOI 10.1023/A:1026524820177; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; Hamamura K, 2005, P NATL ACAD SCI USA, V102, P11041, DOI 10.1073/pnas.0503658102; Hamamura K, 2008, BBA-GEN SUBJECTS, V1780, P513, DOI 10.1016/j.bbagen.2007.11.002; Han NM, 1996, CLIN CANCER RES, V2, P1397; HARAGUCHI M, 1994, P NATL ACAD SCI USA, V91, P10455, DOI 10.1073/pnas.91.22.10455; Kasahara K, 1997, J BIOL CHEM, V272, P29947, DOI 10.1074/jbc.272.47.29947; Kasai A, 2005, GENES CELLS, V10, P1175, DOI 10.1111/j.1365-2443.2005.00909.x; Ko K, 2006, ONCOGENE, V25, P6924, DOI 10.1038/sj.onc.1209683; LEDEEN RW, 1982, METHOD ENZYMOL, V83, P139; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; LOGANZO F, 1993, ONCOGENE, V8, P2637; Marchetti D, 1998, ONCOGENE, V16, P3253, DOI 10.1038/sj.onc.1201877; McCabe JB, 2001, MOL BIOL CELL, V12, P3601, DOI 10.1091/mbc.12.11.3601; Mitsuda T, 2002, J BIOL CHEM, V277, P11239, DOI 10.1074/jbc.M107756200; Moon SK, 2004, J BIOL CHEM, V279, P33063, DOI 10.1074/jbc.M313462200; Nakano J, 1996, J INVEST DERMATOL, V107, P543, DOI 10.1111/1523-1747.ep12582802; Nishio M, 2004, J BIOL CHEM, V279, P33368, DOI 10.1074/jbc.M403816200; Ohkawa Y, 2008, BIOCHEM BIOPH RES CO, V373, P14, DOI 10.1016/j.bbrc.2008.05.149; Okada M, 1996, CANCER RES, V56, P2844; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; PARK J, 1995, MOL CELL BIOL, V15, P2374; SUGAWARA K, 1991, BRIT J CANCER, V63, P508, DOI 10.1038/bjc.1991.121; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Wiegandt H, 1985, GLYCOLIPIDS, V10, P199, DOI DOI 10.1016/S0167-7306(08)60022-8; YAMASHIRO S, 1995, GLYCOCONJUGATE J, V12, P894, DOI 10.1007/BF00731251; Yoshida S, 2001, CANCER RES, V61, P4244; Zeng GC, 2000, INT J CANCER, V88, P53, DOI 10.1002/1097-0215(20001001)88:1<53::AID-IJC8>3.0.CO;2-7; Zhang Q, 2006, J BIOL CHEM, V281, P18145, DOI 10.1074/jbc.M512566200	36	46	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18526	18537		10.1074/jbc.M110.164798	http://dx.doi.org/10.1074/jbc.M110.164798			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454696	Green Published, hybrid			2022-12-27	WOS:000290785700025
J	Jo, C; Cho, SJ; Jo, SA				Jo, Chulman; Cho, Sun-Jung; Jo, Sangmee Ahn			Mitogen-activated Protein Kinase Kinase 1 (MEK1) Stabilizes MyoD through Direct Phosphorylation at Tyrosine 156 During Myogenic Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE ATROPHY; IN-VIVO; REGULATORY FACTORS; UBIQUITIN LIGASE; NUCLEAR EXPORT; DNA-BINDING; MAP KINASE; HUMAN P53; C-MOS; TRANSCRIPTION	Previously, we reported that mitogen-activated protein kinase kinase 1 (MEK1) activated in the mid-stage of skeletal muscle differentiation promotes myogenic differentiation. To elucidate the molecular mechanism, we investigated an activity of MEK1 for MyoD. Activated MEK1 associates with MyoD in the nucleus of differentiating myoblasts. In vitro kinase assay using active MEK1, a P-32-labeled protein band corresponding to GST-MyoD was observed but not to mutant GST-MyoD-Y156F. Tyrosine phosphorylation of endogenous MyoD was detected with a specific anti-pMyoD-Y156 antibody; however, this response was blocked by PD184352, a MEK-specific inhibitor. These results indicate that activated MEK1 phosphorylates the MyoD-Y156 residue directly. Interestingly, the protein level of mutant MyoD-Y156F decreased compared with that of wild type but was recovered in the presence of lactacystin, a proteasome inhibitor. The protein level of MyoD-Y156E, which mimics phosphorylation at Tyr-156, was above that of wild type, indicating that the phosphorylation protects MyoD from the ubiquitin proteasome-mediated degradation. In addition, the low protein level of MyoD-Y156F was recovered over that of wild type by an additional mutation at Leu-164, a critical binding residue of MAFbx/AT-1, a Skp, Cullin, F-box (SCF) E3-ubiquitin ligase. The amount of MyoD co-precipitated with MAFbx/AT-1 also was reduced in the presence of active MEK1. Thus, these results suggested that the phosphorylation probably interrupts the binding of MAFbx/AT-1 to MyoD and thereby increases its stability. Collectively, our results suggest that MEK1 activated in differentiating myoblasts stimulates muscle differentiation by phosphorylating MyoD-Y156, which results in MyoD stabilization.	[Jo, Sangmee Ahn] Dankook Univ, Dept Pharm, Coll Pharm, Cheonan Si 330714, Chungnam, South Korea; [Jo, Chulman; Cho, Sun-Jung; Jo, Sangmee Ahn] Korea Ctr Dis Control & Prevent, Div Brain Dis, Ctr Biomed Sci, Natl Inst Hlth, Gangoe Myeon 363951, Chungcheongbuk, South Korea	Dankook University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science	Jo, SA (corresponding author), Dankook Univ, Dept Pharm, Coll Pharm, San 29 Anseo Dong, Cheonan Si 330714, Chungnam, South Korea.	smahn@dankook.ac.kr			National Institute of Health (Korea) [4800-4845-300-210]	National Institute of Health (Korea)	This work was supported by an intramural research fund (4800-4845-300-210) from the National Institute of Health (Korea) and conducted by the Research Fund of Dankook University in 2010.	Abu Hatoum O, 1998, MOL CELL BIOL, V18, P5670, DOI 10.1128/MCB.18.10.5670; Bardwell L, 1996, TRENDS BIOCHEM SCI, V21, P373, DOI 10.1016/S0968-0004(96)30032-7; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; BLAIR WS, 1994, MOL CELL BIOL, V14, P7226, DOI 10.1128/MCB.14.11.7226; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Dorman CM, 1999, ONCOGENE, V18, P5167, DOI 10.1038/sj.onc.1202907; Fukuda M, 1997, J BIOL CHEM, V272, P32642, DOI 10.1074/jbc.272.51.32642; Galceran J, 2003, J NEURAL TRANSM-SUPP, P139; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gredinger E, 1998, J BIOL CHEM, V273, P10436, DOI 10.1074/jbc.273.17.10436; Hughes SM, 1997, MECH DEVELOP, V61, P151, DOI 10.1016/S0925-4773(96)00631-4; Ishido M, 2004, ACTA PHYSIOL SCAND, V180, P281, DOI 10.1046/j.0001-6772.2003.01238.x; Ishido M, 2004, AM J PHYSIOL-CELL PH, V287, pC484, DOI 10.1152/ajpcell.00080.2004; Jaaro H, 1997, P NATL ACAD SCI USA, V94, P3742, DOI 10.1073/pnas.94.8.3742; Jo C, 2005, PROTEIN PEPTIDE LETT, V12, P631, DOI 10.2174/0929866054696064; Jo C, 2005, BBA-MOL CELL RES, V1743, P187, DOI 10.1016/j.bbamcr.2004.11.002; Jo C, 2009, CELL SIGNAL, V21, P1910, DOI 10.1016/j.cellsig.2009.08.008; Kitzmann M, 1999, MOL CELL BIOL, V19, P3167; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; LEIBOVITCH SA, 1991, ONCOGENE, V6, P1617; Lenormand JL, 1997, MOL CELL BIOL, V17, P584, DOI 10.1128/MCB.17.2.584; Lingbeck JM, 2003, J BIOL CHEM, V278, P1817, DOI 10.1074/jbc.M208815200; Liu LN, 1998, CELL GROWTH DIFFER, V9, P699; Maki K, 2008, J IMMUNOL, V181, P494, DOI 10.4049/jimmunol.181.1.494; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Murton AJ, 2008, BBA-MOL BASIS DIS, V1782, P730, DOI 10.1016/j.bbadis.2008.10.011; Pelpel K, 2000, FEBS LETT, V474, P233, DOI 10.1016/S0014-5793(00)01610-0; Perry RLS, 2001, MOL CELL, V8, P291, DOI 10.1016/S1097-2765(01)00302-1; Puri PL, 2002, NAT GENET, V32, P585, DOI 10.1038/ng1023; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Reynaud EG, 1999, MOL CELL BIOL, V19, P7621; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Song A, 1998, MOL CELL BIOL, V18, P4994, DOI 10.1128/MCB.18.9.4994; Takahashi-Yanaga F, 2004, BIOCHEM BIOPH RES CO, V316, P411, DOI 10.1016/j.bbrc.2004.02.061; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Unger T, 1999, EMBO J, V18, P1805, DOI 10.1093/emboj/18.7.1805; Zetser A, 2001, DEV BIOL, V240, P168, DOI 10.1006/dbio.2001.0465; Zhao WD, 2005, J CELL BIOCHEM, V96, P209, DOI 10.1002/jcb.20468	46	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18903	18913		10.1074/jbc.M111.225128	http://dx.doi.org/10.1074/jbc.M111.225128			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454680	hybrid, Green Published			2022-12-27	WOS:000290785700062
J	Yu, ZX; Brodsky, B; Inouye, M				Yu, Zhuoxin; Brodsky, Barbara; Inouye, Masayori			Dissecting a Bacterial Collagen Domain from Streptococcus pyogenes SEQUENCE AND LENGTH-DEPENDENT VARIATIONS IN TRIPLE HELIX STABILITY AND FOLDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-STRUCTURE; PROCOLLAGEN-II; SCL2 PROTEINS; STABILIZATION; STABILITY; IDENTIFICATION; DELETION	To better investigate the relationship between sequence, stability, and folding, the Streptococcus pyogenes collagenous domain CL (Gly-Xaa-Yaa)(79) was divided to create three recombinant triple helix subdomains A, B, and C of almost equal size with distinctive amino acid features: an A domain high in polar residues, a B domain containing the highest concentration of Pro residues, and a very highly charged C domain. Each segment was expressed as a monomer, a linear dimer, and a linear trimer fused with the trimerization domain (V domain) in Escherichia coli. All recombinant proteins studied formed stable triple helical structures, but the stability varied depending on the amino acid sequence in the A, B, and C segments and increased as the triple helix got longer. V-AAA was found to melt at a much lower temperature (31.0 degrees C) than V-ABC (V-CL), whereas V-BBB melted at almost the same temperature (similar to 36-37 degrees C). When heat-denatured, the V domain enhanced refolding for all of the constructs; however, the folding rate was affected by their amino acid sequences and became reduced for longer constructs. The folding rates of all the other constructs were lower than that of the natural V-ABC protein. Amino acid substitution mutations at all Pro residues in the C fragment dramatically decreased stability but increased the folding rate. These results indicate that the thermostability of the bacterial collagen is dominated by the most stable domain in the same manner as found with eukaryotic collagens.	[Yu, Zhuoxin; Brodsky, Barbara; Inouye, Masayori] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Yu, Zhuoxin; Inouye, Masayori] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Tufts University	Brodsky, B (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	Barbara.Brodsky@tufts.edu; inouye@umdnj.edu	Yu, Zhuoxin/L-1512-2013		National Institutes of Health [GM60048]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60048 (to B. B.).	Arnold WV, 1998, J BIOL CHEM, V273, P31822, DOI 10.1074/jbc.273.48.31822; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; Feng YB, 1996, BIOPOLYMERS, V39, P859, DOI 10.1002/(SICI)1097-0282(199612)39:6<859::AID-BIP10>3.3.CO;2-Z; Han RL, 2006, APPL MICROBIOL BIOT, V72, P109, DOI 10.1007/s00253-006-0387-5; JOSSE J, 1964, J MOL BIOL, V9, P269, DOI 10.1016/S0022-2836(64)80207-2; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Ramachandran G.N., 1967, TREATISE COLLAGEN, P103; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Rasmussen M, 2001, MOL MICROBIOL, V40, P1427, DOI 10.1046/j.1365-2958.2001.02493.x; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; SIERON AL, 1993, J BIOL CHEM, V268, P21232; Steplewski A, 2004, J MOL BIOL, V338, P989, DOI 10.1016/j.jmb.2004.03.037; XU C, BIOMACROMOLECULES, V11, P348; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134; Yu ZX, 2010, PROTEIN SCI, V19, P775, DOI 10.1002/pro.356	22	29	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18960	18968		10.1074/jbc.M110.217422	http://dx.doi.org/10.1074/jbc.M110.217422			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454494	hybrid, Green Published			2022-12-27	WOS:000290785700067
J	Gunaratne, J; Goh, MX; Swa, HLF; Lee, FY; Sanford, E; Wong, LM; Hogue, KA; Blackstock, WP; Okumura, K				Gunaratne, Jayantha; Goh, Mei Xian; Swa, Hannah Lee Foon; Lee, Fen Yee; Sanford, Emma; Wong, Loke Meng; Hogue, Kelly A.; Blackstock, Walter P.; Okumura, Koichi			Protein Interactions of Phosphatase and Tensin Homologue (PTEN) and Its Cancer-associated G20E Mutant Compared by Using Stable Isotope Labeling by Amino Acids in Cell Culture-based Parallel Affinity Purification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR CANDIDATE; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; GLIOMA-CELLS; DOMAIN; P53; TRANSFORMATION; COMPLEXES; MIGRATION; PATHWAY; PHOSPHORYLATION	The tumor suppressor PTEN (phosphatase and tensin homologue) negatively regulates the PI3K pathway through its lipid phosphatase activity and is one of the most commonly lost tumor suppressors in human cancers. Though the tumor suppressive function involves the lipid phosphatase-dependent and -independent activities of PTEN, the mechanism leading to the phosphatase-independent function of PTEN is understood poorly. Some PTEN mutants have lipid phosphatase activity but fail to suppress cell growth. Here, we use a cancer-associated mutant, G20E, to gain insight into the phosphatase-independent function of PTEN by investigating protein-protein interactions using MS-based stable isotope labeling by amino acids in cell culture (SILAC). A strategy named parallel affinity purification (PAP) and SILAC has been developed to prioritize interactors and to compare the interactions between wild-type and G20E PTEN. Clustering of the prioritized interactors acquired by the PAP-SILAC approach shows three distinct clusters: 1) wild-type-specific interactors, 2) interactors unique to the G20E mutant, and 3) proteins common to wild-type and mutant. These interactors are involved mainly in cell migration and apoptosis pathways. We further demonstrate that the wild-type-specific interactor, NUDTL16L1, is required for the regulatory function of wild-type PTEN in cell migration. These findings contribute to a better understanding of the mechanisms of the phosphatase-dependent and -independent functions of PTEN.	[Goh, Mei Xian; Lee, Fen Yee; Sanford, Emma; Wong, Loke Meng; Okumura, Koichi] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117456, Singapore; [Gunaratne, Jayantha; Swa, Hannah Lee Foon; Hogue, Kelly A.; Blackstock, Walter P.] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Mass Spectrometry & Syst Biol Lab, Singapore 138673, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Okumura, K (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, 28 Med Dr, Singapore 117456, Singapore.	csiko@nus.edu.sg			National Medical Research Council (NMRC), Singapore; Agency for Science, Technology, and Research (A*STAR), Singapore	National Medical Research Council (NMRC), Singapore(National Medical Research Council, Singapore); Agency for Science, Technology, and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the grant of National Medical Research Council (NMRC), Singapore and Agency for Science, Technology, and Research (A*STAR), Singapore.	Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Baciu PC, 2000, J CELL SCI, V113, P315; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Buchhop S, 1997, NUCLEIC ACIDS RES, V25, P3868, DOI 10.1093/nar/25.19.3868; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Chang CJ, 2008, MOL CELL BIOL, V28, P3281, DOI 10.1128/MCB.00310-08; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chen SH, 2008, MOL BIOL CELL, V19, P3909, DOI 10.1091/mbc.E08-04-0433; Cox DM, 2002, BIOTECHNIQUES, V33, P267, DOI 10.2144/02332bm02; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Doan AT, 2007, EXP CELL RES, V313, P2667, DOI 10.1016/j.yexcr.2007.05.013; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gunzl Arthur, 2009, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471140864.ps1919s55; Han SY, 2000, CANCER RES, V60, P3147; Hayes MJ, 2009, J BIOL CHEM, V284, P10202, DOI 10.1074/jbc.M807043200; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Maier D, 1999, CANCER RES, V59, P5479; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Okahara F, 2004, J BIOL CHEM, V279, P45300, DOI 10.1074/jbc.C400377200; Okahara F, 2006, MOL BIOL CELL, V17, P4888, DOI 10.1091/mbc.E06-04-0301; Okumura K, 2005, P NATL ACAD SCI USA, V102, P2703, DOI 10.1073/pnas.0409370102; Okumura K, 2006, J BIOL CHEM, V281, P26562, DOI 10.1074/jbc.M605391200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Selbach M, 2006, NAT METHODS, V3, P981, DOI 10.1038/nmeth972; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012	44	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18093	18103		10.1074/jbc.M111.221184	http://dx.doi.org/10.1074/jbc.M111.221184			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454687	hybrid, Green Published			2022-12-27	WOS:000290585200070
J	Li, LX; Hossain, MA; Sadat, S; Hager, L; Liu, L; Tam, L; Schroer, S; Huogen, L; Fantus, IG; Connelly, PW; Woo, M; Ng, DS				Li, Lixin; Hossain, Mohammad A.; Sadat, Sabreena; Hager, Lauren; Liu, Lu; Tam, Laetitia; Schroer, Stephanie; Huogen, Lu; Fantus, I. George; Connelly, Philip W.; Woo, Minna; Ng, Dominic S.			Lecithin Cholesterol Acyltransferase Null Mice Are Protected from Diet-induced Obesity and Insulin Resistance in a Gender-specific Manner through Multiple Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SKELETAL-MUSCLE; GENE-EXPRESSION; OXIDATIVE STRESS; ADIPOSE-TISSUE; DEFICIENT MICE; FATTY-ACID; IN-VIVO; METABOLISM; DISEASE	Complete lecithin cholesterol acyltransferase(LCAT) deficiency uniformly results in a profound HDL deficiency. We recently reported unexpected enhanced insulin sensitivity in LCAT knock-out mice in the LDL receptor knock-out background (Ldlr(-/-) x Lcat(-/-); double knock-out (DKO)), when compared with their Ldlr(-/-) x Lcat(+/+) (single knock-out (SKO)) controls. Here, we report that LCAT-deficient mice (DKO and Lcat(-/-)) are protected against high fat high sucrose (HFHS) diet-induced obesity without hypophagia in a gender-specific manner compared with their respective (SKO and WT) controls. The metabolic phenotypes are more pronounced in the females. Changes in endoplasmic reticulum stress were examined as a possible mechanism for the metabolic protection. The female DKO mice developed attenuated HFHS-induced endoplasmic reticulum stress as evidenced by a lack of increase in mRNA levels of the hepatic unfolded protein response (UPR) markers Grp78 and CHOP compared with SKO controls. The DKO female mice were also protected against diet-induced insulin resistance. In white adipose tissue of chow-fed DKO mice, we also observed a reduction in UPR, gene markers for adipogenesis, and markers for activation of Wnt signaling. In skeletal muscles of female DKO mice, we observed an unexpected increase in UCP1 in association with increase in phospho-AMPK alpha, PGC1 alpha, and UCP3 expressions. This increase in UCP1 was associated with ectopic islands of brown adipocytes between skeletal muscle fibers. Our findings suggest that LCAT deficiency confers gender-specific protection against diet-induced obesity and insulin resistance at least in part through regulation in UPR, white adipose tissue adipogenesis, and brown adipocyte partitioning.	[Li, Lixin; Hossain, Mohammad A.; Sadat, Sabreena; Hager, Lauren; Liu, Lu; Tam, Laetitia; Connelly, Philip W.; Woo, Minna; Ng, Dominic S.] St Michaels Hosp, Dept Med, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Huogen, Lu; Fantus, I. George] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Huogen, Lu; Fantus, I. George] Univ Hlth Network, Toronto Gen Res Inst, Banting & Best Diabet Ctr, Toronto, ON M5G 2C4, Canada; [Schroer, Stephanie; Woo, Minna] Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2N9, Canada; [Schroer, Stephanie; Woo, Minna] Univ Toronto, Ontario Canc Inst, Inst Med Sci, Toronto, ON M5G 2N9, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Ng, DS (corresponding author), St Michaels Hosp, Dept Med, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 30 Bond St,Shuter Wing,Rm 3-041, Toronto, ON M5B 1W8, Canada.	ngd@smh.toronto.on.ca	Connelly, Philip W/B-7583-2012; Li, Lixin/F-3034-2014	Connelly, Philip W/0000-0001-7244-6843; Li, Lixin/0000-0003-3016-4228	Heart and Stroke Foundation of Ontario [NA 6331]; Canadian Institutes of Health Research [MOP 77527, MOP-191501, MOP 97979]; Banting and Best Diabetes Center; Department of Laboratory Medicine and Pathobiology at the University of Toronto	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Banting and Best Diabetes Center; Department of Laboratory Medicine and Pathobiology at the University of Toronto	This work was supported in part by Grant-in-aid NA 6331 from the Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research Operating Grants MOP 77527 (to D.S.N.), MOP-191501 (to M. W.), and MOP 97979 (to I. G. F.); a Banting and Best Diabetes Center summer studentship (to L. T.); and Department of Laboratory Medicine and Pathobiology at the University of Toronto summer studentships (to S. S.).	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Benton CR, 2008, APPL PHYSIOL NUTR ME, V33, P843, DOI 10.1139/H08-074; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Calabresi L, 2009, CIRCULATION, V120, P628, DOI 10.1161/CIRCULATIONAHA.108.818143; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Keipert S, 2010, BBA-BIOENERGETICS, V1797, P324, DOI 10.1016/j.bbabio.2009.11.008; Li LX, 2007, AM J PHYSIOL-ENDOC M, V293, pE587, DOI 10.1152/ajpendo.00278.2007; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Moore GBT, 2001, BIOCHEM BIOPH RES CO, V283, P785, DOI 10.1006/bbrc.2001.4848; Neschen S, 2008, PHYSIOL GENOMICS, V33, P333, DOI 10.1152/physiolgenomics.00226.2007; Ng DS, 2008, CARDIOVASC PATHOL, V17, P226, DOI 10.1016/j.carpath.2007.10.001; Ng DS, 2004, J BIOL CHEM, V279, P7636, DOI 10.1074/jbc.M309439200; Ng DS, 2002, J BIOL CHEM, V277, P11715, DOI 10.1074/jbc.M112320200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Rousset X, 2009, CURR OPIN ENDOCRINOL, V16, P163, DOI 10.1097/MED.0b013e328329233b; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sethi AA, 2010, CLIN CHEM, V56, P1128, DOI 10.1373/clinchem.2009.139931; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Song H, 2006, AM J PHYSIOL-ENDOC M, V290, pE17, DOI 10.1152/ajpendo.00597.2004; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Wright WS, 2007, DIABETES, V56, P295, DOI 10.2337/db06-1339; Zhu XH, 2004, AM J PATHOL, V165, P1269, DOI 10.1016/S0002-9440(10)63386-X	36	40	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17809	17820		10.1074/jbc.M110.180893	http://dx.doi.org/10.1074/jbc.M110.180893			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454561	hybrid, Green Published			2022-12-27	WOS:000290585200044
J	Strube, CP; Homann, A; Gamer, M; Jahn, D; Seibel, J; Heinz, DW				Strube, Christian P.; Homann, Arne; Gamer, Martin; Jahn, Dieter; Seibel, Juergen; Heinz, Dirk W.			Polysaccharide Synthesis of the Levansucrase SacB from Bacillus megaterium Is Controlled by Distinct Surface Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ASPERGILLUS-AWAMORI; SUBSTRATE; SUBTILIS; ENZYMES; INULOSUCRASE; INVERTASE	Despite the widespread biological function of carbohydrates, the polysaccharide synthesis mechanisms of glycosyltransferases remain largely unexplored. Bacterial levansucrases (glycoside hydrolase family 68) synthesize high molecular weight, beta-(2,6)-linked levan from sucrose by transfer of fructosyl units. The kinetic and biochemical characterization of Bacillus megaterium levansucrase SacB variants Y247A, Y247W, N252A, D257A, and K373A reveal novel surface motifs remote from the sucrose binding site with distinct influence on the polysaccharide product spectrum. The wild type activity (k(cat)) and substrate affinity (K-m) are maintained. The structures of the SacB variants reveal clearly distinguishable subsites for polysaccharide synthesis as well as an intact active site architecture. These results lead to a new understanding of polysaccharide synthesis mechanisms. The identified surface motifs are discussed in the context of related glycosyltransferases.	[Homann, Arne; Seibel, Juergen] Univ Wurzburg, Dept Organ Chem, D-97074 Wurzburg, Germany; [Strube, Christian P.; Heinz, Dirk W.] Helmholtz Ctr Infect Res, Dept Mol Struct Biol, D-38124 Braunschweig, Germany; [Gamer, Martin; Jahn, Dieter] Tech Univ Carolo Wilhelmina Braunschweig, Dept Microbiol, D-38106 Braunschweig, Germany	University of Wurzburg; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology	Seibel, J (corresponding author), Univ Wurzburg, Dept Organ Chem, D-97074 Wurzburg, Germany.	seibel@chemie.uni-wuerzburg.de; dih@helmholtz-hzi.de	Seibel, Juergen/A-6908-2015	Seibel, Juergen/0000-0002-8036-4853; Jahn, Dieter/0000-0002-4064-9205	Deutsche Forschungsgemeinschaft through Collaborative Research Centre [(SFB) 578]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft through Collaborative Research Centre(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft through Collaborative Research Centre (SFB) 578.; Supported by the Fonds der Chemischen Industrie.	Alberto F, 2006, BIOCHEM J, V395, P457, DOI [10.1042/BJ20051936, 10.1042/Bj20051936]; Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beine R, 2008, J BIOTECHNOL, V138, P33, DOI 10.1016/j.jbiotec.2008.07.1998; Beisel HG, 1999, EMBO J, V18, P2313, DOI 10.1093/emboj/18.9.2313; CHAMBERT R, 1974, EUR J BIOCHEM, V41, P285, DOI 10.1111/j.1432-1033.1974.tb03269.x; CHAMBERT R, 1991, BIOCHEM J, V279, P35, DOI 10.1042/bj2790035; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DWEK RA, 1996, GLYCOBIOLOGY, V96, P97; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEINGOLD DS, 1956, BIOCHEM J, V64, P351, DOI 10.1042/bj0640351; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HESTRIN S, 1956, BIOCHEM J, V64, P340, DOI 10.1042/bj0640340; Homann A, 2007, BIOCHEM J, V407, P189, DOI 10.1042/BJ20070600; Homann A, 2009, NAT PROD REP, V26, P1555, DOI 10.1039/b909990p; Homann A, 2009, APPL MICROBIOL BIOT, V83, P209, DOI 10.1007/s00253-009-1989-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kralj S, 2004, MICROBIOL-SGM, V150, P2099, DOI 10.1099/mic.0.27105-0; Kralj S, 2008, FEBS J, V275, P6002, DOI 10.1111/j.1742-4658.2008.06729.x; Kulminskaya AA, 2003, BBA-PROTEINS PROTEOM, V1650, P22, DOI 10.1016/S1570-9639(03)00187-0; MANTSALA P, 1982, FEMS MICROBIOL LETT, V13, P395, DOI 10.1016/0378-1097(82)90198-7; Martinez-Fleites C, 2005, BIOCHEM J, V390, P19, DOI 10.1042/BJ20050324; Meng G, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-16; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagem RAP, 2004, J MOL BIOL, V344, P471, DOI 10.1016/j.jmb.2004.09.024; Ozimek LK, 2006, MICROBIOL-SGM, V152, P1187, DOI 10.1099/mic.0.28484-0; van Hijum SAFT, 2006, MICROBIOL MOL BIOL R, V70, P157, DOI 10.1128/MMBR.70.1.157-176.2006; van Hijum SAFT, 2003, FEBS LETT, V534, P207, DOI 10.1016/S0014-5793(02)03841-3; Varki A., 1999, ESSENTIALS GLYCOBIOL; Wong C.-H., 2003, CARBOHYDRATE BASED D	31	76	80	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17593	17600		10.1074/jbc.M110.203166	http://dx.doi.org/10.1074/jbc.M110.203166			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454585	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000290585200022
J	Dar, AA; Majid, S; de Semir, D; Nosrati, M; Bezrookove, V; Kashani-Sabet, M				Dar, Altaf A.; Majid, Shahana; de Semir, David; Nosrati, Mehdi; Bezrookove, Vladimir; Kashani-Sabet, Mohammed			miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER; TARGET GENES; EXPRESSION; MICRORNAS; APOPTOSIS; FAMILY; DIFFERENTIATION; OVEREXPRESSION; PROGRESSION; METASTASIS	MicroRNAs (miRNAs) regulate gene expression by repressing translation or directing sequence-specific degradation of complementary mRNA. Here, we report that expression of miR-205 is significantly suppressed in melanoma specimens when compared with nevi and is correlated inversely with melanoma progression. miRNA target databases predicted E2F1 and E2F5 as putative targets. The expression levels of E2F1 and E2F5 were correlated inversely with that of miR-205 in melanoma cell lines. miR-205 significantly suppressed the luciferase activity of reporter plasmids containing the 3'-UTR sequences complementary to either E2F1 or E2F5. Overexpression of miR-205 in melanoma cells reduced E2F1 and E2F5 protein levels. The proliferative capacity of melanoma cells was suppressed by miR-205 and mediated by E2F-regulated AKT phosphorylation. miR-205 overexpression resulted in induction of apoptosis, as evidenced by increased cleaved caspase-3, poly-(ADP-ribose) polymerase, and cytochrome c release. Stable overexpression of miR-205 suppressed melanoma cell proliferation, colony formation, and tumor cell growth in vivo and induced a senescence phenotype accompanied by elevated expression of p16INK4A and other markers for senescence. E2F1 overexpression in miR-205-expressing cells partially reversed the effects on melanoma cell growth and senescence. These results demonstrate a novel role for miR-205 as a tumor suppressor in melanoma.	[Kashani-Sabet, Mohammed] Calif Pacific Med Ctr, Ctr Melanoma Res & Treatment, Res Inst, San Francisco, CA 94107 USA; [Majid, Shahana] Vet Affairs Med Ctr, Dept Urol, San Francisco, CA 94121 USA; [Majid, Shahana] Univ Calif San Francisco, San Francisco, CA 94121 USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Kashani-Sabet, M (corresponding author), Calif Pacific Med Ctr, Ctr Melanoma Res & Treatment, Res Inst, 475 Brannan St,Ste 220, San Francisco, CA 94107 USA.	kashani@cpmcri.org			National Institutes of Health, United States Public Health Service [CA114337, CA122947]; Herschel and Diana Zackheim Endowment Fund; NATIONAL CANCER INSTITUTE [R01CA122947, R01CA114337] Funding Source: NIH RePORTER	National Institutes of Health, United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Herschel and Diana Zackheim Endowment Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, United States Public Health Service Grants CA114337 and CA122947 (to M. K.-S.). This work was also supported by the Herschel and Diana Zackheim Endowment Fund.	Alla V, 2010, JNCI-J NATL CANCER I, V102, P127, DOI 10.1093/jnci/djp458; Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Dar AA, 2008, CANCER-AM CANCER SOC, V112, P1688, DOI 10.1002/cncr.23371; Dar AA, 2010, J INVEST DERMATOL, V130, P2071, DOI 10.1038/jid.2010.70; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Guo XM, 2007, CIRC RES, V101, P1113, DOI 10.1161/CIRCRESAHA.107.157644; Haferkamp S, 2008, AGING CELL, V7, P733, DOI 10.1111/j.1474-9726.2008.00422.x; Halaban R, 2000, J EXP MED, V191, P1005, DOI 10.1084/jem.191.6.1005; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang EY, 2001, ONCOGENE, V20, P7051, DOI 10.1038/sj.onc.1204897; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kitago M, 2009, CLIN CANCER RES, V15, P2988, DOI 10.1158/1078-0432.CCR-08-3172; Kothandaraman Narasimhan, 2010, BMC Cancer, V10, P64, DOI 10.1186/1471-2407-10-64; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Ladu S, 2008, GASTROENTEROLOGY, V135, P1322, DOI 10.1053/j.gastro.2008.07.012; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Michael MZ, 2003, MOL CANCER RES, V1, P882; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nelson MA, 2006, CANCER BIOL THER, V5, P407, DOI 10.4161/cbt.5.4.2512; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Pierce AM, 1999, MOL CELL BIOL, V19, P6408; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; SAITO M, 1995, GENOMICS, V25, P130, DOI 10.1016/0888-7543(95)80118-6; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Thomas GV, 2004, CLIN CANCER RES, V10, P8351, DOI 10.1158/1078-0432.CCR-04-0130; Tong AW, 2008, CANCER GENE THER, V15, P341, DOI 10.1038/cgt.2008.8; Tuve S, 2004, INT J CANCER, V108, P162, DOI 10.1002/ijc.11552; Umemura S, 2009, BRIT J CANCER, V100, P764, DOI 10.1038/sj.bjc.6604900; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yi R, 2010, CELL DEATH DIFFER, V17, P229, DOI 10.1038/cdd.2009.92	51	185	192	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16606	16614		10.1074/jbc.M111.227611	http://dx.doi.org/10.1074/jbc.M111.227611			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454583	Green Published, hybrid			2022-12-27	WOS:000290301900009
J	Larue, K; Ford, RC; Willis, LM; Whitfield, C				Larue, Kane; Ford, Robert C.; Willis, Lisa M.; Whitfield, Chris			Functional and Structural Characterization of Polysaccharide Co-polymerase Proteins Required for Polymer Export in ATP-binding Cassette Transporter-dependent Capsule Biosynthesis Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT SUCCINOGLYCAN; CELL-SURFACE EXPRESSION; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; OUTER-MEMBRANE; CHAIN-LENGTH; NEISSERIA-MENINGITIDIS; POLYSIALIC ACID; GENE-CLUSTER; TYROSINE AUTOKINASE	Neisseria meningitidis serogroup B and Escherichia coli K1 bacteria produce a capsular polysaccharide (CPS) that is composed of alpha 2,8-linked polysialic acid (PSA). Biosynthesis of PSA in these bacteria occurs via an ABC (ATP-binding cassette) transporter-dependent pathway. In N. meningitidis, export of PSA to the surface of the bacterium requires two proteins that form an ABC transporter (CtrC and CtrD) and two additional proteins, CtrA and CtrB, that are proposed to form a cell envelope-spanning export complex. CtrA is a member of the outer membrane polysaccharide export (OPX) family of proteins, which are proposed to form a pore to mediate export of CPSs across the outer membrane. CtrB is an inner membrane protein belonging to the polysaccharide co-polymerase (PCP) family. PCP proteins involved in other bacterial polysaccharide assembly systems form structures that extend into the periplasm from the inner membrane. There is currently no structural information available for PCP or OPX proteins involved in an ABC transporter-dependent CPS biosynthesis pathway to support their proposed roles in polysaccharide export. Here, we report cryo-EM images of purified CtrB reconstituted into lipid bilayers. These images contained molecular top and side views of CtrB and showed that it formed a conical oligomer that extended similar to 125 angstrom from the membrane. This structure is consistent with CtrB functioning as a component of an envelope-spanning complex. Cross-complementation of CtrA and CtrB in E. coli mutants with defects in genes encoding the corresponding PCP and OPX proteins show that PCP-OPX pairs require interactions with their cognate partners to export polysaccharide. These experiments add further support for the model of an ABC transporter-PCP-OPX multiprotein complex that functions to export CPS across the cell envelope.	[Larue, Kane; Willis, Lisa M.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Ford, Robert C.] Univ Manchester, Fac Life Sci, Manchester M60 1QD, Lancs, England	University of Guelph; University of Manchester	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca		Ford, Robert/0000-0002-0958-1505; Willis, Lisa/0000-0001-6204-033X	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by operating funding from the Canadian Institutes of Health Research (to C. W.).	AMOS LA, 1983, PROG BIOPHYS MOL BIO, V39, P183, DOI 10.1016/0079-6107(83)90017-2; Arrecubieta C, 2001, J BIOL CHEM, V276, P4245, DOI 10.1074/jbc.M008183200; BASTIN DA, 1993, MOL MICROBIOL, V7, P725, DOI 10.1111/j.1365-2958.1993.tb01163.x; BATCHELOR RA, 1992, J BACTERIOL, V174, P5228, DOI 10.1128/JB.174.16.5228-5236.1992; BATCHELOR RA, 1991, J BACTERIOL, V173, P5699, DOI 10.1128/jb.173.18.5699-5704.1991; Bechet E, 2010, MOL MICROBIOL, V77, P1315, DOI 10.1111/j.1365-2958.2010.07291.x; Becker A, 1998, J BACTERIOL, V180, P395, DOI 10.1128/JB.180.2.395-399.1998; BECKER A, 1995, MOL MICROBIOL, V16, P191, DOI 10.1111/j.1365-2958.1995.tb02292.x; Bliss JM, 1996, MOL MICROBIOL, V21, P221, DOI 10.1046/j.1365-2958.1996.6461357.x; BRONNER D, 1993, J BACTERIOL, V175, P5984, DOI 10.1128/JB.175.18.5984-5992.1993; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CIESLEWICZ MJ, 1993, J BACTERIOL, V175, P8018, DOI 10.1128/JB.175.24.8018-8023.1993; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Clarke BR, 2009, J BIOL CHEM, V284, P30662, DOI 10.1074/jbc.M109.052878; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Collins RF, 2006, J BIOL CHEM, V281, P2144, DOI 10.1074/jbc.M508078200; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; CROSS AS, 1986, J INFECT DIS, V154, P497, DOI 10.1093/infdis/154.3.497; Culham DE, 2003, BIOCHEMISTRY-US, V42, P11815, DOI 10.1021/bi034939j; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; Daniels C, 1999, MOL MICROBIOL, V34, P181, DOI 10.1046/j.1365-2958.1999.01591.x; DEVI SJN, 1991, INFECT IMMUN, V59, P732, DOI 10.1128/IAI.59.2.732-736.1991; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Doublet P, 2002, J BIOL CHEM, V277, P37339, DOI 10.1074/jbc.M204465200; Drummelsmith J, 2000, EMBO J, V19, P57, DOI 10.1093/emboj/19.1.57; FIGUEROA J, 1993, IMMUNOL RES, V12, P295, DOI 10.1007/BF02918259; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Harvey D, 1999, SEMIN PERINATOL, V23, P218, DOI 10.1016/S0146-0005(99)80066-4; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Klein NJ, 1996, J INFECT DIS, V173, P172, DOI 10.1093/infdis/173.1.172; Kos V, 2009, J BIOL CHEM, V284, P2947, DOI 10.1074/jbc.M807213200; Larue K, 2009, J BIOL CHEM, V284, P7395, DOI 10.1074/jbc.M809068200; Lee DC, 2008, EMBO J, V27, P1758, DOI 10.1038/emboj.2008.97; Lo RYC, 2001, INFECT IMMUN, V69, P4458, DOI 10.1128/IAI.69.7.4458-4464.2001; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MCNEIL G, 1994, MICROB PATHOGENESIS, V16, P153, DOI 10.1006/mpat.1994.1016; McNulty C, 2006, MOL MICROBIOL, V59, P907, DOI 10.1111/j.1365-2958.2005.05010.x; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; Morona R, 2000, MICROBIOL-UK, V146, P1, DOI 10.1099/00221287-146-1-1; Morona R, 2009, TRENDS BIOCHEM SCI, V34, P78, DOI 10.1016/j.tibs.2008.11.001; Nesper J, 2003, J BIOL CHEM, V278, P49763, DOI 10.1074/jbc.M308775200; PAZZANI C, 1993, J BACTERIOL, V175, P5978, DOI 10.1128/JB.175.18.5978-5983.1993; Phoenix DA, 2001, BIOCHEM BIOPH RES CO, V285, P976, DOI 10.1006/bbrc.2001.5266; PLATONOV AE, 1995, CLIN EXP IMMUNOL, V100, P32, DOI 10.1111/j.1365-2249.1995.tb03600.x; Silver RP, 2001, RES MICROBIOL, V152, P357, DOI 10.1016/S0923-2508(01)01207-4; Steenbergen SM, 2008, MOL MICROBIOL, V68, P1252, DOI 10.1111/j.1365-2958.2008.06231.x; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; VIMR ER, 1985, J BACTERIOL, V164, P854, DOI 10.1128/JB.164.2.854-860.1985; VIMR ER, 1984, P NATL ACAD SCI-BIOL, V81, P1971, DOI 10.1073/pnas.81.7.1971; VIMR ER, 1989, J BACTERIOL, V171, P1106, DOI 10.1128/jb.171.2.1106-1117.1989; Vimr ER, 2009, MICROBIOL-SGM, V155, P9, DOI 10.1099/mic.0.023564-0; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200; Ye LW, 2001, J BACTERIOL, V183, P2490, DOI 10.1128/JB.183.8.2490-2496.2001	62	26	26	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16658	16668		10.1074/jbc.M111.228221	http://dx.doi.org/10.1074/jbc.M111.228221			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454677	hybrid, Green Published			2022-12-27	WOS:000290301900014
J	Peng, Z; Tang, Y; Luo, HJ; Jiang, F; Yang, JA; Sun, L; Li, JD				Peng, Zhen; Tang, Yong; Luo, Hunjin; Jiang, Fang; Yang, Jiannan; Sun, Lin; Li, Jia-Da			Disease-causing Mutation in PKR2 Receptor Reveals a Critical Role of Positive Charges in the Second Intracellular Loop for G-protein Coupling and Receptor Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-ACTIVATED RHODOPSIN; COVALENT CROSS-LINKING; KALLMANN-SYNDROME; CRYSTAL-STRUCTURE; COMPLEX-FORMATION; OLFACTORY-BULB; PROKINETICIN 2; CONTACT SITES; AMINO-ACIDS; IDENTIFICATION	Prokineticins are a pair of signal factors involved in many physiological processes by binding to two closely related G-protein-coupled receptors, PKR1 and PKR2. Recently, mutations in prokineticin 2 (PK2) and PKR2 are found to be associated with Kallmann syndrome and/or idiopathic hypogonadotropic hypogonadism, disorders characterized by delayed puberty and infertility. However, little is known how PKRs interact and activate G-proteins to elicit signal transduction. In the present study, we took advantage of one disease-associated mutation (R164Q) located in the second intracellular (IL2) loop of PKR2, to investigate the role of IL2 loop in the cell signaling, G-protein binding and receptor trafficking. R164Q mutant PKR2 showed normal cell surface expression and ligand binding capacity. However, the PKR2 signaling was abolished by R164Q mutation. We demonstrated that R164Q mutation disrupted the interaction of IL2 loop to the G alpha(q), G alpha(i), and G alpha(16)-proteins. A positive-charged amino acid at this position is required for proper function, and the signaling efficacy and potency depend on the net amount of positive charges. We also demonstrated that the interactive partner of Arg-164 may localize in the C-terminal five residues of G alpha(q)-protein. Aseries of mutation analysis indicated that the basic amino acids at the C terminus of IL2 loop may function cooperatively in GPCRs. Furthermore, R164Q mutation also results in minimal ligand-induced endocytosis of PKR2. As many GPCRs share structural homology in the C terminus of IL2 loop, our findings may have general application in understanding structure and function of GPCRs.	[Peng, Zhen; Tang, Yong; Luo, Hunjin; Jiang, Fang; Yang, Jiannan; Sun, Lin; Li, Jia-Da] Cent S Univ, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Li, Jia-Da] Cent S Univ, Sch Biol Sci & Technol, Changsha 410078, Hunan, Peoples R China	Central South University; Central South University	Li, JD (corresponding author), 110 Xiangya St, Changsha 410078, Hunan, Peoples R China.	lijiada@sklmg.edu.cn		Li, Jia-Da/0000-0002-4236-3518	National Natural Science Foundation of China [30970958, 81070481]; Hunan Province Government; Central South University of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Province Government; Central South University of China	This project was supported by National Natural Science Foundation of China (Grants 30970958 and 81070481), the Lotus Scholar Professorship Funds from Hunan Province Government, and a research grant provided by the Central South University of China.	Abreu AP, 2008, J CLIN ENDOCR METAB, V93, P4113, DOI 10.1210/jc.2008-0958; Bullock CM, 2004, MOL PHARMACOL, V65, P582, DOI 10.1124/mol.65.3.582; Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; IidaKlein A, 1997, J BIOL CHEM, V272, P6882, DOI 10.1074/jbc.272.11.6882; Itoh Y, 2001, P NATL ACAD SCI USA, V98, P4883, DOI 10.1073/pnas.051632998; Jaakola VP, 2010, CURR OPIN STRUC BIOL, V20, P401, DOI 10.1016/j.sbi.2010.05.002; Keramidas M, 2008, J ENDOCRINOL, V196, P473, DOI 10.1677/JOE-07-0255; Li JD, 2009, NEUROPSYCHOPHARMACOL, V34, P367, DOI 10.1038/npp.2008.61; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; Monnier C, 2009, HUM MOL GENET, V18, P75, DOI 10.1093/hmg/ddn318; MORO O, 1993, J BIOL CHEM, V268, P22273; Ng KL, 2005, SCIENCE, V308, P1923, DOI 10.1126/science.1112103; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Saito Y, 2005, ENDOCRINOLOGY, V146, P3452, DOI 10.1210/en.2005-0115; Sarfati J, 2010, J CLIN ENDOCR METAB, V95, P659, DOI 10.1210/jc.2009-0843; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SIBLEY DR, 1987, CELL, V48, P913, DOI 10.1016/0092-8674(87)90700-8; Sinisi AA, 2008, HUM REPROD, V23, P2380, DOI 10.1093/humrep/den247; Wacker JL, 2008, J BIOL CHEM, V283, P31068, DOI 10.1074/jbc.M805251200; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Xia S, 2004, P NATL ACAD SCI USA, V101, P15207, DOI 10.1073/pnas.0406571101; Xie W, 1997, J BIOL CHEM, V272, P24948, DOI 10.1074/jbc.272.40.24948; Zhou Q. -Y., 2008, V46, P181, DOI 10.1007/400_2007_053	37	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16615	16622		10.1074/jbc.M111.223784	http://dx.doi.org/10.1074/jbc.M111.223784			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454486	Green Published, hybrid			2022-12-27	WOS:000290301900010
J	Suzuki, T; Wakabayashi, C; Tanaka, K; Feniouk, BA; Yoshida, M				Suzuki, Toshiharu; Wakabayashi, Chiaki; Tanaka, Kazumi; Feniouk, Boris A.; Yoshida, Masasuke			Modulation of Nucleotide Specificity of Thermophilic FoF1-ATP Synthase by epsilon-Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON MOTIVE FORCE; C-TERMINAL DOMAIN; COLI ATP SYNTHASE; ESCHERICHIA-COLI; ADENOSINE-TRIPHOSPHATASE; F0F1-ATP SYNTHASE; F1F0-ATP SYNTHASE; F-1-ATPASE; ROTATION; MECHANISM	The C-terminal two alpha-helices of the epsilon-subunit of thermophilic Bacillus FoF1-ATP synthase (TFoF1) adopt two conformations: an extended long arm ("up-state") and a retracted hairpin ("down-state"). As ATP becomes poor, changes the conformation from the down-state to the up-state and suppresses further ATP hydrolysis. Using TFoF1 expressed in Escherichia coli, we compared TFoF1 with up-and down-state epsilon in the NTP (ATP, GTP, UTP, and CTP) synthesis reactions. TFoF1 with the up-state epsilon was achieved by inclusion of hexokinase in the assay and TFoF1 with the down-state epsilon was represented by epsilon Delta c-TFoF1, in which epsilon lacks C-terminal helices and hence cannot adopt the up-state under any conditions. The results indicate that TFoF1 with the down-state epsilon synthesizes GTP at the same rate of ATP, whereas TFoF1 with the up-state epsilon synthesizes GTP at a half-rate. Though rates are slow, TFoF1 with the down-state epsilon even catalyzes UTP and CTP synthesis. Authentic TFoF1 from Bacillus cells also synthesizes ATP and GTP at the same rate in the presence of adenosine 5'-(beta,gamma-imino) triphosphate (AMP-PNP), an ATP analogue that has been known to stabilize the downstate. NTP hydrolysis and NTP-driven proton pumping activity of epsilon Delta c-TFoF1 suggests similar modulation of nucleotide specificity in NTP hydrolysis. Thus, depending on its conformation, epsilon-subunit modulates substrate specificity of TFoF1.	[Suzuki, Toshiharu; Wakabayashi, Chiaki; Tanaka, Kazumi; Feniouk, Boris A.; Yoshida, Masasuke] Japan Sci & Technol Corp, Int Res Project ICORP, ATP Synth Regulat Project, Tokyo 1350064, Japan; [Yoshida, Masasuke] Kyoto Sangyo Univ, Dept Mol Biosci, Kyoto 6038555, Japan	Japan Science & Technology Agency (JST); Kyoto Sangyo University	Yoshida, M (corresponding author), Japan Sci & Technol Corp, Int Res Project ICORP, ATP Synth Regulat Project, Aomi 2-41, Tokyo 1350064, Japan.	masasuke.yoshida@cc.kyoto-su.ac.jp	Feniouk, Boris/F-2380-2012	Feniouk, Boris/0000-0003-0474-7411				BAGNARA AS, 1973, EUR J BIOCHEM, V36, P422, DOI 10.1111/j.1432-1033.1973.tb02927.x; Boyer PD, 2002, J BIOL CHEM, V277, P39045, DOI 10.1074/jbc.X200001200; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; Feniouk Boris A., 2008, V45, P279, DOI 10.1007/400_2007_043; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; Feniouk BA, 2010, BIOPHYS J, V98, P434, DOI 10.1016/j.bpj.2009.10.023; Garcia JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; Iino R, 2005, J BIOL CHEM, V280, P40130, DOI 10.1074/jbc.M506160200; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kato Y, 1997, J BIOL CHEM, V272, P24906, DOI 10.1074/jbc.272.40.24906; Kato-Yamada Y, 2003, J BIOL CHEM, V278, P36013, DOI 10.1074/jbc.M306140200; Kato-Yamada Y, 2000, J BIOL CHEM, V275, P35746, DOI 10.1074/jbc.M006575200; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; Konno H, 2004, BIOCHEM BIOPH RES CO, V318, P17, DOI 10.1016/j.bbrc.2004.03.179; Masaike T, 2006, BIOCHEM BIOPH RES CO, V342, P800, DOI 10.1016/j.bbrc.2006.02.017; MORIKAWA M, 1980, J BIOCHEM-TOKYO, V87, P441, DOI 10.1093/oxfordjournals.jbchem.a132764; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; Neidhardt F. C., 1987, CELLULAR MOL BIOL, P445; Noji H, 2001, J BIOL CHEM, V276, P25480, DOI 10.1074/jbc.M102200200; PENEFSKY HS, 1974, J BIOL CHEM, V249, P3579; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Saita E, 2010, J BIOL CHEM, V285, P11411, DOI 10.1074/jbc.M109.099143; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; SMITH JB, 1977, BIOCHEMISTRY-US, V16, P306, DOI 10.1021/bi00621a023; SONE N, 1975, J BIOL CHEM, V250, P7917; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Suzuki T, 2007, P NATL ACAD SCI USA, V104, P20776, DOI 10.1073/pnas.0708075105; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Uhlin U, 1997, STRUCTURE, V5, P1219, DOI 10.1016/S0969-2126(97)00272-4; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; WILKENS S, 1995, NAT STRUCT BIOL, V2, P961, DOI 10.1038/nsb1195-961; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	38	4	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16807	16813		10.1074/jbc.M110.209965	http://dx.doi.org/10.1074/jbc.M110.209965			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454506	Green Published, hybrid			2022-12-27	WOS:000290301900030
J	Woldt, E; Matz, RL; Terrand, J; Mlih, M; Gracia, C; Foppolo, S; Martin, S; Bruban, V; Ji, J; Velot, E; Herz, J; Boucher, P				Woldt, Estelle; Matz, Rachel L.; Terrand, Jerome; Mlih, Mohamed; Gracia, Celine; Foppolo, Sophie; Martin, Sophie; Bruban, Veronique; Ji, Julie; Velot, Emilie; Herz, Joachim; Boucher, Philippe			Differential Signaling by Adaptor Molecules LRP1 and ShcA Regulates Adipogenesis by the Insulin-like Growth Factor-1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; LIPOPROTEIN RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; IGF-I; PHOSPHOINOSITIDE 3-KINASE; ADIPOCYTE DIFFERENTIATION; TYROSINE PHOSPHORYLATION; CYTOPLASMIC DOMAIN; UROKINASE RECEPTOR; PROTEIN LRP	The low density lipoprotein receptor-related protein (LRP1) is a transmembrane receptor that integrates multiple signaling pathways. Its cytoplasmic domain serves as docking sites for several adaptor proteins such as the Src homology 2/alpha-collagen (ShcA), which also binds to several tyrosine kinase receptors such as the insulin-like growth factor 1 (IGF-1) receptor. However, the physiological significance of the physical interaction between LRP1 and ShcA, and whether this interaction modifies tyrosine kinase receptor signaling, are still unknown. Here we report that LRP1 forms a complex with the IGF-1 receptor, and that LRP1 is required for ShcA to become sensitive to IGF-1 stimulation. Upon IGF-1 treatment, ShcA is tyrosine phosphorylated and translocates to the plasma membrane only in the presence of LRP1. This leads to the recruitment of the growth factor receptor-bound protein 2 (Grb2) to ShcA, and activation of the Ras/MAP kinase pathway. Conversely, in the absence of ShcA, IGF-1 signaling bifurcates toward the Akt/mammalian target of rapamycin pathway and accelerates adipocyte differentiation when cells are stimulated for adipogenesis. These results establish the LRP1-ShcA complex as an essential component in the IGF-1-regulated pathway for MAP kinase and Akt/mammalian target of rapamycin activation, and may help to understand the IGF-1 signaling shift from clonal expansion to growth-arrested cells and differentiation during adipogenesis.	[Woldt, Estelle; Matz, Rachel L.; Terrand, Jerome; Mlih, Mohamed; Gracia, Celine; Foppolo, Sophie; Martin, Sophie; Bruban, Veronique; Ji, Julie; Velot, Emilie; Boucher, Philippe] Univ Strasbourg, CNRS, UMR7213, F-67401 Illkirch Graffenstaden, France; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Texas System; University of Texas Southwestern Medical Center Dallas	Matz, RL (corresponding author), Univ Strasbourg, CNRS, UMR7213, F-67401 Illkirch Graffenstaden, France.	rachel.matz-westphal@unistra.fr; philippe.boucher@unistra.fr	martin, sophie/AAP-3498-2021; Velot, Emilie/P-6561-2019; Mlih, Mohamed/O-4834-2019	Velot, Emilie/0000-0001-8620-5696; Mlih, Mohamed/0000-0003-3491-9616; Gracia, Celine/0000-0002-3312-6465; Martin, Sophie/0000-0002-2907-7445; MATZ, Rachel/0000-0001-5832-7063; Terrand, jerome/0000-0002-8169-7713; Boucher, Philippe/0000-0002-3928-9812	National Institutes of Health; Centre National Pour la Recherche Scientifique (CNRS); Nouvelle Societe Francaise d'atherosclerose (NSFA); Fondation pour la Recherche Medicale (FRM); Fondation de France; Agence Nationale de la Recherche [ANR-06-Physio-032]; American Health Assistance Foundation; Humboldt Foundation [SFB780]; Consortium for Frontotemporal Dementia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre National Pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Nouvelle Societe Francaise d'atherosclerose (NSFA); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation de France(Fondation de France); Agence Nationale de la Recherche(French National Research Agency (ANR)); American Health Assistance Foundation; Humboldt Foundation(Alexander von Humboldt Foundation); Consortium for Frontotemporal Dementia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by grants from the National Institutes of Health (to J. H.), the Centre National Pour la Recherche Scientifique (CNRS), Nouvelle Societe Francaise d'atherosclerose (NSFA), Fondation pour la Recherche Medicale (FRM), Fondation de France, and Agence Nationale de la Recherche Grant ANR-06-Physio-032.; Supported by grants from the American Health Assistance Foundation, the Humboldt Foundation, SFB780, and the Consortium for Frontotemporal Dementia.	Barnes H, 2003, ONCOGENE, V22, P3589, DOI 10.1038/sj.onc.1206504; BLAIKIE P, 1994, J BIOL CHEM, V269, P32031; BONEY CM, 1994, ENDOCRINOLOGY, V135, P1863, DOI 10.1210/en.135.5.1863; Boney CM, 1998, ENDOCRINOLOGY, V139, P1638, DOI 10.1210/en.139.4.1638; Boney CM, 2000, MOL ENDOCRINOL, V14, P805, DOI 10.1210/me.14.6.805; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; CONESE M, 1995, J CELL BIOL, V131, P1609, DOI 10.1083/jcb.131.6.1609; CRAPARO A, 1995, J BIOL CHEM, V270, P15639, DOI 10.1074/jbc.270.26.15639; Dey BR, 1996, MOL ENDOCRINOL, V10, P631, DOI 10.1210/me.10.6.631; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Herz J, 2009, J LIPID RES, V50, pS287, DOI 10.1194/jlr.R800077-JLR200; Holzenberger M, 2001, ENDOCRINOLOGY, V142, P4469, DOI 10.1210/en.142.10.4469; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Laviola L, 2007, CURR PHARM DESIGN, V13, P663, DOI 10.2174/138161207780249146; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Mantuano E, 2010, J BIOL CHEM, V285, P14259, DOI 10.1074/jbc.M109.085126; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Pessin Jeffrey E., 1999, Endocrine Journal, V46, pS11, DOI 10.1507/endocrj.46.Suppl_S11; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; REICHMAN CT, 1992, CELL GROWTH DIFFER, V3, P451; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sakaue H, 1998, J BIOL CHEM, V273, P28945, DOI 10.1074/jbc.273.44.28945; Salani B, 2008, ENDOCRINOLOGY, V149, P461, DOI 10.1210/en.2007-0312; Scavo LM, 2004, J CLIN ENDOCR METAB, V89, P3543, DOI 10.1210/jc.2003-031682; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; STAHL A, 1995, J CELL BIOL, V129, P335, DOI 10.1083/jcb.129.2.335; Takayama Y, 2005, J BIOL CHEM, V280, P18504, DOI 10.1074/jbc.M410265200; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; TOMIYAMA K, 1995, BIOCHEM BIOPH RES CO, V212, P263, DOI 10.1006/bbrc.1995.1965; Webb DJ, 2000, J CELL SCI, V113, P123; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xia XM, 1999, J CELL PHYSIOL, V178, P9, DOI 10.1002/(SICI)1097-4652(199901)178:1<9::AID-JCP2>3.0.CO;2-#; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; YOKOTE K, 1994, J BIOL CHEM, V269, P15337; Yu WH, 2008, MOL CELL BIOCHEM, V310, P11, DOI 10.1007/s11010-007-9661-9; Zhang JC, 1998, J BIOL CHEM, V273, P32273, DOI 10.1074/jbc.273.48.32273; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006922	48	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16775	16782		10.1074/jbc.M110.212878	http://dx.doi.org/10.1074/jbc.M110.212878			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454706	Green Published, hybrid			2022-12-27	WOS:000290301900026
J	Jung, T; Gross, W; Zoller, M				Jung, Thorsten; Gross, Wolfgang; Zoeller, Margot			CD44v6 Coordinates Tumor Matrix-triggered Motility and Apoptosis Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; GROWTH-FACTOR; PLASMINOGEN-ACTIVATOR; EXTRACELLULAR-MATRIX; PREMETASTATIC NICHE; INVASIVE GROWTH; CARCINOMA-CELLS; RAT-TUMOR; HYALURONAN; CANCER	Tumor progression requires a crosstalk with the tumor surrounding, where the tumor matrix plays an essential role. We recently reported that only the matrix delivered by a CD44v6-competent (ASML(wt)), but not that of a CD44v6-deficient (ASML-CD44v(kd)) rat pancreatic adenocarcinoma line supports metastasis formation. We here describe that this matrix provides an important feedback toward the tumor cell and that CD44v6 accounts for orchestrating signals received from the matrix. ASML(wt) cells contain more hyaluronan synthase-3 and secrete higher amounts of > 50 kDa HA than ASML-CD44v(kd) cells, which secrete more hyaluronidase. Only the ASML(wt)-matrix supports migration and apoptosis resistance, which both can be initiated via CD44v6, c-Met, and alpha 6 beta 4 ligand binding and proceed via FAK, PI3K/Akt, and MAPK activation, respectively. However, c-Met-and alpha 6 beta 4-initiated signaling are strongly augmented by the association with CD44v6 as only very weak effects are observed in CD44v6-deficient cells. The same CD44v6-dependent convergence of motility-and apoptosis resistance-related signals also accounts for human tumor lines. Thus, CD44v6 promotes motility and apoptosis resistance via its involvement in assembling a matrix that, in turn, triggers activation of signaling cascades, which proceeds, independent of the initiating receptor-ligand interaction, in a concerted action via CD44v6.	[Jung, Thorsten; Zoeller, Margot] Univ Hosp Surg, Dept Tumor Cell Biol, D-69120 Heidelberg, Germany; [Gross, Wolfgang] Heidelberg Univ, Dept Expt Surg, D-69120 Heidelberg, Germany; [Zoeller, Margot] German Canc Res Ctr, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Zoller, M (corresponding author), Univ Hosp Surg, Dept Tumor Cell Biol, Neuenheimer Feld 365, D-69120 Heidelberg, Germany.	margot.zoeller@uni-heidelberg.de		Gross, Wolfgang/0000-0002-5431-7594	DFG [SPP1190]; NCT	DFG(German Research Foundation (DFG)); NCT	This work was supported by the DFG/SPP1190 and NCT (to M. Z.).	Adamia Sophia, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P3, DOI 10.2174/1568006053005056; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; Berdiaki A, 2009, BBA-GEN SUBJECTS, V1790, P1258, DOI 10.1016/j.bbagen.2009.06.013; Bertotti A, 2003, TRENDS BIOCHEM SCI, V28, P527, DOI 10.1016/j.tibs.2003.09.001; Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bourguignon LYW, 2001, J MAMMARY GLAND BIOL, V6, P287, DOI 10.1023/A:1011371523994; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; da Costa CA, 2007, CURR MOL MED, V7, P650, DOI 10.2174/156652407782564426; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Fjeldstad K, 2005, CURR DRUG TARGETS, V6, P665, DOI 10.2174/1389450054863662; Foger N, 2000, EUR J IMMUNOL, V30, P2888; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Girish KS, 2007, LIFE SCI, V80, P1921, DOI 10.1016/j.lfs.2007.02.037; Gobom J, 2001, ANAL CHEM, V73, P434, DOI 10.1021/ac001241s; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hill A, 2006, CANCER LETT, V237, P1, DOI 10.1016/j.canlet.2005.05.006; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Jung T, 2009, NEOPLASIA, V11, P1093, DOI 10.1593/neo.09822; Klingbeil P, 2009, MOL CANCER RES, V7, P168, DOI 10.1158/1541-7786.MCR-08-0207; Klosek SK, 2009, BIOCHEM BIOPH RES CO, V379, P1097, DOI 10.1016/j.bbrc.2009.01.023; Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82; Kobayashi H, 2002, INT J CANCER, V102, P379, DOI 10.1002/ijc.10710; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Kuhn NZ, 2010, J CELL PHYSIOL, V222, P268, DOI 10.1002/jcp.21940; Lamontagne CA, 2008, EXP CELL RES, V314, P227, DOI 10.1016/j.yexcr.2007.07.013; Lee KH, 2008, CLIN EXP METASTAS, V25, P89, DOI 10.1007/s10585-007-9106-6; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lynch CC, 2007, CANCER RES, V67, P6760, DOI 10.1158/0008-5472.CAN-07-0026; Marhaba R, 2004, J MOL HISTOL, V35, P211; MATZKU S, 1983, INVAS METAST, V3, P109; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Nie Daotai, 2010, Front Biosci (Schol Ed), V2, P184; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Orian-Rousseau W, 2007, MOL BIOL CELL, V18, P76, DOI 10.1091/mbc.E06-08-0674; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pucci S, 2009, ADV CANCER RES, V105, P93, DOI 10.1016/S0065-230X(09)05006-4; RUDY W, 1993, CANCER RES, V53, P1262; Sercu S, 2008, CANCER INVEST, V26, P375, DOI 10.1080/07357900701788148; Sherman L, 1998, GENE DEV, V12, P1058, DOI 10.1101/gad.12.7.1058; STERN M, 1992, MATRIX, V12, P397, DOI 10.1016/S0934-8832(11)80036-3; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Stern R, 2008, SEMIN CANCER BIOL, V18, P238, DOI 10.1016/j.semcancer.2008.03.014; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Tsang TY, 2008, APOPTOSIS, V13, P1135, DOI 10.1007/s10495-008-0241-6; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Tsukita S, 1997, TRENDS BIOCHEM SCI, V22, P53, DOI 10.1016/S0968-0004(96)10071-2; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; van der Voort R, 1999, J BIOL CHEM, V274, P6499, DOI 10.1074/jbc.274.10.6499; Wai PY, 2008, CANCER METAST REV, V27, P103, DOI 10.1007/s10555-007-9104-9; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yu Q, 2004, CLIN EXP METASTAS, V21, P235, DOI 10.1023/B:CLIN.0000037705.25256.d3; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	70	63	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.208421	http://dx.doi.org/10.1074/jbc.M110.208421			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21372142	Green Published, hybrid			2022-12-27	WOS:000290022800027
J	Sucic, S; El-Kasaby, A; Kudlacek, O; Sarker, S; Sitte, HH; Marin, P; Freissmuth, M				Sucic, Sonja; El-Kasaby, Ali; Kudlacek, Oliver; Sarker, Subhodeep; Sitte, Harald H.; Marin, Philippe; Freissmuth, Michael			The Serotonin Transporter Is an Exclusive Client of the Coat Protein Complex II (COPII) Component SEC24C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; GABA TRANSPORTER-1; CELL-LINE; FUNCTIONAL EXPRESSION; DOPAMINE TRANSPORTER; OLIGOMER FORMATION; C-TERMINUS; EXPORT; TRAFFICKING; GENE	The transporters for serotonin (SERT), dopamine, and noradrenaline have a conserved hydrophobic core but divergent N and C termini. The C terminus harbors the binding site for the coat protein complex II (COPII) cargo-binding protein SEC24. Here we explored which SEC24 isoform was required for export of SERT from the endoplasmic reticulum (ER). Three lines of evidence argue that SERT can only exit the ER by recruiting SEC24C: (i) Mass spectrometry showed that a peptide corresponding to the C terminus of SERT recruited SEC24C-containing COPII complexes from mouse brain lysates. (ii) Depletion of individual SEC24 isoforms by siRNAs revealed that SERT was trapped in the ER only if SEC24C was down-regulated, in both, cells that expressed SERT endogenously or after transfection. The combination of all siRNAs was not more effective than that directed against SEC24C. ASERT mutant in which the SEC24C-binding motif ((RI608)-R-607) was replaced by alanine was insensitive to down-regulation of SEC24C levels. (iii) Overexpression of a SEC24C variant with a mutation in the candidate cargo-binding motif (SEC24C-D796V/D797N) but not of the corresponding mutant SEC24D-D733V/D734N reduced SERT surface levels. In contrast, noradrenaline and dopamine transporters and the more distantly related GABA transporter 1 relied on SEC24D for ER export. These observations demonstrate that closely related transporters are exclusive client cargo proteins for different SEC24 isoforms. The short promoter polymorphism results in reduced SERT cell surface levels and renders affected individuals more susceptible to depression. By inference, variations in the Sec24C gene may also affect SERT cell surface levels and thus be linked to mood disorders.	[Sucic, Sonja; El-Kasaby, Ali; Kudlacek, Oliver; Sarker, Subhodeep; Sitte, Harald H.; Freissmuth, Michael] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [El-Kasaby, Ali] Mansoura Univ, Fac Vet Med, Dept Pharmacol, Mansoura, Egypt; [Marin, Philippe] Univ Montpellier 1, INSERM U661, CNRS UMR 5203, Inst Genom Fonct, Montpellier 5, France; [Marin, Philippe] Univ Montpellier 2, INSERM U661, CNRS UMR 5203, Inst Genom Fonct, Montpellier 5, France	Medical University of Vienna; Egyptian Knowledge Bank (EKB); Mansoura University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Freissmuth, M (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringer Str 13A, A-1090 Vienna, Austria.	michael.freissmuth@meduniwien.ac.at	Sitte, Harald/N-2681-2013; Sitte, Harald/O-7025-2019	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Sucic, Sonja/0000-0001-5136-8022; Freissmuth, Michael/0000-0001-9398-1765; Kudlacek, Oliver/0000-0002-3086-8551; Sarker, Subhodeep/0000-0002-2222-2072	Austrian Science Fund/Fonds zur Forderung der Wissenschaftlichen Forschung [SFB35]; Egyptian Ministry of Higher Education and State for Scientific Research; Austrian Science Fund (FWF) [F 3506] Funding Source: researchfish	Austrian Science Fund/Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Egyptian Ministry of Higher Education and State for Scientific Research(Ministry of Higher Education & Scientific Research (MHESR)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Project Program Grant SFB35 from the Austrian Science Fund/Fonds zur Forderung der Wissenschaftlichen Forschung (to M. F.), and a stipend (to A. E.-K.) from Egyptian Ministry of Higher Education and State for Scientific Research.	Bartolomucci A, 2010, DIS MODEL MECH, V3, P459, DOI 10.1242/dmm.004614; Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; COOL DR, 1991, J BIOL CHEM, V266, P15750; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; El-Kasaby A, 2010, J BIOL CHEM, V285, P39201, DOI 10.1074/jbc.M110.118000; Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200; Farhan H, 2008, J CELL SCI, V121, P753, DOI 10.1242/jcs.017681; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Fernandez-Sanchez E, 2008, BIOCHEM J, V409, P669, DOI 10.1042/BJ20070533; Hahn MK, 2003, J NEUROSCI, V23, P4470; Karg K., 2011, ARCH GEN PS IN PRESS; KING SC, 1992, BIOCHEM BIOPH RES CO, V183, P487, DOI 10.1016/0006-291X(92)90508-I; Larsen MB, 2006, BIOCHEMISTRY-US, V45, P1331, DOI 10.1021/bi0508688; Lesch K. P., 2011, CURR TOP BE IN PRESS; Li YL, 2007, J NEUROSCI RES, V85, P2601, DOI 10.1002/jnr.21216; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Ohisa S, 2010, DEV BIOL, V342, P85, DOI 10.1016/j.ydbio.2010.03.016; Qi YP, 1997, J NEUROSCI, V17, P1217; Reiterer V, 2008, J NEUROSCI, V28, P12453, DOI 10.1523/JNEUROSCI.3451-08.2008; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siddiqi S, 2010, J LIPID RES, V51, P1093, DOI 10.1194/jlr.M002758; Sitte HH, 2003, EUR J PHARMACOL, V479, P229, DOI 10.1016/j.ejphar.2003.08.072; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Wansleeben C, 2010, DEVELOPMENT, V137, P1067, DOI 10.1242/dev.041434; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Yamayoshi S, 2008, CELL HOST MICROBE, V3, P168, DOI 10.1016/j.chom.2008.02.001; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	35	60	60	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.230037	http://dx.doi.org/10.1074/jbc.M111.230037			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454670	hybrid, Green Published			2022-12-27	WOS:000290022800085
J	Dongre, M; Singh, NS; Dureja, C; Peddada, N; Solanki, AK; Ashish; Raychaudhuri, S				Dongre, Mitesh; Singh, Naorem Santa; Dureja, Chetna; Peddada, Nagesh; Solanki, Ashish K.; Ashish; Raychaudhuri, Saumya			Evidence on How a Conserved Glycine in the Hinge Region of HapR Regulates Its DNA Binding Ability LESSONS FROM A NATURAL VARIANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; VIBRIO-CHOLERAE; PROTEIN; RESOLUTION; RECEPTOR; HARVEYI	HapR has been recognized as a quorum-sensing master regulator in Vibrio cholerae. Because it controls a plethora of disparate cellular events, the absence of a functional HapR affects the physiology of V. cholerae to a great extent. In the current study, we pursued an understanding of an observation of a natural protease-deficient non-O1, non-O139 variant V. cholerae strain V2. Intriguingly, a nonfunctional HapR (henceforth designated as HapR(V2)) harboring a substitution of glycine to aspartate at position 39 of the N-terminal hinge region has been identified. An in vitro gel shift assay clearly suggested the inability of HapR(V2) to interact with various cognate promoters. Reinstatement of glycine at position 39 restores DNA binding ability of HapR(V2) (HapR(V2G)), thereby rescuing the protease-negative phenotype of this strain. The elution profile of HapR(V2) and HapR(V2G) proteins in size-exclusion chromatography and their circular dichroism spectra did not reflect any significant differences to explain the functional discrepancies between the two proteins. To gain insight into the structure-function relationship of these two proteins, we acquired small/wide angle x-ray scattering data from samples of the native and G39D mutant. Although Guinier analysis and indirect Fourier transformation of scattering indicated only a slight difference in the shape parameters, structure reconstruction using dummy amino acids concluded that although HapR adopts a "Y" shape similar to its crystal structure, the G39D mutation in hinge drastically altered the DNA binding domains by bringing them in close proximity. This altered spatial orientation of the helix-turn-helix domains in this natural variant provides the first structural evidence on the functional role of the hinge region in quorum sensing-related DNA-binding regulatory proteins of Vibrio spp.	[Dongre, Mitesh; Singh, Naorem Santa; Dureja, Chetna; Peddada, Nagesh; Solanki, Ashish K.; Ashish; Raychaudhuri, Saumya] CSIR, Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Ashish (corresponding author), CSIR, Inst Microbial Technol, Sector 39A, Chandigarh 160036, India.	ashgang@imtech.res.in; saumya@rocketmail.com	Peddada, Nagesh/L-6760-2019; Raychaudhuri, Saumya/AFL-0368-2022; Solanki, Ashish K/F-5210-2017	Solanki, Ashish K/0000-0002-5043-1699; dongre, mitesh/0000-0002-7151-1137; Peddada, Nagesh/0000-0003-4033-7305	Council of Scientific and Industrial Research India; Department of Biotechnology [BT/PR6918/BRB/10/454/2005]; Supra Institutional Project [SIP-10/IMTECH/CSIR]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; Council of Scientific and Industrial Research and Department of Biotechnology, India	Council of Scientific and Industrial Research India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; Supra Institutional Project; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Council of Scientific and Industrial Research and Department of Biotechnology, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the grants from the Council of Scientific and Industrial Research India, Department of Biotechnology Grant BT/PR6918/BRB/10/454/2005 and Supra Institutional Project SIP-10/IMTECH/CSIR. Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886.; Supported by Council of Scientific and Industrial Research and Department of Biotechnology, India, research fellowships.	De Silva RS, 2007, J BACTERIOL, V189, P5683, DOI 10.1128/JB.01807-06; Glatter O., 1982, SMALL ANGLE XRAY SCA; Griese JJ, 2010, NUCLEIC ACIDS RES, V38, P3454, DOI 10.1093/nar/gkq038; Haelens A, 2007, CANCER RES, V67, P4514, DOI 10.1158/0008-5472.CAN-06-1701; Ishikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006734; Joelsson A, 2006, INFECT IMMUN, V74, P1141, DOI 10.1128/IAI.74.2.1141-1147.2006; Joelsson A, 2007, APPL ENVIRON MICROB, V73, P3742, DOI 10.1128/AEM.02804-06; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; LITTLE JW, 1985, P NATL ACAD SCI USA, V82, P2301, DOI 10.1073/pnas.82.8.2301; Matz C, 2005, P NATL ACAD SCI USA, V102, P16819, DOI 10.1073/pnas.0505350102; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Raychaudhuri S, 2006, GENE, V369, P126, DOI 10.1016/j.gene.2005.10.031; Silva AJ, 2004, J BACTERIOL, V186, P6374, DOI 10.1128/JB.186.19.6374-6382.2004; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tsou AM, 2009, NUCLEIC ACIDS RES, V37, P2747, DOI 10.1093/nar/gkp121; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	21	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15043	15049		10.1074/jbc.M110.209346	http://dx.doi.org/10.1074/jbc.M110.209346			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21383015	hybrid, Green Published			2022-12-27	WOS:000289788300034
J	Yang, Z; Cooper, PR; Damera, G; Mukhopadhyay, I; Cho, H; Kehrl, JH; Panettieri, RA; Druey, KM				Yang, Zhao; Cooper, Philip R.; Damera, Gautam; Mukhopadhyay, Indranil; Cho, Hyeseon; Kehrl, John H.; Panettieri, Reynold A., Jr.; Druey, Kirk M.			beta-Agonist-associated Reduction in RGS5 Expression Promotes Airway Smooth Muscle Hyper-responsiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY BETA(2)-ADRENOCEPTOR DESENSITIZATION; DOWN-REGULATION; BLOOD-PRESSURE; PROTEIN; RECEPTORS; G(I); REGULATORS; ASTHMA; ENDOTHELIN-1; HYPERTROPHY	Although short-acting and long-acting inhaled beta(2)-adrenergic receptor agonists (SABA and LABA, respectively) relieve asthma symptoms, use of either agent alone without concomitant anti-inflammatory drugs (corticosteroids) may increase the risk of disease exacerbation in some patients. We found previously that pretreatment of human precision-cut lung slices (PCLS) with SABA impaired subsequent beta(2)-agonist-induced bronchodilation, which occurred independently of changes in receptor quantities. Here we provide evidence that prolonged exposure of cultured human airway smooth muscle (HuASM) cells to beta(2)-agonists directly augments procontractile signaling pathways elicited by several compounds including thrombin, bradykinin, and histamine. Such treatment did not increase surface receptor amounts or expression of G proteins and downstream effectors (phospholipase C beta and myosin light chain). In contrast, beta-agonists decreased expression of regulator of G protein signaling 5 (RGS5), which is an inhibitor of G-protein-coupled receptor (GPCR) activity. RGS5 knockdown in HuASM increased agonist-evoked intracellular calcium flux and myosin light chain (MLC) phosphorylation, which are prerequisites for contraction. PCLS from Rgs5(-/-) mice contracted more to carbachol than those from WT mice, indicating that RGS5 negatively regulates bronchial smooth muscle contraction. Repetitive beta(2)-agonist use may not only lead to reduced bronchoprotection but also to sensitization of excitation-contraction signaling pathways as a result of reduced RGS5 expression.	[Yang, Zhao; Mukhopadhyay, Indranil; Druey, Kirk M.] NIAID, Mol Signal Transduct Sect, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA; [Cho, Hyeseon; Kehrl, John H.] NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Cooper, Philip R.; Damera, Gautam; Panettieri, Reynold A., Jr.] Univ Penn, Pulm Allergy & Crit Care Div, Airways Biol Initiat, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania	Druey, KM (corresponding author), 10 Ctr Dr,Rm 11N242, Bethesda, MD 20892 USA.	kdruey@niaid.nih.gov	panettieri, reynold/AAG-9485-2019; Kehrl, John/AAE-6292-2019; Yang, Zhiyong/E-7834-2013	Seefeldt, Lance/0000-0002-6457-9504; Yang, Zhiyong/0000-0001-8186-9450; Kehrl, John/0000-0002-6526-159X	National Institutes of Health, NIAID [AI000939];  [HL5452235];  [HL543102];  [HL544157]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000939, Z01AI000939] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, NIAID (Grant No. AI000939 L. A. D., to K. M. D.) and by Grants HL5452235, HL543102, and HL544157 (to R. A. P.).	Agrawal DK, 2004, J ALLERGY CLIN IMMUN, V113, P503, DOI 10.1016/j.jaci.2003.12.039; Bai Y, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-34; Bansal G, 2008, J IMMUNOL, V181, P7882, DOI 10.4049/jimmunol.181.11.7882; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Bentley J Kelley, 2008, Proc Am Thorac Soc, V5, P89, DOI 10.1513/pats.200705-063VS; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Billington CK, 2003, RESP RES, V4; Black JL, 2009, CHEST, V136, P1095, DOI 10.1378/chest.09-0354; Borchers MT, 2003, AM J PHYSIOL-LUNG C, V285, pL114, DOI 10.1152/ajplung.00322.2002; Broadley KJ, 2006, EUR J PHARMACOL, V533, P15, DOI 10.1016/j.ejphar.2005.12.060; Chen CH, 1997, J BIOL CHEM, V272, P8679, DOI 10.1074/jbc.272.13.8679; Cho H, 2003, FASEB J, V17, P440, DOI 10.1096/fj.02-0340fje; Cho H, 2008, MOL CELL BIOL, V28, P2590, DOI 10.1128/MCB.01889-07; Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; Cooper PR, 2009, PULM PHARMACOL THER, V22, P398, DOI 10.1016/j.pupt.2008.09.008; Cooper PR, 2008, J ALLERGY CLIN IMMUN, V122, P734, DOI 10.1016/j.jaci.2008.07.040; Cooper PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010235; Damera G, 2009, BRIT J PHARMACOL, V158, P1429, DOI 10.1111/j.1476-5381.2009.00428.x; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Faisy C, 2006, AM J RESP CELL MOL, V34, P410, DOI 10.1165/rcmb.2005-0091OC; Finney PA, 2000, J CLIN INVEST, V106, P125, DOI 10.1172/JCI8374; Finney PA, 2001, BRIT J PHARMACOL, V132, P1261, DOI 10.1038/sj.bjp.0703946; Gu S, 2009, CLIN SCI, V116, P391, DOI 10.1042/CS20080272; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hershenson MB, 2008, ANNU REV PATHOL-MECH, V3, P523, DOI 10.1146/annurev.pathmechdis.1.110304.100213; Hu AH, 2008, AM J PHYSIOL-LUNG C, V294, pL1055, DOI 10.1152/ajplung.00021.2008; Huang CF, 1997, P NATL ACAD SCI USA, V94, P6159, DOI 10.1073/pnas.94.12.6159; Huang XY, 2006, MOL CELL BIOL, V26, P6870, DOI 10.1128/MCB.00314-06; Kehrl JH, 2004, CRIT REV IMMUNOL, V24, P409; Kehrl JH, 2002, INT J BIOCHEM CELL B, V34, P432, DOI 10.1016/S1357-2725(01)00141-8; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Mak JCW, 2000, MOL PHARMACOL, V57, P857; McCoy KL, 2009, PROG MOL BIOL TRANSL, V86, P49, DOI 10.1016/S1877-1173(09)86003-1; McGraw DW, 2007, J CLIN INVEST, V117, P1391, DOI 10.1172/JCI30489; McGraw DW, 2006, PHYSIOL GENOMICS, V27, P171, DOI 10.1152/physiolgenomics.00044.2006; McGraw DW, 2003, J CLIN INVEST, V112, P619, DOI 10.1172/JCI200318193; Meurs H, 2008, EUR RESPIR J, V32, P487, DOI 10.1183/09031936.00023608; Misior AM, 2009, AM J RESP CELL MOL, V41, P24, DOI 10.1165/rcmb.2008-0266OC; Munakata Mitsuru, 2006, Allergol Int, V55, P235, DOI 10.2332/allergolint.55.235; Nguyen LP, 2009, P NATL ACAD SCI USA, V106, P2435, DOI 10.1073/pnas.0810902106; Nino G, 2010, J ALLERGY CLIN IMMUN, V125, P1020, DOI 10.1016/j.jaci.2010.02.007; Nino G, 2009, AM J PHYSIOL-LUNG C, V297, pL746, DOI 10.1152/ajplung.00079.2009; Nunn C, 2010, CELL SIGNAL, V22, P1231, DOI 10.1016/j.cellsig.2010.03.015; Penn Raymond B, 2008, Proc Am Thorac Soc, V5, P47, DOI 10.1513/pats.200705-054VS; Penn RB, 2009, P NATL ACAD SCI USA, V106, P2095, DOI 10.1073/pnas.0812935106; Scheschonka A, 2000, MOL PHARMACOL, V58, P719, DOI 10.1124/mol.58.4.719; Seki N, 1998, J HUM GENET, V43, P202, DOI 10.1007/s100380050071; Snabaitis AK, 2005, CELL SIGNAL, V17, P655, DOI 10.1016/j.cellsig.2004.10.008; Song KS, 2009, AM J PHYSIOL-LUNG C, V296, pL684, DOI 10.1152/ajplung.90396.2008; Tovey SC, 2010, J BIOL CHEM, V285, P12979, DOI 10.1074/jbc.M109.096016; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005	54	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11444	11455		10.1074/jbc.M110.212480	http://dx.doi.org/10.1074/jbc.M110.212480			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21454640	Green Published, hybrid			2022-12-27	WOS:000288797100056
